PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Basile, LA; Ellefson, D; Gluzman-Poltorak, Z; Junes-Gill, K; Mar, V; Mendonca, S; Miller, JD; Tom, J; Trinh, A; Gallaher, TK				Basile, Lena A.; Ellefson, Dolph; Gluzman-Poltorak, Zoya; Junes-Gill, Katiana; Mar, Vernon; Mendonca, Sarita; Miller, Joseph D.; Tom, Jamie; Trinh, Alice; Gallaher, Timothy K.			HemaMax (TM), a Recombinant Human Interleukin-12, Is a Potent Mitigator of Acute Radiation Injury in Mice and Non-Human Primates	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; NATURAL-KILLER-CELLS; INTERFERON-GAMMA; DOSE INTERLEUKIN-12; GROWTH-FACTOR; BONE-MARROW; PHASE-I; ERYTHROPOIETIN; IL-12; CYTOKINE	HemaMax, a recombinant human interleukin-12 (IL-12), is under development to address an unmet medical need for effective treatments against acute radiation syndrome due to radiological terrorism or accident when administered at least 24 hours after radiation exposure. This study investigated pharmacokinetics, pharmacodynamics, and efficacy of m-HemaMax (recombinant murine IL-12), and HemaMax to increase survival after total body irradiation (TBI) in mice and rhesus monkeys, respectively, with no supportive care. In mice, m-HemaMax at an optimal 20 ng/mouse dose significantly increased percent survival and survival time when administered 24 hours after TBI between 8-9 Gy (p<0.05 Pearson's chi-square test). This survival benefit was accompanied by increases in plasma interferon-gamma (IFN-gamma) and erythropoietin levels, recovery of femoral bone hematopoiesis characterized with the presence of IL-12 receptor beta(2) subunit-expressing myeloid progenitors, megakaryocytes, and osteoblasts. Mitigation of jejunal radiation damage was also examined. At allometrically equivalent doses, HemaMax showed similar pharmacokinetics in rhesus monkeys compared to m-HemaMax in mice, but more robustly increased plasma IFN-gamma levels. HemaMax also increased plasma erythropoietin, IL-15, IL-18, and neopterin levels. At non-human primate doses pharmacologically equivalent to murine doses, HemaMax (100 ng/Kg and 250 ng/Kg) administered at 24 hours after TBI (6.7 Gy/LD50/30) significantly increased percent survival of HemaMax groups compared to vehicle (p<0.05 Pearson's chi-square test). This survival benefit was accompanied by a significantly higher leukocyte (neutrophils and lymphocytes), thrombocyte, and reticulocyte counts during nadir (days 12-14) and significantly less weight loss at day 12 compared to vehicle. These findings indicate successful interspecies dose conversion and provide proof of concept that HemaMax increases survival in irradiated rhesus monkeys by promoting hematopoiesis and recovery of immune functions and possibly gastrointestinal functions, likely through a network of interactions involving dendritic cells, osteoblasts, and soluble factors such as IL-12, IFN-gamma, and cytoprotectant erythropoietin.	[Basile, Lena A.; Ellefson, Dolph; Gluzman-Poltorak, Zoya; Junes-Gill, Katiana; Mar, Vernon; Mendonca, Sarita; Tom, Jamie; Trinh, Alice; Gallaher, Timothy K.] Neumedicines Inc, Pasadena, CA USA; [Miller, Joseph D.] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90033 USA	University of Southern California	Basile, LA (corresponding author), Neumedicines Inc, Pasadena, CA USA.	basile@neumedicines.com	Wilson, Matthew H/K-3193-2013		Biomedical Advanced Research and Development Authority [HHS0100200800060C]	Biomedical Advanced Research and Development Authority	This study was funded with a contract from the Biomedical Advanced Research and Development Authority (Contract No. HHS0100200800060C). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 1999, STEM CELLS, V17, P92, DOI 10.1002/stem.170092; Akimoto T, 2000, KIDNEY INT, V58, P269, DOI 10.1046/j.1523-1755.2000.00162.x; ANAGNOSTOU A, 1994, P NATL ACAD SCI USA, V91, P3974, DOI 10.1073/pnas.91.9.3974; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Basile LA, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-26; Bekaii-Saab TS, 2009, MOL CANCER THER, V8, P2983, DOI 10.1158/1535-7163.MCT-09-0820; BELLONE G, 1994, J IMMUNOL, V153, P930; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; BROXMEYER HE, 1983, J IMMUNOL, V131, P1300; Buemi M, 2003, J NEUROPATH EXP NEUR, V62, P228, DOI 10.1093/jnen/62.3.228; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Cetin H, 2007, CLIN EXP PHARMACOL P, V34, P1181, DOI 10.1111/j.1440-1681.2007.04695.x; Chao NJ, 2007, EXP HEMATOL, V35, P24, DOI 10.1016/j.exphem.2007.01.008; Chen BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011056; Chen TC, 2007, EXP HEMATOL, V35, P203, DOI 10.1016/j.exphem.2006.10.002; Chong ZZ, 2002, CIRCULATION, V106, P2973, DOI 10.1161/01.CIR.0000039103.58920.1F; Chong ZZ, 2002, J CEREBR BLOOD F MET, V22, P503, DOI 10.1097/00004647-200205000-00001; Colombo MP, 2002, CYTOKINE GROWTH F R, V13, P155, DOI 10.1016/S1359-6101(01)00032-6; de Barros APDN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009093; Dinarello CA, 2003, J INFECT DIS, V187, pS370, DOI 10.1086/374751; Dominici M, 2009, BLOOD, V114, P2333, DOI 10.1182/blood-2008-10-183459; Donnelly EH, 2010, SOUTH MED J, V103, P541, DOI 10.1097/SMJ.0b013e3181ddd571; Drouet M, 2010, INT J RADIAT BIOL, V86, P636, DOI 10.3109/09553001003789604; Dumont F, 2010, EXPERT OPIN THER PAT, V20, P73, DOI 10.1517/13543770903490429; FRASER JK, 1989, EXP HEMATOL, V17, P10; FUCHS D, 1988, IMMUNOL TODAY, V9, P150, DOI 10.1016/0167-5699(88)91203-0; Garcia MI, 2009, DEV BIOL, V331, P58, DOI 10.1016/j.ydbio.2009.04.020; Gattoni A, 2006, Clin Ter, V157, P377; Genc S, 2002, NEUROSCI LETT, V321, P73, DOI 10.1016/S0304-3940(02)00041-1; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; GIMBLE JM, 1993, EXP HEMATOL, V21, P224; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; Hamada T, 1998, J EXP MED, V188, P539, DOI 10.1084/jem.188.3.539; Herodin F, 2005, EXP HEMATOL, V33, P1071, DOI 10.1016/j.exphem.2005.04.007; HIRAYAMA F, 1994, BLOOD, V83, P92; Hodohara K, 2000, BLOOD, V95, P769, DOI 10.1182/blood.V95.3.769.003a49_769_775; JACOBSEN SEW, 1993, J EXP MED, V178, P413, DOI 10.1084/jem.178.2.413; Jaquet K, 2002, MICROVASC RES, V64, P326, DOI 10.1006/mvre.2002.2426; Johnson SM, 2010, J CLIN INVEST, V120, P2528, DOI 10.1172/JCI41402; Kiel MJ, 2006, IMMUNITY, V25, P862, DOI 10.1016/j.immuni.2006.11.005; Kumral A, 2005, BIOL NEONATE, V87, P15, DOI 10.1159/000080490; Kurz K, 2010, IMMUNOBIOLOGY, V215, P452, DOI 10.1016/j.imbio.2009.08.007; Lacy MQ, 2009, LEUKEMIA RES, V33, P1485, DOI 10.1016/j.leukres.2009.01.020; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Lenzi R, 2002, CLIN CANCER RES, V8, P3686; Lenzi R, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-66; Leonard JP, 1997, BLOOD, V90, P2541; Lifshitz L, 2009, MOL IMMUNOL, V46, P713, DOI 10.1016/j.molimm.2008.10.004; Little RF, 2007, BLOOD, V110, P4165, DOI 10.1182/blood-2007-06-097568; Liu J, 2006, GLIA, V53, P360, DOI 10.1002/glia.20289; Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002; Macdougall IC, 2002, NEPHROL DIAL TRANSPL, V17, P39, DOI 10.1093/ndt/17.suppl_11.39; MEANS RT, 1991, BLOOD, V78, P2564; Melichar B, 2003, J IMMUNOTHER, V26, P270, DOI 10.1097/00002371-200305000-00010; Morceau F, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/405016; Nakanishi K, 2001, CYTOKINE GROWTH F R, V12, P53, DOI 10.1016/S1359-6101(00)00015-0; NETA R, 1994, J IMMUNOL, V153, P4230; Parsa CJ, 2003, J CLIN INVEST, V112, P999, DOI 10.1172/JCI200318200; PLOEMACHER RE, 1993, LEUKEMIA, V7, P1381; PLOEMACHER RE, 1993, LEUKEMIA, V7, P1374; Sagiv SP, 2008, EXP HEMATOL, V36, P1682, DOI 10.1016/j.exphem.2008.07.010; Savino R, 2004, CELL DEATH DIFFER, V11, pS2, DOI 10.1038/sj.cdd.4401469; Sela S, 2001, NEPHRON, V88, P205, DOI 10.1159/000045991; Singh VK, 2005, EXP MOL PATHOL, V78, P156, DOI 10.1016/j.yexmp.2004.10.003; Stonier SW, 2010, IMMUNOL LETT, V127, P85, DOI 10.1016/j.imlet.2009.09.009; TERRELL TG, 1993, INT REV EXP PATHOL, V34, P73; Trinchieri G, 1998, ADV IMMUNOL, V70, P83, DOI 10.1016/S0065-2776(08)60387-9; U.S. Food and Drug Administration. Center for Drug Evaluation and Research, 2005, FDA GUID EST MAX SAF; Varma TK, 2002, CLIN DIAGN LAB IMMUN, V9, P530, DOI 10.1128/CDLI.9.3.530-543.2002; Vijay-Kumar M, 2008, J IMMUNOL, V180, P8280, DOI 10.4049/jimmunol.180.12.8280; Wang JF, 1998, BLOOD, V92, P756, DOI 10.1182/blood.V92.3.756.415k36_756_764; Wang ZY, 2009, FREE RADICAL BIO MED, V46, P1032, DOI 10.1016/j.freeradbiomed.2008.11.027; Weiss JF, 2009, INT J RADIAT BIOL, V85, P539, DOI 10.1080/09553000902985144; WERNER ER, 1990, J BIOL CHEM, V265, P3189; Williams JP, 2010, RADIAT RES, V173, P557, DOI 10.1667/RR1880.1; Yuan RR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001924; Zhang S, 2008, BIOCHEM BIOPH RES CO, V372, P509, DOI 10.1016/j.bbrc.2008.05.081; Zhao X, 2010, STEM CELLS, V28, P122, DOI 10.1002/stem.252; ZOU JJ, 1995, J BIOL CHEM, V270, P5864, DOI 10.1074/jbc.270.11.5864; ZOUMBOS NC, 1984, J IMMUNOL, V133, P769	81	45	52	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e30434	10.1371/journal.pone.0030434	http://dx.doi.org/10.1371/journal.pone.0030434			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22383962	Green Published, Green Submitted, gold			2022-12-27	WOS:000302916800004
J	Kozak, LP; Koza, RA; Anunciado-Koza, R; Mendoza, T; Newman, S				Kozak, Leslie P.; Koza, Robert A.; Anunciado-Koza, Rea; Mendoza, Tamra; Newman, Susan			Inherent Plasticity of Brown Adipogenesis in White Fat of Mice Allows for Recovery from Effects of Post-Natal Malnutrition	PLOS ONE			English	Article							DIET-INDUCED OBESITY; MITOCHONDRIAL UNCOUPLING PROTEIN; ADIPOSE-TISSUE; INDUCED THERMOGENESIS; GENE-EXPRESSION; ENERGY-BALANCE; UCP1; ADIPOCYTES; INDUCTION; MUSCLE	Interscapular brown adipose tissue (iBAT) is formed during fetal development and stable for the life span of the mouse. In addition, brown adipocytes also appear in white fat depots (wBAT) between 10 and 21 days of age in mice maintained at a room temperature of 23 degrees C. However, this expression is transient. By 60 days of age the brown adipocytes have disappeared, but they can re-emerge if the adult mouse is exposed to the cold (5 degrees C) or treated with beta 3-adrenergic agonists. Since the number of brown adipocytes that can be induced in white fat influences the capacity of the mouse to resist the obese state, we determined the effects of the nutritional conditions on post-natal development (birth to 21 days) of wBAT and its long-term effects on diet-induced obesity (DIO). Under-nutrition caused essentially complete suppression of wBAT in inguinal fat at 21 days of age, as indicated by expression of Ucp1 and genes of mitochondrial structure and function based upon microarray and qRT-PCR analysis, whereas over-nutrition had no discernible effects on wBAT induction. Surprisingly, the suppression of wBAT at 21 days of age did not affect DIO in adult mice maintained at 23 degrees C, nor did it affect the reduction in obesity or cold tolerance when DIO mice were exposed to the cold at 5 degrees C for one week. Gene expression analysis indicated that mice raised under conditions that suppressed wBAT at 21 days of age were able to normally induce wBAT as adults. Therefore, neither severe hypoleptinemia nor hypoinsulinemia during suckling permanently impaired brown adipogenesis in white fat. In addition, energy balance studies of DIO mice exposed to cold indicates that mice with reduced adipose stores preferentially increased food intake, whereas those with larger adipose tissue depots preferred to utilize energy from their adipose stores.	[Kozak, Leslie P.] Polish Acad Sci, Inst Anim Reprod & Food Res, Olsztyn, Poland; [Koza, Robert A.; Anunciado-Koza, Rea; Mendoza, Tamra; Newman, Susan] Pennington Biomed Res Ctr, Baton Rouge, LA USA	Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Kozak, LP (corresponding author), Polish Acad Sci, Inst Anim Reprod & Food Res, Olsztyn, Poland.	l.kozak@pan.olsztyn.pl			Foundation for Polish Science; programme WELCOME [WELCOME/2010-4/3]; EU in Poland; EU in Poland within the REFRESH [FP7-REGPOT-2010-1-264103]; National Institutes of Health (NIH) [1P30-DK072476, P20-RR0021954]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER	Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); programme WELCOME; EU in Poland; EU in Poland within the REFRESH; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Foundation for Polish Science, programme WELCOME, no. WELCOME/2010-4/3 entitled "Nutrition and ambient temperature during early development can reduce susceptibility to obesity" financed by EU Structural Funds in Poland within the Innovative Economy Programme and REFRESH project (FP7-REGPOT-2010-1-264103). This research was also supported by National Institutes of Health (NIH) 1P30-DK072476 and NIH P20-RR0021954 to the Pennington Biomedical Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almind K, 2007, P NATL ACAD SCI USA, V104, P2366, DOI 10.1073/pnas.0610416104; Bostrom P, 2005, ARTERIOSCL THROM VAS, V25, P1945, DOI 10.1161/01.ATV.0000179676.41064.d4; BUKOWIECKI L, 1982, AM J PHYSIOL, V242, pE353, DOI 10.1152/ajpendo.1982.242.6.E353; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Collins S, 1997, ENDOCRINOLOGY, V138, P405, DOI 10.1210/en.138.1.405; Coulter AA, 2003, PHYSIOL GENOMICS, V14, P139, DOI 10.1152/physiolgenomics.00057.2003; COUSIN B, 1992, J CELL SCI, V103, P931; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; GIRALT M, 1990, EUR J BIOCHEM, V193, P297, DOI 10.1111/j.1432-1033.1990.tb19336.x; Goudriaan JR, 2001, ARTERIOSCL THROM VAS, V21, P1488, DOI 10.1161/hq0901.095147; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Hansen JB, 2006, BIOCHEM J, V398, P153, DOI 10.1042/BJ20060402; HIMMSHAGEN J, 1994, AM J PHYSIOL, V266, pR1371, DOI 10.1152/ajpregu.1994.266.4.R1371; HIRNING U, 1989, CELL DIFFER DEV, V27, P243, DOI 10.1016/0922-3371(89)90704-1; Hofmann WE, 2001, J BIOL CHEM, V276, P12460, DOI 10.1074/jbc.M100466200; JACOBSSON A, 1985, J BIOL CHEM, V260, P6250; Jimenez-Chillaron JC, 2006, DIABETOLOGIA, V49, P1974, DOI 10.1007/s00125-006-0311-7; Kiskinis E, 2007, EMBO J, V26, P4831, DOI 10.1038/sj.emboj.7601908; Kopecky J, 1996, AM J PHYSIOL-ENDOC M, V270, pE768, DOI 10.1152/ajpendo.1996.270.5.E768; Koza RA, 2000, J BIOL CHEM, V275, P34486, DOI 10.1074/jbc.M002136200; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Kozak LP, 2010, PROG MOL BIOL TRANSL, V94, P75, DOI 10.1016/S1877-1173(10)94004-0; Kozak LP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011015; Kozak LP, 2010, CELL METAB, V11, P263, DOI 10.1016/j.cmet.2010.03.009; Landsberg L, 2006, CELL MOL NEUROBIOL, V26, P497, DOI 10.1007/s10571-006-9010-7; Nikonova L, 2008, FASEB J, V22, P3925, DOI 10.1096/fj.08-108266; Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005	34	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e30392	10.1371/journal.pone.0030392	http://dx.doi.org/10.1371/journal.pone.0030392			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22383960	gold, Green Published, Green Submitted			2022-12-27	WOS:000302916800003
J	Chagne, D; Crowhurst, RN; Troggio, M; Davey, MW; Gilmore, B; Lawley, C; Vanderzande, S; Hellens, RP; Kumar, S; Cestaro, A; Velasco, R; Main, D; Rees, JD; Iezzoni, A; Mockler, T; Wilhelm, L; Van de Weg, E; Gardiner, SE; Bassil, N; Peace, C				Chagne, David; Crowhurst, Ross N.; Troggio, Michela; Davey, Mark W.; Gilmore, Barbara; Lawley, Cindy; Vanderzande, Stijn; Hellens, Roger P.; Kumar, Satish; Cestaro, Alessandro; Velasco, Riccardo; Main, Dorrie; Rees, Jasper D.; Iezzoni, Amy; Mockler, Todd; Wilhelm, Larry; Van de Weg, Eric; Gardiner, Susan E.; Bassil, Nahla; Peace, Cameron			Genome-Wide SNP Detection, Validation, and Development of an 8K SNP Array for Apple	PLOS ONE			English	Article							X DOMESTICA BORKH.; TRANSCRIPTION FACTOR; SHELF-LIFE; FRUIT; DISCOVERY; GENE; TRANSFERABILITY; IDENTIFICATION; POLYMORPHISM; DIVERSITY	As high-throughput genetic marker screening systems are essential for a range of genetics studies and plant breeding applications, the International RosBREED SNP Consortium (IRSC) has utilized the Illumina Infinium (R) II system to develop a medium-to high-throughput SNP screening tool for genome-wide evaluation of allelic variation in apple (Malusxdomestica) breeding germplasm. For genome-wide SNP discovery, 27 apple cultivars were chosen to represent worldwide breeding germplasm and re-sequenced at low coverage with the Illumina Genome Analyzer II. Following alignment of these sequences to the whole genome sequence of 'Golden Delicious', SNPs were identified using SoapSNP. A total of 2,113,120 SNPs were detected, corresponding to one SNP to every 288 bp of the genome. The Illumina GoldenGate (R) assay was then used to validate a subset of 144 SNPs with a range of characteristics, using a set of 160 apple accessions. This validation assay enabled fine-tuning of the final subset of SNPs for the Illumina Infinium (R) II system. The set of stringent filtering criteria developed allowed choice of a set of SNPs that not only exhibited an even distribution across the apple genome and a range of minor allele frequencies to ensure utility across germplasm, but also were located in putative exonic regions to maximize genotyping success rate. A total of 7867 apple SNPs was established for the IRSC apple 8K SNP array v1, of which 5554 were polymorphic after evaluation in segregating families and a germplasm collection. This publicly available genomics resource will provide an unprecedented resolution of SNP haplotypes, which will enable marker-locus-trait association discovery, description of the genetic architecture of quantitative traits, investigation of genetic variation (neutral and functional), and genomic selection in apple.	[Chagne, David; Gardiner, Susan E.] Palmerston N Res Ctr, Palmerston North, New Zealand; [Crowhurst, Ross N.; Hellens, Roger P.] DSIR, Mt Albert Res Ctr, Auckland, New Zealand; [Troggio, Michela; Cestaro, Alessandro; Velasco, Riccardo] Fdn Edmund Mach, IASMA Res & Innovat Ctr, San Michele All Adige, Trento, Italy; [Davey, Mark W.; Vanderzande, Stijn] Katholieke Univ Leuven, Lab Fruit Breeding & Biotechnol, Dept Biosyst, Louvain, Belgium; [Gilmore, Barbara; Bassil, Nahla] ARS, USDA, Corvallis, OR USA; [Lawley, Cindy] Illumina Inc, Hayward, CA USA; [Kumar, Satish] Hawkes Bay Res Ctr, Havelock N, New Zealand; [Main, Dorrie; Peace, Cameron] Washington State Univ, Dept Hort & Landscape Architecture, Pullman, WA 99164 USA; [Rees, Jasper D.] Agr Res Council, Onderstepoort, South Africa; [Iezzoni, Amy] Michigan State Univ, Dept Hort, E Lansing, MI 48824 USA; [Mockler, Todd] Donald Danforth Plant Sci Ctr, St Louis, MO USA; [Wilhelm, Larry] Oregon Hlth & Sci Univ, Portland, OR USA; [Van de Weg, Eric] Univ Wageningen & Res Ctr, Wageningen, Netherlands	New Zealand Institute for Plant & Food Research Ltd; Fondazione Edmund Mach; KU Leuven; United States Department of Agriculture (USDA); Illumina; Washington State University; Agricultural Research Council of South Africa; Michigan State University; Donald Danforth Plant Science Center; Oregon Health & Science University; Wageningen University & Research	Chagne, D (corresponding author), Palmerston N Res Ctr, Palmerston North, New Zealand.	cpeace@wsu.edu	Rees, David Jasper Gilbert/AAZ-8073-2020; Gardiner, Susan Elizabeth/A-2477-2010; Chagne, David/A-2596-2010; Van de Weg, Eric W/G-3225-2011; Crowhurst, Ross N/N-8892-2017; Mockler, Todd C/L-2609-2013; Rees, Jasper/D-9672-2011	Rees, David Jasper Gilbert/0000-0003-3321-1325; Gardiner, Susan Elizabeth/0000-0002-4884-8743; Chagne, David/0000-0003-4018-0694; Van de Weg, Eric W/0000-0002-9443-5974; Crowhurst, Ross N/0000-0003-0608-2134; Mockler, Todd C/0000-0002-0462-5775; Rees, Jasper/0000-0003-3321-1325; Kumar, Satish/0000-0002-9857-5640; Hellens, Roger/0000-0003-2094-0887; Cestaro, Alessandro/0000-0003-1439-5165; Velasco, Riccardo/0000-0002-8760-5031; Davey, Mark/0000-0002-4633-0991	U.S. Department of Agriculture's National Institute of Food and Agriculture-Specialty Crop Research Initiative [2009-51181-05808]; New Zealand Ministry of Science and Innovation [C06X0812]; PREVAR Ltd; Plant and Food Research's Pipfruit Internal Investment Project; research office of the Provincia autonoma di Trento	U.S. Department of Agriculture's National Institute of Food and Agriculture-Specialty Crop Research Initiative; New Zealand Ministry of Science and Innovation; PREVAR Ltd; Plant and Food Research's Pipfruit Internal Investment Project; research office of the Provincia autonoma di Trento	This work was partially funded by the U.S. Department of Agriculture's National Institute of Food and Agriculture-Specialty Crop Research Initiative project, "RosBREED: Enabling marker-assisted breeding in Rosaceae'' (2009-51181-05808). Apple genomics at Plant and Food Research is partially supported by the New Zealand Ministry of Science and Innovation project C06X0812 "Exploiting Opportunities from Horticultural Genomics'', PREVAR Ltd, as well as Plant and Food Research's Pipfruit Internal Investment Project. Apple genome research at Istituto Agrarie San Michele Adige-Fundazione Edmund Mach is supported by the research office of the Provincia autonoma di Trento. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bushakra JM, 2012, TREE GENET GENOMES, V8, P643, DOI 10.1007/s11295-011-0450-y; Cabrera A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-562; Celton JM, 2009, TREE GENET GENOMES, V5, P93, DOI 10.1007/s11295-008-0171-z; Chagne D, 2008, GENOMICS, V92, P353, DOI 10.1016/j.ygeno.2008.07.008; Costa F, 2008, TREE GENET GENOMES, V4, P575, DOI 10.1007/s11295-008-0133-5; Costa F, 2005, EUPHYTICA, V141, P181, DOI 10.1007/s10681-005-6805-4; Eckert AJ, 2009, TREE GENET GENOMES, V5, P225, DOI 10.1007/s11295-008-0183-8; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Espley RV, 2009, PLANT CELL, V21, P168, DOI 10.1105/tpc.108.059329; Gao ZS, 2005, THEOR APPL GENET, V111, P171, DOI 10.1007/s00122-005-2018-4; Giovannoni J, 2001, ANNU REV PLANT PHYS, V52, P725, DOI 10.1146/annurev.arplant.52.1.725; Grattapaglia D, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-65; Guitton B, 2012, J EXP BOT, V63, P131, DOI 10.1093/jxb/err261; Han YP, 2009, GENOMICS, V93, P282, DOI 10.1016/j.ygeno.2008.11.005; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Iezzoni A, 2010, ACTA HORTIC, V859, P389; Illa E, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-9; Kenis K, 2008, TREE GENET GENOMES, V4, P647, DOI 10.1007/s11295-008-0140-6; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar S, 2012, TREE GENET GENOMES, V8, P1, DOI 10.1007/s11295-011-0425-z; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liebhard R, 2002, MOL BREEDING, V10, P217, DOI 10.1023/A:1020525906332; Lijavetzky D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-424; Maliepaard C, 1998, THEOR APPL GENET, V97, P60, DOI 10.1007/s001220050867; Micheletti D, 2011, TREE GENET GENOMES, V7, P857, DOI 10.1007/s11295-011-0380-8; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Myles S, 2011, P NATL ACAD SCI USA, V108, P3530, DOI 10.1073/pnas.1009363108; Myles S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008219; Nelson JC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-352; Newcomb RD, 2006, PLANT PHYSIOL, V141, P147, DOI 10.1104/pp.105.076208; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; Peace Cameron, 2009, V6, P19, DOI 10.1007/978-0-387-77491-6_2; Pindo M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-12; Rowan DD, 2009, J AGR FOOD CHEM, V57, P7953, DOI 10.1021/jf901678v; Shen GQ, 2009, METHODS MOL BIOL, V578, P293, DOI 10.1007/978-1-60327-411-1_19; Silfverberg-Dilworth E, 2006, TREE GENET GENOMES, V2, P202, DOI 10.1007/s11295-006-0045-1; Van de Weg WE, 2004, ACTA HORTIC, P45, DOI 10.17660/ActaHortic.2004.663.1; van Dyk MM, 2009, ACTA HORTIC, V814, P681; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Vezzulli S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-128; Wang AD, 2012, MOL BREEDING, V29, P379, DOI 10.1007/s11032-011-9554-1; Wang A, 2009, PLANT PHYSIOL, V151, P391, DOI 10.1104/pp.109.135822; Wang J, 2008, PROTOCOL EXCHANGE; Wang YH, 2008, ANNU REV PLANT BIOL, V59, P253, DOI 10.1146/annurev.arplant.59.032607.092902; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Yamamoto T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-267	48	206	216	2	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31745	10.1371/journal.pone.0031745	http://dx.doi.org/10.1371/journal.pone.0031745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363718	Green Published, gold			2022-12-27	WOS:000302873700088
J	Cona, G; Arcara, G; Tarantino, V; Bisiacchi, PS				Cona, Giorgia; Arcara, Giorgio; Tarantino, Vincenza; Bisiacchi, Patrizia Silvia			Electrophysiological Correlates of Strategic Monitoring in Event-Based and Time-Based Prospective Memory	PLOS ONE			English	Article							TASK INTERFERENCE; PREFRONTAL CORTEX; RETRIEVAL; REALIZATION; DEMANDS; INVOLVEMENT; INTENTIONS; COMPONENT; COVARIES; REMEMBER	Prospective memory (PM) is the ability to remember to accomplish an action when a particular event occurs (i.e., event-based PM), or at a specific time (i.e., time-based PM) while performing an ongoing activity. Strategic Monitoring is one of the basic cognitive functions supporting PM tasks, and involves two mechanisms: a retrieval mode, which consists of maintaining active the intention in memory; and target checking, engaged for verifying the presence of the PM cue in the environment. The present study is aimed at providing the first evidence of event-related potentials (ERPs) associated with time-based PM, and at examining differences and commonalities in the ERPs related to Strategic Monitoring mechanisms between event-and time-based PM tasks. The addition of an event-based or a time-based PM task to an ongoing activity led to a similar sustained positive modulation of the ERPs in the ongoing trials, mainly expressed over prefrontal and frontal regions. This modulation might index the retrieval mode mechanism, similarly engaged in the two PM tasks. On the other hand, two further ERP modulations were shown specifically in an event-based PM task. An increased positivity was shown at 400-600 ms post-stimulus over occipital and parietal regions, and might be related to target checking. Moreover, an early modulation at 130-180 ms post-stimulus seems to reflect the recruitment of attentional resources for being ready to respond to the event-based PM cue. This latter modulation suggests the existence of a third mechanism specific for the event-based PM; that is, the "readiness mode''.	[Cona, Giorgia; Arcara, Giorgio; Tarantino, Vincenza; Bisiacchi, Patrizia Silvia] Univ Padua, Dept Gen Psychol, Padua, Italy; [Arcara, Giorgio] Univ Padua, Dept Informat Engn, Padua, Italy; [Bisiacchi, Patrizia Silvia] Univ Padua, Dept Clin & Expt Med, Ctr Interdipartimentale Ric Modellist Alterazioni, Padua, Italy	University of Padua; University of Padua; University of Padua	Cona, G (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	giorgia.cona@unipd.it	Arcara, Giorgio/K-6351-2016	Arcara, Giorgio/0000-0001-6270-6883; , Giorgia/0000-0003-1844-9327; bisiacchi, patrizia/0000-0003-2760-8000; Tarantino, Vincenza/0000-0002-5836-3811	Bial Foundation [146/08]; Italian government MIUR [200879eb93_002]	Bial Foundation(Bial Foundation); Italian government MIUR(Ministry of Education, Universities and Research (MIUR))	This study was supported by a grant from the Bial Foundation (146/08) to PSB, and by a grant from Italian government MIUR number 200879eb93_002 to PSB; http://www.bial.com/pt/; http://www.istruzione.it/web/ricerca/home. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, J CLIN NEUROPHYSIOL, V8, P200, DOI 10.1097/00004691-199104000-00007; [Anonymous], 1983, CANADIAN PSYCHOL; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Bisiacchi PS, 2011, NEUROPSYCHOLOGIA, V49, P2225, DOI 10.1016/j.neuropsychologia.2011.05.007; Bisiacchi PS, 2009, NEUROPSYCHOLOGIA, V47, P1362, DOI 10.1016/j.neuropsychologia.2009.01.034; Brandimonte M, 1996, PROSPECTIVE MEMORY T; Burgess PW, 2011, NEUROPSYCHOLOGIA, V49, P2246, DOI 10.1016/j.neuropsychologia.2011.02.014; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Chen Y, 2007, NEUROREPORT, V18, P1951, DOI 10.1097/WNR.0b013e3282f202dd; Chen YZ, 2009, NEUROREPORT, V20, P81, DOI 10.1097/WNR.0b013e32831ac700; d'Ydewalle G, 1999, EUR J COGN PSYCHOL, V11, P219, DOI 10.1080/713752309; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Development Core Team, 2011, R LANG ENV STAT COMP; Duzel E, 2000, ACTA PSYCHOL, V105, P195, DOI 10.1016/S0001-6918(00)00061-5; Einstein G. O., 1996, PROSPECTIVE MEMORY T, P115; Einstein GO, 2010, J EXP PSYCHOL LEARN, V36, P1082, DOI 10.1037/a0019184; Einstein GO, 2005, J EXP PSYCHOL GEN, V134, P327, DOI 10.1037/0096-3445.134.3.327; EINSTEIN GO, 1995, J EXP PSYCHOL LEARN, V21, P996, DOI 10.1037/0278-7393.21.4.996; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Gilbert SJ, 2009, J EXP PSYCHOL LEARN, V35, P905, DOI 10.1037/a0015535; GOSCHKE T, 1993, J EXP PSYCHOL LEARN, V19, P1211, DOI 10.1037/0278-7393.19.5.1211; Goshke T., 1996, PROSPECTIVE MEMORY T, P53; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Guynn M. J., 2008, PROSPECTIVE MEMORY C, P53; Guynn MJ, 2003, INT J PSYCHOL, V38, P245, DOI 10.1080/00207590344000178; HARRIS JE, 1982, HUM LEARN, V1, P123; Hicks JL, 2005, J MEM LANG, V53, P430, DOI 10.1016/j.jml.2005.04.001; Jager T, 2008, J GEN PSYCHOL, V135, P4, DOI 10.3200/GENP.135.1.4-22; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kalpouzos G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013304; Kliegel M, PROSPECTIVE MEMORY C; Knight JB, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/neuro.09.005.2010; Kvavilashvili L, 2007, J EXP PSYCHOL GEN, V136, P112, DOI 10.1037/0096-3445.136.1.112; Lawrence M. A., 2011, EZ EASY ANAL VISUALI; Mantyla T, 2006, TIMING THE FUTURE: THE CASE FOR A TIME-BASED PROSPECTIVE MEMORY, P191, DOI 10.1142/9789812707123_0008; Marsh RL, 2006, MEM COGNITION, V34, P1037, DOI 10.3758/BF03193250; Marsh RL, 2003, J EXP PSYCHOL LEARN, V29, P861, DOI 10.1037/0278-7393.29.5.861; Marsh RL, 2000, APPL COGNITIVE PSYCH, V14, pS29, DOI 10.1002/acp.769.abs; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McDaniel MA, 2011, NEUROPSYCHOLOGIA, V49, P2147, DOI 10.1016/j.neuropsychologia.2010.12.029; McFarland CP, 2009, NEUROPSYCHOLOGIA, V47, P1660, DOI 10.1016/j.neuropsychologia.2009.02.023; McIntosh AR, 1997, HUM BRAIN MAPP, V5, P323, DOI 10.1002/(SICI)1097-0193(1997)5:4<323::AID-HBM20>3.0.CO;2-D; Morcom AM, 2002, NEUROREPORT, V13, P149, DOI 10.1097/00001756-200201210-00034; Nyberg L, 1995, NEUROREPORT, V7, P249, DOI 10.1097/00001756-199512000-00060; Nyberg L, 1999, COGNITIVE NEUROSCIENCE OF MEMORY, P43; Okuda J, 2007, INT J PSYCHOPHYSIOL, V64, P233, DOI 10.1016/j.ijpsycho.2006.09.009; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pinheiro J, 2001, MIXED EFFECTS MODELS; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Reynolds JR, 2009, CEREB CORTEX, V19, P1208, DOI 10.1093/cercor/bhn164; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Smith RE, 2004, J EXP PSYCHOL LEARN, V30, P756, DOI 10.1037/0278-7393.30.4.756; Smith RE, 2003, J EXP PSYCHOL LEARN, V29, P347, DOI 10.1037/0278-7393.29.3.347; Smith RE, 2007, J EXP PSYCHOL LEARN, V33, P734, DOI 10.1037/0278-7393.33.4.734; Tarantino V, MONITORING MEC UNPUB; Tulving E, 1998, ADVANCES IN PSYCHOLOGICAL SCIENCE, VOL 2, P441; Vogel EK, 2000, PSYCHOPHYSIOLOGY, V37, P190, DOI 10.1111/1469-8986.3720190; Volle E, 2011, NEUROPSYCHOLOGIA, V49, P2185, DOI 10.1016/j.neuropsychologia.2011.02.045; West R, 2006, NEUROPSYCHOLOGIA, V44, P197, DOI 10.1016/j.neuropsychologia.2005.05.003; West R, 2005, PSYCHOPHYSIOLOGY, V42, P698, DOI 10.1111/j.1469-8986.2005.00361.x; West R, 2001, COGNITIVE BRAIN RES, V12, P1, DOI 10.1016/S0926-6410(01)00014-3; West R, 2007, MEM COGNITION, V35, P1034, DOI 10.3758/BF03193476; West R, 2005, NEUROPSYCHOLOGIA, V43, P418, DOI 10.1016/j.neuropsychologia.2004.06.012; West R, 2007, INT J PSYCHOPHYSIOL, V64, P215, DOI 10.1016/j.ijpsycho.2006.09.004; West R, 2011, CAN J EXP PSYCHOL, V65, P38, DOI 10.1037/a0022810; West R, 2011, NEUROPSYCHOLOGIA, V49, P2233, DOI 10.1016/j.neuropsychologia.2010.12.028; West R, 2002, COGN AFFECT BEHAV NE, V2, P162, DOI 10.3758/CABN.2.2.162	71	30	31	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31659	10.1371/journal.pone.0031659	http://dx.doi.org/10.1371/journal.pone.0031659			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926ZM	22363699	gold, Green Published, Green Submitted			2022-12-27	WOS:000302873700081
J	Huang, DC; Zhang, RZ; Kim, KC; Suarez, AV				Huang, Dingcheng; Zhang, Runzhi; Kim, Ke Chung; Suarez, Andrew V.			Spatial Pattern and Determinants of the First Detection Locations of Invasive Alien Species in Mainland China	PLOS ONE			English	Article							BIOLOGICAL INVASIONS; STRATEGIES; TRADE	Background: The unintentional transport of species as a result of human activities has reached unprecedented rates. Once established, introduced species can be nearly impossible to eradicate. It is therefore essential to identify and monitor locations where invaders are most likely to establish new populations. Despite the obvious value of early detection, how does an agency identify areas that are most vulnerable to new invaders? Here we propose a novel approach by using the "first detection location'' (FDL) of introduced species in China to quantify characteristics of areas where introduced species are first reported. Methodology/Principal Findings: We obtained FDLs for 166 species (primarily agricultural and forestry pests) that were unintentionally introduced into China prior to 2008 from literature searches. The spatial pattern and determinants of FDLs were examined at the provincial level. The spatial pattern of FDLs varied among provinces with more commerce and trade and economically developed provinces in coastal regions having more FDLs than interior provinces. For example, 74.6% of FDLs were distributed in coastal regions despite that they only cover 15.6% of the total area in China. Variables that may be indicators of "introduction pressure'' (e.g. the amount of received commerce) had an overwhelming effect on the number of FDLs in each province (R-2 = 0.760). Conclusions/Significance: Our results suggest that "introduction pressure'' may be one of the most important factors that determine the locations where newly-introduced species are first detected, and that open and developed provinces in China should be prioritized when developing monitoring programs that focus on locating and managing new introductions. Our study illustrates that FDL approaches can contribute to the study and management of biological invasions not only for China but also for elsewhere.	[Huang, Dingcheng; Zhang, Runzhi] Chinese Acad Sci, Inst Zool, CAS Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Huang, Dingcheng] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Kim, Ke Chung] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Suarez, Andrew V.] Univ Illinois, Dept Entomol, Dept Anim Biol, Urbana, IL 61801 USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Illinois System; University of Illinois Urbana-Champaign	Zhang, RZ (corresponding author), Chinese Acad Sci, Inst Zool, CAS Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	zhangrz@ioz.ac.cn			Natural Science Foundation of China [30525039]; Chinese Academy of Sciences [KSCX2-YW-N-42]; National research programs of China [2005DKA21402/2006FY110500]; Division Of Environmental Biology [1020979] Funding Source: National Science Foundation	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National research programs of China; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by Natural Science Foundation of China program (30525039), Chinese Academy of Sciences program (KSCX2-YW-N-42) and National research programs of China (2005DKA21402/2006FY110500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert Peter, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P52, DOI 10.1078/1433-8319-00004; Breiman L., 2017, CLASSIFICATION REGRE; China Association of Port-of-Entry, 2003, PRACT MAN PORTS ENTR; Cohen AN, 1998, SCIENCE, V279, P555, DOI 10.1126/science.279.5350.555; Costello CJ, 2003, P NATL ACAD SCI USA, V100, P3321, DOI 10.1073/pnas.0636536100; DAISIE, 2008, HDB AL SPEC EUR; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Ding JQ, 2008, BIOSCIENCE, V58, P317, DOI 10.1641/B580407; Genovesi P, 2005, BIOL INVASIONS, V7, P127, DOI 10.1007/s10530-004-9642-9; Genovesi P., 2003, P CONV CONS EUR WILD; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Haack RA, 1997, J FOREST, V95, P11; Harvey CT, 2009, DIVERS DISTRIB, V15, P429, DOI 10.1111/j.1472-4642.2008.00550.x; Hulme PE, 2006, J APPL ECOL, V43, P835, DOI 10.1111/j.1365-2664.2006.01227.x; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Jeschke JM, 2005, P NATL ACAD SCI USA, V102, P7198, DOI 10.1073/pnas.0501271102; Leung B, 2007, P ROY SOC B-BIOL SCI, V274, P2603, DOI 10.1098/rspb.2007.0841; Levine JM, 2003, CONSERV BIOL, V17, P322, DOI 10.1046/j.1523-1739.2003.02038.x; Li Z., 2002, INVASIVE ALIEN SPECI; Lin W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001208; Liu J, 2005, DIVERS DISTRIB, V11, P341, DOI 10.1111/j.1366-9516.2005.00162.x; Lockwood J, 2001, BIOTIC HOMOGENIZATIO; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; McBeath GA, 2006, ENVIRON GOV ASIA, P1; McNeely JA, 2001, GLOBAL STRATEGY INVA; Meentemeyer RK, 2008, ECOL APPL, V18, P377, DOI 10.1890/07-1150.1; Mehta SV, 2007, ECOL ECON, V61, P237, DOI 10.1016/j.ecolecon.2006.10.024; National Bureau of Statistics of China, 1986, CHIN STAT YB; National Invasive Species Council, 2008, 2008 2012 NAT INV SP; RICHARDSON DM, 2008, DIVERS DISTRIB, V14, P161, DOI DOI 10.1111/J.1472-4642.2008.00464.X; Steinberg G, 1995, TREESTRUCTURED NONPA; SUN Y, 1982, J JIANGSU FOR SCI TE, V9, P47; Venette RC, 2002, ANNU REV ENTOMOL, V47, P143, DOI 10.1146/annurev.ento.47.091201.145147; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Wan F, 2008, BIOL INVASIONS LEGIS; Wan FH, 2009, RES BIOL INVASIONS C; Wan FH, 2005, BIOL MANAGEMENT INVA; Weber E, 2008, BIOL INVASIONS, V10, P1411, DOI 10.1007/s10530-008-9216-3; Westphal MI, 2008, BIOL INVASIONS, V10, P391, DOI 10.1007/s10530-007-9138-5; Wheeler Alfred G. Jr, 2009, P475, DOI 10.1002/9781444308211.ch21; Wu SH, 2010, BIOL INVASIONS, V12, P2179, DOI 10.1007/s10530-009-9620-3; Xie Y, 2008, BIOINVASION ECOLOGIC; Xu H, 2004, CHECKLIST INVASIVE A, P432; Xu Hai-Gen, 2004, Shengwu Duoyangxing, V12, P626; Xu HG, 2006, BIODIVERS CONSERV, V15, P2893, DOI 10.1007/s10531-005-2575-5; Zeng Ling, 2005, Chinese Bulletin of Entomology, V42, P144; 张润志, 2008, [中国科学. C辑, 生命科学, Science in China. Series C, Life Sciences], V38, P1095	47	31	39	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31734	10.1371/journal.pone.0031734	http://dx.doi.org/10.1371/journal.pone.0031734			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363715	Green Submitted, Green Published, gold			2022-12-27	WOS:000302873700086
J	Akinsola, AK; Ota, MOC; Enwere, GC; Okoko, BJ; Zaman, SMA; Saaka, M; Nsekpong, ED; Odutola, AA; Greenwood, BM; Cutts, FT; Adegbola, RA				Akinsola, Adebayo K.; Ota, Martin O. C.; Enwere, Godwin C.; Okoko, Brown J.; Zaman, Syed M. A.; Saaka, Mark; Nsekpong, Ekpedeme D.; Odutola, Aderonke A.; Greenwood, Brian M.; Cutts, Felicity T.; Adegbola, Richard A.			Pneumococcal Antibody Concentrations and Carriage of Pneumococci more than 3 Years after Infant Immunization with a Pneumococcal Conjugate Vaccine	PLOS ONE			English	Article							INFLUENZAE TYPE-B; STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; INVASIVE-DISEASE; CHILDREN; IMMUNOGENICITY; SEROTYPE; EFFICACY; GAMBIA; TRIAL	Background: A 9-valent pneumococcal conjugate vaccine (PCV-9), given in a 3-dose schedule, protected Gambian children against pneumococcal disease and reduced nasopharyngeal carriage of pneumococci of vaccine serotypes. We have studied the effect of a booster or delayed primary dose of 7-valent conjugate vaccine (PCV-7) on antibody and nasopharyngeal carriage of pneumococci 3-4 years after primary vaccination. Methodology/Principal Findings: We recruited a subsample of children who had received 3 doses of either PCV-9 or placebo (controls) into this follow-up study. Pre- and post-PCV-7 pneumococcal antibody concentrations to the 9 serotypes in PCV-9 and nasopharyngeal carriage of pneumococci were determined before and at intervals up to 18 months post-PCV7. We enrolled 282 children at a median age of 45 months (range, 38-52 months); 138 had received 3 doses of PCV-9 in infancy and 144 were controls. Before receiving PCV-7, a high proportion of children had antibody concentrations > 0.35 mu g/mL to most of the serotypes in PCV-9 (average of 75% in the PCV-9 and 66% in the control group respectively). The geometric mean antibody concentrations in the vaccinated group were significantly higher compared to controls for serotypes 6B, 14, and 23F. Antibody concentrations were significantly increased to serotypes in the PCV-7 vaccine both 6-8 weeks and 16-18 months after PCV-7. Antibodies to serotypes 6B, 9V and 23F were higher in the PCV-9 group than in the control group 6-8 weeks after PCV-7, but only the 6B difference was sustained at 16-18 months. There was no significant difference in nasopharyngeal carriage between the two groups. Conclusions/Significance: Pneumococcal antibody concentrations in Gambian children were high 34-48 months after a 3-dose primary infant vaccination series of PCV-9 for serotypes other than serotypes 1 and 18C, and were significantly higher than in control children for 3 of the 9 serotypes. Antibody concentrations increased after PCV-7 and remained raised for at least 18 months.	[Akinsola, Adebayo K.; Ota, Martin O. C.; Enwere, Godwin C.; Okoko, Brown J.; Zaman, Syed M. A.; Saaka, Mark; Nsekpong, Ekpedeme D.; Odutola, Aderonke A.; Adegbola, Richard A.] MRC, Gambia Unit, Banjul, Gambia; [Greenwood, Brian M.; Cutts, Felicity T.] London Sch Hyg & Trop Med, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Akinsola, AK (corresponding author), MRC, Gambia Unit, Banjul, Gambia.	radegbola@hotmail.com			UK Medical Research Council; MRC [MC_UP_A900_1122, MC_U190071468] Funding Source: UKRI; Medical Research Council [MC_UP_A900_1122, MC_U190071468] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEGBOLA RA, 1994, PEDIATR INFECT DIS J, V13, P975, DOI 10.1097/00006454-199411000-00008; Adegbola RA, 2006, TROP MED INT HEALTH, V11, P1128, DOI 10.1111/j.1365-3156.2006.01652.x; Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P93; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Cheung YB, 2009, PEDIATR INFECT DIS J, V28, P990, DOI 10.1097/INF.0b013e3181a78185; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Dagan R, 2005, J INFECT DIS, V192, P367, DOI 10.1086/431679; Goetghebuer T, 2000, TROP MED INT HEALTH, V5, P207, DOI 10.1046/j.1365-3156.2000.00535.x; Goldblatt D, 2005, J INFECT DIS, V192, P387, DOI 10.1086/431524; Heath PT, 2002, ARCH DIS CHILD, V86, P396, DOI 10.1136/adc.86.6.396; Hill PC, 2008, CLIN INFECT DIS, V46, P807, DOI 10.1086/528688; Hill PC, 2006, CLIN INFECT DIS, V43, P673, DOI 10.1086/506941; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Madhi SA, 2007, VACCINE, V25, P2451, DOI 10.1016/j.vaccine.2006.09.019; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009; Miernyk KM, 2000, CLIN INFECT DIS, V31, P34, DOI 10.1086/313907; Mulholland EK, 1999, PEDIATR INFECT DIS J, V18, pS35, DOI 10.1097/00006454-199910001-00007; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Obaro SK, 2000, PEDIATR INFECT DIS J, V19, P463, DOI 10.1097/00006454-200005000-00014; Obaro SK, 1996, LANCET, V348, P271, DOI 10.1016/S0140-6736(05)65585-7; ODempsey TJD, 1996, PEDIATR INFECT DIS J, V15, P431, DOI 10.1097/00006454-199605000-00010; Ota MO, 2011, VACCINE, V29, P2999, DOI 10.1016/j.vaccine.2011.01.098; Palmer A, 1999, J TROP PEDIATRICS, V45, P51, DOI 10.1093/tropej/45.1.51; Russell FM, 2010, CLIN VACCINE IMMUNOL, V17, P1970, DOI 10.1128/CVI.00117-10; Saaka M, 2008, VACCINE, V26, P3719, DOI 10.1016/j.vaccine.2008.04.066; Siber GR, 2007, VACCINE, V25, P3816, DOI 10.1016/j.vaccine.2007.01.119; Trotter CL, 2008, VACCINE, V26, P4434, DOI 10.1016/j.vaccine.2008.05.073; Usen S, 1998, PEDIATR INFECT DIS J, V17, P23, DOI 10.1097/00006454-199801000-00006; Weinberger DM, 2008, J INFECT DIS, V197, P1511, DOI 10.1086/587941; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	32	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31050	10.1371/journal.pone.0031050	http://dx.doi.org/10.1371/journal.pone.0031050			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363544	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000302871500025
J	Alshatwi, AA; Shafi, G; Hasan, TN; Syed, NA; Al-Hazzani, AA; Alsaif, MA; Alsaif, AA				Alshatwi, Ali A.; Shafi, Gowhar; Hasan, Tarique N.; Syed, Naveed Ahmed; Al-Hazzani, Amal A.; Alsaif, Mohammed A.; Alsaif, Abdulaziz A.			Differential Expression Profile and Genetic Variants of MicroRNAs Sequences in Breast Cancer Patients	PLOS ONE			English	Article							DISEASES; PROGNOSIS; DIAGNOSIS; MIRNAS; RISK; SNP	The technology available for cancer diagnosis and prognosis is not yet satisfactory at the molecular level, and requires further improvements. Micro RNAs (miRNAs) have been recently reported as useful biomarkers in diseases including cancer. We performed a miRNA expression profiling study using peripheral blood from breast cancer patients to detect and identify characteristic patterns. A total of 100 breast cancer patients and 89 healthy patients were recruited for miRNA genotyping and expression profiling. We found that hs-miR-196a2 in premenopausal patients, and hs-miR-499, hs-miR-146a and hs-miR-196a2 postmenopausal patients, may discriminate breast cancer patients from healthy individuals. In addition, we found a significant association between two microRNA polymorphisms (hs-miR-196a2 and hs-miR-499) and breast cancer risk. However, no significant association between the hs-miR-146a gene and breast cancer risk was found. In summary, the study demonstrates that peripheral blood miRNAs and their expression and genotypic profiles can be developed as biomarkers for early diagnosis and prognosis of breast cancer.	[Alshatwi, Ali A.; Shafi, Gowhar; Hasan, Tarique N.; Syed, Naveed Ahmed] King Saud Univ, MCBRL, Dept Food Sci & Nutr, Coll Food & Agr Sci, Riyadh, Saudi Arabia; [Al-Hazzani, Amal A.] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh 11451, Saudi Arabia; [Alsaif, Mohammed A.] King Saud Univ, Coll Appl Med Sci, Riyadh 11451, Saudi Arabia; [Alsaif, Abdulaziz A.] King Saud Univ, Coll Med, Riyadh 11461, Saudi Arabia	King Saud University; King Saud University; King Saud University; King Saud University	Alshatwi, AA (corresponding author), King Saud Univ, MCBRL, Dept Food Sci & Nutr, Coll Food & Agr Sci, Riyadh, Saudi Arabia.	alialshatwi@gmail.com	Alshatwi, Ali/E-5271-2014; Syed, Naveed/K-2318-2012	Alshatwi, Ali/0000-0002-2441-553X; Noorul Hasan, Tarique/0000-0002-7744-9637	National Plan for Sciences and Technology, King Saud University, Riyadh, Saudi Arabia [09-BIO675-02]	National Plan for Sciences and Technology, King Saud University, Riyadh, Saudi Arabia	The authors would like to acknowledge National Plan for Sciences and Technology, King Saud University, Riyadh, Saudi Arabia (Project No. 09-BIO675-02), for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshatwi AA, 2011, FUND CLIN PHARM, DOI [10.1111/j.1472-8206.2011.00939, DOI 10.1111/J.1472-8206.2011.00939]; Aumiller V, 2008, BBA-GENE REGUL MECH, V1779, P692, DOI 10.1016/j.bbagrm.2008.04.008; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Bushati N, 2008, CURR OPIN NEUROBIOL, V18, P292, DOI 10.1016/j.conb.2008.07.001; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Carissimi C, 2009, AUTOIMMUN REV, V8, P520, DOI 10.1016/j.autrev.2009.01.008; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chin LJ, 2008, CANCER RES, V68, P8535, DOI 10.1158/0008-5472.CAN-08-2129; Couzin J, 2008, SCIENCE, V319, P1782, DOI 10.1126/science.319.5871.1782; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Elkum N, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-222; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Lawrie CH, 2007, INT J CANCER, V121, P1156, DOI 10.1002/ijc.22800; Li LC, 2008, RNA BIOL, V5, P61, DOI 10.4161/rna.5.2.5989; Maqbool Z, 2008, SAUDI MED J, V29, P507; Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x; Mocellin S, 2009, MINI-REV MED CHEM, V9, P70, DOI 10.2174/138955709787001802; Nelson PT, 2008, BRAIN PATHOL, V18, P130, DOI 10.1111/j.1750-3639.2007.00120.x; Raveche ES, 2007, BLOOD, V109, P5079, DOI 10.1182/blood-2007-02-071225; Ruijs MW, 2007, FAM CANCER, V6, P311; Shafi G, 2010, CAN J NEUROL SCI, V37, P177, DOI 10.1017/S0317167100009902; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu ZB, 2007, NUCLEIC ACIDS RES, V35, P4535, DOI 10.1093/nar/gkm480; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	28	62	64	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30049	10.1371/journal.pone.0030049	http://dx.doi.org/10.1371/journal.pone.0030049			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363415	Green Submitted, Green Published, gold			2022-12-27	WOS:000302871500005
J	Blamires, SJ; Wu, CL; Tso, IM				Blamires, Sean J.; Wu, Chun-Lin; Tso, I-Min			Variation in Protein Intake Induces Variation in Spider Silk Expression	PLOS ONE			English	Article							CLAVIPES DRAGLINE SILK; MECHANICAL-PROPERTIES; AMPULLATE SILKS; C-13 NMR; WEB; EVOLUTION; SEQUENCE; PROLINE; FIBROIN; STOICHIOMETRY	Background: It is energetically expensive to synthesize certain amino acids. The proteins (spidroins) of spider major ampullate (MA) silk, MaSp1 and MaSp2, differ in amino acid composition. Glutamine and proline are prevalent in MaSp2 and are expensive to synthesize. Since most orb web spiders express high proline silk they might preferentially attain the amino acids needed for silk from food and shift toward expressing more MaSp1 in their MA silk when starved. Methodology/Principal Findings: We fed three spiders; Argiope aetherea, Cyrtophora moluccensis and Leucauge blanda, high protein, low protein or no protein solutions. A. aetherea and L. blanda MA silks are high in proline, while C. moluccesnsis MA silks are low in proline. After 10 days of feeding we determined the amino acid compositions and mechanical properties of each species' MA silk and compared them between species and treatments with pre-treatment samples, accounting for ancestry. We found that the proline and glutamine of A. aetherea and L. blanda silks were affected by protein intake; significantly decreasing under the low and no protein intake treatments. Glutmaine composition in C. moluccensis silk was likewise affected by protein intake. However, the composition of proline in their MA silk was not significantly affected by protein intake. Conclusions: Our results suggest that protein limitation induces a shift toward different silk proteins with lower glutamine and/or proline content. Contradictions to the MaSp model lie in the findings that C. moluccensis MA silks did not experience a significant reduction in proline and A. aetherea did not experience a significant reduction in serine on low/no protein. The mechanical properties of the silks could not be explained by a MaSp1 expressional shift. Factors other than MaSp expression, such as the expression of spidroin-like orthologues, may impact on silk amino acid composition and spinning and glandular processes may impact mechanics.	[Blamires, Sean J.; Tso, I-Min] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan; [Wu, Chun-Lin] Ind Technol Res Inst, Ctr Measurement Stand, Hsinchu, Taiwan; [Tso, I-Min] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan	Tunghai University; Industrial Technology Research Institute - Taiwan; National Chung Hsing University	Blamires, SJ (corresponding author), Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan.	spider@thu.edu.tw			National Science Council, Taiwan [NSC 98-2811-B-029-002]; NSC [NSC 97-2311-B-029-002-MY3, NSC 99-2621-B-029-002-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); NSC(Ministry of Science and Technology, Taiwan)	The work was supported by a National Science Council, Taiwan postdoctoral grant to S.J.B. (NSC 98-2811-B-029-002) and NSC grants (NSC 97-2311-B-029-002-MY3; NSC 99-2621-B-029-002-MY3) to I.M.T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011234; Ayoub NA, 2008, MOL BIOL EVOL, V25, P277, DOI 10.1093/molbev/msm246; Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514; Blackledge TA, 2006, J EXP BIOL, V209, P3131, DOI 10.1242/jeb.02327; Blackledge TA, 2009, P NATL ACAD SCI USA, V106, P5229, DOI 10.1073/pnas.0901377106; Blamires SJ, 2010, J EXP BIOL, V213, P3906, DOI 10.1242/jeb.046730; Blamires S. J., 2012, SILKS PROPERTIES PRO, P139; Blamires SJ, 2011, ANIM BEHAV, V81, P955, DOI 10.1016/j.anbehav.2011.01.022; Blamires SJ, 2010, ANIM BEHAV, V80, P947, DOI 10.1016/j.anbehav.2010.09.011; Blamires SJ, 2009, ECOL ENTOMOL, V34, P545, DOI 10.1111/j.1365-2311.2009.01095.x; Blomberg SP, 2002, J EVOLUTION BIOL, V15, P899, DOI 10.1046/j.1420-9101.2002.00472.x; Bonev B, 2006, BIOPOLYMERS, V82, P134, DOI 10.1002/bip.20471; Boutry C, 2008, J EXP ZOOL PART A, V309A, P542, DOI 10.1002/jez.487; Brooks AE, 2008, BIOMACROMOLECULES, V9, P1506, DOI 10.1021/bm701124p; Colgin MA, 1998, PROTEIN SCI, V7, P667, DOI 10.1002/pro.5560070315; Craig CL, 1999, INT J BIOL MACROMOL, V24, P109, DOI 10.1016/S0141-8130(99)00006-9; Craig CL, 2003, SPIDERWEBS SILK TRAC; Creager MS, 2011, COMP BIOCHEM PHYS A, V159, P219, DOI 10.1016/j.cbpa.2011.02.010; Creighton T. E., 1984, PROTEINS STRUCTURES, V2nd; D'Mello J. P. F., 2003, Amino acids in animal nutrition, P71, DOI 10.1079/9780851996547.0071; Dicko C, 2004, BIOCHEMISTRY-US, V43, P14080, DOI 10.1021/bi0483413; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Fagan WF, 2004, ECOL LETT, V7, P876, DOI 10.1111/j.1461-0248.2004.00641.x; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Gaines WA, 2008, INSECT MOL BIOL, V17, P465, DOI 10.1111/j.1365-2583.2008.00828.x; Garb JE, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-243; Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561; Gosline J, 2002, PHILOS T R SOC B, V357, P121, DOI 10.1098/rstb.2001.1022; Gosline JM, 1999, J EXP BIOL, V202, P3295; Guehrs KH, 2008, INSECT MOL BIOL, V17, P553, DOI 10.1111/j.1365-2583.2008.00826.x; Guhrs K H, 2000, J Biotechnol, V74, P121; Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0; Hayashi CY, 2002, MOL SYSTEMATICS EVOL; Higgins L, 1999, PHYSIOL ENTOMOL, V24, P263, DOI 10.1046/j.1365-3032.1999.00135.x; Higgins LE, 2007, INT J BIOL MACROMOL, V40, P201, DOI 10.1016/j.ijbiomac.2006.07.007; Hijirida DH, 1996, BIOPHYS J, V71, P3442, DOI 10.1016/S0006-3495(96)79539-5; HINMAN MB, 1992, J BIOL CHEM, V267, P19320; Holland GP, 2008, BIOMACROMOLECULES, V9, P651, DOI 10.1021/bm700950u; Hu X, 2006, CELL MOL LIFE SCI, V63, P1986, DOI 10.1007/s00018-006-6090-y; Jensen K, 2010, J INSECT PHYSIOL, V56, P1095, DOI 10.1016/j.jinsphys.2010.03.001; Karasov W. H., 2007, PHYSL ECOLOGY ANIMAL; Knight DP, 2001, NATURWISSENSCHAFTEN, V88, P179, DOI 10.1007/s001140100220; Lewis RV, 2006, CHEM REV, V106, P3762, DOI 10.1021/cr010194g; Liao CP, 2009, BEHAV ECOL, V20, P1194, DOI 10.1093/beheco/arp119; Liu Y, 2008, BIOMACROMOLECULES, V9, P1782, DOI 10.1021/bm7014174; Liu Y, 2008, BIOMACROMOLECULES, V9, P116, DOI 10.1021/bm700877g; Maddison WP, 2000, J THEOR BIOL, V202, P195, DOI 10.1006/jtbi.1999.1050; Mayntz D, 2005, SCIENCE, V307, P111, DOI 10.1126/science.1105493; Mayntz D, 2003, OIKOS, V101, P631, DOI 10.1034/j.1600-0706.2003.12408.x; Mayntz D, 2009, BIOL LETTERS, V5, P735, DOI 10.1098/rsbl.2009.0431; Nelson D.L., 2005, LEHNINGER PRINCIPLES, DOI DOI 10.1002/BMB.2005.494033010419; NISBET AD, 1981, EUR J BIOCHEM, V115, P335, DOI 10.1111/j.1432-1033.1981.tb05243.x; Porter D, 2009, ADV MATER, V21, P487, DOI 10.1002/adma.200801332; Quinn GP, 2003, EXPT DESIGN DATA ANA; Savage KN, 2008, J EXP BIOL, V211, P1937, DOI 10.1242/jeb.014217; Savage KN, 2008, J EXP BIOL, V211, P1948, DOI 10.1242/jeb.014225; Scheibel T, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-14; SIMMONS A, 1994, MACROMOLECULES, V27, P5235, DOI 10.1021/ma00096a060; Sponner A, 2005, NAT MATER, V4, P772, DOI 10.1038/nmat1493; Sponner A, 2005, BIOCHEMISTRY-US, V44, P4727, DOI 10.1021/bi047671k; Swanson BO, 2006, APPL PHYS A-MATER, V82, P213, DOI 10.1007/s00339-005-3427-6; Tso IM, 2007, ETHOLOGY, V113, P324, DOI 10.1111/j.1439-0310.2007.01318.x; Tso IM, 2005, J EXP BIOL, V208, P1053, DOI 10.1242/jeb.01437; Vollrath F, 2000, J Biotechnol, V74, P67; Vollrath F, 2001, P ROY SOC B-BIOL SCI, V268, P2339, DOI 10.1098/rspb.2001.1590; WORK RW, 1987, J ARACHNOL, V15, P65; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120; Zax DB, 2004, BIOMACROMOLECULES, V5, P732, DOI 10.1021/bm034309x	68	41	41	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31626	10.1371/journal.pone.0031626	http://dx.doi.org/10.1371/journal.pone.0031626			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363691	gold, Green Submitted, Green Published			2022-12-27	WOS:000302871500066
J	Erent, M; Drummond, DR; Cross, RA				Erent, Muriel; Drummond, Douglas R.; Cross, Robert A.			S. pombe Kinesins-8 Promote Both Nucleation and Catastrophe of Microtubules	PLOS ONE			English	Article							SINGLE-HEADED KINESIN; FISSION YEAST; INTERPHASE MICROTUBULES; DYNAMIC INSTABILITY; SCHIZOSACCHAROMYCES-POMBE; MITOTIC SPINDLE; MOTOR PROTEINS; CHROMOSOME CONGRESSION; LENGTH; MOVEMENT	The skinesins-8 were originally thought to be microtubule depolymerases, but are now emerging as more versatile catalysts of microtubule dynamics. We show here that S. pombe Klp5-436 and Klp6-440 are non-processive plus-end-directed motors whose in vitro velocities on S. pombe microtubules at 7 and 23 nm s(-1) are too slow to keep pace with the growing tips of dynamic interphase microtubules in living S. pombe. In vitro, Klp5 and 6 dimers exhibit a hitherto-undescribed combination of strong enhancement of microtubule nucleation with no effect on growth rate or catastrophe frequency. By contrast in vivo, both Klp5 and Klp6 promote microtubule catastrophe at cell ends whilst Klp6 also increases the number of interphase microtubule arrays (IMAs). Our data support a model in which Klp5/6 bind tightly to free tubulin heterodimers, strongly promoting the nucleation of new microtubules, and then continue to land as a tubulin-motor complex on the tips of growing microtubules, with the motors then dissociating after a few seconds residence on the lattice. In vivo, we predict that only at cell ends, when growing microtubule tips become lodged and their growth slows down, will Klp5/6 motor activity succeed in tracking growing microtubule tips. This mechanism would allow Klp5/6 to detect the arrival of microtubule tips at cells ends and to amplify the intrinsic tendency for microtubules to catastrophise in compression at cell ends. Our evidence identifies Klp5 and 6 as spatial regulators of microtubule dynamics that enhance both microtubule nucleation at the cell centre and microtubule catastrophe at the cell ends.	[Erent, Muriel; Drummond, Douglas R.; Cross, Robert A.] Univ Warwick, Ctr Mechanochem Cell Biol, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England	University of Warwick	Erent, M (corresponding author), Univ Warwick, Ctr Mechanochem Cell Biol, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.	D.Drummond@mechanochemistry.org	Cross, Robert A/F-1798-2011	Cross, Robert A/0000-0002-0004-7832; Drummond, Douglas/0000-0003-4155-3747	Marie Curie Cancer Care; Medical Research Council [G0200542]; MRC [G0200542] Funding Source: UKRI	Marie Curie Cancer Care; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Marie Curie Cancer Care (www.mariecurie.org.uk), Medical Research Council ( www.mrc.ac.uk, Grant G0200542). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso MC, 2007, SCIENCE, V316, P120, DOI 10.1126/science.1136985; Behrens R, 2002, J CELL BIOL, V157, P783, DOI 10.1083/jcb.200112027; BERLINER E, 1995, NATURE, V373, P718, DOI 10.1038/373718a0; Braun M, 2009, NAT CELL BIOL, V11, P724, DOI 10.1038/ncb1878; Bringmann H, 2004, SCIENCE, V303, P1519, DOI 10.1126/science.1094838; Brunner D, 2000, CELL, V102, P695, DOI 10.1016/S0092-8674(00)00091-X; Busch KE, 2004, CURR BIOL, V14, P548, DOI 10.1016/j.cub.2004.03.029; Carazo-Salas RE, 2005, SCIENCE, V309, P297, DOI 10.1126/science.1113465; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Carter NJ, 2006, CELL BIOL LAB HDB, P371; Catarinella M, 2009, ANGEW CHEM INT EDIT, V48, P9072, DOI 10.1002/anie.200904510; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cottingham FR, 1997, J CELL BIOL, V138, P1041, DOI 10.1083/jcb.138.5.1041; Crevel IMTC, 1997, J MOL BIOL, V273, P160, DOI 10.1006/jmbi.1997.1319; des Georges A, 2008, NAT STRUCT MOL BIOL, V15, P1102, DOI 10.1038/nsmb.1482; Drummond DR, 2011, METHODS MOL BIOL, V777, P29, DOI 10.1007/978-1-61779-252-6_3; Drummond DR, 2000, CURR BIOL, V10, P766, DOI 10.1016/S0960-9822(00)00570-4; Drummond DR, 2011, SEM CELL DEV BIOL; Du YQ, 2010, CURR BIOL, V20, P374, DOI 10.1016/j.cub.2009.12.049; Foethke D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.76; Friel CT, 2011, EMBO J; Gandhi R, 2004, MOL BIOL CELL, V15, P121, DOI 10.1091/mbc.E03-05-0342; Garcia MA, 2002, EMBO J, V21, P6015, DOI 10.1093/emboj/cdf611; Garcia MA, 2002, CURR BIOL, V12, P610, DOI 10.1016/S0960-9822(02)00761-3; Gatt MK, 2005, J CELL SCI, V118, P2671, DOI 10.1242/jcs.02410; GELLES J, 1995, BIOPHYS J, V68, pS276; Gelles J, 1995, BIOPHYS J, V68, p282S; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Grissom PM, 2009, MOL BIOL CELL, V20, P963, DOI 10.1091/mbc.E08-09-0979; Gupta ML, 2006, NAT CELL BIOL, V8, P913, DOI 10.1038/ncb1457; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Hoog JL, 2007, DEV CELL, V12, P349, DOI 10.1016/j.devcel.2007.01.020; HOHEISEL JD, 1993, CELL, V73, P109, DOI 10.1016/0092-8674(93)90164-L; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Huang Y, 2009, CELL CYCLE, V8, P2643, DOI 10.4161/cc.8.16.9366; HUNT AJ, 1993, P NATL ACAD SCI USA, V90, P11653, DOI 10.1073/pnas.90.24.11653; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; Janson ME, 2003, J CELL BIOL, V161, P1029, DOI 10.1083/jcb.200301147; Jaqaman K, 2010, J CELL BIOL, V188, P665, DOI 10.1083/jcb.200909005; Kamei T, 2005, BIOPHYS J, V88, P2068, DOI 10.1529/biophysj.104.049759; LOCKHART A, 1994, EMBO J, V13, P751, DOI 10.1002/j.1460-2075.1994.tb06317.x; Mayr MI, 2007, CURR BIOL, V17, P488, DOI 10.1016/j.cub.2007.02.036; Meadows JC, 2011, DEV CELL, V20, P739, DOI 10.1016/j.devcel.2011.05.008; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mizukami T, 1993, Tanpakushitsu Kakusan Koso, V38, P677; Newton CN, 2002, J BIOL CHEM, V277, P42456, DOI 10.1074/jbc.M207134200; Pereira AJ, 1997, J CELL BIOL, V136, P1081, DOI 10.1083/jcb.136.5.1081; Peters C, 2010, EMBO J, V29, P3437, DOI 10.1038/emboj.2010.220; Sagolla MJ, 2003, J CELL SCI, V116, P4891, DOI 10.1242/jcs.00796; Sanchez-Perez I, 2005, EMBO J, V24, P2931, DOI 10.1038/sj.emboj.7600761; Savoian MS, 2010, J CELL SCI, V123, P767, DOI 10.1242/jcs.055905; Sproul LR, 2005, CURR BIOL, V15, P1420, DOI 10.1016/j.cub.2005.06.066; Stout JR, 2011, MOL BIOL CELL, V22, P3070, DOI 10.1091/mbc.E11-04-0363; Straight AF, 1998, J CELL BIOL, V143, P687, DOI 10.1083/jcb.143.3.687; Stumpff J, 2008, DEV CELL, V14, P252, DOI 10.1016/j.devcel.2007.11.014; Stumpff J, 2011, MOL CELL, V43, P764, DOI 10.1016/j.molcel.2011.07.022; Su XL, 2011, MOL CELL, V43, P751, DOI 10.1016/j.molcel.2011.06.027; Tanaka TU, 2005, NAT REV MOL CELL BIO, V6, P929, DOI 10.1038/nrm1764; Tanenbaum ME, 2011, CURR BIOL, V21, P1356, DOI 10.1016/j.cub.2011.07.017; Tanenbaum ME, 2009, CURR BIOL, V19, P1703, DOI 10.1016/j.cub.2009.08.027; Tischer C, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.5; Tran PT, 1999, BIOL BULL, V197, P262, DOI 10.2307/1542640; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; Unsworth A, 2008, MOL BIOL CELL, V19, P5104, DOI 10.1091/mbc.E08-02-0224; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; Varga V, 2009, CELL, V138, P1174, DOI 10.1016/j.cell.2009.07.032; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Wang HF, 2010, CYTOSKELETON, V67, P715, DOI 10.1002/cm.20482; Warburg O., 1942, BIOCHEM Z, V310, P384; Wargacki MM, 2010, CELL CYCLE, V9, P2581, DOI 10.4161/cc.9.13.12076; Waterman-Storer C, 1998, CURRENT PROTOCOLS CE; Weaver LN, 2011, CURRENT BIOL CB; West RR, 2008, CELL MOTIL CYTOSKEL, V65, P626, DOI 10.1002/cm.20289; West RR, 2002, J CELL SCI, V115, P931; West RR, 2001, MOL BIOL CELL, V12, P3919, DOI 10.1091/mbc.12.12.3919; Wickstead B, 2006, MOL BIOL CELL, V17, P1734, DOI 10.1091/mbc.E05-11-1090; Zhu CJ, 2005, MOL BIOL CELL, V16, P3187, DOI 10.1091/mbc.E05-02-0167	78	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30738	10.1371/journal.pone.0030738	http://dx.doi.org/10.1371/journal.pone.0030738			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363481	Green Published, Green Submitted, gold			2022-12-27	WOS:000302871500015
J	Lieu, MH; Vallejos, MJ; Michael, E; Tsunoda, S				Lieu, Minh-Ha; Vallejos, Maximiliano J.; Michael, Emily; Tsunoda, Susan			Mechanisms Underlying Stage-1 TRPL Channel Translocation in Drosophila Photoreceptors	PLOS ONE			English	Article							INAD-SIGNALING COMPLEXES; SUBCELLULAR TRANSLOCATION; ACTIN-FILAMENTS; SACCHAROMYCES-CEREVISIAE; DEPENDENT TRANSLOCATION; VISUAL ARRESTIN; LIPID RAFTS; MYOSIN-III; CA2+ ENTRY; LIGHT	Background: channels function as key mediators of sensory transduction and other cellular signaling pathways. In Drosophila, TRP and TRPL are the light-activated channels in photoreceptors. While TRP is statically localized in the signaling compartment of the cell (the rhabdomere), TRPL localization is regulated by light. TRPL channels translocate out of the rhabdomere in two distinct stages, returning to the rhabdomere with dark-incubation. Translocation of TRPL channels regulates their availability, and thereby the gain of the signal. Little, however, is known about the mechanisms underlying this trafficking of TRPL channels. Methodology/Principal Findings: We first examine the involvement of de novo protein synthesis in TRPL translocation. We feed flies cycloheximide, verify inhibition of protein synthesis, and test for TRPL translocation in photoreceptors. We find that protein synthesis is not involved in either stage of TRPL translocation out of the rhabdomere, but that re-localization to the rhabdomere from stage-1, but not stage-2, depends on protein synthesis. We also characterize an ex vivo eye preparation that is amenable to biochemical and genetic manipulation. We use this preparation to examine mechanisms of stage-1 TRPL translocation. We find that stage-1 translocation is: induced with ATP depletion, unaltered with perturbation of the actin cytoskeleton or inhibition of endocytosis, and slowed with increased membrane sterol content. Conclusions/Significance: Our results indicate that translocation of TRPL out of the rhabdomere is likely due to protein transport, and not degradation/re-synthesis. Re-localization from each stage to the rhabdomere likely involves different strategies. Since TRPL channels can translocate to stage-1 in the absence of ATP, with no major requirement of the cytoskeleton, we suggest that stage-1 translocation involves simple diffusion through the apical membrane, which may be regulated by release of a light-dependent anchor in the rhabdomere.	[Lieu, Minh-Ha; Michael, Emily] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Vallejos, Maximiliano J.; Tsunoda, Susan] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA	Boston University; Colorado State University	Lieu, MH (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	Susan.Tsunoda@colostate.edu			National Institutes of Health (NIH) [EY013751]; NATIONAL EYE INSTITUTE [R01EY013751] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was funded by a National Institutes of Health (NIH) grant to ST (EY013751). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agam K, 2000, J NEUROSCI, V20, P5748, DOI 10.1523/JNEUROSCI.20-15-05748.2000; Agam K, 2004, CELL CALCIUM, V35, P87, DOI 10.1016/j.ceca.2003.08.001; Alloway PG, 2000, NEURON, V28, P129, DOI 10.1016/S0896-6273(00)00091-X; Arthington-Skaggs BA, 1999, J CLIN MICROBIOL, V37, P3332, DOI 10.1128/JCM.37.10.3332-3337.1999; Bahner M, 2002, NEURON, V34, P83, DOI 10.1016/S0896-6273(02)00630-X; Baumann O, 2001, NEUROSCI LETT, V306, P181, DOI 10.1016/S0304-3940(01)01900-0; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Calvert PD, 2006, TRENDS CELL BIOL, V16, P560, DOI 10.1016/j.tcb.2006.09.001; CASELLA JF, 1981, NATURE, V293, P302, DOI 10.1038/293302a0; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Cronin MA, 2004, J CELL SCI, V117, P4797, DOI 10.1242/jcs.01371; Cronin MA, 2006, J CELL SCI, V119, P2935, DOI 10.1242/jcs.03049; Eroglu C, 2003, P NATL ACAD SCI USA, V100, P10219, DOI 10.1073/pnas.1737042100; GRIGLIATTI TA, 1973, MOL GEN GENET, V120, P107, DOI 10.1007/BF00267238; Hardie RC, 2003, J BIOL CHEM, V278, P18851, DOI 10.1074/jbc.M300310200; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hongay C, 2002, EMBO J, V21, P4114, DOI 10.1093/emboj/cdf415; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; KEESLER GA, 1992, ARCH BIOCHEM BIOPHYS, V296, P474, DOI 10.1016/0003-9861(92)90600-2; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; Kosloff M, 2003, EMBO J, V22, P459, DOI 10.1093/emboj/cdg054; Lee SJ, 2004, NEURON, V43, P95, DOI 10.1016/j.neuron.2004.06.014; Lee SJ, 2003, NEURON, V39, P121, DOI 10.1016/S0896-6273(03)00390-8; Leung HT, 2000, J NEUROSCI, V20, P6797, DOI 10.1523/JNEUROSCI.20-18-06797.2000; Li LH, 2002, J GEN PHYSIOL, V119, P105, DOI 10.1085/jgp.119.1.105; Mehta D, 2003, J BIOL CHEM, V278, P33492, DOI 10.1074/jbc.M302401200; Meyer NE, 2006, J CELL SCI, V119, P2592, DOI 10.1242/jcs.02986; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; Oberegelsbacher C, 2011, EUR J CELL BIOL, V90, P620, DOI 10.1016/j.ejcb.2011.02.003; Orem NR, 2002, VISION RES, V42, P497, DOI 10.1016/S0042-6989(01)00229-2; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; REDEGELD FAM, 1992, EUR J PHARM-ENVIRON, V228, P229, DOI 10.1016/0926-6917(92)90034-A; Richter D, 2011, J BIOL CHEM, V286, P34234, DOI 10.1074/jbc.M111.278564; Rietveld A, 1999, J BIOL CHEM, V274, P12049, DOI 10.1074/jbc.274.17.12049; Sanxaridis PD, 2007, MOL CELL NEUROSCI, V36, P36, DOI 10.1016/j.mcn.2007.05.006; Satoh AK, 2010, NEURON, V67, P997, DOI 10.1016/j.neuron.2010.08.024; SLATER EC, 1966, B SOC CHIM BIOL, V48, P1151; Slepak VZ, 2008, IUBMB LIFE, V60, P2, DOI 10.1002/iub.7; TROCHA PJ, 1976, ARCH BIOCHEM BIOPHYS, V174, P45, DOI 10.1016/0003-9861(76)90322-2; Tsunoda S, 2001, J NEUROSCI, V21, P150, DOI 10.1523/JNEUROSCI.21-01-00150.2001; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Verkhovsky AB, 1997, J CELL SCI, V110, P1693; WICK AN, 1957, J BIOL CHEM, V224, P963	47	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31622	10.1371/journal.pone.0031622	http://dx.doi.org/10.1371/journal.pone.0031622			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363689	gold, Green Published, Green Submitted			2022-12-27	WOS:000302871500065
J	Alexander, J; Ward, S; Mendy, J; Manayani, DJ; Farness, P; Avanzini, JB; Guenther, B; Garduno, F; Jow, L; Snarsky, V; Ishioka, G; Dong, X; Vang, L; Newman, MJ; Mayall, T				Alexander, Jeff; Ward, Simone; Mendy, Jason; Manayani, Darly J.; Farness, Peggy; Avanzini, Jenny B.; Guenther, Ben; Garduno, Fermin; Jow, Lily; Snarsky, Victoria; Ishioka, Glenn; Dong, Xin; Vang, Lo; Newman, Mark J.; Mayall, Tim			Pre-Clinical Evaluation of a Replication-Competent Recombinant Adenovirus Serotype 4 Vaccine Expressing Influenza H5 Hemagglutinin	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; VIRAL VECTORS; AVIAN INFLUENZA; PREEXISTING IMMUNITY; PANDEMIC INFLUENZA; VIRUS-VACCINES; US MILITARY; B-VACCINE; IMMUNIZATION; IMMUNOGENICITY	Background: Influenza virus remains a significant health and social concern in part because of newly emerging strains, such as avian H5N1 virus. We have developed a prototype H5N1 vaccine using a recombinant, replication-competent Adenovirus serotype 4 (Ad4) vector, derived from the U. S. military Ad4 vaccine strain, to express the hemagglutinin (HA) gene from A/Vietnam/1194/2004 influenza virus (Ad4-H5-Vtn). Our hypothesis is that a mucosally-delivered replicating Ad4-H5-Vtn recombinant vector will be safe and induce protective immunity against H5N1 influenza virus infection and disease pathogenesis. Methodology/Principal Findings: The Ad4-H5-Vtn vaccine was designed with a partial deletion of the E3 region of Ad4 to accommodate the influenza HA gene. Replication and growth kinetics of the vaccine virus in multiple human cell lines indicated that the vaccine virus is attenuated relative to the wild type virus. Expression of the HA transgene in infected cells was documented by flow cytometry, western blot analysis and induction of HA-specific antibody and cellular immune responses in mice. Of particular note, mice immunized intranasally with the Ad4-H5-Vtn vaccine were protected against lethal H5N1 reassortant viral challenge even in the presence of pre-existing immunity to the Ad4 wild type virus. Conclusions/Significance: Several non-clinical attributes of this vaccine including safety, induction of HA-specific humoral and cellular immunity, and efficacy were demonstrated using an animal model to support Phase 1 clinical trial evaluation of this new vaccine.	[Alexander, Jeff; Ward, Simone; Mendy, Jason; Manayani, Darly J.; Farness, Peggy; Avanzini, Jenny B.; Guenther, Ben; Garduno, Fermin; Jow, Lily; Snarsky, Victoria; Ishioka, Glenn; Dong, Xin; Vang, Lo; Newman, Mark J.; Mayall, Tim] PaxVax Inc, San Diego, CA USA		Alexander, J (corresponding author), PaxVax Inc, San Diego, CA USA.	jalexander@paxvax.com		Newman, Mark J./0000-0002-0433-6690	Wellcome Trust, London, United Kingdom	Wellcome Trust, London, United Kingdom(Wellcome Trust)	This work was supported by The Wellcome Trust, London, United Kingdom (www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaman M, 2011, EMERG INFECT DIS, V17, P1056; Alcock R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000490; Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Appaiahgari MB, 2006, MICROBES INFECT, V8, P92, DOI 10.1016/j.micinf.2005.05.023; Arevalo MT, 2009, FEMS IMMUNOL MED MIC, V55, P346, DOI 10.1111/j.1574-695X.2008.00518.x; Barouch DH, 2005, HUM GENE THER, V16, P149, DOI 10.1089/hum.2005.16.149; Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Belyakov IM, 1999, P NATL ACAD SCI USA, V96, P4512, DOI 10.1073/pnas.96.8.4512; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Cerullo V, 2007, MOL THER, V15, P378, DOI 10.1038/sj.mt.6300031; CHENGALVALA MV, 1994, J GEN VIROL, V75, P125, DOI 10.1099/0022-1317-75-1-125; COUCH ROBERT B., 1963, AMER REV RESP DIS, V88, P394; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; Croyle MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003548; Dubey S, 2007, JAIDS-J ACQ IMM DEF, V45, P20, DOI 10.1097/QAI.0b013e3180377b5b; FULGINITI VA, 1967, J AMER MED ASSOC, V202, P1075, DOI 10.1001/jama.202.12.1075; Gabitzsch ES, 2009, VACCINE, V27, P6394, DOI 10.1016/j.vaccine.2009.06.028; Gao WT, 2006, J VIROL, V80, P1959, DOI 10.1128/JVI.80.4.1959-1964.2006; GAYDOS CA, 1995, MIL MED, V160, P300, DOI 10.1093/milmed/160.6.300; Gurwith M J, 1989, Semin Respir Infect, V4, P299; Hartman ZC, 2007, VIROLOGY, V358, P357, DOI 10.1016/j.virol.2006.08.041; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; Hoelscher MA, 2008, J INFECT DIS, V197, P1185, DOI 10.1086/529522; Holman DH, 2008, VACCINE, V26, P2627, DOI 10.1016/j.vaccine.2008.02.053; HSU KHL, 1994, VACCINE, V12, P607; Huang XP, 2009, HUM GENE THER, V20, P293, DOI 10.1089/hum.2008.141; JOHNSON PR, 1985, J MED VIROL, V17, P325, DOI 10.1002/jmv.1890170405; Kajon AE, 2007, J INFECT DIS, V196, P67, DOI 10.1086/518442; Kaneko H, 2004, ANTIVIR RES, V61, P63, DOI 10.1016/j.antiviral.2003.08.003; Khanam S, 2009, VACCINE, V27, P6011, DOI 10.1016/j.vaccine.2009.07.073; Knowles MK, 2009, VACCINE, V27, P6619, DOI 10.1016/j.vaccine.2009.08.005; Limbach KJ, 2009, PARASITE IMMUNOL, V31, P501, DOI 10.1111/j.1365-3024.2009.01141.x; Lore K, 2007, J IMMUNOL, V179, P1721, DOI 10.4049/jimmunol.179.3.1721; LUBECK MD, 1989, P NATL ACAD SCI USA, V86, P6763, DOI 10.1073/pnas.86.17.6763; Ludwig SL, 1998, J INFECT DIS, V178, P1776, DOI 10.1086/314498; Lyons A, 2008, VACCINE, V26, P2890, DOI [10.1016/j.vaccine.2008.03.037, 10.1016/J.vaccine.2008.03.037]; Muruve DA, 1999, HUM GENE THER, V10, P965, DOI 10.1089/10430349950018364; Narang A, 2009, HUM VACCINES, V5, P414, DOI 10.4161/hv.5.6.8176; Neumann G, 2010, CELL RES, V20, P51, DOI 10.1038/cr.2009.124; Park KS, 2009, VIROLOGY, V395, P182, DOI 10.1016/j.virol.2009.09.018; PEDREIRA FA, 1968, P SOC EXP BIOL MED, V129, P472; REED L. J., 1938, AMER JOUR HYG, V27, P493; Richardson JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005308; Robert-Guroff M, 2007, CURR OPIN BIOTECH, V18, P546, DOI 10.1016/j.copbio.2007.10.010; Roelvink PW, 1998, J VIROL, V72, P7909, DOI 10.1128/JVI.72.10.7909-7915.1998; Rollier CS, 2011, CURR OPIN IMMUNOL, V23, P377, DOI 10.1016/j.coi.2011.03.006; Santosuosso M, 2005, J IMMUNOL, V174, P7986, DOI 10.4049/jimmunol.174.12.7986; Shabram PW, 1997, HUM GENE THER, V8, P453, DOI 10.1089/hum.1997.8.4-453; Soboleski MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021937; Steitz J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010492; TACKET CO, 1992, VACCINE, V10, P673, DOI 10.1016/0264-410X(92)90088-2; Thacker EE, 2009, EXPERT REV VACCINES, V8, P761, DOI [10.1586/erv.09.29, 10.1586/ERV.09.29]; TOP FH, 1971, J INFECT DIS, V124, P148, DOI 10.1093/infdis/124.2.148; Tucker SN, 2008, EXPERT REV VACCINES, V7, P25, DOI 10.1586/14760584.7.1.25; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; Webster RG, 2006, EMERG INFECT DIS, V12, P3, DOI 10.3201/eid1201.051024; Wood JM, 2004, NAT REV MICROBIOL, V2, P842, DOI 10.1038/nrmicro979; Xiang ZQ, 2003, J VIROL, V77, P10780, DOI 10.1128/JVI.77.20.10780-10789.2003; Zhu JG, 2007, J VIROL, V81, P3170, DOI 10.1128/JVI.02192-06	60	50	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31177	10.1371/journal.pone.0031177	http://dx.doi.org/10.1371/journal.pone.0031177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363572	Green Published, gold			2022-12-27	WOS:000302853600120
J	Blaise, S; Kneib, M; Rousseau, A; Gambino, F; Chenard, MP; Messadeq, N; Muckenstrum, M; Alpy, F; Tomasetto, C; Humeau, Y; Rio, MC				Blaise, Sebastien; Kneib, Marie; Rousseau, Adrien; Gambino, Frederic; Chenard, Marie-Pierre; Messadeq, Nadia; Muckenstrum, Martine; Alpy, Fabien; Tomasetto, Catherine; Humeau, Yann; Rio, Marie-Christine			In Vivo Evidence That TRAF4 Is Required for Central Nervous System Myelin Homeostasis	PLOS ONE			English	Article							NECROSIS-FACTOR-RECEPTOR; CEREBELLAR PURKINJE-CELLS; TRAF4-DEFICIENT MICE; MOTOR COORDINATION; DEFICIENCY LEADS; MUTANT MICE; FAMILY; MOUSE; PROTEIN; INHIBITION	Tumor Necrosis Factor Receptor-Associated Factors (TRAFs) are major signal transducers for the TNF and interleukin-1/Toll-like receptor superfamilies. However, TRAF4 does not fit the paradigm of TRAF function in immune and inflammatory responses. Its physiological and molecular functions remain poorly understood. Behavorial analyses show that TRAF4-deficient mice (TRAF4-KO) exhibit altered locomotion coordination typical of ataxia. TRAF4-KO central nervous system (CNS) ultrastructure shows strong myelin perturbation including disorganized layers and disturbances in paranode organization. TRAF4 was previously reported to be expressed by CNS neurons. Using primary cell culture, we now show that TRAF4 is also expressed by oligodendrocytes, at all stages of their differentiation. Moreover, histology and electron microscopy show degeneration of a high number of Purkinje cells in TRAF4-KO mice, that was confirmed by increased expression of the Bax pro-apoptotic marker (immunofluorescence), TUNEL analysis, and caspase-3 activation and PARP1 cleavage (western blotting). Consistent with this phenotype, MAG and NogoA, two myelin-induced neurite outgrowth inhibitors, and their neuron partners, NgR and p75NTR were overexpressed (Q-RT-PCR and western blotting). The strong increased phosphorylation of Rock2, a RhoA downstream target, indicated that the NgR/p75NTR/RhoA signaling pathway, known to induce actin cytoskeleton rearrangement that favors axon regeneration inhibition and neuron apoptosis, is activated in the absence of TRAF4 (western blotting). Altogether, these results provide conclusive evidence for the pivotal contribution of TRAF4 to myelination and to cerebellar homeostasis, and link the loss of TRAF4 function to demyelinating or neurodegenerative diseases.	[Blaise, Sebastien; Rousseau, Adrien; Messadeq, Nadia; Alpy, Fabien; Tomasetto, Catherine; Rio, Marie-Christine] Univ Strasbourg, Ctr Natl Rech Sci,Inst Natl Sante & Rech Med, Funct Genom & Canc Dept,UMR7104, Inst Genet & Biol Mol & Cellulaire,U964, Illkirch Graffenstaden, France; [Kneib, Marie; Gambino, Frederic; Humeau, Yann] Ctr Natl Rech Sci, UPR3212, Strasbourg, France; [Chenard, Marie-Pierre; Muckenstrum, Martine] Ctr Hosp Univ Hautepierre, Dept Pathol, Strasbourg, France; Univ Reims, Reims, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Strasbourg; Universite de Reims Champagne-Ardenne	Blaise, S (corresponding author), Univ Reims, Ctr Natl Rech Sci, UMR6237, Reims, France.	rio@igbmc.fr	BLAISE, Sebastien/AAS-1022-2020; Alpy, Fabien/H-8941-2016; Alpy, Fabien/ABD-5893-2020; Chenard, Marie-Pierre/O-2373-2016; Tomasetto, Catherine Laure/J-2783-2014	BLAISE, Sebastien/0000-0003-3012-1500; Alpy, Fabien/0000-0002-0526-0720; Alpy, Fabien/0000-0002-0526-0720; Tomasetto, Catherine Laure/0000-0002-1811-5848; gambino, frederic/0000-0002-2981-5030; Rousseau, Adrien/0000-0001-8130-5380	Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; l'Agence Nationale pour la Recherche; Hopital Universitaire de Strasbourg; Association pour la Recherche sur le Cancer; Ligue Nationale Francaise contre le Cancer; Comites du Haut-Rhin et du Bas-Rhin; Institut National du Cancer; Fond National pour la Sante [ACI 2007]	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); l'Agence Nationale pour la Recherche(French National Research Agency (ANR)); Hopital Universitaire de Strasbourg; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nationale Francaise contre le Cancer(Ligue nationale contre le cancer); Comites du Haut-Rhin et du Bas-Rhin; Institut National du Cancer(Institut National du Cancer (INCA) France); Fond National pour la Sante	This work was supported by funds from the Institut National de la Sante et de la Recherche Medicale, the Centre National de la Recherche Scientifique, l'Agence Nationale pour la Recherche, the Hopital Universitaire de Strasbourg, the Association pour la Recherche sur le Cancer, the Ligue Nationale Francaise contre le Cancer (Equipe labellisee LIGUE 2010) and the Comites du Haut-Rhin et du Bas-Rhin, the Institut National du Cancer, Fond National pour la Sante ACI 2007 Canceropole Grand-Est. SB was recipient of an Institut National du Cancer fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloy EM, 2006, BRAIN CELL BIOL, V35, P137, DOI 10.1007/s11068-007-9014-3; Ariel M, 2009, CEREBELLUM, V8, P463, DOI 10.1007/s12311-009-0123-7; Aston C, 2004, J NEUROSCI RES, V77, P858, DOI 10.1002/jnr.20208; Becker EBE, 2009, P NATL ACAD SCI USA, V106, P6706, DOI 10.1073/pnas.0810599106; Bellen HJ, 1998, TRENDS NEUROSCI, V21, P444, DOI 10.1016/S0166-2236(98)01267-3; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; Blaise SA, 2007, AM J PATHOL, V170, P667, DOI 10.2353/ajpath.2007.060339; Boggs JM, 2006, CELL MOL LIFE SCI, V63, P1945, DOI 10.1007/s00018-006-6094-7; Buchet D, 2009, NEUROSCI LETT, V456, P112, DOI 10.1016/j.neulet.2008.09.086; Budel S, 2008, J NEUROSCI, V28, P13161, DOI 10.1523/JNEUROSCI.3828-08.2008; Camilleri-Broet S, 2007, ONCOGENE, V26, P142, DOI 10.1038/sj.onc.1209762; Cherfils-Vicini J, 2008, IMMUNOLOGY, V124, P562, DOI 10.1111/j.1365-2567.2008.02810.x; Christianson JA, 2007, NEUROSCIENCE, V145, P303, DOI 10.1016/j.neuroscience.2006.11.064; Chung JY, 2002, J CELL SCI, V115, P679; Contet C, 2006, NEUROPSYCHOPHARMACOL, V31, P1733, DOI 10.1038/sj.npp.1300934; D'Amelio M, 2010, CELL DEATH DIFFER, V17, P1104, DOI 10.1038/cdd.2009.180; Deiss V, 2000, NEUROSCIENCE, V95, P903; Dupuis L, 2008, P NATL ACAD SCI USA, V105, P740, DOI 10.1073/pnas.0703842105; Esparza EM, 2004, CELL MOL LIFE SCI, V61, P3087, DOI 10.1007/s00018-004-4417-0; Gambino F, 2009, EUR J NEUROSCI, V30, P1476, DOI 10.1111/j.1460-9568.2009.06975.x; Gao WC, 2006, J NEUROSCI, V26, P8377, DOI 10.1523/JNEUROSCI.2434-06.2006; Garwicz M, 2002, BRAIN RES REV, V40, P152, DOI 10.1016/S0165-0173(02)00198-4; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; Grusser-Cornehls U, 2001, PROG NEUROBIOL, V63, P489, DOI 10.1016/S0301-0082(00)00024-1; Guillemot L, 2008, BBA-BIOMEMBRANES, V1778, P601, DOI 10.1016/j.bbamem.2007.09.032; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Heitz S, 2008, DEV NEUROBIOL, V68, P332, DOI 10.1002/dneu.20555; Hoeger H, 2000, LIFE SCI, V66, P947, DOI 10.1016/S0024-3205(99)00678-5; Huber AB, 2002, J NEUROSCI, V22, P3553; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Inoue J, 2000, EXP CELL RES, V254, P14, DOI 10.1006/excr.1999.4733; Ito M, 2008, NAT REV NEUROSCI, V9, P304, DOI 10.1038/nrn2332; Kalkan T, 2009, MOL BIOL CELL, V20, P3436, DOI 10.1091/mbc.E08-03-0325; Kedinger V, 2005, GENE EXPR PATTERNS, V5, P545, DOI 10.1016/j.modgep.2004.10.011; Kedinger V, 2007, ADV EXP MED BIOL, V597, P60; Kedinger V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003518; Lalonde R, 2007, BRAIN RES, V1140, P51, DOI 10.1016/j.brainres.2006.01.031; Lee M, 2001, J NEUROSCI, V21, P3849, DOI 10.1523/JNEUROSCI.21-11-03849.2001; Lee PR, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.004.2009; Liem RKH, 2009, J CLIN INVEST, V119, P1814, DOI 10.1172/JCI38003; Liu HZ, 1999, CURR BIOL, V9, P101, DOI 10.1016/S0960-9822(99)80023-2; Mandillo S, 2008, PHYSIOL GENOMICS, V34, P243, DOI 10.1152/physiolgenomics.90207.2008; Masson R, 1998, MECH DEVELOP, V71, P187, DOI 10.1016/S0925-4773(97)00192-5; Mathew SJ, 2009, J CELL SCI, V122, P1939, DOI 10.1242/jcs.044487; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Motrescu ER, 2008, ONCOGENE, V27, P6347, DOI 10.1038/onc.2008.218; NORMAN DJ, 1995, DEVELOPMENT, V121, P1183; Pietrobon D, 2010, J PHYSIOL-LONDON, V588, P1871, DOI 10.1113/jphysiol.2010.188003; Preiss A, 2001, MECH DEVELOP, V100, P109, DOI 10.1016/S0925-4773(00)00506-2; REGNIER CH, 1995, J BIOL CHEM, V270, P25715, DOI 10.1074/jbc.270.43.25715; Regnier CH, 2002, P NATL ACAD SCI USA, V99, P5585, DOI 10.1073/pnas.052124799; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Rousseau Adrien, 2011, Cancers (Basel), V3, P2734, DOI 10.3390/cancers3022734; Shiels H, 2000, AM J PATHOL, V157, P679, DOI 10.1016/S0002-9440(10)64578-6; Simons M, 2006, J CELL SCI, V119, P4381, DOI 10.1242/jcs.03242; Spencer T, 2003, CURR OPIN NEUROBIOL, V13, P133, DOI 10.1016/S0959-4388(03)00012-6; Takeshita F, 2005, EUR J IMMUNOL, V35, P2477, DOI 10.1002/eji.200526151; Teigler A, 2009, HUM MOL GENET, V18, P1897, DOI 10.1093/hmg/ddp110; Terry S, 2010, PHYSIOLOGY, V25, P16, DOI 10.1152/physiol.00034.2009; Thaxton C, 2009, RESULTS PROBL CELL D, V48, P1, DOI 10.1007/400_2009_3; Timmann D, 2008, CEREBELLUM, V7, P602, DOI 10.1007/s12311-008-0066-4; Trapp BD, 2009, LANCET NEUROL, V8, P280, DOI 10.1016/S1474-4422(09)70043-2; Wajant H, 1998, J MOL EVOL, V47, P656, DOI 10.1007/PL00006423; Walter JT, 2006, NAT NEUROSCI, V9, P389, DOI 10.1038/nn1648; Wu RF, 2005, J CELL BIOL, V171, P893, DOI 10.1083/jcb.200507004; Xie F, 2008, EXP NEUROL, V209, P302, DOI 10.1016/j.expneurol.2007.07.005; Ye X, 1999, J BIOL CHEM, V274, P30202, DOI 10.1074/jbc.274.42.30202	67	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30917	10.1371/journal.pone.0030917	http://dx.doi.org/10.1371/journal.pone.0030917			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363515	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600089
J	Hosono, K; Ishigami, C; Takahashi, M; Park, DH; Hirami, Y; Nakanishi, H; Ueno, S; Yokoi, T; Hikoya, A; Fujita, T; Zhao, Y; Nishina, S; Shin, JP; Kim, IT; Yamamoto, S; Azuma, N; Terasaki, H; Sato, M; Kondo, M; Minoshima, S; Hotta, Y				Hosono, Katsuhiro; Ishigami, Chie; Takahashi, Masayo; Park, Dong Ho; Hirami, Yasuhiko; Nakanishi, Hiroshi; Ueno, Shinji; Yokoi, Tadashi; Hikoya, Akiko; Fujita, Taichi; Zhao, Yang; Nishina, Sachiko; Shin, Jae Pil; Kim, In Taek; Yamamoto, Shuichi; Azuma, Noriyuki; Terasaki, Hiroko; Sato, Miho; Kondo, Mineo; Minoshima, Shinsei; Hotta, Yoshihiro			Two Novel Mutations in the EYS Gene Are Possible Major Causes of Autosomal Recessive Retinitis Pigmentosa in the Japanese Population	PLOS ONE			English	Article							USH2A GENE; IDENTIFICATION; ORTHOLOG; FREQUENT	Retinitis pigmentosa (RP) is a highly heterogeneous genetic disease including autosomal recessive (ar), autosomal dominant (ad), and X-linked inheritance. Recently, arRP has been associated with mutations in EYS (Eyes shut homolog), which is a major causative gene for this disease. This study was conducted to determine the spectrum and frequency of EYS mutations in 100 Japanese arRP patients. To determine the prevalence of EYS mutations, all EYS exons were screened for mutations by polymerase chain reaction amplification, and sequence analysis was performed. We detected 67 sequence alterations in EYS, of which 21 were novel. Of these, 7 were very likely pathogenic mutations, 6 were possible pathogenic mutations, and 54 were predicted non-pathogenic sequence alterations. The minimum observed prevalence of distinct EYS mutations in our study was 18% (18/100, comprising 9 patients with 2 very likely pathogenic mutations and the remaining 9 with only one such mutation). Among these mutations, 2 novel truncating mutations, c.4957_4958insA (p.S1653KfsX2) and c.8868C>A (p.Y2956X), were identified in 16 patients and accounted for 57.1% (20/35 alleles) of the mutated alleles. Although these 2 truncating mutations were not detected in Japanese patients with adRP or Leber's congenital amaurosis, we detected them in Korean arRP patients. Similar to Japanese arRP results, the c.4957_4958insA mutation was more frequently detected than the c.8868C>.A mutation. The 18% estimated prevalence of very likely pathogenic mutations in our study suggests a major involvement of EYS in the pathogenesis of arRP in the Japanese population. Mutation spectrum of EYS in 100 Japanese patients, including 13 distinct very likely and possible pathogenic mutations, was largely different from the previously reported spectrum in patients from non-Asian populations. Screening for c. 4957_4958insA and c.8868C>A mutations in the EYS gene may therefore be very effective for the genetic testing and counseling of RP patients in Japan.	[Hosono, Katsuhiro; Hikoya, Akiko; Fujita, Taichi; Zhao, Yang; Sato, Miho; Hotta, Yoshihiro] Hamamatsu Univ Sch Med, Dept Ophthalmol, Hamamatsu, Shizuoka, Japan; [Ishigami, Chie; Takahashi, Masayo] RIKEN Ctr Dev Biol, Lab Retinal Regenerat, Kobe, Hyogo, Japan; [Park, Dong Ho; Shin, Jae Pil; Kim, In Taek] Kyungpook Natl Univ Hosp, Dept Ophthalmol, Taegu, South Korea; [Hirami, Yasuhiko] Inst Biomed Res & Innovat Hosp, Dept Ophthalmol, Kobe, Hyogo, Japan; [Nakanishi, Hiroshi] Hamamatsu Univ Sch Med, Dept Otolaryngol, Hamamatsu, Shizuoka, Japan; [Ueno, Shinji; Terasaki, Hiroko; Kondo, Mineo] Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Nagoya, Aichi 4648601, Japan; [Yokoi, Tadashi; Nishina, Sachiko; Azuma, Noriyuki] Natl Ctr Child Hlth & Dev, Dept Ophthalmol, Tokyo, Japan; [Yokoi, Tadashi; Nishina, Sachiko; Azuma, Noriyuki] Natl Ctr Child Hlth & Dev, Cell Biol Lab, Tokyo, Japan; [Zhao, Yang; Minoshima, Shinsei] Hamamatsu Univ Sch Med, Med Photon Res Ctr, Dept Photomed Genom, Basic Med Photon Lab, Hamamatsu, Shizuoka, Japan; [Yamamoto, Shuichi] Chiba Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Chiba, Japan	Hamamatsu University School of Medicine; RIKEN; Kyungpook National University; Kyungpook National University Hospital; Institute for Biomedical Research & Innovation (IBRI); Hamamatsu University School of Medicine; Nagoya University; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; Hamamatsu University School of Medicine; Chiba University	Hosono, K (corresponding author), Hamamatsu Univ Sch Med, Dept Ophthalmol, Hamamatsu, Shizuoka, Japan.	hosono@hama-med.ac.jp	Ueno, Shinji/M-5063-2014; Terasaki, Hiroko/M-5054-2014; Hotta, Yoshihiro/O-5115-2019	Hotta, Yoshihiro/0000-0003-4052-5066; Minoshima, Satoshi/0000-0002-0043-3047	Ministry of Health, Labour and Welfare (Research on Measures for Intractable Diseases); Japan Society for the Promotion of Science [23592561, 23791975]; Grants-in-Aid for Scientific Research [22390327, 23592562, 23592603, 24659770] Funding Source: KAKEN	Ministry of Health, Labour and Welfare (Research on Measures for Intractable Diseases)(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by research grants from the Ministry of Health, Labour and Welfare (Research on Measures for Intractable Diseases) and from the Japan Society for the Promotion of Science (Grant-in-Aid for Scientific Research (C) 23592561 and Grant-in Aid for Young Scientists (B) 23791975). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Aziz MM, 2008, NAT GENET, V40, P1285, DOI 10.1038/ng.241; Abd El-Aziz MM, 2010, INVEST OPHTH VIS SCI, V51, P4266, DOI 10.1167/iovs.09-5109; Audo I, 2010, HUM MUTAT, V31, pE1406, DOI 10.1002/humu.21249; Bandah-Rozenfeld D, 2010, INVEST OPHTH VIS SCI, V51, P4387, DOI 10.1167/iovs.09-4732; Barragan I, 2010, HUM MUTAT, V31, pE1772, DOI 10.1002/humu.21334; Collin RWJ, 2008, AM J HUM GENET, V83, P594, DOI 10.1016/j.ajhg.2008.10.014; Dreyer B, 2001, AM J HUM GENET, V69, P228, DOI 10.1086/321269; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hayakawa M, 1997, JPN J OPHTHALMOL, V41, P1, DOI 10.1016/S0021-5155(96)00018-4; HOTTA Y, 1992, Nippon Ganka Gakkai Zasshi, V96, P237; Huang YK, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-121; Jin ZB, 2008, J MED GENET, V45, P465, DOI 10.1136/jmg.2007.056416; Khan MI, 2010, MOL VIS, V16, P2753; Littink KW, 2010, OPHTHALMOLOGY, V117, P2026, DOI 10.1016/j.ophtha.2010.01.040; Pieras JI, 2011, INVEST OPHTH VIS SCI, V52, P5625, DOI 10.1167/iovs.11-7292; Rivolta C, 2000, AM J HUM GENET, V66, P1975, DOI 10.1086/302926; Seyedahmadia BJ, 2004, EXP EYE RES, V79, P167, DOI 10.1016/j.exer.2004.03.005	17	74	77	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31036	10.1371/journal.pone.0031036	http://dx.doi.org/10.1371/journal.pone.0031036			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363543	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600103
J	Lee, J; Hong, SW; Chae, SW; Kim, DH; Choi, JH; Bae, JC; Park, SE; Rhee, EJ; Park, CY; Oh, KW; Park, SW; Kim, SW; Lee, WY				Lee, Jinmi; Hong, Seok-Woo; Chae, Seoung Wan; Kim, Dong Hoon; Choi, Ji Hun; Bae, Ji Cheol; Park, Se Eun; Rhee, Eun-Jung; Park, Cheol-Young; Oh, Ki-Won; Park, Sung-Woo; Kim, Sun-Woo; Lee, Won-Young			Exendin-4 Improves Steatohepatitis by Increasing Sirt1 Expression in High-Fat Diet-Induced Obese C57BL/6J Mice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; HEPATIC STEATOSIS; GLP-1 RECEPTOR; FOOD-INTAKE; INSULIN-RESISTANCE; ENERGY-EXPENDITURE; DIABETES-MELLITUS; SIGNALING PATHWAY; LIVER-DISEASE; RISK-FACTORS	The effects of exendin-4 on Sirt1 expression as a mechanism of reducing fatty liver have not been previously reported. Therefore, we investigated whether the beneficial effects of exendin-4 treatment on fatty liver are mediated via Sirt1 in high-fat (HF) diet-induced obese C57BL/6J mice and related cell culture models. Exendin-4 treatment decreased body weight, serum free fatty acid (FA), and triglyceride levels in HF-induced obese C57BL/6J mice. Histological analysis showed that exendin-4 reversed HF-induced hepatic accumulation of lipids and inflammation. Exendin-4 treatment increased mRNA and protein expression of Sirt1 and its downstream factor, AMPK, in vivo and also induced genes associated with FA oxidation and glucose metabolism. In addition, a significant increase in the hepatic expression of Lkb1 and Nampt mRNA was observed in exendin-4-treated groups. We also observed increased expression of phospho-Foxo1 and GLUT2, which are involved in hepatic glucose metabolism. In HepG2 and Huh7 cells, mRNA and protein expressions of GLP-1R were increased by exendin-4 treatment in a dose-dependent manner. Exendin-4 enhanced protein expression of Sirt1 and phospho-AMPK alpha in HepG2 cells treated with 0.4 mM palmitic acid. We also found that Sirt1 was an upstream regulator of AMPK in hepatocytes. A novel finding of this study was the observation that expression of GLP-1R is proportional to exendin-4 concentration and exendin-4 could attenuate fatty liver through activation of Sirt1.	[Lee, Jinmi; Hong, Seok-Woo] Sungkyunkwan Univ, Sch Med, Inst Med Res, Kangbuk Samsung Hosp, Seoul, South Korea; [Chae, Seoung Wan; Kim, Dong Hoon] Sungkyunkwan Univ, Sch Med, Dept Pathol, Kangbuk Samsung Hosp, Seoul, South Korea; [Choi, Ji Hun; Bae, Ji Cheol; Park, Se Eun; Rhee, Eun-Jung; Park, Cheol-Young; Oh, Ki-Won; Park, Sung-Woo; Kim, Sun-Woo; Lee, Won-Young] Sungkyunkwan Univ, Sch Med, Dept Endocrinol & Metab, Kangbuk Samsung Hosp, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, J (corresponding author), Sungkyunkwan Univ, Sch Med, Inst Med Res, Kangbuk Samsung Hosp, Seoul, South Korea.	drlwy@hanmail.net	Rhee, Eun-Jung/M-9294-2015; LEE, WON-YOUNG/C-7249-2018; Park, Cheol-Young/C-6690-2018	Rhee, Eun-Jung/0000-0002-6108-7758; LEE, WON-YOUNG/0000-0002-1082-7592; Park, Cheol-Young/0000-0002-9415-9965	Samsung Biomedical Research Institute [C-A8-223-2]; Korea Science and Engineering Foundation by the Ministry of Education, Science and Technology [S-2010-1115-000]	Samsung Biomedical Research Institute(Samsung); Korea Science and Engineering Foundation by the Ministry of Education, Science and Technology	This study was supported by a grant from Samsung Biomedical Research Institute # C-A8-223-2 (http://www.sbri.or.kr) and Korea Science and Engineering Foundation by the Ministry of Education, Science and Technology # S-2010-1115-000 (http://www.mest.go.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2006, POSTGRAD MED J, V82, P315, DOI 10.1136/pgmj.2005.042200; Ahren B, 2004, HORM METAB RES, V36, P867, DOI 10.1055/s-2004-826178; Ajmo JM, 2008, AM J PHYSIOL-GASTR L, V295, pG833, DOI 10.1152/ajpgi.90358.2008; Arnes L, 2009, REGUL PEPTIDES, V153, P88, DOI 10.1016/j.regpep.2008.08.005; Awazawa M, 2009, BIOCHEM BIOPH RES CO, V382, P51, DOI 10.1016/j.bbrc.2009.02.131; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Bellentani S, 2000, ANN INTERN MED, V132, P112, DOI 10.7326/0003-4819-132-2-200001180-00004; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Chaudhary N, 2009, CURR OPIN CLIN NUTR, V12, P431, DOI 10.1097/MCO.0b013e32832cdaae; Ding XK, 2006, HEPATOLOGY, V43, P173, DOI 10.1002/hep.21006; Donahey JCK, 1998, BRAIN RES, V779, P75, DOI 10.1016/S0006-8993(97)01057-3; Fulco M, 2008, CELL CYCLE, V7, P3669, DOI 10.4161/cc.7.23.7164; Giorgino F, 2006, DIABETES RES CLIN PR, V74, pS152, DOI 10.1016/S0168-8227(06)70021-3; Gupta NA, 2010, HEPATOLOGY, V51, P1584, DOI 10.1002/hep.23569; Gutzwiller JP, 1999, AM J PHYSIOL-REG I, V276, pR1541, DOI 10.1152/ajpregu.1999.276.5.R1541; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Klonoff DC, 2008, CURR MED RES OPIN, V24, P275, DOI 10.1185/030079908X253870; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Park S, 2010, METABOLISM, V59, P123, DOI 10.1016/j.metabol.2009.06.026; Purushotham A, 2009, AGING-US, V1, P669, DOI 10.18632/aging.100076; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Song ZY, 2007, BASIC CLIN PHARMACOL, V101, P262, DOI 10.1111/j.1742-7843.2007.00116.x; Svegliati-Baroni G, 2011, LIVER INT, V31, P1285, DOI 10.1111/j.1478-3231.2011.02462.x; Szayna M, 2000, ENDOCRINOLOGY, V141, P1936, DOI 10.1210/en.141.6.1936; THORENS B, 1993, DIABETES, V42, P1678, DOI 10.2337/diabetes.42.11.1678; Tiikkainen M, 2003, DIABETES, V52, P701, DOI 10.2337/diabetes.52.3.701; Tushuizen ME, 2006, LIVER INT, V26, P1015, DOI 10.1111/j.1478-3231.2006.01315.x; Wang GL, 2009, BIOCHEM BIOPH RES CO, V380, P644, DOI 10.1016/j.bbrc.2009.01.163; Yamada T, 2010, J GASTROEN HEPATOL, V25, P352, DOI 10.1111/j.1440-1746.2009.05998.x; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	34	76	81	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31394	10.1371/journal.pone.0031394	http://dx.doi.org/10.1371/journal.pone.0031394			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363635	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600145
J	Suzue, T; Hoshikawa, Y; Nishihara, S; Fujikawa, A; Miyatake, N; Sakano, N; Yoda, T; Yoshioka, A; Hirao, T				Suzue, Takeshi; Hoshikawa, Yoichi; Nishihara, Shuzo; Fujikawa, Ai; Miyatake, Nobuyuki; Sakano, Noriko; Yoda, Takeshi; Yoshioka, Akira; Hirao, Tomohiro			The New School Absentees Reporting System for Pandemic Influenza A/H1N1 2009 Infection in Japan	PLOS ONE			English	Article							SYNDROMIC SURVEILLANCE SYSTEM; NEW-YORK-CITY; DISEASE SURVEILLANCE	Objective: To evaluate the new Japanese School Absentees Reporting System for Infectious Disease (SARSID) for pandemic influenza A/H1N1 2009 infection in comparison with the National epidemiological Surveillance of Infectious Disease (NESID). Methods: We used data of 53,223 students (97.7%) in Takamatsu city Japan. Data regarding school absentees in SARSID was compared with that in NESID from Oct 13, 2009 to Jan 12, 2010. Results: Similar trends were observed both in SARSID and NESID. However, the epidemic trend for influenza in SARSID was thought to be more sensitive than that in NESID. Conclusion: The epidemic trend for influenza among school-aged children could be easily and rapidly assessed by SARSID compared to NESID. SARSID might be useful for detecting the epidemic trend of influenza.	[Suzue, Takeshi; Yoda, Takeshi; Yoshioka, Akira; Hirao, Tomohiro] Kagawa Univ, Fac Med, Dept Publ Hlth, Takamatsu, Kagawa 760, Japan; [Hoshikawa, Yoichi; Nishihara, Shuzo] Kagawa Prefectural Govt, Fac Med, Dept Hlth & Welf, Kagawa, Japan; [Fujikawa, Ai] Takamatsu City Publ Hlth Ctr, Kagawa, Japan; [Miyatake, Nobuyuki; Sakano, Noriko] Kagawa Univ, Fac Med, Dept Hyg, Takamatsu, Kagawa 760, Japan	Kagawa University; Kagawa University	Suzue, T (corresponding author), Kagawa Univ, Fac Med, Dept Publ Hlth, Takamatsu, Kagawa 760, Japan.	suzue@med.kagawa-u.ac.jp	Yoda, Takeshi/AAW-5384-2021	Yoda, Takeshi/0000-0001-6950-5056	Kagawa University	Kagawa University	This research was supported in part by a research grant from the Kagawa University fund of regional contribution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Besculides M, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-105; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Doroshenko Alexander, 2005, MMWR Suppl, V54, P117; Greenko J, 2003, J URBAN HEALTH, V80, pI50; Hatchett RJ, 2007, P NATL ACAD SCI USA, V104, P7582, DOI 10.1073/pnas.0610941104; Kamigaki T, 2009, PLOS CURR, V1, DOI DOI 10.1371/CURRENTS.RRN1139; Khazeni N, 2009, ANN INTERN MED, V151, P829, DOI [10.7326/0000605-200912150-00157, 10.7326/0003-4819-151-12-200912150-00157]; Lazarus R, 2002, EMERG INFECT DIS, V8, P753, DOI 10.3201/eid0808.020239; Ohkusa Yasushi, 2005, MMWR Suppl, V54, P47; Ohta A, 2007, J EPIDEMIOL, V17, pS14, DOI 10.2188/jea.17.S14; Schmidt WP, 2010, EURO SURVEILL, V15; Sugiura H, 2010, EPIDEMIOL INFECT, V13, P1; Taniguchi K, 2007, J EPIDEMIOL, V17, pS3, DOI 10.2188/jea.17.S3; World Health Organization, 2009, INFL LIK ILL US MEX; Wu TSJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-18	15	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30639	10.1371/journal.pone.0030639	http://dx.doi.org/10.1371/journal.pone.0030639			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363458	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600045
J	Zhang, QW; Zhang, XM; Wu, H; Seto, D; Zhang, HJ; Chen, ZW; Wan, CS; Zheng, BJ				Zhang, Qiwei; Zhang, Xiaomin; Wu, Hao; Seto, Donald; Zhang, Hao-Jie; Chen, Zhiwei; Wan, Chengsong; Zheng, Bo-Jian			Parental LTRs Are Important in a Construct of a Stable and Efficient Replication-Competent Infectious Molecular Clone of HIV-1 CRF08_BC	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CELLULAR TRANSCRIPTION FACTOR; CIRCULATING RECOMBINANT; FUNCTIONAL-ANALYSIS; SUBTYPE; EXPRESSION; RETROVIRUS; SEQUENCES; PROVINCE; TATA	Circulating recombinant forms (CRFs) of HIV-1 have been identified in southern China in recent years. CRF08_BC is one of the most predominant subtypes circulating in China. In order to study HIV subtype biology and to provide a tool for biotechnological applications, the first full-length replication-competent infectious molecular clone harboring CRF08_BC is reported. The construction of this clone pBRGX indicates that a moderate-copy number vector is required for its amplification in E. coli. In addition, it is shown that the parental CRF08_BC LTRs are important for generating this efficient replication-competent infectious clone. These observations may aid in the construction of infectious clones from other subtypes. Both the pBRGX-derived virus and its parental isolate contain CCR5 tropism. Their full-length genomes were also sequenced, analyzed, compared and deposited in GenBank (JF719819 and JF719818, respectively). The availability of pBRGX as the first replication-competent molecular clone of CRF08_BC provides a useful tool for a wide range of studies of this newly emergent HIV subtype, including the development of HIV vaccine candidates, antiviral drug screening and drug resistance analysis.	[Zhang, Qiwei; Zhang, Xiaomin; Wu, Hao; Zhang, Hao-Jie; Chen, Zhiwei; Zheng, Bo-Jian] Univ Hong Kong, Dept Microbiol, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Zhang, Qiwei; Wan, Chengsong] So Med Univ, Dept Microbiol, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China; [Seto, Donald] George Mason Univ, Sch Syst Biol, Manassas, VA USA; [Chen, Zhiwei] Univ Hong Kong, AIDS Inst, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Southern Medical University - China; George Mason University; University of Hong Kong	Zhang, QW (corresponding author), Univ Hong Kong, Dept Microbiol, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China.	zhang.qiwei@yahoo.com; bzheng@hkucc.hku.hk	Chen, Zhiwei/B-7793-2019; Zhang, Qiwei/D-9110-2012; Zhang, Qiwei/AAX-1977-2020	Chen, Zhiwei/0000-0002-4511-2888; Zhang, Qiwei/0000-0002-2770-111X; 	AIDS Trust; Hong Kong SAR Government; HKU [200907176015]	AIDS Trust; Hong Kong SAR Government; HKU(University of Hong Kong)	This work was financially supported by AIDS Trust Fund, Hong Kong SAR Government and HKU Small Project Funding (200907176015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Azzi S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0016001; BERKHOUT B, 1992, J VIROL, V66, P139, DOI 10.1128/JVI.66.1.139-149.1992; Chen L, 2011, AIDS RES HUM RETROVI; Courtois G, 2005, CELL MOL LIFE SCI, V62, P1682, DOI 10.1007/s00018-005-5031-5; GARCIA JA, 1989, EMBO J, V8, P765, DOI 10.1002/j.1460-2075.1989.tb03437.x; GRIFFIN GE, 1989, NATURE, V339, P70, DOI 10.1038/339070a0; JONES KA, 1986, SCIENCE, V232, P755, DOI 10.1126/science.3008338; KAWAMURA M, 1992, VIROLOGY, V188, P850, DOI 10.1016/0042-6822(92)90540-6; KOYANAGI Y, 1988, SCIENCE, V241, P1673, DOI 10.1126/science.3047875; Kusagawa S, 2002, AIDS RES HUM RETROV, V18, P115, DOI 10.1089/08892220252779656; Laeyendecker O, 2005, JAIDS-J ACQ IMM DEF, V38, P356; Li L, 2010, AIDS RES HUM RETROV, V26, P711, DOI 10.1089/aid.2010.0001; MARCINIAK RA, 1990, CELL, V63, P791, DOI 10.1016/0092-8674(90)90145-5; Meng ZF, 2008, AIDS RES HUM RETROV, V24, P259, DOI 10.1089/aid.2007.0128; Mochizuki N, 1999, AIDS RES HUM RETROV, V15, P1321, DOI 10.1089/088922299310223; Montano MA, 1997, J VIROL, V71, P8657, DOI 10.1128/JVI.71.11.8657-8665.1997; Montano MA, 1998, J VIROL, V72, P8446, DOI 10.1128/JVI.72.10.8446-8452.1998; Mu YX, 2011, VIRUS RES, V156, P81, DOI 10.1016/j.virusres.2011.01.001; MUESING MA, 1987, CELL, V48, P691, DOI 10.1016/0092-8674(87)90247-9; Mukai T, 2002, AIDS RES HUM RETROV, V18, P585, DOI 10.1089/088922202753747932; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Naghavi MH, 1999, AIDS RES HUM RETROV, V15, P1293, DOI 10.1089/088922299310197; Ndung'u T, 2001, J VIROL, V75, P4964, DOI 10.1128/JVI.75.11.4964-4972.2001; Novelli P, 2002, AIDS RES HUM RETROV, V18, P85, DOI 10.1089/088922202753394754; PEDEN KWC, 1992, J ACQ IMMUN DEF SYND, V5, P313; Pereira LA, 2000, NUCLEIC ACIDS RES, V28, P663, DOI 10.1093/nar/28.3.663; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; PRAKASH K, 1991, BIOCHEM BIOPH RES CO, V179, P1377, DOI 10.1016/0006-291X(91)91725-R; Qiu J, 2011, SCIENCE, V332, P1253, DOI 10.1126/science.332.6035.1253; de Arellano ER, 2010, ANTIVIR RES, V88, P152, DOI 10.1016/j.antiviral.2010.08.007; Rodriguez MA, 2006, VIROLOGY, V345, P328, DOI 10.1016/j.virol.2005.09.053; ROSEN CA, 1985, CELL, V41, P813, DOI 10.1016/S0092-8674(85)80062-3; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010631; Shi BS, 2004, AIDS RES HUM RETROV, V20, P1015, DOI 10.1089/aid.2004.20.1015; Su Qi-jian, 2010, Chinese Journal of Virology, V26, P290; Takeuchi H, 2002, AIDS RES HUM RETROV, V18, P1127, DOI 10.1089/088922202320567860; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tebit DM, 2004, VIROLOGY, V326, P329, DOI 10.1016/j.virol.2004.05.027; Tebit DM, 2003, VIROLOGY, V313, P645, DOI 10.1016/S0042-6822(03)00381-7; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Tee KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006666; van der Sluis RM, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-73; Vodicka MA, 1997, VIROLOGY, V233, P193, DOI 10.1006/viro.1997.8606; Wang Z, 2008, AIDS RES HUM RETROV, V24, P251, DOI 10.1089/aid.2007.0226; Wu S-I, 2010, ARCH VIROL, P1; Yang RG, 2002, AIDS, V16, P1401, DOI 10.1097/00002030-200207050-00012; Yu G, 2009, AIDS RES HUM RETROV, V25, P869, DOI 10.1089/aid.2008.0312; Yu XF, 1999, J ACQ IMMUN DEF SYND, V22, P180; ZENG Y, 1986, AIDS RES, V2, pS147; Zhang HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006108; Zhang QW, 2009, VACCINE, V27, P1145, DOI 10.1016/j.vaccine.2008.12.039; Zhang Y, 2006, PLOS MED, V3, P2065, DOI 10.1371/journal.pmed.0030443; Zhao XY, 2005, JAIDS-J ACQ IMM DEF, V38, P509, DOI 10.1097/01.qai.0000151004.19128.4a; Zhao XY, 2004, AIDS, V18, P1729, DOI 10.1097/01.aids.0000131382.15232.dc; ZHENG XW, 1994, AIDS, V8, P1141, DOI 10.1097/00002030-199408000-00017	59	20	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31233	10.1371/journal.pone.0031233	http://dx.doi.org/10.1371/journal.pone.0031233			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363589	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600127
J	Habel, JC; Husemann, M; Schmitt, T; Zachos, FE; Honnen, AC; Petersen, B; Parmakelis, A; Stathi, I				Habel, Jan C.; Husemann, Martin; Schmitt, Thomas; Zachos, Frank E.; Honnen, Ann-Christin; Petersen, Britt; Parmakelis, Aristeidis; Stathi, Iasmi			Microallopatry Caused Strong Diversification in Buthus scorpions (Scorpiones: Buthidae) in the Atlas Mountains (NW Africa)	PLOS ONE			English	Article							MESOBUTHUS-GIBBOSUS SCORPIONES; GENETIC DIVERSITY; GENUS BUTHUS; NORTH-AFRICA; GIBRALTAR; STRAIT; POPULATIONS; SPECIATION; OCCITANUS; CO1	The immense biodiversity of the Atlas Mountains in North Africa might be the result of high rates of microallopatry caused by mountain barriers surpassing 4000 meters leading to patchy habitat distributions. We test the influence of geographic structures on the phylogenetic patterns among Buthus scorpions using mtDNA sequences. We sampled 91 individuals of the genus Buthus from 51 locations scattered around the Atlas Mountains (Antiatlas, High Atlas, Middle Atlas and Jebel Sahro). We sequenced 452 bp of the Cytochrome Oxidase I gene which proved to be highly variable within and among Buthus species. Our phylogenetic analysis yielded 12 distinct genetic groups one of which comprised three subgroups mostly in accordance with the orographic structure of the mountain systems. Main clades overlap with each other, while subclades are distributed parapatrically. Geographic structures likely acted as long-term barriers among populations causing restriction of gene flow and allowing for strong genetic differentiation. Thus, genetic structure and geographical distribution of genetic (sub) clusters follow the classical theory of allopatric differentiation where distinct groups evolve without range overlap until reproductive isolation and ecological differentiation has built up. Philopatry and low dispersal ability of Buthus scorpions are the likely causes for the observed strong genetic differentiation at this small geographic scale.	[Habel, Jan C.] Nat Hist Museum Luxembourg, Luxembourg, Luxembourg; [Husemann, Martin] Baylor Univ, Dept Biol, Waco, TX 76798 USA; [Schmitt, Thomas] Univ Trier, Dept Biogeog, Trier, Germany; [Zachos, Frank E.] Nat Hist Museum Vienna, Vienna, Austria; [Honnen, Ann-Christin] Univ Kiel, Inst Zool, D-24098 Kiel, Germany; [Petersen, Britt] Univ Hosp SH Campus Kiel, Inst Clin Mol Biol, Kiel, Germany; [Parmakelis, Aristeidis] Natl & Kapodistrian Univ Athens, Dept Ecol & Taxon, Athens 11528, Greece; [Stathi, Iasmi] Univ Crete, Nat Hist Museum Crete, Iraklion, Crete, Greece	Baylor University; Universitat Trier; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; National & Kapodistrian University of Athens; University of Crete	Habel, JC (corresponding author), Nat Hist Museum Luxembourg, Luxembourg, Luxembourg.	Janchristianhabel@gmx.de	Husemann, Martin/C-4414-2015; Parmakelis, Aristeidis/AAD-1162-2020; Löscher, Britt-Sabina/I-1671-2012; Habel, Jan Christian/H-2112-2019	Husemann, Martin/0000-0001-5536-6681; Parmakelis, Aristeidis/0000-0003-3092-4194; Löscher, Britt-Sabina/0000-0001-9022-9017; Honnen, Ann-Christin/0000-0003-4355-7231; Habel, Jan Christian/0000-0003-1378-9381; Stathi, Iasmi/0000-0003-0747-1203	Fonds National de la Recherche Luxembourg; German Academic Exchange Service	Fonds National de la Recherche Luxembourg(Luxembourg National Research Fund); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD))	Funding was performed by the "Fonds National de la Recherche Luxembourg'' and the "German Academic Exchange Service''; furthermore, the Natural History Museum Luxembourg supported field work and laboratory analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglade F., 1990, Bulletin de la Societe Europeenne d'Arachnologie Hors Serie, P5; Barraclough TG, 2000, AM NAT, V155, P419, DOI 10.1086/303332; Brownell PH, 2001, SCORPION BIOL RES, P448; Cosson JF, 2005, MOL ECOL, V14, P1151, DOI 10.1111/j.1365-294X.2005.02476.x; De Lattin G., 1949, VERH DT ZOOL GES, V42, P143; Drummond AJ, 2006, GENEIOUS V5 0 3; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fet V., 2000, Catalog of the scorpions of the world (1758-1998); Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fritz U, 2006, ZOOL SCR, V35, P97, DOI 10.1111/j.1463-6409.2005.00218.x; Froufe E, 2008, BIOLOGIA, V63, P1157, DOI 10.2478/s11756-008-0176-y; Gantenbein B, 2005, P ROY SOC B-BIOL SCI, V272, P697, DOI 10.1098/rspb.2004.3017; Gantenbein B, 2004, EVOLUTION, V58, P2486, DOI 10.1111/j.0014-3820.2004.tb00878.x; Gantenbein B, 2004, BIOL J LINN SOC, V81, P519, DOI 10.1111/j.1095-8312.2003.00295.x; Gantenbein B, 2003, MOL PHYLOGENET EVOL, V28, P119, DOI 10.1016/S1055-7903(03)00031-9; Gomez A, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P155, DOI 10.1007/1-4020-4904-8_5; Habel JC, 2010, BIOL J LINN SOC, V99, P818, DOI 10.1111/j.1095-8312.2010.01394.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Joger U, 2007, ZOOL ANZ, V246, P293, DOI 10.1016/j.jcz.2007.09.002; Kaltsas D, 2008, J NAT HIST, V42, P513, DOI 10.1080/00222930701835498; Kaltsas D, 2010, J NAT HIST, V44, P1445, DOI 10.1080/00222931003632732; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lourenco Wilson R., 2002, Biogeographica (Paris), V78, P109; Lourenco WR, 2003, REV SUISSE ZOOL, V110, P875, DOI 10.5962/bhl.part.80218; Nylander JAA, 2004, MRMODELTEST 2 3; Polis G.A., 1990, P161; POLIS GA, 1985, OECOLOGIA, V67, P273, DOI 10.1007/BF00384298; Pollard DA, 2006, PLOS GENET, V2, P10; Rambaut A., 2007, TRACER RELEASE 1 4; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Schmitt T, 2006, MOL ECOL, V15, P1889, DOI 10.1111/j.1365-294X.2006.02900.x; Sousa P, 2011, AFR INVERTEBR, V52, P135, DOI 10.5733/afin.052.0106; Sousa P, 2010, J ARACHNOL, V38, P206, DOI 10.1636/H08-98.1; Stockmann R., 2010, SCORPIONS WORLD; SWOFFORD DL, PAUP PHYLOGENETIC AN; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vachon M, 1962, B MUSEUM NATL HIST 2, V34, P345; Vachon M, 1952, ETUDES SCORPIONS, P241; YAMASHITA T, 1995, J ARACHNOL, V23, P60	41	20	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e29403	10.1371/journal.pone.0029403	http://dx.doi.org/10.1371/journal.pone.0029403			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22383951	Green Published, Green Submitted, gold			2022-12-27	WOS:000302918500004
J	Cebrian, E; Rodriguez-Prieto, C				Cebrian, Emma; Rodriguez-Prieto, Conxi			Marine Invasion in the Mediterranean Sea: The Role of Abiotic Factors When There Is No Biological Resistance	PLOS ONE			English	Article							RACEMOSA VAR. CYLINDRACEA; FRAGILE SSP TOMENTOSOIDES; CAULERPA-TAXIFOLIA; CHROMATIC ADAPTATION; VEGETATION PATTERNS; SEASONAL DYNAMICS; NORRIS RHODOPHYTA; ADRIATIC SEA; ALGAL FLORA; TEMPERATURE	The tropical red alga Womersleyella setacea (Rhodomelaceae, Rhodophyta) is causing increasing concern in the Mediterranean Sea because of its invasive behavior. After its introduction it has colonized most Mediterranean areas, but the mechanism underlying its acclimatization and invasion process remains unknown. To understand this process, we decided i) to assess in situ the seasonal biomass and phenological patterns of populations inhabiting the Mediterranean Sea in relation to the main environmental factors, and ii) to experimentally determine if the tolerance of W. setacea to different light and temperature conditions can explain its colonization success, as well as its bathymetric distribution range. The bathymetric distribution, biomass, and phenology of W. setacea were studied at two localities, and related to irradiance and temperature values recorded in situ. Laboratory experiments were set up to study survival, growth and reproduction under contrasting light and temperature conditions in the short, mid, and long term. Results showed that, in the studied area, the bathymetric distribution of W. setacea is restricted to a depth belt between 25 and 40 m deep, reaching maximum biomass values (126 g dw m(-2)) at 30 m depth. In concordance, although in the short term W. setacea survived and grew in a large range of environmental conditions, its life requirements for the mid and long term were dim light levels and low temperatures. Biomass of Womersleyella setacea did not show any clear seasonal pattern, though minimum values were reported in spring. Reproductive structures were always absent. Bearing in mind that no herbivores feed on Womersleyella setacea and that its thermal preferences are more characteristic of temperate than of tropical seaweeds, low light (50 mu mol photon m(-2) s(-1)) and low temperature (12 degrees C) levels are critical for W. setacea survival and growth, thus probably determining its spread and bathymetric distribution across the Mediterranean Sea.	[Cebrian, Emma; Rodriguez-Prieto, Conxi] Univ Girona, Fac Ciencies, Dept Ciencies Ambientals, Girona, Spain; [Cebrian, Emma] Ctr Estudis Avancats Blanes CSIC, Blanes, Spain	Universitat de Girona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB)	Cebrian, E (corresponding author), Univ Girona, Fac Ciencies, Dept Ciencies Ambientals, Girona, Spain.	emma.cebrian@udg.edu	Prieto, Conxi Rodriguez/AAG-6987-2019; Cebrian, Emma/J-9640-2012	Prieto, Conxi Rodriguez/0000-0003-4935-1250; Cebrian, Emma/0000-0001-7588-0135	European Union reintegration [ERG-2009-248252]; Spanish Ministry of Science and Innovation [CGL2004-05556-C02-01]; Spanish Science and Innovation Ministry [JCI-2008-02753]	European Union reintegration; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Science and Innovation Ministry(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by an European Union reintegration grant (ERG-2009-248252) and a grant from the Spanish Ministry of Science and Innovation (CGL2004-05556-C02-01). Dr. Cebrian was funded by a Juan de la Cierva program (JCI-2008-02753) of the Spanish Science and Innovation Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIROLDI L, 1995, BOT MAR, V38, P227, DOI 10.1515/botm.1995.38.1-6.227; Airoldi L, 2000, ECOLOGY, V81, P798, DOI 10.2307/177378; Airoldi L, 1998, MAR ECOL PROG SER, V165, P271, DOI 10.3354/meps165271; Antoniadou C, 2007, J MAR BIOL ASSOC UK, V87, P629, DOI 10.1017/S0025315407048151; Athanasiadis A, 1997, BOT MAR, V40, P473, DOI 10.1515/botm.1997.40.1-6.473; Ballesteros E, 1992, ARXIUS SECCIO CIENCI, V101, P1; Ballesteros E, 1983, HIST NATURAL ARXIPEL, P663; Ballesteros E, 2006, OCEANOGR MAR BIOL, V44, P123; Ballesteros E, 2009, ESTUAR COAST SHELF S, V82, P477, DOI 10.1016/j.ecss.2009.02.013; Battelli C, 2008, PLANT BIOSYST, V142, P120, DOI 10.1080/11263500701872747; Benedetti-Cecchi L, 1989, GIORNALE BOT ITALIAN, V123, P49; Boudouresque CF, 2002, MAR POLLUT BULL, V44, P32, DOI 10.1016/S0025-326X(01)00150-3; BREEMAN AM, 1988, HELGOLANDER MEERESUN, V42, P199, DOI 10.1007/BF02366043; Cebrian E, 2004, SCI MAR, V68, P69, DOI 10.3989/scimar.2004.68n169; Cebrian E, 2011, BIOL INVASIONS, V13, P1397, DOI 10.1007/s10530-010-9898-1; Cebrian E, 2010, AQUAT BOT, V92, P81, DOI 10.1016/j.aquabot.2009.10.007; Cebrian E, 2009, ESTUAR COAST SHELF S, V83, P469, DOI 10.1016/j.ecss.2009.04.026; Chisholm JRM, 2000, MAR ECOL PROG SER, V201, P189, DOI 10.3354/meps201189; Drew EA, 1983, SUBLITTORAL ECOLOGY, P10; DRING MJ, 1981, LIMNOL OCEANOGR, V26, P271, DOI 10.4319/lo.1981.26.2.0271; DROOP M. R., 1967, BRIT PHYCOL BULL, V3, P295; Garrabou J, 1997, THESIS U BARCELONA B; GARRIGUE C, 1994, OCEANOL ACTA, V17, P563; Gollan JR, 2006, MAR FRESHWATER RES, V57, P685, DOI 10.1071/MF05253; GUIRY MD, 1984, PHYCOLOGIA, V23, P357, DOI 10.2216/i0031-8884-23-3-357.1; Hata H, 2002, J EXP MAR BIOL ECOL, V270, P215, DOI 10.1016/S0022-0981(02)00029-1; Hewitt CL, 2002, INVASIVE AQUATIC SPECIES OF EUROPE: DISTRIBUTION, IMPACTS AND MANAGEMENT, P456; HOLLENBERG GJ, 1968, PAC SCI, V22, P56; Ivesa L, 2006, AQUAT BOT, V85, P324, DOI 10.1016/j.aquabot.2006.06.009; Ivesa L, 2006, PERIOD BIOL, V108, P111; Izquierdo Ramirez C., 2003, MORFOLOGIA DESENVOLU, P115; Klein J, 2008, MAR POLLUT BULL, V56, P205, DOI 10.1016/j.marpolbul.2007.09.043; Komatsu T, 1997, MAR ECOL PROG SER, V146, P145, DOI 10.3354/meps146145; Lewin J., 1966, PHYCOLOGIA, V6, P1, DOI [10.2216/i0031-8884-6-1-1.1, DOI 10.2216/I0031-8884-6-1-1.1]; Linares C, MAR ECOL PR IN PRESS; Littler DS, MARINE PLANTS CARIBB; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Meinesz A, 1995, BOT MAR, V38, P499, DOI 10.1515/botm.1995.38.1-6.499; Mezgui Y, 2007, RAC SPA PUBL, P111; Morand P, 1996, BOT MAR, V39, P491, DOI 10.1515/botm.1996.39.1-6.491; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Piazzi L, 2002, BOT MAR, V45, P243, DOI 10.1515/BOT.2002.023; Piazzi L, 2001, BOT MAR, V44, P509, DOI 10.1515/BOT.2001.057; Piazzi L, 2009, BIOL INVASIONS, V11, P193, DOI 10.1007/s10530-008-9224-3; Pillen Thomas L., 1998, P327; RAMUS J, 1983, J PHYCOL, V19, P86, DOI 10.1111/j.0022-3646.1983.00086.x; Rindi F, 1999, HYDROBIOLOGIA, V399, P91; Rodriguez-Prieto C., 2005, ACT 15 S BOT CRIPT B, P54; Ruitton S, 2005, AQUAT BOT, V82, P55, DOI 10.1016/j.aquabot.2005.02.008; Sala E, 1997, MAR ECOL PROG SER, V152, P273, DOI 10.3354/meps152273; Sanchez N., 2005, THESIS U GIRONA GIRO, P227; Scheibling RE, 2008, J EXP MAR BIOL ECOL, V355, P103, DOI 10.1016/j.jembe.2007.12.002; Serio D, 2006, BOT MAR, V49, P135, DOI 10.1515/BOT.2006.018; Strong JA, 2009, J MAR BIOL ASSOC UK, V89, P303, DOI 10.1017/S0025315408003226; Sumi CBT, 2005, MAR ECOL PROG SER, V292, P203, DOI 10.3354/meps292203; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; Thibaut T, 2004, AQUAT BOT, V80, P291, DOI 10.1016/j.aquabot.2004.07.009; Thresher R.E., 2000, MARINE BIOINVASIONS, P24; Tomas F, 2011, ESTUAR COAST SHELF S, V92, P27, DOI 10.1016/j.ecss.2010.12.004; Tomas F, 2011, BIOL INVASIONS, V13, P1559, DOI 10.1007/s10530-010-9913-6; VERLAQUE M, 1989, BOT MAR, V32, P101, DOI 10.1515/botm.1989.32.2.101; VERLAQUE M, 1994, OCEANOL ACTA, V17, P1; Williams SL, 2002, MAR ECOL PROG SER, V233, P307, DOI 10.3354/meps233307; ZABALA M, 1989, Scientia Marina, V53, P3; Zenetos A, 2010, MEDITERR MAR SCI, V11, P381, DOI 10.12681/mms.87	65	10	12	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31135	10.1371/journal.pone.0031135	http://dx.doi.org/10.1371/journal.pone.0031135			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363565	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700029
J	Bourez, S; Le Lay, S; Van den Daelen, C; Louis, C; Larondelle, Y; Thome, JP; Schneider, YJ; Dugail, I; Debier, C				Bourez, Sophie; Le Lay, Soazig; Van den Daelen, Carine; Louis, Caroline; Larondelle, Yvan; Thome, Jean-Pierre; Schneider, Yves-Jacques; Dugail, Isabelle; Debier, Cathy			Accumulation of Polychlorinated Biphenyls in Adipocytes: Selective Targeting to Lipid Droplets and Role of Caveolin-1	PLOS ONE			English	Article							LOW-DENSITY LIPOPROTEIN; ADIPOSE-TISSUE; MEMBRANE-FLUIDITY; CELL-SURFACE; PCBS; 2,4,5,2',4',5'-HEXACHLOROBIPHENYL; LOCALIZATION; STIMULATION; TRAFFICKING; CHOLESTEROL	Background: Polychlorinated biphenyls (PCBs) are persistent environmental pollutants that preferentially accumulate in lipid-rich tissues of contaminated organisms. Although the adipose tissue constitutes a major intern reservoir of PCBs and recent epidemiological studies associate PCBs to the development of obesity and its related disorders, little is known about the mechanisms involved in their uptake by the adipose tissue and their intracellular localization in fat cells. Methodology/Principal Findings: We have examined the intracellular distribution of PCBs in mouse cultured adipocytes and tested the potential involvement of caveolin-1, an abundant adipocyte membrane protein, in the uptake of these compounds by fat cells. We show that 2,4,4'-trichlorobiphenyl (PCB-28), 2,3',4,4',5-pentachlorobiphenyl (PCB-118) and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB-153) congeners rapidly and extensively accumulate in 3T3-L1 or mouse embryonic fibroblast (MEF) derived cultured adipocytes. The dynamics of accumulation differed between the 3 congeners tested. By subcellular fractionation of primary adipocytes, we demonstrate that these pollutants were almost exclusively recovered within the lipid droplet fraction and practically not associated to cell membranes. The absence of caveolin-1 expression in primary adipocytes from cav-1 deficient mice did not modify lipid droplet selective targeting of PCBs. In cav-1 KO MEF differentiated adipocytes, PCB accumulation was decreased, which correlated with reduced cell triglyceride content. Conversely, adenoviral mediated cav-1 overexpressing in 3T3-L1 cells, which had no impact on total cell lipid content, did not change PCB accumulation. Conclusion/Significance: Our data indicate that caveolin-1 per se is not required for selective PCB accumulation, but rather point out a primary dependence on adipocyte triglyceride content. If the crucial role of lipid droplets in energy homeostasis is considered, the almost exclusive accumulation of PCBs in these organelles warrants future attention as the impairment of their function could be linked to the worldwide obesity epidemic.	[Bourez, Sophie; Van den Daelen, Carine; Louis, Caroline; Larondelle, Yvan; Schneider, Yves-Jacques; Debier, Cathy] UCLouvain, Inst Sci Vie, Louvain, Belgium; [Le Lay, Soazig; Dugail, Isabelle] Univ Paris 06, UMR S 872, Paris, France; [Thome, Jean-Pierre] Univ Liege, Lab Ecol Anim & Ecotoxicol, Liege, Belgium	Universite Catholique Louvain; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; University of Liege	Bourez, S (corresponding author), UCLouvain, Inst Sci Vie, Louvain, Belgium.	cathy.debier@uclouvain.be	Le Lay, Soazig/N-6862-2018; Dugail, Isabelle/L-1567-2017; Le Lay, Soazig/AAI-2442-2021	Dugail, Isabelle/0000-0003-3631-2252; Le Lay, Soazig/0000-0003-2456-2422				Arsenescu V, 2008, ENVIRON HEALTH PERSP, V116, P761, DOI 10.1289/ehp.10554; BECKER MM, 1982, J TOXICOL ENV HEALTH, V9, P225, DOI 10.1080/15287398209530157; BERANEK SR, 1984, ENVIRON RES, V34, P103, DOI 10.1016/0013-9351(84)90079-3; Blouin CM, 2010, J LIPID RES, V51, P945, DOI 10.1194/jlr.M001016; Briand N, 2011, DIABETES, V60, P448, DOI 10.2337/db10-0856; Carpenter David O., 2006, Reviews on Environmental Health, V21, P1; Couet J, 2001, ADV DRUG DELIVER REV, V49, P223, DOI 10.1016/S0169-409X(01)00139-9; De Saeger S, 2005, CHEMOSPHERE, V58, P953, DOI 10.1016/j.chemosphere.2004.09.069; Debier C, 2003, MAR ECOL PROG SER, V247, P237, DOI 10.3354/meps247237; Dirinck E, 2011, OBESITY, V19, P709, DOI 10.1038/oby.2010.133; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Hectors TLM, 2011, DIABETOLOGIA, V54, P1273, DOI 10.1007/s00125-011-2109-5; Irigaray P, 2006, FEBS J, V273, P1362, DOI 10.1111/j.1742-4658.2006.05159.x; Kim CA, 2008, J CLIN ENDOCR METAB, V93, P1129, DOI 10.1210/jc.2007-1328; Kim MJ, 2011, ENVIRON HEALTH PERSP, V119, P377, DOI 10.1289/ehp.1002848; KODAVANTI PRS, 1993, TOXICOL APPL PHARM, V123, P97, DOI 10.1006/taap.1993.1226; Le Lay S, 2006, TRAFFIC, V7, P549, DOI 10.1111/j.1600-0854.2006.00406.x; Lee DH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015977, 10.1371/journal.pone.0026172]; Lim EJ, 2007, AM J PHYSIOL-HEART C, V293, pH3340, DOI 10.1152/ajpheart.00921.2007; Lim EJ, 2008, CHEM-BIOL INTERACT, V176, P71, DOI 10.1016/j.cbi.2008.08.007; LopezAparicio P, 1997, PESTIC BIOCHEM PHYS, V57, P54, DOI 10.1006/pest.1997.2256; MATTHEWS HB, 1984, FUND APPL TOXICOL, V4, P420, DOI 10.1016/0272-0590(84)90199-4; Meeker JD, 2011, ENVIRON HEALTH PERSP, V119, P1010, DOI 10.1289/ehp.1002922; Mullerova D, 2007, PHYSIOL RES, V56, P375, DOI 10.33549/physiolres.931022; Pelletier C, 2003, Obes Rev, V4, P17, DOI 10.1046/j.1467-789X.2003.00085.x; Pilch PF, 2011, TRENDS ENDOCRIN MET, V22, P318, DOI 10.1016/j.tem.2011.04.001; Pol A, 2005, MOL BIOL CELL, V16, P2091, DOI 10.1091/mbc.E04-08-0737; RODBELL M, 1964, J BIOL CHEM, V239, P375; Sharma DK, 2004, MOL BIOL CELL, V15, P3114, DOI 10.1091/mbc.E04-03-0189; SPINDLERVOMACHKA M, 1984, TOXICOL APPL PHARM, V74, P70, DOI 10.1016/0041-008X(84)90271-0; Tan YS, 2004, TOXICOL SCI, V80, P54, DOI 10.1093/toxsci/kfh119; Thorn H, 2003, MOL BIOL CELL, V14, P3967, DOI 10.1091/mbc.E03-01-0050; Uittenbogaard A, 2000, J BIOL CHEM, V275, P11278, DOI 10.1074/jbc.275.15.11278; Ulbrich B, 2004, ARCH TOXICOL, V78, P483, DOI 10.1007/s00204-004-0583-y; Wang N, 2010, ENVIRON SCI TECHNOL, V44, P4334, DOI 10.1021/es9038775; Wassermann M, 1979, Ann N Y Acad Sci, V320, P69; Wong PW, 1996, MOL PHARMACOL, V49, P740; Yilmaz B, 2006, TOXICOLOGY, V217, P184, DOI 10.1016/j.tox.2005.09.008; Yu GW, 2011, J ENVIRON PUBLIC HEA, V2011, DOI 10.1155/2011/417980	40	30	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31834	10.1371/journal.pone.0031834	http://dx.doi.org/10.1371/journal.pone.0031834			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363745	Green Published, gold, Green Submitted			2022-12-27	WOS:000302871500092
J	Lian, H; Wang, L; Zhang, JM				Lian, Hai; Wang, Lei; Zhang, Jingmin			Increased Risk of Breast Cancer Associated with CC Genotype of Has-miR-146a Rs2910164 Polymorphism in Europeans	PLOS ONE			English	Article							FUNCTIONAL POLYMORPHISM; GENETIC-VARIATION; MICRORNA GENES; MIR-146A GENE; EXPRESSION; METAANALYSIS; VARIANTS; AGE	Background: Emerging evidence suggests that microRNAs play a critical role in the pathogenesis of breast cancer. Several molecular epidemiological studies were conducted in recent years to evaluate the association between has-miR-146a rs2910164 polymorphism and breast cancer risk in diverse populations. However, the results remain conflicting rather than conclusive. Methodology/Principal findings: We performed a meta-analysis of 6 case-control studies that included 4238 breast-cancer cases and 4469 case-free controls. We assessed the strength of the association, using odds ratios (ORs) with 95% confidence intervals (CIs). Overall, this meta-analysis showed that the rs2910164 polymorphism was not associated with a significantly increased risk of breast cancer in all genetic models (for GC vs GG: OR = 1.00, 95% CI = 0.9021.09, P-heterpgeneity = 0.364; for CC vs GG: OR = 1.16, 95% CI = 0.9821.36, P-heterpgeneity = 0.757; for GC+CC vs GG: OR = 1.02, 95% CI = 0.9321.12, P-heterpgeneity = 0.562; for CC vs GC+GG: OR = 1.10, 95% CI = 0.9621.26, P-heterpgeneity = 0.441). However, in the stratified analysis by ethnicity, we found the rs2910164 polymorphism was associated with increased breast cancer risk among Europeans in homozygote comparison (CC vs. GG: OR = 1.29, 95% CI = 1.0221.63, P-heterpgeneity = 0.950, P = 0.032) and recessive model (CC vs. GC+GG: OR = 1.31, 95% CI = 1.0521.65, P-heterpgeneity = 0.839, P = 0.019). No publication bias was found in the present study. Conclusions/Significance: This meta-analysis suggests, for the first time, that the CC homozygote of rs2910164 may contribute to breast cancer susceptibility in Europeans.	[Lian, Hai] Acad Mil Med Sci, Dept Pathol, Inst 11, Changchun, Peoples R China; [Wang, Lei] Chaoyang Dist Peoples Hosp, Elect Diag Div, Changchun, Peoples R China; [Zhang, Jingmin] Jilin Univ, Sch Pharm, Changchun 130023, Peoples R China	Academy of Military Medical Sciences - China; Jilin University	Lian, H (corresponding author), Acad Mil Med Sci, Dept Pathol, Inst 11, Changchun, Peoples R China.	lianhai1975@hotmail.com; zjm6978@hotmail.com						Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anderson BO, 2008, WORLD J SURG, V32, P2578, DOI 10.1007/s00268-007-9454-z; Buffa FM, 2011, CANCER RES, V71, P5635, DOI 10.1158/0008-5472.CAN-11-0489; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Catucci I, 2010, HUM MUTAT, V31, pE1052, DOI 10.1002/humu.21141; Coughlin SS, 2009, CANCER EPIDEMIOL, V33, P315, DOI 10.1016/j.canep.2009.10.003; de Keyser CE, 2011, PHARMACOGENOMICS J, V11, P72, DOI 10.1038/tpj.2010.11; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Garcia AI, 2011, HUM MUTAT; Garcia AI, 2011, EMBO MOL MED, V3, P279, DOI 10.1002/emmm.201100136; George GP, 2011, MOL BIOL REP, V38, P1609, DOI 10.1007/s11033-010-0270-4; Guo H, 2010, FAM CANCER, V9, P599, DOI 10.1007/s10689-010-9370-5; Hoffman AE, 2009, CANCER RES, V69, P5970, DOI 10.1158/0008-5472.CAN-09-0236; HOLM S, 1979, SCAND J STAT, V6, P65; Hu ZB, 2009, HUM MUTAT, V30, P79, DOI 10.1002/humu.20837; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Madeleine MM, 2011, BREAST CANCER RES TR, V129, P887, DOI 10.1007/s10549-011-1520-4; MANTEL N, 1959, J NATL CANCER I, V22, P719; Okubo M, 2010, HELICOBACTER, V15, P524, DOI 10.1111/j.1523-5378.2010.00806.x; Pastrello C, 2010, CARCINOGENESIS, V31, P2124, DOI 10.1093/carcin/bgq184; Peng SH, 2011, BREAST CANCER RES TR, V127, P309, DOI 10.1007/s10549-011-1459-5; Permuth-Wey J, 2011, J NEUROONCOL; Rothe F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020980; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Shen J, 2008, CARCINOGENESIS, V29, P1963, DOI 10.1093/carcin/bgn172; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Williams AE, 2008, BIOCHEM SOC T, V36, P1211, DOI 10.1042/BST0361211; Wong MW, 2011, BREAST CANCER RES TR, V127, P853, DOI 10.1007/s10549-011-1443-0; Xu B, 2010, PROSTATE, V70, P467, DOI 10.1002/pros.21080; Xu T, 2008, CARCINOGENESIS, V29, P2126, DOI 10.1093/carcin/bgn195; Xu W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020471; Zeng Y, 2010, WORLD J GASTROENTERO, V16, P3578, DOI 10.3748/wjg.v16.i28.3578; Zhang B, 2011, LANCET ONCOL, V12, P477, DOI 10.1016/S1470-2045(11)70076-6; Zhang Y, 2007, NAT GENET, V39, P1167, DOI 10.1038/ng2110	39	55	57	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31615	10.1371/journal.pone.0031615	http://dx.doi.org/10.1371/journal.pone.0031615			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363684	gold, Green Published, Green Submitted			2022-12-27	WOS:000302871500061
J	Shanmugam, A; Rajoria, S; George, AL; Mittelman, A; Suriano, R; Tiwari, RK				Shanmugam, Arulkumaran; Rajoria, Shilpi; George, Andrea L.; Mittelman, Abraham; Suriano, Robert; Tiwari, Raj K.			Synthetic Toll Like Receptor-4 (TLR-4) Agonist Peptides as a Novel Class of Adjuvants	PLOS ONE			English	Article							MONOPHOSPHORYL-LIPID-A; CELL RESPONSES; ENDOTOXIN; INFLAMMATION; LIGANDS; SEPSIS	Background: Adjuvants serve as catalysts of the innate immune response by initiating a localized site of inflammation that is mitigated by the interactions between antigens and toll like receptor (TLR) proteins. Currently, the majority of vaccines are formulated with aluminum based adjuvants, which are associated with various side effects. In an effort to develop a new class of adjuvants, agonists of TLR proteins, such as bacterial products, would be natural candidates. Lipopolysaccharide (LPS), a major structural component of gram negative bacteria cell walls, induces the systemic inflammation observed in septic shock by interacting with TLR-4. The use of synthetic peptides of LPS or TLR-4 agonists, which mimic the interaction between TLR-4 and LPS, can potentially regulate cellular signal transduction pathways such that a localized inflammatory response is achieved similar to that generated by adjuvants. Methodology/Principal Findings: We report the identification and activity of several peptides isolated using phage display combinatorial peptide technology, which functionally mimicked LPS. The activity of the LPS-TLR-4 interaction was assessed by NF-kappa B nuclear translocation analyses in HEK-BLUE (TM)-4 cells, a cell culture model that expresses only TLR-4, and the murine macrophage cell line, RAW264.7. Furthermore, the LPS peptide mimics were capable of inducing inflammatory cytokine secretion from RAW264.7 cells. Lastly, ELISA analysis of serum from vaccinated BALB/c mice revealed that the LPS peptide mimics act as a functional adjuvant. Conclusions/Significance: Our data demonstrate the identification of synthetic peptides that mimic LPS by interacting with TLR-4. This LPS mimotope-TLR-4 interaction will allow for the development and use of these peptides as a new class of adjuvants, namely TLR-4 agonists.	[Shanmugam, Arulkumaran; Rajoria, Shilpi; George, Andrea L.; Mittelman, Abraham; Suriano, Robert; Tiwari, Raj K.] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA	New York Medical College	Shanmugam, A (corresponding author), New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA.	robert_suriano@nymc.edu; raj_tiwari@nymc.edu			Applied Vaccine Therapeutics, LLC; National Institute of Health [RO1CA131946]; NATIONAL CANCER INSTITUTE [R01CA131946] Funding Source: NIH RePORTER	Applied Vaccine Therapeutics, LLC; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by: Applied Vaccine Therapeutics, LLC and National Institute of Health grant RO1CA131946 (RKT).	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Beveridge TJ, 2001, BIOTECH HISTOCHEM, V76, P111, DOI 10.1080/714028139; Bochud PY, 2003, BMJ-BRIT MED J, V326, P262, DOI 10.1136/bmj.326.7383.262; Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Cinel I, 2009, CRIT CARE MED, V37, P291, DOI 10.1097/CCM.0b013e31819267fb; Douagi I, 2009, J IMMUNOL, V182, P1991, DOI 10.4049/jimmunol.0802257; Ellett JD, 2010, J IMMUNOL, V184, P5849, DOI 10.4049/jimmunol.0902024; Hack CE, 1997, ADV IMMUNOL, V66, P101, DOI 10.1016/S0065-2776(08)60597-0; Harris J, 2010, EUR J IMMUNOL, V40, P634, DOI 10.1002/eji.200940172; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; Hou YC, 2003, J IMMUNOL, V170, P4373, DOI 10.4049/jimmunol.170.8.4373; Huleatt JW, 2007, VACCINE, V25, P763, DOI 10.1016/j.vaccine.2006.08.013; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kaisho T, 2002, BBA-MOL CELL RES, V1589, P1, DOI 10.1016/S0167-4889(01)00182-3; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Leung JYK, 2008, CELL MOL LIFE SCI, V65, P2732, DOI 10.1007/s00018-008-8184-1; Means TK, 2000, LIFE SCI, V68, P241, DOI 10.1016/S0024-3205(00)00939-5; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Nempont C, 2008, J IMMUNOL, V181, P2036, DOI 10.4049/jimmunol.181.3.2036; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; PARMLEY SF, 1988, GENE, V73, P305, DOI 10.1016/0378-1119(88)90495-7; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; SASSE KC, 1995, CRIT CARE MED, V23, P1040, DOI 10.1097/00003246-199506000-00008; Schijns VEJC, 2000, CURR OPIN IMMUNOL, V12, P456, DOI 10.1016/S0952-7915(00)00120-5; SCHNEERSON R, 1991, J IMMUNOL, V147, P2136; Shanmugam A, 2011, CELL STRESS CHAPERON, V16, P225, DOI 10.1007/s12192-010-0234-6; SMITH GP, 1993, METHOD ENZYMOL, V217, P228; Stoll LL, 2006, CURR PHARM DESIGN, V12, P4229, DOI 10.2174/138161206778743501; Wille-Reece U, 2005, P NATL ACAD SCI USA, V102, P15190, DOI 10.1073/pnas.0507484102; Wilson-Welder JH, 2009, J PHARM SCI-US, V98, P1278, DOI 10.1002/jps.21523	32	82	87	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30839	10.1371/journal.pone.0030839	http://dx.doi.org/10.1371/journal.pone.0030839			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363498	Green Submitted, gold, Green Published			2022-12-27	WOS:000302871500019
J	Watt, RG; Tsakos, G; de Oliveira, C; Hamer, M				Watt, Richard G.; Tsakos, Georgios; de Oliveira, Cesar; Hamer, Mark			Tooth Loss and Cardiovascular Disease Mortality Risk - Results from the Scottish Health Survey	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PERIODONTAL-DISEASE; MYOCARDIAL-INFARCTION; ORAL INFECTIONS; OLDER-PEOPLE; COHORT; STROKE; TEETH; EPIDEMIOLOGY; ASSOCIATIONS	Background: Tooth loss is associated with increased cardiovascular disease (CVD) mortality risk. This association may however be due to residual confounding. We aimed to assess whether tooth loss is associated with specific CVD mortality endpoints in a national population sample adjusting for potential confounders. Methods and Results: We used a prospective cohort design and data from the Scottish Health Survey. We combined data from surveys in 1995, 1998, 2003 and linked this to mortality records. Dental status was classified through self-reports as natural teeth only, natural teeth and dentures, and no natural teeth (edentate). Cox proportional hazards models were used to estimate risk of CVD mortality by dental status adjusting for potential confounders. The sample consisted of 12871 participants. They were followed for 8.0 (SD: 3.3) years. During 103173 person-years, there were 1480 cases of all-cause mortality, 498 of CVD, and 515 of cancer. After adjusting for demographic, socio-economic, behavioural and health status, edentate subjects had significantly higher risk of all-cause (HR, 1.30; 95% CI, 1.12,1.50) and CVD mortality (HR, 1.49; 95% CI, 1.16,1.92) compared to subjects with natural teeth only. Dental status was not significantly associated with cancer mortality in fully adjusted analysis. Further analysis for CVD mortality showed that in the fully adjusted model, edentate subjects had 2.97 (95% CI, 1.46, 6.05) times higher risk for stroke-related mortality. Conclusions: In a national population sample of Scottish adults, being edentate was an independent predictor of total CVD mortality, although this was mainly driven by fatal stroke events.	[Watt, Richard G.; Tsakos, Georgios; de Oliveira, Cesar; Hamer, Mark] UCL, Dept Epidemiol & Publ Hlth, London, England	University of London; University College London	Watt, RG (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	r.watt@ucl.ac.uk	de Oliveira, Cesar/B-5251-2019; Hamer, Mark/AAJ-6814-2021; Hamer, Mark/C-1602-2008	Hamer, Mark/0000-0002-8726-7992; Hamer, Mark/0000-0002-8726-7992; Tsakos, Georgios/0000-0002-5086-235X; Watt, Richard/0000-0001-6229-8584; De Oliveira, Cesar/0000-0002-4099-4762				Abnet CC, 2005, INT J EPIDEMIOL, V34, P467, DOI 10.1093/ije/dyh375; [Anonymous], 2009, ANN REPORT CHIEF MED; Bahekar AA, 2007, AM HEART J, V154, P830, DOI 10.1016/j.ahj.2007.06.037; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251.49515.c214656957, DOI 10.1161/01.HYP.0000107251.49515.C214656957]; Choe H, 2009, ATHEROSCLEROSIS, V203, P550, DOI 10.1016/j.atherosclerosis.2008.07.017; de Oliveira C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2451; Desvarieux M, 2005, CIRCULATION, V111, P576, DOI 10.1161/01.CIR.0000154582.37101.15; Desvarieux M, 2003, STROKE, V34, P2120, DOI 10.1161/01.STR.0000085086.50957.22; Fukai K, 2007, GERIATR GERONTOL INT, V7, P341, DOI 10.1111/j.1447-0594.2007.00422.x; Haraszthy VI, 2000, J PERIODONTOL, V71, P1554, DOI 10.1902/jop.2000.71.10.1554; Heitmann BL, 2008, PREV MED, V47, P156, DOI 10.1016/j.ypmed.2008.04.007; Holmlund A, 2010, J PERIODONTOL, V81, P870, DOI 10.1902/jop.2010.090680; Hujoel PP, 2002, PERIODONTOL 2000, V30, P51, DOI 10.1034/j.1600-0757.2002.03005.x; Humphrey LL, 2008, J GEN INTERN MED, V23, P2079, DOI 10.1007/s11606-008-0787-6; Joshipura K J, 1998, Ann Periodontol, V3, P175, DOI 10.1902/annals.1998.3.1.175; KLOCK KS, 1991, COMMUNITY DENT ORAL, V19, P336, DOI 10.1111/j.1600-0528.1991.tb00183.x; KWEIDER M, 1993, SCOT MED J, V38, P73, DOI 10.1177/003693309303800304; Li Q, 2010, DIABETOLOGIA, V53, P2320, DOI 10.1007/s00125-010-1862-1; Loos BG, 2000, J PERIODONTOL, V71, P1528, DOI 10.1902/jop.2000.71.10.1528; Mann JI, 2002, LANCET, V360, P783, DOI 10.1016/S0140-6736(02)09901-4; Michaud DS, 2008, LANCET ONCOL, V9, P550, DOI 10.1016/S1470-2045(08)70106-2; Nowjack-Raymer RE, 2003, J DENT RES, V82, P123, DOI 10.1177/154405910308200209; OSLER W, 1908, MODERN MED ITS THEOR; Petersen PE, 2005, B WORLD HEALTH ORGAN, V83, P661; Scannapieco Frank A, 2003, Ann Periodontol, V8, P38, DOI 10.1902/annals.2003.8.1.38; Sheiham A, 2001, PUBLIC HEALTH NUTR, V4, P797, DOI 10.1079/PHN2000116; Simons Leon A, 2009, Heart Lung Circ, V18, P330, DOI 10.1016/j.hlc.2009.05.001; Slots J, 2001, INT DENT J, V51, P417, DOI 10.1002/j.1875-595X.2001.tb00854.x; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Spahr A, 2006, ARCH INTERN MED, V166, P554, DOI 10.1001/archinte.166.5.554; Steele JG, 2000, BRIT DENT J, V189, P598, DOI 10.1038/sj.bdj.4800840a; Tu YK, 2007, HEART, V93, P1098, DOI 10.1136/hrt.2006.097410; Valtonen VV, 1999, AM HEART J, V138, pS431, DOI 10.1016/S0002-8703(99)70269-3; Wilhelmsen L, 2005, EUR HEART J, V26, P1916, DOI 10.1093/eurheartj/ehi412; Wu TJ, 2000, ARCH INTERN MED, V160, P2749, DOI 10.1001/archinte.160.18.2749	35	67	68	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30797	10.1371/journal.pone.0030797	http://dx.doi.org/10.1371/journal.pone.0030797			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363491	Green Published, gold, Green Submitted			2022-12-27	WOS:000302871500018
J	Abad-Grau, MM; Medina-Medina, N; Montes-Soldado, R; Matesanz, F; Bafna, V				Abad-Grau, Mara M.; Medina-Medina, Nuria; Montes-Soldado, Rosana; Matesanz, Fuencisla; Bafna, Vineet			Sample Reproducibility of Genetic Association Using Different Multimarker TDTs in Genome-Wide Association Studies: Characterization and a New Approach	PLOS ONE			English	Article							TRANSMISSION/DISEQUILIBRIUM TEST; MULTIPLE-SCLEROSIS; HAPLOTYPE SIMILARITY; TESTS; MODEL; RISK; MS	Multimarker Transmission/Disequilibrium Tests (TDTs) are very robust association tests to population admixture and structure which may be used to identify susceptibility loci in genome-wide association studies. Multimarker TDTs using several markers may increase power by capturing high-degree associations. However, there is also a risk of spurious associations and power reduction due to the increase in degrees of freedom. In this study we show that associations found by tests built on simple null hypotheses are highly reproducible in a second independent data set regardless the number of markers. As a test exhibiting this feature to its maximum, we introduce the multimarker 2-Groups TDT (mTDT(2G)), a test which under the hypothesis of no linkage, asymptotically follows a chi(2) distribution with 1 degree of freedom regardless the number of markers. The statistic requires the division of parental haplotypes into two groups: disease susceptibility and disease protective haplotype groups. We assessed the test behavior by performing an extensive simulation study as well as a real-data study using several data sets of two complex diseases. We show that mTDT(2G) test is highly efficient and it achieves the highest power among all the tests used, even when the null hypothesis is tested in a second independent data set. Therefore, mTDT(2G) turns out to be a very promising multimarker TDT to perform genome-wide searches for disease susceptibility loci that may be used as a preprocessing step in the construction of more accurate genetic models to predict individual susceptibility to complex diseases.	[Abad-Grau, Mara M.; Medina-Medina, Nuria; Montes-Soldado, Rosana] Univ Granada, ETS Ingn Informat & Telecomunicac CITIC, Dept Lenguajes & Sistemas Informat, Granada, Spain; [Matesanz, Fuencisla] CSIC, Inst Parasitologa & Biomed Lopez Neyra, Granada, Spain; [Bafna, Vineet] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA	University of Granada; Consejo Superior de Investigaciones Cientificas (CSIC); University of California System; University of California San Diego	Abad-Grau, MM (corresponding author), Univ Granada, ETS Ingn Informat & Telecomunicac CITIC, Dept Lenguajes & Sistemas Informat, Granada, Spain.	mabad@ugr.es	Soldado, Rosana Montes/AAT-7222-2021; Bafna, Vineet/AAY-8111-2020; Matesanz, Fuencisla/F-3715-2016; Medina, Nuria Medina/B-1743-2012; Montes, Rosana/C-2434-2012; Abad Grau, María del Mar/B-2172-2012	Soldado, Rosana Montes/0000-0002-0183-044X; Bafna, Vineet/0000-0002-5810-6241; Matesanz, Fuencisla/0000-0002-9429-1819; Medina, Nuria Medina/0000-0002-6013-732X; Montes, Rosana/0000-0002-0183-044X; Abad Grau, María del Mar/0000-0001-8470-9719	Spanish Research Program [TIN2007-67418-C03-03, PIA12009-07]; Health Research Fund FEDER [PI081636]; Andalusian Research Program [P08-TIC-03717]; European Regional Development Fund	Spanish Research Program(Spanish Government); Health Research Fund FEDER; Andalusian Research Program; European Regional Development Fund(European Commission)	The authors have been partially supported by the Spanish Research Program under projects TIN2007-67418-C03-03 and PIA12009-07, by the Health Research Fund FEDER (PI081636), by the Andalusian Research Program under project P08-TIC-03717, and by the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Grau MM, 2010, HUM GENET, V128, P325, DOI 10.1007/s00439-010-0854-z; Abecasis GR, 2001, AM J HUM GENET, V69, P198; Alcina A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004137; Betensky RA, 2000, ANN HUM GENET, V64, P567, DOI 10.1046/j.1469-1809.2000.6460567.x; Bickeboller H, 1995, GENET EPIDEMIOL, V12, P865, DOI 10.1002/gepi.1370120656; Bourgain C, 2001, AM J HUM GENET, V68, P154, DOI 10.1086/316933; Clayton D, 1999, AM J HUM GENET, V65, P1161, DOI 10.1086/302566; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Fan RZ, 2001, ADV APPL STAT, V1, P277; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gregory J, 2007, NAT GENET, V39, P1053; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hafler JP, 2009, GENES IMMUN, V10, P5, DOI 10.1038/gene.2008.82; Hellenthal G, 2007, BIOINFORMATICS, V23, P520, DOI 10.1093/bioinformatics/btl622; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Jager PD, 2008, P NATL ACAD SCI USA, V106, P5264; Kaplan NL, 1997, AM J HUM GENET, V60, P691; Kristjansdottir G, 2008, J MED GENET, V45, P362, DOI 10.1136/jmg.2007.055012; Lam JC, 2000, AM J HUM GENET, V66, P659, DOI 10.1086/302756; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; Marchini J, 2005, NAT GENET, V39, P906; Matesanz F, 2007, J NEUROL, V254, P682, DOI 10.1007/s00415-006-0416-4; Montes R, 2009, LECT NOTES COMPUT SC, V5518, P1097, DOI 10.1007/978-3-642-02481-8_166; Ott J., 1999, ANAL HUMAN GENETIC L; Ramagopalan SV, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-10; Rinaldo A, 2005, GENET EPIDEMIOL, V28, P193, DOI 10.1002/gepi.20056; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Seltman H, 2001, AM J HUM GENET, V68, P223; Sevon P, 2006, IEEE ACM T COMPUT BI, V3, P174, DOI 10.1109/TCBB.2006.28; Sham P, 1997, AM J HUM GENET, V61, P774; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Tang R, 2009, ANN HUM GENET, V73, P631, DOI 10.1111/j.1469-1809.2009.00543.x; Tzeng JY, 2003, AM J HUM GENET, V72, P891, DOI 10.1086/373881; Yu K, 2005, GENET EPIDEMIOL, V29, P323, DOI 10.1002/gepi.20102; Yu K, 2004, GENET EPIDEMIOL, V27, P182, DOI 10.1002/gepi.20022; Zhang SL, 2003, AM J HUM GENET, V73, P566, DOI 10.1086/378205; Zhao JY, 2007, HUM GENET, V121, P357, DOI 10.1007/s00439-007-0322-6; Zoledziewska M, 2007, GENES IMMUN, V10, P15	44	5	5	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e29613	10.1371/journal.pone.0029613	http://dx.doi.org/10.1371/journal.pone.0029613			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363405	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600007
J	Fujii, T; Albarede, F				Fujii, Toshiyuki; Albarede, Francis			Ab Initio Calculation of the Zn Isotope Effect in Phosphates, Citrates, and Malates and Applications to Plants and Soil	PLOS ONE			English	Article							HYPERACCUMULATOR ARABIDOPSIS-HALLERI; ORTHOPHOSPHATE SOLUTIONS; ZINC; FRACTIONATION; PH; EQUILIBRIA; COMPLEXES; DENSITY; ROOT	Stable Zn isotopes are fractionated in roots and leaves of plants. Analyses demonstrate that the heavy Zn isotopes are enriched in the root system of plants with respect to shoots and leaves as well as the host soil, but the fractionation mechanisms remain unclear. Here we show that the origin of this isotope fractionation is due to a chemical isotope effect upon complexation by Zn malates and citrates in the aerial parts and by phosphates in the roots. We calculated the Zn isotope effect in aqueous citrates, malates, and phosphates by ab initio methods. For pH <5, the Zn isotopic compositions of the various parts of the plants are expected to be similar to those of groundwater. In the neutral to alkaline region, the calculations correctly predict that Zn-66 is enriched over Zn-64 in roots, which concentrate phosphates, with respect to leaves, which concentrate malates and citrates, by about one permil. It is proposed that Zn isotope fractionation represents a useful tracer of Zn availability and mobility in soils.	[Fujii, Toshiyuki] Kyoto Univ, Inst Res Reactor, Osaka 59004, Japan; [Albarede, Francis] Ecole Normale Super Lyon, F-69364 Lyon, France	Kyoto University; Ecole Normale Superieure de Lyon (ENS de LYON)	Fujii, T (corresponding author), Kyoto Univ, Inst Res Reactor, Osaka 59004, Japan.	tosiyuki@rri.kyoto-u.ac.jp	Fujii, Toshiyuki/AAD-1450-2019; Albarede, Francis/A-8871-2011	Albarede, Francis/0000-0003-1994-1428				Arnold T, 2008, ANAL BIOANAL CHEM, V398, P3115; Aucour AM, 2011, ENVIRON SCI TECHNOL, V45, P9212, DOI 10.1021/es200874x; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BERNER RA, 1973, EARTH PLANET SC LETT, V18, P77, DOI 10.1016/0012-821X(73)90037-X; BERTHON G, 1987, AGENTS ACTIONS, V22, P231, DOI 10.1007/BF02009051; Bibikova TN, 1998, DEVELOPMENT, V125, P2925; BIGELEISEN J, 1947, J CHEM PHYS, V15, P261, DOI 10.1063/1.1746492; Black JR, 2011, GEOCHIM COSMOCHIM AC, V75, P769, DOI 10.1016/j.gca.2010.11.019; CAPONE S, 1986, TALANTA, V33, P763, DOI 10.1016/0039-9140(86)80184-9; CHILDS CW, 1970, INORG CHEM, V9, P2465, DOI 10.1021/ic50093a017; Fasano JM, 2001, PLANT CELL, V13, P907, DOI 10.1105/tpc.13.4.907; Frisch G. W., 2013, GAUSSIAN 09; Fujii T, 2011, GEOCHIM COSMOCHIM AC, V75, P7632, DOI 10.1016/j.gca.2011.09.036; Fujii T, 2010, J PHYS CHEM A, V114, P2543, DOI 10.1021/jp908642f; IULIANO M, 1994, ANN CHIM-ROME, V84, P187; Kent DB, 2007, WATER RESOUR RES, V43, DOI 10.1029/2005WR004841; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Magini M, 1988, XRAY DIFFRACTION ION; Makar GKR, 1976, J CHEM SOC DA, V11, P1016; Marechal CN, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/1999GC000029; Millam J., GAUSSVIEW VERSION 5; Moynier F, 2009, CHEM GEOL, V267, P125, DOI 10.1016/j.chemgeo.2008.09.017; Peel K, 2009, LIMNOL OCEANOGR, V54, P1699, DOI 10.4319/lo.2009.54.5.1699; Rulisek L, 1999, J PHYS CHEM A, V103, P1634, DOI 10.1021/jp983540f; Sarret G, 2002, PLANT PHYSIOL, V130, P1815, DOI 10.1104/pp.007799; Stevenson FJ, 1999, CYCLES SOIL CARBON N; Swanson SJ, 2011, ANNU REV PLANT BIOL, V62, P273, DOI 10.1146/annurev-arplant-042110-103832; UPCHURCH JB, 1974, ENVIRON SCI TECHNOL, V8, P56, DOI 10.1021/es60086a002; UREY HC, 1947, J CHEM SOC, P562, DOI 10.1039/jr9470000562; Viers J, 2007, CHEM GEOL, V239, P124, DOI 10.1016/j.chemgeo.2007.01.005; Weiss DJ, 2005, NEW PHYTOL, V165, P703, DOI 10.1111/j.1469-8137.2004.01307.x	31	59	60	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30726	10.1371/journal.pone.0030726	http://dx.doi.org/10.1371/journal.pone.0030726			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363478	Green Published, gold			2022-12-27	WOS:000302853600061
J	Johannsen, NM; Swift, DL; Johnson, WD; Dixit, VD; Earnest, CP; Blair, SN; Church, TS				Johannsen, Neil M.; Swift, Damon L.; Johnson, William D.; Dixit, Vishwa D.; Earnest, Conrad P.; Blair, Steven N.; Church, Timothy S.			Effect of Different Doses of Aerobic Exercise on Total White Blood Cell (WBC) and WBC Subfraction Number in Postmenopausal Women: Results from DREW	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; INCREASED CARDIOVASCULAR RISK; LEUKOCYTE COUNT; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; MORTALITY; LEPTIN; ASSOCIATIONS; NEUTROPHILS; OVERWEIGHT	Background: Elevated total white blood cell (WBC) count is associated with an increased risk of coronary heart disease and death. Aerobic exercise is associated with lower total WBC, neutrophil, and monocyte counts. However, no studies have evaluated the effect of the amount of aerobic exercise (dose) on total WBC and WBC subfraction counts. Purpose: To examine the effects of 3 different doses of aerobic exercise on changes in total WBC and WBC subfraction counts and independent effects of changes in fitness, adiposity, markers of inflammation (IL-6, TNF-alpha, C-reactive protein), fasting glucose metabolism, and adiponectin. Methods: Data from 390 sedentary, overweight/obese postmenopausal women from the DREW study were used in these analyses. Women were randomized to a non-exercise control group or one of 3 exercise groups: energy expenditure of 4, 8, or 12 kcal kg(-1).week(-1) (KKW) for 6 months at an intensity of 50% VO2peak. Results: A dose-dependent decrease in total WBC counts (trend P = 0.002) was observed with a significant decrease in the 12KKW group (-163.1 +/- 140.0 cells/mu L; mean +/- 95%CI) compared with the control (138.6 +/- 144.7 cells/mu L). A similar response was seen in the neutrophil subfraction (trend P = 0.001) with a significant decrease in the 12KKW group (-152.6 +/- 115.1 cells/mu L) compared with both the control and 4KKW groups (96.4 +/- 119.0 and 21.9 +/- 95.3 cells/mu L, respectively) and in the 8KKW group (-102.4 +/- 125.0 cells/mu L) compared with the control. When divided into high/low baseline WBC categories (median split), a dose-dependent decrease in both total WBCs (P = 0.003) and neutrophils (P<0.001) was observed in women with high baseline WBC counts. The effects of exercise dose on total WBC and neutrophil counts persisted after accounting for significant independent effects of change in waist circumference and IL-6. Conclusion: Aerobic exercise training reduces total WBC and neutrophil counts, in a dose-dependent manner, in overweight/obese postmenopausal women and is especially beneficial for those with systemic low grade inflammation.	[Johannsen, Neil M.; Swift, Damon L.; Earnest, Conrad P.; Church, Timothy S.] Pennington Biomed Res Ctr, Dept Prevent Med, Baton Rouge, LA USA; [Johnson, William D.] Pennington Biomed Res Ctr, Dept Biostat, Baton Rouge, LA USA; [Dixit, Vishwa D.] Pennington Biomed Res Ctr, Immunobiol Lab, Baton Rouge, LA USA; [Blair, Steven N.] Univ S Carolina, Dept Exercise Sci, Columbia, SC 29208 USA; [Blair, Steven N.] Univ S Carolina, Dept Epidemiol & Biostat, Columbia, SC 29208 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Johannsen, NM (corresponding author), Pennington Biomed Res Ctr, Dept Prevent Med, Baton Rouge, LA USA.	neil.johannsen@pbrc.edu	Earnest, Conrad P./M-6849-2017; Johnson, William/N-1972-2017	Earnest, Conrad P./0000-0002-6546-1268; Johnson, William/0000-0002-3823-4094	National Institutes of Health (NHLBI) [HL066262]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER	National Institutes of Health (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the National Institutes of Health (NHLBI) HL066262. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli F, 2010, OBSTET GYNECOL, V115, P695, DOI 10.1097/AOG.0b013e3181d53df6; [Anonymous], 1996, JAMA J AM MED ASS, V276, P241; Arsenault BJ, 2009, ATHEROSCLEROSIS, V207, P530, DOI 10.1016/j.atherosclerosis.2009.05.009; Brown DW, 2001, J CLIN EPIDEMIOL, V54, P316, DOI 10.1016/S0895-4356(00)00296-1; Church TS, 2007, JAMA-J AM MED ASSOC, V297, P2081, DOI 10.1001/jama.297.19.2081; Church TS, 2002, INT J OBESITY, V26, P805, DOI 10.1038/sj.ijo.0802001; Claycombe K, 2008, P NATL ACAD SCI USA, V105, P2017, DOI 10.1073/pnas.0712053105; de Gonzalo-Calvo D, 2011, AGE; Dixit VD, 2004, J CLIN INVEST, V114, P57, DOI 10.1172/JCI200421134; Dixon JB, 2006, OBES SURG, V16, P251, DOI 10.1381/096089206776116453; Gillum RF, 2005, ANN EPIDEMIOL, V15, P266, DOI 10.1016/j.annepidem.2004.08.009; GILLUM RF, 1993, AM HEART J, V125, P855, DOI 10.1016/0002-8703(93)90181-8; GRIMM RH, 1985, JAMA-J AM MED ASSOC, V254, P1932, DOI 10.1001/jama.254.14.1932; Horne BD, 2005, J AM COLL CARDIOL, V45, P1638, DOI 10.1016/j.jacc.2005.02.054; Johannsen NM, 2010, BRIT J SPORT MED, V44, P588, DOI 10.1136/bjsm.2008.050682; Kakanis MW, 2010, EXERC IMMUNOL REV, V16, P119; KANNEL WB, 1992, JAMA-J AM MED ASSOC, V267, P1253, DOI 10.1001/jama.267.9.1253; Margolis KL, 2005, ARCH INTERN MED, V165, P500, DOI 10.1001/archinte.165.5.500; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Michishita R, 2010, AM J MED SCI, V339, P152, DOI 10.1097/MAJ.0b013e3181c6a980; Morss GM, 2004, MED SCI SPORT EXER, V36, P336, DOI 10.1249/01.MSS.0000113738.06267.E5; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pratley R E, 1995, Obes Res, V3, P563; Rana JS, 2007, J INTERN MED, V262, P678, DOI 10.1111/j.1365-2796.2007.01864.x; Services. USDoHaH, 1996, PHYS ACT HLTH REP SU, P9; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vozarova B, 2002, DIABETES, V51, P455, DOI 10.2337/diabetes.51.2.455; Whaley M, 1995, ACSMS GUIDELINES EXE; Wheeler JG, 2004, EUR HEART J, V25, P1287, DOI 10.1016/j.ehj.2004.05.002; Zarkesh-Esfahani H, 2004, J IMMUNOL, V172, P1809, DOI 10.4049/jimmunol.172.3.1809	30	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31319	10.1371/journal.pone.0031319	http://dx.doi.org/10.1371/journal.pone.0031319			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363616	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600139
J	Kamat, A; Misra, V; Cassol, E; Ancuta, P; Yan, ZY; Li, C; Morgello, S; Gabuzda, D				Kamat, Anupa; Misra, Vikas; Cassol, Edana; Ancuta, Petronela; Yan, Zhenyu; Li, Cheng; Morgello, Susan; Gabuzda, Dana			A Plasma Biomarker Signature of Immune Activation in HIV Patients on Antiretroviral Therapy	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; HEPATITIS-C-VIRUS; T-CELL-ACTIVATION; NATURAL-KILLER-CELLS; DISEASE PROGRESSION; INTERFERON-GAMMA; MICROBIAL TRANSLOCATION; SIGMA-1 RECEPTORS; DENDRITIC CELLS; CRACK-COCAINE	Background: Immune activation is a strong predictor of disease progression in HIV infection. Combinatorial plasma biomarker signatures that represent surrogate markers of immune activation in both viremic and aviremic HIV patients on combination antiretroviral therapy (cART) have not been defined. Here, we identify a plasma inflammatory biomarker signature that distinguishes between both viremic and aviremic HIV patients on cART and healthy controls and examine relationships of this signature to markers of disease progression. Methods: Multiplex profiling and ELISA were used to detect 15 cytokines/chemokines, soluble IL-2R (sIL-2R), and soluble CD14 (sCD14) in plasma from 57 HIV patients with CD4 nadir <300 cells/mu l and 29 healthy controls. Supervised and unsupervised analyses were used to identify biomarkers explaining variance between groups defined by HIV status or drug abuse. Relationships between biomarkers and disease markers were examined by Spearman correlation. Results: The majority (91%) of HIV subjects were on cART, with 38% having undetectable viral loads (VL). Hierarchical clustering identified a biomarker cluster in plasma consisting of two interferon-stimulated gene products (CXCL9 and CXCL10), T cell activation marker (sIL-2R), and monocyte activation marker (sCD14) that distinguished both viremic and aviremic HIV patients on cART from controls (p<0.0001) and were top-ranked in variables important in projection plots. IL-12 and CCL4 were also elevated in viremic and aviremic patients compared to controls (p<0.05). IL-12 correlated with IFN alpha, IFN gamma, CXCL9, and sIL-2R (p<0.05). CXCL10 correlated positively with plasma VL and percentage of CD16+ monocytes, and inversely with CD4 count (p = 0.001, <0.0001, and 0.04, respectively). Conclusion: A plasma inflammatory biomarker signature consisting of CXCL9, CXCL10, sIL-2R, and sCD14 may be useful as a surrogate marker to monitor immune activation in both viremic and aviremic HIV patients on cART during disease progression and therapeutic responses.	[Kamat, Anupa; Misra, Vikas; Cassol, Edana; Gabuzda, Dana] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Kamat, Anupa; Cassol, Edana; Gabuzda, Dana] Harvard Univ, Sch Med, Boston, MA USA; [Ancuta, Petronela] Univ Montreal, Dept Microbiol & Immunol, Fac Med, CHUM Res Ctr, Montreal, PQ H3C 3J7, Canada; [Yan, Zhenyu; Li, Cheng] Dana Farber Canc Inst, Dept Biostat, Boston, MA 02115 USA; [Morgello, Susan] Mt Sinai Med Ctr, New York, NY 10029 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Universite de Montreal; Harvard University; Dana-Farber Cancer Institute; Icahn School of Medicine at Mount Sinai	Kamat, A (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA.	dana_gabuzda@dfci.harvard.edu	Cassol, Edana/Z-6301-2019		National Institutes of Health [DA30985, DA28994, U01MH083501, R24MH59724, U01MH083506, R24MH59745, U01MH083507, R24 NS45491, 5U01MH083500, NS38841, U01MH083545, N01MH32002]; Canadian Institutes of Health Research (CIHR); Fonds de la Recherche en Sante Quebec (FRSQ); CNS HIV Antiretroviral Therapy Effects Research (CHARTER) [N01MH22005]; Harvard Center for AIDS Research and Dana-Farber Cancer Institute/Harvard Center for Cancer Research; NATIONAL CANCER INSTITUTE [P30CA006516] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [N01MH022005, R24MH059745, P30MH062512, U01MH083507, U01MH083501, R24MH059724, U01MH083506, U01MH083545, U01MH083500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R24NS045491, R24NS038841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030985, DP1DA028994] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); CNS HIV Antiretroviral Therapy Effects Research (CHARTER); Harvard Center for AIDS Research and Dana-Farber Cancer Institute/Harvard Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants DA30985 and DA28994 to Dr. Gabuzda. Dr. Cassol was supported by a fellowship award from Canadian Institutes of Health Research (CIHR). Dr. Ancuta was supported by a Salary Award from Fonds de la Recherche en Sante Quebec (FRSQ). National NeuroAIDS Tissue Consortium (NNTC) sites were supported by National Institutes of Health Grants U01MH083501, R24MH59724, U01MH083506, R24MH59745, U01MH083507, R24 NS45491, 5U01MH083500, NS38841, U01MH083545, and N01MH32002. CNS HIV Antiretroviral Therapy Effects Research (CHARTER) was supported by N01MH22005. Core facilities were supported by the Harvard Center for AIDS Research and Dana-Farber Cancer Institute/Harvard Center for Cancer Research grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison RD, 2009, J INFECT DIS, V200, P619, DOI 10.1086/600107; Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Anthony KB, 2003, JAIDS-J ACQ IMM DEF, V33, P125, DOI 10.1097/00126334-200306010-00002; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Arico E, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-67; Aukrust P, 1999, J INFECT DIS, V179, P74, DOI 10.1086/314572; Barqasho B, 2009, HIV MED, V10, P94, DOI 10.1111/j.1468-1293.2008.00657.x; Baum MK, 2009, JAIDS-J ACQ IMM DEF, V50, P93, DOI 10.1097/QAI.0b013e3181900129; Berres ML, 2011, HEPATOLOGY, V53, P596, DOI 10.1002/hep.24098; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; Boasso A, 2008, CLIN IMMUNOL, V126, P235, DOI 10.1016/j.clim.2007.08.015; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Byrnes AA, 2008, J LEUKOCYTE BIOL, V84, P1447, DOI 10.1189/jlb.0708438; Carrico AW, 2008, BRAIN BEHAV IMMUN, V22, P1257, DOI 10.1016/j.bbi.2008.07.010; Cassol E, 2010, J INFECT DIS, V202, P723, DOI 10.1086/655229; Catalfamo M, 2011, J IMMUNOL, V186, P2106, DOI 10.4049/jimmunol.1002000; Catalfamo M, 2008, P NATL ACAD SCI USA, V105, P19851, DOI 10.1073/pnas.0810032105; Cook JA, 2008, AIDS, V22, P1355, DOI 10.1097/QAD.0b013e32830507f2; d'Ettorre G, 2006, IMMUNOL LETT, V103, P192, DOI 10.1016/j.imlet.2005.10.001; d'Ettorre G, 2011, AIDS RES HUM RETROVI; Dandekar Satya, 2007, Curr HIV/AIDS Rep, V4, P10, DOI 10.1007/s11904-007-0002-0; Deeks SG, 2004, J CLIN INVEST, V113, P808, DOI 10.1172/JCI200421318; Domenici E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009166; Eberly MD, 2009, J IMMUNOL, V182, P1439, DOI 10.4049/jimmunol.182.3.1439; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Fischer-Smith T, 2008, AIDS RES HUM RETROV, V24, P417, DOI 10.1089/aid.2007.0193; Forcina G, 2004, CYTOKINE, V25, P283, DOI 10.1016/j.cyto.2003.12.004; French MA, 2009, J INFECT DIS, V200, P1212, DOI 10.1086/605890; Gan XH, 1998, CLIN IMMUNOL IMMUNOP, V89, P181, DOI 10.1006/clin.1998.4607; Gonzalez VD, 2010, CLIN IMMUNOL, V135, P12, DOI 10.1016/j.clim.2009.12.005; Han JY, 2009, JAIDS-J ACQ IMM DEF, V52, P553, DOI 10.1097/QAI.0b013e3181c1d4fe; Hardy GAD, 2009, BLOOD, V113, P5497, DOI 10.1182/blood-2008-11-190231; Hasin DS, 1996, AM J PSYCHIAT, V153, P1195; Hazenberg MD, 2000, BLOOD, V95, P249, DOI 10.1182/blood.V95.1.249.001k40_249_255; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Kalayjian RC, 2010, J INFECT DIS, V201, P1796, DOI 10.1086/652750; Keating SM, 2011, AIDS, V25, P1823, DOI 10.1097/QAD.0b013e3283489d1f; Lane BR, 2003, VIROLOGY, V307, P122, DOI 10.1016/S0042-6822(02)00045-4; Lehmann C, 2008, JAIDS-J ACQ IMM DEF, V48, P522, DOI 10.1097/QAI.0b013e31817f97cf; Manches O, 2008, J CLIN INVEST, V118, P3431, DOI 10.1172/JCI34823; Mohty AM, 2010, IMMUNOBIOLOGY, V215, P113, DOI 10.1016/j.imbio.2009.03.008; Mueller YM, 2008, J IMMUNOL, V180, P350, DOI 10.4049/jimmunol.180.1.350; Mueller YM, 2010, EUR CYTOKINE NETW, V21, P219, DOI 10.1684/ecn.2010.0198; Navarro G, 2010, P NATL ACAD SCI USA, V107, P18676, DOI 10.1073/pnas.1008911107; Neely GG, 2004, J IMMUNOL, V172, P4225, DOI 10.4049/jimmunol.172.7.4225; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Ortiz Alexandra M, 2009, Curr Infect Dis Rep, V11, P239, DOI 10.1007/s11908-009-0035-1; Padovan E, 2002, J LEUKOCYTE BIOL, V71, P669; Reiberger T, 2008, ANTIVIR THER, V13, P969; Rempel H, 2010, AIDS, V24, P1415, DOI 10.1097/QAD.0b013e32833ac623; Rios-Olivares E, 2006, DRUG ALCOHOL DEPEN, V85, P236, DOI 10.1016/j.drugalcdep.2006.05.013; Roberts L, 2010, AIDS, V24, P819, DOI 10.1097/QAD.0b013e3283367836; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Rodriguez AR, 2007, J GEN VIROL, V88, P641, DOI 10.1099/vir.0.82154-0; Roe B, 2007, J INFECT DIS, V196, P1053, DOI 10.1086/520935; Roth MD, 2005, J LEUKOCYTE BIOL, V78, P1198, DOI 10.1189/jlb.0405219; Ruckert R, 2009, IMMUNOLOGY, V126, P63, DOI 10.1111/j.1365-2567.2008.02878.x; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Sarkar S, 2003, J MED PRIMATOL, V32, P247, DOI 10.1034/j.1600-0684.2003.00031.x; Schmidt B, 2005, VIROLOGY, V343, P256, DOI 10.1016/j.virol.2005.09.059; Schroecksnadel K, 2007, CURR DRUG METAB, V8, P225, DOI 10.2174/138920007780362608; Stuart JWTC, 2000, J ACQ IMMUN DEF SYND, V25, P203, DOI 10.1097/00126334-200011010-00001; Stylianou E, 2000, CLIN EXP IMMUNOL, V119, P479, DOI 10.1046/j.1365-2249.2000.01144.x; Stylianou E, 1999, CLIN EXP IMMUNOL, V116, P115; Tan DBA, 2011, CLIN IMMUNOL, V139, P115, DOI 10.1016/j.clim.2011.02.015; Tarkowski M., 2011, AIDS RES HUM RETROVI; Thieblemont N, 1995, EUR J IMMUNOL, V25, P3418, DOI 10.1002/eji.1830251232; Tilton JC, 2006, J VIROL, V80, P11486, DOI 10.1128/JVI.00324-06; Torti C, 2004, VIRAL IMMUNOL, V17, P279, DOI 10.1089/0882824041310630; Vrisekoop N, 2008, J IMMUNOL, V181, P1573, DOI 10.4049/jimmunol.181.2.1573; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Zeremski M, 2007, JAIDS-J ACQ IMM DEF, V45, P262; Zeremski M, 2011, J INFECT DIS, V204, P832, DOI 10.1093/infdis/jir424	75	91	92	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30881	10.1371/journal.pone.0030881	http://dx.doi.org/10.1371/journal.pone.0030881			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363505	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600080
J	Meisel, C; Kuehn, C				Meisel, Christian; Kuehn, Christian			Scaling Effects and Spatio-Temporal Multilevel Dynamics in Epileptic Seizures	PLOS ONE			English	Article							SPIKE-WAVE DISCHARGES; HOMOCLINIC ORBITS; STABILITY LOSS; TIME; BRAIN; PHASE; SYNCHRONIZATION; PREDICTION; OSCILLATIONS; PERSISTENCE	Epileptic seizures are one of the most well-known dysfunctions of the nervous system. During a seizure, a highly synchronized behavior of neural activity is observed that can cause symptoms ranging from mild sensual malfunctions to the complete loss of body control. In this paper, we aim to contribute towards a better understanding of the dynamical systems phenomena that cause seizures. Based on data analysis and modelling, seizure dynamics can be identified to possess multiple spatial scales and on each spatial scale also multiple time scales. At each scale, we reach several novel insights. On the smallest spatial scale we consider single model neurons and investigate early-warning signs of spiking. This introduces the theory of critical transitions to excitable systems. For clusters of neurons (or neuronal regions) we use patient data and find oscillatory behavior and new scaling laws near the seizure onset. These scalings lead to substantiate the conjecture obtained from mean-field models that a Hopf bifurcation could be involved near seizure onset. On the largest spatial scale we introduce a measure based on phase-locking intervals and wavelets into seizure modelling. It is used to resolve synchronization between different regions in the brain and identifies time-shifted scaling laws at different wavelet scales. We also compare our wavelet-based multiscale approach with maximum linear cross-correlation and mean-phase coherence measures.	[Meisel, Christian; Kuehn, Christian] Max Planck Inst Phys Komplexer Syst, Dresden, Germany; [Meisel, Christian] Univ Clin Carl Gustav Carus, Dept Neurol, Dresden, Germany	Max Planck Society; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Meisel, C (corresponding author), Max Planck Inst Phys Komplexer Syst, Dresden, Germany.	meisel@mpipks-dresden.mpg.de	Kuehn, Christian/H-3950-2014	Kuehn, Christian/0000-0002-7063-6173; Meisel, Christian/0000-0003-2984-5480				Alley RB, 2003, SCIENCE, V299, P2005, DOI 10.1126/science.1081056; BAK P, 1995, P NATL ACAD SCI USA, V92, P6689, DOI 10.1073/pnas.92.15.6689; Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Beggs JM, 2003, J NEUROSCI, V23, P11167; Berglund N, 2009, STOCHASTIC METHODS N, V2, P65; Berglund N, 2006, PROB APPL S; Bosnyakova D, 2007, CLIN NEUROPHYSIOL, V118, P1736, DOI 10.1016/j.clinph.2007.04.013; Bosnyakova D, 2006, J NEUROSCI METH, V154, P80, DOI 10.1016/j.jneumeth.2005.12.006; Breakspear M, 2006, CEREB CORTEX, V16, P1296, DOI 10.1093/cercor/bhj072; Breakspear M, 2005, PHILOS T R SOC B, V360, P1051, DOI 10.1098/rstb.2005.1643; Bullmore ET, 2003, STAT METHODS MED RES, V12, P375, DOI 10.1191/0962280203sm339ra; Bullmore ET, 2001, HUM BRAIN MAPP, V12, P61, DOI 10.1002/1097-0193(200102)12:2<61::AID-HBM1004>3.0.CO;2-W; Carpenter SR, 2008, ECOL LETT, V11, P128, DOI 10.1111/j.1461-0248.2007.01131.x; Chavez M, 2003, IEEE T BIO-MED ENG, V50, P571, DOI 10.1109/TBME.2003.810696; Clark JS, 2001, SCIENCE, V293, P657, DOI 10.1126/science.293.5530.657; da Silva FL, 2003, EPILEPSIA, V44, P72, DOI 10.1111/j.0013-9580.2003.12005.x; Deco G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000092; Desroches M, 2012, SIAM REV IN PRESS; DeVille REL, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031105; Ermentrout GB, 2010, MATH FDN NEUROSCIENC; Feldwisch-Drentrup H, 2010, EPILEPSIA, V51, P1598, DOI 10.1111/j.1528-1167.2009.02497.x; FitzHugh R., 1955, B MATH BIOPHYS, V17, P257, DOI [10.1007/BF02477753, DOI 10.1007/BF02477753, 10.1007/bf02477753]; Freidlin M.I., 2012, RANDOM PERTURBATIONS; Gardiner C., 2009, STOCHASTIC METHODS; GASPARD P, 1987, J STAT PHYS, V48, P151, DOI 10.1007/BF01010405; Grasman J., 1987, ASYMPTOTIC METHODS R; Guckenheimer J, 2003, NONLINEAR DYNAMICS AND CHAOS: WHERE DO WE GO FROM HERE?, P1; Guckenheimer J, 2009, DISCRETE CONT DYN-S, V2, P851, DOI 10.3934/dcdss.2009.2.851; Guckenheimer J, 2009, SIAM J APPL DYN SYST, V8, P854, DOI 10.1137/080741999; HANGGI P, 1990, REV MOD PHYS, V62, P251, DOI 10.1103/RevModPhys.62.251; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Ihle M, 2011, COMPUT METH PROG BIO; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Jost J, 2006, PARTIAL DIFFERENTIAL; Kalitzin SN, 2010, EPILEPSY BEHAV, V17, P310, DOI 10.1016/j.yebeh.2009.12.023; Kapiris PG, 2005, EUROPHYS LETT, V69, P657, DOI 10.1209/epl/i2004-10383-2; Keener J., 2008, MATH PHYSL, V1; KELSO JAS, 1992, PHYS LETT A, V169, P134, DOI 10.1016/0375-9601(92)90583-8; Kitzbichler MG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000314; Kuehn C., 2011, ARXIV11012908, P1; Kuehn C, 2011, PHYSICA D, V240, P1020, DOI 10.1016/j.physd.2011.02.012; Kuhnert MT, 2010, CHAOS, V20, DOI 10.1063/1.3504998; Kuznetsov Yu. A., 2004, ELEMENTS APPL BIFURC, Vthird; Lehnertz K, 2009, J NEUROSCI METH, V183, P42, DOI 10.1016/j.jneumeth.2009.05.015; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Levina A, 2007, NAT PHYS, V3, P857, DOI 10.1038/nphys758; Lindner B, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.022901; Lindner B, 2004, PHYS REP, V392, P321, DOI 10.1016/j.physrep.2003.10.015; Lindner B, 1999, PHYS REV E, V60, P7270, DOI 10.1103/PhysRevE.60.7270; Litt B, 2002, LANCET NEUROL, V1, P22, DOI 10.1016/S1474-4422(02)00003-0; LU Y.-C., 1976, SINGULARITY THEORY I; Marten F, 2009, PHILOS T R SOC A, V367, P1145, DOI 10.1098/rsta.2008.0255; Meisel C, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.061917; Mishchenko E. F., 1980, DIFFERENTIAL EQUATIO; Molaee-Ardekani B, 2010, NEUROIMAGE, V52, P1109, DOI 10.1016/j.neuroimage.2009.12.049; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Mormann F, 2003, EPILEPSY RES, V53, P173, DOI 10.1016/S0920-1211(03)00002-0; Mormann F, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.021912; Mormann F, 2007, BRAIN, V130, P314, DOI 10.1093/brain/awl241; Muratov CB, 2005, PHYSICA D, V210, P227, DOI 10.1016/j.physd.2005.07.014; Muratov CB, 2008, CHAOS, V18, DOI 10.1063/1.2779852; NAGUMO J, 1962, P IRE, V50, P2061, DOI 10.1109/JRPROC.1962.288235; NEISHTADT AI, 1987, DIFF EQUAT+, V23, P1385; NEISHTADT AI, 1988, DIFF EQUAT+, V24, P171; Osorio I, 2002, EPILEPSIA, V43, P1522, DOI 10.1046/j.1528-1157.2002.11102.x; Osorio I, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021919; Perc M, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.016207; Petermann T, 2009, P NATL ACAD SCI USA, V106, P15921, DOI 10.1073/pnas.0904089106; Richardson MP, 2011, PROG BIOPHYS MOL BIO, V105, P5, DOI 10.1016/j.pbiomolbio.2010.09.019; Robinson PA, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041924; Rocsoreanu C., 2000, FITZHUGH NAGUMO MODE; Rodrigues S, 2010, BIOL CYBERN, V102, P145, DOI 10.1007/s00422-009-0357-y; Rodrigues S, 2009, J COMPUT NEUROSCI, V27, P507, DOI 10.1007/s10827-009-0166-2; Rosenblum MG, 1997, PHYS REV LETT, V78, P4193, DOI 10.1103/PhysRevLett.78.4193; Rubin J, 2007, BIOL CYBERN, V97, P5, DOI 10.1007/s00422-007-0153-5; Sagues F, 2007, REV MOD PHYS, V79, P829, DOI 10.1103/RevModPhys.79.829; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Schelter B, 2006, CHAOS, V16, DOI 10.1063/1.2137623; Schelter B, SEIZURE PREDICITION; Shusterman V, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.061911; Strogatz S., 2000, NONLINEAR DYNAMICS C; Subasi A, 2005, EXPERT SYST APPL, V29, P343, DOI 10.1016/j.eswa.2005.04.007; Suffczynski P, 2006, IEEE T BIO-MED ENG, V53, P524, DOI 10.1109/TBME.2005.869800; Suffczynski P, 2004, NEUROSCIENCE, V126, P467, DOI 10.1016/j.neuroscience.2004.03.014; Suffczynski P, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051917; Taylor P, 2011, J COMPUT NEUROSCI, P1; Van der Pol B., 1920, RADIO REV, V1, P701; van Luijtelaar G, 2011, CLIN NEUROPHYSIOL, V122, P687, DOI 10.1016/j.clinph.2010.10.038; Volman V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020572; Wendling F, 2003, BRAIN, V126, P1449, DOI 10.1093/brain/awg144; Wendling Fabrice, 2008, Expert Rev Neurother, V8, P889, DOI 10.1586/14737175.8.6.889; Whitcher B, 2005, SIGNAL PROCESS, V85, P2065, DOI 10.1016/j.sigpro.2005.07.002; Wiggins S., 2003, INTRO APPL NONLINEAR, DOI 10.1007/b97481	95	49	49	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30371	10.1371/journal.pone.0030371	http://dx.doi.org/10.1371/journal.pone.0030371			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363431	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600025
J	Wu, Y; Dong, YZ; Song, P; Zou, MH				Wu, Yong; Dong, Yunzhou; Song, Ping; Zou, Ming-Hui			Activation of the AMP-Activated Protein Kinase (AMPK) by Nitrated Lipids in Endothelial Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; FATTY-ACID TRANSDUCTION; SMOOTH-MUSCLE-CELLS; HUMAN BLOOD-PLASMA; HEME OXYGENASE-1; OXIDATIVE STRESS; IN-VIVO; VASCULAR-DISEASE; UPSTREAM KINASE; GENE-EXPRESSION	The AMP-activated protein kinase (AMPK) is an important regulator of endothelial metabolic and functional homeostasis. Here, we examined the regulation of AMPK by nitrated oleic acid (OA-NO2) and investigated the implications in endothelial function. Treatment of bovine aortic endothelial cells (BAECs) with OA-NO2 induced a significant increase in both AMPK-Thr172 phosphorylation and AMPK activity as well as upregulation of heme oxygenase (HO)-1 and hypoxia-inducible factor (HIF)-1 alpha. Pharmacologic inhibition or genetic ablation of HO-1 or HIF-1 alpha abolished OA-NO2-induced AMPK phosphorylation. OA-NO2 induced a dramatic increase in extracellular signal-regulated kinase (ERK) 1/2 phosphorylation that was abrogated by the HO-1 inhibitor, zinc deuteroporphyrin IX 2,4-bis-ethylene glycol (ZnBG). Inhibition of ERK1/2 using UO126 or PD98059 reduced but did not abolish OA-NO2-induced HIF-1 alpha upregulation, suggesting that OA-NO2/HO-1-initiated HIF-1 alpha induction is partially dependent on ERK1/2 activity. In addition, OA-NO2 enhanced endothelial intracellular Ca2+, an effect that was inhibited by the HIF-1 alpha inhibitor, YC-1, and by HIF-1 alpha siRNA. These results implicate the involvement of HIF-1 alpha. Experiments using the Ca2+/calmodulin-dependent protein kinase kinase ( CaMKK) inhibitor STO-609, the selective CaMKII inhibitor KN-93, and an isoform-specific siRNA demonstrated that OA-NO2-induced AMPK phosphorylation was dependent on CaMKK beta. Together, these results demonstrate that OA-NO2 activates AMPK in endothelial cells via an HO-1-dependent mechanism that increases HIF-1 alpha protein expression and Ca2+/CaMKK beta activation.	[Wu, Yong; Dong, Yunzhou; Song, Ping; Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Sect Mol Med,Dept Med, Oklahoma City, OK 73190 USA; [Wu, Yong] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of California System; University of California Riverside	Wu, Y (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Sect Mol Med,Dept Med, Oklahoma City, OK 73190 USA.	ming-hui-zou@ouhsc.edu	Song, Ping/N-8456-2018; Song, Ping/D-6972-2011	Song, Ping/0000-0002-6143-4270; Song, Ping/0000-0002-2654-6162	National Institutes of Health; Juvenile Diabetes Research Foundation; Oklahoma Center for the Advancement of Science and Technology (OCAST); American Diabetes Association; Travis Endowed Chair in Endocrinology at the University of Oklahoma Health Science Center; American Heart Association.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110488, R01HL105157] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Oklahoma Center for the Advancement of Science and Technology (OCAST); American Diabetes Association(American Diabetes Association); Travis Endowed Chair in Endocrinology at the University of Oklahoma Health Science Center; American Heart Association.(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants, a grant from the Juvenile Diabetes Research Foundation, a grant from the Oklahoma Center for the Advancement of Science and Technology (OCAST), a grant-in-aid from the American Diabetes Association, and funds from the Travis Endowed Chair in Endocrinology at the University of Oklahoma Health Science Center (all to Dr. Zou). Dr. M. H. Zou is a receipient of National Established Investigator Award of American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aley PK, 2005, J BIOL CHEM, V280, P13349, DOI 10.1074/jbc.M413674200; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Brahimi-Horn C, 2005, CELL SIGNAL, V17, P1, DOI 10.1016/j.cellsig.2004.04.010; Bussolati B, 2004, BLOOD, V103, P761, DOI 10.1182/blood-2003-06-1974; Chin BY, 2007, P NATL ACAD SCI USA, V104, P5109, DOI 10.1073/pnas.0609611104; Coles B, 2002, CIRC RES, V91, P375, DOI 10.1161/01.RES.0000032114.68919.EF; da Silva CG, 2006, CIRC RES, V98, pE39, DOI 10.1161/01.RES.0000215436.92414.1d; Davis BJ, 2006, DIABETES, V55, P496, DOI 10.2337/diabetes.55.02.06.db05-1064; Deramaudt BMJM, 1998, J CELL BIOCHEM, V68, P121, DOI 10.1002/(SICI)1097-4644(19980101)68:1<121::AID-JCB12>3.0.CO;2-K; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dulak J, 2008, CIRCULATION, V117, P231, DOI 10.1161/CIRCULATIONAHA.107.698316; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Freeman BA, 2008, J BIOL CHEM, V283, P15515, DOI 10.1074/jbc.R800004200; Gorczynski MJ, 2006, ORG LETT, V8, P2305, DOI 10.1021/ol060548w; Halliwell B, 2000, CARDIOVASC RES, V47, P410, DOI 10.1016/S0008-6363(00)00097-3; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; HAWLEY SA, 1995, J BIOL CHEM, V270, P27186, DOI 10.1074/jbc.270.45.27186; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; HAYASHI K, 1995, FEBS LETT, V370, P37, DOI 10.1016/0014-5793(95)00786-9; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Ischiropoulos H, 2003, J CLIN INVEST, V111, P163, DOI 10.1172/JCI200317638; Ishikawa K, 1997, J CLIN INVEST, V100, P1209, DOI 10.1172/JCI119634; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Lassegue B, 2001, CIRC RES, V88, P888, DOI 10.1161/hh0901.090299; Lima ES, 2003, J LIPID RES, V44, P1660, DOI 10.1194/jlr.M200467-JLR200; Lima ES, 2002, BIOCHEMISTRY-US, V41, P10717, DOI 10.1021/bi025504j; Liu XM, 2011, AM J PHYSIOL-HEART C, V300, pH84, DOI 10.1152/ajpheart.00749.2010; Marx N, 1999, ARTERIOSCL THROM VAS, V19, P546, DOI 10.1161/01.ATV.19.3.546; Moriel P, 2001, FREE RADICAL BIO MED, V30, P318, DOI 10.1016/S0891-5849(00)00467-6; Motterlini R, 1996, AM J PHYSIOL-HEART C, V270, pH107, DOI 10.1152/ajpheart.1996.270.1.H107; Mount PF, 2008, ATHEROSCLEROSIS, V200, P28, DOI 10.1016/j.atherosclerosis.2007.12.003; Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Park H, 2002, J BIOL CHEM, V277, P32571, DOI 10.1074/jbc.M201692200; Polte T, 1997, J MOL CELL CARDIOL, V29, P3305, DOI 10.1006/jmcc.1997.0565; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Ruderman NB, 2003, BIOCHEM SOC T, V31, P202, DOI 10.1042/bst0310202; Soares MP, 2001, IMMUNOL REV, V184, P275, DOI 10.1034/j.1600-065x.2001.1840124.x; Soares MP, 1998, NAT MED, V4, P1073, DOI 10.1038/2063; Stahmann N, 2006, MOL CELL BIOL, V26, P5933, DOI 10.1128/MCB.00383-06; Sutter CH, 2000, P NATL ACAD SCI USA, V97, P4748, DOI 10.1073/pnas.080072497; Taylor CT, 2008, BIOCHEM J, V409, P19, DOI 10.1042/BJ20071249; Villacorta L, 2007, AM J PHYSIOL-HEART C, V293, pH770, DOI 10.1152/ajpheart.00261.2007; Wang J, 2005, FASEB J, V19, pA1278; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Willis D, 1996, NAT MED, V2, P87, DOI 10.1038/nm0196-87; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Wright MM, 2006, P NATL ACAD SCI USA, V103, P4299, DOI 10.1073/pnas.0506541103; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Zhang YJ, 2006, ARTERIOSCL THROM VAS, V26, P1281, DOI 10.1161/01.ATV.0000221230.08596.98; Ziello Jennifer E, 2007, Yale J Biol Med, V80, P51; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200; Zou MH, 2002, J BIOL CHEM, V277, P32552, DOI 10.1074/jbc.M204512200; Zou MH, 2004, ENDOTHELIUM-J ENDOTH, V11, P89, DOI 10.1080/10623320490482619; Zou MH, 2008, CLIN EXP PHARMACOL P, V35, P535, DOI 10.1111/j.1440-1681.2007.04851.x	59	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31056	10.1371/journal.pone.0031056	http://dx.doi.org/10.1371/journal.pone.0031056			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363546	gold, Green Submitted, Green Published			2022-12-27	WOS:000302853600104
J	Xue, LJ; Zhang, JJ; Xue, HW				Xue, Liang-Jiao; Zhang, Jing-Jing; Xue, Hong-Wei			Genome-Wide Analysis of the Complex Transcriptional Networks of Rice Developing Seeds	PLOS ONE			English	Article							GENE-EXPRESSION; ENDOSPERM DEVELOPMENT; ARABIDOPSIS-THALIANA; TEMPERATURE STRESS; FREEZING TOLERANCE; IDENTIFICATION; REGULATOR; INSIGHTS; DATABASE; PROTEIN	Background: The development of rice (Oryza sativa) seed is closely associated with assimilates storage and plant yield, and is fine controlled by complex regulatory networks. Exhaustive transcriptome analysis of developing rice embryo and endosperm will help to characterize the genes possibly involved in the regulation of seed development and provide clues of yield and quality improvement. Principal Findings: Our analysis showed that genes involved in metabolism regulation, hormone response and cellular organization processes are predominantly expressed during rice development. Interestingly, 191 transcription factor (TF)-encoding genes are predominantly expressed in seed and 59 TFs are regulated during seed development, some of which are homologs of seed-specific TFs or regulators of Arabidopsis seed development. Gene co-expression network analysis showed these TFs associated with multiple cellular and metabolism pathways, indicating a complex regulation of rice seed development. Further, by employing a cold-resistant cultivar Hanfeng (HF), genome-wide analyses of seed transcriptome at normal and low temperature reveal that rice seed is sensitive to low temperature at early stage and many genes associated with seed development are down-regulated by low temperature, indicating that the delayed development of rice seed by low temperature is mainly caused by the inhibition of the development-related genes. The transcriptional response of seed and seedling to low temperature is different, and the differential expressions of genes in signaling and metabolism pathways may contribute to the chilling tolerance of HF during seed development. Conclusions: These results provide informative clues and will significantly improve the understanding of rice seed development regulation and the mechanism of cold response in rice seed.	[Xue, Liang-Jiao; Zhang, Jing-Jing; Xue, Hong-Wei] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Xue, HW (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China.	hwxue@sibs.ac.cn	Xue, Liangjiao/F-3554-2016; Xue, Liangjiao/AAE-7123-2022; Xue, Liang-Jiao/N-3675-2014	Xue, Liangjiao/0000-0003-1766-5298; Xue, Liang-Jiao/0000-0003-1766-5298	Chinese Academy of Sciences [KSCX2-YW-N-058]; Shanghai Institutes for Biological Sciences [SIBS2008004]	Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Institutes for Biological Sciences(Chinese Academy of Sciences)	This study was supported by Chinese Academy of Sciences (KSCX2-YW-N-058) and Shanghai Institutes for Biological Sciences (SIBS2008004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2006, J BIOL CHEM, V281, P37636, DOI 10.1074/jbc.M605895200; Agarwal P, 2011, BIOESSAYS, V33, P189, DOI 10.1002/bies.201000107; Attia KA, 2009, CURR ISSUES MOL BIOL, V11, pI29, DOI 10.21775/cimb.011.i29; Benjamini Y, 2001, ANN STAT, V29, P1165; Caldana C, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-7; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Druka Arnis, 2006, Functional & Integrative Genomics, V6, P202, DOI 10.1007/s10142-006-0025-4; Duan K, 2005, PLANT MOL BIOL, V57, P785, DOI 10.1007/s11103-005-1803-4; Ducruet JM, 2007, PHOTOSYNTH RES, V93, P159, DOI 10.1007/s11120-007-9132-x; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Forestan C, 2010, PLANT PHYSIOL, V152, P1373, DOI 10.1104/pp.109.150193; Fu FF, 2010, PLANT PHYSIOL, V154, P927, DOI 10.1104/pp.110.159517; Gao G, 2006, BIOINFORMATICS, V22, P1286, DOI 10.1093/bioinformatics/btl107; Ge XM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-114; Hannah MA, 2006, PLANT PHYSIOL, V142, P98, DOI 10.1104/pp.106.081141; HATTORI T, 1994, PLANT MOL BIOL, V24, P805, DOI 10.1007/BF00029862; Hieber AD, 2000, BBA-PROTEIN STRUCT M, V1482, P84, DOI 10.1016/S0167-4838(00)00141-2; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hobo T, 1999, P NATL ACAD SCI USA, V96, P15348, DOI 10.1073/pnas.96.26.15348; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; Iba K, 2002, ANNU REV PLANT BIOL, V53, P225, DOI 10.1146/annurev.arplant.53.100201.160729; Itoh J, 2005, PLANT CELL PHYSIOL, V46, P23, DOI 10.1093/pcp/pci501; IZAWA T, 1994, PLANT CELL, V6, P1277, DOI 10.1105/tpc.6.9.1277; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Kerk NM, 2003, PLANT PHYSIOL, V132, P27, DOI 10.1104/pp.102.018127; Kim CK, 2011, J APPL GENET, V52, P161, DOI 10.1007/s13353-011-0027-3; Kondou Y, 2008, PLANT PHYSIOL, V147, P1924, DOI 10.1104/pp.108.118364; Kurata N, 2005, PLANT CELL PHYSIOL, V46, P48, DOI 10.1093/pcp/pci506; Laudencia-Chingcuanco DL, 2007, PLANT MOL BIOL, V63, P651, DOI 10.1007/s11103-006-9114-y; Le BH, 2010, P NATL ACAD SCI USA, V107, P8063, DOI 10.1073/pnas.1003530107; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Lee JM, 2002, FUNCT INTEGR GENOMIC, V2, P13, DOI 10.1007/s10142-002-0046-6; Liu XL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-730; Liu XH, 2008, GENOMICS, V91, P378, DOI 10.1016/j.ygeno.2007.12.002; Long TA, 2006, CURR OPIN CELL BIOL, V18, P710, DOI 10.1016/j.ceb.2006.09.004; Matsuda F, 2005, BIOSCI BIOTECH BIOCH, V69, P778, DOI 10.1271/bbb.69.778; Nagasaki H, 2007, P NATL ACAD SCI USA, V104, P14867, DOI 10.1073/pnas.0704339104; Nakase M, 1997, PLANT MOL BIOL, V33, P513, DOI 10.1023/A:1005784717782; Olsen OA, 2004, PLANT CELL, V16, pS214, DOI 10.1105/tpc.017111; Onai K, 2005, GENES CELLS, V10, P963, DOI 10.1111/j.1365-2443.2005.00892.x; Riano-Pachon DM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-42; Roxrud I, 2007, PLANT CELL PHYSIOL, V48, P471, DOI 10.1093/pcp/pcm016; Ruuska SA, 2002, PLANT CELL, V14, P1191, DOI 10.1105/tpc.000877; SATAKE T, 1970, Proceedings of the Crop Science Society of Japan, V39, P468; Sato T, 1996, MOL GEN GENET, V251, P13; Sato Y, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-10; Sazuka T, 2009, PLANT J, V60, P227, DOI 10.1111/j.1365-313X.2009.03952.x; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Sun XD, 2010, CURR OPIN PLANT BIOL, V13, P611, DOI 10.1016/j.pbi.2010.08.009; Suzuki N, 2008, J BIOL CHEM, V283, P9269, DOI 10.1074/jbc.M709187200; Thirumurugan T, 2008, MOL GENET GENOMICS, V279, P279, DOI 10.1007/s00438-007-0312-3; Tu QC, 2008, J INTEGR PLANT BIOL, V50, P1078, DOI 10.1111/j.1744-7909.2008.00714.x; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Xue H, 2007, CURR OPIN PLANT BIOL, V10, P483, DOI 10.1016/j.pbi.2007.07.003; Yan SP, 2006, MOL CELL PROTEOMICS, V5, P484, DOI 10.1074/mcp.M500251-MCP200; Yang HJ, 2002, PLANT MOL BIOL, V50, P379, DOI 10.1023/A:1019859612791; Young TE, 2000, PLANT MOL BIOL, V44, P283, DOI 10.1023/A:1026588408152; Zhu JH, 2007, CURR OPIN PLANT BIOL, V10, P290, DOI 10.1016/j.pbi.2007.04.010; Zhu T, 2003, PLANT BIOTECHNOL J, V1, P59, DOI 10.1046/j.1467-7652.2003.00006.x	60	66	69	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31081	10.1371/journal.pone.0031081	http://dx.doi.org/10.1371/journal.pone.0031081			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363552	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600109
J	Hartley, C; Berthouze, L; Mathieson, SR; Boylan, GB; Rennie, JM; Marlow, N; Farmer, SF				Hartley, Caroline; Berthouze, Luc; Mathieson, Sean R.; Boylan, Geraldine B.; Rennie, Janet M.; Marlow, Neil; Farmer, Simon F.			Long-Range Temporal Correlations in the EEG Bursts of Human Preterm Babies	PLOS ONE			English	Article							HUMAN BRAIN OSCILLATIONS; NEURONAL AVALANCHES; ACTIVITY PATTERNS; SOMATOSENSORY CORTEX; ELECTRICAL-ACTIVITY; THETA-OSCILLATIONS; PREMATURE-INFANTS; CORTICAL CIRCUITS; SPECTRAL-ANALYSIS; SCALING BEHAVIOR	The electrical activity in the very early human preterm brain, as recorded by scalp EEG, is mostly discontinuous and has bursts of high-frequency oscillatory activity nested within slow-wave depolarisations of high amplitude. The temporal organisation of the occurrence of these EEG bursts has not been previously investigated. We analysed the distribution of the EEG bursts in 11 very preterm (23-30 weeks gestational age) human babies through two estimates of the Hurst exponent. We found long-range temporal correlations (LRTCs) in the occurrence of these EEG bursts demonstrating that even in the very immature human brain, when the cerebral cortical structure is far from fully developed, there is non-trivial temporal structuring of electrical activity.	[Hartley, Caroline] UCL, Ctr Math & Phys Life Sci & Expt Biol, London, England; [Hartley, Caroline; Berthouze, Luc] UCL, Inst Child Hlth, London, England; [Berthouze, Luc] Univ Sussex, Ctr Computat Neurosci & Robot, Brighton, E Sussex, England; [Mathieson, Sean R.; Rennie, Janet M.; Marlow, Neil] Elizabeth Garrett Anderson Univ Coll London, Inst Womens Hlth, London, England; [Boylan, Geraldine B.] Natl Univ Ireland Univ Coll Cork, Neonatal Brain Res Grp, Dept Paediat & Child Hlth, Cork, Ireland; [Farmer, Simon F.] UCL, Inst Neurol, London, England	University of London; University College London; University of London; University College London; University of Sussex; University of London; University College London; University College Cork; University of London; University College London	Hartley, C (corresponding author), UCL, Ctr Math & Phys Life Sci & Expt Biol, London, England.	s.farmer@ucl.ac.uk	Farmer, Simon F/D-1969-2012; Berthouze, Luc/C-4168-2008; Boylan, Geraldine B/F-3019-2012; Marlow, Neil/D-2918-2009	Farmer, Simon F/0000-0001-5193-8195; Berthouze, Luc/0000-0003-3774-2369; Marlow, Neil/0000-0001-5890-2953; Boylan, Geraldine/0000-0003-0920-5291; Hartley, Caroline/0000-0002-7981-0836	Wellcome Trust; CoMPLEX (Centre for Mathematics and Physics in the Life Sciences and Experimental Biology), University College London; EPSRC (Engineering and Physical Sciences Research Council); UCLH CBRC (University College London Hospitals Comprehensive Biomedical Research Centre)	Wellcome Trust(Wellcome TrustEuropean Commission); CoMPLEX (Centre for Mathematics and Physics in the Life Sciences and Experimental Biology), University College London; EPSRC (Engineering and Physical Sciences Research Council)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UCLH CBRC (University College London Hospitals Comprehensive Biomedical Research Centre)	SM, JR and Neil Marlow are funded by the Wellcome Trust to SM, JR and NM are funded by the Wellcome Trust. CH was funded through CoMPLEX (Centre for Mathematics and Physics in the Life Sciences and Experimental Biology), University College London. LB was funded by the EPSRC (Engineering and Physical Sciences Research Council). SF was funded by UCLH CBRC (University College London Hospitals Comprehensive Biomedical Research Centre). (www.ucl.ac.uk/complex, www.epsrc.ac.uk, http://www.uclh.org/Research/CBRC/Pages/Home.aspx, www.wellcome.ac.uk). None of the funding was specifically for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON CM, 1985, ELECTROEN CLIN NEURO, V60, P95, DOI 10.1016/0013-4694(85)90015-X; Andre M, 2010, NEUROPHYSIOL CLIN, V40, P59, DOI 10.1016/j.neucli.2010.02.002; Beggs JM, 2003, J NEUROSCI, V23, P11167; BELL AH, 1991, J CLIN NEUROPHYSIOL, V8, P312, DOI 10.1097/00004691-199107010-00007; BENDA GI, 1989, ELECTROEN CLIN NEURO, V72, P189, DOI 10.1016/0013-4694(89)90243-5; Berthouze L, 2010, CLIN NEUROPHYSIOL, V121, P1187, DOI 10.1016/j.clinph.2010.02.163; Bhattacharya J, 2005, NEUROSCIENCE, V131, P547, DOI 10.1016/j.neuroscience.2004.11.013; Biagioni E, 2000, CLIN NEUROPHYSIOL, V111, P2145, DOI 10.1016/S1388-2457(00)00479-X; BIAGIONI E, 1994, ELECTROEN CLIN NEURO, V91, P154, DOI 10.1016/0013-4694(94)90065-5; Chakrabarty S, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.061706; Chan DWS, 2010, BRAIN DEV-JPN, V32, P482, DOI 10.1016/j.braindev.2009.07.006; Dupont E, 2006, NATURE, V439, P79, DOI 10.1038/nature04264; Eswaran H, 2007, CLIN NEUROPHYSIOL, V118, P1940, DOI 10.1016/j.clinph.2007.05.072; Gao JB, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016117; GHOSH A, 1992, SCIENCE, V255, P1441, DOI 10.1126/science.1542795; Gireesh ED, 2008, P NATL ACAD SCI USA, V105, P7576, DOI 10.1073/pnas.0800537105; Hayakawa M, 2001, ARCH DIS CHILD-FETAL, V84, pF163, DOI 10.1136/fn.84.3.F163; Hu K, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011114; Johnson S, 2009, ARCH DIS CHILD-FETAL, V94, pF283, DOI 10.1136/adc.2008.152793; Johnson S, 2009, PEDIATRICS, V124, pE249, DOI 10.1542/peds.2008-3743; Kanold PO, 2010, ANNU REV NEUROSCI, V33, P23, DOI 10.1146/annurev-neuro-060909-153244; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Khazipov R, 2004, NATURE, V432, P758, DOI 10.1038/nature03132; Khazipov R, 2006, TRENDS NEUROSCI, V29, P414, DOI 10.1016/j.tins.2006.05.007; Kilb W, 2011, EUR J NEUROSCI, V34, P1677, DOI 10.1111/j.1460-9568.2011.07878.x; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; KOSTOVIC I, 1990, J COMP NEUROL, V297, P441, DOI 10.1002/cne.902970309; Lamblin MD, 1999, NEUROPHYSIOL CLIN, V29, P123, DOI 10.1016/S0987-7053(99)80051-3; Linkenkaer-Hansen K, 2005, J NEUROSCI, V25, P10131, DOI 10.1523/JNEUROSCI.3244-05.2005; Linkenkaer-Hansen K, 2004, EUR J NEUROSCI, V19, P203, DOI 10.1111/j.1460-9568.2004.03116.x; Linkenkaer-Hansen K, 2001, J NEUROSCI, V21, P1370; Linkenkaer-Hansen K, 2007, J NEUROSCI, V27, P13882, DOI 10.1523/JNEUROSCI.3083-07.2007; McSharry PE, 2005, DFA MATLAB CODE FOUN; Niemarkt HJ, 2011, PEDIATR RES, V70, P529, DOI 10.1203/PDR.0b013e31822d748b; Nikulin VV, 2005, NEUROSCIENCE, V130, P549, DOI 10.1016/j.neuroscience.2004.10.007; Nikulin VV, 2004, CLIN NEUROPHYSIOL, V115, P1896, DOI 10.1016/j.clinph.2004.03.019; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Petermann T, 2009, P NATL ACAD SCI USA, V106, P15921, DOI 10.1073/pnas.0904089106; Poil SS, 2008, HUM BRAIN MAPP, V29, P770, DOI 10.1002/hbm.20590; Ribeiro TL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014129; Robinson PM, 1995, ANN STAT, V23, P1630, DOI 10.1214/aos/1176324317; Schumacher EM, 2011, PEDIATR RES, V69, P413, DOI 10.1203/PDR.0b013e31821267d2; Segev R, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.118102; Taqqu MS, 1995, FRACTALS, V3, P785, DOI 10.1142/S0218348X95000692; Vanhatalo S, 2002, CLIN NEUROPHYSIOL, V113, P1822, DOI 10.1016/S1388-2457(02)00292-4; Vanhatalo S, 2005, EUR J NEUROSCI, V22, P2799, DOI 10.1111/j.1460-9568.2005.04459.x; Vanhatalo S, 2006, SEMIN FETAL NEONAT M, V11, P471, DOI 10.1016/j.siny.2006.07.008; Victor S, 2005, PEDIATR RES, V57, P336, DOI 10.1203/01.PDR.0000153868.77623.43; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Yang JW, 2009, J NEUROSCI, V29, P9011, DOI 10.1523/JNEUROSCI.5646-08.2009	51	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31543	10.1371/journal.pone.0031543	http://dx.doi.org/10.1371/journal.pone.0031543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363669	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000302873700067
J	Koelsch, S; Enge, J; Jentschke, S				Koelsch, Stefan; Enge, Juliane; Jentschke, Sebastian			Cardiac Signatures of Personality	PLOS ONE			English	Article							HEART; DEPRESSION; DISORDER; SCHIZOPHRENIA; ALEXITHYMIA; ASSOCIATION; VARIABILITY; NEUROTICISM; SUBSTANCE; DOPAMINE	Background: There are well-established relations between personality and the heart, as evidenced by associations between negative emotions on the one hand, and coronary heart disease or chronic heart failure on the other. However, there are substantial gaps in our knowledge about relations between the heart and personality in healthy individuals. Here, we investigated whether amplitude patterns of the electrocardiogram (ECG) correlate with neurotisicm, extraversion, agreeableness, warmth, positive emotion, and tender-mindedness as measured with the Neuroticism-Extraversion-Openness (NEO) personality inventory. Specifically, we investigated (a) whether a cardiac amplitude measure that was previously reported to be related to flattened affectivity (referred to as E-k values) would explain variance of NEO scores, and (b) whether correlations can be found between NEO scores and amplitudes of the ECG. Methodology/Principal Findings: NEO scores and rest ECGs were obtained from 425 healthy individuals. Neuroticism and positive emotion significantly differed between individuals with high and low E-k values. In addition, stepwise cross-validated regressions indicated correlations between ECG amplitudes and (a) agreeableness, as well as (b) positive emotion. Conclusions/Significance: These results are the first to demonstrate that ECG amplitude patterns provide information about the personality of an individual as measured with NEO personality scales and facets. These findings open new perspectives for a more efficient personality assessment using cardiac measures, as well as for more efficient risk-stratification and pre-clinical diagnosis of individuals at risk for cardiac, affective and psychosomatic disorders.	[Koelsch, Stefan; Enge, Juliane; Jentschke, Sebastian] Free Univ Berlin, Berlin, Germany	Free University of Berlin	Koelsch, S (corresponding author), Free Univ Berlin, Berlin, Germany.	koelsch@cbs.mpg.de	Jentschke, Sebastian/C-1618-2008; Koelsch, Stefan/AAV-1556-2020	Jentschke, Sebastian/0000-0003-2576-5432; 	Freie University Berlin; Max Planck Society; German Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF) [01EZ1024A]	Freie University Berlin; Max Planck Society(Max Planck SocietyFoundation CELLEX); German Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Freie University Berlin and by the Max Planck Society and by a grant from the German Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF, grant-nr. 01EZ1024A, awareded to SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams D., 2004, BASIC CLIN NEUROCARD, P1; Agelink MW, 2002, PSYCHIAT RES, V113, P139, DOI 10.1016/S0165-1781(02)00225-1; Agewall S, 1996, AM J HYPERTENS, V9, P545, DOI 10.1016/0895-7061(95)00355-X; ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P789; Barrick MR, 1996, J APPL PSYCHOL, V81, P261, DOI 10.1037/0021-9010.81.3.261; Berlin HA, 2005, AM J PSYCHIAT, V162, P2360, DOI 10.1176/appi.ajp.162.12.2360; Bird G, 2010, BRAIN, V133, P1515, DOI 10.1093/brain/awq060; Borkenau P., 1993, NEO FUNF FAKTOREN IN; Bruni R, 2006, ANN NY ACAD SCI, V1069, P208, DOI 10.1196/annals.1351.018; Camm AJ, 1996, CIRCULATION, V93, P1043; Canli T., 2006, BIOL PERSONALITY IND; Cardinal R, 2004, BASIC CLIN NEUROCARD, P315; Carney RM, 2005, PSYCHOSOM MED, V67, pS29, DOI 10.1097/01.psy.0000162254.61556.d5; Chechetto D, 2004, BASIC CLIN NEUROCARD, P220; Cloninger CR, 2000, CURR OPIN PSYCHIATR, V13, P611, DOI 10.1097/00001504-200011000-00024; Cooper JE, 1994, POCKET GUIDE ICD 10; Costa P.T, 1992, REVISED NEOPERSONALI; Craig AD, 2005, TRENDS COGN SCI, V9, P566, DOI 10.1016/j.tics.2005.10.005; Critchley HD, 2005, BRAIN, V128, P75, DOI 10.1093/brain/awh324; Damasio AR, 2000, ARCH GEN PSYCHIAT, V57, P128, DOI 10.1001/archpsyc.57.2.128; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Davidson RJ, 2001, ANN NY ACAD SCI, V935, P191, DOI 10.1111/j.1749-6632.2001.tb03481.x; Deckersbach T, 2006, DEPRESS ANXIETY, V23, P133, DOI 10.1002/da.20152; Denollet J, 2010, CIRC-CARDIOVASC QUAL, V3, P546, DOI 10.1161/CIRCOUTCOMES.109.934406; Depue RA, 1999, BEHAV BRAIN SCI, V22, P491; Eysenck H.J., 1967, BIOL BASIS PERSONALI; Finholt T. A., 2003, EC INNOVATION NEW TE, V12, P5, DOI DOI 10.1080/10438590303119; Friedman BH, 1998, J PSYCHOSOM RES, V44, P133, DOI 10.1016/S0022-3999(97)00202-X; Gagnon C, 2004, BASIC CLIN NEUROCARD, P393; Hall C, 2004, EUR J HEART FAIL, V6, P257, DOI 10.1016/j.ejheart.2003.12.015; Horackova M, 2004, BASIC CLIN NEUROCARD, P61; Irwin MR, 2008, BRAIN BEHAV IMMUN, V22, P129, DOI 10.1016/j.bbi.2007.07.013; Kemp AH, 2010, BIOL PSYCHIAT, V67, P1067, DOI [10.1016/j.biopsych.2009.11.019, 10.1016/j.biopsych.2009.12.012]; Koelsch S, 2007, EUR J NEUROSCI, V26, P3328, DOI 10.1111/j.1460-9568.2007.05889.x; LANE RD, 1987, PSYCHOSOM MED, V49, P274, DOI 10.1097/00006842-198705000-00006; Luchner A, 2002, HYPERTENSION, V39, P99, DOI 10.1161/hy0102.100537; MCCRAE RR, 1983, J CONSULT CLIN PSYCH, V51, P882, DOI 10.1037/0022-006X.51.6.882; Mols F, 2010, HEART, V96, P30, DOI 10.1136/hrt.2009.170357; Ostendorf F., 2004, NEO PI R NEO PERSONL; Paulhus D.L., 1986, PERSONALITY ASSESSME, P143, DOI [DOI 10.1007/978-3-642-70751-3_8, 10.1007/978-3-642-70751-3_8]; Paulhus DL, 1998, J PERS, V66, P1025, DOI 10.1111/1467-6494.00041; Pauls CA, 2003, PERS INDIV DIFFER, V35, P263, DOI 10.1016/S0191-8869(02)00187-3; Riese H, 2007, PSYCHOL MED, V37, P257, DOI 10.1017/S0033291706009160; SANDER D, 1995, J NEUROL, V242, P313, DOI 10.1007/BF00878874; Schiffer AA, 2008, EUR J HEART FAIL, V10, P922, DOI 10.1016/j.ejheart.2008.07.010; Schlogl A., 2007, BRAIN COMPUTER INTER; Sterzer P, 2007, NEUROIMAGE, V37, P335, DOI 10.1016/j.neuroimage.2007.04.043; SWERDLOW NR, 1987, BEHAV BRAIN SCI, V10, P197, DOI 10.1017/S0140525X00047488; Wolkowitz O. M., 2003, PSYCHONEUROENDOCRINO; Yeragani VK, 2000, PSYCHIAT RES, V93, P225, DOI 10.1016/S0165-1781(00)00119-0; ZAMRINI EY, 1990, NEUROLOGY, V40, P1408, DOI 10.1212/WNL.40.9.1408; Zuckerman M., 1991, PSYCHOBIOLOGY PERSON	53	15	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31441	10.1371/journal.pone.0031441	http://dx.doi.org/10.1371/journal.pone.0031441			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926ZM	22363649	Green Submitted, Green Published, gold			2022-12-27	WOS:000302873700059
J	Takeuchi, D; Kerdsin, A; Pienpringam, A; Loetthong, P; Samerchea, S; Luangsuk, P; Khamisara, K; Wongwan, N; Areeratana, P; Chiranairadul, P; Lertchayanti, S; Petcharat, S; Yowang, A; Chaiwongsaen, P; Nakayama, T; Akeda, Y; Hamada, S; Sawanpanyalert, P; Dejsirilert, S; Oishi, K				Takeuchi, Dan; Kerdsin, Anusak; Pienpringam, Anupong; Loetthong, Phacharaphan; Samerchea, Sutit; Luangsuk, Pakkinee; Khamisara, Kasean; Wongwan, Nithita; Areeratana, Prasanee; Chiranairadul, Piphat; Lertchayanti, Suwat; Petcharat, Sininat; Yowang, Amara; Chaiwongsaen, Phanupong; Nakayama, Tatsuya; Akeda, Yukihiro; Hamada, Shigeyuki; Sawanpanyalert, Pathom; Dejsirilert, Surang; Oishi, Kazunori			Population-Based Study of Streptococcus suis Infection in Humans in Phayao Province in Northern Thailand	PLOS ONE			English	Article							MENINGITIS; OUTBREAK; SICHUAN	Background: Streptococcus suis infection in humans has received increasing worldwide recognition. Methods and Findings: A prospective study of S. suis infection in humans was conducted in Phayao Province in northern Thailand to determine the incidence and the risk behaviors of the disease in this region in 2010. Thirty-one cases were confirmed. The case fatality rate was 16.1%, and the estimated incidence rate was 6.2 per 100,000 in the general population. The peak incidence occurred in May. The median age of the patients was 53 years and 64.5% were men. Consumption of raw pork products was confirmed in 22 cases and the median incubation period (range) was 2 days (0-11) after consumption of raw pork products. Isolates from 31 patients were confirmed as serotype 2 in 23 patients (74.2%) and serotype 14 in eight patients (25.8%). The major se(uence types (STs) were ST1 (n = 20) for serotype 2 and ST105 (n = 8) for serotype 14. The epidemiological analysis suggested three possible clusters, which included 17 cases. In the largest possible cluster of 10 cases in Chiang Kham and its neighboring districts in May, the source of infection in four cases was identified as a raw pork dish served at the same restaurant in this district. Microbiological analysis confirmed that three of four cases associated with consumption of raw pork at this restaurant were attributable to an identical strain of serotype 2 with ST1 and pulsotype A2. Conclusions: Our data suggest a high incidence rate of S. suis infection in the general population in Phayao Province in 2010 and confirm a cluster of three cases in 31 human cases. Food safety control should be strengthened especially for raw pork products in northern Thailand.	[Takeuchi, Dan; Nakayama, Tatsuya; Akeda, Yukihiro; Oishi, Kazunori] Osaka Univ, Lab Clin Res Infect Dis, Int Res Ctr Infect Dis, Microbial Dis Res Inst, Osaka, Japan; [Kerdsin, Anusak; Petcharat, Sininat; Sawanpanyalert, Pathom; Dejsirilert, Surang] Minist Publ Hlth, Natl Inst Hlth, Dept Med Sci, Nonthaburi, Thailand; [Pienpringam, Anupong; Luangsuk, Pakkinee; Khamisara, Kasean; Areeratana, Prasanee] Chiang Kham Gen Hosp, Phayao, Thailand; [Loetthong, Phacharaphan; Wongwan, Nithita; Chiranairadul, Piphat] Phayao Prov Hosp, Phayao, Thailand; [Samerchea, Sutit; Lertchayanti, Suwat] Phayao Publ Hlth Off, Phayao, Thailand; [Yowang, Amara; Chaiwongsaen, Phanupong] Chiang Rai Reg Med Sci Ctr, Chiang Rai, Thailand; [Hamada, Shigeyuki] Thailand Japan Res Collaborat Ctr Emerging & Reem, Nonthaburi, Thailand	Osaka University; Ministry of Public Health - Thailand	Takeuchi, D (corresponding author), Osaka Univ, Lab Clin Res Infect Dis, Int Res Ctr Infect Dis, Microbial Dis Res Inst, Osaka, Japan.	oishik@biken.osaka-u.ac.jp	Kerdsin, Anusak/H-5360-2019; Nakayama, Tatsuya/AAU-5242-2020	Kerdsin, Anusak/0000-0003-1055-3656; 	Department of Medical Sciences, Ministry of Public Health of Thailand [21406027]; Ministry of Education, Science and Culture, and the Ministry of Health, Labor and Welfare of Japan; Research Centers for Emerging and Reemerging Infectious Diseases	Department of Medical Sciences, Ministry of Public Health of Thailand; Ministry of Education, Science and Culture, and the Ministry of Health, Labor and Welfare of Japan; Research Centers for Emerging and Reemerging Infectious Diseases	This work was supported by research grants from the Department of Medical Sciences, Ministry of Public Health of Thailand, and Grants-in-Aid for Scientific Research (B: 21406027), and the program of Research Centers for Emerging and Reemerging Infectious Diseases launched by a project commissioned by the Ministry of Education, Science and Culture, and the Ministry of Health, Labor and Welfare of Japan. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENDS JP, 1988, REV INFECT DIS, V10, P131; Cheung PY, 2008, INT J FOOD MICROBIOL, V127, P316, DOI 10.1016/j.ijfoodmicro.2008.08.006; Fongcom A, 2009, SE ASIAN J TROP MED, V40, P511; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; HO DTN, 2011, PLOS ONE, V0006; Kerdsin A, 2011, LANCET, V378, P960, DOI 10.1016/S0140-6736(11)60923-9; Kerdsin A, 2011, EMERG INFECT DIS, V17, P835, DOI 10.3201/eid1705.100754; Kerdsin A, 2009, J MED MICROBIOL, V58, P1508, DOI 10.1099/jmm.0.013656-0; Khadthasrima N, 2008, HUMAN STREPTOCOCCUS; King SJ, 2002, J CLIN MICROBIOL, V40, P3671, DOI 10.1128/JCM.40.10.3671-3680.2002; Luey CKY, 2007, J MICROBIOL METH, V68, P648, DOI 10.1016/j.mimet.2006.10.010; Ma E, 2008, EPIDEMIOL INFECT, V136, P1691, DOI 10.1017/S0950268808000332; Marois C, 2004, J CLIN MICROBIOL, V42, P3169, DOI 10.1128/JCM.42.7.3169-3175.2004; Navacharoen N, 2009, J LARYNGOL OTOL, V123, P857, DOI 10.1017/S0022215109004939; Hoa NT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017943; Rehm T, 2007, J MED MICROBIOL, V56, P102, DOI 10.1099/jmm.0.46616-0; Wangsomboonsiri W, 2008, J INFECTION, V57, P392, DOI 10.1016/j.jinf.2008.08.006; Wertheim HFL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005973; Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763; Ye CY, 2006, EMERG INFECT DIS, V12, P1203, DOI 10.3201/eid1708.060232; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194	21	47	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31265	10.1371/journal.pone.0031265	http://dx.doi.org/10.1371/journal.pone.0031265			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363601	gold, Green Published, Green Submitted			2022-12-27	WOS:000302873700041
J	Volter, C; Strobach, T; Aichert, DS; Wostmann, N; Costa, A; Moller, HJ; Schubert, T; Ettinger, U				Voelter, Christoph; Strobach, Tilo; Aichert, Desiree S.; Woestmann, Nicola; Costa, Anna; Moeller, Hans-Juergen; Schubert, Torsten; Ettinger, Ulrich			Schizotypy and Behavioural Adjustment and the Role of Neuroticism	PLOS ONE			English	Article							PSYCHOMETRICALLY IDENTIFIED SCHIZOTYPY; ANTERIOR CINGULATE CORTEX; III-R CRITERIA; PERSONALITY-TRAITS; COGNITIVE CONTROL; SCHIZOPHRENIA; CONFLICT; DEPRESSION; DISORDERS; SYMPTOMS	Objective: In the present study the relationship between behavioural adjustment following cognitive conflict and schizotypy was investigated using a Stroop colour naming paradigm. Previous research has found deficits with behavioural adjustment in schizophrenia patients. Based on these findings, we hypothesized that individual differences in schizotypy, a personality trait reflecting the subclinical expression of the schizophrenia phenotype, would be associated with behavioural adjustment. Additionally, we investigated whether such a relationship would be explained by individual differences in neuroticism, a non-specific measure of negative trait emotionality known to be correlated with schizotypy. Methods: 106 healthy volunteers (mean age: 25.1, 60% females) took part. Post-conflict adjustment was measured in a computer-based version of the Stroop paradigm. Schizotypy was assessed using the Schizotypal Personality Questionnaire (SPQ) and Neuroticism using the NEO-FFI. Results: We found a negative correlation between schizotypy and post-conflict adjustment (r = -.30, p <.01); this relationship remained significant when controlling for effects of neuroticism. Regression analysis revealed that particularly the subscale No Close Friends drove the effect. Conclusion: Previous findings of deficits in cognitive control in schizophrenia patients were extended to the subclinical personality expression of the schizophrenia phenotype and found to be specific to schizotypal traits over and above the effects of negative emotionality.	[Voelter, Christoph; Strobach, Tilo; Schubert, Torsten; Ettinger, Ulrich] Univ Munich, Dept Psychol, Munich, Germany; [Voelter, Christoph; Aichert, Desiree S.; Woestmann, Nicola; Costa, Anna; Moeller, Hans-Juergen; Ettinger, Ulrich] Univ Munich, Dept Psychiat, D-8000 Munich, Germany	University of Munich; University of Munich	Volter, C (corresponding author), Univ Munich, Dept Psychol, Munich, Germany.	ulrich.ettinger@med.uni-muenchen.de	Ettinger, Ulrich/D-3731-2014; Strobach, Tilo/E-9469-2013	Ettinger, Ulrich/0000-0002-0160-0281; Volter, Christoph/0000-0002-8368-7201; Schubert, Torsten/0000-0002-6514-6145; Strobach, Tilo/0000-0001-7840-0651	Deutsche Forschungsgemeinschaft [ET 31/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (ET 31/2-1) (http://www.dfg.de/en/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKENHEIL M, 1999, MINIINTERNATIONAL IN; Aichert DS, PSYCHOPHYSI IN PRESS; Alain C, 2002, CEREB CORTEX, V12, P840, DOI 10.1093/cercor/12.8.840; American Psychiatric Association, 1987, DSM 3 R DIAGN STAT M; Bates AT, 2002, CLIN NEUROPHYSIOL, V113, P1454, DOI 10.1016/S1388-2457(02)00154-2; BERENBAUM H, 1994, J ABNORM PSYCHOL, V103, P148, DOI 10.1037/0021-843X.103.1.148; Borkenau P, 1993, NEOFUENF FAKTOREN IN; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braunstein-Bercovitz H, 2000, SCHIZOPHR RES, V46, P255, DOI 10.1016/S0920-9964(00)00021-9; Camisa KM, 2005, PSYCHIAT RES, V133, P23, DOI 10.1016/j.psychres.2004.09.002; Carter CS, 2001, AM J PSYCHIAT, V158, P1423, DOI 10.1176/appi.ajp.158.9.1423; Claridge G, 2001, PERS INDIV DIFFER, V31, P383, DOI 10.1016/S0191-8869(00)00144-6; CLARIDGE G, 1984, PERS INDIV DIFFER, V5, P633, DOI 10.1016/0191-8869(84)90111-9; Claridge G. S., 1995, SCHIZOTYPAL PERSONAL; Ettinger U, 2005, BIOL PSYCHOL, V68, P61, DOI 10.1016/j.biopsycho.2004.03.014; EYSENCK HJ, 1993, PSYCHOL REP, V73, P59, DOI 10.2466/pr0.1993.73.1.59; FERGUSSON DM, 1989, SOC PSYCH PSYCH EPID, V24, P275, DOI 10.1007/BF01788029; Ford JM, 1999, PSYCHOPHYSIOLOGY, V36, P667, DOI 10.1111/1469-8986.3660667; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gooding DC, 2006, SCHIZOPHR RES, V82, P27, DOI 10.1016/j.schres.2005.11.015; Gruzelier JH, 1996, SCHIZOPHRENIA BULL, V22, P621, DOI 10.1093/schbul/22.4.621; Gurrera RJ, 2000, J NERV MENT DIS, V188, P31, DOI 10.1097/00005053-200001000-00006; Gurrera RJ, 2005, SCHIZOPHR RES, V80, P243, DOI 10.1016/j.schres.2005.08.002; Hazlett EA, 2008, SCHIZOPHR RES, V101, P111, DOI 10.1016/j.schres.2007.12.472; Heerlein A, 1998, PSYCHOPATHOLOGY, V31, P15, DOI 10.1159/000029019; Holmes AJ, 2007, EMOTION, V7, P68, DOI 10.1037/1528-3542.7.1.68; KENDLER KS, 1991, PSYCHIAT RES, V36, P19, DOI 10.1016/0165-1781(91)90114-5; Kerns JG, 2005, AM J PSYCHIAT, V162, P1833, DOI 10.1176/appi.ajp.162.10.1833; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kerns JG, 2006, NEUROIMAGE, V33, P399, DOI 10.1016/j.neuroimage.2006.06.012; Kerns JG, 2006, J ABNORM PSYCHOL, V115, P418, DOI 10.1037/0021-843X.115.3.418; Klein C, 1997, DIAGNOSTICA, V43, P347; Lehrl S., 1995, MEHRFACHWAHL WORTSCH; LENZENWEGER MF, 1994, SCHIZOPHRENIA BULL, V20, P345, DOI 10.1093/schbul/20.2.345; Lewandowski KE, 2006, SCHIZOPHR RES, V83, P225, DOI 10.1016/j.schres.2005.11.024; LIPP OV, 1994, PERS INDIV DIFFER, V17, P395, DOI 10.1016/0191-8869(94)90286-0; Mayr U, 2004, TRENDS COGN SCI, V8, P145, DOI 10.1016/j.tics.2004.02.006; Nigg JT, 2000, PSYCHOL BULL, V126, P220, DOI 10.1037/0033-2909.126.2.220; Noguchi H, 2008, PSYCHIAT RES, V161, P162, DOI 10.1016/j.psychres.2007.07.023; RAINE A, 1994, SCHIZOPHRENIA BULL, V20, P191, DOI 10.1093/schbul/20.1.191; RAINE A, 1991, SCHIZOPHRENIA BULL, V17, P555, DOI 10.1093/schbul/17.4.555; Raine A., 1995, SCHIZOTYPAL PERSONAL; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Vollema MG, 2000, SCHIZOPHRENIA BULL, V26, P565, DOI 10.1093/oxfordjournals.schbul.a033478	45	14	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30078	10.1371/journal.pone.0030078	http://dx.doi.org/10.1371/journal.pone.0030078			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926YY	22363416	Green Published, Green Submitted, gold			2022-12-27	WOS:000302871500006
J	Blanco, M; Campos, F; Rodriguez-Yanez, M; Arias, S; Fernandez-Ferro, J; Gomez-Sanchez, JC; Castillo, J				Blanco, Miguel; Campos, Francisco; Rodriguez-Yanez, Manuel; Arias, Susana; Fernandez-Ferro, Jose; Carlos Gomez-Sanchez, Jose; Castillo, Jose			Neuroprotection or Increased Brain Damage Mediated by Temperature in Stroke Is Time Dependent	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; BODY-TEMPERATURE; THERAPEUTIC HYPOTHERMIA; MODERATE HYPOTHERMIA; COPENHAGEN STROKE; CARDIAC-ARREST; METAANALYSIS; FEASIBILITY; SEVERITY; THROMBOLYSIS	The control of temperature during the acute phase of stroke may be a new therapeutic target that can be applied in all stroke patients, however therapeutic window or timecourse of the temperature effect is not well established. Our aim is to study the association between changes in body temperature in the first 72 hours and outcome in patients with ischemic (IS) and hemorrhagic (ICH) stroke. We prospectively studied 2931 consecutive patients (2468 with IS and 463 with ICH). Temperature was obtained at admission, and at 24, 48 and 72 hours after admission. Temperature was categorized as low (<36 degrees C), normal (36-37 degrees C) and high (>37 degrees C). As the main variable, we studied functional outcome at 3 months determined by modified Rankin Scale. Temperature in stroke patients is higher than in controls, and increases gradually in the first 72 hours after stroke. A positive correlation between temperature and stroke severity determined by NIHSS was found at 24 and 48 hours, but not at admission or 72 hours. In a logistic regression model, high temperature was associated with poor outcome at 24 hours (OR 2.05, 95% CI 1.59-2.64, p<0.0001) and 48 hours (OR 1.93, 95% CI 1.08-2.34, p = 0.007), but not at admission or 72 hours. Temperature increases in patients with stroke in the first 72 hours, with the harmful effect of high temperature occurring in the first 48 hours. The neuroprotective effect of low temperature occurs within the first 24 hours from stroke onset.	[Blanco, Miguel; Campos, Francisco; Rodriguez-Yanez, Manuel; Arias, Susana; Fernandez-Ferro, Jose; Castillo, Jose] Univ Santiago de Compostela, Hosp Clin Univ, Clin Neurosci Res Lab, Dept Neurol, Santiago De Compostela, Spain; [Carlos Gomez-Sanchez, Jose] Hosp Clin Univ, Dept Neurol, Salamanca, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela	Blanco, M (corresponding author), Univ Santiago de Compostela, Hosp Clin Univ, Clin Neurosci Res Lab, Dept Neurol, Santiago De Compostela, Spain.	jose.castillo@usc.es	Rodríguez-Yáñez, Manuel/ABI-1283-2020; Ferro, Jose/ABH-1763-2021	Rodríguez-Yáñez, Manuel/0000-0002-5381-8557; Castillo, Jose/0000-0002-6685-3001; Fernandez-Ferro, Jose/0000-0003-1172-0153; Gomez-Sanchez, Jose Carlos/0000-0001-6096-7051	Spanish Ministry of Science and Innovation [SAF2011-30517]; Fondo de Investigaciones Sanitarias, Instituto Salud Carlos III [RETICS-RD06/0026]; Xunta de Galicia (Conselleria de Innovacion, Industria e Comercio) [09CSA057918PR]; Xunta de Galicia (Conselleria de Sanidade) [PS09/32]; Xunta de Galicia (Programa Angeles Alvarino); Fundacion Mutua Madrilena; Red de Investigacion Cooperativa Neurovascular	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondo de Investigaciones Sanitarias, Instituto Salud Carlos III(Instituto de Salud Carlos III); Xunta de Galicia (Conselleria de Innovacion, Industria e Comercio)(Xunta de Galicia); Xunta de Galicia (Conselleria de Sanidade)(Xunta de Galicia); Xunta de Galicia (Programa Angeles Alvarino)(Xunta de Galicia); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Red de Investigacion Cooperativa Neurovascular	This project has been partially supported by grants from the Spanish Ministry of Science and Innovation SAF2011-30517 and Fondo de Investigaciones Sanitarias, Instituto Salud Carlos III, RETICS-RD06/0026; Xunta de Galicia (Conselleria de Innovacion, Industria e Comercio: 09CSA057918PR; Conselleria de Sanidade: PS09/32 and Programa Angeles Alvarino); Fundacion Mutua Madrilena and by Red de Investigacion Cooperativa Neurovascular. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Boysen G, 2001, STROKE, V32, P413, DOI 10.1161/01.STR.32.2.413; Castellanos Mar, 2007, Cerebrovasc Dis, V24 Suppl 1, P7, DOI 10.1159/000107374; CASTILLO J, 1994, CEREBROVASC DIS, V4, P66, DOI 10.1159/000108454; Ceulemans AG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-74; Clark DL, 2008, EXP NEUROL, V212, P386, DOI 10.1016/j.expneurol.2008.04.016; den Hertog HM, 2011, J NEUROL, V258, P302, DOI 10.1007/s00415-010-5756-4; den Hertog HM, 2009, LANCET NEUROL, V8, P434, DOI 10.1016/S1474-4422(09)70051-1; Ernon L, 2006, ACTA NEUROL SCAND, V114, P23, DOI 10.1111/j.1600-0404.2006.00596.x; Fingas M, 2009, EXP NEUROL, V219, P156, DOI 10.1016/j.expneurol.2009.05.007; Friedman LK, 2001, MOL BRAIN RES, V86, P34, DOI 10.1016/S0169-328X(00)00252-7; Georgiadis D, 2001, STROKE, V32, P2550, DOI 10.1161/hs1101.097382; Greer DM, 2008, STROKE, V39, P3029, DOI 10.1161/STROKEAHA.108.521583; Hajat C, 2000, STROKE, V31, P410, DOI 10.1161/01.STR.31.2.410; Holzer M, 2002, NEW ENGL J MED, V346, P549; Jaramillo A, 2008, J NEUROL SCI, V266, P1, DOI 10.1016/j.jns.2007.08.037; Kammersgaard LP, 2000, STROKE, V31, P2251, DOI 10.1161/01.STR.31.9.2251; Kammersgaard LP, 2002, STROKE, V33, P1759, DOI 10.1161/01.STR.0000019910.90280.F1; Karaszewski B, 2006, ANN NEUROL, V60, P438, DOI 10.1002/ana.20957; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Kollmar R, 2009, STROKE, V40, P1907, DOI 10.1161/STROKEAHA.108.530410; Leira R, 2012, CLIN SCI, V122, P113, DOI 10.1042/CS20110143; Millan M, 2008, EUR J NEUROL, V15, P1384, DOI 10.1111/j.1468-1331.2008.02321.x; Naess H, 2010, ACTA NEUROL SCAND, V122, P414, DOI 10.1111/j.1600-0404.2010.01331.x; Olsen TS, 2003, LANCET NEUROL, V2, P410, DOI 10.1016/S1474-4422(03)00436-8; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Reith J, 1996, LANCET, V347, P422, DOI 10.1016/S0140-6736(96)90008-2; Saini M, 2009, STROKE, V40, P3051, DOI 10.1161/STROKEAHA.109.556134; Schwab S, 2001, STROKE, V32, P2033, DOI 10.1161/hs0901.095394; Schwarzenberg H, 1998, CARDIOVASC INTER RAD, V21, P142, DOI 10.1007/s002709900231; Sims JR, 2009, NEUROLOGY, V72, P2104, DOI 10.1212/WNL.0b013e3181aa5329; Steiner T, 2001, STROKE, V32, P2833, DOI 10.1161/hs1201.99511; Tang XN, 2009, J NEUROTRAUM, V26, P325, DOI 10.1089/neu.2008.0594; Tomsick TA, 2010, NEUROLOGY, V74, P1069, DOI 10.1212/WNL.0b013e3181d76b8f; van der Worp HB, 2007, BRAIN, V130, P3063, DOI 10.1093/brain/awm083; van der Worp HB, 2010, J CEREBR BLOOD F MET, V30, P1079, DOI 10.1038/jcbfm.2010.44; Yenari MA, 2006, NEUROCHEM INT, V49, P164, DOI 10.1016/j.neuint.2006.03.016; YOUNG AB, 1988, J NEUROSURG, V69, P375, DOI 10.3171/jns.1988.69.3.0375	39	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30700	10.1371/journal.pone.0030700	http://dx.doi.org/10.1371/journal.pone.0030700			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363473	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600057
J	Bristow, CL; Babayeva, MA; LaBrunda, M; Mullen, MP; Winston, R				Bristow, Cynthia L.; Babayeva, Mariya A.; LaBrunda, Michelle; Mullen, Michael P.; Winston, Ronald			alpha(1)Proteinase Inhibitor Regulates CD4(+) Lymphocyte Levels and Is Rate Limiting in HIV-1 Disease	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN-LEUKOCYTE ELASTASE; MONOCLONAL-ANTIBODIES; NEUTROPHIL ELASTASE; GLYCOPROTEIN GP120; DIABETES-MELLITUS; SERINE PROTEASES; IMMUNE-COMPLEXES; LDL RECEPTOR; BONE-MARROW	Background: The regulation of adult stem cell migration through human hematopoietic tissue involves the chemokine CXCL12 (SDF-1) and its receptor CXCR4 (CD184). In addition, human leukocyte elastase (HLE) plays a key role. When HLE is located on the cell surface (HLECS), it acts not as a proteinase, but as a receptor for alpha(1)proteinase inhibitor (alpha 1PI, alpha(1)antitrypsin, SerpinA1). Binding of alpha 1PI to HLECS forms a motogenic complex. We previously demonstrated that alpha 1PI deficiency attends HIV-1 disease and that alpha 1PI augmentation produces increased numbers of immunocompetent circulating CD4(+) lymphocytes. Herein we investigated the mechanism underlying the alpha 1PI deficiency that attends HIV-1 infection. Methods and Findings: Active alpha 1PI in HIV-1 subjects (median 17 mu M, n = 35) was significantly below normal (median 36 mu M, p<0.001, n = 30). In HIV-1 uninfected subjects, CD4(+) lymphocytes were correlated with the combined factors alpha 1PI, HLECS+ lymphocytes, and CXCR4(+) lymphocytes (r(2) = 0.91, p<0.001, n = 30), but not CXCL12. In contrast, in HIV-1 subjects with >220 CD4 cells/mu l, CD4(+) lymphocytes were correlated solely with active alpha 1PI (r(2) = 0.93, p<0.0001, n = 26). The monoclonal anti-HIV-1 gp120 antibody 3F5 present in HIV-1 patient blood is shown to bind and inactivate human alpha 1PI. Chimpanzee alpha 1PI differs from human alpha 1PI by a single amino acid within the 3F5-binding epitope. Unlike human alpha 1PI, chimpanzee alpha 1PI did not bind 3F5 or become depleted following HIV-1 challenge, consistent with the normal CD4(+) lymphocyte levels and benign syndrome of HIV-1 infected chimpanzees. The presence of IgG-alpha 1PI immune complexes correlated with decreased CD4(+) lymphocytes in HIV-1 subjects. Conclusions: This report identifies an autoimmune component of HIV-1 disease that can be overcome therapeutically. Importantly, results identify an achievable vaccine modification with the novel objective to protect against AIDS as opposed to the current objective to protect against HIV-1 infection.	[Bristow, Cynthia L.; Babayeva, Mariya A.] Weill Cornell Med Coll, New York, NY USA; [Bristow, Cynthia L.; Babayeva, Mariya A.; Winston, Ronald] Inst Human Genet & Biochem, Vesenaz, Switzerland; [LaBrunda, Michelle] Holmes Reg Med Ctr, Melbourne, FL USA; [Mullen, Michael P.] Mt Sinai Sch Med, New York, NY USA	Cornell University; Icahn School of Medicine at Mount Sinai	Bristow, CL (corresponding author), Weill Cornell Med Coll, New York, NY USA.	cyb2005@med.cornell.edu			University of North Carolina Center for AIDS Research; Harry Winston Research Foundation	University of North Carolina Center for AIDS Research; Harry Winston Research Foundation	Research was supported by the University of North Carolina Center for AIDS Research and Harry Winston Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMARA A, 1994, CLIN EXP IMMUNOL, V96, P379, DOI 10.1111/j.1365-2249.1994.tb06038.x; ARTHUR LO, 1992, SCIENCE, V258, P1935, DOI 10.1126/science.1470916; BANDA MJ, 1988, J BIOL CHEM, V263, P4481; Benson KF, 2003, NAT GENET, V35, P90, DOI 10.1038/ng1224; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Bristow CL, 2003, BLOOD, V102, P4479, DOI 10.1182/blood-2003-05-1635; BRISTOW CL, 1993, INT IMMUNOL, V5, P79, DOI 10.1093/intimm/5.1.79; Bristow CL, 2001, CLIN DIAGN LAB IMMUN, V8, P937, DOI 10.1128/CDLI.8.5.937-942.2001; BRISTOW CL, 1995, INT IMMUNOL, V7, P239, DOI 10.1093/intimm/7.2.239; Bristow CL, 1998, CLIN IMMUNOL IMMUNOP, V89, P247, DOI 10.1006/clin.1998.4605; Bristow CL, 2008, J IMMUNOL, V180, P492, DOI 10.4049/jimmunol.180.1.492; Bristow CL, 2010, SOLUBLE FACTORS MEDIATING INNATE IMMUNE RESPONSES TO HIV INFECTION, P102; Cai TQ, 1996, J EXP MED, V184, P1213, DOI 10.1084/jem.184.4.1213; Cao CZ, 2006, EMBO J, V25, P1860, DOI 10.1038/sj.emboj.7601082; Cepinskas G, 1999, J CELL SCI, V112, P1937; Cordelier P, 2003, BBA-MOL BASIS DIS, V1638, P197, DOI 10.1016/S0925-4439(03)00084-X; CYGLER M, 1991, SCIENCE, V253, P442, DOI 10.1126/science.1713710; Freissmuth D, 2003, FRONT BIOSCI-LANDMRK, V8, pS733, DOI 10.2741/1124; Garwicz D, 2005, HAEMATOLOGICA, V90, P38; Girard M, 1998, AIDS RES HUM RETROV, V14, P1357, DOI 10.1089/aid.1998.14.1357; Girard M, 1997, VIROLOGY, V232, P98, DOI 10.1006/viro.1997.8560; GOLDING H, 1988, J EXP MED, V167, P914, DOI 10.1084/jem.167.3.914; GULLBERG U, 1995, J BIOL CHEM, V270, P12912, DOI 10.1074/jbc.270.21.12912; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hellerstein MK, 2003, J CLIN INVEST, V112, P956, DOI 10.1172/JCI200317533; Horwitz M, 1999, NAT GENET, V23, P433, DOI 10.1038/70544; Horwitz M, 2004, TRENDS MOL MED, V10, P163, DOI 10.1016/j.molmed.2004.02.002; Janciauskiene S, 2001, ATHEROSCLEROSIS, V158, P41, DOI 10.1016/S0021-9150(00)00767-X; JEPPSSON JO, 1985, J CHROMATOGR, V327, P173, DOI 10.1016/S0021-9673(01)81646-0; JOSLIN G, 1991, J BIOL CHEM, V266, P11282; Koito A, 1989, Int Immunol, V1, P613, DOI 10.1093/intimm/1.6.613; Kuiperij HB, 2009, EXP HEMATOL, V37, P641, DOI 10.1016/j.exphem.2009.02.004; Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Letvin NL, 1997, P NATL ACAD SCI USA, V94, P9378, DOI 10.1073/pnas.94.17.9378; MARLINK R, 1994, SCIENCE, V265, P1587, DOI 10.1126/science.7915856; MARTODAM RR, 1981, BIOCHIM BIOPHYS ACTA, V667, P328, DOI 10.1016/0005-2795(81)90199-9; MISUMI Y, 1991, J BIOL CHEM, V266, P16954; MOLMENTI EP, 1993, J CLIN INVEST, V92, P2022, DOI 10.1172/JCI116797; MOORE JP, 1994, J VIROL, V68, P5142, DOI 10.1128/JVI.68.8.5142-5155.1994; MOORE JP, 1994, J VIROL, V68, P469, DOI 10.1128/JVI.68.1.469-484.1994; Munch J, 2007, CELL, V129, P263, DOI 10.1016/j.cell.2007.02.042; OWEN FL, 1984, IMMUNOL REV, V82, P29, DOI 10.1111/j.1600-065X.1984.tb01116.x; Person RE, 2003, NAT GENET, V34, P308, DOI 10.1038/ng1170; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; Ribeiro RM, 2002, P NATL ACAD SCI USA, V99, P15572, DOI 10.1073/pnas.242358099; Rodman TC, 1999, HUM IMMUNOL, V60, P631, DOI 10.1016/S0198-8859(99)00052-X; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Rubinstein DB, 1999, CLIN IMMUNOL, V90, P352, DOI 10.1006/clim.1998.4668; Rutjens E, 2003, FRONT BIOSCI-LANDMRK, V8, pD1134, DOI 10.2741/1125; Shapiro L, 2001, FASEB J, V15, P115, DOI 10.1096/fj.00-0311com; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Strickland DK, 1997, TRENDS CARDIOVAS MED, V7, P9, DOI 10.1016/S1050-1738(96)00120-X; Tavor S, 2005, BLOOD, V106, P2120, DOI 10.1182/blood-2004-12-4964; VIRELLA G, 1981, DIABETOLOGIA, V21, P184; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Winkler IG, 2005, J EXP MED, V201, P1077, DOI 10.1084/jem.20042299; Yahata T, 2006, BLOOD, V108, P2446, DOI 10.1182/blood-2006-02-002204	58	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31383	10.1371/journal.pone.0031383	http://dx.doi.org/10.1371/journal.pone.0031383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363634	gold, Green Published, Green Submitted			2022-12-27	WOS:000302853600144
J	Fu, Y; Kunz, R; Wu, JH; Dong, C				Fu, Yi; Kunz, Robert; Wu, Jianhua; Dong, Cheng			Study of Local Hydrodynamic Environment in Cell-Substrate Adhesion Using Side-View mu PIV Technology	PLOS ONE			English	Article							WALL-SHEAR-STRESS; LEUKOCYTE ROLLING ADHESION; MICRO-PIV; BLOOD-FLOW; ADHERENT LEUKOCYTES; MELANOMA ADHESION; SURFACE ADHESION; TUMOR-METASTASIS; CANCER; DEFORMATION	Tumor cell adhesion to the endothelium under shear flow conditions is a critical step that results in circulation-mediated tumor metastasis. This study presents experimental and computational techniques for studying the local hydrodynamic environment around adherent cells and how local shear conditions affect cell-cell interactions on the endothelium in tumor cell adhesion. To study the local hydrodynamic profile around heterotypic adherent cells, a side-view flow chamber assay coupled with micro particle imaging velocimetry (mPIV) technique was developed, where interactions between leukocytes and tumor cells in the near-endothelial wall region and the local shear flow environment were characterized. Computational fluid dynamics (CFD) simulations were also used to obtain quantitative flow properties around those adherent cells. Results showed that cell dimension and relative cell-cell positions had strong influence on local shear rates. The velocity profile above leukocytes and tumor cells displayed very different patterns. Larger cell deformations led to less disturbance to the flow. Local shear rates above smaller cells were observed to be more affected by relative positions between two cells.	[Fu, Yi; Wu, Jianhua] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China; [Fu, Yi; Dong, Cheng] Penn State Univ, Dept Bioengn, University Pk, PA 16802 USA; [Kunz, Robert] Penn State Univ, Appl Res Lab, University Pk, PA 16802 USA	South China University of Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Fu, Y (corresponding author), S China Univ Technol, Sch Biosci & Bioengn, Guangzhou, Guangdong, Peoples R China.	cxd23@psu.edu	Kunz, Robert/GOV-3020-2022		National Institute of Health [CA-125707]; National Science Foundation [CBET-0729091]; National Natural Science Foundation of China [31170887]; Chinese Scholarship Council; NATIONAL CANCER INSTITUTE [R01CA125707] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000127] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work is supported by grants from National Institute of Health Grants (CA-125707, to C. D.), National Science Foundation Grant (CBET-0729091, to C. D.) National Natural Science Foundation of China (31170887, to J.W.), and the Fellowship from Chinese Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao J, 1997, ANN BIOMED ENG, V25, P573, DOI 10.1007/BF02684196; Cao J, 1998, MICROVASC RES, V55, P124, DOI 10.1006/mvre.1997.2064; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chambers AF, 1995, CANCER METAST REV, V14, P279, DOI 10.1007/BF00690599; Chapman GB, 1997, BIORHEOLOGY, V34, P37, DOI 10.1016/S0006-355X(97)00003-6; Chapman GB, 1998, BIOPHYS J, V74, P3292, DOI 10.1016/S0006-3495(98)78036-1; CHIEN S, 1987, ANNU REV PHYSIOL, V49, P177, DOI 10.1146/annurev.ph.49.030187.001141; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dong C, 2005, FRONT BIOSCI-LANDMRK, V10, P379, DOI 10.2741/1535; Dong C, 1999, ANN BIOMED ENG, V27, P298, DOI 10.1114/1.143; Dong C, 2000, J BIOMECH, V33, P35, DOI 10.1016/S0021-9290(99)00174-8; Dong Cheng, 2005, Molecular & Cellular Biomechanics, V2, P145; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; GASIC GJ, 1984, CANCER METAST REV, V3, P99, DOI 10.1007/BF00047657; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Gui L, 2002, P 11 INT S APPL LAS, V12, P4; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Herr I, 2001, BLOOD, V98, P2603, DOI 10.1182/blood.V98.9.2603; Hoskins M, 2008, THESIS PENNSYLVANIA; Hoskins MH, 2009, J FLUID STRUCT, V25, P936, DOI 10.1016/j.jfluidstructs.2009.02.002; Jadhav S, 2005, BIOPHYS J, V88, P96, DOI 10.1529/biophysj.104.051029; Jadhav S, 2007, J BIOMECH, V40, P2891, DOI 10.1016/j.jbiomech.2007.03.017; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kahler CJ, 2006, EXP FLUIDS, V41, P327, DOI 10.1007/s00348-006-0167-0; Kitano H, 2004, NAT REV CANCER, V4, P227, DOI 10.1038/nrc1300; Lee JY, 2007, PHYSIOL MEAS, V28, P1149, DOI 10.1088/0967-3334/28/10/002; LEE KH, 1992, J INVEST DERMATOL, V98, P79, DOI 10.1111/1523-1747.ep12495643; Lei X, 1999, J BIOMECH ENG-T ASME, V121, P636, DOI 10.1115/1.2800866; Leong C, 2007, B AM PHYS SOC, V52; Leyton-Mange J, 2006, J BIOMECH ENG-T ASME, V128, P271, DOI 10.1115/1.2165689; Liang S, 2005, EXP CELL RES, V310, P282, DOI 10.1016/j.yexcr.2005.07.028; Liang S, 2008, ANN BIOMED ENG, V36, P661, DOI 10.1007/s10439-008-9445-8; Lima R, 2007, J BIOMECH, V40, P2752, DOI 10.1016/j.jbiomech.2007.01.012; Lima R, 2006, MEAS SCI TECHNOL, V17, P797, DOI 10.1088/0957-0233/17/4/026; Lindken R, 2009, LAB CHIP, V9, P2551, DOI 10.1039/b906558j; Lyczkowski RW, 2009, ANN BIOMED ENG, V37, P1516, DOI 10.1007/s10439-009-9729-7; MCGOVERN VJ, 1982, J CUTAN PATHOL, V9, P61, DOI 10.1111/j.1600-0560.1982.tb01044.x; Meinhart CD, 1999, EXP FLUIDS, V27, P414, DOI 10.1007/s003480050366; Meinhart CD, 2000, J FLUID ENG-T ASME, V122, P285, DOI 10.1115/1.483256; Melero I, 2007, NAT REV CANCER, V7, P95, DOI 10.1038/nrc2051; Munn LL, 2008, ANN BIOMED ENG, V36, P534, DOI 10.1007/s10439-007-9429-0; Nguyen C, 2008, 14 INT S APPL LAS TE, P7; Pappu V, 2008, COMPUT BIOL MED, V38, P738, DOI 10.1016/j.compbiomed.2008.04.002; Pawar P, 2008, AM J PHYSIOL-HEART C, V295, pH1439, DOI 10.1152/ajpheart.91536.2007; Pickard JE, 2009, BIOPHYS J, V96, P4249, DOI 10.1016/j.bpj.2009.01.060; Poelma C, 2008, EXP FLUIDS, V45, P703, DOI 10.1007/s00348-008-0476-6; Poelma C, 2010, J R SOC INTERFACE, V7, P91, DOI 10.1098/rsif.2009.0063; Pommer M, 2005, P 6 INT S PART IM VE, V5, P21; Rossi M, 2008, PROCEEDINGS OF THE 6TH INTERNATIONAL CONFERENCE ON NANOCHANNELS, MICROCHANNELS, AND MINICHANNELS, PTS A AND B, P1093; Santiago JG, 1998, EXP FLUIDS, V25, P316, DOI 10.1007/s003480050235; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Silva G, 2008, INT J HEAT FLUID FL, V29, P1211, DOI 10.1016/j.ijheatfluidflow.2008.03.013; Slattery MJ, 2005, AM J PHYSIOL-CELL PH, V288, pC831, DOI 10.1152/ajpcell.00439.2004; Slattery MJ, 2003, INT J CANCER, V106, P713, DOI 10.1002/ijc.11297; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Sugii Y, 2005, MEAS SCI TECHNOL, V16, P1126, DOI 10.1088/0957-0233/16/5/011; Tolouei E, IN VITRO MICROPIV ME; Voorhees A, 2007, P ROY SOC A-MATH PHY, V463, P1409, DOI 10.1098/rspa.2006.1805; Wereley ST, 2010, ANNU REV FLUID MECH, V42, P557, DOI 10.1146/annurev-fluid-121108-145427; Ying H, 1999, NAT MED, V5, P823, DOI 10.1038/10548; YOUNGREN GK, 1975, J FLUID MECH, V69, P377, DOI 10.1017/S0022112075001486; ZETTER BR, 1993, SEMIN CANCER BIOL, V4, P219; Zhang P, 2011, J IMMUNOL, V186, P242, DOI 10.4049/jimmunol.1000494; Zhu C, 2008, ANN BIOMED ENG, V36, P604, DOI 10.1007/s10439-008-9464-5	67	6	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30721	10.1371/journal.pone.0030721	http://dx.doi.org/10.1371/journal.pone.0030721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363477	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600060
J	Gao, X; Zhu, YB; Li, G; Huang, HT; Zhang, GB; Wang, FM; Sun, J; Yang, QT; Zhang, XG; Lu, BF				Gao, Xin; Zhu, Yibei; Li, Gang; Huang, Haitao; Zhang, Guangbo; Wang, Fengming; Sun, Jing; Yang, Qianting; Zhang, Xueguang; Lu, Binfeng			TIM-3 Expression Characterizes Regulatory T Cells in Tumor Tissues and Is Associated with Lung Cancer Progression	PLOS ONE			English	Article							AUTOIMMUNE; INFLAMMATION; GENERATION; INDUCTION; RESPONSES; PROMOTES; TH17	Background: T cell immunoglobulin-3 (TIM-3) has been established as a negative regulatory molecule and plays a critical role in immune tolerance. TIM-3 is upregulated in exhausted CD8(+) T cells in both chronic infection and tumor. However, the nature of TIM-3(+)CD4(+) T cells in the tumor microenvironment is unclear. This study is to characterize TIM-3 expressing lymphocytes within human lung cancer tissues and establish clinical significance of TIM-3 expression in lung cancer progression. Methodology: A total of 51 human lung cancer tissue specimens were obtained from pathologically confirmed and newly diagnosed non-small cell lung cancer (NSCLC) patients. Leukocytes from tumor tissues, distal normal lung tissues, and peripheral blood mononuclear cells (PBMC) were analyzed for TIM-3 surface expression by flow cytometry. TIM-3 expression on tumor-infiltrating lymphocytes (TILs) was correlated with clinicopathological parameters. Conclusions: TIM-3 is highly upregulated on both CD4(+) and CD8(+) TILs from human lung cancer tissues but negligibly expressed on T cells from patients' peripheral blood. Frequencies of IFN-gamma(+) cells were reduced in TIM-3(+)CD8(+) TILs compared to TIM-3(-)CD8(+) TILs. However, the level of TIM-3 expression on CD8(+) TILs failed to associate with any clinical pathological parameter. Interestingly, we found that approximately 70% of TIM-3(+)CD4(+) TILs expressed FOXP3 and about 60% of FOXP3(+) TILs were TIM-3(+). Importantly, TIM-3 expression on CD4(+) T cells correlated with poor clinicopathological parameters of NSCLC such as nodal metastasis and advanced cancer stages. Our study reveals a new role of TIM-3 as an important immune regulator in the tumor microenvironment via its predominant expression in regulatory T cells.	[Gao, Xin; Zhu, Yibei; Li, Gang; Wang, Fengming; Sun, Jing; Zhang, Xueguang] Soochow Univ, Inst Med Biotechnol, Dept Immunol, Suzhou, Peoples R China; [Zhu, Yibei; Lu, Binfeng] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA USA; [Lu, Binfeng] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Huang, Haitao; Zhang, Guangbo] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Clin Immunol, Suzhou, Peoples R China; [Zhang, Xueguang] Soochow Univ, Jiangsu Prov Key Lab Stem Cell Res, Suzhou, Peoples R China; [Yang, Qianting] Shenzhen Third Peoples Hosp, Shenzhen Clin Ctr Infect Dis, Shenzhen, Peoples R China	Soochow University - China; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Soochow University - China; Soochow University - China	Gao, X (corresponding author), Soochow Univ, Inst Med Biotechnol, Dept Immunol, Suzhou, Peoples R China.	xueguangzh@yahoo.com.cn; binfeng@pitt.edu		Gao, Xin/0000-0001-8622-1522	NSFC (National Natural Science Foundation of China) [30528008]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0849]; Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD); Cancer Research Institute; University of Pittsburgh; Eleven-Fifth Mega-Scientific Project on "prevention and treatment of AIDS, viral hepatitis and other infectious diseases" [2008ZX10003-012]; China Scholarship council; NSFC [31170866]; Jiangsu Natural Science Fund [BK2011289]; Suzhou Social Development Project [SYS201009]	NSFC (National Natural Science Foundation of China)(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD); Cancer Research Institute; University of Pittsburgh(University of Pittsburgh); Eleven-Fifth Mega-Scientific Project on "prevention and treatment of AIDS, viral hepatitis and other infectious diseases"; China Scholarship council(China Scholarship Council); NSFC(National Natural Science Foundation of China (NSFC)); Jiangsu Natural Science Fund; Suzhou Social Development Project	This work is partly supported by NSFC (National Natural Science Foundation of China) grants 30528008, Program for Changjiang Scholars and Innovative Research Team in University (IRT0849) and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD) (to BL and XZ). BL was partly supported by the Young Investigator Award from Cancer Research Institute and University of Pittsburgh Startup fund. QY is supported by Eleven-Fifth Mega-Scientific Project on "prevention and treatment of AIDS, viral hepatitis and other infectious diseases" (2008ZX10003-012). GL and XG are supported by a scholarship from China Scholarship council. YZ is supported by NSFC grant 31170866, Jiangsu Natural Science Fund BK2011289 and Suzhou Social Development Project (SYS201009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Boenisch O, 2010, J IMMUNOL, V185, P5806, DOI 10.4049/jimmunol.0903435; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Hastings WD, 2009, EUR J IMMUNOL, V39, P2492, DOI 10.1002/eji.200939274; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Lu BF, 2011, IMMUNOL RES, V50, P269, DOI 10.1007/s12026-011-8227-9; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sakuishi K, 2011, TRENDS IMMUNOL, V21, P21; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Wang L, 2008, P NATL ACAD SCI USA, V105, P9331, DOI 10.1073/pnas.0710441105; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271; Zhu YB, 2010, J IMMUNOL, V185, P3174, DOI 10.4049/jimmunol.1000749; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	21	249	280	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30676	10.1371/journal.pone.0030676	http://dx.doi.org/10.1371/journal.pone.0030676			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363469	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000302853600053
J	Qasem, L; Cardew, A; Wilson, A; Griffiths, I; Halsey, LG; Shepard, ELC; Gleiss, AC; Wilson, R				Qasem, Lama; Cardew, Antonia; Wilson, Alexis; Griffiths, Iwan; Halsey, Lewis G.; Shepard, Emily L. C.; Gleiss, Adrian C.; Wilson, Rory			Tri-Axial Dynamic Acceleration as a Proxy for Animal Energy Expenditure; Should We Be Summing Values or Calculating the Vector?	PLOS ONE			English	Article							DOUBLY-LABELED WATER; HEART-RATE; BODY ACCELERATION; FORAGING STRATEGIES; OXYGEN-CONSUMPTION; SWIM SPEED; LOCOMOTION; PENGUINS; BEHAVIOR; ENERGETICS	Dynamic body acceleration (DBA) has been used as a proxy for energy expenditure in logger-equipped animals, with researchers summing the acceleration (overall dynamic body acceleration - ODBA) from the three orthogonal axes of devices. The vector of the dynamic body acceleration (VeDBA) may be a better proxy so this study compared ODBA and VeDBA as proxies for rate of oxygen consumption using humans and 6 other species. Twenty-one humans on a treadmill ran at different speeds while equipped with two loggers, one in a straight orientation and the other skewed, while rate of oxygen consumption ((V) over dotO(2)) was recorded. Similar data were obtained from animals but using only one (straight) logger. In humans, both ODBA and VeDBA were good proxies for (V) over dotO(2) with all r(2) values exceeding 0.88, although ODBA accounted for slightly but significantly more of the variation in (V) over dotO(2) than did VeDBA (P<0.03). There were no significant differences between ODBA and VeDBA in terms of the change in (V) over dotO(2) VO2 estimated by the acceleration data in a simulated situation of the logger being mounted straight but then becoming skewed (P = 0.744). In the animal study, ODBA and VeDBA were again good proxies for (V) over dotO(2) with all r(2) values exceeding 0.70 although, again, ODBA accounted for slightly, but significantly, more of the variation in (V) over dotO(2) than did VeDBA (P < 0.03). The simultaneous contraction of muscles, inserted variously for limb stability, may produce muscle oxygen use that at least partially equates with summing components to derive DBA. Thus, a vectorial summation to derive DBA cannot be assumed to be the more 'correct' calculation. However, although within the limitations of our simple study, ODBA appears a marginally better proxy for (V) over dotO(2). In the unusual situation where researchers are unable to guarantee at least reasonably consistent device orientation, they should use VeDBA as a proxy for (V) over dotO(2).	[Qasem, Lama; Shepard, Emily L. C.; Wilson, Rory] Swansea Univ, Coll Sci, Swansea, W Glam, Wales; [Cardew, Antonia; Griffiths, Iwan] Swansea Univ, Coll Engn, Swansea, W Glam, Wales; [Wilson, Alexis] Lon Gwynfryn, Swansea, W Glam, Wales; [Halsey, Lewis G.] Univ Roehampton, Sch Life Sci, London, England; [Gleiss, Adrian C.] Murdoch Univ, Ctr Fish & Fisheries Res, Murdoch, WA 6150, Australia	Swansea University; Swansea University; Roehampton University; Murdoch University	Qasem, L (corresponding author), Swansea Univ, Coll Sci, Swansea, W Glam, Wales.	583065@swansea.ac.uk	Halsey, Lewis/B-8498-2011	Halsey, Lewis/0000-0002-0786-7585; Gleiss, Adrian/0000-0002-9960-2858; Shepard, Emily/0000-0001-7325-6398	Rolex Awards for Enterprise; Damascus University	Rolex Awards for Enterprise; Damascus University	This study was supported by the Rolex Awards for Enterprise and Damascus University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RM., 2003, PRINCIPLES ANIMAL LO; Bartumeus F, 2009, J PHYS A, P42; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Bergman CM, 2001, J ANIM ECOL, V70, P289, DOI 10.1046/j.1365-2656.2001.00496.x; Bevan RM, 2002, FUNCT ECOL, V16, P175, DOI 10.1046/j.1365-2435.2002.00622.x; Boisclair D, 1989, CANADIAN J FISHERIES, V46, P1856; BOUTEN CV, 1994, MED SCI SPORT EXER, V26, P1516; BUTLER PJ, 1992, J EXP BIOL, V170, P35; CAVAGNA GA, 1977, J PHYSIOL-LONDON, V268, P467, DOI 10.1113/jphysiol.1977.sp011866; Clark TD, 2010, J COMP PHYSIOL B, V180, P673, DOI 10.1007/s00360-009-0442-5; FRAPPELL PB, 1989, J THEOR BIOL, V138, P479, DOI 10.1016/S0022-5193(89)80046-3; Froget G, 2004, J EXP BIOL, V207, P3917, DOI 10.1242/jeb.01232; Gleiss AC, NATURE COMM IN PRESS; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; Gleiss AC, 2010, J EXP MAR BIOL ECOL, V385, P85, DOI 10.1016/j.jembe.2010.01.012; Laich AG, 2011, J EXP MAR BIOL ECOL, V399, P151, DOI 10.1016/j.jembe.2011.01.008; Green JA, 2009, J EXP BIOL, V212, P471, DOI 10.1242/jeb.026377; Green JA, 2002, FUNCT ECOL, V16, P671, DOI 10.1046/j.1365-2435.2002.00670.x; Halsey LG, 2009, COMP BIOCHEM PHYS A, V152, P197, DOI 10.1016/j.cbpa.2008.09.021; Halsey LG, 2008, ZOOLOGY, V111, P231, DOI 10.1016/j.zool.2007.07.011; Halsey LG, 2007, ZOOLOGY, V110, P81, DOI 10.1016/j.zool.2006.09.001; Halsey LG, 2011, COMP BIOCHEM PHYS A, V158, P247, DOI 10.1016/j.cbpa.2011.01.001; Halsey LG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010170; Halsey LG, 2009, J FIELD ORNITHOL, V80, P171, DOI 10.1111/j.1557-9263.2009.00219.x; Hooker SK, 1999, P ROY SOC B-BIOL SCI, V266, P671, DOI 10.1098/rspb.1999.0688; Johnson MP, 2003, IEEE J OCEANIC ENG, V28, P3, DOI 10.1109/JOE.2002.808212; Karasov WH, 1992, INTEGR COMP BIOL, V32, P238; May R, 2010, ECOL MODEL, V221, P936, DOI 10.1016/j.ecolmodel.2009.12.024; McGregor SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007355; MEIJER GA, 1989, MED SCI SPORT EXER, V21, P343; MURRAY MG, 1991, J ANIM ECOL, V60, P1029, DOI 10.2307/5429; NAGY KA, 1987, ECOL MONOGR, V57, P111, DOI 10.2307/1942620; Nagy KA, 2001, NUTR ABSTR REV B, V71, P21; Nagy KA, 1984, ENERGY UTILIZATION F; OWEN RB, 1969, COMP BIOCHEM PHYSIOL, V31, P431, DOI 10.1016/0010-406X(69)90024-3; Pfau T, 2006, J EXP BIOL, V209, P3742, DOI 10.1242/jeb.02439; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Sakai M, 2011, MAMM STUDY, V36, P55, DOI 10.3106/041.036.0107; SCHMIDTNIELSEN K, 1972, SCIENCE, V177, P222, DOI 10.1126/science.177.4045.222; Shaffer SA, 2004, J AVIAN BIOL, V35, P551, DOI 10.1111/j.0908-8857.2004.03264.x; Shepard ELC, 2009, P ROY SOC B-BIOL SCI, V276, P3149, DOI 10.1098/rspb.2009.0683; Shepard Emily L. C., 2010, Endangered Species Research, V10, P47, DOI 10.3354/esr00084; Shepard Emily L. C., 2008, Endangered Species Research, V4, P157, DOI 10.3354/esr00052; Shipley LA, 2007, OIKOS, V116, P1964, DOI 10.1111/j.2007.0030-1299.15974.x; SPEAKMAN JR, 1988, SCI PROG, V72, P227; TATNER P, 1986, AUK, V103, P169; Terrier P, 2001, MED SCI SPORT EXER, V33, P1912, DOI 10.1097/00005768-200111000-00017; Wilson Rory P., 2008, Endangered Species Research, V4, P123, DOI 10.3354/esr00064; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; Wilson RP, 2002, MAR ECOL PROG SER, V228, P241, DOI 10.3354/meps228241; YAMAMOTO Y, 1991, EUR J APPL PHYSIOL O, V63, P55, DOI 10.1007/BF00760802; Zajac FE, 2002, GAIT POSTURE, V16, P215, DOI 10.1016/S0966-6362(02)00068-1; Zhang K, 2004, MED SCI SPORT EXER, V36, P883, DOI 10.1249/01.MSS.0000126585.40962.22	53	182	186	4	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31187	10.1371/journal.pone.0031187	http://dx.doi.org/10.1371/journal.pone.0031187			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363576	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600123
J	Fiebig, T; Boll, H; Figueiredo, G; Kerl, HU; Nittka, S; Groden, C; Kramer, M; Brockmann, MA				Fiebig, Teresa; Boll, Hanne; Figueiredo, Giovanna; Kerl, Hans Ulrich; Nittka, Stefanie; Groden, Christoph; Kramer, Martin; Brockmann, Marc A.			Three-Dimensional In Vivo Imaging of the Murine Liver: A Micro-Computed Tomography-Based Anatomical Study	PLOS ONE			English	Article							MOUSE; HEPATECTOMY; MODEL; CT	Various murine models are currently used to study acute and chronic pathological processes of the liver, and the efficacy of novel therapeutic regimens. The increasing availability of high-resolution small animal imaging modalities presents researchers with the opportunity to precisely identify and describe pathological processes of the liver. To meet the demands, the objective of this study was to provide a three-dimensional illustration of the macroscopic anatomical location of the murine liver lobes and hepatic vessels using small animal imaging modalities. We analysed micro-CT images of the murine liver by integrating additional information from the published literature to develop comprehensive illustrations of the macroscopic anatomical features of the murine liver and hepatic vasculature. As a result, we provide updated three-dimensional illustrations of the macroscopic anatomy of the murine liver and hepatic vessels using micro-CT. The information presented here provides researchers working in the field of experimental liver disease with a comprehensive, easily accessable overview of the macroscopic anatomy of the murine liver.	[Fiebig, Teresa; Boll, Hanne; Figueiredo, Giovanna; Kerl, Hans Ulrich; Groden, Christoph; Brockmann, Marc A.] Heidelberg Univ, Med Fac Mannheim, Dept Neuroradiol, D-6800 Mannheim, Germany; [Nittka, Stefanie] Heidelberg Univ, Med Fac Mannheim, Dept Clin Chem, D-6800 Mannheim, Germany; [Kramer, Martin] Univ Giessen, Small Anim Clin, Dept Vet Clin Sci, Giessen, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Justus Liebig University Giessen	Fiebig, T (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Neuroradiol, D-6800 Mannheim, Germany.	brockmann@gmx.de			Federal Ministry of Education and Research; Land Baden-Wurttemberg (HBFG) [125-648]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Land Baden-Wurttemberg (HBFG)	The acquisition of the micro-CT (Yxlon Y. Fox) was funded by the Federal Ministry of Education and Research and the Land Baden-Wurttemberg (HBFG grant # 125-648). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almajdub M, 2007, CONTRAST MEDIA MOL I, V2, P88, DOI 10.1002/cmmi.130; Boll H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025692; COOK M.J, 1965, ANATOMY LAB MOUSE; Dogdas B, 2007, PHYS MED BIOL, V52, P577, DOI 10.1088/0031-9155/52/3/003; Dorner M, 2011, NATURE, V474, P208, DOI 10.1038/nature10168; Duan YN, 2011, PARASITOLOGY, V138, P1003, DOI 10.1017/S0031182011000667; Fernandez-Dominguez I, 2011, ULTRASOUND MED BIOL, V37, P1161, DOI 10.1016/j.ultrasmedbio.2011.04.012; Fox JG, 2007, MOUSE BIOMEDICAL RES, P1; Gabele E, 2011, ALCOHOL CLIN EXP RES, V35, P1361, DOI 10.1111/j.1530-0277.2011.01472.x; Galvez J, 2011, VISIBLE MOUSE PROJEC; Graham KC, 2008, INVEST RADIOL, V43, P488, DOI 10.1097/RLI.0b013e318172f5b5; Greene AK, 2003, J INVEST SURG, V16, P99, DOI 10.1080/08941930390194424; Hedrich H., 2004, LAB MOUSE, P117; HOLLANDER CF, 1987, ARCH TOXICOL, P244; Hummel KP, 1966, BIOL LAB MOUSE; Hutchins GD, 2008, ILAR J, V49, P54, DOI 10.1093/ilar.49.1.54; Inderbitzin D, 2007, METHODS, V43, P46, DOI 10.1016/j.ymeth.2007.03.010; Jensen MR, 2003, HEPATOLOGY, V37, P862, DOI 10.1053/jhep.2003.50137; Kagadis GC, 2010, MED PHYS, V37, P6421, DOI 10.1118/1.3515456; Kline TL, 2011, CELLS TISSUES ORGANS, V194, P431, DOI 10.1159/000323482; Kogure K, 1999, J Hepatobiliary Pancreat Surg, V6, P171, DOI 10.1007/s005340050101; Kolbekova P, 2011, PARASITOL RES, V108, P1007, DOI 10.1007/s00436-010-2145-y; Kuhara T, 2011, EUR J NUTR IN PRESS; Loudos G, 2011, EUR J RADIOL, V78, P287, DOI 10.1016/j.ejrad.2010.06.025; Madrahimov N, 2006, ANN SURG, V244, P89, DOI 10.1097/01.sla.0000218093.12408.0f; Maronpot RR, 1999, PATHOLOGY MOUSE, P120; Martiniova L, 2010, METHODS, V50, P20, DOI 10.1016/j.ymeth.2009.05.016; Martins PNA, 2008, LIVER INT, V28, P3, DOI 10.1111/j.1478-3231.2007.01628.x; Martins PNA, 2007, LIVER INT, V27, P384, DOI 10.1111/j.1478-3231.2006.01414.x; May D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021478; Nomenclature ICoVGA, 2005, NOM AN VET; Popesko P, 1992, COLOUR ATLAS ANATOMY, P107; RAUCH H, 1952, GENETICS, V37, P617; Schambach SJ, 2010, METHODS, V50, P2, DOI 10.1016/j.ymeth.2009.08.007; Studer P, 2008, GASTROENTEROLOGY, V134, pA875; Takamasa I, 2001, COLOR ATLAS SECTIONA; Van Steenkiste C, 2010, LIVER INT, V30, P1211, DOI 10.1111/j.1478-3231.2010.02276.x; Yan AW, 2011, HEPATOLOGY, V53, P96, DOI 10.1002/hep.24018	38	35	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31179	10.1371/journal.pone.0031179	http://dx.doi.org/10.1371/journal.pone.0031179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22363574	Green Published, Green Submitted, gold			2022-12-27	WOS:000302730100052
J	Fields, RL; Ponzio, TA; Kawasaki, M; Gainer, H				Fields, Raymond L.; Ponzio, Todd A.; Kawasaki, Makoto; Gainer, Harold			Cell-Type Specific Oxytocin Gene Expression from AAV Delivered Promoter Deletion Constructs into the Rat Supraoptic Nucleus in vivo	PLOS ONE			English	Article							ADENOASSOCIATED VIRAL VECTOR; HYPOTHALAMO-NEUROHYPOPHYSEAL SYSTEM; MESSENGER RIBONUCLEIC-ACIDS; POLYMERASE-CHAIN-REACTION; MAGNOCELLULAR NEURONS; VASOPRESSIN GENE; RESPONSE ELEMENT; HYPOTHALAMONEUROHYPOPHYSEAL SYSTEM; TRANSGENIC MICE; NERVOUS-SYSTEM	The magnocellular neurons (MCNs) in the hypothalamus selectively express either oxytocin (OXT) or vasopressin (AVP) neuropeptide genes, a property that defines their phenotypes. Here we examine the molecular basis of this selectivity in the OXT MCNs by stereotaxic microinjections of adeno-associated virus (AAV) vectors that contain various OXT gene promoter deletion constructs using EGFP as the reporter into the rat supraoptic nucleus (SON). Two weeks following injection of the AAVs, immunohistochemical assays of EGFP expression from these constructs were done to determine whether the EGFP reporter co-localizes with either the OXT- or AVP-immunoreactivity in the MCNs. The results show that the key elements in the OT gene promoter that regulate the cell-type specific expression the SON are located -216 to -100 bp upstream of the transcription start site. We hypothesize that within this 116 bp domain a repressor exists that inhibits expression specifically in AVP MCNs, thereby leading to the cell-type specific expression of the OXT gene only in the OXT MCNs.	[Fields, Raymond L.; Ponzio, Todd A.; Kawasaki, Makoto; Gainer, Harold] NINDS, Neurochem Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Fields, RL (corresponding author), NINDS, Neurochem Lab, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	gainerh@ninds.nih.gov	Ponzio, Todd/AAV-2374-2021	Ponzio, Todd/0000-0002-3174-1229; Kawasaki, Makoto/0000-0001-8410-5800	Intramural Research Program of the National Institutes of Health; National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002723] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Neurological Disorders and Stroke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAN RAH, 1993, MOL ENDOCRINOL, V7, P47, DOI 10.1210/me.7.1.47; ADAN RAH, 1991, BIOCHEM BIOPH RES CO, V175, P117, DOI 10.1016/S0006-291X(05)81208-2; ADAN RAH, 1992, J BIOL CHEM, V267, P3771; Allan DW, 2003, CELL, V113, P73, DOI 10.1016/S0092-8674(03)00204-6; Armstrong WE, 1995, PROG NEUROBIOL, V47, P291, DOI 10.1016/0301-0082(95)00025-9; BENBARAK Y, 1985, J NEUROSCI, V5, P81; BRADLEY DJ, 1992, J NEUROSCI, V12, P2288; BROWNSTEIN MJ, 1980, SCIENCE, V207, P373, DOI 10.1126/science.6153132; Burbach JPH, 2001, PHYSIOL REV, V81, P1197, DOI 10.1152/physrev.2001.81.3.1197; BURBACH JPH, 1994, J BIOL CHEM, V269, P15046; Burger C, 2005, HUM GENE THER, V16, P781, DOI 10.1089/hum.2005.16.781; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Chen H, 1998, GENE THER, V5, P50, DOI 10.1038/sj.gt.3300547; Chu K, 1997, J MOL ENDOCRINOL, V19, P163, DOI 10.1677/jme.0.0190163; Chu K, 1999, J MOL ENDOCRINOL, V23, P337, DOI 10.1677/jme.0.0230337; Coulson JM, 2003, BIOCHEM J, V369, P549, DOI 10.1042/BJ20021176; DASILVA SL, 1995, TRENDS NEUROSCI, V18, P542, DOI 10.1016/0166-2236(95)98376-A; DASILVA SL, 1995, MOL BRAIN RES, V30, P131, DOI 10.1016/0169-328X(94)00289-Q; Davies J, 2003, J NEUROENDOCRINOL, V15, P42, DOI 10.1046/j.1365-2826.2003.00865.x; de Backer MWA, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-81; de Backer MWA, 2010, HUM GENE THER, V21, P673, DOI 10.1089/hum.2009.169; Doherty FC, 2011, J NEUROSCI METH, V197, P238, DOI 10.1016/j.jneumeth.2011.02.026; Fields RL, 2003, J NEUROSCI, V23, P7801; Gainer H, 1998, ADV EXP MED BIOL, V449, P15; Gainer H, 1995, ADV EXP MED BIOL, V395, P1; Garza JC, 2008, J ENDOCRINOL, V197, P471, DOI 10.1677/JOE-08-0009; Geller SF, 2007, MOL VIS, V13, P730; Glasgow E, 1999, ENDOCRINOLOGY, V140, P5391, DOI 10.1210/en.140.11.5391; Heinrichs M, 2009, FRONT NEUROENDOCRIN, V30, P548, DOI 10.1016/j.yfrne.2009.05.005; Hindmarch C, 2006, P NATL ACAD SCI USA, V103, P1609, DOI 10.1073/pnas.0507450103; Ho MY, 2002, MOL CELL ENDOCRINOL, V186, P17, DOI 10.1016/S0303-7207(01)00677-3; Hokfelt T, 2000, NEUROPHARMACOLOGY, V39, P1337, DOI 10.1016/S0028-3908(00)00010-1; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; IVELL R, 1984, EMBO J, V3, P2351, DOI 10.1002/j.1460-2075.1984.tb02139.x; Ivell R, 1998, ADV EXP MED BIOL, V449, P297; Jeong SW, 2001, EXP NEUROL, V171, P255, DOI 10.1006/exnr.2001.7785; Kim JK, 1996, MOL CELL ENDOCRINOL, V123, P179, DOI 10.1016/S0303-7207(96)03912-3; KIYAMA H, 1990, J NEUROENDOCRINOL, V2, P257, DOI 10.1111/j.1365-2826.1990.tb00401.x; Knobloch S, 2012, NEURON, V73, P1; Kuroda H, 2008, J GENE MED, V10, P1163, DOI 10.1002/jgm.1249; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; Li C, 2009, GENE THER, V16, P43, DOI 10.1038/gt.2008.134; Lim ST, 2010, PHARMACOL RES, V61, P14, DOI 10.1016/j.phrs.2009.10.002; LIPKIN SM, 1992, P NATL ACAD SCI USA, V89, P1209, DOI 10.1073/pnas.89.4.1209; Lo HR, 2004, BIOTECHNOL PROGR, V20, P354, DOI 10.1021/bp034132i; Mason MRJ, 2010, MOL THER, V18, P715, DOI 10.1038/mt.2010.19; MEZEY E, 1991, ENDOCRINOLOGY, V129, P1814, DOI 10.1210/endo-129-4-1814; MIYATA S, 1994, BRAIN RES BULL, V34, P169, DOI 10.1016/0361-9230(94)90057-4; Mutsuga N, 2005, ENDOCRINOLOGY, V146, P1254, DOI 10.1210/en.2004-1202; Negrete A, 2007, J GENE MED, V9, P938, DOI 10.1002/jgm.1092; Nelson SB, 2006, TRENDS NEUROSCI, V29, P339, DOI 10.1016/j.tins.2006.05.004; O'Reilly D.R., 1994, BACULOVIRUS EXPRESSI; Okazaki T, 1997, J BIOL CHEM, V272, P32274, DOI 10.1074/jbc.272.51.32274; Osten P, 2007, Handb Exp Pharmacol, P177; Papale A, 2009, J NEUROSCI METH, V185, P1, DOI 10.1016/j.jneumeth.2009.08.013; Peter J, 2002, FRONT NEUROENDOCRIN, V23, P342, DOI 10.1016/S0091-3022(02)00005-5; RICHARD S, 1991, J BIOL CHEM, V266, P21428; RICHARD S, 1990, J BIOL CHEM, V265, P6098; RICHTER D, 1988, AM J PHYSIOL, V255, pF207, DOI 10.1152/ajprenal.1988.255.2.F207; Sladek CD, 2004, J NEUROENDOCRINOL, V16, P365, DOI 10.1111/j.0953-8194.2004.01187.x; Smith RH, 2009, MOL THER, V17, P1888, DOI 10.1038/mt.2009.128; Snyder BR, 2011, HUM GENE THER, V22, P1129, DOI 10.1089/hum.2011.008; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Urabe M, 2002, HUM GENE THER, V13, P1935, DOI 10.1089/10430340260355347; van den Pol AN, 2009, J COMP NEUROL, V516, P456, DOI 10.1002/cne.22131; WALTHER N, 1991, J NEUROENDOCRINOL, V3, P539, DOI 10.1111/j.1365-2826.1991.tb00315.x; Wang B, 2008, GENE THER, V15, P1489, DOI 10.1038/gt.2008.104; WEHRENBERG U, 1994, P NATL ACAD SCI USA, V91, P1440, DOI 10.1073/pnas.91.4.1440; WHITNALL MH, 1985, J NEUROSCI, V5, P98; Xi D, 1999, ENDOCRINOLOGY, V140, P4677, DOI 10.1210/en.140.10.4677; YOUNG WS, 1990, J NEUROENDOCRINOL, V2, P917, DOI 10.1111/j.1365-2826.1990.tb00660.x; Yue C, 2008, J NEUROENDOCRINOL, V20, P227, DOI 10.1111/j.1365-2826.2007.01640.x; Zhang B, 2001, J NEUROENDOCRINOL, V13, P29, DOI 10.1046/j.1365-2826.2001.00593.x; Zincarelli C, 2010, CTS-CLIN TRANSL SCI, V3, P81, DOI 10.1111/j.1752-8062.2010.00190.x	76	19	19	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32085	10.1371/journal.pone.0032085	http://dx.doi.org/10.1371/journal.pone.0032085			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363799	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700141
J	Larsen, JM; Steen-Jensen, DB; Laursen, JM; Sondergaard, JN; Musavian, HS; Butt, TM; Brix, S				Larsen, Jeppe Madura; Steen-Jensen, Daniel Bisgaard; Laursen, Janne Marie; Sondergaard, Jonas Norskov; Musavian, Hanieh Sadat; Butt, Tariq Mahmood; Brix, Susanne			Divergent Pro-Inflammatory Profile of Human Dendritic Cells in Response to Commensal and Pathogenic Bacteria Associated with the Airway Microbiota	PLOS ONE			English	Article							ESCHERICHIA-COLI LIPOPOLYSACCHARIDE; HAEMOPHILUS-INFLUENZAE; MORAXELLA-CATARRHALIS; BRONCHOALVEOLAR LAVAGE; FECAL MICROBIOTA; IMMUNE-RESPONSE; LIPID-A; EXACERBATIONS; CYTOKINES; ASTHMA	Recent studies using culture-independent methods have characterized the human airway microbiota and report microbial communities distinct from other body sites. Changes in these airway bacterial communities appear to be associated with inflammatory lung disease, yet the pro-inflammatory properties of individual bacterial species are unknown. In this study, we compared the immune stimulatory capacity on human monocyte-derived dendritic cells (DCs) of selected airway commensal and pathogenic bacteria predominantly associated with lungs of asthma or COPD patients (pathogenic Haemophillus spp. and Moraxella spp.), healthy lungs (commensal Prevotella spp.) or both (commensal Veillonella spp. and Actinomyces spp.). All bacteria were found to induce activation of DCs as demonstrated by similar induction of CD83, CD40 and CD86 surface expression. However, asthma and COPD-associated pathogenic bacteria provoked a 3-5 fold higher production of IL-23, IL-12p70 and IL-10 cytokines compared to the commensal bacteria. Based on the differential cytokine production profiles, the studied airway bacteria could be segregated into three groups (Haemophilus spp. and Moraxella spp. vs. Prevotella spp. and Veillonella spp. vs. Actinomyces spp.) reflecting their pro-inflammatory effects on DCs. Co-culture experiments found that Prevotella spp. were able to reduce Haemophillus influenzae-induced IL-12p70 in DCs, whereas no effect was observed on IL-23 and IL-10 production. This study demonstrates intrinsic differences in DC stimulating properties of bacteria associated with the airway microbiota.	[Larsen, Jeppe Madura; Steen-Jensen, Daniel Bisgaard; Laursen, Janne Marie; Sondergaard, Jonas Norskov; Musavian, Hanieh Sadat; Butt, Tariq Mahmood; Brix, Susanne] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark	Technical University of Denmark	Larsen, JM (corresponding author), Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark.	jeml@bio.dtu.dk	Pedersen, Susanne Brix/B-3484-2009; Nørskov Søndergaard, Jonas/P-6147-2015; Bisgaard, Hans/N-4761-2016; Larsen, Jeppe Madura/K-6518-2019; Moll, Janne Marie/AAT-8956-2021	Pedersen, Susanne Brix/0000-0001-8951-6705; Nørskov Søndergaard, Jonas/0000-0002-4438-6756; Bisgaard, Hans/0000-0003-4131-7592; Larsen, Jeppe Madura/0000-0003-1492-0708; Moll, Janne Marie/0000-0002-3514-4528; Musavian, Hanieh/0000-0002-0161-4392; Steen-Jensen, Daniel Bisgaard/0000-0002-7891-4502	Lundbeck Foundation	Lundbeck Foundation(Lundbeckfonden)	The study was funded by the Lundbeck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was funded by a independent research grant to SB from the Lundbeck Foundation. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The authors have no other competing interests to declare.	Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Alhawi M, 2009, J MED MICROBIOL, V58, P1015, DOI 10.1099/jmm.0.009936-0; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; BAUGHMAN RP, 1987, CHEST, V91, P233, DOI 10.1378/chest.91.2.233; Berenson CS, 2006, AM J RESP CRIT CARE, V174, P31, DOI 10.1164/rccm.200509-1461OC; Berenson CS, 2005, INFECT IMMUN, V73, P2728, DOI 10.1128/IAI.73.5.2728-2735.2005; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Bisgaard H, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4978; Caroff M, 2003, CARBOHYD RES, V338, P2431, DOI 10.1016/j.carres.2003.07.010; Caroff M, 2002, MICROBES INFECT, V4, P915, DOI 10.1016/S1286-4579(02)01612-X; Charlson ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015216; Coats SR, 2005, J IMMUNOL, V175, P4490, DOI 10.4049/jimmunol.175.7.4490; Coats SR, 2003, INFECT IMMUN, V71, P6799, DOI 10.1128/IAI.71.12.6799-6807.2003; de Heer HJ, 2005, SEMIN IMMUNOL, V17, P295, DOI 10.1016/j.smim.2005.05.002; Dubin PJ, 2008, IMMUNOL REV, V226, P160, DOI 10.1111/j.1600-065X.2008.00703.x; Elson G, 2007, BLOOD, V109, P1574, DOI 10.1182/blood-2006-06-032961; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Fink J, 2006, FEMS IMMUNOL MED MIC, V46, P198, DOI 10.1111/j.1574-695X.2005.00022.x; Galdiero M, 2004, INFECT IMMUN, V72, P1204, DOI 10.1128/IAI.72.2.1204-1209.2004; Gaschler GJ, 2009, AM J RESP CRIT CARE, V179, P666, DOI 10.1164/rccm.200808-1306OC; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; Gibson PG, 2001, CHEST, V119, P1329, DOI 10.1378/chest.119.5.1329; Goriely S, 2006, BLOOD, V107, P1078, DOI 10.1182/blood-2005-06-2416; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Haldar P, 2007, J ALLERGY CLIN IMMUN, V119, P1043, DOI 10.1016/j.jaci.2007.02.042; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Hashimoto M, 2003, FEBS LETT, V543, P98, DOI 10.1016/S0014-5793(03)00414-9; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Hunter CA, 2005, NAT REV IMMUNOL, V5, P521, DOI 10.1038/nri1648; KAHN FW, 1987, J INFECT DIS, V155, P862, DOI 10.1093/infdis/155.5.862; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Kelly D, 2005, TRENDS IMMUNOL, V26, P326, DOI 10.1016/j.it.2005.04.008; King PT, 2003, AM J RESP CRIT CARE, V167, P587, DOI 10.1164/rccm.200207-728OC; Knobloch J, 2011, AM J RESP CRIT CARE, V183, P204, DOI 10.1164/rccm.201002-0199OC; Larsen JM, 2007, IMMUNOLOGY, V121, P276, DOI 10.1111/j.1365-2567.2007.02575.x; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; MASOUD H, 1994, EUR J BIOCHEM, V220, P209, DOI 10.1111/j.1432-1033.1994.tb18616.x; Matera G, 2009, CLIN VACCINE IMMUNOL, V16, P1804, DOI 10.1128/CVI.00310-09; Medini D, 2008, NAT REV MICROBIOL, V6, P419, DOI 10.1038/nrmicro1901; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Moghaddam SJ, 2008, AM J RESP CELL MOL, V38, P629, DOI 10.1165/rcmb.2007-0366OC; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Murphy TF, 2000, CHEST, V118, P204, DOI 10.1378/chest.118.1.204; PITTMAN MARGARET, 1931, JOUR EXP MED, V53, P471, DOI 10.1084/jem.53.4.471; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sartor RB, 2005, CURR OPIN GASTROEN, V21, P44; Schweda EKH, 2008, INNATE IMMUN-LONDON, V14, P199, DOI 10.1177/1753425908095958; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Sethi S, 2007, AM J RESP CRIT CARE, V176, P356, DOI 10.1164/rccm.200703-417OC; Sheil B, 2007, J NUTR, V137, p819S, DOI 10.1093/jn/137.3.819S; Sokol H, 2006, INFLAMM BOWEL DIS, V12, P106, DOI 10.1097/01.MIB.0000200323.38139.c6; Somerville JE, 1996, J CLIN INVEST, V97, P359, DOI 10.1172/JCI118423; Sonnenburg JL, 2004, NAT IMMUNOL, V5, P569, DOI 10.1038/ni1079; St Geme JW, 2002, CELL MICROBIOL, V4, P191; THORPE JE, 1987, J INFECT DIS, V155, P855, DOI 10.1093/infdis/155.5.855; Verduin CM, 2002, CLIN MICROBIOL REV, V15, P125, DOI 10.1128/CMR.15.1.125-144.2002; Zhang Z, 2009, J CLIN INVEST, V119, P1899, DOI 10.1172/JCI36731; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588	63	80	85	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31976	10.1371/journal.pone.0031976	http://dx.doi.org/10.1371/journal.pone.0031976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363778	gold, Green Published, Green Submitted			2022-12-27	WOS:000302873700129
J	Vetterkind, S; Saphirstein, RJ; Morgan, KG				Vetterkind, Susanne; Saphirstein, Robert J.; Morgan, Kathleen G.			Stimulus-Specific Activation and Actin Dependency of Distinct, Spatially Separated ERK1/2 Fractions in A7r5 Smooth Muscle Cells	PLOS ONE			English	Article							SIGNAL-REGULATED KINASES; RAT THORACIC AORTA; MAP-KINASE; PROTEIN-KINASES; PHENOTYPIC MODULATION; PROLIFERATION; PATHWAY; CAVEOLIN-1; CALPONIN; PHOSPHORYLATION	A proliferative response of smooth muscle cells to activation of extracellular signal regulated kinases 1 and 2 (ERK1/2) has been linked to cardiovascular disease. In fully differentiated smooth muscle, however, ERK1/2 activation can also regulate contraction. Here, we use A7r5 smooth muscle cells, stimulated with 12-deoxyphorbol 13-isobutylate 20-acetate (DPBA) to induce cytoskeletal remodeling or fetal calf serum (FCS) to induce proliferation, to identify factors that determine the outcomes of ERK1/2 activation in smooth muscle. Knock down experiments, immunoprecipitation and proximity ligation assays show that the ERK1/2 scaffold caveolin-1 mediates ERK1/2 activation in response to DPBA, but not FCS, and that ERK1/2 is released from caveolin-1 upon DPBA, but not FCS, stimulation. Conversely, ERK1/2 associated with the actin cytoskeleton is significantly reduced after FCS, but not DPBA stimulation, as determined by Triton X fractionation. Furthermore, cytochalasin treatment inhibits DPBA, but not FCS-induced ERK1/2 phosphorylation, indicating that the actin cytoskeleton is not only a target but also is required for ERK1/2 activation. Our results show that (1) at least two ERK1/2 fractions are regulated separately by specific stimuli, and that (2) the association of ERK1/2 with the actin cytoskeleton regulates the outcome of ERK1/2 signaling.	[Vetterkind, Susanne; Saphirstein, Robert J.; Morgan, Kathleen G.] Boston Univ, Dept Hlth Sci, Boston, MA 02215 USA	Boston University	Vetterkind, S (corresponding author), Boston Univ, Dept Hlth Sci, Boston, MA 02215 USA.	svetter@bu.edu		Morgan, Kathleen/0000-0003-3300-3630	National Institutes of Health [HL80003, HL86655]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL086655, R01HL080003] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (www.nih.gov) grant numbers HL80003 and HL86655. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; Atten MJ, 1998, ANTICANCER RES, V18, P4377; BASHEY A, 1994, BLOOD, V83, P949, DOI 10.1182/blood.V83.4.949.bloodjournal834949; Bharadwaj S., 2008, J CANC MOL, V4, P139; Burgstaller G, 2005, AM J PHYSIOL-HEART C, V288, pH3001, DOI 10.1152/ajpheart.01002.2004; Campbell DH, 1999, CANCER RES, V59, P5376; Carrillo-Sepulveda MA, 2010, MOL CELL BIOCHEM, V341, P279, DOI 10.1007/s11010-010-0459-9; CHILDS TJ, 1992, J BIOL CHEM, V267, P22853; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Firulli AB, 1998, IN VITRO CELL DEV-AN, V34, P217; Furuchi T, 1998, J BIOL CHEM, V273, P21099, DOI 10.1074/jbc.273.33.21099; Galbiati F, 1998, EMBO J, V17, P6633, DOI 10.1093/emboj/17.22.6633; Gimona M, 2003, MOL BIOL CELL, V14, P2482, DOI 10.1091/mbc.E02-11-0743; Gosens R, 2010, J CELL MOL MED; Gu ZZ, 2007, EXP CELL RES, V313, P849, DOI 10.1016/j.yexcr.2006.12.005; Horowitz A, 1996, PHYSIOL REV, V76, P967, DOI 10.1152/physrev.1996.76.4.967; Hu YH, 2000, ARTERIOSCL THROM VAS, V20, P18, DOI 10.1161/01.ATV.20.1.18; Hunter I, 2011, CARDIOVASC RES, V90, P557, DOI 10.1093/cvr/cvr039; Ishibe S, 2004, MOL CELL, V16, P257, DOI 10.1016/j.molcel.2004.10.006; Ishihata A, 2002, EUR J PHARMACOL, V445, P247, DOI 10.1016/S0014-2999(02)01790-9; Je HD, 2001, J PHYSIOL-LONDON, V537, P567, DOI 10.1111/j.1469-7793.2001.00567.x; Je HD, 2004, AM J PHYSIOL-HEART C, V286, pH91, DOI 10.1152/ajpheart.00472.2003; KHALIL RA, 1995, CIRC RES, V76, P1101, DOI 10.1161/01.RES.76.6.1101; Kim J, 2005, EUR J PHARMACOL, V514, P209, DOI 10.1016/j.ejphar.2005.03.030; KIMES BW, 1976, EXP CELL RES, V98, P349, DOI 10.1016/0014-4827(76)90446-8; Kusuhara M, 1997, ARTERIOSCL THROM VAS, V17, P141, DOI 10.1161/01.ATV.17.1.141; Leinweber BD, 1999, BIOCHEM J, V344, P117, DOI 10.1042/0264-6021:3440117; Liao DF, 1996, CIRC RES, V79, P1007, DOI 10.1161/01.RES.79.5.1007; Luo DX, 2010, BIOCHEM BIOPH RES CO, V391, P1693, DOI 10.1016/j.bbrc.2009.12.132; MARTE BM, 1995, ONCOGENE, V10, P167; McNicol A, 2001, THROMB RES, V103, P25, DOI 10.1016/S0049-3848(01)00271-7; Menice CB, 1997, J BIOL CHEM, V272, P25157, DOI 10.1074/jbc.272.40.25157; Peterson TE, 2003, ARTERIOSCL THROM VAS, V23, P1521, DOI 10.1161/01.ATV.0000081743.35125.05; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Roy J, 2001, DIFFERENTIATION, V67, P50, DOI 10.1046/j.1432-0436.2001.067001050.x; Sathish V, 2011, AM J PHYSIOL-LUNG C, V300, pL920, DOI 10.1152/ajplung.00322.2010; Schrick C, 2007, NEURON, V55, P786, DOI 10.1016/j.neuron.2007.07.034; Sen A, 2010, J BIOL CHEM, V285, P28787, DOI 10.1074/jbc.M110.134064; Touyz RM, 1999, J HYPERTENS, V17, P907, DOI 10.1097/00004872-199917070-00006; Vetterkind S, 2005, EXP CELL RES, V305, P392, DOI 10.1016/j.yexcr.2005.01.012; Wang JB, 2009, J CELL SCI, V122, P2024, DOI 10.1242/jcs.044644; Xiao DL, 2002, AM J PHYSIOL-HEART C, V282, pH292, DOI 10.1152/ajpheart.2002.282.1.H292; Xu QB, 1996, J CLIN INVEST, V97, P508, DOI 10.1172/JCI118442; Zhang Y, 1997, ATHEROSCLEROSIS, V133, P37, DOI 10.1016/S0021-9150(97)00113-5	44	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e30409	10.1371/journal.pone.0030409	http://dx.doi.org/10.1371/journal.pone.0030409			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363435	Green Submitted, Green Published, gold			2022-12-27	WOS:000302873700007
J	Walker, J; Storch, G; Quach-Wong, B; Sonnenfeld, J; Aaron, G				Walker, Jeffrey; Storch, Gregory; Quach-Wong, Bonnie; Sonnenfeld, Julian; Aaron, Gloster			Propagation of Epileptiform Events across the Corpus Callosum in a Cingulate Cortical Slice Preparation	PLOS ONE			English	Article							LONG-TERM POTENTIATION; SEIZURES BEGET SEIZURES; INHIBITION CONTRIBUTES; FEEDFORWARD INHIBITION; PIRIFORM CORTEX; CEREBRAL-CORTEX; IN-VITRO; ANTERIOR; RAT; SYNCHRONY	We report on a novel mouse in vitro brain slice preparation that contains intact callosal axons connecting anterior cingulate cortices (ACC). Callosal connections are demonstrated by the ability to regularly record epileptiform events between hemispheres (bilateral events). That the correlation of these events depends on the callosum is demonstrated by the bisection of the callosum in vitro. Epileptiform events are evoked with four different methods: (1) bath application of bicuculline (a GABA-A antagonist); (2) bicuculline+MK801 (an NMDA receptor antagonist), (3) a zero magnesium extracellular solution (0Mg); (4) focal application of bicuculline to a single cortical hemisphere. Significant increases in the number of epileptiform events, as well as increases in the ratio of bilateral events to unilateral events, are observed during bath applications of bicuculline, but not during applications of bicuculline+MK-801. Long ictal-like events (defined as events > 20 seconds) are only observed in 0Mg. Whole cell patch clamp recordings of single neurons reveal strong feedforward inhibition during focal epileptiform events in the contralateral hemisphere. Within the ACC, we find differences between the rostral areas of ACC vs. caudal ACC in terms of connectivity between hemispheres, with the caudal regions demonstrating shorter interhemispheric latencies. The morphologies of many patch clamped neurons show callosally-spanning axons, again demonstrating intact callosal circuits in this in vitro preparation.	[Walker, Jeffrey; Storch, Gregory; Quach-Wong, Bonnie; Sonnenfeld, Julian; Aaron, Gloster] Wesleyan Univ, Dept Biol, Neurosci & Behav Program, Middletown, CT 06459 USA	Wesleyan University	Walker, J (corresponding author), Wesleyan Univ, Dept Biol, Neurosci & Behav Program, Middletown, CT 06459 USA.	gaaron@wesleyan.edu			Wesleyan University	Wesleyan University	All funds for this study were supplied by in-house grants from Wesleyan University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron G, 2006, SYNAPSE, V60, P437, DOI 10.1002/syn.20316; ANDERSON WW, 1986, BRAIN RES, V398, P215, DOI 10.1016/0006-8993(86)91274-6; Asadi-Pooya AA, 2008, EPILEPSY BEHAV, V13, P271, DOI 10.1016/j.yebeh.2008.04.020; Ben-Ari Yehezkel, 2006, Critical Reviews in Neurobiology, V18, P135; Berg AT, 1997, J CLIN NEUROPHYSIOL, V14, P102, DOI 10.1097/00004691-199703000-00003; Cisse Y, 2004, J NEUROPHYSIOL, V92, P3221, DOI 10.1152/jn.00537.2004; Cookson S, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100032; DECURTIS M, 1994, J NEUROPHYSIOL, V71, P2463, DOI 10.1152/jn.1994.71.6.2463; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Erickson TC, 1940, ARCH NEURO PSYCHIATR, V43, P429, DOI 10.1001/archneurpsyc.1940.02280030003001; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Hauser WA, 2002, PROG BRAIN RES, V135, P215; HORNE AL, 1986, EUR J PHARMACOL, V122, P231, DOI 10.1016/0014-2999(86)90107-X; Kang J, 2010, NEUROSCIENCE, V169, P1601, DOI 10.1016/j.neuroscience.2010.06.020; KANTER ED, 1993, J NEUROSCI, V13, P2477, DOI 10.1523/JNEUROSCI.13-06-02477.1993; Khalilov I, 2003, NAT NEUROSCI, V6, P1079, DOI 10.1038/nn1125; Kumar SS, 2001, J NEUROPHYSIOL, V86, P2973, DOI 10.1152/jn.2001.86.6.2973; Liauw J, 2005, J NEUROPHYSIOL, V94, P878, DOI 10.1152/jn.01205.2004; Liauw Jason, 2003, Shengli Xuebao, V55, P373; MARCUS EM, 1966, ARCH NEUROL-CHICAGO, V14, P601, DOI 10.1001/archneur.1966.00470120033006; MARCUS EM, 1968, ARCH NEUROL-CHICAGO, V19, P99, DOI 10.1001/archneur.1968.00480010117010; MUSGRAVE J, 1980, EPILEPSIA, V21, P369, DOI 10.1111/j.1528-1157.1980.tb04084.x; Panuccio G, 2009, EPILEPSIA, V50, P521, DOI 10.1111/j.1528-1167.2008.01779.x; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; RALSTON BL, 1961, ELECTROEN CLIN NEURO, V13, P591, DOI 10.1016/0013-4694(61)90173-0; SAH P, 1991, J PHYSIOL-LONDON, V433, P615, DOI 10.1113/jphysiol.1991.sp018446; Sills Graeme J, 2007, Epilepsy Curr, V7, P103, DOI 10.1111/j.1535-7511.2007.00189.x; SPENCER SS, 1988, EPILEPSIA, V29, pS85, DOI 10.1111/j.1528-1157.1988.tb05802.x; SPENCER SS, 1993, EPILEPSIA, V34, P561, DOI 10.1111/j.1528-1157.1993.tb02596.x; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Swadlow HA, 1998, J NEUROPHYSIOL, V79, P567, DOI 10.1152/jn.1998.79.2.567; TANAKA E, 1994, J NEUROSCI, V14, P1106, DOI 10.1523/JNEUROSCI.14-03-01106.1994; Trevelyan AJ, 2007, J NEUROSCI, V27, P3383, DOI 10.1523/JNEUROSCI.0145-07.2007; Trevelyan AJ, 2006, J NEUROSCI, V26, P12447, DOI 10.1523/JNEUROSCI.2787-06.2006; VOGT BA, 1982, J NEUROPHYSIOL, V48, P1257, DOI 10.1152/jn.1982.48.6.1257; VOGT BA, 1981, J COMP NEUROL, V201, P265, DOI 10.1002/cne.902010210; Vogt BA, 2004, CINGULATE CORTEX DIS, P705; WALTHER H, 1986, NEUROSCI LETT, V69, P156, DOI 10.1016/0304-3940(86)90595-1; WHITTINGTON MA, 1995, J PHYSIOL-LONDON, V486, P723, DOI 10.1113/jphysiol.1995.sp020848	39	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31415	10.1371/journal.pone.0031415	http://dx.doi.org/10.1371/journal.pone.0031415			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363643	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700057
J	Wilkars, W; Liu, ZQ; Lewis, AS; Stoub, TR; Ramos, EM; Brandt, N; Nicholson, DA; Chetkovich, DM; Bender, RA				Wilkars, Wiebke; Liu, Zhiqiang; Lewis, Alan S.; Stoub, Travis R.; Ramos, Elena M.; Brandt, Nicola; Nicholson, Daniel A.; Chetkovich, Dane M.; Bender, Roland A.			Regulation of Axonal HCN1 Trafficking in Perforant Path Involves Expression of Specific TRIP8b Isoforms	PLOS ONE			English	Article							ACTIVITY-DEPENDENT REGULATION; H-CHANNEL SUBUNITS; I-H; PACEMAKER CHANNELS; SURFACE EXPRESSION; LOCALIZATION; PLASTICITY; PHOSPHORYLATION; NEURONS; FAMILY	The functions of HCN channels in neurons depend critically on their subcellular localization, requiring fine-tuned machinery that regulates subcellular channel trafficking. Here we provide evidence that regulatory mechanisms governing axonal HCN channel trafficking involve association of the channels with specific isoforms of the auxiliary subunit TRIP8b. In the medial perforant path, which normally contains HCN1 channels in axon terminals in immature but not in adult rodents, we found axonal HCN1 significantly increased in adult mice lacking TRIP8b (TRIP8b(-/-)). Interestingly, adult mice harboring a mutation that results in expression of only the two most abundant TRIP8b isoforms (TRIP8b[1b/2](-/-)) exhibited an HCN1 expression pattern similar to wildtype mice, suggesting that presence of one or both of these isoforms (TRIP8b(1a), TRIP8b(1a-4)) prevents HCN1 from being transported to medial perforant path axons in adult mice. Concordantly, expression analyses demonstrated a strong increase of expression of both TRIP8b isoforms in rat entorhinal cortex with age. However, when overexpressed in cultured entorhinal neurons of rats, TRIP8b(1a), but not TRIP8b(1a-4), altered substantially the subcellular distribution of HCN1 by promoting somatodendritic and reducing axonal expression of the channels. Taken together, we conclude that TRIP8b isoforms are important regulators of HCN1 trafficking in entorhinal neurons and that the alternatively-spliced isoform TRIP8b(1a) could be responsible for the age-dependent redistribution of HCN channels out of perforant path axon terminals.	[Wilkars, Wiebke; Brandt, Nicola; Bender, Roland A.] Univ Hamburg, Med Ctr, Inst Neuroanat, Hamburg, Germany; [Liu, Zhiqiang; Lewis, Alan S.; Chetkovich, Dane M.] Northwestern Univ, Feinberg Sch Med, Davee Dept Neurol & Clin Neurosci, Chicago, IL 60611 USA; [Stoub, Travis R.; Ramos, Elena M.; Nicholson, Daniel A.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Chetkovich, Dane M.] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA	University of Hamburg; Northwestern University; Feinberg School of Medicine; Rush University; Northwestern University; Feinberg School of Medicine	Wilkars, W (corresponding author), Univ Hamburg, Med Ctr, Inst Neuroanat, Hamburg, Germany.	rbender@uke.uni-hamburg.de	Chetkovich, Dane/AAV-5457-2021; Stoub, Travis/ABF-7039-2021; Lewis, Alan/AAV-9582-2021	Lewis, Alan/0000-0002-7165-5376; Brandt, Nicola/0000-0003-2483-9292; Bender, Ralf/0000-0001-7179-0626; Nicholson, Dan/0000-0002-1963-0569	Deutsche Forschungsgemeinschaft (DFG) [BE4107/2-1]; National Institutes of Health (NIH) [NS05595, NS059934, NS064757, AG031574, AG017139]; Brain Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059934, F30NS064757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG031574, K99AG031574, RF1AG017139, R56AG017139, R01AG017139] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a Deutsche Forschungsgemeinschaft (DFG) grant BE4107/2-1 (RAB), National Institutes of Health (NIH) grants NS05595, NS059934 (DMC), NS064757 (ASL), AG031574 and AG017139 (DAN), and the Brain Research Foundation (DMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Banker G, CULTURING NERVE CELL; Bender RA, 2001, NEUROSCIENCE, V106, P689, DOI 10.1016/S0306-4522(01)00314-1; Bender RA, 2003, J NEUROSCI, V23, P6826, DOI 10.1523/jneurosci.23-17-06826.2003; Bender RA, 2007, J NEUROSCI, V27, P4697, DOI 10.1523/JNEUROSCI.4699-06.2007; Bender RA, 2008, PROG NEUROBIOL, V86, P129, DOI 10.1016/j.pneurobio.2008.09.007; Brandt N, 2007, EMBO J, V26, P2371, DOI 10.1038/sj.emboj.7601680; Brewster A, 2002, J NEUROSCI, V22, P4591, DOI 10.1523/JNEUROSCI.22-11-04591.2002; Brewster AL, 2007, CEREB CORTEX, V17, P702, DOI 10.1093/cercor/bhk021; Chen K, 2001, NAT MED, V7, P331, DOI 10.1038/85480; Dyhrfjeld-Johnsen J, 2009, FRONT NEUROSCI-SWITZ, V3, P25, DOI 10.3389/neuro.01.005.2009; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Franz O, 2000, EUR J NEUROSCI, V12, P2685, DOI 10.1046/j.1460-9568.2000.00151.x; Giocomo LM, 2011, CELL, V147, P1159, DOI 10.1016/j.cell.2011.08.051; Han Y, 2011, J BIOL CHEM; Hardel N, 2008, CARDIOVASC RES, V79, P52, DOI 10.1093/cvr/cvn062; Jung S, 2007, J NEUROSCI, V27, P13012, DOI 10.1523/JNEUROSCI.3605-07.2007; Kanyshkova T, 2012, NEUROBIOL DIS, V45, P450, DOI 10.1016/j.nbd.2011.08.032; Lewis AS, 2011, J NEUROSCI, V31, P7424, DOI 10.1523/JNEUROSCI.0936-11.2011; Lewis AS, 2011, MOL CELL NEUROSCI, V46, P357, DOI 10.1016/j.mcn.2010.11.007; Lewis AS, 2010, CHANNELS, V4, P215, DOI 10.4161/chan.4.3.11630; Lewis AS, 2009, J NEUROSCI, V29, P6250, DOI 10.1523/JNEUROSCI.0856-09.2009; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Marcelin B, 2009, NEUROBIOL DIS, V33, P436, DOI 10.1016/j.nbd.2008.11.019; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Noam Y, 2010, J BIOL CHEM, V285, P14724, DOI 10.1074/jbc.M109.070391; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; Notomi T, 2004, J COMP NEUROL, V471, P241, DOI 10.1002/cne.11039; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Piskorowski R, 2011, NEURON, V70, P495, DOI 10.1016/j.neuron.2011.03.023; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Santoro B, 2004, J NEUROSCI, V24, P10750, DOI 10.1523/JNEUROSCI.3300-04.2004; Santoro B, 2003, TRENDS NEUROSCI, V26, P550, DOI 10.1016/j.tins.2003.08.003; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Santoro B, 2011, J NEUROSCI, V31, P4074, DOI 10.1523/JNEUROSCI.5707-10.2011; Santoro B, 2009, NEURON, V62, P802, DOI 10.1016/j.neuron.2009.05.009; Shah MM, 2004, NEURON, V44, P495, DOI 10.1016/j.neuron.2004.10.011; Shin M, 2008, NEUROBIOL DIS, V32, P26, DOI 10.1016/j.nbd.2008.06.013; Shin M, 2007, J BIOL CHEM, V282, P33168, DOI 10.1074/jbc.M703736200; Surges R, 2006, EUR J NEUROSCI, V24, P94, DOI 10.1111/j.1460-9568.2006.04880.x; Trinidad JC, 2006, MOL CELL PROTEOMICS, V5, P914, DOI 10.1074/mcp.T500041-MCP200; Varga C, 2010, NAT NEUROSCI, V13, P822, DOI 10.1038/nn.2570; Vasilyev DV, 2002, J NEUROSCI, V22, P8992; Wang J, 2002, NEURON, V36, P451, DOI 10.1016/S0896-6273(02)00968-6; Zolles G, 2009, NEURON, V62, P814, DOI 10.1016/j.neuron.2009.05.008	45	20	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32181	10.1371/journal.pone.0032181	http://dx.doi.org/10.1371/journal.pone.0032181			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363812	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700153
J	Chiang, LL; Karvar, S; Hamm-Alvarez, SF				Chiang, Lilian; Karvar, Serhan; Hamm-Alvarez, Sarah F.			Direct Imaging of RAB27B-Enriched Secretory Vesicle Biogenesis in Lacrimal Acinar Cells Reveals Origins on a Nascent Vesicle Budding Site	PLOS ONE			English	Article							TRANS-GOLGI NETWORK; MEMBRANE-BINDING PROPERTIES; POLARIZED EPITHELIAL-CELLS; STIMULATED SECRETION; CYTOPLASMIC DYNEIN; PLASMA-MEMBRANE; MYOSIN VB; MELANOSOME TRANSPORT; PROTEIN SECRETION; ZYMOGEN GRANULES	This study uses YFP-tagged Rab27b expression in rabbit lacrimal gland acinar cells, which are polarized secretory epithelial cells, to characterize early stages of secretory vesicle trafficking. Here we demonstrate the utility of YFP-Rab27b to delineate new perspectives on the mechanisms of early vesicle biogenesis in lacrimal gland acinar cells, where information is significantly limited. Protocols were developed to deplete the mature YFP-Rab27b-enriched secretory vesicle pool in the subapical region of the cell, and confocal fluorescence microscopy was used to track vesicle replenishment. This analysis revealed a basally-localized organelle, which we termed the "nascent vesicle site,'' from which nascent vesicles appeared to emerge. Subapical vesicular YFP-Rab27b was co-localized with p150(Glued), a component of the dynactin cofactor of cytoplasmic dynein. Treatment with the microtubule-targeted agent, nocodazole, did not affect release of mature secretory vesicles, although during vesicle repletion it significantly altered nascent YFP-Rab27b-enriched secretory vesicle localization. Instead of moving to the subapical region, these vesicles were trapped at the nascent vesicle site which was adjacent to, if not a sub-compartment of, the trans-Golgi network. Finally, YFP-Rab27b-enriched secretory vesicles which reached the subapical cytoplasm appeared to acquire the actin-based motor protein, Myosin 5C. Our findings show that Rab27b enrichment occurs early in secretory vesicle formation, that secretory vesicles bud from a visually discernable nascent vesicle site, and that transport from the nascent vesicle site to the subapical region requires intact microtubules.	[Chiang, Lilian; Hamm-Alvarez, Sarah F.] Univ So Calif, Sch Pharm, Los Angeles, CA 90089 USA; [Karvar, Serhan; Hamm-Alvarez, Sarah F.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Chiang, LL (corresponding author), Univ So Calif, Sch Pharm, Los Angeles, CA 90089 USA.	shalvar@usc.edu		Hamm-Alvarez, Sarah/0000-0001-8195-5703	National Institutes of Health [R01EY011386]; NATIONAL EYE INSTITUTE [R01EY011386] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health R01EY011386 (to SHA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apodaca G, 2001, TRAFFIC, V2, P149, DOI 10.1034/j.1600-0854.2001.020301.x; BAKER D, 1990, P NATL ACAD SCI USA, V87, P355, DOI 10.1073/pnas.87.1.355; BUSSONMABILLOT S, 1982, J CELL BIOL, V95, P105, DOI 10.1083/jcb.95.1.105; Chen D, 1997, BIOCHEM MOL MED, V60, P27, DOI 10.1006/bmme.1996.2559; Chen XQ, 2002, J BIOL CHEM, V277, P18002, DOI 10.1074/jbc.M201248200; Chen XQ, 2004, BIOCHEM BIOPH RES CO, V323, P1157, DOI 10.1016/j.bbrc.2004.08.212; Chiang LL, 2011, AM J PHYSIOL-CELL PH, V301, pC507, DOI 10.1152/ajpcell.00355.2010; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; da Costa SR, 1998, J CELL SCI, V111, P1267; da Costa SR, 2002, ADV EXP MED BIOL, V506, P199; DAVIDSON HW, 1993, J BIOL CHEM, V268, P4216; de Souza GA, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r72; Derby MC, 2004, J CELL SCI, V117, P5865, DOI 10.1242/jcs.01497; Evans E, 2008, AM J PHYSIOL-CELL PH, V294, pC662, DOI 10.1152/ajpcell.00623.2006; FATH KR, 1994, J CELL BIOL, V126, P661, DOI 10.1083/jcb.126.3.661; Fukuda M, 2006, BIOCHEM BIOPH RES CO, V343, P666, DOI 10.1016/j.bbrc.2006.03.001; FULLARD RJ, 1990, INVEST OPHTH VIS SCI, V31, P1119; Gierow JP, 1996, AM J PHYSIOL-CELL PH, V271, pC1685, DOI 10.1152/ajpcell.1996.271.5.C1685; GIEROW JP, 1995, EXP EYE RES, V60, P511, DOI 10.1016/S0014-4835(05)80066-1; GILL SR, 1991, J CELL BIOL, V115, P1639, DOI 10.1083/jcb.115.6.1639; Gomi H, 2007, MOL BIOL CELL, V18, P4377, DOI 10.1091/mbc.E07-05-0409; Goud B, 2010, TRENDS CELL BIOL, V20, P329, DOI 10.1016/j.tcb.2010.02.006; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Hume AN, 2006, MOL BIOL CELL, V17, P4720, DOI 10.1091/mbc.E06-05-0457; Hume AN, 2001, J CELL BIOL, V152, P795, DOI 10.1083/jcb.152.4.795; Imai A, 2004, J CELL SCI, V117, P1945, DOI 10.1242/jcs.01048; Imai A, 2009, EUR J ORAL SCI, V117, P224, DOI 10.1111/j.1600-0722.2009.00618.x; Izumi T, 2003, CELL STRUCT FUNCT, V28, P465, DOI 10.1247/csf.28.465; Jacobs DT, 2009, MOL BIOL CELL, V20, P4471, DOI 10.1091/mbc.E08-08-0865; JEDD G, 1995, J CELL BIOL, V131, P583, DOI 10.1083/jcb.131.3.583; Jerdeva GV, 2005, J CELL SCI, V118, P4797, DOI 10.1242/jcs.02573; Jerdeva GV, 2005, AM J PHYSIOL-CELL PH, V289, pC1052, DOI 10.1152/ajpcell.00546.2004; Kogel T, 2010, RESULTS PROBL CELL D, V50, P1, DOI 10.1007/400_2009_31; Kraemer J, 1999, EUR J CELL BIOL, V78, P265, DOI 10.1016/S0171-9335(99)80060-0; Kuroda TS, 2005, METHOD ENZYMOL, V403, P419, DOI 10.1016/S0076-6879(05)03037-5; Lapierre LA, 2005, METHOD ENZYMOL, V403, P715, DOI 10.1016/S0076-6879(05)03062-4; Lise MF, 2006, J BIOL CHEM, V281, P3669, DOI 10.1074/jbc.M511725200; Marchelletta RR, 2008, AM J PHYSIOL-CELL PH, V295, pC13, DOI 10.1152/ajpcell.00330.2007; Miserey-Lenkei S, 2010, NAT CELL BIOL, V12, P645, DOI 10.1038/ncb2067; Nedvetsky PI, 2007, TRAFFIC, V8, P110, DOI 10.1111/j.1600-0854.2006.00508.x; Ngyen D, 2003, J CELL PHYSIOL, V197, P400, DOI 10.1002/jcp.10373; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Pfeffer SR, 2007, ANNU REV BIOCHEM, V76, P629, DOI 10.1146/annurev.biochem.76.061705.130002; Pickett JA, 2006, TRAFFIC, V7, P109, DOI 10.1111/j.1600-0854.2005.00372.x; Qian LM, 2004, EXP EYE RES, V79, P665, DOI 10.1016/j.exer.2004.07.007; Riedel D, 2002, MOL CELL BIOL, V22, P6487, DOI 10.1128/MCB.22.18.6487-6497.2002; ROBIN P, 1995, EUR J CELL BIOL, V67, P227; Rodriguez OC, 2002, J CELL SCI, V115, P991; Rottger S, 1998, J CELL SCI, V111, P45; Sanghi S, 2001, J MOL BIOL, V310, P127, DOI 10.1006/jmbi.2001.4748; Schluter OM, 2002, J BIOL CHEM, V277, P40919, DOI 10.1074/jbc.M203704200; Seabra MC, 2004, TRAFFIC, V5, P393, DOI 10.1111/j.1398-9219.2004.00190.x; Seabra MC, 2002, TRENDS MOL MED, V8, P23, DOI 10.1016/S1471-4914(01)02227-4; Suda J, 2010, GASTROENTER IN PRESS; Tolmachova T, 2007, P NATL ACAD SCI USA, V104, P5872, DOI 10.1073/pnas.0609879104; Valentijn JA, 2000, P NATL ACAD SCI USA, V97, P1091, DOI 10.1073/pnas.97.3.1091; Valentijn KM, 1999, J CELL SCI, V112, P81; VANSETTEN GB, 1989, GRAEF ARCH CLIN EXP, V227, P184, DOI 10.1007/BF02169794; Vaughan KT, 2005, BBA-MOL CELL RES, V1744, P316, DOI 10.1016/j.bbamcr.2005.05.001; Vilalta PM, 1998, J CELL SCI, V111, P1841; Wang YR, 2003, J CELL SCI, V116, P2051, DOI 10.1242/jcs.00398; WHITE T, 1995, J BIOL CHEM, V270, P24156, DOI 10.1074/jbc.270.41.24156; WONG DH, 1992, J CELL BIOL, V117, P1171, DOI 10.1083/jcb.117.6.1171; Wu H, 2008, TRENDS CELL BIOL, V18, P397, DOI 10.1016/j.tcb.2008.06.007; Wu KJ, 2006, EXP EYE RES, V83, P84, DOI 10.1016/j.exer.2005.11.009; Wu XF, 1997, J CELL SCI, V110, P847; Wu XF, 2001, J CELL SCI, V114, P1091; Xie JS, 2006, J VIROL, V80, P11833, DOI 10.1128/JVI.00857-06; Yoshie S, 2000, HISTOCHEM CELL BIOL, V113, P259, DOI 10.1007/s004180000130; Yoshino A, 2003, J CELL SCI, V116, P4441, DOI 10.1242/jcs.00746	71	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31789	10.1371/journal.pone.0031789	http://dx.doi.org/10.1371/journal.pone.0031789			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363735	Green Published, Green Submitted, gold			2022-12-27	WOS:000302871500089
J	Guerra, SM; Rodriguez-Garcia, A; Santos-Aberturas, J; Vicente, CM; Payero, TD; Martin, JF; Aparicio, JF				Guerra, Susana M.; Rodriguez-Garcia, Antonio; Santos-Aberturas, Javier; Vicente, Claudia M.; Payero, Tamara D.; Martin, Juan F.; Aparicio, Jesus F.			LAL Regulators SCO0877 and SCO7173 as Pleiotropic Modulators of Phosphate Starvation Response and Actinorhodin Biosynthesis in Streptomyces coelicolor	PLOS ONE			English	Article							PHOR-PHOP SYSTEM; GENE-CLUSTER; ANTIBIOTIC PRODUCTION; IN-VIVO; MORPHOLOGICAL-DIFFERENTIATION; ESCHERICHIA-COLI; EXPRESSION; PROTEIN; IDENTIFICATION; METABOLISM	LAL regulators (Large ATP-binding regulators of the LuxR family) constitute a poorly studied family of transcriptional regulators. Several regulators of this class have been identified in antibiotic and other secondary metabolite gene clusters from actinomycetes, thus they have been considered pathway-specific regulators. In this study we have obtained two disruption mutants of LAL genes from S. coelicolor (Delta 0877 and Delta 7173). Both mutants were deficient in the production of the polyketide antibiotic actinorhodin, and antibiotic production was restored upon gene complementation of the mutants. The use of whole-genome DNA microarrays and quantitative PCRs enabled the analysis of the transcriptome of both mutants in comparison with the wild type. Our results indicate that the LAL regulators under study act globally affecting various cellular processes, and amongst them the phosphate starvation response and the biosynthesis of the blue-pigmented antibiotic actinorhodin. Both regulators act as negative modulators of the expression of the two-component phoRP system and as positive regulators of actinorhodin biosynthesis. To our knowledge this is the first characterization of LAL regulators with wide implications in Streptomyces metabolism.	[Guerra, Susana M.; Rodriguez-Garcia, Antonio; Santos-Aberturas, Javier; Vicente, Claudia M.; Payero, Tamara D.; Martin, Juan F.; Aparicio, Jesus F.] Inst Biotechnol INBIOTEC, Leon, Spain; [Guerra, Susana M.; Rodriguez-Garcia, Antonio; Santos-Aberturas, Javier; Payero, Tamara D.; Martin, Juan F.; Aparicio, Jesus F.] Univ Leon, Area Microbiol, E-24071 Leon, Spain	Universidad de Leon	Guerra, SM (corresponding author), Inst Biotechnol INBIOTEC, Leon, Spain.	jesus.aparicio@unileon.es	Susana, Susana/L-9204-2015; Rodríguez-García, Antonio/A-9461-2011; Aparicio, Jesús F./K-8686-2014; Santos-Aberturas, Javier/AAE-8162-2021	Susana, Susana/0000-0003-2243-2376; Rodríguez-García, Antonio/0000-0001-8118-9762; Aparicio, Jesús F./0000-0003-4242-4701; Vicente, Claudia M./0000-0001-8205-6486	Spanish Ministerio de Ciencia e Innovacion [BIO2007-67585, BIO2010-19911]; Junta de Castilla y Leon (Grupo de Excelencia) [GR117]; Ministerio de Ciencia e Innovacion [AP2005-3644, AP2007-02055]; University of Leon; Junta de Castilla y Leon [E-24-2009-0053914]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Castilla y Leon (Grupo de Excelencia)(Junta de Castilla y Leon); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); University of Leon; Junta de Castilla y Leon(Junta de Castilla y Leon)	This work was supported by the Spanish Ministerio de Ciencia e Innovacion (BIO2007-67585 and BIO2010-19911 to JFA); and the Junta de Castilla y Leon (Grupo de Excelencia GR117). FPU fellowships of the Ministerio de Ciencia e Innovacion (AP2005-3644 to JSA, AP2007-02055 to T.D.P.); a fellowship from the University of Leon (to SMG); and a contract from the Junta de Castilla y Leon (E-24-2009-0053914 to CMV). The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Ainsa JA, 2000, J BACTERIOL, V182, P5470, DOI 10.1128/JB.182.19.5470-5478.2000; Anton N, 2007, MICROBIOL-SGM, V153, P3174, DOI 10.1099/mic.0.2007/009126-0; Aparicio JF, 1996, GENE, V169, P9, DOI 10.1016/0378-1119(95)00800-4; Aparicio JF, 1999, J BIOL CHEM, V274, P10133, DOI 10.1074/jbc.274.15.10133; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bibb M, 1996, MICROBIOL-SGM, V142, P1335, DOI 10.1099/13500872-142-6-1335; Bibb MJ, 2005, CURR OPIN MICROBIOL, V8, P208, DOI 10.1016/j.mib.2005.02.016; Boos W, 1998, MICROBIOL MOL BIOL R, V62, P204, DOI 10.1128/MMBR.62.1.204-229.1998; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Caffrey P, 2008, CURR TOP MED CHEM, V8, P639, DOI 10.2174/156802608784221479; Carmody M, 2004, GENE, V343, P107, DOI 10.1016/j.gene.2004.08.006; CHAMPNESS WC, 1994, REGULATION OF BACTERIAL DIFFERENTIATION, P61; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Schrijver A, 1999, MICROBIOL-UK, V145, P1287, DOI 10.1099/13500872-145-6-1287; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; DOULL JL, 1990, APPL MICROBIOL BIOT, V32, P449, DOI 10.1007/BF00903781; Enriquez LL, 2006, FEMS MICROBIOL LETT, V257, P312, DOI 10.1111/j.1574-6968.2006.00189.x; FERNANDEZMORENO MA, 1994, J BIOL CHEM, V269, P24854; Floriano B, 1996, MOL MICROBIOL, V21, P385, DOI 10.1046/j.1365-2958.1996.6491364.x; Gehring AM, 2001, J BACTERIOL, V183, P5991, DOI 10.1128/JB.183.20.5991-5996.2001; Ghorbel S, 2006, J BACTERIOL, V188, P677, DOI 10.1128/JB.188.2.677-686.2006; Ghorbel S, 2006, J BACTERIOL, V188, P6269, DOI 10.1128/JB.00202-06; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Hopwood DA, 1999, MICROBIOL-UK, V145, P2183, DOI 10.1099/00221287-145-9-2183; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kodani S, 2004, P NATL ACAD SCI USA, V101, P11448, DOI 10.1073/pnas.0404220101; Li WC, 2006, J BACTERIOL, V188, P8368, DOI 10.1128/JB.00933-06; Lian W, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-56; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manteca A, 2010, J PROTEOME RES, V9, P4801, DOI 10.1021/pr100513p; Martin JF, 2000, ENCY MICROBIOLOGY, V4, P213; Mehra S, 2006, J IND MICROBIOL BIOT, V33, P159, DOI 10.1007/s10295-005-0034-7; Mendes MV, 2007, METAB ENG, V9, P217, DOI 10.1016/j.ymben.2006.10.003; Pawlik K, 2007, ARCH MICROBIOL, V187, P87, DOI 10.1007/s00203-006-0176-7; Ritchie ME, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-261; Rodriguez-Garcia A, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni086; Rodriguez-Garcia A, 2007, PROTEOMICS, V7, P2410, DOI 10.1002/pmic.200600883; Sambrook J., 2001, MOL CLONING LAB MANU; Santos-Aberturas J, 2011, J BIOL CHEM, V286, P9150, DOI 10.1074/jbc.M110.182428; Santos-Beneit F, 2009, MOL MICROBIOL, V72, P53, DOI 10.1111/j.1365-2958.2009.06624.x; Sartor M, 2004, BIOTECHNIQUES, V36, P790, DOI 10.2144/04365ST02; Sekurova ON, 2004, J BACTERIOL, V186, P1345, DOI 10.1128/JB.186.5.1345-1354.2004; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sola-Landa A, 2003, P NATL ACAD SCI USA, V100, P6133, DOI 10.1073/pnas.0931429100; Sola-Landa A, 2005, MOL MICROBIOL, V56, P1373, DOI 10.1111/j.1365-2958.2005.04631.x; Talaat AM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf103; VOGTLI M, 1994, MOL MICROBIOL, V14, P643, DOI 10.1111/j.1365-2958.1994.tb01303.x; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Widdick DA, 2006, P NATL ACAD SCI USA, V103, P17927, DOI 10.1073/pnas.0607025103; Wilson DJ, 2001, J BACTERIOL, V183, P3468, DOI 10.1128/JB.183.11.3468-3475.2001; Wu W, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-191; Zotchev S, 2000, MICROBIOL-UK, V146, P611, DOI 10.1099/00221287-146-3-611	54	27	34	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31475	10.1371/journal.pone.0031475	http://dx.doi.org/10.1371/journal.pone.0031475			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363654	gold, Green Submitted, Green Published			2022-12-27	WOS:000302871500047
J	Lucchi, NW; Poorak, M; Oberstaller, J; DeBarry, J; Srinivasamoorthy, G; Goldman, I; Xayavong, M; da Silva, AJ; Peterson, DS; Barnwell, JW; Kissinger, J; Udhayakumar, V				Lucchi, Naomi W.; Poorak, Mitra; Oberstaller, Jenna; DeBarry, Jeremy; Srinivasamoorthy, Ganesh; Goldman, Ira; Xayavong, Maniphet; da Silva, Alexandre J.; Peterson, David S.; Barnwell, John W.; Kissinger, Jessica; Udhayakumar, Venkatachalam			A New Single-Step PCR Assay for the Detection of the Zoonotic Malaria Parasite Plasmodium knowlesi	PLOS ONE			English	Article							COMPARATIVE GENOMICS; ANTIGENIC VARIATION; ANOPHELES-LATENS; HUMAN INFECTIONS; HUMANS; DIAGNOSIS; THAILAND; TRANSMISSION; VIETNAM; MACAQUES	Background: Recent studies in Southeast Asia have demonstrated substantial zoonotic transmission of Plasmodium knowlesi to humans. Microscopically, P. knowlesi exhibits several stage-dependent morphological similarities to P. malariae and P. falciparum. These similarities often lead to misdiagnosis of P. knowlesi as either P. malariae or P. falciparum and PCR-based molecular diagnostic tests are required to accurately detect P. knowlesi in humans. The most commonly used PCR test has been found to give false positive results, especially with a proportion of P. vivax isolates. To address the need for more sensitive and specific diagnostic tests for the accurate diagnosis of P. knowlesi, we report development of a new single-step PCR assay that uses novel genomic targets to accurately detect this infection. Methodology and Significant Findings: We have developed a bioinformatics approach to search the available malaria parasite genome database for the identification of suitable DNA sequences relevant for molecular diagnostic tests. Using this approach, we have identified multi-copy DNA sequences distributed in the P. knowlesi genome. We designed and tested several novel primers specific to new target sequences in a single-tube, non-nested PCR assay and identified one set of primers that accurately detects P. knowlesi. We show that this primer set has 100% specificity for the detection of P. knowlesi using three different strains (Nuri, H, and Hackeri), and one human case of malaria caused by P. knowlesi. This test did not show cross reactivity with any of the four human malaria parasite species including 11 different strains of P. vivax as well as 5 additional species of simian malaria parasites. Conclusions: The new PCR assay based on novel P. knowlesi genomic sequence targets was able to accurately detect P. knowlesi. Additional laboratory and field-based testing of this assay will be necessary to further validate its utility for clinical diagnosis of P. knowlesi.	[Lucchi, Naomi W.; Poorak, Mitra; Udhayakumar, Venkatachalam] Atlanta Res & Educ Fdn, Decatur, GA USA; [Lucchi, Naomi W.; Poorak, Mitra; Goldman, Ira; Xayavong, Maniphet; da Silva, Alexandre J.; Barnwell, John W.; Udhayakumar, Venkatachalam] Ctr Dis Control & Prevent, Malaria Branch, Div Parasit Dis & Malaria, Ctr Global Hlth, Atlanta, GA USA; [Oberstaller, Jenna; Kissinger, Jessica] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [DeBarry, Jeremy; Srinivasamoorthy, Ganesh; Peterson, David S.; Kissinger, Jessica] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Kissinger, Jessica] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA	Centers for Disease Control & Prevention - USA; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Lucchi, NW (corresponding author), Atlanta Res & Educ Fdn, Decatur, GA USA.	vxu0@cdc.gov	Kissinger, Jessica/M-9920-2019; Kissinger, Jessica C/E-9610-2010	Kissinger, Jessica/0000-0002-6413-1101; Kissinger, Jessica C/0000-0002-6413-1101; Oberstaller, Jenna/0000-0002-3033-2212; Peterson, David/0000-0003-4394-6181; DeBarry, Jeremy/0000-0001-5718-2675; Lucchi, Naomi/0000-0001-8789-8041	Atlanta Research and Education Foundation; Centers for Disease Control and Prevention/University of Georgia Collaborative Seed; University of Georgia Research Computing Center; NIH [GM007103, R01 AI068908]; University of Georgia Department of Genetics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007103] Funding Source: NIH RePORTER	Atlanta Research and Education Foundation; Centers for Disease Control and Prevention/University of Georgia Collaborative Seed; University of Georgia Research Computing Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Georgia Department of Genetics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the Atlanta Research and Education Foundation, the Centers for Disease Control and Prevention/University of Georgia Collaborative Seed Grant, the University of Georgia Research Computing Center (a partnership between the Office of the Vice President for Research and the Office of the Chief Information Officer), NIH Training Grant T32 GM007103, an Alton Fellowship awarded through the University of Georgia Department of Genetics and by NIH grant R01 AI068908. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khedery B, 1999, MOL CELL, V3, P131, DOI 10.1016/S1097-2765(00)80304-4; Babady NE, 2009, AM J TROP MED HYG, V81, P516, DOI 10.4269/ajtmh.2009.81.516; Berry A, 2011, AM J TROP MED HYG, V84, P535, DOI 10.4269/ajtmh.2011.10-0622; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; *CDCP, 2008, MMWR-MORBID MORTAL W, V58, P229; CHIN W, 1968, AM J TROP MED HYG, V17, P355, DOI 10.4269/ajtmh.1968.17.355; Coatneyi GR, 1971, PRIMATE MALARIAS, P381; Collins WE, 2012, ANNU REV ENTOMOL, V57, P107, DOI 10.1146/annurev-ento-121510-133540; Cox-Singh J, 2008, CLIN INFECT DIS, V46, P165, DOI 10.1086/524888; Cox-Singh J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-10; Cox-Singh J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-269; Daneshvar C, 2009, CLIN INFECT DIS, V49, P852, DOI 10.1086/605439; DeBarry JD, 2011, MOL BIOL EVOL, V28, P2855, DOI 10.1093/molbev/msr103; Demas A, 2011, J CLIN MICROBIOL, V49, P2411, DOI 10.1128/JCM.02603-10; Divis PCS, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-344; Eyles D. E., 1962, Indian Journal of Malariology, V16, P285; EYLES D. E., 1962, MED JOUR MALAYA, V17, P85; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Hoosen A, 2011, TRAVEL MED INFECT DI; Imwong M, 2009, J CLIN MICROBIOL, V47, P4173, DOI 10.1128/JCM.00811-09; Iseki H, 2010, J CLIN MICROBIOL, V48, P2509, DOI 10.1128/JCM.00331-10; Johnston SP, 2006, J CLIN MICROBIOL, V44, P1087, DOI 10.1128/JCM.44.3.1087-1089.2006; Jongwutiwes S, 2004, EMERG INFECT DIS, V10, P2211, DOI 10.3201/eid1012.040293; Jongwutiwes S, 2011, EMERG INFECT DIS, V17, P1799, DOI 10.3201/eid1710.110349; Khim N, 2011, EMERG INFECT DIS, V17, P1900, DOI 10.3201/eid1710.110355; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lapp SA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-181; Lee KS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002015; Lee KS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-73; Lee KS, 2009, INT J PARASITOL, V39, P1125, DOI 10.1016/j.ijpara.2009.03.003; Luchavez J, 2008, EMERG INFECT DIS, V14, P811, DOI 10.3201/eid1405.071407; Ng OT, 2008, EMERG INFECT DIS, V14, P814, DOI 10.3201/eid1405.070863; Ong CWM, 2009, AM J TROP MED HYG, V80, P927, DOI 10.4269/ajtmh.2009.80.927; Osman MMM, 2010, TROP MED INT HEALTH, V15, P1442, DOI 10.1111/j.1365-3156.2010.02659.x; Putaporntip C, 2011, CLIN MICROBIOL INFEC, V17, P1484, DOI 10.1111/j.1469-0691.2011.03507.x; Putaporntip C, 2009, J INFECT DIS, V199, P1143, DOI 10.1086/597414; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Sulistyaningsih E, 2010, EMERG INFECT DIS, V16, P1033, DOI 10.3201/eid1606.100022; Tang THT, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-219; Tan CH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-52; Van den Eede P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-20; Van den Eede P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-249; Vythilingam I, 2006, T ROY SOC TROP MED H, V100, P1087, DOI 10.1016/j.trstmh.2006.02.006; Vythilingam I, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-26	44	36	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31848	10.1371/journal.pone.0031848	http://dx.doi.org/10.1371/journal.pone.0031848			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363751	Green Published, gold			2022-12-27	WOS:000302871500095
J	Alinsug, MV; Chen, FF; Luo, M; Tai, R; Jiang, LW; Wu, KQ				Alinsug, Malona V.; Chen, Fang Fang; Luo, Ming; Tai, Ready; Jiang, Liwen; Wu, Keqiang			Subcellular Localization of Class II HDAs in Arabidopsis thaliana: Nucleocytoplasmic Shuttling of HDA15 Is Driven by Light	PLOS ONE			English	Article							REVERSIBLE HISTONE ACETYLATION; GENE-EXPRESSION; NUCLEAR EXPORT; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; DEACETYLASES HDA6; GENOME-WIDE; KINASE; PROTEINS; ABA	Class II histone deacetylases in humans and other model organisms undergo nucleocytoplasmic shuttling. This unique functional regulatory mechanism has been well elucidated in eukaryotic organisms except in plant systems. In this study, we have paved the baseline evidence for the cytoplasmic and nuclear localization of Class II HDAs as well as their mRNA expression patterns. RT-PCR analysis on the different vegetative parts and developmental stages reveal that Class II HDAs are ubiquitously expressed in all tissues with minimal developmental specificity. Moreover, stable and transient expression assays using HDA-YFP/GFP fusion constructs indicate cytoplasmic localization of HDA5, HDA8, and HDA14 further suggesting their potential for nuclear transport and deacetylating organellar and cytoplasmic proteins. Organelle markers and stains confirm HDA14 to abound in the mitochondria and chloroplasts while HDA5 localizes in the ER. HDA15, on the other hand, shuttles in and out of the nucleus upon light exposure. In the absence of light, it is exported out of the nucleus where further re-exposition to light treatments signals its nuclear import. Unlike HDA5 which binds with 14-3-3 proteins, HDA15 fails to interact with these chaperones. Instead, HDA15 relies on its own nuclear localization and export signals to navigate its subcellular compartmentalization classifying it as a Class IIb HDA. Our study indicates that nucleocytoplasmic shuttling is indeed a hallmark for all eukaryotic Class II histone deacetylases.	[Alinsug, Malona V.; Chen, Fang Fang; Luo, Ming; Tai, Ready; Wu, Keqiang] Natl Taiwan Univ, Inst Plant Biol, Coll Life Sci, Taipei 10764, Taiwan; [Luo, Ming] Chinese Acad Sci, S China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China; [Jiang, Liwen] Chinese Univ Hong Kong, Sch Life Sci, Ctr Cell & Dev Biol, Hong Kong, Hong Kong, Peoples R China	National Taiwan University; Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese University of Hong Kong	Alinsug, MV (corresponding author), Natl Taiwan Univ, Inst Plant Biol, Coll Life Sci, Taipei 10764, Taiwan.	kewu@ntu.edu.tw	Wu, Keqiang/C-9743-2013; JIANG, Liwen/S-6046-2018	Wu, Keqiang/0000-0002-5791-3594; JIANG, Liwen/0000-0002-7829-1472; Alinsug, Malona V/0000-0001-9279-0705	National Science Council of Taiwan [97-2311-B-002-004-MY3, 98-2628-B-002-016-MY3, 99-2321-B-002-027-MY3]; National Taiwan University [98R0066-36, 99R80840]; Democratic Pacific Union; NSC	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University); Democratic Pacific Union; NSC(Ministry of Science and Technology, Taiwan)	This study was funded by grants from the National Science Council of Taiwan (97-2311-B-002-004-MY3, 98-2628-B-002-016-MY3 and 99-2321-B-002-027-MY3) and National Taiwan University (98R0066-36 and 99R80840). MVA is supported by a grant from the Democratic Pacific Union graduate studies program and research fellowship from NSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alinsug MV, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-37; Aoyagi S, 2005, TRENDS CELL BIOL, V15, P565, DOI 10.1016/j.tcb.2005.09.003; Bakin RE, 2004, J BIOL CHEM, V279, P51218, DOI 10.1074/jbc.M409271200; Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Benhamed M, 2006, PLANT CELL, V18, P2893, DOI 10.1105/tpc.106.043489; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bunney TD, 2002, PLANT MOL BIOL, V50, P1041, DOI 10.1023/A:1021231805697; Chang IF, 2009, PROTEOMICS, V9, P2967, DOI 10.1002/pmic.200800445; Chang SR, 2005, P NATL ACAD SCI USA, V102, P8120, DOI 10.1073/pnas.0503275102; Chen LT, 2010, PLANT SIGNAL BEHAV, V5, P1318, DOI 10.4161/psb.5.10.13168; Chen LT, 2010, J EXP BOT, V61, P3345, DOI 10.1093/jxb/erq154; Chen ZJ, 2007, BBA-GENE STRUCT EXPR, V1769, P295, DOI 10.1016/j.bbaexp.2007.04.007; Chua YL, 2003, PLANT CELL, V15, P1468, DOI 10.1105/tpc.011825; Chung PJ, 2009, FEBS LETT, V583, P2249, DOI 10.1016/j.febslet.2009.06.003; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cutler SR, 2000, P NATL ACAD SCI USA, V97, P3718, DOI 10.1073/pnas.97.7.3718; Dequiedt F, 2005, J EXP MED, V201, P793, DOI 10.1084/jem.20042034; Earley K, 2006, GENE DEV, V20, P1283, DOI 10.1101/gad.1417706; Ferl RJ, 2004, PHYSIOL PLANTARUM, V120, P173, DOI 10.1111/j.0031-9317.2004.0239.x; Finkemeier I, 2011, PLANT PHYSIOL, V155, P1779, DOI 10.1104/pp.110.171595; Gampala SS, 2007, DEV CELL, V13, P177, DOI 10.1016/j.devcel.2007.06.009; Gregoire S, 2005, MOL CELL BIOL, V25, P2273, DOI 10.1128/MCB.25.6.2273-2287.2005; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Guardiola AR, 2002, J BIOL CHEM, V277, P3350, DOI 10.1074/jbc.M109861200; Hollender C, 2008, J INTEGR PLANT BIOL, V50, P875, DOI 10.1111/j.1744-7909.2008.00704.x; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Huber SC, 2002, PLANT MOL BIOL, V50, P1053, DOI 10.1023/A:1021284002779; Igarashi D, 2001, PLANT CELL, V13, P2483, DOI 10.1105/tpc.13.11.2483; Ishida S, 2004, PLANT CELL, V16, P2641, DOI 10.1105/tpc.104.024604; Kao HY, 2002, J BIOL CHEM, V277, P187, DOI 10.1074/jbc.M108931200; Kim KC, 2008, PLANT CELL, V20, P2357, DOI 10.1105/tpc.107.055566; Kim MA, 2007, EXP MOL MED, V39, P205, DOI 10.1038/emm.2007.23; Ko MH, 2009, J BIOL CHEM, V284, P2482, DOI 10.1074/jbc.M804901200; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Lee LY, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-24; Li Y, 2008, J BIOL CHEM, V283, P12686, DOI 10.1074/jbc.C700185200; Linseman DA, 2003, J BIOL CHEM, V278, P41472, DOI 10.1074/jbc.M307245200; Long JA, 2006, SCIENCE, V312, P1520, DOI 10.1126/science.1123841; Lopez-Molina L, 2002, PLANT J, V32, P317, DOI 10.1046/j.1365-313X.2002.01430.x; Lu Q, 2010, PLANT J, V61, P259, DOI 10.1111/j.1365-313X.2009.04048.x; Martin M, 2007, ONCOGENE, V26, P5450, DOI 10.1038/sj.onc.1210613; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2000, P NATL ACAD SCI USA, V97, P14400, DOI 10.1073/pnas.260501497; Miao YS, 2007, NAT PROTOC, V2, P2348, DOI 10.1038/nprot.2007.360; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Nishino TG, 2008, BIOCHEM BIOPH RES CO, V377, P852, DOI 10.1016/j.bbrc.2008.10.079; Oecking C, 2009, CURR OPIN PLANT BIOL, V12, P760, DOI 10.1016/j.pbi.2009.08.003; Pandey R, 2002, NUCLEIC ACIDS RES, V30, P5036, DOI 10.1093/nar/gkf660; Parmigiani RB, 2008, P NATL ACAD SCI USA, V105, P9633, DOI 10.1073/pnas.0803749105; Parra M, 2005, J BIOL CHEM, V280, P13762, DOI 10.1074/jbc.M413396200; Paul AL, 2009, J PROTEOME RES, V8, P1913, DOI 10.1021/pr8008644; Roberts MR, 2003, TRENDS PLANT SCI, V8, P218, DOI 10.1016/S1360-1385(03)00056-6; Ryu H, 2007, PLANT CELL, V19, P2749, DOI 10.1105/tpc.107.053728; Schoonheim PJ, 2007, PLANT J, V49, P289, DOI 10.1111/j.1365-313X.2006.02955.x; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Scroggins BT, 2007, MOL CELL, V25, P151, DOI 10.1016/j.molcel.2006.12.008; Sehnke PC, 2002, PLANT MOL BIOL, V50, P1011, DOI 10.1023/A:1021289127519; Sehnke PC, 2002, PLANT CELL, V14, pS339, DOI 10.1105/tpc.010430; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Sheldon CC, 2006, PLANT J, V45, P871, DOI 10.1111/j.1365-313X.2006.02652.x; Sohn EJ, 2003, PLANT CELL, V15, P1057, DOI 10.1105/tpc.009779; Tanaka M, 2008, PLANT PHYSIOL, V146, P149, DOI 10.1104/pp.107.111674; Tian L, 2005, GENETICS, V169, P337, DOI 10.1534/genetics.104.033142; Tian L, 2003, GENETICS, V165, P399; Tian L, 2001, P NATL ACAD SCI USA, V98, P200, DOI 10.1073/pnas.011347998; To TK, 2011, BIOCHEM BIOPH RES CO, V406, P414, DOI 10.1016/j.bbrc.2011.02.058; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; van der Linden AM, 2007, EMBO J, V26, P358, DOI 10.1038/sj.emboj.7601479; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Wallace DC, 2010, GENE DEV, V24, P1571, DOI 10.1101/gad.1960210; Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006; Wang AH, 2001, MOL CELL BIOL, V21, P5992, DOI 10.1128/MCB.21.17.5992-6005.2001; Wu K, 2008, J EXP BOT, V59, P225, DOI 10.1093/jxb/erm300; Wu KQ, 2000, PLANT J, V22, P19, DOI 10.1046/j.1365-313x.2000.00711.x; Wu X, 2011, PLANT PHYSIOL, V155, P1769, DOI 10.1104/pp.110.165852; Xu CR, 2005, P NATL ACAD SCI USA, V102, P14469, DOI 10.1073/pnas.0503143102; Yamamoto K, 2003, J BIOL CHEM, V278, P34525, DOI 10.1074/jbc.M304188200; Yanagisawa S, 2003, NATURE, V425, P521, DOI 10.1038/nature01984; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yu CW, 2011, PLANT PHYSIOL, V156, P173, DOI 10.1104/pp.111.174417; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhou CH, 2005, PLANT CELL, V17, P1196, DOI 10.1105/tpc.104.028514	88	40	47	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30846	10.1371/journal.pone.0030846	http://dx.doi.org/10.1371/journal.pone.0030846			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363501	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600077
J	Braido, F; Baiardini, I; Menoni, S; Gani, F; Senna, GE; Ridolo, E; Schoepf, V; Rogkakou, A; Canonica, GW				Braido, Fulvio; Baiardini, Ilaria; Menoni, Stefania; Gani, Federica; Senna, Gian Enrico; Ridolo, Erminia; Schoepf, Veruska; Rogkakou, Anthi; Canonica, Giorgio Walter			Patients with Asthma and Comorbid Allergic Rhinitis: Is Optimal Quality of Life Achievable in Real Life?	PLOS ONE			English	Article								Objectives: Asthma trials suggest that patients reaching total disease control have an optimal Health Related Quality of Life (HRQoL). Moreover, rhinitis is present in almost 80% of asthmatics and impacts asthma control and patient HRQoL. We explored whether optimal HRQoL was reachable in a real-life setting, and evaluated the disease and patient related patterns associated to optimal HRQoL achievement. Methods and Findings: Asthma and rhinitis HRQoL, illness perception, mood profiles, rhinitis symptoms and asthma control were assessed by means of validated tools in patients classified according to GINA and ARIA guidelines. Optimal HRQoL, identified by a Rhinasthma Global Summary (GS) score <= 20 (score ranging from 0 to 100, where 100 represents the worst possible HRQoL), was reached by 78/209 (37.32%). With the exception of age, no associations were found between clinical and demographic characteristics and optimal HRQoL achievement. Patients reaching an optimal HRQoL differed in disease perception and mood compared to those not reaching an optimal HRQoL. Asthma control was significantly associated with optimal HRQoL (chi(2) = 49.599; p < 0.001) and well-controlled and totally controlled patients significantly differed in achieving optimal HRQoL (chi(2) = 7.617; p < 0.006). Conclusion: Approximately one third of the patients in our survey were found to have an optimal HRQoL. While unsatisfactory disease control was the primary reason why the remainder failed to attain optimal HRQoL, it is clear that illness perception and mood also played parts. Therefore, therapeutic plans should be directed not only toward achieving the best possible clinical control of asthma and comorbid rhinitis, but also to incorporating individualized elements according to patient-related characteristics.	[Braido, Fulvio; Baiardini, Ilaria; Schoepf, Veruska; Rogkakou, Anthi; Canonica, Giorgio Walter] Osped S Martino Genoa, Allergy & Resp Dis Clin, Genoa, Italy; [Menoni, Stefania] Univ Genoa, Dept Hlth Sci, Biostat Unit, Genoa, Italy; [Gani, Federica] AOU San Luigi, Resp Dis Div, Allergy Unit, Turin, Italy; [Senna, Gian Enrico] Verona Major Hosp, Allergy Serv, Verona, Italy; [Ridolo, Erminia] Univ Parma, I-43100 Parma, Italy	University of Genoa; University of Parma	Braido, F (corresponding author), Osped S Martino Genoa, Allergy & Resp Dis Clin, Genoa, Italy.	fulvio.braido@unige.it	Senna, Gianenrico/AAC-5201-2022; /AAT-7555-2020; canonica, giorgio walter/ABF-2037-2020; braido, fulvio/C-5320-2012	Senna, Gianenrico/0000-0003-4172-3216; canonica, giorgio walter/0000-0001-8467-2557; braido, fulvio/0000-0003-2460-4709				Baiardini I, 2003, ALLERGY, V58, P289, DOI 10.1034/j.1398-9995.2003.00079.x; Bateman ED, 2007, EUR RESPIR J, V29, P56, DOI 10.1183/09031936.00128505; Bateman ED, 2002, EUR RESPIR J, V20, P588, DOI 10.1183/09031936.02.00294702; Bateman ED, 2004, AM J RESP CRIT CARE, V170, P836, DOI 10.1164/rccm.200401-033OC; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet J, 2006, J ALLERGY CLIN IMMUN, V117, P158, DOI 10.1016/j.jaci.2005.09.047; Braido F, 2007, CLIN EXP ALLERGY, V37, P788, DOI 10.1111/j.1365-2222.2007.02702.x; Braido F, 2010, ALLERGY, V65, P959, DOI 10.1111/j.1398-9995.2010.02383.x; Braido F, 2009, ALLERGY, V64, P937, DOI 10.1111/j.1398-9995.2008.01932.x; Ford ES, 2004, J ASTHMA, V41, P327, DOI 10.1081/JAS-120026090; Global Initiative for Asthma (GINA), GLOB STRAT ASTHM MAN; Laforest L, 2005, INT ARCH ALLERGY IMM, V136, P281, DOI 10.1159/000083955; Leynaert B, 2000, AM J RESP CRIT CARE, V162, P1391, DOI 10.1164/ajrccm.162.4.9912033; Lubetkin EI, 2005, QUAL LIFE RES, V14, P2187, DOI 10.1007/s11136-005-8028-5; McNair D.M., 1992, POMS MANUAL PROFILE; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; O'Byrne PM, 2008, CHEST, V134, P1192, DOI 10.1378/chest.08-1018; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Rothman ML, 2007, VALUE HEALTH, V10, pS66, DOI 10.1111/j.1524-4733.2007.00269.x; Schatz M, 2006, J ALLERGY CLIN IMMUN, V117, P549, DOI 10.1016/j.jaci.2006.01.011; Shen J, 2011, EXPERT REV PHARM OUT, V11, P447, DOI [10.1586/erp.11.48, 10.1586/ERP.11.48]; Valovirta Erkka, 2006, BMC Pulm Med, V6 Suppl 1, pS3, DOI 10.1186/1471-2466-6-S1-S3	23	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31178	10.1371/journal.pone.0031178	http://dx.doi.org/10.1371/journal.pone.0031178			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363573	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600121
J	Muscedere, ML; Traniello, JFA				Muscedere, Mario L.; Traniello, James F. A.			Division of Labor in the Hyperdiverse Ant Genus Pheidole Is Associated with Distinct Subcaste- and Age-Related Patterns of Worker Brain Organization	PLOS ONE			English	Article							MUSHROOM BODIES; VOLUME CHANGES; ANTENNAL LOBE; EVOLUTION; HYMENOPTERA; PLASTICITY; SIZE; EXPERIENCE; FORMICIDAE; NUMBER	The evolutionary success of ants and other social insects is considered to be intrinsically linked to division of labor among workers. The role of the brains of individual ants in generating division of labor, however, is poorly understood, as is the degree to which interspecific variation in worker social phenotypes is underscored by functional neurobiological differentiation. Here we demonstrate that dimorphic minor and major workers of different ages from three ecotypical species of the hyperdiverse ant genus Pheidole have distinct patterns of neuropil size variation. Brain subregions involved in sensory input (optic and antennal lobes), sensory integration, learning and memory (mushroom bodies), and motor functions (central body and subesophageal ganglion) vary significantly in relative size, reflecting differential investment in neuropils that likely regulate subcaste- and age-correlated task performance. Worker groups differ in brain size and display patterns of altered isometric and allometric subregion scaling that affect brain architecture independently of brain size variation. In particular, mushroom body size was positively correlated with task plasticity in the context of both age-and subcaste-related polyethism, providing strong, novel support that greater investment in this neuropil increases behavioral flexibility. Our findings reveal striking levels of developmental plasticity and evolutionary flexibility in Pheidole worker neuroanatomy, supporting the hypothesis that mosaic alterations of brain composition contribute to adaptive colony structure and interspecific variation in social organization.	[Muscedere, Mario L.] Boston Univ, Program Neurosci, Dept Biol, Boston, MA 02215 USA	Boston University	Muscedere, ML (corresponding author), Boston Univ, Program Neurosci, Dept Biol, Boston, MA 02215 USA.	mario@bu.edu	Muscedere, Mario/A-6064-2011	Muscedere, Mario/0000-0002-4898-3961	National Science Foundation [IOB 0725013, IOB 0724591]	National Science Foundation(National Science Foundation (NSF))	This work was funded by the following National Science Foundation (www.nsf.gov) grants: Graduate Research Fellowship to ML Muscedere; IOB 0725013 to JFA Traniello; IOB 0724591 to Wulfila Gronenberg (U. of AZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebes A, 2001, J NEUROSCI, V21, P6264, DOI 10.1523/JNEUROSCI.21-16-06264.2001; Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; Bonabeau E, 1997, TRENDS ECOL EVOL, V12, P188, DOI 10.1016/S0169-5347(97)01048-3; Bucher D, 2000, J NEUROSCI METH, V100, P135, DOI 10.1016/S0165-0270(00)00245-4; Byrne RW, 2004, P ROY SOC B-BIOL SCI, V271, P1693, DOI 10.1098/rspb.2004.2780; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; Catania KC, 2002, P NATL ACAD SCI USA, V99, P5692, DOI 10.1073/pnas.072097999; Chittka L, 2009, CURR BIOL, V19, pR995, DOI 10.1016/j.cub.2009.08.023; Darwin C., 1871, P423; Delgado J, 1997, PHYS REV E, V55, P2338, DOI 10.1103/PhysRevE.55.2338; DETRAIN C, 1992, BEHAV ECOL SOCIOBIOL, V29, P405, DOI 10.1007/BF00170170; DEVOOGD TJ, 1993, P ROY SOC B-BIOL SCI, V254, P75, DOI 10.1098/rspb.1993.0129; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; DURST C, 1994, BEHAV NEURAL BIOL, V62, P259, DOI 10.1016/S0163-1047(05)80025-1; Ehmer B, 2004, J COMP NEUROL, V469, P198, DOI 10.1002/cne.11014; Fahrbach SE, 2006, ANNU REV ENTOMOL, V51, P209, DOI 10.1146/annurev.ento.51.110104.150954; Fahrbach SE, 1998, LEARN MEMORY, V5, P115; Fahrbach SE, 2003, J NEUROBIOL, V57, P141, DOI 10.1002/neu.10256; Farris SM, 2011, ARTHROPOD STRUCT DEV, V40, P368, DOI 10.1016/j.asd.2011.02.004; Farris SM, 2011, P ROY SOC B-BIOL SCI, V278, P940, DOI 10.1098/rspb.2010.2161; Farris SM, 2005, P NATL ACAD SCI USA, V102, P17394, DOI 10.1073/pnas.0508430102; Farris SM, 2001, J NEUROSCI, V21, P6395, DOI 10.1523/JNEUROSCI.21-16-06395.2001; Garnier Simon, 2007, Swarm Intelligence, V1, P3, DOI 10.1007/s11721-007-0004-y; Groh C, 2011, ARTHROPOD STRUCT DEV, V40, P358, DOI 10.1016/j.asd.2010.12.002; Gronenberg W, 1996, J EXP BIOL, V199, P2011; Gronenberg Wulfila, 2009, P377; Heisenberg M, 1998, LEARN MEMORY, V5, P1; Holldobler B., 1990, pi; Ishikawa Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002617; Iwaniuk AN, 2004, P ROY SOC B-BIOL SCI, V271, pS148, DOI 10.1098/rsbl.2003.0127; Iwaniuk AN, 2001, BRAIN BEHAV EVOLUT, V57, P87, DOI 10.1159/000047228; Kelber C, 2010, DEV NEUROBIOL, V70, P222, DOI 10.1002/dneu.20782; Kuebler LS, 2010, J COMP NEUROL, V518, P352, DOI 10.1002/cne.22217; Kuhn-Buhlmann S, 2006, J NEUROBIOL, V66, P511, DOI 10.1002/neu.20235; Leingartner A, 2007, P NATL ACAD SCI USA, V104, P4153, DOI 10.1073/pnas.0611723104; Maleszka J, 2009, J COMP PHYSIOL A, V195, P733, DOI 10.1007/s00359-009-0449-0; Mertl AL, 2010, INSECT SOC, V57, P441, DOI 10.1007/s00040-010-0102-5; Mertl AL, 2009, BEHAV ECOL SOCIOBIOL, V63, P1411, DOI 10.1007/s00265-009-0797-3; Molina Y, 2009, P ROY SOC B-BIOL SCI, V276, P3345, DOI 10.1098/rspb.2009.0817; Molina Y, 2008, DEV NEUROBIOL, V68, P950, DOI 10.1002/dneu.20633; Muscedere ML, 2011, NATURWISSENSCHAFTEN, V98, P783, DOI 10.1007/s00114-011-0828-6; Muscedere ML, 2009, ANIM BEHAV, V77, P911, DOI 10.1016/j.anbehav.2008.12.018; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; O'Donnell S, 2004, NEUROSCI LETT, V356, P159, DOI 10.1016/j.neulet.2003.11.053; Ott SR, 2010, P ROY SOC B-BIOL SCI, V277, P3087, DOI 10.1098/rspb.2010.0694; PATEL A D, 1990, Psyche (Cambridge), V97, P181, DOI 10.1155/1990/56747; Pitnick S, 2006, P ROY SOC B-BIOL SCI, V273, P719, DOI 10.1098/rspb.2005.3367; Robinson EJH, 2009, INSECT SOC, V56, P1, DOI 10.1007/s00040-008-1035-0; Roth TC, 2009, P R SOC B, V276, P401, DOI 10.1098/rspb.2008.1184; Seid MA, 2005, J COMP NEUROL, V488, P269, DOI 10.1002/cne.20545; Seid MA, 2005, NATURWISSENSCHAFTEN, V92, P198, DOI 10.1007/s00114-005-0610-8; Seid MA, 2008, DEV NEUROBIOL, V68, P1325, DOI 10.1002/dneu.20663; Seid MA, 2006, BEHAV ECOL SOCIOBIOL, V60, P631, DOI 10.1007/s00265-006-0207-z; Sherry DF, 2006, ANNU REV PSYCHOL, V57, P167, DOI 10.1146/annurev.psych.56.091103.070324; Shultz S, 2010, BIOL J LINN SOC, V100, P111, DOI 10.1111/j.1095-8312.2010.01427.x; Smith AR, 2010, P ROY SOC B-BIOL SCI, V277, P2157, DOI 10.1098/rspb.2010.0269; Smith CR, 2008, NAT REV GENET, V9, P735, DOI 10.1038/nrg2429; Sole RV, 2000, ARTIF LIFE, V6, P219, DOI 10.1162/106454600568843; Stieb SM, 2010, DEV NEUROBIOL, V70, P408, DOI 10.1002/dneu.20785; Strausfeld NJ, 2009, J COMP NEUROL, V513, P265, DOI 10.1002/cne.21948; SUGA N, 1976, SCIENCE, V194, P542, DOI 10.1126/science.973140; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Wilson E.O., 2003, PHEIDOLE NEW WORLD D, V1; WILSON EO, 1976, BEHAV ECOL SOCIOBIOL, V1, P63, DOI 10.1007/BF00299953; Winnington AP, 1996, J COMP NEUROL, V365, P479, DOI 10.1002/(SICI)1096-9861(19960212)365:3<479::AID-CNE10>3.0.CO;2-M; WITHERS GS, 1993, NATURE, V364, P238, DOI 10.1038/364238a0	67	72	72	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31618	10.1371/journal.pone.0031618	http://dx.doi.org/10.1371/journal.pone.0031618			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363686	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600149
J	Nicol, S; Chades, I				Nicol, Sam; Chades, Iadine			Which States Matter? An Application of an Intelligent Discretization Method to Solve a Continuous POMDP in Conservation Biology	PLOS ONE			English	Article							VALUE-ITERATION; SPACE	When managing populations of threatened species, conservation managers seek to make the best conservation decisions to avoid extinction. Making the best decision is difficult because the true population size and the effects of management are uncertain. Managers must allocate limited resources between actively protecting the species and monitoring. Resources spent on monitoring reduce expenditure on management that could be used to directly improve species persistence. However monitoring may prevent sub-optimal management actions being taken as a result of observation error. Partially observable Markov decision processes (POMDPs) can optimize management for populations with partial detectability, but the solution methods can only be applied when there are few discrete states. We use the Continuous U-Tree (CU-Tree) algorithm to discretely represent a continuous state space by using only the states that are necessary to maintain an optimal management policy. We exploit the compact discretization created by CU-Tree to solve a POMDP on the original continuous state space. We apply our method to a population of sea otters and explore the trade-off between allocating resources to management and monitoring. We show that accurately discovering the population size is less important than management for the long term survival of our otter population.	[Nicol, Sam] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA; [Chades, Iadine] CSIRO, CSIRO Ecosyst Sci, Brisbane, Qld, Australia	University of Alaska System; University of Alaska Fairbanks; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Nicol, S (corresponding author), Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA.	scnicol@alaska.edu	Nicol, Sam/I-1074-2012; Chades, iadine/A-4052-2011	Nicol, Sam/0000-0002-1160-7444; Chades, iadine/0000-0002-7442-2850	University of Queensland; applied environmental decision analysis research center; CSIRO ecosystem sciences	University of Queensland(University of Queensland); applied environmental decision analysis research center; CSIRO ecosystem sciences	The work was supported by a University of Queensland postgraduate research scholarship. The University of Queensland website is http://www.uq.edu.au/. An additional stipend scholarship was provided to SN by the applied environmental decision analysis research center (http://www.aeda.edu.au/). IC received salary from CSIRO ecosystem sciences while participating in the research (http://www.csiro.au/org/CSE.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellman R., 1957, DYNAMIC PROGRAMMING; Cassandra A., PARTIALLY OBSERVABLE; Chades I, 2008, P NATL ACAD SCI USA, V105, P13936, DOI 10.1073/pnas.0805265105; Chernova S, 2006, WS0613 AAAI; Erez T, 2010, P UAI 2010; Gerber LR, 2004, BIODIVERS CONSERV, V13, P2741, DOI 10.1007/s10531-004-2146-1; Gibbons J, 2003, NONPARAMETRIC STAT I, P239; Kaelbling LP, 1998, ARTIF INTELL, V101, P99, DOI 10.1016/S0004-3702(98)00023-X; Laidre KL, 2002, WILDLIFE SOC B, V30, P1172; Lance M.M., 2004, WASHINGTON STATE REC; Lee ISK, 2004, ENG APPL ARTIF INTEL, V17, P577, DOI 10.1016/j.engappai.2004.08.005; Li L., 2006, ISAIM; Madani O, 2003, ARTIF INTELL, V147, P5, DOI 10.1016/S0004-3702(02)00378-8; McCallum A. K., 1995, THESIS U ROCHESTER R; McDonald-Madden E, 2011, ECOL APPL, V21, P844, DOI 10.1890/09-2075.1; Morris W. F., 2002, QUANTITATIVE CONSERV; PAPADIMITRIOU CH, 1987, MATH OPER RES, V12, P441, DOI 10.1287/moor.12.3.441; Porta JM, 2006, J MACH LEARN RES, V7, P2329; Puterman M.L., 2014, MARKOV DECISION PROC; Tomberlin D, 2010, P 5 IEMSS C ENV MOD; Uther WTB, 1998, FIFTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-98) AND TENTH CONFERENCE ON INNOVATIVE APPLICATIONS OF ARTIFICAL INTELLIGENCE (IAAI-98) - PROCEEDINGS, P769; White B, 2005, ECOL MODEL, V189, P241, DOI 10.1016/j.ecolmodel.2005.03.010; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	24	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e28993	10.1371/journal.pone.0028993	http://dx.doi.org/10.1371/journal.pone.0028993			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363398	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600003
J	Poncin, G; Beaulieu, A; Humblet, C; Thiry, A; Oda, K; Boniver, J; Defresne, MP				Poncin, Geraldine; Beaulieu, Aurore; Humblet, Chantal; Thiry, Albert; Oda, Kimimitsu; Boniver, Jacques; Defresne, Marie-Paule			Characterization of Spontaneous Bone Marrow Recovery after Sublethal Total Body Irradiation: Importance of the Osteoblastic/Adipocytic Balance	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HEMATOPOIETIC-STEM; STROMAL CELLS; INHIBIT DIFFERENTIATION; ALKALINE-PHOSPHATASE; IN-VITRO; NICHE; MAINTENANCE; OSTEOBLASTS; ADIPOCYTES	Many studies have already examined the hematopoietic recovery after irradiation but paid with very little attention to the bone marrow microenvironment. Nonetheless previous studies in a murine model of reversible radio-induced bone marrow aplasia have shown a significant increase in alkaline phosphatase activity (ALP) prior to hematopoietic regeneration. This increase in ALP activity was not due to cell proliferation but could be attributed to modifications of the properties of mesenchymal stem cells (MSC). We thus undertook a study to assess the kinetics of the evolution of MSC correlated to their hematopoietic supportive capacities in mice treated with sub lethal total body irradiation. In our study, colony-forming units - fibroblasts (CFU-Fs) assay showed a significant MSC rate increase in irradiated bone marrows. CFU-Fs colonies still possessed differentiation capacities of MSC but colonies from mice sacrificed 3 days after irradiation displayed high rates of ALP activity and a transient increase in osteoblastic markers expression while pparc and neuropilin-1 decreased. Hematopoietic supportive capacities of CFU-Fs were also modified: as compared to controls, irradiated CFU-Fs significantly increased the proliferation rate of hematopoietic precursors and accelerated the differentiation toward the granulocytic lineage. Our data provide the first evidence of the key role exerted by the balance between osteoblasts and adipocytes in spontaneous bone marrow regeneration. First, (pre) osteoblast differentiation from MSC stimulated hematopoietic precursor's proliferation and granulopoietic regeneration. Then, in a second time (pre) osteoblasts progressively disappeared in favour of adipocytic cells which down regulated the proliferation and granulocytic differentiation and then contributed to a return to pre-irradiation conditions.	[Poncin, Geraldine; Beaulieu, Aurore; Humblet, Chantal; Thiry, Albert; Boniver, Jacques; Defresne, Marie-Paule] Univ Liege, Dept Cytol & Histol & Pathol Anat Giga R, Liege, Belgium; [Oda, Kimimitsu] Niigata Univ, Dept Biochem, Grad Sch Med & Dent Sci, Niigata, Japan	University of Liege; Niigata University	Poncin, G (corresponding author), Univ Liege, Dept Cytol & Histol & Pathol Anat Giga R, CHU B23, Liege, Belgium.	G.poncin@ulg.ac.be			University of Liege; FRS-FNRS (Televie); Fond Leon Fredericq; Centre anti-cancereux; Grants-in-Aid for Scientific Research [21592355] Funding Source: KAKEN	University of Liege(University of Liege); FRS-FNRS (Televie)(Fonds de la Recherche Scientifique - FNRS); Fond Leon Fredericq; Centre anti-cancereux; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This project is co-financed by the University of Liege, the FRS-FNRS (Televie), the Fond Leon Fredericq and the Centre anti-cancereux. Geraldine Poncin and Aurore Beaulieu are Televie (FRS-FNRS) fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almohamad K, 2003, INT J RADIAT BIOL, V79, P259, DOI 10.1080/0955300031000085740; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Belaid-Choucair Z, 2008, STEM CELLS, V26, P1556, DOI 10.1634/stemcells.2008-0068; BIANCO P, 1993, BONE, V14, P315, DOI 10.1016/8756-3282(93)90158-7; Bianco P, 2011, BEST PRACT RES CL HA, V24, P37, DOI 10.1016/j.beha.2011.01.005; Brusnahan SK, 2010, MECH AGEING DEV, V131, P718, DOI 10.1016/j.mad.2010.10.002; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; DEBRUYN PPH, 1981, SEMIN HEMATOL, V18, P179; Dennis JE, 2002, STEM CELLS, V20, P205, DOI 10.1634/stemcells.20-3-205; DILLY SA, 1993, J CLIN PATHOL, V46, P611, DOI 10.1136/jcp.46.7.611; Dominici M, 2009, BLOOD, V114, P2333, DOI 10.1182/blood-2008-10-183459; Georgiou KR, 2010, CURR MOL MED, V10, P440, DOI 10.2174/156652410791608243; Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777; Hubin F, 2005, STEM CELLS, V23, P1626, DOI 10.1634/stemcells.2005-0041; Hubin F, 2004, CELL TRANSPLANT, V13, P823, DOI 10.3727/000000004783983387; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jo DY, 2003, BRIT J HAEMATOL, V121, P649, DOI 10.1046/j.1365-2141.2003.04326.x; Jung Y, 2006, BONE, V38, P497, DOI 10.1016/j.bone.2005.10.003; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kutznetsov S, 2004, J CELL BIOL, V167, P1113; Kuznetsov SA, 1997, BRIT J HAEMATOL, V97, P561, DOI 10.1046/j.1365-2141.1997.902904.x; Lataillade JJ, 2002, BLOOD, V99, P1117, DOI 10.1182/blood.V99.4.1117; Levesque JP, 2010, LEUKEMIA, V24, P1979, DOI 10.1038/leu.2010.214; Lo Celso C, 2009, J BIOPHOTONICS, V2, P619, DOI 10.1002/jbio.200910072; Ma J, 2007, HAEMATOLOGICA, V92, P889, DOI 10.3324/haematol.11106; Mayack SR, 2008, BLOOD, V112, P519, DOI 10.1182/blood-2008-01-133710; Meirelles LD, 2003, BRIT J HAEMATOL, V123, P702, DOI 10.1046/j.1365-2141.2003.04669.x; Minguell JJ, 2001, EXP BIOL MED, V226, P507, DOI 10.1177/153537020122600603; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nakao N, 2010, AM J PATHOL, V177, P547, DOI 10.2353/ajpath.2010.091042; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Neiva K, 2005, BRAZ J MED BIOL RES, V38, P1449, DOI 10.1590/S0100-879X2005001000001; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Prince HM, 2004, BRIT J HAEMATOL, V126, P536, DOI 10.1111/j.1365-2141.2004.05081.x; Ren HY, 2006, BIOCHEM BIOPH RES CO, V347, P12, DOI 10.1016/j.bbrc.2006.05.169; Slayton WB, 2007, STEM CELLS, V25, P2945, DOI 10.1634/stemcells.2007-0158; SNYDER F, 1965, RADIAT RES, V25, P417, DOI 10.2307/3571982; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Sun SK, 2003, STEM CELLS, V21, P527, DOI 10.1634/stemcells.21-5-527; Thomas T, 1999, ENDOCRINOLOGY, V140, P1630, DOI 10.1210/en.140.4.1630; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Van Overstraeten-Schloegel N, 2006, EUR J HAEMATOL, V76, P488, DOI 10.1111/j.1600-0609.2006.00633.x; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; WESTEN H, 1979, J EXP MED, V150, P919, DOI 10.1084/jem.150.4.919; WHYTE MP, 1995, J CLIN INVEST, V95, P1440, DOI 10.1172/JCI117814; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; WILSON DA, 1972, INFECT IMMUN, V5, P461, DOI 10.1128/IAI.5.4.461-466.1972; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534; Wolf NS, 2003, EXP CELL RES, V290, P346, DOI 10.1016/S0014-4827(03)00321-5; Xie QP, 2009, DIFFERENTIATION, V77, P483, DOI 10.1016/j.diff.2009.01.001; Yang Y, 2010, BIOELECTROMAGNETICS, V31, P277, DOI 10.1002/bem.20560; Zhang C, 2010, MED HYPOTHESES, V76, P241	56	20	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30818	10.1371/journal.pone.0030818	http://dx.doi.org/10.1371/journal.pone.0030818			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363493	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600070
J	Rellick, SL; O'Leary, H; Piktel, D; Walton, C; Fortney, JE; Akers, SM; Martin, KH; Denvir, J; Boskovic, G; Primerano, DA; Vos, J; Bailey, N; Gencheva, M; Gibson, LF				Rellick, Stephanie L.; O'Leary, Heather; Piktel, Debbie; Walton, Cheryl; Fortney, James E.; Akers, Stephen M.; Martin, Karen H.; Denvir, James; Boskovic, Goran; Primerano, Donald A.; Vos, Jeffrey; Bailey, Nathanael; Gencheva, Marieta; Gibson, Laura F.			Bone Marrow Osteoblast Damage by Chemotherapeutic Agents	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELL; HIGH-DOSE CHEMOTHERAPY; STROMAL CELLS; IN-VITRO; TRANSPLANT RECIPIENTS; SOLID TUMORS; GROWTH; NICHE; PROGENITORS; CHEMOTAXIS	Hematopoietic reconstitution, following bone marrow or stem cell transplantation, requires a microenvironment niche capable of supporting both immature progenitors and stem cells with the capacity to differentiate and expand. Osteoblasts comprise one important component of this niche. We determined that treatment of human primary osteoblasts (HOB) with melphalan or VP-16 resulted in increased phospho-Smad2, consistent with increased TGF-beta 1 activity. This increase was coincident with reduced HOB capacity to support immature B lineage cell chemotaxis and adherence. The supportive deficit was not limited to committed progenitor cells, as human embryonic stem cells (hESC) or human CD34+ bone marrow cells co-cultured with HOB pre-exposed to melphalan, VP-16 or rTGF-beta 1 had profiles distinct from the same populations co-cultured with untreated HOB. Functional support deficits were downstream of changes in HOB gene expression profiles following chemotherapy exposure. Melphalan and VP-16 induced damage of HOB suggests vulnerability of this critical niche to therapeutic agents frequently utilized in pre-transplant regimens and suggests that dose escalated chemotherapy may contribute to post-transplantation hematopoietic deficits by damaging structural components of this supportive niche.	[Rellick, Stephanie L.; O'Leary, Heather; Akers, Stephen M.; Gencheva, Marieta; Gibson, Laura F.] W Virginia Univ, Sch Med, Canc Cell Biol Program, Morgantown, WV 26506 USA; [Rellick, Stephanie L.; O'Leary, Heather; Piktel, Debbie; Fortney, James E.; Akers, Stephen M.; Gencheva, Marieta; Gibson, Laura F.] W Virginia Univ, Sch Med, Alexander B Osborn Hematopoiet Malignancy & Trans, Morgantown, WV 26506 USA; [Gibson, Laura F.] W Virginia Univ, Sch Med, Dept Microbiol Immunol & Cell Biol, Morgantown, WV 26506 USA; [Walton, Cheryl] W Virginia Univ, Sch Med, Dept Pediat, Morgantown, WV 26506 USA; [Martin, Karen H.] W Virginia Univ, Sch Med, Dept Neurobiol & Anat, Morgantown, WV 26506 USA; [Denvir, James] W Virginia Univ, Sch Med, Dept Stat, Morgantown, WV 26506 USA; [Boskovic, Goran; Primerano, Donald A.] Marshall Univ, Microarray Core Facil, Huntington, WV USA; [Vos, Jeffrey; Bailey, Nathanael] W Virginia Univ, Sch Med, Dept Pathol, Morgantown, WV 26506 USA	West Virginia University; West Virginia University; West Virginia University; West Virginia University; West Virginia University; West Virginia University; Marshall University; West Virginia University	Rellick, SL (corresponding author), W Virginia Univ, Sch Med, Canc Cell Biol Program, Morgantown, WV 26506 USA.	lgibson@hsc.wvu.edu	Vos, Jeffrey/W-7374-2019	Vos, Jeffrey/0000-0002-6715-1415; Gibson, Laura/0000-0002-7291-9046; O'Leary, Heather/0000-0003-1321-1520; Bailey, Nathanael/0000-0002-6747-680X; Martin, Karen/0000-0001-8916-4092	National Institutes of Health (NIH) [R01 HL056888, P20 RR016440]; National Cancer Institute (NCI) [RO1 CA134573]; Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program; WV Research Trust; NATIONAL CANCER INSTITUTE [R01CA134573] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016440] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103488] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program; WV Research Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) R01 HL056888 (Dr. Gibson), NIH P20 RR016440 (Dr. Gibson), National Cancer Institute (NCI) RO1 CA134573 and the Alexander B. Osborn Hematopoietic Malignancy and Transplantation Program, the WV Research Trust Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anscher MS, 2008, INT J RADIAT ONCOL, V71, P829, DOI 10.1016/j.ijrobp.2008.02.046; Avigdor A, 2004, BLOOD, V103, P2981, DOI 10.1182/blood-2003-10-3611; Batard P, 2000, J CELL SCI, V113, P383; Biswas S, 2007, J CLIN INVEST, V117, P1305, DOI 10.1172/JCI30740; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cao J, 2008, CANCER LETT, V263, P197, DOI 10.1016/j.canlet.2008.01.011; Chabanon A, 2008, STEM CELLS, V26, P3150, DOI 10.1634/stemcells.2008-0219; Corazza F, 2004, PEDIATR RES, V55, P152, DOI 10.1203/01.PDR.0000099773.71438.91; Davies JH, 2002, CALCIFIED TISSUE INT, V70, P408, DOI 10.1007/s002230020039; Davies JH, 2002, BONE, V31, P319, DOI 10.1016/S8756-3282(02)00822-0; DEVRIES EGE, 1995, STEM CELLS, V13, P597, DOI 10.1002/stem.5530130604; DITTEL BN, 1995, BLOOD, V86, P2833; Dutt P, 1998, J IMMUNOL, V161, P3652; El-Badri NS, 1998, EXP HEMATOL, V26, P110; Fan C, 2011, CURR MOL MED, V11, P140, DOI 10.2174/156652411794859223; Galotto M, 1999, EXP HEMATOL, V27, P1460, DOI 10.1016/S0301-472X(99)00076-4; Gibson, 2003, ANAL PHARM, V4, P21; Gibson L F, 1997, Biol Blood Marrow Transplant, V3, P122; GIBSON LF, 1993, BLOOD, V82, P3005; Gillette Jennifer M, 2009, Commun Integr Biol, V2, P305; Guest I, 2000, IMMUNOPHARMACOLOGY, V46, P103, DOI 10.1016/S0162-3109(99)00168-X; Guo Y, 2005, STEM CELLS, V23, P1324, DOI 10.1634/stemcells.2005-0085; Jabbour E, 2006, BLOOD, V108, P1421, DOI 10.1182/blood-2006-02-001933; Jo DY, 2000, J CLIN INVEST, V105, P101, DOI 10.1172/JCI7954; Jung Y, 2006, BONE, V38, P497, DOI 10.1016/j.bone.2005.10.003; Jung YG, 2008, STEM CELLS, V26, P2042, DOI 10.1634/stemcells.2008-0149; LAGNEAUX L, 1995, LEUKEMIA LYMPHOMA, V17, P127, DOI 10.3109/10428199509051712; Legras S, 1997, BLOOD, V89, P1905, DOI 10.1182/blood.V89.6.1905; Li J, 2004, BRIT J HAEMATOL, V127, P326, DOI 10.1111/j.1365-2141.2004.05200.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Morris JC, 2008, J CLIN ONCOL S, V26, P2008; NEBEN S, 1993, EXP HEMATOL, V21, P156; Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513; Nieboer P, 2004, EUR J CANCER, V40, P1199, DOI 10.1016/j.ejca.2004.01.029; Nieboer P, 2001, BONE MARROW TRANSPL, V27, P959, DOI 10.1038/sj.bmt.1703030; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; RYAN DH, 1991, J CLIN INVEST, V88, P995, DOI 10.1172/JCI115403; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Syed HA, 2006, BIOTECHNIQUES, V41, P685, DOI 10.2144/000112290; Taichman RS, 2005, BLOOD, V105, P2631, DOI 10.1182/blood-2004-06-2480; Taichman RS, 1998, STEM CELLS, V16, P7, DOI 10.1002/stem.160007; Tauchmanova L, 2002, J CLIN ENDOCR METAB, V87, P5058, DOI 10.1210/jc.2002-020800; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Wang L, 2005, STEM CELLS, V23, P1122, DOI 10.1634/stemcells.2004-0354; Xian CJ, 2008, J CELL PHYSIOL, V214, P777, DOI 10.1002/jcp.21274; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384	50	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30758	10.1371/journal.pone.0030758	http://dx.doi.org/10.1371/journal.pone.0030758			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363485	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600066
J	Zhao, XR; Higashikawa, F; Noda, M; Kawamura, Y; Matoba, Y; Kumagai, T; Sugiyama, M				Zhao, Xingrong; Higashikawa, Fumiko; Noda, Masafumi; Kawamura, Yusuke; Matoba, Yasuyuki; Kumagai, Takanori; Sugiyama, Masanori			The Obesity and Fatty Liver Are Reduced by Plant-Derived Pediococcus pentosaceus LP28 in High Fat Diet-Induced Obese Mice	PLOS ONE			English	Article							STEAROYL-COA DESATURASE-1; LACTIC-ACID BACTERIA; PPAR-GAMMA; CD36; DIFFERENTIATION; CONTRIBUTES; METABOLISM; EXPRESSION; PROBIOTICS; RECEPTOR	We evaluated the effect of an oral administration of a plant-derived lactic acid bacterium, Pediococcus pentosaceus LP28 (LP28), on metabolic syndrome by using high fat diet-induced obese mice. The obese mice were divided into 2 groups and fed either a high fat or regular diet for 8 weeks. Each group was further divided into 3 groups, which took LP28, another plant-derived Lactobacillus plantarum SN13T (SN13T) or no lactic acid bacteria (LAB). The lean control mice were fed a regular diet without inducing obesity prior to the experiment. LP28 reduced body weight gain and liver lipid contents (triglyceride and cholesterol), in mice fed a high fat diet for 8 weeks (40%, 54%, and 70% less than those of the control group without LAB, and P = 0.018, P<0.001, and P = 0.021, respectively), whereas SN13T and the heat treated LP28 at 121 degrees C for 15 min were ineffective. Abdominal visceral fat in the high fat diet mice fed with LP28 was also lower than that without LAB by 44%, although it was not significant but borderline (P = 0.076). The sizes of the adipocytes and the lipid droplets in the livers were obviously decreased. A real-time PCR analyses showed that lipid metabolism-related genes, such as CD36 (P = 0.013), SCD1 encoding stearoyl-CoA desaturase 1 (not significant but borderline, P = 0.066), and PPAR gamma encoding peroxisome proliferator-activated receptor gamma (P = 0.039), were down-regulated by taking LP28 continuously, when compared with those of the control group. In conclusion, LP28 may be a useful LAB strain for the prevention and reduction of the metabolic syndrome.	[Zhao, Xingrong; Higashikawa, Fumiko; Noda, Masafumi; Kawamura, Yusuke; Matoba, Yasuyuki; Kumagai, Takanori; Sugiyama, Masanori] Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Biotechnol, Hiroshima, Japan	Hiroshima University	Zhao, XR (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Biotechnol, Hiroshima, Japan.	sugi@hiroshima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [22790068] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by City Area Program for Industry-Academia-Government joint research (Hiroshima area) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to MS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; Adolfsson O, 2004, AM J CLIN NUTR, V80, P245, DOI 10.1093/ajcn/80.2.245; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; de LeBlanc AD, 2007, BRIT J NUTR, V98, pS105, DOI 10.1017/S0007114507839602; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Greco D, 2008, AM J PHYSIOL-GASTR L, V294, pG1281, DOI 10.1152/ajpgi.00074.2008; Higashikawa F, 2010, NUTRITION, V26, P367, DOI 10.1016/j.nut.2009.05.008; HIRAISHI A, 1992, LETT APPL MICROBIOL, V15, P210, DOI 10.1111/j.1472-765X.1992.tb00765.x; Jin HK, 2010, BIOL PHARM BULL, V33, P289, DOI 10.1248/bpb.33.289; Koonen DPY, 2007, DIABETES, V56, P2863, DOI 10.2337/db07-0907; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lau DCW, 2007, CAN MED ASSOC J, V176, P1103, DOI 10.1503/cmaj.070306; Liong MT, 2006, J DAIRY SCI, V89, P1390, DOI 10.3168/jds.S0022-0302(06)72207-X; MacDonald MLE, 2008, J LIPID RES, V49, P217, DOI 10.1194/jlr.M700478-JLR200; Mathieu P, 2008, CAN J CARDIOL, V24, P521; Nguyen TDT, 2007, INT J FOOD MICROBIOL, V113, P358, DOI 10.1016/j.ijfoodmicro.2006.08.015; Nomura M, 2006, J APPL MICROBIOL, V101, P396, DOI 10.1111/j.1365-2672.2006.02949.x; Ntambi JM, 1999, J LIPID RES, V40, P1549; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rolfe RD, 2000, J NUTR, V130, p396S, DOI 10.1093/jn/130.2.396S; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Wada T, 2009, MICROBIOL-SGM, V155, P1726, DOI 10.1099/mic.0.022871-0; Wang YP, 2009, APPL MICROBIOL BIOT, V84, P341, DOI 10.1007/s00253-009-2012-x; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; West NP, 2009, EXERC IMMUNOL REV, V15, P107; World Health Organization, 2000, WHO TECH REP SER, V894, p[i, 1]; Zabala A, 2006, NUTRITION, V22, P528, DOI 10.1016/j.nut.2005.10.005; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037	32	61	64	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30696	10.1371/journal.pone.0030696	http://dx.doi.org/10.1371/journal.pone.0030696			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363472	Green Published, gold			2022-12-27	WOS:000302853600056
J	Heibel, SK; Lopez, GY; Panglao, M; Sodha, S; Marino-Ramirez, L; Tuchman, M; Caldovic, L				Heibel, Sandra Kirsch; Lopez, Giselle Yvette; Panglao, Maria; Sodha, Sonal; Marino-Ramirez, Leonardo; Tuchman, Mendel; Caldovic, Ljubica			Transcriptional Regulation of N-Acetylglutamate Synthase	PLOS ONE			English	Article							PHOSPHATE SYNTHETASE-I; UREA CYCLE ENZYMES; HEPATOCYTE NUCLEAR FACTOR-1; BOX-BINDING PROTEINS; GENE-EXPRESSION; RAT-LIVER; ARGININOSUCCINATE SYNTHETASE; ORNITHINE TRANSCARBAMYLASE; ASPARTATE-AMINOTRANSFERASE; BASAL TRANSCRIPTION	The urea cycle converts toxic ammonia to urea within the liver of mammals. At least 6 enzymes are required for ureagenesis, which correlates with dietary protein intake. The transcription of urea cycle genes is, at least in part, regulated by glucocorticoid and glucagon hormone signaling pathways. N-acetylglutamate synthase (NAGS) produces a unique cofactor, N-acetylglutamate (NAG), that is essential for the catalytic function of the first and rate-limiting enzyme of ureagenesis, carbamyl phosphate synthetase 1 (CPS1). However, despite the important role of NAGS in ammonia removal, little is known about the mechanisms of its regulation. We identified two regions of high conservation upstream of the translation start of the NAGS gene. Reporter assays confirmed that these regions represent promoter and enhancer and that the enhancer is tissue specific. Within the promoter, we identified multiple transcription start sites that differed between liver and small intestine. Several transcription factor binding motifs were conserved within the promoter and enhancer regions while a TATA-box motif was absent. DNA-protein pull-down assays and chromatin immunoprecipitation confirmed binding of Sp1 and CREB, but not C/EBP in the promoter and HNF-1 and NF-Y, but not SMAD3 or AP-2 in the enhancer. The functional importance of these motifs was demonstrated by decreased transcription of reporter constructs following mutagenesis of each motif. The presented data strongly suggest that Sp1, CREB, HNF-1, and NF-Y, that are known to be responsive to hormones and diet, regulate NAGS transcription. This provides molecular mechanism of regulation of ureagenesis in response to hormonal and dietary changes.	[Heibel, Sandra Kirsch; Tuchman, Mendel; Caldovic, Ljubica] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Heibel, Sandra Kirsch] Univ Maryland, Mol & Cellular Biol Program, College Pk, MD 20742 USA; [Lopez, Giselle Yvette] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Panglao, Maria] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA; [Sodha, Sonal] Johns Hopkins Sch Med Baltimore, Baltimore, MD USA; [Marino-Ramirez, Leonardo] NIH, Computat Biol Branch, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA	Children's National Health System; University System of Maryland; University of Maryland College Park; Duke University; George Washington University; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Heibel, SK (corresponding author), Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA.	ljubica@cnmcresearch.org	Lopez, Giselle/M-2575-2019; Lopez, Giselle/GSM-7271-2022; Mariño-Ramírez, Leonardo/N-5395-2019; Mariño-Ramírez, Leonardo/I-5759-2013	Mariño-Ramírez, Leonardo/0000-0002-5716-8512; Mariño-Ramírez, Leonardo/0000-0002-5716-8512; Caldovic, Ljubica/0000-0002-9140-5585; /0000-0001-5435-6668	Public Health Service from National Institutes of Health [R01DK064913]; NIH; NLM; NCBI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064913] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM082713] Funding Source: NIH RePORTER	Public Health Service from National Institutes of Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NLM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NCBI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by Public Health Service Grant R01DK064913 from the National Institutes of Health. This research was also supported in part by the Intramural Research Program of the NIH, NLM, NCBI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Musa DMA, 1999, MOL GENET METAB, V68, P346, DOI 10.1006/mgme.1999.2905; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSON GM, 1991, MOL CELL BIOL, V11, P1935, DOI 10.1128/MCB.11.4.1935; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BOYCE FM, 1989, SOMAT CELL MOLEC GEN, V15, P113, DOI 10.1007/BF01535071; BOYCE FM, 1986, MOL CELL BIOL, V6, P1244, DOI 10.1128/MCB.6.4.1244; BOYCE FM, 1989, SOMAT CELL MOLEC GEN, V15, P123, DOI 10.1007/BF01535072; Caldovic L, 2002, BIOCHEM BIOPH RES CO, V299, P581, DOI 10.1016/S0006-291X(02)02696-7; Caldovic L, 2002, BIOCHEM J, V364, P825, DOI 10.1042/BJ20020161; Callens N, 2003, BIOCHEM BIOPH RES CO, V312, P702, DOI 10.1016/j.bbrc.2003.10.176; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Christoffels VM, 1996, J BIOL CHEM, V271, P31243, DOI 10.1074/jbc.271.49.31243; CHRISTOFFELS VM, 1995, J BIOL CHEM, V270, P24932, DOI 10.1074/jbc.270.42.24932; Christoffels VM, 1998, MOL CELL BIOL, V18, P6305, DOI 10.1128/MCB.18.11.6305; Convertini P, BIOCH BIOPHYS RES CO, V404, P376; De Cesare D, 2000, PROG NUCLEIC ACID RE, V64, P343, DOI 10.1016/S0079-6603(00)64009-6; Deng WG, 2003, ANAL BIOCHEM, V323, P12, DOI 10.1016/j.ab.2003.08.007; DORN A, 1987, CELL, V50, P863, DOI 10.1016/0092-8674(87)90513-7; DUBOIS N, 1988, BIOCHIM BIOPHYS ACTA, V950, P321, DOI 10.1016/0167-4781(88)90128-5; Ekblad E, 2002, PEPTIDES, V23, P251, DOI 10.1016/S0196-9781(01)00601-5; Emami KH, 1998, NUCLEIC ACIDS RES, V26, P839, DOI 10.1093/nar/26.3.839; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Geng M, AMINO ACIDS, V40, P1513; GOPING IS, 1994, J BIOL CHEM, V269, P3891; Guei TR, 2008, BIOCHEM BIOPH RES CO, V377, P257, DOI 10.1016/j.bbrc.2008.09.118; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hazra A, 2008, GENE REGUL SYST BIO, V2, P1; Heibel SK, 2011, HUM MUTAT, V32, P1153, DOI 10.1002/humu.21553; Heibel SK, HUM MUTAT, V32, P1153; HOWELL BW, 1989, MOL CELL BIOL, V9, P2928, DOI 10.1128/MCB.9.7.2928; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; JACKSON MJ, 1988, J BIOL CHEM, V263, P16388; JUANG HH, 1995, J BIOL CHEM, V270, P12629, DOI 10.1074/jbc.270.21.12629; KADONAGA JT, 1988, SCIENCE, V242, P1566, DOI 10.1126/science.3059495; KAWAMOTO S, 1982, EUR J BIOCHEM, V123, P637; Kim HJ, BIOCH BIOPHYS ACTA, V1809, P184; KIMURA A, 1993, J BIOL CHEM, V268, P11125; Kimura T, 2001, FEBS LETT, V494, P105, DOI 10.1016/S0014-5793(01)02320-1; Klein H, 2007, GENOME INFORM SER, V18, P109; Ktistaki E, 1997, SCIENCE, V277, P109, DOI 10.1126/science.277.5322.109; KUO CJ, 1992, NATURE, V355, P457, DOI 10.1038/355457a0; LAGACE M, 1992, GENE, V118, P231, DOI 10.1016/0378-1119(92)90193-S; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Lomenick JP, 2009, J CLIN ENDOCR METAB, V94, P4463, DOI 10.1210/jc.2009-0949; LUKINIUS AIC, 1986, J HISTOCHEM CYTOCHEM, V34, P719, DOI 10.1177/34.6.3517149; Luksan O, 2010, HUM MUTAT, V31, pE1294, DOI 10.1002/humu.21215; LUNDBERG JM, 1982, P NATL ACAD SCI-BIOL, V79, P4471, DOI 10.1073/pnas.79.14.4471; Majumder P, 2008, J EXP MED, V205, P785, DOI 10.1084/jem.20071843; Marino-Ramirez L, 2004, NUCLEIC ACIDS RES, V32, P949, DOI 10.1093/nar/gkh246; MATSUBASA T, 1994, J BIOCHEM, V116, P1044, DOI 10.1093/oxfordjournals.jbchem.a124626; Matuoka K, 1999, EXP CELL RES, V253, P365, DOI 10.1006/excr.1999.4605; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Michels AJ, 2009, AM J PHYSIOL-CELL PH, V297, pC1220, DOI 10.1152/ajpcell.00348.2009; Mitchell S, 2008, MOL GENET METAB, V93, P258; Montminy M, 2004, ANN ENDOCRINOL-PARIS, V65, P73, DOI 10.1016/S0003-4266(04)95634-X; Morris SM, 2002, ANNU REV NUTR, V22, P87, DOI 10.1146/annurev.nutr.22.110801.140547; MORRIS SM, 1987, ARCH BIOCHEM BIOPHYS, V256, P343, DOI 10.1016/0003-9861(87)90455-3; Muckenfuss H, 2007, NUCLEIC ACIDS RES, V35, P3784, DOI 10.1093/nar/gkm340; MURAKAMI T, 1989, DEV GENET, V10, P393, DOI 10.1002/dvg.1020100507; MURAKAMI T, 1990, MOL CELL BIOL, V10, P1180, DOI 10.1128/MCB.10.3.1180; MyrsenAxcrona U, 1997, REGUL PEPTIDES, V68, P165, DOI 10.1016/S0167-0115(96)02113-1; NEBES VL, 1988, MOL ENDOCRINOL, V2, P444, DOI 10.1210/mend-2-5-444; Neill MA, 2009, MOL GENET METAB, V97, P121, DOI 10.1016/j.ymgme.2009.02.009; NISHIYORI A, 1994, J BIOL CHEM, V269, P1323; Pallai R, GENE, V459, P11; PAVEPREUX M, 1990, J BIOL CHEM, V265, P4444; Pollard KS, GENOME RES, V20, P110; Renda M, 2007, J BIOL CHEM, V282, P33336, DOI 10.1074/jbc.M706213200; Renga B, BIOCH BIOPHYS ACTA, V1812, P1522; RYALL JC, 1986, EUR J BIOCHEM, V156, P453, DOI 10.1111/j.1432-1033.1986.tb09603.x; SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0; SCHIBLER U, 1987, ANNU REV GENET, V21, P237, DOI 10.1146/annurev.ge.21.120187.001321; SCHIMKE RT, 1963, J BIOL CHEM, V238, P1012; SCHIMKE RT, 1962, J BIOL CHEM, V237, P1921; Schoneveld OJLM, 2005, BIOCHIMIE, V87, P1033, DOI 10.1016/j.biochi.2005.02.015; Schoneveld OJLM, 2007, BIOCHIMIE, V89, P574, DOI 10.1016/j.biochi.2006.12.013; SHIGESADA K, 1978, EUR J BIOCHEM, V84, P285, DOI 10.1111/j.1432-1033.1978.tb12167.x; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; SLADEK FM, 1993, RECEPTOR, V3, P223; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; SNODGRASS PJ, 1991, ENZYME, V45, P30, DOI 10.1159/000468862; Solomon SS, 2008, LIFE SCI, V83, P305, DOI 10.1016/j.lfs.2008.06.024; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Sunyakumthorn P, 2005, BIOCHEM BIOPH RES CO, V329, P188, DOI 10.1016/j.bbrc.2005.01.108; Takiguchi M, 1995, BIOCHEM J, V312, P649, DOI 10.1042/bj3120649; TAKIGUCHI M, 1991, J BIOL CHEM, V266, P9186; TATIBANA M, 1982, ADV EXP MED BIOL, V153, P207; Tue NT, GENE, V473, P1; UCHIYAMA C, 1981, J BIOCHEM-TOKYO, V89, P1777, DOI 10.1093/oxfordjournals.jbchem.a133377; VANHUIJSDUIJNEN RH, 1990, EMBO J, V9, P3119, DOI 10.1002/j.1460-2075.1990.tb07509.x; Wang Z., FEBS J, V277, P4066; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Xiang H, 2006, MOL CELL BIOL, V26, P8599, DOI 10.1128/MCB.01062-06; Zhang W, BIOCH BIOPHYS ACTA, V1809, P236	94	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e29527	10.1371/journal.pone.0029527	http://dx.doi.org/10.1371/journal.pone.0029527			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22383952	Green Published, gold			2022-12-27	WOS:000302918500005
J	Burger, NE; Kopf, D; Spreng, CP; Yoong, J; Sood, N				Burger, Nicholas E.; Kopf, Daniel; Spreng, Connor P.; Yoong, Joanne; Sood, Neeraj			Healthy Firms: Constraints to Growth among Private Health Sector Facilities in Ghana and Kenya	PLOS ONE			English	Article							LOW-INCOME COUNTRIES; QUALITY; CARE	Background: Health outcomes in developing countries continue to lag the developed world, and many countries are not on target to meet the Millennium Development Goals. The private health sector provides much of the care in many developing countries (e. g., approximately 50 percent in Sub-Saharan Africa), but private providers are often poorly integrated into the health system. Efforts to improve health systems performance will need to include the private sector and increase its contributions to national health goals. However, the literature on constraints private health care providers face is limited. Methodology/Principal Findings: We analyze data from a survey of private health facilities in Kenya and Ghana to evaluate growth constraints facing private providers. A significant portion of facilities (Ghana: 62 percent; Kenya: 40 percent) report limited access to finance as the most significant barrier they face; only a small minority of facilities report using formal credit institutions to finance day to day operations (Ghana: 6 percent; Kenya: 11 percent). Other important barriers include corruption, crime, limited demand for goods and services, and poor public infrastructure. Most facilities have paper-based rather than electronic systems for patient records (Ghana: 30 percent; Kenya: 22 percent), accounting (Ghana: 45 percent; Kenya: 27 percent), and inventory control (Ghana: 41 percent; Kenya: 24 percent). A majority of clinics in both countries report undertaking activities to improve provider skills and to monitor the level and quality of care they provide. However, only a minority of pharmacies report undertaking such activities. Conclusions/Significance: The results suggest that improved access to finance and improving business processes especially among pharmacies would support improved contributions by private health facilities. These strategies might be complementary if providers are more able to take advantage of increased access to finance when they have the business processes in place for operating a successful business and health facility.	[Burger, Nicholas E.; Yoong, Joanne] RAND Corp, Arlington, VA USA; [Kopf, Daniel] Univ London London Sch Econ & Polit Sci, Dept Econ, London WC2A 2AE, England; [Spreng, Connor P.] World Bank, Washington, DC 20433 USA; [Sood, Neeraj] Univ So Calif, Sch Pharm, Los Angeles, CA USA	RAND Corporation; University of London; London School Economics & Political Science; The World Bank; University of Southern California	Burger, NE (corresponding author), RAND Corp, Arlington, VA USA.	nburger@rand.org		Sood, Neeraj/0000-0001-9805-213X; Yoong, Joanne/0000-0002-0162-9885	World Bank Group; World Bank	World Bank Group; World Bank(The World Bank India)	This research was supported by funding from the World Bank Group (www.worldbank.org), and the World Bank conducted a review process of the data collection effort through its standard review system. One of the authors (Spreng) was employed by the World Bank Group while contributing to the manuscript as a researcher. Outside of the aforementioned research and review relationship, the funding organization had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All views expressed are those of the authors.	Anderson James H., 2006, ANTICORRUPTION TRANS; Berman PA, 1998, WORLD DEV, V26, P1463, DOI 10.1016/S0305-750X(98)00059-X; Brugha R, 1998, HEALTH POLICY PLANN, V13, P107, DOI 10.1093/heapol/13.2.107; Das J, 2008, J ECON PERSPECT, V22, P93, DOI 10.1257/jep.22.2.93; Gauthier B, 2007, METHODOLOGICAL APPRO; Gilson L, 2007, WHO COMM SOC DET HLT; Goel P, 1996, SOC SCI MED, V42, P1155, DOI 10.1016/0277-9536(95)00388-6; International Finance Corporation (IFC), 2008, BUS HLTH AFR PARTN P; Mills A, 2002, B WORLD HEALTH ORGAN, V80, P325; Oxfam, 2009, 125 OXF; Preker AS, 2003, PRIVATE PARTICIPATIO; Sauerborn R, 2001, INT J QUAL HEALTH C, V13, P281, DOI 10.1093/intqhc/13.4.281; Sood N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027194; Transparency International (TI), 2010, CORR PERC IND 2010; UNDP Economic Commission for Africa African Union African Development Bank Group, 2010, ASS PROGR AFR MILL D; WHO, 2008, PHARMAFORUM 0121; Witter S., 2010, MAPPING USER FEES HL; World Bank Group, 2011, HLTH PARTN GOV CAN E; Yoong J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013243	19	2	2	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e27885	10.1371/journal.pone.0027885	http://dx.doi.org/10.1371/journal.pone.0027885			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	927OG	22383944	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916800001
J	Cornish, GH; Tung, SL; Marshall, D; Ley, S; Seddon, BP				Cornish, Georgina H.; Tung, Sim L.; Marshall, Daniel; Ley, Steve; Seddon, Benedict P.			Tissue Specific Deletion of Inhibitor of Kappa B Kinase 2 with OX40-Cre Reveals the Unanticipated Expression from the OX40 Locus in Skin Epidermis	PLOS ONE			English	Article							T-CELLS; IKK COMPLEX; MOLECULAR CHARACTERIZATION; INCONTINENTIA PIGMENTI; LIVER DEGENERATION; MICE LACKING; IN-VIVO; ACTIVATION; INFLAMMATION; COMPONENT	NF-kappa B signalling plays an essential role in T cell activation and generation of regulatory and memory populations in vivo. In the present study, we aimed to investigate the role of NF-kappa B signalling in post-activation T cells using tissue specific ablation of inhibitor of kappa-B kinase 2 expression, an important component of the inhibitor of kappa-B kinase complex in canonical NF-kappa B signalling. The OX40 antigen is expressed on activated T cells. Therefore, we used previously described mouse strain expressing Cre recombinase from the endogenous OX40 locus. Ablation of IKK2 expression using OX40(Cre) mice resulted in the development of an inflammatory response in the skin epidermis causing wide spread skin lesions. The inflammatory response was characterised by extensive leukocytic infiltrate in skin tissue, hyperplasia of draining lymph nodes and widespread activation in the T cell compartment. Surprisingly, disease development did not depend on T cells but was rather associated with an unanticipated expression of Cre in skin epidermis, and activation of the T cell compartment did not require Ikbk2 deletion in T cells. Employment of Cre reporter strains revealed extensive Cre activity in skin epidermis. Therefore, development of skin lesions was rather more likely explained by deletion of Ikbk2 in skin keratinocytes in OX40(Cre) mice.	[Cornish, Georgina H.] Kings Coll London, Acad Dept Rheumatol, Ctr Mol & Cellular Biol Inflammat, London WC2R 2LS, England; [Tung, Sim L.; Marshall, Daniel; Ley, Steve; Seddon, Benedict P.] Natl Inst Med Res, MRC, London NW7 1AA, England	University of London; King's College London; MRC National Institute for Medical Research	Cornish, GH (corresponding author), Kings Coll London, Acad Dept Rheumatol, Ctr Mol & Cellular Biol Inflammat, London WC2R 2LS, England.	bseddon@nimr.mrc.ac.uk		Seddon, Benedict/0000-0003-4352-3373; Cornish, Georgina/0000-0002-1984-6677	Medical Research Council, U.K., [U117573801]; MRC [MC_U117573801] Funding Source: UKRI; Medical Research Council [MC_U117573801] Funding Source: researchfish	Medical Research Council, U.K.,(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Medical Research Council, U.K., under programme code U117573801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BAUM PR, 1994, EMBO J, V13, P3992, DOI 10.1002/j.1460-2075.1994.tb06715.x; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; FUCHS E, 1980, CELL, V19, P1033, DOI 10.1016/0092-8674(80)90094-X; FUCHS E, 1978, CELL, V15, P887, DOI 10.1016/0092-8674(78)90273-8; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Kim JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006580; Klinger M, 2009, J IMMUNOL, V182, P4581, DOI 10.4049/jimmunol.0900010; LANDY SJ, 1993, J MED GENET, V30, P53, DOI 10.1136/jmg.30.1.53; LEUBE RE, 1988, J CELL BIOL, V106, P1249, DOI 10.1083/jcb.106.4.1249; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; LLOYD C, 1995, J CELL BIOL, V129, P1329, DOI 10.1083/jcb.129.5.1329; MALLETT S, 1990, EMBO J, V9, P1063, DOI 10.1002/j.1460-2075.1990.tb08211.x; Marques Rute, 2009, Journal of Biology (London), V8, P93, DOI 10.1186/jbiol194; McGowan K, 1998, Subcell Biochem, V31, P173; Mercurio F, 1999, MOL CELL BIOL, V19, P1526; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Repass JF, 2009, GENESIS, V47, P281, DOI 10.1002/dvg.20497; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Schluns KS, 2005, INT J BIOCHEM CELL B, V37, P1567, DOI 10.1016/j.biocel.2005.02.017; Schmidt-Supprian M, 2003, IMMUNITY, V19, P377, DOI 10.1016/S1074-7613(03)00237-1; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Smahi A, 2000, NATURE, V405, P466; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sriskantharajah S, 2009, NAT IMMUNOL, V10, P38, DOI 10.1038/ni.1685; Stratis A, 2006, J INVEST DERMATOL, V126, P614, DOI 10.1038/sj.jid.5700092; Takeda I, 2004, J IMMUNOL, V172, P3580, DOI 10.4049/jimmunol.172.6.3580; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yang JQ, 2010, EMBO J, V29, P3421, DOI 10.1038/emboj.2010.214; Zandi E, 1999, MOL CELL BIOL, V19, P4547; Zheng Y, 2003, J EXP MED, V197, P861, DOI 10.1084/jem.20021610	45	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32193	10.1371/journal.pone.0032193	http://dx.doi.org/10.1371/journal.pone.0032193			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363815	gold, Green Submitted, Green Published			2022-12-27	WOS:000302873700156
J	Hovden, AO; Karlsen, M; Jonsson, R; Appel, S				Hovden, Arnt-Ove; Karlsen, Marie; Jonsson, Roland; Appel, Silke			The Bacterial Preparation OK432 Induces IL-12p70 Secretion in Human Dendritic Cells in a TLR3 Dependent Manner	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; CYTOTOXIC T-LYMPHOCYTES; STREPTOCOCCAL PREPARATION; OK-432; CANCER; IMMUNOTHERAPY; ANTICANCER; MATURATION; LIGAND; ACID	Dendritic cells (DC) used in therapeutic cancer immunotherapy have to be able to stimulate T cells resulting in an immune response that can efficiently target the cancer cells. One of the critical hurdles has been the lack of IL-12p70 production when maturating the DC, which is rectified by using the bacterial preparation OK432 (trade name Picibanil) to mature the cells. In order to identify the mechanism behind OK432 stimulation of DC, we investigated the contribution of different TLR to examine their involvement in IL-12p70 production. By combining different inhibitors of TLR signaling, we demonstrate here that TLR3 is responsible for the IL-12p70 production of DC induced by OK432. Moreover, our data suggest that the ligand triggering IL-12p70 secretion upon TLR3 stimulation is sensitive to proteinase and partly also RNAse treatment. The fact that a bacterial compound like OK432 can activate the TLR3 pathway in human DC is a novel finding. OK432 demonstrates a critical ability to induce IL-12p70 production, which is of great relevance in DC based cancer immunotherapy.	[Hovden, Arnt-Ove; Karlsen, Marie; Jonsson, Roland; Appel, Silke] Univ Bergen, Gade Inst, Broegelmann Res Lab, Bergen, Norway	University of Bergen	Hovden, AO (corresponding author), Bionor Pharma, Skien, Norway.	silke.appel@gades.uib.no		Appel, Silke/0000-0002-2199-2315	Bergen Translational Research Fund; Bergen Research Foundation; Norwegian Cancer Society; Kreftforeningens paraplystiftelse for kreftforskning; Broegelmann Legacy	Bergen Translational Research Fund; Bergen Research Foundation; Norwegian Cancer Society(Norwegian Cancer Society); Kreftforeningens paraplystiftelse for kreftforskning; Broegelmann Legacy	This work was supported by grants from Bergen Translational Research Fund (to SA), Bergen Research Foundation (to SA), Norwegian Cancer Society (to SA), Kreftforeningens paraplystiftelse for kreftforskning (to A-OH), and Broegelmann Legacy (to RJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SU, 2004, J IMMUNOTHER, V27, P432, DOI 10.1097/00002371-200411000-00003; Aksoy E, 2005, J BIOL CHEM, V280, P277, DOI 10.1074/jbc.M411223200; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Cristina GM, 2010, IMMUNOBIOLOGY, V215, P713; Derbigny WA, 2010, J IMMUNOL; EDY VG, 1976, EUR J BIOCHEM, V61, P563, DOI 10.1111/j.1432-1033.1976.tb10051.x; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Hovden AO, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-2; Itoh T, 2003, CANCER IMMUNOL IMMUN, V52, P207, DOI 10.1007/s00262-002-0337-8; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kawai T, 2007, J BIOCHEM, V141, P137, DOI 10.1093/jb/mvm032; Kim SY, 1998, CANCER-AM CANCER SOC, V83, P2054, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2054::AID-CNCR2>3.0.CO;2-1; Kontani K, 2007, ONCOL REP, V17, P895; Kuznik A, 2011, J IMMUNOL, V186, P4794, DOI 10.4049/jimmunol.1000702; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Marshall-Clarke S, 2007, J BIOL CHEM, V282, P24759, DOI 10.1074/jbc.M700188200; Naito K, 2006, INT J ONCOL, V28, P1481; Nakahara S, 2003, CANCER RES, V63, P4112; Nakamoto Y, 2011, CLIN EXP IMMUNOL, V163, P165, DOI 10.1111/j.1365-2249.2010.04246.x; Nilsen NJ, 2008, J LEUKOCYTE BIOL, V84, P280, DOI 10.1189/jlb.0907656; OKAMOTO H, 1967, JPN J MICROBIOL, V11, P323, DOI 10.1111/j.1348-0421.1967.tb00350.x; OKAMOTO M, 1993, J IMMUNOTHER, V13, P232, DOI 10.1097/00002371-199305000-00002; Okamoto M, 2004, CANCER RES, V64, P5461, DOI 10.1158/0008-5472.CAN-03-4005; Okamoto M, 2003, JNCI-J NATL CANCER I, V95, P316, DOI 10.1093/jnci/95.4.316; Okazaki T, 2007, J PEDIATR SURG, V42, P386, DOI 10.1016/j.jpedsurg.2006.10.012; Osada T, 2006, INT REV IMMUNOL, V25, P377, DOI 10.1080/08830180600992456; Palucka AK, 2007, IMMUNOL REV, V220, P129, DOI 10.1111/j.1600-065X.2007.00575.x; Pan K, 2009, IMMUNOBIOLOGY, V214, P350, DOI 10.1016/j.imbio.2008.10.008; Rescigno M, 2010, EUR J IMMUNOL, V40, P2119, DOI 10.1002/eji.201040474; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Sakamoto J, 2002, J IMMUNOTHER, V25, P405, DOI 10.1097/00002371-200209000-00004; Schuler G, 2010, EUR J IMMUNOL, V40, P2123, DOI 10.1002/eji.201040630; Scott MJ, 2008, J BIOL CHEM, V283, P29433, DOI 10.1074/jbc.M803905200; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Tada H, 2005, INFECT IMMUN, V73, P7967, DOI 10.1128/IAI.73.12.7967-7976.2005; Ueta M, 2010, BRIT J OPHTHALMOL, V94, P1528, DOI 10.1136/bjo.2010.180554; Woolley SL, 2008, J LARYNGOL OTOL, P1	40	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31217	10.1371/journal.pone.0031217	http://dx.doi.org/10.1371/journal.pone.0031217			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363584	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700034
J	Lin, WY; Lee, WC				Lin, Wan-Yu; Lee, Wen-Chung			Presenting the Uncertainties of Odds Ratios Using Empirical-Bayes Prediction Intervals	PLOS ONE			English	Article							FALSE DISCOVERY RATE; CONFIDENCE-INTERVALS; MAXIMUM-LIKELIHOOD; ASSOCIATION; SERIES	Quantifying exposure-disease associations is a central issue in epidemiology. Researchers of a study often present an odds ratio (or a logarithm of odds ratio, logOR) estimate together with its confidence interval (CI), for each exposure they examined. Here the authors advocate using the empirical-Bayes-based 'prediction intervals' (PIs) to bound the uncertainty of logORs. The PI approach is applicable to a panel of factors believed to be exchangeable (no extra information, other than the data itself, is available to distinguish some logORs from the others). The authors demonstrate its use in a genetic epidemiological study on age-related macular degeneration (AMD). The proposed PIs can enjoy straightforward probabilistic interpretations-a 95% PI has a probability of 0.95 to encompass the true value, and the expected number of true values that are being encompassed is 0.95m for a total of m 95% PIs. The PI approach is theoretically more efficient (producing shorter intervals) than the traditional CI approach. In the AMD data, the average efficiency gain is 51.2%. The PI approach is advocated to present the uncertainties of many logORs in a study, for its straightforward probabilistic interpretations and higher efficiency while maintaining the nominal coverage probability.	[Lin, Wan-Yu; Lee, Wen-Chung] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Lin, Wan-Yu] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Lee, Wen-Chung] Natl Taiwan Univ, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan	National Taiwan University; University of Alabama System; University of Alabama Birmingham; National Taiwan University	Lin, WY (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	wenchung@ntu.edu.tw	Huang, HsiaoYuan/F-5985-2012	LIN, WAN-YU/0000-0002-3385-4702; Lee, Wen-Chung/0000-0003-3171-7672	National Science Councils, Taiwan	National Science Councils, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by National Science Councils, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2003, STAT METHODS MED RES, V12, P3, DOI 10.1191/0962280203sm311ra; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen GK, 2007, AM J HUM GENET, V81, P397, DOI 10.1086/519794; Cox DR, 1974, THEORETICAL STAT; Datta S, 2005, BIOINFORMATICS, V21, P1987, DOI 10.1093/bioinformatics/bti301; Datta S, 2004, BIOINFORMATICS, V20, P235, DOI 10.1093/bioinformatics/btg396; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Efron B, 2009, J AM STAT ASSOC, V104, P1015, DOI 10.1198/jasa.2009.tm08523; Gelman A., 2004, BAYESIAN DATA ANAL; GREENLAND S, 1993, STAT MED, V12, P717, DOI 10.1002/sim.4780120802; GREENLAND S, 1994, ARCH ENVIRON HEALTH, V49, P9, DOI 10.1080/00039896.1994.9934409; He K., 1992, STAT-US, V10, P121; Heron EA, 2011, BIOSTATISTICS, V12, P445, DOI 10.1093/biostatistics/kxq072; Huang T, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-44; Hwang JTG, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1587; Hwang JTG, 2009, J ROY STAT SOC B, V71, P265, DOI 10.1111/j.1467-9868.2008.00681.x; King EN, 2002, AM STAT, V56, P163, DOI 10.1198/00031300283; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kraemer HC, 2004, STAT MED, V23, P257, DOI 10.1002/sim.1714; LAIRD NM, 1987, J AM STAT ASSOC, V82, P739, DOI 10.2307/2288778; LAIRD NM, 1989, BIOMETRICS, V45, P481, DOI 10.2307/2531491; Lin Wan-Yu, 2010, BMC Res Notes, V3, P26, DOI 10.1186/1756-0500-3-26; Lin Y, 2003, STAT APPL GENET MOL, V2; Morris C, 1983, PARAMETRIC EMPIRICAL, P25; MORRIS CN, 1983, J AM STAT ASSOC, V78, P47, DOI 10.2307/2287098; Qiu J, 2007, BIOMETRICS, V63, P767, DOI 10.1111/j.1541-0420.2007.00770.x; Rinaldo A, 2005, GENET EPIDEMIOL, V28, P193, DOI 10.1002/gepi.20056; Robbins H, 1956, P 3 BERK S MATH STAT, V1, P157; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Schaid DJ, 2004, GENETICS, V166, P505, DOI 10.1534/genetics.166.1.505; Steenland K, 2000, CANCER EPIDEM BIOMAR, V9, P895; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stromberg U, 2009, EUR J EPIDEMIOL, V24, P737, DOI 10.1007/s10654-009-9393-0; t Mannetje A, 2008, OCCUP ENVIRON MED, V65, P354, DOI 10.1136/oem.2007.035014; WEIR BS, 1979, BIOMETRICS, V35, P235, DOI 10.2307/2529947; Xie Y, 2005, BIOINFORMATICS, V21, P4280, DOI 10.1093/bioinformatics/bti685; Zaykin DV, 2004, GENET EPIDEMIOL, V27, P252, DOI 10.1002/gepi.20015; Zhao YJ, 2010, INT J ENV RES PUB HE, V7, P380, DOI 10.3390/ijerph7020380	38	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32022	10.1371/journal.pone.0032022	http://dx.doi.org/10.1371/journal.pone.0032022			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363789	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700135
J	West, L; Vidwans, SJ; Campbell, NP; Shrager, J; Simon, GR; Bueno, R; Dennis, PA; Otterson, GA; Salgia, R				West, Lisandra; Vidwans, Smruti J.; Campbell, Nicholas P.; Shrager, Jeff; Simon, George R.; Bueno, Raphael; Dennis, Phillip A.; Otterson, Gregory A.; Salgia, Ravi			A Novel Classification of Lung Cancer into Molecular Subtypes	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; PLEURAL MALIGNANT MESOTHELIOMA; 188 CONSECUTIVE PATIENTS; EML4-ALK FUSION GENE; K-RAS; ACQUIRED-RESISTANCE; BCL-2 OVEREXPRESSION; MONOCLONAL-ANTIBODY; KRAS MUTATIONS; T790M MUTATION	The remarkably heterogeneous nature of lung cancer has become more apparent over the last decade. In general, advanced lung cancer is an aggressive malignancy with a poor prognosis. The discovery of multiple molecular mechanisms underlying the development, progression, and prognosis of lung cancer, however, has created new opportunities for targeted therapy and improved outcome. In this paper, we define "molecular subtypes'' of lung cancer based on specific actionable genetic aberrations. Each subtype is associated with molecular tests that define the subtype and drugs that may potentially treat it. We hope this paper will be a useful guide to clinicians and researchers alike by assisting in therapy decision making and acting as a platform for further study. In this new era of cancer treatment, the 'one-size-fits-all' paradigm is being forcibly pushed aside-allowing for more effective, personalized oncologic care to emerge.	[Campbell, Nicholas P.; Salgia, Ravi] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [West, Lisandra; Vidwans, Smruti J.; Shrager, Jeff] CollabRx Inc, Palo Alto, CA USA; [Shrager, Jeff] Stanford Univ, Symbol Syst Program Consulting, Stanford, CA 94305 USA; [Simon, George R.] Med Univ S Carolina, Dept Med, Hematol Oncol Sect, Charleston, SC 29425 USA; [Bueno, Raphael] Brigham & Womens Hosp, Div Thorac Surg, Boston, MA 02115 USA; [Otterson, Gregory A.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Dennis, Phillip A.] NCI, Bethesda, MD 20892 USA	University of Chicago; Stanford University; Medical University of South Carolina; Harvard University; Brigham & Women's Hospital; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Salgia, R (corresponding author), Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA.	rsalgia@medicine.bsd.uchicago.edu			NATIONAL CANCER INSTITUTE [ZIASC010292, ZIABC010748] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahrendt SA, 2001, CANCER, V92, P1525, DOI 10.1002/1097-0142(20010915)92:6<1525::AID-CNCR1478>3.0.CO;2-H; Al-Saad S, 2009, ANTICANCER RES, V29, P4175; Amann JM, 2010, J THORAC ONCOL, V5, P169, DOI 10.1097/JTO.0b013e3181c8cbd9; Biroccio A, 2000, FASEB J, V14, P652, DOI 10.1096/fasebj.14.5.652; BOS JL, 1989, CANCER RES, V49, P4682; BOUTIN C, 1993, CANCER, V72, P389, DOI 10.1002/1097-0142(19930715)72:2<389::AID-CNCR2820720213>3.0.CO;2-V; BOUTIN C, 1993, CANCER, V72, P394, DOI 10.1002/1097-0142(19930715)72:2<394::AID-CNCR2820720214>3.0.CO;2-5; Bronte G, 2010, CANCER TREAT REV, V36, pS21, DOI 10.1016/S0305-7372(10)70016-5; Butrynski JE, 2010, NEW ENGL J MED, V363, P1727, DOI 10.1056/NEJMoa1007056; Camidge DR, 2009, CLIN LUNG CANCER, V10, P262, DOI 10.3816/CLC.2009.n.037; Carbone DP, 2010, LUNG CANCER, V69, P337, DOI 10.1016/j.lungcan.2009.11.019; Chung CH, 2010, CANCER EPIDEM BIOMAR, V19, P358, DOI 10.1158/1055-9965.EPI-09-0937; Cristaudo A, 2005, CANCER RES, V65, P3049, DOI 10.1158/0008-5472.CAN-04-2219; Dai ZY, 2001, NEOPLASIA, V3, P314, DOI 10.1038/sj.neo.7900162; Eccles SA, 2008, CANCER RES, V68, P2850, DOI 10.1158/0008-5472.CAN-07-5256; Edlundh-Rose E, 2006, MELANOMA RES, V16, P471, DOI 10.1097/01.cmr.0000232300.22032.86; Fernandez A, 2001, J NATL CANCER I, V93, P208, DOI 10.1093/jnci/93.3.208; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Goel VK, 2006, J INVEST DERMATOL, V126, P154, DOI 10.1038/sj.jid.5700026; Gordon MS, 2010, CLIN CANCER RES, V16, P699, DOI 10.1158/1078-0432.CCR-09-1365; Hanai J, 2012, J CELL PHYSIOL, V227, P1709, DOI 10.1002/jcp.22895; Heuckmann JM, 2011, CLIN CANCER RES, V17, P7394, DOI 10.1158/1078-0432.CCR-11-1648; Hirsch FR, 2003, LUNG CANCER, V41, pS29, DOI 10.1016/S0169-5002(03)00137-5; Iervolino A, 2002, FASEB J, V16, P1453, DOI 10.1096/fj.02-0122fje; IKEGAKI N, 1994, CANCER RES, V54, P6; Jackman DM, 2009, CLIN CANCER RES, V15, P5267, DOI 10.1158/1078-0432.CCR-09-0888; Janku F, 2010, NAT REV CLIN ONCOL, V7, P401, DOI 10.1038/nrclinonc.2010.64; Jassem J, 2010, J CLIN ONCOL, V28; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; JIANG SX, 1995, J PATHOL, V177, P135, DOI 10.1002/path.1711770206; Jin G, 2010, LUNG CANCER, V69, P279, DOI 10.1016/j.lungcan.2009.11.012; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kanteti R, 2009, J ENVIRON PATHOL TOX, V28, P89, DOI 10.1615/JEnvironPatholToxicolOncol.v28.i2.10; Karp DD, 2009, J CLIN ONCOL, V27, P2516, DOI 10.1200/JCO.2008.19.9331; Kelly K, 2009, EXPERT OPIN BIOL TH, V9, P817, DOI 10.1517/14712590903002039; Kim ES, 2009, J THORAC ONCOL, V4, P444, DOI 10.1097/JTO.0b013e31819d6f91; Kim JS, 2012, CANCER-AM CANCER SOC, V118, P2454, DOI 10.1002/cncr.26492; Kosaka T, 2006, CLIN CANCER RES, V12, P5764, DOI 10.1158/1078-0432.CCR-06-0714; Krishnaswamy S, 2009, CLIN CANCER RES, V15, P5714, DOI 10.1158/1078-0432.CCR-09-0070; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lawrence RE, 2010, CELL ADHES MIGR, V4, P146, DOI 10.4161/cam.4.1.10973; Lucchi M, 2002, EUR J CARDIO-THORAC, V21, P1105, DOI 10.1016/S1010-7940(02)00112-4; Ludovini V, 2011, J THORAC ONCOL, V6, P707, DOI 10.1097/JTO.0b013e31820a3a6b; Ma PC, 2005, CANCER RES, V65, P1479, DOI 10.1158/0008-5472.CAN-04-2650; Ma PC, 2003, CANCER RES, V63, P6272; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Manfredi JJ, 2005, CANCER RES, V65, P2602, DOI 10.1158/0008-5472.CAN-04-2461; Mascaux C, 2005, BRIT J CANCER, V92, P131, DOI 10.1038/sj.bjc.6602258; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Mollberg N, 2011, ADV THER, V28, P173, DOI 10.1007/s12325-010-0103-9; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Nakagawa M, 2012, CLIN LUNG CANCER, V13, P136, DOI 10.1016/j.cllc.2011.10.006; Okano J, 2000, J BIOL CHEM, V275, P30934, DOI 10.1074/jbc.M004112200; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Onitsuka T, 2010, LUNG CANCER, V68, P198, DOI 10.1016/j.lungcan.2009.05.022; Oxnard GR, 2011, CLIN CANCER RES, V17, P1616, DOI 10.1158/1078-0432.CCR-10-2692; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pidgeon GP, 2001, BRIT J CANCER, V85, P273, DOI 10.1054/bjoc.2001.1876; Piekarz RL, 2009, J CLIN ONCOL, V27, P5410, DOI 10.1200/JCO.2008.21.6150; Przybojewska B, 2000, CANCER GENET CYTOGEN, V121, P73, DOI 10.1016/S0165-4608(00)00223-5; Pu X, 2011, LUNG CANCER, V71, P82, DOI 10.1016/j.lungcan.2010.04.008; Quinlan MP, 2009, FUTURE ONCOL, V5, P105, DOI 10.2217/14796694.5.1.105; Ramalingam SS, 2011, J CLIN ONCOL, V29, P4574, DOI 10.1200/JCO.2011.36.6799; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Roushdy-Hammady I, 2001, LANCET, V357, P444, DOI 10.1016/S0140-6736(00)04013-7; Rudin Charles M, 2008, J Natl Compr Canc Netw, V6, P315; Rudin CM, 2004, J CLIN ONCOL, V22, P1110, DOI 10.1200/JCO.2004.10.148; Salgia R, 2011, SEMIN ONCOL, V38, P274, DOI 10.1053/j.seminoncol.2011.01.012; Sattler Martin, 2011, Ther Adv Med Oncol, V3, P171, DOI 10.1177/1758834011408636; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Silverman LR, 2002, J CLIN ONCOL, V20, P2429, DOI 10.1200/JCO.2002.04.117; SLEBOS RJC, 1990, NEW ENGL J MED, V323, P561, DOI 10.1056/NEJM199008303230902; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Spigel DR, 2011, J CLIN ONCOL S, V29; Stefanaki K, 1998, ANTICANCER RES, V18, P1689; Suda K, 2010, CLIN CANCER RES, V16, P5489, DOI 10.1158/1078-0432.CCR-10-1371; Sudhir PR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020199; Tahir SK, 2007, CANCER RES, V67, P1176, DOI 10.1158/0008-5472.CAN-06-2203; Takahashi T, 2010, ANN SURG ONCOL, V17, P889, DOI 10.1245/s10434-009-0808-7; Tan YHC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008972; Toulany M, 2005, RADIOTHER ONCOL, V76, P143, DOI 10.1016/j.radonc.2005.06.024; Van Damme N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-189; Vidwans SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018257; Wong DWS, 2009, CANCER-AM CANCER SOC, V115, P1723, DOI 10.1002/cncr.24181; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Yap TA, 2010, J CLIN ONCOL, V28, P3965, DOI 10.1200/JCO.2009.26.7278; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Zangemeister-Wittke U, 1998, BRIT J CANCER, V78, P1035, DOI 10.1038/bjc.1998.624; Zhang XC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-188; Zhu WG, 2001, CANCER RES, V61, P1327	92	82	89	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31906	10.1371/journal.pone.0031906	http://dx.doi.org/10.1371/journal.pone.0031906			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363766	gold, Green Submitted, Green Published			2022-12-27	WOS:000302873700120
J	Abraham, P; Noury-Desvaux, B; Gernigon, M; Mahe, G; Sauvaget, T; Leftheriotis, G; Le Faucheur, A				Abraham, Pierre; Noury-Desvaux, Benedicte; Gernigon, Marie; Mahe, Guillaume; Sauvaget, Thomas; Leftheriotis, Georges; Le Faucheur, Alexis			The Inter- and Intra-Unit Variability of a Low-Cost GPS Data Logger/Receiver to Study Human Outdoor Walking in View of Health and Clinical Studies	PLOS ONE			English	Article							GLOBAL POSITIONING SYSTEM; TRIAXIAL ACCELEROMETER; MOVEMENT PATTERNS; HUMAN LOCOMOTION; RELIABILITY; SPEED; PREDICTION; CAPACITY; VALIDITY; MONITOR	Purpose: The present study evaluates the intra- and inter-unit variability of the GlobalSat (R) DG100 GPS data logger/receiver (DG100) when estimating outdoor walking distances and speeds. Methods: Two experiments were performed using healthy subjects walking on a 400 m outdoor synthetic track. The two experiments consisted of two different outdoor prescribed walking protocols with distances ranging from 50 to 400 m. Experiment 1 examined the intra-unit variability of the DG100 (test-retest reproducibility) when estimating walking distances. Experiment 2 examined the inter-unit variability of four DG100 devices (unit to unit variability) when estimating walking distances and speeds. Results: The coefficient of variation [95% confidence interval], for the reliability of estimating walking distances, was 2.8 [2.5-3.2] %. The inter-unit variability among the four DG100 units tested ranged from 2.8 [2.5-3.2] % to 3.9 [3.5-4.4] % when estimating distances and from 2.7 [2.4-3.0] % to 3.8 [3.4-4.2] % when estimating speeds. Conclusion: The present study indicates that the DG100, an economical and convenient GPS data logger/receiver, can be reliably used to study human outdoor walking activities in unobstructed conditions. This device let facilitate the use of GPS in studies of health and disease.	[Abraham, Pierre; Gernigon, Marie; Mahe, Guillaume; Sauvaget, Thomas; Leftheriotis, Georges] Univ Hosp, Lab Vasc Invest & Sports Med, Angers, France; [Abraham, Pierre; Noury-Desvaux, Benedicte; Mahe, Guillaume; Leftheriotis, Georges; Le Faucheur, Alexis] Univ Angers, CNRS, UMR6214, Inserm U771,Med Sch, Angers, France; [Noury-Desvaux, Benedicte; Sauvaget, Thomas; Le Faucheur, Alexis] Inst Phys Educ & Sports Sci IFEPSA, APCoSS, UCO 49, Les Ponts De Ce, France	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers	Abraham, P (corresponding author), Univ Hosp, Lab Vasc Invest & Sports Med, Angers, France.	alexislefaucheur@hotmail.com	, Mahe/AAF-7983-2020; LE FAUCHEUR, Alexis/AAK-3232-2021; GERNIGON, Marie/ABD-4108-2021	LE FAUCHEUR, Alexis/0000-0002-3688-6574; GERNIGON, Marie/0000-0002-0303-7293	GENESIA foundation; French "Direction Regionale de la Recherche Clinique"; French National Institute of Health and Medical Research (INSERM)	GENESIA foundation; French "Direction Regionale de la Recherche Clinique"; French National Institute of Health and Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was promoted by the Centre Hospitalier Universitaire d'Angers and was granted in part by GENESIA foundation and the French "Direction Regionale de la Recherche Clinique''. Pierre Abraham benefits from an "Interface'' grant from the French National Institute of Health and Medical Research (INSERM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbero-Alvarez JC, 2010, J SCI MED SPORT, V13, P232, DOI 10.1016/j.jsams.2009.02.005; Barnett A, 2006, MED SCI SPORT EXER, V38, P761, DOI 10.1249/01.mss.0000210206.55941.b2; Barzilay Y, 2011, SPINE, V15, pE263; Bland M., 2000, INTRO MED STAT, P405; Bonomi AG, 2009, MED SCI SPORT EXER, V41, P1770, DOI 10.1249/MSS.0b013e3181a24536; Cho GH, 2011, MED SCI SPORT EXER, V43, P365, DOI 10.1249/MSS.0b013e3181ebec3c; Coutts AJ, 2010, J SCI MED SPORT, V13, P133, DOI 10.1016/j.jsams.2008.09.015; Creange A, 2007, MULT SCLER, V13, P220, DOI 10.1177/1352458506070667; Duffield R, 2010, J SCI MED SPORT, V13, P523, DOI 10.1016/j.jsams.2009.07.003; Duncan MJ, 2007, MED SCI SPORT EXER, V39, P1851, DOI 10.1249/mss.0b013e31811ff31e; Gray AJ, 2010, J SPORTS SCI, P1; Herrmann SD, 2011, ARCH PHYS MED REHAB, V92, P1652, DOI 10.1016/j.apmr.2011.05.001; Hopkins W., 2000, RELIABILITY CONSECUT; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hopkins WG., NEW VIEW STAT; Janssen I, 2010, SPORT BIOMECH, V9, P47, DOI 10.1080/14763141003690229; Jennings Denise, 2010, Int J Sports Physiol Perform, V5, P328; Le Faucheur A, 2008, CIRCULATION, V117, P897, DOI 10.1161/CIRCULATIONAHA.107.725994; Le Faucheur A, 2007, MED SCI SPORT EXER, V39, P1570, DOI 10.1249/mss.0b013e3180cc20c7; Le Faucheur A, 2011, SPINE, V36, P2101, DOI 10.1097/BRS.0b013e3182341ce0; Le Faucheur A, 2010, J VASC SURG, V51, P886, DOI 10.1016/j.jvs.2009.10.120; Maddison R, 2010, PEDIATR EXERC SCI, V22, P392, DOI 10.1123/pes.22.3.392; Maddison R, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-73; Mathie MJ, 2004, MED BIOL ENG COMPUT, V42, P679, DOI 10.1007/BF02347551; Mathie MJ, 2003, MED BIOL ENG COMPUT, V41, P296, DOI 10.1007/BF02348434; Noury-Desvaux B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023027; Perrin O, 2000, MED BIOL ENG COMPUT, V38, P164, DOI 10.1007/BF02344771; Petersen C, 2009, INTJ SPORT PHYSIOL, V4, P381, DOI 10.1123/ijspp.4.3.381; Rodriguez DA, 2005, MED SCI SPORT EXER, V37, pS572, DOI 10.1249/01.mss.0000185297.72328.ce; Rodriguez DA, 2011, J PHYS ACT HLTH; Schutz Y, 2002, INT J OBESITY, V26, P111, DOI 10.1038/sj.ijo.0801856; Shoval Noam, 2008, BMC Geriatr, V8, P7, DOI 10.1186/1471-2318-8-7; Terrier P, 2000, J BIOMECH, V33, P1717, DOI 10.1016/S0021-9290(00)00133-0; Terrier Philippe, 2005, J Neuroeng Rehabil, V2, P28, DOI 10.1186/1743-0003-2-28; Townshend AD, 2008, MED SCI SPORT EXER, V40, P124, DOI 10.1249/mss.0b013e3181590bc2; Troped PJ, 2008, MED SCI SPORT EXER, V40, P972, DOI 10.1249/MSS.0b013e318164c407	36	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31338	10.1371/journal.pone.0031338	http://dx.doi.org/10.1371/journal.pone.0031338			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363623	gold, Green Published			2022-12-27	WOS:000302871500035
J	Cheng, CY; Shaw, N; Zhang, XJ; Zhang, M; Ding, W; Wang, BC; Liu, ZJ				Cheng, Chongyun; Shaw, Neil; Zhang, Xuejun; Zhang, Min; Ding, Wei; Wang, Bi-Cheng; Liu, Zhi-Jie			Structural View of a Non Pfam Singleton and Crystal Packing Analysis	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; RECOGNITION; INFERENCE; CLEAVAGE; SEQUENCE; LIGANDS; ORIGIN; GENES; RNA	Background: Comparative genomic analysis has revealed that in each genome a large number of open reading frames have no homologues in other species. Such singleton genes have attracted the attention of biochemists and structural biologists as a potential untapped source of new folds. Cthe_2751 is a 15.8 kDa singleton from an anaerobic, hyperthermophile Clostridium thermocellum. To gain insights into the architecture of the protein and obtain clues about its function, we decided to solve the structure of Cthe_2751. Results: The protein crystallized in 4 different space groups that diffracted X-rays to 2.37 angstrom (P3(1)21), 2.17 angstrom (P2(1)2(1)2(1)), 3.01 angstrom (P4(1)22), and 2.03 angstrom (C222(1)) resolution, respectively. Crystal packing analysis revealed that the 3-D packing of Cthe_2751 dimers in P4(1)22 and C222(1) is similar with only a rotational difference of 2.69 degrees around the C axes. A new method developed to quantify the differences in packing of dimers in crystals from different space groups corroborated the findings of crystal packing analysis. Cthe_2751 is an all alpha-helical protein with a central hydrophobic core providing thermal stability via pi:cation and pi:pi interactions. A ProFunc analysis retrieved a very low match with a splicing endonuclease, suggesting a role for the protein in the processing of nucleic acids. Conclusions: Non-Pfam singleton Cthe_2751 folds into a known all alpha-helical fold. The structure has increased sequence coverage of non-Pfam proteins such that more protein sequences can be amenable to modelling. Our work on crystal packing analysis provides a new method to analyze dimers of the protein crystallized in different space groups. The utility of such an analysis can be expanded to oligomeric structures of other proteins, especially receptors and signaling molecules, many of which are known to function as oligomers.	[Cheng, Chongyun; Shaw, Neil; Ding, Wei; Liu, Zhi-Jie] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Shaw, Neil; Liu, Zhi-Jie] Kunming Med Univ, Coll Stem Cell & Mol Clin Med, Kunming, Peoples R China; [Zhang, Xuejun] Tianjin Med Univ, Dept Immunol, Tianjin, Peoples R China; [Zhang, Min] Anhui Univ, Sch Life Sci, Hefei 230039, Anhui, Peoples R China; [Wang, Bi-Cheng] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; Kunming Medical University; Tianjin Medical University; Anhui University; University System of Georgia; University of Georgia	Cheng, CY (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	zjliu@ibp.ac.cn	Liu, Zhi-Jie/A-3946-2012	Liu, Zhi-Jie/0000-0001-7279-2893; Shaw, Neil/0000-0003-2722-9967	National Natural Science Foundation of China [30870483, 31070660, 31021062, 31000334]; Ministry of Science and Technology of China [2009DFB30310, 2009CB918803, 2011CB911103]; CAS [YZ200839, KSCX2-EW-J-3]; University of Georgia Research Foundation; Georgia Research Alliance	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); CAS(Chinese Academy of Sciences); University of Georgia Research Foundation; Georgia Research Alliance	This work was supported by the National Natural Science Foundation of China (grants: 30870483, 31070660, 31021062 and 31000334), Ministry of Science and Technology of China (grants: 2009DFB30310, 2009CB918803 and 2011CB911103), CAS Research Grant (YZ200839 and KSCX2-EW-J-3), the University of Georgia Research Foundation and the Georgia Research Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barton B, 2005, J EXP BIOL, V208, P549, DOI 10.1242/jeb.01425; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Brooksbank C, 2005, NUCLEIC ACIDS RES, V33, pD46, DOI 10.1093/nar/gki026; Chen CC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-366; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Domazet-Loso T, 2003, GENOME RES, V13, P2213, DOI 10.1101/gr.1311003; Ekman D, 2010, J MOL BIOL, V396, P396, DOI 10.1016/j.jmb.2009.11.053; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hollingworth D, 2006, RNA, V12, P555, DOI 10.1261/rna.2304506; Karplus K, 2009, NUCLEIC ACIDS RES, V37, pW492, DOI 10.1093/nar/gkp403; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kosa PF, 1997, P NATL ACAD SCI USA, V94, P6042, DOI 10.1073/pnas.94.12.6042; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar A, 2010, ACTA CRYSTALLOGR F, V66, P1309, DOI 10.1107/S1744309110008092; Marques AC, 2005, PLOS BIOL, V3, P1970, DOI 10.1371/journal.pbio.0030357; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Okamura K, 2006, GENOMICS, V88, P690, DOI 10.1016/j.ygeno.2006.06.009; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Shenoy SR, 2010, CURR PROTEIN PEPT SC, V11, P498; Shin Dong Hae, 2007, Journal of Structural and Functional Genomics, V8, P99, DOI 10.1007/s10969-007-9025-4; Shmuely H, 2004, BIOINFORMATICS, V20, P1248, DOI 10.1093/bioinformatics/bth075; So WV, 2000, MOL CELL BIOL, V20, P6935, DOI 10.1128/MCB.20.18.6935-6944.2000; Speers AE, 2010, ACTA CRYSTALLOGR F, V66, P1306, DOI 10.1107/S1744309110035748; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Su J, 2010, PROTEIN CELL, V1, P453, DOI 10.1007/s13238-010-0045-7; Toll-Riera M, 2009, MOL BIOL EVOL, V26, P603, DOI 10.1093/molbev/msn281; Wallner B, 2003, PROTEINS, V53, P534, DOI 10.1002/prot.10536; Watkins HA, 2006, J BACTERIOL, V188, P3589, DOI 10.1128/JB.188.10.3589-3599.2006; Wu ST, 2008, PROTEINS, V72, P547, DOI 10.1002/prot.21945; Xue S, 2006, SCIENCE, V312, P906, DOI 10.1126/science.1126629; Yin YB, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-63; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhou Q, 2008, GENOME RES, V18, P1446, DOI 10.1101/gr.076588.108	42	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31673	10.1371/journal.pone.0031673	http://dx.doi.org/10.1371/journal.pone.0031673			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363703	Green Submitted, gold, Green Published			2022-12-27	WOS:000302871500074
J	Greenfeld, M; Pavlichin, DS; Mabuchi, H; Herschlag, D				Greenfeld, Max; Pavlichin, Dmitri S.; Mabuchi, Hideo; Herschlag, Daniel			Single Molecule Analysis Research Tool (SMART): An Integrated Approach for Analyzing Single Molecule Data	PLOS ONE			English	Article							FLUORESCENCE SPECTROSCOPY; MARKOV-MODELS; HETEROGENEITY; TRAJECTORIES; DYNAMICS; KINETICS; DIFFUSION; ORDER; DNA	Single molecule studies have expanded rapidly over the past decade and have the ability to provide an unprecedented level of understanding of biological systems. A common challenge upon introduction of novel, data-rich approaches is the management, processing, and analysis of the complex data sets that are generated. We provide a standardized approach for analyzing these data in the freely available software package SMART: Single Molecule Analysis Research Tool. SMART provides a format for organizing and easily accessing single molecule data, a general hidden Markov modeling algorithm for fitting an array of possible models specified by the user, a standardized data structure and graphical user interfaces to streamline the analysis and visualization of data. This approach guides experimental design, facilitating acquisition of the maximal information from single molecule experiments. SMART also provides a standardized format to allow dissemination of single molecule data and transparency in the analysis of reported data.	[Greenfeld, Max; Herschlag, Daniel] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Greenfeld, Max; Herschlag, Daniel] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Pavlichin, Dmitri S.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Mabuchi, Hideo] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Greenfeld, M (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	hmabuchi@stanford.edu; herschla@stanford.edu		Mabuchi, Hideo/0000-0002-5156-7678	National Institute of Health [GM49243]; Stanford Graduate Fellowship; National Institute of Health training grant in Biotechnology [5T32GM008412]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049243, R37GM049243, T32GM008412] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Graduate Fellowship(Stanford University); National Institute of Health training grant in Biotechnology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Health (grant GM49243) to DH. MG was supported in part by a National Institute of Health training grant in Biotechnology (5T32GM008412). DP was supported in part by a Stanford Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose WP, 1999, CHEM REV, V99, P2929, DOI 10.1021/cr980132z; AMBROSE WP, 1991, NATURE, V349, P225, DOI 10.1038/349225a0; Andrec M, 2003, J PHYS CHEM A, V107, P7454, DOI 10.1021/jp035514+; Baldini G, 2005, SCIENCE, V309, P1096, DOI 10.1126/science.1115001; BAUM LE, 1970, ANN MATH STAT, V41, P164, DOI 10.1214/aoms/1177697196; Beausang JF, 2007, BIOPHYS J, V92, pL64, DOI 10.1529/biophysj.107.104828; BEDRICK EJ, 1989, TECHNOMETRICS, V31, P437, DOI 10.2307/1269994; Borgia A, 2008, ANNU REV BIOCHEM, V77, P101, DOI 10.1146/annurev.biochem.77.060706.093102; Boukobza E, 2001, J PHYS CHEM B, V105, P12165, DOI 10.1021/jp012016x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bruno WJ, 2006, J COMPUT BIOL, V13, P1574, DOI 10.1089/cmb.2006.13.1574; Cappe O., 2005, SPR S STAT; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; Chung HS, 2009, P NATL ACAD SCI USA, V106, P11837, DOI 10.1073/pnas.0901178106; Churbanov A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S14; Csiszar I, 2000, ANN STAT, V28, P1601; Ditzler MA, 2008, NUCLEIC ACIDS RES, V36, P7088, DOI 10.1093/nar/gkn871; Dolinski K, 1998, YEAST, V14, P1453, DOI 10.1002/(SICI)1097-0061(199812)14:16<1453::AID-YEA348>3.0.CO;2-G; Elenko MP, 2009, J AM CHEM SOC, V131, P9866, DOI 10.1021/ja901880v; English BP, 2006, NAT CHEM BIOL, V2, P168, DOI 10.1038/nchembio0306-168; Giudici P, 2000, BIOMETRICS, V56, P742, DOI 10.1111/j.0006-341X.2000.00742.x; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Greenfeld M, 2011, J BIOL CHEM, V286, P19872, DOI 10.1074/jbc.M111.235465; Greenleaf WJ, 2008, SCIENCE, V319, P630, DOI 10.1126/science.1151298; Gruebele M, 1999, ANNU REV PHYS CHEM, V50, P485, DOI 10.1146/annurev.physchem.50.1.485; Ha T, 1999, P NATL ACAD SCI USA, V96, P9077, DOI 10.1073/pnas.96.16.9077; Hanson JA, 2007, P NATL ACAD SCI USA, V104, P18055, DOI 10.1073/pnas.0708600104; Hastie T., 2009, UNSUPERVISED LEARNIN; HIRSCHFELD T, 1976, APPL OPTICS, V15, P3135, DOI 10.1364/AO.15.003135; Joo C, 2008, ANNU REV BIOCHEM, V77, P51, DOI 10.1146/annurev.biochem.77.070606.101543; Jung S, 2009, J PHYS CHEM B, V113, P13886, DOI 10.1021/jp907019p; KIENKER P, 1989, PROC R SOC SER B-BIO, V236, P269, DOI 10.1098/rspb.1989.0024; Kim SY, 2010, J MOL BIOL, V401, P553, DOI 10.1016/j.jmb.2010.06.050; Lee TH, 2009, J PHYS CHEM B, V113, P11535, DOI 10.1021/jp903831z; LIPORACE LA, 1982, IEEE T INFORM THEORY, V28, P729, DOI 10.1109/TIT.1982.1056544; Lu HP, 2005, ACCOUNTS CHEM RES, V38, P557, DOI 10.1021/ar0401451; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Moerner WE, 2007, P NATL ACAD SCI USA, V104, P12596, DOI 10.1073/pnas.0610081104; NEHER E, 1978, PFLUG ARCH EUR J PHY, V375, P219, DOI 10.1007/BF00584247; Neher E, 2009, SINGLE CHANNEL RECOR; Nymeyer H, 1998, P NATL ACAD SCI USA, V95, P5921, DOI 10.1073/pnas.95.11.5921; ONUCHIC JN, 1995, P NATL ACAD SCI USA, V92, P3626, DOI 10.1073/pnas.92.8.3626; Park J, 2010, CELL, V142, P544, DOI 10.1016/j.cell.2010.07.016; Qin F, 2000, BIOPHYS J, V79, P1915, DOI 10.1016/S0006-3495(00)76441-1; Rhoades E, 2003, P NATL ACAD SCI USA, V100, P3197, DOI 10.1073/pnas.2628068100; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Ryden T, 1998, J APPL ECONOM, V13, P217, DOI 10.1002/(SICI)1099-1255(199805/06)13:3<217::AID-JAE476>3.0.CO;2-V; RYDEN T, 1995, STATISTICS, V26, P345, DOI 10.1080/02331889508802501; SAVEN JG, 1994, J CHEM PHYS, V101, P11037, DOI 10.1063/1.467855; Schroder GF, 2003, J CHEM PHYS, V119, P9920, DOI 10.1063/1.1616511; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Scott SL, 2002, J AM STAT ASSOC, V97, P337, DOI 10.1198/016214502753479464; Selvin PR, SINGLE MOL TECHNIQUE; Sherlock G, 2001, NUCLEIC ACIDS RES, V29, P152, DOI 10.1093/nar/29.1.152; Solomatin SV, 2010, NATURE, V463, P681, DOI 10.1038/nature08717; Stone MD, 2007, NATURE, V446, P458, DOI 10.1038/nature05600; SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335; Veldhuis G, 2009, CHEMBIOCHEM, V10, P436, DOI 10.1002/cbic.200800644; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; Wirth MJ, 2007, ANNU REV PHYS CHEM, V58, P489, DOI 10.1146/annurev.physchem.58.032806.104427; Xie Z, 2004, P NATL ACAD SCI USA, V101, P534, DOI 10.1073/pnas.2636333100; Yang H, 2002, CHEM PHYS, V284, P423, DOI 10.1016/S0301-0104(02)00672-9; Zhuang XW, 2002, SCIENCE, V296, P1473, DOI 10.1126/science.1069013; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048	65	59	60	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30024	10.1371/journal.pone.0030024	http://dx.doi.org/10.1371/journal.pone.0030024			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363412	Green Published, Green Submitted, gold			2022-12-27	WOS:000302871500004
J	Hu, ZG; Liu, HY; Weng, XC; Northoff, G				Hu, Zhiguo; Liu, Hongyan; Weng, Xuchu; Northoff, Georg			Is There a Valence-Specific Pattern in Emotional Conflict in Major Depressive Disorder? An Exploratory Psychological Study	PLOS ONE			English	Article							SELECTIVE ATTENTION; FACIAL EXPRESSIONS; CONSTRUCT ACCESSIBILITY; CLINICAL DEPRESSION; ANXIETY; STIMULI; BIAS; ACTIVATION; MODEL	Objective: Patients with major depressive disorder (MDD) clinically exhibit a deficit in positive emotional processing and are often distracted by especially negative emotional stimuli. Such emotional-cognitive interference in turn hampers the cognitive abilities of patients in their ongoing task. While the psychological correlates of such emotional conflict have been well identified in healthy subjects, possible alterations of emotional conflict in depressed patients remain to be investigated. We conducted an exploratory psychological study to investigate emotional conflict in MDD. We also distinguished depression-related stimuli from negative stimuli in order to check whether the depression-related distractors will induce enhanced conflict in MDD. Methods: A typical word-face Stroop paradigm was adopted. In order to account for valence-specificities in MDD, we included positive and general negative as well as depression-related words in the study. Results: MDD patients demonstrated a specific pattern of emotional conflict clearly distinguishable from the healthy control group. In MDD, the positive distractor words did not significantly interrupt the processing of the negative target faces, while they did in healthy subjects. On the other hand, the depression-related distractor words induced significant emotional conflict to the positive target faces in MDD patients but not in the healthy control group. Conclusion: Our findings demonstrated for the first time an altered valence-specific pattern in emotional conflict in MDD patients. The study sheds a novel and specific light on the affective mechanisms underlying the abnormal emotional-cognitive interference in MDD. Such emotional conflict bears important clinical relevance since it may trigger the widespread cognitive dysfunctions frequently observed in MDD. The present findings may have important clinical implications in both prediction and psychotherapy of MDD.	[Hu, Zhiguo; Weng, Xuchu; Northoff, Georg] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Liu, Hongyan] Zhejiang Sci Tech Univ, Dept Psychol, Hangzhou, Zhejiang, Peoples R China; [Northoff, Georg] Univ Ottawa, Mental Hlth Res Inst, Ottawa, ON, Canada	Hangzhou Normal University; Zhejiang Sci-Tech University; University of Ottawa	Liu, HY (corresponding author), Zhejiang Sci Tech Univ, Dept Psychol, Hangzhou, Zhejiang, Peoples R China.	liuhy709@126.com			National Natural Science Foundation of China (NSFC) [30700234]; Startup Scientific Research Foundation of the Zhejiang Sci-Tech University [1113832-Y]; National Basic Research Program of China (973 Program) [2007CB512306]; Scientific Research Foundation for Distinguished Scholars of the Hangzhou Normal University [PD10002002016001]; Canadian Institutes of Health Research (CIHR); EJLB Foundation-CIHR Michael Smith Chair in Neurosciences and Mental Health; Hope of Depression Research Foundation (HDRF)	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Startup Scientific Research Foundation of the Zhejiang Sci-Tech University; National Basic Research Program of China (973 Program)(National Basic Research Program of China); Scientific Research Foundation for Distinguished Scholars of the Hangzhou Normal University; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); EJLB Foundation-CIHR Michael Smith Chair in Neurosciences and Mental Health(Canadian Institutes of Health Research (CIHR)); Hope of Depression Research Foundation (HDRF)	Support for this work was provided by the National Natural Science Foundation of China (NSFC, 30700234 to ZH), the Startup Scientific Research Foundation of the Zhejiang Sci-Tech University (1113832-Y to HL), the National Basic Research Program of China (973 Program, 2007CB512306 to XW), the Scientific Research Foundation for Distinguished Scholars of the Hangzhou Normal University (PD10002002016001 to XW), the Canadian Institutes of Health Research (CIHR, to GN), EJLB Foundation-CIHR Michael Smith Chair in Neurosciences and Mental Health (to GN), and the Hope of Depression Research Foundation (HDRF, to GN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaro A, 2010, NEUROSCI BIOBEHAV R, V34, P592, DOI 10.1016/j.neubiorev.2009.11.023; Beck A, 1979, COGNITIVE THERAPY DE; BERENBAUM H, 1992, J ABNORM PSYCHOL, V101, P37, DOI 10.1037/0021-843X.101.1.37; Canli T, 2004, NEUROREPORT, V15, P2585, DOI 10.1097/00001756-200412030-00005; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Dalgleish T, 2003, J CLIN CHILD ADOLESC, V32, P10, DOI 10.1207/S15374424JCCP3201_02; Egner T, 2008, CEREB CORTEX, V18, P1475, DOI 10.1093/cercor/bhm179; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Epstein J, 2006, AM J PSYCHIAT, V163, P1784, DOI 10.1176/appi.ajp.163.10.1784; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Gotlib IH, 1988, COGNITION EMOTION, V2, P185, DOI 10.1080/02699938808410923; GOTLIB IH, 1987, J ABNORM PSYCHOL, V96, P199, DOI 10.1037//0021-843X.96.3.199; Gotlib IH, 2004, J ABNORM PSYCHOL, V113, P127, DOI 10.1037/0021-843X.113.1.121; GOTLIB IH, 1984, J PERS SOC PSYCHOL, V47, P427, DOI 10.1037/0022-3514.47.2.427; Grimm S, 2011, WORLD J BIOL PSYCHIA, V12, P627, DOI 10.3109/15622975.2010.545145; Grimm S, 2009, HUM BRAIN MAPP, V30, P2617, DOI 10.1002/hbm.20693; Haas BW, 2007, BEHAV NEUROSCI, V121, P249, DOI 10.1037/0735-7044.121.2.249; Haas BW, 2006, COGN AFFECT BEHAV NE, V6, P152, DOI 10.3758/CABN.6.2.152; HILL AB, 1989, PERS INDIV DIFFER, V10, P915, DOI 10.1016/0191-8869(89)90026-3; Joiner TE, 2003, PSYCHIAT RES, V119, P243, DOI 10.1016/S0165-1781(03)00131-8; Joormann J, 2007, J ABNORM PSYCHOL, V116, P80, DOI 10.1037/0021-843X.116.1.80; Loas G, 1996, J AFFECT DISORDERS, V41, P39, DOI 10.1016/0165-0327(96)00065-1; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; MATHEWS A, 1985, BEHAV RES THER, V23, P563, DOI 10.1016/0005-7967(85)90104-4; MATHEWS A, 1990, BEHAV RES THER, V28, P455, DOI 10.1016/0005-7967(90)90132-3; Mathews A, 1996, BEHAV RES THER, V34, P695, DOI 10.1016/0005-7967(96)00046-0; MCCABE SB, 1995, J ABNORM PSYCHOL, V104, P241, DOI 10.1037/0021-843X.104.1.241; MOGG K, 1991, COGNITION EMOTION, V5, P221, DOI 10.1080/02699939108411036; Northoff G, 2011, NEUROSCI BIOBEHAV R, V35, P1929, DOI 10.1016/j.neubiorev.2010.12.007; Northoff Georg, 2011, NEUROPSYCHOANALYSIS; Ochsner KN, 2009, J COGNITIVE NEUROSCI, V21, P1841, DOI 10.1162/jocn.2009.21129; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Perez MG, 1992, SPAN J PSYCHOL, V2, P11; Schotte CKW, 1997, J AFFECT DISORDERS, V46, P115, DOI 10.1016/S0165-0327(97)00094-3; Sloan DM, 2001, J ABNORM PSYCHOL, V110, P488, DOI 10.1037//0021-843X.110.3.488; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Surguladze S, 2005, BIOL PSYCHIAT, V57, P201, DOI 10.1016/j.biopsych.2004.10.028; Suslow T, 2001, PERCEPT MOTOR SKILL, V92, P857, DOI 10.2466/PMS.92.3.857-868; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Wang LH, 2008, PSYCHIAT RES-NEUROIM, V163, P143, DOI 10.1016/j.pscychresns.2007.10.004; Williams J.M.G., 1997, COGNITIVE PSYCHOL EM, V2nd ed.	41	10	12	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31983	10.1371/journal.pone.0031983	http://dx.doi.org/10.1371/journal.pone.0031983			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926YY	22363782	gold, Green Submitted, Green Published			2022-12-27	WOS:000302871500102
J	Joshi, N; Duhan, V; Lingwal, N; Bhaskar, S; Upadhyay, P				Joshi, Neha; Duhan, Vikas; Lingwal, Neelam; Bhaskar, Sangeeta; Upadhyay, Pramod			Adjuvant Properties of Thermal Component of Hyperthermia Enhanced Transdermal Immunization: Effect on Dendritic Cells	PLOS ONE			English	Article							WHOLE-BODY HYPERTHERMIA; EPIDERMAL LANGERHANS CELLS; CELLULAR IMMUNE-RESPONSE; HEAT-SHOCK; TRANSCUTANEOUS IMMUNIZATION; MICRONEEDLE ARRAYS; JET INJECTIONS; LYMPH-NODE; ACTIVATION; MURINE	Hyperthermia enhanced transdermal (HET) immunization is a novel needle free immunization strategy employing application of antigen along with mild local hyperthermia (42 degrees C) to intact skin resulting in detectable antigen specific Ig in serum. In the present study, we investigated the adjuvant effect of thermal component of HET immunization in terms of maturation of dendritic cells and its implication on the quality of the immune outcome in terms of antibody production upon HET immunization with tetanus toxoid (TT). We have shown that in vitro hyperthermia exposure at 42 degrees C for 30 minutes up regulates the surface expression of maturation markers on bone marrow derived DCs. This observation correlated in vivo with an increased and accelerated expression of maturation markers on DCs in the draining lymph node upon HET immunization in mice. This effect was found to be independent of the antigen delivered and depends only on the thermal component of HET immunization. In vitro hyperthermia also led to enhanced capacity to stimulate CD4+ T cells in allo MLR and promotes the secretion of IL-10 by BMDCs, suggesting a potential for Th2 skewing of T cell response. HET immunization also induced a systemic T cell response to TT, as suggested by proliferation of splenocytes from immunized animal upon in vitro stimulation by TT. Exposure to heat during primary immunization led to generation of mainly IgG class of antibodies upon boosting, similar to the use of conventional alum adjuvant, thus highlighting the adjuvant potential of heat during HET immunization. Lastly, we have shown that mice immunized by tetanus toxoid using HET route exhibited protection against challenge with a lethal dose of tetanus toxin. Thus, in addition to being a painless, needle free delivery system it also has an immune modulatory potential.	[Joshi, Neha; Duhan, Vikas; Lingwal, Neelam; Bhaskar, Sangeeta; Upadhyay, Pramod] Natl Inst Immunol, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Joshi, N (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	pkumar@nii.ac.in	Duhan, Vikas/J-7163-2019	Duhan, Vikas/0000-0002-6337-8225; Joshi, Neha/0000-0002-1643-7341; Bhaskar, Sangeeta/0000-0001-7902-5267	Department of Biotechnology, Govt. of India	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	This work was supported by the core grant from the Department of Biotechnology, Govt. of India to the National Institute of Immunology, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Basu S, 2003, INT IMMUNOL, V15, P1053, DOI 10.1093/intimm/dxg104; Baxter J, 2006, EXPERT REV MED DEVIC, V3, P565, DOI 10.1586/17434440.3.5.565; Belyakov IM, 2004, J CLIN INVEST, V113, P998, DOI 10.1172/JCI200420261; Borkowski TA, 1996, EUR J IMMUNOL, V26, P110, DOI 10.1002/eji.1830260117; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Campos-Neto A, 2001, INFECT IMMUN, V69, P4103, DOI 10.1128/IAI.69.6.4103-4108.2001; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; DeFillipo AM, 2004, MOL IMMUNOL, V41, P785, DOI 10.1016/j.molimm.2004.04.016; Ding Z, 2009, J CONTROL RELEASE, V136, P71, DOI 10.1016/j.jconrel.2009.01.025; Evans SS, 2001, BLOOD, V97, P2727, DOI 10.1182/blood.V97.9.2727; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Jiang HR, 2002, J LEUKOCYTE BIOL, V72, P978; Karande P, 2005, P NATL ACAD SCI USA, V102, P4688, DOI 10.1073/pnas.0501176102; Karande P, 2009, J CONTROL RELEASE; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Laouini D, 2003, J CLIN INVEST, V112, P1058, DOI 10.1172/JCI200318246; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Martin MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010897; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; MITRAGOTRI S, 1995, SCIENCE, V269, P850, DOI 10.1126/science.7638603; Mitragotri S, 2005, NAT REV IMMUNOL, V5, P905, DOI 10.1038/nri1728; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; Mukhopadhaya A, 2007, CANCER RES, V67, P7798, DOI 10.1158/0008-5472.CAN-07-0203; Nagao K, 2009, P NATL ACAD SCI USA, V106, P3312, DOI 10.1073/pnas.0807126106; Ogura M, 2008, ADV DRUG DELIVER REV, V60, P1218, DOI 10.1016/j.addr.2008.03.006; Ostberg JR, 2001, J IMMUNOL, V167, P2666, DOI 10.4049/jimmunol.167.5.2666; Ostberg JR, 2000, CELL STRESS CHAPERON, V5, P458, DOI 10.1379/1466-1268(2000)005<0458:ROIABM>2.0.CO;2; Ostberg JR, 2003, INT J HYPERTHER, V19, P520, DOI 10.1080/02656730310001607986; Ostberg JR, 2000, J LEUKOCYTE BIOL, V68, P815; Pulendran B, 2004, IMMUNOL RES, V29, P187, DOI 10.1385/IR:29:1-3:187; Sallusto F, 2001, CURR OPIN ALLERGY CL, V1, P441, DOI 10.1097/00130832-200110000-00010; Schramm-Baxter J, 2004, J CONTROL RELEASE, V97, P527, DOI 10.1016/j.jconrel.2004.04.006; Schueller G, 2003, INT J ONCOL, V22, P1397; Singh IS, 2000, J BIOL CHEM, V275, P9841, DOI 10.1074/jbc.275.13.9841; STEVENS TL, 1988, NATURE, V334, P255, DOI 10.1038/334255a0; Tournier JN, 2003, J LEUKOCYTE BIOL, V73, P493, DOI 10.1189/jlb.1002506; Upadhyay P, 2006, VACCINE, V24, P5593, DOI 10.1016/j.vaccine.2006.04.039; Vandermeulen G, 2007, J CONTROL RELEASE, V124, P81, DOI 10.1016/j.jconrel.2007.08.010; Zheng H, 2003, EUR J IMMUNOL, V33, P1754, DOI 10.1002/eji.200323687; Zhu QY, 2009, P NATL ACAD SCI USA, V106, P7968, DOI 10.1073/pnas.0812652106	41	10	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e32067	10.1371/journal.pone.0032067	http://dx.doi.org/10.1371/journal.pone.0032067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363798	Green Published, gold, Green Submitted			2022-12-27	WOS:000302871500109
J	Niu, HT; Zhao, LL; Lu, M; Zhang, S; Sun, JH				Niu, Hongtao; Zhao, Lilin; Lu, Min; Zhang, Shuai; Sun, Jianghua			The Ratio and Concentration of Two Monoterpenes Mediate Fecundity of the Pinewood Nematode and Growth of Its Associated Fungi	PLOS ONE			English	Article							BURSAPHELENCHUS-XYLOPHILUS NEMATODA; MONOCHAMUS-ALTERNATUS COLEOPTERA; BARK BEETLE; NEMATOCIDAL ACTIVITY; WILT DISEASE; ESSENTIAL OILS; APHELENCHOIDIDAE; HOST; CERAMBYCIDAE; VOLATILES	The pinewood nematode (PWN) Bursaphelenchus xylophilus, vectored primarily by the sawyer beetle, Monochamus alternatus, is an important invasive pest and causal agent of pine wilt disease of Chinese Masson pine, Pinus massoniana. Previous work demonstrated that the ratios and concentrations of alpha-pinene: beta-pinene differed between healthy trees and those trees containing blue-stain fungus (and M. alternatus pupae). However, the potential influence of the altered monoterpene ratios and concentrations on PWN and associated fungi remained unknown. Our current results show that low concentrations of the monoterpenes within petri dishes reduced PWN propagation, whereas the highest concentration of the monoterpenes increased PWN propagation. The propagation rate of PWN treated with the monoterpene ratio representative of blue-stain infected pine (alpha-pinene:beta-pinene = 1:0.8, 137.6 mg/ml) was significantly higher than that (alpha-pinene:beta-pinene = 1:0.1, 137.6 mg/ml) representative of healthy pines or those damaged by M. alternatus feeding, but without blue stain. Furthermore, inhibition of mycelial growth of associated fungi increased with the concentration of the monoterpenes alpha-pinene and beta-pinene. Additionally, higher levels of beta-pinene (alpha-pinene:beta-pinene = 1:0.8) resulted in greater inhibition of the growth of the associated fungi Sporothrix sp.2 and Ophiostoma ips strains, but had no significant effects on the growth of Sporothrix sp.1, which is the best food resource for PWN. These results suggest that host monoterpenes generally reduce the reproduction of PWN. However, PWN utilizes high monoterpene concentrations and native blue-stain fungus Sporothrix sp.1 to improve its own propagation and overcome host resistance, which may provide clues to understanding the ecological mechanisms of PWN's successful invasion.	[Niu, Hongtao; Zhao, Lilin; Lu, Min; Zhang, Shuai; Sun, Jianghua] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Niu, Hongtao] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Niu, HT (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	sunjh@ioz.ac.cn		sun, jianghua/0000-0002-9465-3672	National Natural Science Foundation of China [30730074, 30970369]; National Basic Science Research Program [2009CB119200, 2012CB114100]; Chinese Academy of Science [KSCX2-EW-J-2]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Science Research Program(National Basic Research Program of China); Chinese Academy of Science(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China (30730074 and 30970369), National Basic Science Research Program (2009CB119200 and 2012CB114100) and Chinese Academy of Science Key Knowledge Innovation Program (KSCX2-EW-J-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AS, 2009, CAN J FOREST RES, V39, P1133, DOI 10.1139/X09-034; Aikawa T, 1998, APPL ENTOMOL ZOOL, V33, P231, DOI 10.1303/aez.33.231; Blodgett JT, 1997, PHYTOPATHOLOGY, V87, P606, DOI 10.1094/PHYTO.1997.87.6.606; BRIDGES JR, 1987, PHYTOPATHOLOGY, V77, P83, DOI 10.1094/Phyto-77-83; Byun-McKay A, 2006, PLANT PHYSIOL, V140, P1009, DOI 10.1104/pp.105.071803; Camurca-Vasconcelos ALF, 2007, VET PARASITOL, V148, P288, DOI 10.1016/j.vetpar.2007.06.012; Cheng XY, 2009, BIOL INVASIONS, V11, P205, DOI 10.1007/s10530-008-9225-2; Choi IH, 2007, RUSS J NEMATOL, V15, P35; DEGROOT RC, 1972, MYCOLOGIA, V64, P863, DOI 10.2307/3757941; Erbilgin N, 2003, AGR FOREST ENTOMOL, V5, P269, DOI 10.1046/j.1461-9563.2003.00186.x; Fan JT, 2007, ANN FOREST SCI, V64, P67, DOI 10.1051/forest:2006089; Fu LG, 1999, CYCADACEAE FAGACEAE, V4, P453; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Hofstetter RW, 2005, J CHEM ECOL, V31, P539, DOI 10.1007/s10886-005-2035-4; Jones JT, 2008, MOL PLANT PATHOL, V9, P357, DOI 10.1111/J.1364-3703.2007.00461.X; KAWAZU K, 1980, AGR BIOL CHEM TOKYO, V44, P631, DOI 10.1080/00021369.1980.10864002; Keeling CI, 2006, NEW PHYTOL, V170, P657, DOI 10.1111/j.1469-8137.2006.01716.x; Kerlinger FN, 1973, MULTIPLE REGRESSION, P282; Kikuchi T, 2004, FEBS LETT, V572, P201, DOI 10.1016/j.febslet.2004.07.039; Klepzig KD, 1996, J CHEM ECOL, V22, P1367, DOI 10.1007/BF02027719; KLEPZIG KD, 1995, J CHEM ECOL, V21, P601, DOI 10.1007/BF02033704; Kong JO, 2007, J NEMATOL, V39, P237; Korsu K, 2010, BIOL INVASIONS, V12, P1363, DOI 10.1007/s10530-009-9553-x; KURODA K, 1991, EUR J FOREST PATHOL, V21, P82; Lei J, 2010, BIOCHEM PHARMACOL, V79, P1062, DOI 10.1016/j.bcp.2009.11.002; LEWINSOHN E, 1991, PLANT PHYSIOL, V96, P44, DOI 10.1104/pp.96.1.44; Lu M, 2010, NEW PHYTOL, V187, P859, DOI 10.1111/j.1469-8137.2010.03316.x; Ludley KE, 2008, SOIL BIOL BIOCHEM, V40, P669, DOI 10.1016/j.soilbio.2007.10.001; Maehara N, 2005, NEMATOLOGY, V7, P161, DOI 10.1163/1568541054879557; Maehara N, 2000, APPL ENTOMOL ZOOL, V35, P413, DOI 10.1303/aez.2000.413; MAMIYA Y, 1983, ANNU REV PHYTOPATHOL, V21, P201, DOI 10.1146/annurev.py.21.090183.001221; MAMIYA Y, 1972, NEMATOLOGICA, V18, P159, DOI 10.1163/187529272X00395; Mumm R, 2006, TRENDS PLANT SCI, V11, P351, DOI 10.1016/j.tplants.2006.05.007; Oh WS, 2009, PLOS ONE, V4, pA22, DOI 10.1371/journal.pone.0007593; Olesen JM, 2002, DIVERS DISTRIB, V8, P181, DOI 10.1046/j.1472-4642.2002.00148.x; PAINE TD, 1994, J CHEM ECOL, V20, P2551, DOI 10.1007/BF02036191; Park IK, 2005, NEMATOLOGY, V7, P767, DOI 10.1163/156854105775142946; Raffa K.F., 1991, P245; RAFFA KF, 1995, OECOLOGIA, V102, P285, DOI 10.1007/BF00329795; Richardson D. M., 1998, ECOLOGY BIOGEOGRAPHY; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Rodriguez-Saona CR, 2009, J CHEM ECOL, V35, P163, DOI 10.1007/s10886-008-9579-z; Seifert K. A., 1999, TAXONOMY ECOLOGY PAT, P141; SMITH RH, 1961, J ECON ENTOMOL, V54, P365; Su JW, 2009, J PLANT RES, V122, P193, DOI 10.1007/s10265-008-0203-7; TOGASHI K, 1989, APPL ENTOMOL ZOOL, V24, P379, DOI 10.1303/aez.24.379; Togashi K, 2006, POPUL ECOL, V48, P271, DOI 10.1007/s10144-006-0011-7; Tomlin ES, 2000, TREE PHYSIOL, V20, P1087; Torchin ME, 2003, NATURE, V421, P628, DOI 10.1038/nature01346; van Bezooijen J., 2006, METHODS TECHNIQUES N; Wang Z, 2010, AFR J MICROBIOL RES, V4, P437; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Zhao LL, 2007, J CHEM ECOL, V33, P1207, DOI 10.1007/s10886-007-9289-y; Zhao LL, 2009, FOREST ECOL MANAG, V258, P1932, DOI 10.1016/j.foreco.2009.07.040	54	32	37	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31716	10.1371/journal.pone.0031716	http://dx.doi.org/10.1371/journal.pone.0031716			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363713	Green Published, gold, Green Submitted			2022-12-27	WOS:000302871500080
J	Pegoraro, G; Voss, TC; Martin, SE; Tuzmen, P; Guha, R; Misteli, T				Pegoraro, Gianluca; Voss, Ty C.; Martin, Scott E.; Tuzmen, Pinar; Guha, Rajarshi; Misteli, Tom			Identification of Mammalian Protein Quality Control Factors by High-Throughput Cellular Imaging	PLOS ONE			English	Article							20S PROTEASOME; ENDOPLASMIC-RETICULUM; IN-VIVO; DEGRADATION; UBIQUITIN; CELLS; TRANSLATION; EXPRESSION; MATURATION; TOXICITY	Protein Quality Control (PQC) pathways are essential to maintain the equilibrium between protein folding and the clearance of misfolded proteins. In order to discover novel human PQC factors, we developed a high-content, high-throughput cell-based assay to assess PQC activity. The assay is based on a fluorescently tagged, temperature sensitive PQC substrate and measures its degradation relative to a temperature insensitive internal control. In a targeted screen of 1591 siRNA genes involved in the Ubiquitin-Proteasome System (UPS) we identified 25 of the 33 genes encoding for 26S proteasome subunits and discovered several novel PQC factors. An unbiased genome-wide siRNA screen revealed the protein translation machinery, and in particular the EIF3 translation initiation complex, as a novel key modulator of misfolded protein stability. These results represent a comprehensive unbiased survey of human PQC components and establish an experimental tool for the discovery of genes that are required for the degradation of misfolded proteins under conditions of proteotoxic stress.	[Pegoraro, Gianluca; Voss, Ty C.] NCI, NCI High Throughput Imaging Facil, NIH, Bethesda, MD 20892 USA; [Martin, Scott E.; Tuzmen, Pinar; Guha, Rajarshi] NIH, Ctr Translat Therapeut, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA	Pegoraro, G (corresponding author), NCI, NCI High Throughput Imaging Facil, NIH, Bethesda, MD 20892 USA.	mistelit@mail.nih.gov	Pegoraro, Gianluca/K-4233-2016	Pegoraro, Gianluca/0000-0003-2843-9464	NIH; NCI; Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010309] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the Intramural Research Program of the NIH, NCI, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Anton LC, 1999, J CELL BIOL, V146, P113, DOI 10.1083/jcb.146.1.113; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Betting J, 1996, J BIOL CHEM, V271, P25790, DOI 10.1074/jbc.271.42.25790; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Burri L, 2000, P NATL ACAD SCI USA, V97, P10348, DOI 10.1073/pnas.190268597; CARLSON N, 1987, J CELL BIOL, V104, P537, DOI 10.1083/jcb.104.3.537; CHOU JY, 1974, J VIROL, V13, P1101, DOI 10.1128/JVI.13.5.1101-1109.1974; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Douglas PM, 2010, BIOPOLYMERS, V93, P229, DOI 10.1002/bip.21304; EDWARDS CAF, 1979, J VIROL, V29, P753, DOI 10.1128/JVI.29.2.753-762.1979; Eichinger CS, 2009, J BIOL CHEM, V284, P30604, DOI 10.1074/jbc.M109.024760; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fricke B, 2007, EMBO REP, V8, P1170, DOI 10.1038/sj.embor.7401091; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; GONEN H, 1994, P NATL ACAD SCI USA, V91, P7648, DOI 10.1073/pnas.91.16.7648; HAAS AL, 1987, J BIOL CHEM, V262, P345; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Heink S, 2005, P NATL ACAD SCI USA, V102, P9241, DOI 10.1073/pnas.0501711102; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Hirano Y, 2008, EMBO J, V27, P2204, DOI 10.1038/emboj.2008.148; Hoefer MM, 2006, INT J BIOL MACROMOL, V38, P259, DOI 10.1016/j.ijbiomac.2006.03.015; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200; Metzger MB, 2009, MOL BIOL CELL, V20, P1006, DOI 10.1091/mbc.E08-02-0140; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Pegoraro G, 2009, NAT CELL BIOL, V11, P1261, DOI 10.1038/ncb1971; Persichetti F, 1996, NEUROBIOL DIS, V3, P183, DOI 10.1006/nbdi.1996.0018; Prasad R, 2010, MOL BIOL CELL, V21, P2117, DOI 10.1091/mbc.E10-02-0111; Qian SB, 2006, J IMMUNOL, V177, P227, DOI 10.4049/jimmunol.177.1.227; Ramos PC, 1998, CELL, V92, P489, DOI 10.1016/S0092-8674(00)80942-3; Richardson PG, 2006, ANNU REV MED, V57, P33, DOI 10.1146/annurev.med.57.042905.122625; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Sha Z, 2009, MOL CELL, V36, P141, DOI 10.1016/j.molcel.2009.09.026; Strack RL, 2008, NAT METHODS, V5, P955, DOI 10.1038/nmeth.1264; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; van Ham TJ, 2009, EMBO MOL MED, V1, P360, DOI 10.1002/emmm.200900051; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Witt E, 2000, J MOL BIOL, V301, P1, DOI 10.1006/jmbi.2000.3959; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489	58	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31684	10.1371/journal.pone.0031684	http://dx.doi.org/10.1371/journal.pone.0031684			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363705	gold, Green Submitted, Green Published			2022-12-27	WOS:000302871500075
J	Martinez-Silva, AV; Aguirre-Martinez, C; Flores-Tinoco, CE; Alejandri-Ramirez, ND; Dinkova, TD				Valeria Martinez-Silva, Ana; Aguirre-Martinez, Cesar; Flores-Tinoco, Carlos E.; Alejandri-Ramirez, Naholi D.; Dinkova, Tzvetanka D.			Translation Initiation Factor AteIF(iso) 4E Is Involved in Selective mRNA Translation in Arabidopsis Thaliana Seedlings	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; EIF4E ISOFORMS; EXPRESSION; CAP; BINDING; GROWTH; PHO1; RECRUITMENT; GERMINATION; EIF(ISO)4E	One of the most regulated steps of translation initiation is the recruitment of mRNA by the translation machinery. In eukaryotes, this step is mediated by the 5'end cap-binding factor eIF4E bound to the bridge protein eIF4G and forming the eIF4F complex. In plants, different isoforms of eIF4E and eIF4G form the antigenically distinct eIF4F and eIF(iso)4F complexes proposed to mediate selective translation. Using a microarray analysis of polyribosome-and non-polyribosome-purified mRNAs from 15 day-old Arabidopsis thaliana wild type [WT] and eIF(iso) 4E knockout mutant [(iso)4E-1] seedlings we found 79 transcripts shifted from polyribosomes toward non-polyribosomes, and 47 mRNAs with the opposite behavior in the knockout mutant. The translationally decreased mRNAs were overrepresented in root-preferentially expressed genes and proteins from the endomembrane system, including several transporters such as the phosphate transporter PHOSPHATE1 (PHO1), Sucrose transporter 3 (SUC3), ABC transporter-like with ATPase activity (MRP11) and five electron transporters, as well as signal transduction, protein modification-and transcription-related proteins. Under normal growth conditions, eIF(iso) 4E expression under the constitutive promoter 35 S enhanced the polyribosomal recruitment of PHO1 supporting its translational preference for eIF(iso) 4E. Furthermore, under phosphate deficiency, the PHO1 protein increased in the eIF(iso) 4E overexpressing plants and decreased in the knockout mutant as compared to wild type. In addition, the knockout mutant had larger root, whereas the 35 S directed expression of eIF(iso) 4E caused shorter root under normal growth conditions, but not under phosphate deficiency. These results indicate that selective translation mediated by eIF(iso)4E is relevant for Arabidopsis root development under normal growth conditions.	[Valeria Martinez-Silva, Ana; Aguirre-Martinez, Cesar; Flores-Tinoco, Carlos E.; Alejandri-Ramirez, Naholi D.; Dinkova, Tzvetanka D.] Univ Nacl Autonoma Mexico, Dept Bioquim, Fac Quim, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Martinez-Silva, AV (corresponding author), Univ Nacl Autonoma Mexico, Dept Bioquim, Fac Quim, Mexico City 04510, DF, Mexico.	cesy@servidor.unam.mx	Dinkova, Tzvetanka/AAE-6073-2020; Dinkova, Tzvetanka/L-5678-2019	Dinkova, Tzvetanka/0000-0001-7971-525X; Flores Tinoco, Carlos Eduardo/0000-0002-6485-8618; Aguirre, Cesar/0000-0001-6302-2600; Martinez-Silva, Ana Valeria/0000-0002-3016-7093	Consejo Nacional de Ciencia y Tecnologia de Mexico (CONACYT) [43669, 81708]; Programa de Apoyo a la Innovacion e Investigacion Tecnologica (PAPIIT-UNAM) [204309]	Consejo Nacional de Ciencia y Tecnologia de Mexico (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a la Innovacion e Investigacion Tecnologica (PAPIIT-UNAM)	This research was supported by Consejo Nacional de Ciencia y Tecnologia de Mexico (CONACYT) grants 43669 and 81708, and by Programa de Apoyo a la Innovacion e Investigacion Tecnologica (PAPIIT-UNAM) grant 204309. AVMS was supported by CONACyT Ph.D. fellowship program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiri A, 2001, DEVELOPMENT, V128, P3899; Baerenfaller K, 2008, SCIENCE, V320, P938, DOI 10.1126/science.1157956; Browning KS, 2004, BIOCHEM SOC T, V32, P589, DOI 10.1042/BST0320589; Bush MS, 2009, PLANT J, V59, P400, DOI 10.1111/j.1365-313X.2009.03882.x; CARBERRY SE, 1991, BIOCHEMISTRY-US, V30, P4542, DOI 10.1021/bi00232a025; Cho PF, 2005, CELL, V121, P411, DOI 10.1016/j.cell.2005.02.024; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dinkova TD, 2003, BIOLOGY OF SEEDS: RECENT RESEARCH ADVANCES, P181, DOI 10.1079/9780851996530.0181; Dinkova TD, 2000, BIOCHEM J, V351, P825, DOI 10.1042/0264-6021:3510825; Dinkova TD, 1999, PHYSIOL PLANTARUM, V107, P419, DOI 10.1034/j.1399-3054.1999.100407.x; Dinkova TD, 2011, SEED SCI RES, V21, P85, DOI 10.1017/S0960258511000043; Duprat A, 2002, PLANT J, V32, P927, DOI 10.1046/j.1365-313X.2002.01481.x; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Fischer PM, 2009, CELL CYCLE, V8, P2535, DOI 10.4161/cc.8.16.9301; Gallie DR, 2001, J BIOL CHEM, V276, P36951, DOI 10.1074/jbc.M103869200; Haghighat A, 1997, J BIOL CHEM, V272, P21677, DOI 10.1074/jbc.272.35.21677; Hamburger D, 2002, PLANT CELL, V14, P889, DOI 10.1105/tpc.000745; Hernandez G, 2005, MECH DEVELOP, V122, P865, DOI 10.1016/j.mod.2005.04.002; Hernandez G, 2005, MECH DEVELOP, V122, P529, DOI 10.1016/j.mod.2004.11.011; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Joshi B, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-48; Kawaguchi R, 2004, PLANT J, V38, P823, DOI 10.1111/j.1365-313X.2004.02090.x; Kaye NM, 2009, J BIOL CHEM, V284, P17742, DOI 10.1074/jbc.M109.009001; Keiper BD, 2000, J BIOL CHEM, V275, P10590, DOI 10.1074/jbc.275.14.10590; Lellis AD, 2010, PLANT MOL BIOL, V74, P249, DOI 10.1007/s11103-010-9670-z; LODISH HF, 1974, NATURE, V251, P385, DOI 10.1038/251385a0; Lopez-Bucio J, 2003, CURR OPIN PLANT BIOL, V6, P280, DOI 10.1016/S1369-5266(03)00035-9; Mayberry LK, 2009, PLANT PHYSIOL, V150, P1844, DOI 10.1104/pp.109.138438; Nicaise V, 2007, FEBS LETT, V581, P1041, DOI 10.1016/j.febslet.2007.02.007; Ptushkina M, 2004, EMBO REP, V5, P311, DOI 10.1038/sj.embor.7400088; Rhoads RE, 2009, J BIOL CHEM, V284, P16711, DOI 10.1074/jbc.R900002200; Rodriguez CM, 1998, PLANT J, V13, P465, DOI 10.1046/j.1365-313X.1998.00047.x; Rouached H, 2011, PLANT J, V65, P557, DOI 10.1111/j.1365-313X.2010.04442.x; Sonenberg N, 2007, MOL CELL, V28, P721, DOI 10.1016/j.molcel.2007.11.018; Song AR, 2010, J CELL SCI, V123, P2228, DOI 10.1242/jcs.063107; Stefanovic A, 2011, PLANT J, V66, P689, DOI 10.1111/j.1365-313X.2011.04532.x; Syntichaki P, 2007, NATURE, V445, P922, DOI 10.1038/nature05603; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	41	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31606	10.1371/journal.pone.0031606	http://dx.doi.org/10.1371/journal.pone.0031606			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363683	gold, Green Submitted, Green Published			2022-12-27	WOS:000302871500060
J	Braun, RD; Bissig, D; North, R; Vistisen, KS; Berkowitz, BA				Braun, Rod D.; Bissig, David; North, Robert; Vistisen, Kerry S.; Berkowitz, Bruce A.			Human Tumor Cell Proliferation Evaluated Using Manganese-Enhanced MRI	PLOS ONE			English	Article							RESONANCE-IMAGING MEMRI; IN-VIVO; CALCIUM-CHANNELS; PROSTATE-CANCER; CA2+ ENTRY; UVEAL MELANOMA; RAT-BRAIN; MN; OVEREXPRESSION; PROGRESSION	Background: Tumor cell proliferation can depend on calcium entry across the cell membrane. As a first step toward the development of a non-invasive test of the extent of tumor cell proliferation in vivo, we tested the hypothesis that tumor cell uptake of a calcium surrogate, Mn2+ [measured with manganese-enhanced MRI (MEMRI)], is linked to proliferation rate in vitro. Methodology/Principal Findings: Proliferation rates were determined in vitro in three different human tumor cell lines: C918 and OCM-1 human uveal melanomas and PC-3 prostate carcinoma. Cells growing at different average proliferation rates were exposed to 1 mM MnCl2 for one hour and then thoroughly washed. MEMRI R-1 values (longitudinal relaxation rates), which have a positive linear relationship with Mn2+ concentration, were then determined from cell pellets. Cell cycle distributions were determined using propidium iodide staining and flow cytometry. All three lines showed Mn2+-induced increases in R-1 compared to cells not exposed to Mn2+. C918 and PC-3 cells each showed a significant, positive correlation between MEMRI R-1 values and proliferation rate (p <= 0.005), while OCM-1 cells showed no significant correlation. Preliminary, general modeling of these positive relationships suggested that pellet R-1 for the PC-3 cells, but not for the C918 cells, could be adequately described by simply accounting for changes in the distribution of the cell cycle-dependent subpopulations in the pellet. Conclusions/Significance: These data clearly demonstrate the tumor-cell dependent nature of the relationship between proliferation and calcium influx, and underscore the usefulness of MEMRI as a non-invasive method for investigating this link. MEMRI is applicable to study tumors in vivo, and the present results raise the possibility of evaluating proliferation parameters of some tumor types in vivo using MEMRI.	[Braun, Rod D.; Bissig, David; North, Robert; Vistisen, Kerry S.; Berkowitz, Bruce A.] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; [Braun, Rod D.] Wayne State Univ, Barbara Ann Karmanos Canc Inst, Detroit, MI USA; [Berkowitz, Bruce A.] Wayne State Univ, Kresge Eye Inst, Detroit, MI USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University	Braun, RD (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA.	rbraun@med.wayne.edu		Bissig, David/0000-0001-9664-5433	Karmanos Cancer Institute; National Institutes of Health (NIH) [EY018109, AG034752]; NIH National Eye Institute [P30EY04068]; NIH Center [P30CA22453]; Juvenile Diabetes Research Foundation; Wayne State University School of Medicine; Research to Prevent Blindness (Kresge Eye Institute); NATIONAL CANCER INSTITUTE [P30CA022453] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY018109, P30EY004068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG034752] Funding Source: NIH RePORTER	Karmanos Cancer Institute; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Wayne State University School of Medicine; Research to Prevent Blindness (Kresge Eye Institute)(Research to Prevent Blindness (RPB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a Pilot Project Grant from Karmanos Cancer Institute (RDB, BAB), National Institutes of Health (NIH) EY018109 (BAB), NIH National Eye Institute Departmental Core Grant (P30EY04068), NIH Center Grant to the Karmanos Cancer Institute (P30CA22453), Juvenile Diabetes Research Foundation (BAB), NIH AG034752 (DB), Wayne State University School of Medicine MD/PhD program (DB), and an unrestricted grant from Research to Prevent Blindness (Kresge Eye Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON M, 1983, J GEN PHYSIOL, V81, P805, DOI 10.1085/jgp.81.6.805; Bading JR, 2008, J NUCL MED, V49, p64S, DOI 10.2967/jnumed.107.046391; Banerjee D, 2007, NEUROIMAGE, V35, P1434, DOI 10.1016/j.neuroimage.2007.02.019; Berkowitz BA, 2006, INVEST OPHTH VIS SCI, V47, P2668, DOI 10.1167/iovs.05-1588; Berkowitz BA, 2009, INVEST OPHTH VIS SCI, V50, P2351, DOI 10.1167/iovs.08-2918; Berkowitz BA, 2009, INVEST OPHTH VIS SCI, V50, P1880, DOI 10.1167/iovs.08-2958; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bissig D, 2009, NEUROIMAGE, V44, P627, DOI 10.1016/j.neuroimage.2008.10.013; Braun RD, 2007, INVEST OPHTH VIS SCI, V48, P963, DOI 10.1167/iovs.06-1156; Buhmeida A, 2006, DIAGN PATHOL, V1, DOI 10.1186/1746-1596-1-4; Cross DJ, 2007, AM J NEURORADIOL, V28, P1865, DOI 10.3174/ajnr.A0693; Daniels KJ, 1996, LAB INVEST, V75, P55; DRAPEAU P, 1984, J PHYSIOL-LONDON, V348, P493, DOI 10.1113/jphysiol.1984.sp015121; Erikson KM, 2007, PHARMACOL THERAPEUT, V113, P369, DOI 10.1016/j.pharmthera.2006.09.002; Fiske JL, 2006, CANCER METAST REV, V25, P493, DOI 10.1007/s10555-006-9017-z; Grimm C, 2003, J BIOL CHEM, V278, P21493, DOI 10.1074/jbc.M300945200; Hasegawa S, 2010, INT J CANC; KAIGHN ME, 1979, INVEST UROL, V17, P16; KANMITCHELL J, 1989, INVEST OPHTH VIS SCI, V30, P829; KJAER L, 1988, ACTA RADIOL, V29, P473; Koretsky AP, 2004, NMR BIOMED, V17, P527, DOI 10.1002/nbm.940; Lin YJ, 1997, MAGN RESON MED, V38, P378, DOI 10.1002/mrm.1910380305; Lipskaia L, 2004, BIOL CELL, V96, P55, DOI 10.1016/j.biolcel.2003.11.001; Lopez S, 2004, INT J FOOD MICROBIOL, V96, P289, DOI 10.1016/j.ijfoodmicro.2004.03.026; Minner S, 2010, CLIN CANCER RES, V16, P1553, DOI 10.1158/1078-0432.CCR-09-2546; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Munaron L, 2004, J CELL MOL MED, V8, P161, DOI 10.1111/j.1582-4934.2004.tb00271.x; Munaron L, 2004, CURR MED CHEM, V11, P1533, DOI 10.2174/0929867043365008; NARITA K, 1990, BRAIN RES, V510, P289, DOI 10.1016/0006-8993(90)91379-U; Panner A, 2006, CELL CALCIUM, V40, P253, DOI 10.1016/j.ceca.2006.04.029; R Core Team, 2020, R LANG ENV STAT COMP; Ritz C, 2011, ENVIRON ECOL STAT, V18, P349, DOI 10.1007/s10651-010-0136-x; Roth JA, 2006, BIOL RES, V39, P45, DOI 10.4067/S0716-97602006000100006; Schokker EP, 1997, J AGR FOOD CHEM, V45, P4740, DOI 10.1021/jf970429i; Seshadri M, 2010, MAGN RESON MED, V64, P902, DOI 10.1002/mrm.22452; SHIBUYA I, 1993, CELL CALCIUM, V14, P33, DOI 10.1016/0143-4160(93)90016-Y; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; Tamano H, 2002, NUCL MED BIOL, V29, P505, DOI 10.1016/S0969-8051(02)00289-5; Taylor JT, 2008, WORLD J GASTROENTERO, V14, P4984, DOI 10.3748/wjg.14.4984; Thebault S, 2006, CANCER RES, V66, P2038, DOI 10.1158/0008-5472.CAN-05-0376; Urruticoechea A, 2005, J CLIN ONCOL, V23, P7212, DOI 10.1200/JCO.2005.07.501; Valera V, 2005, BRIT J SURG, V92, P1002, DOI 10.1002/bjs.4858; VALOIS AA, 1989, TOXICOLOGY, V57, P315, DOI 10.1016/0300-483X(89)90119-4; Wadghiri YZ, 2004, NMR BIOMED, V17, P613, DOI 10.1002/nbm.932; WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293; Yu X, 2005, NAT NEUROSCI, V8, P961, DOI 10.1038/nn1477; Zeng X, 2009, PROSTATE CANC P D; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133	49	13	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30572	10.1371/journal.pone.0030572	http://dx.doi.org/10.1371/journal.pone.0030572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363447	gold, Green Published, Green Submitted			2022-12-27	WOS:000302853600035
J	Cortes, R; Rivera, M; Rosello-Lleti, E; Martinez-Dolz, L; Almenar, L; Azorin, I; Lago, F; Gonzalez-Juanatey, JR; Portoles, M				Cortes, Raquel; Rivera, Miguel; Rosello-Lleti, Esther; Martinez-Dolz, Luis; Almenar, Luis; Azorin, Inmaculada; Lago, Francisca; Ramon Gonzalez-Juanatey, Jose; Portoles, Manuel			Differences in MEF2 and NFAT Transcriptional Pathways According to Human Heart Failure Aetiology	PLOS ONE			English	Article							CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; CARDIAC-HYPERTROPHY; CARDIOMYOCYTE HYPERTROPHY; DILATED CARDIOMYOPATHY; IN-VIVO; CALCINEURIN; MYOCARDIUM; EXPRESSION; MYOCYTES; INSIGHTS	Background: Ca2+ handling machinery modulates the activation of cardiac transcription pathways involved in heart failure (HF). The present study investigated the effect of HF aetiology on Ca+2 handling proteins and NFAT1, MEF2C and GATA4 (transcription factors) in the same cardiac tissue. Methodology and Principal Findings: A total of 83 hearts from ischemic (ICM, n = 43) and dilated (DCM, n = 31) patients undergoing heart transplantation and controls (CNT, n = 9) were analyzed by western blotting. Subcellular distribution was analyzed by fluorescence and electron microscopy. When we compared Ca+2 handling proteins according to HF aetiology, ICM showed higher levels of calmodulin (24%, p<0.01), calcineurin (26%, p<0.01) and Ca2+/Calmodulin-dependent kinase II (CaMKII delta(b) nuclear isoform 62%, p<0.001) than the CNT group. However, these proteins in DCM did not significantly increase. Furthermore, ICM showed a significant elevation in MEF2C (33%, p<0.01), and GATA4 (49%, p<0.05); also NFAT1 (66%, p<0.001) was increased, producing the resultant translocation of this transcriptional factor into the nuclei. These results were supported by fluorescence and electron microscopy analysis. Whereas, DCM only had a significant increase in GATA4 (52%, p<0.05). Correlations between NFAT1 and MEF2C in both groups (ICM r = 0.38 and DCM r = 0.59, p<0.05 and p<0.01, respectively) were found; only ICM showed a correlation between GATA4 and NFAT1 (r = 0.37, p<0.05). Conclusions/Significance: This study shows an increase of Ca2+ handling machinery synthesis and their cardiac transcription pathways in HF, being more markedly increased in ICM. Furthermore, there is a significant association between MEF2, NFAT1 and GATA4. These proteins could be therapeutic targets to improve myocardial function.	[Cortes, Raquel; Rivera, Miguel; Rosello-Lleti, Esther] Hosp Univ La Fe, Cardiocirculatory Unit, Res Ctr, Valencia, Spain; [Martinez-Dolz, Luis; Almenar, Luis] Hosp Univ La Fe, Cardiol Unit, Valencia, Spain; [Lago, Francisca; Ramon Gonzalez-Juanatey, Jose] Hosp Clin Univ, Mol & Cellular Cardiol Unit, Inst Biomed Res, Santiago De Compostela, Spain; [Lago, Francisca; Ramon Gonzalez-Juanatey, Jose] Hosp Clin Univ, Dept Cardiol, Santiago De Compostela, Spain; [Portoles, Manuel] Hosp Univ La Fe, Res Ctr, Cell Biol & Pathol Unit, Valencia, Spain	Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Hospital Universitari i Politecnic La Fe	Cortes, R (corresponding author), Hosp Univ La Fe, Cardiocirculatory Unit, Res Ctr, Valencia, Spain.	portoles_man@gva.es	CORTES, RAQUEL/K-2777-2014; Cortes, Raquel/GQH-6347-2022; Dolz, Luis Martinez/X-4627-2018; PORTOLES, MANUEL/B-4789-2009; Roselló Lletí, Esther/ABG-8503-2020; Roselló-Lletí, Esther/B-2695-2017	CORTES, RAQUEL/0000-0001-9607-997X; Cortes, Raquel/0000-0001-9607-997X; Dolz, Luis Martinez/0000-0001-5145-8191; PORTOLES, MANUEL/0000-0002-4415-7160; Roselló Lletí, Esther/0000-0003-2627-6104; Roselló-Lletí, Esther/0000-0003-2627-6104; Gonzalez Juanatey, Jose Ramon/0000-0001-9681-3388	National Institute of Health "Fondo de Investigaciones Sanitarias of Instituto de Salud Carlos III" [REDINSCOR 06/0003/1001, PI07/0462]	National Institute of Health "Fondo de Investigaciones Sanitarias of Instituto de Salud Carlos III"	This work was supported by grants from the National Institute of Health "Fondo de Investigaciones Sanitarias of Instituto de Salud Carlos III", [REDINSCOR 06/0003/1001, Project PI07/0462]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad F, 2005, ANNU REV GENOM HUM G, V6, P185, DOI 10.1146/annurev.genom.6.080604.162132; Barry SP, 2010, INT REV CEL MOL BIO, V284, P113, DOI 10.1016/S1937-6448(10)84003-1; BEUCKELMANN DJ, 1992, CIRCULATION, V85, P1046, DOI 10.1161/01.CIR.85.3.1046; BOHM M, 1990, CIRCULATION, V82, P1249, DOI 10.1161/01.CIR.82.4.1249; Bueno OF, 2002, CARDIOVASC RES, V53, P806, DOI 10.1016/S0008-6363(01)00493-X; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Cortes R, 2010, CARDIOVASC RES, V85, P464, DOI 10.1093/cvr/cvp336; Frank KF, 2003, CARDIOVASC RES, V57, P20, DOI 10.1016/S0008-6363(02)00694-6; Hasenfuss G, 1998, CARDIOVASC RES, V37, P279, DOI 10.1016/S0008-6363(97)00277-0; Hasenfuss G, 2002, J MOL CELL CARDIOL, V34, P951, DOI 10.1006/jmcc.2002.2037; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Hoch B, 1999, CIRC RES, V84, P713, DOI 10.1161/01.RES.84.6.713; Jefferies JL, 2010, LANCET, V375, P752, DOI 10.1016/S0140-6736(09)62023-7; KAPILOFF MS, 1991, P NATL ACAD SCI USA, V88, P3710, DOI 10.1073/pnas.88.9.3710; Khoo MSC, 2006, CIRCULATION, V114, P1352, DOI 10.1161/CIRCULATIONAHA.106.644583; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Little GH, 2007, J BIOL CHEM, V282, P7219, DOI 10.1074/jbc.M604281200; Lu YM, 2010, BBA-GENE REGUL MECH, V1799, P429, DOI 10.1016/j.bbagrm.2010.02.004; Lynch J, 2005, J CELL BIOL, V170, P37, DOI 10.1083/jcb.200412156; Maier LS, 2003, CIRC RES, V92, P904, DOI 10.1161/01.RES.0000069685.20258.F1; Mishra S, 2003, AM J PHYSIOL-HEART C, V284, pH876, DOI 10.1152/ajpheart.00266.2002; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; Pauschinger M, 1998, CARDIOVASC RES, V37, P123, DOI 10.1016/S0008-6363(97)00217-4; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Putt ME, 2009, CIRC-CARDIOVASC GENE, V2, P212, DOI 10.1161/CIRCGENETICS.108.816686; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; Sossalla S, 2010, CIRC RES, V107, P1150, DOI 10.1161/CIRCRESAHA.110.220418; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhu WD, 2000, J BIOL CHEM, V275, P15239, DOI 10.1074/jbc.275.20.15239	33	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30915	10.1371/journal.pone.0030915	http://dx.doi.org/10.1371/journal.pone.0030915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363514	Green Submitted, gold, Green Published			2022-12-27	WOS:000302853600087
J	Delgado, E; Carrera, C; Nebreda, P; Fernandez-Garcia, A; Pinilla, M; Garcia, V; Perez-Alvarez, L; Thomson, MM				Delgado, Elena; Carrera, Cristina; Nebreda, Paloma; Fernandez-Garcia, Aurora; Pinilla, Milagros; Garcia, Valentina; Perez-Alvarez, Lucia; Thomson, Michael M.			Identification of New Splice Sites Used for Generation of rev Transcripts in Human Immunodeficiency Virus Type 1 Subtype C Primary Isolates	PLOS ONE			English	Article							NF-KAPPA-B; LONG TERMINAL REPEAT; POLYPYRIMIDINE TRACT; FUNCTIONAL-ANALYSIS; CORECEPTOR USAGE; U2 SNRNP; HIV-1; RNA; TAT; ACTIVATION	The HIV-1 primary transcript undergoes a complex splicing process by which more than 40 different spliced RNAs are generated. One of the factors contributing to HIV-1 splicing complexity is the multiplicity of 39 splice sites (3'ss) used for generation of rev RNAs, with two 3'ss, A4a and A4b, being most commonly used, a third site, A4c, used less frequently, and two additional sites, A4d and A4e, reported in only two and one isolates, respectively. HIV-1 splicing has been analyzed mostly in subtype B isolates, and data on other group M clades are lacking. Here we examine splice site usage in three primary isolates of subtype C, the most prevalent clade in the HIV-1 pandemic, by using an in vitro infection assay of peripheral blood mononuclear cells. Viral spliced RNAs were identified by RT-PCR amplification using a fluorescently-labeled primer and software analyses and by cloning and sequencing the amplified products. The results revealed that splice site usage for generation of rev transcripts in subtype C differs from that reported for subtype B, with most rev RNAs using two previously unreported 3'ss, one located 7 nucleotides upstream of 3'ss A4a, designated A4f, preferentially used by two isolates, and another located 14 nucleotides upstream of 3'ss A4c, designated A4g, preferentially used by the third isolate. A new 59 splice site, designated D2a, was also identified in one virus. Usage of the newly identified splice sites is consistent with sequence features commonly found in subtype C viruses. These results show that splice site usage may differ between HIV-1 subtypes.	[Delgado, Elena; Carrera, Cristina; Nebreda, Paloma; Fernandez-Garcia, Aurora; Pinilla, Milagros; Garcia, Valentina; Perez-Alvarez, Lucia; Thomson, Michael M.] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Delgado, E (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain.	mthomson@isciii.es	CARRERA, CRISTINA/N-1887-2019; Thomson, Michael M/P-8949-2017; Delgado, Elena/E-2785-2019	CARRERA, CRISTINA/0000-0003-1608-8820; Thomson, Michael M/0000-0002-0622-7527; Delgado, Elena/0000-0002-0754-8533	Ministerio de Ciencia e Innovacion (Spain) [SAF2007-61688, SAF2010-20961]	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was funded by Ministerio de Ciencia e Innovacion (Spain), Plan Nacional I+D+I, through grants SAF2007-61688 and SAF2010-20961. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe A, 1999, AIDS, V13, P1305, DOI 10.1097/00002030-199907300-00006; Arien KK, 2005, J VIROL, V79, P8979, DOI 10.1128/JVI.79.14.8979-8990.2005; Ball SC, 2003, J VIROL, V77, P1021, DOI 10.1128/JVI.77.2.1021-1038.2003; BENKO DM, 1990, J VIROL, V64, P2505, DOI 10.1128/JVI.64.6.2505-2518.1990; Berkhout B, 1996, ARCH VIROL, V141, P839, DOI 10.1007/BF01718159; Bilodeau PS, 1999, J VIROL, V73, P9764, DOI 10.1128/JVI.73.12.9764-9772.1999; Bjorndal A, 1999, AIDS RES HUM RETROV, V15, P647, DOI 10.1089/088922299310944; Borensztajn K, 2006, PLOS GENET, V2, P1297, DOI 10.1371/journal.pgen.0020138; Buvoli M, 1997, EMBO J, V16, P7174, DOI 10.1093/emboj/16.23.7174; Caputi M, 2004, J VIROL, V78, P6517, DOI 10.1128/JVI.78.12.6517-6526.2004; Carrera C, 2010, AIDS RES HUM RETROV, V26, P815, DOI 10.1089/aid.2010.0011; Coolidge CJ, 1997, NUCLEIC ACIDS RES, V25, P888, DOI 10.1093/nar/25.4.888; Corvelo A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001016; Cuevas MT, 2010, AIDS RES HUM RETROV, V26, P1019, DOI 10.1089/aid.2010.0018; FURTADO MR, 1991, VIROLOGY, V185, P258, DOI 10.1016/0042-6822(91)90773-5; Gao KP, 2008, NUCLEIC ACIDS RES, V36, P2257, DOI 10.1093/nar/gkn073; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; HIV Sequence Database, HIV SEQ DAT; Huang W, 2007, J VIROL, V81, P7885, DOI 10.1128/JVI.00218-07; Iordanskiy S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-85; Jeeninga RE, 2000, J VIROL, V74, P3740, DOI 10.1128/JVI.74.8.3740-3751.2000; Kaleebu P, 2007, JAIDS-J ACQ IMM DEF, V45, P28, DOI 10.1097/QAI.0b013e3180385aa0; Kol G, 2005, HUM MOL GENET, V14, P1559, DOI 10.1093/hmg/ddi164; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; LEAR AL, 1990, J MOL BIOL, V211, P103, DOI 10.1016/0022-2836(90)90014-D; Lemieux AM, 2004, J BIOL CHEM, V279, P52949, DOI 10.1074/jbc.M409896200; Lutzelberger M, 2006, J BIOL CHEM, V281, P18644, DOI 10.1074/jbc.M513698200; Madsen JM, 2005, J VIROL, V79, P10478, DOI 10.1128/JVI.79.16.10478-10486.2005; Madsen JM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-10; Montano MA, 1998, J VIROL, V72, P8446, DOI 10.1128/JVI.72.10.8446-8452.1998; Montano MA, 2000, J INFECT DIS, V181, P76, DOI 10.1086/315185; NELSON KK, 1989, GENE DEV, V3, P1562, DOI 10.1101/gad.3.10.1562; NORTON PA, 1994, NUCLEIC ACIDS RES, V22, P3854, DOI 10.1093/nar/22.19.3854; OREILLY MM, 1995, VIROLOGY, V213, P373, DOI 10.1006/viro.1995.0010; PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993; Quivy V, 2002, J VIROL, V76, P11091, DOI 10.1128/JVI.76.21.11091-11103.2002; REED R, 1989, GENE DEV, V3, P2113, DOI 10.1101/gad.3.12b.2113; Roca X, 2005, RNA, V11, P683, DOI 10.1261/rna.2040605; ROSCIGNO RF, 1993, J BIOL CHEM, V268, P11222; SALFELD J, 1990, EMBO J, V9, P965, DOI 10.1002/j.1460-2075.1990.tb08195.x; SCHWARTZ S, 1990, J VIROL, V64, P2519, DOI 10.1128/JVI.64.6.2519-2529.1990; Si ZH, 1997, NUCLEIC ACIDS RES, V25, P861, DOI 10.1093/nar/25.4.861; SMITH CWJ, 1993, MOL CELL BIOL, V13, P4939, DOI 10.1128/MCB.13.8.4939; SMITH J, 1992, J GEN VIROL, V73, P1825, DOI 10.1099/0022-1317-73-7-1825; STAFFA A, 1994, J VIROL, V68, P3071, DOI 10.1128/JVI.68.5.3071-3079.1994; Stoltzfus CM, 2009, ADV VIRUS RES, V74, P1, DOI 10.1016/S0065-3527(09)74001-1; Swanson AK, 1998, J BIOL CHEM, V273, P34551, DOI 10.1074/jbc.273.51.34551; Tscherning C, 1998, VIROLOGY, V241, P181, DOI 10.1006/viro.1997.8980; Verhoef K, 1996, VIROLOGY, V225, P316, DOI 10.1006/viro.1996.0606; WU J, 1989, GENE DEV, V3, P1553, DOI 10.1101/gad.3.10.1553; ZHUANG Y, 1989, Proceedings of the National Academy of Sciences of the United States of America, V86, P2752, DOI 10.1073/pnas.86.8.2752	52	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30574	10.1371/journal.pone.0030574	http://dx.doi.org/10.1371/journal.pone.0030574			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363449	gold, Green Published, Green Submitted			2022-12-27	WOS:000302853600037
J	Fethers, K; Twin, J; Fairley, CK; Fowkes, FJI; Garland, SM; Fehler, G; Morton, AM; Hocking, JS; Tabrizi, SN; Bradshaw, CS				Fethers, Katherine; Twin, Jimmy; Fairley, Christopher K.; Fowkes, Freya J. I.; Garland, Suzanne M.; Fehler, Glenda; Morton, Anna M.; Hocking, Jane S.; Tabrizi, Sepehr N.; Bradshaw, Catriona S.			Bacterial Vaginosis (BV) Candidate Bacteria: Associations with BV and Behavioural Practices in Sexually-Experienced and Inexperienced Women	PLOS ONE			English	Article							VAGINAL MICROBIAL COMMUNITIES; GARDNERELLA-VAGINALIS; METRONIDAZOLE THERAPY; ATOPOBIUM-VAGINAE; RISK-FACTORS; TRANSMITTED-DISEASES; PCR; PREVALENCE; LESBIANS; HEALTH	Background: In recent years several new fastidious bacteria have been identified that display a high specificity for BV; however no previous studies have comprehensively assessed the behavioural risk associations of these bacterial vaginosis-candidate organisms (BV-COs). Methods: We examined the associations between 8 key previously described BV-COs and BV status established by Nugent's score (NS). We also examined the sexual practices associated with each BV-CO. We incorporated 2 study populations: 193 from a sexually-inexperienced university population and 146 from a highly sexually-active clinic population. Detailed behavioural data was collected by questionnaire and vaginal smears were scored by the Nugent method. Stored samples were tested by quantitative PCR assays for the 8 BV-COs: Atopobium vaginae, Gardnerella vaginalis, Leptotrichia spp., Megasphaera type I, Sneathia spp., and the Clostridia-like bacteria BVAB1, BVAB2 and BVAB3. Associations between BV-COs and BV and behaviours were examined by univariate and multivariable analyses. Results: On univariate analysis, all BV-COs were more common in BV compared to normal flora. However, only Megasphaera type I, BVAB2, A. vaginae and G. vaginalis were significantly independently associated with BV by multivariable analysis. Six of the eight BV-COs (Megasphaera type I, BVAB2, BVAB3, Sneathia, Leptotrichia and G. vaginalis) were rare or absent in sexually-unexposed women, and demonstrated increasing odds of detection with increasing levels of sexual activity and/or numbers of lifetime sexual partners. Only G. vaginalis and A. vaginae were commonly detected in sexually-unexposed women. Megasphaera type I was independently associated with women-who-have-sex-with women (WSW) and lifetime sexual partner numbers, while unprotected penile-vaginal-sex was associated with BVAB2 detection by multivariate analysis. Conclusions: Four of eight key BV-COs were significantly associated with BV after adjusting for the presence of other BVCOs. The majority of BV-COs were absent or rare in sexually-unexposed women, and associated with increasing sexual exposure, suggesting potential sexual transmission of BV-COs.	[Fethers, Katherine; Fowkes, Freya J. I.; Hocking, Jane S.; Bradshaw, Catriona S.] Univ Melbourne, Sch Populat Hlth, Melbourne, Vic, Australia; [Fethers, Katherine; Fairley, Christopher K.; Fehler, Glenda; Morton, Anna M.; Bradshaw, Catriona S.] Alfred Hosp, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Twin, Jimmy; Garland, Suzanne M.; Tabrizi, Sepehr N.] Royal Womens Hosp, Dept Mol Microbiol, Melbourne, Vic, Australia; [Twin, Jimmy; Garland, Suzanne M.; Tabrizi, Sepehr N.] Murdoch Childrens Res Inst, Dept Infect Dis & Microbiol, Melbourne, Vic, Australia; [Fowkes, Freya J. I.] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia; [Garland, Suzanne M.; Tabrizi, Sepehr N.] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Bradshaw, Catriona S.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia	University of Melbourne; Florey Institute of Neuroscience & Mental Health; Murdoch Children's Research Institute; Burnet Institute; University of Melbourne; Monash University	Fethers, K (corresponding author), Univ Melbourne, Sch Populat Hlth, Melbourne, Vic, Australia.	kfethers@mshc.org.au	Hocking, Jane/AAD-5203-2021	Hocking, Jane/0000-0001-9329-8501; Christopher, Fairley/0000-0001-9081-1664; Fowkes, Freya/0000-0001-5832-9464; bradshaw, catriona/0000-0002-6643-5678	Australian National Health and Medical Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Dr. Fethers, Dr. Bradshaw, Dr. Fowkes, Dr. Garland and Dr. Hocking are currently or were supported by the Australian National Health and Medical Research Council Fellowship scheme for the period of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsworth JE, 2007, OBSTET GYNECOL, V109, P114, DOI 10.1097/01.AOG.0000247627.84791.91; Bailey JV, 2004, SEX TRANSM DIS, V31, P691, DOI 10.1097/01.olq.0000143093.70899.68; Berger BJ, 1995, CLIN INFECT DIS, V21, P1402, DOI 10.1093/clinids/21.6.1402; Bradshaw CS, 2006, J INFECT DIS, V194, P828, DOI 10.1086/506621; Bradshaw CS, 2005, OBSTET GYNECOL, V106, P105, DOI 10.1097/01.AOG.0000163247.78533.7b; Bukusi E, 2011, SEX TRANSM DIS, V38, P483, DOI 10.1097/OLQ.0b013e318214b82d; BUMP RC, 1988, AM J OBSTET GYNECOL, V158, P935, DOI 10.1016/0002-9378(88)90097-X; Eren AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026732; Ferris MJ, 2004, J CLIN MICROBIOL, V42, P5892, DOI [10.1128/JCM.42.12.5892-5894.2004, 10.1128/jcm.42.12.5892-5894.2004]; Fethers K, 2000, SEX TRANSM INFECT, V76, P345, DOI 10.1136/sti.76.5.345; Fethers KA, 2008, CLIN INFECT DIS, V47, P1426, DOI 10.1086/592974; Fethers KA, 2011, SEX TRANSM DIS, V38, P124, DOI 10.1097/OLQ.0b013e3181f0bc37; Fethers KA, 2009, J INFECT DIS, V200, P1662, DOI 10.1086/648092; Fredricks DN, 2007, J CLIN MICROBIOL, V45, P3270, DOI 10.1128/JCM.01272-07; Fredricks DN, 2009, J CLIN MICROBIOL, V47, P721, DOI 10.1128/JCM.01384-08; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Goldenberg RL, 1997, CLIN PERINATOL, V24, P23, DOI 10.1016/S0095-5108(18)30182-9; GRAVETT MG, 1986, OBSTET GYNECOL, V67, P229, DOI 10.1097/00006250-198602000-00013; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Hummelen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012078; Hyman RW, 2005, P NATL ACAD SCI USA, V102, P7952, DOI 10.1073/pnas.0503236102; Josey WE, 2008, INT J STD AIDS, V19, P152, DOI 10.1258/ijsa.2007.007260; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Lamont RF, 2000, INT J STD AIDS, V11, P495, DOI 10.1258/0956462001916371; Marrazzo JM, 2002, J INFECT DIS, V185, P1307, DOI 10.1086/339884; Martin David H, 2008, Curr Infect Dis Rep, V10, P128, DOI 10.1007/s11908-008-0023-x; MEIS PJ, 1995, AM J OBSTET GYNECOL, V173, P1231, DOI 10.1016/0002-9378(95)91360-2; Menard JP, 2008, CLIN INFECT DIS, V47, P33, DOI 10.1086/588661; MENGEL MB, 1989, J FAM PRACTICE, V28, P163; Mitchell C, 2009, INFECT DIS OBSTET GY, V2009; Morris MC, 2001, SEX TRANSM INFECT, V77, P63, DOI 10.1136/sti.77.1.63; Nelson DB, 2003, J CLIN EPIDEMIOL, V56, P862, DOI 10.1016/S0895-4356(03)00073-8; Oakley BB, 2008, APPL ENVIRON MICROB, V74, P4898, DOI 10.1128/AEM.02884-07; Papanikolaou EG, 2002, INFECTION, V30, P403, DOI 10.1007/s15010-002-2001-9; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Schellenberg J, 2009, APPL ENVIRON MICROB, V75, P2889, DOI 10.1128/AEM.01640-08; Schwebke JR, 1999, J INFECT DIS, V180, P1632, DOI 10.1086/315065; Schwebke JR, 2005, SEX TRANSM DIS, V32, P654, DOI 10.1097/01.olq.0000175396.10304.62; Skinner CJ, 1996, GENITOURIN MED, V72, P277; Smart S, 2004, SEX TRANSM INFECT, V80, P58, DOI 10.1136/sti.2003.004978; Srinivasan S., 2008, INTERDISCIP PERSPECT, V2008; Strauss Robert A, 2005, Infect Dis Obstet Gynecol, V13, P31; Swidsinski A, 2005, OBSTET GYNECOL, V106, P1013, DOI 10.1097/01.AOG.0000183594.45524.d2; Swidsinski A, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.039; Tabrizi SN, 2004, SEX TRANSM INFECT, V80, P68, DOI 10.1136/sti.2003.006239; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; VEJTORP M, 1988, BRIT J OBSTET GYNAEC, V95, P920, DOI 10.1111/j.1471-0528.1988.tb06581.x; Verhelst R, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-16; VUTYAVANICH T, 1993, OBSTET GYNECOL, V82, P550; Zariffard MR, 2002, FEMS IMMUNOL MED MIC, V34, P277, DOI 10.1111/j.1574-695X.2002.tb00634.x; Zhou X, 2004, MICROBIOL-SGM, V150, P2565, DOI 10.1099/mic.0.26905-0; Zhou X, 2007, ISME J, V1, P121, DOI 10.1038/ismej.2007.12; Zozaya-Hinchliffe M, 2010, J CLIN MICROBIOL, V48, P1812, DOI 10.1128/JCM.00851-09	53	54	56	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30633	10.1371/journal.pone.0030633	http://dx.doi.org/10.1371/journal.pone.0030633			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363457	Green Published, gold			2022-12-27	WOS:000302853600044
J	Graewe, B; De Weerd, P; Farivar, R; Castelo-Branco, M				Graewe, Britta; De Weerd, Peter; Farivar, Reza; Castelo-Branco, Miguel			Stimulus Dependency of Object-Evoked Responses in Human Visual Cortex: An Inverse Problem for Category Specificity	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; FACE PERCEPTION; ELECTROMAGNETIC TOMOGRAPHY; UNFAMILIAR FACES; MOTION-ONSET; N170; RECOGNITION; BRAIN; ERPS; TEXTURE	Many studies have linked the processing of different object categories to specific event-related potentials (ERPs) such as the face-specific N170. Despite reports showing that object-related ERPs are influenced by visual stimulus features, there is consensus that these components primarily reflect categorical aspects of the stimuli. Here, we re-investigated this idea by systematically measuring the effects of visual feature manipulations on ERP responses elicited by both structure-from-motion (SFM)-defined and luminance-defined object stimuli. SFM objects elicited a novel component at 200-250 ms (N250) over parietal and posterior temporal sites. We found, however, that the N250 amplitude was unaffected by restructuring SFM stimuli into meaningless objects based on identical visual cues. This suggests that this N250 peak was not uniquely linked to categorical aspects of the objects, but is strongly determined by visual stimulus features. We provide strong support for this hypothesis by parametrically manipulating the depth range of both SFM- and luminance-defined object stimuli and showing that the N250 evoked by SFM stimuli as well as the well-known N170 to static faces were sensitive to this manipulation. Importantly, this effect could not be attributed to compromised object categorization in low depth stimuli, confirming a strong impact of visual stimulus features on object-related ERP signals. As ERP components linked with visual categorical object perception are likely determined by multiple stimulus features, this creates an interesting inverse problem when deriving specific perceptual processes from variations in ERP components.	[Graewe, Britta; De Weerd, Peter] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands; [Graewe, Britta] Univ Coimbra, Inst Biomeed Res Light & Image, Visual Neurosci Lab, Coimbra, Portugal; [De Weerd, Peter] Radboud Univ Nijmegen, Donders Inst Brain Behav & Cognit, NL-6525 ED Nijmegen, Netherlands; [Farivar, Reza] Harvard Univ, Sch Med, Charlestown, MA USA; [Farivar, Reza] Massachusetts Gen Hosp, A Athinoula Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Castelo-Branco, Miguel] Univ Coimbra, IBILI, Visual Neurosci Lab, Coimbra, Portugal	Maastricht University; Universidade de Coimbra; Radboud University Nijmegen; Harvard University; Harvard University; Massachusetts General Hospital; Universidade de Coimbra	Graewe, B (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands.	britta.graewe@maastrichtuniversity.nl	Castelo-Branco, Miguel/F-3866-2019; Farivar, Reza/AAA-5762-2020; Castelo-Branco, Miguel/E-5689-2010	Castelo-Branco, Miguel/0000-0003-4364-6373; 	Foundation for Science and Technology Portugal [SFRH/BD/37385/2007, PTDC/SAU/NEU/68483/2006, PIC/IC/82986/2007]; Bial Foundation [94/06]; BIN (Brain Imaging Network of Portugal)	Foundation for Science and Technology Portugal(Portuguese Foundation for Science and Technology); Bial Foundation(Bial Foundation); BIN (Brain Imaging Network of Portugal)	This work was supported by a grant to BG, MC-B and PDW (SFRH/BD/37385/2007), Grants PTDC/SAU/NEU/68483/2006 and PIC/IC/82986/2007 from the Foundation for Science and Technology Portugal (http://www.fct.pt/) and the Bial Foundation 94/06 (http://www.bial.com/en/bial_foundation.11/grants.18/grants.a38.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the support of the BIN (Brain Imaging Network of Portugal). We would like to thank Jose Rebola for his help with creating the luminance-defined stimuli and Valerie Goffaux for valuable comments during manuscript revision.	Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; BACH M, 1994, VISION RES, V34, P1541, DOI 10.1016/0042-6989(94)90111-2; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bentin S, 2002, COGNITION, V86, pB1, DOI 10.1016/S0010-0277(02)00124-5; Caharel S, 2002, INT J NEUROSCI, V112, P1499, DOI 10.1080/00207450290158368; Caharel S, 2005, BRAIN COGNITION, V59, P96, DOI 10.1016/j.bandc.2005.05.005; Eimer M, 2000, NEUROREPORT, V11, P2319, DOI 10.1097/00001756-200007140-00050; Eimer M, 1999, NEUROREPORT, V10, P255, DOI 10.1097/00001756-199902050-00010; FARAH MJ, 1988, J EXP PSYCHOL GEN, V117, P248, DOI 10.1037/0096-3445.117.3.248; Farivar R, 2009, BRAIN RES REV, V61, P144, DOI 10.1016/j.brainresrev.2009.05.006; Farivar R, 2009, J NEUROSCI, V29, P5336, DOI 10.1523/JNEUROSCI.4978-08.2009; Fleuaris AV, 2008, BRAIN RES, V1194, P100, DOI 10.1016/j.brainres.2007.11.071; George N, 2005, COGNITIVE BRAIN RES, V24, P663, DOI 10.1016/j.cogbrainres.2005.03.017; Goffaux V, 2003, COGNITIVE BRAIN RES, V16, P416, DOI 10.1016/S0926-6410(03)00056-9; Haushofer J, 2008, J NEUROPHYSIOL, V100, P753, DOI 10.1152/jn.90310.2008; Herrmann MJ, 2005, J NEURAL TRANSM, V112, P1073, DOI 10.1007/s00702-004-0250-8; Hirai M, 2003, NEUROSCI LETT, V344, P41, DOI 10.1016/S0304-3940(03)00413-0; Hopf JM, 2002, J NEUROPHYSIOL, V88, P2088, DOI 10.1152/jn.2002.88.4.2088; Itier RJ, 2002, NEUROIMAGE, V15, P353, DOI 10.1006/nimg.2001.0982; Itier RJ, 2004, CEREB CORTEX, V14, P132, DOI 10.1093/cercor/bhg111; Itier RJ, 2004, NEUROREPORT, V15, P1261, DOI 10.1097/01.wnr.0000127827.73576.d8; Jacques C, 2007, NEUROIMAGE, V36, P863, DOI 10.1016/j.neuroimage.2007.04.016; Jeffreys DA, 1996, EXP BRAIN RES, V111, P100; Jemel B, 2003, COGNITIVE BRAIN RES, V17, P431, DOI 10.1016/S0926-6410(03)00145-9; Jiang Y, 2008, J COGNITIVE NEUROSCI, V20, P553, DOI 10.1162/jocn.2008.20050; Kayaert G, 2005, CEREB CORTEX, V15, P1308, DOI 10.1093/cercor/bhi014; Kriegeskorte N, 2003, J NEUROSCI, V23, P1451, DOI 10.1523/JNEUROSCI.23-04-01451.2003; KUBA M, 1992, DOC OPHTHALMOL, V80, P83, DOI 10.1007/BF00161234; Lamme VAF, 1999, CEREB CORTEX, V9, P406, DOI 10.1093/cercor/9.4.406; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Latinus M, 2006, BRAIN RES, V1123, P179, DOI 10.1016/j.brainres.2006.09.031; Liu CH, 2005, PERCEPT PSYCHOPHYS, V67, P158, DOI 10.3758/BF03195019; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; MOTTER BC, 1994, J NEUROSCI, V14, P2190; Mueller Andreas, 2010, Nonlinear Biomed Phys, V4 Suppl 1, pS1, DOI 10.1186/1753-4631-4-S1-S1; Orban GA, 1999, NEURON, V24, P929, DOI 10.1016/S0896-6273(00)81040-5; Paradis AL, 2000, CEREB CORTEX, V10, P772, DOI 10.1093/cercor/10.8.772; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Pegna AJ, 2004, HUM BRAIN MAPP, V22, P300, DOI 10.1002/hbm.20039; Righart R, 2011, BRAIN TOPOGR, V24, P9, DOI 10.1007/s10548-010-0164-8; Rossion B, 1999, BIOL PSYCHOL, V50, P173, DOI 10.1016/S0301-0511(99)00013-7; Rossion B, 2000, NEUROREPORT, V11, P69, DOI 10.1097/00001756-200001170-00014; Rossion B., 2011, OXFORD HDB ERP COMPO; Rossion Bruno, 2002, Behav Cogn Neurosci Rev, V1, P63, DOI 10.1177/1534582302001001004; Rousselet GA, 2008, BMC NEUROSCI, V10, P114; Rousselet GA, 2008, J VISION, V8, DOI 10.1167/8.12.3; Schellart NAM, 2004, VISION RES, V44, P119, DOI 10.1016/j.visres.2003.09.016; Schlykowa SS, 1993, BRAIN RES COGN BRAIN, V1, P169; Schweinberger SR, 2004, NEUROREPORT, V15, P1501, DOI 10.1097/01.wnr.0000131675.00319.42; Sparacino G, 2002, COMPUT METH PROG BIO, V68, P233, DOI 10.1016/S0169-2607(01)00175-4; Thierry G, 2007, NAT NEUROSCI, V10, P505, DOI 10.1038/nn1864; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Troje NF, 1996, VISION RES, V36, P1761, DOI 10.1016/0042-6989(95)00230-8; VanRullen R, 2001, J COGNITIVE NEUROSCI, V13, P454, DOI 10.1162/08989290152001880; Vizioli L, 2010, J VISION, V10, DOI 10.1167/10.1.15; Vlamings PH, 2009, J VIS, V14, P121; ZEKI S, 1991, J NEUROSCI, V11, P641; Zion-Golumbic E, 2007, CEREB CORTEX, V17, P1741, DOI 10.1093/cercor/bhl100	59	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30727	10.1371/journal.pone.0030727	http://dx.doi.org/10.1371/journal.pone.0030727			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363479	gold, Green Published, Green Submitted			2022-12-27	WOS:000302853600062
J	Wang, QX; Liu, HT; Gao, AN; Yang, XM; Liu, WH; Li, XQ; Li, LH				Wang, Qiuxia; Liu, Huitao; Gao, Ainong; Yang, Xinming; Liu, Weihua; Li, Xiuquan; Li, Lihui			Intergenomic Rearrangements after Polyploidization of Kengyilia thoroldiana (Poaceae: Triticeae) Affected by Environmental Factors	PLOS ONE			English	Article							QINGHAI-XIZANG PLATEAU; MULTICOLOR GISH; THINOPYRUM-INTERMEDIUM; HYBRID SPECIATION; GENOME EVOLUTION; PLANT POLYPLOIDS; GENE-EXPRESSION; DNA-SEQUENCES; WHEAT; HYBRIDIZATION	Polyploidization is a major evolutionary process. Approximately 70-75% species of Triticeae (Poaceae) are polyploids, involving 23 genomes. To investigate intergenomic rearrangements after polyploidization of Triticeae species and to determine the effects of environmental factors on them, nine populations of a typical polyploid Triticeae species, Kengyilia thoroldiana (Keng) J.L. Yang et al. (2n = 6x = 42, StStPPYY), collected from different environments, were studied using genome in situ hybridization (GISH). We found that intergenomic rearrangements occurred between the relatively large P genome and the small genomes, St (8.15%) and Y (22.22%), in polyploid species via various types of translocations compared to their diploid progenitors. However, no translocation was found between the relatively small St and Y chromosomes. Environmental factors may affect rearrangements among the three genomes. Chromosome translocations were significantly more frequent in populations from cold alpine and grassland environments than in populations from valley and lake-basin habitats (P<0.05). The relationship between types of chromosome translocations and altitude was significant (r=0.809, P<0.01). Intergenomic rearrangements associated with environmental factors and genetic differentiation of a single basic genome should be considered as equally important genetic processes during species' ecotype evolution.	[Wang, Qiuxia; Gao, Ainong; Yang, Xinming; Liu, Weihua; Li, Xiuquan; Li, Lihui] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China; [Liu, Huitao] Chinese Acad Agr Sci, Inst Special Wild Anim & Plant Sci, State Key Lab Special Econ Anim Mol Biol, Jilin, Jilin, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences; Institute of Special Animal & Plant Sciences, CAAS	Wang, QX (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China.	gaoainong@caas.net.cn; lilihui@caas.net.cn			National Natural Science Foundation of China [30871520]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support provided by the National Natural Science Foundation of China (project numbers 30871520) is gratefully appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bento M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001402; Bing C.L., 2001, J SYST EVOL, V39, P248; Brysting AK, 2000, ANN BOT-LONDON, V85, P439, DOI 10.1006/anbo.1999.1088; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Chen ZJ, 2006, BIOESSAYS, V28, P240, DOI 10.1002/bies.20374; Chen ZJ, 2004, BIOL J LINN SOC, V82, P689, DOI 10.1111/j.1095-8312.2004.00351.x; Comai L, 2000, PLANT CELL, V12, P1551, DOI 10.1105/tpc.12.9.1551; Crombach A, 2007, MOL BIOL EVOL, V24, P1130, DOI 10.1093/molbev/msm033; DEVOS KM, 1993, THEOR APPL GENET, V85, P784, DOI 10.1007/BF00225020; DEWEY D R, 1984, P209; Dong YS, 2001, THEOR APPL GENET, V103, P98, DOI 10.1007/s001220000522; DONG YS, 1998, CHIN CROPS, V1, P18; Ehrendorfer F, POLYPLOIDY DISTRIBUT, P45; Feldman M, 1997, GENETICS, V147, P1381; Feldman M., 2001, ORIGIN CULTIVATED WH, P1; Gaeta RT, 2010, NEW PHYTOL, V186, P18, DOI 10.1111/j.1469-8137.2009.03089.x; Gale MD, 1998, SCIENCE, V282, P656, DOI 10.1126/science.282.5389.656; GAO YX, 1981, B AM METEOROL SOC, V62, P31, DOI 10.1175/1520-0477(1981)062<0031:SAORRO>2.0.CO;2; Gill B, 1991, NUCL ORGANELLAR GENO, P48; Grant V, ORIGIN ADAPTATIONS; GRANT V, PLANT SPECIATION; GRUN P, 1952, AM J BOT, V39, P318, DOI 10.2307/2438260; Han FP, 2004, THEOR APPL GENET, V109, P1070, DOI 10.1007/s00122-004-1720-y; Han FP, 2003, GENOME, V46, P490, DOI [10.1139/g03-032, 10.1139/G03-032]; Hegarty MJ, 2008, CURR BIOL, V18, pR435, DOI 10.1016/j.cub.2008.03.043; Hegarty MJ, 2005, NEW PHYTOL, V165, P411, DOI 10.1111/j.1469-8137.2004.01253.x; JENSEN KB, 1994, J NEMATOL, V26, P635; Lagercrantz U, 1996, GENETICS, V144, P1903; Leitch AR, 2008, SCIENCE, V320, P481, DOI 10.1126/science.1153585; Leitch IJ, 1997, TRENDS PLANT SCI, V2, P470, DOI 10.1016/S1360-1385(97)01154-0; LEVIN DA, 1983, AM NAT, V122, P1, DOI 10.1086/284115; Lu B, 1995, CHINESE BIODIVERSITY, V2, P63; MASTERSON J, 1994, SCIENCE, V264, P421, DOI 10.1126/science.264.5157.421; Mu J, 2000, CHINESE SCI BULL, V45, P293; Naranjo T, 2004, ENCY PLANT CROP SCI, V1, P270; NEDERLOF PM, 1990, CYTOMETRY, V11, P126, DOI 10.1002/cyto.990110115; Nevo E, 1998, GENET RESOUR CROP EV, V45, P151, DOI 10.1023/A:1008616923427; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Piao SL, 2006, CLIMATIC CHANGE, V74, P253, DOI 10.1007/s10584-005-6339-8; SANKOFF D, 1999, COMP MAPPING GENOME, P124; Sepsi A, 2008, THEOR APPL GENET, V116, P825, DOI 10.1007/s00122-008-0716-4; SHARP PJ, 1988, THEOR APPL GENET, V75, P286, DOI 10.1007/BF00303966; SOLTIS DE, 1993, CRIT REV PLANT SCI, V12, P243, DOI 10.1080/713608048; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Soltis PS, 2000, P NATL ACAD SCI USA, V97, P7051, DOI 10.1073/pnas.97.13.7051; Stebbins G, VARIATION EVOLUTION; STEBBINS G. L., 1971, Chromosomal evolution in higher plants.; Ungerer MC, 1998, P NATL ACAD SCI USA, V95, P11757, DOI 10.1073/pnas.95.20.11757; Wang QX, 2010, GENOME, V53, P241, DOI [10.1139/G09-098, 10.1139/g09-098]; WANG RRC, 1986, CROP SCI, V26, P723, DOI 10.2135/cropsci1986.0011183X002600040018x; Weidema IR, 2000, HEREDITY, V84, P311, DOI 10.1046/j.1365-2540.2000.00669.x; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; WENDEL JF, 1995, P NATL ACAD SCI USA, V92, P280, DOI 10.1073/pnas.92.1.280; Wu J, 2006, THEOR APPL GENET, V114, P13, DOI 10.1007/s00122-006-0405-0; Yen C, 2006, SYSTEMATICS TRITICEA, V3, P1	55	22	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31033	10.1371/journal.pone.0031033	http://dx.doi.org/10.1371/journal.pone.0031033			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363542	gold, Green Submitted, Green Published			2022-12-27	WOS:000302853600102
J	Zhou, CC; Chang, J; Mi, TJ; Abbasi, S; Gu, DM; Huang, L; Zhang, WZ; Kellems, RE; Schwartz, RJ; Xia, Y				Zhou, Cissy Chenyi; Chang, Jiang; Mi, Tiejuan; Abbasi, Shahrzad; Gu, Dongmin; Huang, Le; Zhang, WenZheng; Kellems, Rodney E.; Schwartz, Robert J.; Xia, Yang			Targeted Expression of Cre Recombinase Provokes Placental-Specific DNA Recombination in Transgenic Mice	PLOS ONE			English	Article							ADENOSINE-DEAMINASE; HLA-G; REGULATORY REGION; MOUSE MUTANTS; GENE-TRANSFER; IN-VIVO; TRANSCRIPTION; PREECLAMPSIA; CELLS; STRATEGY	Background: Inadequate placental development is associated with a high incidence of early embryonic lethality and serious pregnancy disorders in both humans and mice. However, the lack of well-defined trophoblast-specific gene regulatory elements has hampered investigations regarding the role of specific genes in placental development and fetal growth. Principal Findings: By random assembly of placental enhancers from two previously characterized genes, trophoblast specific protein a (Tpbpa) and adenosine deaminase (Ada), we identified a chimeric Tpbpa/Ada enhancer that when combined with the basal Ada promoter provided the highest luciferase activity in cultured human trophoblast cells, in comparison with non-trophoblast cell lines. We used this chimeric enhancer arrangement to drive the expression of a Cre recombinase transgene in the placentas of transgenic mice. Cre transgene expression occurred throughout the placenta but not in maternal organs examined or in the fetus. Significance: In conclusion, we have provided both in vitro and in vivo evidence for a novel genetic system to achieve placental transgene expression by the use of a chimeric Tpbpa/Ada enhancer driven transgene. The availability of this expression vector provides transgenic opportunities to direct the production of desired proteins to the placenta.	[Zhou, Cissy Chenyi; Mi, Tiejuan; Abbasi, Shahrzad; Gu, Dongmin; Kellems, Rodney E.; Xia, Yang] Texas A&M Hlth Sci Ctr, Dept Biochem, Houston, TX USA; [Chang, Jiang; Schwartz, Robert J.] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [Huang, Le; Zhang, WenZheng] Univ Texas Houston, Sch Med, Dept Internal Med, Houston, TX USA; [Zhou, Cissy Chenyi; Mi, Tiejuan; Abbasi, Shahrzad; Gu, Dongmin; Kellems, Rodney E.; Xia, Yang] Texas A&M Hlth Sci Ctr, Dept Mol Biol, Houston, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Zhou, CC (corresponding author), Texas A&M Hlth Sci Ctr, Dept Biochem, Houston, TX USA.	yang.xia@uth.tmc.edu	Gu, Dongmin/C-9048-2013	Chang, Jiang/0000-0003-3707-7557	National Institute of Health [HL076558, HL102314, HL094844]; American Heart Association [3760081-AHA-GA, 0855030F]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL094844, K02HL098956, R01HL076558, R01HL102314] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institute of Health Grants HL076558 (Y.X.), HL102314 (J.C.) HL094844 (J.C.) and in part by American Heart Association Grant-in-Aid 3760081-AHA-GA (Y.X.) and 0855030F (J.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; BLACKBURN MR, 1995, J BIOL CHEM, V270, P23891, DOI 10.1074/jbc.270.41.23891; Blackburn MR, 1998, J BIOL CHEM, V273, P5093, DOI 10.1074/jbc.273.9.5093; CALZONETTI T, 1995, DEV BIOL, V171, P615, DOI 10.1006/dbio.1995.1309; Cross JC, 2006, REPROD FERT DEVELOP, V18, P71, DOI 10.1071/RD05121; Deussing J, 2002, GENOMICS, V79, P225, DOI 10.1006/geno.2002.6696; Georgiades P, 2007, BIOTECHNIQUES, V42, P317, DOI 10.2144/000112341; HORUZSKO A, 1994, IMMUNOLOGY, V83, P324; INGOLIA DE, 1985, J BIOL CHEM, V260, P3261; Irani RA, 2009, J EXP MED, V206, P2809, DOI 10.1084/jem.20090872; Joshi MU, 2008, BIOTECHNIQUES, V45, P247, DOI 10.2144/000112913; KNUDSEN TB, 1991, BIOL REPROD, V44, P171, DOI 10.1095/biolreprod44.1.171; Krebs C, 1996, AM J OBSTET GYNECOL, V175, P1534, DOI 10.1016/S0002-9378(96)70103-5; Okada Y, 2007, NAT BIOTECHNOL, V25, P233, DOI 10.1038/nbt1280; Rawn SM, 2008, ANNU REV CELL DEV BI, V24, P159, DOI 10.1146/annurev.cellbio.24.110707.175418; Rossant J, 1999, GENE DEV, V13, P142, DOI 10.1101/gad.13.2.142; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; SCHMIDT CM, 1993, J IMMUNOL, V151, P2633; SCHMIDT CM, 1995, IMMUNOL REV, V147, P53, DOI 10.1111/j.1600-065X.1995.tb00087.x; Senut MC, 1998, J CLIN INVEST, V101, P1565, DOI 10.1172/JCI1959; Shi DQ, 1997, J BIOL CHEM, V272, P2334, DOI 10.1074/jbc.272.4.2334; Thomson JG, 2003, GENESIS, V36, P162, DOI 10.1002/gene.10211; Xing AY, 2000, HUM GENE THER, V11, P167, DOI 10.1089/10430340050016247; YELAVARTHI KK, 1993, J IMMUNOL, V151, P3638; Zhou CC, 2008, NAT MED, V14, P855, DOI 10.1038/nm.1856; Zhou CCY, 2008, HYPERTENSION, V51, P1010, DOI 10.1161/HYPERTENSIONAHA.107.097790; Zhou CC, 2007, CIRC RES, V100, P88, DOI 10.1161/01.RES.0000254703.11154.18; ZHOU Y, 1993, J CLIN INVEST, V91, P950, DOI 10.1172/JCI116316	28	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e29236	10.1371/journal.pone.0029236	http://dx.doi.org/10.1371/journal.pone.0029236			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363401	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600005
J	Bais, MV; Nugent, MA; Stephens, DN; Sume, SS; Kirsch, KH; Sonenshein, GE; Trackman, PC				Bais, Manish V.; Nugent, Matthew A.; Stephens, Danielle N.; Sume, S. Selva; Kirsch, Kathrin H.; Sonenshein, Gail E.; Trackman, Philip C.			Recombinant Lysyl Oxidase Propeptide Protein Inhibits Growth and Promotes Apoptosis of Pre-Existing Murine Breast Cancer Xenografts	PLOS ONE			English	Article							TUMOR-SUPPRESSOR ACTIVITY; TRANSFORMED PHENOTYPE; PHOSPHOHISTONE H3; PROLIFERATION; KI-67; CELLS; RAS; ACTIVATION; CARCINOMA; REPP86	Lysyl oxidase propeptide (LOX-PP) ectopic overexpression inhibits the growth of cancer xenografts. Here the ability and mode of action of purified recombinant LOX-PP (rLOX-PP) protein to inhibit the growth of pre-existing xenografts was determined. Experimental approaches employed were direct intratumoral injection (i.t.) of rLOX-PP protein into murine breast cancer NF639 xenografts, and application of a slow release formulation of rLOX-PP implanted adjacent to tumors in NCR nu/nu mice (n = 10). Tumors were monitored for growth, and after sacrifice were subjected to immunohistochemical and Western blot analyses for several markers of proliferation, apoptosis, and for rLOX-PP itself. Direct i.t. injection of rLOX-PP significantly reduced tumor volume on days 20, 22 and 25 and tumor weight at harvest on day 25 by 30% compared to control. Implantation of beads preloaded with 35 micrograms rLOX-PP (n = 10) in vivo reduced tumor volume and weight at sacrifice when compared to empty beads (p < 0.05). A 30% reduction of tumor volume on days 22 and 25 (p < 0.05) and final tumor weight on day 25 (p < 0.05) were observed with a reduced tumor growth rate of 60% after implantation. rLOX-PP significantly reduced the expression of proliferation markers and Erk1/2 MAP kinase activation, while prominent increases in apoptosis markers were observed. rLOX-PP was detected by immunohistochemistry in harvested rLOX-PP tumors, but not in controls. Data provide pre-clinical findings that support proof of principle for the therapeutic anti-cancer potential of rLOX-PP protein formulations.	[Bais, Manish V.; Stephens, Danielle N.; Sume, S. Selva; Trackman, Philip C.] Boston Univ, Div Oral Biol, Henry M Goldman Sch Dent Med, Boston, MA 02215 USA; [Nugent, Matthew A.; Kirsch, Kathrin H.; Trackman, Philip C.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Sonenshein, Gail E.] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA	Boston University; Boston University; Tufts University	Bais, MV (corresponding author), Boston Univ, Div Oral Biol, Henry M Goldman Sch Dent Med, Boston, MA 02215 USA.	trackman@bu.edu	Trackman, Philip C/AAX-9280-2021	Trackman, Philip C/0000-0001-5064-614X; Nugent, Matthew/0000-0002-8630-4712; Kirsch, Kathrin/0000-0003-1532-1715; Bais, Manish/0000-0003-4198-7377	NIH [R01 DE14066, RO1 CA82742, R01 HL088572]; Department of Defense [W81XWH-08-1-0349 PC073646]; NATIONAL CANCER INSTITUTE [R01CA082742, R01CA143108] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014066] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by NIH grants: R01 DE14066, RO1 CA82742, and R01 HL088572, and Department of Defense Idea Award W81XWH-08-1-0349 PC073646. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almqvist KF, 2009, AM J SPORT MED, V37, P1920, DOI 10.1177/0363546509335463; Andersen MH, 2005, NAT REV DRUG DISCOV, V4, P399, DOI 10.1038/nrd1717; Aune G, 2011, INT J CLIN EXP PATHO, V4, P444; BALKWILL FR, 1986, CANCER RES, V46, P3990; Bondareva A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005620; Bossard C, 2006, J CLIN PATHOL, V59, P706, DOI 10.1136/jcp.2005.030452; Colozza M, 2010, LANCET ONCOL, V11, P414, DOI 10.1016/S1470-2045(10)70089-9; CRONSHAW AD, 1995, BIOCHEM J, V306, P279, DOI 10.1042/bj3060279; de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756; EDELMAN ER, 1992, J CLIN INVEST, V89, P465, DOI 10.1172/JCI115607; EDELMAN ER, 1993, P NATL ACAD SCI USA, V90, P1513, DOI 10.1073/pnas.90.4.1513; ELSON A, 1995, J BIOL CHEM, V270, P26116, DOI 10.1074/jbc.270.44.26116; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5; Guarneri V, 2009, ANN ONCOL, V20, P1193, DOI 10.1093/annonc/mdn761; Hurtado PA, 2008, BIOCHEM BIOPH RES CO, V366, P156, DOI 10.1016/j.bbrc.2007.11.116; KAGAN HM, 1991, AM J RESP CELL MOL, V5, P206, DOI 10.1165/ajrcmb/5.3.206; Kantarci A, 2007, J DENT RES, V86, P888, DOI 10.1177/154405910708600916; Kantarci A, 2006, J PATHOL, V210, P59, DOI 10.1002/path.2000; Kaul G, 2006, J GENE MED, V8, P100, DOI 10.1002/jgm.819; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; Menke C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014527; Min CY, 2007, CANCER RES, V67, P1105, DOI 10.1158/0008-5472.CAN-06-3867; Min CY, 2010, J CELL BIOCHEM, V111, P1160, DOI 10.1002/jcb.22828; Min CY, 2009, CANCER RES, V69, P6685, DOI 10.1158/0008-5472.CAN-08-4818; Mohsenifar J, 2007, ARCH IRAN MED, V10, P27; Nehra A, 1999, J UROLOGY, V162, P910, DOI 10.1097/00005392-199909010-00089; Nishimura R, BREAST CANC, V17, P269; NUGENT MA, 1992, MATER RES SOC SYMP P, V252, P273; OZZELLO L, 1988, J INTERFERON RES, V8, P679, DOI 10.1089/jir.1988.8.679; OZZELLO L, 1988, J INTERFERON RES, V8, P207, DOI 10.1089/jir.1988.8.207; Palamakumbura AH, 2009, ONCOGENE, V28, P3390, DOI 10.1038/onc.2009.203; Palamakumbura AH, 2004, J BIOL CHEM, V279, P40593, DOI 10.1074/jbc.M406639200; Petrovic D, COLL ANTROPOL, V34, P93; Santana RB, 2006, INT J ORAL MAX IMPL, V21, P711; Santisteban M, 2010, BREAST CANCER RES TR, V121, P431, DOI 10.1007/s10549-009-0534-7; Sato S, 2011, MOL CELL BIOL, V31, P2683, DOI 10.1128/MCB.01148-10; Screpanti V, 2005, MOL IMMUNOL, V42, P495, DOI 10.1016/j.molimm.2004.07.033; SHIRAI M, 1990, EUR J CANCER, V26, P1045, DOI 10.1016/0277-5379(90)90048-X; Skaland I, 2009, CELL ONCOL, V31, P261, DOI 10.3233/CLO-2009-0464; Sume SS, 2010, AM J PATHOL, V177, P208, DOI 10.2353/ajpath.2010.090952; Taheri ZM, 2008, ARCH PATHOL LAB MED, V132, P694, DOI 10.1043/1543-2165(2008)132[694:TDVOKA]2.0.CO;2; Tanei T, 2011, EJSO-EUR J SURG ONC, V37, P155, DOI 10.1016/j.ejso.2010.10.009; Ueda S, 2011, BREAST CANCER-TOKYO, V18, P299, DOI 10.1007/s12282-010-0212-y; Uzel MI, 2001, J PERIODONTOL, V72, P921, DOI 10.1902/jop.2001.72.7.921; Uzel MI, 2001, J BIOL CHEM, V276, P22537, DOI 10.1074/jbc.M102352200; Vora SR, 2010, BIOCHEMISTRY-US, V49, P2962, DOI 10.1021/bi902218p; Vora SR, 2010, J BIOL CHEM, V285, P7384, DOI 10.1074/jbc.M109.033597; Wiesner FG, 2009, BREAST, V18, P135, DOI 10.1016/j.breast.2009.02.009; Wu M, 2007, CANCER RES, V67, P6278, DOI 10.1158/0008-5472.CAN-07-0776; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1; Yu L, CANC CYTOPATHOL, V118, P47; Zhao YS, 2009, J BIOL CHEM, V284, P1385, DOI 10.1074/jbc.M802612200	53	31	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e31188	10.1371/journal.pone.0031188	http://dx.doi.org/10.1371/journal.pone.0031188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22363577	Green Published, Green Submitted, gold			2022-12-27	WOS:000302730100053
J	Raza, S; Humayun, A; Abouna, S; Nattkemper, TW; Epstein, DBA; Khan, M; Rajpoot, NM				Raza, Shan-e-Ahmed; Humayun, Ahmad; Abouna, Sylvie; Nattkemper, Tim W.; Epstein, David B. A.; Khan, Michael; Rajpoot, Nasir M.			RAMTaB: Robust Alignment of Multi-Tag Bioimages	PLOS ONE			English	Article							IMAGE REGISTRATION METHODS; PROTEIN CLUSTERS; MICROSCOPY; INFORMATICS; ANNOTATION; SYSTEM	Background: In recent years, new microscopic imaging techniques have evolved to allow us to visualize several different proteins (or other biomolecules) in a visual field. Analysis of protein co-localization becomes viable because molecules can interact only when they are located close to each other. We present a novel approach to align images in a multi-tag fluorescence image stack. The proposed approach is applicable to multi-tag bioimaging systems which (a) acquire fluorescence images by sequential staining and (b) simultaneously capture a phase contrast image corresponding to each of the fluorescence images. To the best of our knowledge, there is no existing method in the literature, which addresses simultaneous registration of multi-tag bioimages and selection of the reference image in order to maximize the overall overlap between the images. Methodology/Principal Findings: We employ a block-based method for registration, which yields a confidence measure to indicate the accuracy of our registration results. We derive a shift metric in order to select the Reference Image with Maximal Overlap (RIMO), in turn minimizing the total amount of non-overlapping signal for a given number of tags. Experimental results show that the Robust Alignment of Multi-Tag Bioimages (RAMTaB) framework is robust to variations in contrast and illumination, yields sub-pixel accuracy, and successfully selects the reference image resulting in maximum overlap. The registration results are also shown to significantly improve any follow-up protein co-localization studies. Conclusions: For the discovery of protein complexes and of functional protein networks within a cell, alignment of the tag images in a multi-tag fluorescence image stack is a key pre-processing step. The proposed framework is shown to produce accurate alignment results on both real and synthetic data. Our future work will use the aligned multi-channel fluorescence image data for normal and diseased tissue specimens to analyze molecular co-expression patterns and functional protein networks.	[Raza, Shan-e-Ahmed; Rajpoot, Nasir M.] Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England; [Humayun, Ahmad] Georgia Inst Technol, Coll Comp, Atlanta, GA 30332 USA; [Abouna, Sylvie; Khan, Michael] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Nattkemper, Tim W.] Univ Bielefeld, Biodata Min Grp, D-33615 Bielefeld, Germany; [Epstein, David B. A.] Univ Warwick, Dept Math, Coventry CV4 7AL, W Midlands, England	University of Warwick; University System of Georgia; Georgia Institute of Technology; University of Warwick; University of Bielefeld; University of Warwick	Raza, S (corresponding author), Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England.	nasir@dcs.warwick.ac.uk	Nattkemper, Tim W/F-3332-2017	Nattkemper, Tim W/0000-0002-7986-1158; Raza, Shan E Ahmed/0000-0002-1097-1738; Khan, Michael/0000-0002-8591-384X; Rajpoot, Nasir/0000-0002-4706-1308	Department of Computer Science at the University of Warwick; University of Warwick on the Institute of Advanced Study (IAS) [IAIC1003]	Department of Computer Science at the University of Warwick; University of Warwick on the Institute of Advanced Study (IAS)	SEAR is partially funded by the Department of Computer Science at the University of Warwick. Part of this work was completed when Dr. Humayun was employed by the University of Warwick on the Institute of Advanced Study (IAS) incubation award# IAIC1003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audet C, 2003, SIAM J OPTIMIZ, V13, P889, DOI 10.1137/S1052623400378742; Barash E, 2010, IEEE T MED IMAGING, V29, P1457, DOI 10.1109/TMI.2010.2045005; Bhattacharya S, 2011, IDENTIFICATION COLON; Bhattacharya S, 2010, J PROTEOME RES, V9, P6112, DOI 10.1021/pr100157p; Bode M, 2007, NATURE METHODS APPL, V4, P1; Can A, 2008, I S BIOMED IMAGING, P288, DOI 10.1109/ISBI.2008.4540989; Chen HM, 2003, IEEE T MED IMAGING, V22, P1111, DOI 10.1109/TMI.2003.816949; Cornett DS, 2007, NAT METHODS, V4, P828, DOI 10.1038/NMETH1094; Friedenberger M, 2007, NAT PROTOC, V2, P2285, DOI 10.1038/nprot.2007.320; Gonzalez R. C., 2008, DIGITAL IMAGE PROCES; Herold J, 2011, WIRES DATA MIN KNOWL, V1, P2, DOI 10.1002/widm.4; Herold J, 2010, COMPUT MED IMAG GRAP, V34, P446, DOI 10.1016/j.compmedimag.2009.10.004; KEYS RG, 1981, IEEE T ACOUST SPEECH, V29, P1153, DOI 10.1109/TASSP.1981.1163711; Kim I, 2007, I S BIOMED IMAGING, P1328, DOI 10.1109/ISBI.2007.357105; Kolda T.G., 2006, GENERATING SET DIREC; Langenkamper D., 2011, P WORKSH COMP SYST B; Li Y, 2011, IEEE T MED IMAGING, V30, P707, DOI 10.1109/TMI.2010.2093908; Likar B, 2001, IMAGE VISION COMPUT, V19, P33, DOI 10.1016/S0262-8856(00)00053-6; Lu XS, 2008, COMPUT MED IMAG GRAP, V32, P202, DOI 10.1016/j.compmedimag.2007.12.001; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Maintz J B, 1998, Med Image Anal, V2, P1, DOI 10.1016/S1361-8415(01)80026-8; Matula P, 2006, IEEE T IMAGE PROCESS, V15, P2388, DOI 10.1109/TIP.2006.875209; Megason SG, 2007, CELL, V130, P784, DOI 10.1016/j.cell.2007.08.031; Murphy RF, 2006, NAT BIOTECHNOL, V24, P1223, DOI 10.1038/nbt1006-1223; Peng HC, 2008, BIOINFORMATICS, V24, P1827, DOI 10.1093/bioinformatics/btn346; Pluim JPW, 2003, IEEE T MED IMAGING, V22, P986, DOI 10.1109/TMI.2003.815867; Rieger B, 2004, MICROSC RES TECHNIQ, V64, P142, DOI 10.1002/jemt.20069; Rohde GK, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 and 2, P712; Rohde GK, 2003, LECT NOTES COMPUT SC, V2717, P214; Salvi J, 2007, IMAGE VISION COMPUT, V25, P578, DOI 10.1016/j.imavis.2006.05.012; Schubert W, 2006, NAT BIOTECHNOL, V24, P1270, DOI 10.1038/nbt1250; Schubert W, 2009, J PROTEOME RES, V8, P2696, DOI 10.1021/pr800944f; Starkuviene V, 2007, BRIT J PHARMACOL, V152, P62, DOI 10.1038/sj.bjp.0707346; Swedlow JR, 2009, TRENDS CELL BIOL, V19, P656, DOI 10.1016/j.tcb.2009.08.007; Swedlow JR, 2009, ANNU REV BIOPHYS, V38, P327, DOI 10.1146/annurev.biophys.050708.133641; Thirion J P, 1998, Med Image Anal, V2, P243, DOI 10.1016/S1361-8415(98)80022-4; van Manen HJ, 2005, P NATL ACAD SCI USA, V102, P10159, DOI 10.1073/pnas.0502746102; Verveer PJ, 2008, HISTOCHEM CELL BIOL, V130, P833, DOI 10.1007/s00418-008-0517-5; Wang YP, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 and 2, P57; Wells W M 3rd, 1996, Med Image Anal, V1, P35; Wilson CA, 2006, IEEE T IMAGE PROCESS, V15, P1939, DOI 10.1109/TIP.2006.873434; Yang SW, 2008, IEEE T IMAGE PROCESS, V17, P493, DOI 10.1109/TIP.2008.918017; Zitova B, 2003, IMAGE VISION COMPUT, V21, P977, DOI 10.1016/S0262-8856(03)00137-9	43	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 8	2012	7	2							e30894	10.1371/journal.pone.0030894	http://dx.doi.org/10.1371/journal.pone.0030894			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924ZP	22363510	Green Submitted, Green Published, gold			2022-12-27	WOS:000302730100030
J	Puthucheary, SD; Puah, SM; Chua, KH				Puthucheary, S. D.; Puah, Suat Moi; Chua, Kek Heng			Molecular Characterization of Clinical Isolates of Aeromonas Species from Malaysia	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; VIRULENCE; IDENTIFICATION; EVOLUTIONARY; ENTEROTOXIN; AQUARIORUM; SPP.	Aeromonas species are common inhabitants of aquatic environments giving rise to infections in both fish and humans. Identification of aeromonads to the species level is problematic and complex due to their phenotypic and genotypic heterogeneity. Methodology/Principal Findings: Aeromonas hydrophila or Aeromonas sp were genetically re-identified using a combination of previously published methods targeting GCAT, 16S rDNA and rpoD genes. Characterization based on the genus specific GCAT-PCR showed that 94 (96%) of the 98 strains belonged to the genus Aeromonas. Considering the patterns obtained for the 94 isolates with the 16S rDNA-RFLP identification method, 3 clusters were recognised, i.e.A. caviae (61%), A. hydrophila (17%) and an unknown group (22%) with atypical RFLP restriction patterns. However, the phylogenetic tree constructed with the obtained rpoD sequences showed that 47 strains (50%) clustered with the sequence of the type strain of A. aquariorum, 18 (19%) with A. caviae, 16 (17%) with A. hydrophila, 12 (13%) with A. veronii and one strain (1%) with the type strain of A. trota. PCR investigation revealed the presence of 10 virulence genes in the 94 isolates as: lip (91%), exu (87%), ela (86%), alt (79%), ser (77%), fla (74%), aer (72%), act (43%), aexT (24%) and ast (23%). Conclusions/Significance: This study emphasizes the importance of using more than one method for the correct identification of Aeromonas strains. The sequences of the rpoD gene enabled the unambiguous identication of the 94 Aeromonas isolates in accordance with results of other recent studies. Aeromonas aquariorum showed to be the most prevalent species (50%) containing an important subset of virulence genes lip/alt/ser/fla/aer. Different combinations of the virulence genes present in the isolates indicate their probable role in the pathogenesis of Aeromonas infections.	[Puthucheary, S. D.] Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia; [Puah, Suat Moi; Chua, Kek Heng] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Puthucheary, SD (corresponding author), Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia.	khchua@um.edu.my	CHUA, KEK HENG/B-5261-2010; Puah, Suat Moi/J-6296-2016	CHUA, KEK HENG/0000-0002-0452-9994; Puah, Suat Moi/0000-0003-1346-3787	University of Malaya	University of Malaya(Universiti Malaya)	This work was supported by University of Malaya High Impact Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott SL, 1998, J CLIN MICROBIOL, V36, P1103, DOI 10.1128/JCM.36.4.1103-1104.1998; Aguilera-Arreola MG, 2007, CAN J MICROBIOL, V53, P877, DOI 10.1139/W07-051; Alperi A, 2008, INT MICROBIOL, V11, P185, DOI 10.2436/20.1501.01.59; Aravena-Roman M, 2011, J CLIN MICROBIOL, V49, P3006, DOI 10.1128/JCM.00472-11; Beaz-Hidalgo R, 2010, SYST APPL MICROBIOL, V33, P149, DOI 10.1016/j.syapm.2010.02.002; Bin Kingombe CI, 2010, APPL ENVIRON MICROB, V76, P425, DOI 10.1128/AEM.01357-09; Bin Kingombe CI, 1999, APPL ENVIRON MICROB, V65, P5293; Borrell N, 1997, J CLIN MICROBIOL, V35, P1671, DOI 10.1128/JCM.35.7.1671-1674.1997; Castilho MCB, 2009, ANTON LEEUW INT J G, V96, P53, DOI 10.1007/s10482-009-9335-6; Chacon MR, 2003, ANTON LEEUW INT J G, V84, P269, DOI 10.1023/A:1026042125243; Chacon MR, 2002, DIAGN MICR INFEC DIS, V44, P221, DOI 10.1016/S0732-8893(02)00455-8; Chopra AK, 1996, MICROB PATHOGENESIS, V21, P357, DOI 10.1006/mpat.1996.0068; Figueras MJ, 2000, INT J SYST EVOL MICR, V50, P2069, DOI 10.1099/00207713-50-6-2069; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Figueras MJ, 2009, J CLIN MICROBIOL, V47, P3742, DOI 10.1128/JCM.02216-08; Figueras MJ, 2011, ENV MICROBIOL REP, V3, P239, DOI 10.1111/j.1758-2229.2010.00216.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lamy B, 2010, CAN J MICROBIOL, V56, P217, DOI [10.1139/W10-006, 10.1139/w10-006]; Lamy B, 2010, DIAGN MICR INFEC DIS, V67, P9, DOI 10.1016/j.diagmicrobio.2009.12.012; Lee W. S., 2001, SMJ Singapore Medical Journal, V42, P057; Martinez-Murcia AJ, 2008, INT J SYST EVOL MICR, V58, P1169, DOI 10.1099/ijs.0.65352-0; Merino S, 1999, INFECT IMMUN, V67, P4008, DOI 10.1128/IAI.67.8.4008-4013.1999; Morandi A, 2005, J BACTERIOL, V187, P6561, DOI 10.1128/JB.187.18.6561-6564.2005; Nam IY, 2007, J MICROBIOL, V45, P297; Nawaz M, 2010, FOOD MICROBIOL, V27, P327, DOI 10.1016/j.fm.2009.11.007; Parker JL, 2011, J INFECTION, V62, P109, DOI 10.1016/j.jinf.2010.12.003; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sen K, 2004, J APPL MICROBIOL, V97, P1077, DOI 10.1111/j.1365-2672.2004.02398.x; Sha J, 2002, INFECT IMMUN, V70, P1924, DOI 10.1128/IAI.70.4.1924-1935.2002; Soler L, 2004, INT J SYST EVOL MICR, V54, P1511, DOI 10.1099/ijs.0.03048-0; Soler L, 2003, J CLIN MICROBIOL, V41, P5732, DOI 10.1128/JCM.41.12.5732-5734.2003; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; VADIVELU J, 1992, SMJ Singapore Medical Journal, V33, P375; VADIVELU J, 1991, J MED MICROBIOL, V34, P363, DOI 10.1099/00222615-34-6-363; Vilches S, 2008, MICROB PATHOGENESIS, V44, P1, DOI 10.1016/j.micpath.2007.06.004; Wu CJ, 2007, J INFECTION, V54, P151, DOI 10.1016/j.jinf.2006.04.002; Yamamoto S, 2000, MICROBIOL-SGM, V146, P2385, DOI 10.1099/00221287-146-10-2385	38	68	72	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e30205	10.1371/journal.pone.0030205	http://dx.doi.org/10.1371/journal.pone.0030205			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22383958	Green Submitted, Green Published, gold			2022-12-27	WOS:000302918500008
J	Gonzalez, LC; Wang, H; Livesay, DR; Jacobs, DJ				Gonzalez, Luis C.; Wang, Hui; Livesay, Dennis R.; Jacobs, Donald J.			Calculating Ensemble Averaged Descriptions of Protein Rigidity without Sampling	PLOS ONE			English	Article							QUANTITATIVE STABILITY/FLEXIBILITY RELATIONSHIPS; CRYSTAL-STRUCTURE; GENERIC RIGIDITY; THIOREDOXIN; NONADDITIVITY; PREDICTIONS; SYSTEMS; MODELS; GRAPHS	Previous works have demonstrated that protein rigidity is related to thermodynamic stability, especially under conditions that favor formation of native structure. Mechanical network rigidity properties of a single conformation are efficiently calculated using the integer body-bar Pebble Game (PG) algorithm. However, thermodynamic properties require averaging over many samples from the ensemble of accessible conformations to accurately account for fluctuations in network topology. We have developed a mean field Virtual Pebble Game (VPG) that represents the ensemble of networks by a single effective network. That is, all possible number of distance constraints (or bars) that can form between a pair of rigid bodies is replaced by the average number. The resulting effective network is viewed as having weighted edges, where the weight of an edge quantifies its capacity to absorb degrees of freedom. The VPG is interpreted as a flow problem on this effective network, which eliminates the need to sample. Across a nonredundant dataset of 272 protein structures, we apply the VPG to proteins for the first time. Our results show numerically and visually that the rigidity characterizations of the VPG accurately reflect the ensemble averaged (PG) over bar properties. This result positions the VPG as an efficient alternative to understand the mechanical role that chemical interactions play in maintaining protein stability.	[Gonzalez, Luis C.; Livesay, Dennis R.] Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC 28223 USA; [Wang, Hui; Jacobs, Donald J.] Univ N Carolina, Dept Phys & Opt Sci, Charlotte, NC 28223 USA	University of North Carolina; University of North Carolina Charlotte; University of North Carolina; University of North Carolina Charlotte	Gonzalez, LC (corresponding author), Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC 28223 USA.	drlivesa@uncc.edu; djacobs1@uncc.edu		Gonzalez-Gurrola, Luis-Carlos/0000-0003-1546-9752	NIH [R01 GM073082]; Mexico's National Council on Science and Technology (CONACYT); Department of Bioinformatics and Genomics at UNC Charlotte; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073082] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mexico's National Council on Science and Technology (CONACYT); Department of Bioinformatics and Genomics at UNC Charlotte; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Primary support for this work has come from NIH R01 GM073082. Luis C. Gonzalez is supported by a graduate fellowship from Mexico's National Council on Science and Technology (CONACYT) and from the Department of Bioinformatics and Genomics at UNC Charlotte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen CY, 2009, P NATL ACAD SCI; Cormen TH, 1991, INTRO ALGORITHMS; Djordjevic S, 1997, STRUCTURE, V5, P545, DOI 10.1016/S0969-2126(97)00210-4; Farrell DW, 2010, PROTEINS, V78, P2908, DOI 10.1002/prot.22810; Ford L. R. J., 1962, FLOWS NETWORKS; Fox N, 2011, 1 IEEE INT C COMP AD; Frey KM, 2010, P NATL ACAD SCI USA, V107, P13707, DOI 10.1073/pnas.1002162107; Fulle S, 2009, METHODS, V49, P181, DOI 10.1016/j.ymeth.2009.04.004; Gabow H. N., 1988, Proceedings of the Twentieth Annual ACM Symposium on Theory of Computing, P407, DOI 10.1145/62212.62252; Georgiev I, 2008, J COMPUT CHEM, V29, P1527, DOI 10.1002/jcc.20909; Gonzalez LC, VIRTUAL PEB IN PRESS; Greene LH, 2003, J MOL BIOL, V334, P781, DOI 10.1016/j.jmb.2003.08.061; GUYON E, 1990, REP PROG PHYS, V53, P373, DOI 10.1088/0034-4885/53/4/001; HENDRICKSON B, 1992, SIAM J COMPUT, V21, P65, DOI 10.1137/0221008; Hespenheide BM, 2004, J PHYS-CONDENS MAT, V16, pS5055, DOI 10.1088/0953-8984/16/44/003; Hespenheide BM, 2002, J MOL GRAPH MODEL, V21, P195, DOI 10.1016/S1093-3263(02)00146-8; Hwang KY, 1998, NAT STRUCT BIOL, V5, P707, DOI 10.1038/1406; IMAI H, 1985, DISCRETE APPL MATH, V10, P79, DOI 10.1016/0166-218X(85)90060-5; Istomin AY, 2008, PROTEINS, V70, P915, DOI 10.1002/prot.21620; Jacobs DJ, 2006, J MOL BIOL, V358, P882, DOI 10.1016/j.jmb.2006.02.015; Jacobs DJ, 2005, BIOPHYS J, V88, P903, DOI 10.1529/biophysj.104.048496; JACOBS DJ, 1995, PHYS REV LETT, V75, P4051, DOI 10.1103/PhysRevLett.75.4051; Jacobs DJ, 2001, PROTEINS, V44, P150, DOI 10.1002/prot.1081; Jacobs DJ, 1998, J PHYS A-MATH GEN, V31, P6653, DOI 10.1088/0305-4470/31/31/012; Jacobs DJ, 1999, RIGIDITY THEORY APPL, P357; Jacobs DJ, 2010, CURR OPIN PHARMACOL, V10, P760, DOI 10.1016/j.coph.2010.09.014; LAMAN G, 1970, J ENG MATH, V4, P331, DOI 10.1007/BF01534980; Lei M, 2004, J COMPUT CHEM, V25, P1133, DOI 10.1002/jcc.20041; Livesay DR, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-17; Livesay DR, 2006, PROTEINS, V62, P130, DOI 10.1002/prot.20745; Livesay DR, 2004, FEBS LETT, V576, P468, DOI 10.1016/j.febslet.2004.09.057; Mottonen JM, 2010, BIOPHYS J, V99, P2245, DOI 10.1016/j.bpj.2010.07.043; Mottonen JM, 2009, PROTEINS, V75, P610, DOI 10.1002/prot.22273; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Rader AJ, 2010, CURR OPIN PHARMACOL, V10, P753, DOI 10.1016/j.coph.2010.09.003; Rader AJ, 2004, P NATL ACAD SCI USA, V101, P7246, DOI 10.1073/pnas.0401429101; Rader AJ, 2004, POLYMER, V45, P659, DOI 10.1016/j.polymer.2003.10.080; Rader AJ, 2002, PNAS, V99; Radestock S, 2011, PROTEINS, V79, P1089, DOI 10.1002/prot.22946; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Ren B, 1998, NAT STRUCT BIOL, V5, P602, DOI 10.1038/862; Roberts KE, 2011, LECT N BIOINFORMAT, V6577, P361, DOI 10.1007/978-3-642-20036-6_35; Salsbury FR, 2010, CURR OPIN PHARMACOL, V10, P738, DOI 10.1016/j.coph.2010.09.016; Smith GD, 1997, ACTA CRYSTALLOGR D, V53, P551, DOI 10.1107/S0907444997005386; Sugihara K., 1980, Bulletin of the Electrotechnical Laboratory, V44, P376; Tan HP, 2009, PROTEINS, V74, P881, DOI 10.1002/prot.22196; TAY TS, 1984, J COMB THEORY B, V36, P95, DOI 10.1016/0095-8956(84)90016-9; Thorpe M., 2005, CURRENT TOPICS PHYS, P97; Verma D, 2010, CURR PROTEIN PEPT SC, V11, P562, DOI 10.2174/138920310794109210; Vorov OK, 2011, BIOPHYS J, V100, P1129, DOI 10.1016/j.bpj.2011.01.027; Vorov OK, 2009, BIOPHYS J, V97, P3000, DOI 10.1016/j.bpj.2009.09.013; Wells SA, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046005; Wells SA, 2005, PHYS BIOL, V2, pS127, DOI 10.1088/1478-3975/2/4/S07; Zavodszky MI, 2004, PROTEINS, V57, P243, DOI 10.1002/prot.20179; Zwier MC, 2010, CURR OPIN PHARMACOL, V10, P745, DOI 10.1016/j.coph.2010.09.008	55	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e29176	10.1371/journal.pone.0029176	http://dx.doi.org/10.1371/journal.pone.0029176			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22383947	gold, Green Published, Green Submitted			2022-12-27	WOS:000302875500001
J	Huo, Q; Zhang, N; Yang, QF				Huo, Qiang; Zhang, Ning; Yang, Qifeng			Epstein-Barr Virus Infection and Sporadic Breast Cancer Risk: A Meta-Analysis	PLOS ONE			English	Article							LYMPHOEPITHELIOMA-LIKE CARCINOMA; REAL-TIME PCR; MEDULLARY CARCINOMA; LYMPHOID STROMA; EBV GENOME; ASSOCIATION; EXPRESSION; DISEASE; ABSENCE; IDENTIFICATION	Background: A large number of epidemiological studies have evaluated the association between Epstein-Barr virus infection and breast carcinoma risk but results have been inconsistent. Methodology: Research using the polymerase chain reaction technique for detecting the Epstein-Barr virus was selected; 24 studies and 1535 cases were reviewed. Information on the study populations, sample types, publication calendar period and histological types of breast carcinoma were collected. An unconditional logistic regression model was used to analyze potential parameters related to the Epstein-Barr virus prevalence. A Kappa test was used to evaluate the consistency in detecting different Epstein-Barr virus DNA regions. Nine studies that included control groups and 1045 breast cancer cases were adopted in this meta-analysis. Conclusions: We found that 29.32% of the patients with breast carcinoma were infected with the Epstein-Barr virus. The prevalence of Epstein-Barr was highest in Asia (35.25%) and lowest in the USA (18.27%). Statistical analysis revealed a trend that showed lobular breast carcinoma might have the strongest association with Epstein-Barr virus infection. This meta-analysis showed a significant increase in breast malignancy risk in patients testing positive for the Epstein-Barr virus (OR = 6.29, 95% CI = 2.13-18.59). This result suggests that an Epstein-Barr virus infection is statistically associated with increased breast carcinoma risk.	[Huo, Qiang; Zhang, Ning; Yang, Qifeng] Shandong Univ, Dept Breast Surg, Sch Med, Qilu Hosp, Jinan 250100, Shandong, Peoples R China	Shandong University	Huo, Q (corresponding author), Shandong Univ, Dept Breast Surg, Sch Med, Qilu Hosp, Jinan 250100, Shandong, Peoples R China.	qifengy@gmail.com	yang, qiang/GYJ-0971-2022; Zhang, Ning/GOJ-8058-2022; Zhang, Ning/GNP-1966-2022	Zhang, Ning/0000-0002-6430-4236; Yang, Qifeng/0000-0003-0576-8513	Program for New Century Excellent Talents in University; Key Project of Chinese Ministry of Education [108080]; National Natural Science Foundation of China [30772133, 81072150]; Independent Innovation Foundation of Shandong University (IIFSDU) [2009JQ007]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Key Project of Chinese Ministry of Education(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Independent Innovation Foundation of Shandong University (IIFSDU)	Dr. Yang is supported by Program for New Century Excellent Talents in University, Key Project of Chinese Ministry of Education (No. 108080) (http://www.moe.edu.cn/), National Natural Science Foundation of China (No. 30772133; No. 81072150) (http://www.nsfc.gov.cn) and Independent Innovation Foundation of Shandong University (IIFSDU, No. 2009JQ007) (http://www.sdu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbach H, 2006, J VIROL, V80, P845, DOI 10.1128/JVI.80.2.845-853.2006; Bonnet M, 1999, J NATL CANCER I, V91, P1376, DOI 10.1093/jnci/91.16.1376; Brink AATP, 2000, J NATL CANCER I, V92, P655, DOI 10.1093/jnci/92.8.655; Chu JS, 1998, CANCER LETT, V124, P53, DOI 10.1016/S0304-3835(97)00449-7; Chu PGG, 2001, AM J PATHOL, V159, P571, DOI 10.1016/S0002-9440(10)61728-2; Cox B, 2010, BRIT J CANCER, V102, P1665, DOI 10.1038/sj.bjc.6605675; Crawford DH, 2001, PHILOS T R SOC B, V356, P461, DOI 10.1098/rstb.2000.0783; Cristina S, 2000, VIRCHOWS ARCH, V437, P198, DOI 10.1007/s004280000204; Dadmanesh F, 2001, HISTOPATHOLOGY, V38, P54, DOI 10.1046/j.1365-2559.2001.01055.x; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Deshpande CG, 2002, LAB INVEST, V82, P1193, DOI 10.1097/01.LAB.0000029150.90532.24; Fan HX, 2001, MOL DIAGN, V6, P279, DOI 10.1054/modi.2001.29161; Fawzy S, 2008, CLIN BIOCHEM, V41, P486, DOI 10.1016/j.clinbiochem.2007.12.017; Fina F, 2001, BRIT J CANCER, V84, P783, DOI 10.1054/bjoc.2000.1672; GAFFEY MJ, 1993, MODERN PATHOL, V6, P721; Glaser SL, 2004, CANCER EPIDEM BIOMAR, V13, P688; Glaser SL, 1998, INT J CANCER, V75, P555; Grinstein S, 2002, CANCER RES, V62, P4876; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Herrmann K, 2003, BREAST CANCER RES, V5, DOI 10.1186/bcr561; HORIUCHI K, 1994, J CLIN PATHOL, V47, P538, DOI 10.1136/jcp.47.6.538; Hsu JL, 2000, CRIT REV ONCOL HEMAT, V34, P27, DOI 10.1016/S1040-8428(00)00046-9; Kalkan A, 2005, MED PRIN PRACT, V14, P268, DOI 10.1159/000085748; Khanna R, 2001, TRENDS MOL MED, V7, P270, DOI 10.1016/S1471-4914(01)02002-0; Kraus RJ, 2001, J VIROL, V75, P867, DOI 10.1128/JVI.75.2.867-877.2001; Kulka J, 2008, HUM PATHOL, V39, P298, DOI 10.1016/j.humpath.2007.08.006; LABRECQUE LG, 1995, CANCER RES, V55, P39; LESPAGNARD L, 1995, AM J CLIN PATHOL, V103, P449; LUQMANI YA, 1995, INT J ONCOL, V6, P899; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mazouni C, 2011, BRIT J CANCER, V104, P332, DOI 10.1038/sj.bjc.6606048; McCall SA, 2001, JNCI-J NATL CANCER I, V93, P148, DOI 10.1093/jnci/93.2.148; Murray PG, 2003, CANCER RES, V63, P2338; Murray PG, 2002, FRONT BIOSCI-LANDMRK, V7, pD519, DOI 10.2741/murray; Perkins RS, 2006, BREAST CANCER RES, V8, DOI 10.1186/BCR1627; Perrigoue JG, 2005, CANCER EPIDEM BIOMAR, V14, P809, DOI 10.1158/1055-9965.EPI-04-0763; Preciado MV, 2005, ARCH PATHOL LAB MED, V129, P377; Preciado MV, 2003, BREAST CANCER RES, V5, DOI 10.1186/bcr599; Serraino D, 2001, J BIOL REG HOMEOS AG, V15, P224; Subramanian C, 2002, J VIROL, V76, P8702, DOI 10.1128/JVI.76.17.8702-8709.2002; Subramanian C, 2002, FRONT BIOSCI-LANDMRK, V7, pD704, DOI 10.2741/subraman; Sugawara Y, 1999, VIROLOGY, V256, P196, DOI 10.1006/viro.1999.9619; Thorne LB, 2005, DIAGN MOL PATHOL, V14, P29, DOI 10.1097/01.pas.0000144448.23464.ab; Trabelsi A, 2008, ANN BIOL CLIN-PARIS, V66, P59, DOI 10.1684/abc.2008.0191; Tsai JH, 2005, J MED VIROL, V75, P276, DOI 10.1002/jmv.20267; Xue SA, 2003, BRIT J CANCER, V89, P113, DOI 10.1038/sj.bjc.6601027; Yasui Y, 2001, CANCER EPIDEM BIOMAR, V10, P9	47	38	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31656	10.1371/journal.pone.0031656	http://dx.doi.org/10.1371/journal.pone.0031656			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363698	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700080
J	Kassubek, J; Sperfeld, AD; Pinkhardt, EH; Unrath, A; Muller, HP; Scharffetter-Kochanek, K; Ludolph, AC; Berneburg, M				Kassubek, Jan; Sperfeld, Anne-Dorte; Pinkhardt, Elmar H.; Unrath, Alexander; Mueller, Hans-Peter; Scharffetter-Kochanek, Karin; Ludolph, Albert C.; Berneburg, Mark			The Cerebro-Morphological Fingerprint of a Progeroid Syndrome: White Matter Changes Correlate with Neurological Symptoms in Xeroderma Pigmentosum	PLOS ONE			English	Article							DNA-REPAIR; COCKAYNE-SYNDROME; FIBER TRACKING; DISORDERS; TRICHOTHIODYSTROPHY; NEURODEGENERATION; GENOTYPE; LESIONS	Background: Xeroderma pigmentosum (XP) is a rare autosomal recessive progeroid syndrome. It has recently been shown that the underlying DNA repair defect plays a central role in the aging process. In addition to skin symptoms, various premature neurological abnormalities have been reported. Methodology/Principal Findings: We present the clinical neurological phenotype in 14 XP patients (seven subtypes), in seven of these patients together with conventional and multiparametric advanced MRI data to assess the macrostructural and microstructural cerebral morphology in comparison to controls, including volumetric measurements, MR spectroscopy (H-1 MRS), and diffusion tensor imaging (DTI). Clinical hallmarks were spinocerebellar ataxia, pyramidal tract signs, and mild cognitive deficits. DTI demonstrated significantly reduced WM directionality in all regions investigated, i.e. the thalamus, the corticospinal tracts and the dorsal corpus callosum. Single patients showed a marked relative hippocampal volume reduction, but the patients were not different from controls in the volumetric measurements of hippocampal and whole brain volumes at group level. However, 1 H MRS demonstrated that the hippocampal formation was metabolically altered. Conclusions: The most prominent feature was the white matter affectation, as assessed by DTI, with volume and directionality reductions of the fiber projections involving both the craniocaudal fibers and the interhemispheric connections. These findings, although heterogeneous among the study sample, could be correlated with the clinico-neurological symptoms. The imaging findings support the position that myelin structures degrade prematurely in the brain of XP patients.	[Kassubek, Jan; Sperfeld, Anne-Dorte; Pinkhardt, Elmar H.; Unrath, Alexander; Mueller, Hans-Peter; Ludolph, Albert C.] Univ Ulm, Dept Neurol, D-7900 Ulm, Germany; [Scharffetter-Kochanek, Karin] Univ Ulm, Dept Dermatol, Ulm, Germany; [Berneburg, Mark] Univ Tubingen, Dept Dermatol, Tubingen, Germany	Ulm University; Ulm University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Kassubek, J (corresponding author), Univ Ulm, Dept Neurol, D-7900 Ulm, Germany.	jan.kassubek@uni-ulm.de	Kassubek, Jan/GPX-0910-2022; Kassubek, Jan/O-1740-2019; Kassubek, Jan/F-2774-2015	Kassubek, Jan/0000-0002-7106-9270; Kassubek, Jan/0000-0002-7106-9270; Kassubek, Jan/0000-0002-7106-9270; Scharffetter-Kochanek, Karin/0000-0002-9655-685X	German Research Foundation (DFG) [KFO142]	German Research Foundation (DFG)(German Research Foundation (DFG))	A.C.L., K.S.K. and M.B. were supported by a grant of the German Research Foundation (DFG) to a Clinical Research Group (KFO142, Molecular and Cellular Aging). There was no external funding of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anttinen A, 2008, BRAIN, V131, P1979, DOI 10.1093/brain/awn126; Berneburg M, 2001, ADV GENET, V43, P71, DOI 10.1016/S0065-2660(01)43004-5; Bootsma D, 2001, MUTAT RES-DNA REPAIR, V485, P37, DOI 10.1016/S0921-8777(00)00080-X; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; Brooks PJ, 2007, NEUROSCIENCE, V145, P1407, DOI 10.1016/j.neuroscience.2006.10.025; Chio A, 2007, J NEUROL NEUROSUR PS, V78, P1349, DOI 10.1136/jnnp.2007.114868; CLEAVER JE, 1968, NATURE, V218, P652, DOI 10.1038/218652a0; de Sanctis C, 1932, RIV SPER FRENIATR ME, V56, P269; Emmert S, 2002, J INVEST DERMATOL, V118, P972, DOI 10.1046/j.1523-1747.2002.01782.x; Faghri S, 2008, J MED GENET, V45, P609, DOI 10.1136/jmg.2008.058743; Gaist D, 2001, EUR J CLIN PHARMACOL, V56, P931, DOI 10.1007/s002280000248; Giesel FL, 2008, EUR J RADIOL, V66, P268, DOI 10.1016/j.ejrad.2007.06.009; Grewal RP, 1999, J NEUROL SCI, V163, P183, DOI 10.1016/S0022-510X(99)00031-3; Hayashi M, 2004, J NEUROPATH EXP NEUR, V63, P1048, DOI 10.1093/jnen/63.10.1048; KANDA T, 1990, BRAIN, V113, P1025, DOI 10.1093/brain/113.4.1025; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Kleijer WJ, 2008, DNA REPAIR, V7, P744, DOI 10.1016/j.dnarep.2008.01.014; Kobayashi T, 1997, HUM MUTAT, V9, P322, DOI 10.1002/(SICI)1098-1004(1997)9:4<322::AID-HUMU4>3.0.CO;2-7; Kraemer KH, 2007, NEUROSCIENCE, V145, P1388, DOI 10.1016/j.neuroscience.2006.12.020; KRAEMER KH, 1987, ARCH DERMATOL, V123, P241, DOI 10.1001/archderm.123.2.241; Lindenbaum Y, 2001, Eur J Paediatr Neurol, V5, P225, DOI 10.1053/ejpn.2001.0523; Ljungman M, 2004, NAT REV CANCER, V4, P727, DOI 10.1038/nrc1435; Ludolph AG, 2008, DEV MED CHILD NEUROL, V50, P524, DOI 10.1111/j.1469-8749.2008.03014.x; Muller HP, 2007, PHYS MED BIOL, V52, pN99, DOI 10.1088/0031-9155/52/6/N01; Muller HP, 2009, MAGN RESON IMAGING, V27, P324, DOI 10.1016/j.mri.2008.07.003; Mueller HP, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-42; Niedernhofer LJ, 2008, MECH AGEING DEV, V129, P408, DOI 10.1016/j.mad.2008.04.010; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Norman GR, 2007, BIOSTATISTICS BARE E; Oh KS, 2006, HUM MUTAT, V27, P1092, DOI 10.1002/humu.20392; Petit-Frere C, 2000, J INVEST DERMATOL, V115, P687, DOI 10.1046/j.1523-1747.2000.00093.x; Rao KS, 2007, NEUROSCIENCE, V145, P1330, DOI 10.1016/j.neuroscience.2006.09.032; Rapin I, 2000, NEUROLOGY, V55, P1442, DOI 10.1212/WNL.55.10.1442; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; ROBBINS JH, 1991, BRAIN, V114, P1335, DOI 10.1093/brain/114.3.1335; Shen YJ, 2004, MAGN RESON MED, V52, P1184, DOI 10.1002/mrm.20267; YAMAMURA K, 1989, BRIT J DERMATOL, V121, P471, DOI 10.1111/j.1365-2133.1989.tb15514.x	37	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e30926	10.1371/journal.pone.0030926	http://dx.doi.org/10.1371/journal.pone.0030926			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363517	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700014
J	Kawafune, K; Hongoh, Y; Hamaji, T; Nozaki, H				Kawafune, Kaoru; Hongoh, Yuichi; Hamaji, Takashi; Nozaki, Hisayoshi			Molecular Identification of Rickettsial Endosymbionts in the Non-Phagotrophic Volvocalean Green Algae	PLOS ONE			English	Article							RIBOSOMAL-RNA; CARTERIA VOLVOCALES; DNA; EVOLUTION; CHLOROPHYTA; BACTERIA; ULTRASTRUCTURE; PHYLOGENIES; PLEODORINA; CILIOPHORA	The order Rickettsiales comprises Gram-negative obligate intracellular bacteria (also called rickettsias) that are mainly associated with arthropod hosts. This group is medically important because it contains human-pathogenic species that cause dangerous diseases. Until now, there has been no report of non-phagotrophic photosynthetic eukaryotes, such as green plants, harboring rickettsias. Methodology/Principal Findings: We examined the bacterial endosymbionts of two freshwater volvocalean green algae: unicellular Carteria cerasiformis and colonial Pleodorina japonica. Epifluorescence microscopy using 4'-6-deamidino-2-phenylindole staining revealed the presence of endosymbionts in all C. cerasiformis NIES-425 cells, and demonstrated a positive correlation between host cell size and the number of endosymbionts. Strains both containing and lacking endosymbionts of C. cerasiformis (NIES-425 and NIES-424) showed > 10-fold increase in cell number and typical sigmoid growth curves over 192 h. A phylogenetic analysis of 16 S ribosomal (r) RNA gene sequences from the endosymbionts of C. cerasiformis and P. japonica demonstrated that they formed a robust clade (hydra group) with endosymbionts of various non-arthropod hosts within the family Rickettsiaceae. There were significantly fewer differences in the 16 S rRNA sequences of the rickettsiacean endosymbionts between C. cerasiformis and P. japonica than in the chloroplast 16 S rRNA or 18 S rRNA of the host volvocalean cells. Fluorescence in situ hybridization demonstrated the existence of the rickettsiacean endosymbionts in the cytoplasm of two volvocalean species. Conclusions/Significance: The rickettsiacean endosymbionts are likely not harmful to their volvocalean hosts and may have been recently transmitted from other non-arthropod organisms. Because rickettsias are the closest relatives of mitochondria, incipient stages of mitochondrial endosymbiosis may be deduced using both strains with and without C. cerasiformis endosymbionts.	[Kawafune, Kaoru; Nozaki, Hisayoshi] Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Bunkyo Ku, Tokyo, Japan; [Hongoh, Yuichi] Tokyo Inst Technol, Dept Biol Sci, Sch Biosci & Biotechnol, Meguro Ku, Tokyo 152, Japan; [Hamaji, Takashi] Kyoto Univ, Dept Bot, Grad Sch Sci, Sakyo Ku, Kyoto, Japan	University of Tokyo; Tokyo Institute of Technology; Kyoto University	Kawafune, K (corresponding author), Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Bunkyo Ku, Tokyo, Japan.	nozaki@biol.s.u-tokyo.ac.jp	Hongoh, Yuichi/A-2303-2014; NOZAKI, HISAYOSHI/G-4926-2014	Hongoh, Yuichi/0000-0002-5901-9625; Hamaji, Takashi/0000-0002-2801-2148; Nozaki, Hisayoshi/0000-0002-9308-4498	Ministry of Education, Culture, Sports, Science and Technology, Japan [20247032, 22112505]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research (nos. 20247032 and 22112505 to HN) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, http://www.mext.go.jp/english/.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; Anonymous, 2009, Japanese Journal of Phycology, V57, P1; Balraj P, 2009, ANN NY ACAD SCI, V1166, P94, DOI 10.1111/j.1749-6632.2009.04517.x; Becker B, 2007, INT REV CYTOL, V264, P1, DOI 10.1016/S0074-7696(07)64001-7; CECH TR, 1988, GENE, V73, P259, DOI 10.1016/0378-1119(88)90492-1; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Darby AC, 2007, TRENDS GENET, V23, P511, DOI 10.1016/j.tig.2007.08.002; Davis MJ, 1998, CURR MICROBIOL, V36, P80, DOI 10.1007/s002849900283; Dumler JS, 2005, BERGEYS MANUAL SYSTE, V2, P96; Dykova I, 2003, FOLIA PARASIT, V50, P161, DOI 10.14411/fp.2003.030; Fawley MW, 2004, J PHYCOL, V40, P223, DOI 10.1111/j.0022-3646.2004.03-081.x; Ferrantini F, 2009, J EUKARYOT MICROBIOL, V56, P119, DOI 10.1111/j.1550-7408.2008.00377.x; Fitzpatrick DA, 2006, MOL BIOL EVOL, V23, P74, DOI 10.1093/molbev/msj009; Fraune S, 2007, P NATL ACAD SCI USA, V104, P13146, DOI 10.1073/pnas.0703375104; Fuchs BM, 2000, APPL ENVIRON MICROB, V66, P3603, DOI 10.1128/AEM.66.8.3603-3607.2000; Ge Y, 2011, MICROBES INFECT, V13, P638, DOI 10.1016/j.micinf.2011.03.003; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hine PM, 2002, DIS AQUAT ORGAN, V49, P207, DOI 10.3354/dao049207; ICHIMURA T, 1977, Bulletin of the Japanese Society of Phycology, V25, P177; KATO S, 1982, Japanese Journal of Phycology, V30, P63; Kikuchi Y, 2005, MICROBIAL ECOL, V49, P265, DOI 10.1007/s00248-004-0140-5; Kikuchi Y, 2002, APPL ENVIRON MICROB, V68, P999, DOI 10.1128/AEM.68.2.999-1004.2002; Kim E, 2010, ISME J, V4, P1108, DOI 10.1038/ismej.2010.40; KOCHERT G, 1970, T AM MICROSC SOC, V89, P475, DOI 10.2307/3224556; KUROIWA T, 1981, EXPERIENTIA, V37, P969, DOI 10.1007/BF01971784; Loy A, 2008, ENVIRON MICROBIOL, V10, P2894, DOI 10.1111/j.1462-2920.2008.01706.x; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Nakada T, 2007, EUR J PHYCOL, V42, P177, DOI 10.1080/09670260601145816; Nakazawa Atsushi, 2004, Journal of Japanese Botany, V79, P255; Noda S, 2003, APPL ENVIRON MICROB, V69, P625, DOI 10.1128/AEM.69.1.625-633.2003; NOZAKI H, 1992, PHYCOLOGIA, V31, P529, DOI 10.2216/i0031-8884-31-6-529.1; NOZAKI H, 1994, PHYCOLOGIA, V33, P239, DOI 10.2216/i0031-8884-33-4-239.1; Nozaki H, 1997, J PHYCOL, V33, P864, DOI 10.1111/j.0022-3646.1997.00864.x; Nozaki H, 2002, MOL PHYLOGENET EVOL, V23, P326, DOI 10.1016/S1055-7903(02)00030-1; NOZAKI H, 1989, PHYCOLOGIA, V28, P252, DOI 10.2216/i0031-8884-28-2-252.1; Nozaki H, 2006, CURR BIOL, V16, pR1018, DOI 10.1016/j.cub.2006.11.019; Nozaki Hisayoshi, 2003, P225, DOI 10.1016/B978-012741550-5/50007-6; Perlman SJ, 2006, P ROY SOC B-BIOL SCI, V273, P2097, DOI 10.1098/rspb.2006.3541; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Setohigashi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019545; Stackebrandt E., 2006, MICROBIOL TODAY, V33, P152; STARR RC, 1993, J PHYCOL, V29, P1, DOI 10.1111/j.0022-3646.1993.00001.x; Sun HY, 2009, APPL ENVIRON MICROB, V75, P7445, DOI 10.1128/AEM.00850-09; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Uchiyama T, 2006, MICROBES INFECT, V8, P801, DOI 10.1016/j.micinf.2005.10.003; Vannini C, 2005, MICROB ECOL, V49, P434, DOI 10.1007/s00248-004-0055-1; Weinert LA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-6; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991	52	26	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31749	10.1371/journal.pone.0031749	http://dx.doi.org/10.1371/journal.pone.0031749			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363720	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700089
J	Ochs, MJ; Sorg, BL; Pufahl, L; Grez, M; Suess, B; Steinhilber, D				Ochs, Meike J.; Sorg, Bernd L.; Pufahl, Laura; Grez, Manuel; Suess, Beatrix; Steinhilber, Dieter			Post-Transcriptional Regulation of 5-Lipoxygenase mRNA Expression via Alternative Splicing and Nonsense-Mediated mRNA Decay	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; GENE-EXPRESSION; CELLS; LEUKOTRIENES; PROTEIN; NMD; DNA	5-Lipoxygenase (5-LO) catalyzes the two initial steps in the biosynthesis of leukotrienes (LT), a group of inflammatory lipid mediators derived from arachidonic acid. Here, we investigated the regulation of 5-LO mRNA expression by alternative splicing and nonsense-mediated mRNA decay (NMD). In the present study, we report the identification of 2 truncated transcripts and 4 novel 5-LO splice variants containing premature termination codons (PTC). The characterization of one of the splice variants, 5-LO Delta 3, revealed that it is a target for NMD since knockdown of the NMD factors UPF1, UPF2 and UPF3b in the human monocytic cell line Mono Mac 6 (MM6) altered the expression of 5-LO Delta 3 mRNA up to 2-fold in a cell differentiation-dependent manner suggesting that cell differentiation alters the composition or function of the NMD complex. In contrast, the mature 5-LO mRNA transcript was not affected by UPF knockdown. Thus, the data suggest that the coupling of alternative splicing and NMD is involved in the regulation of 5-LO gene expression.	[Ochs, Meike J.; Sorg, Bernd L.; Pufahl, Laura; Steinhilber, Dieter] Goethe Univ Frankfurt, Inst Pharmaceut Chem, Frankfurt, Germany; [Ochs, Meike J.; Suess, Beatrix] Goethe Univ Frankfurt, Inst Mol Biosci, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Ochs, MJ (corresponding author), Goethe Univ Frankfurt, Inst Pharmaceut Chem, Frankfurt, Germany.	suess@bio.uni-frankfurt.de; steinhilber@em.uni-frankfurt.de	Steinhilber, Dieter/J-3221-2012		Deutsche Forschungsgemeinschaft [GRK757]; CEF; ECCPS; Aventis Foundation; LOEWE Center for Cell and Gene Therapy Frankfurt	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); CEF; ECCPS; Aventis Foundation; LOEWE Center for Cell and Gene Therapy Frankfurt	The study was supported by the Deutsche Forschungsgemeinschaft (GRK757, CEF and ECCPS), (http://www.dfg.de), the Aventis Foundation (http://www.aventis-foundation.org), and LOEWE Center for Cell and Gene Therapy Frankfurt (B.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselta R, 2010, BLOOD, V115, P2065, DOI 10.1182/blood-2009-09-245092; BOADO RJ, 1992, P NATL ACAD SCI USA, V89, P9044, DOI 10.1073/pnas.89.19.9044; Boudreau LH, 2011, FASEB J, V25, P1097, DOI 10.1096/fj.10-173856; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brett D, 2002, NAT GENET, V30, P29, DOI 10.1038/ng803; BRUNGS M, 1995, P NATL ACAD SCI USA, V92, P107, DOI 10.1073/pnas.92.1.107; Chan WK, 2007, EMBO J, V26, P1820, DOI 10.1038/sj.emboj.7601628; COFFEY MJ, 1993, J LIPID MEDIATOR, V6, P43; DIXON RAF, 1988, P NATL ACAD SCI USA, V85, P416, DOI 10.1073/pnas.85.2.416; Gehring NH, 2005, MOL CELL, V20, P65, DOI 10.1016/j.molcel.2005.08.012; Gehring NH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000120; Gong CG, 2009, GENE DEV, V23, P54, DOI 10.1101/gad.1717309; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Harle D, 1998, EUR J BIOCHEM, V254, P275, DOI 10.1046/j.1432-1327.1998.2540275.x; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Lareau LF, 2004, CURR OPIN STRUC BIOL, V14, P273, DOI 10.1016/j.sbi.2004.05.002; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Pan Q, 2006, GENE DEV, V20, P153, DOI 10.1101/gad.1382806; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Stoffers KL, 2010, J MOL BIOL, V395, P884, DOI 10.1016/j.jmb.2009.10.022; Weischenfeldt J, 2008, GENE DEV, V22, P1381, DOI 10.1101/gad.468808; Werz O, 2005, P NATL ACAD SCI USA, V102, P13164, DOI 10.1073/pnas.0505991102; Wittmann J, 2006, MOL CELL BIOL, V26, P1272, DOI 10.1128/MCB.26.4.1272-1287.2006	26	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31363	10.1371/journal.pone.0031363	http://dx.doi.org/10.1371/journal.pone.0031363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363630	gold, Green Published, Green Submitted			2022-12-27	WOS:000302873700053
J	Tan, CW; Gardiner, BS; Hirokawa, Y; Layton, MJ; Smith, DW; Burgess, AW				Tan, Chin Wee; Gardiner, Bruce S.; Hirokawa, Yumiko; Layton, Meredith J.; Smith, David W.; Burgess, Antony W.			Wnt Signalling Pathway Parameters for Mammalian Cells	PLOS ONE			English	Article							ADENOMATOUS-POLYPOSIS-COLI; BETA-CATENIN DEGRADATION; APC TUMOR-SUPPRESSOR; FUNCTIONAL INTERACTION; PROTEIN ASSEMBLIES; COLORECTAL-CANCER; SYSTEMS BIOLOGY; CANINE KIDNEY; AXIN; ADHESION	Wnt/beta-catenin signalling regulates cell fate, survival, proliferation and differentiation at many stages of mammalian development and pathology. Mutations of two key proteins in the pathway, APC and beta-catenin, have been implicated in a range of cancers, including colorectal cancer. Activation of Wnt signalling has been associated with the stabilization and nuclear accumulation of beta-catenin and consequential up-regulation of beta-catenin/TCF gene transcription. In 2003, Lee et al. constructed a computational model of Wnt signalling supported by experimental data from analysis of time-dependent concentration of Wnt signalling proteins in Xenopus egg extracts. Subsequent studies have used the Xenopus quantitative data to infer Wnt pathway dynamics in other systems. As a basis for understanding Wnt signalling in mammalian cells, a confocal live cell imaging measurement technique is developed to measure the cell and nuclear volumes of MDCK, HEK293T cells and 3 human colorectal cancer cell lines and the concentrations of Wnt signalling proteins beta-catenin, Axin, APC, GSK3 beta and E-cadherin. These parameters provide the basis for formulating Wnt signalling models for kidney/intestinal epithelial mammalian cells. There are significant differences in concentrations of key proteins between Xenopus extracts and mammalian whole cell lysates. Higher concentrations of Axin and lower concentrations of APC are present in mammalian cells. Axin concentrations are greater than APC in kidney epithelial cells, whereas in intestinal epithelial cells the APC concentration is higher than Axin. Computational simulations based on Lee's model, with this new data, suggest a need for a recalibration of the model. A quantitative understanding of Wnt signalling in mammalian cells, in particular human colorectal cancers requires a detailed understanding of the concentrations of key protein complexes over time. Simulations of Wnt signalling in mammalian cells can be initiated with the parameters measured in this report.	[Tan, Chin Wee; Hirokawa, Yumiko; Layton, Meredith J.; Burgess, Antony W.] Ludwig Inst Canc Res, Melbourne Parkville Branch, Parkville, Vic, Australia; [Gardiner, Bruce S.; Smith, David W.] Univ Western Australia, Fac Engn Comp & Math, Perth, WA 6009, Australia; [Tan, Chin Wee] Univ Melbourne, Melbourne Sch Engn, Parkville, Vic 3052, Australia	Ludwig Institute for Cancer Research; University of Western Australia; University of Melbourne	Tan, CW (corresponding author), Ludwig Inst Canc Res, Melbourne Parkville Branch, Parkville, Vic, Australia.	chin.tan@ludwig.edu.au	Smith, David W/H-5856-2014; Tan, Chin Wee/B-1584-2015; Gardiner, Bruce/C-8593-2012	Smith, David W/0000-0003-4864-0288; Tan, Chin Wee/0000-0001-9695-7218; Gardiner, Bruce/0000-0001-8770-5908	National Health and Medical Research Council (NHMRC) [542531]; Victorian Government, Australia; Program Grant [487922]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government, Australia; Program Grant	This work was funded by the National Health and Medical Research Council (NHMRC) Project Grant 542531 "Wnt signalling in colon cancer'', Program Grant 487922 "Colorectal cancer - molecular basis to targeted therapeutics'', and by funds from the Operational Infrastructure Support Program provided by the Victorian Government, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additionally the manuscript is solely the responsibility of the institutions and individual authors and does not reflect the views of NHMRC.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Behrens J, 1999, CANCER METAST REV, V18, P15, DOI 10.1023/A:1006200102166; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bienz M, 2002, NAT REV MOL CELL BIO, V3, P328, DOI 10.1038/nrm806; Bush PG, 2005, OSTEOARTHR CARTILAGE, V13, P54, DOI 10.1016/j.joca.2004.10.007; CHACON E, 1994, BIOPHYS J, V66, P942, DOI 10.1016/S0006-3495(94)80904-X; Cho KH, 2006, FEBS LETT, V580, P3665, DOI 10.1016/j.febslet.2006.05.053; Christofori G, 2003, EMBO J, V22, P2318, DOI 10.1093/emboj/cdg228; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coudreuse D, 2007, DEVELOPMENT, V134, P3, DOI 10.1242/dev.02699; FANTES PA, 1975, J THEOR BIOL, V50, P213, DOI 10.1016/0022-5193(75)90034-X; FARINAS J, 1995, BIOPHYS J, V68, P1613, DOI 10.1016/S0006-3495(95)80335-8; Faux MC, 2004, J CELL SCI, V117, P427, DOI 10.1242/jcs.00862; Faux MC, 2008, ONCOGENE; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; Furuhashi M, 2001, MOL CELL BIOL, V21, P5132, DOI 10.1128/MCB.21.15.5132-5141.2001; GAUSH CR, 1966, P SOC EXP BIOL MED, V122, P931; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Ha NC, 2004, MOL CELL, V15, P511, DOI 10.1016/j.molcel.2004.08.010; Habela CW, 2007, CELL CYCLE, V6, P1613, DOI 10.4161/cc.6.13.4357; Harris TJC, 2005, TRENDS CELL BIOL, V15, P234, DOI 10.1016/j.tcb.2005.03.002; Hogan C, 2004, MOL CELL BIOL, V24, P6690, DOI 10.1128/mcb.24.15.6690-6700.2004; Ideker T, 2001, ANNU REV GENOM HUM G, V2, P343, DOI 10.1146/annurev.genom.2.1.343; Ilyas M, 1999, EUR J CANCER, V35, P1986, DOI 10.1016/S0959-8049(99)00298-1; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Kim D, 2007, ONCOGENE, V26, P4571, DOI 10.1038/sj.onc.1210230; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; LEIGHTON J, 1969, SCIENCE, V163, P472, DOI 10.1126/science.163.3866.472; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Luo W, 2004, NEUROSIGNALS, V13, P99, DOI 10.1159/000076563; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mariadason JM, 2001, CANCER RES, V61, P3465; Mathworks, 2007, MATLAB VERS 7 4 0 28; Migita S, 2010, ANAL METHODS-UK, V2, P657, DOI 10.1039/c0ay00039f; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; Penman GA, 2005, J CELL SCI, V118, P4741, DOI 10.1242/jcs.02589; Polakis P, 2000, GENE DEV, V14, P1837; POOLE CA, 1993, J CELL SCI, V106, P685; RIDLEY AJ, 1995, MOL CELL BIOL, V15, P1110; Rosin-Arbesfeld R, 2001, EMBO J, V20, P5929, DOI 10.1093/emboj/20.21.5929; Rosin-Arbesfeld R, 2003, EMBO J, V22, P1101, DOI 10.1093/emboj/cdg105; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; ROY G, 1987, J MEMBRANE BIOL, V100, P83, DOI 10.1007/BF02209143; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Schwarz-Romond T, 2007, J CELL SCI, V120, P2402, DOI 10.1242/jcs.002956; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Shampine LF, 1997, SIAM J SCI COMPUT, V18, P1, DOI 10.1137/S1064827594276424; SMITH KJ, 1993, P NATL ACAD SCI USA, V90, P2846, DOI 10.1073/pnas.90.7.2846; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Sun YC, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-13; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; van Leeuwen IMM, 2009, CELL PROLIFERAT, V42, P617, DOI 10.1111/j.1365-2184.2009.00627.x; Leeuwen IMM, 2007, J THEOR BIOL, V247, P77, DOI 10.1016/j.jtbi.2007.01.019; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Veranic P, 2008, BIOPHYS J, V95, P4416, DOI 10.1529/biophysj.108.131375; Wawra C, 2007, FEBS LETT, V581, P4043, DOI 10.1016/j.febslet.2007.07.043; Xing Y, 2004, MOL CELL, V15, P523, DOI 10.1016/j.molcel.2004.08.001; YCAS M, 1965, J THEOR BIOL, V9, P444; Zhang Y, 1999, J BIOL CHEM, V274, P35247, DOI 10.1074/jbc.274.49.35247	76	80	86	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31882	10.1371/journal.pone.0031882	http://dx.doi.org/10.1371/journal.pone.0031882			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363759	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700114
J	Wiese, M; Antebi, A; Zheng, H				Wiese, Mary; Antebi, Adam; Zheng, Hui			Regulation of Neuronal APL-1 Expression by Cholesterol Starvation	PLOS ONE			English	Article							BETA-AMYLOID PRECURSOR; CAENORHABDITIS-ELEGANS; APOLIPOPROTEIN-E; DAUER FORMATION; DISEASE; PROTEIN; GENE; REPRODUCTION; REQUIREMENT; RECEPTORS	Background: Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the deposition of beta-amyloid plaques composed primarily of the amyloid-beta peptide, a cleavage product of amyloid precursor protein (APP). While mutations in APP lead to the development of Familial Alzheimer's Disease (FAD), sporadic AD has only one clear genetic modifier: the epsilon 4 allele of the apolipoprotein E (ApoE) gene. Cholesterol starvation in Caenorhabditis elegans leads to molting and arrest phenotypes similar to loss-of-function mutants of the APP ortholog, apl-1 (amyloid precursor-like protein 1), and lrp-1 (lipoprotein receptor-related protein 1), suggesting a potential interaction between apl-1 and cholesterol metabolism. Methodology/Principal Findings: Previously, we found that RNAi knock-down of apl-1 leads to aldicarb hypersensitivity, indicating a defect in synaptic function. Here we find the same defect is recapitulated during lrp-1 knock-down and by cholesterol starvation. A cholesterol-free diet or loss of lrp-1 directly affects APL-1 levels as both lead to loss of APL-1::GFP fluorescence in neurons. However, loss of cholesterol does not affect global transcription or protein levels as seen by qPCR and Western blot. Conclusions: Our results show that cholesterol and lrp-1 are involved in the regulation of synaptic transmission, similar to apl-1. Both are able to modulate APL-1 protein levels in neurons, however cholesterol changes do not affect global apl-1 transcription or APL-1 protein indicating the changes are specific to neurons. Thus, regulation of synaptic transmission and molting by LRP-1 and cholesterol may be mediated by their ability to control APL-1 neuronal protein expression.	[Wiese, Mary; Antebi, Adam; Zheng, Hui] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Wiese, Mary; Antebi, Adam; Zheng, Hui] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Antebi, Adam] Max Planck Inst Biol Ageing, Cologne, Germany	Baylor College of Medicine; Baylor College of Medicine; Max Planck Society	Wiese, M (corresponding author), Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA.	aantebi@bcm.edu; huiz@bcm.edu			NIH [AG032051, AG033467, AG027498]; American Health and Assistance Foundation [A2008-052]; NATIONAL INSTITUTE ON AGING [R01AG033467, R01AG032051, R01AG027498] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health and Assistance Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the NIH (AG032051, AG033467, and AG027498) and the American Health and Assistance Foundation (A2008-052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antebi Adam, 2006, WormBook, P1; Asahina M, 2000, GENES CELLS, V5, P711, DOI 10.1046/j.1365-2443.2000.00361.x; BRENNER S, 1974, GENETICS, V77, P71; Cam JA, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-8; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Edwards SL, 2009, J CELL BIOL, V186, P881, DOI 10.1083/jcb.200902095; Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Grigorenko AP, 2004, P NATL ACAD SCI USA, V101, P14955, DOI 10.1073/pnas.0406462101; Hada K, 2010, DEV BIOL, V344, P1100, DOI 10.1016/j.ydbio.2010.05.508; HIEB WF, 1968, SCIENCE, V160, P778, DOI 10.1126/science.160.3829.778; Hornsten A, 2007, P NATL ACAD SCI USA, V104, P1971, DOI 10.1073/pnas.0603997104; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024; Kurzchalia TV, 2003, NAT CELL BIOL, V5, P684, DOI 10.1038/ncb0803-684; Li J, 2004, DEVELOPMENT, V131, P5741, DOI 10.1242/dev.01408; Merris M, 2003, J LIPID RES, V44, P172, DOI 10.1194/jlr.M200323-JLR200; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Motola DL, 2006, CELL, V124, P1209, DOI 10.1016/j.cell.2006.01.037; SAITO A, 1994, P NATL ACAD SCI USA, V91, P9725, DOI 10.1073/pnas.91.21.9725; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Sluder AE, 1999, GENOME RES, V9, P103; Sluder AE, 2001, TRENDS GENET, V17, P206, DOI 10.1016/S0168-9525(01)02242-9; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sym M, 2000, CURR BIOL, V10, P527, DOI 10.1016/S0960-9822(00)00468-1; Urs AN, 2007, MOL CELL ENDOCRINOL, V265, P174, DOI 10.1016/j.mce.2006.12.016; Wiese M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012790; Wood WB, 1988, NEMATODE CAENORHABDI, Vxiii; Wustner D, 2010, TRAFFIC, V11, P440, DOI 10.1111/j.1600-0854.2010.01040.x; Yochem J, 1999, DEVELOPMENT, V126, P597	30	8	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32038	10.1371/journal.pone.0032038	http://dx.doi.org/10.1371/journal.pone.0032038			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363792	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700137
J	Abela, E; Missimer, J; Wiest, R; Federspiel, A; Hess, C; Sturzenegger, M; Weder, B				Abela, Eugenio; Missimer, John; Wiest, Roland; Federspiel, Andrea; Hess, Christian; Sturzenegger, Matthias; Weder, Bruno			Lesions to Primary Sensory and Posterior Parietal Cortices Impair Recovery from Hand Paresis after Stroke	PLOS ONE			English	Article							TACTILE OBJECT DISCRIMINATION; PREDICTS MOTOR IMPAIRMENT; ARM FUNCTION; FRONTOPARIETAL CIRCUIT; SERIAL MEASUREMENTS; CORTEX; PERFORMANCE; FMRI; CONNECTIVITY; STRENGTH	Background: Neuroanatomical determinants of motor skill recovery after stroke are still poorly understood. Although lesion load onto the corticospinal tract is known to affect recovery, less is known about the effect of lesions to cortical sensorimotor areas. Here, we test the hypothesis that lesions of somatosensory cortices interfere with the capacity to recover motor skills after stroke. Methods: Standardized tests of motor skill and somatosensory functions were acquired longitudinally over nine months in 29 patients with stroke to the pre- and postcentral gyrus, including adjacent areas of the frontal, parietal and insular cortices. We derived the recovery trajectories of each patient for five motor subtest using least-squares curve fitting and objective model selection procedures for linear and exponential models. Patients were classified into subgroups based on their motor recovery models. Lesions were mapped onto diffusion weighted imaging scans and normalized into stereotaxic space using cost-function masking. To identify critical neuranatomical regions, voxel-wise subtractions were calculated between subgroup lesion maps. A probabilistic cytoarchitectonic atlas was used to quantify of lesion extent and location. Results: Twenty-three patients with moderate to severe initial deficits showed exponential recovery trajectories for motor subtests that relied on precise distal movements. Those that retained a chronic motor deficit had lesions that extended to the center of the somatosensory cortex (area 2) and the intraparietal sulcus (areas hIP1, hIP2). Impaired recovery outcome correlated with lesion extent on this areas and somatosensory performance. The rate of recovery, however, depended on the lesion load onto the primary motor cortex (areas 4a, 4p). Conclusions: Our findings support a critical role of uni-and multimodal somatosensory cortices in motor skill recovery. Whereas lesions to these areas influence recovery outcome, lesions to the primary motor cortex affect recovery dynamics. This points to a possible dissociation of neural substrates for different aspects of post-stroke recovery.	[Abela, Eugenio; Weder, Bruno] Kantonsspital St Gallen, Dept Neurol, St Gallen, Switzerland; [Missimer, John] Paul Scherrer Inst, Villigen, Switzerland; [Abela, Eugenio; Wiest, Roland] Univ Hosp Inselspital, SCAN, Inst Diagnost & Intervent Neuroradiol, Bern, Switzerland; [Abela, Eugenio; Wiest, Roland; Federspiel, Andrea; Hess, Christian; Sturzenegger, Matthias; Weder, Bruno] Univ Bern, Bern, Switzerland; [Abela, Eugenio; Hess, Christian; Sturzenegger, Matthias; Weder, Bruno] Univ Hosp Inselspital, Dept Neurol, Bern, Switzerland; [Federspiel, Andrea] Univ Hosp Psychiat, Dept Psychiat Neurophysiol, Bern, Switzerland	Kantonsspital St. Gallen; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Abela, E (corresponding author), Kantonsspital St Gallen, Dept Neurol, St Gallen, Switzerland.	bruno.weder@kssg.ch	Federspiel, Andrea/E-8342-2010	Federspiel, Andrea/0000-0003-3211-2675; Weder, Bruno/0000-0002-8106-9899; Abela, Eugenio/0000-0002-9356-1450	Swiss National Foundation [SNF 3200B0-118018]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was funded by a Swiss National Foundation grant (SNF 3200B0-118018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Amunts K, 2001, NEUROIMAG CLIN N AM, V11, P151; Binkofski F, 2001, CEREBROVASC DIS, V11, P273, DOI 10.1159/000047650; Binkofski F, 2001, BRAIN, V124, P132, DOI 10.1093/brain/124.1.132; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; Bodegard A, 2001, NEURON, V31, P317, DOI 10.1016/S0896-6273(01)00362-2; Bohlhalter S, 2002, BRAIN, V125, P2537, DOI 10.1093/brain/awf245; Culham JC, 2006, CURR OPIN NEUROBIOL, V16, P205, DOI 10.1016/j.conb.2006.03.005; DUNCAN PW, 1992, STROKE, V23, P1084, DOI 10.1161/01.STR.23.8.1084; DYCK PJ, 1993, NEUROLOGY, V43, P1508, DOI 10.1212/WNL.43.8.1508; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Eickhoff SB, 2006, NEUROIMAGE, V32, P570, DOI 10.1016/j.neuroimage.2006.04.204; Grefkes C, 2002, NEURON, V35, P173, DOI 10.1016/S0896-6273(02)00741-9; Hartmann S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003831; HELLER A, 1987, J NEUROL NEUROSUR PS, V50, P714, DOI 10.1136/jnnp.50.6.714; HIKOSAKA O, 1985, BRAIN RES, V325, P375, DOI 10.1016/0006-8993(85)90344-0; Homke L, 2009, HUM BRAIN MAPP, V30, P1444, DOI 10.1002/hbm.20617; Hsiao S, 2008, CURR OPIN NEUROBIOL, V18, P418, DOI 10.1016/j.conb.2008.09.001; HURVICH CM, 1995, BIOMETRICS, V51, P1077, DOI 10.2307/2533006; HYVARINEN J, 1978, J PHYSIOL-LONDON, V283, P539, DOI 10.1113/jphysiol.1978.sp012518; Iwamura Y, 1998, CURR OPIN NEUROBIOL, V8, P522, DOI 10.1016/S0959-4388(98)80041-X; JEBSEN R H, 1969, Archives of Physical Medicine and Rehabilitation, V50, P311; JONES EG, 1978, J COMP NEUROL, V181, P291, DOI 10.1002/cne.901810206; Karnath HO, 2010, BRAIN, V134, P903; Krakauer JW, 2005, SEMIN NEUROL, V25, P384, DOI 10.1055/s-2005-923533; Kwakkel G, 2003, STROKE, V34, P2181, DOI 10.1161/01.STR.0000087172.16305.CD; Lindenberg R, 2010, NEUROLOGY, V74, P280, DOI 10.1212/WNL.0b013e3181ccc6d9; Luft AR, 2004, LEARN MEMORY, V11, P379, DOI 10.1101/lm.72604; Lyden P, 1999, STROKE, V30, P2347, DOI 10.1161/01.STR.30.11.2347; Lyden P D, 1998, J Stroke Cerebrovasc Dis, V7, P113; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; MATHIOWETZ V, 1985, ARCH PHYS MED REHAB, V66, P69; MATTHEWS JNS, 1990, BRIT MED J, V300, P230, DOI 10.1136/bmj.300.6719.230; Nowak DA, 2008, NEUROSCI BIOBEHAV R, V32, P1439, DOI 10.1016/j.neubiorev.2008.05.021; Nudo RJ, 2001, MUSCLE NERVE, V24, P1000, DOI 10.1002/mus.1104; Nudo RJ, 1996, J NEUROSCI, V16, P785; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Papageorgiou E, 2008, NEUROLOGY, V70, P956, DOI 10.1212/01.wnl.0000305962.93520.ed; PAVLIDES C, 1993, J NEUROPHYSIOL, V70, P733, DOI 10.1152/jn.1993.70.2.733; Platz T, 1999, ARCH PHYS MED REHAB, V80, P270, DOI 10.1016/S0003-9993(99)90137-5; SEITZ RJ, 1992, EUR J NEUROSCI, V4, P154, DOI 10.1111/j.1460-9568.1992.tb00862.x; SENN S, 1990, BRIT MED J, V300, P680, DOI 10.1136/bmj.300.6725.680; STERN EB, 1992, AM J OCCUP THER, V46, P647, DOI 10.5014/ajot.46.7.647; Stoeckel MC, 2003, NEUROIMAGE, V19, P1103, DOI 10.1016/S1053-8119(03)00182-4; SUNDERLAND A, 1989, J NEUROL NEUROSUR PS, V52, P1267, DOI 10.1136/jnnp.52.11.1267; Verheyden G, 2008, NEUROREHAB NEURAL RE, V22, P173, DOI 10.1177/1545968307305456; Vidoni ED, 2010, NEUROBIOL LEARN MEM, V93, P532, DOI 10.1016/j.nlm.2010.01.011; Vidoni ED, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-36; WADE DT, 1983, J NEUROL NEUROSUR PS, V46, P521, DOI 10.1136/jnnp.46.6.521; Ward NS, 2004, CURR OPIN NEUROL, V17, P725, DOI 10.1097/00019052-200412000-00013; Ward NS, 2006, BRAIN, V129, P809, DOI 10.1093/brain/awl002; Wu CY, 2000, ARCH PHYS MED REHAB, V81, P95, DOI 10.1053/apmr.2000.0810095; Zhu LL, 2010, STROKE, V41, P910, DOI 10.1161/STROKEAHA.109.577023	54	50	53	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31275	10.1371/journal.pone.0031275	http://dx.doi.org/10.1371/journal.pone.0031275			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363604	Green Published, gold, Green Submitted			2022-12-27	WOS:000302871500030
J	Cordero, F; Beccuti, M; Arigoni, M; Donatelli, S; Calogero, RA				Cordero, Francesca; Beccuti, Marco; Arigoni, Maddalena; Donatelli, Susanna; Calogero, Raffaele A.			Optimizing a Massive Parallel Sequencing Workflow for Quantitative miRNA Expression Analysis	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; BIOCONDUCTOR PACKAGE; RAPID ALIGNMENT; SEQ; GENES; NORMALIZATION; TOOLS; BIAS	Background: Massive Parallel Sequencing methods (MPS) can extend and improve the knowledge obtained by conventional microarray technology, both for mRNAs and short non-coding RNAs, e. g. miRNAs. The processing methods used to extract and interpret the information are an important aspect of dealing with the vast amounts of data generated from short read sequencing. Although the number of computational tools for MPS data analysis is constantly growing, their strengths and weaknesses as part of a complex analytical pipe-line have not yet been well investigated. Primary findings: A benchmark MPS miRNA dataset, resembling a situation in which miRNAs are spiked in biological replication experiments was assembled by merging a publicly available MPS spike-in miRNAs data set with MPS data derived from healthy donor peripheral blood mononuclear cells. Using this data set we observed that short reads counts estimation is strongly under estimated in case of duplicates miRNAs, if whole genome is used as reference. Furthermore, the sensitivity of miRNAs detection is strongly dependent by the primary tool used in the analysis. Within the six aligners tested, specifically devoted to miRNA detection, SHRiMP and MicroRazerS show the highest sensitivity. Differential expression estimation is quite efficient. Within the five tools investigated, two of them (DESseq, baySeq) show a very good specificity and sensitivity in the detection of differential expression. Conclusions: The results provided by our analysis allow the definition of a clear and simple analytical optimized workflow for miRNAs digital quantitative analysis.	[Cordero, Francesca; Arigoni, Maddalena; Calogero, Raffaele A.] Univ Turin, Dept Comp Sci, Turin, Italy; [Cordero, Francesca; Beccuti, Marco; Donatelli, Susanna] Univ Turin, Ctr Mol Biotechnol, Turin, Italy	University of Turin; University of Turin	Cordero, F (corresponding author), Univ Turin, Dept Comp Sci, Turin, Italy.	raffaele.calogero@unito.it	Cordero, Francesca/AAB-3655-2019; Beccuti, Marco/K-7881-2012; Calogero, Raffaele/K-9428-2019	Cordero, Francesca/0000-0002-3143-3330; Calogero, Raffaele/0000-0002-2848-628X; Arigoni, Maddalena/0000-0003-4629-3841; Beccuti, Marco/0000-0001-6125-9460	Italian Association for Cancer Research; Italian Ministero dell'Universita e della Ricerca; University of Torino; EUCAAD (European Consortium for Anticancer Antibody Development) [200755]; Regione Piemonte	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Italian Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); University of Torino; EUCAAD (European Consortium for Anticancer Antibody Development); Regione Piemonte(Regione Piemonte)	This study was funded under the auspices of EUCAAD 200755 (European Consortium for Anticancer Antibody Development). This work was also supported by grants from the Italian Association for Cancer Research; the Italian Ministero dell'Universita e della Ricerca; the University of Torino and Regione Piemonte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon S, 2011, GENOME RES, V21, P1506, DOI 10.1101/gr.121715.111; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Califano A, 1993, Proc Int Conf Intell Syst Mol Biol, V1, P56; Della Beffa C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-571; Emde AK, 2010, BIOINFORMATICS, V26, P123, DOI 10.1093/bioinformatics/btp601; Farrar M, 2007, BIOINFORMATICS, V23, P156, DOI 10.1093/bioinformatics/btl582; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Jayaprakash AD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr693; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Moxon S, 2008, BIOINFORMATICS, V24, P2252, DOI 10.1093/bioinformatics/btn428; Pasaniuc B, 2011, J COMPUT BIOL, V18, P459, DOI 10.1089/cmb.2010.0259; Prufer K, 2008, BIOINFORMATICS, V24, P1530, DOI 10.1093/bioinformatics/btn223; Rasmussen KR, 2006, J COMPUT BIOL, V13, P296, DOI 10.1089/cmb.2006.13.296; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ronen R, 2010, BIOINFORMATICS, V26, P2615, DOI 10.1093/bioinformatics/btq493; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Sanges R, 2007, BIOINFORMATICS, V23, P3406, DOI 10.1093/bioinformatics/btm469; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang WC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-328; Weese D, 2009, GENOME RES, V19, P1646, DOI 10.1101/gr.088823.108; Willenbrock H, 2009, RNA, V15, P2028, DOI 10.1261/rna.1699809; Zheng W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-290; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	34	28	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31630	10.1371/journal.pone.0031630	http://dx.doi.org/10.1371/journal.pone.0031630			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363693	Green Published, gold, Green Submitted			2022-12-27	WOS:000302871500067
J	Lesens, O; Schmidt, A; De Rancourt, F; Poirier, V; Labbe, A; Laurichesse, H; Marty, L; Beytout, J; Vorilhon, P				Lesens, Olivier; Schmidt, Anna; De Rancourt, Florence; Poirier, Veronique; Labbe, Andre; Laurichesse, Henri; Marty, Laurent; Beytout, Jean; Vorilhon, Philippe			Health Care Support Issues for Internationally Adopted Children: A Qualitative Approach to the Needs and Expectations of Families	PLOS ONE			English	Article								Background: Families of internationally adopted children may face specific problems with which general practitioners (GPs) may not be familiar. The aim of the study was to explore problems faced by families before, during and after the arrival of their internationally adopted child and to assess the usefulness of a specific medical structure for internationally adopted children, which could be a resource for the GP. Methodology/Principal Findings: We conducted a qualitative study using individual semistructured guided conversations and interviewed 21 families that had adopted a total of 26 children internationally in the Puy de Dome department, France, in 2003. Quantitative data were used to describe the pathologies diagnosed and the investigations performed. Our study showed that the history of these families, from the start of the adoption project to its achievement, is complex and warrants careful analysis. Health-care providers should not only consider the medical aspects of adoption, but should also be interested in the histories of these families, which may play a role in the forming of attachments between the adoptee and their adoptive parents and prevent further trouble during the development of the child. We also showed that adoptive parents have similar fears or transient difficulties that may be resolved quickly by listening and reassurance. Most such families would support the existence of a specific medical structure for internationally adopted children, which could be a resource for the general practitioner. However, the health-care providers interviewed were divided on the subject and expressed their fear that a special consultation could be stigmatizing to children and families. Conclusions/Significance: A specific consultation with well-trained and experienced practitioners acting in close collaboration with GPs and paediatricians may be of help in better understanding and supporting adopted children and their families.	[Lesens, Olivier] Univ Auvergne, Clermont Univ, LMGE, Clermont Ferrand, France; [Lesens, Olivier; Laurichesse, Henri; Beytout, Jean] Hop Gabriel Montpied, Serv Malad Infect & Trop, Clermont Ferrand, France; [Schmidt, Anna; De Rancourt, Florence; Marty, Laurent; Vorilhon, Philippe] Univ Clermont, Dept Gen Med, Fac Med Clermont Ferrand, Clermont Ferrand, France; [Poirier, Veronique; Labbe, Andre] Unite Reanimat Neonatale & Pediat, Clermont Ferrand, France	Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; CHU Clermont Ferrand	Lesens, O (corresponding author), Univ Auvergne, Clermont Univ, LMGE, Clermont Ferrand, France.	olesens@chu-clermontferrand.fr						Auger L, 2005, ARCH PEDIATRIE, V12, P715, DOI 10.1016/j.arcped.2005.04.004; Body Lawson F, 2008, NEUROPSYCHIAT ENFAN, V56, P461; Britten N, QUALITATIVE INTERVIE; Choulot JJ, 2005, J PEDIAT PUERICULTUR, V18, P409; de Monleon JV, 2003, ARCH PEDIATRIE, V10, p240S, DOI 10.1016/S0929-693X(03)90455-6; France Diplomatie Web site Ministere des Affaires etrangeres et europeennes, 2009, AD INT STAT 2009; Goubier-Boula M. O., 2005, NEUROPSYCHIAT ENFAN, V53, P263; Gunnar M, 2007, CHILD MALTREATMENT, V12, P381, DOI 10.1177/1077559507306719; Keyes MA, 2008, ARCH PEDIAT ADOL MED, V162, P419, DOI 10.1001/archpedi.162.5.419; Kreppner JM, 2001, J ABNORM CHILD PSYCH, V29, P513; Landgren M, 2010, PEDIATRICS, V125, pE1178, DOI 10.1542/peds.2009-0712; Miller LC, 2008, CLIN INFECT DIS, V47, P815, DOI 10.1086/591200; Murray TS, 2005, CLIN MICROBIOL REV, V18, P510, DOI 10.1128/CMR.18.3.510-520.2005; Nickman SL, 2005, J AM ACAD CHILD PSY, V44, P987, DOI 10.1097/01.chi.0000174463.60987.69; Rutter M, 2007, J CHILD PSYCHOL PSYC, V48, P1200, DOI 10.1111/j.1469-7610.2007.01792.x; Schulte JM, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e22; Teilmann G, 2009, HORM RES, V72, P236, DOI 10.1159/000236085	17	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31313	10.1371/journal.pone.0031313	http://dx.doi.org/10.1371/journal.pone.0031313			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926YY	22363614	Green Published, gold			2022-12-27	WOS:000302871500033
J	Lillvis, JL; Gunaratne, CA; Katz, PS				Lillvis, Joshua L.; Gunaratne, Charuni A.; Katz, Paul S.			Neurochemical and Neuroanatomical Identification of Central Pattern Generator Neuron Homologues in Nudipleura Molluscs	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SEA SLUG PLEUROBRANCHAEA; FIXED ACTION PATTERN; MARINE MOLLUSK; NUDIBRANCH MOLLUSKS; TRITONIA-DIOMEDEA; OPISTHOBRANCHIA MOLLUSCA; RHYTHMIC BEHAVIORS; CEREBRAL NEURONS; CLIONE-LIMACINA	Certain invertebrate neurons can be identified by their behavioral functions. However, evolutionary divergence can cause some species to not display particular behaviors, thereby making it impossible to use physiological characteristics related to those behaviors for identifying homologous neurons across species. Therefore, to understand the neural basis of species-specific behavior, it is necessary to identify homologues using characteristics that are independent of physiology. In the Nudipleura mollusc Tritonia diomedea, Cerebral Neuron 2 (C2) was first described as being a member of the swim central pattern generator (CPG). Here we demonstrate that neurochemical markers, in conjunction with previously known neuroanatomical characteristics, allow C2 to be uniquely identified without the aid of electrophysiological measures. Specifically, C2 had three characteristics that, taken together, identified the neuron: 1) a white cell on the dorsal surface of the cerebral ganglion, 2) an axon that projected to the contralateral pedal ganglion and through the pedal commissure, and 3) immunoreactivity for the peptides FMRFamide and Small Cardioactive Peptide B. These same anatomical and neurochemical characteristics also uniquely identified the C2 homologue in Pleurobranchaea californica (called A1), which was previously identified by its analogous role in the Pleurobranchaea swim CPG. Furthermore, these characteristics were used to identify C2 homologues in Melibe leonina, Hermissenda crassicornis, and Flabellina iodinea, species that are phylogenetically closer to Tritonia than Pleurobranchaea, but do not display the same swimming behavior as Tritonia or Pleurobranchaea. These identifications will allow future studies comparing and contrasting the physiological properties of C2 across species that can and cannot produce the type of swimming behavior exhibited by Tritonia.	[Lillvis, Joshua L.; Gunaratne, Charuni A.; Katz, Paul S.] Georgia State Univ, Inst Neurosci, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Lillvis, JL (corresponding author), Georgia State Univ, Inst Neurosci, Atlanta, GA 30303 USA.	lillvis@gsu.edu	Lillvis, Joshua/GMX-3123-2022	Lillvis, Joshua/0000-0002-6235-8759	National Science Foundation [IOS-0814411, IOS-1120950, IOS-1011476]; Direct For Biological Sciences [1120950] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	National Science Foundation (https://www.nsf.gov/): IOS-0814411, IOS-1120950, IOS-1011476. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audesirk T., 1985, NEUROBIOLOGY BEHAV, V8; Bouchet P, 2005, MALACOLOGIA, V47, P1; BOYLE MB, 1983, BRAIN RES, V266, P305, DOI 10.1016/0006-8993(83)90662-5; Bullock T., 1965, STRUCTURE FUNCTION N; Bullock TH, 2000, BRAIN BEHAV EVOLUT, V55, P236, DOI 10.1159/000006657; Calin-Jageman RJ, 2007, J NEUROPHYSIOL, V98, P2382, DOI 10.1152/jn.00572.2007; CROLL RP, 1987, BRAIN RES, V405, P337, DOI 10.1016/0006-8993(87)90303-9; Croll RP, 2001, CELL TISSUE RES, V305, P417, DOI 10.1007/s004410100394; CROLL RP, 1987, NERVOUS SYSTEMS INVE, P41, DOI DOI 10.1007/978-1-4613-1955-9_4; Crow T, 2004, J NEUROPHYSIOL, V91, P2874, DOI 10.1152/jn.00028.2004; Crow T, 2009, J NEUROPHYSIOL, V101, P824, DOI 10.1152/jn.91079.2008; DAVIS WJ, 1971, Z VERGL PHYSIOL, V75, P207; DORSETT DA, 1969, NATURE, V224, P711, DOI 10.1038/224711a0; FARMER W M, 1970, Veliger, V13, P73; Fickbohm DJ, 2001, J COMP NEUROL, V437, P91; Getting P. A., 1989, NETWORK OSCILLATOR U, P215; GETTING PA, 1983, J NEUROPHYSIOL, V49, P1036, DOI 10.1152/jn.1983.49.4.1036; GETTING PA, 1980, J NEUROPHYSIOL, V44, P151, DOI 10.1152/jn.1980.44.1.151; GETTING PA, 1977, J COMP PHYSIOL, V121, P325, DOI 10.1007/BF00613012; GETTING PA, 1981, J NEUROPHYSIOL, V46, P65, DOI 10.1152/jn.1981.46.1.65; Grande C, 2004, MOL PHYLOGENET EVOL, V33, P378, DOI 10.1016/j.ympev.2004.06.008; GRANZOW B, 1981, J EXP BIOL, V90, P283; HUME RI, 1982, J NEUROPHYSIOL, V47, P60, DOI 10.1152/jn.1982.47.1.60; Jezzini SH, 2005, J NEUROSCI METH, V149, P15, DOI 10.1016/j.jneumeth.2005.05.007; Jing J, 2003, J NEUROSCI, V23, P3039; JING J, 1995, J NEUROPHYSIOL, V74, P1900, DOI 10.1152/jn.1995.74.5.1900; Jing J, 1999, J NEUROPHYSIOL, V81, P654, DOI 10.1152/jn.1999.81.2.654; Jing J, 2000, J NEUROPHYSIOL, V83, P1346, DOI 10.1152/jn.2000.83.3.1346; Jing J, 2008, J NEUROSCI, V28, P12349, DOI 10.1523/JNEUROSCI.3855-08.2008; Katz PS, 2001, AM ZOOL, V41, P962, DOI 10.1668/0003-1569(2001)041[0962:ETTCPG]2.0.CO;2; Katz PS., 2009, SCHOLARPEDIA, V4, P3638, DOI [DOI 10.4249/SCHOLARPEDIA.3638, 10.4249/scholarpedia.3638]; Lawrence KA, 2002, BIOL BULL, V203, P144, DOI 10.2307/1543383; MASINOVSKY B, 1988, J COMP NEUROL, V273, P500, DOI 10.1002/cne.902730406; Newcomb JM, 2007, J COMP PHYSIOL A, V193, P425, DOI 10.1007/s00359-006-0196-4; Newcomb JM, 2006, J COMP NEUROL, V499, P485, DOI 10.1002/cne.21111; Newcomb JM, 2009, P R SOC B, V276, P99, DOI 10.1098/rspb.2008.0683; PANCHIN YV, 1995, J NEUROPHYSIOL, V73, P1912, DOI 10.1152/jn.1995.73.5.1912; Pentreath V.W., 1982, P457; Popescu IR, 2002, J NEUROSCI, V22, P1985, DOI 10.1523/JNEUROSCI.22-05-01985.2002; ROBERTS MH, 1988, PEPTIDES, V9, P1323, DOI 10.1016/0196-9781(88)90199-4; Sakurai A, 2011, CURR BIOL, V21, P1036, DOI 10.1016/j.cub.2011.04.040; Sakurai A, 2009, J NEUROSCI, V29, P13115, DOI 10.1523/JNEUROSCI.3485-09.2009; SATTERLIE RA, 1995, J EXP BIOL, V198, P917; SNOW RW, 1982, J NEUROBIOL, V13, P267, DOI 10.1002/neu.480130307; SOINILA S, 1991, BIOL BULL-US, V181, P484, DOI 10.2307/1542369; STRIEDTER GF, 1991, BRAIN BEHAV EVOLUT, V38, P177, DOI 10.1159/000114387; Sudlow LC, 1998, J COMP NEUROL, V395, P466; TAGHERT PH, 1978, J COMP PHYSIOL, V123, P253, DOI 10.1007/BF00656878; Tian LM, 2006, J NEUROPHYSIOL, V96, P327, DOI 10.1152/jn.00035.2006; Vonnemann V, 2005, J MOLLUS STUD, V71, P113, DOI 10.1093/mollus/eyi014; Wagele H, 2000, ZOOL J LINN SOC-LOND, V130, P83, DOI 10.1006/zjls.1999.0214; WATSON WH, 1992, J NEUROBIOL, V23, P173, DOI 10.1002/neu.480230208; WEISS KR, 1976, BRAIN RES, V117, P33, DOI 10.1016/0006-8993(76)90554-0; Wentzell MM, 2009, BRAIN BEHAV EVOLUT, V74, P219, DOI 10.1159/000258668; Willows AOD, 2001, AM ZOOL, V41, P943; WILLOWS AOD, 1973, J NEUROBIOL, V4, P207, DOI 10.1002/neu.480040306; WILLOWS AOD, 1969, SCIENCE, V166, P1549, DOI 10.1126/science.166.3912.1549; Wollscheid E, 1999, MOL PHYLOGENET EVOL, V13, P215, DOI 10.1006/mpev.1999.0664; Wollscheid-Lengeling E, 2001, ORG DIVERS EVOL, V1, P241, DOI 10.1078/1439-6092-00022; YOSHIDA M, 1994, COMP BIOCHEM PHYS A, V107, P269, DOI 10.1016/0300-9629(94)90380-8	60	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31737	10.1371/journal.pone.0031737	http://dx.doi.org/10.1371/journal.pone.0031737			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363716	gold, Green Submitted, Green Published			2022-12-27	WOS:000302871500082
J	Lin, L; Tran, T; Hu, S; Cramer, T; Komuniecki, R; Steven, RM				Lin, Li; Thuy Tran; Hu, Shuang; Cramer, Todd; Komuniecki, Richard; Steven, Robert M.			RHGF-2 Is an Essential Rho-1 Specific RhoGEF that binds to the Multi-PDZ Domain Scaffold Protein MPZ-1 in Caenorhabditis elegans	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; INDUCED NEURITE RETRACTION; C-ELEGANS; EPIDERMAL MORPHOGENESIS; NEUROTRANSMITTER RELEASE; LYSOPHOSPHATIDIC ACID; MYOSIN PHOSPHATASE; TIGHT JUNCTIONS; CELL; RECEPTOR	RhoGEF proteins activate the Rho family of small GTPases and thus play a key role in regulating fundamental cellular processes such as cell morphology and polarity, cell cycle progression and gene transcription. We identified a Caenorhabditis elegans RhoGEF protein, RHGF-2, as a binding partner of the C. elegans multi-PDZ domain scaffold protein MPZ-1 (MUPP1 in mammals). RHGF-2 exhibits significant identity to the mammalian RhoGEFs PLEKHG5/Tech/Syx and contains a class I C-terminal PDZ binding motif (SDV) that interacts most strongly to MPZ-1 PDZ domain eight. RHGF-2 RhoGEF activity is specific to the C. elegans RhoA homolog RHO-1 as determined by direct binding, GDP/GTP exchange and serum response element-driven reporter activity. rhgf-2 is an essential gene since rhgf-2 deletion mutants do not elongate during embryogenesis and hatch as short immobile animals that arrest development. Interestingly, the expression of a functional rhgf-2::gfp transgene appears to be exclusively neuronal and rhgf-2 overexpression results in loopy movement with exaggerated body bends. Transient expression of RHGF-2 in N1E-115 neuroblastoma cells prevents neurite outgrowth similar to constitutive RhoA activation in these cells. Together, these observations indicate neuronally expressed RHGF-2 is an essential RHO-1 specific RhoGEF that binds most strongly to MPZ-1 PDZ domain eight and is required for wild-type C. elegans morphology and growth.	[Lin, Li; Thuy Tran; Hu, Shuang; Cramer, Todd; Komuniecki, Richard; Steven, Robert M.] Univ Toledo, Dept Biol Sci, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Lin, L (corresponding author), Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	robert.steven2@utoledo.edu			National Institutes of Health (NIH) [1R15NS062406, 1R01AI072644]; National Institutes of Health [NIH] National Center for Research Resources; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS062406] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health [NIH] National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grants 1R15NS062406 to Dr. Steven and 1R01AI072644 to Dr. Komuniecki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank John Gray for assistance with bioinformatics, John Plenefisch and Vera Hapiak for microscopy assistance, Qing Zhao for assistance with the statistical analysis, Paul Mains for sharing unpublished data and Joe Culotti for jcIs1; him-5. Additional nematode strains were obtained from the Caenorhabditis Genetics Center (which is funded by the National Institutes of Health [NIH] National Center for Research Resources).	Abe R, 1999, J BIOL CHEM, V274, P30410, DOI 10.1074/jbc.274.43.30410; Ackermann F, 2009, J CELL SCI, V122, P4547, DOI 10.1242/jcs.058263; Adachi M, 2009, MOL CELL BIOL, V29, P2372, DOI 10.1128/MCB.01505-08; Balasubramanian S, 2007, J BIOL CHEM, V282, P4162, DOI 10.1074/jbc.M607695200; Barritt DS, 2000, J CELL BIOCHEM, V79, P213, DOI 10.1002/1097-4644(20001101)79:2<213::AID-JCB50>3.0.CO;2-G; Becamel C, 2001, J BIOL CHEM, V276, P12974, DOI 10.1074/jbc.M008089200; Bi F, 2001, MOL CELL BIOL, V21, P1463, DOI 10.1128/MCB.21.5.1463-1474.2001; Boda B, 2010, CURR OPIN NEUROBIOL, V20, P519, DOI 10.1016/j.conb.2010.03.012; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Chin-Sang ID, 1999, CELL, V99, P781, DOI 10.1016/S0092-8674(00)81675-X; Chin-Sang ID, 2000, TRENDS GENET, V16, P544, DOI 10.1016/S0168-9525(00)02143-0; D'Angelo R, 2007, MOL BIOL CELL, V18, P4780, DOI 10.1091/mbc.E06-12-1144; De Toledo M, 2001, ONCOGENE, V20, P7307, DOI 10.1038/sj.onc.1204921; Wu D, 2006, CELL CYCLE, V5, P1234, DOI 10.4161/cc.5.11.2815; Diogon M, 2007, DEVELOPMENT, V134, P2469, DOI 10.1242/dev.005074; Dooley R, 2009, FEBS J, V276, P7279, DOI 10.1111/j.1742-4658.2009.07435.x; Ernkvist M, 2009, BLOOD, V113, P244, DOI 10.1182/blood-2008-04-153874; Estevez MA, 2008, J NEUROCHEM, V106, P1287, DOI 10.1111/j.1471-4159.2008.05472.x; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; FRANCIS R, 1991, J CELL BIOL, V114, P465, DOI 10.1083/jcb.114.3.465; Fromm C, 1997, P NATL ACAD SCI USA, V94, P10098, DOI 10.1073/pnas.94.19.10098; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Garnaas MK, 2008, CIRC RES, V103, P710, DOI 10.1161/CIRCRESAHA.108.181388; Gebbink MFBG, 1997, J CELL BIOL, V137, P1603, DOI 10.1083/jcb.137.7.1603; George SE, 1998, CELL, V92, P633, DOI 10.1016/S0092-8674(00)81131-9; Goh LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012409; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Hamazaki Y, 2002, J BIOL CHEM, V277, P455, DOI 10.1074/jbc.M109005200; Harris TW, 2010, NUCLEIC ACIDS RES, V38, pD463, DOI 10.1093/nar/gkp952; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; Heller B, 2010, J BIOL CHEM, V285, P12308, DOI 10.1074/jbc.M109.096230; Hiley E, 2006, EMBO J, V25, P5884, DOI 10.1038/sj.emboj.7601458; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hu S, 2011, GENETICS, V189, P137, DOI 10.1534/genetics.111.131227; Hussain NK, 1999, J BIOL CHEM, V274, P15671, DOI 10.1074/jbc.274.22.15671; JALINK K, 1994, J CELL BIOL, V126, P801, DOI 10.1083/jcb.126.3.801; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; Jeansonne B, 2003, CELL MOL BIOL, V49, P13; Jones KA, 2009, P NATL ACAD SCI USA, V106, P19575, DOI 10.1073/pnas.0905884106; Kimber WA, 2002, BIOCHEM J, V361, P525, DOI 10.1042/0264-6021:3610525; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kins S, 2000, NAT NEUROSCI, V3, P22, DOI 10.1038/71096; Koppen M, 2001, NAT CELL BIOL, V3, P983, DOI 10.1038/ncb1101-983; Kranenburg O, 1997, J CELL SCI, V110, P2417; Kranenburg O, 1999, MOL BIOL CELL, V10, P1851, DOI 10.1091/mbc.10.6.1851; Krapivinsky G, 2004, NEURON, V43, P563, DOI 10.1016/j.neuron.2004.08.003; Lanaspa MA, 2008, P NATL ACAD SCI USA, V105, P15797, DOI 10.1073/pnas.0805761105; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Liu ML, 2006, MOL BIOL CELL, V17, P1880, DOI 10.1091/mbc.E06-01-0002; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Mancini A, 2000, FEBS LETT, V482, P54, DOI 10.1016/S0014-5793(00)02036-6; Marx R, 2005, J NEUROCHEM, V92, P850, DOI 10.1111/j.1471-4159.2004.02930.x; Maryon EB, 1996, J CELL BIOL, V134, P885, DOI 10.1083/jcb.134.4.885; Maystadt I, 2007, AM J HUM GENET, V81, P67, DOI 10.1086/518900; McMullan R, 2006, GENE DEV, V20, P65, DOI 10.1101/gad.359706; McMullan R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017265; McPherson CE, 2005, GENE, V347, P125, DOI 10.1016/j.gene.2004.12.028; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mohler WA, 1998, CURR BIOL, V8, P1087, DOI 10.1016/S0960-9822(98)70447-6; Motegi F, 2006, NAT CELL BIOL, V8, P978, DOI 10.1038/ncb1459; Murayama K, 2007, J BIOL CHEM, V282, P4238, DOI 10.1074/jbc.C600234200; Nurnberg A, 2008, J BIOL CHEM, V283, P35526, DOI 10.1074/jbc.M804972200; Palmitessa A, 2010, J BIOL CHEM, V285, P15187, DOI 10.1074/jbc.M110.104612; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Poliak S, 2002, J CELL BIOL, V159, P361, DOI 10.1083/jcb.200207050; Portales-Casamar E, 2006, BIOL CELL, V98, P183, DOI 10.1042/BC20050009; PRIESS JR, 1986, DEV BIOL, V117, P156, DOI 10.1016/0012-1606(86)90358-1; Qadota H, 2008, J MOL BIOL, V383, P747, DOI 10.1016/j.jmb.2008.08.083; Rabiner CA, 2005, NEUROSCIENTIST, V11, P148, DOI 10.1177/1073858404271250; Reid T, 1999, J BIOL CHEM, V274, P33587, DOI 10.1074/jbc.274.47.33587; Rumenapp U, 1999, FEBS LETT, V459, P313, DOI 10.1016/S0014-5793(99)01270-3; Schonegg S, 2006, DEVELOPMENT, V133, P3507, DOI 10.1242/dev.02527; Sebok A, 1999, J NEUROCHEM, V73, P949, DOI 10.1046/j.1471-4159.1999.0730949.x; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Simske JS, 2001, BIOESSAYS, V23, P12, DOI 10.1002/1521-1878(200101)23:1&lt;12::AID-BIES1003&gt;3.0.CO;2-R; Sone M, 1997, SCIENCE, V275, P543, DOI 10.1126/science.275.5299.543; Spencer AG, 2001, P NATL ACAD SCI USA, V98, P13132, DOI 10.1073/pnas.241504098; Steven R, 2005, GENE DEV, V19, P2016, DOI 10.1101/gad.1319905; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tigyi G, 1996, J NEUROCHEM, V66, P537; Vockel M, 2010, EXP DERMATOL, V19, P888, DOI 10.1111/j.1600-0625.2010.01101.x; Wang XM, 1999, MOL CELL, V4, P903, DOI 10.1016/S1097-2765(00)80220-8; Williams SL, 2007, GENE DEV, V21, P2731, DOI 10.1101/gad.1592007; Wissmann A, 1997, GENE DEV, V11, P409, DOI 10.1101/gad.11.4.409; Wu CS, 2011, J BIOL CHEM, V286, P23511, DOI 10.1074/jbc.M111.245209; Wu D, 2010, J BIOL CHEM, V285, P28643, DOI 10.1074/jbc.M110.107649; Xiao H, 2006, DEV BIOL, V298, P379, DOI 10.1016/j.ydbio.2006.06.044; Yu BK, 2010, CELL, V140, P246, DOI 10.1016/j.cell.2009.12.033	92	17	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31499	10.1371/journal.pone.0031499	http://dx.doi.org/10.1371/journal.pone.0031499			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363657	Green Submitted, gold, Green Published			2022-12-27	WOS:000302871500048
J	Dayan, E; Inzelberg, R; Flash, T				Dayan, Eran; Inzelberg, Rivka; Flash, Tamar			Altered Perceptual Sensitivity to Kinematic Invariants in Parkinson's Disease	PLOS ONE			English	Article							BIOLOGICAL MOTION; POWER-LAW; VISUAL DYSFUNCTION; ACTION RECOGNITION; MOTOR DYSFUNCTION; ARM MOVEMENTS; EYE-MOVEMENTS; VELOCITY; IMPAIRMENT; CURVATURE	Ample evidence exists for coupling between action and perception in neurologically healthy individuals, yet the precise nature of the internal representations shared between these domains remains unclear. One experimentally derived view is that the invariant properties and constraints characterizing movement generation are also manifested during motion perception. One prominent motor invariant is the "two-third power law," describing the strong relation between the kinematics of motion and the geometrical features of the path followed by the hand during planar drawing movements. The two-thirds power law not only characterizes various movement generation tasks but also seems to constrain visual perception of motion. The present study aimed to assess whether motor invariants, such as the two thirds power law also constrain motion perception in patients with Parkinson's disease (PD). Patients with PD and age-matched controls were asked to observe the movement of a light spot rotating on an elliptical path and to modify its velocity until it appeared to move most uniformly. As in previous reports controls tended to choose those movements close to obeying the two-thirds power law as most uniform. Patients with PD displayed a more variable behavior, choosing on average, movements closer but not equal to a constant velocity. Our results thus demonstrate impairments in how the two-thirds power law constrains motion perception in patients with PD, where this relationship between velocity and curvature appears to be preserved but scaled down. Recent hypotheses on the role of the basal ganglia in motor timing may explain these irregularities. Alternatively, these impairments in perception of movement may reflect similar deficits in motor production.	[Dayan, Eran; Flash, Tamar] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Dayan, Eran] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Inzelberg, Rivka] Tel Hashomer & Tel Aviv Univ, Sheba Med Ctr, Sagol Neurosci Ctr, Dept Neurol, Tel Aviv, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Chaim Sheba Medical Center	Dayan, E (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	dayan.eran@gmail.com	Inzelberg, Rivka/E-5861-2010; Dayan, Eran/C-3449-2009	Inzelberg, Rivka/0000-0002-0720-0502; Dayan, Eran/0000-0001-9710-9210	Human Frontier Science Program [RGP0054/2004-C]; European Commission [043403, 249858]; Tango	Human Frontier Science Program(Human Frontier Science Program); European Commission(European CommissionEuropean Commission Joint Research Centre); Tango	This work was supported in part by a Human Frontier Science Program Grant (RGP0054/2004-C) [http://www.hfsp.org/], by the European Commission-funded COBOL Contract (043403). [http://ec.europa.eu/index_en.htm] and by Tango. The project Tango acknowledges the financial support of the Future and Emerging Technologies (FET) programme within the Seventh Framework Program for Research of the European Commission, under 14 FET-Open grant number: 249858. [http://cordis.europa.eu/ist/fet/home.html] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEND W, 1982, BRAIN, V105, P331, DOI 10.1093/brain/105.2.331; Alberts JL, 2000, EXP BRAIN RES, V134, P353, DOI 10.1007/s002210000468; Archibald NK, 2009, BRAIN, V132, P1128, DOI 10.1093/brain/awp068; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bennequin D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000426; Beudel M, 2008, NEUROREPORT, V19, P1055, DOI 10.1097/WNR.0b013e328303b7b9; Bidet-Ildei C, 2006, PERCEPTION, V35, P1137, DOI 10.1068/p5482; BODISWOLLNER I, 1987, BRAIN, V110, P1675, DOI 10.1093/brain/110.6.1675; Casile A, 2006, CURR BIOL, V16, P69, DOI 10.1016/j.cub.2005.10.071; Casile A, 2010, CEREB CORTEX, V20, P1647, DOI 10.1093/cercor/bhp229; Castelo-Branco M, 2009, NEUROPSYCHOLOGIA, V47, P314, DOI 10.1016/j.neuropsychologia.2008.09.003; Castiello U, 2000, NEUROPSYCHOLOGIA, V38, P46, DOI 10.1016/S0028-3932(99)00049-4; Castiello U, 2009, NEUROPSYCHOLOGIA, V47, P835, DOI 10.1016/j.neuropsychologia.2008.12.016; Cooper CA, 2009, PARKINSONISM RELAT D, V15, P315, DOI 10.1016/j.parkreldis.2008.07.009; Dayan E, 2007, P NATL ACAD SCI USA, V104, P20582, DOI 10.1073/pnas.0710033104; Decety J, 1999, TRENDS COGN SCI, V3, P172, DOI 10.1016/S1364-6613(99)01312-1; Desmurget M, 2004, BRAIN, V127, P1755, DOI 10.1093/brain/awh206; deSperati C, 1997, J NEUROSCI, V17, P3932; DESPERATI C, 1995, EXP BRAIN RES, V105, P254; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Fabbri-Destro M, 2008, PHYSIOLOGY, V23, P171, DOI 10.1152/physiol.00004.2008; Fahn S., 1987, RECENT DEV PARKINSON, P153; Flach R, 2004, VIS COGN, V11, P461, DOI 10.1080/13506280344000392; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; FLASH T, 1992, EXP NEUROL, V118, P215, DOI 10.1016/0014-4886(92)90038-R; FLASH T, 1992, HUM MOVEMENT SCI, V11, P83, DOI 10.1016/0167-9457(92)90052-D; FLASH T, 1992, PARKINSONS DIS PROBL, P87; Flash T, 2007, BIOL CYBERN, V96, P577, DOI 10.1007/s00422-007-0145-5; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gangitano M, 2004, EUR J NEUROSCI, V20, P2193, DOI 10.1111/j.1460-9568.2004.03655.x; Hamilton AFD, 2006, J NEUROSCI, V26, P1133, DOI 10.1523/JNEUROSCI.4551-05.2006; HARNOIS C, 1990, INVEST OPHTH VIS SCI, V31, P2473; Harrington DL, 1999, REV NEUROSCIENCE, V10, P91, DOI 10.1515/REVNEURO.1999.10.2.91; Hicheur H, 2005, EXP BRAIN RES, V162, P145, DOI 10.1007/s00221-004-2122-8; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; HUFSCHMIDT A, 1995, MOVEMENT DISORD, V10, P267, DOI 10.1002/mds.870100306; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Inzelberg R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003663; Jin DZ, 2009, P NAT AC SCI; Johnson MTV, 1996, BRAIN, V119, P801, DOI 10.1093/brain/119.3.801; Kandel S, 2000, PERCEPT PSYCHOPHYS, V62, P706, DOI 10.3758/BF03206917; LACQUANITI F, 1983, ACTA PSYCHOL, V54, P115, DOI 10.1016/0001-6918(83)90027-6; Lekwuwa GU, 1999, J NEUROL NEUROSUR PS, V66, P746, DOI 10.1136/jnnp.66.6.746; Levit-Binnun N, 2006, EXP BRAIN RES, V172, P533, DOI 10.1007/s00221-006-0355-4; Maetzler W, 2009, LANCET NEUROL, V8, P1158, DOI 10.1016/S1474-4422(09)70291-1; Mahon BZ, 2008, CURR BIOL, V18, pR1068, DOI 10.1016/j.cub.2008.10.001; Mahon BZ, 2005, COGN NEUROPSYCHOL, V22, P480, DOI 10.1080/02643290442000446; Matell MS, 2004, COGNITIVE BRAIN RES, V21, P139, DOI 10.1016/j.cogbrainres.2004.06.012; Meck WH, 2008, CURR OPIN NEUROBIOL, V18, P145, DOI 10.1016/j.conb.2008.08.002; Mosimann UP, 2004, NEUROLOGY, V63, P2091, DOI 10.1212/01.WNL.0000145764.70698.4E; Muslimovic D, 2007, J INT NEUROPSYCH SOC, V13, P920, DOI 10.1017/S1355617707071160; Negri GAL, 2007, COGN NEUROPSYCHOL, V24, P795, DOI 10.1080/02643290701707412; Owen AM, 2004, NEUROSCIENTIST, V10, P525, DOI 10.1177/1073858404266776; Poliakoff E, 2007, NEUROREPORT, V18, P483, DOI 10.1097/WNR.0b013e32805867a1; Pollick FE, 1997, VISION RES, V37, P347, DOI 10.1016/S0042-6989(96)00116-2; Polyakov F, 2009, BIOL CYBERN, V100, P159, DOI 10.1007/s00422-008-0287-0; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; REED CL, 1995, J EXP PSYCHOL HUMAN, V21, P334, DOI 10.1037/0096-1523.21.2.334; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; STERN Y, 1983, J NEUROL NEUROSUR PS, V46, P145, DOI 10.1136/jnnp.46.2.145; Tasko SM, 2004, J PHONETICS, V32, P65, DOI 10.1016/S0095-4470(03)00006-8; Tremblay F, 2008, EXP BRAIN RES, V185, P249, DOI 10.1007/s00221-007-1150-6; TRICK GL, 1994, OPTOMETRY VISION SCI, V71, P242, DOI 10.1097/00006324-199404000-00002; Uc EY, 2005, NEUROLOGY, V65, P1907, DOI 10.1212/01.wnl.0000191565.11065.11; Van Gemmert AWA, 1999, NEUROPSYCHOLOGIA, V37, P685; Van Gemmert AWA, 2003, J NEUROL NEUROSUR PS, V74, P1502, DOI 10.1136/jnnp.74.11.1502; VIVIANI P, 1992, J EXP PSYCHOL HUMAN, V18, P603, DOI 10.1037/0096-1523.18.3.603; VIVIANI P, 1985, J EXP PSYCHOL HUMAN, V11, P828, DOI 10.1037/0096-1523.11.6.828; Viviani P, 2002, ATTENTION PERFORM, V19, P406; Viviani P, 2009, EXP BRAIN RES, V194, P259, DOI 10.1007/s00221-008-1695-z; WANN J, 1988, J EXP PSYCHOL HUMAN, V14, P622, DOI 10.1037/0096-1523.14.4.622; WHITE OB, 1983, BRAIN, V106, P571, DOI 10.1093/brain/106.3.571; Williams LN, 2007, MOVEMENT DISORD, V22, P141, DOI 10.1002/mds.21220	75	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30369	10.1371/journal.pone.0030369	http://dx.doi.org/10.1371/journal.pone.0030369			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363430	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600024
J	Henk, DA; Fisher, MC				Henk, Daniel A.; Fisher, Matthew C.			The Gut Fungus Basidiobolus ranarum Has a Large Genome and Different Copy Numbers of Putatively Functionally Redundant Elongation Factor Genes	PLOS ONE			English	Article							EVOLUTION; ENTOMOPHTHORALES; CRYPTOMONADS; ZYGOMYCOTA; DIVISION; MITOSIS; GTPASE; EFL	Fungal genomes range in size from 2.3 Mb for the microsporidian Encephalitozoon intestinalis up to 8000 Mb for Entomophaga aulicae, with a mean genome size of 37 Mb. Basidiobolus, a common inhabitant of vertebrate guts, is distantly related to all other fungi, and is unique in possessing both EF-1 alpha and EFL genes. Using DNA sequencing and a quantitative PCR approach, we estimated a haploid genome size for Basidiobolus at 350 Mb. However, based on allelic variation, the nuclear genome is at least diploid, leading us to believe that the final genome size is at least 700 Mb. We also found that EFL was in three times the copy number of its putatively functionally overlapping paralog EF-1 alpha. This suggests that gene or genome duplication may be an important feature of B. ranarum evolution, and also suggests that B. ranarum may have mechanisms in place that favor the preservation of functionally overlapping genes.	[Henk, Daniel A.; Fisher, Matthew C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England	Imperial College London	Henk, DA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England.	d.henk@imperial.ac.uk	Fisher, Matthew/B-9094-2011	Fisher, Matthew/0000-0002-1862-6402	Wellcome Trust; Linnean Society of London and Systematics Association	Wellcome Trust(Wellcome TrustEuropean Commission); Linnean Society of London and Systematics Association	This work was supported by grants to Dr. Matthew Fisher's lab at Imperial College London from The Wellcome Trust [084616/A/08/Z] (http://www.wellcome.ac.uk/), and from the Systematics Research Fund supported by the Linnean Society of London and Systematics Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey D, 2011, G3-GENES GENOM GENET, V1, P523, DOI 10.1534/g3.111.000885; Armaleo D, 2009, SYMBIOSIS, V49, P43, DOI 10.1007/s13199-009-0012-3; Benny GL, 2001, MYCOTA, V7, P113; CHATURVEDI VP, 1984, SABOURAUDIA, V22, P185; COREMANS.J, 1973, MYCOPATH MYCOL APPL, V49, P173, DOI 10.1007/BF02050861; Gile GH, 2009, PLOS ONE, V4; Gile GH, 2006, PROTIST, V157, P435, DOI 10.1016/j.protis.2006.06.002; Goyal A, 2010, MYCOPATHOLOGIA, V170, P165, DOI 10.1007/s11046-010-9310-9; Gregory TR, 2007, NUCLEIC ACIDS RES, V35, pD332, DOI 10.1093/nar/gkl828; GUGNANI HC, 1980, MYKOSEN, V23, P260; Gugnani HC, 1999, EUR J EPIDEMIOL, V15, P923, DOI 10.1023/A:1007656818038; Hahn MW, 2009, J HERED, V100, P605, DOI 10.1093/jhered/esp047; HUMBER RA, 1981, MYCOTAXON, V13, P191; HUTCHISON JA, 1970, MYCOLOGIA, V62, P585, DOI 10.2307/3757531; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Kamikawa R, 2008, P NATL ACAD SCI USA, V105, P6965, DOI 10.1073/pnas.0711084105; Keeling PJ, 2004, P NATL ACAD SCI USA, V101, P15380, DOI 10.1073/pnas.0404505101; Lee SC, 2010, MICROBIOL MOL BIOL R, V74, P298, DOI 10.1128/MMBR.00005-10; MURRIN F, 1986, EXP MYCOL, V10, P67, DOI 10.1016/0147-5975(86)90032-0; Noble GP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-82; Olive EW., 1907, ANN MYCOL, V5, P404; ROBINOW CF, 1963, J CELL BIOL, V17, P123, DOI 10.1083/jcb.17.1.123; Sakaguchi M, 2009, GENE, V441, P126, DOI 10.1016/j.gene.2008.05.010; SUN NC, 1972, CARYOLOGIA, V25, P471, DOI 10.1080/00087114.1972.10796501; Tanabe Y, 2005, J GEN APPL MICROBIOL, V51, P267, DOI 10.2323/jgam.51.267; TANAKA K, 1970, PROTOPLASMA, V70, P423, DOI 10.1007/BF01275768; White MM, 2006, MYCOLOGIA, V98, P872, DOI 10.3852/mycologia.98.6.872; Wilhelm J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gkg056; Xue C, 2010, GENETICS, V186, P287, DOI 10.1534/genetics.110.118646	29	18	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31268	10.1371/journal.pone.0031268	http://dx.doi.org/10.1371/journal.pone.0031268			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363602	Green Submitted, Green Published, gold			2022-12-27	WOS:000302853600134
J	Meng, YF; Zhang, F; Blair, T; Gu, HD; Feng, HQ; Wang, JN; Yuan, C; Zhang, ZQ; Qiu, BS; Yang, XM				Meng, Yanfeng; Zhang, Feng; Blair, Tiffany; Gu, Huidong; Feng, Hongqing; Wang, Jinnan; Yuan, Chun; Zhang, Zhaoqi; Qiu, Bensheng; Yang, Xiaoming			MRI of Auto-Transplantation of Bone Marrow-Derived Stem-Progenitor Cells for Potential Repair of Injured Arteries	PLOS ONE			English	Article							IRON-OXIDE; ATHEROSCLEROSIS; TRACKING; SEQUENCE; THERAPY; DISEASE; AGENT; MICE	Background: This study was to validate the feasibility of using clinical 3.0T MRI to monitor the migration of autotransplanted bone marrow (BM)-derived stem-progenitor cells (SPC) to the injured arteries of near-human sized swine for potential cell-based arterial repair. Methodology: The study was divided into two phases. For in vitro evaluation, BM cells were extracted from the iliac crests of 13 domestic pigs and then labeled with a T2 contrast agent, Feridex, and/or a fluorescent tissue marker, PKH26. The viability, the proliferation efficiency and the efficacies of Feridex and/or PKH26 labeling were determined. For in vivo validation, the 13 pigs underwent endovascular balloon-mediated intimal damages of the iliofemoral arteries. The labeled or un-labeled BM cells were autotransplanted back to the same pig from which the BM cells were extracted. Approximately three weeks post-cell transplantation, 3.0T T2-weighted MRI was performed to detect Feridex-created signal voids of the transplanted BM cells in the injured iliofemoral arteries, which was confirmed by subsequent histologic correlation. Principal Findings: Of the in vitro study, the viability of dual-labeled BM cells was 95-98%. The proliferation efficiencies of dual-labeled BM cells were not significantly different compared to those of non-labeled cells. The efficacies of Feridex- and PKH26 labeling were 90% and 100%, respectively. Of the in vivo study, 3.0T MRI detected the auto-transplanted BM cells migrated to the injured arteries, which was confirmed by histologic examinations. Conclusion: This study demonstrates the capability of using clinical 3.0T MRI to monitor the auto-transplantation of BM cells that migrate to the injured arteries of large animals, which may provide a useful MRI technique to monitor cell-based arterial repair.	[Meng, Yanfeng; Zhang, Feng; Blair, Tiffany; Gu, Huidong; Feng, Hongqing; Qiu, Bensheng; Yang, Xiaoming] Univ Washington, Sch Med, Dept Radiol, Image Guided Biomol Intervent Sect, Seattle, WA 98195 USA; [Meng, Yanfeng; Zhang, Zhaoqi] Capital Med Univ, Beijing Anzhen Hosp, Dept Radiol, Beijing, Peoples R China; [Wang, Jinnan] Philips Res N Amer, Clin Sites Res Program, Briarcliff Manor, NY USA; [Yuan, Chun] Univ Washington, Sch Med, Dept Radiol, Vasc Imaging Lab, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Capital Medical University; Philips; Philips Research; University of Washington; University of Washington Seattle	Meng, YF (corresponding author), Univ Washington, Sch Med, Dept Radiol, Image Guided Biomol Intervent Sect, Seattle, WA 98195 USA.	xmyang@u.washington.edu	Meng, Yanfeng/D-1804-2013; Feng, Hongqing/I-5222-2019; Meng, Yanfeng/AAS-4532-2021	Feng, Hongqing/0000-0003-2767-3080; Wang, Jinnan/0000-0002-2882-914X	National Institutes of Health [RO1 HL078672]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012467] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was supported by a National Institutes of Health RO1 HL078672 grant. The funder's website is http://www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens ET, 2005, NAT BIOTECHNOL, V23, P983, DOI 10.1038/nbt1121; Anderson SA, 2006, INVEST RADIOL, V41, P332, DOI 10.1097/01.rli.0000192420.94038.9e; Aoki I, 2006, NMR BIOMED, V19, P50, DOI 10.1002/nbm.1000; Bulte JWM, 2004, METHOD ENZYMOL, V386, P275; Cai JH, 2008, CONTRAST MEDIA MOL I, V3, P72, DOI 10.1002/cmmi.231; Dos Santos F, 2010, J CELL PHYSIOL, V223, P27, DOI 10.1002/jcp.21987; Engberink RDO, 2010, MOL IMAGING, V9, P268, DOI 10.2310/7290.2010.00016; Gao FB, 2007, NMR BIOMED, V20, P673, DOI 10.1002/nbm.1128; Kraitchman DL, 2003, CIRCULATION, V107, P2290, DOI 10.1161/01.CIR.0000070931.62772.4E; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Meng Y, 2010, APPL MAGNETIC RESONA, V40, P105; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Qiu BS, 2008, NAT CLIN PRACT CARD, V5, P396, DOI 10.1038/ncpcardio1217; Qiu BS, 2007, J MAGN RESON IMAGING, V26, P339, DOI 10.1002/jmri.21016; Qiu BS, 2010, ACAD RADIOL, V17, P547, DOI 10.1016/j.acra.2010.02.004; Shimizu Koichi, 2003, Curr Atheroscler Rep, V5, P230, DOI 10.1007/s11883-003-0029-7; Tanaka K, 2008, FASEB J, V22, P428, DOI 10.1096/fj.06-6884com; Wang J, 2007, MAGN RESON MED, V58, P973, DOI 10.1002/mrm.21385; Wang JN, 2010, J MAGN RESON IMAGING, V31, P1256, DOI 10.1002/jmri.22149; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P257, DOI 10.1161/01.ATV.0000198239.41189.5d; Werner N, 2007, ANN MED, V39, P82, DOI 10.1080/07853890601073429; Yu MX, 2010, EXP BIOL MED, V235, P1053, DOI 10.1258/ebm.2010.010058	22	7	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31137	10.1371/journal.pone.0031137	http://dx.doi.org/10.1371/journal.pone.0031137			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363566	Green Submitted, Green Published, gold			2022-12-27	WOS:000302853600115
J	Voyatzis, S; Muzerelle, A; Gaspar, P; Nicol, X				Voyatzis, Sylvie; Muzerelle, Aude; Gaspar, Patricia; Nicol, Xavier			Modeling Activity and Target-Dependent Developmental Cell Death of Mouse Retinal Ganglion Cells Ex Vivo	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; LATERAL GENICULATE-NUCLEUS; SUPERIOR COLLICULUS; RETINOCOLLICULAR PROJECTION; RAT RETINA; POSTNATAL CHANGES; BETA-2 SUBUNIT; NEONATAL-RATS; MICE; AXONS	Programmed cell death is widespread during the development of the central nervous system and serves multiple purposes including the establishment of neural connections. In the mouse retina a substantial reduction of retinal ganglion cells (RGCs) occurs during the first postnatal week, coinciding with the formation of retinotopic maps in the superior colliculus (SC). We previously established a retino-collicular culture preparation which recapitulates the progressive topographic ordering of RGC projections during early post-natal life. Here, we questioned whether this model could also be suitable to examine the mechanisms underlying developmental cell death of RGCs. Brn3a was used as a marker of the RGCs. A developmental decline in the number of Brn3a-immunolabelled neurons was found in the retinal explant with a timing that paralleled that observed in vivo. In contrast, the density of photoreceptors or of starburst amacrine cells increased, mimicking the evolution of these cell populations in vivo. Blockade of neural activity with tetrodotoxin increased the number of surviving Brn3a-labelled neurons in the retinal explant, as did the increase in target availability when one retinal explant was confronted with 2 or 4 collicular slices. Thus, this ex vivo model reproduces the developmental reduction of RGCs and recapitulates its regulation by neural activity and target availability. It therefore offers a simple way to analyze developmental cell death in this classic system. Using this model, we show that ephrin-A signaling does not participate to the regulation of the Brn3a population size in the retina, indicating that eprhin-A-mediated elimination of exuberant projections does not involve developmental cell death.	[Voyatzis, Sylvie; Muzerelle, Aude; Gaspar, Patricia; Nicol, Xavier] Inst Natl Sante & Rech Med, Unite Mixte Rech Sante 839, Paris, France; [Voyatzis, Sylvie; Muzerelle, Aude; Gaspar, Patricia; Nicol, Xavier] Univ Paris 06, Paris, France; [Voyatzis, Sylvie; Muzerelle, Aude; Gaspar, Patricia; Nicol, Xavier] Inst Fer Moulin, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Nicol, X (corresponding author), Inst Natl Sante & Rech Med, Unite Mixte Rech Sante 839, Paris, France.	xavier.nicol@inserm.fr	Gaspar, Patricia/G-8892-2011; Nicol, Xavier/D-6087-2012	Gaspar, Patricia/0000-0003-4217-5717; Nicol, Xavier/0000-0002-0310-8047	Fondation Internationale pour la Recherche en Paraplegie; Region Ile de France; IOF; Institut National de la Sante et de la Recherche Medicale; Universite Pierre et Marie Curie	Fondation Internationale pour la Recherche en Paraplegie; Region Ile de France(Region Ile-de-France); IOF; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Pierre et Marie Curie	This work was supported by a grant from Fondation Internationale pour la Recherche en Paraplegie to PG, a Region Ile de France fellowship to SV, an IOF Marie Curie fellowship to XN, and by Institut National de la Sante et de la Recherche Medicale and Universite Pierre et Marie Curie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800; Bytyqi AH, 2007, EUR J NEUROSCI, V26, P1560, DOI 10.1111/j.1460-9568.2007.05767.x; CRESPO D, 1985, DEV BRAIN RES, V19, P129, DOI 10.1016/0165-3806(85)90238-X; Cui Q, 1995, J NEUROSCI, V15, P8143; Dallimore EJ, 2010, EXP NEUROL, V225, P353, DOI 10.1016/j.expneurol.2010.07.007; Depaepe V, 2005, NATURE, V435, P1244, DOI 10.1038/nature03651; Dhande OS, 2011, J NEUROSCI, V31, P3384, DOI 10.1523/JNEUROSCI.4899-10.2011; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; DRAGER UC, 1980, J COMP NEUROL, V191, P383, DOI 10.1002/cne.901910306; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Eng SR, 2001, J NEUROSCI, V21, P541, DOI 10.1523/JNEUROSCI.21-02-00541.2001; EYSEL UT, 1983, NEUROSCI LETT, V39, P15, DOI 10.1016/0304-3940(83)90158-1; Farah MH, 2005, J COMP NEUROL, V489, P120, DOI 10.1002/cne.20615; FAWCETT JW, 1984, P NATL ACAD SCI-BIOL, V81, P5589, DOI 10.1073/pnas.81.17.5589; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Frade JM, 1997, DEVELOPMENT, V124, P3313; GALLIRESTA L, 1993, J NEUROSCI, V13, P243; GalliResta L, 1996, J NEUROSCI, V16, P2318; Grubb MS, 2003, NEURON, V40, P1161, DOI 10.1016/S0896-6273(03)00789-X; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; HARVEY AR, 1992, J COMP NEUROL, V325, P83, DOI 10.1002/cne.903250108; Haustead DJ, 2008, J NEUROSCI, V28, P7376, DOI 10.1523/JNEUROSCI.1135-08.2008; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Ma YT, 1998, J NEUROSCI, V18, P2097; MCLOON LK, 1981, BRAIN RES, V226, P15; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Nicol X, 2006, J NEUROSCI, V26, P862, DOI 10.1523/JNEUROSCI.3385-05.2006; Nicol X, 2007, NAT NEUROSCI, V10, P340, DOI 10.1038/nn1842; OLEARY DDM, 1986, DEV BRAIN RES, V30, P96, DOI 10.1016/0165-3806(86)90136-7; OLEARY DDM, 1986, J NEUROSCI, V6, P3692; PERRY VH, 1983, J COMP NEUROL, V219, P356, DOI 10.1002/cne.902190309; Quina LA, 2005, J NEUROSCI, V25, P11595, DOI 10.1523/JNEUROSCI.2837-05.2005; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; SACHS GM, 1986, J COMP NEUROL, V246, P395, DOI 10.1002/cne.902460308; SCHEETZ AJ, 1995, VISUAL NEUROSCI, V12, P605, DOI 10.1017/S0952523800008890; SIMINOFF R, 1966, J COMP NEUROL, V127, P435, DOI 10.1002/cne.901270402; SIMON DK, 1990, DEV BIOL, V137, P125, DOI 10.1016/0012-1606(90)90013-9; SIMON DK, 1992, J NEUROSCI, V12, P1212; Spalding KL, 2005, NEUROSCIENCE, V131, P387, DOI 10.1016/j.neuroscience.2004.11.027; Spalding KL, 2004, J NEUROBIOL, V60, P319, DOI 10.1002/neu.20028; THOMPSON I, 1989, J COMP NEUROL, V282, P371; Vecino E, 2004, INT J DEV BIOL, V48, P965, DOI 10.1387/ijdb.041891ev; Voyvodic JT, 1995, EUR J NEUROSCI, V7, P2469, DOI 10.1111/j.1460-9568.1995.tb01045.x; Wikler K C, 1986, Brain Res, V393, P11; Yakura T, 2002, NEUROSCIENCE, V110, P667, DOI 10.1016/S0306-4522(01)00610-8; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; YOUNG RW, 1984, J COMP NEUROL, V229, P362, DOI 10.1002/cne.902290307; YOUNG RW, 1985, DEV BRAIN RES, V21, P229, DOI 10.1016/0165-3806(85)90211-1	49	7	8	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31105	10.1371/journal.pone.0031105	http://dx.doi.org/10.1371/journal.pone.0031105			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363559	gold, Green Published, Green Submitted			2022-12-27	WOS:000302853600112
J	Yoshimura, Y; Zaima, N; Moriyama, T; Kawamura, Y				Yoshimura, Yukihiro; Zaima, Nobuhiro; Moriyama, Tatsuya; Kawamura, Yukio			Different Localization Patterns of Anthocyanin Species in the Pericarp of Black Rice Revealed by Imaging Mass Spectrometry	PLOS ONE			English	Article							ATHEROSCLEROTIC PLAQUE-FORMATION; SUCROSE-SPECIFIC INDUCTION; ANTIOXIDANT ACTIVITY; TISSUE-SECTIONS; SEED COATS; SUPPLEMENTATION; IDENTIFICATION; BIOSYNTHESIS; EXPRESSION; FRACTION	Black rice (Oryza sativa L. Japonica) contains high levels of anthocyanins in the pericarp and is considered an effective health-promoting food. Several studies have identified the molecular species of anthocyanins in black rice, but information about the localization of each anthocyanin species is limited because methodologies for investigating the localization such as determining specific antibodies to anthocyanin, have not yet been developed Matrix-assisted laser desorption/ionization imaging mass spectrometry (MALDI-IMS) is a suitable tool for investigating the localization of metabolites. In this study, we identified 7 species of anthocyanin monoglycosides and 2 species of anthocyanin diglycosides in crude extracts from black rice by matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) analysis. We also analyzed black rice sections by MALDI-IMS and found 2 additional species of anthocyanin pentosides and revealed different localization patterns of anthocyanin species composed of different sugar moieties. Anthocyanin species composed of a pentose moiety (cyanidin-3-O-pentoside and petunidin-3-O-pentoside) were localized in the entire pericarp, whereas anthocyanin species composed of a hexose moiety (cyanidin-3-O-hexoside and peonidin-3-O-hexoside) were focally localized in the dorsal pericarp. These results indicate that anthocyanin species composed of different sugar moieties exhibit different localization patterns in the pericarp of black rice. This is the first detailed investigation into the localization of molecular species of anthocyanins by MALDI-IMS.	[Yoshimura, Yukihiro; Zaima, Nobuhiro; Moriyama, Tatsuya; Kawamura, Yukio] Kinki Univ, Dept Appl Biol Chem, Grad Sch Agr, Nara, Japan	Kindai University (Kinki University)	Yoshimura, Y (corresponding author), Kinki Univ, Dept Appl Biol Chem, Grad Sch Agr, Nara, Japan.	zaimanobuhiro@gmail.com	Yoshimura, Yukihiro/AAJ-5213-2020	Moriyama, Tatsuya/0000-0002-6861-926X	Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (BRAIN)	Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (BRAIN)	This work was supported by the Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (BRAIN) to NZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choung MG, 2001, J AGR FOOD CHEM, V49, P5848, DOI 10.1021/jf010550w; Colsch B, 2010, GLYCOBIOLOGY, V20, P661, DOI 10.1093/glycob/cwq031; Cominelli E, 2008, J PLANT PHYSIOL, V165, P886, DOI 10.1016/j.jplph.2007.06.010; Ding M, 2006, J BIOL CHEM, V281, P17359, DOI 10.1074/jbc.M600861200; FEDOROFF NV, 1984, P NATL ACAD SCI-BIOL, V81, P3825, DOI 10.1073/pnas.81.12.3825; Garcia-Beneytez E, 2003, J AGR FOOD CHEM, V51, P5622, DOI 10.1021/jf0302207; Goto-Inoue N, 2010, ANAL SCI, V26, P821, DOI 10.2116/analsci.26.821; Goto-Inoue N, 2009, GLYCOBIOLOGY, V19, P950, DOI 10.1093/glycob/cwp089; Guo HH, 2007, PLANT FOOD HUM NUTR, V62, P1, DOI 10.1007/s11130-006-0031-7; Guo HH, 2011, J LIPID RES, V52, P908, DOI 10.1194/jlr.M013375; Hayasaka T, 2008, RAPID COMMUN MASS SP, V22, P3415, DOI 10.1002/rcm.3751; Hou ZH, 2010, J AGR FOOD CHEM, V58, P3191, DOI 10.1021/jf904407x; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Ke Z, 2011, J NEUROSCI RES; Khatib-Shahidi S, 2006, ANAL CHEM, V78, P6448, DOI 10.1021/ac060788p; Kim CK, 2011, J APPL GENET, V52, P161, DOI 10.1007/s13353-011-0027-3; Kim Min-Kyoung, 2008, Nutr Res Pract, V2, P46, DOI 10.4162/nrp.2008.2.1.46; Kong JM, 2003, PHYTOCHEMISTRY, V64, P923, DOI 10.1016/S0031-9422(03)00438-2; Kovinich N, 2010, PHYTOCHEMISTRY, V71, P1253, DOI 10.1016/j.phytochem.2010.05.009; Kubo H, 2007, J PLANT RES, V120, P445, DOI 10.1007/s10265-006-0067-7; Lee JH, 2010, FOOD SCI BIOTECHNOL, V19, P391, DOI 10.1007/s10068-010-0055-5; Ling WH, 2002, J NUTR, V132, P20, DOI 10.1093/jn/132.1.20; Lopez LL, 1999, RAPID COMMUN MASS SP, V13, P663, DOI 10.1002/(SICI)1097-0231(19990430)13:8<663::AID-RCM538>3.0.CO;2-H; Mazzuca P, 2005, J MASS SPECTROM, V40, P83, DOI 10.1002/jms.778; Min B, 2011, J FOOD SCI, V76, pC117, DOI 10.1111/j.1750-3841.2010.01929.x; Montefiori M, 2011, PLANT J, V65, P106, DOI 10.1111/j.1365-313X.2010.04409.x; Murphy RC, 2009, J LIPID RES, V50, pS317, DOI 10.1194/jlr.R800051-JLR200; Ogawa K, 2008, J AGR FOOD CHEM, V56, P4457, DOI 10.1021/jf800406v; OPARKA KJ, 1981, PLANTA, V152, P388, DOI 10.1007/BF00385354; REDDY VS, 1994, PLANT PHYSIOL, V105, P1059, DOI 10.1104/pp.105.4.1059; Solfanelli C, 2006, PLANT PHYSIOL, V140, P637, DOI 10.1104/pp.105.072579; Speciale A, 2010, J AGR FOOD CHEM, V58, P12048, DOI 10.1021/jf1029515; Stoeckli M, 2001, NAT MED, V7, P493, DOI 10.1038/86573; Stoeckli M, 2002, ANAL BIOCHEM, V311, P33, DOI 10.1016/S0003-2697(02)00386-X; Tamura S, 2010, BIOCHEM SYST ECOL, V38, P438, DOI 10.1016/j.bse.2010.01.017; Tanaka J, 2011, PHYTOTHER RES; Tanaka J, 2011, J AGR FOOD CHEM, V59, P528, DOI 10.1021/jf103186a; Teng S, 2005, PLANT PHYSIOL, V139, P1840, DOI 10.1104/pp.105.066688; Tohge T, 2005, PLANT J, V42, P218, DOI 10.1111/j.1365-313X.2005.02371.x; Wei YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019455; Xia M, 2003, J NUTR, V133, P744, DOI 10.1093/jn/133.3.744; Xu BJ, 2008, J AGR FOOD CHEM, V56, P8365, DOI 10.1021/jf801196d; Yao I, 2008, PROTEOMICS, V8, P3692, DOI 10.1002/pmic.200701121; Zaima N, 2011, J OLEO SCI, V60, P93, DOI 10.5650/jos.60.93; Zaima N, 2010, RAPID COMMUN MASS SP, V24, P2723, DOI 10.1002/rcm.4693; Zhang MW, 2010, J AGR FOOD CHEM, V58, P7580, DOI 10.1021/jf1007665; Zhang RF, 2011, J AGR FOOD CHEM, V59, P5935, DOI 10.1021/jf201593n	47	61	63	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31285	10.1371/journal.pone.0031285	http://dx.doi.org/10.1371/journal.pone.0031285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363605	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600135
J	Zhou, QQ; Yang, SY; Luo, YJ; Qi, YS; Yan, ZQ; Shi, ZF; Fan, Y				Zhou, Qiquan; Yang, Shengyue; Luo, Yongjun; Qi, Yushu; Yan, Ziqiang; Shi, Zifu; Fan, Yong			A Randomly-Controlled Study on the Cardiac Function at the Early Stage of Return to the Plains after Short-Term Exposure to High Altitude	PLOS ONE			English	Article							TIME 3-DIMENSIONAL ECHOCARDIOGRAPHY; NITRIC-OXIDE; PULMONARY; ENDOTHELIN-1; EXPRESSION; ACCURACY; NATIVES; HUMANS	High altitude acclimatization and adaptation mechanisms have been well clarified, however, high altitude de-adaptation mechanism remains unclear. In this study, we conducted a controlled study on cardiac functions in 96 healthy young male who rapidly entered the high altitude (3700 m) and returned to the plains (1500 m) after 50 days. Ninety eight healthy male who remained at low altitude were recruited as control group. The mean pulmonary arterial pressure (mPAP), left ventricular ejection fraction (LVEF), left ventricular fraction shortening (LVFS), cardiac function index (Tei index) were tested. Levels of serum creatine kinase isoform MB (CK-MB), lactate dehydrogenase isoenzyme-1 (LDH-1), endothelin-1 (ET-1), nitrogen oxide (NO), serum hypoxia-inducible factor-1 alpha (HIF-1 alpha), 8-iso-prostaglandin F-2 alpha (8-iso PGF(2 alpha)), superoxide dismutase (SOD) and malonaldehyde (MDA) were measured at an altitude of 3700 m and 1500 m respectively. The results showed that after short-term exposure to high altitude mPAP and Tei index increased significantly, while LVEF and LVFS decreased significantly. These changes were positively correlated with altitude. On the 15th day after the subjects returned to low altitude, mPAP, LVEF and LVFS levels returned to the same level as those of the control subjects, but the Tei index in the returned subjects was still significantly higher than that in the control subjects (P<.01). We also found that changes in Tei index was positively correlated with mPAP, ET-1, HIF-1 alpha and 8-iso PGF(2 alpha) levels, and negatively correlated with the level of NO, LVEF, LVFS, CK-MB and LDH-1. These findings suggest that cardiac function de-adapts when returning to the plains after short-term exposure to high altitude and the function recovery takes a relatively long time.	[Zhou, Qiquan; Luo, Yongjun; Fan, Yong] Third Mil Med Univ, Coll High Altitude Mil Med, Dept High Altitude Dis, Chongqing, Peoples R China; [Zhou, Qiquan; Luo, Yongjun; Fan, Yong] PLA, Minist Educ, Key Lab High Altitude Med, Chongqing, Peoples R China; [Yang, Shengyue; Qi, Yushu; Yan, Ziqiang] PLA, Hosp 4, Lanzhou Mil Command, Resp Med Ctr, Xining, Peoples R China; [Shi, Zifu] Peoples Liberat Army, Troop Hosp 68303, Wuwei, Peoples R China	Army Medical University	Zhou, QQ (corresponding author), Third Mil Med Univ, Coll High Altitude Mil Med, Dept High Altitude Dis, Chongqing, Peoples R China.	zhouqq9918@yahoo.com			Chinese PLA [2006Z030, 2008Z093]; National Science and Technology Ministry [2009BAI85B03]	Chinese PLA; National Science and Technology Ministry	This work was funded by the Chinese PLA under its 11th 5-Year Plan for Scientific and Technological Research (2006Z030 and 2008Z093), and the National Science and Technology Ministry (2009BAI85B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 1998, FEBS LETT, V428, P32, DOI 10.1016/S0014-5793(98)00481-5; Chua S, 2009, EUR J ECHOCARDIOGR, V10, P619, DOI 10.1093/ejechocard/jep013; DELMAESTRO RF, 1980, ACTA PHYSIOL SCAND, P43; Elvert G, 2003, J BIOL CHEM, V278, P7520, DOI 10.1074/jbc.M211298200; Endo A, 2001, EUR J PEDIATR, V160, P217, DOI 10.1007/PL00008431; Gao Y. Q., 2005, HIGH ALTITUDE MILITA, P237; HEATH D, 1959, BRIT HEART J, V21, P187; Hu RC, 2002, CHINESE MED J-PEKING, V115, P1833; Kanazawa F, 2005, BRAIN RES, V1036, P145, DOI 10.1016/j.brainres.2004.12.019; Lu XZ, 2008, J AM SOC ECHOCARDIOG, V21, P84, DOI 10.1016/j.echo.2007.05.009; MCKENZIE DC, 1991, J APPL PHYSIOL, V70, P2650, DOI 10.1152/jappl.1991.70.6.2650; Mi MT, 1994, ACTA ACAD MED MILITA, V16, P409; Misumi Ikuo, 2002, J Cardiol, V39, P85; Mou YM, 2007, INTRO ECHOCARDIOGRAP, P20; Pratico D, 1999, ATHEROSCLEROSIS, V147, P1210; Risso A, 2007, BLOOD CELL MOL DIS, V38, P83, DOI 10.1016/j.bcmd.2006.10.161; Romero JC, 1999, HYPERTENSION, V34, P943, DOI 10.1161/01.HYP.34.4.943; Savourey G, 1996, EUR J APPL PHYSIOL, V73, P529, DOI 10.1007/BF00357675; Shi Zi-fu, 2011, Zhong Xi Yi Jie He Xue Bao, V9, P395, DOI 10.3736/jcim20110408; Soma J, 2005, BLOOD PRESSURE, V14, P93, DOI 10.1080/08037050510008904; Tang LZ, 1996, CHINESE J CLIN THORA, V3, P9; Tei C, 1996, J Am Soc Echocardiogr, V9, P838, DOI 10.1016/S0894-7317(96)90476-9; Tei C, 1995, J Cardiol, V26, P357; VOGEL JA, 1974, J APPL PHYSIOL, V36, P173, DOI 10.1152/jappl.1974.36.2.173; Wang J, 2005, AM J PHYSIOL-LUNG C, V288, pL1059, DOI 10.1152/ajplung.00448.2004; West JB, 2010, HIGH ALT MED BIOL, V11, P169, DOI 10.1089/ham.2010.1014; Yang M, 1999, CHINA COMTEMPORARY M, V5, P37; Yasuoka K, 2004, PEDIATR CARDIOL, V25, P131, DOI 10.1007/s00246-003-0514-3; Yuan ZhenCai, 2010, Journal of Environment and Health, V27, P987; Zhang Y. B., 1996, PEOPLE HIGH ALTITUDE, P297; 何振华, 2006, [中华结核和呼吸杂志, Chinese Journal of Tuberculosis and Respiratiory Diseases], V29, P775	31	15	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31097	10.1371/journal.pone.0031097	http://dx.doi.org/10.1371/journal.pone.0031097			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363556	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600111
J	Dittrich, CM; Kratz, K; Sendoel, A; Gruenbaum, Y; Jiricny, J; Hengartner, MO				Dittrich, Christina M.; Kratz, Katja; Sendoel, Ataman; Gruenbaum, Yosef; Jiricny, Josef; Hengartner, Michael O.			LEM-3-A LEM Domain Containing Nuclease Involved in the DNA Damage Response in C. elegans	PLOS ONE			English	Article							TO-AUTOINTEGRATION FACTOR; NUCLEOTIDE EXCISION-REPAIR; INDUCED APOPTOSIS; CELL-DIVISION; CHECKPOINT; ENVELOPE; DEATH; GENE; PATHWAY; EMERIN	The small nematode Caenorhabditis elegans displays a spectrum of DNA damage responses similar to humans. In order to identify new DNA damage response genes, we isolated in a forward genetic screen 14 new mutations conferring hypersensitivity to ionizing radiation. We present here our characterization of lem-3, one of the genes identified in this screen. LEM-3 contains a LEM domain and a GIY nuclease domain. We confirm that LEM-3 has DNase activity in vitro. lem-3(lf)mutants are hypersensitive to various types of DNA damage, including ionizing radiation, UV-C light and crosslinking agents. Embryos from irradiated lem-3 hermaphrodites displayed severe defects during cell division, including chromosome mis-segregation and anaphase bridges. The mitotic defects observed in irradiated lem-3 mutant embryos are similar to those found in baf-1 (barrier-to-autointegration factor) mutants. The baf-1 gene codes for an essential and highly conserved protein known to interact with the other two C. elegans LEM domain proteins, LEM-2 and EMR-1. We show that baf-1, lem-2, and emr-1 mutants are also hypersensitive to DNA damage and that loss of lem-3 sensitizes baf-1 mutants even in the absence of DNA damage. Our data suggest that BAF-1, together with the LEM domain proteins, plays an important role following DNA damage - possibly by promoting the reorganization of damaged chromatin.	[Dittrich, Christina M.; Sendoel, Ataman; Hengartner, Michael O.] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Dittrich, Christina M.] Univ Zurich, Mol Life Sci PhD Program, Zurich, Switzerland; [Kratz, Katja; Jiricny, Josef] Univ Zurich, Inst Mol Canc Res, Zurich, Switzerland; [Gruenbaum, Yosef] Hebrew Univ Jerusalem, Dept Genet, Inst Life Sci, IL-91904 Jerusalem, Israel; [Jiricny, Josef] ETH, Dept Biol, Zurich, Switzerland	University of Zurich; University of Zurich; University of Zurich; Hebrew University of Jerusalem; Swiss Federal Institutes of Technology Domain; ETH Zurich	Dittrich, CM (corresponding author), Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland.	michael.hengartner@imls.uzh.ch	Hengartner, Michael O/E-6235-2011	Hengartner, Michael/0000-0002-7584-596X; Sendoel, Ataman/0000-0002-0381-9965	Swiss National Science Foundation; Ernst Hadorn Foundation; Roche Research Foundation; National Institute of Health (NIH) National Center for Research Resources (NCRR); National Bioresource Project in Japan	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ernst Hadorn Foundation; Roche Research Foundation; National Institute of Health (NIH) National Center for Research Resources (NCRR); National Bioresource Project in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Swiss National Science Foundation (MOH), the Ernst Hadorn Foundation (MOH), and the Roche Research Foundation (CMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank P. Gonczy, M. Gotta, A. Hajnal and S. Ahmed for discussion and comments, and A. Spang, A. Hajnal, A. Spilker, M. Pellegrino, and M. Morf for technical help. We thank A. Brachner and R. Foisner for communication of results prior to publication. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the National Institute of Health (NIH) National Center for Research Resources (NCRR), and from the Shohei Mitani mutant collection of the National Bioresource Project in Japan.	Ahmed S, 2001, CURR BIOL, V11, P1934, DOI 10.1016/S0960-9822(01)00604-2; Astin JW, 2008, DNA REPAIR, V7, P267, DOI 10.1016/j.dnarep.2007.10.004; Boulton SJ, 2002, SCIENCE, V295, P127, DOI 10.1126/science.1065986; BRENNER S, 1974, GENETICS, V77, P71; Clejan I, 2006, GENETICS, V173, P1301, DOI 10.1534/genetics.106.058628; Collis SJ, 2007, NAT CELL BIOL, V9, P391, DOI 10.1038/ncb1555; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; Dunin-Horkawicz S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-98; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Gartner Anton, 2008, WormBook, P1, DOI 10.1895/wormbook.1.145.1; Gonczy P, 1999, J CELL BIOL, V144, P927, DOI 10.1083/jcb.144.5.927; Gorjanacz M, 2007, EMBO J, V26, P132, DOI 10.1038/sj.emboj.7601470; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; HARTMAN PS, 1989, GENETICS, V122, P379; HARTMAN PS, 1982, GENETICS, V102, P159; Heyer WD, 2006, NUCLEIC ACIDS RES, V34, P4115, DOI 10.1093/nar/gkl481; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Hofmann ER, 2002, CURR BIOL, V12, P1908, DOI 10.1016/S0960-9822(02)01262-9; Holway AH, 2006, J CELL BIOL, V172, P999, DOI 10.1083/jcb.200512136; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Lee KK, 2000, MOL BIOL CELL, V11, P3089, DOI 10.1091/mbc.11.9.3089; Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937; Liu J, 2003, P NATL ACAD SCI USA, V100, P4598, DOI 10.1073/pnas.0730821100; Margalit A, 2005, P NATL ACAD SCI USA, V102, P3290, DOI 10.1073/pnas.0408364102; Margalit A, 2007, TRENDS CELL BIOL, V17, P202, DOI 10.1016/j.tcb.2007.02.004; Meyerzon M, 2009, DEV BIOL, V327, P433, DOI 10.1016/j.ydbio.2008.12.030; Moser SC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000451; Nehme R, 2008, ONCOGENE, V27, pS30, DOI 10.1038/onc.2009.41; O'Neil Nigel, 2006, WormBook, P1; Praitis V, 2001, GENETICS, V157, P1217; Schmutz C, 2005, EUR J CELL BIOL, V84, P75, DOI 10.1016/j.ejcb.2004.10.004; Schumacher B, 2005, CELL DEATH DIFFER, V12, P153, DOI 10.1038/sj.cdd.4401539; Schumacher B, 2001, CURR BIOL, V11, P1722, DOI 10.1016/S0960-9822(01)00534-6; Segura-Totten M, 2004, TRENDS CELL BIOL, V14, P261, DOI 10.1016/j.tcb.2004.03.004; Stergiou L, 2007, CELL DEATH DIFFER, V14, P1129, DOI 10.1038/sj.cdd.4402115; Stergiou L, 2004, CELL DEATH DIFFER, V11, P21, DOI 10.1038/sj.cdd.4401340; Stergiou L, 2011, CELL DEATH DIFFER, V18, P897, DOI 10.1038/cdd.2010.158; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Zheng RL, 2000, P NATL ACAD SCI USA, V97, P8997, DOI 10.1073/pnas.150240197; Zipperlen P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r19	41	34	45	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e24555	10.1371/journal.pone.0024555	http://dx.doi.org/10.1371/journal.pone.0024555			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22383942	Green Accepted, Green Published, gold			2022-12-27	WOS:000302916100001
J	Fehringer, G; Liu, G; Briollais, L; Brennan, P; Amos, CI; Spitz, MR; Bickeboller, H; Wichmann, HE; Risch, A; Hung, RJ				Fehringer, Gordon; Liu, Geoffrey; Briollais, Laurent; Brennan, Paul; Amos, Christopher I.; Spitz, Margaret R.; Bickeboeller, Heike; Wichmann, H. Erich; Risch, Angela; Hung, Rayjean J.			Comparison of Pathway Analysis Approaches Using Lung Cancer GWAS Data Sets	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCUS; NICOTINE DEPENDENCE; STATISTICAL-METHODS; GENE; VARIANTS; RISK	Pathway analysis has been proposed as a complement to single SNP analyses in GWAS. This study compared pathway analysis methods using two lung cancer GWAS data sets based on four studies: one a combined data set from Central Europe and Toronto (CETO); the other a combined data set from Germany and MD Anderson (GRMD). We searched the literature for pathway analysis methods that were widely used, representative of other methods, and had available software for performing analysis. We selected the programs EASE, which uses a modified Fishers Exact calculation to test for pathway associations, GenGen (a version of Gene Set Enrichment Analysis (GSEA)), which uses a Kolmogorov-Smirnov-like running sum statistic as the test statistic, and SLAT, which uses a p-value combination approach. We also included a modified version of the SUMSTAT method (mSUMSTAT), which tests for association by averaging chi(2) statistics from genotype association tests. There were nearly 18000 genes available for analysis, following mapping of more than 300,000 SNPs from each data set. These were mapped to 421 GO level 4 gene sets for pathway analysis. Among the methods designed to be robust to biases related to gene size and pathway SNP correlation (GenGen, mSUMSTAT and SLAT), the mSUMSTAT approach identified the most significant pathways (8 in CETO and 1 in GRMD). This included a highly plausible association for the acetylcholine receptor activity pathway in both CETO (FDR <= 0.001) and GRMD (FDR = 0.009), although two strong association signals at a single gene cluster (CHRNA3-CHRNA5-CHRNB4) drive this result, complicating its interpretation. Few other replicated associations were found using any of these methods. Difficulty in replicating associations hindered our comparison, but results suggest mSUMSTAT has advantages over the other approaches, and may be a useful pathway analysis tool to use alongside other methods such as the commonly used GSEA (GenGen) approach.	[Fehringer, Gordon; Briollais, Laurent; Hung, Rayjean J.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Prosserman Ctr Hlth Res, Toronto, ON M5G 1X5, Canada; [Liu, Geoffrey] Princess Margaret Hosp, Ontario Canc Inst, Dept Med & Med Biophys, Toronto, ON M4X 1K9, Canada; [Amos, Christopher I.; Spitz, Margaret R.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Brennan, Paul] IARC, Lyon, France; [Bickeboeller, Heike] Univ Gottingen, Dept Genet Epidemiol, Univ Med Ctr, Gottingen, Germany; [Wichmann, H. Erich] Helmholtz Ctr Munich, Inst Epidemiol 1, Neuherberg, Germany; [Risch, Angela] German Canc Res Ctr, Div Epigen & Canc Risk Factors, D-6900 Heidelberg, Germany	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Texas System; UTMD Anderson Cancer Center; World Health Organization; International Agency for Research on Cancer (IARC); University of Gottingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; German Cancer Research Center (DKFZ)	Fehringer, G (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Prosserman Ctr Hlth Res, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	Rayjean.hung@lunenfeld.ca	Wichmann, Heinz Erich/AAA-5695-2022; Briollais, Laurent/A-2941-2013; Risch, Angela/H-2669-2013; Pillay, Nischalan/F-9536-2012; Liu, Geoffrey/N-4421-2016; Bickeböller, Heike/V-2318-2018; Hung, Rayjean J/A-7439-2013	Risch, Angela/0000-0002-8026-5505; Bickeböller, Heike/0000-0002-3361-5488; Liu, Geoffrey/0000-0002-2603-7296	Canadian Cancer Society [020214]; CCO Chair in Population Studies, CCO Chair in Experimental Therapeutics; Alan Brown Chair in Molecular Genomics; National Institute of Health [U19 CA148127-01]; NATIONAL CANCER INSTITUTE [U19CA148127] Funding Source: NIH RePORTER	Canadian Cancer Society(Canadian Cancer Society (CCS)); CCO Chair in Population Studies, CCO Chair in Experimental Therapeutics; Alan Brown Chair in Molecular Genomics; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study is supported by Canadian Cancer Society (grant no. 020214), the CCO Chair in Population Studies, CCO Chair in Experimental Therapeutics, the Alan Brown Chair in Molecular Genomics, and National Institute of Health (U19 CA148127-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Broderick P, 2009, CANCER RES, V69, P6633, DOI 10.1158/0008-5472.CAN-09-0680; Cantor RM, 2010, AM J HUM GENET, V86, P6, DOI 10.1016/j.ajhg.2009.11.017; De la Cruz O, 2010, GENET EPIDEMIOL, V34, P222, DOI 10.1002/gepi.20452; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Holmans P, 2010, ADV GENET, V72, P141, DOI [10.1016/S0065-2660(10)72007-1, 10.1016/B978-0-12-380862-2.00007-2]; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Luo L, 2010, EUR J HUM GENET, V18, P1045, DOI 10.1038/ejhg.2010.62; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Sauter W, 2008, CANCER EPIDEM BIOMAR, V17, P1127, DOI 10.1158/1055-9965.EPI-07-2840; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Tintle Nathan L, 2009, BMC Proc, V3 Suppl 7, pS96; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026; Wang LL, 2011, GENOMICS, V98, P1, DOI 10.1016/j.ygeno.2011.04.006; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Zhao J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-17	26	32	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31816	10.1371/journal.pone.0031816	http://dx.doi.org/10.1371/journal.pone.0031816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363742	Green Submitted, Green Published, gold			2022-12-27	WOS:000302873700103
J	Geerts-Dimitriadou, C; Lu, YY; Geertsema, C; Goldbach, R; Kormelink, R				Geerts-Dimitriadou, Christina; Lu, Yun-Yueh; Geertsema, Corinne; Goldbach, Rob; Kormelink, Richard			Analysis of the Tomato spotted wilt virus Ambisense S RNA-Encoded Hairpin Structure in Translation	PLOS ONE			English	Article							NONSTRUCTURAL PROTEIN NSS; AFFECTING TRANSCRIPTION TERMINATION; TAIL-INDEPENDENT TRANSLATION; CAP-SNATCHING MECHANISM; ESCHERICHIA-COLI RNA; STEM-LOOP STRUCTURE; CDNA-BASED RESCUE; MESSENGER-RNA; INFLUENZA-VIRUS; INTERGENIC REGION	Background: The intergenic region (IR) of ambisense RNA segments from animal- and plant-infecting (-)RNA viruses functions as a bidirectional transcription terminator. The IR sequence of the Tomato spotted wilt virus (TSWV) ambisense S RNA contains stretches that are highly rich in A-residues and U-residues and is predicted to fold into a stable hairpin structure. The presence of this hairpin structure sequence in the 3' untranslated region (UTR) of TSWV mRNAs implies a possible role in translation. Methodology/Principal Findings: To analyse the role of the predicted hairpin structure in translation, various Renilla luciferase constructs containing modified 3' and/or 5' UTR sequences of the TSWV S RNA encoded nucleocapsid (N) gene were analyzed for expression. While good luciferase expression levels were obtained from constructs containing the 5' UTR and the 3' UTR, luciferase expression was lost when the hairpin structure sequence was removed from the 3' UTR. Constructs that only lacked the 5' UTR, still rendered good expression levels. When in addition the entire 3' UTR was exchanged for that of the S RNA encoded non-structural (NSs) gene transcript, containing the complementary hairpin folding sequence, the loss of luciferase expression could only be recovered by providing the 5' UTR sequence of the NSs transcript. Luciferase activity remained unaltered when the hairpin structure sequence was swapped for the analogous one from Tomato yellow ring virus, another distinct tospovirus. The addition of N and NSs proteins further increased luciferase expression levels from hairpin structure containing constructs. Conclusions/Significance: The results suggest a role for the predicted hairpin structure in translation in concert with the viral N and NSs proteins. The presence of stretches highly rich in A-residues does not rule out a concerted action with a poly(A)-tail-binding protein. A common transcription termination and translation strategy for plant- and animal-infecting ambisense RNA viruses is being discussed.	[Geerts-Dimitriadou, Christina; Lu, Yun-Yueh; Geertsema, Corinne; Goldbach, Rob; Kormelink, Richard] Wageningen Univ, Virol Lab, Wageningen, Netherlands	Wageningen University & Research	Geerts-Dimitriadou, C (corresponding author), Wageningen Univ, Virol Lab, Wageningen, Netherlands.	richard.kormelink@wur.nl	Kormelink, Richard/F-7437-2010	Kormelink, Richard/0000-0001-7360-1884	Netherlands Organization of Scientific Research, division of Chemical Sciences (NWO/CW)	Netherlands Organization of Scientific Research, division of Chemical Sciences (NWO/CW)(Netherlands Organization for Scientific Research (NWO)United States Department of Energy (DOE))	This work was financed by The Netherlands Organization of Scientific Research, division of Chemical Sciences (NWO/CW), www.nwo.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon T, 2000, MOL CELL BIOL, V20, P6259, DOI 10.1128/MCB.20.17.6259-6268.2000; Bailey-Serres J, 1999, TRENDS PLANT SCI, V4, P142, DOI 10.1016/S1360-1385(99)01386-2; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Barr JN, 2003, VIROLOGY, V311, P326, DOI 10.1016/S0042-6822(03)00130-2; Blakqori G, 2005, J VIROL, V79, P10420, DOI 10.1128/JVI.79.16.10420-10428.2005; Blakqori G, 2009, J VIROL, V83, P3637, DOI 10.1128/JVI.02201-08; Borman AM, 2000, NUCLEIC ACIDS RES, V28, P4068, DOI 10.1093/nar/28.21.4068; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Bridgen A, 2001, P NATL ACAD SCI USA, V98, P664, DOI 10.1073/pnas.98.2.664; Bucher E, 2003, J VIROL, V77, P1329, DOI 10.1128/JVI.77.2.1329-1336.2003; Burgui I, 2003, J GEN VIROL, V84, P3263, DOI 10.1099/vir.0.19487-0; DEAVILA AC, 1990, J GEN VIROL, V71, P2801, DOI 10.1099/0022-1317-71-12-2801; DEHAAN P, 1990, J GEN VIROL, V71, P1001, DOI 10.1099/0022-1317-71-5-1001; Di Bonito P, 1999, ARCH VIROL, V144, P1947, DOI 10.1007/s007050050717; Dreher TW, 2006, VIROLOGY, V344, P185, DOI 10.1016/j.virol.2005.09.031; Duijsings D, 2001, EMBO J, V20, P2545, DOI 10.1093/emboj/20.10.2545; Duijsings D, 2001, THESIS WAGENINGEN U; ELLIOTT RM, 1990, J GEN VIROL, V71, P501, DOI 10.1099/0022-1317-71-3-501; EMERY VC, 1987, VIROLOGY, V156, P1, DOI 10.1016/0042-6822(87)90430-2; Fabian MR, 2006, RNA, V12, P1304, DOI 10.1261/rna.69506; Fabian MR, 2004, J BIOL CHEM, V279, P28862, DOI 10.1074/jbc.M401272200; Flick K, 2004, J VIROL, V78, P11726, DOI 10.1128/JVI.78.21.11726-11738.2004; GALLIE DR, 1994, GENE, V142, P159, DOI 10.1016/0378-1119(94)90256-9; Gallie DR, 2002, PLANT MOL BIOL, V50, P949, DOI 10.1023/A:1021220910664; Gallie DR, 1998, GENE, V216, P1, DOI 10.1016/S0378-1119(98)00318-7; Geerts-Dimitriadou C, 2011, VIROLOGY, V409, P17, DOI 10.1016/j.virol.2010.09.003; Geerts-Dimitriadou C, 2011, VIROLOGY, V409, P27, DOI 10.1016/j.virol.2010.09.006; GIORGI C, 1991, VIROLOGY, V180, P738, DOI 10.1016/0042-6822(91)90087-R; Habjan M, 2008, J GEN VIROL, V89, P2157, DOI 10.1099/vir.0.2008/002097-0; IAPALUCCI S, 1991, VIROLOGY, V182, P269, DOI 10.1016/0042-6822(91)90670-7; KORMELINK R, 1992, J GEN VIROL, V73, P2795, DOI 10.1099/0022-1317-73-11-2795; KORMELINK R, 1991, VIROLOGY, V181, P459, DOI 10.1016/0042-6822(91)90878-F; Kormelink R, 2011, BUNYAVIRIDAE: MOLECULAR AND CELLULAR BIOLOGY, P163; Leonard S, 2004, J GEN VIROL, V85, P1055, DOI 10.1099/vir.0.19706-0; Lopez N, 2001, J VIROL, V75, P12241, DOI 10.1128/JVI.75.24.12241-12251.2001; Lopez N, 2007, VIRUS RES, V124, P237, DOI 10.1016/j.virusres.2006.10.007; Marion RM, 1997, NUCLEIC ACIDS RES, V25, P4271, DOI 10.1093/nar/25.21.4271; Matsuda D, 2004, VIROLOGY, V321, P36, DOI 10.1016/j.virol.2003.10.023; Meulewaeter F, 2004, NUCLEIC ACIDS RES, V32, P1721, DOI 10.1093/nar/gkh338; MEYER BJ, 1993, J VIROL, V67, P2621, DOI 10.1128/JVI.67.5.2621-2627.1993; Mir MA, 2008, P NATL ACAD SCI USA, V105, P19294, DOI 10.1073/pnas.0807211105; Mir MA, 2008, EMBO J, V27, P3129, DOI 10.1038/emboj.2008.228; Mumford RA, 1996, ANN APPL BIOL, V128, P159, DOI 10.1111/j.1744-7348.1996.tb07097.x; Neeleman L, 2001, P NATL ACAD SCI USA, V98, P14286, DOI 10.1073/pnas.251542798; Nguyen M, 2003, VIRUS RES, V93, P141, DOI 10.1016/S0168-1702(03)00094-7; Pinschewer DD, 2005, J VIROL, V79, P4519, DOI 10.1128/JVI.79.7.4519-4526.2005; PLATT T, 1986, ANNU REV BIOCHEM, V55, P339, DOI 10.1146/annurev.bi.55.070186.002011; QIU Y, 1994, J VIROL, V68, P2425, DOI 10.1128/JVI.68.4.2425-2432.1994; Rao P, 2003, EMBO J, V22, P1188, DOI 10.1093/emboj/cdg109; REYNOLDS R, 1992, J MOL BIOL, V224, P53, DOI 10.1016/0022-2836(92)90575-5; REYNOLDS R, 1992, J MOL BIOL, V224, P31, DOI 10.1016/0022-2836(92)90574-4; Salvatore M, 2002, J VIROL, V76, P1206, DOI 10.1128/JVI.76.3.1206-1212.2002; SCHNELL MJ, 1994, EMBO J, V13, P4195, DOI 10.1002/j.1460-2075.1994.tb06739.x; Schnettler E, 2010, J VIROL, V84, P11542, DOI 10.1128/JVI.00595-10; Scholthof KBG, 2011, MOL PLANT PATHOL, V12, P938, DOI [10.1111/j.1364-3703.2011.00752.x, 10.1111/J.1364-3703.2011.00752.X]; SIDHU MS, 1995, VIROLOGY, V208, P800, DOI 10.1006/viro.1995.1215; SIMONS JF, 1991, J VIROL, V65, P4741, DOI 10.1128/JVI.65.9.4741-4748.1991; SIMONS JF, 1992, J VIROL, V66, P4233, DOI 10.1128/JVI.66.7.4233-4241.1992; SUTTER G, 1995, FEBS LETT, V371, P9, DOI 10.1016/0014-5793(95)00843-X; Takeda A, 2002, FEBS LETT, V532, P75, DOI 10.1016/S0014-5793(02)03632-3; Tortorici MA, 2001, VIRUS RES, V73, P41, DOI 10.1016/S0168-1702(00)00222-7; van Knippenberg I, 2005, VIRUS RES, V110, P125, DOI 10.1016/j.virusres.2005.01.012; van Knippenberg I, 2005, VIROLOGY, V335, P122, DOI 10.1016/j.virol.2005.01.041; van Knippenberg I, 2002, VIROLOGY, V303, P278, DOI 10.1006/viro.2002.1632; WYATT LS, 1995, VIROLOGY, V210, P202, DOI 10.1006/viro.1995.1332; Yanguez E, 2011, VIRUS RES, V156, P1, DOI 10.1016/j.virusres.2010.12.016; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	68	29	30	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31013	10.1371/journal.pone.0031013	http://dx.doi.org/10.1371/journal.pone.0031013			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363535	Green Submitted, gold, Green Published			2022-12-27	WOS:000302873700022
J	Pinheiro, FL; Pacheco, JM; Santos, FC				Pinheiro, Flavio L.; Pacheco, Jorge M.; Santos, Francisco C.			From Local to Global Dilemmas in Social Networks	PLOS ONE			English	Article							EVOLUTIONARY DYNAMICS; INCLUSIVE FITNESS; COOPERATION; GAME; EMERGENCE; SELECTION; TEMPERATURE; FIXATION; BEHAVIOR; SPREAD	Social networks affect in such a fundamental way the dynamics of the population they support that the global, population-wide behavior that one observes often bears no relation to the individual processes it stems from. Up to now, linking the global networked dynamics to such individual mechanisms has remained elusive. Here we study the evolution of cooperation in networked populations and let individuals interact via a 2-person Prisoner's Dilemma - a characteristic defection dominant social dilemma of cooperation. We show how homogeneous networks transform a Prisoner's Dilemma into a population-wide evolutionary dynamics that promotes the coexistence between cooperators and defectors, while heterogeneous networks promote their coordination. To this end, we define a dynamic variable that allows us to track the self-organization of cooperators when co-evolving with defectors in networked populations. Using the same variable, we show how the global dynamics - and effective dilemma - co-evolves with the motifs of cooperators in the population, the overall emergence of cooperation depending sensitively on this co-evolution.	[Pinheiro, Flavio L.; Pacheco, Jorge M.; Santos, Francisco C.] Univ Lisbon, Inst Invest Interdisciplinar, Ctr Matemat & Aplicacoes Fundamentais, Applicat Theoret Phys Grp, P-1699 Lisbon, Portugal; [Pacheco, Jorge M.] Univ Minho, Dept Matemat & Aplicacoes, Braga, Portugal; [Santos, Francisco C.] Univ Tecn Lisboa, Inst Super Tecn, Dept Informat Engn, P-1096 Lisbon, Portugal	Universidade de Lisboa; Universidade do Minho; Universidade de Lisboa; Instituto Superior Tecnico	Pinheiro, FL (corresponding author), Univ Lisbon, Inst Invest Interdisciplinar, Ctr Matemat & Aplicacoes Fundamentais, Applicat Theoret Phys Grp, P-1699 Lisbon, Portugal.	franciscocsantos@ist.utl.pt	Pacheco, Jorge M/B-6116-2008; Pinheiro, Flávio L./F-9214-2011; Santos, Francisco C./W-7781-2019; Pacheco, Jorge M./O-8184-2019; Santos, Francisco C./D-2394-2010	Pacheco, Jorge M/0000-0002-2579-8499; Pinheiro, Flávio L./0000-0002-0561-9641; Santos, Francisco C./0000-0002-9103-2862; Pacheco, Jorge M./0000-0002-2579-8499; Santos, Francisco C./0000-0002-9103-2862	FCT-Portugal	FCT-Portugal(Portuguese Foundation for Science and Technology)	Financial support from FCT-Portugal is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Antal T, 2006, B MATH BIOL, V68, P1923, DOI 10.1007/s11538-006-9061-4; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Bollobas B, RANDOM GRAPHS; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Chalub FACC, 2011, SPRINGER PROC MATH, V1, P239, DOI 10.1007/978-3-642-11456-4_15; Chalub FACC, 2009, THEOR POPUL BIOL, V76, P268, DOI 10.1016/j.tpb.2009.08.006; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Dorogovtsev S, 2010, COMPLEX NETWORKS; Floria LM, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.026106; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; Gintis H., 2000, GAME THEORY EVOLVING; Gokhale CS, 2010, P NATL ACAD SCI USA, V107, P5500, DOI 10.1073/pnas.0912214107; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108103; Gomez-Gardenes J, 2008, J THEOR BIOL, V253, P296, DOI 10.1016/j.jtbi.2008.03.007; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Hauert C, 2005, AM J PHYS, V73, P405, DOI 10.1119/1.1848514; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hauert C, 2002, INT J BIFURCAT CHAOS, V12, P1531, DOI 10.1142/S0218127402005273; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Karlin S., 1975, 1 COURSE STOCHASTIC, V2; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lehmann L, 2007, J EVOLUTION BIOL, V20, P2284, DOI 10.1111/j.1420-9101.2007.01414.x; Lieberman E, 2005, NATURE, V433, P312, DOI 10.1038/nature03204; Lloyd AL, 2001, SCIENCE, V292, P1316, DOI 10.1126/science.1061076; Marshall JAR, 2010, BEHAV ECOL SOCIOBIOL, P1; Masuda N, 2007, P R SOC B, V274, P1815, DOI 10.1098/rspb.2007.0294; Maynard Smith J., 1982, pi; Nakamaru M, 1997, J THEOR BIOL, V184, P65, DOI 10.1006/jtbi.1996.0243; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; Ohtsuki H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108106; Ohtsuki H, 2006, J THEOR BIOL, V243, P86, DOI 10.1016/j.jtbi.2006.06.004; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Onnela JP, 2010, P NATL ACAD SCI USA, V107, P18375, DOI 10.1073/pnas.0914572107; Pacheco JM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000596; Pacheco JM, 2009, P ROY SOC B-BIOL SCI, V276, P315, DOI 10.1098/rspb.2008.1126; Page KM, 2002, J THEOR BIOL, V219, P93, DOI 10.1006/yjtbi.3112; Perc M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/2/022; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Perc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033027; Poncela J, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/184; PRICE GR, 1970, NATURE, V227, P520, DOI 10.1038/227520a0; Santos FC, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056128; Santos FC, 2006, P ROY SOC B-BIOL SCI, V273, P51, DOI 10.1098/rspb.2005.3272; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2006, J EVOLUTION BIOL, V19, P726, DOI 10.1111/j.1420-9101.2005.01063.x; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Santos FC, 2011, P NATL ACAD SCI USA, V108, P10421, DOI 10.1073/pnas.1015648108; Schelling T., 1978, MICROMOTIVES MACROBE; Sigmund K., 2010, CALCULUS SELFISHNESS; Skyrms B., 2001, PROC ADDRESS AM PHIL, V75, P31, DOI DOI 10.2307/3218711; Skyrms B, STAG HUNT EVOLUTION; SMITH JM, 1976, ANIM BEHAV, V24, P159, DOI 10.1016/S0003-3472(76)80110-8; Souza MO, 2009, J THEOR BIOL, V260, P581, DOI 10.1016/j.jtbi.2009.07.010; Szabo G, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.047107; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szabo G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016106; Szolnoki A, 2008, PHYSICA A, V387, P2075, DOI 10.1016/j.physa.2007.11.021; Taylor PD, 2007, J THEOR BIOL, V249, P101, DOI 10.1016/j.jtbi.2007.07.006; Traulsen A, 2009, REV NONLINEAR DYNAMI; Traulsen A, 2007, J THEOR BIOL, V246, P522, DOI 10.1016/j.jtbi.2007.01.002; Traulsen A, 2007, J THEOR BIOL, V244, P349, DOI 10.1016/j.jtbi.2006.08.008; Traulsen A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011909; Traulsen A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021905; Vukov J, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026109; Watts DJ, 2007, NATURE, V445, P489, DOI 10.1038/445489a	74	46	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32114	10.1371/journal.pone.0032114	http://dx.doi.org/10.1371/journal.pone.0032114			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363804	Green Submitted, Green Published, gold			2022-12-27	WOS:000302873700145
J	Abdullahi, O; Karani, A; Tigoi, CC; Mugo, D; Kungu, S; Wanjiru, E; Jomo, J; Musyimi, R; Lipsitch, M; Scott, JAG				Abdullahi, Osman; Karani, Angela; Tigoi, Caroline C.; Mugo, Daisy; Kungu, Stella; Wanjiru, Eva; Jomo, Jane; Musyimi, Robert; Lipsitch, Marc; Scott, J. Anthony G.			The Prevalence and Risk Factors for Pneumococcal Colonization of the Nasopharynx among Children in Kilifi District, Kenya	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; HAEMOPHILUS-INFLUENZAE; ANTIBIOTIC-RESISTANCE; SEROTYPE DISTRIBUTION; UNITED-STATES; RURAL AREA; CARRIAGE; DISEASE; ANTIBODY	Background: Pneumococcal conjugate vaccines (PCV) reduce nasopharyngeal carriage of vaccine-serotype pneumococci but increase in the carriage of non-vaccine serotypes. We studied the epidemiology of carriage among children 3-59 months old before vaccine introduction in Kilifi, Kenya. Methods: In a rolling cross-sectional study from October 2006 to December 2008 we approached 3570 healthy children selected at random from the population register of the Kilifi Health and Demographic Surveillance System and 134 HIV-infected children registered at a specialist clinic. A single nasopharyngeal swab was transported in STGG and cultured on gentamicin blood agar. A single colony of pneumococcus was serotyped by Quellung reaction. Results: Families of 2840 children in the population-based sample and 99 in the HIV-infected sample consented to participate; carriage prevalence was 65.8% (95% CI, 64.0-67.5%) and 76% (95% CI, 66-84%) in the two samples, respectively. Carriage prevalence declined progressively with age from 79% at 6-11 months to 51% at 54-59 months (p < 0.0005). Carriage was positively associated with coryza (Odds ratio 2.63, 95% CI 2.12-3.25) and cough (1.55, 95% CI 1.26-1.91) and negatively associated with recent antibiotic use (0.53 95% CI 0.34-0.81). 53 different serotypes were identified and 42% of isolates were of serotypes contained in the 10-valent PCV. Common serotypes declined in prevalence with age while less common serotypes did not. Conclusion: Carriage prevalence in children was high, serotypes were diverse, and the majority of strains were of serotypes not represented in the 10-valent PCV. Vaccine introduction in Kenya will provide a natural test of virulence for the many circulating non-vaccine serotypes.	[Abdullahi, Osman; Karani, Angela; Tigoi, Caroline C.; Mugo, Daisy; Kungu, Stella; Wanjiru, Eva; Jomo, Jane; Musyimi, Robert; Scott, J. Anthony G.] Ctr Geog Med Res Coast, Kenya Med Res Inst, Wellcome Trust Res Program, Kilifi, Kenya; [Abdullahi, Osman; Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Scott, J. Anthony G.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England	Kenya Medical Research Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Oxford	Abdullahi, O (corresponding author), Ctr Geog Med Res Coast, Kenya Med Res Inst, Wellcome Trust Res Program, Kilifi, Kenya.	oabdulla@hsph.harvard.edu		Lipsitch, Marc/0000-0003-1504-9213	Wellcome Trust [081835, 092654/Z/10/A]	Wellcome Trust(Wellcome TrustEuropean Commission)	Professor Scott is funded by a research fellowship from the Wellcome Trust (grant 081835). The KEMRI-Wellcome Trust Research Programme is supported by core funding from the Wellcome Trust (#092654/Z/10/A). This paper is published with the permission of the Director of the Kenya Medical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi O, 2011, CLIN INFECT DI UNPUB; Abdullahi O, 2008, PEDIATR INFECT DIS J, V27, P59, DOI 10.1097/INF.0b013e31814da70c; Abdullahi O, 2007, J CLIN MICROBIOL, V45, P3408, DOI 10.1128/JCM.01393-07; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P434; Beall B, 2006, J CLIN MICROBIOL, V44, P999, DOI 10.1128/JCM.44.3.999-1017.2006; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Byington CL, 2005, CLIN INFECT DIS, V41, P21, DOI 10.1086/430604; Campbell JD, 2004, PEDIATR INFECT DIS J, V23, P642, DOI 10.1097/01.inf.0000130951.85974.79; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Feikin DR, 2003, PEDIATR INFECT DIS J, V22, P564, DOI 10.1097/00006454-200306000-00016; Goldblatt D, 2005, J INFECT DIS, V192, P387, DOI 10.1086/431524; Gonzalez BE, 2006, PEDIATR INFECT DIS J, V25, P301, DOI 10.1097/01.inf.0000207484.52850.38; HENDLEY JO, 1975, J INFECT DIS, V132, P55, DOI 10.1093/infdis/132.1.55; Hill PC, 2008, CLIN INFECT DIS, V46, P807, DOI 10.1086/528688; Hill PC, 2006, CLIN INFECT DIS, V43, P673, DOI 10.1086/506941; Hill PC, 2010, CLIN INFECT DIS, V50, P1468, DOI 10.1086/652443; Hussain M, 2005, EPIDEMIOL INFECT, V133, P891, DOI 10.1017/S0950268805004012; Joloba ML, 2001, INT J ANTIMICROB AG, V17, P395, DOI 10.1016/S0924-8579(00)00345-9; Kaplan SL, 2004, PEDIATRICS, V113, P443, DOI 10.1542/peds.113.3.443; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Lipsitch M, 2011, EPIDEMIOLOGY UNPUB, DOI 10.1097/EDE.0b013e31824f2f32; LloydEvans N, 1996, PEDIATR INFECT DIS J, V15, P866, DOI 10.1097/00006454-199610000-00007; MASTRO TD, 1993, PEDIATR INFECT DIS J, V12, P824, DOI 10.1097/00006454-199310000-00006; Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009; McCool TL, 2004, INFECT IMMUN, V72, P5807, DOI 10.1128/IAI.72.10.5807-5813.2004; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Nicoletti C, 2007, DIAGN MICR INFEC DIS, V57, P259, DOI 10.1016/j.diagmicrobio.2006.08.021; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; ODempsey TJD, 1996, PEDIATR INFECT DIS J, V15, P431, DOI 10.1097/00006454-199605000-00010; Paul J, 1997, T ROY SOC TROP MED H, V91, P632, DOI 10.1016/S0035-9203(97)90500-9; Reingold A., 2008, Morbidity and Mortality Weekly Report, V57, P144; Rusen ID, 1997, PEDIATR INFECT DIS J, V16, P656, DOI 10.1097/00006454-199707000-00007; Scott JAG, 2011, LANCET, V378, P1316, DOI 10.1016/S0140-6736(11)60888-X; Scott JAG, 2011, CLIN INFECT DIS, V53, P663, DOI 10.1093/cid/cir444; Scott JA, 2011, INT J EPIDEMIO UNPUB; Singleton RJ, 2007, JAMA-J AM MED ASSOC, V297, P1784, DOI 10.1001/jama.297.16.1784; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Smillie WG, 1929, J EXP MED, V50, P233, DOI 10.1084/jem.50.2.233; Steenhoff AP, 2006, CLIN INFECT DIS, V42, P907, DOI 10.1086/500941; Straker E, STUDY NASOPHARYNGEAL; Valles X, 2006, TROP MED INT HEALTH, V11, P358, DOI 10.1111/j.1365-3156.2006.01565.x; Weinberger DM, 2008, J INFECT DIS, V197, P1511, DOI 10.1086/587941; Yomo A, 1997, ANN TROP PAEDIATR, V17, P239, DOI 10.1080/02724936.1997.11747894	44	74	74	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30787	10.1371/journal.pone.0030787	http://dx.doi.org/10.1371/journal.pone.0030787			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363489	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000302871500017
J	de Sampaio, PC; Auslaender, D; Krubasik, D; Failla, AV; Skepper, JN; Murphy, G; English, WR				de Sampaio, Pedro Correa; Auslaender, David; Krubasik, Davia; Failla, Antonio Virgilio; Skepper, Jeremy N.; Murphy, Gillian; English, William R.			A Heterogeneous In Vitro Three Dimensional Model of Tumour-Stroma Interactions Regulating Sprouting Angiogenesis	PLOS ONE			English	Article							SPHEROIDAL COCULTURE MODEL; ENDOTHELIAL GROWTH-FACTOR; MATRIX METALLOPROTEINASES; MULTICELLULAR SPHEROIDS; TYROSINE KINASE; BREAST-CANCER; SOLID TUMORS; MURAL CELLS; FIBRIN GELS; TIP CELLS	Angiogenesis, the formation of new blood vessels, is an essential process for tumour progression and is an area of significant therapeutic interest. Different in vitro systems and more complex in vivo systems have been described for the study of tumour angiogenesis. However, there are few human 3D in vitro systems described to date which mimic the cellular heterogeneity and complexity of angiogenesis within the tumour microenvironment. In this study we describe the Minitumour model - a 3 dimensional human spheroid-based system consisting of endothelial cells and fibroblasts in coculture with the breast cancer cell line MDA-MB-231, for the study of tumour angiogenesis in vitro. After implantation in collagen-I gels, Minitumour spheroids form quantifiable endothelial capillary-like structures. The endothelial cell precapillary sprouts are supported by the fibroblasts, which act as mural cells, and their growth is increased by the presence of cancer cells. Characterisation of the Minitumour model using small molecule inhibitors and inhibitory antibodies show that endothelial sprout formation is dependent on growth factors and cytokines known to be important for tumour angiogenesis. The model also shows a response to anti-angiogenic agents similar to previously described in vivo data. We demonstrate that independent manipulation of the different cell types is possible, using common molecular techniques, before incorporation into the model. This aspect of Minitumour spheroid analysis makes this model ideal for high content studies of gene function in individual cell types, allowing for the dissection of their roles in cell-cell interactions. Finally, using this technique, we were able to show the requirement of the metalloproteinase MT1-MMP in endothelial cells and fibroblasts, but not cancer cells, for sprouting angiogenesis.	[de Sampaio, Pedro Correa; Auslaender, David; Krubasik, Davia; Murphy, Gillian; English, William R.] Univ Cambridge, Dept Oncol, Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Cambridge, England; [Failla, Antonio Virgilio] Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Microscopy Unit, Cambridge, England; [Skepper, Jeremy N.] Univ Cambridge, Dept Physiol Dev & Neurosci, Multiimaging Ctr, Cambridge, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	de Sampaio, PC (corresponding author), Univ Cambridge, Dept Oncol, Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Cambridge, England.	w.english@sheffield.ac.uk		Correa de Sampaio, Pedro/0000-0001-5597-2825; English, William/0000-0003-3024-2441	Cancer Research UK and Hutchinson Whampoa Limited; Portuguese Foundation for Science and Technology (Fundacao para a Ciencia e Tecnologia) [SFRH/BD/35884/2007]; DAAD (Deutscher Akademischer Austausch Dienst); Trinity College Cambridge; British Heart Foundation [FS/03/055/15910]	Cancer Research UK and Hutchinson Whampoa Limited; Portuguese Foundation for Science and Technology (Fundacao para a Ciencia e Tecnologia)(Portuguese Foundation for Science and Technology); DAAD (Deutscher Akademischer Austausch Dienst)(Deutscher Akademischer Austausch Dienst (DAAD)); Trinity College Cambridge; British Heart Foundation(British Heart Foundation)	This work was supported by Cancer Research UK and Hutchinson Whampoa Limited. PCdS was funded by the Portuguese Foundation for Science and Technology (Fundacao para a Ciencia e Tecnologia, grant number SFRH/BD/35884/2007). DK was supported by the DAAD (Deutscher Akademischer Austausch Dienst) and Trinity College Cambridge. A British Heart Foundation Intermediate Research Fellowship (grant number FS/03/055/15910) supported WRE during initiation of the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Birgersdotter A, 2005, SEMIN CANCER BIOL, V15, P405, DOI 10.1016/j.semcancer.2005.06.009; Bishop E T, 1999, Angiogenesis, V3, P335, DOI 10.1023/A:1026546219962; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; CHIQUETEHRISMANN R, 1986, CELL, V47, P131, DOI 10.1016/0092-8674(86)90374-0; Clamp AR, 2005, BRIT J CANCER, V93, P967, DOI 10.1038/sj.bjc.6602820; Cooley LS, 2010, J CELL SCI, V123, P3808, DOI 10.1242/jcs.064279; d'Ortho MP, 1998, FEBS LETT, V421, P159, DOI 10.1016/S0014-5793(97)01555-X; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Deryugina EI, 2002, CANCER RES, V62, P580; Ferrara N, 2009, EUR CYTOKINE NETW, V20, P158, DOI 10.1684/ecn.2009.0170; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; FOLKMAN J, 1972, ANN SURG, V175, P409, DOI 10.1097/00000658-197203000-00014; Freund A, 2003, ONCOGENE, V22, P256, DOI 10.1038/sj.onc.1206113; GALARDY RE, 1994, CANCER RES, V54, P4715; Galvez BG, 2001, J BIOL CHEM, V276, P37491, DOI 10.1074/jbc.M104094200; Genis L, 2006, CANCER METAST REV, V25, P77, DOI 10.1007/s10555-006-7891-z; Ghosh S, 2007, FEBS LETT, V581, P4523, DOI 10.1016/j.febslet.2007.08.038; GORCZYCA W, 1993, ANTICANCER RES, V13, P851; Guttery DS, 2010, CANCER METAST REV, V29, P595, DOI 10.1007/s10555-010-9249-9; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Ivy SP, 2009, NAT REV CLIN ONCOL, V6, P569, DOI 10.1038/nrclinonc.2009.130; Jubb AM, 2006, NAT REV CANCER, V6, P626, DOI 10.1038/nrc1946; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; KAWAKATSU H, 1992, JPN J CANCER RES, V83, P1073, DOI 10.1111/j.1349-7006.1992.tb02724.x; Kebers F, 1998, EXP CELL RES, V240, P197, DOI 10.1006/excr.1998.3935; Kendall RL, 1999, J BIOL CHEM, V274, P6453, DOI 10.1074/jbc.274.10.6453; Kim JB, 2004, BREAST CANCER RES TR, V85, P281, DOI 10.1023/B:BREA.0000025418.88785.2b; Knobloch J, 2008, CELL CYCLE, V7, P1121, DOI 10.4161/cc.7.9.5793; Kopfstein L, 2006, CELL MOL LIFE SCI, V63, P449, DOI 10.1007/s00018-005-5296-8; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Korff T, 2001, FASEB J, V15, P447, DOI 10.1096/fj.00-0139com; KOVALENKO M, 1994, CANCER RES, V54, P6106; Krubasik D, 2008, INT J CANCER, V122, P1261, DOI 10.1002/ijc.23234; KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589; Kunz-Schughart LA, 1999, CELL BIOL INT, V23, P157, DOI 10.1006/cbir.1999.0384; Kunz-Schughart LA, 1998, INT J EXP PATHOL, V79, P1, DOI 10.1046/j.1365-2613.1998.00051.x; Kunz-Schughart LA, 2006, AM J PHYSIOL-CELL PH, V290, pC1385, DOI 10.1152/ajpcell.00248.2005; Lafleur MA, 2002, J CELL SCI, V115, P3427; LAWLEY TJ, 1989, J INVEST DERMATOL, V93, pS59, DOI 10.1111/1523-1747.ep12581070; Lee CC, 2010, INFLAMMATION; Liu H, 2008, ANGIOGENESIS, V11, P223, DOI 10.1007/s10456-008-9102-8; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765; Menu E, 2006, BLOOD, V107, P655, DOI 10.1182/blood-2005-01-0293; MONTESANO R, 1993, J CELL SCI, V105, P1013; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; MuellerKlieser W, 1997, AM J PHYSIOL-CELL PH, V273, pC1109, DOI 10.1152/ajpcell.1997.273.4.C1109; Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1; Naumov GN, 2006, CELL CYCLE, V5, P1779, DOI 10.4161/cc.5.16.3018; Noel A, 2008, SEMIN CELL DEV BIOL, V19, P52, DOI 10.1016/j.semcdb.2007.05.011; Nyberg P, 2008, FRONT BIOSCI, V13, P6537, DOI 10.2741/3173; OFFNER FA, 1992, AM J PATHOL, V141, P601; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Reinmuth N, 2002, CLIN CANCER RES, V8, P3259; Salter JT, 2007, CANCER INVEST, V25, P518, DOI 10.1080/07357900701648516; Sleijfer S, 2004, EUR J CANCER, V40, P2377, DOI 10.1016/j.ejca.2004.07.023; Sudhakar A, 2003, P NATL ACAD SCI USA, V100, P4766, DOI 10.1073/pnas.0730882100; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Walter-Yohrling J, 2003, CANCER CHEMOTH PHARM, V52, P263, DOI 10.1007/s00280-003-0664-2; Wenger A, 2005, CELLS TISSUES ORGANS, V181, P80, DOI 10.1159/000091097; Yana I, 2007, J CELL SCI, V120, P1607, DOI 10.1242/jcs.000679	65	102	102	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30753	10.1371/journal.pone.0030753	http://dx.doi.org/10.1371/journal.pone.0030753			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363483	gold, Green Published, Green Accepted			2022-12-27	WOS:000302871500016
J	Ma, CW; Xiu, ZL; Zeng, AP				Ma, Cheng-Wei; Xiu, Zhi-Long; Zeng, An-Ping			Discovery of Intramolecular Signal Transduction Network Based on a New Protein Dynamics Model of Energy Dissipation	PLOS ONE			English	Article							LYSINE-SENSITIVE ASPARTOKINASE; MOLECULAR-DYNAMICS; COMPLEX NETWORKS; ENZYME; IDENTIFICATION; DEREGULATION; INTEGRATION; INHIBITION	A novel approach to reveal intramolecular signal transduction network is proposed in this work. To this end, a new algorithm of network construction is developed, which is based on a new protein dynamics model of energy dissipation. A key feature of this approach is that direction information is specified after inferring protein residue-residue interaction network involved in the process of signal transduction. This enables fundamental analysis of the regulation hierarchy and identification of regulation hubs of the signaling network. A well-studied allosteric enzyme, E. coli aspartokinase III, is used as a model system to demonstrate the new method. Comparison with experimental results shows that the new approach is able to predict all the sites that have been experimentally proved to desensitize allosteric regulation of the enzyme. In addition, the signal transduction network shows a clear preference for specific structural regions, secondary structural types and residue conservation. Occurrence of super-hubs in the network indicates that allosteric regulation tends to gather residues with high connection ability to collectively facilitate the signaling process. Furthermore, a new parameter of propagation coefficient is defined to determine the propagation capability of residues within a signal transduction network. In conclusion, the new approach is useful for fundamental understanding of the process of intramolecular signal transduction and thus has significant impact on rational design of novel allosteric proteins.	[Ma, Cheng-Wei; Zeng, An-Ping] Hamburg Univ Technol, Inst Bioproc & Biosyst Engn, Hamburg, Germany; [Ma, Cheng-Wei; Xiu, Zhi-Long] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Peoples R China	Hamburg University of Technology; Dalian University of Technology	Ma, CW (corresponding author), Hamburg Univ Technol, Inst Bioproc & Biosyst Engn, Hamburg, Germany.	aze@tu-harburg.de		Zeng, An-Ping/0000-0001-9768-7096	China Scholarship Council	China Scholarship Council(China Scholarship Council)	Dr. Ma acknowledges financial support from China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal MA, 2009, CURR PROTEIN PEPT SC, V10, P161, DOI 10.2174/138920309787847617; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; CASSAN M, 1986, J BIOL CHEM, V261, P1052; Chen Z, 2011, J BIOTECHNOL, V154, P248, DOI 10.1016/j.jbiotec.2011.05.005; Chen Z, 2011, APPL ENVIRON MICROB, V77, P4352, DOI 10.1128/AEM.02912-10; Daily MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000293; Estabrook RA, 2005, P NATL ACAD SCI USA, V102, P994, DOI 10.1073/pnas.0409128102; Farkas IJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001950; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; JORGENSEN WL, 1982, J CHEM PHYS, V77, P4156, DOI 10.1063/1.444325; Juanico B, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.238104; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; Kikuchi Y, 1999, FEMS MICROBIOL LETT, V173, P211, DOI 10.1111/j.1574-6968.1999.tb13504.x; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Kumar S, 2000, PROTEIN SCI, V9, P10; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Luque I, 2002, ANNU REV BIOPH BIOM, V31, P235, DOI 10.1146/annurev.biophys.31.082901.134215; Ma CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026453; Ma HW, 2003, BIOINFORMATICS, V19, P270, DOI 10.1093/bioinformatics/19.2.270; Ma HW, 2004, NUCLEIC ACIDS RES, V32, P6643, DOI 10.1093/nar/gkh1009; Miyata YO, 2001, BIOSCI BIOTECH BIOCH, V65, P1149; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Olsson MHM, 2006, CHEM REV, V106, P1737, DOI 10.1021/cr040427e; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piazza F, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046014; Piazza F, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/2/026001; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Ramon-Maiques S, 2002, STRUCTURE, V10, P329, DOI 10.1016/S0969-2126(02)00721-9; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schreiber F, 2005, BIOINFORMATICS, V21, P3572, DOI 10.1093/bioinformatics/bti556; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Tsai CJ, 2009, MOL BIOSYST, V5, P207, DOI 10.1039/b819720b; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yang Z, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000360	43	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31529	10.1371/journal.pone.0031529	http://dx.doi.org/10.1371/journal.pone.0031529			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363664	Green Published, Green Submitted, gold			2022-12-27	WOS:000302871500053
J	Maeda, K; Kurata, H				Maeda, Kazuhiro; Kurata, Hiroyuki			A Symmetric Dual Feedback System Provides a Robust and Entrainable Oscillator	PLOS ONE			English	Article							MAMMALIAN CIRCADIAN CLOCK; LIGHT-DARK CYCLES; PER-TIM COMPLEX; MULTIPARAMETER SENSITIVITY; DROSOPHILA-MELANOGASTER; BIOCHEMICAL NETWORKS; GENETIC REDUNDANCY; HEAT-SHOCK; MODEL; RHYTHMS	Many organisms have evolved molecular clocks to anticipate daily changes in their environment. The molecular mechanisms by which the circadian clock network produces sustained cycles have extensively been studied and transcriptional-translational feedback loops are common structures to many organisms. Although a simple or single feedback loop is sufficient for sustained oscillations, circadian clocks implement multiple, complicated feedback loops. In general, different types of feedback loops are suggested to affect the robustness and entrainment of circadian rhythms. To reveal the mechanism by which such a complex feedback system evolves, we quantify the robustness and light entrainment of four competing models: the single, semi-dual, dual, and redundant feedback models. To extract the global properties of those models, all plausible kinetic parameter sets that generate circadian oscillations are searched to characterize their oscillatory features. To efficiently perform such analyses, we used the two-phase search (TPS) method as a fast and non-biased search method and quasi-multiparameter sensitivity (QMPS) as a fast and exact measure of robustness to uncertainty of all kinetic parameters. So far the redundant feedback model has been regarded as the most robust oscillator, but our extensive analysis corrects or overcomes this hypothesis. The dual feedback model, which is employed in biology, provides the most robust oscillator to multiple parameter perturbations within a cell and most readily entrains to a wide range of light-dark cycles. The kinetic symmetry between the dual loops and their coupling via a protein complex are found critically responsible for robust and entrainable oscillations. We first demonstrate how the dual feedback architecture with kinetic symmetry evolves out of many competing feedback systems.	[Maeda, Kazuhiro; Kurata, Hiroyuki] Kyushu Inst Technol, Dept Biosci & Bioinformat, Iizuka, Fukuoka, Japan	Kyushu Institute of Technology	Maeda, K (corresponding author), Kyushu Inst Technol, Dept Biosci & Bioinformat, Iizuka, Fukuoka, Japan.	kurata@bio.kyutech.ac.jp	Maeda, Kazuhiro/Y-3151-2019	Maeda, Kazuhiro/0000-0002-6038-1322	Ministry of Education, Culture, Sports, Science and Technology of Japan [22300101]; Japan Society for the Promotion of Science for Young Scientists	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by KAKENHI (Grant-in-Aid for Scientific Research) on Scientific Research (B) (22300101) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. KM was supported by Research Fellowships from the Japan Society for the Promotion of Science for Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Alves R, 2000, BIOINFORMATICS, V16, P534, DOI 10.1093/bioinformatics/16.6.534; Alves R, 2000, BIOINFORMATICS, V16, P786, DOI 10.1093/bioinformatics/16.9.786; Bae K, 2000, J NEUROSCI, V20, P1746; Bagheri N, 2008, J BIOL RHYTHM, V23, P525, DOI 10.1177/0748730408325041; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Cooke J, 1997, TRENDS GENET, V13, P360, DOI 10.1016/S0168-9525(97)01233-X; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; El-Samad H, 2005, P NATL ACAD SCI USA, V102, P2736, DOI 10.1073/pnas.0403510102; GOLDBETER A, 1995, P ROY SOC B-BIOL SCI, V261, P319, DOI 10.1098/rspb.1995.0153; Gonze D, 2000, J STAT PHYS, V101, P649, DOI 10.1023/A:1026410121183; Hao HP, 1997, MOL CELL BIOL, V17, P3687, DOI 10.1128/MCB.17.7.3687; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; Kurata H, 2005, GENOME RES, V15, P590, DOI 10.1101/gr.3463705; Kurata H, 2003, NUCLEIC ACIDS RES, V31, P4071, DOI 10.1093/nar/gkg461; Kurata H, 2006, PLOS COMPUT BIOL, V2, P663, DOI 10.1371/journal.pcbi.0020059; Kurata H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001103; Kurata H, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm769; Kurosawa G, 2002, J THEOR BIOL, V216, P193, DOI 10.1006/jtbi.2002.2546; Kurosawa G, 2006, J THEOR BIOL, V242, P478, DOI 10.1016/j.jtbi.2006.03.016; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; Leloup JC, 2003, P NATL ACAD SCI USA, V100, P7051, DOI 10.1073/pnas.1132112100; Leloup JC, 1998, J BIOL RHYTHM, V13, P70, DOI 10.1177/074873098128999934; Maeda K., 2009, IPSJ T BIOINFO, V2, P2; Maeda K, 2011, J THEOR BIOL, V272, P174, DOI 10.1016/j.jtbi.2010.12.012; Mirsky HP, 2009, P NATL ACAD SCI USA, V106, P11107, DOI 10.1073/pnas.0904837106; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; ROSENBLUM AL, 1971, IEEE T CIRCUITS SYST, VCT18, P592, DOI 10.1109/TCT.1971.1083355; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; SAVAGEAU MA, 1971, NATURE, V229, P542, DOI 10.1038/229542a0; SCHOEFFLER J, 1964, IEEE T CIRCUITS SYST, VCT11, P271, DOI 10.1109/TCT.1964.1082278; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Smolen P, 2004, BIOPHYS J, V86, P2786, DOI 10.1016/S0006-3495(04)74332-5; Smolen P, 2001, J NEUROSCI, V21, P6644, DOI 10.1523/JNEUROSCI.21-17-06644.2001; Stelling J, 2004, P NATL ACAD SCI USA, V101, P13210, DOI 10.1073/pnas.0401463101; THOMAS JH, 1993, TRENDS GENET, V9, P395, DOI 10.1016/0168-9525(93)90140-D; Ueda HR, 2001, J THEOR BIOL, V210, P401, DOI 10.1006/jtbi.2000.2226; Wagner A, 2005, BIOESSAYS, V27, P176, DOI 10.1002/bies.20170; Wilkins AS, 1997, BIOESSAYS, V19, P257, DOI 10.1002/bies.950190312; Xie Z, 2007, J THEOR BIOL, V245, P290, DOI 10.1016/j.jtbi.2006.10.028; Xie Z, 2010, BIOTECHNOL BIOENG, V105, P250, DOI 10.1002/bit.22540; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0	48	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30489	10.1371/journal.pone.0030489	http://dx.doi.org/10.1371/journal.pone.0030489			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363442	Green Published, Green Submitted, gold			2022-12-27	WOS:000302871500009
J	Bijeljac-Babic, R; Serres, J; Hohle, B; Nazzi, T				Bijeljac-Babic, Ranka; Serres, Josette; Hoehle, Barbara; Nazzi, Thierry			Effect of Bilingualism on Lexical Stress Pattern Discrimination in French-Learning Infants	PLOS ONE			English	Article							LANGUAGE DISCRIMINATION; PERCEPTUAL REORGANIZATION; 4-MONTH-OLD INFANTS; VOWEL CONTRASTS; 1ST YEAR; SPEECH; ACQUISITION; NEWBORNS; RHYTHM; DEAFNESS	Monolingual infants start learning the prosodic properties of their native language around 6 to 9 months of age, a fact marked by the development of preferences for predominant prosodic patterns and a decrease in sensitivity to non-native prosodic properties. The present study evaluates the effects of bilingual acquisition on speech perception by exploring how stress pattern perception may differ in French-learning 10-month-olds raised in bilingual as opposed to monolingual environments. Experiment 1 shows that monolinguals can discriminate stress patterns following a long familiarization to one of two patterns, but not after a short familiarization. In Experiment 2, two subgroups of bilingual infants growing up learning both French and another language (varying across infants) in which stress is used lexically were tested under the more difficult short familiarization condition: one with balanced input, and one receiving more input in the language other than French. Discrimination was clearly found for the other-language-dominant subgroup, establishing heightened sensitivity to stress pattern contrasts in these bilinguals as compared to monolinguals. However, the balanced bilinguals' performance was not better than that of monolinguals, establishing an effect of the relative balance of the language input. This pattern of results is compatible with the proposal that sensitivity to prosodic contrasts is maintained or enhanced in a bilingual population compared to a monolingual population in which these contrasts are non-native, provided that this dimension is used in one of the two languages in acquisition, and that infants receive enough input from that language.	[Bijeljac-Babic, Ranka; Serres, Josette; Nazzi, Thierry] Univ Paris 05, Paris, France; [Bijeljac-Babic, Ranka; Serres, Josette; Nazzi, Thierry] CNRS, Lab Psychol Percept, Paris, France; [Bijeljac-Babic, Ranka] Univ Poitiers, Poitiers, France; [Hoehle, Barbara] Univ Potsdam, Potsdam, Germany	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Universite de Poitiers; University of Potsdam	Bijeljac-Babic, R (corresponding author), Univ Paris 05, Paris, France.	ranka.bijeljac-babic@parisdescartes.fr		Hohle, Barbara/0000-0002-9240-6117; Nazzi, Thierry/0000-0002-4378-3661	ANR [07-BLAN-0014-01]; ANR-DFG [09-FASHS-018]; DFG [HO 1960/14-1]	ANR(French National Research Agency (ANR)); ANR-DFG(German Research Foundation (DFG)French National Research Agency (ANR)); DFG(German Research Foundation (DFG))	This study was conducted with the support of ANR grant # 07-BLAN-0014-01 and ANR-DFG grant # 09-FASHS-018 and DFG grant HO 1960/14-1 to TN and BH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albareda-Castellot B, 2011, DEVELOPMENTAL SCI, V14, P395, DOI 10.1111/j.1467-7687.2010.00989.x; Angoujard J-P, 1990, METRICAL STRUCTURE A; BEST CT, 1995, INFANT BEHAV DEV, V18, P339, DOI 10.1016/0163-6383(95)90022-5; Bialystok E, 2008, J EXP PSYCHOL LEARN, V34, P859, DOI 10.1037/0278-7393.34.4.859; Bijeljac-Babic R, 2006, P INT C SPOK LANG PR; Bijeljac-Babic R, 2009, INFANT BEHAV DEV, V32, P476, DOI 10.1016/j.infbeh.2009.06.003; Bosch L, 2003, LANG SPEECH, V46, P217, DOI 10.1177/00238309030460020801; Bosch L, 1997, COGNITION, V65, P33, DOI 10.1016/S0010-0277(97)00040-1; Bosch L, 2003, P 15 ICPHS BARC SPAI; Bosch L, 2001, INFANCY, V2, P29, DOI 10.1207/S15327078IN0201_3; Bunta F, 2007, J SPEECH LANG HEAR R, V50, P999, DOI 10.1044/1092-4388(2007/070); Burns TC, 2007, APPL PSYCHOLINGUIST, V28, P455, DOI 10.1017/S0142716407070257; Byers-Heinlein K, 2010, PSYCHOL SCI, V21, P343, DOI 10.1177/0956797609360758; Christophe A, 1998, DEVELOPMENTAL SCI, V1, P215, DOI 10.1111/1467-7687.00033; DICRISTO A, 2000, FRENCH LANGUAGE STUD, V9, P143; Dupoux E, 1997, J MEM LANG, V36, P406, DOI 10.1006/jmla.1996.2500; Dupoux E, 2001, J ACOUST SOC AM, V110, P1606, DOI 10.1121/1.1380437; Dupoux E, 2008, COGNITION, V106, P682, DOI 10.1016/j.cognition.2007.04.001; Dupoux E, 2010, COGNITION, V114, P266, DOI 10.1016/j.cognition.2009.10.001; Friederici AD, 2007, CURR BIOL, V17, P1208, DOI 10.1016/j.cub.2007.06.011; Goedemans R, 2010, RHYTHM TYPES WORLD A; Goyet L, 2010, BRAIN RES, V1332, P75, DOI 10.1016/j.brainres.2010.03.047; Gut U, 2000, CROSS LINGUISTIC STR, P201; Hohle B, 2009, INFANT BEHAV DEV, V32, P262, DOI 10.1016/j.infbeh.2009.03.004; Hunter M.A., 1988, ADV INFANCY RES, VVol. 5, P69, DOI DOI 10.1037/0012-1649.19.3.338; JUSCZYK PW, 1993, CHILD DEV, V64, P675, DOI 10.2307/1131210; Jusczyk PW, 1999, COGNITIVE PSYCHOL, V39, P159, DOI 10.1006/cogp.1999.0716; JUSCZYK PW, 1993, J MEM LANG, V32, P402, DOI 10.1006/jmla.1993.1022; Kovacs AM, 2009, P NATL ACAD SCI USA, V106, P6556, DOI 10.1073/pnas.0811323106; Kovacs AM, 2009, SCIENCE, V325, P611, DOI 10.1126/science.1173947; Kuhl PK, 2008, PHILOS T R SOC B, V363, P979, DOI 10.1098/rstb.2007.2154; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9096, DOI 10.1073/pnas.1532872100; Mattock K, 2006, INFANCY, V10, P241, DOI 10.1207/s15327078in1003_3; MEHLER J, 1988, COGNITION, V29, P143, DOI 10.1016/0010-0277(88)90035-2; Nazzi T, 1998, J EXP PSYCHOL HUMAN, V24, P756, DOI 10.1037/0096-1523.24.3.756; Nazzi T, 2006, J MEM LANG, V54, P283, DOI 10.1016/j.jml.2005.10.004; Nazzi T, 1998, INFANT BEHAV DEV, V21, P779, DOI 10.1016/S0163-6383(98)90044-3; Nazzi T, 2000, J MEM LANG, V43, P1, DOI 10.1006/jmla.2000.2698; Oller DK, 1997, J CHILD LANG, V24, P407; POLKA L, 1994, J EXP PSYCHOL HUMAN, V20, P421, DOI 10.1037/0096-1523.20.2.421; Ramon-Casas M, 2009, COGNITIVE PSYCHOL, V59, P96, DOI 10.1016/j.cogpsych.2009.02.002; Sansavini A, 1997, DEV PSYCHOL, V33, P3, DOI 10.1037/0012-1649.33.1.3; Schiering R, 2007, AUSTR WORKSH M PLANC; Sebastian-Galles N, 2010, HUM DEV, V53, P245, DOI 10.1159/000321282; Sebastian-Galles N, 2009, DEVELOPMENTAL SCI, V12, P874, DOI 10.1111/j.1467-7687.2009.00829.x; Skoruppa K, 2009, DEVELOPMENTAL SCI, V12, P914, DOI 10.1111/j.1467-7687.2009.00835.x; Sorace A, 2009, INT J BILINGUAL, V13, P195, DOI 10.1177/1367006909339810; Sundara M, 2008, COGNITION, V108, P232, DOI 10.1016/j.cognition.2007.12.013; vanOoijen B, 1997, J ACOUST SOC AM, V102, P3735, DOI 10.1121/1.420136; Weikum WM, 2007, SCIENCE, V316, P1159, DOI 10.1126/science.1137686; WERKER JF, 1984, INFANT BEHAV DEV, V7, P49, DOI 10.1016/S0163-6383(84)80022-3	51	40	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30843	10.1371/journal.pone.0030843	http://dx.doi.org/10.1371/journal.pone.0030843			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926TC	22363500	Green Published, gold			2022-12-27	WOS:000302853600076
J	Han, J; Kim, HJ; Lee, SC; Hong, SP; Park, KW; Jeon, YH; Kim, DS; Cheong, HK; Kim, HS				Han, Jieun; Kim, Hyun Jung; Lee, Sang-Chul; Hong, Seungpyo; Park, Keunwan; Jeon, Young Ho; Kim, Dongsup; Cheong, Hae-Kap; Kim, Hak-Sung			Structure-Based Rational Design of a Toll-like Receptor 4 (TLR4) Decoy Receptor with High Binding Affinity for a Target Protein	PLOS ONE			English	Article							LEUCINE-RICH REPEAT; CRYSTAL-STRUCTURE; MOLECULAR RECOGNITION; TLR4-MD-2 COMPLEX; FORCE-FIELD; SCAFFOLDS	Repeat proteins are increasingly attracting much attention as alternative scaffolds to immunoglobulin antibodies due to their unique structural features. Nonetheless, engineering interaction interface and understanding molecular basis for affinity maturation of repeat proteins still remain a challenge. Here, we present a structure-based rational design of a repeat protein with high binding affinity for a target protein. As a model repeat protein, a Toll-like receptor4 (TLR4) decoy receptor composed of leucine-rich repeat (LRR) modules was used, and its interaction interface was rationally engineered to increase the binding affinity for myeloid differentiation protein 2 (MD2). Based on the complex crystal structure of the decoy receptor with MD2, we first designed single amino acid substitutions in the decoy receptor, and obtained three variants showing a binding affinity (KD) one-order of magnitude higher than the wild-type decoy receptor. The interacting modes and contributions of individual residues were elucidated by analyzing the crystal structures of the single variants. To further increase the binding affinity, single positive mutations were combined, and two double mutants were shown to have about 3000- and 565-fold higher binding affinities than the wild-type decoy receptor. Molecular dynamics simulations and energetic analysis indicate that an additive effect by two mutations occurring at nearby modules was the major contributor to the remarkable increase in the binding affinities.	[Han, Jieun; Lee, Sang-Chul; Kim, Hak-Sung] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Kim, Hyun Jung; Jeon, Young Ho; Cheong, Hae-Kap] Korea Basic Sci Inst, Div Magnet Resonance Res, Cheongwon, Chungbuk, South Korea; [Kim, Hyun Jung] Chungbuk Natl Univ, Coll Pharm, Cheongju, Chungbuk, South Korea; [Hong, Seungpyo; Park, Keunwan; Kim, Dongsup] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Kim, Hak-Sung] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Basic Science Institute (KBSI); Chungbuk National University; Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Han, J (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.	haekap@kbsi.re.kr; skim76@kaist.ac.kr	Hong, Seungpyo/ABA-4461-2021; Kim, Hak-Sung/C-1929-2011; Kim, Dongsup/C-1612-2011	Hong, Seungpyo/0000-0003-1273-0740; LEE, Sangchul/0000-0002-7002-1179	Pioneer Research Program for Converging Technology [20110001745]; WCU [R31-2009-000-10071-0]; Brain Korea 21; Advanced Biomass RD Center [ABC-2010-0029800]; MEST	Pioneer Research Program for Converging Technology; WCU; Brain Korea 21(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Advanced Biomass RD Center; MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Pioneer Research Program for Converging Technology (20110001745), WCU program (R31-2009-000-10071-0), Brain Korea 21, and Advanced Biomass R&D Center (Grant ABC-2010-0029800) of Global Frontier Project funded by MEST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Bublitz M, 2008, J MOL BIOL, V378, P87, DOI 10.1016/j.jmb.2008.01.100; Buchanan SGS, 1996, PROG BIOPHYS MOL BIO, V65, P1, DOI 10.1016/S0079-6107(96)00003-X; Cho SW, 2005, STRUCTURE, V13, P1775, DOI 10.1016/j.str.2005.08.015; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enkhbayar P, 2004, PROTEINS, V54, P394, DOI 10.1002/prot.10605; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jianmin M, 2011, J IMMUNOL, V187, P3683; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Jung K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007403; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Ko J, 2007, J NEUROSCI RES, V85, P2824, DOI 10.1002/jnr.21306; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Liping L, 2011, CHEM BIO CHEM, V12, P1827; Marcotte EM, 1999, J MOL BIOL, V293, P151, DOI 10.1006/jmbi.1999.3136; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nuttall SD, 2008, CURR OPIN PHARMACOL, V8, P609, DOI 10.1016/j.coph.2008.06.007; Papageorgiou AC, 1997, EMBO J, V16, P5162, DOI 10.1093/emboj/16.17.5162; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Skerra A, 2007, CURR OPIN BIOTECH, V18, P295, DOI 10.1016/j.copbio.2007.04.010; Tasumi S, 2009, P NATL ACAD SCI USA, V106, P12891, DOI 10.1073/pnas.0904443106; Velikovsky CA, 2009, NAT STRUCT MOL BIOL, V16, P725, DOI 10.1038/nsmb.1619; Zahnd C, 2007, J MOL BIOL, V369, P1015, DOI 10.1016/j.jmb.2007.03.028	35	24	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30929	10.1371/journal.pone.0030929	http://dx.doi.org/10.1371/journal.pone.0030929			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363519	gold, Green Published, Green Submitted			2022-12-27	WOS:000302853600091
J	Jager, HC; McKinley, TJ; Wood, JLN; Pearce, GP; Williamson, S; Strugnell, B; Done, S; Habernoll, H; Palzer, A; Tucker, AW				Jaeger, Henrike C.; McKinley, Trevelyan J.; Wood, James L. N.; Pearce, Gareth P.; Williamson, Susanna; Strugnell, Benjamin; Done, Stanley; Habernoll, Henrike; Palzer, Andreas; Tucker, Alexander W.			Factors Associated with Pleurisy in Pigs: A Case-Control Analysis of Slaughter Pig Data for England and Wales	PLOS ONE			English	Article							EXPERIMENTAL HEMOPHILUS INFECTION; HAEMOPHILUS-PARASUIS; RISK-FACTORS; SPF-PIGLETS; LESIONS; HERDS; PREVALENCE; SEROVARS; SWINE	A case-control investigation was undertaken to determine management and health related factors associated with pleurisy in slaughter pigs in England and Wales. Methods: The British Pig Executive Pig Health Scheme database of abattoir pathology was used to identify 121 case (. 10% prevalence of pleurisy on 3 or more assessment dates in the preceding 24 months) and 121 control units (<= 5% prevalence of pleurisy on 3 or more assessment dates in the preceding 24 months). Farm data were collected by postal questionnaire. Data from respondents (70 cases and 51 controls) were analysed using simple logistic regression models with Bonferroni corrections. Limited multivariate analyses were also performed to check the robustness of the overall conclusions. Results and Conclusions: Management factors associated with increased odds of pleurisy included no all-in all-out pig flow (OR 9.3, 95% confidence interval [CI]: 3.3-29), rearing of pigs with an age difference of >1 month in the same airspace (OR 6.5 [2.8-17]) and repeated mixing (OR 2.2 [1.4-3.8]) or moving (OR 2.2 [1.5-3.4]) of pigs during the rearing phase. Those associated with decreased odds of pleurisy included filling wean-to-finish or grower-to-finish systems with piglets from <= 3 sources (OR 0.18 [0.07-0.41]) compared to farrow-to-finish systems, cleaning and disinfecting of grower (ORs 0.28 [0.13-0.61] and 0.29 [0.13-0.61]) and finisher (ORs 0.24 [0.11-0.51] and 0.2 [0.09-0.44]) accommodation between groups, and extended down time of grower and finisher accommodation (OR 0.84 [0.75-0.93] and 0.86 [0.77-0.94] respectively for each additional day of downtime). This study demonstrated the value of national-level abattoir pathology data collection systems for case control analyses and generated guidance for on-farm interventions to help reduce the prevalence of pleurisy in slaughter pigs.	[Jaeger, Henrike C.; McKinley, Trevelyan J.; Wood, James L. N.; Pearce, Gareth P.; Tucker, Alexander W.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Williamson, Susanna] Vet Labs Agcy AHVLA, Bury St Edmunds, Suffolk, England; [Strugnell, Benjamin; Done, Stanley] Vet Labs Agcy AHVLA, Thirsk, N Yorkshire, England; [Habernoll, Henrike] BQP Ltd, Stradbroke Business Ctr, Stradbroke, Suffolk, England; [Palzer, Andreas] Univ Munich, Clin Swine, Oberschleissheim, Germany	University of Cambridge; University of Munich	Jager, HC (corresponding author), Garth Partnership, Straight Lane, Beeford, East Yorkshire, England.	awt1000@cam.ac.uk	Wood, James/A-1626-2008; Pearce, Gareth P/D-1044-2013	Wood, James/0000-0002-0258-3188; Pearce, Gareth/0000-0002-0656-6553; Tucker, Alexander William/0000-0003-0062-0843	British Pig Executive (BPEX - a part of the UK's Agricultural and Horticultural Development Board); BBSRC [BB/G019274/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G019274/1] Funding Source: researchfish	British Pig Executive (BPEX - a part of the UK's Agricultural and Horticultural Development Board); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank the British Pig Executive (BPEX - a part of the UK's Agricultural and Horticultural Development Board) for funding this project and providing the BPHS data base. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, BRIT PIG HLTH SCHEME; Augustijn M, 2008, P 20 C INT PIG VET S; Christensen G., 1999, Dansk Veterinartidsskrift, V82, P1006; Cleveland-Nielsen A, 2002, PREV VET MED, V55, P121, DOI 10.1016/S0167-5877(02)00089-2; ELBERS ARW, 1992, PREV VET MED, V14, P217, DOI 10.1016/0167-5877(92)90018-B; Enoe C, 2002, PREV VET MED, V54, P337, DOI 10.1016/S0167-5877(02)00029-6; FALK K, 1991, ACTA VET SCAND, V32, P67; Fraile L, 2010, VET J, V184, P326, DOI 10.1016/j.tvjl.2009.03.029; Gottschalk M, 2006, DIS SWINE, P563; Harrell FE, DESIGN PACKAGE R PAC; Hosmer D. W., APPL LOGISTIC REGRES; Hosmer DW, 1997, STAT MED, V16, P965; JANETSCHKE P, 1977, ARCH EXP VET MED, V31, P129; KIELSTEIN P, 1992, J CLIN MICROBIOL, V30, P862, DOI 10.1128/JCM.30.4.862-865.1992; LECESSIE S, 1991, BIOMETRICS, V47, P1267, DOI 10.2307/2532385; Maes DG, 2001, VET REC, V148, P41, DOI 10.1136/vr.148.2.41; Martin J, 1977, Arch Exp Veterinarmed, V31, P347; Meyns T, 2011, VET J, V187, P388, DOI 10.1016/j.tvjl.2009.12.027; MOUSING J, 1990, PREV VET MED, V9, P107, DOI 10.1016/0167-5877(90)90029-H; Program N-RA, 2010, PROGRAM N RA VERIFIC; Rubies X, 1999, VET MICROBIOL, V66, P245, DOI 10.1016/S0378-1135(99)00007-3; Salak-Johnson JL, 2007, J ANIM SCI, V85, pE81, DOI 10.2527/jas.2006-538; Sanchez-Vazquez MJ, 2011, VET REC, V169, P413, DOI 10.1136/vr.d4814; SCHIMMEL D, 1985, ARCH EXP VET MED, V39, P944; Sorensen V, 2006, DIS SWINE, V9th, P149; Venables WN., 2002, MODERN APPL STAT S 4; Wiegand M, 1997, TIERARZTL PRAX, V25, P226; Zimmerman J., 2006, DIS SWINE, P387	28	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e29655	10.1371/journal.pone.0029655	http://dx.doi.org/10.1371/journal.pone.0029655			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363407	gold, Green Published, Green Submitted			2022-12-27	WOS:000302853600008
J	Timmers, MA; Bird, CE; Skillings, DJ; Smouse, PE; Toonen, RJ				Timmers, Molly A.; Bird, Christopher E.; Skillings, Derek J.; Smouse, Peter E.; Toonen, Robert J.			There's No Place Like Home: Crown-of-Thorns Outbreaks in the Central Pacific Are Regionally Derived and Independent Events	PLOS ONE			English	Article							STARFISH ACANTHASTER-PLANCI; GREAT-BARRIER-REEF; LIMPETS CELLANA SPP.; GENETIC-STRUCTURE; CORAL-REEFS; POPULATION-GENETICS; FEEDING PREFERENCES; HERBIVOROUS FISHES; SEQUENCE ALIGNMENT; ECHINODERMATA	One of the most significant biological disturbances on a tropical coral reef is a population outbreak of the fecund, corallivorous crown-of-thorns sea star, Acanthaster planci. Although the factors that trigger an initial outbreak may vary, successive outbreaks within and across regions are assumed to spread via the planktonic larvae released from a primary outbreak. This secondary outbreak hypothesis is predominantly based on the high dispersal potential of A. planci and the assertion that outbreak populations (a rogue subset of the larger population) are genetically more similar to each other than they are to low-density non-outbreak populations. Here we use molecular techniques to evaluate the spatial scale at which A. planci outbreaks can propagate via larval dispersal in the central Pacific Ocean by inferring the location and severity of gene flow restrictions from the analysis of mtDNA control region sequence (656 specimens, 17 non-outbreak and six outbreak locations, six archipelagos, and three regions). Substantial regional, archipelagic, and subarchipelagic-scale genetic structuring of A. planci populations indicate that larvae rarely realize their dispersal potential and outbreaks in the central Pacific do not spread across the expanses of open ocean. On a finer scale, genetic partitioning was detected within two of three islands with multiple sampling sites. The finest spatial structure was detected at Pearl & Hermes Atoll, between the lagoon and forereef habitats (<10 km). Despite using a genetic marker capable of revealing subtle partitioning, we found no evidence that outbreaks were a rogue genetic subset of a greater population. Overall, outbreaks that occur at similar times across population partitions are genetically independent and likely due to nutrient inputs and similar climatic and ecological conditions that conspire to fuel plankton blooms.	[Timmers, Molly A.] Natl Ocean & Atmospher Adm NOAA Fisheries, Coral Reef Ecosyst Div, Joint Inst Marine & Atmospher Res, Pacific Isl Fisheries Sci Ctr, Honolulu, HI USA; [Bird, Christopher E.; Skillings, Derek J.; Toonen, Robert J.] Univ Hawaii, Hawaii Inst Marine Biol, Sch Ocean & Earth Sci & Technol, Kaneohe, HI USA; [Skillings, Derek J.] Univ Hawaii, Dept Zool, Honolulu, HI 96822 USA; [Smouse, Peter E.] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Hawaii System; University of Hawaii System; Rutgers State University New Brunswick	Timmers, MA (corresponding author), Natl Ocean & Atmospher Adm NOAA Fisheries, Coral Reef Ecosyst Div, Joint Inst Marine & Atmospher Res, Pacific Isl Fisheries Sci Ctr, Honolulu, HI USA.	molly.timmers@noaa.gov	Toonen, Rob/V-6230-2019; Toonen, Rob/K-2891-2012	Toonen, Rob/0000-0001-6339-4340; Toonen, Rob/0000-0001-6339-4340	Experimental Program to Stimulate Competitive Research (EPSCoR) Research Enhancement Activities Program (REAP); National Oceanic and Atmospheric Administration; National Science Foundation (OCE) [06-23678]; National Marine Sanctuaries CRER-HIMB [MOA-2005-008/6882]; Sigma-Xi; United States Department of Agriculture; New Jersey Agricultural Experiment Station [17111]; NSF, Division of Environmental Biology [0514956]	Experimental Program to Stimulate Competitive Research (EPSCoR) Research Enhancement Activities Program (REAP); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); National Science Foundation (OCE)(National Science Foundation (NSF)); National Marine Sanctuaries CRER-HIMB; Sigma-Xi; United States Department of Agriculture(United States Department of Agriculture (USDA)); New Jersey Agricultural Experiment Station; NSF, Division of Environmental Biology	This work was funded by Experimental Program to Stimulate Competitive Research (EPSCoR) Research Enhancement Activities Program (REAP), the National Oceanic and Atmospheric Administration, the National Science Foundation (OCE #06-23678), the National Marine Sanctuaries CRER-HIMB partnership (MOA-2005-008/6882), and a Sigma-Xi Grant-in-Aid research scholarship. Dr. Smouse was supported by United States Department of Agriculture and the New Jersey Agricultural Experiment Station 17111, and the NSF, Division of Environmental Biology 0514956. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Avise J, 2004, MOL MARKERS NATURAL; BABCOCK RC, 1992, AUST J MAR FRESH RES, V43, P525; Barshis DJ, 2010, MOL ECOL, V19, P1705, DOI 10.1111/j.1365-294X.2010.04574.x; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; BENZIE JAH, 1992, MAR BIOL, V112, P119, DOI 10.1007/BF00349735; BENZIE JAH, 1992, AUST J MAR FRESH RES, V43, P597, DOI 10.1071/MF9920597; Benzie JAH, 1997, MAR BIOL, V129, P149, DOI 10.1007/s002270050155; Benzie JAH, 1999, AM ZOOL, V39, P131; Bird CE, 2007, MOL ECOL, V16, P3173, DOI 10.1111/j.1365-294X.2007.03385.x; Bird CE, 2011, MOL ECOL, V20, P2128, DOI 10.1111/j.1365-294X.2011.05081.x; BIRKELAND C, 1982, MAR BIOL, V69, P175, DOI 10.1007/BF00396897; BIRKELAND C, 1990, MAJOR MANAGEMENT PRO; BLACK K, 1995, MAR ECOL PROG SER, V125, P185, DOI 10.3354/meps125185; BLACK KP, 1991, MAR ECOL PROG SER, V69, P55, DOI 10.3354/meps069055; Brodie J, 2005, MAR POLLUT BULL, V51, P266, DOI 10.1016/j.marpolbul.2004.10.035; Chester RH, 1969, ACANTHASTER PLANCI I; Christie MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015715; COLGAN MW, 1987, ECOLOGY, V68, P1592, DOI 10.2307/1939851; Crow J.F, 2010, INTRO POPULATION GEN; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Eble JA, 2011, MAR ECOL PROG SER, V428, P245, DOI 10.3354/meps09083; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ENDEAN R, 1975, Environmental Conservation, V2, P247; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fabricius KE, 2010, CORAL REEFS, V29, P593, DOI 10.1007/s00338-010-0628-z; Faucci A, 2007, THESIS U HAWAII MANO; FAURE G, 1989, J COASTAL RES, V5, P295; GLYNN PW, 1985, MAR ECOL PROG SER, V26, P295, DOI 10.3354/meps026295; GLYNN PW, 1988, ANNU REV ECOL SYST, V19, pU309; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hare MP, 1996, EVOLUTION, V50, P2305, DOI [10.1111/j.1558-5646.1996.tb03618.x, 10.2307/2410699]; Hart AM, 1996, MAR ECOL PROG SER, V132, P21, DOI 10.3354/meps132021; Hart AM, 1996, MAR ECOL PROG SER, V132, P11, DOI 10.3354/meps132011; Hart MW, 2010, INTEGR COMP BIOL, V50, P643, DOI 10.1093/icb/icq068; Hedgecock D, 2007, MAR BIOL, V150, P1173, DOI 10.1007/s00227-006-0441-y; HEDGECOCK D, 1994, GENETICS AND EVOLUTION OF AQUATIC ORGANISMS, P122; HEDGECOCK D, 1994, CAL COOP OCEAN FISH, V35, P73; Houk P, 2010, J OCEANOGR, V66, P435, DOI 10.1007/s10872-010-0038-4; Houk P, 2007, J OCEANOGR, V63, P149, DOI 10.1007/s10872-007-0013-x; Jessop H, 2008, THESIS U HAWAII HILO; JOHNSON LG, 1994, BIOL BULL-US, V187, P304, DOI 10.2307/1542287; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; KARL SA, 1992, SCIENCE, V256, P100, DOI 10.1126/science.1348870; Kenchington RA, 1977, BIOL CONSERV, V11, P03; Kenyon JC, 2006, COAST MANAGE, V34, P339, DOI 10.1080/08920750600686711; Kenyon JC, 2009, B MAR SCI, V84, P199; Kobashi F, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001225; Levitan DR, 2002, ECOLOGY, V83, P464, DOI 10.2307/2680028; LUCAS J S, 1973, Micronesica, V9, P197; LUCAS JS, 1984, J EXP MAR BIOL ECOL, V79, P129, DOI 10.1016/0022-0981(84)90214-4; LUCAS JS, 1982, J EXP MAR BIOL ECOL, V65, P173, DOI 10.1016/0022-0981(82)90043-0; Marko PB, 2012, EVOL ECOL, V26, P291, DOI 10.1007/s10682-011-9467-9; Marko PB, 2011, TRENDS ECOL EVOL, V26, P448, DOI 10.1016/j.tree.2011.05.007; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; MORAN PJ, 1986, OCEANOGR MAR BIOL, V24, P379; MORAN PJ, 1992, MAR BIOL, V113, P509, DOI 10.1007/BF00349178; MORAN PJ, 1988, CORAL REEFS, V7, P125, DOI 10.1007/BF00300972; MORAN PJ, 1985, P 5 INT COR REEF S T, V5, P321; NASH WJ, 1988, CORAL REEFS, V7, P11, DOI 10.1007/BF00301976; NISHIDA M, 1988, MAR BIOL, V98, P359, DOI 10.1007/BF00391112; Palumbi SR, 2003, ECOL APPL, V13, pS146; Pearson RG, 1969, PRELIMINARY STUDY CO; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pratchett MS, 2009, MAR ENVIRON RES, V67, P230, DOI 10.1016/j.marenvres.2009.03.001; Pratchett MS, 2007, PAC SCI, V61, P113, DOI 10.1353/psc.2007.0011; Pratchett MS, 2005, CORAL REEFS, V24, P453, DOI 10.1007/s00338-005-0006-4; Qiu B, 1997, J PHYS OCEANOGR, V27, P431, DOI 10.1175/1520-0485(1997)027<0431:EAFMOT>2.0.CO;2; Sapp J., 1999, WHAT IS NATURAL CORA; Skillings DJ, 2010, P AM AC UND SCI DIV; Sokal R. R., 1981, BIOMETRY; Stat M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015854; Sweatman H, 2008, CURR BIOL, V18, pR598, DOI 10.1016/j.cub.2008.05.033; Timmers M, 2009, THESIS U HAWAII HILO; Timmers MA, 2011, J MARINE BIOL; Toonen RJ, 2011, J MAR BIOL, V2011, DOI DOI 10.1155/2011/460173; Trapon Melanie L., 2011, Journal of Marine Biology, V2011, P1, DOI 10.1155/2011/807625; Uthicke S, 2009, ECOL MONOGR, V79, P3, DOI 10.1890/07-2136.1; Vogler C, 2008, BIOL LETTERS, V4, P696, DOI 10.1098/rsbl.2008.0454; WILLIAMS DM, 1986, MAR ECOL PROG SER, V28, P157, DOI 10.3354/meps028157; Wright S, 1943, GENETICS, V28, P114; YAMAGUCHI M, 1987, Galaxea, V6, P277; Yasuda N, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-17; Yasuda N, 2009, MOL ECOL, V18, P1574, DOI 10.1111/j.1365-294X.2009.04133.x	87	50	51	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31159	10.1371/journal.pone.0031159	http://dx.doi.org/10.1371/journal.pone.0031159			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363570	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600118
J	Volpicelli, F; De Gregorio, R; Pulcrano, S; Perrone-Capano, C; di Porzio, U; Bellenchi, GC				Volpicelli, Floriana; De Gregorio, Roberto; Pulcrano, Salvatore; Perrone-Capano, Carla; di Porzio, Umberto; Bellenchi, Gian Carlo			Direct Regulation of Pitx3 Expression by Nurr1 in Culture and in Developing Mouse Midbrain	PLOS ONE			English	Article							ORPHAN NUCLEAR RECEPTOR; DOPAMINERGIC-NEURONS; DOWNSTREAM TARGET; SUBSTANTIA-NIGRA; BRAIN; CELLS; GENE; TRANSCRIPTION; SURVIVAL; STEM	Due to their correlation with major human neurological diseases, dopaminergic neurons are some of the most studied neuronal subtypes. Mesencephalic dopaminergic (mDA) differentiation requires the activation of a cascade of transcription factors, among which play a crucial role the nuclear receptor Nurr1 and the paired-like homeodomain 3, Pitx3. During development the expression of Nurr1 precedes that of Pitx3 and those of typical dopaminergic markers such as tyrosine hydroxylase (TH) and dopamine Transporter (DAT) that are directly regulated by Nurr1. Interestingly we have previously demonstrated that Nurr1 RNA silencing reduced Pitx3 transcripts, leading to the hypothesis that Nurr1 may control Pitx3 expression. Here we show that Nurr1 overexpression up-regulates that of Pitx3 in a dose-dependent manner by binding to a non-canonical NBRE consensus sequence, located at the 5' site of the gene. Interestingly, this sequence shows the same effect as the canonical one in promoting gene translation, and its deletion abolishes the ability of Nurr1 to sustain reporter gene expression. Moreover, we show that there is a direct interaction between Nurr1 and the Pitx3 gene promoter in dopaminergic cell cultures and midbrain embryonic tissue. Altogether, our results suggest that the regulation of Pitx3 by Nurr1 may be an essential event controlling the development and function of mDA neurons.	[Volpicelli, Floriana; De Gregorio, Roberto; Pulcrano, Salvatore; Perrone-Capano, Carla; di Porzio, Umberto; Bellenchi, Gian Carlo] Inst Genet & Biophys Adriano Buzzati Traverso, Naples, Italy; [Perrone-Capano, Carla] Univ Naples Federico 2, Dept Biol Sci, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Naples Federico II	Volpicelli, F (corresponding author), Inst Genet & Biophys Adriano Buzzati Traverso, Naples, Italy.	giancarlo.bellenchi@igb.cnr.it	Perrone-Capano, Carla/O-7708-2015; Perrone-Capano, Carla/AAX-3217-2020	Perrone-Capano, Carla/0000-0002-6327-9753; Perrone-Capano, Carla/0000-0002-6327-9753; di Porzio, Umberto/0000-0002-2139-8754; Pulcrano, Salvatore/0000-0002-5324-8689; BELLENCHI, GIANCARLO/0000-0002-9302-0021; Volpicelli, Floriana/0000-0003-0618-5504; De Gregorio, Roberto/0000-0001-6024-5913	Fondo per gli Investimenti di Ricerca di Base [FIRB-RBIN062YH4]; MEdical Research ITaly [MERIT-RBNE08LN4P]; Prrogetti di Ricerca di Interesse NAzionale [PRIN-2009TBCZJB_003]; Ministero della Salute [40]	Fondo per gli Investimenti di Ricerca di Base(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); MEdical Research ITaly; Prrogetti di Ricerca di Interesse NAzionale; Ministero della Salute(Ministry of Health, Italy)	This work was supported by "Fondo per gli Investimenti di Ricerca di Base" FIRB-RBIN062YH4, "MEdical Research ITaly" MERIT-RBNE08LN4P, "Prrogetti di Ricerca di Interesse NAzionale" PRIN-2009TBCZJB_003, and Ministero della Salute, Under-40 2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnisalo P, 2002, J BIOL CHEM, V277, P35118, DOI 10.1074/jbc.M201707200; BRUNDIN P, 1985, BRAIN RES, V331, P251, DOI 10.1016/0006-8993(85)91550-1; CHOI HK, 1992, P NATL ACAD SCI USA, V89, P8943, DOI 10.1073/pnas.89.19.8943; Colon-Cesario WI, 2006, LEARN MEMORY, V13, P734, DOI 10.1101/lm.407706; Hermanson E, 2003, EXP CELL RES, V288, P324, DOI 10.1016/S0014-4827(03)00216-7; Hermanson E, 2006, J NEUROCHEM, V97, P1403, DOI 10.1111/j.1471-4159.2006.03829.x; Hwang DY, 2009, J NEUROCHEM, V111, P1202, DOI 10.1111/j.1471-4159.2009.06404.x; Jacobs FMJ, 2009, DEVELOPMENT, V136, P531, DOI 10.1242/dev.029769; Kadkhodaei B, 2009, J NEUROSCI, V29, P15923, DOI 10.1523/JNEUROSCI.3910-09.2009; Martinat C, 2006, P NATL ACAD SCI USA, V103, P2874, DOI 10.1073/pnas.0511153103; Nunes I, 2003, P NATL ACAD SCI USA, V100, P4245, DOI 10.1073/pnas.0230529100; Sacchetti P, 2001, J NEUROCHEM, V76, P1565, DOI 10.1046/j.1471-4159.2001.00181.x; Sacchetti P, 2002, J BIOL CHEM, V277, P35088, DOI 10.1074/jbc.M205816200; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Sakurada K, 1999, DEVELOPMENT, V126, P4017; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Simeone A, 2005, TRENDS NEUROSCI, V28, P62, DOI 10.1016/j.tins.2004.11.007; Sirin O, 2010, NAT CELL BIOL, V12, P1213, DOI 10.1038/ncb2125; Smidt MP, 2004, CELL TISSUE RES, V318, P35, DOI 10.1007/s00441-004-0943-1; Smidt MP, 1997, P NATL ACAD SCI USA, V94, P13305, DOI 10.1073/pnas.94.24.13305; Smits SM, 2003, EUR J NEUROSCI, V18, P1731, DOI 10.1046/j.1460-9568.2003.02885.x; van den Munckhof P, 2003, DEVELOPMENT, V130, P2535, DOI 10.1242/dev.00464; Volpicelli F, 2007, J NEUROCHEM, V102, P441, DOI 10.1111/j.1471-4159.2007.04494.x; Xiao Q, 1996, NEUROSCIENCE, V75, P221, DOI 10.1016/0306-4522(96)00159-5; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	26	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30661	10.1371/journal.pone.0030661	http://dx.doi.org/10.1371/journal.pone.0030661			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363463	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600049
J	Heang, D; Sassa, H				Heang, Dany; Sassa, Hidenori			Antagonistic Actions of HLH/bHLH Proteins Are Involved in Grain Length and Weight in Rice	PLOS ONE			English	Article							LOOP-HELIX PROTEINS; TRANSCRIPTION FACTOR FAMILY; SIGNAL-TRANSDUCTION; CELL ELONGATION; ALPHA-SUBUNIT; LAMINA JOINT; BHLH PROTEIN; DNA-BINDING; ARABIDOPSIS; GENE	Grain size is a major yield component in rice, and partly controlled by the sizes of the lemma and palea. Molecular mechanisms controlling the sizes of these organs largely remain unknown. In this study, we show that an antagonistic pair of basic helix-loop-helix (bHLH) proteins is involved in determining rice grain length by controlling cell length in the lemma/palea. Overexpression of an atypical bHLH, named POSITIVE REGULATOR OF GRAIN LENGTH 1 (PGL1), in lemma/palea increased grain length and weight in transgenic rice. PGL1 is an atypical non-DNA-binding bHLH and assumed to function as an inhibitor of a typical DNA-binding bHLH through heterodimerization. We identified the interaction partner of PGL1 and named it ANTAGONIST OF PGL1 (APG). PGL1 and APG interacted in vivo and localized in the nucleus. As expected, silencing of APG produced the same phenotype as overexpression of PGL1, suggesting antagonistic roles for the two genes. Transcription of two known grain-length-related genes, GS3 and SRS3, was largely unaffected in the PGL1-overexpressing and APG-silenced plants. Observation of the inner epidermal cells of lemma revealed that are caused by increased cell length. PGL1-APG represents a new grain length and weight-controlling pathway in which APG is a negative regulator whose function is inhibited by PGL1.	[Heang, Dany; Sassa, Hidenori] Chiba Univ, Grad Sch Hort, Chiba, Japan	Chiba University	Heang, D (corresponding author), Chiba Univ, Grad Sch Hort, Chiba, Japan.	sassa@faculty.chiba-u.jp	Sassa, Hidenori/Q-7561-2018		Chiba University	Chiba University	This study was supported by Chiba University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikari M, 1999, P NATL ACAD SCI USA, V96, P10284, DOI 10.1073/pnas.96.18.10284; Carretero-Paulet L, 2010, PLANT PHYSIOL, V153, P1398, DOI 10.1104/pp.110.153593; Chen KY, 2007, SCIENCE, V318, P643, DOI 10.1126/science.1148428; de Lucas M, 2008, NATURE, V451, P480, DOI 10.1038/nature06520; Fairchild CD, 2000, GENE DEV, V14, P2377; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; Fuse T., 2001, PLANT BIOTECHNOL, V18, P219, DOI DOI 10.5511/PLANTBI0TECHN0L0GY.18.219; Hamilton CM, 1996, P NATL ACAD SCI USA, V93, P9975, DOI 10.1073/pnas.93.18.9975; Hiei Y, 2008, NAT PROTOC, V3, P824, DOI 10.1038/nprot.2008.46; Hong SK, 1996, DEVELOPMENT, V122, P2051; Hong Z, 2003, PLANT CELL, V15, P2900, DOI 10.1105/tpc.014712; Hyun Y, 2006, PLANT MOL BIOL, V61, P283, DOI 10.1007/s11103-006-0010-2; Khanna R, 2004, PLANT CELL, V16, P3033, DOI 10.1105/tpc.104.025643; Kidokoro S, 2009, PLANT PHYSIOL, V151, P2046, DOI 10.1104/pp.109.147033; Kitagawa K, 2010, PLANT CELL PHYSIOL, V51, P1315, DOI 10.1093/pcp/pcq092; Leivar P, 2011, TRENDS PLANT SCI, V16, P19, DOI 10.1016/j.tplants.2010.08.003; Li XX, 2006, PLANT PHYSIOL, V141, P1167, DOI 10.1104/pp.106.080580; Mao HL, 2010, P NATL ACAD SCI USA, V107, P19579, DOI 10.1073/pnas.1014419107; Martinez-Garcia JF, 2000, SCIENCE, V288, P859, DOI 10.1126/science.288.5467.859; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Oki K, 2009, PLANT CELL PHYSIOL, V50, P161, DOI 10.1093/pcp/pcn182; Sakurai T, 2011, PLANT CELL PHYSIOL, V52, P265, DOI 10.1093/pcp/pcq190; She KC, 2010, PLANT CELL, V22, P3280, DOI 10.1105/tpc.109.070821; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; SUN XH, 1991, MOL CELL BIOL, V11, P5603, DOI 10.1128/MCB.11.11.5603; Takakura Y, 2000, PLANT MOL BIOL, V42, P883, DOI 10.1023/A:1006401816145; Tanaka A, 2009, PLANT PHYSIOL, V151, P669, DOI 10.1104/pp.109.140806; TOKI S, 1992, PLANT PHYSIOL, V100, P1503, DOI 10.1104/pp.100.3.1503; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Tsao KL, 1996, GENE, V169, P59, DOI 10.1016/0378-1119(95)00762-8; VANENGELEN FA, 1995, TRANSGENIC RES, V4, P288, DOI 10.1007/BF01969123; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wang H, 2009, PLANT CELL, V21, P3781, DOI 10.1105/tpc.109.072504; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Wu CY, 2008, PLANT CELL, V20, P2130, DOI 10.1105/tpc.107.055087; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Yamamuro C, 2000, PLANT CELL, V12, P1591, DOI 10.1105/tpc.12.9.1591; Yokoi S, 1998, MOL BREEDING, V4, P269, DOI 10.1023/A:1009671231614; Yoshida S, 1981, FUNDAMENTALS RICE CR; Zhang LY, 2009, PLANT CELL, V21, P3767, DOI 10.1105/tpc.109.070441	41	94	121	5	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31325	10.1371/journal.pone.0031325	http://dx.doi.org/10.1371/journal.pone.0031325			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363621	Green Submitted, gold, Green Published			2022-12-27	WOS:000302873700050
J	Jansson, L; Larsson, J				Jansson, Lina; Larsson, Jonas			Normal Hematopoietic Stem Cell Function in Mice with Enforced Expression of the Hippo Signaling Effector YAP1	PLOS ONE			English	Article							TUMOR-SUPPRESSOR LATS1; GROWTH-CONTROL; SELF-RENEWAL; PROTEIN YAP; DROSOPHILA; PATHWAY; KINASE; TAZ; SIZE; MST2	The Hippo pathway has recently been implicated in the regulation of organ size and stem cells in multiple tissues. The transcriptional cofactor yes-associated protein 1 (Yap1) is the most downstream effector of Hippo signaling and is functionally repressed by the upstream components of the pathway. Overexpression of YAP1 stimulates proliferation of stem and progenitor cells in many tissues, consistent with inhibition of Hippo signaling. To study the role of Hippo signaling in hematopoietic stem cells (HSCs), we created a transgenic model with inducible YAP1 expression exclusively within the hematopoietic system. Following 3 months induction, examination of blood and bone marrow in the induced mice revealed no changes in the distribution of the hematopoietic lineages compared to control mice. Moreover, the progenitor cell compartment was unaltered as determined by colony forming assays and immunophenotyping. To address whether YAP1 affects the quantity and function of HSCs we performed competitive transplantation experiments. We show that ectopic YAP1 expression does not influence HSC function neither during steady state nor in situations of hematopoietic stress. This is in sharp contrast to effects seen on stem-and progenitor cells in other organs and suggests highly tissue specific functions of the Hippo pathway in regulation of stem cells.	[Jansson, Lina; Larsson, Jonas] Lund Univ, Lund Stem Cell Ctr, Lund, Sweden	Lund University	Jansson, L (corresponding author), Lund Univ, Lund Stem Cell Ctr, Lund, Sweden.	Jonas.Larsson@med.lu.se			Swedish Research Counci [325-2008-7549]; Swedish Cancer Foundation [KTR 09 071]; Swedish Pediatric Cancer Foundation [PROJ10/116]	Swedish Research Counci; Swedish Cancer Foundation; Swedish Pediatric Cancer Foundation	This work was supported by grants from the Swedish Research Council (325-2008-7549) (http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html), the Swedish Cancer Foundation (KTR 09 071) (http://www.cancerfonden.se/sv/Information-in-English/) and the Swedish Pediatric Cancer Foundation (PROJ10/116) (http://www.barncancerfonden.se/Om-oss/In-English/) to J.L. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Ema H, 2000, BLOOD, V95, P2284, DOI 10.1182/blood.V95.7.2284.007k14_2284_2288; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Hergovich A, 2006, BIOCHEM BIOPH RES CO, V345, P50, DOI 10.1016/j.bbrc.2006.03.244; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jansson L, 2010, BLOOD, V115, P47, DOI 10.1182/blood-2009-07-235622; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Larsson J, 2008, CELL STEM CELL, V3, P221, DOI 10.1016/j.stem.2008.06.005; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Van Hateren NJ, 2011, DEVELOPMENT, V138, P1893, DOI 10.1242/dev.064204; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Wang KN, 2009, BIOCHEM CELL BIOL, V87, P77, DOI 10.1139/O08-114; Webb C, 2011, BIOCHEMISTRY-US, V50, P3300, DOI 10.1021/bi2001888; XU TA, 1995, DEVELOPMENT, V121, P1053; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	30	48	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32013	10.1371/journal.pone.0032013	http://dx.doi.org/10.1371/journal.pone.0032013			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363786	Green Submitted, Green Published, gold			2022-12-27	WOS:000302873700134
J	Ludlow, LE; Zhou, JK; Tippett, E; Cheng, WJ; Hasang, W; Rogerson, SJ; Jaworowski, A				Ludlow, Louise E.; Zhou, Jingling; Tippett, Emma; Cheng, Wan-Jung; Hasang, Wina; Rogerson, Stephen J.; Jaworowski, Anthony			HIV-1 Inhibits Phagocytosis and Inflammatory Cytokine Responses of Human Monocyte-Derived Macrophages to P-falciparum Infected Erythrocytes	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; VARIANT SURFACE-ANTIGENS; SUB-SAHARAN AFRICA; PLACENTAL MALARIA; CHONDROITIN SULFATE; PREGNANT-WOMEN; BIRTH-WEIGHT; GAMMA; PROTECTION; IMMUNITY	HIV-1 infection increases the risk and severity of malaria by poorly defined mechanisms. We investigated the effect of HIV-(1Ba-L) infection of monocyte-derived macrophages (MDM) on phagocytosis of opsonised P. falciparum infected erythrocytes (IE) and subsequent proinflammatory cytokine secretion. Compared to mock-infected MDM, HIV-1 infection significantly inhibited phagocytosis of IE (median (IQR) (10 (0-28) versus (34 (27-108); IE internalised/100 MDM; p = 0.001) and decreased secretion of IL-6 (1,116 (352-3,387) versus 1,552 (889-6,331); pg/mL; p = 0.0078) and IL-1 beta (16 (7-21) versus 33 (27-65); pg/mL; p = 0.0078). Thus inadequate phagocytosis and cytokine production may contribute to impaired control of malaria in HIV-1 infected individuals.	[Ludlow, Louise E.; Hasang, Wina; Rogerson, Stephen J.] Univ Melbourne, PO Royal Melbourne Hosp, Dept Med RMH, Melbourne, Vic, Australia; [Ludlow, Louise E.; Hasang, Wina; Rogerson, Stephen J.] Royal Melbourne Hosp, Victorian Infect Dis Serv, Parkville, Vic 3050, Australia; [Zhou, Jingling; Tippett, Emma; Cheng, Wan-Jung; Jaworowski, Anthony] Burnet Inst, Ctr Virol, Melbourne, Vic, Australia; [Jaworowski, Anthony] Monash Univ, Dept Med, Clayton, Vic 3800, Australia; [Jaworowski, Anthony] Monash Univ, Dept Immunol, Clayton, Vic 3800, Australia	Royal Melbourne Hospital; University of Melbourne; Royal Melbourne Hospital; Burnet Institute; Monash University; Monash University	Ludlow, LE (corresponding author), Univ Melbourne, PO Royal Melbourne Hosp, Dept Med RMH, Melbourne, Vic, Australia.	lludlow@unimelb.edu.au		Hasang, Wina/0000-0001-8664-7558; Rogerson, Stephen/0000-0003-4287-1982; jaworowski, anthony/0000-0002-3844-805X	Australian NHMRC [400090, 628611]	Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	Funding was provided by Australian NHMRC Project Grants 400090 and 628611 to AJ and SJR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams ET, 2003, J IMMUNOL, V170, P2759, DOI 10.4049/jimmunol.170.5.2759; Ataide R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010807; Azzam R, 2006, AIDS RES HUM RETROV, V22, P619, DOI 10.1089/aid.2006.22.619; BIGGS BA, 1995, J IMMUNOL, V154, P6132; Boeuf P, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-5; Brentlinger PE, 2006, LANCET INFECT DIS, V6, P100, DOI 10.1016/S1473-3099(06)70383-8; CAPSONI F, 1992, CLIN IMMUNOL IMMUNOP, V62, P176, DOI 10.1016/0090-1229(92)90070-5; CELADA A, 1982, CLIN EXP IMMUNOL, V47, P635; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; Feng GQ, 2009, J INFECT DIS, V200, P299, DOI 10.1086/599841; Fried M, 1998, J IMMUNOL, V160, P2523; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Jaworowski A, 2009, CLIN VACCINE IMMUNOL, V16, P312, DOI 10.1128/CVI.00356-08; Kedzierska K, 2002, J IMMUNOL, V168, P2895, DOI 10.4049/jimmunol.168.6.2895; Keen J, 2007, PLOS MED, V4, P912, DOI 10.1371/journal.pmed.0040181; Menendez C, 2000, J INFECT DIS, V181, P1740, DOI 10.1086/315449; Moore JM, 1999, J INFECT DIS, V179, P1218, DOI 10.1086/314737; Moore JM, 2000, J INFECT DIS, V182, P960, DOI 10.1086/315755; Moormann AM, 1999, J INFECT DIS, V180, P1987, DOI 10.1086/315135; Prato M, 2010, CELL MICROBIOL, V12, P1780, DOI 10.1111/j.1462-5822.2010.01508.x; Raghupathy R, 1997, IMMUNOL TODAY, V18, P478, DOI 10.1016/S0167-5699(97)01127-4; Ricke CH, 2000, J IMMUNOL, V165, P3309, DOI 10.4049/jimmunol.165.6.3309; Rogerson SJ, 2003, INFECT IMMUN, V71, P267, DOI 10.1128/IAI.71.1.267-270.2003; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Staalsoe T, 2004, LANCET, V363, P283, DOI 10.1016/S0140-6736(03)15386-X; Steketee RW, 1996, AM J TROP MED HYG, V55, P42, DOI 10.4269/ajtmh.1996.55.42; Ter Kuile FO, 2004, AM J TROP MED HYG, V71, P41, DOI 10.4269/ajtmh.2004.71.41; Yoneto T, 2001, J IMMUNOL, V166, P6236, DOI 10.4049/jimmunol.166.10.6236	28	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32102	10.1371/journal.pone.0032102	http://dx.doi.org/10.1371/journal.pone.0032102			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363802	Green Submitted, Green Published, gold			2022-12-27	WOS:000302873700143
J	Mehta, DR; Ashkar, AA; Mossman, KL				Mehta, Devangi R.; Ashkar, Ali A.; Mossman, Karen L.			The Nitric Oxide Pathway Provides Innate Antiviral Protection in Conjunction with the Type I Interferon Pathway in Fibroblasts	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; HOST-DEFENSE; VIRAL REPLICATION; STIMULATED GENES; IFN-ALPHA/BETA; TARGET GENES; NO SYNTHASE; CELL-LINES; INHIBITION; INFECTION	The innate host response to virus infection is largely dominated by the production of type I interferon and interferon stimulated genes. In particular, fibroblasts respond robustly to viral infection and to recognition of viral signatures such as dsRNA with the rapid production of type I interferon; subsequently, fibroblasts are a key cell type in antiviral protection. We recently found, however, that primary fibroblasts deficient for the production of interferon, interferon stimulated genes, and other cytokines and chemokines mount a robust antiviral response against both DNA and RNA viruses following stimulation with dsRNA. Nitric oxide is a chemical compound with pleiotropic functions; its production by phagocytes in response to interferon-gamma is associated with antimicrobial activity. Here we show that in response to dsRNA, nitric oxide is rapidly produced in primary fibroblasts. In the presence of an intact interferon system, nitric oxide plays a minor but significant role in antiviral protection. However, in the absence of an interferon system, nitric oxide is critical for the protection against DNA viruses. In primary fibroblasts, NF-kappa B and interferon regulatory factor 1 participate in the induction of inducible nitric oxide synthase expression, which subsequently produces nitric oxide. As large DNA viruses encode multiple and diverse immune modulators to disable the interferon system, it appears that the nitric oxide pathway serves as a secondary strategy to protect the host against viral infection in key cell types, such as fibroblasts, that largely rely on the type I interferon system for antiviral protection.	[Mehta, Devangi R.; Ashkar, Ali A.; Mossman, Karen L.] McMaster Univ, Dept Pathol & Mol Med, McMaster Immunol Res Ctr, Michael DeGroote Inst Infect Dis Res, Hamilton, ON, Canada	McMaster University	Mehta, DR (corresponding author), McMaster Univ, Dept Pathol & Mol Med, McMaster Immunol Res Ctr, Michael DeGroote Inst Infect Dis Res, Hamilton, ON, Canada.	mossk@mcmaster.ca		Ashkar, Ali/0000-0003-1139-1468	Canadian Institutes of Health [MOP 57669]	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This study was funded by a Canadian Institutes of Health Research operating grant (MOP 57669) to KLM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike T, 2000, IMMUNOLOGY, V101, P300, DOI 10.1046/j.1365-2567.2000.00142.x; Alam MS, 2002, INFECT IMMUN, V70, P3130, DOI 10.1128/IAI.70.6.3130-3142.2002; Andersen J, 2008, GENES IMMUN, V9, P168, DOI 10.1038/sj.gene.6364449; Auch CJ, 2004, FEBS LETT, V563, P223, DOI 10.1016/S0014-5793(04)00302-3; BANKS TA, 1992, CLIN INFECT DIS, V14, P933, DOI 10.1093/clinids/14.4.933; BI ZB, 1995, J VIROL, V69, P2208, DOI 10.1128/JVI.69.4.2208-2213.1995; Blair LA, 2002, J BIOL CHEM, V277, P359, DOI 10.1074/jbc.M109819200; Buckley CD, 2001, TRENDS IMMUNOL, V22, P199, DOI 10.1016/S1471-4906(01)01863-4; Charville GW, 2008, BIOMATERIALS, V29, P4039, DOI 10.1016/j.biomaterials.2008.07.005; Chu SC, 1998, BIOCHEM BIOPH RES CO, V248, P871, DOI 10.1006/bbrc.1998.9062; Colasanti M, 1999, IUBMB LIFE, V48, P25, DOI 10.1080/713803459; CROEN KD, 1993, J CLIN INVEST, V91, P2446, DOI 10.1172/JCI116479; DavisPoynter NJ, 1996, IMMUNOL CELL BIOL, V74, P513, DOI 10.1038/icb.1996.84; Deonarain R, 2000, J VIROL, V74, P3404, DOI 10.1128/JVI.74.7.3404-3409.2000; DeWitte-Orr SJ, 2010, FUTURE VIROL, V5, P325, DOI 10.2217/FVL.10.18; DeWitte-Orr SJ, 2009, J IMMUNOL, V183, P6545, DOI 10.4049/jimmunol.0900867; Farlik M, 2010, IMMUNITY, V33, P25, DOI 10.1016/j.immuni.2010.07.001; Fujii S, 1999, VIROLOGY, V256, P203, DOI 10.1006/viro.1999.9610; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; KARUPIAH G, 1993, SCIENCE, V261, P1445, DOI 10.1126/science.7690156; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Laszlo F, 1994, BRIT J PHARMACOL, V111, P309; LAVNIKOVA N, 1995, J LEUKOCYTE BIOL, V58, P451, DOI 10.1002/jlb.58.4.451; Lee CS, 2009, BIOL PHARM BULL, V32, P1870, DOI 10.1248/bpb.32.1870; LePage C, 1996, IMMUNOLOGY, V89, P274, DOI 10.1046/j.1365-2567.1996.d01-728.x; Lin RT, 2004, J VIROL, V78, P1675, DOI 10.1128/JVI.78.4.1675-1684.2004; Lo D, 1999, IMMUNOL REV, V169, P225, DOI 10.1111/j.1600-065X.1999.tb01318.x; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; MacLean A, 1998, J GEN VIROL, V79, P825, DOI 10.1099/0022-1317-79-4-825; MAHESHWARI RK, 1980, P NATL ACAD SCI-BIOL, V77, P2284, DOI 10.1073/pnas.77.4.2284; Melchjorsen J, 2010, J VIROL, V84, P11350, DOI 10.1128/JVI.01106-10; MELKOVA Z, 1995, J IMMUNOL, V155, P5711; Melroe GT, 2007, VIROLOGY, V360, P305, DOI 10.1016/j.virol.2006.10.028; Melroe GT, 2004, J VIROL, V78, P8411, DOI 10.1128/JVI.78.16.8411-8420.2004; Minaker RL, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-85; MISKO TP, 1993, EUR J PHARMACOL, V233, P119, DOI 10.1016/0014-2999(93)90357-N; MOORE WM, 1994, J MED CHEM, V37, P3886, DOI 10.1021/jm00049a007; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nazli A, 2009, ANTIVIR RES, V81, P103, DOI 10.1016/j.antiviral.2008.10.005; Noyce R, 2008, NEW RES INNATE IMMUN, P261; Paladino P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010428; Paladino P, 2009, J INTERF CYTOK RES, V29, P599, DOI 10.1089/jir.2009.0074; Pautz A, 2010, NITRIC OXIDE-BIOL CH, V23, P75, DOI 10.1016/j.niox.2010.04.007; PINKERTON KE, 1982, AM J ANAT, V164, P155, DOI 10.1002/aja.1001640206; Rasmussen TB, 2007, J GEN VIROL, V88, P481, DOI 10.1099/vir.0.82453-0; Rimmelzwaan GF, 1999, J VIROL, V73, P8880, DOI 10.1128/JVI.73.10.8880-8883.1999; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Saura M, 1999, IMMUNITY, V10, P21, DOI 10.1016/S1074-7613(00)80003-5; Schilte C, 2010, J EXP MED, V207, P429, DOI 10.1084/jem.20090851; Schroder M, 2005, TRENDS IMMUNOL, V26, P462, DOI 10.1016/j.it.2005.07.002; Smith RS, 1997, AM J PATHOL, V151, P317; Spitsin SV, 1997, MOL MED, V3, P315, DOI 10.1007/BF03401810; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Uetani K, 2001, AM J RESP CELL MOL, V24, P720, DOI 10.1165/ajrcmb.24.6.4297; Umezawa K, 1997, INFECT IMMUN, V65, P2932, DOI 10.1128/IAI.65.7.2932-2940.1997; vandenBroek MF, 1995, IMMUNOL REV, V148, P5; Versteeg GA, 2010, CURR OPIN MICROBIOL, V13, P508, DOI 10.1016/j.mib.2010.05.009; Wessely R, 2001, CIRCULATION, V103, P756; WINK DA, 1991, SCIENCE, V254, P1001, DOI 10.1126/science.1948068; Witte MB, 2000, NITRIC OXIDE-BIOL CH, V4, P572, DOI 10.1006/niox.2000.0307; Zaki MH, 2005, J PHARMACOL SCI, V98, P117, DOI 10.1254/jphs.CRJ05004X; Zaragoza C, 1999, J IMMUNOL, V163, P5497; Zhang SY, 2008, IMMUNOL REV, V226, P29, DOI 10.1111/j.1600-065X.2008.00698.x	67	34	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31688	10.1371/journal.pone.0031688	http://dx.doi.org/10.1371/journal.pone.0031688			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363706	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700083
J	Bozyk, PD; Bentley, JK; Popova, AP; Anyanwu, AC; Linn, MD; Goldsmith, AM; Pryhuber, GS; Moore, BB; Hershenson, MB				Bozyk, Paul D.; Bentley, J. Kelley; Popova, Antonia P.; Anyanwu, Anuli C.; Linn, Marisa D.; Goldsmith, Adam M.; Pryhuber, Gloria S.; Moore, Bethany B.; Hershenson, Marc B.			Neonatal Periostin Knockout Mice Are Protected from Hyperoxia-Induced Alveolar Simplication	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; INDUCED LUNG INJURY; BRONCHOPULMONARY-DYSPLASIA; TRANSFORMING GROWTH-FACTOR-BETA-1; LYSYL OXIDASE; GROWTH-FACTOR; MOUSE LUNG; RESPONSES; EXPRESSION; TGF-BETA-1	In bronchopulmonary dysplasia (BPD), alveolar septae are thickened with collagen and alpha-smooth muscle actin, transforming growth factor (TGF)-beta-positive myofibroblasts. Periostin, a secreted extracellular matrix protein, is involved in TGF-beta-mediated fibrosis and myofibroblast differentiation. We hypothesized that periostin expression is required for hypoalveolarization and interstitial fibrosis in hyperoxia-exposed neonatal mice, an animal model for this disease. We also examined periostin expression in neonatal lung mesenchymal stromal cells and lung tissue of hyperoxia-exposed neonatal mice and human infants with BPD. Two-to-three day-old wild-type and periostin null mice were exposed to air or 75% oxygen for 14 days. Mesenchymal stromal cells were isolated from tracheal aspirates of premature infants. Hyperoxic exposure of neonatal mice increased alveolar wall periostin expression, particularly in areas of interstitial thickening. Periostin co-localized with alpha-smooth muscle actin, suggesting synthesis by myofibroblasts. A similar pattern was found in lung sections of infants dying of BPD. Unlike wild-type mice, hyperoxia-exposed periostin null mice did not show larger air spaces or alpha-smooth muscle-positive myofibroblasts. Compared to hyperoxia-exposed wild-type mice, hyperoxia-exposed periostin null mice also showed reduced lung mRNA expression of alpha-smooth muscle actin, elastin, CXCL1, CXCL2 and CCL4. TGF-beta treatment increased mesenchymal stromal cell periostin expression, and periostin treatment increased TGF-beta-mediated DNA synthesis and myofibroblast differentiation. We conclude that periostin expression is increased in the lungs of hyperoxia-exposed neonatal mice and infants with BPD, and is required for hyperoxia-induced hypoalveolarization and interstitial fibrosis.	[Bozyk, Paul D.; Moore, Bethany B.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Bentley, J. Kelley; Popova, Antonia P.; Linn, Marisa D.; Goldsmith, Adam M.; Hershenson, Marc B.] Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI USA; [Anyanwu, Anuli C.; Hershenson, Marc B.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI USA; [Moore, Bethany B.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Pryhuber, Gloria S.] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Rochester	Bozyk, PD (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA.	mhershen@umich.edu		Bentley, John Kelley/0000-0001-8865-7979; Moore, Bethany/0000-0003-3051-745X	NIH [HL79339, HL90134, HL07749]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL109149, T32HL007749, R01HL090134, R01HL079339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants HL79339 and HL90134 (MBH) and HL07749 (PDB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMY RWM, 1977, J ANAT, V124, P131; Bhatt AJ, 2001, AM J RESP CRIT CARE, V164, P1971, DOI 10.1164/ajrccm.164.10.2101140; Blackwell TS, 2011, J IMMUNOL, V187, P2740, DOI 10.4049/jimmunol.1101495; Blanchard C, 2008, MUCOSAL IMMUNOL, V1, P289, DOI 10.1038/mi.2008.15; Bozyk PD, 2011, STEM CELLS IN PRESS; Burns JS, 2010, TISSUE ENG PT A, V16, P2331, DOI [10.1089/ten.tea.2009.0735, 10.1089/ten.TEA.2009.0735]; Coalson Jacqueline J, 2003, Semin Neonatol, V8, P73, DOI 10.1016/S1084-2756(02)00193-8; Coutu DL, 2008, J BIOL CHEM, V283, P17991, DOI 10.1074/jbc.M708029200; Gauldie J, 2003, AM J PATHOL, V163, P2575, DOI 10.1016/S0002-9440(10)63612-7; Hennrick KT, 2007, AM J RESP CRIT CARE, V175, P1158, DOI 10.1164/rccm.200607-941OC; Hoersch S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-30; Hong HH, 1999, LAB INVEST, V79, P1655; Husain AN, 1998, HUM PATHOL, V29, P710, DOI 10.1016/S0046-8177(98)90280-5; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kaarteenaho-Wiik R, 2004, J PATHOL, V203, P567, DOI 10.1002/path.1547; Kaarteenaho-Wiik R, 2002, J HISTOCHEM CYTOCHEM, V50, P423, DOI 10.1177/002215540205000313; Kanno A, 2008, INT J CANCER, V122, P2707, DOI 10.1002/ijc.23332; Ladha F, 2005, AM J RESP CRIT CARE, V172, P750, DOI 10.1164/rccm.200503-510OC; Li GH, 2010, ATHEROSCLEROSIS, V208, P358, DOI 10.1016/j.atherosclerosis.2009.07.046; Li P, 2004, J APPL PHYSIOL, V97, P1550, DOI 10.1152/japplphysiol.01311.2003; Londhe VA, 2005, PEDIATR RES, V58, P919, DOI 10.1203/01.PDR.0000181377.78061.3E; Maruhashi T, 2010, J BIOL CHEM, V285, P13294, DOI 10.1074/jbc.M109.088864; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Okamoto M, 2011, EUR RESPIR J, V37, P1119, DOI 10.1183/09031936.00059810; Popova AP, 2010, PEDIATRICS, V126, pE1127, DOI 10.1542/peds.2009-3445; Popova AP, 2010, AM J PHYSIOL-LUNG C, V298, pL735, DOI 10.1152/ajplung.00347.2009; Prows DR, 2007, PHYSIOL GENOMICS, V30, P271, DOI 10.1152/physiolgenomics.00038.2007; Ratner V, 2009, AM J RESP CELL MOL, V40, P511, DOI 10.1165/rcmb.2008-0341RC; Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; Sajjan U, 2009, AM J PHYSIOL-LUNG C, V297, pL931, DOI 10.1152/ajplung.00150.2009; Snider P, 2008, CIRC RES, V102, P752, DOI 10.1161/CIRCRESAHA.107.159517; Takayama G, 2006, J ALLERGY CLIN IMMUN, V118, P98, DOI 10.1016/j.jaci.2006.02.046; Toti P, 1997, PEDIATR PULM, V24, P22, DOI 10.1002/(SICI)1099-0496(199707)24:1<22::AID-PPUL4>3.0.CO;2-L; Vi L, 2009, EXP CELL RES, V315, P3574, DOI 10.1016/j.yexcr.2009.07.015; Vicencio AG, 2004, AM J RESP CELL MOL, V31, P650, DOI 10.1165/rcmb.2004-0092OC; Warner BB, 1998, AM J PHYSIOL-LUNG C, V275, pL110, DOI 10.1152/ajplung.1998.275.1.L110; Whitehead GS, 2006, IMMUNOGENETICS, V58, P793, DOI 10.1007/s00251-006-0147-9; Wu S, 2010, AM J RESP CELL MOL, V42, P552, DOI 10.1165/rcmb.2009-0068OC	39	59	60	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31336	10.1371/journal.pone.0031336	http://dx.doi.org/10.1371/journal.pone.0031336			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363622	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600140
J	Radke, S; Guroglu, B; de Bruijn, ERA				Radke, Sina; Guroglu, Berna; de Bruijn, Ellen R. A.			There's Something about a Fair Split: Intentionality Moderates Context-Based Fairness Considerations in Social Decision-Making	PLOS ONE			English	Article							NEURAL BASIS; ROLES; PUNISHMENT; OUTCOMES; CAUSAL	Fairness considerations are a strong motivational force in social decision-making. Here, we investigated the role of intentionality in response to unfair offers in the Ultimatum Game by manipulating both proposers' degree of control over the selection of offers and the context pertaining to the outcomes of offers proposers can choose from. As a result, the design enabled us to disentangle intention-and context-based decision-making processes. Rejection rates were higher when an unfair offer was intentionally chosen over a fair alternative than when it was chosen by the computer, outside proposers' control. This finding provides direct evidence for intention-based decision-making. Also, rejection rates in general were sensitive to the context in which an offer was made, indicating the involvement of both intention-and context-based processes in social decision-making. Importantly, however, the current study highlights the role of intention-based fairness considerations in basic decision-making situations where outcomes are explicitly stated and thus easy to compare. Based on these results, we propose that fairness can be judged on different, but additive levels of (social-) cognitive processing that might have different developmental trajectories.	[Radke, Sina; de Bruijn, Ellen R. A.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Guroglu, Berna; de Bruijn, Ellen R. A.] Leiden Univ, Inst Psychol, Leiden, Netherlands; [Guroglu, Berna; de Bruijn, Ellen R. A.] Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands	Radboud University Nijmegen; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Radke, S (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	s.radke@donders.ru.nl	Radke, Sina/I-6716-2019; Guroglu, Berna/AAL-4664-2021; Güroğlu, Berna/O-1639-2016	Radke, Sina/0000-0002-7844-2824; Guroglu, Berna/0000-0002-5418-8737; Güroğlu, Berna/0000-0002-5418-8737	Netherlands Organisation for Scientific Research (NWO) [451-07-022]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	EDB was supported by a VENI grant from the Netherlands Organisation for Scientific Research (NWO: http://www.nwo.nl/) (451-07-022). The authors report no financial interests. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blake PR, 2011, COGNITION, V120, P215, DOI 10.1016/j.cognition.2011.04.006; BLOUNT S, 1995, ORGAN BEHAV HUM DEC, V63, P131, DOI 10.1006/obhd.1995.1068; Bolton GE, 2005, ECON THEOR, V25, P957, DOI 10.1007/s00199-003-0459-z; Brandts J, 2001, GAME ECON BEHAV, V36, P138, DOI 10.1006/game.2000.0818; Brosnan SF, 2010, EVOL HUM BEHAV, V31, P279, DOI 10.1016/j.evolhumbehav.2010.02.003; Cushman F, 2008, COGNITION, V108, P353, DOI 10.1016/j.cognition.2008.03.006; Dawes CT, 2007, NATURE, V446, P794, DOI 10.1038/nature05651; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Drayton S, 2011, J EXP CHILD PSYCHOL, V108, P532, DOI 10.1016/j.jecp.2010.09.007; Falk A, 2006, GAME ECON BEHAV, V54, P293, DOI 10.1016/j.geb.2005.03.001; Falk A, 2003, ECON INQ, V41, P20, DOI 10.1093/ei/41.1.20; Falk A, 2008, GAME ECON BEHAV, V62, P287, DOI 10.1016/j.geb.2007.06.001; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fehr E, 2007, TRENDS COGN SCI, V11, P419, DOI 10.1016/j.tics.2007.09.002; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; FORSYTHE R, 1994, GAME ECON BEHAV, V6, P347, DOI 10.1006/game.1994.1021; Frith U, 2001, CURR DIR PSYCHOL SCI, V10, P151, DOI 10.1111/1467-8721.00137; Guroglu B, 2010, SCAN, DOI [10.1093/scan/nsq1013, DOI 10.1093/SCAN/NSQ1013]; Guroglu B, 2009, J EXP CHILD PSYCHOL, V104, P398, DOI 10.1016/j.jecp.2009.07.002; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Houser D, 2010, ECON LETT, V109, P20, DOI 10.1016/j.econlet.2010.07.008; Jensen K, 2007, SCIENCE, V318, P107, DOI 10.1126/science.1145850; KAHNEMAN D, 1986, J BUS, V59, pS285, DOI 10.1086/296367; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; Koenigs M, 2010, NEUROPSYCHOLOGIA, V48, P2198, DOI 10.1016/j.neuropsychologia.2010.04.012; Koenigs M, 2009, BEHAV BRAIN RES, V201, P239, DOI 10.1016/j.bbr.2009.03.004; LOEWENSTEIN GF, 1989, J PERS SOC PSYCHOL, V57, P426, DOI 10.1037/0022-3514.57.3.426; Nelissen RMA, 2009, J EXP SOC PSYCHOL, V45, P1227, DOI 10.1016/j.jesp.2009.06.004; Nelson WR, 2002, J ECON BEHAV ORGAN, V48, P423, DOI 10.1016/S0167-2681(01)00245-1; Nelson WR, 2001, AM ECON REV, V91, P1180, DOI 10.1257/aer.91.4.1180; Ohmura Y, 2005, PSYCHOL REP, V96, P533; Pillutla MM, 1996, ORGAN BEHAV HUM DEC, V68, P208, DOI 10.1006/obhd.1996.0100; Rilling JK, 2004, NEUROIMAGE, V22, P1694, DOI 10.1016/j.neuroimage.2004.04.015; Roese NJ, 1997, PSYCHOL BULL, V121, P133, DOI 10.1037/0033-2909.121.1.133; Sandbu ME, 2007, GAME ECON BEHAV, V61, P113, DOI 10.1016/j.geb.2006.11.003; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Suls J., 2000, HDB SOCIAL COMP THEO; Sutter M, 2007, J ECON PSYCHOL, V28, P69, DOI 10.1016/j.joep.2006.09.001; Takagishi H, 2010, J EXP CHILD PSYCHOL, V105, P130, DOI 10.1016/j.jecp.2009.09.005; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; van't Wout M, 2006, EXP BRAIN RES, V169, P564, DOI 10.1007/s00221-006-0346-5; Young L, 2011, COGNITION, V120, P202, DOI 10.1016/j.cognition.2011.04.005	45	34	39	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31491	10.1371/journal.pone.0031491	http://dx.doi.org/10.1371/journal.pone.0031491			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926TC	22363656	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600148
J	Ray, P; Ratagiri, VH; Kabra, SK; Lodha, R; Sharma, S; Sharma, BS; Kalaivani, M; Wig, N				Ray, Pratima; Ratagiri, Vinod H.; Kabra, Sushil K.; Lodha, Rakesh; Sharma, Sumit; Sharma, B. S.; Kalaivani, Mani; Wig, Naveet			Chikungunya Infection in India: Results of a Prospective Hospital Based Multi-Centric Study	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; VIRUS-INFECTION; CLINICAL PROFILE; WEST-BENGAL; EPIDEMIC; OUTBREAK; FEVER; OCEAN; TRANSMISSION; REEMERGENCE	Background: Chikungunya (CHIKV) has recently seen a re-emergence in India with high morbidity. However, the epidemiology and disease burden remain largely undetermined. A prospective multi-centric study was conducted to evaluate clinical, epidemiological and virological features of chikugunya infection in patients with acute febrile illness from various geographical regions of India. Methods and Findings: A total of 540 patients with fever of up to 7days duration were enrolled at Karnataka Institute of Medical Sciences (KIMS), Karnataka (South); Sawai Man Singh Medical College (SMS) Rajasthan (West), and All India Institute of Medical Sciences (AIIMS) New Delhi (North) from June 2008 to May 2009. Serum specimens were screened for chikungunya infection concurrently through RT-PCR and serology (IgM). Phylogenetic analysis was performed using Bioedit and Mega2 programs. Chikungunya infection was detected in 25.37% patients by RT-PCR and/or IgM-ELISA. Highest cases were detected in south (49.36%) followed by west (16.28%) and north (0.56%) India. A difference in proportion of positives by RT-PCR/ELISA with regard to duration of fever was observed (p<0.05). Rashes, joint pain/swelling, abdominal pain and vomiting was frequently observed among chikungunya confirmed cases (p<0.05). Adults were affected more than children. Anti-CHIK antibodies (IgM) were detected for more than 60days of fever onset. Phylogenetic analysis based on E1 gene from KIMS patients (n = 15) revealed similar to 99% homology clustering with Central/East African genotype. An amino acid change from lysine to glutamine at position 132 of E1 gene was frequently observed among strains infecting children. Conclusions: The study documented re-emergence of chikungunya in high frequencies and severe morbidity in south and west India but rare in north. The study emphasizes the need for continuous surveillance for disease burden using multiple diagnostic tests and also warrants the need for an appropriate molecular diagnostic for early detection of chikungunya virus.	[Ray, Pratima; Kabra, Sushil K.; Lodha, Rakesh; Sharma, Sumit] All India Inst Med Sci, Dept Pediat, New Delhi, India; [Wig, Naveet] All India Inst Med Sci, Dept Med, New Delhi 110029, India; [Kalaivani, Mani] All India Inst Med Sci, Dept Biostat, New Delhi, India; [Ratagiri, Vinod H.] Karnataka Inst Med Sci, Dept Pediat, Hubli, Karnataka, India; [Sharma, B. S.] Sawai Man Singh Med Coll, Dept Pediat, Jaipur, Rajasthan, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; SMS Medical College & Hospital	Ray, P (corresponding author), All India Inst Med Sci, Dept Pediat, New Delhi, India.	pratimaray.aiims@gmail.com		Ray, Pratima/0000-0002-2182-2279	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKAT BK, 1964, INDIAN J MED RES, V52, P660; Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105; [Anonymous], 2010, STAT REP DENG 31 08; Arankalle VA, 2007, J GEN VIROL, V88, P1967, DOI 10.1099/vir.0.82714-0; Bandyopadhyay B, 2009, TROP DOCT, V39, P59, DOI 10.1258/td.2008.080077; Bandyopadhyay D, 2008, INT J DERMATOL, V47, P1148, DOI 10.1111/j.1365-4632.2008.03817.x; BANERJEE K, 1965, INDIAN J MED RES, V53, P715; Chahar HS, 2009, EMERG INFECT DIS, V15, P1077, DOI 10.3201/eid1507.080638; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281; Druce JD, 2007, EMERG INFECT DIS, V13, P509, DOI 10.3201/eid1303.060761; Hasebe F, 2002, J MED VIROL, V67, P370, DOI 10.1002/jmv.10085; Kannan M, 2009, INDIAN J MED RES, V129, P311; Krishnamoorthy K, 2009, J VECTOR DIS, V46, P26; Kumar CVMN, 2007, INDIAN J MED RES, V126, P534; Kumar NP, 2008, J GEN VIROL, V89, P1945, DOI 10.1099/vir.0.83628-0; Lahariya Chandrakant, 2006, Journal of Vector Borne Diseases, V43, P151; LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X; Mavalankar D, 2008, EMERG INFECT DIS, V14, P412, DOI 10.3201/eid1403.070720; MCINTOSH BM, 1977, S AFR J SCI, V73, P267; Nandi J., 2008, Dengue Bulletin, V32, P156; Njenga MK, 2008, J GEN VIROL, V89, P2754, DOI 10.1099/vir.0.2008/005413-0; Passi GR, 2008, INDIAN PEDIATR, V45, P240; Pastorino B, 2004, J MED VIROL, V74, P277, DOI 10.1002/jmv.20168; PETERS CJ, 1990, FIELDS VIROLOGY, V1, P713; Peyrefitte CN, 2007, EMERG INFECT DIS, V13, P768, DOI 10.3201/eid1305.061500; Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471; Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0; RAO TR, 1964, INDIAN J MED RES, V52, P727; RAO TR, 1964, CURR SCI, V33, P235; Ray P, 2003, J INFECT DIS, V187, P1786, DOI 10.1086/375243; Renault P, 2007, AM J TROP MED HYG, V77, P727; ROBINSON M. C., 1955, TANGANYIKA TERRITORY IN 1952 53 I TRANS ROY SOC TROP MED AND HYG, V49, P28, DOI 10.1016/0035-9203(55)90080-8; Santhosh SR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-172; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368; Sebastian MR, 2009, INDIAN J PEDIATR, V76, P185, DOI 10.1007/s12098-009-0049-6; Sergon K, 2007, AM J TROP MED HYG, V76, P1189, DOI 10.4269/ajtmh.2007.76.1189; SHAH KV, 1964, INDIAN J MED RES, V52, P703; Sharma S, 2008, J CLIN MICROBIOL, V46, P1343, DOI 10.1128/JCM.02358-07; Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496; Sudeep AB, 2008, J BIOSCIENCES, V33, P443, DOI 10.1007/s12038-008-0063-2; Suryawanshi SD, 2009, INDIAN J MED RES, V129, P438; Valamparampil JJ, 2009, INDIAN J PEDIATR, V76, P151, DOI 10.1007/s12098-009-0045-x; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; Yadav P, 2003, ACTA VIROL, V47, P125; Yergolkar PN, 2006, EMERG INFECT DIS, V12, P1580, DOI 10.3201/eid1210.060529	47	47	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30025	10.1371/journal.pone.0030025	http://dx.doi.org/10.1371/journal.pone.0030025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363413	gold, Green Submitted, Green Published			2022-12-27	WOS:000302853600010
J	Wright, WR; Parzych, K; Crawford, D; Mein, C; Mitchell, JA; Paul-Clark, MJ				Wright, William R.; Parzych, Katarzyna; Crawford, Damian; Mein, Charles; Mitchell, Jane A.; Paul-Clark, Mark J.			Inflammatory Transcriptome Profiling of Human Monocytes Exposed Acutely to Cigarette Smoke	PLOS ONE			English	Article							DIFFERENTIAL GENE-EXPRESSION; AIRWAY EPITHELIAL-CELLS; HEME OXYGENASE-1 GENE; TOBACCO-SMOKE; OXIDATIVE STRESS; MATRIX METALLOPROTEINASES; NORMALIZATION METHODS; ALVEOLAR MACROPHAGES; AQUEOUS EXTRACTS; SMOOTH-MUSCLE	Background: Cigarette smoking is responsible for 5 million deaths worldwide each year, and is a major risk factor for cardiovascular and lung diseases. Cigarette smoke contains a complex mixture of over 4000 chemicals containing 10(15) free radicals. Studies show smoke is perceived by cells as an inflammatory and xenobiotic stimulus, which activates an immune response. The specific cellular mechanisms driving cigarette smoke-induced inflammation and disease are not fully understood, although the innate immune system is involved in the pathology of smoking related diseases. Methodology/Principle findings: To address the impact of smoke as an inflammagen on the innate immune system, THP-1 cells and Human PBMCs were stimulated with 3 and 10% (v/v) cigarette smoke extract (CSE) for 8 and 24 hours. Total RNA was extracted and the transcriptome analysed using Illumina BeadChip arrays. In THP-1 cells, 10% CSE resulted in 80 genes being upregulated and 37 downregulated by >= 1.5 fold after 8 hours. In PBMCs stimulated with 10% CSE for 8 hours, 199 genes were upregulated and 206 genes downregulated by >= 1.5 fold. After 24 hours, the number of genes activated and repressed by >= 1.5 fold had risen to 311 and 306 respectively. The major pathways that were altered are associated with cell survival, such as inducible antioxidants, protein chaperone and folding proteins, and the ubiquitin/proteosome pathway. Conclusions: Our results suggest that cigarette smoke causes inflammation and has detrimental effects on the metabolism and function of innate immune cells. In addition, THP-1 cells provide a genetically stable alternative to primary cells for the study of the effects of cigarette smoke on human monocytes.	[Wright, William R.; Parzych, Katarzyna; Crawford, Damian; Mitchell, Jane A.; Paul-Clark, Mark J.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Cardiothorac Pharmacol Pharmacol & Toxicol, London, England; [Mein, Charles] Barts & London Queen Marys Sch Med & Dent, Genome Ctr, London, England	Imperial College London; University of London; Queen Mary University London	Wright, WR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Cardiothorac Pharmacol Pharmacol & Toxicol, London, England.	m.paul-clark@imperial.ac.uk		Mein, Charles/0000-0003-0811-9658	Wellcome Trust [4627]	Wellcome Trust(Wellcome TrustEuropean Commission)	This manuscript was supported by Wellcome Trust, eGrants Ref: 4627, http://www.wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Anto RJ, 2002, CARCINOGENESIS, V23, P1511, DOI 10.1093/carcin/23.9.1511; Barnes PJ, 2004, PHARMACOL REV, V56, P515, DOI 10.1124/pr.56.4.2; Beane J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r201; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birrell MA, 2008, J CELL PHYSIOL, V214, P27, DOI 10.1002/jcp.21158; Blake DJ, 2010, AM J RESP CELL MOL, V42, P524, DOI 10.1165/rcmb.2009-0054OC; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bosio A, 2002, CARCINOGENESIS, V23, P741, DOI 10.1093/carcin/23.5.741; Burns DM, 2003, PROG CARDIOVASC DIS, V46, P11, DOI 10.1016/S0033-0620(03)00079-3; Churg A, 2002, AM J RESP CRIT CARE, V166, P849, DOI 10.1164/rccm.200202-097OC; Comandini A, 2010, PULM PHARM THER; Croucher DR, 2008, NAT REV CANCER, V8, P535, DOI 10.1038/nrc2400; Demedts IK, 2005, CURR OPIN PHARMACOL, V5, P257, DOI 10.1016/j.coph.2004.12.005; Demirjian L, 2006, BBA-MOL BASIS DIS, V1762, P592, DOI 10.1016/j.bbadis.2006.04.004; Doyle I, 2010, MOL IMMUNOL, V47, P1058, DOI 10.1016/j.molimm.2009.11.008; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; Facchinetti F, 2007, AM J RESP CELL MOL, V37, P617, DOI 10.1165/rcmb.2007-0130OC; Favatier F, 2001, BIOCHEM J, V353, P475, DOI 10.1042/0264-6021:3530475; Fukano Yasuo, 2006, Journal of Toxicological Sciences, V31, P99, DOI 10.2131/jts.31.99; Gebel S, 2004, CARCINOGENESIS, V25, P169, DOI 10.1093/carcin/bgg193; Gebel S, 2006, TOXICOL SCI, V93, P422, DOI 10.1093/toxsci/kfl071; Gelbman BD, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-10; Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15; Gumus ZH, 2008, CANCER PREV RES, V1, P100, DOI 10.1158/1940-6207.CAPR-08-0007; Hackett NR, 2003, AM J RESP CELL MOL, V29, P331, DOI 10.1165/rcmb.2002-0321OC; Halappanavar S, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-56; Han GC, 2006, J PHARMACOL EXP THER, V316, P1025, DOI 10.1124/jpet.105.093542; Hansel TT, 2009, LANCET, V374, P744, DOI 10.1016/S0140-6736(09)61342-8; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Heguy A, 2006, J MOL MED, V84, P318, DOI 10.1007/s00109-005-0008-2; Kent L, 2008, CYTOKINE, V42, P205, DOI 10.1016/j.cyto.2008.02.001; Knorr-Wittmann C, 2005, FREE RADICAL BIO MED, V39, P1438, DOI 10.1016/j.freeradbiomed.2005.07.003; Kuschner WG, 1996, EUR RESPIR J, V9, P1989, DOI 10.1183/09031936.96.09101989; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lou XY, 2007, HUM MOL GENET, V16, P142, DOI 10.1093/hmg/ddl450; Maunders H, 2007, AM J PHYSIOL-LUNG C, V292, pL1248, DOI 10.1152/ajplung.00290.2006; McMaster SK, 2008, BRIT J PHARMACOL, V153, P536, DOI 10.1038/sj.bjp.0707595; Morris T, 2010, P NATL ACAD SCI USA, V107, P8842, DOI 10.1073/pnas.1000373107; Oltmanns U, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-74; Osterud B, 2003, PHYSIOL REV, V83, P1069, DOI 10.1152/physrev.00005.2003; Ouyang Y, 2000, J ALLERGY CLIN IMMUN, V106, P280, DOI 10.1067/mai.2000.107751; Paul-Clark MJ, 2009, AM J RESP CRIT CARE, V179, P299, DOI 10.1164/rccm.200707-1019OC; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-4; Perretti M, 1999, J LEUKOCYTE BIOL, V65, P583, DOI 10.1002/jlb.65.5.583; Pickett G, 2010, TOXICOL SCI, V114, P79, DOI 10.1093/toxsci/kfp298; Pierrou S, 2007, AM J RESP CRIT CARE, V175, P577, DOI 10.1164/rccm.200607-931OC; Port JL, 2004, CARCINOGENESIS, V25, P2275, DOI 10.1093/carcin/bgh243; Rahman I, 1998, AM J PHYSIOL-LUNG C, V275, pL80, DOI 10.1152/ajplung.1998.275.1.L80; Randolph GJ, 2008, CURR OPIN IMMUNOL, V20, P52, DOI 10.1016/j.coi.2007.10.010; Schmid R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-349; Shaykhiev R, 2009, J IMMUNOL, V183, P2867, DOI 10.4049/jimmunol.0900473; Singh A, 2009, FREE RADICAL BIO MED, V46, P376, DOI 10.1016/j.freeradbiomed.2008.10.026; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; Staempfli MR, 2009, NAT REV IMMUNOL, V9, P377, DOI 10.1038/nri2530; Stevenson CS, 2007, AM J PHYSIOL-LUNG C, V293, pL1183, DOI 10.1152/ajplung.00105.2007; Sunaga N, 2002, CANCER EPIDEM BIOMAR, V11, P730; Takaku M, 2009, J BIOL CHEM, V284, P14326, DOI 10.1074/jbc.M807715200; Tomita K, 2002, AM J RESP CRIT CARE, V166, P724, DOI 10.1164/rccm.2104010; van der Vaart H, 2004, THORAX, V59, P713, DOI 10.1136/thx.2003.012468; van Leeuwen DM, 2007, CARCINOGENESIS, V28, P691, DOI 10.1093/carcin/bgl199; van Leeuwen DM, 2005, TOXICOL SCI, V86, P200, DOI 10.1093/toxsci/kfi168; Vihinen P, 2002, INT J CANCER, V99, P157, DOI 10.1002/ijc.10329; Walters MJ, 2005, MOL PHARMACOL, V68, P1343, DOI 10.1124/mol.105.012591; Wright JL, 2008, AM J PHYSIOL-LUNG C, V295, pL1, DOI 10.1152/ajplung.90200.2008	66	37	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30120	10.1371/journal.pone.0030120	http://dx.doi.org/10.1371/journal.pone.0030120			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363418	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600013
J	Arai, T; Oh-ishi, T; Yamamoto, H; Nunoi, H; Kamizono, J; Uehara, M; Kubota, T; Sakurai, T; Kizaki, T; Ohno, H				Arai, Takashi; Oh-ishi, Tsutomu; Yamamoto, Hideaki; Nunoi, Hiroyuki; Kamizono, Junji; Uehara, Masahiko; Kubota, Takeo; Sakurai, Takuya; Kizaki, Takako; Ohno, Hideki			Copy Number Variations Due to Large Genomic Deletion in X-Linked Chronic Granulomatous Disease	PLOS ONE			English	Article							DE-NOVO MUTATION; CHROMOSOME INACTIVATION; MUSCULAR-DYSTROPHY; CYBB GENE; FEMALE; REARRANGEMENTS; HYBRIDIZATION; DUPLICATIONS; MECHANISM	Mutations in genes for any of the six subunits of NADPH oxidase cause chronic granulomatous disease (CGD), but almost 2/3 of CGD cases are caused by mutations in the X-linked CYBB gene, also known as NAD (P) H oxidase 2. Approximately 260 patients with CGD have been reported in Japan, of whom 92 were shown to have mutations of the CYBB gene and 16 to have chromosomal deletions. However, there has been very little detailed analysis of the range of the deletion or close understanding of the disease based on this. We therefore analyzed genomic rearrangements in X-linked CGD using array comparative genomic hybridization analysis, revealing the extent and the types of the deletion genes. The subjects were five Japanese X-linked CGD patients estimated to have large base deletions of 1 kb or more in the CYBB gene (four male patients, one female patient) and the mothers of four of those patients. The five Japanese patients were found to range from a patient exhibiting deletions only of the CYBB gene to a female patient exhibiting an extensive DNA deletion and the DMD and CGD phenotype manifested. Of the other three patients, two exhibited CYBB, XK, and DYNLT3 gene deletions. The remaining patient exhibited both a deletion encompassing DNA subsequent to the CYBB region following intron 2 and the DYNLT3 gene and a complex copy number variation involving the insertion of an inverted duplication of a region from the centromere side of DYNLT3 into the deleted region.	[Arai, Takashi; Oh-ishi, Tsutomu; Yamamoto, Hideaki] Saitama Childrens Med Ctr, Dept Clin Res, Saitama, Japan; [Oh-ishi, Tsutomu] Saitama Childrens Med Ctr, Div Infect Dis, Saitama, Japan; [Nunoi, Hiroyuki] Miyazaki Univ, Dept Pediat, Fac Med, Miyazaki, Japan; [Kamizono, Junji] Kitakyusyu City Yahata Hosp, Dept Pediat, Kitakyushu, Fukuoka, Japan; [Uehara, Masahiko] Hlth Insurance Hitoyoshi Gen Hosp, Dept Pediat, Hitoyoshi, Japan; [Kubota, Takeo] Univ Yamanashi, Dept Epigenet Med, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi, Japan; [Sakurai, Takuya; Kizaki, Takako; Ohno, Hideki] Kyorin Univ, Sch Med, Dept Mol Predict Med & Sport Sci, Mitaka, Tokyo 181, Japan	Saitama Children's Medical Center; Saitama Children's Medical Center; University of Miyazaki; University of Yamanashi; Kyorin University	Arai, T (corresponding author), Saitama Childrens Med Ctr, Dept Clin Res, Saitama, Japan.	ohnoh2o@kyorin-u.ac.jp			Ministry of Education, Culture, Sport, Science and Technology of Japan	Ministry of Education, Culture, Sport, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partially supported by Grants-in-Aid for Specific Project Research from the Ministry of Education, Culture, Sport, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Anderson-Cohen M, 2003, CLIN IMMUNOL, V109, P308, DOI 10.1016/j.clim.2003.08.002; Bonaglia MC, 2009, EUR J HUM GENET, V17, P179, DOI 10.1038/ejhg.2008.160; del Gaudio D, 2008, HUM MUTAT, V29, P1100, DOI 10.1002/humu.20841; FRANCKE U, 1985, AM J HUM GENET, V37, P250; Gono T, 2008, INTERNAL MED, V47, P1053, DOI 10.2169/internalmedicine.47.0919; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Johnston RB, 2001, CURR OPIN HEMATOL, V8, P17, DOI 10.1097/00062752-200101000-00004; Kabuki T, 2003, JAP J CLIN IMMUNOL, V26, P299; KORENBERG JR, 1988, CELL, V53, P391, DOI 10.1016/0092-8674(88)90159-6; Kubota T, 1999, HUM GENET, V104, P49, DOI 10.1007/s004390050909; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Lewis EM, 2008, CLIN IMMUNOL, V129, P372, DOI 10.1016/j.clim.2008.07.022; Mazzarella R, 1998, GENOME RES, V8, P1007, DOI 10.1101/gr.8.10.1007; Nunoi H, 2007, JAP J CLIN IMMUNOL, V30, P1; Roos D, 2010, BLOOD CELL MOL DIS, V45, P246, DOI 10.1016/j.bcmd.2010.07.012; Saunier S, 2000, AM J HUM GENET, V66, P778, DOI 10.1086/302819; Shchelochkov OA, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-16; Shchelochkov OA, 2009, MOL GENET METAB, V96, P97, DOI 10.1016/j.ymgme.2008.11.167; Simon KC, 2005, J MOL DIAGN, V7, P183, DOI 10.1016/S1525-1578(10)60544-2; Srour M, 2008, SEMIN PEDIATR NEUROL, V15, P154, DOI 10.1016/j.spen.2008.09.002; Takada H, 2004, BLOOD, V103, P185, DOI 10.1182/blood-2003-06-1964; Yamada M, 2010, EUR J MED GENET, V53, P383, DOI 10.1016/j.ejmg.2010.08.003; Yoshida M, 1998, CLIN GENET, V52, P102	23	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e27782	10.1371/journal.pone.0027782	http://dx.doi.org/10.1371/journal.pone.0027782			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22383943	Green Published, Green Submitted, gold			2022-12-27	WOS:000302918500001
J	Bellini, R; Medici, A; Calzolari, M; Bonilauri, P; Cavrini, F; Sambri, V; Angelini, P; Dottori, M				Bellini, Romeo; Medici, Anna; Calzolari, Mattia; Bonilauri, Paolo; Cavrini, Francesca; Sambri, Vittorio; Angelini, Paola; Dottori, Michele			Impact of Chikungunya Virus on Aedes albopictus Females and Possibility of Vertical Transmission Using the Actors of the 2007 Outbreak in Italy	PLOS ONE			English	Article							EQUINE ENCEPHALOMYELITIS VIRUS; REUNION ISLAND; INFECTION; DIPTERA; CULICIDAE; STRAINS; VECTOR; PATTERNS; MOSQUITO; AEGYPTI	We investigated the impact of CHIKV strains on some Aedes albopictus (Skuse) reproductive parameters and the possibility of vertical transmission. Two strains were collected in the area where the epidemic occurred in 2007, one isolated from mosquitoes, the other one isolated from a viraemic patient. Different types of blood meals, either infected or non-infected, were offered to Ae. albopictus females, that were then analyzed at increasing time post infection. The virus titre, measured by two RT-PCR methods in the blood meals, influenced the rate of infection and the rate of dissemination of CHIKV in Ae. albopictus body. We found individual variability with respect to the infection/dissemination rates and their latency both considering the female's body and appendages. The hatching rate was significantly lower for the eggs laid by the infected females than for the control eggs, while the mortality during the larval development (from first instar larva to adult emergence) was similar among the progeny of infected and non-infected female groups. Our findings seem to support the hypothesis that the vertical transmission is a rare event under our conditions, and that a certain time period is required in order to get the ovarioles infected. Field observations conducted during the Spring 2008 showed no evidence of the presence of infected overwintering progeny produced by Ae. albopictus females infected during the 2007 outbreak.	[Bellini, Romeo; Medici, Anna] Ctr Agricoltura Ambiente G Nicoli, Bologna, Italy; [Calzolari, Mattia; Bonilauri, Paolo; Dottori, Michele] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Brescia, Italy; [Cavrini, Francesca; Sambri, Vittorio] Univ Bologna, Dept Haematol & Oncol, Reg Reference Ctr Microbiol Emergencies CRREM, Unit Clin Microbiol,S Orsola Malpighi Hosp, Bologna, Italy; [Angelini, Paola] Publ Hlth Serv, Bologna, Italy	IZS Lombardia e Emilia; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Bellini, R (corresponding author), Ctr Agricoltura Ambiente G Nicoli, Bologna, Italy.	rbellini@caa.it	Calzolari, Mattia/AAB-9487-2019; dottori, michele/AAB-3815-2019; Sambri, Vittorio/H-5372-2019	Calzolari, Mattia/0000-0001-7489-2556; Sambri, Vittorio/0000-0002-5012-7355; Dottori, Michele/0000-0002-9975-0367; Bonilauri, Paolo/0000-0002-2625-7993	Italian Ministry of Health [RFPS-2007-7-639191]	Italian Ministry of Health(Ministry of Health, Italy)	The work has been funded through the fund RFPS-2007-7-639191 of the Italian Ministry of Health managed by the Health Agency of the Emilia-Romagna Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AM, 1999, INVERTEBR REPROD DEV, V36, P217, DOI 10.1080/07924259.1999.9652703; Arankalle VA, 2007, J GEN VIROL, V88, P1967, DOI 10.1099/vir.0.82714-0; BEAMAN JR, 1991, J MED ENTOMOL, V28, P161, DOI 10.1093/jmedent/28.1.161; Beltrame A, 2007, EMERG INFECT DIS, V13, P1264, DOI 10.3201/eid1308.070161; Bonilauri P, 2008, EMERG INFECT DIS, V14, P852, DOI 10.3201/eid1405.071144; Carrieri M, 2011, J VECTOR ECOL, V36, P108, DOI 10.1111/j.1948-7134.2011.00147.x; Delatte H, 2008, PARASITE, V15, P3, DOI 10.1051/parasite/2008151003; Dhileepan K, 1996, J MED ENTOMOL, V33, P180, DOI 10.1093/jmedent/33.1.180; Edwards CJ, 2007, J CLIN VIROL, V39, P271, DOI 10.1016/j.jcv.2007.05.008; FOURIE ED, 1979, S AFR MED J, V56, P130; FULHORST CF, 1994, SCIENCE, V263, P676, DOI 10.1126/science.8303276; Haddad N, 2007, J AM MOSQUITO CONTR, V23, P226, DOI 10.2987/8756-971X(2007)23[226:POAAIL]2.0.CO;2; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; Jahan N, 1997, ANN TROP MED PARASIT, V91, P365, DOI 10.1080/00034989760987; Mahmood F, 2004, J MED ENTOMOL, V41, P982, DOI 10.1603/0022-2585-41.5.982; Medici A, 2011, J ECON ENTOMOL, V104, P266, DOI 10.1603/EC10108; Mitchell C. J., 1995, Parassitologia (Rome), V37, P109; MITCHELL CJ, 1991, J AM MOSQUITO CONTR, V7, P446; MOURYA DT, 1987, INDIAN J MED RES, V85, P593; Parola P, 2006, EMERG INFECT DIS, V12, P1493, DOI 10.3201/eid1210.060610; Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002; Pener H., 2003, European Mosquito Bulletin, V14, P32; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(57)90022-6, 10.1016/0035-9203(55)90080-8]; Romi R, 2006, J AM MOSQUITO CONTR, V22, P149, DOI 10.2987/8756-971X(2006)22[149:CAAOOF]2.0.CO;2; ROSEN L, 1987, AM J TROP MED HYG, V37, pS69, DOI 10.4269/ajtmh.1987.37.69S; ROSS R. W., 1956, JOUR HYG, V54, P177; SABATANI A, 1990, Parassitologia (Rome), V32, P301; Santhosh SR, 2008, VIRUS RES, V135, P36, DOI 10.1016/j.virusres.2008.02.004; Scholte EJ, 2007, ECOL CONT VECTOR-BOR, V1, P241; Scott TW, 1998, AM J TROP MED HYG, V59, P341, DOI 10.4269/ajtmh.1998.59.341; Shroyer DA, 1986, J AM MOSQUITO CONTR, V7, P89; Styer LM, 2007, J MED ENTOMOL, V44, P1074, DOI 10.1603/0022-2585(2007)44[1074:WNVIDF]2.0.CO;2; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; TURELL MJ, 1984, AM J TROP MED HYG, V33, P176, DOI 10.4269/ajtmh.1984.33.176; TURELL MJ, 1992, J MED ENTOMOL, V29, P49, DOI 10.1093/jmedent/29.1.49; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; Vazeille M, 2009, MEM I OSWALDO CRUZ, V104, P632, DOI 10.1590/S0074-02762009000400017; White DO, 1986, MED VIROLOGY, P284; Zhang H. L., 1993, Chinese Journal of Virology, V9, P222	42	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e28360	10.1371/journal.pone.0028360	http://dx.doi.org/10.1371/journal.pone.0028360			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22383945	Green Published, Green Submitted, gold			2022-12-27	WOS:000302918500002
J	Diallo, A; Ndam, NT; Moussiliou, A; Dos Santos, S; Ndonky, A; Borderon, M; Oliveau, S; Lalou, R; Le Hesran, JY				Diallo, Abdoulaye; Ndam, Nicaise Tuikue; Moussiliou, Azizath; Dos Santos, Stephanie; Ndonky, Alphousseyni; Borderon, Marion; Oliveau, Sebastien; Lalou, Richard; Le Hesran, Jean-Yves			Asymptomatic Carriage of Plasmodium in Urban Dakar: The Risk of Malaria Should Not Be Underestimated	PLOS ONE			English	Article							REAL-TIME PCR; SOUTHERN SANITARY DISTRICT; SUB-SAHARAN AFRICA; BREEDING SITES; FALCIPARUM; TRANSMISSION; SENEGAL; URBANIZATION; RESISTANCE; BLOOD	Introduction: The objective of this study was to measure the rate of asymptomatic carriage of plasmodium in the Dakar region two years after the implementation of new strategies in clinical malaria management. Methodology: Between October and December 2008, 2952 households selected in 50 sites of Dakar area, were visited for interviews and blood sampling. Giemsa-stained thick blood smears (TBS) were performed for microscopy in asymptomatic adult women and children aged 2 to 10 years. To ensure the quality of the microscopy, we performed a polymerase chain reaction (PCR) with real time qPCR in all positive TBS by microscopy and in a sample of negative TBS and filter paper blood spots. Results: The analysis has concerned 2427 women and 2231 children. The mean age of the women was 35.6 years. The mean age of the children was 5.4 years. The parasite prevalence was 2.01% (49/2427) in women and 2.15% (48/2231) in children. Parasite prevalence varied from one study site to another, ranging from 0 to 7.41%. In multivariate analysis, reporting a malaria episode in 2008 was associated with plasmodium carriage (OR = 2.57, P = 0.002) in women; in children, a malaria episode (OR = 6.19, P < 0.001) and a travel out of Dakar during last 3 months (OR = 2.27, P = 0.023) were associated with plasmodium carriage. Among the positive TBS, 95.8% (93/97) were positive by plasmodium PCR. Among the negative TBS, 13.9% (41/293) were positive by PCR. In blood spots, 15.2% (76/500) were positive by PCR. We estimated at 16.5% the parasite prevalence if PCR were performed in 4658 TBS. Conclusion: Parasite prevalence in Dakar area seemed to be higher than the rate found by microscopy. PCR may be the best tool for measuring plasmodium prevalence in the context of low transmission. Environmental conditions play a major role in the heterogeneity of parasite prevalence within sites.	[Diallo, Abdoulaye; Ndam, Nicaise Tuikue; Le Hesran, Jean-Yves] Inst Rech Dev, UMR Mere & Enfant Face Infect Trop 216, Paris, France; [Diallo, Abdoulaye; Ndam, Nicaise Tuikue; Le Hesran, Jean-Yves] Univ Paris 05, Fac Pharmaceut Sci, Paris, France; [Dos Santos, Stephanie; Ndonky, Alphousseyni] Univ Cheikh Anta Diop, UMR151, Lab Populat Environm & Dev, Inst Rech Dev, Dakar, Senegal; [Dos Santos, Stephanie; Lalou, Richard] Univ Aix Marseille 1, UMR151, Lab Populat Environm & Dev, Inst Rech Dev, Marseille, France; [Ndam, Nicaise Tuikue; Moussiliou, Azizath] Inst Rech Dev, UMR Mere & Enfant Face Infect Trop 216, Cotonou, Benin; [Borderon, Marion; Oliveau, Sebastien] Univ Aix Marseille 1, UFR Sci Geog & Amenagement, UMR ESPACE 6012, Aix En Provence, France	UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); University Cheikh Anta Diop Dakar; UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Universite Cote d'Azur	Diallo, A (corresponding author), Inst Rech Dev, UMR Mere & Enfant Face Infect Trop 216, Paris, France.	diallaye@yahoo.fr	borderon, marion/AAF-6287-2020; Oliveau, Sebastien/D-4382-2015; LALOU, Richard/A-7322-2017	borderon, marion/0000-0002-1449-3665; Oliveau, Sebastien/0000-0003-1473-5051; Tuikue Ndam, Nicaise/0000-0003-2646-2513; LALOU, Richard/0000-0001-9489-7661; LE HESRAN, Jean-Yves/0000-0003-4814-7952	national agency of research of the French government (ANR-SEST); IRD	national agency of research of the French government (ANR-SEST)(French National Research Agency (ANR)); IRD	This project was funded by the national agency of research of the French government (ANR-SEST 2007). AD received financial support from IRD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonio-Nkondjio C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-154; Awolola T. S., 2007, Journal of Vector Borne Diseases, V44, P241; Bereczky S, 2005, AM J TROP MED HYG, V72, P249, DOI 10.4269/ajtmh.2005.72.249; Bob NS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009817; Bousema JT, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-18; Cnops L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-370; Diallo S, 2000, Sante, V10, P221; Diallo S, 1998, B SOC PATHOL EXOT, V91, P259; Diallo S, 1998, B SOC PATHOL EXOT, V91, P208; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Donnelly MJ, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-12; Eichner M, 2001, T ROY SOC TROP MED H, V95, P497, DOI 10.1016/S0035-9203(01)90016-1; Gadiaga L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-312; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Keiser J, 2004, AM J TROP MED HYG, V71, P118, DOI 10.4269/ajtmh.2004.71.118; Machault V, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-138; Malhotra I, 2005, J CLIN MICROBIOL, V43, P3630, DOI 10.1128/JCM.43.8.3630-3635.2005; Mangold KA, 2005, J CLIN MICROBIOL, V43, P2435, DOI 10.1128/JCM.43.5.2435-2440.2005; Mayor A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-9; McKenzie FE, 2003, AM J TROP MED HYG, V69, P372, DOI 10.4269/ajtmh.2003.69.372; Ministere de l'economie et des finances ANdlSedlD, 2008, 3 REC GEN POP HAB 20, P163; Ministere de la Sante et de la Prevention Medicale C, 2006, ENQ DEM SANT SEN 200; Ministere de la sante ' et de la prevention CdRplDHC, 2009, ENQ NAT DUR PAL SEN, P24; Mockenhaupt FP, 2000, TROP MED INT HEALTH, V5, P167, DOI 10.1046/j.1365-3156.2000.00532.x; Ndiaye P, 2006, Med Trop (Mars), V66, P74; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Pages F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-178; Parizot IPS, 2004, U444 INSERM, VU444, P203; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Robert V, 2003, AM J TROP MED HYG, V68, P169, DOI 10.4269/ajtmh.2003.68.169; Rougemont M, 2004, J CLIN MICROBIOL, V42, P5636, DOI 10.1128/JCM.42.12.5636-5643.2004; Sabatinelli G, 1986, Parassitologia, V28, P17; Shokoples SE, 2009, J CLIN MICROBIOL, V47, P975, DOI 10.1128/JCM.01858-08; Soumare M, 1999, Dakar Med, V44, P8; Staedke SG, 2003, AM J TROP MED HYG, V69, P244, DOI 10.4269/ajtmh.2003.69.244; Stepniewska K, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-249; Taylor SM, 2010, J CLIN MICROBIOL, V48, P512, DOI 10.1128/JCM.01800-09; TRAPE JF, 1992, AM J TROP MED HYG, V47, P181, DOI 10.4269/ajtmh.1992.47.181; TRAPE JF, 1993, AM J TROP MED HYG, V48, P748, DOI 10.4269/ajtmh.1993.48.748; Unies N, 2008, WORLD URBANIZATION P, P32; VERCRUYSSE J, 1983, B WORLD HEALTH ORGAN, V61, P821; Vo TKD, 2007, T ROY SOC TROP MED H, V101, P422, DOI 10.1016/j.trstmh.2006.09.004; Wade S, TELEDETECTION CATAST, P5; WATTS TE, 1990, T ROY SOC TROP MED H, V84, P196, DOI 10.1016/0035-9203(90)90251-9	44	45	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31100	10.1371/journal.pone.0031100	http://dx.doi.org/10.1371/journal.pone.0031100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363558	Green Published, gold			2022-12-27	WOS:000302873700026
J	Gregoracci, GB; Nascimento, JR; Cabral, AS; Paranhos, R; Valentin, JL; Thompson, CC; Thompson, FL				Gregoracci, Gustavo B.; Nascimento, Juliana R.; Cabral, Anderson S.; Paranhos, Rodolfo; Valentin, Jean L.; Thompson, Cristiane C.; Thompson, Fabiano L.			Structuring of Bacterioplankton Diversity in a Large Tropical Bay	PLOS ONE			English	Article							GLOBAL PATTERNS; BACTERIAL; BIODIVERSITY; ENRICHMENT; VARIABLES; RESOURCE; ECOLOGY; VIBRIOS; ESTUARY; WATERS	Structuring of bacterioplanktonic populations and factors that determine the structuring of specific niche partitions have been demonstrated only for a limited number of colder water environments. In order to better understand the physical chemical and biological parameters that may influence bacterioplankton diversity and abundance, we examined their productivity, abundance and diversity in the second largest Brazilian tropical bay (Guanabara Bay, GB), as well as seawater physical chemical and biological parameters of GB. The inner bay location with higher nutrient input favored higher microbial (including vibrio) growth. Metagenomic analysis revealed a predominance of Gammaproteobacteria in this location, while GB locations with lower nutrient concentration favored Alphaproteobacteria and Flavobacteria. According to the subsystems (SEED) functional analysis, GB has a distinctive metabolic signature, comprising a higher number of sequences in the metabolism of phosphorus and aromatic compounds and a lower number of sequences in the photosynthesis subsystem. The apparent phosphorus limitation appears to influence the GB metagenomic signature of the three locations. Phosphorus is also one of the main factors determining changes in the abundance of planktonic vibrios, suggesting that nutrient limitation can be observed at community (metagenomic) and population levels (total prokaryote and vibrio counts).	[Gregoracci, Gustavo B.; Nascimento, Juliana R.; Thompson, Fabiano L.] Fed Univ Rio de Janeiro UFRJ, Microbiol Lab, Inst Biol, Rio De Janeiro, Brazil; [Cabral, Anderson S.; Paranhos, Rodolfo] Fed Univ Rio de Janeiro UFRJ, Lab Hydrobiol, Inst Biol, Rio De Janeiro, Brazil; [Valentin, Jean L.] Fed Univ Rio de Janeiro UFRJ, Lab Zooplankton, Inst Biol, Rio De Janeiro, Brazil; [Thompson, Cristiane C.] IOC FIOCRUZ, Lab Mol Genet Microorganisms, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Gregoracci, GB (corresponding author), Fed Univ Rio de Janeiro UFRJ, Microbiol Lab, Inst Biol, Rio De Janeiro, Brazil.	fabiano.thompson@biologia.ufrj.br	VALENTIN, JEAN L/I-9403-2012; Paranhos, Rodolfo/F-1927-2011; Gregoracci, Gustavo B/E-1848-2013; Thompson, Cristiane C/I-5783-2016	Thompson, Fabiano/0000-0002-7562-1683; Gregoracci, Gustavo/0000-0001-6896-1068	federal (CNPq); federal (CAPES); state (FAPERJ)	federal (CNPq)(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); federal (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); state (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	The authors would like to thank federal (CNPq and CAPES) and state (FAPERJ) funding agencies for their support. RP acknowledges grants to the Microbial Observatory of Rio de Janeiro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, NATURE, V430, P551, DOI 10.1038/nature02649; Aiyar SE, 2002, J BACTERIOL, V184, P1349, DOI 10.1128/JB.184.5.1349-1358.2002; Andrade L, 2003, J MICROBIOL METH, V55, P841, DOI 10.1016/j.mimet.2003.08.002; Austin B, 2005, ENVIRON MICROBIOL, V7, P1488, DOI 10.1111/j.1462-2920.2005.00847.x; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Burkholder JM, 2006, LIMNOL OCEANOGR, V51, P463, DOI 10.4319/lo.2006.51.1_part_2.0463; Cardinale BJ, 2011, NATURE, V472, P86, DOI 10.1038/nature09904; Christensen JH, 2010, ENVIRON POLLUT, V158, P3290, DOI 10.1016/j.envpol.2010.07.015; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; Dinsdale EA, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P231, DOI 10.1007/978-94-007-0114-4_16; Eiler A, 2006, APPL ENVIRON MICROB, V72, P6004, DOI 10.1128/AEM.00917-06; Eilers H, 2000, APPL ENVIRON MICROB, V66, P4634, DOI 10.1128/AEM.66.11.4634-4640.2000; Ferguson Wood EJ, MICROBIOLOGY OCEANS; Fuhrman JA, 2005, APPL ENVIRON MICROB, V71, P4523, DOI 10.1128/AEM.71.8.4523-4530.2005; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105; Gilbert JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015545; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P3132, DOI 10.1111/j.1462-2920.2009.02017.x; Grasshoff K., 1999, METHODS SEAWATER ANA, V3rd; Gravel D, 2011, NATURE, V469, P89, DOI 10.1038/nature09592; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; IBGE, 2010, I BRAS GEOGR EST CEN; Jiao NZ, 2006, J MAR BIOL ASSOC UK, V86, P543, DOI 10.1017/S0025315406013452; Kirchman D. L., MICROBIAL ECOLOGY OC; Leibold MA, 2008, NATURE, V454, P39, DOI 10.1038/454039a; Louis VR, 2003, APPL ENVIRON MICROB, V69, P2773, DOI 10.1128/AEM.69.5.2773-2785.2003; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Nemergut DR, 2011, ENVIRON MICROBIOL, V13, P135, DOI 10.1111/j.1462-2920.2010.02315.x; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; PITCHER DG, 1989, LETT APPL MICROBIOL, V8, P151, DOI 10.1111/j.1472-765X.1989.tb00262.x; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Rezende CE, 2010, ESTUAR COAST SHELF S, V87, P479, DOI 10.1016/j.ecss.2010.02.008; Seo JS, 2009, INT J ENV RES PUB HE, V6, P278, DOI 10.3390/ijerph6010278; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson FL, 2011, ARCH MICROBIOL, V193, P105, DOI 10.1007/s00203-010-0644-y; Thompson FL, 2005, APPL ENVIRON MICROB, V71, P5107, DOI 10.1128/AEM.71.9.5107-5115.2005; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; Vezzulli L, 2010, ENVIRON MICROBIOL, V12, P2007, DOI 10.1111/j.1462-2920.2010.02209.x; Vieira RP, 2008, ENVIRON MICROBIOL, V10, P189, DOI 10.1111/j.1462-2920.2007.01443.x; Yoshiyama K, 2006, LIMNOL OCEANOGR, V51, P424, DOI 10.4319/lo.2006.51.1_part_2.0424	46	48	49	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31408	10.1371/journal.pone.0031408	http://dx.doi.org/10.1371/journal.pone.0031408			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363639	Green Submitted, Green Published, gold			2022-12-27	WOS:000302873700056
J	Miyazaki, A; Yogosawa, S; Murakami, A; Kitamura, D				Miyazaki, Atsuko; Yogosawa, Satomi; Murakami, Akikazu; Kitamura, Daisuke			Identification of CMTM7 as a Transmembrane Linker of BLNK and the B-Cell Receptor	PLOS ONE			English	Article							NON-ITAM TYROSINE; ANTIGEN RECEPTOR; SIGNAL-TRANSDUCTION; PROTEIN BLNK; ACTIVATION; REQUIREMENT; BETA; BASH; ASSOCIATION; LYMPHOCYTES	BLNK is a pivotal adaptor protein in the signal transduction pathway from the IgM class B-cell receptor. BLNK is phosphorylated by Syk and binds various signaling intermediates, leading to cellular events including MAP-kinase activation, culminating in cellular activation. It remains unclear how BLNK is initially recruited to the surface IgM (sIgM) complex to which Syk is also recruited. Here we show that CMTM7, a tetra-spanning membrane protein of unknown function, co-localized with clathrin and sIgM at the plasma membrane. RNA-interference-mediated knockdown of CMTM7 expression in B cells resulted in an impairment of sIgM-ligation-induced tyrosine phosphorylation of BLNK, which was due to an impaired interaction of BLNK and Syk, and in a failure to activate JNK and ERK, but not upstream kinases such as Src-family kinases and Syk. CMTM7 was bound to BLNK in a membrane fraction, and their association was augmented after sIgM ligation. Exogenous CMTM7 or a mutant with an N-terminal deletion (Delta N), but not one with a C-terminal deletion (Delta C) that is defective in membrane localization, were able to restore BLNK-Syk binding, BLNK phosphorylation and ERK activation in the CMTM7-knockdown B cells. In addition, CMTM7 and the Delta N, but not the Delta C, were constitutively associated with sIgM, and this binding was required for BLNK recruitment to sIgM. From these data, we conclude that CMTM7 functions to link sIgM and BLNK in the plasma membrane, to recruit BLNK to the vicinity of Syk, and to initiate the BLNK- mediated signal transduction.	[Miyazaki, Atsuko; Yogosawa, Satomi; Kitamura, Daisuke] Tokyo Univ Sci, RIBS, Div Mol Biol Lab, Noda, Chiba 278, Japan; [Murakami, Akikazu] Tokyo Univ Sci, RIBS, Div Azuma Lab, Noda, Chiba 278, Japan	Tokyo University of Science; Tokyo University of Science	Miyazaki, A (corresponding author), Tokyo Univ Sci, RIBS, Div Mol Biol Lab, Noda, Chiba 278, Japan.	kitamura@rs.noda.tus.ac.jp		Murakami, Akikazu/0000-0003-3064-3237	Japan Society for the Promotion of Science [21113526, 22390097]; Ministry of Education, Culture, Sports, Science and Technology of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research(B) (22390097) and on Innovative Areas (21113526) from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/e-grants/index. html) and Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.mext.go.jp/english/research_promotion/1303820.htm), respectively, to DK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abudula A, 2007, J BIOL CHEM, V282, P29059, DOI 10.1074/jbc.M704043200; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Engels N, 2001, EUR J IMMUNOL, V31, P2126, DOI 10.1002/1521-4141(200107)31:7<2126::AID-IMMU2126>3.0.CO;2-O; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Goitsuka R, 1998, J IMMUNOL, V161, P5804; Han WL, 2003, GENOMICS, V81, P609, DOI 10.1016/S0888-7543(03)00095-8; Hayashi K, 2003, IMMUNITY, V18, P825, DOI 10.1016/S1074-7613(03)00142-0; Hayashi K, 2000, P NATL ACAD SCI USA, V97, P2755, DOI 10.1073/pnas.040575697; Imamura Y, 2004, J BIOL CHEM, V279, P26425, DOI 10.1074/jbc.M403685200; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; Kabak S, 2002, MOL CELL BIOL, V22, P2524, DOI 10.1128/MCB.22.8.2524-2535.2002; Kim JH, 2005, J IMMUNOL, V175, P147, DOI 10.4049/jimmunol.175.1.147; KIM KJ, 1979, J IMMUNOL, V122, P549; Kitamura D, 2007, IMMUNE SYSTEM RECOGN, P99; Kohler F, 2005, NAT IMMUNOL, V6, P204, DOI 10.1038/ni1163; Kremyanskaya M, 2005, J IMMUNOL, V174, P1501, DOI 10.4049/jimmunol.174.3.1501; Kulathu Y, 2008, EMBO J, V27, P1333, DOI 10.1038/emboj.2008.62; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; Oda A, 2008, INT IMMUNOL, V20, P1417, DOI 10.1093/intimm/dxn101; Oh-Hora M, 2003, J EXP MED, V198, P1841, DOI 10.1084/jem.20031547; Pappu R, 1999, SCIENCE, V286, P1949, DOI 10.1126/science.286.5446.1949; Patterson HCK, 2006, IMMUNITY, V25, P55, DOI 10.1016/j.immuni.2006.04.014; Pierce SK, 2010, NAT REV IMMUNOL, V10, P767, DOI 10.1038/nri2853; Pike KA, 2005, J IMMUNOL, V174, P2012, DOI 10.4049/jimmunol.174.4.2012; Reth M, 1997, ANNU REV IMMUNOL, P15453; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P599, DOI 10.1016/S0968-0004(02)02229-6; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Siemasko K, 2002, J IMMUNOL, V168, P2127, DOI 10.4049/jimmunol.168.5.2127; Stoddart A, 2002, IMMUNITY, V17, P451, DOI 10.1016/S1074-7613(02)00416-8; Tan JEL, 2001, J BIOL CHEM, V276, P20055, DOI 10.1074/jbc.M010800200; Tolar P, 2009, IMMUNITY, V30, P44, DOI 10.1016/j.immuni.2008.11.007; Xu SL, 2000, INT IMMUNOL, V12, P397, DOI 10.1093/intimm/12.3.397	33	27	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31829	10.1371/journal.pone.0031829	http://dx.doi.org/10.1371/journal.pone.0031829			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363743	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700104
J	Vonhoff, F; Williams, A; Ryglewski, S; Duch, C				Vonhoff, Fernando; Williams, Alison; Ryglewski, Stefanie; Duch, Carsten			Drosophila as a Model for MECP2 Gain of Function in Neurons	PLOS ONE			English	Article							SEVERE MENTAL-RETARDATION; CPG BINDING DOMAIN; RETT-SYNDROME; DNA METHYLATION; TRANSCRIPTIONAL REPRESSOR; MOUSE MODEL; SYNAPTIC PLASTICITY; DUPLICATION; MOTOR; ABNORMALITIES	Methyl-CpG-binding protein 2 (MECP2) is a multi-functional regulator of gene expression. In humans loss of MECP2 function causes classic Rett syndrome, but gain of MECP2 function also causes mental retardation. Although mouse models provide valuable insight into Mecp2 gain and loss of function, the identification of MECP2 genetic targets and interactors remains time intensive and complicated. This study takes a step toward utilizing Drosophila as a model to identify genetic targets and cellular consequences of MECP2 gain-of function mutations in neurons, the principle cell type affected in patients with Rett-related mental retardation. We show that heterologous expression of human MECP2 in Drosophila motoneurons causes distinct defects in dendritic structure and motor behavior, as reported with MECP2 gain of function in humans and mice. Multiple lines of evidence suggest that these defects arise from specific MECP2 function. First, neurons with MECP2-induced dendrite loss show normal membrane currents. Second, dendritic phenotypes require an intact methyl-CpG-binding domain. Third, dendritic defects are amended by reducing the dose of the chromatin remodeling protein, osa, indicating that MECP2 may act via chromatin remodeling in Drosophila. MECP2-induced motoneuron dendritic defects cause specific motor behavior defects that are easy to score in genetic screening. In sum, our data show that some aspects of MECP2 function can be studied in the Drosophila model, thus expanding the repertoire of genetic reagents that can be used to unravel specific neural functions of MECP2. However, additional genes and signaling pathways identified through such approaches in Drosophila will require careful validation in the mouse model.	[Vonhoff, Fernando; Williams, Alison; Ryglewski, Stefanie; Duch, Carsten] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Vonhoff, F (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	carsten.duch@asu.edu	Vonhoff, Fernando/AAH-8909-2021	Vonhoff, Fernando/0000-0002-0679-1857; Duch, Carsten/0000-0002-6962-6023	National Institutes of Health [RO1NS072128]; Science Foundation Arizona; German Research Foundation (DFG) [RY117/1-1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072128] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science Foundation Arizona; German Research Foundation (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support by National Institutes of Health to CD (RO1NS072128), by the Science Foundation Arizona to AW, and by the German Research Foundation (DFG) to SR (RY117/1-1) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MJ, 1998, J COMP NEUROL, V397, P519, DOI 10.1002/(SICI)1096-9861(19980810)397:4<519::AID-CNE5>3.0.CO;2-4; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; ARMSTRONG D, 1995, J NEUROPATH EXP NEUR, V54, P195, DOI 10.1097/00005072-199503000-00006; Armstrong DD, 2005, J CHILD NEUROL, V20, P747, DOI 10.1177/08830738050200082401; Armstrong DD, 1998, J NEUROPATH EXP NEUR, V57, P1013, DOI 10.1097/00005072-199811000-00003; Asaka Y, 2006, NEUROBIOL DIS, V21, P217, DOI 10.1016/j.nbd.2005.07.005; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; BAUMAN ML, 1995, NEUROLOGY, V45, P1581, DOI 10.1212/WNL.45.8.1581; BELICHENKO PV, 1994, NEUROREPORT, V5, P1509, DOI 10.1097/00001756-199407000-00025; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; Boerner J, 2010, J COMP NEUROL, V518, P2437, DOI 10.1002/cne.22346; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Brembs B, 2007, J NEUROSCI, V27, P11122, DOI 10.1523/JNEUROSCI.2704-07.2007; Burrows M., 1996, NEUROBIOLOGY INSECT; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Consoulas C, 2002, J NEUROSCI, V22, P4906, DOI 10.1523/JNEUROSCI.22-12-04906.2002; Cukier HN, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000179; del Gaudio D, 2006, GENET MED, V8, P784, DOI 10.1097/01.gim.0000250502.28516.3c; Dickinson MH, 1997, COMP BIOCHEM PHYS A, V116, P223, DOI 10.1016/S0300-9629(96)00162-4; Duch C, 2004, J NEUROSCI, V24, P9826, DOI 10.1523/JNEUROSCI.3189-04.2004; Duch C, 2008, J NEUROPHYSIOL, V100, P2525, DOI 10.1152/jn.90758.2008; Dunn HG, 2001, CAN J NEUROL SCI, V28, P16; Evers JF, 2006, DEV BIOL, V297, P214, DOI 10.1016/j.ydbio.2006.05.012; Evers JF, 2005, J NEUROPHYSIOL, V93, P2331, DOI 10.1152/jn.00761.2004; Fayyazuddin A, 2006, PLOS BIOL, V4, P420, DOI 10.1371/journal.pbio.0040063; Fry SN, 2008, J NEUROSCI METH, V171, P110, DOI 10.1016/j.jneumeth.2008.02.016; Gatto CL, 2011, CURR OPIN NEURO 0517; Ghosh RP, 2010, MOL CELL BIOL, V30, P4656, DOI 10.1128/MCB.00379-10; Ghosh RP, 2010, BIOCHEMISTRY-US, V49, P4395, DOI 10.1021/bi9019753; Gordon S, 2006, P NATL ACAD SCI USA, V103, P4311, DOI 10.1073/pnas.0510109103; Gowher H, 2000, EMBO J, V19, P6918, DOI 10.1093/emboj/19.24.6918; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; HAGBERG B, 1985, ACTA PAEDIATR SCAND, V74, P405, DOI 10.1111/j.1651-2227.1985.tb10993.x; Harikrishnan KN, 2005, NAT GENET, V37, P254, DOI 10.1038/ng1516; Hartwig CL, 2008, DEV NEUROBIOL, V68, P1225, DOI 10.1002/dneu.20655; Hendrich B, 2003, TRENDS GENET, V19, P269, DOI 10.1016/S0168-9525(03)00080-5; Hu KP, 2006, NAT GENET, V38, P962, DOI 10.1038/ng0906-962; IKEDA K, 1988, J COMP NEUROL, V273, P436, DOI 10.1002/cne.902730312; Jeffery L, 2004, J BIOL CHEM, V279, P49479, DOI 10.1074/jbc.M409070200; Jentarra GM, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-19; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Luikenhuis S, 2004, P NATL ACAD SCI USA, V101, P6033, DOI 10.1073/pnas.0401626101; Lyko F, 2000, NATURE, V408, P538, DOI 10.1038/35046205; Lyko F, 2011, TRENDS GENET, V27, P127, DOI 10.1016/j.tig.2011.01.003; Matarazzo V, 2004, MOL CELL NEUROSCI, V27, P44, DOI 10.1016/j.mcn.2004.05.005; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Moretti P, 2006, CURR OPIN GENET DEV, V16, P276, DOI 10.1016/j.gde.2006.04.009; Nan XS, 1996, MOL CELL BIOL, V16, P414; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Percy AK, 2002, NEUROL CLIN, V20, P1125, DOI 10.1016/S0733-8619(02)00022-1; Ramocki MB, 2010, AM J MED GENET A, V152A, P1079, DOI 10.1002/ajmg.a.33184; Reiter LT, 2001, GENOME RES, V11, P1114, DOI 10.1101/gr.169101; Restifo LL, 2005, MENT RETARD DEV D R, V11, P286, DOI 10.1002/mrdd.20083; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Ryglewski S, 2011, J PHYSL         1219, V19; Ryglewski S, 2009, J NEUROPHYSIOL, V102, P3673, DOI 10.1152/jn.00693.2009; Schmitt S, 2004, NEUROIMAGE, V23, P1283, DOI 10.1016/j.neuroimage.2004.06.047; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Tripodi M, 2008, PLOS BIOL, V6, P2172, DOI 10.1371/journal.pbio.0060260; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Venken KJT, 2005, NAT REV GENET, V6, P167, DOI 10.1038/nrg1553; Vonhoff F, 2010, J COMP NEUROL, V518, P2169, DOI 10.1002/cne.22380; Yasui DH, 2007, P NATL ACAD SCI USA, V104, P19416, DOI 10.1073/pnas.0707442104; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102; Yusufzai TM, 2000, NUCLEIC ACIDS RES, V28, P4172, DOI 10.1093/nar/28.21.4172; Zhang YQ, 2005, TRENDS GENET, V21, P37, DOI 10.1016/j.tig.2004.11.003	68	23	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31835	10.1371/journal.pone.0031835	http://dx.doi.org/10.1371/journal.pone.0031835			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363746	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700106
J	Zhong, LM; Zong, Y; Sun, L; Guo, JZ; Zhang, W; He, Y; Song, R; Wang, WM; Xiao, CJ; Lu, D				Zhong, Lian-Mei; Zong, Yi; Sun, Lin; Guo, Jia-Zhi; Zhang, Wei; He, Ying; Song, Rui; Wang, Wen-Min; Xiao, Chun-Jie; Lu, Di			Resveratrol Inhibits Inflammatory Responses via the Mammalian Target of Rapamycin Signaling Pathway in Cultured LPS-Stimulated Microglial Cells	PLOS ONE			English	Article							PROTEIN; ACTIVATION; DISEASE; CYTOKINES; BRAIN; PTEN; CYCLOOXYGENASE-2; CHONDROCYTES; PHOSPHATASE; EXPRESSION	Background: Resveratrol have been known to possess many pharmacological properties including antioxidant, cardioprotective and anticancer effects. Although current studies indicate that resveratrol produces neuroprotection against neurological disorders, the precise mechanisms for its beneficial effects are still not fully understood. We investigate the effect of anti-inflammatory and mechamisms of resveratrol by using lipopolysaccharide (LPS)-stimulated murine microglial BV-2 cells. Methodology/Principal Findings: BV-2 cells were treated with resveratrol (25, 50, and 100 mu M) and/or LPS (1 mu g/ml). Nitric oxide (NO) and prostaglandin E2 (PGE2) were measured by Griess reagent and ELISA. The mRNA and protein levels of proinflammatory proteins and cytokines were analysed by RT-PCR and double immunofluorescence labeling, respectively. Phosphorylation levels of PTEN (phosphatase and tensin homolog deleted on chromosome 10), Akt, mammalian target of rapamycin (mTOR), mitogen-activated protein kinases (MAPKs) cascades, inhibitor kappa B-alpha (I kappa B-alpha) and cyclic AMP-responsive element-binding protein (CREB) were measured by western blot. Resveratrol significantly attenuated the LPS-induced expression of NO, PGE2, inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta) and nuclear factor-kappa B (NF-kappa B) in BV-2 cells. Resveratrol increased PTEN, Akt and mTOR phosphorylation in a dose-dependent manner or a time-dependent manner. Rapamycin (10 nM), a specific mTOR inhibitor, blocked the effects of resveratrol on LPS-induced microglial activation. In addition, mTOR inhibition partially abolished the inhibitory effect of resveratrol on the phosphorylation of I kappa B-alpha, CREB, extracellular signal-regulated kinase 1/2 (ERK1/2), c-Jun N-terminal protein kinase (JNK), and p38 mitogen-activated protein kinase (p38 MAPK). Conclusion and Implications: This study indicates that resveratrol inhibited LPS-induced proinflammatory enzymes and proinflammatory cytokines via down-regulation phosphorylation of NF-kappa B, CREB and MAPKs family in a mTOR-dependent manner. These findings reveal, in part, the molecular basis underlying the anti-inflammatory properties of resveratrol.	[Zhong, Lian-Mei; Xiao, Chun-Jie] Yunnan Univ, Sch Life Sci, Kunming, Yunnan, Peoples R China; [Zhong, Lian-Mei; Zhang, Wei; Wang, Wen-Min] Kunming Med Univ, Affiliated Hosp 1, Dept Neurol, Kunming, Yunnan, Peoples R China; [Zong, Yi; Guo, Jia-Zhi; He, Ying; Lu, Di] Kunming Med Univ, Dept Anat, Kunming, Yunnan, Peoples R China; [Sun, Lin; Song, Rui] Kunming Med Univ, Affiliated Hosp 2, Dept Cardiol, Kunming, Yunnan, Peoples R China	Yunnan University; Kunming Medical University; Kunming Medical University; Kunming Medical University	Zhong, LM (corresponding author), Yunnan Univ, Sch Life Sci, Kunming, Yunnan, Peoples R China.	xiao2009cj@yahoo.com.cn; ludi20040609@126.com			National Natural Sciences Foundation of China [30860336, 30560170]; Department of Science and Technology of Yunnan Province [2008CC007, 2009CI033]; Joint Special Funds for the Department of Science and Technology of Yunnan Province-Kunming Medical University [2008CD016, 2010CD156, 2011FB177]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Yunnan Province; Joint Special Funds for the Department of Science and Technology of Yunnan Province-Kunming Medical University	This work was supported in part by grants (30860336 and 30560170) from the National Natural Sciences Foundation of China, grants (2008CC007 and 2009CI033) from the Department of Science and Technology of Yunnan Province, and grants (2008CD016, 2010CD156 and 2011FB177) from the Joint Special Funds for the Department of Science and Technology of Yunnan Province-Kunming Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmone-Cat MA, 2003, J NEUROCHEM, V84, P413, DOI 10.1046/j.1471-4159.2003.01562.x; Anekonda TS, 2006, BRAIN RES REV, V52, P316, DOI 10.1016/j.brainresrev.2006.04.004; Ankeny DP, 2009, NEUROSCIENCE, V158, P1112, DOI 10.1016/j.neuroscience.2008.07.001; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Cao Q, 2010, J NEUROSCI RES, V88, P2701, DOI 10.1002/jnr.22429; Choi Y, 2009, BRIT J PHARMACOL, V156, P933, DOI 10.1111/j.1476-5381.2009.00022.x; Danz EDB, 2009, FREE RADICAL BIO MED, V46, P1589, DOI 10.1016/j.freeradbiomed.2009.03.011; Dello Russo C, 2009, BIOCHEM PHARMACOL, V78, P1242, DOI 10.1016/j.bcp.2009.06.097; Doi Y, 2009, AM J PATHOL, V175, P2121, DOI 10.2353/ajpath.2009.090418; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Fontana A, 2010, BRAIN, V133, P1300, DOI 10.1093/brain/awq086; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Hatziieremia S, 2006, BRIT J PHARMACOL, V149, P188, DOI 10.1038/sj.bjp.0706856; Imler TJ, 2009, INT IMMUNOPHARMACOL, V9, P134, DOI 10.1016/j.intimp.2008.10.015; Klegeris A, 2007, CURR OPIN NEUROL, V20, P351, DOI 10.1097/WCO.0b013e3280adc943; Ledesma MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012127; Lee KS, 2006, MOL PHARMACOL, V69, P1829, DOI 10.1124/mol.106.022228; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liang X, 2007, J MOL NEUROSCI, V33, P94, DOI 10.1007/s12031-007-0058-8; Lim JY, 2010, EUR J PHARMACOL, V642, P10, DOI 10.1016/j.ejphar.2010.05.047; Lu DY, 2006, BIOCHEM PHARMACOL, V72, P992, DOI 10.1016/j.bcp.2006.06.038; Lu XF, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-46; Marques FZ, 2009, INT J BIOCHEM CELL B, V41, P2125, DOI 10.1016/j.biocel.2009.06.003; Matsuda T, 2005, AM J TRANSPLANT, V5, P484, DOI 10.1046/j.1600-6143.2004.00716.x; McGeer PL, 2004, PARKINSONISM RELAT D, V10, pS3, DOI 10.1016/j.parkreldis.2004.01.005; Nakajima K, 1998, Hum Cell, V11, P141; Nam KN, 2008, EUR J PHARMACOL, V589, P53, DOI 10.1016/j.ejphar.2008.03.034; Nam KN, 2010, EUR J PHARMACOL, V648, P110, DOI 10.1016/j.ejphar.2010.09.003; Olas B, 2008, PLATELETS, V19, P70, DOI 10.1080/09537100701708506; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Shakibaei M, 2009, MOL NUTR FOOD RES, V53, P115, DOI 10.1002/mnfr.200800148; Shakibaei M, 2008, BIOCHEM PHARMACOL, V76, P1426, DOI 10.1016/j.bcp.2008.05.029; Suzumura A, 2006, ANN NY ACAD SCI, V1088, P219, DOI 10.1196/annals.1366.012; Szczepanik AM, 2003, J ALZHEIMERS DIS, V5, P105, DOI 10.3233/JAD-2003-5205; Tansey MG, 2010, NEUROBIOL DIS, V37, P510, DOI 10.1016/j.nbd.2009.11.004; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Tsoyi K, 2009, ATHEROSCLEROSIS, V207, P412, DOI 10.1016/j.atherosclerosis.2009.05.012; Vaillancourt F, 2007, J CELL BIOCHEM, V100, P1217, DOI 10.1002/jcb.21110; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	43	129	135	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32195	10.1371/journal.pone.0032195	http://dx.doi.org/10.1371/journal.pone.0032195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363816	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700157
J	Britton, JR				Britton, J. Robert			Testing Strength of Biotic Resistance against an Introduced Fish: Inter-Specific Competition or Predation through Facultative Piscivory?	PLOS ONE			English	Article							INVASION-RESISTANCE; TROPHIC POSITION; CONSEQUENCES; MODELS; TROUT	Biotic resistance is the process where aspects of the receiving environment inhibit the establishment and invasion of an introduced species. Resistance against an introduced fish can be through strong competition and/or predation from resident fishes. Here, the biotic resistance against introduced topmouth gudgeon Pseudorasbora parva (a highly invasive fish in Europe) by resident carp Cyprinus carpio was tested in experimental mesocosms. The introduction scenario was six adult P. parva (three male, three female) on a single occasion. Resistance to their establishment was provided by three and six resident C. carpio whose effects on P. parva growth and reproduction were compared to a Control (no resident fish at the time of introduction) and treatments containing three and six P. parva. After 120 days, the growth rates of the introduced P. parva were significantly depressed in C. carpio presence and in mesocosms with three C. carpio present, significantly decreased numbers of 0+P. parva were recorded. Where six C. carpio were present, no 0+P. parva were recorded, indicating resistance strength increased with carp abundance. In contrast, there were no differences in P. parva reproduction and growth rates between the Control and treatments containing conspecifics. Stable isotope analysis (delta N-15, delta C-13) revealed C. carpio were feeding at one trophic level above 0+P. parva, suggesting the process of resistance was predation (facultative piscivory) rather than competition. Thus, if P. parva are to establish and invade following an introduction, they must overcome this biotic resistance from cyprinid fishes such as C. carpio.	Bournemouth Univ, Sch Appl Sci, Ctr Conservat Ecol & Environm Change, Poole BH12 5BB, Dorset, England	Bournemouth University	Britton, JR (corresponding author), Bournemouth Univ, Sch Appl Sci, Ctr Conservat Ecol & Environm Change, Poole BH12 5BB, Dorset, England.	rbritton@bournemouth.ac.uk	Britton, Robert/AAO-6673-2020; Britton, Robert/B-5040-2009	Britton, Robert/0000-0003-1853-3086; Britton, Robert/0000-0003-1853-3086	Natural Environment Research Council (NERC) [NE/H000429/1]; Natural Environment Research Council [NE/H000429/1] Funding Source: researchfish; NERC [NE/H000429/1] Funding Source: UKRI	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Natural Environment Research Council (NERC research grant reference number NE/H000429/1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALTZ DM, 1993, ECOL APPL, V3, P246, DOI 10.2307/1941827; Benjamin JR, 2007, T AM FISH SOC, V136, P875, DOI 10.1577/T06-115.1; Britton JR, 2007, J FISH BIOL, V71, P239, DOI 10.1111/j.1095-8649.2007.01669.x; Britton JR, 2010, FRESHWATER BIOL, V55, P1130, DOI 10.1111/j.1365-2427.2010.02396.x; Britton JR, 2011, ECOL FRESHW FISH, V20, P74, DOI 10.1111/j.1600-0633.2010.00460.x; Britton JR, 2011, BIOL CONSERV, V144, P2177, DOI 10.1016/j.biocon.2011.05.008; Britton JR, 2010, BIOL INVASIONS, V12, P1533, DOI 10.1007/s10530-009-9566-5; Britton JR, 2010, BIOL INVASIONS, V12, P125, DOI 10.1007/s10530-009-9436-1; Carlsson NOL, 2011, FRESHWATER BIOL, V56, P1630, DOI 10.1111/j.1365-2427.2011.02602.x; CASE TJ, 1991, BIOL J LINN SOC, V42, P239, DOI 10.1111/j.1095-8312.1991.tb00562.x; Crawley MJ, 1999, ECOL LETT, V2, P140; Cross WF, 2002, OIKOS, V96, P251, DOI 10.1034/j.1600-0706.2002.960207.x; Cucherousset J, 2012, FISHERIES MANAG ECOL, V19, P111, DOI 10.1111/j.1365-2400.2011.00824.x; deRivera CE, 2005, ECOLOGY, V86, P3364, DOI 10.1890/05-0479; Dzialowski AR, 2007, BIOL INVASIONS, V9, P257, DOI 10.1007/s10530-006-9030-8; Gozlan RE, 2005, NATURE, V435, P1046, DOI 10.1038/4351046a; Gozlan RE, 2010, FISH FISH, V11, P315, DOI 10.1111/j.1467-2979.2010.00361.x; Gozlan RE, 2009, INT J PARASITOL, V39, P1055, DOI 10.1016/j.ijpara.2009.04.012; Grey J, 2006, POL J ECOL, V54, P563; HERBOLD B, 1986, AM NAT, V128, P751, DOI 10.1086/284600; Jensen GC, 2007, MAR BIOL, V151, P2231, DOI 10.1007/s00227-007-0658-4; Korsu K, 2009, NATURWISSENSCHAFTEN, V96, P347, DOI 10.1007/s00114-008-0482-9; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Oyugi DO, 2012, REV FISH BIOL FISHER, V22, P499, DOI 10.1007/s11160-011-9243-5; Pimm SL, 1989, BIOL INVASIONS GLOBA, P351; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; ROBINSON JV, 1988, OECOLOGIA, V77, P445, DOI 10.1007/BF00377258; Simon A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018560; Stachowicz JJ, 1999, SCIENCE, V286, P1577, DOI 10.1126/science.286.5444.1577; Syvaranta J, 2010, AQUAT BIOL, V8, P137, DOI 10.3354/ab00220; Tilman D, 1997, ECOLOGY, V78, P81, DOI 10.1890/0012-9658(1997)078[0081:CIRLAG]2.0.CO;2; Vander Zanden MJ, 2000, CAN J FISH AQUAT SCI, V57, P725, DOI 10.1139/cjfas-57-4-725; Vander Zanden MJ, 1999, NATURE, V401, P464, DOI 10.1038/46762	33	16	16	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31707	10.1371/journal.pone.0031707	http://dx.doi.org/10.1371/journal.pone.0031707			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363711	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000302871500078
J	Li, J; Yu, L; Tian, YM; Zhang, KQ				Li, Juan; Yu, Li; Tian, Yanmei; Zhang, Ke-Qin			Molecular Evolution of the Deuterolysin (M35) Family Genes in Coccidioides	PLOS ONE			English	Article							DETECTING POSITIVE SELECTION; AMINO-ACID SITES; SWISS-MODEL; PHYLOGENETIC ANALYSIS; SEQUENCE ALIGNMENT; LIKELIHOOD METHOD; SOFTWARE PACKAGE; SIDE-CHAIN; RATIO; METALLOPROTEINASE	Coccidioides is a primary fungal pathogen of humans, causing life-threatening respiratory disease known as coccidioidomycosis (Valley fever) in immunocompromised individuals. Recently, Sharpton et al (2009) found that the deuterolysin (M35) family genes were significantly expanded in both the Coccidioides genus and in U. reesii, and that Coccidioides has acquired three more M35 family genes than U. reesii. In the present work, phylogenetic analyses based on a total of 28 M35 family genes using different alignments and tree-building methods consistently revealed five clades with high nodal supports. Interestingly, likelihood ratio tests suggested significant differences in selective pressure on the ancestral lineage of three additional duplicated M35 family genes from Coccidioides species compared to the other lineages in the phylogeny, which may be associated with novel functional adaptations of M35 family genes in the Coccidioides species, e.g., recent pathogenesis acquisition. Our study adds to the expanding view of M35 family gene evolution and functions as well as establishes a theoretical foundation for future experimental investigations.	[Li, Juan] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Minist Educ, Kunming, Peoples R China; Yunnan Univ, Key Lab Microbial Resources, Minist Educ, Kunming, Peoples R China	Yunnan University; Yunnan University	Li, J (corresponding author), Yunnan Univ, Lab Conservat & Utilizat Bioresources, Minist Educ, Kunming, Peoples R China.	kqzhang111@yahoo.com.cn	zhang, ke/AAH-8217-2019		National Natural Science Foundation of China [31100894]; National Basic Research Program of China [2007CB411600]; Science Foundation of Yunnan University [2010C03Z]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Science Foundation of Yunnan University	This work is funded by the National Natural Science Foundation Program of China (31100894), the National Basic Research Program of China (2007CB411600), and the Science Foundation of Yunnan University (approved no. 2010C03Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bielawski Joseph P., 2003, Journal of Structural and Functional Genomics, V3, P201, DOI 10.1023/A:1022642807731; Bielawski JP, 2004, J MOL EVOL, V59, P121, DOI 10.1007/s00239-004-2597-8; Bonferroni C. E., 1936, TEORIA STAT CLASSI C; Bonferroni C. E, 1935, STUDI ONORE PROFESSO, V13; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chapman MA, 2008, MOL BIOL EVOL, V25, P1260, DOI 10.1093/molbev/msn001; Chen K, 2000, J COMPUT BIOL, V7, P429, DOI 10.1089/106652700750050871; Cole GT, 2004, MED MYCOL, V42, P189, DOI 10.1080/13693780410001687349; Creighton TE, 1993, PROTEINS STRUCTURES, P417; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Desjarlais JR, 1999, J MOL BIOL, V290, P305, DOI 10.1006/jmbi.1999.2866; Dixon DM, 2001, J APPL MICROBIOL, V91, P602, DOI 10.1046/j.1365-2672.2001.01496.x; Durand D, 2006, J COMPUT BIOL, V13, P320, DOI 10.1089/cmb.2006.13.320; Dutheil J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-255; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fisher MC, 2002, MYCOLOGIA, V94, P73, DOI 10.2307/3761847; Force A, 1999, GENETICS, V151, P1531; Galgiani JN, 1999, ANN INTERN MED, V130, P293, DOI 10.7326/0003-4819-130-4-199902160-00015; Gillespie J.H., 1992, CAUSES MOL EVOLUTION; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hector RF, 2005, PLOS MED, V2, P15, DOI 10.1371/journal.pmed.0020002; Hector R, 2007, ANN NY ACAD SCI, V1111, P259, DOI 10.1196/annals.1406.035; Hori T, 2001, ACTA CRYSTALLOGR D, V57, P361, DOI 10.1107/S0907444900019740; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hung CY, 2005, INFECT IMMUN, V73, P6689, DOI 10.1128/IAI.73.10.6689-6703.2005; Hung CY, 2002, INFECT IMMUN, V70, P3443, DOI 10.1128/IAI.70.7.3443-3456.2002; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lewis PO, 2005, SYST BIOL, V54, P241, DOI 10.1080/10635150590924208; Loughran NB, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-101; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2001, GENETICS, V159, P1789; McAuley KE, 2001, ACTA CRYSTALLOGR D, V57, P1571, DOI 10.1107/S090744490101335X; Miyoshi S, 2000, MICROBES INFECT, V2, P91, DOI 10.1016/S1286-4579(00)00280-X; Najmanovich R, 2000, PROTEINS, V39, P261, DOI 10.1002/(SICI)1097-0134(20000515)39:3<261::AID-PROT90>3.0.CO;2-4; Nielsen R, 1998, GENETICS, V148, P929; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; Ohno S., 1970, P1; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ramos OHP, 2001, GENET MOL BIOL, V24, P285, DOI 10.1590/S1415-47572001000100037; Saubolle MA, 2007, J CLIN MICROBIOL, V45, P26, DOI 10.1128/JCM.02230-06; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sharpton TJ, 2009, GENOME RES, V19, P1722, DOI 10.1101/gr.087551.108; Smith CE, 1940, AM J PUBLIC HEALTH N, V30, P600, DOI 10.2105/AJPH.30.6.600; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Suzuki Y, 2001, MOL BIOL EVOL, V18, P2179, DOI 10.1093/oxfordjournals.molbev.a003764; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	66	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31536	10.1371/journal.pone.0031536	http://dx.doi.org/10.1371/journal.pone.0031536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363666	Green Published, gold, Green Submitted			2022-12-27	WOS:000302871500055
J	Polo, LM; Gil-Ortiz, F; Cantin, A; Rubio, V				Mariano Polo, Luis; Gil-Ortiz, Fernando; Cantin, Angel; Rubio, Vicente			New Insight into the Transcarbamylase Family: The Structure of Putrescine Transcarbamylase, a Key Catalyst for Fermentative Utilization of Agmatine	PLOS ONE			English	Article							FURIOSUS ORNITHINE CARBAMOYLTRANSFERASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; STREPTOCOCCUS-FAECALIS; DEIMINASE SYSTEM; ENZYME-SYNTHESIS; GENE-CLUSTER; CARBAMYL-P; PROTEIN; ARGININE	Transcarbamylases reversibly transfer a carbamyl group from carbamylphosphate (CP) to an amine. Although aspartate transcarbamylase and ornithine transcarbamylase (OTC) are well characterized, little was known about putrescine transcarbamylase (PTC), the enzyme that generates CP for ATP production in the fermentative catabolism of agmatine. We demonstrate that PTC (from Enterococcus faecalis), in addition to using putrescine, can utilize L-ornithine as a poor substrate. Crystal structures at 2.5 angstrom and 2.0 angstrom resolutions of PTC bound to its respective bisubstrate analog inhibitors for putrescine and ornithine use, N-(phosphonoacetyl)-putrescine and delta-N-(phosphonoacetyl)-L-ornithine, shed light on PTC preference for putrescine. Except for a highly prominent C-terminal helix that projects away and embraces an adjacent subunit, PTC closely resembles OTCs, suggesting recent divergence of the two enzymes. Since differences between the respective 230 and SMG loops of PTC and OTC appeared to account for the differential preference of these enzymes for putrescine and ornithine, we engineered the 230-loop of PTC to make it to resemble the SMG loop of OTCs, increasing the activity with ornithine and greatly decreasing the activity with putrescine. We also examined the role of the C-terminal helix that appears a constant and exclusive PTC trait. The enzyme lacking this helix remained active but the PTC trimer stability appeared decreased, since some of the enzyme eluted as monomers from a gel filtration column. In addition, truncated PTC tended to aggregate to hexamers, as shown both chromatographically and by X-ray crystallography. Therefore, the extra C-terminal helix plays a dual role: it stabilizes the PTC trimer and, by shielding helix 1 of an adjacent subunit, it prevents the supratrimeric oligomerizations of obscure significance observed with some OTCs. Guided by the structural data we identify signature traits that permit easy and unambiguous annotation of PTC sequences.	[Mariano Polo, Luis; Gil-Ortiz, Fernando; Rubio, Vicente] Inst Biomed Valencia, Valencia, Spain; [Mariano Polo, Luis; Gil-Ortiz, Fernando; Rubio, Vicente] Ctr Invest Biomed Red Enfermedades Raras, Valencia, Spain; [Cantin, Angel] Univ Politecn Valencia, Inst Tecnol Quim, Consejo Super Invest Cient, E-46071 Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Tecnologia Quimica (ITQ)	Polo, LM (corresponding author), Inst Biomed Valencia, Valencia, Spain.	rubio@ibv.csic.es	CANOS, AVELINO CORMA/A-3040-2013; Rubio, Vicente/K-7919-2014; Cantin, Angel/I-4282-2015	CANOS, AVELINO CORMA/0000-0002-2232-3527; Rubio, Vicente/0000-0001-8124-1196; Gil-Ortiz, Fernando/0000-0001-5897-2724; Cantin, Angel/0000-0002-3219-1919	Spanish Ministry for Science [BFU2008-05021]; Valencian Government [Prometeo/2009/051]; Consejo Superior de Investigaciones Cientificas-Banco de Santander; JAE-DOC of the Consejo Superior de Investigaciones Cientificas; European Union; European Molecular Biology Laboratory	Spanish Ministry for Science(Spanish Government); Valencian Government; Consejo Superior de Investigaciones Cientificas-Banco de Santander; JAE-DOC of the Consejo Superior de Investigaciones Cientificas; European Union(European Commission); European Molecular Biology Laboratory	This work was supported by grants BFU2008-05021 of the Spanish Ministry for Science and Prometeo/2009/051 of the Valencian Government. The European Union and the European Molecular Biology Laboratory funded synchrotron visits. LMP was supported by a Consejo Superior de Investigaciones Cientificas-Banco de Santander fellowship and FGO by a JAE-DOC contract of the Consejo Superior de Investigaciones Cientificas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOKI Y, 1988, BIOCHEM J, V250, P735, DOI 10.1042/bj2500735; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Chen JS, 2009, FOODBORNE PATHOG DIS, V6, P365, DOI 10.1089/fpd.2008.0207; Clantin B, 2001, EUR J BIOCHEM, V268, P3937, DOI 10.1046/j.1432-1327.2001.02302.x; CUNIN R, 1986, MICROBIOL REV, V50, P314, DOI 10.1128/MMBR.50.3.314-352.1986; de las Rivas B, 2009, J MOL BIOL, V393, P425, DOI 10.1016/j.jmb.2009.08.002; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; EVANS DR, 1993, BIOCHEM SOC T, V21, P186, DOI 10.1042/bst0210186; Galkin A, 2009, PROTEINS, V76, P1049, DOI 10.1002/prot.22469; Gileadi Opher, 2008, V426, P221, DOI 10.1007/978-1-60327-058-8_14; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; Griswold AR, 2006, J BACTERIOL, V188, P834, DOI 10.1128/JB.188.3.834-841.2006; Griswold AR, 2004, J BACTERIOL, V186, P1902, DOI 10.1128/JB.186.6.1902-1904.2004; Ha Y, 1997, P NATL ACAD SCI USA, V94, P9550, DOI 10.1073/pnas.94.18.9550; JONES ME, 1963, SCIENCE, V140, P1373, DOI 10.1126/science.140.3574.1373; KANTROWITZ ER, 1988, SCIENCE, V241, P669, DOI 10.1126/science.3041592; Keefe AD, 1995, J MOL EVOL, V41, P693; Kotaka M, 2006, J BIOL CHEM, V281, P31544, DOI 10.1074/jbc.M605886200; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUO LC, 1988, BIOCHEMISTRY-US, V27, P8823, DOI 10.1021/bi00424a021; Labedan B, 1999, J MOL EVOL, V49, P461, DOI 10.1007/PL00006569; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landete JM, 2010, INT MICROBIOL, V13, P169, DOI 10.2436/20.1501.01.123; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Legrain C, 1997, EUR J BIOCHEM, V247, P1046, DOI 10.1111/j.1432-1033.1997.01046.x; Lipscomb WN, 2011, ACC CHEM RES IN PRES; Liu YL, 2009, J BACTERIOL, V191, P7363, DOI 10.1128/JB.01054-09; Liu YL, 2009, APPL ENVIRON MICROB, V75, P2629, DOI 10.1128/AEM.02145-08; Llacer JL, 2007, J BACTERIOL, V189, P1254, DOI 10.1128/JB.01216-06; Low DE, 2001, CLIN INFECT DIS, V32, pS133, DOI 10.1086/320185; MARSHALL M, 1972, J BIOL CHEM, V247, P1654; Massant J, 2003, ACTA CRYSTALLOGR D, V59, P2140, DOI 10.1107/S0907444903019231; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Naumoff DG, 2004, MICROBIOL-SGM, V150, P3908, DOI 10.1099/mic.0.27640-0; Naumoff DG, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-52; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Ramon-Maiques S, 2002, BIOCHEMISTRY-US, V41, P3916, DOI 10.1021/bi011637d; ROBEY EA, 1985, P NATL ACAD SCI USA, V82, P361, DOI 10.1073/pnas.82.2.361; Rulisek L, 1998, J INORG BIOCHEM, V71, P115, DOI 10.1016/S0162-0134(98)10042-9; Shi DS, 1998, J BIOL CHEM, V273, P34247, DOI 10.1074/jbc.273.51.34247; SIMON JP, 1982, J BACTERIOL, V150, P1085, DOI 10.1128/JB.150.3.1085-1090.1982; SIMON JP, 1982, J BACTERIOL, V152, P676; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TIGIER H, 1965, BIOCHEM BIOPH RES CO, V19, P209, DOI 10.1016/0006-291X(65)90506-1; VANDERWAUVEN C, 1986, ARCH MICROBIOL, V145, P386, DOI 10.1007/BF00470876; VILLERET V, 1995, P NATL ACAD SCI USA, V92, P10762, DOI 10.1073/pnas.92.23.10762; Villeret V, 1998, P NATL ACAD SCI USA, V95, P2801, DOI 10.1073/pnas.95.6.2801; WARGNIES B, 1979, EUR J BIOCHEM, V101, P143, DOI 10.1111/j.1432-1033.1979.tb04226.x; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Xi HL, 2000, J BACTERIOL, V182, P5332, DOI 10.1128/JB.182.19.5332-5341.2000; Xu Y, 2007, MICROBIOL MOL BIOL R, V71, P36, DOI 10.1128/MMBR.00032-06; Zhang PF, 2009, BIOCHEMISTRY-US, V48, P766, DOI 10.1021/bi801831r	57	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31528	10.1371/journal.pone.0031528	http://dx.doi.org/10.1371/journal.pone.0031528			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363663	Green Published, Green Submitted, gold			2022-12-27	WOS:000302871500052
J	Spindler, SR; Li, R; Dhahbi, JM; Yamakawa, A; Sauer, F				Spindler, Stephen R.; Li, Rui; Dhahbi, Joseph M.; Yamakawa, Amy; Sauer, Frank			Novel Protein Kinase Signaling Systems Regulating Lifespan Identified by Small Molecule Library Screening Using Drosophila	PLOS ONE			English	Article							DIETARY RESTRICTION; GROWTH; INHIBITORS; PATHWAY; ASSAY	Protein kinase signaling cascades control most aspects of cellular function. The ATP binding domains of signaling protein kinases are the targets of most available inhibitors. These domains are highly conserved from mammals to flies. Herein we describe screening of a library of small molecule inhibitors of protein kinases for their ability to increase Drosophila lifespan. We developed an assay system which allowed screening using the small amounts of materials normally present in commercial chemical libraries. The studies identified 17 inhibitors, the majority of which targeted tyrosine kinases associated with the epidermal growth factor receptor (EGFR), platelet-derived growth factor (PDGF)/vascular endothelial growth factor (VEGF) receptors, G-protein coupled receptor (GPCR), Janus kinase (JAK)/signal transducer and activator of transcription (STAT), the insulin and insulin-like growth factor (IGFI) receptors. Comparison of the protein kinase signaling effects of the inhibitors in vitro defined a consensus intracellular signaling profile which included decreased signaling by p38MAPK (p38), c-Jun N-terminal kinase (JNK) and protein kinase C (PKC). If confirmed, many of these kinases will be novel additions to the signaling cascades known to regulate metazoan longevity.	[Spindler, Stephen R.; Li, Rui; Dhahbi, Joseph M.; Yamakawa, Amy; Sauer, Frank] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Spindler, SR (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	spindler@ucr.edu			Alva LLC	Alva LLC	The research was supported by Alva LLC, a private, basic research foundation. Alva has no web site. To the best of the authors' knowledge, Alva is not associated with any commercial entity. The one agreement the author was asked to (and did) make with Alva regarding their funding is that the author make the results freely available and report them in peer reviewed publications. Alva's funder, a high net worth individual, prefers to remain anonymous. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Aritakula A, 2008, J BIOSCIENCES, V33, P731, DOI 10.1007/s12038-008-0093-9; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Baldal EA, 2005, MECH AGEING DEV, V126, P407, DOI 10.1016/j.mad.2004.09.035; Biteau B, 2011, EXP GERONTOL, V46, P349, DOI 10.1016/j.exger.2010.11.003; Chen JM, 2010, P NATL ACAD SCI USA, V107, P20774, DOI 10.1073/pnas.1009223107; Clancy David J., 2001, Drosophila Information Service, V84, P168; DRIVER CJI, 1986, EXP GERONTOL, V21, P497, DOI 10.1016/0531-5565(86)90002-1; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Goto M, 2008, BIOSCI TRENDS, V2, P218; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Johnson EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012799; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Karpac J, 2009, TRENDS ENDOCRIN MET, V20, P100, DOI 10.1016/j.tem.2008.11.004; LAMB MJ, 1968, NATURE, V220, P808, DOI 10.1038/220808a0; Li R, 2011, PLOS ONE IN PRESS; Libert S, 2008, MOL IMMUNOL, V45, P810, DOI 10.1016/j.molimm.2007.06.353; Mair W, 2005, PLOS BIOL, V3, P1305, DOI 10.1371/journal.pbio.0030223; MILLER RS, 1958, ECOLOGY, V39, P118, DOI 10.2307/1929973; Min KJ, 2006, MECH AGEING DEV, V127, P93, DOI 10.1016/j.mad.2005.09.004; Min KJ, 2007, EXP GERONTOL, V42, P247, DOI 10.1016/j.exger.2006.10.009; Oliva JL, 2005, GROWTH FACTORS, V23, P245, DOI 10.1080/08977190500366043; Spindler SR, 2010, FUTURE OF AGING: PATHWAYS TO HUMAN LIFE EXTENSION, P367, DOI 10.1007/978-90-481-3999-6_12; Spindler SR, 2010, AGEING RES REV, V9, P324, DOI 10.1016/j.arr.2009.10.003; Tohyama D, 2010, BIOCHEM BIOPH RES CO, V394, P112, DOI 10.1016/j.bbrc.2010.02.126; Tschape JA, 2002, EMBO J, V21, P6367, DOI 10.1093/emboj/cdf636; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X	28	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e29782	10.1371/journal.pone.0029782	http://dx.doi.org/10.1371/journal.pone.0029782			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363408	Green Published, gold, Green Submitted			2022-12-27	WOS:000302871500002
J	Sun, XQ; Zhu, YJ; Guo, JL; Peng, B; Bai, MM; Hang, YY				Sun, Xiao-Qin; Zhu, Ying-Jie; Guo, Jian-Lin; Peng, Bin; Bai, Ming-Ming; Hang, Yue-Yu			DNA Barcoding the Dioscorea in China, a Vital Group in the Evolution of Monocotyledon: Use of matK Gene for Species Discrimination	PLOS ONE			English	Article							LAND PLANTS; PSBA-TRNH; PHYLOGENY; TAXONOMY; RBCL; IDENTIFICATION; STENOPHORA; REGION; SPACER	Background: Dioscorea is an important plant genus in terms of food supply and pharmaceutical applications. However, its classification and identification are controversial. DNA barcoding is a recent aid to taxonomic identification and uses a short standardized DNA region to discriminate plant species. In this study, the applicability of three candidate DNA barcodes (rbcL, matK, and psbA-trnH) to identify species within Dioscorea was tested. Methodology/Principal Findings: One-hundred and forty-eight individual plant samples of Dioscorea, encompassing 38 species, seven varieties and one subspecies, representing majority species distributed in China of this genus, were collected from its main distributing areas. Samples were assessed by PCR amplification, sequence quality, extent of specific genetic divergence, DNA barcoding gap, and the ability to discriminate between species. matK successfully identified 23.26% of all species, compared with 9.30% for rbcL and 11.63% for psbA-trnH. Therefore, matK is recommended as the best DNA barcoding candidate. We found that the combination of two or three loci achieved a higher success rate of species discrimination than one locus alone. However, experimental cost would be much higher if two or three loci, rather than a single locus, were assessed. Conclusions: We conclude that matK is a strong, although not perfect, candidate as a DNA barcode for Dioscorea identification. This assessment takes into account both its ability for species discrimination and the cost of experiments.	[Sun, Xiao-Qin; Guo, Jian-Lin; Peng, Bin; Bai, Ming-Ming; Hang, Yue-Yu] Inst Bot, Jiangsu Prov Key Lab Plant Ex Situ Conservat, Nanjing, Jiangsu, Peoples R China; [Sun, Xiao-Qin; Guo, Jian-Lin; Peng, Bin; Bai, Ming-Ming; Hang, Yue-Yu] Chinese Acad Sci, Nanjing, Jiangsu, Peoples R China; [Zhu, Ying-Jie] Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plant Dev, Beijing 100730, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College	Sun, XQ (corresponding author), Inst Bot, Jiangsu Prov Key Lab Plant Ex Situ Conservat, Nanjing, Jiangsu, Peoples R China.	hangyueyu@yahoo.com.cn	Zhu, Yingjie/W-3315-2017	Zhu, Yingjie/0000-0003-1849-6019	Chinese Academy of Sciences [2009-LSF-GBOWS-01]	Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by the Research Fund for the Largescale Scientific Facilities of the Chinese Academy of Sciences (2009-LSF-GBOWS-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRICH J, 1988, CURR GENET, V14, P137, DOI 10.1007/BF00569337; Applezweig N, 1962, STEROID DRUGS; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; BURKILL I. H., 1951, FLORA MALESIANA, V4, P293; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Chin H. C., 1985, ACTA PHYTOTAXON SIN, V23, P11; CORRELL D. S., 1955, ECON BOT, V9, P307, DOI 10.1007/BF02985309; Coursey D. G., 1967, TROPICAL AGR SERIES; DAHLGREN G, 1989, BOT J LINN SOC, V100, P197, DOI 10.1111/j.1095-8339.1989.tb01717.x; Degras L., 1993, The yam: a tropical root crop.; Fay Michael F., 1997, Kew Bulletin, V52, P111, DOI 10.2307/4117844; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Fujii K., 1936, J PHARM SOC JAPAN, V56, P408; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hajibabaei M, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-24; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hollingsworth PM, 2008, HEREDITY, V101, P1, DOI 10.1038/hdy.2008.16; Huang Chun-hong, 2003, Acta Botanica Yunnanica, V25, P641; Kawabe A, 1997, GENES GENET SYST, V72, P253, DOI 10.1266/ggs.72.253; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2008, P NATL ACAD SCI USA, V105, P2761, DOI 10.1073/pnas.0800476105; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; LAHAYE R, 2008, TEST PSBK PSBI ATPF; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; LAWTON J. R. W., 1967, PROC LINN SOC LONDON, V178, P153; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Logacheva MD, 2008, PLANT SYST EVOL, V270, P139, DOI 10.1007/s00606-007-0619-x; Marshall E, 2005, SCIENCE, V307, P1037, DOI 10.1126/science.307.5712.1037; Mast AR, 2002, AM J BOT, V89, P1311, DOI 10.3732/ajb.89.8.1311; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miege J, 1982, YAMS IGNAMES, P243; Miller JT, 2003, SYST BOT, V28, P558; Newmaster S G, 2008, Mol Ecol Resour, V8, P480, DOI 10.1111/j.1471-8286.2007.02002.x; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Okonkwo S. N. C., 1985, ADV YAM RES BIOCH TE, P3; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Pennisi E, 2007, SCIENCE, V318, P190, DOI 10.1126/science.318.5848.190; RAMACHANDRAN K, 1968, CYTOLOGIA, V33, P401, DOI 10.1508/cytologia.33.401; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Schindel DE, 2005, NATURE, V435, P17, DOI 10.1038/435017b; Schols P, 2005, SYST BOT, V30, P750, DOI 10.1600/036364405775097743; Schols P, 2003, BOT J LINN SOC, V143, P375, DOI 10.1111/j.1095-8339.2003.00227.x; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; SMITH BEN W., 1937, BULL TORREY BOT CLUB, V64, P189, DOI 10.2307/2481142; Su P, 1987, ACTA PHYTOTAXONOMICA, V25, P357; Tate JA, 2003, SYST BOT, V28, P723; Thomas C, 2009, SCIENCE, V325, P526, DOI 10.1126/science.325_526; Wan J.R., 1994, ACTA BOT BOREALI-OCC, V14, P128; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Whipple IG, 2007, AM J BOT, V94, P551, DOI 10.3732/ajb.94.4.551; Wilkin P, 2005, SYST BOT, V30, P736, DOI 10.1600/036364405775097879; Winkworth RC, 2005, AM J BOT, V92, P653, DOI 10.3732/ajb.92.4.653; Gao X, 2008, J SYST EVOL, V46, P315, DOI 10.3724/SP.J.1002.2008.08007; Yoo HS, 2006, MOL CELLS, V22, P323; Zhang MZ, 1982, COMP ANATOMY CHINESE, P1	60	26	39	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e32057	10.1371/journal.pone.0032057	http://dx.doi.org/10.1371/journal.pone.0032057			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363795	Green Published, Green Submitted, gold			2022-12-27	WOS:000302871500108
J	Wang, LZ; Beuerle, T; Timbilla, J; Ober, D				Wang, Linzhu; Beuerle, Till; Timbilla, James; Ober, Dietrich			Independent Recruitment of a Flavin-Dependent Monooxygenase for Safe Accumulation of Sequestered Pyrrolizidine Alkaloids in Grasshoppers and Moths	PLOS ONE			English	Article							N-OXIDE; CYTOCHROME-P450; SEQUESTRATION; METABOLISM; LEPIDOPTERA; DEFENSE; ENZYME	Several insect lineages have developed diverse strategies to sequester toxic pyrrolizidine alkaloids from food-plants for their own defense. Here, we show that in two highly divergent insect taxa, the hemimetabolous grasshoppers and the holometabolous butterflies, an almost identical strategy evolved independently for safe accumulation of pyrrolizidine alkaloids. This strategy involves a pyrrolizidine alkaloid N-oxygenase that transfers the pyrrolizidine alkaloids to their respective N-oxide, enabling the insects to avoid high concentrations of toxic pyrrolizidine alkaloids in the hemolymph. We have identified a pyrrolizidine alkaloid N-oxygenase, which is a flavin-dependent monooxygenase, of the grasshopper Zonocerus variegatus. After heterologous expression in E. coli, this enzyme shows high specificity for pyrrolizidine alkaloids of various structural types and for the tropane alkaloid atropine as substrates, a property that has been described previously for a pyrrolizidine alkaloid N-oxygenase of the arctiid moth Grammia geneura. Phylogenetic analyses of insect flavin-dependent monooxygenase sequences suggest that independent gene duplication events preceded the establishment of this specific enzyme in the lineages of the grasshoppers and of arctiid moths. Two further flavin-dependent monooxygenase sequences have been identified from Z. variegatus sharing amino acid identities of approximately 78% to the pyrrolizidine alkaloid N-oxygenase. After heterologous expression, both enzymes are also able to catalyze the N-oxygenation of pyrrolizidine alkaloids, albeit with a 400-fold lower specific activity. With respect to the high sequence identity between the three Z. variegatus sequences this ability to N-oxygenize pyrrolizidine alkaloids is interpreted as a relict of a former bifunctional ancestor gene of which one of the gene copies optimized this activity for the specific adaptation to pyrrolizidine alkaloid containing food plants.	[Wang, Linzhu; Ober, Dietrich] Univ Kiel, Inst Bot, D-2300 Kiel, Germany; [Wang, Linzhu; Ober, Dietrich] Univ Kiel, Bot Garden, Kiel, Germany; [Beuerle, Till] Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmaceut Biol, D-38106 Braunschweig, Germany; [Timbilla, James] CUNY Queensborough Community Coll, New York, NY 11364 USA	University of Kiel; University of Kiel; Braunschweig University of Technology; City University of New York (CUNY) System	Wang, LZ (corresponding author), Univ Wurzburg, Wurzburg, Germany.	dober@bot.uni-kiel.de		Beuerle, Till/0000-0001-5037-6653				Ai JW, 2010, MOL BIOL REP, V37, P1657, DOI 10.1007/s11033-009-9580-9; Alfieri A, 2008, P NATL ACAD SCI USA, V105, P6572, DOI 10.1073/pnas.0800859105; BERNAYS E, 1977, J ZOOL, V182, P85, DOI 10.1111/j.1469-7998.1977.tb04142.x; Bernays EA, 2000, J CHEM ECOL, V26, P1773, DOI 10.1023/A:1005578804865; Boppre M., 1994, NEW TRENDS LOCUST CO, P107; Cashman JR, 2005, BIOCHEM BIOPH RES CO, V338, P599, DOI 10.1016/j.bbrc.2005.08.009; CASHMAN JR, 1995, CHEM RES TOXICOL, V8, P165, DOI 10.1021/tx00044a001; CHAPMAN RF, 1986, ANNU REV ENTOMOL, V31, P479, DOI 10.1146/annurev.en.31.010186.002403; Dobler S, 2000, J CHEM ECOL, V26, P1281, DOI 10.1023/A:1005444313447; EHMKE A, 1991, J CHEM ECOL, V17, P2367, DOI 10.1007/BF00994588; EISNER T, 1995, P NATL ACAD SCI USA, V92, P50, DOI 10.1073/pnas.92.1.50; Eswaramoorthy S, 2006, P NATL ACAD SCI USA, V103, P9832, DOI 10.1073/pnas.0602398103; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Feyereisen R., 2005, P1; Fraaije MW, 2002, FEBS LETT, V518, P43, DOI 10.1016/S0014-5793(02)02623-6; Hartmann T, 2000, TOP CURR CHEM, V209, P207; HARTMANN T, 1990, BIOCHEM SYST ECOL, V18, P549, DOI 10.1016/0305-1978(90)90127-2; Hartmann T, 2001, INSECT BIOCHEM MOLEC, V31, P1041, DOI 10.1016/S0965-1748(01)00052-2; Hartmann Thomas, 2009, P55; Hartmann Thomas, 2008, P213, DOI 10.1007/978-1-4020-8182-8_10; Huan JY, 1998, TOXICOL LETT, V99, P127, DOI 10.1016/S0378-4274(98)00152-0; Hung CF, 1997, INSECT BIOCHEM MOLEC, V27, P377, DOI 10.1016/S0965-1748(97)00009-X; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kekeunou S, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-17; Langel D, 2011, PHYTOCHEMIS IN PRESS, DOI [10.1016/j.phytochem.2010.012.1014, DOI 10.1016/J.PHYTOCHEM.2010.1012.1014]; Li WM, 2003, P NATL ACAD SCI USA, V100, P14593, DOI 10.1073/pnas.1934643100; Li XC, 2004, P NATL ACAD SCI USA, V101, P2939, DOI 10.1073/pnas.0308691101; Lindigkeit R, 1997, EUR J BIOCHEM, V245, P626, DOI 10.1111/j.1432-1033.1997.00626.x; Mattocks A.R., 1986, CHEM TOXICOLOGY PYRR; Narberhaus I, 2003, J COMP PHYSIOL B, V173, P483, DOI 10.1007/s00360-003-0356-6; Naumann C, 2002, P NATL ACAD SCI USA, V99, P6085, DOI 10.1073/pnas.082674499; Ober D, 1999, J BIOL CHEM, V274, P32040, DOI 10.1074/jbc.274.45.32040; PASTEELS JM, 1988, ENTOMOL EXP APPL, V49, P55, DOI 10.1111/j.1570-7458.1988.tb02476.x; PHILLIPS IR, 1995, CHEM-BIOL INTERACT, V96, P17, DOI 10.1016/0009-2797(94)03580-2; ROTHSCHILD M, 1979, BIOL J LINN SOC, V12, P305, DOI 10.1111/j.1095-8312.1979.tb00062.x; Sehlmeyer S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010435; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tijet N, 2001, GENE, V262, P189, DOI 10.1016/S0378-1119(00)00533-3; VONNICKISCHROSENEGK E, 1993, J CHEM ECOL, V19, P1889, DOI 10.1007/BF00983794; WILLIAMS DE, 1989, DRUG METAB DISPOS, V17, P380	40	17	17	6	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31796	10.1371/journal.pone.0031796	http://dx.doi.org/10.1371/journal.pone.0031796			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363737	Green Published, Green Submitted, gold			2022-12-27	WOS:000302871500090
J	Zhang, H; Van der Lee, T; Waalwijk, C; Chen, WQ; Xu, J; Xu, JS; Zhang, Y; Feng, J				Zhang, Hao; Van der Lee, Theo; Waalwijk, Cees; Chen, Wanquan; Xu, Jin; Xu, Jingsheng; Zhang, Ye; Feng, Jie			Population Analysis of the Fusarium graminearum Species Complex from Wheat in China Show a Shift to More Aggressive Isolates	PLOS ONE			English	Article							HEAD BLIGHT PATHOGEN; MYCOTOXIN CHEMOTYPES; GENETIC DIVERSITY; GIBBERELLA-ZEAE; F-ASIATICUM; BARLEY; CLADE; DEOXYNIVALENOL; RECOGNITION; RESISTANCE	A large number of Fusarium isolates was collected from blighted wheat spikes originating from 175 sampling sites, covering 15 provinces in China. Species and trichothecene chemotype determination by multilocus genotyping (MLGT) indicated that F. graminearum s. str. with the 15-acetyl deoxynivalenol (15ADON) chemotype and F. asiaticum with either the nivalenol (NIV) or the 3-acetyl deoxynivalenol (3ADON) chemotype were the dominant causal agents. Bayesian model-based clustering with allele data obtained with 12 variable number of tandem repeats (VNTR) markers, detected three genetic clusters that also show distinct chemotypes. High levels of population genetic differentiation and low levels of effective number of migrants were observed between these three clusters. Additional genotypic analyses revealed that F. graminearum s. str. and F. asiaticum are sympatric. In addition, composition analysis of these clusters indicated a biased gene flow from 3ADON to NIV producers in F. asiaticum. In phenotypic analyses, F. asiaticum that produce 3ADON revealed significant advantages over F. asiaticum that produce NIV in pathogenicity, growth rate, fecundity, conidial length, trichothecene accumulation and resistance to benzimidazole. These results suggest that natural selection drives the spread of a more vigorous, more toxigenic pathogen population which also shows higher levels of fungicide resistance.	[Zhang, Hao; Chen, Wanquan; Xu, Jin; Xu, Jingsheng; Zhang, Ye; Feng, Jie] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Van der Lee, Theo; Waalwijk, Cees] Plant Res Int, Wageningen, Netherlands	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Zhang, H (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	wqchen@ippcaas.cn; jfeng@ippcaas.cn	Waalwijk, Cees/B-2522-2013; vanderlee, Theo A.J./J-7296-2013; Waalwijk, Cees/X-9439-2019	Waalwijk, Cees/0000-0001-5367-2108; Zhang, Hao/0000-0002-2155-0592	National Basic Research and Development Program (973 Program) [2009CB119200]; project of Special Fund for Agro-scientific Research in the Public Interest [nyhyzx07-048]; International Scientific and Technical Cooperation [2009DFA31980]	National Basic Research and Development Program (973 Program)(National Basic Research Program of China); project of Special Fund for Agro-scientific Research in the Public Interest; International Scientific and Technical Cooperation	This work was supported by the National Basic Research and Development Program (973 Program) (no. 2009CB119200), and a project of Special Fund for Agro-scientific Research in the Public Interest (nyhyzx07-048), and a project of International Scientific and Technical Cooperation (No. 2009DFA31980). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Alexander NJ, 1998, APPL ENVIRON MICROB, V64, P221; [Anonymous], 2000, P INT S WHEAT IMPROV; Bai GH, 1996, PLANT DIS, V80, P975, DOI 10.1094/PD-80-0975; Chen CJ, 2009, PHYTOPATHOLOGY, V99, P1403, DOI 10.1094/PHYTO-99-12-1403; CWSCG, 1984, J SHANGHAI NORMAL CO, P69; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Gale LR, 2011, PHYTOPATHOLOGY, V101, P124, DOI 10.1094/PHYTO-03-10-0067; Gale LR, 2005, GENETICS, V171, P985, DOI 10.1534/genetics.105.044842; Gale LR, 2002, PHYTOPATHOLOGY, V92, P1315, DOI 10.1094/PHYTO.2002.92.12.1315; Geiser DM, 2004, EUR J PLANT PATHOL, V110, P473, DOI 10.1023/B:EJPP.0000032386.75915.a0; Guo XW, 2008, PLANT DIS, V92, P756, DOI 10.1094/PDIS-92-5-0756; Ji L, 2007, J PHYTOPATHOL, V155, P505, DOI 10.1111/j.1439-0434.2007.01270.x; Ji LJ, 2007, POPULATION GENETIC D, P8; Jurgenson JE, 2002, GENETICS, V160, P1451; Karugia GW, 2009, PLANT DIS, V93, P170, DOI 10.1094/PDIS-93-2-0170; Karugia GW, 2009, J GEN PLANT PATHOL, V75, P110, DOI 10.1007/s10327-009-0153-5; Kimura M, 1998, J BIOL CHEM, V273, P1654, DOI 10.1074/jbc.273.3.1654; Lee J, 2009, APPL ENVIRON MICROB, V75, P3289, DOI 10.1128/AEM.02287-08; Li Wei, 2010, Mycosystema, V29, P51; Liddell CM, 2003, FUSARIUM HEAD BLIGHT OF WHEAT & BARLEY, P35; McMullen M, 1997, PLANT DIS, V81, P1340, DOI 10.1094/PDIS.1997.81.12.1340; MILLER JD, 1991, MYCOLOGIA, V83, P121, DOI 10.2307/3759927; Monds RD, 2005, MYCOL RES, V109, P410, DOI 10.1017/S0953756204002217; O'Donnell K, 2004, FUNGAL GENET BIOL, V41, P600, DOI 10.1016/j.fgb.2004.03.003; O'Donnell K, 2000, P NATL ACAD SCI USA, V97, P7905, DOI 10.1073/pnas.130193297; O'Donnell K, 2008, FUNGAL GENET BIOL, V45, P1514, DOI 10.1016/j.fgb.2008.09.002; PARRY DW, 1995, PLANT PATHOL, V44, P207, DOI 10.1111/j.1365-3059.1995.tb02773.x; Pestka JJ, 2005, J TOXICOL ENV HEAL B, V8, P39, DOI 10.1080/10937400590889458; Pritchard JK, 2000, GENETICS, V155, P945; Puri KD, 2010, PHYTOPATHOLOGY, V100, P1007, DOI 10.1094/PHYTO-12-09-0332; Qu B, 2008, PLANT PATHOL, V57, P15, DOI 10.1111/j.1365-3059.2007.01711.x; Sarver BAJ, 2011, FUNGAL GENET BIOL, V48, P1096, DOI 10.1016/j.fgb.2011.09.002; Starkey DE, 2007, FUNGAL GENET BIOL, V44, P1191, DOI 10.1016/j.fgb.2007.03.001; Suga H, 2008, PHYTOPATHOLOGY, V98, P159, DOI 10.1094/PHYTO-98-2-0159; Suga H, 2004, MOL ECOL NOTES, V4, P468, DOI 10.1111/j.1471-8286.2004.00703.x; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; UENO Y, 1973, J BIOCHEM-TOKYO, V74, P285; Vogelgsang S, 2009, EUR J PLANT PATHOL, V123, P477, DOI 10.1007/s10658-008-9379-x; Waalwijk C, 2004, EUR J PLANT PATHOL, V110, P481, DOI 10.1023/B:EJPP.0000032387.52385.13; Ward TJ, 2002, P NATL ACAD SCI USA, V99, P9278, DOI 10.1073/pnas.142307199; Ward TJ, 2008, FUNGAL GENET BIOL, V45, P473, DOI 10.1016/j.fgb.2007.10.003; Yang L, 2008, PHYTOPATHOLOGY, V98, P719, DOI 10.1094/PHYTO-98-6-0719; Yli-Mattila T, 2009, MYCOLOGIA, V101, P841, DOI 10.3852/08-217; Zhang H, 2010, PHYTOPATHOLOGY, V100, P328, DOI 10.1094/PHYTO-100-4-0328; Zhang JB, 2007, MYCOL RES, V111, P967, DOI 10.1016/j.mycres.2007.06.008; Zhang Z, 2010, EUR J PLANT PATHOL, V127, P239, DOI 10.1007/s10658-010-9588-y; Zhuang QS., 2003, CHINESE WHEAT IMPROV	49	116	140	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31722	10.1371/journal.pone.0031722	http://dx.doi.org/10.1371/journal.pone.0031722			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363714	Green Published, gold, Green Submitted			2022-12-27	WOS:000302871500081
J	Hardoim, PR; Hardoim, CCP; van Overbeek, LS; van Elsas, JD				Hardoim, Pablo R.; Hardoim, Cristiane C. P.; van Overbeek, Leonard S.; van Elsas, Jan Dirk			Dynamics of Seed-Borne Rice Endophytes on Early Plant Growth Stages	PLOS ONE			English	Article							SP-NOV.; BACTERIAL ENDOPHYTES; PROMOTING RHIZOBACTERIA; ENTEROBACTER-CLOACAE; BIOLOGICAL-CONTROL; ROOT COLONIZATION; GEN. NOV.; DIVERSITY; SOIL; COMMUNITIES	Bacterial endophytes are ubiquitous to virtually all terrestrial plants. With the increasing appreciation of studies that unravel the mutualistic interactions between plant and microbes, we increasingly value the beneficial functions of endophytes that improve plant growth and development. However, still little is known on the source of established endophytes as well as on how plants select specific microbial communities to establish associations. Here, we used cultivation-dependent and independent approaches to assess the endophytic bacterrial community of surface-sterilized rice seeds, encompassing two consecutive rice generations. We isolated members of nine bacterial genera. In particular, organisms affiliated with Stenotrophomonas maltophilia and Ochrobactrum spp. were isolated from both seed generations. PCR-based denaturing gradient gel electrophoresis (PCR-DGGE) of seed-extracted DNA revealed that approximately 45% of the bacterial community from the first seed generation was found in the second generation as well. In addition, we set up a greenhouse experiment to investigate abiotic and biotic factors influencing the endophytic bacterial community structure. PCR-DGGE profiles performed with DNA extracted from different plant parts showed that soil type is a major effector of the bacterial endophytes. Rice plants cultivated in neutral-pH soil favoured the growth of seed-borne Pseudomonas oryzihabitans and Rhizobium radiobacter, whereas Enterobacter-like and Dyella ginsengisoli were dominant in plants cultivated in low-pH soil. The seed-borne Stenotrophomonas maltophilia was the only conspicuous bacterial endophyte found in plants cultivated in both soils. Several members of the endophytic community originating from seeds were observed in the rhizosphere and surrounding soils. Their impact on the soil community is further discussed.	[Hardoim, Pablo R.; Hardoim, Cristiane C. P.; van Elsas, Jan Dirk] Univ Groningen, Ctr Ecol & Evolutionary Studies, Dept Microbial Ecol, Groningen, Netherlands; [Hardoim, Pablo R.; van Overbeek, Leonard S.] Plant Res Int, Wageningen, Netherlands	University of Groningen	Hardoim, PR (corresponding author), Univ Groningen, Ctr Ecol & Evolutionary Studies, Dept Microbial Ecol, Groningen, Netherlands.	phardoim@gmail.com	Hardoim, Cristiane C.P./D-4544-2015; Hardoim, Pablo Rodrigo/M-7048-2013	Hardoim, Cristiane C.P./0000-0003-4650-0177; Hardoim, Pablo Rodrigo/0000-0002-5079-4959	University of Groningen; Plant Research International	University of Groningen; Plant Research International(Plant Research International)	This study was supported by a collaborative agreement between the University of Groningen and Plant Research International. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandham R, 2008, J BASIC MICROB, V48, P439, DOI 10.1002/jobm.200700380; Andreote FD, 2009, APPL ENVIRON MICROB, V75, P3396, DOI 10.1128/AEM.00491-09; BAKER KF, 1966, ANNU REV PHYTOPATHOL, V14, P311; Behrendt U, 2002, INT J SYST EVOL MICR, V52, P1441, DOI 10.1099/00207713-52-5-1441; Belimov AA, 2001, CAN J MICROBIOL, V47, P642, DOI 10.1139/cjm-47-7-642; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Collavino MM, 2010, BIOL FERT SOILS, V46, P727, DOI 10.1007/s00374-010-0480-x; Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Cottyn B, 2009, J APPL MICROBIOL, V107, P885, DOI 10.1111/j.1365-2672.2009.04268.x; DECLEENE M, 1985, PHYTOPATHOL Z, V113, P81; deFreitas JR, 1997, BIOL FERT SOILS, V24, P358, DOI 10.1007/s003740050258; Dias ACF, 2009, WORLD J MICROB BIOT, V25, P189, DOI 10.1007/s11274-008-9878-0; Puente ME, 2009, ENVIRON EXP BOT, V66, P402, DOI 10.1016/j.envexpbot.2009.04.007; Glick BR, 2007, CRIT REV PLANT SCI, V26, P227, DOI 10.1080/07352680701572966; GLICK BR, 1994, CAN J MICROBIOL, V40, P911, DOI 10.1139/m94-146; Hallmann J, 1997, CAN J MICROBIOL, V43, P895, DOI 10.1139/m97-131; Hallmann J, 2006, MICROBIAL ROOT ENDOP, V9, P15, DOI DOI 10.1007/3-540-33526-9_2; Hardoim PR, 2008, TRENDS MICROBIOL, V16, P463, DOI 10.1016/j.tim.2008.07.008; Hardoim PR, 2011, FEMS MICROBIOL ECOL, V77, P154, DOI 10.1111/j.1574-6941.2011.01092.x; Hardoim PR, 2011, BACTERIAL ENDOPHYTES, P77; Hashidoko Y, 2006, TROPICS, V15, P391, DOI 10.3759/tropics.15.391; Hayward AC, 2010, J APPL MICROBIOL, V108, P756, DOI 10.1111/j.1365-2672.2009.04471.x; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; Holland MA, 1997, PLANT PHYSIOL, V115, P865, DOI 10.1104/pp.115.3.865; HUREK T, 1994, J BACTERIOL, V176, P1913, DOI 10.1128/jb.176.7.1913-1923.1994; Idris A, 2009, J AGR SCI-CAMBRIDGE, V147, P17, DOI 10.1017/S0021859608008174; Johnston-Monje D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020396; Jung HM, 2009, INT J SYST EVOL MICR, V59, P460, DOI 10.1099/ijs.0.64514-0; Kaga H, 2009, MICROBES ENVIRON, V24, P154, DOI 10.1264/jsme2.ME09113; Kageyama K, 2003, APPL ENVIRON MICROB, V69, P1114, DOI 10.1128/AEM.69.2.1114-1120.2003; Kampfer P, 2000, INT J SYST EVOL MICR, V50, P355, DOI 10.1099/00207713-50-1-355; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Lai WA, 2006, INT J SYST EVOL MICR, V56, P787, DOI 10.1099/ijs.0.64007-0; Lebuhn M, 2000, INT J SYST EVOL MICR, V50, P2207, DOI 10.1099/00207713-50-6-2207; Loaces I, 2011, MICROB ECOL, V61, P606, DOI 10.1007/s00248-010-9780-9; Lucero M, 2008, PLANT SCI, V174, P570, DOI 10.1016/j.plantsci.2008.02.012; Lucero ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017693; Mano H., 2006, Microbes and Environments, V21, P86, DOI 10.1264/jsme2.21.86; Mano H, 2008, MICROBES ENVIRON, V23, P109, DOI 10.1264/jsme2.23.109; Mano H, 2007, MICROBES ENVIRON, V22, P175, DOI 10.1264/jsme2.22.175; Mastretta C, 2009, INT J PHYTOREMEDIAT, V11, P251, DOI 10.1080/15226510802432678; Mehnaz S, 2010, SOIL BIOL BIOCHEM, V42, P1848, DOI 10.1016/j.soilbio.2010.07.003; Miche L, 2001, APPL ENVIRON MICROB, V67, P3046, DOI 10.1128/AEM.67.7.3046-3052.2001; MUNDT JO, 1976, APPL ENVIRON MICROB, V32, P694, DOI 10.1128/AEM.32.5.694-698.1976; Cuong ND, 2011, MICROB ECOL, V62, P425, DOI 10.1007/s00248-011-9823-x; Oehrle NW, 2000, CAN J MICROBIOL, V46, P600, DOI 10.1139/cjm-46-7-600; Okunishi S., 2005, MICROBES ENVIRON, V20, P168, DOI [10.1264/jsme2.20.168, DOI 10.1264/JSME2.20.168]; Patten CL, 2002, APPL ENVIRON MICROB, V68, P3795, DOI 10.1128/AEM.68.8.3795-3801.2002; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Ramette A, 2011, SYST APPL MICROBIOL, V34, P180, DOI 10.1016/j.syapm.2010.10.005; Reiter B, 2002, APPL ENVIRON MICROB, V68, P2261, DOI 10.1128/AEM.68.5.2261-2268.2002; Roberts DP, 2007, SOIL BIOL BIOCHEM, V39, P2150, DOI 10.1016/j.soilbio.2007.03.027; Ryan RP, 2009, NAT REV MICROBIOL, V7, P514, DOI 10.1038/nrmicro2163; Sessitsch A, 2005, INT J SYST EVOL MICR, V55, P1187, DOI 10.1099/ijs.0.63149-0; Shrestha PM, 2007, ENVIRON MICROBIOL, V9, P2464, DOI 10.1111/j.1462-2920.2007.01364.x; Steindler L, 2008, FEMS MICROBIOL LETT, V288, P102, DOI 10.1111/j.1574-6968.2008.01344.x; Stevens P, 2010, ANTON LEEUW INT J G, V97, P171, DOI 10.1007/s10482-009-9400-1; Sturz AV, 2001, CAN J MICROBIOL, V47, P1013, DOI 10.1139/cjm-47-11-1013; Sun L, 2008, MICROB ECOL, V55, P415, DOI 10.1007/s00248-007-9287-1; Taghavi S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000943; Taghavi S, 2009, APPL ENVIRON MICROB, V75, P748, DOI 10.1128/AEM.02239-08; van der Lelie D, 2009, CRIT REV PLANT SCI, V28, P346, DOI 10.1080/07352680903241204; Venema JH, 2008, ENVIRON EXP BOT, V63, P359, DOI 10.1016/j.envexpbot.2007.12.015; Weyens N, 2009, TRENDS BIOTECHNOL, V27, P591, DOI 10.1016/j.tibtech.2009.07.006	65	245	278	8	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30438	10.1371/journal.pone.0030438	http://dx.doi.org/10.1371/journal.pone.0030438			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363438	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600031
J	Lei, D; Ma, J; Shen, XM; Du, XX; Shen, GH; Liu, W; Yan, X; Li, GY				Lei, Du; Ma, Jun; Shen, Xiaoming; Du, Xiaoxia; Shen, Guohua; Liu, Wei; Yan, Xu; Li, Gengying			Changes in the Brain Microstructure of Children with Primary Monosymptomatic Nocturnal Enuresis: A Diffusion Tensor Imaging Study	PLOS ONE			English	Article							BLADDER CONTROL; MICTURITION; THALAMUS; SLEEP; ELECTROENCEPHALOGRAPHY; INCONTINENCE; POTENTIALS; MATURATION; DISORDERS; CHILDHOOD	Background: Primary monosymptomatic nocturnal enuresis (PMNE) is a common disorder in school-aged children. Previous studies have suggested that a developmental delay might play a role in the pathology of children with PMNE. However, microstructural abnormalities in the brains of these children have not been thoroughly investigated. Methodology/Principal Findings: In this work, we evaluated structural changes in the brains of children with PMNE using diffusion tensor imaging (DTI). Two groups consisting of 26 children with PMNE and 26 healthy controls were scanned using magnetic resonance DTI. The diffusion parameters of fractional anisotropy (FA) and mean diffusivity (MD) were subjected to whole-brain, voxel-wise group comparisons using statistical parametric mapping (SPM). When compared to healthy subjects, children with PMNE showed both a decrease in FA and an increase in MD in the thalamus. MD also increased in the frontal lobe, the anterior cingulate cortex and the insula; these areas are all involved in controlling micturition. The significant changes seen in the thalamus could affect both urine storage and arousal from sleep. Conclusions/Significance: The microstructure abnormalities were observed in the thalamus, the medial frontal gyrus, the anterior cingulate cortex and the insula, which are involved in micturition control network. This indicates developmental delay in these areas may be the cause of PMNE.	[Lei, Du; Du, Xiaoxia; Shen, Guohua; Liu, Wei; Yan, Xu; Li, Gengying] E China Normal Univ, Dept Phys, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China; [Ma, Jun; Shen, Xiaoming] Shanghai Jiao Tong Univ, Sch Med,Shanghai Childrens Med Ctr, XinHua Hosp Affiliated,Dept Dev & Behav Pediat, Shanghai Key Lab Childrens Environm Hlth, Shanghai 200030, Peoples R China	East China Normal University; Shanghai Jiao Tong University	Lei, D (corresponding author), E China Normal Univ, Dept Phys, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China.	merryxiaoxia@163.com; gyli@phy.ecnu.edu.cn	Ma, Jun/R-8732-2019	Du, Xiaoxia/0000-0001-8470-7852	Science and Technology Commission of Shanghai [08DZ1900702]; Shanghai Children's Medical Center; Shanghai Key Laboratory of Children's Environmental Health [10DZ2272200, 09DZ2200900]; Development of Science and Technology Fund of Pudong New Area, Shanghai [PKJ2009-Y03]	Science and Technology Commission of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Children's Medical Center; Shanghai Key Laboratory of Children's Environmental Health; Development of Science and Technology Fund of Pudong New Area, Shanghai	This research was funded by the Science and Technology Commission of Shanghai (08DZ1900702), the Shanghai Children's Medical Center Fund, the Shanghai Key Laboratory of Children's Environmental Health (10DZ2272200, 09DZ2200900), and the Development of Science and Technology Fund of Pudong New Area, Shanghai (PKJ2009-Y03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkonyi B, 2011, AM J NEURORADIOL, V32, P962, DOI 10.3174/ajnr.A2417; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Barnea-Goraly N, 2005, CEREB CORTEX, V15, P1848, DOI 10.1093/cercor/bhi062; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bava S, 2010, BRAIN RES, V1327, P38, DOI 10.1016/j.brainres.2010.02.066; Beckel Jonathan M, 2011, Handb Exp Pharmacol, P149, DOI 10.1007/978-3-642-16499-6_8; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Blok BFM, 1997, BRAIN, V120, P111, DOI 10.1093/brain/120.1.111; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cheon KA, 2011, BRAIN RES, V1417, P77, DOI 10.1016/j.brainres.2011.08.020; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Eckert U, 2011, HUM BRAIN MAPP; Ferraz-Filho JR, 2011, PEDIAT RADIOL; Fowler CJ, 2010, NEUROUROL URODYNAM, V29, P49, DOI 10.1002/nau.20740; Freitag CM, 2006, DEV MED CHILD NEUROL, V48, P278, DOI 10.1017/S0012162206000600; Giorgio A, 2010, NEUROIMAGE, V49, P94, DOI 10.1016/j.neuroimage.2009.08.003; Griffiths D, 2005, J UROLOGY, V174, P1862, DOI 10.1097/01.ju.0000177450.34451.97; Griffiths D, 2008, NEUROUROL URODYNAM, V27, P466, DOI 10.1002/nau.20549; Griffiths D, 2007, NEUROIMAGE, V37, P1, DOI 10.1016/j.neuroimage.2007.04.061; Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7; Hallioglu O, 2001, J CHILD NEUROL, V16, P714, DOI 10.1177/088307380101601002; Jan JE, 2009, J PINEAL RES, V46, P1, DOI 10.1111/j.1600-079X.2008.00628.x; Karlidag R, 2004, NEUROUROL URODYNAM, V23, P237, DOI 10.1002/nau.20031; Kawauchi A, 1998, BRIT J UROL, V81, P72, DOI 10.1046/j.1464-410x.1998.00012.x; Kuchel GA, 2009, J GERONTOL A-BIOL, V64, P902, DOI 10.1093/gerona/glp037; Lei D, 2011, HUM BRAIN MAPP, DOI [10.1002/hbm.21411, DOI 10.1002/HBM.21411.]; Lei D, 2012, NEUROUROL URODYNAM, V31, P99, DOI 10.1002/nau.21205; Matsuura S, 2002, J UROLOGY, V168, P2035, DOI 10.1016/S0022-5347(05)64290-5; Mukherjee P, 2001, RADIOLOGY, V221, P349, DOI 10.1148/radiol.2212001702; Namatame S, 2010, NEUROL SCI, V31, P205, DOI 10.1007/s10072-009-0189-5; Neveus T, 2003, ACTA PAEDIATR, V92, P1118, DOI 10.1080/08035250310005837; Neveus T, 2006, J UROLOGY, V176, P314, DOI 10.1016/S0022-5347(06)00305-3; Neveus T, 2009, CURR OPIN PEDIATR, V21, P199, DOI 10.1097/MOP.0b013e3283229b12; Nour S, 2000, BRAIN, V123, P781, DOI 10.1093/brain/123.4.781; Riccabona M, 2010, UROLOGE, V49, P861, DOI 10.1007/s00120-010-2328-2; Sherman SM, 2007, CURR OPIN NEUROBIOL, V17, P417, DOI 10.1016/j.conb.2007.07.003; Sherman SM, 2005, PROG BRAIN RES, V149, P107, DOI 10.1016/S0079-6123(05)49009-3; Snook L, 2007, NEUROIMAGE, V34, P243, DOI 10.1016/j.neuroimage.2006.07.021; Tai CF, 2009, J NEUROPHYSIOL, V102, P2719, DOI 10.1152/jn.00700.2009; Theunis M, 2002, EUR UROL, V41, P660, DOI 10.1016/S0302-2838(02)00127-6; Verhoeven JS, 2010, HUM BRAIN MAPP, V31, P470, DOI 10.1002/hbm.20880; Wilke M, 2001, NEUROIMAGE, V13, P814, DOI 10.1006/nimg.2001.0751; Yu B, 2011, J PAEDIAT CHILD HLTH	44	34	41	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31023	10.1371/journal.pone.0031023	http://dx.doi.org/10.1371/journal.pone.0031023			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363538	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600099
J	Osorio-Paz, I; Sanchez-Chavez, G; Salceda, R				Osorio-Paz, Ixchel; Sanchez-Chavez, Gustavo; Salceda, Rocio			Control of Glycogen Content in Retina: Allosteric Regulation of Glycogen Synthase	PLOS ONE			English	Article							RABBIT SKELETAL-MUSCLE; RICH PRIMARY CULTURES; GLUCOSE-TRANSPORTER; INSULIN-RECEPTORS; OUTER SEGMENTS; RAT RETINA; HUMAN EYE; METABOLISM; HYPOGLYCEMIA; BRAIN	Retinal tissue is exceptional because it shows a high level of energy metabolism. Glycogen content represents the only energy reserve in retina, but its levels are limited. Therefore, elucidation of the mechanisms controlling glycogen content in retina will allow us to understand retina response under local energy demands that can occur under normal and pathological conditions. Thus, we studied retina glycogen levels under different experimental conditions and correlated them with glucose-6-phosphate (G-6-P) content and glycogen synthase (GS) activity. Glycogen and G-6-P content were studied in ex vivo retinas from normal, fasted, streptozotocin-treated, and insulin-induced hypoglycemic rats. Expression levels of GS and its phosphorylated form were also analyzed. Ex vivo retina from normal rats showed low G-6-P (14+/-2 pmol/mg protein) and glycogen levels (43+/-3 nmol glycosyl residues/mg protein), which were increased 6 and 3 times, respectively, in streptozotocin diabetic rats. While no changes in phosphorylated GS levels were observed in any condition tested, a positive correlation was found between G-6-P levels with GS activity and glycogen content. The results indicated that in vivo, retina glycogen may act as an immediately accessible energy reserve and that its content was controlled primarily by G-6-P allosteric activation of GS. Therefore, under hypoglycemic situations retina energy supply is strongly compromised and could lead to the alterations observed in type 1 diabetes.	[Osorio-Paz, Ixchel; Sanchez-Chavez, Gustavo; Salceda, Rocio] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Div Neurociencias, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Osorio-Paz, I (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Div Neurociencias, Mexico City 04510, DF, Mexico.	rsalceda@ifc.unam.mx		Sanchez-Chavez, Gustavo/0000-0002-1331-9358; Osorio-Paz, Ixchel/0000-0002-3754-7304	Direccion General de Asuntos del Personal Academico/Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica UNAM/DGAPA/PAPIIT [IN207810-3]	Direccion General de Asuntos del Personal Academico/Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica UNAM/DGAPA/PAPIIT	This work was supported by a grant from the Direccion General de Asuntos del Personal Academico/Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica UNAM/DGAPA/PAPIIT (IN207810-3) (http://dgapa.unam.mx/investigacion/papiit/conv_papiit_2010.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouskila M, 2010, CELL METAB, V12, P456, DOI 10.1016/j.cmet.2010.10.006; Brown AM, 2003, J PHYSIOL-LONDON, V549, P501, DOI 10.1113/jphysiol.2003.042416; Coffe V, 2004, J NEUROCHEM, V88, P885, DOI 10.1046/j.1471-4159.2003.02207.x; Cryer PE, 2002, DIABETOLOGIA, V45, P937, DOI 10.1007/s00125-002-0822-9; Cryer PE, 2004, NEW ENGL J MED, V350, P2272, DOI 10.1056/NEJMra031354; Daneman D, 2006, LANCET, V367, P847, DOI 10.1016/S0140-6736(06)68341-4; DAS A, 1984, CURR EYE RES, V3, P1397, DOI 10.3109/02713688409000835; DRINGEN R, 1993, GLIA, V8, P143, DOI 10.1002/glia.440080302; DRINGEN R, 1992, J NEUROCHEM, V58, P511, DOI 10.1111/j.1471-4159.1992.tb09750.x; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Emery M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021586; FERNANDEZNOVELL JM, 1994, EUR J BIOCHEM, V226, P665, DOI 10.1111/j.1432-1033.1994.tb20094.x; Graymore C. N., 1970, BIOCH EYE, P645; HSU SC, 1991, J BIOL CHEM, V266, P21745; Khan MI, 2011, VISION RES, V51, P1623, DOI 10.1016/j.visres.2011.05.003; Lawrence JC, 1997, DIABETES, V46, P541, DOI 10.2337/diabetes.46.4.541; MAGISTRETTI PJ, 1988, DIABETES METAB, V14, P237; MANTYCH GJ, 1993, ENDOCRINOLOGY, V133, P600, DOI 10.1210/en.133.2.600; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Michal G, 1984, METHOD ENZYMAT AN, P191; PARKER PJ, 1983, EUR J BIOCHEM, V130, P227; Pfeiffer-Guglielmi B, 2005, GLIA, V49, P84, DOI 10.1002/glia.20102; ROSENZWEIG SA, 1990, J BIOL CHEM, V265, P18030; Salceda R, 1998, NEUROCHEM RES, V23, P893, DOI 10.1023/A:1022467230259; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Sanchez-Chavez G, 2008, NEUROCHEM RES, V33, P1301, DOI 10.1007/s11064-007-9583-7; Siegelaar SE, 2010, ENDOCR REV, V31, P171, DOI 10.1210/er.2009-0021; SWANSON RA, 1992, CAN J PHYSIOL PHARM, V70, pS138, DOI 10.1139/y92-255; Takata K, 1997, INT REV CYTOL, V172, P1, DOI 10.1016/S0074-7696(08)62357-8; Umino Y, 2006, P NATL ACAD SCI USA, V103, P19541, DOI 10.1073/pnas.0604478104; VillarPalasi C, 1997, FASEB J, V11, P544, DOI 10.1096/fasebj.11.7.9212078; WALDBILLIG RJ, 1987, EXP EYE RES, V45, P837, DOI 10.1016/S0014-4835(87)80100-8; WINKLER BS, 1981, J GEN PHYSIOL, V77, P667, DOI 10.1085/jgp.77.6.667	33	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30822	10.1371/journal.pone.0030822	http://dx.doi.org/10.1371/journal.pone.0030822			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363495	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600072
J	Scrima, M; De Marco, C; Fabiani, F; Franco, R; Pirozzi, G; Rocco, G; Ravo, M; Weisz, A; Zoppoli, P; Ceccarelli, M; Botti, G; Malanga, D; Viglietto, G				Scrima, Marianna; De Marco, Carmela; Fabiani, Fernanda; Franco, Renato; Pirozzi, Giuseppe; Rocco, Gaetano; Ravo, Maria; Weisz, Alessandro; Zoppoli, Pietro; Ceccarelli, Michele; Botti, Gerardo; Malanga, Donatella; Viglietto, Giuseppe			Signaling Networks Associated with AKT Activation in Non-Small Cell Lung Cancer (NSCLC): New Insights on the Role of Phosphatydil-Inositol-3 kinase	PLOS ONE			English	Article							PIK3CA GENE; PHOSPHORYLATED AKT; THERAPEUTIC TARGET; COLORECTAL-CANCER; PTEN EXPRESSION; KRAS MUTATIONS; THYROID-TUMORS; HIGH-FREQUENCY; PATHWAY; CARCINOMA	Aberrant activation of PI3K/AKT signalling represents one of the most common molecular alterations in lung cancer, though the relative contribution of the single components of the cascade to the NSCLC development is still poorly defined. In this manuscript we have investigated the relationship between expression and genetic alterations of the components of the PI3K/AKT pathway [KRAS, the catalytic subunit of PI3K (p110 alpha), PTEN, AKT1 and AKT2] and the activation of AKT in 107 surgically resected NSCLCs and have analyzed the existing relationships with clinico-pathologic features. Expression analysis was performed by immunohistochemistry on Tissue Micro Arrays (TMA); mutation analysis was performed by DNA sequencing; copy number variation was determined by FISH. We report that activation of PI3K/AKT pathway in Italian NSCLC patients is associated with high grade (G3-G4 compared with G1-G2; n = 83; p < 0.05) and more advanced disease (TNM stage III vs. stages I and II; n = 26; p, 0.05). In addition, we found that PTEN loss (41/104, 39%) and the overexpression of p110 alpha (27/92, 29%) represent the most frequent aberration observed in NSCLCs. Less frequent molecular lesions comprised the overexpression of AKT2 (18/83, 22%) or AKT1 (17/96, 18%), and KRAS mutation (7/63, 11%). Our results indicate that, among all genes, only p110 alpha overexpression was significantly associated to AKT activation in NSCLCs (p = 0.02). Manipulation of p110 alpha expression in lung cancer cells carrying an active PI3K allele (NCI-H460) efficiently reduced proliferation of NSCLC cells in vitro and tumour growth in vivo. Finally, RNA profiling of lung epithelial cells (BEAS-2B) expressing a mutant allele of PIK3 (E545K) identified a network of transcription factors such as MYC, FOS and HMGA1, not previously recognised to be associated with aberrant PI3K signalling in lung cancer.	[Scrima, Marianna; De Marco, Carmela; Zoppoli, Pietro; Ceccarelli, Michele; Malanga, Donatella; Viglietto, Giuseppe] Inst Genet Res Gaetano Salvatore, Avellino, Italy; [De Marco, Carmela; Fabiani, Fernanda; Malanga, Donatella; Viglietto, Giuseppe] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy; [Franco, Renato; Pirozzi, Giuseppe; Rocco, Gaetano; Botti, Gerardo] Natl Canc Inst, Fdn G Pascale, Naples, Italy; [Ravo, Maria; Weisz, Alessandro] Univ Salerno, Mol Med Lab, Fac Med & Surg, I-84081 Baronissi, Italy; [Ceccarelli, Michele] Univ Sannio, Dept Biol & Environm Studies, Benevento, Italy	Magna Graecia University of Catanzaro; IRCCS Fondazione Pascale; University of Salerno; University of Sannio	Scrima, M (corresponding author), Inst Genet Res Gaetano Salvatore, Avellino, Italy.	viglietto@unicz.it	De Marco, Carmela/J-6797-2015; Viglietto, Giuseppe/AAC-2852-2019; Zoppoli, Pietro/J-9954-2018; Weisz, Alessandro/A-1317-2014; scrima, marianna/J-7431-2016; scrima, marianna/ABE-3003-2021; Malanga, Donatella/J-4877-2018; Rocco, Gaetano/K-4801-2016; Scrima, Marianna/S-3320-2017; Ceccarelli, Michele/AGP-1739-2022	De Marco, Carmela/0000-0002-4893-4246; Viglietto, Giuseppe/0000-0003-2327-7515; Zoppoli, Pietro/0000-0002-7860-9655; Weisz, Alessandro/0000-0003-0455-2083; scrima, marianna/0000-0003-4636-7695; scrima, marianna/0000-0003-4636-7695; Malanga, Donatella/0000-0002-0491-7698; Rocco, Gaetano/0000-0003-4150-8604; Scrima, Marianna/0000-0003-4636-7695; Ravo, Maria/0000-0003-1003-2922; Ceccarelli, Michele/0000-0002-4702-6617; Franco, Renato/0000-0002-8340-3184; Botti, Gerardo/0000-0002-6287-733X	Associazione Italiana Ricerca sul Cancro (AIRC); European Union (I.P: CRESCENDO) [LSHM-CT-2005-018652]; Ministero dell'Universita e della Ricerca [2008CJ4SYW_004]	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); European Union (I.P: CRESCENDO); Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from the Associazione Italiana Ricerca sul Cancro (AIRC) to GV and AW and by European Union (I.P: CRESCENDO, contract n.er LSHM-CT-2005-018652), Ministero dell'Universita e della Ricerca (PRIN, Grant n.er 2008CJ4SYW_004) to A. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubaker J, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-51; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Amodio N, 2010, AM J PATHOL, V177, P2622, DOI 10.2353/ajpath.2010.091075; Aziz SA, 2009, CLIN CANCER RES, V15, P3029, DOI 10.1158/1078-0432.CCR-08-2768; Balsara BR, 2004, CARCINOGENESIS, V25, P2053, DOI 10.1093/carcin/bgh226; Balsara BR, 2002, ONCOGENE, V21, P6877, DOI 10.1038/sj.onc.1205836; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bouchard C, 1999, EMBO J, V18, P5321, DOI 10.1093/emboj/18.19.5321; Brognard J, 2001, CANCER RES, V61, P3986; Carnero A, 2010, CURR PHARM DESIGN, V16, P34, DOI 10.2174/138161210789941865; Carvalho S, 2010, VIRCHOWS ARCH, V456, P235, DOI 10.1007/s00428-010-0881-0; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Endoh H, 2006, J THORAC ONCOL, V1, P629; Gandhi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004576; Garnis C, 2006, INT J CANCER, V118, P1556, DOI 10.1002/ijc.21491; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Hirsh FR, 2004, WHO CLASSIFICATION T, P16; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kawano O, 2007, LUNG CANCER, V58, P159, DOI 10.1016/j.lungcan.2007.06.020; Kirkegaard T, 2010, HISTOPATHOLOGY, V56, P203, DOI 10.1111/j.1365-2559.2009.03467.x; Kurie JM, 2004, CHEST, V125, p141S, DOI 10.1378/chest.125.5_suppl.141S-a; Lee SH, 2002, APMIS, V110, P587, DOI 10.1034/j.1600-0463.2002.11007811.x; Lim WT, 2007, ONCOL REP, V17, P853; Lin Y, 2009, ENDOCR-RELAT CANCER, V16, P301, DOI 10.1677/ERC-08-0167; Liu JF, 2010, WORLD J GASTROENTERO, V16, P4986, DOI 10.3748/wjg.v16.i39.4986; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loupakis F, 2009, J CLIN ONCOL, V27, P2622, DOI 10.1200/JCO.2008.20.2796; Malanga D, 2008, CELL CYCLE, V7, P665, DOI 10.4161/cc.7.5.5485; Marks JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000426; Massion PP, 2002, CANCER RES, V62, P3636; Memmott RM, 2010, CLIN CANCER RES, V16, P4, DOI 10.1158/1078-0432.CCR-09-0234; Minna JD, 2002, CANCER CELL, V1, P49, DOI 10.1016/S1535-6108(02)00027-2; Mountain CF, 2000, SEMIN SURG ONCOL, V18, P106, DOI 10.1002/(SICI)1098-2388(200003)18:2<106::AID-SSU4>3.0.CO;2-P; Oda K, 2005, CANCER RES, V65, P10669, DOI 10.1158/0008-5472.CAN-05-2620; REDDEL RR, 1988, CANCER RES, V48, P1904; Riely Gregory J, 2009, Proc Am Thorac Soc, V6, P201, DOI 10.1513/pats.200809-107LC; Rimm DL, 2001, CANCER J, V7, P24; RODENHUIS S, 1988, CANCER RES, V48, P5738; Rychahou PG, 2008, P NATL ACAD SCI USA, V105, P20315, DOI 10.1073/pnas.0810715105; SAMBROOK J, 1992, MOL CLONING LAB MANU; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Tang JM, 2006, LUNG CANCER, V51, P181, DOI 10.1016/j.lungcan.2005.10.003; Tsao AS, 2003, CANCER EPIDEM BIOMAR, V12, P660; Tsurutani J, 2006, J CLIN ONCOL, V24, P306, DOI 10.1200/JCO.2005.02.4133; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang GX, 2010, CLIN NEUROL NEUROSUR, V112, P324, DOI 10.1016/j.clineuro.2010.01.003; Wang YG, 2007, J CLIN ENDOCR METAB, V92, P2387, DOI 10.1210/jc.2006-2019; Wu GJ, 2005, J CLIN ENDOCR METAB, V90, P4688, DOI 10.1210/jc.2004-2281; Xu Cheng-Xiong, 2010, Front Biosci (Elite Ed), V2, P1472; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	57	92	98	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30427	10.1371/journal.pone.0030427	http://dx.doi.org/10.1371/journal.pone.0030427			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363436	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600029
J	Wang, YH; Ledgerwood, C; Grills, C; Fitzgerald, DC; Hamilton, PW				Wang, Yinhai; Ledgerwood, Craig; Grills, Claire; Fitzgerald, Denise C.; Hamilton, Peter W.			A Robust Co-Localisation Measurement Utilising Z-Stack Image Intensity Similarities for Biological Studies	PLOS ONE			English	Article							CROSS-CORRELATION SPECTROSCOPY; CONFOCAL MICROSCOPY; COMPLEX; CELLS	Background: Co-localisation is a widely used measurement in immunohistochemical analysis to determine if fluorescently labelled biological entities, such as cells, proteins or molecules share a same location. However the measurement of co-localisation is challenging due to the complex nature of such fluorescent images, especially when multiple focal planes are captured. The current state-of-art co-localisation measurements of 3-dimensional (3D) image stacks are biased by noise and cross-overs from non-consecutive planes. Method: In this study, we have developed Co-localisation Intensity Coefficients (CICs) and Co-localisation Binary Coefficients (CBCs), which uses rich z-stack data from neighbouring focal planes to identify similarities between image intensities of two and potentially more fluorescently-labelled biological entities. This was developed using z-stack images from murine organotypic slice cultures from central nervous system tissue, and two sets of pseudo-data. A large amount of non-specific cross-over situations are excluded using this method. This proposed method is also proven to be robust in recognising co-localisations even when images are polluted with a range of noises. Results: The proposed CBCs and CICs produce robust co-localisation measurements which are easy to interpret, resilient to noise and capable of removing a large amount of false positivity, such as non-specific cross-overs. Performance of this method of measurement is significantly more accurate than existing measurements, as determined statistically using pseudo datasets of known values. This method provides an important and reliable tool for fluorescent 3D neurobiological studies, and will benefit other biological studies which measure fluorescence co-localisation in 3D.	[Wang, Yinhai; Grills, Claire; Hamilton, Peter W.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Ledgerwood, Craig; Fitzgerald, Denise C.] Queens Univ Belfast, Ctr Infect & Immun, Belfast, Antrim, North Ireland	Queens University Belfast; Queens University Belfast	Wang, YH (corresponding author), Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland.	y.wang@qub.ac.uk; d.fitzgerald@qub.ac.uk		, denise/0000-0002-8608-430X	Department for Employment and Learning through its "Strengthening the all-Island Research Base" initiative; Biotechnology and Biological Sciences Research Council [BB/J01026X/1] Funding Source: researchfish; BBSRC [BB/J01026X/1] Funding Source: UKRI	Department for Employment and Learning through its "Strengthening the all-Island Research Base" initiative; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Department for Employment and Learning through its "Strengthening the all-Island Research Base" initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRENS JH, 1974, COMPUTING, V12, P223, DOI 10.1007/BF02293108; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Botti M, 2005, ANATOMIA HISTOLOGIA, V34, P6; Comeau JWD, 2008, MOL BIOSYST, V4, P672, DOI 10.1039/b719826d; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Debanne D, 2011, PHYSIOL REV, V91, P555, DOI 10.1152/physrev.00048.2009; Fletcher PA, 2010, BIOPHYS J, V99, P1996, DOI 10.1016/j.bpj.2010.07.006; Forutanpour B, 2010, H04N5232 WIPO DIAZ H; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gonzalez R.C., 2017, DIGITAL IMAGE PROCES, V4th ed.; Villalta JI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019031; Lachmanovich E, 2003, J MICROSC-OXFORD, V212, P122, DOI 10.1046/j.1365-2818.2003.01239.x; Landmann L, 2004, MICROSC RES TECHNIQ, V64, P103, DOI 10.1002/jemt.20066; Landmann L, 2002, J MICROSC-OXFORD, V208, P134, DOI 10.1046/j.1365-2818.2002.01068.x; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lian J, 2010, SIGNAL PROCESS, V90, P684, DOI 10.1016/j.sigpro.2009.07.010; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; MANDERS EMM, 1992, J CELL SCI, V103, P857; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Riner K, 2005, ANATOMIA HISTOLOGIA, V34, P43; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; Steensel Bv, 1996, J CELL SCI, V109, P782; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tong H, 2004, BLUR DETECTION DIGIT; Wiseman PW, 2000, J MICROSC-OXFORD, V200, P14, DOI 10.1046/j.1365-2818.2000.00736.x; Wu Y, 2010, BIOPHYS J, V98, P493, DOI 10.1016/j.bpj.2009.10.037; Zhang H, 2011, EXPT NEUROL IN PRESS; Zhou Wang, 1999, CIRCUITS SYSTEMS 2 A, V46, P78	29	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30632	10.1371/journal.pone.0030632	http://dx.doi.org/10.1371/journal.pone.0030632			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363456	gold, Green Submitted, Green Published			2022-12-27	WOS:000302853600043
J	Zhang, YH; Li, CM; Sun, XR; Kuang, XL; Ruan, XC				Zhang, Yuehong; Li, Chunmei; Sun, Xuerong; Kuang, Xielan; Ruan, Xiangcai			High Glucose Decreases Expression and Activity of p-glycoprotein in Cultured Human Retinal Pigment Epithelium Possibly through iNOS Induction	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PREGNANE-X-RECEPTOR; BLOOD-BRAIN-BARRIER; INDUCED DIABETIC-RATS; MULTIDRUG-RESISTANCE; TRANSPORT FUNCTION; ABC-TRANSPORTERS; GENE-EXPRESSION; TIGHT JUNCTIONS; CELL-LINES	Inhibition of p-glycoprotein under hyperglycemic conditions has been reported in various barrier tissues including blood-brain barrier, intestine, and kidney, and has been linked to significant clinical complications. However, whether this is also true for the outer blood-retinal barrier constituted by retinal pigment epithelium, or has a role in pathogenesis of diabetic retinopathy is not yet clear. In this study, using cultured human retinal pigment epithelium cell line D407, we found that high glucose exposure induced a significant decrease in p-glycoprotein expression both at mRNA and at protein levels, accompanied by an attenuated p-glycoprotein activity determined by intracellular rhodamine 123 retention. In marked contrast, the expressions of both mRNA and protein levels of inducible nitrate oxide synthase (iNOS) increased, and were accompanied by increased extracellular nitrate/nitrite production by Griess reaction. In addition, mRNA levels of nuclear receptors revealed a decreased expression of pregnane X receptor after the exposure of high glucose. However, the subsequent alterations in production of nitrate/nitrite, functional expression of p-glycoprotein, and mRNA levels of pregnane X receptor were partially blocked when pretreated with S, S'-1,3-phenylene-bis(1,2-ethanediyl)-bis-isothiourea center dot 2HBr (PBITU), a selective iNOS inhibitor. Moreover, the effects of PBITU were antagonized with the addition of L-arginine, a substrate for NO synthesis. Our in vitro results suggest for the first time that iNOS induction plays a novel role in decreased p-glycoprotein expression and transport function at the human outer blood-retinal barrier under hyperglycemic conditions and further support the concept of inhibiting iNOS pathway as a therapeutic strategy for diabetic retinopathy.	[Zhang, Yuehong; Ruan, Xiangcai] Guangzhou Med Univ, Affiliated Hosp, Municipal Peoples Hosp Guangzhou 1, Dept Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Zhang, Yuehong; Ruan, Xiangcai] Guangzhou Med Univ, Affiliated Hosp, Municipal Peoples Hosp Guangzhou 1, Dept Anesthesiol, Guangzhou, Guangdong, Peoples R China; [Li, Chunmei; Sun, Xuerong; Kuang, Xielan] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Sun Yat Sen University	Zhang, YH (corresponding author), Guangzhou Med Univ, Affiliated Hosp, Municipal Peoples Hosp Guangzhou 1, Dept Ophthalmol, Guangzhou, Guangdong, Peoples R China.	xc_ruan@hotmail.com	Ruan, Xiangcai/L-9904-2016	Ruan, Xiangcai/0000-0001-6112-7994; Zhang, Yuehong/0000-0002-1990-9439	Natural Science Foundation of Guangdong Province [S2011010000587]; Natural Science Foundation of China [30700786]	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by Natural Science Foundation of Guangdong Province (grant S2011010000587) and Natural Science Foundation of China (grant 30700786). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber AJ, 2010, INVEST OPHTH VIS SCI, V52, P1156; Bauer B, 2005, EXP BIOL MED, V230, P118; Bauer B, 2004, MOL PHARMACOL, V66, P413; Bellamy WT, 1996, ANNU REV PHARMACOL, V36, P161, DOI 10.1146/annurev.pa.36.040196.001113; Congdon NG, 2003, JAMA-J AM MED ASSOC, V290, P2057, DOI 10.1001/jama.290.15.2057; Constable PA, 2006, EXP EYE RES, V83, P24, DOI 10.1016/j.exer.2005.10.029; DAVIS AA, 1995, INVEST OPHTH VIS SCI, V36, P955; do Carmo A, 1998, GEN PHARMACOL, V30, P319, DOI 10.1016/S0306-3623(97)00363-7; Du YP, 2002, J NEUROCHEM, V80, P771, DOI 10.1046/j.0022-3042.2001.00737.x; Dussault I, 2002, CRIT REV EUKAR GENE, V12, P53, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i1.30; El-Asrar AM, 2001, AM J OPHTHALMOL, V132, P551, DOI 10.1016/S0002-9394(01)01127-8; FORD JM, 1990, CANCER RES, V50, P1748; Frank RN, 2004, NEW ENGL J MED, V350, P48, DOI 10.1056/NEJMra021678; GOUREAU O, 1994, BIOCHEM BIOPH RES CO, V198, P120, DOI 10.1006/bbrc.1994.1017; GOUREAU O, 1994, J NEUROCHEM, V63, P310; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; Hartley DP, 2004, MOL PHARMACOL, V65, P1159, DOI 10.1124/mol.65.5.1159; Hartmann G, 2005, DRUG METAB DISPOS, V33, P820, DOI 10.1124/dmd.104.002568; Heemskerk S, 2007, PFLUG ARCH EUR J PHY, V454, P321, DOI 10.1007/s00424-007-0210-x; Holtkamp GM, 2001, PROG RETIN EYE RES, V20, P29, DOI 10.1016/S1350-9462(00)00017-3; Juan CC, 2008, OBESITY, V16, P1219, DOI 10.1038/oby.2008.200; Kalitsky-Szirtes J, 2004, DRUG METAB DISPOS, V32, P20, DOI 10.1124/dmd.32.1.20; Kennedy BG, 2002, MOL VIS, V8, P422; Kern TS, 2007, EXP DIABETES RES, DOI 10.1155/2007/95103; Kern TS, 2000, INVEST OPHTH VIS SCI, V41, P3972; Kim YK, 2007, BIOCHEM BIOPH RES CO, V355, P136, DOI 10.1016/j.bbrc.2007.01.117; Kowluru RA, 2000, CURR EYE RES, V21, P814, DOI 10.1076/ceyr.21.4.814.5545; Kuwano M, 2003, CANCER SCI, V94, P9, DOI 10.1111/j.1349-7006.2003.tb01344.x; LEE JS, 1994, MOL PHARMACOL, V46, P627; Liu Y, 2008, NEUROSCIENCE, V153, P796, DOI 10.1016/j.neuroscience.2008.03.019; Luker GD, 1999, J BIOL CHEM, V274, P6979, DOI 10.1074/jbc.274.11.6979; Maeng HJ, 2007, DRUG METAB DISPOS, V35, P1996, DOI 10.1124/dmd.107.015800; Mannermaa E, 2009, PHARM RES-DORD, V26, P1785, DOI 10.1007/s11095-009-9890-6; Mitchell BF, 2005, AM J OBSTET GYNECOL, V192, P1304, DOI 10.1016/j.ajog.2005.01.040; MORIYAMA M, 1991, TOHOKU J EXP MED, V164, P191, DOI 10.1620/tjem.164.191; Naggar H, 2002, INVEST OPHTH VIS SCI, V43, P556; Nawa A, 2010, LIFE SCI, V86, P402, DOI 10.1016/j.lfs.2010.01.009; Nowicki Michael T, 2008, Drug Metab Lett, V2, P11; Rosenfeld JM, 2003, MOL ENDOCRINOL, V17, P1268, DOI 10.1210/me.2002-0421; Simo R, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/190724; SPARROW JR, 1994, EXP EYE RES, V59, P129, DOI 10.1006/exer.1994.1091; Toell A, 2002, J CELL BIOCHEM, V85, P72, DOI 10.1002/jcb.10104; Tramonti G, 2006, AM J PHYSIOL-RENAL, V291, pF972, DOI 10.1152/ajprenal.00110.2006; Uchiyama T, 2005, FEBS LETT, V579, P2499, DOI 10.1016/j.febslet.2005.03.065; van Waarde WM, 2002, GASTROENTEROLOGY, V122, P1842, DOI 10.1053/gast.2002.33582; Villarroel M, 2009, EXP EYE RES, V89, P913, DOI 10.1016/j.exer.2009.07.017; Wang JH, 2005, J NUCL MED, V46, P1537; Woo HB, 2005, BIOORG MED CHEM LETT, V15, P3782, DOI 10.1016/j.bmcl.2005.05.064; Wood JPM, 2004, INVEST OPHTH VIS SCI, V45, P1272, DOI 10.1167/iovs.03-0693; Wu KC, 2009, LIFE SCI, V85, P775, DOI 10.1016/j.lfs.2009.10.014; Zech JC, 1998, INVEST OPHTH VIS SCI, V39, P1600; Zheng L, 2007, DIABETOLOGIA, V50, P1987, DOI 10.1007/s00125-007-0734-9; Zhou SF, 2008, XENOBIOTICA, V38, P802, DOI 10.1080/00498250701867889 	53	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31631	10.1371/journal.pone.0031631	http://dx.doi.org/10.1371/journal.pone.0031631			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363694	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600150
J	Wilquin, H; Delevoye-Turrell, Y				Wilquin, Helene; Delevoye-Turrell, Yvonne			Motor Agency: A New and Highly Sensitive Measure to Reveal Agency Disturbances in Early Psychosis	PLOS ONE			English	Article							ULTRA-HIGH RISK; NEUROMOTOR PRECURSORS; CLINICAL-PRACTICE; SCHIZOPHRENIA; SELF; CHILDHOOD; PRODROME; DURATION; SENSE; ONSET	Background: Early diagnosis of young adults at risk of schizophrenia is essential for preventive approaches of the illness. Nevertheless, classic screening instruments are difficult to use because of the non-specific nature of the signs at this pre-onset phase of illness. The objective of the present contribution was to propose an innovating test that can probe the more specific symptom of psychosis, i.e., the sense of agency, which is defined as being the immediate experience of oneself as the cause of an action. More specifically, we tested whether motor agency is abnormal in early psychosis. Methods: Thirty-two young symptomatic patients and their age-matched controls participated in the study. 15 of these patients were at ultra high-risk for developing psychosis (UHR), and 17 patients were suffering from first-episode psychosis (FEP). Patients' neurocognitive capacities were assessed through the use of seven neuropsychological tests. A motor agency task was also introduced to obtain an objective indicator of the degree of sense of agency, by contrasting force levels applied during other and self-produced collisions between a hand-held objet and a pendulum. Results: As reported in the literature for adult controls, healthy adolescents used more efficient force levels in self than in other-imposed collisions. For both UHR and FEP patients, abnormally high levels of grip force were used for self-produced collisions, leading to an absence of difference between self and other. The normalized results revealed that motor agency differentiated patients from controls with a higher level of sensitivity than the more classic neuropsychological test battery. Conclusions: This study is in favour of the existence of an abnormal sense of agency early in the psychotic illness. Because it is quick and none verbal, motor agency may be a valuable tool to use in complement to classic interviews, especially when investigating complex ineffable experiences that are difficult to explicitly describe.	[Wilquin, Helene; Delevoye-Turrell, Yvonne] Univ Lille Nord France, Lille, France; [Wilquin, Helene; Delevoye-Turrell, Yvonne] URECA, UDL3, Villeneuve Dascq, France; [Wilquin, Helene] Clin Lautreamont, Loos, France	Universite de Lille - ISITE; Universite de Lille	Wilquin, H (corresponding author), Univ Lille Nord France, Lille, France.	yvonne.delevoye@univ-lille3.fr	Wilquin, Helene/AAH-4442-2021	Wilquin, Helene/0000-0002-6732-6537	ANRt [558/2007]; MESHS-USR [3185];  [ANR-2010-BLAN-1903-01]	ANRt(French National Research Agency (ANR)); MESHS-USR; 	Funding: Dr. Delevoye-Turrell and Dr. Wilquin report no financial relationships with commercial interests. This research was supported by grants from (a) ANRt (CIFRE n<SUP>o</SUP>558/2007)(http://www.anrt.asso.fr/), (b) MESHS-USR 3185- and (c) ANR-2010-BLAN-1903-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL RQ, 1992, PSYCHIATRY, V55, P370; Brewer WJ, 2005, AM J PSYCHIAT, V162, P71, DOI 10.1176/appi.ajp.162.1.71; Bulot V, 2007, EXP BRAIN RES, V183, P115, DOI 10.1007/s00221-007-1027-8; Cannon M, 2002, ARCH GEN PSYCHIAT, V59, P449, DOI 10.1001/archpsyc.59.5.449; Cermolacce M, 2007, CONSCIOUS COGN, V16, P703, DOI 10.1016/j.concog.2007.05.013; Delevoye-Turrell Y, 2002, NEUROREPORT, V13, P1537, DOI 10.1097/00001756-200208270-00010; Delevoye-Turrell YN, 2003, Q J EXP PSYCHOL-A, V56, P1113, DOI 10.1080/02724980245000025; Eustache F., 2005, MANUEL NEUROPSYCHOLO; Gallagher S, 2010, NEW IDEAS PSYCHOL; Grootens KP, 2009, SCHIZOPHR RES, V107, P294, DOI 10.1016/j.schres.2008.09.032; Haroun N, 2006, SCHIZOPHRENIA BULL, V32, P166, DOI 10.1093/schbul/sbj007; Hauser M, 2010, SCHIZOPHR RES; Hauser M, 2010, PSYCHIAT RES; Jardri R, 2007, MOL PSYCHIATR, V12, P320, DOI 10.1038/sj.mp.4001968; Jardri R, 2009, NEUROPSYCHOLOGIA, V47, P132, DOI 10.1016/j.neuropsychologia.2008.08.006; Joa I, 2008, SCHIZOPHRENIA BULL, V34, P466, DOI 10.1093/schbul/sbm095; KAY SR, 1989, BRITISH JOURNAL OF PSYCHIATRY, VOL 155, SUPP NO. 7, P59, DOI 10.1192/S0007125000291514; Klosterkotter J, 2009, DTSCH ARZTEBL INT, V105, P532, DOI 10.3238/arztebl.2008.0532; Lallart E, 2009, CYBERPSYCHOL BEHAV, V12, P139, DOI 10.1089/cpb.2008.0070; Lecardeur L, 2009, SCHIZOPHR RES, V107, P303, DOI 10.1016/j.schres.2008.09.003; LOEBEL AD, 1992, AM J PSYCHIAT, V149, P1183; Mittal VA, 2008, ARCH GEN PSYCHIAT, V65, P165, DOI 10.1001/archgenpsychiatry.2007.23; Mittal VA, 2006, J ABNORM PSYCHOL, V115, P351, DOI 10.1037/0021-843X.115.2.351; Nelson B, 2009, NEUROSCI BIOBEHAV R, V33, P807, DOI 10.1016/j.neubiorev.2009.01.002; Nelson B, 2008, SCHIZOPHRENIA BULL, V34, P381, DOI 10.1093/schbul/sbm094; Niendam TA, 2006, SCHIZOPHR RES, V84, P100, DOI 10.1016/j.schres.2006.02.005; Norman RMG, 2005, BRIT J PSYCHIAT, V187, pS19, DOI 10.1192/bjp.187.48.s19; Owens DGC, 2006, PSYCHOL MED, V36, P1501; Parnas J, 1998, NEUROL PSYCHIAT BR, V6, P97; Perkins DO, 2005, AM J PSYCHIAT, V162, P1785, DOI 10.1176/appi.ajp.162.10.1785; Rosso IM, 2000, SCHIZOPHRENIA BULL, V26, P367, DOI 10.1093/oxfordjournals.schbul.a033459; Schiffman J, 2004, AM J PSYCHIAT, V161, P2021, DOI 10.1176/appi.ajp.161.11.2021; Seidman LJ, 2010, ARCH GEN PSYCHIAT, V67, P578, DOI 10.1001/archgenpsychiatry.2010.66; Stip E, 2003, COMPR PSYCHIAT, V44, P331, DOI 10.1016/S0010-440X(03)00086-5; WALKER EF, 1994, SCHIZOPHRENIA BULL, V20, P441, DOI 10.1093/schbul/20.3.441; Yung AR, 2008, SCHIZOPHR RES, V105, P10, DOI 10.1016/j.schres.2008.07.012; Yung AR, 2005, AUST NZ J PSYCHIAT, V39, P964, DOI 10.1080/j.1440-1614.2005.01714.x; Yung AR, 2003, SCHIZOPHRENIA BULL, V29, P859, DOI 10.1093/oxfordjournals.schbul.a007052; Yung AR, 1996, SCHIZOPHRENIA BULL, V22, P353, DOI 10.1093/schbul/22.2.353; Yung AR, 2003, SCHIZOPHR RES, V60, P21, DOI 10.1016/S0920-9964(02)00167-6	40	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e30449	10.1371/journal.pone.0030449	http://dx.doi.org/10.1371/journal.pone.0030449			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	927OV	22383963	Green Published, gold, Green Submitted			2022-12-27	WOS:000302918500010
J	Zhou, JF; Fang, WH; Yang, XL; Zhou, S; Hu, LL; Li, XC; Qi, XY; Su, H; Xie, LY				Zhou, Junfang; Fang, Wenhong; Yang, Xianle; Zhou, Shuai; Hu, Linlin; Li, Xincang; Qi, Xinyong; Su, Hang; Xie, Layue			A Nonluminescent and Highly Virulent Vibrio harveyi Strain Is Associated with "Bacterial White Tail Disease'' of Litopenaeus vannamei Shrimp	PLOS ONE			English	Article							PENAEUS-MONODON LARVAE; BASS LATES-CALCARIFER; LUMINESCENT VIBRIOS; GENE-EXPRESSION; RT-PCR; PHILIPPINES; HATCHERY; INDIA; WATER; SEA	Recurrent outbreaks of a disease in pond-cultured juvenile and subadult Litopenaeus vannamei shrimp in several districts in China remain an important problem in recent years. The disease was characterized by "white tail'' and generally accompanied by mass mortalities. Based on data from the microscopical analyses, PCR detection and 16S rRNA sequencing, a new Vibrio harveyi strain (designated as strain HLB0905) was identified as the etiologic pathogen. The bacterial isolation and challenge tests demonstrated that the HLB0905 strain was nonluminescent but highly virulent. It could cause mass mortality in affected shrimp during a short time period with a low dose of infection. Meanwhile, the histopathological and electron microscopical analysis both showed that the HLB0905 strain could cause severe fiber cell damages and striated muscle necrosis by accumulating in the tail muscle of L. vannamei shrimp, which led the affected shrimp to exhibit white or opaque lesions in the tail. The typical sign was closely similar to that caused by infectious myonecrosis (IMN), white tail disease (WTD) or penaeid white tail disease (PWTD). To differentiate from such diseases as with a sign of "white tail'' but of non-bacterial origin, the present disease was named as "bacterial white tail disease (BWTD)''. Present study revealed that, just like IMN and WTD, BWTD could also cause mass mortalities in pond-cultured shrimp. These results suggested that some bacterial strains are changing themselves from secondary to primary pathogens by enhancing their virulence in current shrimp aquaculture system.	[Zhou, Junfang; Fang, Wenhong; Zhou, Shuai; Hu, Linlin; Li, Xincang; Su, Hang; Xie, Layue] Chinese Acad Fisheries Sci, E China Sea Fisheries Res Inst, Key Lab Marine & Estuarine Fisheries Resources &, Shanghai, Peoples R China; [Yang, Xianle] Aquat Pathogen Collect Ctr Minist, Shanghai, Peoples R China; [Qi, Xinyong] Shanghai Anim Dis Control Ctr, Shanghai, Peoples R China	Chinese Academy of Fishery Sciences; East China Sea Fisheries Research Institute, CAFS	Zhou, JF (corresponding author), Chinese Acad Fisheries Sci, E China Sea Fisheries Res Inst, Key Lab Marine & Estuarine Fisheries Resources &, Shanghai, Peoples R China.	junfangzhou@yahoo.cn; whfang06@yahoo.com.cn	Yang, Xian/GVU-9087-2022		National Non-profit Institutes (East China Sea Fisheries Research Institute) [2009 T06, 2011 T03, 2007 M25]; Provincial Natural Science Foundation of Jiangsu [BK2010269]; Three-project for Aquaculture in Jiangsu Province [PJ2010-51]; China Postdoctoral Science Foundation [20080440654]	National Non-profit Institutes (East China Sea Fisheries Research Institute); Provincial Natural Science Foundation of Jiangsu(Natural Science Foundation of Jiangsu Province); Three-project for Aquaculture in Jiangsu Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the Special Research Fund for the National Non-profit Institutes (East China Sea Fisheries Research Institute, grant# 2009 T06, 2011 T03 and 2007 M25), the Provincial Natural Science Foundation of Jiangsu (grant# BK2010269), the Three-project for Aquaculture in Jiangsu Province (grant# PJ2010-51) and China Postdoctoral Science Foundation (grant# 20080440654). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham TJ, 2004, AQUACULTURE, V232, P81, DOI 10.1016/S0044-8486(03)00485-X; Ahmed N, 2008, NAT REV MICROBIOL, V6, P387, DOI 10.1038/nrmicro1889; Alavandi SV, 2006, LETT APPL MICROBIOL, V43, P566, DOI 10.1111/j.1472-765X.2006.01986.x; Aziz RK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009798; Bell TA, 1988, HDB NORMAL PENAEID S; Chitov T, 2009, MAEJO INT J SCI TECH, V3, P88; Chrisolite B, 2008, AQUACULTURE, V275, P13, DOI 10.1016/j.aquaculture.2007.12.016; de la Pena LD, 2001, FISH PATHOL, V36, P133, DOI 10.3147/jsfp.36.133; Flegel T, 2005, DIS ASIAN AQUACULTUR, P329; Haldar S, 2010, MICROBIOL RES, V165, P639, DOI 10.1016/j.micres.2009.12.001; Lavilla-Pitogo CR, 1998, AQUACULTURE, V164, P337, DOI 10.1016/S0044-8486(98)00198-7; LAVILLAPITOGO CR, 1990, AQUACULTURE, V91, P1, DOI 10.1016/0044-8486(90)90173-K; Lee KK, 1997, REP FISH DIS RES, V18, P33; Lightner D.V., 2004, GLOB AQUACULT ADVOCA, V7, P85; Lightner DV, 1998, AQUACULTURE, V164, P201, DOI 10.1016/S0044-8486(98)00187-2; Lilley BN, 2000, MOL MICROBIOL, V36, P940, DOI 10.1046/j.1365-2958.2000.01913.x; Liu PC, 1999, LETT APPL MICROBIOL, V28, P428, DOI 10.1046/j.1365-2672.1999.00555.x; Mok KC, 2003, EMBO J, V22, P870, DOI 10.1093/emboj/cdg085; Munro J, 2003, DIS AQUAT ORGAN, V54, P187, DOI 10.3354/dao054187; Otta S. K., 1999, Journal of Aquaculture in the Tropics, V14, P309; Poulos BT, 2006, DIS AQUAT ORGAN, V73, P69, DOI 10.3354/dao073069; Qian D, 2003, J FISH DIS, V26, P521, DOI 10.1046/j.1365-2761.2003.00486.x; Ramasamy P, 2000, J FISH DIS, V23, P77, DOI 10.1046/j.1365-2761.2000.00208.x; Ransangan J, 2009, J AQUAT ANIM HEALTH, V21, P150, DOI 10.1577/H09-002.1; Ruangpan L, 1999, DIS AQUAT ORGAN, V35, P195, DOI 10.3354/dao035195; Ruwandeepika HAD, 2011, J APPL MICROBIOL, V110, P399, DOI 10.1111/j.1365-2672.2010.04892.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Selvin J, 2004, AQUACULTURE, V236, P277, DOI 10.1016/j.aquaculture.2004.01.021; Shakibazadeh S, 2009, ANN MICROBIOL, V59, P425, DOI 10.1007/BF03175126; Shinoda S, 1999, J NAT TOXINS, V8, P259; Sung HH, 2001, AQUACULTURE, V192, P101, DOI 10.1016/S0044-8486(00)00458-0; Tang KFJ, 2007, DIS AQUAT ORGAN, V75, P183, DOI 10.3354/dao075183; Tendencia EA, 2002, AQUAC RES, V33, P455, DOI 10.1046/j.1365-2109.2002.00688.x; Thompson FL, 2007, APPL ENVIRON MICROB, V73, P4279, DOI 10.1128/AEM.00020-07; Uma A., 2008, Tamilnadu Journal of Veterinary and Animal Sciences, V4, P188; Vandenberghe J, 1999, APPL ENVIRON MICROB, V65, P2592; Vaseeharan B, 2003, MICROBIOL RES, V158, P299, DOI 10.1078/0944-5013-00208; Vezzulli L, 2010, ENVIRON MICROBIOL, V12, P2007, DOI 10.1111/j.1462-2920.2010.02209.x; Vezzulli L, 2009, MICROB ECOL, V58, P808, DOI 10.1007/s00248-009-9542-8; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Zhong YB, 2006, INFECT IMMUN, V74, P6001, DOI 10.1128/IAI.00512-06; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	42	81	96	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e29961	10.1371/journal.pone.0029961	http://dx.doi.org/10.1371/journal.pone.0029961			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22383954	Green Published, gold, Green Submitted			2022-12-27	WOS:000302918500006
J	Bhoo-Pathy, N; Hartman, M; Yip, CH; Saxena, N; Taib, NA; Lim, SE; Iau, P; Adami, HO; Bulgiba, AM; Lee, SC; Verkooijen, HM				Bhoo-Pathy, Nirmala; Hartman, Mikael; Yip, Cheng-Har; Saxena, Nakul; Taib, Nur Aishah; Lim, Siew-Eng; Iau, Philip; Adami, Hans-Olov; Bulgiba, Awang M.; Lee, Soo-Chin; Verkooijen, Helena M.			Ethnic Differences in Survival after Breast Cancer in South East Asia	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; AFRICAN-AMERICAN; STAGE; WOMEN; OBESITY; RACE; DIAGNOSIS; MALAYSIA	Background: The burden of breast cancer in Asia is escalating. We evaluated the impact of ethnicity on survival after breast cancer in the multi-ethnic region of South East Asia. Methodology/Principal Findings: Using the Singapore-Malaysia hospital-based breast cancer registry, we analyzed the association between ethnicity and mortality following breast cancer in 5,264 patients diagnosed between 1990 and 2007 (Chinese: 71.6%, Malay: 18.4%, Indian: 10.0%). We compared survival rates between ethnic groups and calculated adjusted hazard ratios (HR) to estimate the independent effect of ethnicity on survival. Malays (n = 968) presented at a significantly younger age, with larger tumors, and at later stages than the Chinese and Indians. Malays were also more likely to have axillary lymph node metastasis at similar tumor sizes and to have hormone receptor negative and poorly differentiated tumors. Five year overall survival was highest in the Chinese women (75.8%; 95%CI: 74.4%-77.3%) followed by Indians (68.0%; 95%CI: 63.8%-72.2%), and Malays (58.5%; 95%CI: 55.2%-61.7%). Compared to the Chinese, Malay ethnicity was associated with significantly higher risk of all-cause mortality (HR: 1.34; 95%CI: 1.19-1.51), independent of age, stage, tumor characteristics and treatment. Indian ethnicity was not significantly associated with risk of mortality after breast cancer compared to the Chinese (HR: 1.14; 95%CI: 0.98-1.34). Conclusion: In South East Asia, Malay ethnicity is independently associated with poorer survival after breast cancer. Research into underlying reasons, potentially including variations in tumor biology, psychosocial factors, treatment responsiveness and lifestyle after diagnosis, is warranted.	[Bhoo-Pathy, Nirmala] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Bhoo-Pathy, Nirmala] Kuala Lumpur Hosp, Natl Clin Res Ctr, Kuala Lumpur, Malaysia; [Hartman, Mikael; Saxena, Nakul; Verkooijen, Helena M.] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Hartman, Mikael; Iau, Philip] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 117595, Singapore; [Yip, Cheng-Har; Taib, Nur Aishah] Univ Malaya, Fac Med, Dept Surg, Kuala Lumpur, Malaysia; [Lim, Siew-Eng; Lee, Soo-Chin] Natl Univ Hlth Syst, Natl Univ Canc Inst, Dept Hematol Oncol, Singapore, Singapore; [Adami, Hans-Olov] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Adami, Hans-Olov] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Bulgiba, Awang M.] Univ Malaya, Julius Ctr Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Verkooijen, Helena M.] Univ Med Ctr Utrecht, Imaging Div, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; National University of Singapore; National University of Singapore; Universiti Malaya; National University of Singapore; Harvard University; Harvard T.H. Chan School of Public Health; Karolinska Institutet; Universiti Malaya; Utrecht University; Utrecht University Medical Center	Bhoo-Pathy, N (corresponding author), Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	h.m.verkooijen@umcutrecht.nl	Yip, Cheng-Har/B-1909-2010; Lee, Soo Chin/S-9111-2016; LIM, SIEW ENG/AGO-6654-2022; Pathy, Nirmala Bhoo/C-1228-2010; Bulgiba, Awang/B-8271-2010; Taib, Nur Aishah Mohd/B-2370-2010; Iau, Philip/B-4641-2011; Hartman, Mikael/B-4324-2011	Lee, Soo Chin/0000-0002-5835-6419; Pathy, Nirmala Bhoo/0000-0003-0568-8863; Bulgiba, Awang/0000-0002-5313-0445; Taib, Nur Aishah Mohd/0000-0001-8419-0478; Hartman, Mikael/0000-0001-5726-9965	European Union [MY/AsiaLink/044 (128-713)]; Singapore National Medical Research Council [NMRC/1180/2008]; Ministry of Higher Education, Malaysia [UM.C/HIR/MOHE/06]	European Union(European Commission); Singapore National Medical Research Council(National Medical Research Council, Singapore); Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia)	Dr. Bhoo-Pathy was financially supported by the European Union, AsiaLink program MY/AsiaLink/044 (128-713). Dr. Verkooijen and Dr. Hartman were supported by the Singapore National Medical Research Council ( grant no. NMRC/1180/2008). The Malaysian data was supported by a High Impact Research Grant (UM.C/HIR/MOHE/06) from the Ministry of Higher Education, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuin J, 2011, LANCET, V377, P534, DOI 10.1016/S0140-6736(10)61426-2; Amend K, 2006, CANCER RES, V66, P8327, DOI 10.1158/0008-5472.CAN-06-1927; Amin S., 2004, J SOCIO-ECON, V33, P291, DOI [https://doi.org/10.1016/j.socec.2003.12.023, DOI 10.1016/J.SOCEC.2003.12.023]; Bradley CJ, 2002, J NATL CANCER I, V94, P490; Brawley OW, 2002, JNCI-J NATL CANCER I, V94, P471; Chlebowski RT, 2005, J CLIN ONCOL, V23, P1345, DOI 10.1200/JCO.2005.10.949; Coughlin SS, 2009, CANCER EPIDEMIOL, V33, P315, DOI 10.1016/j.canep.2009.10.003; Deglise C, 2010, BREAST CANCER RES TR, V120, P185, DOI 10.1007/s10549-009-0459-1; Deurenberg-Yap M, 2001, INT J OBESITY, V25, P1554, DOI 10.1038/sj.ijo.0801739; Deurenberg-Yap M, 2001, ASIA PAC J CLIN NUTR, V10, P39, DOI 10.1046/j.1440-6047.2001.00202.x; Fan L, 2008, PHARMACOGENET GENOM, V18, P621, DOI 10.1097/FPC.0b013e328301a869; Hershman D, 2005, J CLIN ONCOL, V23, P6639, DOI 10.1200/JCO.2005.12.633; Ismail M N, 2002, Obes Rev, V3, P203, DOI 10.1046/j.1467-789X.2002.00074.x; Lal S, 2007, PHARMACOGENOMICS, V8, P567, DOI 10.2217/14622416.8.6.567; Lannin DR, 1998, JAMA-J AM MED ASSOC, V279, P1801, DOI 10.1001/jama.279.22.1801; Lim GCC, 2004, 2 NAT CANC REG; Ma BBY, 2010, LANCET ONCOL, V11, P75, DOI 10.1016/S1470-2045(09)70160-3; Mak KH, 2003, EUR HEART J, V24, P151, DOI 10.1016/S0195-668X(02)00423-2; McKenzie F, 2009, EPIDEMIOL REV, V31, P52, DOI 10.1093/epirev/mxp007; Newman LA, 2006, J CLIN ONCOL, V24, P1342, DOI 10.1200/JCO.2005.03.3472; Pathy NB, 2011, BREAST, V20, pS75, DOI 10.1016/j.breast.2011.01.015; Pisani P, 2006, INT J CANCER, V118, P149, DOI 10.1002/ijc.21343; Ravdin PM, 2007, NEW ENGL J MED, V356, P1670, DOI 10.1056/NEJMsr070105; RICHARDSON JL, 1992, BRIT J CANCER, V65, P922, DOI 10.1038/bjc.1992.193; Saw SH, 2007, POPULATION SINGAPORE; Saw Swee-Hock, 2007, POPULATION MALAYSIA; Seow A, 2003, TRENDS CANC INCIDENC; Shu XO, 2009, JAMA-J AM MED ASSOC, V302, P2437, DOI 10.1001/jama.2009.1783; Taib NA, 2007, ASIAN PAC J CANCER P, V8, P141; Taib NABM, 2008, ASIAN PAC J CANCER P, V9, P197; Telli ML, 2011, BREAST CANCER RES TR, V127, P471, DOI 10.1007/s10549-010-1173-8; Wang PP, 1996, BREAST CANCER RES TR, V37, P197, DOI 10.1007/BF01806501	32	54	57	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e30995	10.1371/journal.pone.0030995	http://dx.doi.org/10.1371/journal.pone.0030995			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363531	Green Published, gold			2022-12-27	WOS:000302873700020
J	Ching, KH; Burbelo, PD; Tipton, C; Wei, CW; Petri, M; Sanz, I; Iadarola, MJ				Ching, Kathryn H.; Burbelo, Peter D.; Tipton, Christopher; Wei, Chungwen; Petri, Michelle; Sanz, Ignacio; Iadarola, Michael J.			Two Major Autoantibody Clusters in Systemic Lupus Erythematosus	PLOS ONE			English	Article							ALPHA MONOCLONAL-ANTIBODY; 4-ANTIGEN MIXTURE; SJOGRENS-SYNDROME; PHASE-I; INTERFERON; INFECTION; DISEASE; ASSOCIATION; PROFILE; COHORT	Systemic lupus erythematosus is a chronic autoimmune disease of complex clinical presentation and etiology and is likely influenced by numerous genetic and environmental factors. While a large number of susceptibility genes have been identified, the production of antibodies against a distinct subset of nuclear proteins remains a primary distinguishing characteristic in disease diagnosis. However, the utility of autoantibody biomarkers for disease sub-classification and grouping remains elusive, in part, because of the difficulty in large scale profiling using a uniform, quantitative platform. In the present study serological profiles of several known SLE antigens, including Sm-D3, RNP-A, RNP-70k, Ro52, Ro60, and La, as well as other cytokine and neuronal antigens were obtained using the luciferase immunoprecipitation systems (LIPS) approach. The resulting autoantibody profiles revealed that 88% of a pilot cohort and 98% of a second independent cohort segregated into one of two distinct clusters defined by autoantibodies against Sm/anti-RNP or Ro/La autoantigens, proteins often involved in RNA binding activities. The Sm/RNP cluster was associated with a higher prevalence of serositis in comparison to the Ro/La cluster (P = 0.0022). However, from the available clinical information, no other clinical characteristics were associated with either cluster. In contrast, evaluation of autoantibodies on an individual basis revealed an association between anti-Sm (P = 0.006), RNP-A (P = 0.018) and RNP-70k (P = 0.010) autoantibodies and mucocutaneous symptoms and between anti-RNP-70k and musculoskeletal manifestations (P = 0.059). Serologically active, but clinically quiescent disease also had a higher prevalence of anti-IFN-alpha autoantibodies. Based on our findings that most SLE patients belong to either a Sm/RNP or Ro/La autoantigen cluster, these results suggest the possibility that alterations in RNA-RNA-binding protein interactions may play a critical role in triggering and/or the pathogenesis of SLE.	[Ching, Kathryn H.; Burbelo, Peter D.; Iadarola, Michael J.] Natl Inst Dent & Craniofacial Res, Neurobiol & Pain Therapeut Sect, Lab Sensory Biol, Bethesda, MD USA; [Tipton, Christopher; Wei, Chungwen; Sanz, Ignacio] Univ Rochester, Med Ctr, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Petri, Michelle] Johns Hopkins Univ, Sch Med, Dept Med, Div Rheumatol, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Rochester; Johns Hopkins University	Ching, KH (corresponding author), USDA, Albany, CA USA.	ching.kathryn@gmail.com			Division of Intramural Research; National Institute of Dental and Craniofacial Research; National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR043727, U19AI56390, R37 AI049660-06A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI049660, U19AI056390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000724] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL090034] Funding Source: NIH RePORTER	Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); CLINICAL CENTER	This work was supported by the Division of Intramural Research, National Institute of Dental and Craniofacial Research. This study was also supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases R01 AR043727 (MP), U19AI56390 (IS) and R37 AI049660-06A1 (IS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Burbelo PD, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-22; Burbelo PD, 2011, EXPERT REV PROTEOMIC, V8, P309, DOI [10.1586/EPR.11.23, 10.1586/epr.11.23]; Burbelo PD, 2010, BLOOD, V116, P4848, DOI 10.1182/blood-2010-05-286161; Burbelo PD, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-97; Burbelo PD, 2010, AM J TRANSL RES, V2, P145; Burbelo Peter D, 2009, J Vis Exp, DOI 10.3791/1549; Burbelo PD, 2009, AUTOIMMUNITY, V42, P515, DOI 10.1080/08916930902911738; Burbelo PD, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000438; Burbelo PD, 2009, CLIN VACCINE IMMUNOL, V16, P621, DOI 10.1128/CVI.00474-08; Chung SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001323; Deocharan B, 2002, J IMMUNOL, V168, P3072, DOI 10.4049/jimmunol.168.6.3072; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hoffman IEA, 2004, ANN RHEUM DIS, V63, P1155, DOI 10.1136/ard.2003.013417; Isenberg DA, 1997, BRIT J RHEUMATOL, V36, P229; Jurencak R, 2009, J RHEUMATOL, V36, P416, DOI 10.3899/jrheum.080588; Liu E, 2007, CLIN IMMUNOL, V125, P120, DOI 10.1016/j.clim.2007.08.005; Lockshin MD, 2006, LUPUS, V15, P753, DOI 10.1177/0961203306069353; Malik S, 2007, LUPUS, V16, P863, DOI 10.1177/0961203307083365; Meager A, 2006, PLOS MED, V3, P1152, DOI 10.1371/journal.pmed.0030289; Merrill JT, 2011, ANN RHEUM DIS, V70, P1905, DOI 10.1136/ard.2010.144485; Morimoto AM, 2011, ARTHRITIS RHEUM; Nikpour M, 2008, ANN RHEUM DIS, V67, P1069, DOI 10.1136/ard.2007.074765; Powell JJ, 1999, ENVIRON HEALTH PERSP, V107, P667; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Sestak AL, 2011, ANN RHEUM DIS, V70, pI37, DOI 10.1136/ard.2010.138057; Sherer Y, 2004, SEMIN ARTHRITIS RHEU, V34, P501, DOI 10.1016/j.semarthrit.2004.07.002; Slavikova M, 2003, J INTERF CYTOK RES, V23, P143, DOI 10.1089/107999003321532475; Somers E, 2002, J RHEUMATOL, V29, P2531; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tang XH, 2010, MEDICINE, V89, P62, DOI 10.1097/MD.0b013e3181cb449c; To CH, 2005, ARTHRITIS RHEUM-US, V52, P4003, DOI 10.1002/art.21414; VONWUSSOW P, 1988, RHEUMATOL INT, V8, P225, DOI 10.1007/BF00269199; Weckerle CE, 2011, ARTHRITIS RHEUM-US, V63, P1044, DOI 10.1002/art.30187; Yao YH, 2009, ARTHRITIS RHEUM, V60, P1785, DOI 10.1002/art.24557	37	74	77	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32001	10.1371/journal.pone.0032001	http://dx.doi.org/10.1371/journal.pone.0032001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363785	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700133
J	Justiniano, SE; Mathew, A; Mitra, S; Manivannan, SN; Simcox, A				Justiniano, Steven E.; Mathew, Anne; Mitra, Sayan; Manivannan, Sathiya N.; Simcox, Amanda			Loss of the Tumor Suppressor Pten Promotes Proliferation of Drosophila melanogaster Cells In Vitro and Gives Rise to Continuous Cell Lines	PLOS ONE			English	Article							SIGNALING PATHWAY; GENE; GROWTH; CANCER; APOPTOSIS; RECEPTOR; KINASE; SIZE; POLARITY; ENCODES	In vivo analysis of Drosophila melanogaster has enhanced our understanding of many biological processes, notably the mechanisms of heredity and development. While in vivo analysis of mutants has been a strength of the field, analyzing fly cells in culture is valuable for cell biological, biochemical and whole genome approaches in which large numbers of homogeneous cells are required. An efficient genetic method to derive Drosophila cell lines using expression of an oncogenic form of Ras (Ras(V12)) has been developed. Mutations in tumor suppressors, which are known to cause cell hyperproliferation in vivo, could provide another method for generating Drosophila cell lines. Here we screened Drosophila tumor suppressor mutations to test if they promoted cell proliferation in vitro. We generated primary cultures and determined when patches of proliferating cells first emerged. These cells emerged on average at 37 days in wild-type cultures. Using this assay we found that a Pten mutation had a strong effect. Patches of proliferating cells appeared on average at 11 days and the cultures became confluent in about 3 weeks, which is similar to the timeframe for cultures expressing Ras(V12). Three Pten mutant cell lines were generated and these have now been cultured for between 250 and 630 cell doublings suggesting the life of the mutant cells is likely to be indefinite. We conclude that the use of Pten mutants is a powerful means to derive new Drosophila cell lines.	[Justiniano, Steven E.; Mathew, Anne; Mitra, Sayan; Manivannan, Sathiya N.; Simcox, Amanda] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Justiniano, SE (corresponding author), Ohio State Univ, Dept Mol Genet, 484 W 12Th Ave, Columbus, OH 43210 USA.	simcox.1@osu.edu		Justiniano, Steven/0000-0003-1381-9309; Manivannan, Sathiyanarayanan/0000-0002-9470-2390	National Institutes of Health [R01GM071856, 1R21HD063119-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD063119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071856] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institutes of Health (R01GM071856 and 1R21HD063119-01; http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Brumby AM, 2005, NAT REV CANCER, V5, P626, DOI 10.1038/nrc1671; Cherbas L, 2011, GENOME RES, V21, P301, DOI 10.1101/gr.112961.110; Clancy JL, 2003, ONCOGENE, V22, P5070, DOI 10.1038/sj.onc.1206775; Echalier G., 1997, DROSOPHILA CELLS CUL; Frank DJ, 2002, DEVELOPMENT, V129, P399; Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103; Gao XS, 2000, DEV BIOL, V221, P404, DOI 10.1006/dbio.2000.9680; GATEFF E, 1978, SCIENCE, V200, P1448, DOI 10.1126/science.96525; GATEFF E, 1967, AM ZOOL, V7, P760; Goberdhan DCI, 1999, GENE DEV, V13, P3244, DOI 10.1101/gad.13.24.3244; Gonzalez C, 2007, NAT REV GENET, V8, P462, DOI 10.1038/nrg2103; Grzeschik NA, 2010, CURR BIOL, V20, P573, DOI 10.1016/j.cub.2010.01.055; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Hariharan IK, 2006, ANNU REV GENET, V40, P335, DOI 10.1146/annurev.genet.39.073003.100738; Hayflick L, 1997, BIOCHEMISTRY-MOSCOW+, V62, P1180; Huang H, 1999, DEVELOPMENT, V126, P5365; Humbert PO, 2008, ONCOGENE, V27, P6888, DOI 10.1038/onc.2008.341; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; Kockel L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000990; KRAEMER PM, 1986, J NATL CANCER I, V76, P703, DOI 10.1093/jnci/76.4.703; Leonardi J, 2011, DEVELOPMENT, V138, P3569, DOI 10.1242/dev.068361; Ling C, 2010, P NATL ACAD SCI USA, V107, P10532, DOI 10.1073/pnas.1004279107; MANSFIELD E, 1994, DEV BIOL, V165, P507, DOI 10.1006/dbio.1994.1271; Oldham S, 2002, DEVELOPMENT, V129, P4103; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pardue ML, 2011, P NATL ACAD SCI US; Parsons LM, 2010, FLY, V4, P288, DOI 10.4161/fly.4.4.13116; Prober DA, 2002, GENE DEV, V16, P2286, DOI 10.1101/gad.991102; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Robinson BS, 2010, CURR BIOL, V20, P582, DOI 10.1016/j.cub.2010.03.019; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Simcox A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000142; Simcox AA, 2008, FLY, V2, P306, DOI 10.4161/fly.7427; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Willecke M, 2011, ONCOGENE; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; XU TA, 1995, DEVELOPMENT, V121, P1053	41	7	7	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31417	10.1371/journal.pone.0031417	http://dx.doi.org/10.1371/journal.pone.0031417			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363644	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700058
J	Kim, M; Soontornniyomkij, V; Ji, BH; Zhou, XJ				Kim, MinJung; Soontornniyomkij, Virawudh; Ji, Baohu; Zhou, Xianjin			System-Wide Immunohistochemical Analysis of Protein Co-Localization	PLOS ONE			English	Article							HIPPOCAMPAL DENTATE GYRUS; ANTIBODY ELUTION; CALRETININ; EXPRESSION	Background: The analysis of co-localized protein expression in a tissue section is often conducted with immunofluorescence histochemical staining which is typically visualized in localized regions. On the other hand, chromogenic immunohistochemical staining, in general, is not suitable for the detection of protein co-localization. Here, we developed a new protocol, based on chromogenic immunohistochemical stain, for system-wide detection of protein co-localization and differential expression. Methodology/Principal Findings: In combination with a removable chromogenic stain, an efficient antibody stripping method was developed to enable sequential immunostaining with different primary antibodies regardless of antibody's host species. Sections were scanned after each staining, and the images were superimposed together for the detection of protein co-localization and differential expression. As a proof of principle, differential expression and co-localization of glutamic acid decarboxylase67 (GAD67) and parvalbumin proteins was examined in mouse cortex. Conclusions/Significance: All parvalbumin-containing neurons express GAD67 protein, and GAD67-positive neurons that do not express parvalbumin were readily visualized from thousands of other neurons across mouse cortex. The method provided a global view of protein co-localization as well as differential expression across an entire tissue section. Repeated use of the same section could combine assessments of co-localization and differential expression of multiple proteins.	[Kim, MinJung; Soontornniyomkij, Virawudh; Ji, Baohu; Zhou, Xianjin] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kim, M (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.	xzhou@ucsd.edu	Ji, Baohu/A-1333-2013; Ji, Baohu/D-2281-2014; Soontornniyomkij, Virawudh/C-7852-2009	Soontornniyomkij, Virawudh/0000-0002-0471-7020	National Institute of Mental Health [R01MH073991]; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073991] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute of Mental Health R01MH073991 (X.Z.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Christensen, 2009, ED GUIDE IMMUNOHISTO; Glass G, 2009, J HISTOCHEM CYTOCHEM, V57, P899, DOI 10.1369/jhc.2009.953612; Kanaani J, 2010, J CELL BIOL, V190, P911, DOI 10.1083/jcb.200912101; Pirici D, 2009, J HISTOCHEM CYTOCHEM, V57, P567, DOI 10.1369/jhc.2009.953240; Seress L, 2008, HIPPOCAMPUS, V18, P425, DOI 10.1002/hipo.20403; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; TRAMU G, 1978, J HISTOCHEM CYTOCHEM, V26, P322, DOI 10.1177/26.4.207771; Zhou X, 2007, GENES BRAIN BEHAV, V6, P269, DOI 10.1111/j.1601-183X.2006.00256.x	8	19	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32043	10.1371/journal.pone.0032043	http://dx.doi.org/10.1371/journal.pone.0032043			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363794	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700138
J	Marchetti, G; Nasta, P; Bai, F; Gatti, F; Bellistri, GM; Tincati, C; Borghi, F; Carosi, G; Puoti, M; Monforte, AD				Marchetti, Giulia; Nasta, Paola; Bai, Francesca; Gatti, Francesca; Bellistri, Giusi Maria; Tincati, Camilla; Borghi, Federica; Carosi, Giampiero; Puoti, Massimo; Monforte, Antonella d'Arminio			Circulating sCD14 Is Associated with Virological Response to Pegylated-Interferon-Alpha/Ribavirin Treatment in HIV/HCV Co-Infected Patients	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; IMMUNODEFICIENCY-VIRUS INFECTION; GENOME-WIDE ASSOCIATION; T-CELL-ACTIVATION; HIV-INFECTION; LIVER-DISEASE; MICROBIAL TRANSLOCATION; IMMUNE ACTIVATION; GENETIC-VARIATION; ANTIRETROVIRAL THERAPY	Objectives: Microbial translocation (MT) through the gut accounts for immune activation and CD4+ loss in HIV and may influence HCV disease progression in HIV/HCV co-infection. We asked whether increased MT and immune activation may hamper anti-HCV response in HIV/HCV patients. Methods: 98 HIV/HCV patients who received pegylated-alpha-interferon (peg-INF-alpha)/ribavirin were retrospectively analyzed. Baseline MT (lipopolysaccharide, LPS), host response to MT (sCD14), CD38+HLA-DR+CD4+/CD8+, HCV genotype, severity of liver disease were assessed according to Early Virological Response (EVR: HCV-RNA < 50 IU/mL at week 12 of therapy or >= 2 log(10) reduction from baseline after 12 weeks of therapy) and Sustained Virological Response (SVR: HCV-RNA < 50 IU/mL 24 weeks after end of therapy). Mann-Whitney/Chi-square test and Pearson's correlation were used. Multivariable regression was performed to determine factors associated with EVR/SVR. Results: 71 patients displayed EVR; 41 SVR. Patients with HCV genotypes 1-4 and cirrhosis presented a trend to higher sCD14, compared to patients with genotypes 2-3 (p = 0.053) and no cirrhosis (p = 0.052). EVR and SVR patients showed lower levels of circulating sCD14 (p = 0.0001, p = 0.026, respectively), but similar T-cell activation compared to Non-EVR (Null Responders, NR) and Non-SVR (N-SVR) subjects. sCD14 resulted the main predictive factor of EVR (0.145 for each sCD14 unit more, 95%CI 0.031-0.688, p = 0.015). SVR was associated only with HCV genotypes 2-3 (AOR 0.022 for genotypes 1-4 vs 2-3, 95%CI 0.001-0.469, p = 0.014). Conclusions: In HIV/HCV patients sCD14 correlates with the severity of liver disease and predicts early response to peg-INF-alpha/ribavirin, suggesting MT-driven immune activation as pathway of HIV/HCV co-infection and response to therapy.	[Marchetti, Giulia; Bai, Francesca; Bellistri, Giusi Maria; Tincati, Camilla; Monforte, Antonella d'Arminio] Univ Milan, San Paolo Hosp, Clin Infect Dis & Trop Med, Dept Med Surg & Dent, Milan, Italy; [Nasta, Paola; Gatti, Francesca; Borghi, Federica; Carosi, Giampiero] Univ Brescia, Inst Infect & Trop Dis, Brescia, Italy; [Puoti, Massimo] AO Osped Niguarda Ca Granda, Dept Infect Dis, Milan, Italy	San Paolo-Polo Universitaria Hospital; University of Milan; University of Brescia; Ospedale Niguarda Ca' Granda	Marchetti, G (corresponding author), Univ Milan, San Paolo Hosp, Clin Infect Dis & Trop Med, Dept Med Surg & Dent, Milan, Italy.	giulia.marchetti@unimi.it	Bai, Francesca/K-4823-2018; Gori, Andrea/AAC-6078-2022; Marchetti, Giulia/GPX-7655-2022; Puoti, Massimo/AAA-6580-2020; TINCATI, CAMILLA/K-4501-2018; MARCHETTI, GIULIA CARLA/K-4384-2018	Puoti, Massimo/0000-0003-3278-7138; TINCATI, CAMILLA/0000-0002-3083-2962; MARCHETTI, GIULIA CARLA/0000-0002-4498-4828	Universita degli Studi di Milano [PUR 2009]	Universita degli Studi di Milano	This work was funded by grant support (PUR 2009), Universita degli Studi di Milano. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselah T, 2008, GUT, V57, P516, DOI 10.1136/gut.2007.128611; Balagopal A, 2008, GASTROENTEROLOGY, V135, P226, DOI 10.1053/j.gastro.2008.03.022; Berzsenyi MD, 2007, GASTROENTEROLOGY, V133, P1821, DOI 10.1053/j.gastro.2007.08.076; Bica I, 2001, CLIN INFECT DIS, V32, P492, DOI 10.1086/318501; Blackard JT, 2008, J VIRAL HEPATITIS, V15, P323, DOI 10.1111/j.1365-2893.2008.00970.x; BODE C, 1987, J HEPATOL, V4, P8, DOI 10.1016/S0168-8278(87)80003-X; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brettschneider J, 2002, J NEUROIMMUNOL, V133, P193, DOI 10.1016/S0165-5728(02)00353-3; Bruno R, 2002, AM J GASTROENTEROL, V97, P1598, DOI 10.1111/j.1572-0241.2002.05817.x; Bruno R, 2007, JAIDS-J ACQ IMM DEF, V46, P297, DOI 10.1097/QAI.0b013e31814be887; Caradonna L, 2002, CURR PHARM DESIGN, V8, P995, DOI 10.2174/1381612024606983; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Dolganiuc A, 2007, GASTROENTEROLOGY, V133, P1627, DOI 10.1053/j.gastro.2007.08.003; Elefsiniotis IS, 2009, INTERVIROLOGY, V52, P247, DOI 10.1159/000228548; Enomoto N, 1999, HEPATOLOGY, V29, P1680, DOI 10.1002/hep.510290633; Farnik H, 2009, LIVER INT, V29, P23, DOI 10.1111/j.1478-3231.2008.01969.x; Funderburg N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001915; GAETA GB, 1982, DIGESTION, V23, P239, DOI 10.1159/000198756; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gonzalez VD, 2010, CLIN IMMUNOL, V135, P12, DOI 10.1016/j.clim.2009.12.005; Gonzalez VD, 2009, J VIROL, V83, P11407, DOI 10.1128/JVI.01211-09; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Harte AL, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-15; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Kamal SM, 2009, LIVER INT, V29, P39, DOI 10.1111/j.1478-3231.2008.01930.x; Kovacs A, 2010, J INFECT DIS, V201, P823, DOI 10.1086/650997; Marchetti G, 2011, AIDS, V25, P1385, DOI 10.1097/QAD.0b013e3283471d10; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; McGovern BH, 2007, J ACQUIR IMMUNE D S2, V45, pS47; McGovern BH, 2007, J ACQUIR IMMUNE D S2, V45, pS66; Puoti M, 2003, J BIOL REG HOMEOS AG, V17, P144; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rempel H, 2010, AIDS, V24, P1415, DOI 10.1097/QAD.0b013e32833ac623; Rockstroh JK, 2005, J INFECT DIS, V192, P992, DOI 10.1086/432762; Rockstroh JK, 2006, J HEPATOL, V44, pS25, DOI 10.1016/j.jhep.2005.11.007; Rosenthal E, 2009, HIV MED, V10, P282, DOI 10.1111/j.1468-1293.2008.00686.x; Sandler NG, 2011, GASTROENTEROLOGY, V141, P1220, DOI 10.1053/j.gastro.2011.06.063; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sarasin-Filipowicz M, 2009, MOL CELL BIOL, V29, P4841, DOI 10.1128/MCB.00224-09; Soriano V, 2008, J INFECT DIS, V198, P1337, DOI 10.1086/592171; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thurman RG, 1998, AM J PHYSIOL-GASTR L, V275, pG605, DOI 10.1152/ajpgi.1998.275.4.G605; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Vermehren J, 2011, CLIN MICROBIOL INFEC, V17, P122, DOI 10.1111/j.1469-0691.2010.03430.x; Wyles David L, 2010, Top HIV Med, V18, P132; Yu JW, 2007, J GASTROEN HEPATOL, V22, P832, DOI 10.1111/j.1440-1746.2007.04904.x	52	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32028	10.1371/journal.pone.0032028	http://dx.doi.org/10.1371/journal.pone.0032028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363790	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700136
J	Nielsen, SY; Hjollund, NH; Andersen, AMN; Henriksen, TB; Kantso, B; Krogfelt, KA; Molbak, K				Nielsen, Stine Yde; Hjollund, Niels Henrik; Andersen, Anne-Marie Nybo; Henriksen, Tine Brink; Kantso, Bjorn; Krogfelt, Karen Angeliki; Molbak, Kare			Presence of Antibodies Against Coxiella burnetii and Risk of Spontaneous Abortion: A Nested Case-Control Study	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; Q-FEVER; FOLLOW-UP; PREGNANCY; DIAGNOSIS; IMMUNOFLUORESCENCE; INFECTION; OUTBREAK; DENMARK; HUMANS	Background and Aims: Q fever is a bacterial zoonosis caused by infection with Coxiella burnetii. It is well established that Q fever causes fetal loss in small ruminants. The suspicion has been raised that pregnant women may also experience adverse pregnancy outcome when the infection is acquired or reactivated during pregnancy. The purpose of this study was to assess the potential association between serologic markers of infection with C. burnetii and spontaneous abortion. Methods: A nested case-control study within the Danish National Birth Cohort, a cohort of 100,418 pregnancies recruited from 1996-2002. Women were recruited in first trimester of pregnancy and followed prospectively. Median gestational age at enrolment was 8 weeks (25 and 75 percentiles: 7 weeks; 10 weeks). During pregnancy, a blood sample was collected at gestational week 6-12 and stored in a bio bank. For this study, a case sample of 218 pregnancies was drawn randomly among the pregnancies in the cohort which ended with a miscarriage before 22 gestational weeks, and a reference group of 482 pregnancies was selected in a random fashion among all pregnancies in the cohort. From these pregnancies, serum samples were screened for antibodies against C. burnetii in a commercial enzyme-linked immunosorbent assay (ELISA). Samples that proved IgG or IgM antibody positive were subsequently confirmatory tested by an immunofluorescence (IFA) test. Results: Among cases, 11 (5%) were C. burnetii positive in ELISA of which one was confirmed in the IFA assay compared to 29 (6%) ELISA positive and 3 IFA confirmed in the random sample. Conclusions: We found no evidence of a higher prevalence of C. burnetii antibodies in serum samples from women who later miscarried and the present study does not indicate a major association between Q fever infection and spontaneous abortion in humans. Very early first trimester abortions were, however, not included in the study.	[Nielsen, Stine Yde; Hjollund, Niels Henrik] Reg Hosp W Jutland, Dept Occupat Med, Herning, Denmark; [Nielsen, Stine Yde; Henriksen, Tine Brink] Aarhus Univ Hosp Skejby, Perinatal Epidemiol Res Unit, Aarhus, Denmark; [Hjollund, Niels Henrik] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; [Andersen, Anne-Marie Nybo] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Henriksen, Tine Brink] Aarhus Univ Hosp Skejby, Dept Pediat, Aarhus, Denmark; [Kantso, Bjorn] Statens Serum Inst, Dept Microbiol Diagnost, DK-2300 Copenhagen, Denmark; [Krogfelt, Karen Angeliki] Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen, Denmark; [Molbak, Kare] Statens Serum Inst, Dept Epidemiol, DK-2300 Copenhagen, Denmark	Aarhus University; Aarhus University; University of Copenhagen; Aarhus University; Statens Serum Institut; Statens Serum Institut; Statens Serum Institut	Nielsen, SY (corresponding author), Reg Hosp W Jutland, Dept Occupat Med, Herning, Denmark.	stineyde@dadlnet.dk	Andersen, Anne-Marie Nybo/E-4993-2013; Krogfelt, Karen Angeliki/P-2430-2018; Nybo Andersen, Anne-Marie/AAA-1997-2022; Krogfelt, Karen Angeliki A/O-8145-2016	Andersen, Anne-Marie Nybo/0000-0002-4296-8488; Nybo Andersen, Anne-Marie/0000-0002-4296-8488; Krogfelt, Karen Angeliki A/0000-0001-7536-3453; Molbak, Kare/0000-0002-3100-4990; Hjollund, Niels Henrik I/0000-0002-6697-6597	Danish Working Environment Research Fund; Danish Ramazzinicenter; Danish Veterinary Association; Danish Cattle Levy-fund; Milk Levy Fund; Viking Danmark	Danish Working Environment Research Fund; Danish Ramazzinicenter; Danish Veterinary Association; Danish Cattle Levy-fund; Milk Levy Fund; Viking Danmark	This study was partially supported by: Danish Working Environment Research Fund: http://arbejdstilsynet.dk/da/om%20arbejdstilsynet/arbejdsmiljoforskningsfonden/om-arbejdsmiljoforskningsfonden.aspx, Danish Ramazzinicenter: www. ramazzini. dk, The Danish Veterinary Association: www. ddd.dk, Danish Cattle Levy-fund: http://kvaegafgiftsfonden.dk, The Milk Levy Fund: www.maelkeafgiftsfonden.dk, and Viking Danmark: http://vikinggenetics.com. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger JF, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-5; Andersen AG, 2001, THESIS U COPENHAGEN; Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016; Bacci S, 2011, ZOONOSES PUBLIC HLTH; Ben Amara A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015315; Berri M, 2007, RES VET SCI, V83, P47, DOI 10.1016/j.rvsc.2006.11.001; Bildfell RJ, 2000, J VET DIAGN INVEST, V12, P419, DOI 10.1177/104063870001200505; Bosnjak E, 2010, CLIN MICROBIOL INFEC, V16, P1285, DOI 10.1111/j.1469-0691.2009.03062.x; Carcopino X, 2007, CLIN INFECT DIS, V45, P548, DOI 10.1086/520661; Carcopino X, 2009, ANN NY ACAD SCI, V1166, P79, DOI 10.1111/j.1749-6632.2009.04519.x; Field PR, 2000, J CLIN MICROBIOL, V38, P1645, DOI 10.1128/JCM.38.4.1645-1647.2000; Field PR, 2002, J CLIN MICROBIOL, V40, P3526, DOI 10.1128/JCM.40.9.3526-3529.2002; Fournier PE, 1998, J CLIN MICROBIOL, V36, P1823, DOI 10.1128/JCM.36.7.1823-1834.1998; Hansen MS, 2011, VET J; Healy B, 2011, CLIN INFECT DIS, V52, P1013, DOI 10.1093/cid/cir132; Marmion BP, 2005, QJM-INT J MED, V98, P7, DOI 10.1093/qjmed/hci009; McCaughey C, 2008, ZOONOSES PUBLIC HLTH, V55, P189, DOI 10.1111/j.1863-2378.2008.01109.x; Nigro G, 2011, J MATERN FETAL NEONA; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Parker NR, 2006, LANCET, V367, P679, DOI 10.1016/S0140-6736(06)68266-4; Raoult D, 2002, ARCH INTERN MED, V162, P701, DOI 10.1001/archinte.162.6.701; Stein A, 2000, J INFECT DIS, V181, P188, DOI 10.1086/315166; Tissot-Dupont H, 2007, CLIN INFECT DIS, V44, P232, DOI 10.1086/510389; Vaidya VM, 2008, J CLIN MICROBIOL, V46, P2038, DOI 10.1128/JCM.01874-07; van der Hoek W, 2010, EUROSURVEILLANCE, V15, P4; van der Hoek W, 2011, BMC INFECT DIS, V11, DOI 10.1186/1472-6963-11-57; Villumsen S, 2009, DIAGN MICR INFEC DIS, V65, P93, DOI 10.1016/j.diagmicrobio.2009.06.004; Wilcox AJ, 2010, FERTILITY PREGNANCY, P324	28	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31909	10.1371/journal.pone.0031909	http://dx.doi.org/10.1371/journal.pone.0031909			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363769	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700123
J	Rankin, J; Walker, JJ; Windle, R; Lightman, SL; Terry, JR				Rankin, James; Walker, Jamie J.; Windle, Richard; Lightman, Stafford L.; Terry, John R.			Characterizing Dynamic Interactions between Ultradian Glucocorticoid Rhythmicity and Acute Stress Using the Phase Response Curve	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; ACTH-SECRETION; RECEPTOR; BRAIN; FEEDBACK; RATS; HYPOTHALAMUS; ADAPTATION	The hypothalamic-pituitary-adrenal (HPA) axis is a dynamic oscillatory hormone signalling system that regulates the pulsatile secretion of glucocorticoids from the adrenal glands. In addition to regulation of basal levels of glucocorticoids, the HPA axis provides a rapid hormonal response to stress that is vitally important for homeostasis. Recently it has become clear that glucocorticoid pulses encode an important biological signal that regulates receptor signalling both in the central nervous system and in peripheral tissues. It is therefore important to understand how stressful stimuli disrupt the pulsatile dynamics of this system. Using a computational model that incorporates the crucial feed-forward and feedback components of the axis, we provide novel insight into experimental observations that the size of the stress-induced hormonal response is critically dependent on the timing of the stress. Further, we employ the theory of Phase Response Curves to show that an acute stressor acts as a phase-resetting mechanism for the ultradian rhythm of glucocorticoid secretion. Using our model, we demonstrate that the magnitude of an acute stress is a critical factor in determining whether the system resets via a Type 1 or Type 0 mechanism. By fitting our model to our in vivo stress-response data, we show that the glucocorticoid response to an acute noise stress in rats is governed by a Type 0 phase-resetting curve. Our results provide additional evidence for the concept of a deterministic sub-hypothalamic oscillator regulating the ultradian glucocorticoid rhythm, which constitutes a highly responsive peripheral hormone system that interacts dynamically with hypothalamic inputs to regulate the overall hormonal response to stress.	[Rankin, James; Walker, Jamie J.] Univ Bristol, Bristol Ctr Appl Nonlinear Math, Bristol, Avon, England; [Rankin, James] INRIA Sophia Antipolis, Sophia Antipolis, France; [Walker, Jamie J.; Lightman, Stafford L.; Terry, John R.] Univ Bristol, Henry Wellcome Labs Integrat Neurosci & Endocrino, Bristol, Avon, England; [Windle, Richard] Univ Nottingham, Sch Nursing Midwifery & Physiotherapy, Nottingham NG7 2RD, England; [Terry, John R.] Univ Sheffield, Dept Automat Control & Syst Engn, Sheffield, S Yorkshire, England; [Terry, John R.] Univ Sheffield, Sheffield Inst Translat Neurosci, Sheffield, S Yorkshire, England	University of Bristol; University of Bristol; University of Nottingham; University of Sheffield; University of Sheffield	Rankin, J (corresponding author), Univ Bristol, Bristol Ctr Appl Nonlinear Math, Bristol, Avon, England.	J.Terry@exeter.ac.uk	Terry, John/ABA-2609-2020; Terry, John/P-6585-2014; Terry, John/F-5734-2010; Rankin, James/AAN-9648-2021	Terry, John/0000-0002-6829-5736; Rankin, James/0000-0002-8850-6027; Lightman, Stafford/0000-0002-8546-9646	Engineering and Physical Sciences Research Council (EPSRC) [EP/E032249/1]; Wellcome Trust [074112/Z/04/Z]; MRC [MR/J008893/1] Funding Source: UKRI; Medical Research Council [MR/J008893/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Engineering and Physical Sciences Research Council (EPSRC) grant EP/E032249/1 and The Wellcome Trust grant 074112/Z/04/Z. The original biological data was generated from a Wellcome Trust grant to Stafford Lightman and Colin Ingram. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson HC, 2008, AM J PHYSIOL-ENDOC M, V294, pE1011, DOI 10.1152/ajpendo.00721.2007; Brown E, 2004, NEURAL COMPUT, V16, P673, DOI 10.1162/089976604322860668; Conway-Campbell BL, 2010, J NEUROENDOCRINOL, V22, P1093, DOI 10.1111/j.1365-2826.2010.02051.x; Dallman MF, 2005, FRONT NEUROENDOCRIN, V26, P103, DOI 10.1016/j.yfrne.2005.08.001; DALLMAN MF, 1987, RECENT PROG HORM RES, V43, P113; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Droste SK, 2008, ENDOCRINOLOGY, V149, P3244, DOI 10.1210/en.2008-0103; Glass L., 1988, CLOCKS CHAOS RHYTHMS; Gupta S, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-8; Hinz B, 2000, PHARMACEUT RES, V17, P1273, DOI 10.1023/A:1026499604848; IXART G, 1991, EXP BRAIN RES, V87, P153; JONES MT, 1977, J ENDOCRINOL, V73, P405, DOI 10.1677/joe.0.0730405; Lightman SL, 2010, NAT REV NEUROSCI, V11, P710, DOI 10.1038/nrn2914; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; MERSHON JL, 1992, ENDOCRINOLOGY, V130, P2991, DOI 10.1210/en.130.5.2991; Russell GM, 2010, J NEUROSCI, V30, P6106, DOI 10.1523/JNEUROSCI.5332-09.2010; Spiga F, 2009, J ENDOCRINOL, V200, P273, DOI 10.1677/JOE-08-0421; Stavreva DA, 2009, NAT CELL BIOL, V11, P1093, DOI 10.1038/ncb1922; Walker JJ, 2010, J NEUROENDOCRINOL, V22, P1226, DOI 10.1111/j.1365-2826.2010.02087.x; Walker JJ, 2010, P ROY SOC B-BIOL SCI, V277, P1627, DOI 10.1098/rspb.2009.2148; Windle RJ, 1998, ENDOCRINOLOGY, V139, P443, DOI 10.1210/en.139.2.443; Windle RJ, 1998, ENDOCRINOLOGY, V139, P4044, DOI 10.1210/en.139.10.4044; Windle RJ, 2001, J NEUROENDOCRINOL, V13, P905, DOI 10.1046/j.1365-2826.2001.00715.x; Winfree AT., 1980, GEOMETRY BIOL TIME	24	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e30978	10.1371/journal.pone.0030978	http://dx.doi.org/10.1371/journal.pone.0030978			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363526	Green Submitted, gold, Green Published			2022-12-27	WOS:000302873700017
J	Seidel, C; Zekert, N; Fischer, R				Seidel, Constanze; Zekert, Nadine; Fischer, Reinhard			The Aspergillus nidulans Kinesin-3 Tail Is Necessary and Sufficient to Recognize Modified Microtubules	PLOS ONE			English	Article							MOTOR PROTEINS; ALPHA-TUBULIN; FHA DOMAIN; IDENTIFICATION; TRANSPORT; DYNACTIN; NCKIN3; DYNEIN; KIF1A; GENE	Posttranslational microtubule modifications (PTMs) are numerous; however, the biochemical and cell biological roles of those modifications remain mostly an enigma. The Aspergillus nidulans kinesin-3 UncA uses preferably modified microtubules (MTs) as tracks for vesicle transportation. Here, we show that a positively charged region in the tail of UncA (amino acids 1316 to 1402) is necessary for the recognition of modified MTs. Chimeric proteins composed of the kinesin-1 motor domain and the UncA tail displayed the same specificity as UncA, suggesting that the UncA tail is sufficient to establish specificity. Interaction between the UncA tail and alpha-tubulin was shown using a yeast two-hybrid assay and in A. nidulans by bimolecular fluorescence complementation. This is the first demonstration of how a kinesin-3 motor protein distinguishes among different MT populations in fungal cells, and how specificity determination depends on the tail rather than the motor domain, as has been demonstrated for kinesin 1 in neuronal cells.	[Seidel, Constanze; Zekert, Nadine; Fischer, Reinhard] Karlsruhe Inst Technol, Dept Microbiol, Inst Appl Biosci, Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology	Seidel, C (corresponding author), Karlsruhe Inst Technol, Dept Microbiol, Inst Appl Biosci, Karlsruhe, Germany.	reinhard.fischer@bio.uka.de	Fischer, Reinhard/I-1220-2016	Fischer, Reinhard/0000-0002-6704-2569	German Science Foundation [FOR1334]; Deutsche Forschungsgemeinschaft; Karlsruhe Institute of Technology	German Science Foundation(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Karlsruhe Institute of Technology(Helmholtz Association)	The study was funded by the German Science Foundation FOR1334. We thank Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Karlsruhe Institute of Technology for support. CS is a fellow of the Landesgraduiertenforderung of the state Baden Wurttemberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adio S, 2006, J BIOL CHEM, V281, P37782, DOI 10.1074/jbc.M605061200; Adio S, 2009, FEBS J, V276, P3641, DOI 10.1111/j.1742-4658.2009.07083.x; Penalva MA, 2010, CURR OPIN MICROBIOL, V13, P684, DOI 10.1016/j.mib.2010.09.005; ARCE CA, 1975, EUR J BIOCHEM, V59, P145, DOI 10.1111/j.1432-1033.1975.tb02435.x; Dietrich KA, 2008, P NATL ACAD SCI USA, V105, P8938, DOI 10.1073/pnas.0803575105; Dunn S, 2008, J CELL SCI, V121, P1085, DOI 10.1242/jcs.026492; Fuchs F, 2005, MOL BIOL CELL, V16, P153, DOI 10.1091/mbc.E04-05-0413; Hill TW., 2001, FUNGAL GENET NEWSL, V48, P20, DOI [DOI 10.4148/1941-4765.1173, 10.4148/1941-4765.1173]; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P877, DOI 10.1038/nrm2807; Huckaba TM, 2011, J BIOL CHEM, V286, P7457, DOI 10.1074/jbc.M110.167023; Ikegami K, 2007, P NATL ACAD SCI USA, V104, P3213, DOI 10.1073/pnas.0611547104; Konishi Y, 2009, NAT NEUROSCI, V12, P559, DOI 10.1038/nn.2314; Lee JR, 2004, EMBO J, V23, P1506, DOI 10.1038/sj.emboj.7600164; Lehmler C, 1997, EMBO J, V16, P3464, DOI 10.1093/emboj/16.12.3464; Marx A, 2009, CELL MOTIL CYTOSKEL, V66, P958, DOI 10.1002/cm.20392; Mialhe A, 2001, CANCER RES, V61, P5024; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; MORRIS NR, 1979, CELL, V16, P437; Nitta R, 2008, NAT STRUCT MOL BIOL, V15, P1067, DOI 10.1038/nsmb.1487; Oakley BR, 2004, FUNGAL GENET BIOL, V41, P420, DOI 10.1016/j.fgb.2003.11.013; Quinones GB, 2011, MOL BIOL CELL, V22, P1045, DOI 10.1091/mbc.E10-06-0519; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Requena N, 2001, MOL MICROBIOL, V42, P121, DOI 10.1046/j.1365-2958.2001.02609.x; Sambrook J., 1999, MOL CLONING LAB MANU; Schuster M, 2011, P NATL ACAD SCI USA, V108, P3618, DOI 10.1073/pnas.1015839108; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; SHEIRNEISS G, 1978, CELL, V15, P639, DOI 10.1016/0092-8674(78)90032-6; Tomishige M, 2002, SCIENCE, V297, P2263, DOI 10.1126/science.1073386; Westerholm-Parvinen A, 2000, FEBS LETT, V486, P285, DOI 10.1016/S0014-5793(00)02310-3; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; YELTON MM, 1984, P NATL ACAD SCI-BIOL, V81, P1470, DOI 10.1073/pnas.81.5.1470; Zekert N, 2009, MOL BIOL CELL, V20, P673, DOI 10.1091/mbc.E08-07-0685; Zhang J, 2003, MOL BIOL CELL, V14, P1479, DOI 10.1091/mbc.E02-08-0516; Zhang J, 2011, J CELL BIOL, V193, P1245, DOI 10.1083/jcb.201011022	34	11	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30976	10.1371/journal.pone.0030976	http://dx.doi.org/10.1371/journal.pone.0030976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363525	Green Published, gold, Green Submitted			2022-12-27	WOS:000302871500022
J	Kinnamon, DD; Hershberger, RE; Martin, ER				Kinnamon, Daniel D.; Hershberger, Ray E.; Martin, Eden R.			Reconsidering Association Testing Methods Using Single-Variant Test Statistics as Alternatives to Pooling Tests for Sequence Data with Rare Variants	PLOS ONE			English	Article							SAMPLE-SIZE; LINKAGE DISEQUILIBRIUM; COMMON DISEASES; GENETIC-MARKERS; ALLELE MODEL; SUSCEPTIBILITY; POWER; SNPS	Association tests that pool minor alleles into a measure of burden at a locus have been proposed for case-control studies using sequence data containing rare variants. However, such pooling tests are not robust to the inclusion of neutral and protective variants, which can mask the association signal from risk variants. Early studies proposing pooling tests dismissed methods for locus-wide inference using nonnegative single-variant test statistics based on unrealistic comparisons. However, such methods are robust to the inclusion of neutral and protective variants and therefore may be more useful than previously appreciated. In fact, some recently proposed methods derived within different frameworks are equivalent to performing inference on weighted sums of squared single-variant score statistics. In this study, we compared two existing methods for locus-wide inference using nonnegative single-variant test statistics to two widely cited pooling tests under more realistic conditions. We established analytic results for a simple model with one rare risk and one rare neutral variant, which demonstrated that pooling tests were less powerful than even Bonferroni-corrected single-variant tests in most realistic situations. We also performed simulations using variants with realistic minor allele frequency and linkage disequilibrium spectra, disease models with multiple rare risk variants and extensive neutral variation, and varying rates of missing genotypes. In all scenarios considered, existing methods using nonnegative single-variant test statistics had power comparable to or greater than two widely cited pooling tests. Moreover, in disease models with only rare risk variants, an existing method based on the maximum single-variant Cochran-Armitage trend chi-square statistic in the locus had power comparable to or greater than another existing method closely related to some recently proposed methods. We conclude that efficient locus-wide inference using single-variant test statistics should be reconsidered as a useful framework for devising powerful association tests in sequence data with rare variants.	[Kinnamon, Daniel D.; Martin, Eden R.] Univ Miami, Miller Sch Med, Dept Human Genet, Dr John T Macdonald Fdn, Miami, FL 33136 USA; [Hershberger, Ray E.] Univ Miami, Miller Sch Med, Cardiovasc Div, Miami, FL 33136 USA	University of Miami; University of Miami	Kinnamon, DD (corresponding author), Univ Miami, Miller Sch Med, Dept Human Genet, Dr John T Macdonald Fdn, Miami, FL 33136 USA.	emartin1@med.miami.edu	Kinnamon, Daniel D./J-4207-2013	Kinnamon, Daniel D./0000-0002-0867-5227; Hershberger, Ray/0000-0001-5683-6526	National Institutes of Health [RC2HG005605, HL58626]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058626] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported by National Institutes of Health grants RC2HG005605 (ERM, DDK) and HL58626 (REH). No additional external funding was received for this study. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonarakis SE, 2010, VOGEL AND MOTULSKY'S HUMAN GENETICS, FOURTH EDITION, P31, DOI 10.1007/978-3-540-37654-5_2; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; Casella G., 2002, STAT INFERENCE, V2nd; Chapman J, 2008, GENET EPIDEMIOL, V32, P560, DOI 10.1002/gepi.20330; Davison AC, 1997, BOOTSTRAP METHODS TH; Ernst MD, 2004, STAT SCI, V19, P676, DOI 10.1214/088342304000000396; Freidlin B, 2002, HUM HERED, V53, P146, DOI 10.1159/000064976; GOODNIGHT JH, 1979, AM STAT, V33, P149, DOI 10.2307/2683825; Hoffmann TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013584; Hoh J, 2001, GENOME RES, V11, P2115, DOI 10.1101/gr.204001; Hoh J, 2003, NAT REV GENET, V4, P701, DOI 10.1038/nrg1155; HUDSON RR, 1985, GENETICS, V109, P611; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; Ionita-Laza I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001289; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Leemis LM, 1996, AM STAT, V50, P63, DOI 10.2307/2685046; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Little R.J.A., 2002, STAT ANAL MISSING DA; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; McIntyre LM, 2000, GENET EPIDEMIOL, V19, P18, DOI 10.1002/1098-2272(200007)19:1<18::AID-GEPI2>3.0.CO;2-Y; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Nachman MW, 2000, GENETICS, V156, P297; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Rampersaud E, 2010, ANN HUM GENET, V74, P110, DOI 10.1111/j.1469-1809.2010.00566.x; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Slager SL, 2001, HUM HERED, V52, P149, DOI 10.1159/000053370; Sul JH, 2011, GENETICS, V188, P181, DOI 10.1534/genetics.110.125070; Thomas DC, 2004, STAT METHODS GENETIC; Timm NH, 2002, APPL MULTIVARIATE AN, DOI 10.1007/b98963; WEIR BS, 1979, HEREDITY, V42, P105, DOI 10.1038/hdy.1979.10; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029	39	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30238	10.1371/journal.pone.0030238	http://dx.doi.org/10.1371/journal.pone.0030238			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363423	gold, Green Published, Green Submitted			2022-12-27	WOS:000302853600017
J	Preuss, SB; Meister, R; Xu, QZ; Urwin, CP; Tripodi, FA; Screen, SE; Anil, VS; Zhu, SQ; Morrell, JA; Liu, G; Ratcliffe, OJ; Reuber, TL; Khanna, R; Goldman, BS; Bell, E; Ziegler, TE; McClerren, AL; Ruff, TG; Petracek, ME				Preuss, Sasha B.; Meister, Robert; Xu, Qingzhang; Urwin, Carl P.; Tripodi, Federico A.; Screen, Steven E.; Anil, Veena S.; Zhu, Shuquan; Morrell, James A.; Liu, Grace; Ratcliffe, Oliver J.; Reuber, T. Lynne; Khanna, Rajnish; Goldman, Barry S.; Bell, Erin; Ziegler, Todd E.; McClerren, Amanda L.; Ruff, Thomas G.; Petracek, Marie E.			Expression of the Arabidopsis thaliana BBX32 Gene in Soybean Increases Grain Yield	PLOS ONE			English	Article							CIRCADIAN CLOCK; FLOWERING TIME; KEY PATHWAYS; ARABIDOPSIS; COMPONENTS; CONSTANS; CCA1; FOOD; LHY; PRODUCTIVITY	Crop yield is a highly complex quantitative trait. Historically, successful breeding for improved grain yield has led to crop plants with improved source capacity, altered plant architecture, and increased resistance to abiotic and biotic stresses. To date, transgenic approaches towards improving crop grain yield have primarily focused on protecting plants from herbicide, insects, or disease. In contrast, we have focused on identifying genes that, when expressed in soybean, improve the intrinsic ability of the plant to yield more. Through the large scale screening of candidate genes in transgenic soybean, we identified an Arabidopsis thaliana B-box domain gene (AtBBX32) that significantly increases soybean grain yield year after year in multiple transgenic events in multi-location field trials. In order to understand the underlying physiological changes that are associated with increased yield in transgenic soybean, we examined phenotypic differences in two AtBBX32-expressing lines and found increases in plant height and node, flower, pod, and seed number. We propose that these phenotypic changes are likely the result of changes in the timing of reproductive development in transgenic soybean that lead to the increased duration of the pod and seed development period. Consistent with the role of BBX32 in A. thaliana in regulating light signaling, we show that the constitutive expression of AtBBX32 in soybean alters the abundance of a subset of gene transcripts in the early morning hours. In particular, AtBBX32 alters transcript levels of the soybean clock genes GmTOC1 and LHY-CCA1-like2 (GmLCL2). We propose that through the expression of AtBBX32 and modulation of the abundance of circadian clock genes during the transition from dark to light, the timing of critical phases of reproductive development are altered. These findings demonstrate a specific role for AtBBX32 in modulating soybean development, and demonstrate the validity of expressing single genes in crops to deliver increased agricultural productivity.	[Preuss, Sasha B.; Meister, Robert; Xu, Qingzhang; Urwin, Carl P.; Tripodi, Federico A.; Screen, Steven E.; Zhu, Shuquan; Morrell, James A.; Liu, Grace; Goldman, Barry S.; Bell, Erin; Ziegler, Todd E.; McClerren, Amanda L.; Ruff, Thomas G.; Petracek, Marie E.] Monsanto Co, St Louis, MO 63167 USA; [Anil, Veena S.] Monsanto Co, Monsanto Res Ctr, Bangalore, Karnataka, India; [Ratcliffe, Oliver J.; Reuber, T. Lynne; Khanna, Rajnish] Mendel Biotechnol Inc, Hayward, CA USA	Monsanto; Monsanto	Preuss, SB (corresponding author), Monsanto Co, St Louis, MO 63167 USA.	sasha.preuss@monsanto.com	Anil, Veena/ABI-3683-2020	Anil, Veena/0000-0002-7404-7683; Ziegler, Todd/0000-0001-8947-5763; Reuber, Lynne/0000-0001-7806-2437	Monsanto Company; Mendel Biotechnology	Monsanto Company; Mendel Biotechnology	This work was supported by the Monsanto Company and conducted in collaboration with Mendel Biotechnology. Since all authors are or were employed by Monsanto (SBP, RM, QX, CPU, FAT, SES, VSA, SZ, JAM, GL, BSG, EB, TEZ, ALM, TGR, MEP) or Mendel Biotechnology (OJR, TLR, RK) the funders played a role in the design, data analysis and the decision to publish.; All authors are or were affiliated with the Monsanto Company or Mendel Biotechnology, who were also funders of this study. In the United States, the authors have one issued patent: US 7,692,067 ("Yield and Stress Tolerance in Transgenic Plants"). This does not alter the authors' attempt to adhere to all the PLoS ONE policies on sharing data and materials.	Alston JM, 2009, SCIENCE, V325, P1209, DOI 10.1126/science.1170451; BOARD JE, 1995, CROP SCI, V35, P846, DOI 10.2135/cropsci1995.0011183X003500030035x; Burney JA, 2010, P NATL ACAD SCI US; Carpenter AC, 1997, CROP SCI, V37, P1520, DOI 10.2135/cropsci1997.0011183X003700050018x; Covington MF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r130; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Edgerton MD, 2009, PLANT PHYSIOL, V149, P7, DOI 10.1104/pp.108.130195; Egli DB, 2004, ADV AGRON, V83, P243, DOI 10.1016/S0065-2113(04)83005-0; EGLI DB, 1993, FIELD CROP RES, V32, P147, DOI 10.1016/0378-4290(93)90027-K; Endo-Higashi N, 2011, PLANT CELL PHYSIOL, V52, P1083, DOI 10.1093/pcp/pcr059; ETHREDGE WJ, 1989, AGRON J, V81, P947, DOI 10.2134/agronj1989.00021962008100060020x; Fehr W. R., 1971, STAGE DEV DESCRIPTIO; Fujiwara S, 2008, PLANT CELL, V20, P2960, DOI 10.1105/tpc.108.061531; GOLI A, 1986, CROP SCI, V26, P156, DOI 10.2135/cropsci1986.0011183X002600010036x; Green RE, 2005, SCIENCE, V308, P1257; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Heatherly L.G., 2004, SOYBEANS, V16, P451, DOI [10.2134/agronmonogr16.3ed.c10, DOI 10.2134/AGRONMONOGR16.3ED.C10]; High-Level Expert Forum, 2009, FEED WORLD 2050; Holtan HE, 2011, PLANT PHYSIOL, V156, P2109, DOI 10.1104/pp.111.177139; JIANG HF, 1993, AGRON J, V85, P221, DOI 10.2134/agronj1993.00021962008500020011x; Khanna R, 2009, PLANT CELL, V21, P3416, DOI 10.1105/tpc.109.069088; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Liu H, 2009, J PLANT PHYSIOL, V166, P278, DOI 10.1016/j.jplph.2008.06.003; Liu LJ, 2008, PLANT CELL, V20, P292, DOI 10.1105/tpc.107.057281; LOGEMANN J, 1987, ANAL BIOCHEM, V163, P16, DOI 10.1016/0003-2697(87)90086-8; Mizoguchi T, 2002, DEV CELL, V2, P629, DOI 10.1016/S1534-5807(02)00170-3; Mockler T, 2003, P NATL ACAD SCI USA, V100, P2140, DOI 10.1073/pnas.0437826100; Niwa Y, 2007, PLANT CELL PHYSIOL, V48, P925, DOI 10.1093/pcp/pcm067; Pruneda-Paz JL, 2010, TRENDS PLANT SCI, V15, P259, DOI 10.1016/j.tplants.2010.03.003; Rosegrant MW, 2003, SCIENCE, V302, P1917, DOI 10.1126/science.1092958; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; SCHWEITZER LE, 1985, CROP SCI, V25, P995, DOI 10.2135/cropsci1985.0011183X002500060023x; Specht JE, 1999, CROP SCI, V39, P1560, DOI 10.2135/cropsci1999.3961560x; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014	38	67	70	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30717	10.1371/journal.pone.0030717	http://dx.doi.org/10.1371/journal.pone.0030717			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363475	Green Submitted, Green Published, gold			2022-12-27	WOS:000302853600059
J	Saba, R; Gushue, S; Huzarewich, RLCH; Manguiat, K; Medina, S; Robertson, C; Booth, SA				Saba, Reuben; Gushue, Shantel; Huzarewich, Rhiannon L. C. H.; Manguiat, Kathy; Medina, Sarah; Robertson, Catherine; Booth, Stephanie A.			MicroRNA 146a (miR-146a) Is Over-Expressed during Prion Disease and Modulates the Innate Immune Response and the Microglial Activation State	PLOS ONE			English	Article							NF-KAPPA-B; PROTEIN-COUPLED RECEPTOR; TOLL-LIKE RECEPTORS; HUMAN BRAIN-CELLS; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASES; MOUSE MODEL; MICE; INFLAMMATION; TOLL-LIKE-RECEPTOR-2	Increasing evidence supports the involvement of microRNAs ( miRNAs) in inflammatory and immune processes in prion neuropathogenesis. MiRNAs are small, non-coding RNA molecules which are emerging as key regulators of numerous cellular processes. We established miR-146a over-expression in prion-infected mouse brain tissues concurrent with the onset of prion deposition and appearance of activated microglia. Expression profiling of a variety of central nervous system derived cell-lines revealed that miR-146a is preferentially expressed in cells of microglial lineage. Prominent up-regulation of miR-146a was evident in the microglial cell lines BV-2 following TLR2 or TLR4 activation and also EOC 13.31 via TLR2 that reached a maximum 24-48 hours post-stimulation, concomitant with the return to basal levels of transcription of induced cytokines. Gain-and loss-of-function studies with miR-146a revealed a substantial deregulation of inflammatory response pathways in response to TLR2 stimulation. Significant transcriptional alterations in response to miR-146a perturbation included downstream mediators of the pro-inflammatory transcription factor, nuclear factor-kappa B (NF-kappa B) and the JAK-STAT signaling pathway. Microarray analysis also predicts a role for miR-146a regulation of morphological changes in microglial activation states as well as phagocytic mediators of the oxidative burst such as CYBA and NOS3. Based on our results, we propose a role for miR-146a as a potent modulator of microglial function by regulating the activation state during prion induced neurodegeneration.	[Saba, Reuben; Gushue, Shantel; Huzarewich, Rhiannon L. C. H.; Manguiat, Kathy; Medina, Sarah; Robertson, Catherine; Booth, Stephanie A.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Mol PathoBiol, Winnipeg, MB, Canada; [Saba, Reuben; Gushue, Shantel; Booth, Stephanie A.] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada	Public Health Agency of Canada; University of Manitoba	Saba, R (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Mol PathoBiol, Winnipeg, MB, Canada.	Stephanie.Booth@phac-aspc.gc.ca	Booth, Stephanie/AAX-6671-2020	Booth, Stephanie/0000-0001-8108-5955	PrioNet Canada; Public Health Agency of Canada; Genomics Initiative for Government Laboratories	PrioNet Canada; Public Health Agency of Canada; Genomics Initiative for Government Laboratories	This study was supported by the PrioNet Canada, the Public Health Agency of Canada and the Canadian Biotechnology Strategy Fund: Genomics Initiative for Government Laboratories. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen KQ, 2006, J BIOL CHEM, V281, P3651, DOI 10.1074/jbc.M508125200; COUTINHO A, 1978, IMMUNOGENETICS, V7, P17, DOI 10.1007/BF01843983; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; Giese A, 1998, BRAIN PATHOL, V8, P449; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Henneke P, 2002, J IMMUNOL, V169, P3970, DOI 10.4049/jimmunol.169.7.3970; Hill JM, 2009, NEUROREPORT, V20, P1500, DOI 10.1097/WNR.0b013e3283329c05; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Hu GK, 2010, AM J PHYSIOL-GASTR L, V298, pG542, DOI 10.1152/ajpgi.00490.2009; Hughes MM, 2010, GLIA, V58, P2017, DOI 10.1002/glia.21070; Iribarren P, 2005, FASEB J, V19, P2032, DOI 10.1096/fj.05-4578fje; Junker A, 2009, BRAIN, V132, P3342, DOI 10.1093/brain/awp300; Kakimura J, 2002, FASEB J, V16, P601, DOI 10.1096/fj.01-0530fje; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Landreth GE, 2009, CURR TOP MICROBIOL, V336, P137, DOI 10.1007/978-3-642-00549-7_8; Lemmers B, 2007, J BIOL CHEM, V282, P7416, DOI 10.1074/jbc.M606721200; Letiembre M, 2009, NEUROBIOL AGING, V30, P759, DOI 10.1016/j.neurobiolaging.2007.08.018; Li YY, 2011, NEUROSCI LETT, V487, P94, DOI 10.1016/j.neulet.2010.09.079; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; Lukiw WJ, 2008, J BIOL CHEM, V283, P31315, DOI 10.1074/jbc.M805371200; Michaud JP, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-5; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Perry MM, 2008, J IMMUNOL, V180, P5689, DOI 10.4049/jimmunol.180.8.5689; Pichler K, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-100; Pogue AI, 2009, J INORG BIOCHEM, V103, P1591, DOI 10.1016/j.jinorgbio.2009.05.012; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Prinz M, 2003, EMBO REP, V4, P195, DOI 10.1038/sj.embor.embor731; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Qin HW, 2005, BLOOD, V106, P3114, DOI 10.1182/blood-2005-02-0759; Richard KL, 2008, J NEUROSCI, V28, P5784, DOI 10.1523/JNEUROSCI.1146-08.2008; Saba Reuben, 2006, BMC Biotechnol, V6, P47, DOI 10.1186/1472-6750-6-47; Saba R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003652; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sethi S, 2002, LANCET, V360, P229, DOI 10.1016/S0140-6736(02)09513-2; Shepard LW, 2001, J BIOL CHEM, V276, P45979, DOI 10.1074/jbc.M104783200; Spinner DS, 2008, J VIROL, V82, P10701, DOI 10.1128/JVI.00522-08; Spinner DS, 2007, J LEUKOCYTE BIOL, V81, P1374, DOI 10.1189/jlb.1106665; Stoeck K, 2006, J NEUROIMMUNOL, V172, P175, DOI 10.1016/j.jneuroim.2005.10.008; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tahara K, 2006, BRAIN, V129, P3006, DOI 10.1093/brain/awl249; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Walker WS, 1995, J NEUROIMMUNOL, V63, P163, DOI 10.1016/0165-5728(95)00146-8; Wang Y, 2007, EXP NEUROL, V203, P168, DOI 10.1016/j.expneurol.2006.08.006; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Zipprich JT, 2009, RNA, V15, P781, DOI 10.1261/rna.1448009	55	121	127	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30832	10.1371/journal.pone.0030832	http://dx.doi.org/10.1371/journal.pone.0030832			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363497	Green Submitted, gold, Green Published			2022-12-27	WOS:000302853600074
J	Sriram, KB; Larsen, JE; Francis, SMS; Wright, CM; Clarke, BE; Duhig, EE; Brown, KM; Hayward, NK; Yang, IA; Bowman, RV; Fong, KM				Sriram, Krishna B.; Larsen, Jill E.; Francis, Santiyagu M. Savarimuthu; Wright, Casey M.; Clarke, Belinda E.; Duhig, Edwina E.; Brown, Kevin M.; Hayward, Nicholas K.; Yang, Ian A.; Bowman, Rayleen V.; Fong, Kwun M.			Array-Comparative Genomic Hybridization Reveals Loss of SOCS6 Is Associated with Poor Prognosis in Primary Lung Squamous Cell Carcinoma	PLOS ONE			English	Article							COPY NUMBER VARIATION; GENE-EXPRESSION; BREAST-CANCER; DNA; MICROARRAY; MARKER; STAGE; ADENOCARCINOMA; AMPLIFICATION; PROGRESSION	Background: Primary tumor recurrence commonly occurs after surgical resection of lung squamous cell carcinoma (SCC). Little is known about the genes driving SCC recurrence. Methods: We used array comparative genomic hybridization (aCGH) to identify genes affected by copy number alterations that may be involved in SCC recurrence. Training and test sets of resected primary lung SCC were assembled. aCGH was used to determine genomic copy number in a training set of 62 primary lung SCCs (28 with recurrence and 34 with no evidence of recurrence) and the altered copy number of candidate genes was confirmed by quantitative PCR (qPCR). An independent test set of 72 primary lung SCCs (20 with recurrence and 52 with no evidence of recurrence) was used for biological validation. mRNA expression of candidate genes was studied using qRT-PCR. Candidate gene promoter methylation was evaluated using methylation microarrays and Sequenom EpiTYPER analysis. Results: 18q22.3 loss was identified by aCGH as being significantly associated with recurrence (p = 0.038). Seven genes within 18q22.3 had aCGH copy number loss associated with recurrence but only SOCS6 copy number was both technically replicated by qPCR and biologically validated in the test set. SOCS6 copy number loss correlated with reduced mRNA expression in the study samples and in the samples with copy number loss, there was a trend for increased methylation, albeit non-significant. Overall survival was significantly poorer in patients with SOCS6 loss compared to patients without SOCS6 loss in both the training (30 vs. 43 months, p = 0.023) and test set (27 vs. 43 months, p = 0.010). Conclusion: Reduced copy number and mRNA expression of SOCS6 are associated with disease recurrence in primary lung SCC and may be useful prognostic biomarkers.	[Sriram, Krishna B.; Larsen, Jill E.; Francis, Santiyagu M. Savarimuthu; Wright, Casey M.; Yang, Ian A.; Bowman, Rayleen V.; Fong, Kwun M.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Sriram, Krishna B.; Francis, Santiyagu M. Savarimuthu; Yang, Ian A.; Bowman, Rayleen V.; Fong, Kwun M.] Prince Charles Hosp, Dept Thorac Med, Brisbane, Qld 4032, Australia; [Larsen, Jill E.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Clarke, Belinda E.; Duhig, Edwina E.] Prince Charles Hosp, Dept Anat Pathol, Brisbane, Qld 4032, Australia; [Brown, Kevin M.] Translat Genom Res Inst TGen, Integrat Canc Genom Div, Phoenix, AZ USA; [Hayward, Nicholas K.] Queensland Inst Med Res, Oncogen Lab, Brisbane, Qld 4006, Australia	University of Queensland; Prince Charles Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; Prince Charles Hospital; Translational Genomics Research Institute; QIMR Berghofer Medical Research Institute	Sriram, KB (corresponding author), Univ Queensland, Sch Med, Brisbane, Qld, Australia.	bajee.sriram@uqconnect.edu.au	Wright, Casey M/J-9693-2014; Bowman, Rayleen V/G-4144-2013; Fong, Kwun M/G-6369-2010; Wright, Casey/G-1078-2011; hayward, nick/AAV-8802-2020; Yang, Ian A/B-9609-2008; Dodds, Casey/HGC-6866-2022; Larsen, Jill E/G-3787-2010; hayward, nicholas k/C-1367-2015; Sriram, Krishna Bajee/J-9316-2014	Wright, Casey M/0000-0001-9214-5749; Yang, Ian A/0000-0001-8338-1993; Larsen, Jill E/0000-0001-7806-3931; hayward, nicholas k/0000-0003-4760-1033; Fong, Kwun/0000-0002-6507-1403; Sriram, Krishna Bajee/0000-0002-1865-2133	NHMRC; Queensland Smart State project; UQ; Cancer Council Queensland; Queensland Clinical Research Fellowship; Prince Charles Hospital Foundation; NATIONAL CANCER INSTITUTE [ZIACP010201] Funding Source: NIH RePORTER	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Queensland Smart State project; UQ; Cancer Council Queensland(Cancer Council Queensland); Queensland Clinical Research Fellowship; Prince Charles Hospital Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NH&MRC and Queensland Smart State project grants; UQ Postgraduate Medical Scholarship and NH&MRC Postgraduate Medical Scholarship (to KBS), NH&MRC Practitioner Fellowship (KMF), NH&MRC Career Development Award (IAY), NH&MRC Biomedical Scholarship (SMS, CMW), Cancer Council Queensland Senior Research Fellowship (KMF), Queensland Clinical Research Fellowship (KMF, IAY) and The Prince Charles Hospital Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2007, ONCOL REP, V17, P1005; Balmain A, 2003, NAT GENET, V33, P238, DOI 10.1038/ng1107; Balsara BR, 2002, ONCOGENE, V21, P6877, DOI 10.1038/sj.onc.1205836; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bayle J, 2004, J BIOL CHEM, V279, P12249, DOI 10.1074/jbc.M313381200; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Boelens MC, 2009, LUNG CANCER, V66, P372, DOI 10.1016/j.lungcan.2009.02.017; Boone PM, 2010, HUM MUTAT, V31, P1326, DOI 10.1002/humu.21360; Boyd D Barry, 2003, Integr Cancer Ther, V2, P315, DOI 10.1177/1534735403259152; Carrasco DR, 2006, CANCER CELL, V9, P313, DOI 10.1016/j.ccr.2006.03.019; Chansky K, 2009, J THORAC ONCOL, V4, P792, DOI 10.1097/JTO.0b013e3181a7716e; Charchar FJ, 2010, HYPERTENSION, V55, P1231, DOI 10.1161/HYPERTENSIONAHA.109.141663; Choi YW, 2007, LUNG CANCER, V55, P43, DOI 10.1016/j.lungcan.2006.09.018; Detterbeck FC, 2009, CHEST, V136, P260, DOI 10.1378/chest.08-0978; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Ehrich M, 2006, CANCER RES, V66, P10911, DOI 10.1158/0008-5472.CAN-06-0400; Etemadmoghadam D, 2009, CLIN CANCER RES, V15, P1417, DOI 10.1158/1078-0432.CCR-08-1564; Goldstraw P, 2011, LANCET, V378, P1727, DOI 10.1016/S0140-6736(10)62101-0; Hassan HT, 2009, LEUKEMIA RES, V33, P5, DOI 10.1016/j.leukres.2008.06.011; Hoffman PC, 2000, LANCET, V355, P479, DOI 10.1016/S0140-6736(00)82038-3; Iwakawa R, 2011, CLIN CANCER RES, V17, P1481, DOI 10.1158/1078-0432.CCR-10-2484; Jarvinen AK, 2008, GENE CHROMOSOME CANC, V47, P500, DOI 10.1002/gcc.20551; Jonsson G, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2596; Kang JU, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-237; Kondo Y, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001559; Krebs DL, 2002, MOL CELL BIOL, V22, P4567, DOI 10.1128/MCB.22.13.4567-4578.2002; Kristensen LS, 2009, CLIN CHEM, V55, P1471, DOI 10.1373/clinchem.2008.121962; Lai RH, 2010, CANCER LETT, V288, P75, DOI 10.1016/j.canlet.2009.06.025; Lai RH, 2009, GENE, V448, P64, DOI 10.1016/j.gene.2009.07.022; Larsen JE, 2007, CARCINOGENESIS, V28, P760, DOI 10.1093/carcin/bgl207; Larsen L, 2002, APMIS, V110, P833, DOI 10.1034/j.1600-0463.2002.1101201.x; Luk C, 2001, CANCER GENET CYTOGEN, V125, P87, DOI 10.1016/S0165-4608(00)00363-0; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Newnham GM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-93; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pei JM, 2001, GENE CHROMOSOME CANC, V31, P282, DOI 10.1002/gcc.1145; Petersen S, 2000, BRIT J CANCER, V82, P65; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Przybytkowski E, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-16; Scott WJ, 2007, CHEST, V132, p234S, DOI 10.1378/chest.07-1378; Spiro SG, 2005, AM J RESP CRIT CARE, V172, P523, DOI 10.1164/rccm.200504-531OE; Sung JS, 2010, CANCER GENET CYTOGEN, V198, P27, DOI 10.1016/j.cancergencyto.2009.12.001; Sy SMH, 2004, EUR J CANCER, V40, P1082, DOI 10.1016/j.ejca.2004.01.012; Takebayashi S, 2004, GENE CHROMOSOME CANC, V41, P145, DOI 10.1002/gcc.20066; Tan DSP, 2007, LAB INVEST, V87, P737, DOI 10.1038/labinvest.3700593; Tanaka T, 2009, DIAGN MOL PATHOL, V18, P219, DOI 10.1097/PDM.0b013e3181910f17; Tommasi S, 2010, ANAL CELL PATHOL, V33, P113, DOI [10.1155/2010/468280, 10.3233/ACP-CLO-2010-0544]; Ueno T, 2002, CLIN CANCER RES, V8, P526; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Yamamoto S, 2009, MODERN PATHOL, V22, P499, DOI 10.1038/modpathol.2008.234; Yan WS, 2005, TUMOR BIOL, V26, P158, DOI 10.1159/000086488	54	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30398	10.1371/journal.pone.0030398	http://dx.doi.org/10.1371/journal.pone.0030398			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363434	Green Published, gold			2022-12-27	WOS:000302853600028
J	Zallocchi, M; Meehan, DT; Delimont, D; Rutledge, J; Gratton, MA; Flannery, J; Cosgrove, D				Zallocchi, Marisa; Meehan, Daniel T.; Delimont, Duane; Rutledge, Joseph; Gratton, Michael Anne; Flannery, John; Cosgrove, Dominic			Role for a Novel Usher Protein Complex in Hair Cell Synaptic Maturation	PLOS ONE			English	Article							ALTERNATIVE SPLICE FORMS; CA(V)1.3 CA2+ CHANNELS; ANKLE-LINK COMPLEX; RIBBON SYNAPSES; MUTANT ALLELES; MYOSIN-VIIA; TIP-LINK; GENOMIC STRUCTURE; COUPLED RECEPTOR; PLASMA-MEMBRANE	The molecular mechanisms underlying hair cell synaptic maturation are not well understood. Cadherin-23 (CDH23), protocadherin-15 (PCDH15) and the very large G-protein coupled receptor 1 (VLGR1) have been implicated in the development of cochlear hair cell stereocilia, while clarin-1 has been suggested to also play a role in synaptogenesis. Mutations in CDH23, PCDH15, VLGR1 and clarin-1 cause Usher syndrome, characterized by congenital deafness, vestibular dysfunction and retinitis pigmentosa. Here we show developmental expression of these Usher proteins in afferent spiral ganglion neurons and hair cell synapses. We identify a novel synaptic Usher complex comprised of clarin-1 and specific isoforms of CDH23, PCDH15 and VLGR1. To establish the in vivo relevance of this complex, we performed morphological and quantitative analysis of the neuronal fibers and their synapses in the Clrn1-/- mouse, which was generated by incomplete deletion of the gene. These mice showed a delay in neuronal/synaptic maturation by both immunostaining and electron microscopy. Analysis of the ribbon synapses in Ames waltzer(av3J) mice also suggests a delay in hair cell synaptogenesis. Collectively, these results show that, in addition to the well documented role for Usher proteins in stereocilia development, Usher protein complexes comprised of specific protein isoforms likely function in synaptic maturation as well.	[Zallocchi, Marisa; Meehan, Daniel T.; Delimont, Duane; Cosgrove, Dominic] Boys Town Natl Res Hosp, Omaha, NE 68131 USA; [Rutledge, Joseph; Gratton, Michael Anne] St Louis Univ, St Louis, MO 63103 USA; [Flannery, John] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Cosgrove, Dominic] Univ Nebraska Med Ctr, Omaha, NE USA	Boys Town National Research Hospital; Saint Louis University; University of California System; University of California Berkeley; University of Nebraska System; University of Nebraska Medical Center	Zallocchi, M (corresponding author), Boys Town Natl Res Hosp, Omaha, NE 68131 USA.	dominic.cosgrove@boystown.org	Zallocchi, Marisa/HHS-7445-2022	Flannery, John/0000-0002-0720-8897	IBIF, Creighton University, Omaha, NE [RR17417-01]; NIH [R01 DC004844, DC006442]; Foundation Fighting Blindness; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006442, R01DC004844] Funding Source: NIH RePORTER	IBIF, Creighton University, Omaha, NE; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Confocal microscopy was conducted at the IBIF, Creighton University, Omaha, NE (C06 Grant RR17417-01, NCRR, NIH). Electron microscopy was conducted at the RCAVS at Washington University (P300DC046651). This work was supported by NIH grants R01 DC004844 to DC, DC006442 to MAG, and a grant from The Foundation Fighting Blindness to JF. The IBIF (Integrated Biomedical Imaging Facility) and RCAVS (Research Center for Auditory and Vestibular Studies) are CORE services provided by University facilities funded by the NIH. The support does indeed represent a source of funding. As users the authors are requested to acknowledge the support in any publications resulting from data acquired through use of the facilities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adato A, 2002, EUR J HUM GENET, V10, P339, DOI 10.1038/sj.ejhg.5200831; Ahmed ZM, 2003, HUM MOL GENET, V12, P3215, DOI 10.1093/hmg/ddg358; Ahmed ZM, 2008, HUM GENET, V124, P215, DOI 10.1007/s00439-008-0543-3; Ahmed ZM, 2006, J NEUROSCI, V26, P7022, DOI 10.1523/JNEUROSCI.1163-06.2006; Ahmed ZM, 2008, MOL VIS, V14, P2227; Alagramam KN, 2001, HUM MOL GENET, V10, P1709, DOI 10.1093/hmg/10.16.1709; Alagramam KN, 2001, NAT GENET, V27, P99, DOI 10.1038/83837; Alagramam KN, 2007, GENOMICS, V90, P482, DOI 10.1016/j.ygeno.2007.06.007; Alagramam KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019183; Barclay M, 2010, NEUROSCI LETT, V478, P51, DOI 10.1016/j.neulet.2010.01.063; Beurg M, 2010, J NEUROSCI, V30, P13281, DOI 10.1523/JNEUROSCI.2528-10.2010; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; BOUGHMAN JA, 1983, J CHRON DIS, V36, P595, DOI 10.1016/0021-9681(83)90147-9; Boyer S, 2004, BRAIN RES PROTOC, V13, P91, DOI 10.1016/j.brainresprot.2004.02.004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Cosgrove D, 2010, HEARING RES, V259, P117, DOI 10.1016/j.heares.2009.09.006; DANNHOF BJ, 1993, HEARING RES, V66, P8, DOI 10.1016/0378-5955(93)90255-Y; Di Palma F, 2001, GENE, V281, P31, DOI 10.1016/S0378-1119(01)00761-2; El-Amraoui A, 2005, J CELL SCI, V118, P4593, DOI 10.1242/jcs.02636; Fuchs PA, 2003, CURR OPIN NEUROBIOL, V13, P452, DOI 10.1016/S0959-4388(03)00098-9; Geller SF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000607; Geng RS, 2009, HUM MOL GENET, V18, P2748, DOI 10.1093/hmg/ddp210; GILLOYZAGA P, 1990, EUR ARCH OTO-RHINO-L, V248, P40, DOI 10.1007/BF00634780; Grati M, 2006, J NEUROSCI, V26, P6386, DOI 10.1523/JNEUROSCI.1215-06.2006; Gregory FD, 2011, NAT NEUROSCI, V14, P1109, DOI 10.1038/nn.2895; Hallgren B, 1959, ACTA PSYCHIAT SCAND, V138, P100; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Haywood-Watson RJL, 2006, INVEST OPHTH VIS SCI, V47, P3074, DOI 10.1167/iovs.06-0108; Heidrych P, 2008, HUM MOL GENET, V17, P3814, DOI 10.1093/hmg/ddn279; Heidrych P, 2009, HUM MOL GENET, V18, P2779, DOI 10.1093/hmg/ddp213; Huang LC, 2007, DEVELOPMENT, V134, P2925, DOI 10.1242/dev.001925; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Knirsch M, 2007, J NEUROSCI, V27, P6442, DOI 10.1523/JNEUROSCI.5364-06.2007; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; Kremer H, 2006, HUM MOL GENET, V15, pR262, DOI 10.1093/hmg/ddl205; Lagziel A, 2005, DEV BIOL, V280, P295, DOI 10.1016/j.ydbio.2005.01.015; Lagziel A, 2009, MOL VIS, V15, P1843; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; Lefevre G, 2008, DEVELOPMENT, V135, P1427, DOI 10.1242/dev.012922; Legendre K, 2008, J CELL SCI, V121, P3347, DOI 10.1242/jcs.028134; Lillo C, 2006, ADV EXP MED BIOL, V572, P341; Maerker T, 2008, HUM MOL GENET, V17, P71, DOI 10.1093/hmg/ddm285; McGee J, 2006, J NEUROSCI, V26, P6543, DOI 10.1523/JNEUROSCI.0693-06.2006; McMillan DR, 2004, MOL CELL NEUROSCI, V26, P322, DOI 10.1016/j.mcn.2004.02.005; McMillan DR, 2002, J BIOL CHEM, V277, P785, DOI 10.1074/jbc.M108929200; Michalski N, 2007, J NEUROSCI, V27, P6478, DOI 10.1523/JNEUROSCI.0342-07.2007; Moser T, 2006, J PHYSIOL-LONDON, V576, P55, DOI 10.1113/jphysiol.2006.114835; Nemzou RM, 2006, NEUROSCIENCE, V141, P1849, DOI 10.1016/j.neuroscience.2006.05.057; Nikkila H, 2000, MOL ENDOCRINOL, V14, P1351, DOI 10.1210/me.14.9.1351; Petit C, 2001, ANNU REV GENOM HUM G, V2, P271, DOI 10.1146/annurev.genom.2.1.271; PUJOL R, 1985, ACTA OTO-LARYNGOL, P5; Raphael Y, 2003, BRAIN RES BULL, V60, P397, DOI 10.1016/S0361-9230(03)00047-9; Reiners J, 2005, MOL VIS, V11, P347; Reiners J, 2003, INVEST OPHTH VIS SCI, V44, P5006, DOI 10.1167/iovs.03-0483; Reiners J, 2006, EXP EYE RES, V83, P97, DOI 10.1016/j.exer.2005.11.010; Rivolta MN, 2002, GENOME RES, V12, P1091, DOI 10.1101/gr.225602; Rivolta MN, 1998, P ROY SOC B-BIOL SCI, V265, P1595, DOI 10.1098/rspb.1998.0477; Roux I, 2009, HUM MOL GENET, V18, P4615, DOI 10.1093/hmg/ddp429; Ruel J, 2007, HEARING RES, V227, P19, DOI 10.1016/j.heares.2006.08.017; Safieddine S, 1999, EUR J NEUROSCI, V11, P803, DOI 10.1046/j.1460-9568.1999.00487.x; Scheel H, 2002, HUM MOL GENET, V11, P1757, DOI 10.1093/hmg/11.15.1757; Sendin G, 2007, J NEUROSCI, V27, P3163, DOI 10.1523/JNEUROSCI.3974-06.2007; Senften M, 2006, J NEUROSCI, V26, P2060, DOI 10.1523/JNEUROSCI.4251-05.2006; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; SIMMONS DD, 1994, NEUROREPORT, V5, P1309, DOI 10.1097/00001756-199406270-00003; Skradski SL, 2001, NEURON, V31, P537, DOI 10.1016/S0896-6273(01)00397-X; SOBKOWICZ HM, 1982, J NEUROSCI, V2, P942; SOBKOWICZ HM, 1986, J NEUROCYTOL, V15, P693, DOI 10.1007/BF01625188; Soni LE, 2005, CELL MOTIL CYTOSKEL, V62, P13, DOI 10.1002/cm.20080; Staub E, 2002, TRENDS BIOCHEM SCI, V27, P441, DOI 10.1016/S0968-0004(02)02163-1; Tomita S, 2007, P NATL ACAD SCI USA, V104, P18784, DOI 10.1073/pnas.0708970104; van Wijk E, 2006, HUM MOL GENET, V15, P751, DOI 10.1093/hmg/ddi490; Webb SW, 2011, DEVELOPMENT, V138, P1607, DOI 10.1242/dev.060061; Weil D, 2003, HUM MOL GENET, V12, P463, DOI 10.1093/hmg/ddg051; Weston MD, 2004, AM J HUM GENET, V74, P357, DOI 10.1086/381685; Yagi H, 2005, J NEUROCHEM, V92, P191, DOI 10.1111/j.1471-4159.2004.02875.x; Yagi H, 2007, GENES CELLS, V12, P235, DOI 10.1111/j.1365-2443.2007.01046.x; Zallocchi M, 2010, BIOCHEMISTRY-US, V49, P1236, DOI 10.1021/bi9020617; Zallocchi M, 2009, HEARING RES, V255, P109, DOI 10.1016/j.heares.2009.06.006	82	35	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30573	10.1371/journal.pone.0030573	http://dx.doi.org/10.1371/journal.pone.0030573			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363448	gold, Green Published, Green Submitted			2022-12-27	WOS:000302853600036
J	Zhang, WZ; Shen, YJ; Wang, RJ; Liu, AQ; Ling, H; Li, YH; Cao, JP; Zhang, XY; Shu, J; Zhang, LX				Zhang, Weizhe; Shen, Yujuan; Wang, Rongjun; Liu, Aiqin; Ling, Hong; Li, Yihong; Cao, Jianping; Zhang, Xiaoyun; Shu, Jing; Zhang, Longxian			Cryptosporidium cuniculus and Giardia duodenalis in Rabbits: Genetic Diversity and Possible Zoonotic Transmission	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; DAIRY-CATTLE; NEW-ZEALAND; GENOTYPES; IDENTIFICATION; HUMANS; PREVALENCE; CHINA; POPULATION; RUMINANTS	Background: Cryptosporidium and Giardia are the two important zoonotic pathogens causing diarrhea of humans and animals worldwide. Considering the human cryptosporidiosis outbreak and sporadic cases caused by C. cuniculus, the important public health significance of G. duodenalis and little obtained information regarding rabbit infected with Cryptosporidium and Giardia in China, the aim of this study is to determine the prevalence and molecularly characterize Cryptosporidium and Giardia in rabbits in Heilongjiang Province, China. Methodology/Principal Findings: 378 fecal samples were obtained from rabbits in Heilongjiang Province. Cryptosporidium oocysts and Giardia cysts were detected using Sheather's sugar flotation technique and Lugol's iodine stain method, respectively. The infection rates of Cryptosporidium and Giardia were 2.38% (9/378) and 7.41% (28/378), respectively. Genotyping of Cryptosporidium spp. was done by DNA sequencing of the small subunit rRNA (SSU rRNA) gene and all the nine isolates were identified as Cryptosporidium cuniculus. The nine isolates were further subtyped using the 60-kDa glycoprotein (gp60) gene and two subtypes were detected, including VbA32 (n = 3) and a new subtype VbA21 (n = 6). G. duodenalis genotypes and subtypes were identified by sequence analysis of the triosephosphate isomerase (TPI) gene. The assemblage B (belonging to eight different subtypes B-I to B-VIII) was found in 28 G. duodenalis-positive samples. Conclusions/Significance: The rabbits have been infected with Cryptosporidium and Giardia in Heilongjiang Province. The results show that the rabbits pose a threat to human health in the studied areas. Genotypes and subgenotypes of C. cuniculus and G. duodenalis in this study might present the endemic genetic characterization of population structure of the two parasites.	[Zhang, Weizhe; Liu, Aiqin; Ling, Hong; Li, Yihong; Zhang, Xiaoyun; Shu, Jing] Harbin Med Coll, Dept Parasitol, Harbin, Heilongjiang, Peoples R China; [Shen, Yujuan; Cao, Jianping] World Hlth Org, Chinese Ctr Dis Control & Prevent, Key Lab Parasite & Vector Biol, Natl Inst Parasit Dis,Minist Hlth,Collaborating C, Shanghai, Peoples R China; [Wang, Rongjun; Zhang, Longxian] Henan Agr Univ Zhengzhou, Coll Anim Sci & Vet Med, Zhengzhou, Henan, Peoples R China	Harbin Medical University; Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; World Health Organization	Zhang, WZ (corresponding author), Harbin Med Coll, Dept Parasitol, Harbin, Heilongjiang, Peoples R China.	liuaiqin1128@126.com; zhanglx8999@yahoo.com.cn	Zhang, Longxian/HGE-1918-2022; Zhang, Longxian/I-9223-2019; Zhang, Longxian/R-7799-2019; Cao, Jianping/AFL-5468-2022	Zhang, Longxian/0000-0002-5706-131X; Cao, Jianping/0000-0002-1974-0047; ling, hong/0000-0002-1886-1242	Natural Science Foundation of Heilongjiang Province [D200628]; Chinese Special Program for Scientific Research of Public Health [200802012]	Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Chinese Special Program for Scientific Research of Public Health	AL was supported by the Natural Science Foundation of Heilongjiang Province (No. D200628) and YS was supported by grants from the Chinese Special Program for Scientific Research of Public Health (No. 200802012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves M, 2003, J CLIN MICROBIOL, V41, P2744, DOI 10.1128/JCM.41.6.2744-2747.2003; Bouzid M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-213; Cama VA, 2003, J EUKARYOT MICROBIOL, V50, P531, DOI 10.1111/j.1550-7408.2003.tb00620.x; Castro-Hermida JA, 2007, PARASITOL RES, V101, P1443, DOI 10.1007/s00436-007-0624-6; Chalmers RM, 2009, EMERG INFECT DIS, V15, P829, DOI 10.3201/eid1505.081419; Coklin T, 2007, VET PARASITOL, V150, P297, DOI 10.1016/j.vetpar.2007.09.014; Fayer R, 2007, VET PARASITOL, V145, P260, DOI 10.1016/j.vetpar.2006.12.009; Fayer R, 2010, EXP PARASITOL, V124, P90, DOI 10.1016/j.exppara.2009.03.005; Feng Y, 2007, APPL ENVIRON MICROB, V73, P6475, DOI 10.1128/AEM.01034-07; Hoque M. Ekramul, 2002, International Journal of Infectious Diseases, V6, P191, DOI 10.1016/S1201-9712(02)90110-4; Hoque ME, 2003, EPIDEMIOL INFECT, V131, P655, DOI 10.1017/S0950268803008598; Lasek-Nesselquist E, 2010, INT J PARASITOL, V40, P1063, DOI 10.1016/j.ijpara.2010.02.015; Learmonth JJ, 2004, APPL ENVIRON MICROB, V70, P3973, DOI 10.1128/AEM.70.7.3973-3978.2004; Learmonth JJ, 2003, WATER SCI TECHNOL, V47, P21, DOI 10.2166/wst.2003.0150; Lu SQ, 1996, J PARASITOL, V82, P659, DOI 10.2307/3283799; Men Jing-tao, 2009, Journal of Jilin Agricultural University, V31, P447; Molloy SF, 2010, AM J TROP MED HYG, V82, P608, DOI 10.4269/ajtmh.2010.09-0624; Monis PT, 2003, INFECT GENET EVOL, V3, P29, DOI 10.1016/S1567-1348(02)00149-1; Ni H, 2008, ACTA ACAD MED QINGDA, V42, P158; Nolan MJ, 2010, INFECT GENET EVOL, V10, P1179, DOI 10.1016/j.meegid.2010.07.020; Read CM, 2004, INFECT GENET EVOL, V4, P125, DOI 10.1016/j.meegid.2004.02.001; Robinson G, 2010, ZOONOSES PUBLIC HLTH, V57, pE1, DOI 10.1111/j.1863-2378.2009.01308.x; Robinson G, 2008, EMERG INFECT DIS, V14, P1800, DOI 10.3201/eid1411.080239; Robinson G, 2010, INT J PARASITOL, V40, P1539, DOI 10.1016/j.ijpara.2010.05.010; Ryan U, 2003, APPL ENVIRON MICROB, V69, P4302, DOI 10.1128/AEM.69.7.4302-4307.2003; Shi K, 2010, J CLIN MICROBIOL, V48, P3263, DOI 10.1128/JCM.00819-10; Shiibashi T, 2006, J VET MED SCI, V68, P281, DOI 10.1292/jvms.68.281; Sprong H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000558; Sulaiman IM, 2005, J CLIN MICROBIOL, V43, P2805, DOI 10.1128/JCM.43.6.2805-2809.2005; Sulaiman IM, 2003, EMERG INFECT DIS, V9, P1444, DOI 10.3201/eid0911.030084; Tian Zong-cheng, 2002, Chinese Journal of Parasitology and Parasitic Diseases, V20, P72; Traub R, 2005, VET PARASITOL, V130, P317, DOI 10.1016/j.vetpar.2005.02.011; Traub RJ, 2004, PARASITOLOGY, V128, P253, DOI 10.1017/S0031182003004505; Tyzzer E. E., 1912, Archiv fuer Protistenkunde Jena, V26; Waldron LS, 2010, EMERG INFECT DIS, V16, P2006, DOI 10.3201/eid1612.100715; Wang RJ, 2011, EXP PARASITOL, V127, P42, DOI 10.1016/j.exppara.2010.06.034; Xiao LH, 2002, INT J PARASITOL, V32, P1773, DOI 10.1016/S0020-7519(02)00197-2; Xiao LH, 1999, APPL ENVIRON MICROB, V65, P3386; Xiao LH, 2008, INT J PARASITOL, V38, P1239, DOI 10.1016/j.ijpara.2008.03.006; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018	40	38	43	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31262	10.1371/journal.pone.0031262	http://dx.doi.org/10.1371/journal.pone.0031262			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363600	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600133
J	Yeh, CB; Hsieh, MJ; Hsieh, YH; Chien, MH; Chiou, HL; Yang, SF				Yeh, Chao-Bin; Hsieh, Ming-Ju; Hsieh, Yi-Hsien; Chien, Ming-Hsien; Chiou, Hui-Ling; Yang, Shun-Fa			Antimetastatic Effects of Norcantharidin on Hepatocellular Carcinoma by Transcriptional Inhibition of MMP-9 through Modulation of NF-kB Activity	PLOS ONE			English	Article							LUNG-CANCER CELLS; TERMINALIA-CATAPPA L.; HUMAN HEPATOMA-CELLS; SIGNALING PATHWAYS; DOWN-REGULATION; ORAL-CANCER; KAPPA-B; ANTICANCER ACTIVITY; IN-VITRO; INVASION	Background: The rate of morbidity and mortality of hepatocellular carcinoma (HCC) in Taiwan has not lessened because of difficulty in treating tumor metastasis. Norcantharidin (NCTD) is currently used as an anticancer drug for hepatoma, breast cancer, and colorectal adenocarcinoma. NCTD possesses various biological anticancer activities, including apoptosis. However, detailed effects and molecular mechanisms of NCTD on metastasis are unclear. Thus, HCC cells were subjected to treatment with NCTD and then analyzed to determine the effects of NCTD on cell metastasis. Methodology/Principal Findings: Modified Boyden chamber assays revealed that NCTD treatment inhibited cell migration and invasion capacities of HCC cells substantially. Results of zymography and western blotting showed that activities and protein levels of matrix metalloproteinase-9 (MMP-9) and urokinase plasminogen activator (u-PA) were inhibited by NCTD. Western blot analysis showed that NCTD inhibits phosphorylation of ERK1/2. Testing of mRNA level, quantitative real-time PCR, and promoter assays evaluated the inhibitory effects of NCTD on MMP-9 and u-PA expression in HCC cells. The chromatin immunoprecipitation (ChIP) assay for analyzing the genomic DNA sequences bound to these proteins was reactive to the transcription protein nuclear factor (NF)-kappaB, which was inhibited by NCTD. The expression of NF-kappa B was measured by western blot analysis, which revealed decreased nuclear-factor DNA-binding activity after NCTD treatment. Conclusions: NCTD inhibited MMP-9 and u-PA expression through the phosphorylation of ERK1/2 and NF-kappaB signaling pathway which serves as a powerful chemopreventive agent in HCC cell metastasis.	[Yeh, Chao-Bin] Chung Shan Med Univ, Sch Med, Dept Emergency Med, Taichung, Taiwan; [Yeh, Chao-Bin] Chung Shan Med Univ Hosp, Dept Emergency Med, Taichung, Taiwan; [Hsieh, Ming-Ju; Chiou, Hui-Ling] Chung Shan Med Univ, Sch Med Lab & Biotechnol, Taichung, Taiwan; [Hsieh, Yi-Hsien] Chung Shan Med Univ, Sch Med, Dept Biochem, Taichung, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Wan Fang Hosp, Taipei, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Yeh, CB (corresponding author), Chung Shan Med Univ, Sch Med, Dept Emergency Med, Taichung, Taiwan.	hlchiou@csmu.edu.tw; ysf@csmu.edu.tw	Yang, Shun-Fa/AAN-1519-2020; Hsieh, Ming-Ju/GQB-3025-2022	Yang, Shun-Fa/0000-0002-0365-7927; Hsieh, Ming-Ju/0000-0001-9726-3234; Yeh, Chao-Bin/0000-0002-3978-5576	Chung Shan Medical University Hospital, Taiwan [CSH-2011-C-001]	Chung Shan Medical University Hospital, Taiwan	This study was supported by a research grant from Chung Shan Medical University Hospital, Taiwan (CSH-2011-C-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; An W, 2004, J KOREAN MED SCI, V19, P560, DOI 10.3346/jkms.2004.19.4.560; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang C, 2011, MOL BIOL REP, V38, P163, DOI 10.1007/s11033-010-0090-6; Chang C, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-145; Chen PN, 2005, CHEM-BIOL INTERACT, V156, P141, DOI 10.1016/j.cbi.2005.08.005; Chen YJ, 2005, ANTI-CANCER DRUG, V16, P293, DOI 10.1097/00001813-200503000-00008; Chen YN, 2002, INT J CANCER, V100, P158, DOI 10.1002/ijc.10479; Chen YN, 2003, BRIT J PHARMACOL, V140, P461, DOI 10.1038/sj.bjp.0705461; Chen YJ, 2008, ANTI-CANCER DRUG, V19, P55, DOI 10.1097/CAD.0b013e3282f18826; Chen YJ, 2009, CHEM-BIOL INTERACT, V181, P440, DOI 10.1016/j.cbi.2009.07.004; Chu SC, 2004, MOL CARCINOGEN, V40, P143, DOI 10.1002/mc.20018; Chu SC, 2007, FOOD CHEM TOXICOL, V45, P1194, DOI 10.1016/j.fct.2006.12.028; Cimmino F, 2011, J NEUROONCOL    0707; Fan YZ, 2007, HEPATOB PANCREAT DIS, V6, P72; Fang Y., 1993, Yaoxue Xuebao, V28, P931; Ghiso JAA, 1999, EUR J BIOCHEM, V263, P295, DOI 10.1046/j.1432-1327.1999.00507.x; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Hill TA, 2008, CHEMMEDCHEM, V3, P1878, DOI 10.1002/cmdc.200800192; Hsiao YC, 2007, CHEM-BIOL INTERACT, V167, P193, DOI 10.1016/j.cbi.2007.02.012; Huang Y, 2009, CYTOTECHNOLOGY, V59, P201, DOI [10.1007/s10616-009-9210-3, 10.1007/s10616-009-9221-0]; Kim D, 2001, FASEB J, V15, P1953, DOI 10.1096/fj.01-0198com; Liao HF, 2011, TOXICOL IN VITRO, V25, P206, DOI 10.1016/j.tiv.2010.11.001; Luan JL, 2010, CYTOTECHNOLOGY, V62, P349, DOI 10.1007/s10616-009-9250-8; Ma Y, 2011, CANCER LETT, V301, P75, DOI 10.1016/j.canlet.2010.10.022; McCluskey A, 2001, ANTI-CANCER DRUG DES, V16, P291; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nagendraprabhu P, 2011, INVEST NEW DRUG, V29, P207, DOI 10.1007/s10637-009-9342-5; Peng F, 2002, J CANCER RES CLIN, V128, P223, DOI 10.1007/S00432-002-0326-5; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Saxena NK, 2007, CANCER RES, V67, P2497, DOI 10.1158/0008-5472.CAN-06-3075; Sliva D, 2004, CURR CANCER DRUG TAR, V4, P327, DOI 10.2174/1568009043332961; Takada Y, 2004, J BIOL CHEM, V279, P15096, DOI 10.1074/jbc.M311192200; WANG GS, 1989, J ETHNOPHARMACOL, V26, P147, DOI 10.1016/0378-8741(89)90062-7; Wang ZD, 2010, ONCOL REP, V23, P413, DOI 10.3892/or_00000650; Weng CJ, 2008, CARCINOGENESIS, V29, P147, DOI 10.1093/carcin/bgm261; Weng CJ, 2009, J AGR FOOD CHEM, V57, P5049, DOI 10.1021/jf900828k; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Yang HY, 2007, ANTI-CANCER DRUG, V18, P1133, DOI 10.1097/CAD.0b013e3282eeb1c5; Yang PY, 2011, TOXICOL IN VITRO, V25, P699, DOI 10.1016/j.tiv.2011.01.011; Yang PY, 2010, TOXICOL IN VITRO, V24, P766, DOI 10.1016/j.tiv.2009.12.025; Yang SF, 2008, J DENT RES, V87, P401, DOI 10.1177/154405910808700413; Yang SF, 2007, J ETHNOPHARMACOL, V110, P483, DOI 10.1016/j.jep.2006.10.010; Yang SF, 2008, ARCH ORAL BIOL, V53, P287, DOI 10.1016/j.archoralbio.2007.09.001; Yang SF, 2010, J BIOL CHEM, V285, P29808, DOI 10.1074/jbc.M110.108183; Yang SF, 2010, FOOD CHEM TOXICOL, V48, P1052, DOI 10.1016/j.fct.2010.01.019; Yeh CB, 2010, EUR J MED CHEM, V45, P3981, DOI 10.1016/j.ejmech.2010.05.053	47	97	105	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31055	10.1371/journal.pone.0031055	http://dx.doi.org/10.1371/journal.pone.0031055			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22363545	Green Published, gold, Green Submitted			2022-12-27	WOS:000302180600026
J	Zhang, LM; Chen, YQ; Wong, HS; Zhou, SG; Mamitsuka, H; Zhu, SF				Zhang, Lianming; Chen, Yiqing; Wong, Hau-San; Zhou, Shuigeng; Mamitsuka, Hiroshi; Zhu, Shanfeng			TEPITOPEpan: Extending TEPITOPE for Peptide Binding Prediction Covering over 700 HLA-DR Molecules	PLOS ONE			English	Article							MHC CLASS-I; GENERATION; DATABASE; SERVERS	Motivation: Accurate identification of peptides binding to specific Major Histocompatibility Complex Class II (MHC-II) molecules is of great importance for elucidating the underlying mechanism of immune recognition, as well as for developing effective epitope-based vaccines and promising immunotherapies for many severe diseases. Due to extreme polymorphism of MHC-II alleles and the high cost of biochemical experiments, the development of computational methods for accurate prediction of binding peptides of MHC-II molecules, particularly for the ones with few or no experimental data, has become a topic of increasing interest. TEPITOPE is a well-used computational approach because of its good interpretability and relatively high performance. However, TEPITOPE can be applied to only 51 out of over 700 known HLA DR molecules. Method: We have developed a new method, called TEPITOPEpan, by extrapolating from the binding specificities of HLA DR molecules characterized by TEPITOPE to those uncharacterized. First, each HLA-DR binding pocket is represented by amino acid residues that have close contact with the corresponding peptide binding core residues. Then the pocket similarity between two HLA-DR molecules is calculated as the sequence similarity of the residues. Finally, for an uncharacterized HLA-DR molecule, the binding specificity of each pocket is computed as a weighted average in pocket binding specificities over HLA-DR molecules characterized by TEPITOPE. Result: The performance of TEPITOPEpan has been extensively evaluated using various data sets from different viewpoints: predicting MHC binding peptides, identifying HLA ligands and T-cell epitopes and recognizing binding cores. Among the four state-of-the-art competing pan-specific methods, for predicting binding specificities of unknown HLA-DR molecules, TEPITOPEpan was roughly the second best method next to NETMHCIIpan-2.0. Additionally, TEPITOPEpan achieved the best performance in recognizing binding cores. We further analyzed the motifs detected by TEPITOPEpan, examining the corresponding literature of immunology. Its online server and PSSMs therein are available at http://www.biokdd.fudan.edu.cn/Service/TEPITOPEpan/.	[Zhang, Lianming; Chen, Yiqing; Zhou, Shuigeng; Zhu, Shanfeng] Fudan Univ, Sch Comp Sci, Shanghai 200433, Peoples R China; [Zhang, Lianming; Chen, Yiqing; Zhou, Shuigeng; Zhu, Shanfeng] Fudan Univ, Shanghai Key Lab Intelligent Informat Proc, Shanghai 200433, Peoples R China; [Wong, Hau-San] City Univ Hong Kong, Dept Comp Sci, Hong Kong, Hong Kong, Peoples R China; [Mamitsuka, Hiroshi] Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Uji 611, Japan	Fudan University; Fudan University; City University of Hong Kong; Kyoto University	Zhang, LM (corresponding author), Fudan Univ, Sch Comp Sci, Shanghai 200433, Peoples R China.	zhusf@fudan.edu.cn	Mamitsuka, Hiroshi/R-1110-2016	Mamitsuka, Hiroshi/0000-0002-6607-5617; WONG, Hau-San/0000-0002-1530-7529	National Basic Research Program of China [2010CB126604]; National Nature Science Foundation of China [61170097, 60903076]; Japan Society for the Promotion of Science (JSPS); City University of Hong Kong [7008044]	National Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); City University of Hong Kong(City University of Hong Kong)	Yiqing Chen and Shuigeng Zhou were supported in part by the National Basic Research Program of China under grant No. 2010CB126604. Shanfeng Zhu was supported by The National Nature Science Foundation of China (Grant No. 61170097 and No. 60903076) and the Japan Society for the Promotion of Science (JSPS) Invitation Fellowship. Hau-San Wong was supported by City University of Hong Kong [Project No. 7008044]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bordner AJ, 2010, BMC BIOINFORMATICS, V11, P14; Bordner AJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-482; Brusic V, 2002, IMMUNOL CELL BIOL, V80, P280, DOI 10.1046/j.1440-1711.2002.01088.x; Bui HH, 2005, IMMUNOGENETICS, V57, P304, DOI 10.1007/s00251-005-0798-y; Janeway C., 2005, IMMUNOBIOLOGY IMMUNE; Lin HH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-8; Lin HH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S22; Lund O, 2005, IMMUNOLOGICAL BIOINF; Lundegaard Claus, 2010, Immunome Res, V6 Suppl 2, pS3, DOI 10.1186/1745-7580-6-S2-S3; Marsh SGE, 2010, TISSUE ANTIGENS, V75, P291, DOI 10.1111/j.1399-0039.2010.01466.x; Marsh SGE, 2001, HLA FACTSBOOK; Nielsen M, 2004, BIOINFORMATICS, V20, P1388, DOI 10.1093/bioinformatics/bth100; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Nielsen Morten, 2010, Immunome Res, V6, P9, DOI 10.1186/1745-7580-6-9; Nielsen M, 2010, IMMUNOLOGY, V130, P319, DOI 10.1111/j.1365-2567.2010.03268.x; Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296; Nielsen M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000107; Peters B, 2006, PLOS COMPUT BIOL, V2, P574, DOI 10.1371/journal.pcbi.0020065; Pfeifer N, 2008, LECT N BIOINFORMAT, V5251, P210, DOI 10.1007/978-3-540-87361-7_18; Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Robinson J, 2011, NUCLEIC ACIDS RES, V39, pD1171, DOI 10.1093/nar/gkq998; Salomon J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-501; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Zaitlen N, 2008, J COMPUT BIOL, V15, P927, DOI 10.1089/cmb.2007.0183; Zhang GL, 2011, J IMMUNOL METHODS, V374, P18, DOI 10.1016/j.jim.2011.07.007; Zhang H, 2009, BIOINFORMATICS, V25, P1293, DOI 10.1093/bioinformatics/btp137; Zhang H, 2009, BIOINFORMATICS, V25, P83, DOI 10.1093/bioinformatics/btn579; Zhang LM, 2012, BRIEF BIOINFORM, V13, P350, DOI 10.1093/bib/bbr060	34	63	71	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e30483	10.1371/journal.pone.0030483	http://dx.doi.org/10.1371/journal.pone.0030483			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22383964	gold, Green Published, Green Submitted			2022-12-27	WOS:000302916100004
J	Bernardes, A; Batista, FAH; Neto, MD; Figueira, ACM; Webb, P; Saidemberg, D; Palma, MS; Polikarpov, I				Bernardes, Amanda; Batista, Fernanda A. H.; Neto, Mario de Oliveira; Figueira, Ana Carolina M.; Webb, Paul; Saidemberg, Daniel; Palma, Mario S.; Polikarpov, Igor			Low-Resolution Molecular Models Reveal the Oligomeric State of the PPAR and the Conformational Organization of Its Domains in Solution	PLOS ONE			English	Article							RETINOID-X-RECEPTOR; HYDROGEN-DEUTERIUM EXCHANGE; THYROID-HORMONE; DNA-BINDING; CRYSTAL-STRUCTURE; SCATTERING DATA; RXR-ALPHA; NUCLEAR; PROTEINS; DIMERS	The peroxisome proliferator-activated receptors (PPARs) regulate genes involved in lipid and carbohydrate metabolism, and are targets of drugs approved for human use. Whereas the crystallographic structure of the complex of full length PPAR gamma and RXR alpha is known, structural alterations induced by heterodimer formation and DNA contacts are not well understood. Herein, we report a small-angle X-ray scattering analysis of the oligomeric state of hPPAR gamma alone and in the presence of retinoid X receptor (RXR). The results reveal that, in contrast with other studied nuclear receptors, which predominantly form dimers in solution, hPPAR gamma remains in the monomeric form by itself but forms heterodimers with hRXR alpha. The low-resolution models of hPPAR gamma/RXR alpha complexes predict significant changes in opening angle between heterodimerization partners (LBD) and extended and asymmetric shape of the dimer (LBD-DBD) as compared with X-ray structure of the full-length receptor bound to DNA. These differences between our SAXS models and the high-resolution crystallographic structure might suggest that there are different conformations of functional heterodimer complex in solution. Accordingly, hydrogen/deuterium exchange experiments reveal that the heterodimer binding to DNA promotes more compact and less solvent-accessible conformation of the receptor complex.	[Bernardes, Amanda; Batista, Fernanda A. H.; Neto, Mario de Oliveira; Polikarpov, Igor] Univ Sao Paulo, Inst Phys Sao Carlos, Sao Paulo, Brazil; [Figueira, Ana Carolina M.] CNPEM, Natl Lab Biosci, Sao Paulo, Brazil; [Webb, Paul] Methodist Hosp, Ctr Diabet, Houston, TX 77030 USA; [Webb, Paul] Methodist Hosp, Canc Res Unit, Houston, TX 77030 USA; [Saidemberg, Daniel; Palma, Mario S.] Univ Estadual Sao Paulo UNESP, Inst Biosci Rio Claro, Dept Biol, Ctr Study Social Insects CEIS, Sao Paulo, Brazil; [Saidemberg, Daniel; Palma, Mario S.] Natl Inst Sci & Technol Immunol INCT Iii, Sao Paulo, Brazil	Universidade de Sao Paulo; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston; Universidade Estadual Paulista	Bernardes, A (corresponding author), Univ Sao Paulo, Inst Phys Sao Carlos, Sao Paulo, Brazil.	ipolikarpov@ifsc.usp.br	Fapesp, Biota/F-8655-2017; Neto, Mario Oliveira/F-2717-2013; Bernardes, Amanda/H-8910-2012; Batista, Fernanda A.H./E-1633-2013; Polikarpov, Igor/D-2575-2012; Figueira, Ana Carolina/X-1649-2019; Palma, Mario Sergio/E-7800-2012; Palma, Mario/N-3903-2019	Fapesp, Biota/0000-0002-9887-8449; Figueira, Ana Carolina/0000-0002-7023-8490; Palma, Mario Sergio/0000-0002-7363-8211; Oliveira Neto, Mario/0000-0002-6226-7419; Polikarpov, Igor/0000-0001-9496-4174	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [06/00182-8, 07/58443-4, 08/05637-9, 08/00078-1, 10/17048-8]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) via grants 06/00182-8, 07/58443-4, 08/05637-9, 08/00078-1 and 10/17048-8, and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). We also thank the staff of the National Synchrotron Light Laboratory (LNLS, Brazil) for access to the SAXS beamline and others facilities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosio ALB, 2007, J BIOL CHEM, V282, P18625, DOI 10.1074/jbc.M702538200; Amoutzias GD, 2008, TRENDS BIOCHEM SCI, V33, P220, DOI 10.1016/j.tibs.2008.02.002; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; BUGGE TH, 1992, EMBO J, V11, P1409, DOI 10.1002/j.1460-2075.1992.tb05186.x; Calgaro MR, 2007, PROTEIN SCI, V16, P1762, DOI 10.1110/ps.062692207; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Chen Y, 2003, P NATL ACAD SCI USA, V100, P15492, DOI 10.1073/pnas.2533045100; Chen ZP, 1998, J MOL BIOL, V275, P55, DOI 10.1006/jmbi.1997.1413; Chiarelli F, 2008, VASC HEALTH RISK MAN, V4, P297; Cox SL, 2006, DRUG TODAY, V42, P139, DOI 10.1358/dot.2006.42.3.937961; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Engen JR, 1999, BIOCHEMISTRY-US, V38, P8926, DOI 10.1021/bi982611y; Englander JJ, 2003, P NATL ACAD SCI USA, V100, P7057, DOI 10.1073/pnas.1232301100; Feige JN, 2005, J BIOL CHEM, V280, P17880, DOI 10.1074/jbc.M500786200; Figueira ACM, 2006, CELL BIOCHEM BIOPHYS, V44, P453, DOI 10.1385/CBB:44:3:453; Fischer H, 2003, J BIOL CHEM, V278, P16030, DOI 10.1074/jbc.M206953200; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Forster F, 2008, J MOL BIOL, V382, P1089, DOI 10.1016/j.jmb.2008.07.074; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Glass CK, 2000, GENE DEV, V14, P121; Gronemeyer H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.273pe34; Guinier A., 1955, SMALL ANGLE SCATTERI; Hammersley AP, 1997, FIT2D INTRO OVERVIEW; Hamuro Y, 2006, PROTEIN SCI, V15, P1883, DOI 10.1110/ps.062103006; Hamuro Yoshitomo, 2003, J Biomol Tech, V14, P171; Khurana R, 2001, J BIOL CHEM, V276, P22715, DOI 10.1074/jbc.M011499200; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lenhard JM, 2001, RECEPTOR CHANNEL, V7, P249; Mahindroo N, 2005, J MED CHEM, V48, P8194, DOI 10.1021/jm0506930; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Figueira ACM, 2007, BIOCHEMISTRY-US, V46, P1273, DOI 10.1021/bi061698h; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Rastinejad F, 2001, CURR OPIN STRUC BIOL, V11, P33, DOI 10.1016/S0959-440X(00)00165-2; Rochel N, 2011, NAT STRUCT MOL BIOL, V18, P564, DOI 10.1038/nsmb.2054; SCHWABE JWR, 1993, CELL, V75, P567, DOI 10.1016/0092-8674(93)90390-C; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Szanto A, 2008, IMMUNOBIOLOGY, V213, P789, DOI 10.1016/j.imbio.2008.07.015; Yan XG, 2004, BIOCHEMISTRY-US, V43, P909, DOI 10.1021/bi030183c; YU VC, 1991, CELL, V67, P1251, DOI 10.1016/0092-8674(91)90301-E	47	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31852	10.1371/journal.pone.0031852	http://dx.doi.org/10.1371/journal.pone.0031852			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363753	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700108
J	Giron-Michel, J; Azzi, S; Khawam, K; Mortier, E; Caignard, A; Devocelle, A; Ferrini, S; Croce, M; Francois, H; Lecru, L; Charpentier, B; Chouaib, S; Azzarone, B; Eid, P				Giron-Michel, Julien; Azzi, Sandy; Khawam, Krystel; Mortier, Erwan; Caignard, Anne; Devocelle, Aurore; Ferrini, Silvano; Croce, Michela; Francois, Helene; Lecru, Lola; Charpentier, Bernard; Chouaib, Salem; Azzarone, Bruno; Eid, Pierre			Interleukin-15 Plays a Central Role in Human Kidney Physiology and Cancer through the gamma c Signaling Pathway	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; RECEPTOR-ALPHA-CHAIN; RENAL-CELL CARCINOMA; E-CADHERIN; HUMAN MONOCYTES; CELIAC-DISEASE; IL-2 RECEPTOR; BETA-CHAIN; T-CELLS; EXPRESSION	The ability of Interleukin-15 (IL-15) to activate many immune antitumor mechanisms renders the cytokine a good candidate for the therapy of solid tumors, particularly renal cell carcinoma. Although IL-15 is being currently used in clinical trials, the function of the cytokine on kidney's components has not been extensively studied; we thus investigated the role of IL-15 on normal and tumor renal epithelial cells. Herein, we analyzed the expression and the biological functions of IL-15 in normal renal proximal tubuli (RPTEC) and in their neoplastic counterparts, the renal clear cell carcinomas (RCC). This study shows that RPTEC express a functional heterotrimeric IL-15R alpha beta gamma c complex whose stimulation with physiologic concentrations of rhIL-15 is sufficient to inhibit epithelial mesenchymal transition (EMT) commitment preserving E-cadherin expression. Indeed, IL-15 is not only a survival factor for epithelial cells, but it can also preserve the renal epithelial phenotype through the gamma c-signaling pathway, demonstrating that the cytokine possess a wide range of action in epithelial homeostasis. In contrast, in RCC in vitro and in vivo studies reveal a defect in the expression of gamma c-receptor and JAK3 associated kinase, which strongly impacts IL-15 signaling. Indeed, in the absence of the gamma c/JAK3 couple we demonstrate the assembly of an unprecedented functional high affinity IL-15R alpha beta heterodimer, that in response to physiologic concentrations of IL-15, triggers an unbalanced signal causing the down-regulation of the tumor suppressor gene E-cadherin, favoring RCC EMT process. Remarkably, the rescue of IL-15/gamma c-dependent signaling (STAT5), by co-transfecting gamma c and JAK3 in RCC, inhibits EMT reversion. In conclusion, these data highlight the central role of IL-15 and gamma c-receptor signaling in renal homeostasis through the control of E-cadherin expression and preservation of epithelial phenotype both in RPTEC (up-regulation) and RCC (down-regulation).	[Giron-Michel, Julien; Azzi, Sandy; Khawam, Krystel; Devocelle, Aurore; Francois, Helene; Lecru, Lola; Charpentier, Bernard; Azzarone, Bruno; Eid, Pierre] Hop Paul Brousse, INSERM, UMR 1014, Villejuif, France; [Mortier, Erwan] Univ Nantes, INSERM, UMRS 892, Inst Rech Therapeut, Nantes, France; [Caignard, Anne] Univ Paris 05, Inst Cochin, INSERM, U1016, Paris, France; [Ferrini, Silvano; Croce, Michela] Inst Nazl Ric Canc, Lab Immunotherapy, Genoa, Italy; [Chouaib, Salem] Univ Paris 11, INSERM, UMR 753, Inst Gustave Roussy, Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Genoa; IRCCS AOU San Martino IST; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Giron-Michel, J (corresponding author), Hop Paul Brousse, INSERM, UMR 1014, Villejuif, France.	bazzarone@hotmail.com; pierre.eid@inserm.fr	Azzarone, Bruno/AAH-9251-2019; Mortier, Erwan/AAH-7925-2021; Giron-michel, Julien/GNP-7299-2022; Mortier, Erwan/B-2189-2009; Giron-Michel, Julien/Q-4503-2018; Mortier, Erwan/ABG-6465-2021; Caignard, Anne/F-8159-2013; Croce, Michela/AAA-8966-2020	Azzarone, Bruno/0000-0002-5962-3849; Giron-michel, Julien/0000-0001-6613-6099; Giron-Michel, Julien/0000-0001-6613-6099; Mortier, Erwan/0000-0002-6321-6488; Caignard, Anne/0000-0001-9923-6045; Croce, Michela/0000-0003-4683-4951; Ferrini, Silvano/0000-0001-7254-2616; Francois, Helene/0000-0001-7436-9554	Agence Francaise de Biomedicine; ARC (Association pour la Recherche sur le Cancer) [RAC11005LLA]; InCa; NRB-Vaincre le Cancer; AIRC (Associazione Italiana per la Ricerca sul Cancro) [5642]; Italian Ministry of Health; Societe Francaise de Nephrologie; Fondazione Italiana per la Lotta al Neuroblastoma	Agence Francaise de Biomedicine; ARC (Association pour la Recherche sur le Cancer)(Fondation ARC pour la Recherche sur le Cancer); InCa(Institut National du Cancer (INCA) France); NRB-Vaincre le Cancer; AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy); Societe Francaise de Nephrologie; Fondazione Italiana per la Lotta al Neuroblastoma	This work was supported by grants from Agence Francaise de Biomedicine, ARC (Association pour la Recherche sur le Cancer) (N degrees RAC11005LLA), InCa, NRB-Vaincre le Cancer, AIRC (Associazione Italiana per la Ricerca sul Cancro) IG project 5642 and Italian Ministry of Health. S.A. was a recipient of ARC and NRB-Vaincre le Cancer doctoral fellowships. K.K. was a recipient of doctoral fellowships from Societe Francaise de Nephrologie, ARC and NRB-Vaincre le Cancer. M.C. was a recipient of a fellowship from Fondazione Italiana per la Lotta al Neuroblastoma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorosi S, 2009, J IMMUNOL, V182, P3304, DOI 10.4049/jimmunol.0802400; ANDERSON DM, 1995, J BIOL CHEM, V270, P29862; ATZPODIEN J, 1995, J CLIN ONCOL, V13, P497, DOI 10.1200/JCO.1995.13.2.497; BOSCO MC, 1994, BLOOD, V83, P2995, DOI 10.1182/blood.V83.10.2995.2995; Budagian V, 2006, CYTOKINE GROWTH F R, V17, P259, DOI 10.1016/j.cytogfr.2006.05.001; Bussolati B, 2008, FASEB J, V22, P3696, DOI 10.1096/fj.08-102590; Cortes JR, 2007, J IMMUNOL, V179, P3881, DOI 10.4049/jimmunol.179.6.3881; Damiano L, 2010, ONCOGENE, V29, P3677, DOI 10.1038/onc.2010.128; Davies M, 2005, J CELL BIOCHEM, V95, P918, DOI 10.1002/jcb.20458; de Totero D, 2008, BLOOD, V111, P517, DOI 10.1182/blood-2007-04-087882; Di Sabatino A, 2006, GUT, V55, P469, DOI 10.1136/gut.2005.068684; Eini H, 2009, J INTERFERON CYTOKIN, V30, P1; Fiorito S, 2005, RHEUMATOLOGY, V44, P164, DOI 10.1093/rheumatology/keh431; Franciszkiewicz K, 2009, CANCER RES, V69, P6249, DOI 10.1158/0008-5472.CAN-08-3571; Gambaro G, 2007, AM J PHYSIOL-RENAL, V293, pF1758, DOI 10.1152/ajprenal.00350.2007; Garcia-Tunon I, 2004, BREAST CANCER RES, V6, pR1, DOI 10.1186/bcr730; Ge N, 2004, INT ARCH ALLERGY IMM, V135, P235, DOI 10.1159/000081309; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; Giron-Michel J, 2005, BLOOD, V106, P2302, DOI 10.1182/blood-2005-01-0064; Giron-Michel J, 2009, BLOOD, V113, P4541, DOI 10.1182/blood-2008-12-195289; Hamada S, 2007, J CELL PHYSIOL, V213, P768, DOI 10.1002/jcp.21148; Han YJ, 2006, BLOOD, V108, P2796, DOI 10.1182/blood-2006-04-017434; Hofmann SR, 2004, MOL CELL BIOL, V24, P5039, DOI 10.1128/MCB.24.11.5039-5049.2004; Jakobisiak M, 2011, CYTOKINE GROWTH F R, V22, P99, DOI 10.1016/j.cytogfr.2011.04.001; Khawam K, 2009, CANCER RES, V69, P1561, DOI 10.1158/0008-5472.CAN-08-3198; Kovanen PE, 2004, IMMUNOL REV, V202, P67, DOI 10.1111/j.0105-2896.2004.00203.x; Kuniyasu H, 2003, CLIN CANCER RES, V9, P4802; LAI KS, 1995, J BIOL CHEM, V270, P25028, DOI 10.1074/jbc.270.42.25028; Le Floc'h A, 2007, J EXP MED, V204, P559, DOI 10.1084/jem.20061524; Maiuri L, 2000, GASTROENTEROLOGY, V119, P996, DOI 10.1053/gast.2000.18149; Mortier E, 2004, J IMMUNOL, V173, P1681, DOI 10.4049/jimmunol.173.3.1681; MUSSO T, 1995, J EXP MED, V181, P1425, DOI 10.1084/jem.181.4.1425; Nishiyama R, 2001, J BIOL CHEM, V276, P35571, DOI 10.1074/jbc.M106013200; Notarangelo LD, 2000, IMMUNOBIOLOGY, V202, P106, DOI 10.1016/S0171-2985(00)80058-3; Obermeier F, 2006, EUR J IMMUNOL, V36, P2691, DOI 10.1002/eji.200535173; Ogbomo H, 2010, BIOCHEM PHARMACOL, V79, P188, DOI 10.1016/j.bcp.2009.07.026; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Reichert TE, 2000, ONCOGENE, V19, P514, DOI 10.1038/sj.onc.1203391; Reinecker HC, 1996, GASTROENTEROLOGY, V111, P1706, DOI 10.1016/S0016-5085(96)70036-7; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Sanchez-Tillo E, 2010, ONCOGENE, V29, P3490, DOI 10.1038/onc.2010.102; Sasson R, 2003, BIOCHEM PHARMACOL, V66, P1393, DOI 10.1016/S0006-2952(03)00489-1; Shinozaki M, 2002, J CLIN INVEST, V109, P951, DOI 10.1172/JCI200214574; Stone KP, 2011, J NEUROCHEM, V116, P544, DOI 10.1111/j.1471-4159.2010.07142.x; Tejman-Yarden N, 2005, NEPHROL DIAL TRANSPL, V20, P516, DOI 10.1093/ndt/gfh616; Tsukadaira A, 2002, EXP LUNG RES, V28, P123, DOI 10.1080/019021402753462040; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Viey E, 2005, EXPERT REV ANTICANC, V5, P973, DOI 10.1586/14737140.5.6.973; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Weiler M, 1998, J AM SOC NEPHROL, V9, P1194; Wells A, 2008, CLIN EXP METASTAS, V25, P621, DOI 10.1007/s10585-008-9167-1; Wong WK, 2003, TRANSPLANTATION, V75, P505, DOI 10.1097/01.TP.0000045708.39879.C7; Woods NB, 2006, NATURE, V440, P1123, DOI 10.1038/4401123a; Xu GS, 2008, NEPHROLOGY, V13, P694, DOI 10.1111/j.1440-1797.2008.00998.x; Yabu JM, 2007, SEMIN NEPHROL, V27, P479, DOI 10.1016/j.semnephrol.2007.03.009; Yanagita M, 2002, BIOCHEM BIOPH RES CO, V297, P329, DOI 10.1016/S0006-291X(02)02201-5; Zhang GQ, 2007, J AM SOC NEPHROL, V18, P846, DOI 10.1681/ASN.2006080886; Zheng GP, 2009, AM J PATHOL, V175, P580, DOI 10.2353/ajpath.2009.080983	59	24	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31624	10.1371/journal.pone.0031624	http://dx.doi.org/10.1371/journal.pone.0031624			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363690	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700078
J	Jagadeesan, R; Collins, PJ; Daglish, GJ; Ebert, PR; Schlipalius, DI				Jagadeesan, Rajeswaran; Collins, Patrick J.; Daglish, Gregory J.; Ebert, Paul R.; Schlipalius, David I.			Phosphine Resistance in the Rust Red Flour Beetle, Tribolium castaneum (Coleoptera: Tenebrionidae): Inheritance, Gene Interactions and Fitness Costs	PLOS ONE			English	Article							LESSER GRAIN BORER; FUMIGATION	The recent emergence of heritable high level resistance to phosphine in stored grain pests is a serious concern among major grain growing countries around the world. Here we describe the genetics of phosphine resistance in the rust red flour beetle Tribolium castaneum (Herbst), a pest of stored grain as well as a genetic model organism. We investigated three field collected strains of T. castaneum viz., susceptible (QTC4), weakly resistant (QTC1012) and strongly resistant (QTC931) to phosphine. The dose-mortality responses of their test- and inter-cross progeny revealed that most resistance was conferred by a single major resistance gene in the weakly (3.2x) resistant strain. This gene was also found in the strongly resistant (431x) strain, together with a second major resistance gene and additional minor factors. The second major gene by itself confers only 12-206x resistance, suggesting that a strong synergistic epistatic interaction between the genes is responsible for the high level of resistance (431x) observed in the strongly resistant strain. Phosphine resistance is not sex linked and is inherited as an incompletely recessive, autosomal trait. The analysis of the phenotypic fitness response of a population derived from a single pair inter-strain cross between the susceptible and strongly resistant strains indicated the changes in the level of response in the strong resistance phenotype; however this effect was not consistent and apparently masked by the genetic background of the weakly resistant strain. The results from this work will inform phosphine resistance management strategies and provide a basis for the identification of the resistance genes.	[Jagadeesan, Rajeswaran; Ebert, Paul R.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Jagadeesan, Rajeswaran; Collins, Patrick J.; Daglish, Gregory J.; Schlipalius, David I.] Agrisci Queensland, Dept Employment Econ Dev & Innovat, Ecosci Precinct, Brisbane, Qld, Australia	University of Queensland	Jagadeesan, R (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.	david.schlipalius@deedi.qld.gov.au	Jagadeesan, Rajeswaran/K-8804-2019; Schlipalius, David/B-8155-2011	Schlipalius, David/0000-0002-8102-7031; Daglish, Gregory/0000-0003-1940-2643; Jagadeesan, Rajeswaran/0000-0002-9890-5953; Ebert, Paul/0000-0002-4435-0737	Australian Government's Cooperative Research Centre for National Plant Biosecurity; University of Queensland International Postgraduate Scholarship	Australian Government's Cooperative Research Centre for National Plant Biosecurity(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); University of Queensland International Postgraduate Scholarship	This work was supported by the Australian Government's Cooperative Research Centre for National Plant Biosecurity and a University of Queensland International Postgraduate Scholarship (awarded to Dr. Jagadeesan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Abdi Herve, 2007, ENCYCL MEASUR STATIS, V2, P651; ANDRES LA, 1960, J ECON ENTOMOL, V53, P626, DOI 10.1093/jee/53.4.626; [Anonymous], 1975, FAO PLANT PROTECT B, V23, P12; Ansell M. R., 1990, P 5 INT WORK C STOR, P961; Ansell MR, 1992, THESIS U READING REA; Athie I., 2005, Brazilian Journal of Food Technology, V8, P143; BEKON KA, 1988, AGRON TROP, V43, P59; Bell CH, 2000, CROP PROT, V19, P563, DOI 10.1016/S0261-2194(00)00073-9; Bengston M, 1999, J ECON ENTOMOL, V92, P17, DOI 10.1093/jee/92.1.17; Benhalima H, 2004, J STORED PROD RES, V40, P241, DOI 10.1016/S0022-474X(03)00012-2; Bui CH, 1999, P 7 INT WORK C STOR, P648; Collins P.J., 2001, P INT C CONTR ATM FU, P593; Collins PJ, 2002, J ECON ENTOMOL, V95, P862, DOI 10.1603/0022-0493-95.4.862; Daglish GJ, 2002, PEST MANAG SCI, V58, P1015, DOI 10.1002/ps.532; Finney DJ, PROBIT ANAL; GEORGHIOU GP, 1969, EXP PARASITOL, V26, P224, DOI 10.1016/0014-4894(69)90116-7; Hardstone MC, 2010, PESTIC BIOCHEM PHYS, V97, P123, DOI 10.1016/j.pestbp.2009.07.010; Hoy MA, 1998, PHILOS T ROY SOC B, V353, P1787, DOI 10.1098/rstb.1998.0331; Lenormand T, 1998, P ROY SOC B-BIOL SCI, V265, P1985, DOI 10.1098/rspb.1998.0529; Li Yan-Sheng, 1994, Acta Entomologica Sinica, V37, P271; Lorini I, 2007, PEST MANAG SCI, V63, P358, DOI 10.1002/ps.1344; Magnin M, 1986, RESISTANCE INSECTICI; NAKAKITA H, 1987, J PESTIC SCI, V12, P299; Payne RW, 2004, GENSTAT WINDOWS RELE; Pimentel MAG, 2007, PEST MANAG SCI, V63, P876, DOI 10.1002/ps.1416; PREISLER HK, 1990, J ECON ENTOMOL, V83, P1649, DOI 10.1093/jee/83.5.1649; Rajendran S, 2004, PEST MANAG SCI, V60, P1114, DOI 10.1002/ps.931; Rajendran S, 2000, J STORED PROD RES, V36, P101, DOI 10.1016/S0022-474X(99)00038-7; RAYMOND M, 1989, GENETICS, V123, P543; ROUSH RT, 1987, ANNU REV ENTOMOL, V32, P361, DOI 10.1146/annurev.en.32.010187.002045; Roush RT., 1990, PESTICIDE RESISTANCE, P97, DOI DOI 10.1007/978-1-4684-6429-0_5; Schlipalius DI, 2008, HEREDITY, V100, P506, DOI 10.1038/hdy.2008.4; Schlipalius DI, 2002, GENETICS, V161, P773; Sokal R.R., 2012, BIOMETRY; Sousa AH, 2009, J STORED PROD RES, V45, P241, DOI 10.1016/j.jspr.2009.04.003; STONE BF, 1968, B WORLD HEALTH ORGAN, V38, P325; Taylor R. W. D., 1986, 1986 British Crop Protection Conference. Pests and diseases. Volume 2. Proceedings of a conference held at Brighton Metropole, England, November 17-20, 1986., P607; TSUKAMOTO MASUHISA, 1963, BOTYU KAGAKU BUL INST CONTR, V28, P91; Tyler P. S., 1983, International Pest Control, V25, P10; Wallbank B, 1998, AUSTR POSTH TECHN C, P295; Wang DX, 2006, J STORED PROD RES, V42, P207, DOI 10.1016/j.jspr.2005.02.001; Yang C, 1998, P 7 INT WORK C STOR, P617	43	95	100	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31582	10.1371/journal.pone.0031582	http://dx.doi.org/10.1371/journal.pone.0031582			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363681	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000302873700077
J	Koguchi, Y; Buenafe, AC; Thauland, TJ; Gardell, JL; Bivins-Smith, ER; Jacoby, DB; Slifka, MK; Parker, DC				Koguchi, Yoshinobu; Buenafe, Abigail C.; Thauland, Timothy J.; Gardell, Jennifer L.; Bivins-Smith, Elizabeth R.; Jacoby, David B.; Slifka, Mark K.; Parker, David C.			Preformed CD40L Is Stored in Th1, Th2, Th17, and T Follicular Helper Cells as Well as CD4(+)8(-) Thymocytes and Invariant NKT Cells but Not in Treg Cells	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; THYMIC EPITHELIAL-CELLS; DENDRITIC CELLS; IN-VIVO; IMMUNE-RESPONSES; EFFECTOR FUNCTION; POSTTRANSCRIPTIONAL REGULATION; SECRETORY LYSOSOMES; CD40-CD40 LIGAND; TRANSGENIC MICE	CD40L is essential for the development of adaptive immune responses. It is generally thought that CD40L expression in CD4(+) T cells is regulated transcriptionally and made from new mRNA following antigen recognition. However, imaging studies show that the majority of cognate interactions between effector CD4(+) T cells and APCs in vivo are too short to allow de novo CD40L synthesis. We previously showed that Th1 effector and memory cells store preformed CD40L (pCD40L) in lysosomal compartments and mobilize it onto the plasma membrane immediately after antigenic stimulation, suggesting that primed CD4(+) T cells may use pCD40L to activate APCs during brief encounters. Indeed, our recent study showed that pCD40L is sufficient to mediate selective activation of cognate B cells and trigger DC activation in vitro. In this study, we show that pCD40L is present in Th1 and follicular helper T cells developed during infection with lymphocytic choriomeningitis virus, Th2 cells in the airway of asthmatic mice, and Th17 cells from the CNS of animals with experimental autoimmune encephalitis (EAE). pCD40L is nearly absent in both natural and induced Treg cells, even in the presence of intense inflammation such as occurs in EAE. We also found pCD40L expression in CD4 single positive thymocytes and invariant NKT cells. Together, these results suggest that pCD40L may function in T cell development as well as an unexpectedly broad spectrum of innate and adaptive immune responses, while its expression in Treg cells is repressed to avoid compromising their suppressive activity.	[Koguchi, Yoshinobu; Thauland, Timothy J.; Gardell, Jennifer L.; Slifka, Mark K.; Parker, David C.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA; [Buenafe, Abigail C.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Bivins-Smith, Elizabeth R.; Jacoby, David B.] Oregon Hlth & Sci Univ, Div Pulm & Crit Care Med, Portland, OR 97201 USA; [Slifka, Mark K.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Koguchi, Y (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA.	parkerd@ohsu.edu	Parker, David C/A-5428-2008	Jacoby, David/0000-0003-2195-9512; Parker, David/0000-0003-4456-2788; Koguchi, Yoshinobu/0000-0002-5733-5755	National Institutes of Health [ROI AI050823, R01 AI070934, R21 AI077032, AI054458, HL061013, HL071795, AI075064, T32 AI078903]; Oregon National Primate Research Center [RR000163]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061013, R01HL071795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070934, R01AI054458, R01AI050823, R01AI092080, T32AI078903, R21AI075064, R21AI077032] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oregon National Primate Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health grants ROI AI050823, R01 AI070934, and R21 AI077032 to DCP, AI054458 to MKS, HL061013, HL071795, and AI075064 to DBJ, and Oregon National Primate Research Center grant (RR000163) to MKS. JLG and TJT have been supported as trainees on an institutional training grant from the NIH (T32 AI078903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Barral P, 2010, NAT IMMUNOL, V11, P303, DOI 10.1038/ni.1853; Beadling C, 2005, BLOOD, V105, P1179, DOI 10.1182/blood-2004-07-2833; Beal AM, 2009, IMMUNITY, V31, P632, DOI 10.1016/j.immuni.2009.09.004; Becher B, 2001, J EXP MED, V193, P967, DOI 10.1084/jem.193.8.967; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Bolduc A, 2010, J IMMUNOL, V185, P220, DOI 10.4049/jimmunol.0901689; BOWEN F, 1995, EUR J IMMUNOL, V25, P2830, DOI 10.1002/eji.1830251018; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Buenafe AC, 2007, J NEUROIMMUNOL, V182, P32, DOI 10.1016/j.jneuroim.2006.09.004; Campbell DJ, 2001, NAT IMMUNOL, V2, P876, DOI 10.1038/ni0901-876; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; CASAMAYORPALLEJA M, 1995, J EXP MED, V181, P1293, DOI 10.1084/jem.181.4.1293; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; Chun T, 2003, J EXP MED, V197, P907, DOI 10.1084/jem.20021366; Clegg CH, 1997, INT IMMUNOL, V9, P1111, DOI 10.1093/intimm/9.8.1111; Cohen GB, 2005, J IMMUNOL METHODS, V302, P103, DOI 10.1016/j.jim.2005.05.002; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; de Berg PJV, 2008, CURR OPIN IMMUNOL, V20, P339, DOI 10.1016/j.coi.2008.03.007; De Santo C, 2008, J CLIN INVEST, V118, P4036, DOI 10.1172/JCI36264; Erickson LD, 2002, J CLIN INVEST, V109, P613, DOI 10.1172/JCI200214110; Fathman CG, 2007, NAT REV IMMUNOL, V7, P599, DOI 10.1038/nri2131; Feau S, 2011, NAT IMMUNOL, V12, P908, DOI 10.1038/ni.2079; FOY TM, 1995, J EXP MED, V182, P1377, DOI 10.1084/jem.182.5.1377; Fujii SI, 2004, J EXP MED, V199, P1607, DOI 10.1084/jem.20040317; Galli G, 2007, P NATL ACAD SCI USA, V104, P3984, DOI 10.1073/pnas.0700191104; Gerritse K, 1996, P NATL ACAD SCI USA, V93, P2499, DOI 10.1073/pnas.93.6.2499; Gray DHD, 2006, BLOOD, V108, P3777, DOI 10.1182/blood-2006-02-004531; Guiducci C, 2005, EUR J IMMUNOL, V35, P557, DOI 10.1002/eji.200425810; Heller KN, 2006, J EXP MED, V203, P805, DOI 10.1084/jem.20060215; Huse M, 2008, NAT IMMUNOL, V9, P1105, DOI 10.1038/ni.f.215; Irla M, 2008, IMMUNITY, V29, P451, DOI 10.1016/j.immuni.2008.08.007; Jain A, 2011, BLOOD, V118, P3811, DOI 10.1182/blood-2011-04-351254; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kasprowicz DJ, 2003, J IMMUNOL, V171, P1216, DOI 10.4049/jimmunol.171.3.1216; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; KeaneMyers A, 1997, J IMMUNOL, V158, P2042; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Kitamura H, 1999, J EXP MED, V189, P1121, DOI 10.1084/jem.189.7.1121; Koguchi Y, 2007, BLOOD, V110, P2520, DOI 10.1182/blood-2007-03-081299; Koguchi Y, 2011, J IMMUNOL, V187, P626, DOI 10.4049/jimmunol.1004083; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Kriegel MA, 2009, P NATL ACAD SCI USA, V106, P16770, DOI 10.1073/pnas.0908957106; Kweon MN, 1999, J IMMUNOL, V162, P1904; Leadbetter EA, 2008, P NATL ACAD SCI USA, V105, P8339, DOI 10.1073/pnas.0801375105; Lee BO, 2002, J EXP MED, V196, P693, DOI 10.1084/jem.20020845; Lesley R, 2006, P NATL ACAD SCI USA, V103, P10717, DOI 10.1073/pnas.0601539103; Lettesjo H, 2000, J IMMUNOL, V165, P4095, DOI 10.4049/jimmunol.165.7.4095; Li W, 2011, INT IMMUNOPHARMACOL, V11, P1205, DOI 10.1016/j.intimp.2011.03.021; Lineberry NB, 2008, J IMMUNOL, V181, P1622, DOI 10.4049/jimmunol.181.3.1622; Lohning M, 1998, P NATL ACAD SCI USA, V95, P6930, DOI 10.1073/pnas.95.12.6930; MacDonald KPA, 1997, J CLIN INVEST, V100, P2404, DOI 10.1172/JCI119781; Martin-Fontecha A, 2008, J EXP MED, V205, P2561, DOI 10.1084/jem.20081212; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; Mellor AL, 2011, J IMMUNOL, V186, P4535, DOI 10.4049/jimmunol.1002937; Murphy K, 2008, JANEWAYS IMMUNOBIOLO; Nurieva RI, 2010, IMMUNITY, V32, P670, DOI 10.1016/j.immuni.2010.05.002; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.0.CO;2-O; PARKER DC, 1993, ANNU REV IMMUNOL, V11, P331, DOI 10.1146/annurev.iy.11.040193.001555; Perona-Wright G, 2010, NAT IMMUNOL, V11, P520, DOI 10.1038/ni.1866; Pham LV, 2002, IMMUNITY, V16, P37, DOI 10.1016/S1074-7613(01)00258-8; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; ROY M, 1995, EUR J IMMUNOL, V25, P596, DOI 10.1002/eji.1830250243; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Sharma MD, 2010, IMMUNITY, V33, P942, DOI 10.1016/j.immuni.2010.11.022; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Taraban VY, 2008, J IMMUNOL, V180, P4615, DOI 10.4049/jimmunol.180.7.4615; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Vavassori S, 2009, RNA BIOL, V6, P259, DOI 10.4161/rna.6.3.8581; Vavassori S, 2009, EUR J IMMUNOL, V39, P2224, DOI 10.1002/eji.200839163; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; YELLIN MJ, 1994, J IMMUNOL, V152, P598; Yi YJ, 2000, J IMMUNOL, V165, P6627, DOI 10.4049/jimmunol.165.11.6627; Yoshimoto T, 2003, J EXP MED, V197, P997, DOI 10.1084/jem.20021701; Zaretsky AG, 2009, J EXP MED, V206, P991, DOI 10.1084/jem.20090303; Zhou F, 2005, HEPATOLOGY, V42, P372, DOI 10.1002/hep.20802; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	84	34	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31296	10.1371/journal.pone.0031296	http://dx.doi.org/10.1371/journal.pone.0031296			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363608	gold, Green Published, Green Submitted			2022-12-27	WOS:000302873700044
J	Peters-Klimm, F; Laux, G; Campbell, S; Muller-Tasch, T; Lossnitzer, N; Schultz, JH; Remppis, A; Junger, J; Nikendei, C				Peters-Klimm, Frank; Laux, Gunter; Campbell, Stephen; Mueller-Tasch, Thomas; Lossnitzer, Nicole; Schultz, Jobst-Hendrik; Remppis, Andrew; Juenger, Jana; Nikendei, Christoph			Physician and Patient Predictors of Evidence-Based Prescribing in Heart Failure: A Multilevel Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; CLINICAL-PRACTICE; PRIMARY-CARE; GENERAL-PRACTICE; EDUCATIONAL INTERVENTION; EFFECTIVE MANAGEMENT; SELF-ASSESSMENT; BEHAVIOR-CHANGE; EUROPEAN SURVEY; GUIDELINES	Background: The management of patients with heart failure (HF) needs to account for changeable and complex individual clinical characteristics. The use of renin angiotensin system inhibitors (RAAS-I) to target doses is recommended by guidelines. But physicians seemingly do not sufficiently follow this recommendation, while little is known about the physician and patient predictors of adherence. Methods: To examine the coherence of primary care (PC) physicians' knowledge and self-perceived competencies regarding RAAS-I with their respective prescribing behavior being related to patient-associated barriers. Cross-sectional follow-up study after a randomized medical educational intervention trial with a seven month observation period. PC physicians (n = 37) and patients with systolic HF (n = 168) from practices in Baden-Wuerttemberg. Measurements were knowledge (blueprint-based multiple choice test), self-perceived competencies (questionnaire on global confidence in the therapy and on frequency of use of RAAS-I), and patient variables (age, gender, NYHA functional status, blood pressure, potassium level, renal function). Prescribing was collected from the trials' documentation. The target variable consisted of >= 50% of recommended RAAS-I dosage being investigated by two-level logistic regression models. Results: Patients (69% male, mean age 68.8 years) showed symptomatic and objectified left ventricular (NYHA II vs. III/IV: 51% vs. 49% and mean LVEF 33.3%) and renal (GFR < 50%: 22%) impairment. Mean percentage of RAAS-I target dose was 47%, 59% of patients receiving >= 50%. Determinants of improved prescribing of RAAS-I were patient age (OR 0.95, CI 0.92-0.99, p = 0.01), physician's global self-confidence at follow-up (OR 1.09, CI 1.02-1.05, p = 0.01) and NYHA class (II vs. III/IV) (OR 0.63, CI 0.38-1.05, p = 0.08). Conclusions: A change in physician's confidence as a predictor of RAAS-I dose increase is a new finding that might reflect an intervention effect of improved physicians' intention and that might foster novel strategies to improve safe evidence-based prescribing. These should include targeting knowledge, attitudes and skills.	[Peters-Klimm, Frank; Laux, Gunter; Campbell, Stephen] Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv Res, Baden Wurttemberg, Germany; [Mueller-Tasch, Thomas; Lossnitzer, Nicole; Schultz, Jobst-Hendrik; Juenger, Jana; Nikendei, Christoph] Univ Heidelberg Hosp, Dept Psychosomat & Gen Internal Med, Baden Wurttemberg, Germany; [Remppis, Andrew] Univ Heidelberg Hosp, Dept Cardiol & Pneumol, Baden Wurttemberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Peters-Klimm, F (corresponding author), Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv Res, Baden Wurttemberg, Germany.	frank.peters-klimm@med.uni-heidelberg.de	Laux, Gunter/AAL-9020-2021	Schultz, Jobst-Hendrik/0000-0001-9433-3970; Campbell, Stephen/0000-0002-2328-4136	German Ministry of Education and Research (BMBF) [01GI0205]; Competence Network of Heart Failure	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Competence Network of Heart Failure	No current external funding sources for this study. The corresponding parental trial was funded by the German Ministry of Education and Research (BMBF), grant no. 01GI0205 (http://www.gesundheitsforschung-bmbf.de/de/350.php) and by the Competence Network of Heart Failure (www.knhi.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2008, HEALTH PSYCHOL, V27, P379, DOI 10.1037/0278-6133.27.3.379; Abraham C, 2009, PSYCHOL HEALTH MED, V14, P1, DOI 10.1080/13548500802537903; Baker R, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005470.pub2; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Cleland JGF, 2002, LANCET, V360, P1631, DOI 10.1016/S0140-6736(02)11601-1; Cleland JGF, 2002, HEART, V88, P5; Cochrane LJ, 2007, J CONTIN EDUC HEALTH, V27, P94, DOI 10.1002/chp.106; de Groote P, 2007, EUR J HEART FAIL, V9, P1205, DOI 10.1016/j.ejheart.2007.09.008; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; Eva KW, 2005, ACAD MED, V80, pS46, DOI 10.1097/00001888-200510001-00015; Fuat A, 2003, BRIT MED J, V326, P196, DOI 10.1136/bmj.326.7382.196; Grol R, 1997, BRIT MED J, V315, P418, DOI 10.1136/bmj.315.7105.418; Hickling JA, 2001, BRIT J GEN PRACT, V51, P615; Hoppe UC, 2005, Z KARDIOL, V94, P488, DOI 10.1007/s00392-005-0268-4; Hoppe UC, 2001, Z KARDIOL, V90, P218, DOI 10.1007/s003920170187; Hudon C, 2005, J CLIN EPIDEMIOL, V58, P603, DOI 10.1016/j.jclinepi.2004.10.017; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Kasje Willeke N, 2005, BMC Fam Pract, V6, P19, DOI 10.1186/1471-2296-6-19; Kasje WN, 2005, EUR J CLIN PHARMACOL, V61, P145, DOI 10.1007/s00228-005-0897-6; Kern D, 1998, CURRICULUM DEV MED E; Khunti K, 2002, EUR J HEART FAIL, V4, P771, DOI 10.1016/S1388-9842(02)00119-8; Komajda M, 2005, EUR HEART J, V26, P1653, DOI 10.1093/eurheartj/ehi251; Komajda M, 2003, EUR HEART J, V24, P464, DOI 10.1016/S0195-668X(02)00700-5; Koschack J, 2009, INT J CLIN PRACT, V63, P226, DOI 10.1111/j.1742-1241.2008.01937.x; Lenzen MJ, 2005, EUR HEART J, V26, P2706, DOI 10.1093/eurheartj/ehi499; Leopold SS, 2005, J BONE JOINT SURG AM, V87A, P1031, DOI 10.2106/JBJS.D.02434; LUKE DR, 1990, CLIN PHARMACOL THER, V48, P503, DOI 10.1038/clpt.1990.186; McCoubrie P, 2004, MED TEACH, V26, P709, DOI 10.1080/01421590400013495; McMurray JJ, 2000, HEART, V83, P596, DOI 10.1136/heart.83.5.596; McMurray JJV, 2005, LANCET, V365, P1877, DOI 10.1016/S0140-6736(05)66621-4; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Moret L, 2004, AM J INFECT CONTROL, V32, P384, DOI 10.1016/j.ajic.2004.02.004; Muth C, 2006, HEART FAILURE CLIN P; Peters-Klimm F, 2008, CLIN RES CARDIOL, V97, P244, DOI 10.1007/s00392-007-0617-6; Peters-Klimm F, 2008, J EVAL CLIN PRACT, V14, P823, DOI 10.1111/j.1365-2753.2008.01060.x; Peters-Klimm F, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-68; Phillips SM, 2004, MED J AUSTRALIA, V181, P78, DOI 10.5694/j.1326-5377.2004.tb06178.x; Robertson N, 1996, QUAL HEALTH CARE, V5, P51, DOI 10.1136/qshc.5.1.51; Rutten FH, 2003, EUR J HEART FAIL, V5, P337, DOI 10.1016/S1388-9842(03)00050-3; Shaw B, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005470; Sinha S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008522; Skinner EA, 1996, J PERS SOC PSYCHOL, V71, P549, DOI 10.1037/0022-3514.71.3.549; Sturm HB, 2007, PHARMACOEPIDEM DR S, V16, P96, DOI 10.1002/pds.1216; Sturm HB, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-57; Sturm HB, 2006, EUR J HEART FAIL, V8, P31, DOI 10.1016/j.ejheart.2005.03.010; Swedberg K, 2005, EUR HEART J SUPPL, V7, pJ21, DOI 10.1093/eurheartj/sui059; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; van Weel C, 2006, LANCET, V367, P550, DOI 10.1016/S0140-6736(06)68198-1; VANLEEUWEN YD, 1995, FAM PRACT, V12, P313, DOI 10.1093/fampra/12.3.313; Walker AE, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-22	50	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31082	10.1371/journal.pone.0031082	http://dx.doi.org/10.1371/journal.pone.0031082			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363553	Green Submitted, Green Published, gold			2022-12-27	WOS:000302873700024
J	Sarkar, S; Tang, XLL; Das, D; Spencer, JS; Lowary, TL; Suresh, MR				Sarkar, Susmita; Tang, Xinli L.; Das, Dipankar; Spencer, John S.; Lowary, Todd L.; Suresh, Mavanur R.			A Bispecific Antibody Based Assay Shows Potential for Detecting Tuberculosis in Resource Constrained Laboratory Settings	PLOS ONE			English	Article							MYCOBACTERIAL LIPOARABINOMANNAN; MONOCLONAL-ANTIBODIES; CLINICAL UTILITY; PULMONARY TUBERCULOSIS; SPUTUM SAMPLES; P24 ANTIGEN; LAM-ELISA; DIAGNOSIS; URINE; INFECTION	The re-emergence of tuberculosis (TB) as a global public health threat highlights the necessity of rapid, simple and inexpensive point-of-care detection of the disease. Early diagnosis of TB is vital not only for preventing the spread of the disease but also for timely initiation of treatment. The later in turn will reduce the possible emergence of multi-drug resistant strains of Mycobacterium tuberculosis. Lipoarabinomannan (LAM) is an important non-protein antigen of the bacterial cell wall, which is found to be present in different body fluids of infected patients including blood, urine and sputum. We have developed a bispecific monoclonal antibody with predetermined specificities towards the LAM antigen and a reporter molecule horseradish peroxidase (HRPO). The developed antibody was subsequently used to design a simple low cost immunoswab based assay to detect LAM antigen. The limit of detection for spiked synthetic LAM was found to be 5.0 ng/ml (bovine urine), 0.5 ng/ml (rabbit serum) and 0.005 ng/ml (saline) and that for bacterial LAM from M. tuberculosis H37Rv was found to be 0.5 ng/ml (rabbit serum). The assay was evaluated with 21 stored clinical serum samples (14 were positive and 7 were negative in terms of anti-LAM titer). In addition, all 14 positive samples were culture positive. The assay showed 100% specificity and 64% sensitivity (95% confidence interval). In addition to good specificity, the end point could be read visually within two hours of sample collection. The reported assay might be used as a rapid tool for detecting TB in resource constrained laboratory settings.	[Sarkar, Susmita; Tang, Xinli L.; Das, Dipankar; Suresh, Mavanur R.] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada; [Spencer, John S.] Colorado State Univ, Dept Microbiol, Ft Collins, CO 80523 USA; [Spencer, John S.] Colorado State Univ, Dept Immunol, Ft Collins, CO 80523 USA; [Spencer, John S.] Colorado State Univ, Dept Pathol, Ft Collins, CO 80523 USA; [Lowary, Todd L.] Univ Alberta, Dept Chem, Edmonton, AB, Canada; [Lowary, Todd L.] Univ Alberta, Alberta Ingenu Ctr Carbohydrate Sci, Edmonton, AB, Canada	University of Alberta; Colorado State University; Colorado State University; Colorado State University; University of Alberta; University of Alberta	Sarkar, S (corresponding author), Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2N8, Canada.	msuresh@pharmacy.ualberta.ca	Lowary, Todd L/F-9608-2019; Spencer, John S/G-6968-2017	Lowary, Todd L/0000-0002-8331-8211; Spencer, John S/0000-0002-8051-3038	Alberta Ingenuity Centre for Carbohydrate Science (AICCS), Alberta, Canada	Alberta Ingenuity Centre for Carbohydrate Science (AICCS), Alberta, Canada	The authors acknowledge the Alberta Ingenuity Centre for Carbohydrate Science (AICCS), Alberta, Canada, for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe F, 2007, SCAND J IMMUNOL, V66, P176, DOI 10.1111/j.1365-3083.2007.01978.x; Arias-Bouda LMP, 2000, J CLIN MICROBIOL, V38, P2278; Benator D, 2002, LANCET, V360, P528, DOI 10.1016/S0140-6736(02)09742-8; Bennion BJ, 2003, P NATL ACAD SCI USA, V100, P5142, DOI 10.1073/pnas.0930122100; Bhatnagar PK, 2008, J CHROMATOGR B, V863, P235, DOI 10.1016/j.jchromb.2008.01.003; Boehme C, 2005, T ROY SOC TROP MED H, V99, P893, DOI 10.1016/j.trstmh.2005.04.014; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; Campos M, 2008, AM J RESP CRIT CARE, V178, P300, DOI 10.1164/rccm.200803-381OC; Cao Y, 1998, BIOCONJUGATE CHEM, V9, P635, DOI 10.1021/bc980044l; Chatterjee D, 1998, GLYCOBIOLOGY, V8, P113, DOI 10.1093/glycob/8.2.113; Chaudhary M, 2010, INDIAN J MED MICROBI, V28, P281, DOI 10.4103/0255-0857.71805; Das D, 2005, METH MOLEC MED, V109, P329; Dheda K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009848; Dheda K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004689; Dorman SE, 2010, CLIN INFECT DIS, V50, pS173, DOI 10.1086/651488; Gadikota RR, 2003, J CARBOHYD CHEM, V22, P459, DOI 10.1081/CAR-120025322; Gennaro ML, 2000, CLIN INFECT DIS, V30, pS243, DOI 10.1086/313868; Guttikonda S, 2007, J IMMUNOL METHODS, V327, P1, DOI 10.1016/j.jim.2007.06.010; HUNTER SW, 1986, J BIOL CHEM, V261, P2345; INDERLIED CB, 1993, CLIN MICROBIOL REV, V6, P266, DOI 10.1128/CMR.6.3.266-310.1993; Jozefowski S, 2008, BIOESSAYS, V30, P943, DOI 10.1002/bies.20815; Kaur D, 2002, MICROBIOL-SGM, V148, P3049, DOI 10.1099/00221287-148-10-3049; Keeler Emmett, 2006, Nature, V444 Suppl 1, P49, DOI 10.1038/nature05446; Koraka P, 2003, J CLIN MICROBIOL, V41, P4154, DOI 10.1128/JCM.41.9.4154-4159.2003; Kreutz FT, 1998, HYBRIDOMA, V17, P267, DOI 10.1089/hyb.1998.17.267; KRIJGER FW, 1994, ACTA TROP, V56, P55, DOI 10.1016/0001-706X(94)90040-X; Lalvani A, 2008, AUTOIMMUN REV, V8, P147, DOI 10.1016/j.autrev.2008.07.011; Lawn SD, 2011, LANCET INFECT D 1017; Lipman NS, 2005, ILAR J, V46, P258, DOI 10.1093/ilar.46.3.258; Luetkemeyer Anne F, 2010, Top HIV Med, V18, P143; Mabey D, 2004, NAT REV MICROBIOL, V2, P231, DOI 10.1038/nrmicro841; Madariaga MG, 2007, J AM BOARD FAM MED, V20, P540, DOI 10.3122/jabfm.2007.06.070109; Mahadevan S., 1997, Indian Journal of Pediatrics, V64, P97, DOI 10.1007/BF02795786; MILES SA, 1993, NEW ENGL J MED, V328, P297, DOI 10.1056/NEJM199302043280501; Murase T, 2009, J MOL BIOL, V392, P381, DOI 10.1016/j.jmb.2009.06.074; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; Patel VB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015664; Patel VB, 2009, FLUIDS BARRIERS CNS, V6, DOI 10.1186/1743-8454-6-13; Peter J, 2010, CURR OPIN PULM MED, V16, P262, DOI 10.1097/MCP.0b013e328337f23a; Rademacher C, 2007, J AM CHEM SOC, V129, P10489, DOI 10.1021/ja0723380; Reither K, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-141; Ritter MA, 2000, METH MOLEC MED, V40, P23, DOI 10.1385/1-59259-076-4:23; Russell D, 1998, KEYST C TB MOL MECH; SADA E, 1992, J CLIN MICROBIOL, V30, P2415, DOI 10.1128/JCM.30.9.2415-2418.1992; Sarkar S, 2011, J PHARM PHARM SCI, V14, P148, DOI 10.18433/J33591; Shahhosseini S, 2007, J VIROL METHODS, V143, P29, DOI 10.1016/j.jviromet.2007.02.004; Shahhosseini S, 2006, J PHARM PHARM SCI, V9, P26; Spencer JS, 2011, CLIN VACCINE IMMUNOL, V18, P260, DOI 10.1128/CVI.00472-10; Strohmeier GR, 1999, MICROBES INFECT, V1, P709, DOI 10.1016/S1286-4579(99)80072-0; SURESH MR, 1986, METHOD ENZYMOL, V121, P210; SURESH MR, 1986, P NATL ACAD SCI USA, V83, P7989, DOI 10.1073/pnas.83.20.7989; Tang XL, 2004, CLIN DIAGN LAB IMMUN, V11, P752, DOI 10.1128/CDLI.11.4.752-757.2004; Theron G, 2011, EUR RESP J      1110; Tong M, 2005, J IMMUNOL METHODS, V301, P154, DOI 10.1016/j.jim.2005.04.004; VASUDEVACHARI MB, 1993, J CLIN IMMUNOL, V13, P185, DOI 10.1007/BF00919971	55	18	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32340	10.1371/journal.pone.0032340	http://dx.doi.org/10.1371/journal.pone.0032340			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363820	Green Submitted, Green Published, gold			2022-12-27	WOS:000302873700161
J	Harrer, A; Pilz, G; Einhaeupl, M; Oppermann, K; Hitzl, W; Wipfler, P; Sellner, J; Golaszewski, S; Afazel, S; Haschke-Becher, E; Trinka, E; Kraus, J				Harrer, Andrea; Pilz, Georg; Einhaeupl, Max; Oppermann, Katrin; Hitzl, Wolfgang; Wipfler, Peter; Sellner, Johann; Golaszewski, Stefan; Afazel, Shahrzad; Haschke-Becher, Elisabeth; Trinka, Eugen; Kraus, Joerg			Lymphocyte Subsets Show Different Response Patterns to In Vivo Bound Natalizumab-A Flow Cytometric Study on Patients with Multiple Sclerosis	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PERIPHERAL-BLOOD; CEREBROSPINAL-FLUID; ADHESION MOLECULES; MONONUCLEAR-CELLS; CONTROLLED TRIAL; INTERFERON-BETA; EXPRESSION; MS	Natalizumab is an effective monoclonal antibody therapy for the treatment of relapsing- remitting multiple sclerosis (RRMS) and interferes with immune cell migration into the central nervous system by blocking the alpha(4) subunit of very-late activation antigen-4 (VLA-4). Although well tolerated and very effective, some patients still suffer from relapses in spite of natalizumab therapy or from unwanted side effects like progressive multifocal leukoencephalopathy (PML). In search of a routine-qualified biomarker on the effectiveness of natalizumab therapy we applied flow cytometry and analyzed natalizumab binding to alpha(4) and alpha(4) integrin surface levels on T-cells, B-cells, natural killer (NK) cells, and NKT cells from 26 RRMS patients under up to 72 weeks of therapy. Four-weekly infusions of natalizumab resulted in a significant and sustained increase of lymphocyte-bound natalizumab (p<0.001) which was paralleled by a significant decrease in detectability of the alpha(4) integrin subunit on all lymphocyte subsets (p<0.001). We observed pronounced natalizumab accumulations on T and B cells at single measurements in all patients who reported clinical disease activity (n = 4). The natalizumab binding capacity of in vitro saturated lymphocytes collected during therapy was strongly diminished compared to treatment-naive cells indicating a therapy-induced reduction of alpha(4). Summing up, this pilot study shows that flow cytometry is a useful method to monitor natalizumab binding to lymphocytes from RRMS patients under therapy. Investigating natalizumab binding provides an opportunity to evaluate the molecular level of effectiveness of natalizumab therapy in individual patients. In combination with natalizumab saturation experiments, it possibly even provides a means of studying the feasability of patient-tailored infusion intervals. A routine-qualified biomarker on the basis of individual natalizumab saturation on lymphocyte subsets might be an effective tool to improve treatment safety.	[Harrer, Andrea; Pilz, Georg; Einhaeupl, Max; Oppermann, Katrin; Wipfler, Peter; Sellner, Johann; Golaszewski, Stefan; Trinka, Eugen; Kraus, Joerg] Paracelsus Med Univ, Christian Doppler Klin, Dept Neurol, Salzburg, Austria; [Afazel, Shahrzad; Haschke-Becher, Elisabeth] Paracelsus Med Univ, Christian Doppler Klin, Cent Lab, Salzburg, Austria; [Hitzl, Wolfgang] Paracelsus Med Univ, Res Off, Salzburg, Austria	Paracelsus Private Medical University; Paracelsus Private Medical University; Paracelsus Private Medical University	Harrer, A (corresponding author), Paracelsus Med Univ, Christian Doppler Klin, Dept Neurol, Salzburg, Austria.	a.harrer@salk.at	Hitzl, Wolfgang/A-1068-2013; Selllner, Johann/AAB-1263-2019	Wipfler, Peter/0000-0003-4982-4855; Hitzl, Wolfgang/0000-0002-7696-1479; Harrer, Andrea/0000-0001-7717-6125; Trinka, Eugen/0000-0002-5950-2692; Pilz, Georg/0000-0001-8764-2628	Biogen-Idec	Biogen-Idec(Biogen)	This study was partially funded by Biogen-Idec via unrestricted research grants to ET and JK. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airas L, 2008, CLIN EXP IMMUNOL, V151, P235, DOI 10.1111/j.1365-2249.2007.03555.x; Baumann A, 2006, CURR DRUG METAB, V7, P15, DOI 10.2174/138920006774832604; Bielekova B, 2006, P NATL ACAD SCI USA, V103, P5941, DOI 10.1073/pnas.0601335103; Calabresi PA, 2007, NEUROLOGY, V69, P1391, DOI 10.1212/01.wnl.0000277457.17420.b5; Cavers M, 2002, CLIN EXP IMMUNOL, V127, P60, DOI 10.1046/j.1365-2249.2002.01711.x; Clifford DB, 2010, LANCET NEUROL, V9, P438, DOI 10.1016/S1474-4422(10)70028-4; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; Defer G, 2011, J NEUROL SCI; Eikelenboom MJ, 2005, J NEUROIMMUNOL, V158, P222, DOI 10.1016/j.jneuroim.2004.09.005; Foster GR, 2004, J IMMUNOL, V173, P1663, DOI 10.4049/jimmunol.173.3.1663; Harrer A, 2011, J NEUROIMMUNOL, V234, P148, DOI 10.1016/j.jneuroim.2011.03.001; HOUFF SA, 1988, NEW ENGL J MED, V318, P301, DOI 10.1056/NEJM198802043180507; Kastrukoff LF, 1998, J NEUROIMMUNOL, V86, P123, DOI 10.1016/S0165-5728(98)00014-9; Kastrukoff LF, 2003, J NEUROIMMUNOL, V145, P103, DOI 10.1016/j.jneuroim.2003.10.001; Kraus J, 1998, ACTA NEUROL SCAND, V98, P102; Kraus J, 2001, J LAB MED, V25, P548; Kraus J, 2006, DRUG DISCOV TODAY, V11, P755, DOI 10.1016/j.drudis.2006.06.008; Krumbholz M, 2008, NEUROLOGY, V71, P1350, DOI 10.1212/01.wnl.0000327671.91357.96; Lutterotti A, 2008, J NEUROL SCI, V274, P18, DOI 10.1016/j.jns.2008.05.021; Martin MD, 2008, ARCH NEUROL-CHICAGO, V65, P1596, DOI 10.1001/archneur.65.12.noc80051; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Millonig A, 2010, J NEUROIMMUNOL, V227, P190, DOI 10.1016/j.jneuroim.2010.07.012; Niino M, 2006, ANN NEUROL, V59, P748, DOI 10.1002/ana.20859; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Rispens T, 2011, ANAL BIOCHEM, V411, P271, DOI 10.1016/j.ab.2011.01.001; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Saraste M, 2007, NEUROL SCI, V28, P121, DOI 10.1007/s10072-007-0803-3; Sheremata WA, 1999, NEUROLOGY, V52, P1072, DOI 10.1212/WNL.52.5.1072; Skarica M, 2011, J NEUROIMMUNOL, V235, P70, DOI 10.1016/j.jneuroim.2011.02.010; Sorensen PS, 2011, MULT SCLER; Stuve O, 2005, ARCH NEUROL-CHICAGO, V62, P1620, DOI 10.1001/archneur.62.10.1620; Stuve O, 2006, ARCH NEUROL-CHICAGO, V63, P1383, DOI 10.1001/archneur.63.10.1383; von Andrian UH, 2003, NEW ENGL J MED, V348, P68, DOI 10.1056/NEJMe020157; Wipfler P, 2011, MULT SCLER, V17, P16, DOI 10.1177/1352458510383075; Wipfler P, 2011, DRUG DISCOV TODAY, V16, P8, DOI 10.1016/j.drudis.2010.10.011; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Zohren F, 2008, BLOOD, V111, P3893, DOI 10.1182/blood-2007-10-120329	38	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31784	10.1371/journal.pone.0031784	http://dx.doi.org/10.1371/journal.pone.0031784			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363732	gold, Green Published, Green Submitted			2022-12-27	WOS:000302871500087
J	Kearney, MF; Spindler, J; Wiegand, A; Shao, W; Anderson, EM; Maldarelli, F; Ruscetti, FW; Mellors, JW; Hughes, SH; Le Grice, SFJ; Coffin, JM				Kearney, Mary F.; Spindler, Jonathan; Wiegand, Ann; Shao, Wei; Anderson, Elizabeth M.; Maldarelli, Frank; Ruscetti, Francis W.; Mellors, John W.; Hughes, Steve H.; Le Grice, Stuart F. J.; Coffin, John M.			Multiple Sources of Contamination in Samples from Patients Reported to Have XMRV Infection	PLOS ONE			English	Article							VIRUS-RELATED VIRUS; CHRONIC-FATIGUE-SYNDROME; RETROVIRUS XMRV; BLOOD-CELLS; MOUSE DNA; LEUKEMIA	Xenotropic murine leukemia virus (MLV)-related retrovirus (XMRV) was reported to be associated with prostate cancer by Urisman, et al. in 2006 and chronic fatigue syndrome (CFS) by Lombardi, et al. in 2009. To investigate this association, we independently evaluated plasma samples from 4 patients with CFS reported by Lombardi, et al. to have XMRV infection and from 5 healthy controls reported to be XMRV uninfected. We also analyzed viral sequences obtained from supernatants of cell cultures found to contain XMRV after coculture with 9 clinical samples from 8 patients. A qPCR assay capable of distinguishing XMRV from endogenous MLVs showed that the viral sequences detected in the CFS patient plasma behaved like endogenous MLVs and not XMRV. Single-genome sequences (N = 89) from CFS patient plasma were indistinguishable from endogenous MLVs found in the mouse genome that are distinct from XMRV. By contrast, XMRV sequences were detected by qPCR in 2 of the 5 plasma samples from healthy controls (sequencing of the qPCR product confirmed XMRV not MLV). Single-genome sequences (N = 234) from the 9 culture supernatants reportedly positive for XMRV were indistinguishable from XMRV sequences obtained from 22Rv1 and XMRV-contaminated 293T cell-lines. These results indicate that MLV DNA detected in the plasma samples from CFS patients evaluated in this study was from contaminating mouse genomic DNA and that XMRV detected in plasma samples from healthy controls and in cultures of patient samples was due to cross-contamination with XMRV (virus or nucleic acid).	[Kearney, Mary F.; Spindler, Jonathan; Wiegand, Ann; Anderson, Elizabeth M.; Maldarelli, Frank; Hughes, Steve H.; Le Grice, Stuart F. J.] NCI, HIV Drug Resistance Program, Frederick, MD 21701 USA; [Shao, Wei] SAIC, Adv Biomed Comp Ctr, Frederick, MD USA; [Ruscetti, Francis W.] NCI, Expt Immunol Lab, Canc & Inflammat Program, Frederick, MD 21701 USA; [Mellors, John W.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Coffin, John M.] Tufts Univ, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tufts University	Kearney, MF (corresponding author), NCI, HIV Drug Resistance Program, Frederick, MD 21701 USA.	kearneym@mail.nih.gov	Maldarelli, Frank/O-2428-2016; Kearney, Mary/AAU-8132-2020	Kearney, Mary/0000-0003-3839-6576	FM Kirby Foundation; National Cancer Institute; National Cancer Institute (SAIC) [25XS119]; NATIONAL CANCER INSTITUTE [ZIABC010494, ZIABC010252] Funding Source: NIH RePORTER	FM Kirby Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute (SAIC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr. Coffin was a Research Professor of the American Cancer Society, with support from the FM Kirby Foundation. Funding for this research was provided by the Intramural Research Program of the National Cancer Institute. Dr. Mellors was supported by a contract from the National Cancer Institute (SAIC contract 25XS119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cornelissen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012040; Erlwein O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017592; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; FRANKEL WN, 1990, GENETICS, V124, P221; Garson JA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-13; Gray ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018096; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Hohn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015632; Huber BT, 2010, RETROVIROLOGY, V7; Hue S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-111; Jern P, 2007, PLOS GENET, V3, P2014, DOI 10.1371/journal.pgen.0030183; Jern P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000367; Kearney MF, 2011, ADV VIROL, V2011, DOI 10.1155/2011/272193; Knouf EC, 2009, J VIROL, V83, P7353, DOI 10.1128/JVI.00546-09; Knox K, 2011, SCIENCE; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Mikovits JA, 2010, VIRULENCE, V1, P386, DOI 10.4161/viru.1.5.12486; Mikovits JA, 2010, AIDS REV, V12, P149; Oakes B, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-109; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Paprotka T, 2011, SCIENCE; Robinson MJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-108; Sato E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-110; Satterfield BC, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-12; Sfanos KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020874; Shin CH, 2011, J VIROLOGY; Smith RA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-112; Stang A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-86; Switzer WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019065; Tuke PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019953; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Zhang YA, 2011, CANC BIOL THERAPY, V12	33	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30889	10.1371/journal.pone.0030889	http://dx.doi.org/10.1371/journal.pone.0030889			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363509	Green Accepted, Green Published, gold			2022-12-27	WOS:000302871500020
J	Sharma, YV; Cojocaru, RI; Ritter, LM; Khattree, N; Brooks, M; Scott, A; Swaroop, A; Goldberg, AFX				Sharma, Yagya V.; Cojocaru, Radu I.; Ritter, Linda M.; Khattree, Nidhi; Brooks, Matthew; Scott, Alison; Swaroop, Anand; Goldberg, Andrew F. X.			Protective Gene Expression Changes Elicited by an Inherited Defect in Photoreceptor Structure	PLOS ONE			English	Article							NRL(-/-) MOUSE RETINA; RDS MUTANT MICE; CELL-DEATH; MESSENGER-RNA; ALTERED EXPRESSION; FACTOR MEF2C; DEGENERATION; LIGHT; IDENTIFICATION; MICROGLIA	Inherited defects in retinal photoreceptor structure impair visual transduction, disrupt relationship with the retinal pigment epithelium (RPE), and compromise cell viability. A variety of progressive retinal degenerative diseases can result, and knowledge of disease etiology remains incomplete. To investigate pathogenic mechanisms in such instances, we have characterized rod photoreceptor and retinal gene expression changes in response to a defined insult to photoreceptor structure, using the retinal degeneration slow (rds) mouse model. Global gene expression profiling was performed on flow-sorted rds and wild-type rod photoreceptors immediately prior and subsequent to times at which OSs are normally elaborated. Dysregulated genes were identified via microarray hybridization, and selected candidates were validated using quantitative PCR analyses. Both the array and qPCR data revealed that gene expression changes were generally modest and dispersed amongst a variety of known functional networks. Although genes showing major (> 5-fold) differential expression were identified in a few instances, nearly all displayed transient temporal profiles, returning to WT levels by postnatal day (P) 21. These observations suggest that major defects in photoreceptor cell structure may induce early homeostatic responses, which function in a protective manner to promote cell viability. We identified a single key gene, Egr1, that was dysregulated in a sustained fashion in rds rod photoreceptors and retina. Egr1 upregulation was associated with microglial activation and migration into the outer retina at times subsequent to the major peak of photoreceptor cell death. Interestingly, this response was accompanied by neurotrophic factor upregulation. We hypothesize that activation of Egr1 and neurotrophic factors may represent a protective immune mechanism which contributes to the characteristically slow retinal degeneration of the rds mouse model.	[Sharma, Yagya V.; Ritter, Linda M.; Khattree, Nidhi; Goldberg, Andrew F. X.] Oakland Univ, Eye Res Inst, Rochester, MI 48309 USA; [Brooks, Matthew; Scott, Alison; Swaroop, Anand] Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Cojocaru, Radu I.; Brooks, Matthew; Swaroop, Anand] NEI, Neurobiol Neurodegenerat & Repair Lab, NIH, Bethesda, MD 20892 USA	Oakland University; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Sharma, YV (corresponding author), Oakland Univ, Eye Res Inst, Rochester, MI 48309 USA.	goldberg@oakland.edu		Swaroop, Anand/0000-0002-1975-1141; Scott, Alison/0000-0001-6969-4707	E. Matilda Zeigler Foundation; National Institutes of Health [EY013246, RR017890]; Foundation Fighting Blindness and intramural funds of the National Eye Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017890] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [ZIAEY000473, R01EY013246] Funding Source: NIH RePORTER	E. Matilda Zeigler Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness and intramural funds of the National Eye Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the E. Matilda Zeigler Foundation and the National Institutes of Health [EY013246 and RR017890] to AFXG, and by The Foundation Fighting Blindness and intramural funds of the National Eye Institute to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL N, 1994, FEBS LETT, V339, P253, DOI 10.1016/0014-5793(94)80426-5; Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; BARTHEL LK, 1990, J HISTOCHEM CYTOCHEM, V38, P1383, DOI 10.1177/38.9.2201738; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Boon CJF, 2008, PROG RETIN EYE RES, V27, P213, DOI 10.1016/j.preteyeres.2008.01.002; Bramall AN, 2010, ANNU REV NEUROSCI, V33, P441, DOI 10.1146/annurev-neuro-060909-153227; Brand C, 2005, MOL VIS, V11, P309; Cai X, 2010, FASEB J, V24, P1178, DOI 10.1096/fj.09-139147; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; Clarke G, 2000, NATURE, V406, P195, DOI 10.1038/35018098; Conley SM, 2009, EXP EYE RES, V89, P278, DOI 10.1016/j.exer.2009.03.023; Demos C, 2008, MOL VIS, V14, P1639; Escher P, 2011, INVEST OPHTH VIS SCI, V52, P5933, DOI 10.1167/iovs.10-6978; Fischer AJ, 1999, NAT NEUROSCI, V2, P706, DOI 10.1038/11167; Gehrig A, 2007, INVEST OPHTH VIS SCI, V48, P891, DOI 10.1167/iovs.06-0641; Goldberg AFX, 2007, INVEST OPHTH VIS SCI, V48, P2975, DOI 10.1167/iovs.07-0049; Goldberg AFX, 2006, INT REV CYTOL, V253, P131, DOI 10.1016/S0074-7696(06)53004-9; Hackam AS, 2004, INVEST OPHTH VIS SCI, V45, P2929, DOI 10.1167/iovs.03-1184; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hao H, 2011, J BIOL CHEM, V286, P34893, DOI 10.1074/jbc.M111.271072; Harada T, 2002, J NEUROSCI, V22, P9228, DOI 10.1523/jneurosci.22-21-09228.2002; Hsiau THC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000643; Hughes EH, 2003, INVEST OPHTH VIS SCI, V44, P2229, DOI 10.1167/iovs.02-0824; Humphries A, 2004, BIOCHEM BIOPH RES CO, V320, P551, DOI 10.1016/j.bbrc.2004.06.006; JANSEN HG, 1984, J COMP NEUROL, V224, P71, DOI 10.1002/cne.902240107; Karlstetter M, 2010, IMMUNOBIOLOGY, V215, P685, DOI 10.1016/j.imbio.2010.05.010; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Kohl S, 1997, J MED GENET, V34, P620, DOI 10.1136/jmg.34.8.620; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Langmann T, 2009, NEUROMOL MED, V11, P87, DOI 10.1007/s12017-009-8061-6; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Lohr HR, 2006, EXP EYE RES, V83, P380, DOI 10.1016/j.exer.2006.01.014; Man PS, 2008, MOL VIS, V14, P1176; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mortimer SE, 2008, J BIOL CHEM, V283, P36354, DOI 10.1074/jbc.M806143200; Nakahara M, 2005, J BIOL CHEM, V280, P29128, DOI 10.1074/jbc.M503817200; Petrey D, 2009, CURR OPIN STRUC BIOL, V19, P363, DOI 10.1016/j.sbi.2009.02.001; Pierce EA, 2001, BIOESSAYS, V23, P605, DOI 10.1002/bies.1086; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Rex TS, 2004, MOL THER, V10, P855, DOI 10.1016/j.ymthe.2004.07.027; Rohrer B, 2004, J BIOL CHEM, V279, P41903, DOI 10.1074/jbc.M405085200; Sancho-Pelluz J, 2008, MOL NEUROBIOL, V38, P253, DOI 10.1007/s12035-008-8045-9; SANYAL S, 1980, J COMP NEUROL, V194, P193, DOI 10.1002/cne.901940110; SANYAL S, 1981, NEUROSCI LETT, V21, P23, DOI 10.1016/0304-3940(81)90051-3; Schlichtenbrede FC, 2003, J GENE MED, V5, P757, DOI 10.1002/jgm.401; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Simon P, 2004, EUR J NEUROSCI, V20, P3371, DOI 10.1111/j.1460-9568.2004.03811.x; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Thiel G, 2010, CELL CALCIUM, V47, P397, DOI 10.1016/j.ceca.2010.02.005; Travis GH, 1998, AM J HUM GENET, V62, P503, DOI 10.1086/301772; TRAVIS GH, 1989, NATURE, V338, P70, DOI 10.1038/338070a0; Usukura J, 1995, PROG RETIN EYE RES, V15, P113, DOI 10.1016/1350-9462(95)00006-2; VANNIE R, 1978, TISSUE ANTIGENS, V12, P106, DOI 10.1111/j.1399-0039.1978.tb01305.x; Virolle T, 2003, J BIOL CHEM, V278, P11802, DOI 10.1074/jbc.M210279200; Vucic D, 2011, NAT REV MOL CELL BIO, V12, P439, DOI 10.1038/nrm3143; Xue W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020326; Yoshida S, 2004, HUM MOL GENET, V13, P1487, DOI 10.1093/hmg/ddh160; Yu JD, 2004, J BIOL CHEM, V279, P42211, DOI 10.1074/jbc.M408223200; Zhang C, 2005, MOL VIS, V11, P887	61	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31371	10.1371/journal.pone.0031371	http://dx.doi.org/10.1371/journal.pone.0031371			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363631	Green Submitted, Green Published, gold			2022-12-27	WOS:000302871500037
J	Higgins, MF; Russell, NE; Crossey, PA; Nyhan, KC; Brazil, DP; McAuliffe, FM				Higgins, Mary F.; Russell, Noirin E.; Crossey, Paul A.; Nyhan, Kristine C.; Brazil, Derek P.; McAuliffe, Fionnuala M.			Maternal and Fetal Placental Growth Hormone and IGF Axis in Type 1 Diabetic Pregnancy	PLOS ONE			English	Article							FACTOR-I; INSULIN REQUIREMENTS; BINDING-PROTEIN; VARIANT GENE; WOMEN; EXPRESSION; SERUM; HYPOGLYCEMIA; MACROSOMIA; MELLITUS	Aim: Placental growth hormone (PGH) is a major growth hormone in pregnancy and acts with Insulin Like Growth Factor I (IGF-I) and Insulin Like Growth Hormone Binding Protein 3 (IGFBP3). The aim of this study was to investigate PGH, IGF-I and IGFBP3 in non-diabetic (ND) compared to Type 1 Diabetic (T1DM) pregnancies. Methods: This is a prospective study. Maternal samples were obtained from 25 ND and 25 T1DM mothers at 36 weeks gestation. Cord blood was obtained after delivery. PGH, IGF-I and IGFBP3 were measured using ELISA. Results: There was no difference in delivery type, gender of infants or birth weight between groups. In T1DM, maternal PGH significantly correlated with ultrasound estimated fetal weight (r = 0.4, p = 0.02), birth weight (r = 0.51, p<0.05) and birth weight centile (r = 0.41, p = 0.03) PGH did not correlate with HbA1c. Maternal IGF-I was lower in T1DM (p = 0.03). Maternal and fetal serum IGFBP3 was higher in T1DM. Maternal third trimester T1DM serum had a significant band at 16 kD on western blot, which was not present in ND. Conclusion: Maternal T1DM PGH correlated with both antenatal fetal weight and birth weight, suggesting a significant role for PGH in growth in diabetic pregnancy. IGFBP3 is significantly increased in maternal and fetal serum in T1DM pregnancies compared to ND controls, which was explained by increased proteolysis in maternal but not fetal serum. These results suggest that the normal PGH-IGF-I-IGFBP3 axis in pregnancy is abnormal in T1DM pregnancies, which are at higher risk of macrosomia.	[Higgins, Mary F.; Russell, Noirin E.; McAuliffe, Fionnuala M.] Univ Coll Dublin, Natl Matern Hosp, Sch Med & Med Sci, UCD Obstet & Gynaecol, Dublin 2, Ireland; [Higgins, Mary F.; Crossey, Paul A.; Nyhan, Kristine C.; McAuliffe, Fionnuala M.] Univ Coll Dublin, Inst Biomol & Biomed Res, UCD Conway, Dublin 2, Ireland; [Brazil, Derek P.] Queens Univ Belfast, Ctr Vis & Vasc Sci, Belfast, Antrim, North Ireland	National Maternity Hospital, Dublin; University College Dublin; University College Dublin; Queens University Belfast	Higgins, MF (corresponding author), Univ Coll Dublin, Natl Matern Hosp, Sch Med & Med Sci, UCD Obstet & Gynaecol, Dublin 2, Ireland.	Fionnuala.mcauliffe@ucd.ie		Higgins, Mary/0000-0002-6469-5169; Russell, Noirin/0000-0002-2759-3294; Brazil, Derek/0000-0003-1375-1076	Health Research Board Ireland	Health Research Board Ireland	This study was funded by Health Research Board Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsat E, 1998, MOL CELL ENDOCRINOL, V140, P121, DOI 10.1016/S0303-7207(98)00040-9; Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Barbour LA, 2004, ENDOCRINOLOGY, V145, P1144, DOI 10.1210/en.2003-1297; BERK MA, 1989, PEDIATRICS, V83, P1029; Bjorklund AO, 1998, BRIT J OBSTET GYNAEC, V105, P649, DOI 10.1111/j.1471-0528.1998.tb10180.x; Confidential Enquiry into Maternal and Child Health, 2005, PREGN WOM TYP 1 TYP; COOKE NE, 1988, J CLIN INVEST, V82, P270, DOI 10.1172/JCI113582; Corrigan N, 2009, BIRTH DEFECTS RES A, V85, P523, DOI 10.1002/bdra.20567; Diabet Control Complications Trial Res Grp, 1996, AM J OBSTET GYNECOL, V174, P1343; DiPiro J, 1989, GYNAECOLOGIC DISORDE; ERIKSSON T, 1989, J PSYCHIAT RES, V23, P241, DOI 10.1016/0022-3956(89)90029-0; FRANKENNE F, 1988, J CLIN ENDOCR METAB, V66, P1171, DOI 10.1210/jcem-66-6-1171; Fuglsang J, 2008, HORM METAB RES, V40, P189, DOI 10.1055/s-2007-1004575; Fuglsang J, 2005, GROWTH HORM IGF RES, V15, P223, DOI 10.1016/j.ghir.2005.03.004; Fuglsang J, 2003, J CLIN ENDOCR METAB, V88, P4355, DOI 10.1210/jc.2003-030726; GULER HP, 1989, ACTA ENDOCRINOL-COP, V121, P753, DOI 10.1530/acta.0.1210753; Higgins M, 2010, CURR DIABETES REV, V6, P116, DOI 10.2174/157339910790909431; Higgins MF, 2008, EUR J OBSTET GYN R B, V140, P43, DOI 10.1016/j.ejogrb.2008.02.021; Holmes RP, 1999, HUM REPROD, V14, P1879, DOI 10.1093/humrep/14.7.1879; Hu LM, 1999, MOL CELL ENDOCRINOL, V157, P131, DOI 10.1016/S0303-7207(99)00152-5; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Langer O, 2000, CLIN OBSTET GYNECOL, V43, P283, DOI 10.1097/00003081-200006000-00006; Liu YJ, 1996, ENDOCR J, V43, P221, DOI 10.1507/endocrj.43.221; McIntyre HD, 2000, J CLIN ENDOCR METAB, V85, P1143, DOI 10.1210/jc.85.3.1143; McIntyre HD, 2002, HORM METAB RES, V34, P250; MIRLESSE V, 1993, PEDIATR RES, V34, P439, DOI 10.1203/00006450-199310000-00011; Mittal P, 2007, J MATERN-FETAL NEO M, V20, P651, DOI 10.1080/14767050701463571; Nielsen LR, 2008, DIABETIC MED, V25, P826, DOI 10.1111/j.1464-5491.2008.02495.x; Russell NE, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.07.016; SARA VR, 1990, PHYSIOL REV, V70, P591, DOI 10.1152/physrev.1990.70.3.591; SELDEN RF, 1988, P NATL ACAD SCI USA, V85, P8241, DOI 10.1073/pnas.85.21.8241; TAN K, 1986, J CLIN ENDOCR METAB, V63, P651, DOI 10.1210/jcem-63-3-651; WHITTAKER PG, 1990, OBSTET GYNECOL, V76, P223; Yamashita H, 2000, CLIN OBSTET GYNECOL, V43, P87, DOI 10.1097/00003081-200003000-00009	34	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e29164	10.1371/journal.pone.0029164	http://dx.doi.org/10.1371/journal.pone.0029164			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363400	Green Submitted, Green Published, gold			2022-12-27	WOS:000302853600004
J	Niechwiej-Szwedo, E; Goltz, HC; Chandrakumar, M; Wong, AMF				Niechwiej-Szwedo, Ewa; Goltz, Herbert C.; Chandrakumar, Manokaraananthan; Wong, Agnes M. F.			The Effect of Sensory Uncertainty Due to Amblyopia (Lazy Eye) on the Planning and Execution of Visually-Guided 3D Reaching Movements	PLOS ONE			English	Article							BINOCULAR VISION; ONLINE CONTROL; MOTOR CONTROL; SPATIAL LOCALIZATION; MACAQUE MONKEYS; DEFICITS; HUMANS; HAND; CUES; INFORMATION	Background: Impairment of spatiotemporal visual processing in amblyopia has been studied extensively, but its effects on visuomotor tasks have rarely been examined. Here, we investigate how visual deficits in amblyopia affect motor planning and online control of visually-guided, unconstrained reaching movements. Methods: Thirteen patients with mild amblyopia, 13 with severe amblyopia and 13 visually-normal participants were recruited. Participants reached and touched a visual target during binocular and monocular viewing. Motor planning was assessed by examining spatial variability of the trajectory at 50-100 ms after movement onset. Online control was assessed by examining the endpoint variability and by calculating the coefficient of determination (R-2) which correlates the spatial position of the limb during the movement to endpoint position. Results: Patients with amblyopia had reduced precision of the motor plan in all viewing conditions as evidenced by increased variability of the reach early in the trajectory. Endpoint precision was comparable between patients with mild amblyopia and control participants. Patients with severe amblyopia had reduced endpoint precision along azimuth and elevation during amblyopic eye viewing only, and along the depth axis in all viewing conditions. In addition, they had significantly higher R-2 values at 70% of movement time along the elevation and depth axes during amblyopic eye viewing. Conclusion: Sensory uncertainty due to amblyopia leads to reduced precision of the motor plan. The ability to implement online corrections depends on the severity of the visual deficit, viewing condition, and the axis of the reaching movement. Patients with mild amblyopia used online control effectively to compensate for the reduced precision of the motor plan. In contrast, patients with severe amblyopia were not able to use online control as effectively to amend the limb trajectory especially along the depth axis, which could be due to their abnormal stereopsis.	[Niechwiej-Szwedo, Ewa; Goltz, Herbert C.; Chandrakumar, Manokaraananthan; Wong, Agnes M. F.] Hosp Sick Children, Dept Ophthalmol & Vis Sci, Toronto, ON M5G 1X8, Canada; [Goltz, Herbert C.; Wong, Agnes M. F.] Univ Toronto, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Niechwiej-Szwedo, E (corresponding author), Hosp Sick Children, Dept Ophthalmol & Vis Sci, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	agnes.wong@sickkids.ca	Chandrakumar, Manokaraananthan/AHD-0133-2022	Goltz, Herbert/0000-0002-6496-754X	Canadian Institutes of Health Research (CIHR) [MOP 106663]; Canadian Foundation for Innovation (CFI); Department of Ophthalmology and Vision Sciences and Research Training Centre at The Hospital for Sick Children	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Department of Ophthalmology and Vision Sciences and Research Training Centre at The Hospital for Sick Children	Supported by grant MOP 106663 from the Canadian Institutes of Health Research (CIHR), Leaders Opportunity Fund from the Canadian Foundation for Innovation (CFI), and the Department of Ophthalmology and Vision Sciences and Research Training Centre at The Hospital for Sick Children. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apker GA, 2010, J NEUROPHYSIOL, V104, P2654, DOI 10.1152/jn.00590.2010; Barnes GR, 2001, J PHYSIOL-LONDON, V533, P281, DOI 10.1111/j.1469-7793.2001.0281b.x; Barrett BT, 2003, INVEST OPHTH VIS SCI, V44, P1555, DOI 10.1167/iovs.02-0515; Battaglia PW, 2007, J NEUROSCI, V27, P6984, DOI 10.1523/JNEUROSCI.1309-07.2007; Bays PM, 2007, J PHYSIOL-LONDON, V578, P387, DOI 10.1113/jphysiol.2006.120121; BEDELL HE, 1985, INVEST OPHTH VIS SCI, V26, P909; BEDELL HE, 1983, AM J OPTOM PHYS OPT, V60, P426; Bernstein N, 1967, COORDINATION REGULAT; Bonneh YS, 2007, VISION RES, V47, P1950, DOI 10.1016/j.visres.2007.02.015; Bradshaw MF, 2004, SPATIAL VISION, V17, P95, DOI 10.1163/156856804322778288; Bradshaw MF, 2003, SPATIAL VISION, V16, P295, DOI 10.1163/156856803322467545; Brenner E, 2006, EXP BRAIN RES, V170, P302, DOI 10.1007/s00221-005-0213-9; Brenner E, 2000, VISION RES, V40, P1649, DOI 10.1016/S0042-6989(00)00062-6; Churchland MM, 2006, NEURON, V52, P1085, DOI 10.1016/j.neuron.2006.10.034; CONTI P, 1980, PERCEPT MOTOR SKILL, V50, P239, DOI 10.2466/pms.1980.50.1.239; Crawford JD, 2004, J NEUROPHYSIOL, V92, P10, DOI 10.1152/jn.00117.2004; Danckert J, 2001, EXP BRAIN RES, V137, P303; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Desmurget M, 1998, NEUROSCI BIOBEHAV R, V22, P761, DOI 10.1016/S0149-7634(98)00004-9; DESMURGET M, 1995, CAN J PHYSIOL PHARM, V73, P262, DOI 10.1139/y95-037; Diedrichsen J, 2010, TRENDS COGN SCI, V14, P31, DOI 10.1016/j.tics.2009.11.004; El-Shamayleh Y, 2010, J NEUROSCI, V30, P12198, DOI 10.1523/JNEUROSCI.3055-10.2010; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Faisal AA, 2009, J NEUROPHYSIOL, V101, P1901, DOI 10.1152/jn.90974.2008; FRISEN L, 1975, INVEST OPHTH VISUAL, V14, P528; FRONIUS M, 1994, VISION RES, V34, P689, DOI 10.1016/0042-6989(94)90022-1; FRONIUS M, 1989, INVEST OPHTH VIS SCI, V30, P2034; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; GORDON J, 1987, EXP BRAIN RES, V67, P253, DOI 10.1007/BF00248547; Grant S, 2007, INVEST OPHTH VIS SCI, V48, P1139, DOI 10.1167/iovs.06-0976; Grant S, 2011, STRABISMUS, V19, P119, DOI 10.3109/09273972.2011.600423; Greenwald HS, 2009, VISUAL NEUROSCI, V26, P63, DOI 10.1017/S0952523808080668; Greenwald HS, 2005, VISION RES, V45, P1975, DOI 10.1016/j.visres.2005.01.025; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Heath M, 2005, MOTOR CONTROL, V9, P281, DOI 10.1123/mcj.9.3.281; Heath M, 2008, MOTOR CONTROL, V12, P252, DOI 10.1123/mcj.12.3.252; Hess RF, 1999, VISION RES, V39, P901, DOI 10.1016/S0042-6989(98)00157-6; HESS RF, 1992, VISION RES, V32, P1319, DOI 10.1016/0042-6989(92)90225-8; HESS RF, 1985, VISION RES, V25, P1577, DOI 10.1016/0042-6989(85)90128-2; Hess RF, 2010, OPTOMETRY VISION SCI, V87, P697, DOI 10.1097/OPX.0b013e3181ea18e9; Hess RF, 2009, EUR J NEUROSCI, V29, P1064, DOI 10.1111/j.1460-9568.2009.06650.x; Hillis JM, 2004, J VISION, V4, P967, DOI 10.1167/4.12.1; Ho CS, 2005, VISION RES, V45, P1615, DOI 10.1016/j.visres.2004.12.009; Hrisos S, 2006, BRIT J OPHTHALMOL, V90, P836, DOI 10.1136/bjo.2006.090910; Hu B, 2011, J VISION, V11, DOI 10.1167/11.7.23; Jacobs RA, 1999, VISION RES, V39, P3621, DOI 10.1016/S0042-6989(99)00088-7; Khan MA, 2005, EXP BRAIN RES, V164, P395, DOI 10.1007/s00221-005-2325-7; Khan MA, 2006, NEUROSCI BIOBEHAV R, V30, P1106, DOI 10.1016/j.neubiorev.2006.05.002; Kiorpes L, 1998, J NEUROSCI, V18, P6411; Kiorpes L, 2006, STRABISMUS, V14, P3, DOI 10.1080/09273970500536193; Knill DC, 2011, J NEUROSCI, V31, P1219, DOI 10.1523/JNEUROSCI.3522-09.2011; Knill DC, 2005, J VISION, V5, P103, DOI 10.1167/5.2.2; Knill DC, 2004, J NEUROPHYSIOL, V91, P1350, DOI 10.1152/jn.00184.2003; Kravitz DJ, 2011, NAT REV NEUROSCI, V12, P217, DOI 10.1038/nrn3008; Krigolson A, 2006, EXP BRAIN RES, V170, P127, DOI 10.1007/s00221-006-0386-x; Latash ML, 2002, EXERC SPORT SCI REV, V30, P26, DOI 10.1097/00003677-200201000-00006; Levi DM, 2006, STRABISMUS, V14, P11, DOI 10.1080/09273970500536243; LEVI DM, 1994, VISION RES, V34, P3293, DOI 10.1016/0042-6989(94)90066-3; LEVI DM, 1983, VISION RES, V23, P1005, DOI 10.1016/0042-6989(83)90011-1; Loftus A, 2004, EXP BRAIN RES, V158, P317, DOI 10.1007/s00221-004-1905-2; Mansouri B, 2009, INVEST OPHTH VIS SCI, V50, P3218, DOI 10.1167/iovs.08-2914; McIntyre J, 1998, J NEUROSCI, V18, P8423, DOI 10.1523/JNEUROSCI.18-20-08423.1998; McIntyre J, 1997, J NEUROPHYSIOL, V78, P1601, DOI 10.1152/jn.1997.78.3.1601; McKee SP, 2003, J VISION, V3, P380, DOI 10.1167/3.5.5; Melmoth DR, 2006, EXP BRAIN RES, V171, P371, DOI 10.1007/s00221-005-0273-x; Melmoth DR, 2009, INVEST OPHTH VIS SCI, V50, P3711, DOI 10.1167/iovs.08-3229; MERIGAN WH, 1990, VISION RES, V30, P985, DOI 10.1016/0042-6989(90)90107-V; Messier J, 1999, EXP BRAIN RES, V125, P139, DOI 10.1007/s002210050669; Mirabella G, 2011, ARCH OPHTHALMOL-CHIC, V129, P176, DOI 10.1001/archophthalmol.2010.354; MISHKIN M, 1982, BEHAV BRAIN RES, V6, P57, DOI 10.1016/0166-4328(82)90081-X; MOVSHON JA, 1987, J NEUROSCI, V7, P1340; Neely KA, 2008, EXP BRAIN RES, V186, P375, DOI 10.1007/s00221-007-1238-z; Niechwiej-Szwedo E, 2011, INVEST OPHTH VIS SCI, V52, P795, DOI 10.1167/iovs.10-6092; O'Connor AR, 2010, OPTOMETRY VISION SCI, V87, P942, DOI 10.1097/OPX.0b013e3181fd132e; O'Connor AR, 2009, INVEST OPHTH VIS SCI, V51, P2019; Popple AV, 2008, J VISION, V8, DOI 10.1167/8.13.12; Redon C, 2005, NEUROREPORT, V16, P2065, DOI 10.1097/00001756-200512190-00020; ROSSETTI Y, 1994, EXP BRAIN RES, V101, P323, DOI 10.1007/BF00228753; SCHMIDT RA, 1979, PSYCHOL REV, V86, P415, DOI 10.1037//0033-295X.86.5.415; SERVOS P, 1994, EXP BRAIN RES, V98, P119; Servos P, 1998, EXP BRAIN RES, V119, P92, DOI 10.1007/s002210050323; Sharma V, 2000, NAT NEUROSCI, V3, P496, DOI 10.1038/74872; Simmers AJ, 2006, VISION RES, V46, P2571, DOI 10.1016/j.visres.2006.01.009; Simmers AJ, 2003, VISION RES, V43, P729, DOI 10.1016/S0042-6989(02)00684-3; Sireteanu R, 2007, STRABISMUS, V15, P45, DOI 10.1080/09273970601180263; Snyder LH, 2000, CURR OPIN NEUROBIOL, V10, P747, DOI 10.1016/S0959-4388(00)00152-5; Sober SJ, 2003, J NEUROSCI, V23, P6982, DOI 10.1523/JNEUROSCI.23-18-06982.2003; Suttle CM, 2011, INVEST OPHTH VIS SCI, V52, P1851, DOI 10.1167/iovs.10-6341; Thiel A, 2009, VISION RES, V49, P287, DOI 10.1016/j.visres.2008.08.005; Trommershauser J, 2005, J NEUROSCI, V25, P7169, DOI 10.1523/JNEUROSCI.1906-05.2005; van Beers RJ, 2004, J NEUROPHYSIOL, V91, P1050, DOI 10.1152/jn.00652.2003; van Beers RJ, 2002, PHILOS T R SOC B, V357, P1137, DOI 10.1098/rstb.2002.1101; van Beers RJ, 1998, EXP BRAIN RES, V122, P367, DOI 10.1007/s002210050525; vanBeers RJ, 1996, EXP BRAIN RES, V111, P253, DOI 10.1007/BF00227302; Webber AL, 2008, INVEST OPHTH VIS SCI, V49, P594, DOI 10.1167/iovs.07-0869; Webber AL, 2009, OPTOMETRY VISION SCI, V86, P760, DOI 10.1097/OPX.0b013e3181a523b7; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Wolpert DM, 2007, HUM MOVEMENT SCI, V26, P511, DOI 10.1016/j.humov.2007.05.005; Woo GC, 1991, CLIN EXP OPTOM, V74, P1	99	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31075	10.1371/journal.pone.0031075	http://dx.doi.org/10.1371/journal.pone.0031075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363549	Green Published, gold			2022-12-27	WOS:000302853600106
J	Wang, Q; Bolhuis, J; Rothkopf, CA; Kolling, T; Knopf, M; Triesch, J				Wang, Quan; Bolhuis, Jantina; Rothkopf, Constantin A.; Kolling, Thorsten; Knopf, Monika; Triesch, Jochen			Infants in Control: Rapid Anticipation of Action Outcomes in a Gaze-Contingent Paradigm	PLOS ONE			English	Article							PERCEPTION; CATEGORIES; ATTENTION	Infants' poor motor abilities limit their interaction with their environment and render studying infant cognition notoriously difficult. Exceptions are eye movements, which reach high accuracy early, but generally do not allow manipulation of the physical environment. In this study, real-time eye tracking is used to put 6- and 8-month-old infants in direct control of their visual surroundings to study the fundamental problem of discovery of agency, i.e. the ability to infer that certain sensory events are caused by one's own actions. We demonstrate that infants quickly learn to perform eye movements to trigger the appearance of new stimuli and that they anticipate the consequences of their actions in as few as 3 trials. Our findings show that infants can rapidly discover new ways of controlling their environment. We suggest that gaze-contingent paradigms offer effective new ways for studying many aspects of infant learning and cognition in an interactive fashion and provide new opportunities for behavioral training and treatment in infants.	[Wang, Quan; Rothkopf, Constantin A.; Triesch, Jochen] Frankfurt Inst Adv Studies, Frankfurt, Germany; [Bolhuis, Jantina; Kolling, Thorsten; Knopf, Monika] Goethe Univ Frankfurt, Dept Psychol, Frankfurt, Germany	Goethe University Frankfurt	Wang, Q (corresponding author), Frankfurt Inst Adv Studies, Frankfurt, Germany.	triesch@fias.uni-frankfurt.de	Kolling, Thorsten/AAN-9694-2020	Wang, Quan/0000-0003-4826-2408; Rothkopf, Constantin/0000-0002-5636-0801	Bundesministerium fur Bildung und Forschung [FKZ 01GQ0840]; European Union [IM-CLeVeR, FP7-ICT-IP-231722]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); European Union(European Commission)	This work was supported by the Bundesministerium fur Bildung und Forschung (http://www.bmbf.de/) project "Bernstein Focus: Neurotechnology Frankfurt, FKZ 01GQ0840" and by the European Union (http://ec.europa.eu/research/fp7/) under grant IM-CLeVeR, FP7-ICT-IP-231722. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APGAR V, 1953, Curr Res Anesth Analg, V32, P260; BAILLARGEON R, 1985, COGNITION, V20, P191, DOI 10.1016/0010-0277(85)90008-3; BRONSON GW, 1990, J EXP CHILD PSYCHOL, V49, P101, DOI 10.1016/0022-0965(90)90051-9; COHEN LB, 1972, CHILD DEV, V43, P869, DOI 10.2307/1127638; Csibra G, 1999, COGNITION, V72, P237, DOI 10.1016/S0010-0277(99)00039-6; Deligianni F, 2011, DEV PSYCHOL, V47, P1499, DOI 10.1037/a0025659; FANTZ RL, 1964, SCIENCE, V146, P668, DOI 10.1126/science.146.3644.668; HAITH MM, 1988, CHILD DEV, V59, P467, DOI 10.2307/1130325; HOROWITZ FD, 1972, DEV PSYCHOL, V7, P90, DOI 10.1037/h0032855; JOHNSON MH, 1991, J COGNITIVE NEUROSCI, V3, P335, DOI 10.1162/jocn.1991.3.4.335; Johnson SP, 2003, P NATL ACAD SCI USA, V100, P10568, DOI 10.1073/pnas.1630655100; Johnson S, 1998, DEVELOPMENTAL SCI, V1, P233, DOI 10.1111/1467-7687.00036; KALNINS IV, 1973, PERCEPTION, V2, P307, DOI 10.1068/p020307; Kenward B, 2010, INFANCY, V15, P337, DOI 10.1111/j.1532-7078.2009.00018.x; McMurray B, 2004, INFANCY, V6, P203, DOI 10.1207/s15327078in0602_4; QUINN PC, 1993, PERCEPTION, V22, P463, DOI 10.1068/p220463; Reader SM, 1973, BEHAV RES METH INSTR, V5, P218; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; ROVEECOLLIER CK, 1980, SCIENCE, V208, P1159, DOI 10.1126/science.7375924; Smith WC, 2003, COGNITIVE PSYCHOL, V46, P31, DOI 10.1016/S0010-0285(02)00501-7; Wass S, 2011, CURR BIOL, V21, P1543, DOI 10.1016/j.cub.2011.08.004	21	37	37	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30884	10.1371/journal.pone.0030884	http://dx.doi.org/10.1371/journal.pone.0030884			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926TC	22363507	Green Submitted, Green Published, gold			2022-12-27	WOS:000302853600082
J	Boyapalle, S; Wong, T; Garay, J; Teng, M; Juan-Vergara, HS; Mohapatra, S; Mohapatra, S				Boyapalle, Sandhya; Wong, Terianne; Garay, Julio; Teng, Michael; San Juan-Vergara, Homero; Mohapatra, Subhra; Mohapatra, Shyam			Respiratory Syncytial Virus NS1 Protein Colocalizes with Mitochondrial Antiviral Signaling Protein MAVS following Infection	PLOS ONE			English	Article							NF-KAPPA-B; ENHANCED PULMONARY HISTOPATHOLOGY; NONSTRUCTURAL PROTEINS; RIG-I; BALB/C MICE; RSV; INHIBITION; GENE; TRANSCRIPTION; EXPRESSION	Respiratory syncytial virus (RSV) nonstructural protein 1(NS1) attenuates type-I interferon (IFN) production during RSV infection; however the precise role of RSV NS1 protein in orchestrating the early host-virus interaction during infection is poorly understood. Since NS1 constitutes the first RSV gene transcribed and the production of IFN depends upon RLR (RIG-I-like receptor) signaling, we reasoned that NS1 may interfere with this signaling. Herein, we report that NS1 is localized to mitochondria and binds to mitochondrial antiviral signaling protein (MAVS). Live-cell imaging of rgRSV-infected A549 human epithelial cells showed that RSV replication and transcription occurs in proximity to mitochondria. NS1 localization to mitochondria was directly visualized by confocal microscopy using a cell-permeable chemical probe for His(6)-NS1. Further, NS1 colocalization with MAVS in A549 cells infected with RSV was shown by confocal laser microscopy and immunoelectron microscopy. NS1 protein is present in the mitochondrial fraction and co-immunoprecipitates with MAVS in total cell lysatesof A549 cells transfected with the plasmid pNS1-Flag. By immunoprecipitation with anti-RIG-I antibody, RSV NS1 was shown to associate with MAVS at an early stage of RSV infection, and to disrupt MAVS interaction with RIG-I (retinoic acid inducible gene) and the downstream IFN antiviral and inflammatory response. Together, these results demonstrate that NS1 binds to MAVS and that this binding inhibits the MAVS-RIG-I interaction required for IFN production.	[Boyapalle, Sandhya; Mohapatra, Subhra; Mohapatra, Shyam] James A Haley Vet Adm Hosp, Tampa, FL USA; [Boyapalle, Sandhya; Wong, Terianne; Garay, Julio; Mohapatra, Subhra; Mohapatra, Shyam] Univ S Florida, Nanomed Res Ctr, Tampa, FL USA; [Boyapalle, Sandhya; Wong, Terianne; Garay, Julio; San Juan-Vergara, Homero; Mohapatra, Subhra; Mohapatra, Shyam] Dept Internal Med, Div Translat Med, Tampa, FL USA; [Teng, Michael] Dept Allergy & Immunol, Tampa, FL USA; [Mohapatra, Subhra] Univ S Florida, Coll Med, Dept Mol Med, Tampa, FL USA; [San Juan-Vergara, Homero] Fdn Univ Norte, Dept Med, Barranquilla, Colombia	US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Universidad del Norte	Boyapalle, S (corresponding author), James A Haley Vet Adm Hosp, Tampa, FL USA.	smohapat@health.usf.edu; smohapat@health.usf.edu	Teng, Michael N./I-5006-2012; Mohapatra, Subhra/A-1381-2012	Teng, Michael N./0000-0002-0722-3659; Tripp, Ralph/0000-0002-2924-9956; San Juan Vergara, Homero/0000-0002-3808-4647	Veterns Affairs (VA); University of South Florida (USF)	Veterns Affairs (VA); University of South Florida (USF)	This work is supported by a Veterns Affairs (VA) Career Scientist award and VA Merit Review award to Shyam Mohapatra, and a University of South Florida (USF) Health Development grant to Subhra Mohapatra. TW was supported by a USF Signature Research Doctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker Y, 2006, VIRUS GENES, V33, P235, DOI 10.1007/s11262-006-0064-x; Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Bitko V, 2007, J VIROL, V81, P1786, DOI 10.1128/JVI.01420-06; Blanchard SS, 2006, PEDIATR TRANSPLANT, V10, P826, DOI 10.1111/j.1399-3046.2006.00583.x; Boyapalle S, 2008, VIROLOGY, V375, P401, DOI 10.1016/j.virol.2008.02.008; CONNORS M, 1994, J VIROL, V68, P5321, DOI 10.1128/JVI.68.8.5321-5325.1994; DeVincenzo J, 2008, ANTIVIR RES, V77, P225, DOI 10.1016/j.antiviral.2007.11.009; DeVincenzo J, 2010, P NATL ACAD SCI USA, V107, P8800, DOI 10.1073/pnas.0912186107; Ebbert JO, 2005, RESPIRATION, V72, P263, DOI 10.1159/000085367; Egger D, 2005, J GEN VIROL, V86, P707, DOI 10.1099/vir.0.80442-0; Delgado MF, 2009, NAT MED, V15, P34, DOI 10.1038/nm.1894; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; Hainfeld JF, 1999, J STRUCT BIOL, V127, P185, DOI 10.1006/jsbi.1999.4149; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Knecht S, 2009, J MOL RECOGNIT, V22, P270, DOI 10.1002/jmr.941; KONG X, 2007, GENET VACCINES THER, V5, P1; Kong XY, 2003, BIOCHEM BIOPH RES CO, V306, P616, DOI 10.1016/S0006-291X(03)01008-8; Krishnan B, 2007, CHEM BIOL DRUG DES, V69, P31, DOI 10.1111/j.1747-0285.2007.00463.x; Kumar M, 1999, VACCINE, V18, P558, DOI 10.1016/S0264-410X(99)00185-1; Ling Z, 2008, PROTEIN EXPRES PURIF, V57, P261, DOI 10.1016/j.pep.2007.09.017; Ling Z, 2009, J VIROL, V83, P3734, DOI 10.1128/JVI.02434-08; Liu P, 2007, J VIROL, V81, P1401, DOI 10.1128/JVI.01740-06; Lo MS, 2005, J VIROL, V79, P9315, DOI 10.1128/JVI.79.14.9315-9319.2005; Mohapatra SS, 2008, CLIN MICROBIOL REV, V21, P495, DOI 10.1128/CMR.00054-07; Munir S, 2008, J VIROL, V82, P8780, DOI 10.1128/JVI.00630-08; MURPHY BR, 1990, VACCINE, V8, P497, DOI 10.1016/0264-410X(90)90253-I; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Schlender J, 2000, J VIROL, V74, P8234, DOI 10.1128/JVI.74.18.8234-8242.2000; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Spann KM, 2005, J VIROL, V79, P5353, DOI 10.1128/JVI.79.9.5353-5362.2005; Swedan S, 2011, J VIROL, V85, P10090, DOI 10.1128/JVI.00413-11; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tran KC, 2004, J VIROL, V78, P692, DOI 10.1128/JVI.78.2.692-699.2004; WONG DT, 1983, MED CLIN N AM, V67, P1075, DOI 10.1016/S0025-7125(16)31167-1; Zamora MR, AM J RESP CRIT CARE; Zhang WD, 2005, NAT MED, V11, P56, DOI 10.1038/nm1174	37	70	75	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e29386	10.1371/journal.pone.0029386	http://dx.doi.org/10.1371/journal.pone.0029386			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22383950	Green Submitted, Green Published, gold			2022-12-27	WOS:000302918500003
J	Brehm, JH; Scott, Y; Koontz, DL; Perry, S; Hammer, S; Katzenstein, D; Mellors, JW; Sluis-Cremer, N				Brehm, Jessica H.; Scott, Yanille; Koontz, Dianna L.; Perry, Steven; Hammer, Scott; Katzenstein, David; Mellors, John W.; Sluis-Cremer, Nicolas		AIDS Clinical Trials Grp Study 175	Zidovudine (AZT) Monotherapy Selects for the A360V Mutation in the Connection Domain of HIV-1 Reverse Transcriptase	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HIGH-LEVEL RESISTANCE; THYMIDINE ANALOG MUTATIONS; RNASE-H DOMAINS; CONFERS ZIDOVUDINE; N348I; NUCLEOSIDE; INHIBITORS; MECHANISM; EXCISION	Background: We previously demonstrated in vitro that zidovudine (AZT) selects for A371V in the connection domain and Q509L in ribonuclease H (RNase H) domain of HIV-1 reverse transcriptase (RT) which, together with the thymidine analog mutations D67N, K70R and T215F, confer greater than 100-fold AZT resistance. The goal of the current study was to determine whether AZT monotherapy in HIV-1 infected patients also selects the A371V, Q509L or other mutations in the C-terminal domains of HIV-1 RT. Methodology/Principal Findings: Full-length RT sequences in plasma obtained pre- and post-therapy were compared in 23 participants who received AZT monotherapy from the AIDS Clinical Trials Group study 175. Five of the 23 participants reached a primary study endpoint. Mutations significantly associated with AZT monotherapy included K70R (p = 0.003) and T215Y (p = 0.013) in the polymerase domain of HIV-1 RT, and A360V (p = 0.041) in the connection domain of HIV-1 RT. HIV-1 drug susceptibility assays demonstrated that A360V, either alone or in combination with thymidine analog mutations, decreased AZT susceptibility in recombinant viruses containing participant-derived full-length RT sequences or site-directed mutant RT. Biochemical studies revealed that A360V enhances the AZT-monophosphate excision activity of purified RT by significantly decreasing the frequency of secondary RNase H cleavage events that reduce the RNA/DNA duplex length and promote template/primer dissociation. Conclusions: The A360V mutation in the connection domain of RT was selected in HIV-infected individuals that received AZT monotherapy and contributed to AZT resistance.	[Brehm, Jessica H.; Scott, Yanille; Koontz, Dianna L.; Perry, Steven; Mellors, John W.; Sluis-Cremer, Nicolas] Univ Pittsburgh, Sch Med, Dept Med, Div Infect Dis, Pittsburgh, PA 15260 USA; [Scott, Yanille] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; [Hammer, Scott] Columbia Univ, Med Ctr, New York, NY USA; [Katzenstein, David] Ctr AIDS Res, Div Infect Dis, Stanford, CA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Columbia University	Brehm, JH (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Div Infect Dis, Pittsburgh, PA 15260 USA.	nps2@pitt.edu		Powderly, William/0000-0001-7808-3086; katzenstein, david/0000-0002-8593-4560	National Institute of Health Allergy and Infectious Diseases [R01 AI081571]; National Institutes of Health; NIH/NIAID [5T32AI065380-04]; University of Pittsburgh Clinical Translational Science Institute [T32-5TL1RR024155-04]; Virology Support Laboratory of the ACTG Central Group [204VC009, 1U01AI068636-01]; National Cancer Institute (SAIC) [25XS119];  [AI069470]; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069470, U01AI068636, T32AI065380, UM1AI069423, UM1AI069470, UM1AI069477, R01AI081571] Funding Source: NIH RePORTER	National Institute of Health Allergy and Infectious Diseases; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Pittsburgh Clinical Translational Science Institute(University of Pittsburgh); Virology Support Laboratory of the ACTG Central Group; National Cancer Institute (SAIC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by R01 AI081571 from the National Institute of Health Allergy and Infectious Diseases, National Institutes of Health, the Pitt AIDS Research Training Program (NIH/NIAID 5T32AI065380-04), the University of Pittsburgh Clinical Translational Science Institute (T32-5TL1RR024155-04), a Virology Support Laboratory subcontract (204VC009) of the ACTG Central Group Grant (1U01AI068636-01), and by a grant from the National Cancer Institute (SAIC contract 25XS119). SMH is supported by AI069470. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis AB, INFECT GENET EVOL, V10, P380; Brehm JH, 2007, J VIROL, V81, P7852, DOI 10.1128/JVI.02203-06; Brehm JH, 2008, BIOCHEMISTRY-US, V47, P14020, DOI 10.1021/bi8014778; Delviks-Frankenberry KA, 2008, P NATL ACAD SCI USA, V105, P10943, DOI 10.1073/pnas.0804660105; Delviks-Frankenberry KA, 2007, J VIROL, V81, P6837, DOI 10.1128/JVI.02820-06; Ehteshami M, 2008, J BIOL CHEM, V283, P22222, DOI 10.1074/jbc.M803521200; Hachiya A, 2008, J VIROL, V82, P3261, DOI 10.1128/JVI.01154-07; Hammer SM, 1996, NEW ENGL J MED, V335, P1081, DOI 10.1056/NEJM199610103351501; Harrigan PR, 1996, J VIROL, V70, P5930, DOI 10.1128/JVI.70.9.5930-5934.1996; Hooker DJ, 1996, J VIROL, V70, P8010, DOI 10.1128/JVI.70.11.8010-8018.1996; Johnson Victoria A, 2010, Top HIV Med, V18, P156; KELLAM P, 1992, P NATL ACAD SCI USA, V89, P1934, DOI 10.1073/pnas.89.5.1934; LARDER BA, 1989, SCIENCE, V246, P1155, DOI 10.1126/science.2479983; LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x; Lengruber RB, 2011, J ANTIMICROB CHEMOTH, V66, P702, DOI 10.1093/jac/dkr005; Marcelin AG, 2004, J MED VIROL, V72, P162, DOI 10.1002/jmv.10550; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; MMWR Morb Mortal Wkly Rep, 1987, MMWR MORB MORTAL S1, V14, p1S; Nikolenko GN, 2007, P NATL ACAD SCI USA, V104, P317, DOI 10.1073/pnas.0609642104; Parikh UM, 2005, ANTIMICROB AGENTS CH, V49, P1139, DOI 10.1128/AAC.49.3.1139-1144.2005; Radzio J, 2008, MOL PHARMACOL, V73, P601, DOI 10.1124/mol.107.038596; Radzio J, 2010, AIDS, V24, P659, DOI 10.1097/QAD.0b013e328336781d; Shi CF, 1997, ANTIMICROB AGENTS CH, V41, P2781, DOI 10.1128/AAC.41.12.2781; Tu XY, 2010, NAT STRUCT MOL BIOL, V17, P1202, DOI 10.1038/nsmb.1908; von Wyl V, 2010, CLIN INFECT DIS, V51, P620, DOI 10.1086/655764; von Wyl V, 2010, J INFECT DIS, V201, P1054, DOI 10.1086/651168; Yap SH, 2007, PLOS MED, V4, P1887, DOI 10.1371/journal.pmed.0040335	28	6	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31558	10.1371/journal.pone.0031558	http://dx.doi.org/10.1371/journal.pone.0031558			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363673	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000302873700071
J	Cartier-Michaud, A; Malo, M; Charriere-Bertrand, C; Gadea, G; Anguille, C; Supiramaniam, A; Lesne, A; Delaplace, F; Hutzler, G; Roux, P; Lawrence, DA; Barlovatz-Meimon, G				Cartier-Michaud, Amandine; Malo, Michel; Charriere-Bertrand, Cecile; Gadea, Gilles; Anguille, Christelle; Supiramaniam, Ajitha; Lesne, Annick; Delaplace, Franck; Hutzler, Guillaume; Roux, Pierre; Lawrence, Daniel A.; Barlovatz-Meimon, Georgia			Matrix-Bound PAI-1 Supports Cell Blebbing via RhoA/ROCK1 Signaling	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; RECEPTOR-RELATED PROTEIN; UROKINASE RECEPTOR; IN-VIVO; EPITHELIAL-CELLS; HUMAN CARCINOMA; RHO-KINASE; MIGRATION; CANCER; VITRONECTIN	The microenvironment of a tumor can influence both the morphology and the behavior of cancer cells which, in turn, can rapidly adapt to environmental changes. Increasing evidence points to the involvement of amoeboid cell migration and thus of cell blebbing in the metastatic process; however, the cues that promote amoeboid cell behavior in physiological and pathological conditions have not yet been clearly identified. Plasminogen Activator Inhibitor type-1 (PAI-1) is found in high amount in the microenvironment of aggressive tumors and is considered as an independent marker of bad prognosis. Here we show by immunoblotting, activity assay and immunofluorescence that, in SW620 human colorectal cancer cells, matrix-associated PAI-1 plays a role in the cell behavior needed for amoeboid migration by maintaining cell blebbing, localizing PDK1 and ROCK1 at the cell membrane and maintaining the RhoA/ROCK1/MLC-P pathway activation. The results obtained by modeling PAI-1 deposition around tumors indicate that matrix-bound PAI-1 is heterogeneously distributed at the tumor periphery and that, at certain spots, the elevated concentrations of matrix-bound PAI-1 needed for cancer cells to undergo the mesenchymal-amoeboid transition can be observed. Matrix-bound PAI-1, as a matricellular protein, could thus represent one of the physiopathological requirements to support metastatic formation.	[Cartier-Michaud, Amandine; Malo, Michel; Charriere-Bertrand, Cecile; Supiramaniam, Ajitha; Delaplace, Franck; Hutzler, Guillaume; Barlovatz-Meimon, Georgia] Evry Val Essonne Univ, IBISC EA 4526, Evry, France; [Charriere-Bertrand, Cecile; Barlovatz-Meimon, Georgia] Univ Paris Est Creteil, Creteil, France; [Gadea, Gilles; Anguille, Christelle; Roux, Pierre] Univ Montpellier, CRBM UMR CNRS 5237, F-34059 Montpellier, France; [Lesne, Annick] Inst Hautes Etud Sci, F-91440 Bures Sur Yvette, France; [Lesne, Annick] LPTMC UMR 7600 CNRS, Paris, France; [Lawrence, Daniel A.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA	UDICE-French Research Universities; Universite Paris Saclay; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite de Montpellier; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); University of Michigan System; University of Michigan	Cartier-Michaud, A (corresponding author), Evry Val Essonne Univ, IBISC EA 4526, Evry, France.	georgia.barlovatz@ibisc.fr	DELAPLACE, FRANCK/T-3979-2019; Roux, Pierre/D-8833-2017; Gilles, Gadea/M-9966-2015; Lesne, Annick/W-9444-2018	DELAPLACE, FRANCK/0000-0002-1035-7754; Gilles, Gadea/0000-0001-6325-4866; Lesne, Annick/0000-0002-6647-612X; Lawrence, Daniel/0000-0003-3126-1935; CHARRIERE-BERTRAND, Cecile/0000-0003-2522-1400	IBISC; Evry Genopole; CNRS ACI [050009DR11]; CNRS/Inserm [GDR 2647]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079639] Funding Source: NIH RePORTER	IBISC; Evry Genopole; CNRS ACI; CNRS/Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)Centre National de la Recherche Scientifique (CNRS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors are grateful to the following for their financial support: IBISC (grant "Action Incitative''), Evry Genopole (grant "Aide a l'acquisition d'equipement semi-lourd''), the CNRS ACI Program "Complexite du vivant'' (grant # 050009DR11), and the GDR 2647 "STIC-Sante'' CNRS/Inserm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaboe M, 2003, BBA-MOL BASIS DIS, V1638, P72, DOI 10.1016/S0925-4439(03)00059-0; Maxwell CA, 2008, J CELL SCI, V121, P925, DOI 10.1242/jcs.022038; Ass K, 2008, CANCER TREAT REV, V34, P122, DOI 10.1016/j.ctrv.2007.10.005; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Chazaud B, 2002, AM J PATHOL, V160, P237, DOI 10.1016/S0002-9440(10)64367-2; Chorostowska-Wynimko J, 2004, INT J MOL MED, V13, P759; CUBELLIS MV, 1990, EMBO J, V9, P1079, DOI 10.1002/j.1460-2075.1990.tb08213.x; Czekay RP, 2003, J CELL BIOL, V160, P781, DOI 10.1083/jcb.200208117; Czekay RP, 2001, MOL BIOL CELL, V12, P1467, DOI 10.1091/mbc.12.5.1467; Deng G, 1996, J CELL BIOL, V134, P1563, DOI 10.1083/jcb.134.6.1563; Diehl HC, 2007, PROTEOM CLIN APPL, V1, P47, DOI 10.1002/prca.200600491; Duffy MJ, 2004, CLIN BIOCHEM, V37, P541, DOI 10.1016/j.clinbiochem.2004.05.013; ESTREICHER A, 1990, J CELL BIOL, V111, P783, DOI 10.1083/jcb.111.2.783; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Friedl P, 2009, CANCER METAST REV, V28, P129, DOI 10.1007/s10555-008-9174-3; Ghiso JAA, 2002, ONCOGENE, V21, P2513, DOI 10.1038/sj/onc/1205342; HEEGAARD CW, 1995, J BIOL CHEM, V270, P20855, DOI 10.1074/jbc.270.35.20855; Huang YF, 2003, J CLIN INVEST, V112, P379, DOI 10.1172/JCI200318038; Jo M, 2002, J BIOL CHEM, V277, P12479, DOI 10.1074/jbc.M111147200; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kjoller L, 2001, J CELL BIOL, V152, P1145, DOI 10.1083/jcb.152.6.1145; Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3; Leverrier Y, 2001, NAT CELL BIOL, V3, pE91, DOI 10.1038/35070151; Liu D, 2002, CANCER CELL, V1, P445, DOI 10.1016/S1535-6108(02)00072-7; Malo M, 2010, MATH POPUL STUD, V17, P136, DOI 10.1080/08898480.2010.490996; Mantovani A, 2009, NATURE, V457, P36, DOI 10.1038/457036b; Maquerlot F, 2006, AM J PATHOL, V169, P1624, DOI 10.2353/ajpath.2006.051053; Minor KH, 2002, J BIOL CHEM, V277, P10337, DOI 10.1074/jbc.M109564200; Nguyen DHD, 1999, J CELL BIOL, V146, P149, DOI 10.1083/jcb.146.1.149; Nykjaer A, 1997, EMBO J, V16, P2610, DOI 10.1093/emboj/16.10.2610; Pankova K, 2010, CELL MOL LIFE SCI, V67, P63, DOI 10.1007/s00018-009-0132-1; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Planus E, 1997, J CELL SCI, V110, P1091; Providence KM, 2008, ARCH DERMATOL RES, V300, P303, DOI 10.1007/s00403-008-0845-2; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rougier JP, 1998, KIDNEY INT, V54, P87, DOI 10.1046/j.1523-1755.1998.00955.x; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Samarakoon R, 2005, J CELL PHYSIOL, V204, P236, DOI 10.1002/jcp.20279; SEEBACHER T, 1992, EXP CELL RES, V203, P504, DOI 10.1016/0014-4827(92)90029-8; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Stefansson S, 1996, NATURE, V383, P441, DOI 10.1038/383441a0; Stefansson S, 1996, J BIOL CHEM, V271, P8215, DOI 10.1074/jbc.271.14.8215; Stefansson S, 1998, J BIOL CHEM, V273, P6358, DOI 10.1074/jbc.273.11.6358; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; TOMASINIJOHANSSON BR, 1994, EXP CELL RES, V214, P303, DOI 10.1006/excr.1994.1262; Umeda T, 1997, J PATHOL, V183, P388; van Niel G, 2001, GASTROENTEROLOGY, V121, P337, DOI 10.1053/gast.2001.26263; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; Vinot S, 2008, METHOD ENZYMOL, V439, P413, DOI 10.1016/S0076-6879(07)00429-6; Waltz DA, 1997, J CLIN INVEST, V100, P58, DOI 10.1172/JCI119521; WANG N, 1995, AM J PHYSIOL-CELL PH, V268, pC1062, DOI 10.1152/ajpcell.1995.268.4.C1062; Wang ZY, 2005, EXP EYE RES, V80, P1, DOI 10.1016/j.exer.2004.06.006; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wyckoff JB, 2006, CURR BIOL, V16, P1515, DOI 10.1016/j.cub.2006.05.065	57	23	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32204	10.1371/journal.pone.0032204	http://dx.doi.org/10.1371/journal.pone.0032204			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363817	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700158
J	Egger, J; Kapur, T; Dukatz, T; Kolodziej, M; Zukic, D; Freisleben, B; Nimsky, C				Egger, Jan; Kapur, Tina; Dukatz, Thomas; Kolodziej, Malgorzata; Zukic, Dzenan; Freisleben, Bernd; Nimsky, Christopher			Square-Cut: A Segmentation Algorithm on the Basis of a Rectangle Shape	PLOS ONE			English	Article							IMAGES	We present a rectangle-based segmentation algorithm that sets up a graph and performs a graph cut to separate an object from the background. However, graph-based algorithms distribute the graph's nodes uniformly and equidistantly on the image. Then, a smoothness term is added to force the cut to prefer a particular shape. This strategy does not allow the cut to prefer a certain structure, especially when areas of the object are indistinguishable from the background. We solve this problem by referring to a rectangle shape of the object when sampling the graph nodes, i.e., the nodes are distributed non-uniformly and non-equidistantly on the image. This strategy can be useful, when areas of the object are indistinguishable from the background. For evaluation, we focus on vertebrae images from Magnetic Resonance Imaging (MRI) datasets to support the time consuming manual slice-by-slice segmentation performed by physicians. The ground truth of the vertebrae boundaries were manually extracted by two clinical experts (neurological surgeons) with several years of experience in spine surgery and afterwards compared with the automatic segmentation results of the proposed scheme yielding an average Dice Similarity Coefficient (DSC) of 90.97 +/- 2.2%.	[Egger, Jan; Kapur, Tina] Harvard Univ, Brigham & Womens Hosp, Sch Med, Surg Planning Lab,Dept Radiol, Boston, MA 02115 USA; [Egger, Jan; Dukatz, Thomas; Kolodziej, Malgorzata; Nimsky, Christopher] Univ Marburg, Dept Neurosurg, Marburg, Germany; [Egger, Jan; Freisleben, Bernd] Univ Marburg, Dept Math & Comp Sci, Marburg, Germany; [Zukic, Dzenan] Univ Siegen, Comp Graph Grp, Siegen, Germany	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Philipps University Marburg; Philipps University Marburg; Universitat Siegen	Egger, J (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Surg Planning Lab,Dept Radiol, Boston, MA 02115 USA.	egger@bwh.harvard.edu	Nimsky, Christopher/E-3702-2014	Nimsky, Christopher/0000-0002-8216-9410; Zukic, Dzenan/0000-0002-9546-9703; Freisleben, Bernd/0000-0002-7205-8389	NIH [P41RR19703, R03EB013792]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR019703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB005149, R03EB013792] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work is supported by NIH P41RR19703 and R03EB013792. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], DSLICER FREE OP SOUR; Bauer MHA, 2010, 20 INT C PATT REC IC; Boykov Y, 2004, IEEE T PATTERN ANAL, V26, P1124, DOI 10.1109/TPAMI.2004.60; Carballido-Gamio J, 2004, IEEE T MED IMAGING, V23, P36, DOI 10.1109/TMI.2003.819929; DSlicer Wiki, 36 DSLICER WIK; Egger J., 2008, 4th European Conference of the International Federation for Medical and Biological Engineering - ECIFMBE 2008, P584; Egger J, 2012, P BILDV MED IN PRESS; Egger J, 2011, 4 NCIGT NIH IM GUID; Egger J., 2010, P 6 RUSS BAV C BIOM; Egger J, 2011, J MED SYSTEMS JOMS; Egger J., 2010, LNCS, V6376, P383; Egger J., 2009, 12 INT C MED IM COMP; Egger J, 2010, BIOS PROC C DGBMT; Ghebreab S, 2004, IEEE T BIO-MED ENG, V51, P1821, DOI 10.1109/TBME.2004.831540; Grady L, 2006, IEEE T PATTERN ANAL, V28, P469, DOI 10.1109/TPAMI.2006.57; Hicks GE, 2009, SPINE, V34, P1301, DOI 10.1097/BRS.0b013e3181a18263; Hoad CL, 2002, PHYS MED BIOL, V47, P3503, DOI 10.1088/0031-9155/47/19/305; Huang SH, 2009, IEEE T MED IMAGING, V28, P1595, DOI 10.1109/TMI.2009.2023362; Ishikawa H, 1998, PROC CVPR IEEE, P125, DOI 10.1109/CVPR.1998.698598; JACKSON RP, 1989, SPINE, V14, P1362, DOI 10.1097/00007632-198912000-00013; Jeanneret B, 1997, Acta Chir Orthop Traumatol Cech, V64, P133; Joaquim AF, 2009, ARQ NEURO-PSIQUIAT, V67, P553, DOI 10.1590/S0004-282X2009000300039; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Klinder T, 2008, LECT NOTES COMPUT SC, V5241, P227, DOI 10.1007/978-3-540-85988-8_28; Li K, 2006, IEEE T PATTERN ANAL, V28, P119, DOI 10.1109/TPAMI.2006.19; McInerney T, 1996, Med Image Anal, V1, P91, DOI 10.1016/S1361-8415(96)80007-7; Michopoulou SK, 2009, IEEE T BIO-MED ENG, V56, P2225, DOI 10.1109/TBME.2009.2019765; Molyneux A, 2002, LANCET, V360, P1267, DOI 10.1016/S0140-6736(02)11314-6; Peng ZG, 2005, P ANN INT IEEE EMBS, P2527; Richards PJ, 2010, SPINE, V35, P430, DOI 10.1097/BRS.0b013e3181cdde47; Sampat M. P., 2006, IEEE INT C IM PROC; Seifert S, 2009, SPIE MED IMAGING C; Shi RQ, 2007, 2007 IEEE/ICME INTERNATIONAL CONFERENCE ON COMPLEX MEDICAL ENGINEERING, VOLS 1-4, P713, DOI 10.1109/ICCME.2007.4381830; Stern D, 2011, P SPIE MED IMAGING, V7963; Veksler O, 2008, LECT NOTES COMPUT SC, V5304, P454, DOI 10.1007/978-3-540-88690-7_34; Vezhnevets V., 2005, P GRAPH, V1, P150, DOI DOI 10.1016/J.AJ0D0.2004.07.036; Weber MA, 2007, RADIOLOGE, V47, P492, DOI 10.1007/s00117-007-1495-7; Weese J., 2001, Information Processing in Medical Imaging. 17th International Conference, IPMI 2001. Proceedings (Lecture Notes in Computer Science Vol.2082), P380; Yao JH, 2006, I S BIOMED IMAGING, P390; Zou KH, 2004, ACAD RADIOL, V11, P178, DOI 10.1016/S1076-6332(03)00671-8	41	39	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31064	10.1371/journal.pone.0031064	http://dx.doi.org/10.1371/journal.pone.0031064			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363547	Green Submitted, Green Published, gold			2022-12-27	WOS:000302873700023
J	Gomez-Brandon, M; Lores, M; Dominguez, J				Gomez-Brandon, Maria; Lores, Marta; Dominguez, Jorge			Species-Specific Effects of Epigeic Earthworms on Microbial Community Structure during First Stages of Decomposition of Organic Matter	PLOS ONE			English	Article							FUNGAL GROWTH-RATES; LEUCINE INCORPORATION; ENZYME-ACTIVITIES; PIG SLURRY; SOIL; GUT; LUMBRICUS; BACTERIA; TRANSIT; BIOMASS	Background: Epigeic earthworms are key organisms in organic matter decomposition because of the interactions they establish with microorganisms. The earthworm species and the quality and/or substrate availability are expected to be major factors influencing the outcome of these interactions. Here we tested whether and to what extent the epigeic earthworms Eisenia andrei, Eisenia fetida and Perionyx excavatus, widely used in vermicomposting, are capable of altering the microbiological properties of fresh organic matter in the short-term. We also questioned if the earthworm-induced modifications to the microbial communities are dependent on the type of substrate ingested. Methodology/Principal Findings: To address these questions we determined the microbial community structure (phospholipid fatty acid profiles) and microbial activity (basal respiration and microbial growth rates) of three types of animal manure (cow, horse and rabbit) that differed in microbial composition, after being processed by each species of earthworm for one month. No differences were found between earthworm-worked samples with regards to microbial community structure, irrespective of type of manure, which suggests the existence of a bottleneck effect of worm digestion on microbial populations of the original material consumed. Moreover, in mesocosms containing cow manure the presence of E. andrei resulted not only in a decrease in bacterial and fungal biomass, but also in a reduced bacterial growth rate and total microbial activity, while no such reduction was found with E. fetida and P. excavatus. Conclusions/Significance: Our results point to the species of earthworm with its associated gut microbiota as a strong determinant of the process shaping the structure of microbial communities in the short-term. This must nonetheless be weighed against the fact that further knowledge is necessary to evaluate whether the changes in the composition of microbiota in response to the earthworm species is accompanied by a change in the microbial community diversity and/or function.	[Gomez-Brandon, Maria; Dominguez, Jorge] Univ Vigo, Dept Ecoloxia & Biol Anim, Fac Biol, Vigo 36310, Spain; [Gomez-Brandon, Maria] Univ Innsbruck, Inst Microbiol, A-6020 Innsbruck, Austria; [Lores, Marta] Fac Quim, Lab Invest & Desarrollo Soluc Analit, Dept Quim Analit, Santiago De Compostela, Spain	Universidade de Vigo; University of Innsbruck; Universidade de Santiago de Compostela	Gomez-Brandon, M (corresponding author), Univ Innsbruck, Inst Microbiol, A-6020 Innsbruck, Austria.	mariagomez@uvigo.es	Gómez-Brandón, Maria/D-7050-2011; Domínguez, Jorge/M-2046-2014; Domínguez, Jorge/T-7647-2019; Lores, Marta/F-9220-2015; Gomez-Brandon, Maria/Q-4421-2016	Domínguez, Jorge/0000-0002-4313-8582; Domínguez, Jorge/0000-0002-4313-8582; Lores, Marta/0000-0001-7683-8342; Gomez-Brandon, Maria/0000-0003-4744-535X	Spanish Ministerio de Ciencia e Innovacion [CTM2009-08477]; Fundacion Alfonso Martin Escudero	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Alfonso Martin Escudero	This research was financially supported by the Spanish Ministerio de Ciencia e Innovacion (CTM2009-08477). Maria Gomez Brandon was supported by a postdoctoral research grant from Fundacion Alfonso Martin Escudero. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aira M, 2006, BIOL FERT SOILS, V42, P371, DOI 10.1007/s00374-005-0047-4; Aira M, 2009, J HAZARD MATER, V161, P1234, DOI 10.1016/j.jhazmat.2008.04.073; Aira M, 2009, J HAZARD MATER, V162, P1404, DOI 10.1016/j.jhazmat.2008.06.031; Aira M, 2008, SOIL BIOL BIOCHEM, V40, P2511, DOI 10.1016/j.soilbio.2008.06.010; Aira M, 2007, MICROB ECOL, V54, P662, DOI 10.1007/s00248-007-9223-4; Aira M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016354; Aira M, 2010, APPL SOIL ECOL, V46, P143, DOI 10.1016/j.apsoil.2010.06.001; Aira M, 2006, MICROB ECOL, V52, P738, DOI 10.1007/s00248-006-9109-x; BAATH E, 1994, BIOL FERT SOILS, V17, P147, DOI 10.1007/BF00337747; Baath E, 2001, SOIL BIOL BIOCHEM, V33, P1571, DOI 10.1016/S0038-0717(01)00073-6; Baath E, 2001, SOIL BIOL BIOCHEM, V33, P2011, DOI 10.1016/S0038-0717(01)00137-7; Bardgett R. D., 2005, The biology of soil: a community and ecosystem approach; Berg B, 2006, ADV ECOL RES, V38, P1, DOI 10.1016/S0065-2504(05)38001-X; Byzov BA, 2007, EUR J SOIL BIOL, V43, pS149, DOI 10.1016/j.ejsobi.2007.08.012; Curry JP, 2007, PEDOBIOLOGIA, V50, P463, DOI 10.1016/j.pedobi.2006.09.001; Daane LL, 1997, APPL ENVIRON MICROB, V63, P679, DOI 10.1128/AEM.63.2.679-686.1997; Dominguez J, 2010, MICROBES AT WORK: FROM WASTES TO RESOURCES, P93, DOI 10.1007/978-3-642-04043-6_5; Drake HL, 2007, ANNU REV MICROBIOL, V61, P169, DOI 10.1146/annurev.micro.61.080706.093139; Edwards CA, 1996, BIOL ECOLOGY EARTHWO, DOI DOI 10.1016/S0167-8809(97)88859-7; Flegel M, 2000, SOIL BIOL BIOCHEM, V32, P1191, DOI 10.1016/S0038-0717(00)00035-3; FROSTEGARD A, 1993, APPL ENVIRON MICROB, V59, P3605; Furlong MA, 2002, APPL ENVIRON MICROB, V68, P1265, DOI 10.1128/AEM.68.3.1265-1279.2002; Gomez-Brandon M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024786; Gomez-Brandon M, 2011, BIORESOURCE TECHNOL, V102, P4171, DOI 10.1016/j.biortech.2010.12.057; Gomez-Brandon M, 2010, APPL SOIL ECOL, V44, P237, DOI 10.1016/j.apsoil.2009.12.010; Hendriksen Niels Bohse, 1995, Acta Zoologica Fennica, V196, P115; Knapp BA, 2008, B ENTOMOL RES, V98, P271, DOI 10.1017/S0007485308006056; Knapp BA, 2009, SOIL BIOL BIOCHEM, V41, P2299, DOI 10.1016/j.soilbio.2009.08.011; Lavelle P., 2001, SOIL ECOLOGY; Lores M, 2006, SOIL BIOL BIOCHEM, V38, P2993, DOI 10.1016/j.soilbio.2006.05.001; Manna MC, 2003, BIORESOURCE TECHNOL, V88, P197, DOI 10.1016/S0960-8524(02)00318-8; Monroy F, 2008, APPL SOIL ECOL, V39, P127, DOI 10.1016/j.apsoil.2007.11.011; Monroy F, 2011, PEDOBIOLOGIA, V54, P93, DOI 10.1016/j.pedobi.2010.10.003; Monroy F, 2009, SCI TOTAL ENVIRON, V407, P5411, DOI 10.1016/j.scitotenv.2009.06.048; NEWELL SY, 1991, ECOLOGY, V72, P1547, DOI 10.2307/1940954; Pawlett M, 2009, BIOL FERT SOILS, V45, P361, DOI 10.1007/s00374-008-0339-6; PEDERSEN JC, 1993, BIOL FERT SOILS, V16, P227, DOI 10.1007/BF00361413; Rousk J, 2007, SOIL BIOL BIOCHEM, V39, P2173, DOI 10.1016/j.soilbio.2007.03.023; Rudi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007528; Sampedro L, 2008, APPL SOIL ECOL, V38, P91, DOI 10.1016/j.apsoil.2007.10.008; Scheu S, 2002, OECOLOGIA, V133, P254, DOI 10.1007/s00442-002-1023-4; Schonholzer F, 1999, FEMS MICROBIOL ECOL, V28, P235, DOI 10.1016/S0168-6496(98)00111-1; Seeber J, 2008, BIOL FERT SOILS, V44, P783, DOI 10.1007/s00374-008-0282-6; SIMS GK, 1995, COMMUN SOIL SCI PLAN, V26, P303, DOI 10.1080/00103629509369298; Stainier DYR, 2005, SCIENCE, V307, P1902, DOI 10.1126/science.1108709; Thakuria D, 2010, ISME J, V4, P357, DOI 10.1038/ismej.2009.124; VERMUE M, 1993, BIOTECHNOL BIOENG, V42, P747, DOI 10.1002/bit.260420610; Wardle DA, 2006, ECOL LETT, V9, P870, DOI 10.1111/j.1461-0248.2006.00931.x; White David C., 1998, P255; Williams AP, 2006, FEMS MICROBIOL ECOL, V58, P54, DOI 10.1111/j.1574-6941.2006.00142.x; Zelles L, 1997, CHEMOSPHERE, V35, P275, DOI 10.1016/S0045-6535(97)00155-0; Zhang BG, 2000, SOIL BIOL BIOCHEM, V32, P2055, DOI 10.1016/S0038-0717(00)00111-5	52	53	57	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31895	10.1371/journal.pone.0031895	http://dx.doi.org/10.1371/journal.pone.0031895			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363763	gold, Green Published			2022-12-27	WOS:000302873700117
J	Seong, I; Min, HJ; Lee, JH; Yeo, CY; Kang, DM; Oh, ES; Hwang, ES; Kim, J				Seong, Ikjoo; Min, Hyun Jung; Lee, Jung-Hyun; Yeo, Chang-Yeol; Kang, Dong Min; Oh, Eok-Soo; Hwang, Eun Sook; Kim, Jaesang			Sox10 Controls Migration of B16F10 Melanoma Cells through Multiple Regulatory Target Genes	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SOX10; NEURONAL DIFFERENTIATION; METASTASIS; HYALURONAN; MELANOCYTES; MITF; INVOLVEMENT; EXPRESSION; PROTEIN; NESTIN	It is believed that the inherent differentiation program of melanocytes during embryogenesis predisposes melanoma cells to high frequency of metastasis. Sox10, a transcription factor expressed in neural crest stem cells and a subset of progeny lineages, plays a key role in the development of melanocytes. We show that B16F10 melanoma cells transfected with siRNAs specific for Sox10 display reduced migratory activity which in turn indicated that a subset of transcriptional regulatory target genes of Sox10 is likely to be involved in migration and metastasis of melanoma cells. We carried out a microarray-based gene expression profiling using a Sox10-specific siRNA to identify relevant regulatory targets and found that multiple genes including melanocortin-1 receptor (Mc1r) partake in the regulation of migration. We provide evidences that the effect of Sox10 on migration is mediated in large part by Mitf, a transcription factor downstream to Sox10. Among the mouse melanoma cell lines examined, however, only B16F10 showed robust down-regulation of Sox10 and inhibition of cell migration indicating that further dissection of dosage effects and/or cell line-specific regulatory networks is necessary. The involvement of Mc1r in migration was studied in detail in vivo using a murine metastasis model. Specifically, B16F10 melanoma cells treated with a specific siRNA showed reduced tendency in metastasizing to and colonizing the lung after being injected in the tail vein. These data reveal a cadre of novel regulators and mediators involved in migration and metastasis of melanoma cells that represents potential targets of therapeutic intervention.	[Seong, Ikjoo; Min, Hyun Jung; Lee, Jung-Hyun; Yeo, Chang-Yeol; Kang, Dong Min; Oh, Eok-Soo; Hwang, Eun Sook; Kim, Jaesang] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea	Ewha Womans University	Seong, I (corresponding author), Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea.	jkim1964@ewha.ac.kr	Lee, Jung-Hyun/AAL-2954-2021; Min, Hyunjung/ABA-8709-2020	Lee, Jung-Hyun/0000-0003-1913-0027; Yeo, Chang-Yeol/0000-0002-4440-1215; Kang, Dongmin/0000-0001-5997-625X	National Research Foundation of Korea (NRF) [2010-0028042]; Brain Research Center [2010K000803]; Ministry of Education, Science and Technology (MEST), Republic of Korea; National Research and Development Program for Cancer Control, Ministry of Health, Welfare and Family Affairs, Republic of Korea [0620130]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Brain Research Center; Ministry of Education, Science and Technology (MEST), Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research and Development Program for Cancer Control, Ministry of Health, Welfare and Family Affairs, Republic of Korea	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF; 2010-0028042) and by a grant (2010K000803) from Brain Research Center of the 21st Century Frontier Research Program, both funded by the Ministry of Education, Science and Technology (MEST), Republic of Korea and by a grant (0620130) from the National Research and Development Program for Cancer Control, Ministry of Health, Welfare and Family Affairs, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsdottir M, 2010, MELANOMA RES, V20, P468, DOI 10.1097/CMR.0b013e3283403ccd; Amarzguioui M, 2006, CLIN CANCER RES, V12, P4055, DOI 10.1158/1078-0432.CCR-05-2482; Aoki H, 2002, LIFE SCI, V71, P2171, DOI 10.1016/S0024-3205(02)01996-3; Bakos RM, 2010, EXP DERMATOL, V19, pE89, DOI 10.1111/j.1600-0625.2009.00991.x; Bharadwaj AG, 2009, AM J PATHOL, V174, P1027, DOI 10.2353/ajpath.2009.080501; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Candille SI, 2007, SCIENCE, V318, P1418, DOI 10.1126/science.1147880; Dutton KA, 2001, DEVELOPMENT, V128, P4113; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Flammiger A, 2009, J INVEST DERMATOL, V129, P945, DOI 10.1038/jid.2008.316; Garcia-Borron JC, 2005, PIGM CELL RES, V18, P393, DOI 10.1111/j.1600-0749.2005.00278.x; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Jilaveanu LB, 2009, CLIN DERMATOL, V27, P614, DOI 10.1016/j.clindermatol.2008.09.020; KAMEYAMA K, 1990, INT J CANCER, V45, P1151, DOI 10.1002/ijc.2910450627; Kelsh RN, 2006, BIOESSAYS, V28, P788, DOI 10.1002/bies.20445; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; Kurisu S, 2005, ONCOGENE, V24, P1309, DOI 10.1038/sj.onc.1208177; LANE PW, 1984, J HERED, V75, P435, DOI 10.1093/oxfordjournals.jhered.a109980; Le Pape E, 2009, P NATL ACAD SCI USA, V106, P1802, DOI 10.1073/pnas.0806753106; Lee KE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-408; Lee M, 2000, J BIOL CHEM, V275, P37978, DOI 10.1074/jbc.M003816200; Liu GS, 2006, MOL PHARMACOL, V69, P440, DOI 10.1124/mol.105.015404; Lo LC, 2002, DEVELOPMENT, V129, P1553; Mitra D, 2009, HEMATOL ONCOL CLIN N, V23, P447, DOI 10.1016/j.hoc.2009.03.003; Mollaaghababa R, 2003, ONCOGENE, V22, P3024, DOI 10.1038/sj.onc.1206442; Murata J, 1997, INVAS METAST, V17, P82; Piras F, 2010, ONCOL REP, V23, P17, DOI 10.3892/or_00000601; Roh J, 2006, DIFFERENTIATION, V74, P542, DOI 10.1111/j.1432-0436.2006.00084.x; Sanchez-Mas J, 2004, PIGM CELL RES, V17, P386, DOI 10.1111/j.1600-0749.2004.00160.x; Sugahara KN, 2006, J BIOL CHEM, V281, P5861, DOI 10.1074/jbc.M506740200; Tachibana M, 2000, PIGM CELL RES, V13, P230, DOI 10.1034/j.1600-0749.2000.130404.x; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Uong A, 2010, J CELL PHYSIOL, V222, P38, DOI 10.1002/jcp.21935; Voelcker V, 2008, EXP DERMATOL, V17, P100, DOI 10.1111/j.1600-0625.2007.00638.x; Wegner M, 2005, PIGM CELL RES, V18, P74, DOI 10.1111/j.1600-0749.2005.00218.x; White RM, 2008, CELL STEM CELL, V3, P242, DOI 10.1016/j.stem.2008.08.005; Zhang YJ, 2002, J BIOL CHEM, V277, P38328, DOI 10.1074/jbc.M205576200	39	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31477	10.1371/journal.pone.0031477	http://dx.doi.org/10.1371/journal.pone.0031477			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363655	Green Submitted, gold, Green Published			2022-12-27	WOS:000302873700062
J	Suzuki, M; Tanaka, H; Tanimura, A; Tanabe, K; Oe, N; Rai, S; Kon, S; Fukumoto, M; Takei, K; Abe, T; Matsumura, I; Kanakura, Y; Watanabe, T				Suzuki, Mai; Tanaka, Hirokazu; Tanimura, Akira; Tanabe, Kenji; Oe, Natsuko; Rai, Shinya; Kon, Syunsuke; Fukumoto, Manabu; Takei, Kohji; Abe, Takaya; Matsumura, Itaru; Kanakura, Yuzuru; Watanabe, Toshio			The Clathrin Assembly Protein PICALM Is Required for Erythroid Maturation and Transferrin Internalization in Mice	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; LABILE IRON POOL; MEDIATED ENDOCYTOSIS; COATED PITS; RNA INTERFERENCE; CELL BIOLOGY; EPSIN 1; CALM; MUTATIONS; RECEPTOR	Phosphatidylinositol binding clathrin assembly protein (PICALM), also known as clathrin assembly lymphoid myeloid leukemia protein (CALM), was originally isolated as part of the fusion gene CALM/AF10, which results from the chromosomal translocation t(10;11)(p13;q14). CALM is sufficient to drive clathrin assembly in vitro on lipid monolayers and regulates clathrin-coated budding and the size and shape of the vesicles at the plasma membrane. However, the physiological role of CALM has yet to be elucidated. Here, the role of CALM in vivo was investigated using CALM-deficient mice. CALM-deficient mice exhibited retarded growth in utero and were dwarfed throughout their shortened life-spans. Moreover, CALM-deficient mice suffered from severe anemia, and the maturation and iron content in erythroid precursors were severely impaired. CALM-deficient erythroid cells and embryonic fibroblasts exhibited impaired clathrin-mediated endocytosis of transferrin. These results indicate that CALM is required for erythroid maturation and transferrin internalization in mice.	[Suzuki, Mai; Watanabe, Toshio] Nara Womens Univ, Dept Biol Sci, Grad Sch Humanities & Sci, Nara 630, Japan; [Tanaka, Hirokazu; Rai, Shinya; Matsumura, Itaru] Kinki Univ, Div Hematol, Dept Internal Med, Osaka, Japan; [Tanimura, Akira; Kanakura, Yuzuru] Osaka Univ, Dept Hematol & Oncol, Grad Sch Med, Osaka, Japan; [Tanabe, Kenji; Oe, Natsuko; Takei, Kohji] Okayama Univ, Dept Neurosci, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Kon, Syunsuke] Tohoku Univ, Dept Mol Immunol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Fukumoto, Manabu] Tohoku Univ, Dept Pathol, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan; [Abe, Takaya] RIKEN Ctr Dev Biol, Lab Anim Resources & Genet Engn, Kobe, Hyogo, Japan	Nara Womens University; Kindai University (Kinki University); Osaka University; Okayama University; Tohoku University; Tohoku University; RIKEN	Suzuki, M (corresponding author), Nara Womens Univ, Dept Biol Sci, Grad Sch Humanities & Sci, Nara 630, Japan.	toshiwatana@cc.nara-wu.ac.jp	Fukumoto, Manabu/L-1444-2019	Tanabe, Kenji/0000-0003-2645-9429; Tanimura, Akira/0000-0002-2039-5543; Takei, Kohji/0000-0002-6555-9425	Ministry of Education, Science, Sports, Culture and Technology, Japan; Kurokawa Cancer Research Foundation; Japan Health Foundation; Naito Foundation; Japan Science Society; Nara Women's University; Grants-in-Aid for Scientific Research [23770148] Funding Source: KAKEN	Ministry of Education, Science, Sports, Culture and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kurokawa Cancer Research Foundation(Kurokawa Cancer Research Foundation); Japan Health Foundation(Japan Health Foundation); Naito Foundation(Naito Memorial Foundation); Japan Science Society; Nara Women's University(Nara Womens University); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by research grants from the Ministry of Education, Science, Sports, Culture and Technology, Japan; Kurokawa Cancer Research Foundation; The Japan Health Foundation; The Naito Foundation; Sasakawa Scientific Research Grant from The Japan Science Society; and Nara Women's University Intramural Grant for Project Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLE S, 1986, EMBO J, V5, P3143, DOI 10.1002/j.1460-2075.1986.tb04621.x; Bushlin I, 2008, J NEUROSCI, V28, P10257, DOI 10.1523/JNEUROSCI.2471-08.2008; Caudell D, 2008, LEUKEMIA, V22, P678, DOI 10.1038/sj.leu.2405074; Chen H, 2009, P NATL ACAD SCI USA, V106, P13838, DOI 10.1073/pnas.0907008106; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; Deshpande AJ, 2011, LEUKEMIA, V25, P1718, DOI 10.1038/leu.2011.153; Deshpande AJ, 2006, CANCER CELL, V10, P363, DOI 10.1016/j.ccr.2006.08.023; Dreyling MH, 1996, P NATL ACAD SCI USA, V93, P4804, DOI 10.1073/pnas.93.10.4804; Epsztejn S, 1997, ANAL BIOCHEM, V248, P31, DOI 10.1006/abio.1997.2126; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gillooly DJ, 2001, SCIENCE, V291, P993, DOI 10.1126/science.291.5506.993; Gunshin H, 2005, J CLIN INVEST, V115, P1258, DOI [10.1172/JCI200524356, 10.1172/JCI24356]; Harel A, 2008, TRAFFIC, V9, P417, DOI 10.1111/j.1600-0854.2007.00694.x; Henriques CM, 2010, BLOOD, V115, P3269, DOI 10.1182/blood-2009-10-246876; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Hom RA, 2007, J MOL BIOL, V373, P412, DOI 10.1016/j.jmb.2007.08.016; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Karaszi E, 2001, BRIT J HAEMATOL, V112, P308, DOI 10.1046/j.1365-2141.2001.02554.x; Kazazic M, 2009, TRAFFIC, V10, P235, DOI 10.1111/j.1600-0854.2008.00858.x; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; KIRCHHAUSEN T, 1981, CELL, V23, P755, DOI 10.1016/0092-8674(81)90439-6; Klebig ML, 2003, P NATL ACAD SCI USA, V100, P8360, DOI 10.1073/pnas.1432634100; Kon S, 2008, EXP CELL RES, V314, P1415, DOI 10.1016/j.yexcr.2007.11.006; Legendre-Guillemin V, 2004, J CELL SCI, V117, P9, DOI 10.1242/jcs.00928; Lei JT, 2008, J LEUKOCYTE BIOL, V84, P499, DOI 10.1189/jlb.1207828; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; Meyerholz A, 2005, TRAFFIC, V6, P1225, DOI 10.1111/j.1600-0854.2005.00355.x; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; POTTER MD, 1995, MAMM GENOME, V6, P70, DOI 10.1007/BF00303247; Potter MD, 1997, BLOOD, V90, P1850, DOI 10.1182/blood.V90.5.1850; Prus E, 2008, BRIT J HAEMATOL, V142, P301, DOI 10.1111/j.1365-2141.2008.07192.x; Richardson DR, 1997, BBA-REV BIOMEMBRANES, V1331, P1, DOI 10.1016/S0304-4157(96)00014-7; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Schultze AE, 1997, COMP HAEMATOL INT, V7, P143, DOI 10.1007/BF02652592; Schultze AE, 1999, LAB ANIM SCI, V49, P260; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Stoddart A, 2011, ONCOGENE        0627, DOI [10.1038/onc.2011.251, DOI 10.1038/ONC.2011.251]; Sulahian R, 2009, BLOOD, V113, P5287, DOI 10.1182/blood-2008-09-179572; Tanabe K, 2005, MOL BIOL CELL, V16, P1617, DOI 10.1091/mbc.E04-08-0683; Tanabe K, 2009, J CELL BIOL, V185, P939, DOI 10.1083/jcb.200803153; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; UNGEWICKELL E, 1981, NATURE, V289, P420, DOI 10.1038/289420a0; Vanden Broeck D, 2006, BIOTECHNIQUES, V41, P475, DOI 10.2144/000112265; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458	48	37	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31854	10.1371/journal.pone.0031854	http://dx.doi.org/10.1371/journal.pone.0031854			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363754	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700109
J	Yi, CX; Heppner, KM; Kirchner, H; Tong, J; Bielohuby, M; Gaylinn, BD; Muller, TD; Bartley, E; Davis, HW; Zhao, YM; Joseph, A; Kruthaupt, T; Ottaway, N; Kabra, D; Habegger, KM; Benoit, SC; Bidlingmaier, M; Thorner, MO; Perez-Tilve, D; Tschop, MH; Pfluger, PT				Yi, Chun-Xia; Heppner, Kristy M.; Kirchner, Henriette; Tong, Jenny; Bielohuby, Maximillian; Gaylinn, Bruce D.; Mueller, Timo D.; Bartley, Erin; Davis, Harold W.; Zhao, Yongmei; Joseph, Anupama; Kruthaupt, Traci; Ottaway, Nickki; Kabra, Dhiraj; Habegger, Kirk M.; Benoit, Stephen C.; Bidlingmaier, Martin; Thorner, Michael O.; Perez-Tilve, Diego; Tschoep, Matthias H.; Pfluger, Paul T.			The GOAT-Ghrelin System Is Not Essential for Hypoglycemia Prevention during Prolonged Calorie Restriction	PLOS ONE			English	Article							HORMONE SECRETAGOGUE RECEPTOR; UNACYLATED GHRELIN; INSULIN-SECRETION; ENERGY-BALANCE; PEPTIDE; ACYLTRANSFERASE; ADIPOSITY; STOMACH; HUMANS; MICE	Objective: Ghrelin acylation by ghrelin O-acyltransferase (GOAT) has recently been reported to be essential for the prevention of hypoglycemia during prolonged negative energy balance. Using a unique set of four different genetic loss-of-function models for the GOAT/ghrelin/growth hormone secretagogue receptor (GHSR) system, we thoroughly tested the hypothesis that lack-of-ghrelin activation or signaling would lead to hypoglycemia during caloric deprivation. Methodology: Male and female knockout (KO) mice for GOAT, ghrelin, GHSR, or both ghrelin and GHSR (dKO) were subjected to prolonged calorie restriction (40% of ad libitum chow intake). Body weight, fat mass, and glucose levels were recorded daily and compared to wildtype (WT) controls. Forty-eight hour blood glucose profiles were generated for each individual mouse when 2% or less body fat mass was reached. Blood samples were obtained for analysis of circulating levels of acyl-and desacyl-ghrelin, IGF-1, and insulin. Principal Findings: Chronic calorie restriction progressively decreased body weight and body fat mass in all mice regardless of genotype. When fat mass was depleted to 2% or less of body weight for 2 consecutive days, random hypoglycemic events occurred in some mice across all genotypes. There was no increase in the incidence of hypoglycemia in any of the four loss-of-function models for ghrelin signaling including GOAT KO mice. Furthermore, no differences in insulin or IGF-1 levels were observed between genotypes. Conclusion: The endogenous GOAT-ghrelin-GHSR system is not essential for the maintenance of euglycemia during prolonged calorie restriction.	[Yi, Chun-Xia; Mueller, Timo D.; Kabra, Dhiraj; Tschoep, Matthias H.; Pfluger, Paul T.] Helmholtz Ctr Munich, Inst Diabet & Obes, Neuherberg, Germany; [Heppner, Kristy M.; Kirchner, Henriette; Tong, Jenny; Bartley, Erin; Davis, Harold W.; Zhao, Yongmei; Joseph, Anupama; Kruthaupt, Traci; Ottaway, Nickki; Habegger, Kirk M.; Benoit, Stephen C.; Perez-Tilve, Diego] Univ Cincinnati, Metab Dis Inst, Cincinnati, OH USA; [Bielohuby, Maximillian; Bidlingmaier, Martin] Univ Munich, Med Klin Innenstadt, Endocrine Res Unit, D-8000 Munich, Germany; [Gaylinn, Bruce D.; Thorner, Michael O.] Univ Virginia, Dept Med, Div Endocrinol, Charlottesville, VA USA	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University System of Ohio; University of Cincinnati; University of Munich; University of Virginia	Yi, CX (corresponding author), Helmholtz Ctr Munich, Inst Diabet & Obes, Neuherberg, Germany.	paul.pfluger@helmholtz-muenchen.de	Yi, Chun-Xia/J-4068-2016; Tschoep, Matthias H/I-5443-2014; Gaylinn, Bruce/AAD-4663-2020; Müller, Timo D./AAZ-4445-2020; Pfluger, Paul T/A-3770-2019	Yi, Chun-Xia/0000-0003-1184-4615; Pfluger, Paul T/0000-0002-8118-7588; Habegger, Kirk/0000-0002-0342-5480; Muller, Timo/0000-0002-0624-9339; Bidlingmaier, Martin/0000-0002-4681-6668; Perez-Tilve, Diego/0000-0002-0351-4133; Gaylinn, Bruce/0000-0003-1195-0864; Tschoep, Matthias/0000-0002-4744-371X	Hilda and Preston Davis Foundation; Davis Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076037] Funding Source: NIH RePORTER	Hilda and Preston Davis Foundation; Davis Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Hilda and Preston Davis Foundation - Davis Foundation Postdoctoral Fellowship Program in Eating Disorders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bednarek MA, 2000, J MED CHEM, V43, P4370, DOI 10.1021/jm0001727; Broglio F, 2004, J CLIN ENDOCR METAB, V89, P3062, DOI 10.1210/jc.2003-031964; Broglio F, 2001, J CLIN ENDOCR METAB, V86, P5083, DOI 10.1210/jc.86.10.5083; Delhanty PJD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011749; Gauna C, 2006, MOL CELL ENDOCRINOL, V251, P103, DOI 10.1016/j.mce.2006.03.040; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Kiewiet RM, 2009, EUR J ENDOCRINOL, V161, P567, DOI 10.1530/EJE-09-0339; Kirchner H, 2009, NAT MED, V15, P741, DOI 10.1038/nm.1997; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lin LG, 2011, AGING CELL, V10, P996, DOI 10.1111/j.1474-9726.2011.00740.x; Liu JH, 2008, J CLIN ENDOCR METAB, V93, P1980, DOI 10.1210/jc.2007-2235; Lucidi P, 2002, DIABETES, V51, P2911, DOI 10.2337/diabetes.51.10.2911; Ma XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016391; Pfluger PT, 2008, AM J PHYSIOL-GASTR L, V294, pG610, DOI 10.1152/ajpgi.00321.2007; Reimer MK, 2003, ENDOCRINOLOGY, V144, P916, DOI 10.1210/en.2002-220819; Sun YX, 2008, ENDOCRINOLOGY, V149, P843, DOI 10.1210/en.2007-0271; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Zhao TJ, 2010, P NATL ACAD SCI USA, V107, P7467, DOI 10.1073/pnas.1002271107	19	40	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32100	10.1371/journal.pone.0032100	http://dx.doi.org/10.1371/journal.pone.0032100			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363801	gold, Green Submitted, Green Published			2022-12-27	WOS:000302873700142
J	Zhao, Y; Ding, X; Ye, X; Dai, ZM; Yang, JS; Yang, WJ				Zhao, Yang; Ding, Xia; Ye, Xiang; Dai, Zhong-Min; Yang, Jin-Shu; Yang, Wei-Jun			Involvement of Cyclin K Posttranscriptional Regulation in the Formation of Artemia Diapause Cysts	PLOS ONE			English	Article							RNA-POLYMERASE-II; 38000-MR POLY(A)-BINDING PROTEIN; SHOCK/ALPHA-CRYSTALLIN PROTEIN; TERMINAL DOMAIN CTD; P-TEFB KINASE; MESSENGER RIBONUCLEOPROTEINS; CRYPTOBIOTIC GASTRULAE; INDUCED APOPTOSIS; ENCYSTED EMBRYOS; SUBUNIT STRUCTURE	Background: Artemia eggs tend to develop ovoviviparously to yield nauplius larvae in good rearing conditions; while under adverse situations, they tend to develop oviparously and encysted diapause embryos are formed instead. However, the intrinsic mechanisms regulating this process are not well understood. Principal Finding: This study has characterized the function of cyclin K, a regulatory subunit of the positive transcription elongation factor b (P-TEFb) in the two different developmental pathways of Artemia. In the diapause-destined embryo, Western blots showed that the cyclin K protein was down-regulated as the embryo entered dormancy and reverted to relatively high levels of expression once development resumed, consistent with the fluctuations in phosphorylation of position 2 serines (Ser2) in the C-terminal domain (CTD) of the largest subunit (Rpb1) of RNA polymerase II (RNAP II). Interestingly, the cyclin K transcript levels remained constant during this process. In vitro translation data indicated that the template activity of cyclin K mRNA stored in the postdiapause cyst was repressed. In addition, in vivo knockdown of cyclin K in developing embryos by RNA interference eliminated phosphorylation of the CTD Ser2 of RNAP II and induced apoptosis by inhibiting the extracellular signal-regulated kinase (ERK) survival signaling pathway. Conclusions/Significance: Taken together, these findings reveal a role for cyclin K in regulating RNAP II activity during diapause embryo development, which involves the post-transcriptional regulation of cyclin K. In addition, a further role was identified for cyclin K in regulating the control of cell survival during embryogenesis through ERK signaling pathways.	[Zhao, Yang; Ye, Xiang; Yang, Jin-Shu; Yang, Wei-Jun] Zhejiang Univ, Minist Educ, Key Lab Conservat Biol Endangered Wildlife, Hangzhou 310003, Zhejiang, Peoples R China; [Zhao, Yang; Ye, Xiang; Yang, Jin-Shu; Yang, Wei-Jun] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Ding, Xia] Nanchang Univ, Coll Life Sci, Nanchang, Jiangxi, Peoples R China; [Dai, Zhong-Min] Hangzhou Normal Univ, Coll Life & Environm Sci, Inst Dev & Regenerat Biol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Nanchang University; Hangzhou Normal University	Zhao, Y (corresponding author), Zhejiang Univ, Minist Educ, Key Lab Conservat Biol Endangered Wildlife, Hangzhou 310003, Zhejiang, Peoples R China.	w_jyang@cls.zju.edu.cn	ding, xia/CAG-9445-2022	ding, xia/0000-0003-1535-2642; Yang, Wei-Jun/0000-0002-4591-8830; Yang, Jin-Shu/0000-0001-6680-7737; Dai, Zhong-Min/0000-0003-4083-1901	National Natural Sciences Foundation of China [40730212, 40876069]; National Basic Research Program of China (973) [2010CB833803]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973)(National Basic Research Program of China)	This work was supported by the National Natural Sciences Foundation of China (40730212 and 40876069) and National Basic Research Program of China (973 Program, 2010CB833803). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGSHAW JC, 1976, NUCLEIC ACIDS RES, V3, P1449, DOI 10.1093/nar/3.6.1449; BAGSHAW JC, 1978, DIFFERENTIATION, V10, P13, DOI 10.1111/j.1432-0436.1978.tb00940.x; Bensaude O, 1999, BIOCHEM CELL BIOL, V77, P249, DOI 10.1139/bcb-77-4-249; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen S, 2011, BIOL REPROD, V85, P31, DOI 10.1095/biolreprod.110.090340; Cho HS, 2009, J VET SCI, V10, P23, DOI 10.4142/jvs.2009.10.1.23; Cho S, 2010, CELL CYCLE, V9, P1697, DOI 10.4161/cc.9.9.11346; CLEGG JS, 1994, EXP CELL RES, V212, P77, DOI 10.1006/excr.1994.1120; Copf T, 2006, DEV BIOL, V298, P87, DOI 10.1016/j.ydbio.2006.07.024; CRUCES J, 1984, EUR J BIOCHEM, V141, P279, DOI 10.1111/j.1432-1033.1984.tb08189.x; Dai JQ, 2008, J BIOL CHEM, V283, P1705, DOI 10.1074/jbc.M707853200; Dai L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020187; Dai ZM, 2011, BIOSCIENCE REP, V31, P17, DOI 10.1042/BSR20090141; DALESSIO JM, 1977, DIFFERENTIATION, V8, P53, DOI 10.1111/j.1432-0436.1977.tb00920.x; DALESSIO JM, 1979, DEV BIOL, V70, P71, DOI 10.1016/0012-1606(79)90007-1; DEHERDT E, 1984, EUR J BIOCHEM, V139, P155; DEHERDT E, 1982, EUR J BIOCHEM, V122, P453; Edwards MC, 1998, MOL CELL BIOL, V18, P4291, DOI 10.1128/MCB.18.7.4291; Fu TJ, 1999, J BIOL CHEM, V274, P34527, DOI 10.1074/jbc.274.49.34527; Gao N, 2011, APOPTOSIS, V16, P511, DOI 10.1007/s10495-011-0580-6; Jones JC, 2004, J BIOL CHEM, V279, P24957, DOI 10.1074/jbc.M402218200; Leucci E, 2007, J CELL PHYSIOL, V212, P411, DOI 10.1002/jcp.21032; Liang P, 1999, DEV BIOL, V207, P445, DOI 10.1006/dbio.1998.9138; Lin X, 2002, J BIOL CHEM, V277, P16873, DOI 10.1074/jbc.M200117200; Liu QY, 2007, CELL RES, V17, P163, DOI 10.1038/sj.cr.7310144; Liu YL, 2009, J BIOL CHEM, V284, P16931, DOI 10.1074/jbc.M109.004051; Moon DO, 2006, INT IMMUNOPHARMACOL, V6, P1796, DOI 10.1016/j.intimp.2006.07.027; Napolitano G, 2000, GENE, V254, P139, DOI 10.1016/S0378-1119(00)00278-X; Ni ZY, 2004, MOL CELL, V13, P55, DOI 10.1016/S1097-2765(03)00526-4; Ostrakhovitch EA, 2005, J CELL BIOCHEM, V95, P1120, DOI 10.1002/jcb.20484; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Palancade B, 2001, J CELL SCI, V114, P2483; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Poele RHT, 1999, ONCOGENE, V18, P5765, DOI 10.1038/sj.onc.1202961; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Ramanathan Y, 2001, J BIOL CHEM, V276, P10913, DOI 10.1074/jbc.M010975200; RENART J, 1976, CELL DIFFER DEV, V5, P97, DOI 10.1016/0045-6039(76)90003-8; Robert AB, 1991, ARTEMIA BIOL; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; Shim EY, 2002, GENE DEV, V16, P2135, DOI 10.1101/gad.999002; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; SLEGERS H, 1981, EUR J BIOCHEM, V117, P111; SLEGERS H, 1977, FEBS LETT, V80, P390, DOI 10.1016/0014-5793(77)80483-3; Taube R, 2002, MOL CELL BIOL, V22, P321, DOI 10.1128/MCB.22.1.321-331.2002; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Willsie JK, 2001, J EXP BIOL, V204, P2339; Yodmuang S, 2006, BIOCHEM BIOPH RES CO, V341, P351, DOI 10.1016/j.bbrc.2005.12.186; Yu DS, 2010, EMBO REP, V11, P876, DOI 10.1038/embor.2010.153; Zhu S, 2008, ONCOGENE, V27, P1580, DOI 10.1038/sj.onc.1210790; Zhu XJ, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-21	51	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32129	10.1371/journal.pone.0032129	http://dx.doi.org/10.1371/journal.pone.0032129			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363807	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700148
J	Almen, MS; Bringeland, N; Fredriksson, R; Schioth, HB				Almen, Markus Sallman; Bringeland, Nathalie; Fredriksson, Robert; Schioth, Helgi B.			The Dispanins: A Novel Gene Family of Ancient Origin That Contains 14 Human Members	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; WEST NILE VIRUS; SEQUENCE; IDENTIFICATION; PREDICTION; MARKER	The Interferon induced transmembrane proteins (IFITM) are a family of transmembrane proteins that is known to inhibit cell invasion of viruses such as HIV-1 and influenza. We show that the IFITM genes are a subfamily in a larger family of transmembrane (TM) proteins that we call Dispanins, which refers to a common 2TM structure. We mined the Dispanins in 36 eukaryotic species, covering all major eukaryotic groups, and investigated their evolutionary history using Bayesian and maximum likelihood approaches to infer a phylogenetic tree. We identified ten human genes that together with the known IFITM genes form the Dispanin family. We show that the Dispanins first emerged in eukaryotes in a common ancestor of choanoflagellates and metazoa, and that the family later expanded in vertebrates where it forms four subfamilies (A-D). Interestingly, we also find that the family is found in several different phyla of bacteria and propose that it was horizontally transferred to eukaryotes from bacteria in the common ancestor of choanoflagellates and metazoa. The bacterial and eukaryotic sequences have a considerably conserved protein structure. In conclusion, we introduce a novel family, the Dispanins, together with a nomenclature based on the evolutionary origin.	[Almen, Markus Sallman; Bringeland, Nathalie; Fredriksson, Robert; Schioth, Helgi B.] Uppsala Univ, Dept Neurosci, BMC, Uppsala, Sweden	Uppsala University	Almen, MS (corresponding author), Uppsala Univ, Dept Neurosci, BMC, Uppsala, Sweden.	markus.sallman-almen@neuro.uu.se	Fredriksson, Robert/AAH-3921-2019; Schioth, Helgi/AAQ-7239-2020	Fredriksson, Robert/0000-0002-2810-3226; Sallman Almen, Markus/0000-0001-9591-9228	Swedish Research Council; Novo Nordisk Foundation; Swedish Royal Academy of Sciences; Magnus Bergvall Foundation; Goran Gustafssons foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Royal Academy of Sciences; Magnus Bergvall Foundation; Goran Gustafssons foundation	The studies were supported by the Swedish Research Council, The Novo Nordisk Foundation, Swedish Royal Academy of Sciences, and Magnus Bergvall Foundation. RF was supported by the Goran Gustafssons foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almen MS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-50; Andreu P, 2006, CANCER RES, V66, P1949, DOI 10.1158/0008-5472.CAN-05-2731; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; de Chaldee M, 2006, GENOMICS, V87, P200, DOI 10.1016/j.ygeno.2005.10.009; Eddy Sean R, 2009, Genome Inform, V23, P205; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Fredriksson R, 2008, FEBS LETT, V582, P3811, DOI 10.1016/j.febslet.2008.10.016; FRIEDMAN RL, 1984, CELL, V38, P745, DOI 10.1016/0092-8674(84)90270-8; Hanagata N, 2010, J BONE MINER METAB; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Knotts TA, 2009, PPAR RES, V2009, DOI 10.1155/2009/867678; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lange UC, 2008, MOL CELL BIOL, V28, P4688, DOI 10.1128/MCB.00272-08; Liao DQ, 1999, AM J HUM GENET, V64, P24, DOI 10.1086/302221; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Moffatt P, 2008, J BONE MINER RES, V23, P1497, DOI 10.1359/JBMR.080412; Oort PJ, 2007, MOL CELL ENDOCRINOL, V276, P24, DOI 10.1016/j.mce.2007.06.005; Rask-Andersen M, 2011, NAT REV DRUG DISCOV, V10, P579, DOI 10.1038/nrd3478; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tanaka SS, 2005, DEV CELL, V9, P745, DOI 10.1016/j.devcel.2005.10.010; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]	33	63	86	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31961	10.1371/journal.pone.0031961	http://dx.doi.org/10.1371/journal.pone.0031961			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363774	Green Published, gold, Green Submitted			2022-12-27	WOS:000302871500098
J	Askins, RA; Folsom-O'Keefe, CM; Hardy, MC				Askins, Robert A.; Folsom-O'Keefe, Corrine M.; Hardy, Margaret C.			Effects of Vegetation, Corridor Width and Regional Land Use on Early Successional Birds on Powerline Corridors	PLOS ONE			English	Article							RIGHTS-OF-WAY; REPRODUCTIVE SUCCESS; CONSERVATION VALUE; SHRUBLAND BIRDS; FOREST; HABITAT; BIODIVERSITY; LANDSCAPE; FRAGMENTATION; COMMUNITIES	Powerline rights-of-way (ROWs) often provide habitat for early successional bird species that have suffered long-term population declines in eastern North America. To determine how the abundance of shrubland birds varies with habitat within ROW corridors and with land use patterns surrounding corridors, we ran Poisson regression models on data from 93 plots on ROWs and compared regression coefficients. We also determined nest success rates on a 1-km stretch of ROW. Seven species of shrubland birds were common in powerline corridors. However, the nest success rates for prairie warbler (Dendroica discolor) and field sparrow (Spizella pusilla) were < 21%, which is too low to compensate for estimated annual mortality. Some shrubland bird species were more abundant on narrower ROWs or at sites with lower vegetation or particular types of vegetation, indicating that vegetation management could be refined to favor species of high conservation priority. Also, several species were more abundant in ROWs traversing unfragmented forest than those near residential areas or farmland, indicating that corridors in heavily forested regions may provide better habitat for these species. In the area where we monitored nests, brood parasitism by brown-headed cowbirds (Molothrus ater) occurred more frequently close to a residential area. Although ROWs support dense populations of shrubland birds, those in more heavily developed landscapes may constitute sink habitat. ROWs in extensive forests may contribute more to sustaining populations of early successional birds, and thus may be the best targets for habitat management.	[Askins, Robert A.; Folsom-O'Keefe, Corrine M.; Hardy, Margaret C.] Connecticut Coll, Dept Biol, New London, CT 06320 USA	Connecticut College	Askins, RA (corresponding author), Connecticut Coll, Dept Biol, New London, CT 06320 USA.	raask@conncoll.edu	Hardy, Margaret C/A-5576-2009	Hardy, Margaret C/0000-0001-5033-4322	State Wildlife; Connecticut Department of Environmental Protection Wildlife Division [2008-8086]; Connecticut Light and Power Company; Northeast Utilities Foundation; Connecticut College; Northeast Utilities Transmission	State Wildlife; Connecticut Department of Environmental Protection Wildlife Division; Connecticut Light and Power Company; Northeast Utilities Foundation; Connecticut College; Northeast Utilities Transmission	Funding was provided by the State Wildlife Grants Program administered by the Connecticut Department of Environmental Protection Wildlife Division (Grant No. 2008-8086, http://www.ct.gov/dep/cwp/view.asp?a = 2723&q=326164&depNav_GID = 1655#SWG); Connecticut Light and Power Company, Northeast Utilities Transmission (http://www.transmission-nu.com/default.asp), Northeast Utilities Foundation (http://northeastutilitiesfoundation.org/what/index.html) and the Andrew W. Mellon Undergraduate Research Fund, Environmental Studies Program, Connecticut College (http://www.conncoll.edu/departments/envirostudies/7338.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alldredge MW, 2008, J APPL ECOL, V45, P1349, DOI 10.1111/j.1365-2664.2008.01517.x; ANDERSON SH, 1977, AM MIDL NAT, V97, P216, DOI 10.2307/2424698; ASKINS RA, 1994, WILDLIFE SOC B, V22, P339; Askins RA, 2001, WILDLIFE SOC B, V29, P407; Askins RA, 2007, FOREST ECOL MANAG, V250, P137, DOI 10.1016/j.foreco.2007.05.009; Bevanger K, 1998, BIOL CONSERV, V86, P67, DOI 10.1016/S0006-3207(97)00176-6; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; Bramble W. C., 1994, Journal of Arboriculture, V20, P124; BRAMBLE W C, 1992, Journal of Arboriculture, V18, P23; Brawn JD, 2001, ANNU REV ECOL SYST, V32, P251, DOI 10.1146/annurev.ecolsys.32.081501.114031; Brower J.E., 1998, FIELD LAB METHODS GE; Burhans DE, 2006, ECOL APPL, V16, P394, DOI 10.1890/04-0927; Carey M, 1994, BIRDS N AM; Clarke DJ, 2008, LANDSCAPE URBAN PLAN, V86, P257, DOI 10.1016/j.landurbplan.2008.03.005; Clarke DJ, 2006, WILDLIFE RES, V33, P615, DOI 10.1071/WR05085; CLEAR, 2008, CONN CHANG LANDSC; Confer JL, 2003, FOREST ECOL MANAG, V185, P193, DOI 10.1016/S0378-1127(03)00255-X; DeGraaf RM, 2003, FOREST ECOL MANAG, V185, P179, DOI 10.1016/S0378-1127(03)00254-8; DeGraaf RM, 1996, CONSERVATION FAUNAL, P3, DOI DOI 10.1007/978-94-009-1521-31; Dessecker DR, 1997, NC195 DEP AGR FOR SE; Dettmers R, 1999, J WILDLIFE MANAGE, V63, P815, DOI 10.2307/3802794; Dettmers R, 2003, FOREST ECOL MANAG, V185, P81, DOI 10.1016/S0378-1127(03)00248-2; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Flaspohler DJ, 2001, CONSERV BIOL, V15, P173, DOI 10.1046/j.1523-1739.2001.99397.x; Ford TB, 2001, AUK, V118, P864, DOI 10.1642/0004-8038(2001)118[0864:RSOFDS]2.0.CO;2; Friesen LE, 1995, CONSERV BIOL, V9, P1408, DOI 10.1046/j.1523-1739.1995.09061408.x; Gale GA, 1997, CONSERV BIOL, V11, P246, DOI 10.1046/j.1523-1739.1997.95141.x; GUREVITCH J, 2006, ECOLOGY PLANTS; Hewson CM, 2009, IBIS, V151, P464, DOI 10.1111/j.1474-919X.2009.00937.x; Hutto RL, 2003, WILDLIFE SOC B, V31, P903; JOHNSON DH, 1979, AUK, V96, P651; Johnson DH, 2008, J WILDLIFE MANAGE, V72, P857, DOI 10.2193/2007-294; King DI, 2009, BIOL CONSERV, V142, P2672, DOI 10.1016/j.biocon.2009.06.016; King DI, 2002, WILDLIFE SOC B, V30, P868; King DI, 2001, J WILDLIFE MANAGE, V65, P345, DOI 10.2307/3802914; Kubel JE, 2008, WILSON J ORNITHOL, V120, P801, DOI 10.1676/06-114.1; Lensu T, 2011, J ENVIRON MANAGE, V92, P2539, DOI 10.1016/j.jenvman.2011.05.019; Lowther P. E., 1993, BIRDS N AM ONLINE; Manolis JC, 2000, AUK, V117, P615, DOI 10.1642/0004-8038(2000)117[0615:UNFISS]2.0.CO;2; MAYFIELD HF, 1975, WILSON BULL, V87, P456; Meehan Amy L., 1997, Virginia Journal of Science, V48, P259; NIERING WA, 1974, ECOLOGY, V55, P784, DOI 10.2307/1934414; Nolan V., 1978, ORNITHOL MONOGR, V26, P1; Paquet JY, 2006, FOREST ECOL MANAG, V227, P59, DOI 10.1016/j.foreco.2006.02.009; R Core Team, 2018, R LANG ENV STAT COMP; RICH AC, 1994, CONSERV BIOL, V8, P1109, DOI 10.1046/j.1523-1739.1994.08041109.x; Ricklefs R., 1969, SMITHSON CONTRIB ZOO, P1, DOI [10.5479/si.00810282.9, DOI 10.5479/SI.00810282.9]; Rodewald AD, 2005, J WILDLIFE MANAGE, V69, P681, DOI 10.2193/0022-541X(2005)069[0681:EAAOSB]2.0.CO;2; Rubolini D, 2005, BIRD CONSERV INT, V15, P131, DOI 10.1017/S0959270905000109; Rudd H, 2002, RESTOR ECOL, V10, P368, DOI 10.1046/j.1526-100X.2002.02041.x; RUDNICKY TC, 1993, ECOL APPL, V3, P357, DOI 10.2307/1941838; Russell KN, 2005, BIOL CONSERV, V124, P133, DOI 10.1016/j.biocon.2005.01.022; Sauer J.R., 2008, N AM BREEDING BIRD S; Schlossberg S, 2011, LANDSCAPE URBAN PLAN, V103, P64, DOI 10.1016/j.landurbplan.2011.06.001; Slay C., 2010, THESIS U ARKANSAS FA; Stevens DW, 1996, ENVIRON MANAGE, V20, P873; Temple SA, 1996, ENVIRON MANAGE, V20, P873, DOI 10.1007/BF01205967; Thompson FR, 2002, STUD AVIAN BIOL-SER, P8; Yahner Richard H., 2003, Journal of Arboriculture, V29, P156; Yahner Richard H., 2002, Journal of Arboriculture, V28, P123; Yahner Richard H., 2001, Journal of Arboriculture, V27, P215; Yahner Richard H., 2004, Journal of Arboriculture, V30, P288; Yamaura Y, 2009, ANIM CONSERV, V12, P110, DOI 10.1111/j.1469-1795.2008.00227.x; Zuckerberg B, 2012, J WILDLIFE MANAGE, V76, P1072, DOI 10.1002/jwmg.326; [No title captured]	65	26	26	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31520	10.1371/journal.pone.0031520	http://dx.doi.org/10.1371/journal.pone.0031520			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363660	Green Submitted, gold, Green Published			2022-12-27	WOS:000302871500050
J	Chiu, HW; Chen, YA; Ho, SY; Wang, YJ				Chiu, Hui-Wen; Chen, Yi-An; Ho, Sheng-Yow; Wang, Ying-Jan			Arsenic Trioxide Enhances the Radiation Sensitivity of Androgen-Dependent and -Independent Human Prostate Cancer Cells	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; INCREASED MITOTIC ARREST; MALIGNANT GLIOMA-CELLS; COMBINATION TREATMENT; IONIZING-RADIATION; CLINICAL-EFFICACY; INDUCED AUTOPHAGY; UP-REGULATION; IN-VITRO; APOPTOSIS	Prostate cancer is the most common malignancy in men. In the present study, LNCaP (androgen-sensitive human prostate cancer cells) and PC-3 cells (androgen-independent human prostate cancer cells) were used to investigate the anti-cancer effects of ionizing radiation (IR) combined with arsenic trioxide (ATO) and to determine the underlying mechanisms in vitro and in vivo. We found that IR combined with ATO increases the therapeutic efficacy compared to individual treatments in LNCaP and PC-3 human prostate cancer cells. In addition, combined treatment showed enhanced reactive oxygen species (ROS) generation compared to treatment with ATO or IR alone in PC-3 cells. Combined treatment induced autophagy and apoptosis in LNCaP cells, and mainly induced autophagy in PC-3 cells. The cell death that was induced by the combined treatment was primarily the result of inhibition of the Akt/mTOR signaling pathways. Furthermore, we found that the combined treatment of cells pre-treated with 3-MA resulted in a significant change in AO-positive cells and cytotoxicity. In an in vivo study, the combination treatment had anti-tumor growth effects. These novel findings suggest that combined treatment is a potential therapeutic strategy not only for androgen-dependent prostate cancer but also for androgen-independent prostate cancer.	[Chiu, Hui-Wen; Chen, Yi-An; Wang, Ying-Jan] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Ho, Sheng-Yow] Sinlau Christian Hosp, Tainan, Taiwan	National Cheng Kung University	Chiu, HW (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan.	yjwang@mail.ncku.edu.tw			National Science Council, Taiwan (NSC) [98-2314-B-006-034-MY2]; Sinlau Christian Hospital, Tainan, Taiwan	National Science Council, Taiwan (NSC)(Ministry of Science and Technology, Taiwan); Sinlau Christian Hospital, Tainan, Taiwan	This study was supported by the National Science Council, Taiwan (NSC 98-2314-B-006-034-MY2) and the Sinlau Christian Hospital, Tainan, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghaei M, 2011, PROSTATE; Antman KH, 2001, ONCOLOGIST, V6, P1, DOI 10.1634/theoncologist.6-suppl_2-1; Basu Sujit, 2010, Hormones & Cancer, V1, P223, DOI 10.1007/s12672-010-0044-4; Befani CD, 2011, J MOL MED BERL; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Chiu HW, 2010, AUTOPHAGY, V6, P353, DOI 10.4161/auto.6.3.11229; Chiu HW, 2009, AUTOPHAGY, V5, P472, DOI 10.4161/auto.5.4.7759; Chun YJ, 2002, FEBS LETT, V519, P195, DOI 10.1016/S0014-5793(02)02765-5; Corcelle EA, 2009, FEBS J, V276, P6084, DOI 10.1111/j.1742-4658.2009.07332.x; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Dehm SM, 2006, J CELL BIOCHEM, V99, P333, DOI 10.1002/jcb.20794; Friedrichs W, 2011, NUTR CANCER, V63, P771, DOI 10.1080/01635581.2011.570892; Ho SY, 2009, CHEM-BIOL INTERACT, V179, P304, DOI 10.1016/j.cbi.2008.12.015; Hsu KF, 2009, AUTOPHAGY, V5, P451, DOI 10.4161/auto.5.4.7666; Kang YH, 2008, ONCOL REP, V20, P637, DOI 10.3892/or_00000053; Kanzawa T, 2005, ONCOGENE, V24, P980, DOI 10.1038/sj.onc.1208095; Kim R, 2006, J PATHOL, V208, P319, DOI 10.1002/path.1885; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Lian J, 2011, CELL DEATH DIFFER, V18, P60, DOI 10.1038/cdd.2010.74; Lian JQ, 2010, AUTOPHAGY, V6, P1201, DOI [10.1038/cdd.2010.74, 10.4161/auto.6.8.13549]; Lockshin RA, 2004, INT J BIOCHEM CELL B, V36, P2405, DOI 10.1016/j.biocel.2004.04.011; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; McCubrey JA, 2006, MOL PHARMACOL, V70, P437, DOI 10.1124/mol.106.026252; MCDONNELL TJ, 1995, SEMIN CANCER BIOL, V6, P53, DOI 10.1006/scbi.1995.0007; Murillo H, 2001, ENDOCRINOLOGY, V142, P4795, DOI 10.1210/en.142.11.4795; Nakamura Y, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-100; OSBORNE CK, 1987, EUR J CANCER CLIN ON, V23, P1189; Paglin S, 2001, CANCER RES, V61, P439; Peng PL, 2008, INT J RADIAT ONCOL, V70, P529, DOI 10.1016/j.ijrobp.2007.08.034; PROBERT JC, 1975, RADIOLOGY, V114, P155, DOI 10.1148/114.1.155; Qian WB, 2007, LEUKEMIA RES, V31, P329, DOI 10.1016/j.leukres.2006.06.021; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shen Y, 2001, LEUKEMIA, V15, P735, DOI 10.1038/sj.leu.2402106; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640; Toepfer N, 2011, CANCER BIOL THER, V12, P691, DOI 10.4161/cbt.12.8.15978; Vorotnikova E, 2010, RADIAT RES, V173, P748, DOI 10.1667/RR1948.1; Wang J, 2008, CANCER RES, V68, P3152, DOI 10.1158/0008-5472.CAN-07-5348; Wen Y, 2000, CANCER RES, V60, P6841; Westervelt P, 2002, P NATL ACAD SCI USA, V99, P9468, DOI 10.1073/pnas.132657799; Xiao D, 2010, J BIOL CHEM, V285, P26558, DOI 10.1074/jbc.M109.063255; Yang ZNJ, 2011, CANCER BIOL THER, V11, P169, DOI 10.4161/cbt.11.2.14663; Zelefsky MJ, 2008, INT J RADIAT ONCOL, V71, P1028, DOI 10.1016/j.ijrobp.2007.11.066; Zhang HY, 2009, TOXICOL SCI, V110, P376, DOI 10.1093/toxsci/kfp101	45	34	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31579	10.1371/journal.pone.0031579	http://dx.doi.org/10.1371/journal.pone.0031579			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363680	Green Published, Green Submitted, gold			2022-12-27	WOS:000302871500058
J	Floerl, S; Majcherczyk, A; Possienke, M; Feussner, K; Tappe, H; Gatz, C; Feussner, I; Kues, U; Polle, A				Floerl, Saskia; Majcherczyk, Andrzej; Possienke, Mareike; Feussner, Kirstin; Tappe, Hella; Gatz, Christiane; Feussner, Ivo; Kuees, Ursula; Polle, Andrea			Verticillium longisporum Infection Affects the Leaf Apoplastic Proteome, Metabolome, and Cell Wall Properties in Arabidopsis thaliana	PLOS ONE			English	Article							XYLEM SAP PROTEOME; GERMIN-LIKE PROTEINS; SPRUCE PICEA-ABIES; DISEASE RESISTANCE; SECRETED PROTEINS; OILSEED RAPE; GENE FAMILY; DIFFERENTIAL INTERACTIONS; SERINE-CARBOXYPEPTIDASE; POLYACRYLAMIDE GELS	Verticillium longisporum (VL) is one of the most devastating diseases in important oil crops from the family of Brassicaceae. The fungus resides for much time of its life cycle in the extracellular fluid of the vascular system, where it cannot be controlled by conventional fungicides. To obtain insights into the biology of VL-plant interaction in the apoplast, the secretome consisting of the extracellular proteome and metabolome as well as cell wall properties were studied in the model Brassicaceae, Arabidopsis thaliana. VL infection resulted in increased production of cell wall material with an altered composition of carbohydrate polymers and increased lignification. The abundance of several hundred soluble metabolites changed in the apoplast of VL-infected plants including signalling and defence compounds such as glycosides of salicylic acid, lignans and dihydroxybenzoic acid as well as oxylipins. The extracellular proteome of healthy leaves was enriched in antifungal proteins. VL caused specific increases in six apoplast proteins (three peroxidases PRX52, PRX34, P37, serine carboxypeptidase SCPL20, alpha-galactosidase AGAL2 and a germin-like protein GLP3), which have functions in defence and cell wall modification. The abundance of a lectin-like, chitin-inducible protein (CILLP) was reduced. Since the transcript levels of most of the induced proteins were not elevated until late infection time points (> 20 dpi), whereas those of CILLP and GLP3 were reduced at earlier time points, our results may suggest that VL enhances its virulence by rapid down-regulation and delay of induction of plant defence genes.	[Floerl, Saskia; Polle, Andrea] Univ Gottingen, Dept Forest Bot & Tree Physiol, Busgen Inst, Gottingen, Germany; [Majcherczyk, Andrzej; Kuees, Ursula] Univ Gottingen, Dept Mol Wood Biotechnol & Tech Mycol, Busgen Inst, Gottingen, Germany; [Possienke, Mareike; Feussner, Kirstin; Feussner, Ivo] Univ Gottingen, Dept Plant Biochem, Albrecht von Haller Inst, Gottingen, Germany; [Tappe, Hella; Gatz, Christiane] Univ Gottingen, Dept Mol Biol & Physiol Plants, Albrecht von Haller Inst, Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen; University of Gottingen	Floerl, S (corresponding author), Univ Gottingen, Dept Forest Bot & Tree Physiol, Busgen Inst, Gottingen, Germany.	apolle@gwdg.de	Kües, Ursula/B-8280-2008; Majcherczyk, Andrzej/B-8267-2008; Feussner, Ivo/H-9320-2013	Kües, Ursula/0000-0001-9180-4079; Majcherczyk, Andrzej/0000-0002-1616-6983; Feussner, Ivo/0000-0002-9888-7003; Polle, Andrea/0000-0001-8697-6394	German Science Foundation [Po 362/15, Fe 446/6-1, FOR 546]	German Science Foundation(German Research Foundation (DFG))	The authors would like to thank the German Science Foundation for financial support to FOR 546, Po 362/15 and Fe 446/6-1. The funder has no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agrawal GK, 2010, PROTEOMICS, V10, P799, DOI 10.1002/pmic.200900514; Alvarez S, 2006, J PROTEOME RES, V5, P963, DOI 10.1021/pr050471q; Bartsch M, 2010, J BIOL CHEM, V285, P25654, DOI 10.1074/jbc.M109.092569; Bayer EM, 2006, PROTEOMICS, V6, P301, DOI 10.1002/pmic.200500046; Bergmeyer HU, 1974, METHODEN ENZYMATISCH, VI, P649; Bindschedler LV, 2006, PLANT J, V47, P851, DOI 10.1111/j.1365-313X.2006.02837.x; BINNS AN, 1987, P NATL ACAD SCI USA, V84, P980, DOI 10.1073/pnas.84.4.980; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Boudart G, 2005, PROTEOMICS, V5, P212, DOI 10.1002/pmic.200400882; Brinkmann K, 2002, J CHEM ECOL, V28, P2483, DOI 10.1023/A:1021484002582; Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542; Chang S, 1993, PLANT MOL BIOL REP, V11, P113, DOI DOI 10.1007/BF02670468; Charmont S, 2005, PHYTOCHEMISTRY, V66, P453, DOI 10.1016/j.phytochem.2004.12.013; Chrost B, 2007, PLANTA, V225, P311, DOI 10.1007/s00425-006-0350-9; Cosio C, 2009, J EXP BOT, V60, P391, DOI 10.1093/jxb/ern318; Cowley T, 2005, PEST MANAG SCI, V61, P572, DOI 10.1002/ps.1026; Cui YX, 2000, PHYSIOL MOL PLANT P, V56, P25, DOI 10.1006/pmpp.1999.0245; Demont-Caulet N, 2010, PHYTOCHEMISTRY, V71, P1673, DOI 10.1016/j.phytochem.2010.06.011; Denness L, 2011, PLANT PHYSIOL, V156, P1364, DOI 10.1104/pp.111.175737; Druebert G, 2011, THESIS U GOTTINGEN G; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Dubery IA, 1997, PHYTOCHEMISTRY, V44, P1429, DOI 10.1016/S0031-9422(96)00635-8; Dunker S, 2008, J PHYTOPATHOL, V156, P698, DOI 10.1111/j.1439-0434.2008.01429.x; Dunwell JM, 2008, CRIT REV PLANT SCI, V27, P342, DOI 10.1080/07352680802333938; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Eynck C, 2007, EUR J PLANT PATHOL, V118, P259, DOI 10.1007/s10658-007-9144-6; Eynck C, 2009, PHYTOPATHOLOGY, V99, P802, DOI 10.1094/PHYTO-99-7-0802; Eynck C, 2009, J PLANT DIS PROTECT, V116, P63, DOI 10.1007/BF03356288; Floerl S, 2010, J PLANT PATHOL, V92, P693; Floerl S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-129; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Fradin EF, 2006, MOL PLANT PATHOL, V7, P71, DOI [10.1111/j.1364-3703.2006.00323.x, 10.1111/J.1364-3703.2006.00323.X]; Fradin EF, 2009, PLANT PHYSIOL, V150, P320, DOI 10.1104/pp.109.136762; Fraser CM, 2005, PLANT PHYSIOL, V138, P1136, DOI 10.1104/pp.104.057950; Gayoso C, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-232; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Haffner E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-235; Hano C, 2006, PLANTA, V223, P975, DOI 10.1007/s00425-005-0156-1; HRUZ T, 2008, BIOINFORMATICS; Hwang B, 2010, MOLECULES, V15, P3507, DOI 10.3390/molecules15053507; Irshad M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-94; Jamet E, 2008, PROTEOMICS, V8, P893, DOI 10.1002/pmic.200700938; Johansson A, 2006, EUR J PLANT PATHOL, V114, P139, DOI 10.1007/s10658-005-2333-2; Johansson A, 2006, MOL PLANT MICROBE IN, V19, P958, DOI 10.1094/MPMI-19-0958; Kacurakova M, 2000, CARBOHYD POLYM, V43, P195, DOI 10.1016/S0144-8617(00)00151-X; Kaever A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-92; Karapapa VK, 1997, MYCOL RES, V101, P1281, DOI 10.1017/S0953756297003985; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kawchuk LM, 2001, P NATL ACAD SCI USA, V98, P6511, DOI 10.1073/pnas.091114198; Klosterman SJ, 2009, ANNU REV PHYTOPATHOL, V47, P39, DOI 10.1146/annurev-phyto-080508-081748; Knecht K, 2010, MOL PLANT MICROBE IN, V23, P446, DOI 10.1094/MPMI-23-4-0446; Kruger W., 1989, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes, V41, P49; Lichtenthaler H., 1985, ANALYSIS-UK, V11, P591, DOI [10.1042/bst0110591, DOI 10.1042/BST0110591]; Ligat L, 2011, PROTEOMICS, V11, P1798, DOI 10.1002/pmic.201000781; Loake G, 2007, CURR OPIN PLANT BIOL, V10, P466, DOI 10.1016/j.pbi.2007.08.008; Ludwikow A, 2004, CELL MOL BIOL LETT, V9, P829; Manosalva PM, 2009, PLANT PHYSIOL, V149, P286, DOI 10.1104/pp.108.128348; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; MCCANN MC, 1992, PLANT PHYSIOL, V100, P1940, DOI 10.1104/pp.100.4.1940; Membre N, 2000, PLANTA, V211, P345, DOI 10.1007/s004250000277; Nahlik K, 2010, MOL MICROBIOL, V78, P964, DOI 10.1111/j.1365-2958.2010.07384.x; Naumann A, 2005, FUNGAL GENET BIOL, V42, P829, DOI 10.1016/j.fgb.2005.06.003; NEUHOFF V, 1990, BIOL CHEM H-S, V371, pA10; Njoroge SMC, 2011, PHYTOPATHOLOGY, V101, P523, DOI 10.1094/PHYTO-08-10-0219; Otter T, 1997, PLANT CELL PHYSIOL, V38, P595, DOI 10.1093/oxfordjournals.pcp.a029209; Passardi F, 2006, PLANTA, V223, P965, DOI 10.1007/s00425-005-0153-4; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; POLLE A, 1990, PLANT PHYSIOL, V94, P312, DOI 10.1104/pp.94.1.312; Pomar F, 2004, NEW PHYTOL, V163, P111, DOI 10.1111/j.1469-8137.2004.01092.x; Popper ZA, 2011, ANNU REV PLANT BIOL, V62, P567, DOI 10.1146/annurev-arplant-042110-103809; Ramonell K, 2005, PLANT PHYSIOL, V138, P1027, DOI 10.1104/pp.105.060947; Ratzinger A, 2009, J PLANT RES, V122, P571, DOI 10.1007/s10265-009-0237-5; Romano PGN, 2004, PLANT PHYSIOL, V134, P1268, DOI 10.1104/pp.103.022160; Rozen S, 2000, Methods Mol Biol, V132, P365; Schmitz G, 2010, MOL PLANT MICROBE IN, V23, P1584, DOI 10.1094/MPMI-02-10-0045; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Singh S, 2012, MOL PLANT MICROBE IN, V25, P569, DOI 10.1094/MPMI-08-11-0217; Smit F, 1997, PHYTOCHEMISTRY, V44, P811, DOI 10.1016/S0031-9422(96)00595-X; Subramanian S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-119; Talboys P.W., 1958, T BRIT MYCOL SOC, V41, P249, DOI [10.1016/S0007-1536(58)80037-6, DOI 10.1016/S0007-1536(58)80037-6]; TEUTONICO RA, 1991, PLANT PHYSIOL, V97, P288, DOI 10.1104/pp.97.1.288; Tjamos SE, 2005, MOL PLANT MICROBE IN, V18, P555, DOI 10.1094/MPMI-18-0555; Tripathi LP, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-200; Veronese P, 2003, PLANT J, V35, P574, DOI 10.1046/j.1365-313X.2003.01830.x; Welinder KG, 2002, EUR J BIOCHEM, V269, P6063, DOI 10.1046/j.1432-1033.2002.03311.x; Yamamoto R, 1997, PLANT CELL PHYSIOL, V38, P980, DOI 10.1093/oxfordjournals.pcp.a029262; Zeise K, 2002, J PHYTOPATHOL, V150, P112, DOI 10.1046/j.1439-0434.2002.00730.x; Zhang ZQ, 2007, PLANT PHYSIOL, V145, P450, DOI 10.1104/pp.107.106021; Zhou AF, 2005, J BIOL CHEM, V280, P35554, DOI 10.1074/jbc.M503299200; Zhou GW, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-9; ZUREK DM, 1994, PLANT PHYSIOL, V104, P161, DOI 10.1104/pp.104.1.161	91	86	90	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31435	10.1371/journal.pone.0031435	http://dx.doi.org/10.1371/journal.pone.0031435			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363647	gold, Green Published, Green Submitted			2022-12-27	WOS:000302871500044
J	Jasmine, F; Rahaman, R; Dodsworth, C; Roy, S; Paul, R; Raza, M; Paul-Brutus, R; Kamal, M; Ahsan, H; Kibriya, MG				Jasmine, Farzana; Rahaman, Ronald; Dodsworth, Charlotte; Roy, Shantanu; Paul, Rupash; Raza, Maruf; Paul-Brutus, Rachelle; Kamal, Mohammed; Ahsan, Habibul; Kibriya, Muhammad G.			A Genome-Wide Study of Cytogenetic Changes in Colorectal Cancer Using SNP Microarrays: Opportunities for Future Personalized Treatment	PLOS ONE			English	Article							COPY NUMBER CHANGES; LOSS-OF-HETEROZYGOSITY; CHROMOSOMAL INSTABILITY; UNIPARENTAL DISOMY; MICROSATELLITE INSTABILITY; DISEASE PROGRESSION; TUMOR-SUPPRESSOR; IN-SITU; HYBRIDIZATION; COLON	In colorectal cancer (CRC), chromosomal instability (CIN) is typically studied using comparative-genomic hybridization (CGH) arrays. We studied paired (tumor and surrounding healthy) fresh frozen tissue from 86 CRC patients using Illumina's Infinium-based SNP array. This method allowed us to study CIN in CRC, with simultaneous analysis of copy number (CN) and B-allele frequency (BAF) - a representation of allelic composition. These data helped us to detect mono-allelic and bi-allelic amplifications/deletion, copy neutral loss of heterozygosity, and levels of mosaicism for mixed cell populations, some of which can not be assessed with other methods that do not measure BAF. We identified associations between CN abnormalities and different CRC phenotypes (histological diagnosis, location, tumor grade, stage, MSI and presence of lymph node metastasis). We showed commonalities between regions of CN change observed in CRC and the regions reported in previous studies of other solid cancers (e.g. amplifications of 20q, 13q, 8q, 5p and deletions of 18q, 17p and 8p). From Therapeutic Target Database, we identified relevant drugs, targeted to the genes located in these regions with CN changes, approved or in trials for other cancers and common diseases. These drugs may be considered for future therapeutic trials in CRC, based on personalized cytogenetic diagnosis. We also found many regions, harboring genes, which are not currently targeted by any relevant drugs that may be considered for future drug discovery studies. Our study shows the application of high density SNP arrays for cytogenetic study in CRC and its potential utility for personalized treatment.	[Jasmine, Farzana; Rahaman, Ronald; Dodsworth, Charlotte; Roy, Shantanu; Paul-Brutus, Rachelle; Ahsan, Habibul; Kibriya, Muhammad G.] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA; [Paul, Rupash; Raza, Maruf; Kamal, Mohammed] BSMMU, Dept Pathol, Dhaka, Bangladesh	University of Chicago; University of Chicago; University of Chicago; Robert H. Lurie Comprehensive Cancer Center; University of Chicago; Bangabandhu Sheikh Mujib Medical University (BSMMU)	Jasmine, F (corresponding author), Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA.	kibriya@uchicago.edu	RAZA, AKM MARUF/S-6883-2016; RAZA, AKM MARUF/P-2736-2019	RAZA, AKM MARUF/0000-0003-0251-4518; RAZA, AKM MARUF/0000-0003-0251-4518; Rahaman, Ronald/0000-0002-8917-8934	National Institutes of Health [U01 CA122171, P30 CA 014599, P42ES010349, R01CA102484, R01CA107431]; NATIONAL CANCER INSTITUTE [R01CA107431, R01CA102484, P30CA014599, U01CA122171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010349] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health grants U01 CA122171, P30 CA 014599, P42ES010349, R01CA102484, and R01CA107431. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2005, COLORECTAL DIS, V7, P571, DOI 10.1111/j.1463-1318.2005.00818.x; Andersen CL, 2007, CARCINOGENESIS, V28, P38, DOI 10.1093/carcin/bgl086; Aragane H, 2001, INT J CANCER, V94, P623, DOI 10.1002/ijc.1522; BARDI G, 1993, CANCER, V71, P306, DOI 10.1002/1097-0142(19930115)71:2<306::AID-CNCR2820710207>3.0.CO;2-C; Berg M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-100; Bianchi F, 2009, J MOL DIAGN, V11, P248, DOI 10.2353/jmoldx.2009.080155; Boelens MC, 2009, LUNG CANCER, V66, P372, DOI 10.1016/j.lungcan.2009.02.017; Brenner BM, 2010, MUTAT RES-FUND MOL M, V693, P46, DOI 10.1016/j.mrfmmm.2010.04.002; Chalmers IJ, 2001, CANCER GENET CYTOGEN, V126, P39, DOI 10.1016/S0165-4608(00)00376-9; Chen X, 2002, NUCLEIC ACIDS RES, V30, P412, DOI 10.1093/nar/30.1.412; Conlin LK, 2010, HUM MOL GENET, V19, P1263, DOI 10.1093/hmg/ddq003; De Angelis PM, 1999, BRIT J CANCER, V80, P526; DELATTRE O, 1989, LANCET, V2, P353; Derks S, 2008, CARCINOGENESIS, V29, P434, DOI 10.1093/carcin/bgm270; Diep CB, 2006, GENE CHROMOSOME CANC, V45, P31, DOI 10.1002/gcc.20261; Douglas EJ, 2004, CANCER RES, V64, P4817, DOI 10.1158/0008-5472.CAN-04-0328; Downey T, 2006, METHOD ENZYMOL, V411, P256, DOI 10.1016/S0076-6879(06)11013-7; Gaasenbeek M, 2006, CANCER RES, V66, P3471, DOI 10.1158/0008-5472.CAN-05-3285; Ghadimi BM, 2003, CLIN CANCER RES, V9, P1808; Giefing M, 2011, GENE CHROMOSOME CANC, V50, P154, DOI 10.1002/gcc.20840; Grade M, 2006, CELL ONCOL, V28, P71; Grade M, 2009, CANCER GENET CYTOGEN, V193, P19, DOI 10.1016/j.cancergencyto.2009.03.016; Gu GY, 2011, CANCER GENET-NY, V204, P57, DOI 10.1016/j.cancergencyto.2010.10.003; Hermsen M, 2002, GASTROENTEROLOGY, V123, P1109, DOI 10.1053/gast.2002.36051; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Janavicius R, 2010, CLIN CHEM, V56, P1750, DOI 10.1373/clinchem.2010.150680; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jenkins RB, 1997, CANCER RES, V57, P524; Job B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015145; Kazama Y, 2005, CANCER, V103, P2023, DOI 10.1002/cncr.21022; Kibriya MG, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-50; Knosel T, 2002, VIRCHOWS ARCH, V440, P187, DOI 10.1007/s004280100493; Knosel T, 2003, HISTOPATHOLOGY, V43, P323, DOI 10.1046/j.1365-2559.2003.01720.x; Lanza G, 2011, DIGEST LIVER DIS, V43, pS344, DOI 10.1016/S1590-8658(11)60590-2; Lapunzina P, 2011, BIOL CELL, V103, P303, DOI 10.1042/BC20110013; Lindblom A, 2001, CURR OPIN ONCOL, V13, P63, DOI 10.1097/00001622-200101000-00013; Lips EH, 2007, J PATHOL, V212, P269, DOI 10.1002/path.2180; Lips EH, 2005, CANCER RES, V65, P10188, DOI 10.1158/0008-5472.CAN-05-2486; LOTHE RA, 1993, CANCER RES, V53, P5849; Matsuyama H, 2001, CLIN CANCER RES, V7, P3139; Middeldorp A, 2008, J PATHOL, V216, P25, DOI 10.1002/path.2375; Middeldorp A, 2011, INT J CANC; Moore MA, 2010, ASIAN PAC J CANCER P, V11, P49; Moskaluk CA, 1998, GENE CHROMOSOME CANC, V22, P305, DOI 10.1002/(SICI)1098-2264(199808)22:4<305::AID-GCC6>3.3.CO;2-U; Nakao K, 2004, CARCINOGENESIS, V25, P1345, DOI 10.1093/carcin/bgh134; Nakao M, 2009, CANCER GENET CYTOGEN, V188, P70, DOI 10.1016/j.cancergencyto.2008.09.013; Nancarrow DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001093; Nymark P, 2006, CANCER RES, V66, P5737, DOI 10.1158/0008-5472.CAN-06-0199; Peng DF, 2003, J PATHOL, V201, P439, DOI 10.1002/path.1459; Pettus JA, 2004, CANCER GENET CYTOGEN, V154, P110, DOI 10.1016/j.cancergencyto.2004.05.019; Pino MS, 2010, GASTROENTEROLOGY, V138, P2059, DOI 10.1053/j.gastro.2009.12.065; Reid JF, 2009, GENE CHROMOSOME CANC, V48, P953, DOI 10.1002/gcc.20697; Ried T, 1996, GENE CHROMOSOME CANC, V15, P234, DOI 10.1002/(SICI)1098-2264(199604)15:4<234::AID-GCC5>3.0.CO;2-2; Sandberg AA, 2010, CANCER GENET CYTOGEN, V203, P102, DOI 10.1016/j.cancergencyto.2010.10.004; Sheffer M, 2009, P NATL ACAD SCI USA, V106, P7131, DOI 10.1073/pnas.0902232106; Sillars-Hardebol AH, 2010, TUMOR BIOL, V31, P89, DOI 10.1007/s13277-009-0012-1; Uchida M, 2010, J PATHOL, V221, P96, DOI 10.1002/path.2686; Watanabe T, 2001, NEW ENGL J MED, V344, P1196, DOI 10.1056/NEJM200104193441603; Zhang C, 2010, ACTA BIOCH BIOPH SIN, V42, P834, DOI 10.1093/abbs/gmq088; Zhu F, 2010, NUCLEIC ACIDS RES, V38, pD787, DOI 10.1093/nar/gkp1014	62	39	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31968	10.1371/journal.pone.0031968	http://dx.doi.org/10.1371/journal.pone.0031968			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363777	Green Submitted, Green Published, gold			2022-12-27	WOS:000302871500100
J	Shenfeld, M; Hachmo, Y; Frenkel, M; Dafni, N; Boettcher, M; Hoheisel, JD; Dotan, I; Canaani, D				Shenfeld, Michal; Hachmo, Yafit; Frenkel, Moran; Dafni, Naomi; Boettcher, Michael; Hoheisel, Joerg D.; Dotan, Iris; Canaani, Dan			ER-Alpha-cDNA As Part of a Bicistronic Transcript Gives Rise to High Frequency, Long Term, Receptor Expressing Cell Clones	PLOS ONE			English	Article							BREAST-CANCER; SYNTHETIC LETHALITY; GENE-EXPRESSION; IRES; ACTIVATION; RESISTANT; CONSENSUS; CREATION; VECTORS; THERAPY	Within the large group of Estrogen Receptor alpha (ER alpha)-negative breast cancer patients, there is a subgroup carrying the phenotype ER alpha(-), PR-, and Her2(-), named accordingly "Triple-Negative'' (TN). Using cell lines derived from this TN group, we wished to establish cell clones, in which ER alpha is ectopically expressed, forming part of a synthetic lethality screening system. Initially, we generated cell transfectants expressing a mono-cistronic ER alpha transcription unit, adjacent to a separate dominant selectable marker transcription unit. However, the yield of ER alpha expressing colonies was rather low (5-12.5%), and only about half of these displayed stable ectopic ER alpha expression over time. Generation and maintenance of such cell clones under minimal exposure to the ER alpha ligand, did not improve yield or expression stability. Indeed, other groups have also reported grave difficulties in obtaining ectopic expression of ER alpha in ER alpha-deficient breast carcinoma cells. We therefore switched to transfecting these cell lines with pER alpha-IRES, a plasmid vector encoding a bicistronic translation mRNA template: ER alpha Open Reading Frame (ORF) being upstream followed by a dominant-positive selectable marker (hygro(R)) ORF, directed for translation from an Internal Ribosome Entry Site (IRES). Through usage of this bicistronic vector linkage system, it was possible to generate a very high yield of ER alpha expressing cell clones (50-100%). The stability over time of these clones was also somewhat improved, though variations between individual cell clones were evident. Our successful experience with ER alpha in this system may serve as a paradigm for other genes where ectopic expression meets similar hardships.	[Shenfeld, Michal; Hachmo, Yafit; Frenkel, Moran; Dafni, Naomi; Dotan, Iris; Canaani, Dan] Tel Aviv Univ, Fac Life Sci, Dept Biochem & Mol Biol, Ramat Aviv, Israel; [Boettcher, Michael; Hoheisel, Joerg D.] Deutsch Krebsforschungszentrum, Dept Funct Genome Anal, D-6900 Heidelberg, Germany	Tel Aviv University; Helmholtz Association; German Cancer Research Center (DKFZ)	Shenfeld, M (corresponding author), Tel Aviv Univ, Fac Life Sci, Dept Biochem & Mol Biol, Ramat Aviv, Israel.	canaani@post.tau.ac.il		Boettcher, Michael/0000-0003-0986-4465	German-Israeli Foundation for Scientific Development; Israel Cancer Research Fund; David Orgler Fund for Cancer Research	German-Israeli Foundation for Scientific Development(German-Israeli Foundation for Scientific Research and Development); Israel Cancer Research Fund; David Orgler Fund for Cancer Research	This work was funded by a grant to DC and JDH from the G.I.F., the German-Israeli Foundation for Scientific Development. DC was also supported by Israel Cancer Research Fund project grant, and the David Orgler Fund for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boettcher M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-7; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Canaani D, 2009, BRIT J CANCER, V100, P1213, DOI 10.1038/sj.bjc.6605000; Douin V, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-16; GARCIA M, 1992, P NATL ACAD SCI USA, V89, P11538, DOI 10.1073/pnas.89.23.11538; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gurtu V, 1996, BIOCHEM BIOPH RES CO, V229, P295, DOI 10.1006/bbrc.1996.1795; Hartwell LH, 1997, SCIENCE, V278, P1064, DOI 10.1126/science.278.5340.1064; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; JIANG SY, 1992, JNCI-J NATL CANCER I, V84, P580, DOI 10.1093/jnci/84.8.580; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kreike B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1771; Lev DC, 2003, CLIN EXP METASTAS, V20, P515; Lewis JS, 2005, J STEROID BIOCHEM, V94, P131, DOI 10.1016/j.jsbmb.2004.12.032; Lord CJ, 2008, CURR OPIN PHARMACOL, V8, P363, DOI 10.1016/j.coph.2008.06.016; Mak HY, 2001, MOL CELL BIOL, V21, P4379, DOI 10.1128/MCB.21.13.4379-4390.2001; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Planas-Silva MD, 1999, CANCER RES, V59, P4788; PRICE JE, 1990, CANCER RES, V50, P717; Rees S, 1996, BIOTECHNIQUES, V20, P102; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; WANG H, 1995, J BIOL CHEM, V270, P23322, DOI 10.1074/jbc.270.40.23322; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	27	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31977	10.1371/journal.pone.0031977	http://dx.doi.org/10.1371/journal.pone.0031977			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363779	Green Submitted, Green Published, gold			2022-12-27	WOS:000302871500101
J	Chang, J; Dinney, CP; Huang, MS; Wu, XF; Gu, J				Chang, Joshua; Dinney, Colin P.; Huang, Maosheng; Wu, Xifeng; Gu, Jian			Genetic Variants in Telomere-Maintenance Genes and Bladder Cancer Risk	PLOS ONE			English	Article							LENGTH; SUSCEPTIBILITY; ASSOCIATION; EXPRESSION; SHELTERIN	Telomeres are critical in maintaining genomic stability. Genetic variants in telomere pathway genes may affect telomere and telomerase function, and subsequently cancer risk. We evaluated 126 SNPs from 10 genes related to telomere regulation in relation to bladder cancer risk. Five SNPs, 4 from TEP1 gene and 1 from PINX1 gene, were found to be highly significant (P<0.01). Out of these, the most significant association was found in rs2228041 of TEP1 (OR 1.66, 95% CI 1.19-2.31) while rs1469557 of PINX1 had a protective effect (OR 0.75, 95% CI 0.61-0.93). Haplotype analysis showed that a TEP1 haplotype consisting of the variant alleles of 7 SNPs exhibited a 2.28 fold increased risk (95% CI 1.13-4.60). We then performed cumulative analysis of multiple risk variants, as well as Classification and Regression Tree (CART) to look for gene-gene interactions. In cumulative effect analysis, the group with 4-5 risk variants had an OR of 2.57 (95% CI = 1.62-4.09) versus the reference group with 0 risk variants. The CART analysis categorized individuals into five subgroups with different bladder cancer risk profiles based on their distinct genotype background. To our knowledge, this is one of the largest, most comprehensive studies on bladder cancer risk concerning telomere-regulating pathway gene SNPs and our results support that genetic variations of telomere maintenance modulate bladder cancer risk individually and jointly.	[Chang, Joshua; Wu, Xifeng; Gu, Jian] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Dinney, Colin P.] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Chang, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.	jiangu@mdanderson.org	Gu, Jian/Q-4780-2018	Gu, Jian/0000-0003-3499-0973; Dinney, Colin/0000-0002-8969-711X	National Institutes of Health [CA131335, CA74880, CA91846, CA127615]; NATIONAL CANCER INSTITUTE [R01CA131335, R01CA074880, U01CA127615, P50CA091846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health grants CA131335, CA74880, CA91846, and CA127615. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew AS, 2009, HUM GENET, V125, P527, DOI 10.1007/s00439-009-0645-6; Artandi SE, 2002, P NATL ACAD SCI USA, V99, P8191, DOI 10.1073/pnas.112515399; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Baird DM, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S146239941000147X; Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Broberg K, 2005, CARCINOGENESIS, V26, P1263, DOI 10.1093/carcin/bgi063; Carreon T, 2006, FRONT BIOSCI-LANDMRK, V11, P2889, DOI 10.2741/2017; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DELANGE T, 1995, TELOMERES, P265; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Greider CW, 1998, P NATL ACAD SCI USA, V95, P90, DOI 10.1073/pnas.95.1.90; Hiyama E, 2003, CANCER LETT, V194, P221, DOI 10.1016/S0304-3835(02)00709-7; Jeanclos E, 2000, HYPERTENSION, V36, P195, DOI 10.1161/01.HYP.36.2.195; Klapper W, 2001, MECH AGEING DEV, V122, P695, DOI 10.1016/S0047-6374(01)00223-8; Mathon NE, 2001, NAT REV CANCER, V1, P203, DOI 10.1038/35106045; Mavrommatis J, 2005, ANTICANCER RES, V25, P3109; McGrath M, 2007, CANCER EPIDEM BIOMAR, V16, P815, DOI 10.1158/1055-9965.EPI-06-0961; Mirabello L, 2010, CANCER CAUSE CONTROL, V21, P77, DOI 10.1007/s10552-009-9436-6; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Risques RA, 2007, CANCER EPIDEM BIOMAR, V16, P2649, DOI 10.1158/1055-9965.EPI-07-0624; Shao L, 2007, J UROLOGY, V178, P1492, DOI 10.1016/j.juro.2007.05.112; Smith NL, 2007, JAMA-J AM MED ASSOC, V297, P489, DOI 10.1001/jama.297.5.489; Terry PD, 2006, INT J CANCER, V118, P3170, DOI 10.1002/ijc.21768; Verfaillie Catherine M, 2002, Hematology Am Soc Hematol Educ Program, P369; Wentzensen IM, 2011, CANCER EPIDEM BIOMAR, V20, P1238, DOI 10.1158/1055-9965.EPI-11-0005; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011; Wu XF, 2007, FRONT BIOSCI-LANDMRK, V12, P192, DOI 10.2741/2058; Zheng YL, 2011, HUM MOL GENET, V20, P378, DOI 10.1093/hmg/ddq461; Zhou XZ, 2011, J CLIN INVEST, V121, P1266, DOI 10.1172/JCI43452; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4	33	14	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30665	10.1371/journal.pone.0030665	http://dx.doi.org/10.1371/journal.pone.0030665			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363464	Green Published, gold			2022-12-27	WOS:000302853600050
J	de la Concha, EG; Cavanillas, ML; Cenit, MC; Urcelay, E; Arroyo, R; Fernandez, O; Alvarez-Cermeno, JC; Leyva, L; Villar, LM; Nunez, C				de la Concha, Emilio G.; Cavanillas, Maria L.; Cenit, M. Carmen; Urcelay, Elena; Arroyo, Rafael; Fernandez, Oscar; Alvarez-Cermeno, Jose C.; Leyva, Laura; Villar, Luisa M.; Nunez, Concepcion			DRB1*03:01 Haplotypes: Differential Contribution to Multiple Sclerosis Risk and Specific Association with the Presence of Intrathecal IgM Bands	PLOS ONE			English	Article							OLIGOCLONAL IGM; DISEASE COURSE; SUSCEPTIBILITY; ALLELES; POLYMORPHISM; POPULATION; RESISTANCE; SARDINIA; HLA-DRB1; PREDICTS	Background: Multiple sclerosis (MS) is a multifactorial disease with a genetic basis. The strongest associations with the disease lie in the Human Leukocyte Antigen (HLA) region. However, except for the DRB1*15:01 allele, the main risk factor associated to MS so far, no consistent effect has been described for any other variant. One example is HLA-DRB1*03:01, with a heterogeneous effect across populations and studies. We postulate that those discrepancies could be due to differences in the diverse haplotypes bearing that allele. Thus, we aimed at studying the association of DRB1*03:01 with MS susceptibility considering this allele globally and stratified by haplotypes. We also evaluated the association with the presence of oligoclonal IgM bands against myelin lipids (OCMB) in cerebrospinal fluid. Methods: Genotyping of HLA-B, -DRB1 and -DQA1 was performed in 1068 MS patients and 624 ethnically matched healthy controls. One hundred and thirty-nine MS patients were classified according to the presence (M+, 58 patients)/absence (M-, 81 patients) of OCMB. Comparisons between groups (MS patients vs. controls and M+ vs. M-) were performed with the chisquare test or the Fisher exact test. Results: Association of DRB1*03: 01 with MS susceptibility was observed but with different haplotypic contribution, being the ancestral haplotype (AH) 18.2 the one causing the highest risk. Comparisons between M+, M- and controls showed that the AH 18.2 was affecting only M+ individuals, conferring a risk similar to that caused by DRB1*15:01. Conclusions: The diverse DRB1*03:01-containing haplotypes contribute with different risk to MS susceptibility. The AH 18.2 causes the highest risk and affects only to individuals showing OCMB.	[de la Concha, Emilio G.; Cavanillas, Maria L.; Cenit, M. Carmen; Urcelay, Elena; Nunez, Concepcion] Hosp Clin San Carlos, Inst Invest Sanitaria San Carlos IdISSC, Dept Clin Immunol, Madrid, Spain; [Arroyo, Rafael] Hosp Clin San Carlos, Inst Invest Sanitaria San Carlos IdISSC, Dept Neurol, Madrid, Spain; [Fernandez, Oscar] Hosp Reg Univ Carlos Haya, Clin Neurosci Inst, Dept Neurol, Malaga, Spain; [Alvarez-Cermeno, Jose C.] Hosp Ramon & Cajal, Dept Neurol, E-28034 Madrid, Spain; [Leyva, Laura] Hosp Reg Univ Carlos Haya & Fdn IMABIS, Clin Neurosci Inst, Res Lab, Malaga, Spain; [Villar, Luisa M.] Hosp Ramon & Cajal, Dept Immunol, E-28034 Madrid, Spain	Hospital Clinico San Carlos; Hospital Clinico San Carlos; Hospital Carlos Haya; Hospital Universitario Ramon y Cajal; Hospital Universitario Ramon y Cajal	de la Concha, EG (corresponding author), Hosp Clin San Carlos, Inst Invest Sanitaria San Carlos IdISSC, Dept Clin Immunol, Madrid, Spain.	conchita.npardo@gmail.com	Cenit, Maria Carmen MC/E-9538-2017; Leyva, Laura/B-5574-2019; Leyva, Laura/R-2187-2019	Cenit, Maria Carmen MC/0000-0001-8667-5313; Leyva, Laura/0000-0003-0620-9625; Leyva, Laura/0000-0003-0620-9625; Urcelay, Elena/0000-0001-8470-8396; Villar, Luisa M/0000-0002-9067-3668	Fondo de Investigaciones Sanitarias [PI10/1985]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III)	This work was supported by project PI10/1985 from "Fondo de Investigaciones Sanitarias". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcellos LF, 2006, HUM MOL GENET, V15, P2813, DOI 10.1093/hmg/ddl223; Baschal EE, 2009, CLIN IMMUNOL, V132, P203, DOI 10.1016/j.clim.2009.03.530; Benedek G, 2010, GENES IMMUN, V11, P423, DOI 10.1038/gene.2010.20; Bosca I, 2010, MULT SCLER J, V16, P810, DOI 10.1177/1352458510371961; Dyment DA, 2005, HUM MOL GENET, V14, P2019, DOI 10.1093/hmg/ddi206; Fernandez-Arquero M, 1999, NEUROLOGY, V53, P1361, DOI 10.1212/WNL.53.6.1361; Garcia-Barragan N, 2009, EUR J NEUROL, V16, P380, DOI 10.1111/j.1468-1331.2008.02504.x; Lincoln MR, 2009, P NATL ACAD SCI USA, V106, P7542, DOI 10.1073/pnas.0812664106; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marrosu MG, 2001, HUM MOL GENET, V10, P2907, DOI 10.1093/hmg/10.25.2907; Marrosu MG, 1997, AM J HUM GENET, V61, P454; Martinez A, 2004, NEUROLOGY, V62, P809, DOI 10.1212/01.WNL.0000113722.93895.8B; Masterman T, 2000, ANN NEUROL, V48, P211, DOI 10.1002/1531-8249(200008)48:2<211::AID-ANA11>3.3.CO;2-I; NEDOSPASOV SA, 1991, J IMMUNOL, V147, P1053; Perini P, 2006, J NEUROL NEUROSUR PS, V77, P953, DOI 10.1136/jnnp.2005.086116; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Ramagopalan SV, 2007, PLOS GENET, V3, P1607, DOI 10.1371/journal.pgen.0030150; Thangarajh M, 2008, MULT SCLER J, V14, P1208, DOI 10.1177/1352458508095729; Villar LM, 2005, J CLIN INVEST, V115, P187, DOI 10.1172/JCI200522833; Villar LM, 2010, CLIN IMMUNOL, V137, P51, DOI 10.1016/j.clim.2010.06.007	20	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31018	10.1371/journal.pone.0031018	http://dx.doi.org/10.1371/journal.pone.0031018			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363536	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600097
J	Thoby-Brisson, M; Bouvier, J; Glasco, DM; Stewart, ME; Dean, C; Murdoch, JN; Champagnat, J; Fortin, G; Chandrasekhar, A				Thoby-Brisson, Muriel; Bouvier, Julien; Glasco, Derrick M.; Stewart, Michelle E.; Dean, Charlotte; Murdoch, Jennifer N.; Champagnat, Jean; Fortin, Gilles; Chandrasekhar, Anand			Brainstem Respiratory Oscillators Develop Independently of Neuronal Migration Defects in the Wnt/PCP Mouse Mutant looptail	PLOS ONE			English	Article							BRANCHIOMOTOR NEURONS; MOTOR-NEURONS; NEURAL-TUBE; HINDBRAIN; PHOX2B; RHYTHM; GENE; CHEMOSENSITIVITY; ZEBRAFISH; IDENTIFICATION	The proper development and maturation of neuronal circuits require precise migration of component neurons from their birthplace (germinal zone) to their final positions. Little is known about the effects of aberrant neuronal position on the functioning of organized neuronal groups, especially in mammals. Here, we investigated the formation and properties of brainstem respiratory neurons in looptail (Lp) mutant mice in which facial motor neurons closely apposed to some respiratory neurons fail to migrate due to loss of function of the Wnt/Planar Cell Polarity (PCP) protein Vangl2. Using calcium imaging and immunostaining on embryonic hindbrain preparations, we found that respiratory neurons constituting the embryonic parafacial oscillator (e-pF) settled at the ventral surface of the medulla in Vangl2(Lp/+) and Vangl2(Lp/Lp) embryos despite the failure of tangential migration of its normally adjacent facial motor nucleus. Anatomically, the e-pF neurons were displaced medially in Lp/+ embryos and rostro-medially Lp/Lp embryos. Pharmacological treatments showed that the e-pF oscillator exhibited characteristic network properties in both Lp/+ and Lp/Lp embryos. Furthermore, using hindbrain slices, we found that the other respiratory oscillator, the preBotzinger complex, was also anatomically and functionally established in Lp mutants. Importantly, the displaced e-pF oscillator established functional connections with the preBotC oscillator in Lp/+ mutants. Our data highlight the robustness of the developmental processes that assemble the neuronal networks mediating an essential physiological function.	[Thoby-Brisson, Muriel; Bouvier, Julien; Champagnat, Jean; Fortin, Gilles] CNRS Inst Neurobiol A Fessard, Neurobiol & Dev UPR 3294, Gif Sur Yvette, France; [Glasco, Derrick M.; Chandrasekhar, Anand] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Glasco, Derrick M.; Chandrasekhar, Anand] Univ Missouri, Bond Life Sci Ctr, Columbia, MO USA; [Stewart, Michelle E.; Dean, Charlotte; Murdoch, Jennifer N.] Med Res Council Harwell, Mammalian Genet Unit, Oxford, England; [Chandrasekhar, Anand] Univ Missouri, Interdisciplinary Neurosci Program, Columbia, MO USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Missouri System; University of Missouri Columbia	Thoby-Brisson, M (corresponding author), Univ Bordeaux 2, CNRS Inst Neurosci Cognit & Integrat Aquitaine, UMR 5287, F-33076 Bordeaux, France.	muriel.thoby-brisson@u-bordeaux2.fr; AnandC@missouri.edu	Thoby-Brisson, Muriel/E-1167-2014; Bouvier, Julien/C-1018-2017	Thoby-Brisson, Muriel/0000-0003-3214-1724; Bouvier, Julien/0000-0002-1307-4426; Fortin, Gilles/0000-0002-2123-8603	Centre National de la Recherche Scientifique; Medical Research Council; Institut National de la Sante et de la Recherche Medicale; ANR [ANR-07-Neuro-007-01]; University of Missouri; National Institutes of Health [NS040449]; MRC [G120/861, MC_UP_1502/1] Funding Source: UKRI; Medical Research Council [G120/861, MC_UP_1502/1] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040449, R56NS040449] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); ANR(French National Research Agency (ANR)); University of Missouri; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Centre National de la Recherche Scientifique, the Medical Research Council, Institut National de la Sante et de la Recherche Medicale (M.T.-B.), ANR grant ANR-07-Neuro-007-01 (G. F.), Research Leave (RL-08-013) and Research Council (URC-08-030) grants from the University of Missouri (A. C.), and a National Institutes of Health (NS040449) grant (A. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn D, 2000, MECH DEVELOP, V95, P253, DOI 10.1016/S0925-4773(00)00346-4; AICARDI J, 1994, CAN J NEUROL SCI, V21, P185, DOI 10.1017/S0317167100041159; Bingham S, 2002, DEV BIOL, V242, P149, DOI 10.1006/dbio.2001.0532; Borday C, 2005, RESP PHYSIOL NEUROBI, V149, P63, DOI 10.1016/j.resp.2005.02.014; Bouvier J, 2010, NAT NEUROSCI, V13, P1066, DOI 10.1038/nn.2622; Chandrasekhar A, 2004, DEV DYNAM, V229, P143, DOI 10.1002/dvdy.10444; Dubreuil V, 2008, P NATL ACAD SCI USA, V105, P1067, DOI 10.1073/pnas.0709115105; Dubreuil V, 2009, J NEUROSCI, V29, P14836, DOI 10.1523/JNEUROSCI.2623-09.2009; Garel S, 2000, DEVELOPMENT, V127, P5297; Gilland E, 2005, BRAIN BEHAV EVOLUT, V66, P234, DOI 10.1159/000088128; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Guerrini R, 2010, NEUROBIOL DIS, V38, P154, DOI 10.1016/j.nbd.2009.02.008; Huckstepp RTR, 2010, J PHYSIOL-LONDON, V588, P3901, DOI 10.1113/jphysiol.2010.192088; Janczewski WA, 2006, J PHYSIOL-LONDON, V570, P407, DOI 10.1113/jphysiol.2005.098848; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Kraus F, 2001, MECH DEVELOP, V100, P87, DOI 10.1016/S0925-4773(00)00499-8; Lalonde R, 2007, BRAIN RES, V1140, P51, DOI 10.1016/j.brainres.2006.01.031; Merte J, 2010, NAT CELL BIOL, V12, P41, DOI 10.1038/ncb2002; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Mulkey DK, 2004, NAT NEUROSCI, V7, P1360, DOI 10.1038/nn1357; Onimaru H, 2003, J NEUROSCI, V23, P1478, DOI 10.1523/JNEUROSCI.23-04-01478.2003; Onimaru H, 2008, J NEUROSCI, V28, P12845, DOI 10.1523/JNEUROSCI.3625-08.2008; Pattyn A, 2000, DEVELOPMENT, V127, P1349; Paudyal A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-87; Rose MF, 2009, NEURON, V64, P341, DOI 10.1016/j.neuron.2009.10.023; SCHNEIDERMAUNOURY S, 1993, CELL, V75, P1199, DOI 10.1016/0092-8674(93)90329-O; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Song MR, 2007, ARCH PHARM RES, V30, P1273, DOI 10.1007/BF02980268; Studer M, 1996, NATURE, V384, P630, DOI 10.1038/384630a0; Thoby-Brisson M, 2005, J NEUROSCI, V25, P4307, DOI 10.1523/JNEUROSCI.0551-05.2005; Thoby-Brisson M, 2009, NAT NEUROSCI, V12, P1028, DOI 10.1038/nn.2354; Torban E, 2007, GENE EXPR PATTERNS, V7, P346, DOI 10.1016/j.modgep.2006.07.007; Verrotti A, 2010, EUR J PAEDIATR NEURO, V14, P1, DOI 10.1016/j.ejpn.2009.01.005; Vivancos V, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-7	34	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31140	10.1371/journal.pone.0031140	http://dx.doi.org/10.1371/journal.pone.0031140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363567	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600116
J	Zuno-Floriano, FG; Miller, MG; Aldana-Madrid, ML; Hengel, MJ; Gaikwad, NW; Tolstikov, V; Contreras-Cortes, AG				Zuno-Floriano, Fabiola G.; Miller, Marion G.; Aldana-Madrid, Maria L.; Hengel, Matt J.; Gaikwad, Nilesh W.; Tolstikov, Vladimir; Contreras-Cortes, Ana G.			Effect of Acinetobacter sp on Metalaxyl Degradation and Metabolite Profile of Potato Seedlings (Solanum tuberosum L.) Alpha Variety	PLOS ONE			English	Article							PLANT-GROWTH; PSEUDOMONAS-FLUORESCENS; BACTERIAL ENDOPHYTES; SUSPENSION-CULTURES; 16S RDNA; COLONIZATION; ROOTS; BIODEGRADATION; MICROORGANISMS; IDENTIFICATION	One of the most serious diseases in potato cultivars is caused by the pathogen Phytophthora infestans, which affects leaves, stems and tubers. Metalaxyl is a fungicide that protects potato plants from Phytophthora infestans. In Mexico, farmers apply metalaxyl 35 times during the cycle of potato production and the last application is typically 15 days before harvest. There are no records related to the presence of metalaxyl in potato tubers in Mexico. In the present study, we evaluated the effect of Acinetobacter sp on metalaxyl degradation in potato seedlings. The effect of bacteria and metalaxyl on the growth of potato seedlings was also evaluated. A metabolite profile analysis was conducted to determine potential molecular biomarkers produced by potato seedlings in the presence of Acinetobacter sp and metalaxyl. Metalaxyl did not affect the growth of potato seedlings. However, Acinetobacter sp strongly affected the growth of inoculated seedlings, as confirmed by plant length and plant fresh weights which were lower in inoculated potato seedlings (40% and 27%, respectively) compared to the controls. Acinetobacter sp also affected root formation. Inoculated potato seedlings showed a decrease in root formation compared to the controls. LC-MS/MS analysis of metalaxyl residues in potato seedlings suggests that Acinetobacter sp did not degrade metalaxyl. GC-TOF-MS platform was used in metabolic profiling studies. Statistical data analysis and metabolic pathway analysis allowed suggesting the alteration of metabolic pathways by both Acinetobacter sp infection and metalaxyl treatment. Several hundred metabolites were detected, 137 metabolites were identified and 15 metabolic markers were suggested based on statistical change significance found with PLS-DA analysis. These results are important for better understanding the interactions of putative endophytic bacteria and pesticides on plants and their possible effects on plant metabolism.	[Zuno-Floriano, Fabiola G.; Miller, Marion G.; Hengel, Matt J.; Gaikwad, Nilesh W.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Aldana-Madrid, Maria L.] Univ Sonora, Dept Invest & Posgrad Alimentos, Hermosillo 83000, Sonora, Mexico; [Contreras-Cortes, Ana G.] Ctr Interdisciplinario Invest Desarrollo Integral, Dept Biotecnol, Morelia, Michoacan, Mexico; [Gaikwad, Nilesh W.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Tolstikov, Vladimir] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA	University of California System; University of California Davis; Universidad de Sonora; University of California System; University of California Davis; University of California System; University of California Davis	Zuno-Floriano, FG (corresponding author), Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA.	fgzuno@ucdavis.edu	Tolstikov, Vladimir/P-2465-2019	Tolstikov, Vladimir/0000-0002-0445-884X	National Institute of Environmental Health Science (NIEHS) [T32E507059]; University of California Institute for Mexico; United States (UC MEXUS-CONACyT) [CN-07-55]	National Institute of Environmental Health Science (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); University of California Institute for Mexico; United States (UC MEXUS-CONACyT)	This study has been carried out with financial support from the National Institute of Environmental Health Science (NIEHS) Postdoctoral Training Grant T32E507059 and University of California Institute for Mexico and the United States (UC MEXUS-CONACyT) No. CN-07-55. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna IB, 2008, MANEJO INTEGRADO TIZ; Adachi K, 2002, SOIL SCI PLANT NUTR, V48, P889, DOI 10.1080/00380768.2002.10408717; Alonso FA, 2002, CULTIVO PATATA, P155; Andreote FD, 2010, ANTON LEEUW INT J G, V97, P389, DOI 10.1007/s10482-010-9421-9; Araujo WL, 2002, APPL ENVIRON MICROB, V68, P4906, DOI 10.1128/AEM.68.10.4906-4914.2002; BAILEY AM, 1986, CAN J MICROBIOL, V32, P562, DOI 10.1139/m86-105; Barka EA, 2000, FEMS MICROBIOL LETT, V186, P91, DOI 10.1111/j.1574-6968.2000.tb09087.x; BioRad, 1994, BIORAD B; Borba N., 2008, PAPA ALIMENTO BASICO; BUSINELLI M, 1984, J AGR FOOD CHEM, V32, P644, DOI 10.1021/jf00123a054; Chanika E, 2011, BIORESOURCE TECHNOL, V102, P3184, DOI 10.1016/j.biortech.2010.10.145; Claassens MMJ, 2000, POTATO RES, V43, P347, DOI 10.1007/BF02360540; COLE DJ, 1987, PESTIC BIOCHEM PHYS, V28, P354, DOI 10.1016/0048-3575(87)90131-3; Defernez M, 2004, J AGR FOOD CHEM, V52, P6075, DOI 10.1021/jf049522e; Dini FA, 2009, APPL ENVIRON MICROB, V75, P3396; Elvira-Recuenco M, 2000, CAN J MICROBIOL, V46, P1036, DOI 10.1139/cjm-46-11-1036; Farre EM, 2001, PLANT PHYSIOL, V127, P685, DOI 10.1104/pp.127.2.685; Fiehn O, 2008, PLANT J, V53, P691, DOI 10.1111/j.1365-313X.2007.03387.x; Food and Agriculture Organization of the United Nations, 1995, PEST RES FOOD 1995 1; FROMMEL MI, 1993, PLANT SOIL, V150, P51, DOI 10.1007/BF00779175; Garbeva P, 2001, MICROBIAL ECOL, V41, P369, DOI 10.1007/s002480000096; Garcia-Gonzalez M. M., 2005, Terra, V23, P65; Germaine K, 2004, FEMS MICROBIOL ECOL, V48, P109, DOI 10.1016/j.femsec.2003.12.009; Germaine KJ, 2006, FEMS MICROBIOL ECOL, V57, P302, DOI 10.1111/j.1574-6941.2006.00121.x; GRIFONI A, 1995, FEMS MICROBIOL LETT, V127, P85, DOI 10.1111/j.1574-6968.1995.tb07454.x; GROSS D, 1986, 6 INT C PEST CHEM OT; Hamilton D, 2004, METALAXYL M 212; Hansen M, 1997, FEMS MICROBIOL ECOL, V23, P353, DOI 10.1111/j.1574-6941.1997.tb00416.x; Hartmann A, 2000, ANAL PRESENCE DIVERS, P927; Holland MA, 1997, PLANT PHYSIOL, V115, P865, DOI 10.1104/pp.115.3.865; Hongsawat P, 2011, J HAZARD MATER, V186, P1300, DOI 10.1016/j.jhazmat.2010.12.002; Kamrin MA, 1997, PESTICIDE PROFILES T, P437; Liu FY, 2007, J ENVIRON SCI, V19, P1257, DOI 10.1016/S1001-0742(07)60205-8; Ma Y, 2011, J HAZARD MATER, V195, P230, DOI 10.1016/j.jhazmat.2011.08.034; Martinez L, 2003, PLANT SOIL, V257, P35, DOI 10.1023/A:1026283311770; Massoud AH, 2008, J ENVIRON SCI, V20, P262, DOI 10.1016/S1001-0742(08)60041-8; McGuinness MC, 2007, ENG LIFE SCI, V7, P611, DOI 10.1002/elsc.200720218; McGuinness M, 2009, INT J ENV RES PUB HE, V6, P2226, DOI 10.3390/ijerph6082226; Mehta N, 1997, ECOTOX ENVIRON SAFE, V37, P119, DOI 10.1006/eesa.1997.1533; NELSON LM, 2004, PLANT GROWTH PROMOTI; Nowak J, 1999, POTATO RES, V42, P505, DOI 10.1007/BF02358167; OWEN WJ, 1986, PESTIC BIOCHEM PHYS, V26, P75, DOI 10.1016/0048-3575(86)90064-7; Pelczar M, 1988, ELEMENTOS MICROBIOLO, P95; Pelczar M, 1998, MICROBIOLOGIA, P60; Pena HB, 2007, INTERCIENCIA, V32, P560; Prieto P, 2008, FEMS MICROBIOL ECOL, V64, P297, DOI 10.1111/j.1574-6941.2008.00450.x; Purez W., 2008, MANUAL TECNICO TIZON; Rainey PB, 1999, ENVIRON MICROBIOL, V1, P243, DOI 10.1046/j.1462-2920.1999.00040.x; Reinhold-Hurek B, 2011, CURR OPIN PLANT BIOL, V14, P435, DOI 10.1016/j.pbi.2011.04.004; Riveros B. F., 2003, Agricultura Tecnica, V63, P117; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; Rosenblueth M, 2006, MOL PLANT MICROBE IN, V19, P827, DOI 10.1094/MPMI-19-0827; Ryan RP, 2008, FEMS MICROBIOL LETT, V278, P1, DOI 10.1111/j.1574-6968.2007.00918.x; Sahay NS, 1999, FEMS MICROBIOL LETT, V181, P297, DOI 10.1111/j.1574-6968.1999.tb08858.x; Singh P, 2004, BIOCHEM BIOPH RES CO, V317, P697, DOI 10.1016/j.bbrc.2004.03.112; Staden J. Van, 1979, Plant, Cell and Environment, V2, P93, DOI 10.1111/j.1365-3040.1979.tb00780.x; Strobel G, 2004, J NAT PROD, V67, P257, DOI 10.1021/np030397v; Sturz AV, 2000, APPL SOIL ECOL, V15, P183, DOI 10.1016/S0929-1393(00)00094-9; STURZ AV, 1995, PLANT SOIL, V175, P257, DOI 10.1007/BF00011362; Sukul P, 2000, REV ENVIRON CONTAM T, V164, P1; Thurston HD, 1990, LATE BLIGHT COMPENDI, P40; Tolstikov V, 2011, MET BIOM DISC PROJ M; Torres-Rubio M. G., 2000, Revista Latinoamericana de Microbiologia, V42, P171; Turnbull GA, 2001, FEMS MICROBIOL ECOL, V36, P21, DOI 10.1111/j.1574-6941.2001.tb00822.x; Verma SC, 2004, BIOTECHNOL LETT, V26, P425, DOI 10.1023/B:BILE.0000018263.94440.ab; VISSER RGF, 1994, PHYSIOL PLANTARUM, V90, P285, DOI [10.1111/j.1399-3054.1994.tb00389.x, 10.1034/j.1399-3054.1994.900207.x]; Weyens N, 2009, CURR OPIN BIOTECH, V20, P248, DOI 10.1016/j.copbio.2009.02.012; World Health Organization and Food and Agriculture Organization of the United Nations, 2004, ORGANIZATION; Xie S, 2009, J ENVIRON SCI, V21, P76, DOI 10.1016/S1001-0742(09)60014-0; Yanni YG, 2001, AUST J PLANT PHYSIOL, V28, P845, DOI 10.1071/PP01069; Zadra C, 2002, J AGR FOOD CHEM, V50, P5373, DOI 10.1021/jf020310w; Zuno-Floriano Fabiola G., 2009, Terra Latinoam, V27, P207	72	6	6	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31221	10.1371/journal.pone.0031221	http://dx.doi.org/10.1371/journal.pone.0031221			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363586	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600125
J	Seki, T; Yoshino, K; Tanaka, S; Dohi, E; Onji, T; Yamamoto, K; Hide, I; Paulson, HL; Saito, N; Sakai, N				Seki, Takahiro; Yoshino, Ken-ich; Tanaka, Shigeru; Dohi, Eisuke; Onji, Tomoya; Yamamoto, Kazuhiro; Hide, Izumi; Paulson, Henry L.; Saito, Naoaki; Sakai, Norio			Establishment of a Novel Fluorescence-Based Method to Evaluate Chaperone-Mediated Autophagy in a Single Neuron	PLOS ONE			English	Article							SPINOCEREBELLAR ATAXIA TYPE-14; PROTEIN-DEGRADATION; OXIDATIVE STRESS; TRANSGENIC MICE; ALPHA-SYNUCLEIN; PKC-GAMMA; CELLS; DISEASE; IDENTIFICATION; NEURODEGENERATION	Background: Chaperone-mediated autophagy (CMA) is a selective autophagy-lysosome protein degradation pathway. The role of CMA in normal neuronal functions and in neural disease pathogenesis remains unclear, in part because there is no available method to monitor CMA activity at the single-cell level. Methodology/Principal Findings: We sought to establish a single-cell monitoring method by visualizing translocation of CMA substrates from the cytosol to lysosomes using the HaloTag (HT) system. GAPDH, a CMA substrate, was fused to HT (GAPDH-HT); this protein accumulated in the lysosomes of HeLa cells and cultured cerebellar Purkinje cells (PCs) after labeling with fluorescent dye-conjugated HT ligand. Lysosomal accumulation was enhanced by treatments that activate CMA and prevented by siRNA-mediated knockdown of LAMP2A, a lysosomal receptor for CMA, and by treatments that inactivate CMA. These results suggest that lysosomal accumulation of GAPDH-HT reflects CMA activity. Using this method, we revealed that mutant gamma PKC, which causes spinocerebellar ataxia type 14, decreased CMA activity in cultured PCs. Conclusion/Significance: In the present study, we established a novel fluorescent-based method to evaluate CMA activity in a single neuron. This novel method should be useful and valuable for evaluating the role of CMA in various neuronal functions and neural disease pathogenesis.	[Seki, Takahiro; Tanaka, Shigeru; Dohi, Eisuke; Onji, Tomoya; Yamamoto, Kazuhiro; Hide, Izumi; Sakai, Norio] Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol & Pharmacol Neurosci, Hiroshima, Japan; [Seki, Takahiro; Paulson, Henry L.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Yoshino, Ken-ich; Saito, Naoaki] Kobe Univ, Biosignal Res Ctr, Mol Pharmacol Lab, Kobe, Hyogo 657, Japan	Hiroshima University; University of Michigan System; University of Michigan; Kobe University	Seki, T (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol & Pharmacol Neurosci, Hiroshima, Japan.	tseki@hiroshima-u.ac.jp	Sakai, Norio/AAM-5822-2021; Dohi, Eisuke/I-7197-2019; Tanaka, Shigeru/O-3908-2015	Sakai, Norio/0000-0002-6648-8761; Tanaka, Shigeru/0000-0003-3247-9098; Seki, Takahiro/0000-0002-9894-4768	Ministry of Education, Sports and Culture; Takeda Science Foundation; Uehara Memorial Foundation; Naito Foundation; Suzuken Memorial Foundation; Tokyo Biochemical Research Foundation; Japanese Smoking Research Association; Grants-in-Aid for Scientific Research [21591086] Funding Source: KAKEN	Ministry of Education, Sports and Culture; Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Suzuken Memorial Foundation; Tokyo Biochemical Research Foundation; Japanese Smoking Research Association; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Sports and Culture and by grants from the Takeda Science Foundation, the Uehara Memorial Foundation, the Naito Foundation, Suzuken Memorial Foundation, the Tokyo Biochemical Research Foundation and the Japanese Smoking Research Association. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Adachi N, 2008, J BIOL CHEM, V283, P19854, DOI 10.1074/jbc.M801492200; Alvarez-Erviti L, 2010, ARCH NEUROL-CHICAGO, V67, P1464, DOI 10.1001/archneurol.2010.198; Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Bandyopadhyay U, 2010, MOL CELL, V39, P535, DOI 10.1016/j.molcel.2010.08.004; Bauer PO, 2010, NAT BIOTECHNOL, V28, P256, DOI 10.1038/nbt.1608; Chen DH, 2003, AM J HUM GENET, V72, P839, DOI 10.1086/373883; Chen DH, 2005, NEUROLOGY, V64, P1258, DOI 10.1212/01.WNL.0000156801.64549.6B; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 2000, J CELL SCI, V113, P4441; DICE JF, 1982, J BIOL CHEM, V257, P4624; Finn PE, 2005, AUTOPHAGY, V1, P141, DOI 10.4161/auto.1.3.2000; GOUGH NR, 1995, DNA CELL BIOL, V14, P863, DOI 10.1089/dna.1995.14.863; Grune T, 2004, INT J BIOCHEM CELL B, V36, P2519, DOI 10.1016/j.biocel.2004.04.020; Hiramoto K, 2006, MOVEMENT DISORD, V21, P1355, DOI 10.1002/mds.20970; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabuta T, 2008, J BIOL CHEM, V283, P23731, DOI 10.1074/jbc.M801918200; Kaushik S, 2008, MOL BIOL CELL, V19, P2179, DOI 10.1091/mbc.E07-11-1155; Kaushik S, 2009, METHOD ENZYMOL, V452, P297, DOI 10.1016/S0076-6879(08)03619-7; Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477; Liu H, 2009, FASEB J, V23, P3383, DOI 10.1096/fj.09-134296; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Majeski AE, 2004, INT J BIOCHEM CELL B, V36, P2435, DOI 10.1016/j.biocel.2004.02.013; Martinez-Vicente M, 2005, EXP GERONTOL, V40, P622, DOI 10.1016/j.exger.2005.07.005; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; McCray BA, 2008, NEUROSIGNALS, V16, P75, DOI 10.1159/000109761; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Ross CA, 2004, TRENDS CELL BIOL, V14, P703, DOI 10.1016/j.tcb.2004.10.006; Rothenberg C, 2010, HUM MOL GENET, V19, P3219, DOI 10.1093/hmg/ddq231; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Sahu R, 2011, DEV CELL, V20, P131, DOI 10.1016/j.devcel.2010.12.003; Sakai N, 2002, MOL PHARMACOL, V61, P1453, DOI 10.1124/mol.61.6.1453; Seki T, 2005, J BIOL CHEM, V280, P29096, DOI 10.1074/jbc.M501716200; Seki T, 2007, EUR J NEUROSCI, V26, P3126, DOI 10.1111/j.1460-9568.2007.05933.x; Seki T, 2009, NEUROBIOL DIS, V33, P260, DOI 10.1016/j.nbd.2008.10.013; Suvorova ES, 2005, TRAFFIC, V6, P100, DOI 10.1111/j.1600-0854.2004.00256.x; Verbeek DS, 2008, J CELL SCI, V121, P2339, DOI 10.1242/jcs.027698; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014	41	34	35	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31232	10.1371/journal.pone.0031232	http://dx.doi.org/10.1371/journal.pone.0031232			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22363588	Green Published, Green Submitted, gold			2022-12-27	WOS:000302180600032
J	Lapalikar, GV; Taylor, MC; Warden, AC; Scott, C; Russell, RJ; Oakeshott, JG				Lapalikar, Gauri V.; Taylor, Matthew C.; Warden, Andrew C.; Scott, Colin; Russell, Robyn J.; Oakeshott, John G.			F420H2-Dependent Degradation of Aflatoxin and other Furanocoumarins Is Widespread throughout the Actinomycetales	PLOS ONE			English	Article							COENZYME F-420; F-420-DEPENDENT GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; MYCOBACTERIUM-TUBERCULOSIS; RHODOCOCCUS-ERYTHROPOLIS; BIOSYNTHESIS; STREPTOMYCES; 2,4,6-TRINITROPHENOL; FLAVIN; B-1; 2,4-DINITROPHENOL	Two classes of F-420-dependent reductases (FDR-A and FDR-B) that can reduce aflatoxins and thereby degrade them have previously been isolated from Mycobacterium smegmatis. One class, the FDR-A enzymes, has up to 100 times more activity than the other. F-420 is a cofactor with a low reduction potential that is largely confined to the Actinomycetales and some Archaea and Proteobacteria. We have heterologously expressed ten FDR-A enzymes from diverse Actinomycetales, finding that nine can also use F420H2 to reduce aflatoxin. Thus FDR-As may be responsible for the previously observed degradation of aflatoxin in other Actinomycetales. The one FDR-A enzyme that we found not to reduce aflatoxin belonged to a distinct clade (herein denoted FDR-AA), and our subsequent expression and analysis of seven other FDR-AAs from M. smegmatis found that none could reduce aflatoxin. Certain FDR-A and FDR-B enzymes that could reduce aflatoxin also showed activity with coumarin and three furanocoumarins (angelicin, 8-methoxysporalen and imperatorin), but none of the FDR-AAs tested showed any of these activities. The shared feature of the compounds that were substrates was an alpha,beta-unsaturated lactone moiety. This moiety occurs in a wide variety of otherwise recalcitrant xenobiotics and antibiotics, so the FDR-As and FDR-Bs may have evolved to harness the reducing power of F-420 to metabolise such compounds. Mass spectrometry on the products of the FDR-catalyzed reduction of coumarin and the other furanocoumarins shows their spontaneous hydrolysis to multiple products.	[Lapalikar, Gauri V.; Taylor, Matthew C.; Warden, Andrew C.; Scott, Colin; Russell, Robyn J.; Oakeshott, John G.] Commonwealth Sci & Ind Res Org, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Lapalikar, GV (corresponding author), Commonwealth Sci & Ind Res Org, Canberra, ACT, Australia.	m.taylor@csiro.au	Russell, Robyn/C-5449-2008; Warden, Andrew C/C-1484-2008; Taylor, Matthew/B-5903-2009; Scott, Colin/A-4682-2009; Oakeshott, John G/B-5365-2009	Russell, Robyn/0000-0001-5600-3305; Warden, Andrew C/0000-0003-2683-9798; Taylor, Matthew/0000-0001-9576-1555; Scott, Colin/0000-0001-6110-6982; Oakeshott, John G/0000-0001-8324-7874	CSIRO Synthetic Enzymes Emerging Science Initiative	CSIRO Synthetic Enzymes Emerging Science Initiative	This project was funded under CSIRO Synthetic Enzymes Emerging Science Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts JF, 2006, INT J FOOD MICROBIOL, V109, P121, DOI 10.1016/j.ijfoodmicro.2006.01.019; Alexeev I, 2007, P NATL ACAD SCI USA, V104, P6170, DOI 10.1073/pnas.0700579104; Barnes MR, 1997, J BACTERIOL, V179, P6145, DOI 10.1128/jb.179.19.6145-6153.1997; Bashiri G, 2008, J BIOL CHEM, V283, P17531, DOI 10.1074/jbc.M801854200; Bashiri G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015803; Berkessel A, 2005, ANGEW CHEM INT EDIT, V44, P807, DOI 10.1002/anie.200461442; Bornemann C, 1997, BIOCHEM J, V325, P623, DOI 10.1042/bj3250623; BRODERSEN R, 1946, ACTA PHARMACOL TOX, V2, P109; Bugg TDH, 1997, BIOCHEM SOC T, V25, P81, DOI 10.1042/bst0250081; Choi KP, 2001, J BACTERIOL, V183, P7058, DOI 10.1128/JB.183.24.7058-7066.2001; Chung JY, 2002, J BACTERIOL, V184, P6115, DOI 10.1128/JB.184.22.6115-6122.2002; CIEGLER A, 1966, APPL MICROBIOL, V14, P934, DOI 10.1128/AEM.14.6.934-939.1966; de Poorter LMI, 2005, MICROBIOL-SGM, V151, P1697, DOI 10.1099/mic.0.27679-0; DRAPER RD, 1968, ARCH BIOCHEM BIOPHYS, V125, P802, DOI 10.1016/0003-9861(68)90517-1; Ebert S, 1999, J BACTERIOL, V181, P2669, DOI 10.1128/JB.181.9.2669-2674.1999; Ebert S, 2001, BIODEGRADATION, V12, P367, DOI 10.1023/A:1014447700775; Gerratana B, 2010, MED RES REV; Griese JJ, 2006, J MOL BIOL, V361, P140, DOI 10.1016/j.jmb.2006.06.007; Grill S, 2008, J BACTERIOL, V190, P1546, DOI 10.1128/JB.01586-07; Guerra-Lopez D, 2007, MICROBIOL-SGM, V153, P2724, DOI 10.1099/mic.0.2006/009241-0; HAMAMOTO T, 1985, J ANTIBIOT, V38, P533, DOI 10.7164/antibiotics.38.533; Heiss G, 2002, MICROBIOL-SGM, V148, P799, DOI 10.1099/00221287-148-3-799; Hormisch D, 2004, SYST APPL MICROBIOL, V27, P653, DOI 10.1078/0723202042369866; Isabelle D, 2002, APPL ENVIRON MICROB, V68, P5750, DOI 10.1128/AEM.68.11.5750-5755.2002; JACOBSON F, 1984, BIOCHEMISTRY-US, V23, P979, DOI 10.1021/bi00300a028; KAKINUMA K, 1986, J BIOL CHEM, V261, P9426; Kaneko M, 2003, J BACTERIOL, V185, P20, DOI 10.1128/JB.185.1.20-27.2003; Li W, 2009, APPL ENVIRON MICROB, V75, P2869, DOI 10.1128/AEM.02326-08; LYNEN F, 1953, BIOCHIM BIOPHYS ACTA, V12, P299, DOI 10.1016/0006-3002(53)90149-8; Mack M, 2006, APPL MICROBIOL BIOT, V71, P265, DOI 10.1007/s00253-006-0421-7; Manjunatha UH, 2006, P NATL ACAD SCI USA, V103, P431, DOI 10.1073/pnas.0508392103; Oja T, 2008, CHEM BIOL, V15, P1046, DOI 10.1016/j.chembiol.2008.07.022; OTANI S, 1974, J ANTIBIOT, V27, P88, DOI 10.7164/antibiotics.27.88; PITTS JN, 1983, ENVIRON HEALTH PERSP, V47, P115, DOI 10.2307/3429504; Purwantini E, 1997, FEMS MICROBIOL LETT, V146, P129, DOI 10.1016/S0378-1097(96)00465-X; Purwantini E, 2009, P NATL ACAD SCI USA, V106, P6333, DOI 10.1073/pnas.0812883106; Selengut JD, 2010, J BACTERIOL, V192, P5788, DOI 10.1128/JB.00425-10; Singh R, 2008, SCIENCE, V322, P1392, DOI 10.1126/science.1164571; Spence EL, 1996, J BACTERIOL, V178, P5249, DOI 10.1128/jb.178.17.5249-5256.1996; STRICKLAND S, 1973, J BIOL CHEM, V248, P2944; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor MC, 2010, MOL MICROBIOL, V78, P561, DOI 10.1111/j.1365-2958.2010.07356.x; Teniola OD, 2005, INT J FOOD MICROBIOL, V105, P111, DOI 10.1016/j.ijfoodmicro.2005.05.004; Wagacha JM, 2008, INT J FOOD MICROBIOL, V124, P1, DOI 10.1016/j.ijfoodmicro.2008.01.008	44	43	50	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e30114	10.1371/journal.pone.0030114	http://dx.doi.org/10.1371/journal.pone.0030114			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22383957	Green Published, gold, Green Submitted			2022-12-27	WOS:000302918500007
J	Armstrong, G; Phillips, B				Armstrong, Graeme; Phillips, Ben			Fire History from Life-History: Determining the Fire Regime that a Plant Community Is Adapted Using Life-Histories	PLOS ONE			English	Article							NORTHERN AUSTRALIA; PERSISTENCE; MANAGEMENT; KIMBERLEY; CLIMATE; BIODIVERSITY; COEXISTENCE; SAVANNA; IMPACTS; ECOLOGY	Wildfire is a fundamental disturbance process in many ecological communities, and is critical in maintaining the structure of some plant communities. In the past century, changes in global land use practices have led to changes in fire regimes that have radically altered the composition of many plant communities. As the severe biodiversity impacts of inappropriate fire management regimes are recognized, attempts are being made to manage fires within a more 'natural' regime. In this aim, the focus has typically been on determining the fire regime to which the community has adapted. Here we take a subtly different approach and focus on the probability of a patch being burnt. We hypothesize that competing sympatric taxa from different plant functional groups are able to coexist due to the stochasticity of the fire regime, which creates opportunities in both time and space that are exploited differentially by each group. We exploit this situation to find the fire probability at which three sympatric grasses, from different functional groups, are able to co-exist. We do this by parameterizing a spatio-temporal simulation model with the life-history strategies of the three species and then search for the fire frequency and scale at which they are able to coexist when in competition. The simulation gives a clear result that these species only coexist across a very narrow range of fire probabilities centred at 0.2. Conversely, fire scale was found only to be important at very large scales. Our work demonstrates the efficacy of using competing sympatric species with different regeneration niches to determine the probability of fire in any given patch. Estimating this probability allows us to construct an expected historical distribution of fire return intervals for the community; a critical resource for managing fire-driven biodiversity in the face of a growing carbon economy and ongoing climate change.	[Armstrong, Graeme] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia; [Phillips, Ben] James Cook Univ, Ctr Trop Biodivers & Climate Change, Townsville, Qld 4811, Australia	Charles Darwin University; James Cook University	Armstrong, G (corresponding author), Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia.	graeme.armstrong@fba.org.au	Phillips, Ben/C-7957-2009	Phillips, Ben/0000-0003-2580-2336	Australian Wildlife Conservancy; Holsworth Wildlife Research Endowment; Northern Territory Research and Innovation Fund; Australian Research Council	Australian Wildlife Conservancy; Holsworth Wildlife Research Endowment; Northern Territory Research and Innovation Fund; Australian Research Council(Australian Research Council)	Financial support was provided by Australian Wildlife Conservancy, Australian Research Council, Holsworth Wildlife Research Endowment, and the Northern Territory Research and Innovation Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, S PLUS; Archibald S, 2010, INT J WILDLAND FIRE, V19, P774, DOI [10.1071/WF08207, 10.1071/WF10008]; Armstrong G, 2011, HEREDITY, V107, P558, DOI 10.1038/hdy.2011.42; Armstrong G, 2011, INT J WILDLAND FIRE, V20, P974, DOI 10.1071/WF10130; Armstrong G, 2011, AUSTRAL ECOL, V36, P849, DOI 10.1111/j.1442-9993.2010.02228.x; Bond WJ, 2001, TRENDS ECOL EVOL, V16, P45, DOI 10.1016/S0169-5347(00)02033-4; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Bowman DMJS, 1998, NEW PHYTOL, V140, P385, DOI [10.1046/j.1469-8137.1998.00289.x, 10.1111/j.1469-8137.1998.00289.x]; Bunk S, 2004, PLOS BIOL, V2, P154, DOI 10.1371/journal.pbio.0020054; Crowley G, 2009, AUSTRAL ECOL, V34, P196, DOI 10.1111/j.1442-9993.2008.01921.x; Duren OC, 2010, FIRE ECOL, V6, P76, DOI 10.4996/fireecology.0602076; Enright NJ, 2008, GEOGR COMPASS, V2, P979, DOI 10.1111/j.1749-8198.2008.00126.x; ERNST WHO, 1992, VEGETATIO, V102, P1, DOI 10.1007/BF00031700; Fensham RJ, 1997, J BIOGEOGR, V24, P11, DOI 10.1111/j.1365-2699.1997.tb00046.x; Flannigan MD, 2009, INT J WILDLAND FIRE, V18, P483, DOI 10.1071/WF08187; Groeneveld J, 2002, J ECOL, V90, P762, DOI 10.1046/j.1365-2745.2002.00712.x; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; Higgins SI, 2008, J ECOL, V96, P679, DOI 10.1111/j.1365-2745.2008.01391.x; Higuera PE, 2011, HOLOCENE, V21, P327, DOI 10.1177/0959683610374882; Jongejans E, 1999, OIKOS, V87, P362, DOI 10.2307/3546752; Keith David, 1996, Proceedings of the Linnean Society of New South Wales, V116, P37; Keith DA, 2007, J ECOL, V95, P1324, DOI 10.1111/j.1365-2745.2007.01302.x; Krawchuk MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005102; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; Legge Sarah, 2011, Ecological Management & Restoration, V12, P84, DOI 10.1111/j.1442-8903.2011.00595.x; Lehmann CER, 2008, J APPL ECOL, V45, P1304, DOI 10.1111/j.1365-2664.2008.01496.x; Niklasson M, 2000, ECOLOGY, V81, P1484, DOI 10.1890/0012-9658(2000)081[1484:NASOFL]2.0.CO;2; Noble IR, 1996, J VEG SCI, V7, P329, DOI 10.2307/3236276; ODOWD DJ, 1984, ECOLOGY, V65, P1052, DOI 10.2307/1938313; Ooi MKJ, 2006, INT J WILDLAND FIRE, V15, P261, DOI 10.1071/WF05024; Pausas JG, 2004, ECOLOGY, V85, P1085, DOI 10.1890/02-4094; Preece N, 2002, J BIOGEOGR, V29, P321, DOI 10.1046/j.1365-2699.2002.00677.x; Russell-Smith J, 2003, INT J WILDLAND FIRE, V12, P283, DOI 10.1071/WF03015; Russell-Smith J, 2010, AUST J BOT, V58, P300, DOI 10.1071/BT99210; RussellSmith J, 1997, HUM ECOL, V25, P159, DOI 10.1023/A:1021970021670; Strassburg BBN, 2010, CONSERV LETT, V3, P98, DOI 10.1111/j.1755-263X.2009.00092.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000938; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Vigilante T, 2004, AUST J BOT, V52, P405, DOI 10.1071/BT03157; WESTOBY M, 1988, AUST J ECOL, V13, P161, DOI 10.1111/j.1442-9993.1988.tb00965.x; Wood SW, 2010, FOREST ECOL MANAG, V260, P438, DOI 10.1016/j.foreco.2010.04.037; Yates CP, 2008, INT J WILDLAND FIRE, V17, P768, DOI 10.1071/WF07150; Yates CJ, 2010, AUSTRAL ECOL, V35, P374, DOI 10.1111/j.1442-9993.2009.02044.x; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	46	4	5	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31544	10.1371/journal.pone.0031544	http://dx.doi.org/10.1371/journal.pone.0031544			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363670	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000302873700068
J	Gao, N; Cheng, SP; Budhraja, A; Liu, EH; Chen, JP; Chen, DY; Yang, ZL; Luo, J; Shi, XL; Zhang, Z				Gao, Ning; Cheng, Senping; Budhraja, Amit; Liu, E-Hu; Chen, Jieping; Chen, Deying; Yang, Zailin; Luo, Jia; Shi, Xianglin; Zhang, Zhuo			3, 3 '-Diindolylmethane Exhibits Antileukemic Activity In Vitro and In Vivo through a Akt-Dependent Process	PLOS ONE			English	Article							BREAST-CANCER CELLS; PROTEIN-KINASE B/AKT; DOWN-REGULATION; OXIDATIVE STRESS; CYCLE ARREST; APOPTOSIS; ACTIVATION; INDOLE-3-CARBINOL; PATHWAY; INHIBITION	3,3'-diindolylmethane (DIM), one of the active products derived from Brassica plants, is a promising antitumor agent. The present study indicated that DIM significantly induced apoptosis in U937 human leukemia cells in dose- and time-dependent manners. These events were also noted in other human leukemia cells (Jurkat and HL-60) and primary human leukemia cells (AML) but not in normal bone marrow mononuclear cells. We also found that DIM-induced lethality is associated with caspases activation, myeloid cell leukemia-1 (Mcl-1) down-regulation, p21(cip1/waf1) up-regulation, and Akt inactivation accompanied by c-jun NH2-terminal kinase (JNK) activation. Enforced activation of Akt by a constitutively active Akt construct prevented DIM-mediated caspase activation, Mcl-1 down-regulation, JNK activation, and apoptosis. Conversely, DIM lethality was potentiated by the PI3K inhibitor LY294002. Interruption of the JNK pathway by pharmacologic or genetic approaches attenuated DIM-induced caspases activation, Mcl-1 down-regulation, and apoptosis. Lastly, DIM inhibits tumor growth of mouse U937 xenograft, which was related to induction of apoptosis and inactivation of Akt, as well as activation of JNK. Collectively, these findings suggest that DIM induces apoptosis in human leukemia cell lines and primary human leukemia cells, and exhibits antileukemic activity in vivo through Akt inactivation and JNK activation.	[Gao, Ning; Liu, E-Hu; Chen, Deying] 3rd Mil Med Univ, Dept Pharmacognosy, Coll Pharm, Chongqing, Peoples R China; [Gao, Ning; Cheng, Senping; Budhraja, Amit; Shi, Xianglin; Zhang, Zhuo] Univ Kentucky, Grad Ctr Toxicol, Coll Med, Lexington, KY USA; [Chen, Jieping; Yang, Zailin] 3rd Mil Med Univ, Dept Hematol, Southwest Hosp, Chongqing, Peoples R China; [Luo, Jia] Univ Kentucky, Dept Internal Med, Lexington, KY USA	Army Medical University; University of Kentucky; Army Medical University; University of Kentucky	Gao, N (corresponding author), 3rd Mil Med Univ, Dept Pharmacognosy, Coll Pharm, Chongqing, Peoples R China.	gaoning59@yahoo.com.cn; zhuo.zhang@uky.edu	Zhang, Zhuo/B-8601-2012; Shi, Xianglin/B-8588-2012; Luo, Jia/E-4674-2012	Luo, Jia/0000-0002-6968-3618; Budhraja, Amit/0000-0002-4216-8608	NIH [RO1 ES015375, 1R21ES019249]; National Natural Science Foundation of China [30971288]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES019249, R01ES015375] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The study was supported by NIH Grants RO1 ES015375 (X.Shi), 1R21ES019249 (Zhuo Zhang) and National Natural Science Foundation of China (No. 30971288). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Araki T, 2002, BIOCHEM BIOPH RES CO, V290, P1275, DOI 10.1006/bbrc.2002.6329; Bae JY, 2003, J BIOL CHEM, V278, P5195, DOI 10.1074/jbc.M201988200; Bhuiyan MMR, 2006, CANCER RES, V66, P10064, DOI 10.1158/0008-5472.CAN-06-2011; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chen YB, 2006, AM J PATHOL, V169, P1833, DOI 10.2353/ajpath.2006.060234; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; DEKRUIF CA, 1991, CHEM-BIOL INTERACT, V80, P303, DOI 10.1016/0009-2797(91)90090-T; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; El-Deiry WS, 1998, CURR TOP MICROBIOL, V227, P121; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Gao N, 2005, ONCOGENE, V24, P3797, DOI 10.1038/sj.onc.1208530; Gartel AL, 2002, MOL CANCER THER, V1, P639; Gong YX, 2006, CANCER RES, V66, P4880, DOI 10.1158/0008-5472.CAN-05-4162; GROSE KR, 1992, CHEM RES TOXICOL, V5, P188, DOI 10.1021/tx00026a007; Guo YL, 1998, J BIOL CHEM, V273, P4027, DOI 10.1074/jbc.273.7.4027; HARPER JW, 1993, CELL, V75, P805; Hong CB, 2002, CARCINOGENESIS, V23, P1297, DOI 10.1093/carcin/23.8.1297; Howells LM, 2002, MOL CANCER THER, V1, P1161; Jin L, 1999, CANCER RES, V59, P3991; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kandel ES, 2002, MOL CELL BIOL, V22, P7831, DOI 10.1128/MCB.22.22.7831-7841.2002; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kim YS, 2004, EXP MOL MED, V36, P157, DOI 10.1038/emm.2004.22; Kuo ML, 2001, ONCOGENE, V20, P677, DOI 10.1038/sj.onc.1204140; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Liu TC, 2000, AM J HEMATOL, V63, P170, DOI 10.1002/(SICI)1096-8652(200004)63:4<170::AID-AJH2>3.0.CO;2-0; Liu W, 2003, CELL DEATH DIFFER, V10, P772, DOI 10.1038/sj.cdd.4401238; Mao JH, 2004, GENE DEV, V18, P1800, DOI 10.1101/gad.1213804; MCDANELL R, 1988, FOOD CHEM TOXICOL, V26, P59, DOI 10.1016/0278-6915(88)90042-7; Nachshon-Kedmi M, 2004, BRIT J CANCER, V91, P1358, DOI 10.1038/sj.bjc.6602145; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Ozes ON, 1999, NATURE, V401, P82; Persad S, 2000, P NATL ACAD SCI USA, V97, P3207, DOI 10.1073/pnas.060579697; Rahman KMW, 2005, CANCER RES, V65, P364; Reed GA, 2006, CANCER EPIDEM BIOMAR, V15, P2477, DOI 10.1158/1055-9965.EPI-06-0396; Ross JA, 2002, CANCER EPIDEM BIOMAR, V11, P777; Seymour JD, 2003, AM J EPIDEMIOL, V157, P980, DOI 10.1093/aje/kwg077; Song JJ, 2005, J CELL BIOL, V170, P61, DOI 10.1083/jcb.200502070; STEINMETZ KA, 1991, CANCER CAUSE CONTROL, V2, P325, DOI 10.1007/BF00051672; Stresser DM, 2000, DRUG METAB DISPOS, V28, P1440; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wong GYC, 1997, J CELL BIOCHEM, P111; Zhang R, 2004, CIRC RES, V94, P1483, DOI 10.1161/01.RES.0000130525.37646.a7	48	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31783	10.1371/journal.pone.0031783	http://dx.doi.org/10.1371/journal.pone.0031783			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363731	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700097
J	Piecewicz, SM; Pandey, A; Roy, B; Xiang, SH; Zetter, BR; Sengupta, S				Piecewicz, Stephanie M.; Pandey, Ambarish; Roy, Bhaskar; Xiang, Soh Hua; Zetter, Bruce R.; Sengupta, Shiladitya			Insulin-Like Growth Factors Promote Vasculogenesis in Embryonic Stem Cells	PLOS ONE			English	Article							FACTOR-I RECEPTOR; HYPOXIA-INDUCIBLE FACTOR-2-ALPHA; ENDOTHELIAL-CELLS; SIGNALING PATHWAY; PROGENITOR CELLS; CYCLOLIGNAN PPP; FACTOR 1-ALPHA; MOUSE MODEL; IGF-I; EXPRESSION	The ability of embryonic stem cells to differentiate into endothelium and form functional blood vessels has been well established and can potentially be harnessed for therapeutic angiogenesis. However, after almost two decades of investigation in this field, limited knowledge exists for directing endothelial differentiation. A better understanding of the cellular mechanisms regulating vasculogenesis is required for the development of embryonic stem cell-based models and therapies. In this study, we elucidated the mechanistic role of insulin-like growth factors (IGF1 and 2) and IGF receptors (IGFR1 and 2) in endothelial differentiation using an embryonic stem cell embryoid body model. Both IGF1 or IGF2 predisposed embryonic stem to differentiate towards a mesodermal lineage, the endothelial precursor germ layer, as well as increased the generation of significantly more endothelial cells at later stages. Inhibition of IGFR1 signaling using neutralizing antibody or a pharmacological inhibitor, picropodophyllin, significantly reduced IGF-induced mesoderm and endothelial precursor cell formation. We confirmed that IGF-IGFR1 signaling stabilizes HIF1 alpha and leads to up-regulation of VEGF during vasculogenesis in embryoid bodies. Understanding the mechanisms that are critical for vasculogenesis in various models will bring us one step closer to enabling cell based therapies for neovascularization.	[Piecewicz, Stephanie M.; Pandey, Ambarish; Roy, Bhaskar; Xiang, Soh Hua; Sengupta, Shiladitya] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Piecewicz, Stephanie M.; Sengupta, Shiladitya] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Roy, Bhaskar] Indian Inst Technol, Dept Med Sci & Technol, Kharagpur 721302, W Bengal, India; [Zetter, Bruce R.] Harvard Univ, Childrens Hosp, Sch Med, Dept Surg, Boston, MA 02115 USA; [Zetter, Bruce R.] Harvard Univ, Childrens Hosp, Sch Med, Vasc Biol Program, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School	Piecewicz, SM (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA.	stephanie.piecewicz@gmail.com; shiladit@mit.edu			Department of Defense Era of Hope [W81XWH-07-1-0482]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL098049] Funding Source: NIH RePORTER	Department of Defense Era of Hope; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	SS is supported by a Department of Defense Era of Hope Scholar award (W81XWH-07-1-0482). This work was supported by an American Heart Association Scientist Development Grant to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akeno N, 2002, ENDOCRINOLOGY, V143, P420, DOI 10.1210/en.143.2.420; ARAI T, 1994, J BIOL CHEM, V269, P20388; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Beck L, 1997, FASEB J, V11, P365, DOI 10.1096/fasebj.11.5.9141503; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Blanchard F, 1999, J BIOL CHEM, V274, P24685, DOI 10.1074/jbc.274.35.24685; Catrina SB, 2005, BRIT J CANCER, V92, P1467, DOI 10.1038/sj.bjc.6602408; Catrina SB, 2006, CLIN CANCER RES, V12, P4506, DOI 10.1158/1078-0432.CCR-05-2473; Chao W, 2008, CYTOKINE GROWTH F R, V19, P111, DOI 10.1016/j.cytogfr.2008.01.005; Chen LG, 2010, STEM CELLS, V28, P57, DOI 10.1002/stem.251; Coolican SA, 1997, J BIOL CHEM, V272, P6653, DOI 10.1074/jbc.272.10.6653; Economou MA, 2008, INVEST OPHTH VIS SCI, V49, P2620, DOI 10.1167/iovs.07-0742; Feldser D, 1999, CANCER RES, V59, P3915; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Girnita A, 2004, CANCER RES, V64, P236, DOI 10.1158/0008-5472.CAN-03-2522; GRANT MB, 1993, ANN NY ACAD SCI, V692, P230; Han RNN, 2003, AM J RESP CELL MOL, V28, P159, DOI 10.1165/rcmb.4764; Hanjaya-Putra D, 2009, BIOTECHNOL PROGR, V25, P2, DOI 10.1002/btpr.129; Harfouche R, 2009, CIRCULATION, V120, P1883, DOI 10.1161/CIRCULATIONAHA.108.837724; Hartnett L, 2010, INT J DEV BIOL, V54, P573, DOI 10.1387/ijdb.092922lh; Huang YH, 2009, FASEB J, V23, P2076, DOI 10.1096/fj.08-121939; Humpert PM, 2008, MOL MED, V14, P301, DOI 10.2119/2007-00052.Humpert; IKEZU T, 1995, J BIOL CHEM, V270, P29224, DOI 10.1074/jbc.270.49.29224; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Kaufman DS, 2004, BLOOD, V103, P1325, DOI 10.1182/blood-2003-03-0799; Koch H, 2005, STEM CELLS DEV, V14, P621, DOI 10.1089/scd.2005.14.621; Kouroupi G, 2010, J NEUROCHEM, V115, P460, DOI 10.1111/j.1471-4159.2010.06939.x; LeRoith D, 1997, NEW ENGL J MED, V336, P633, DOI 10.1056/NEJM199702273360907; Maeng YS, 2009, BLOOD, V113, P233, DOI 10.1182/blood-2008-06-162891; McCloskey KE, 2009, METHOD MOL BIOL, V330, P287; Menu E, 2006, BLOOD, V107, P655, DOI 10.1182/blood-2005-01-0293; Morali OG, 2000, DEV BIOL, V227, P133, DOI 10.1006/dbio.2000.9875; NAKAOHAYASHI J, 1992, ATHEROSCLEROSIS, V92, P141, DOI 10.1016/0021-9150(92)90273-J; Padin-Iruegas ME, 2009, CIRCULATION, V120, P876, DOI 10.1161/CIRCULATIONAHA.109.852285; Paye JMD, 2006, ANN BIOMED ENG, V34, P618, DOI 10.1007/s10439-005-9064-6; Ramirez-Bergeron DL, 2004, DEVELOPMENT, V131, P4623, DOI 10.1242/dev.01310; RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769; RISAU W, 1988, DEVELOPMENT, V102, P471; Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Schmid C, 1995, CELL BIO INT, V19; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Siddle K, 2001, BIOCHEM SOC T, V29, P513, DOI 10.1042/BST0290513; SLACK JMW, 1987, NATURE, V326, P197, DOI 10.1038/326197a0; Sun FL, 1997, NATURE, V389, P809, DOI 10.1038/39797; Sun X, 2009, CELL BIOL INT, V33, P1201, DOI 10.1016/j.cellbi.2009.08.005; Treins C, 2005, MOL ENDOCRINOL, V19, P1304, DOI 10.1210/me.2004-0239; Vasilcanu D, 2004, ONCOGENE, V23, P7854, DOI 10.1038/sj.onc.1208065; Vittet D, 1996, BLOOD, V88, P3424, DOI 10.1182/blood.V88.9.3424.bloodjournal8893424	50	56	60	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32191	10.1371/journal.pone.0032191	http://dx.doi.org/10.1371/journal.pone.0032191			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363814	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700155
J	Bengtsson, JM; Trona, F; Montagne, N; Anfora, G; Ignell, R; Witzgall, P; Jacquin-Joly, E				Bengtsson, Jonas M.; Trona, Federica; Montagne, Nicolas; Anfora, Gianfranco; Ignell, Rickard; Witzgall, Peter; Jacquin-Joly, Emmanuelle			Putative Chemosensory Receptors of the Codling Moth, Cydia pomonella, Identified by Antennal Transcriptome Analysis	PLOS ONE			English	Article							CANDIDATE PHEROMONE RECEPTORS; SEX-PHEROMONE; SPODOPTERA-LITTORALIS; OLFACTORY RECEPTORS; SEQUENCE ALIGNMENT; ODORANT RECEPTORS; LEPIDOPTERA; FEMALE; PLANT; TORTRICIDAE	The codling moth, Cydia pomonella, is an important fruit pest worldwide. As nocturnal animals, adults depend to a large extent on olfactory cues for detection of food and mates, and, for females, oviposition sites. In insects, odor detection is mediated by odorant receptors (ORs) and ionotropic receptors (IRs), which ensure the specificity of the olfactory sensory neuron responses. In this study, our aim was to identify chemosensory receptors in the codling moth as a means to uncover new targets for behavioral interference. Using next-generation sequencing techniques, we identified a total of 43 candidate ORs, one gustatory receptor and 15 IRs in the antennal transcriptome. Through Blast and sequence similarity analyses we annotated the insect obligatory co-receptor ORco, five genes clustering in a conserved clade containing sex pheromone receptors, one homolog of the Bombyx mori female-enriched receptor BmorOR30 (but no homologs of the other B. mori female-enriched receptors) and one gene clustering in the sugar receptor family. Among the candidate IRs, we identified homologs of the two highly conserved co-receptors IR8a and IR25a, and one homolog of an IR involved in phenylethyl amine detection in Drosophila. Our results open for functional characterization of the chemosensory receptors of C. pomonella, with potential for new or refined applications of semiochemicals for control of this pest insect.	[Bengtsson, Jonas M.; Trona, Federica; Anfora, Gianfranco] Fdn Edmund Mach, Res & Innovat Ctr, San Michele All Adige, Italy; [Montagne, Nicolas; Jacquin-Joly, Emmanuelle] INRA, UMR Physiol Insecte Signalisat & Commun A 1272, F-78026 Versailles, France; [Montagne, Nicolas; Jacquin-Joly, Emmanuelle] Univ Paris 06, UMR Physiol Insecte Signalisat & Commun A 1272, Paris, France; [Ignell, Rickard; Witzgall, Peter] Swedish Univ Agr Sci, Div Chem Ecol, Dept Plant Protect Biol, Alnarp, Sweden	Fondazione Edmund Mach; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Swedish University of Agricultural Sciences	Bengtsson, JM (corresponding author), Fdn Edmund Mach, Res & Innovat Ctr, San Michele All Adige, Italy.	Jonas.Bengtsson@Fmach.it	Witzgall, Peter/N-6429-2013	Witzgall, Peter/0000-0002-4697-3380; Jacquin-Joly, Emmanuelle/0000-0002-6904-2036; Montagne, Nicolas/0000-0001-8810-3853; Bengtsson, Jonas M/0000-0003-1995-5950; ANFORA, Gianfranco/0000-0003-2545-1409	Trentino region and Marie Curie [COFUND - Trentino] [226070]; Linnaeus initiative; Institut National de la Recherche Agronomique-Universite Pierre et Marie Curie [INRA-UPMC]; Agence Nationale de la Recherche, France [ANR-09-BLAN-0239-01]	Trentino region and Marie Curie [COFUND - Trentino]; Linnaeus initiative; Institut National de la Recherche Agronomique-Universite Pierre et Marie Curie [INRA-UPMC]; Agence Nationale de la Recherche, France(French National Research Agency (ANR))	This work was supported by a project cofunded by the Trentino region and Marie Curie [COFUND - Trentino, 226070], the Linnaeus initiative "Insect Chemical Ecology, Ethology and Evolution'' IC-E3 [Formas, SLU], the Institut National de la Recherche Agronomique-Universite Pierre et Marie Curie [INRA-UPMC] and Agence Nationale de la Recherche [ANR-09-BLAN-0239-01, France]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Ache BW, 2005, NEURON, V48, P417, DOI 10.1016/j.neuron.2005.10.022; Ai M, 2010, NATURE, V468, P691, DOI 10.1038/nature09537; Anderson AR, 2009, INSECT BIOCHEM MOLEC, V39, P189, DOI 10.1016/j.ibmb.2008.11.002; Ansebo L, 2005, J INSECT PHYSIOL, V51, P1066, DOI 10.1016/j.jinsphys.2005.05.003; ARN H, 1985, EXPERIENTIA, V41, P1482, DOI 10.1007/BF01950048; Backman AC, 2000, J COMP PHYSIOL A, V186, P513, DOI 10.1007/s003590000101; Bengtsson M, 2006, ENTOMOL EXP APPL, V118, P77, DOI 10.1111/j.1570-7458.2006.00359.x; Bengtsson M, 2001, J AGR FOOD CHEM, V49, P3736, DOI 10.1021/jf0100548; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Brigaud I, 2009, FEBS J, V276, P6537, DOI 10.1111/j.1742-4658.2009.07351.x; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; de Bruyne M, 2008, J CHEM ECOL, V34, P882, DOI 10.1007/s10886-008-9485-4; Ebbinghaus D, 1998, J INSECT PHYSIOL, V44, P49, DOI 10.1016/S0022-1910(97)00101-7; EINHORN J, 1984, CR ACAD SCI III-VIE, V299, P773; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Garczynski SF, 2011, INSECT SCI; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grosse-Wilde E, 2007, EUR J NEUROSCI, V25, P2364, DOI 10.1111/j.1460-9568.2007.05512.x; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Ioriatti C, 2009, PEST MANAG SCI, V65, P306, DOI 10.1002/ps.1689; Jordan MD, 2009, CHEM SENSES, V34, P383, DOI 10.1093/chemse/bjp010; Jorgensen K, 2007, CHEM SENSES, V32, P863, DOI 10.1093/chemse/bjm057; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Knudsen JT, 2006, BOT REV, V72, P1, DOI 10.1663/0006-8101(2006)72[1:DADOFS]2.0.CO;2; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Krieger J, 2002, EUR J NEUROSCI, V16, P619, DOI 10.1046/j.1460-9568.2002.02109.x; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Legeai F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-86; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; LJUNGBERG H, 1993, J INSECT PHYSIOL, V39, P253, DOI 10.1016/0022-1910(93)90096-A; Lombarkia N, 2008, ENTOMOL EXP APPL, V128, P57, DOI 10.1111/j.1570-7458.2008.00741.x; Mitsuno H, 2008, EUR J NEUROSCI, V28, P893, DOI 10.1111/j.1460-9568.2008.06429.x; Miura N, 2009, INT J BIOL SCI, V5, P319; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Olivier V, 2011, INSECT MOL BIOL, V20, P189, DOI 10.1111/j.1365-2583.2010.01057.x; PALANASWAMY P, 1978, J CHEM ECOL, V4, P649, DOI 10.1007/BF00990275; ROELOFS W, 1971, SCIENCE, V174, P297, DOI 10.1126/science.174.4006.297; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Sato K, 2011, P NATL ACAD SCI USA, V108, P11680, DOI 10.1073/pnas.1019622108; Schneider D, 1998, J COMP PHYSIOL A, V182, P153, DOI 10.1007/s003590050166; Tanaka K, 2009, CURRENT BIOL; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; Trona F, 2010, J EXP BIOL, V213, P4291, DOI 10.1242/jeb.047365; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang G, 2011, INSECT MOL BIOL, V20, P125, DOI 10.1111/j.1365-2583.2010.01045.x; Wanner KW, 2008, INSECT MOL BIOL, V17, P621, DOI 10.1111/j.1365-2583.2008.00836.x; Wanner KW, 2007, INSECT MOL BIOL, V16, P107, DOI 10.1111/j.1365-2583.2007.00708.x; Wanner KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008685; Witzgall P, 2001, ENTOMOL EXP APPL, V101, P131, DOI 10.1023/A:1019270515505; Witzgall P, 2008, ANNU REV ENTOMOL, V53, P503, DOI 10.1146/annurev.ento.53.103106.093323; Witzgall P, 2010, J CHEM ECOL, V36, P80, DOI 10.1007/s10886-009-9737-y; Yang J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021128, 10.1371/journal.pone.0024111]; Yang ZH, 2004, J CHEM ECOL, V30, P619, DOI 10.1023/B:JOEC.0000018633.94002.af	61	132	151	3	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31620	10.1371/journal.pone.0031620	http://dx.doi.org/10.1371/journal.pone.0031620			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363688	Green Published, gold, Green Submitted			2022-12-27	WOS:000302871500064
J	Cao, GL; Gu, MX; Zhu, M; Gao, JY; Yin, Y; Marshall, C; Xiao, M; Ding, J; Miao, DS				Cao, Guangliang; Gu, Minxia; Zhu, Min; Gao, Junying; Yin, Ying; Marshall, Charles; Xiao, Ming; Ding, Jiong; Miao, Dengshun			Bmi-1 Absence Causes Premature Brain Degeneration	PLOS ONE			English	Article							CELL SELF-RENEWAL; HUMAN EPILEPTOGENIC HIPPOCAMPUS; HEMATOPOIETIC STEM-CELLS; GLUTAMINE-SYNTHETASE; EXTRACELLULAR GLUTAMATE; OXIDATIVE STRESS; ASTROGLIAL CELLS; PROLIFERATION; INK4A; NEURODEGENERATION	Bmi-1, a polycomb transcriptional repressor, is implicated in cell cycle regulation and cell senescence. Its absence results in generalized astrogliosis and epilepsy during the postnatal development, but the underlying mechanisms are poorly understood. Here, we demonstrate the occurrence of oxidative stress in the brain of four-week-old Bmi-1 null mice. The mice showed various hallmarks of neurodegeneration including synaptic loss, axonal demyelination, reactive gliosis and brain mitochondrial damage. Moreover, astroglial glutamate transporters and glutamine synthetase decreased in the Bmi-1 null hippocampus, which might contribute to the sporadic epileptic-like seizures in these mice. These results indicate that Bmi-1 is required for maintaining endogenous antioxidant defenses in the brain, and its absence subsequently causes premature brain degeneration.	[Cao, Guangliang; Gu, Minxia; Gao, Junying; Xiao, Ming; Ding, Jiong] Nanjing Med Univ, Dept Anat, Jiangsu Prov Key Lab Neurodegenerat, Nanjing, Jiangsu, Peoples R China; [Zhu, Min; Yin, Ying; Miao, Dengshun] Nanjing Med Univ, Dept Anat, Res Ctr Bone & Stem Cells, Nanjing, Jiangsu, Peoples R China; [Marshall, Charles] Univ Kentucky, Ctr Excellence Rural Hlth, Dept Rehabil Sci, Hazard, KY USA	Nanjing Medical University; Nanjing Medical University; University of Kentucky	Cao, GL (corresponding author), Nanjing Med Univ, Dept Anat, Jiangsu Prov Key Lab Neurodegenerat, Nanjing, Jiangsu, Peoples R China.	mingx@njmu.edu.cn		Miao, Dengshun/0000-0002-2682-3502; Xiao, Ming/0000-0001-5528-9102	National Nature and Scientific Foundation of China [30971020, 30830103]; Natural Science Foundation of Jiangsu Educational Department [09KJA310003]	National Nature and Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Educational Department	This work was supported by grants from the National Nature and Scientific Foundation of China Key Project (No. 30971020 to M. Xiao, No. 30830103 to D. Miao) and the Natural Science Foundation of Jiangsu Educational Department (09KJA310003 to M. Xiao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKEMA MJ, 1993, HUM MOL GENET, V2, P1597, DOI 10.1093/hmg/2.10.1597; Allen NJ, 2009, NATURE, V457, P675, DOI 10.1038/457675a; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Binder DK, 2006, GLIA, V54, P358, DOI 10.1002/glia.20394; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Bjornsen LP, 2007, NEUROBIOL DIS, V25, P319, DOI 10.1016/j.nbd.2006.09.014; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Butterfield DA, 1997, J NEUROCHEM, V68, P2451; Castegna A, 2002, FREE RADICAL BIO MED, V33, P562, DOI 10.1016/S0891-5849(02)00914-0; Chatoo W, 2009, J NEUROSCI, V29, P529, DOI 10.1523/JNEUROSCI.5303-08.2009; David Y, 2009, J NEUROSCI, V29, P10588, DOI 10.1523/JNEUROSCI.2323-09.2009; Demarque M, 2004, J NEUROSCI, V24, P3289, DOI 10.1523/JNEUROSCI.5338-03.2004; Dimri GP, 2002, CANCER RES, V62, P4736; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Eid T, 2004, LANCET, V363, P28, DOI 10.1016/S0140-6736(03)15166-5; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Fasano CA, 2009, GENE DEV, V23, P561, DOI 10.1101/gad.1743709; Gonsette RE, 2008, J NEUROL SCI, V274, P48, DOI 10.1016/j.jns.2008.06.029; Grinstein Edgar, 2009, J Stem Cells, V4, P141; Hayry V, 2008, NEUROPATH APPL NEURO, V34, P555, DOI 10.1111/j.1365-2990.2008.00949.x; He S, 2009, DEV BIOL, V328, P257, DOI 10.1016/j.ydbio.2009.01.020; Ischiropoulos H, 2003, J CLIN INVEST, V111, P163, DOI 10.1172/JCI200317638; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Li S, 1997, J NEUROPATH EXP NEUR, V56, P901, DOI 10.1097/00005072-199708000-00008; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Liu L, 2010, NEUROSCIENCE, V169, P596, DOI 10.1016/j.neuroscience.2010.05.028; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Napoli I, 2009, NEUROSCIENCE, V158, P1030, DOI 10.1016/j.neuroscience.2008.06.046; Oguro H, 2006, J EXP MED, V203, P2247, DOI 10.1084/jem.20052477; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Samuelsson C, 2000, NEUROSCI LETT, V289, P185, DOI 10.1016/S0304-3940(00)01284-2; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Shin EJ, 2005, NEUROSCIENCE, V133, P715, DOI 10.1016/j.neuroscience.2005.02.030; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stoll G, 1999, PROG NEUROBIOL, V58, P233, DOI 10.1016/S0301-0082(98)00083-5; van der Hel WS, 2005, NEUROLOGY, V64, P326, DOI 10.1212/01.WNL.0000149636.44660.99; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Wilson JX, 1997, CAN J PHYSIOL PHARM, V75, P1149, DOI 10.1139/cjpp-75-10-11-1149; Wong M, 2003, ANN NEUROL, V54, P251, DOI 10.1002/ana.10648; Zencak D, 2005, J NEUROSCI, V25, P5774, DOI 10.1523/JNEUROSCI.3452-04.2005; Zhang HW, 2010, J BONE MINER RES, V25, P640, DOI 10.1359/jbmr.090812	48	19	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e32015	10.1371/journal.pone.0032015	http://dx.doi.org/10.1371/journal.pone.0032015			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363787	Green Published, gold, Green Submitted			2022-12-27	WOS:000302871500104
J	D'Agata, EMC; Horn, MA; Ruan, SG; Webb, GF; Wares, JR				D'Agata, Erika M. C.; Horn, Mary Ann; Ruan, Shigui; Webb, Glenn F.; Wares, Joanna R.			Efficacy of Infection Control Interventions in Reducing the Spread of Multidrug-Resistant Organisms in the Hospital Setting	PLOS ONE			English	Article							LACTAMASE-PRODUCING ENTEROBACTERIACEAE; INTENSIVE-CARE UNITS; STAPHYLOCOCCUS-AUREUS; ANTIMICROBIAL RESISTANCE; ENTEROCOCCI; COLONIZATION; TRANSMISSION; IMPACT; SURVEILLANCE; PATHOGENS	Multidrug-resistant organisms (MDRO) continue to spread in hospitals globally, but the population-level impact of recommended preventive strategies and the relative benefit of individual strategies targeting all MDRO in the hospital setting are unclear. To explore the dynamics of MDRO transmission in the hospital, we develop a model extending data from clinical individual-level studies to quantify the impact of hand hygiene, contact precautions, reducing antimicrobial exposure and screening surveillance cultures in decreasing the prevalence of MDRO colonization and infection. The effect of an ongoing increase in the influx of patients colonized with MDRO into the hospital setting is also quantified. We find that most recommended strategies have substantial effect in decreasing the prevalence of MDRO over time. However, screening for asymptomatic MDRO colonization among patients who are not receiving antimicrobials is of minimal value in reducing the spread of MDRO.	[D'Agata, Erika M. C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Infect Dis, Boston, MA 02215 USA; [Horn, Mary Ann; Webb, Glenn F.] Vanderbilt Univ, Dept Math, Nashville, TN USA; [Horn, Mary Ann] Natl Sci Fdn, Div Math Sci, Arlington, VA 22230 USA; [Ruan, Shigui] Univ Miami, Dept Math, Coral Gables, FL 33124 USA; [Wares, Joanna R.] Univ Richmond, Dept Math & Comp Sci, Richmond, VA 23173 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Vanderbilt University; National Science Foundation (NSF); NSF - Directorate for Mathematical & Physical Sciences (MPS); NSF - Division of Mathematical Sciences (DMS); University of Miami; University of Richmond	D'Agata, EMC (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Infect Dis, Boston, MA 02215 USA.	edagata@bidmc.harvard.edu	Ruan, Shigui/AAF-9165-2020; Webb, Glenn/AAW-7228-2021	Ruan, Shigui/0000-0002-6348-8205; 	joint Division of Mathematical Sciences/National Institute of General Medical Sciences (DMS/NIGMS) Initiative through National Institutes of Health (NIH) [R01GM083607]; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083607] Funding Source: NIH RePORTER	joint Division of Mathematical Sciences/National Institute of General Medical Sciences (DMS/NIGMS) Initiative through National Institutes of Health (NIH); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the joint Division of Mathematical Sciences/National Institute of General Medical Sciences (DMS/NIGMS) Initiative through National Institutes of Health (NIH) Grant R01GM083607 (EMCD, GFW, SR). This work was also partially supported by the National Science Foundation (MAH, SR). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin DJ, 1999, P NATL ACAD SCI USA, V96, P6908, DOI 10.1073/pnas.96.12.6908; Baker SE, 2010, INFECT CONT HOSP EP, V31, P42, DOI 10.1086/649222; Bedimo R, 2001, CLIN INFECT DIS, V33, P1706, DOI 10.1086/338215; Ben-Ami R, 2006, CLIN INFECT DIS, V42, P925, DOI 10.1086/500936; Bonten MJM, 2001, CLIN INFECT DIS, V33, P1739, DOI 10.1086/323761; Burke JP, 2003, NEW ENGL J MED, V348, P651, DOI 10.1056/NEJMhpr020557; Calderwood MS, 2008, INFECT CONT HOSP EP, V29, P1019, DOI 10.1086/591454; Cooper B, 2004, BIOSTATISTICS, V5, P223, DOI 10.1093/biostatistics/5.2.223; D'Agata EMC, 2002, CLIN INFECT DIS, V34, P167, DOI 10.1086/338234; D'Agata EMC, 2007, J THEOR BIOL, V249, P487, DOI 10.1016/j.jtbi.2007.08.011; Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386; Donskey CJ, 2000, NEW ENGL J MED, V343, P1925, DOI 10.1056/NEJM200012283432604; Donskey CJ, 2006, CLIN INFECT DIS, V43, pS62, DOI 10.1086/504481; Friedmann R, 2009, INFECT CONT HOSP EP, V30, P534, DOI 10.1086/597505; Gbaguidi-Haore H, 2008, INFECT CONT HOSP EP, V29, P1118, DOI 10.1086/592697; Huang SS, 2007, J INFECT DIS, V195, P330, DOI 10.1086/510622; Huang SS, 2007, J INFECT DIS, V195, P339, DOI 10.1086/510624; Koopman J, 2004, ANNU REV PUBL HEALTH, V25, P303, DOI 10.1146/annurev.publhealth.25.102802.124353; Lautenbach E, 2008, ANN INTERN MED, V148, P474, DOI 10.7326/0003-4819-148-6-200803180-00009; Lipsitch M, 2002, EMERG INFECT DIS, V8, P347, DOI 10.3201/eid0804.010312; Montecalvo MA, 1995, INFECT CONT HOSP EP, V16, P680; O'Fallon E, 2009, CLIN INFECT DIS, V48, P1375, DOI 10.1086/598194; Olivier CN, 2008, INFECT CONT HOSP EP, V29, P404, DOI 10.1086/587647; Ostrowsky BE, 1999, ARCH INTERN MED, V159, P1467, DOI 10.1001/archinte.159.13.1467; Raboud J, 2005, INFECT CONT HOSP EP, V26, P607, DOI 10.1086/502589; Schwaber MJ, 2006, ANTIMICROB AGENTS CH, V50, P1257, DOI 10.1128/AAC.50.4.1257-1262.2006; Sebille V, 1997, INFECT CONT HOSP EP, V18, P84; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS165, DOI 10.1016/j.ajic.2007.10.006; Temime L, 2009, P NATL ACAD SCI USA, V106, P18420, DOI 10.1073/pnas.0900974106; Trick WE, 2007, INFECT CONT HOSP EP, V28, P42, DOI 10.1086/510809; Yokoe DS, 2008, INFECT CONT HOSP EP, V29, pS3, DOI 10.1086/591063; Yokoe DS, 2008, INFECT CONT HOSP EP, V29, pS12, DOI 10.1086/591060	32	43	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30170	10.1371/journal.pone.0030170	http://dx.doi.org/10.1371/journal.pone.0030170			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363420	Green Submitted, gold, Green Published			2022-12-27	WOS:000302871500007
J	Kunisawa, J; Hashimoto, E; Ishikawa, I; Kiyono, H				Kunisawa, Jun; Hashimoto, Eri; Ishikawa, Izumi; Kiyono, Hiroshi			A Pivotal Role of Vitamin B9 in the Maintenance of Regulatory T Cells In Vitro and In Vivo	PLOS ONE			English	Article							REDUCED FOLATE CARRIER; WATER-SOLUBLE VITAMINS; RETINOIC-ACID; INTESTINAL-ABSORPTION; AUTOIMMUNE-DISEASE; DENDRITIC CELLS; INDUCTION; RESPONSES; DIFFERENTIATION; INTERLEUKIN-2	Dietary factors regulate immunological function, but the underlying mechanisms remain elusive. Here we show that vitamin B9 is a survival factor for regulatory T (Treg) cells expressing high levels of vitamin B9 receptor (folate receptor 4). In vitamin B9-reduced condition in vitro, Treg cells could be differentiated from native T cells but failed to survive. The impaired survival of Treg cells was associated with decreased expression of anti-apoptotic Bcl2 and independent of IL-2. In vivo depletion of dietary vitamin B9 resulted in the reduction of Treg cells in the small intestine, a site for the absorption of dietary vitamin B9. These findings provide a new link between diet and the immune system, which could maintain the immunological homeostasis in the intestine.	[Kunisawa, Jun; Hashimoto, Eri; Ishikawa, Izumi; Kiyono, Hiroshi] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mucosal Immunol, Tokyo, Japan; [Kunisawa, Jun; Kiyono, Hiroshi] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Chiba, Japan; [Kunisawa, Jun; Kiyono, Hiroshi] Japan Sci & Technol Agcy, Tokyo, Japan; [Kiyono, Hiroshi] Univ Tokyo, Grad Sch Med, Tokyo, Japan	University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); University of Tokyo	Kunisawa, J (corresponding author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mucosal Immunol, Tokyo, Japan.	kunisawa@ims.u-tokyo.ac.jp	Kiyono, Hiroshi/AAC-6735-2022		Ministry of Education, Culture, Sports, Science and Technology of Japan [22689015, 23116506, 23229004, 19059003, 021-07124]; Ministry of Health and Welfare of Japan; Global Center of Excellence of the Center of Education and Research for Advanced Genome-based Medicine; Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN); Yakult Bio-Science Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Global Center of Excellence of the Center of Education and Research for Advanced Genome-based Medicine; Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN); Yakult Bio-Science Foundation	This work was supported by grants from: the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant-in-Aid for Young Scientists A [22689015 to J.K.] for Scientific Research on Innovative Areas [23116506 to J.K.], for Scientific Research S [23229004 to H. K.], for Scientific Research on Priority Area [19059003 to H. K.], and for JSPS Fellows (021-07124 to Y.K.); the Ministry of Health and Welfare of Japan (to J.K. and H. K.); the Global Center of Excellence Program of the Center of Education and Research for Advanced Genome-based Medicine (to H. K.); the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN; to J.K.); and the Yakult Bio-Science Foundation (to J.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Aufreiter S, 2009, AM J CLIN NUTR, V90, P116, DOI 10.3945/ajcn.2008.27345; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Biswal BK, 2009, J BIOCHEM, V146, P693, DOI 10.1093/jb/mvp130; Bourre-Tessier J, 2010, J RHEUMATOL, V37, P1416, DOI 10.3899/jrheum.090153; Cebra JJ, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P335, DOI 10.1016/B978-012491543-5/50022-X; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Courtemanche C, 2004, J IMMUNOL, V173, P3186, DOI 10.4049/jimmunol.173.5.3186; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gangjee A, 2008, ANTI-CANCER AGENT ME, V8, P205, DOI 10.2174/187152008783497064; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Gohda M, 2008, J IMMUNOL, V180, P5335, DOI 10.4049/jimmunol.180.8.5335; Hanson LA, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P1159, DOI 10.1016/B978-012491543-5/50069-3; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Iyer R, 2009, J FOOD SCI, V74, pR114, DOI 10.1111/j.1750-3841.2009.01359.x; JANSEN G, 1990, J BIOL CHEM, V265, P18272; Jia ZC, 2009, IMMUNOL INVEST, V38, P718, DOI 10.3109/08820130903171003; Kiyone H., 2008, FUNDAMENTAL IMMUNOLO, P983; Kunisawa J, 2007, J EXP MED, V204, P2335, DOI 10.1084/jem.20062446; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Low PS, 2009, CURR OPIN CHEM BIOL, V13, P256, DOI 10.1016/j.cbpa.2009.03.022; Matherly LH, 2007, CANCER METAST REV, V26, P111, DOI 10.1007/s10555-007-9046-2; MILLER LT, 1990, ANN NY ACAD SCI, V587, P49, DOI 10.1111/j.1749-6632.1990.tb00132.x; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Pompei A, 2007, APPL ENVIRON MICROB, V73, P179, DOI 10.1128/AEM.01763-06; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Said HM, 2011, BIOCHEM J, V437, P357, DOI 10.1042/BJ20110326; Said HM, 2006, CURR OPIN GASTROEN, V22, P140, DOI 10.1097/01.mog.0000203870.22706.52; Salazar MD, 2007, CANCER METAST REV, V26, P141, DOI 10.1007/s10555-007-9048-0; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Stover PJ, 2004, NUTR REV, V62, pS3, DOI 10.1111/j.1753-4887.2004.tb00070.x; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Troen AM, 2006, J NUTR, V136, P189, DOI 10.1093/jn/136.1.189; Wintergerst ES, 2007, ANN NUTR METAB, V51, P301, DOI 10.1159/000107673; Yamaguchi T, 2007, IMMUNITY, V27, P145, DOI 10.1016/j.immuni.2007.04.017; Zhao RB, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000969	41	84	90	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e32094	10.1371/journal.pone.0032094	http://dx.doi.org/10.1371/journal.pone.0032094			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363800	Green Published, gold, Green Submitted			2022-12-27	WOS:000302871500110
J	Van Wielendaele, P; Dillen, S; Marchal, E; Badisco, L; Vanden Broeck, J				Van Wielendaele, Pieter; Dillen, Senne; Marchal, Elisabeth; Badisco, Liesbeth; Vanden Broeck, Jozef			CRF-Like Diuretic Hormone Negatively Affects Both Feeding and Reproduction in the Desert Locust, Schistocerca gregaria	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; OVARY MATURATING PARSIN; CENTRAL-NERVOUS-SYSTEM; TOBACCO HORNWORM; CORPORA CARDIACA; MANDUCA-SEXTA; ECDYSTEROID-PHOSPHATES; HEMOLYMPH ECDYSTEROIDS; ENZYME-IMMUNOASSAY; MATURING PARSIN	Diuretic hormones (DH) related to the vertebrate Corticotropin Releasing Factor (CRF) have been identified in diverse insect species. In the migratory locust, Locusta migratoria, the CRF-like DH (CRF/DH) is localized in the same neurosecretory cells as the Ovary Maturating Parsin (OMP), a neurohormone that stimulates oocyte growth, vitellogenesis and hemolymph ecdysteroid levels in adult female locusts. In this study, we investigated whether CRF-like DH can influence feeding and reproduction in the desert locust, Schistocerca gregaria. We identified two highly similar S. gregaria CRF-like DH precursor cDNAs, each of which also encodes an OMP isoform. Alignment with other insect CRF-like DH precursors shows relatively high conservation of the CRF/DH sequence while the precursor region corresponding to OMP is not well conserved. Quantitative real-time RT-PCR revealed that the precursor transcripts mainly occur in the central nervous system and their highest expression level was observed in the brain. Injection of locust CRF/DH caused a significantly reduced food intake, while RNAi knockdown stimulated food intake. Therefore, our data indicate that CRF-like DH induces satiety. Furthermore, injection of CRF/DH in adult females retarded oocyte growth and caused lower ecdysteroid titers in hemolymph and ovaries, while RNAi knockdown resulted in opposite effects. The observed effects of CRF/DH may be part of a wider repertoire of neurohormonal activities, constituting an integrating control system that affects food intake and excretion, as well as anabolic processes like oocyte growth and ecdysteroidogenesis, following a meal. Our discussion about the functional relationship between CRF/DH and OMP led to the hypothesis that OMP may possibly act as a monitoring peptide that can elicit negative feedback effects.	[Van Wielendaele, Pieter; Dillen, Senne; Marchal, Elisabeth; Badisco, Liesbeth; Vanden Broeck, Jozef] Katholieke Univ Leuven, Div Anim Physiol & Neurobiol, Inst Zool, Louvain, Belgium	KU Leuven	Van Wielendaele, P (corresponding author), Katholieke Univ Leuven, Div Anim Physiol & Neurobiol, Inst Zool, Louvain, Belgium.	jozef.vandenbroeck@bio.kuleuven.be		Vanden Broeck, Jozef/0000-0001-7653-0516; Marchal, Elisabeth/0000-0003-1310-4792; Van Wielendaele, Pieter/0000-0003-1492-6165	K.U. Leuven Research Foundation [GOA/11/02]; Research Foundation of Flanders (FWO-Flanders); Interuniversity Attraction Poles program (Belgian Science Policy) [IAP P6/14]; 'Agentschap voor Innovatie door Wetenschap en Technologie' (IWT)	K.U. Leuven Research Foundation; Research Foundation of Flanders (FWO-Flanders)(FWO); Interuniversity Attraction Poles program (Belgian Science Policy)(Belgian Federal Science Policy Office); 'Agentschap voor Innovatie door Wetenschap en Technologie' (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by grants from the K.U. Leuven Research Foundation (Grant GOA/11/02, www.kuleuven.be/bof), the Research Foundation of Flanders (FWO-Flanders, www.fwo.be) and the Interuniversity Attraction Poles program (Belgian Science Policy, Grant IAP P6/14, www.belspo.be). P.V.W., E.M. and L.B. were supported by a scholarship from the 'Agentschap voor Innovatie door Wetenschap en Technologie' (IWT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anzi B, 2010, CURR BIOL, V20, P969, DOI 10.1016/j.cub.2010.04.039; ARASE K, 1989, PHYSIOL BEHAV, V45, P565, DOI 10.1016/0031-9384(89)90074-7; Audsley N, 1997, PEPTIDES, V18, P59, DOI 10.1016/S0196-9781(96)00234-3; Audsley N, 1997, REGUL PEPTIDES, V69, P25, DOI 10.1016/S0167-0115(96)02125-8; Badisco L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017274; Badisco L, 2011, PEPTIDES, V32, P573, DOI 10.1016/j.peptides.2010.11.008; Baldwin DC, 2001, PEPTIDES, V22, P147, DOI 10.1016/S0196-9781(00)00371-5; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bonte M, 2008, J ECON ENTOMOL, V101, P1127, DOI 10.1603/0022-0493(2008)101[1127:DARFOO]2.0.CO;2; BOWNES M, 1988, P NATL ACAD SCI USA, V85, P1554, DOI 10.1073/pnas.85.5.1554; Brugge VAT, 1999, J EXP BIOL, V202, P2017; Cabrero P, 2002, J EXP BIOL, V205, P3799; Chapman RF, 2003, ANNU REV ENTOMOL, V48, P455, DOI 10.1146/annurev.ento.48.091801.112629; CHEN YT, 1994, CELL TISSUE RES, V278, P493, DOI 10.1007/BF00331367; COAST GM, 1994, PERSPECTIVES IN COMPARATIVE ENDOCRINOLOGY, P67; COOPER RA, 1992, J ECON ENTOMOL, V85, P838, DOI 10.1093/jee/85.3.838; DIGAN ME, 1992, P NATL ACAD SCI USA, V89, P11074, DOI 10.1073/pnas.89.22.11074; Downer KE, 2007, J INSECT PHYSIOL, V53, P106, DOI 10.1016/j.jinsphys.2006.10.013; FERIN M, 1993, ANN NY ACAD SCI, V697, P106, DOI 10.1111/j.1749-6632.1993.tb49927.x; FURUTANI Y, 1983, NATURE, V301, P537, DOI 10.1038/301537a0; Furuya K, 1998, PEPTIDES, V19, P619, DOI 10.1016/S0196-9781(97)00475-0; Gade G, 2003, PEST MANAG SCI, V59, P1063, DOI 10.1002/ps.755; Gade G, 2004, ANNU REV ENTOMOL, V49, P93, DOI 10.1146/annurev.ento.49.061802.123354; Girardie J, 1998, J INSECT PHYSIOL, V44, P1063, DOI 10.1016/S0022-1910(98)00066-3; GIRARDIE J, 1991, EUR J BIOCHEM, V202, P1121, DOI 10.1111/j.1432-1033.1991.tb16479.x; Girardie J, 1996, J INSECT PHYSIOL, V42, P215, DOI 10.1016/0022-1910(95)00097-6; Girardie J, 1998, INSECT BIOCHEM MOLEC, V28, P641, DOI 10.1016/S0965-1748(98)00053-8; GJ Goldsworthy, 1999, RECENT DEV COMP ENDO, P231; Glinwood R, 2011, OECOLOGIA, V166, P637, DOI 10.1007/s00442-010-1892-x; Goldsworthy GJ, 2003, PEPTIDES, V24, P1607, DOI 10.1016/j.peptides.2003.09.010; Hatle JD, 2003, ARCH INSECT BIOCHEM, V52, P45, DOI 10.1002/arch.10067; Hatle JD, 1979, J INSECT PHYSL, V25, P701; Hector CE, 2009, J EXP BIOL, V212, P3142, DOI 10.1242/jeb.033175; Hummon AB, 2006, SCIENCE, V314, P647, DOI 10.1126/science.1124128; Ignell R, 2009, P NATL ACAD SCI USA, V106, P13070, DOI 10.1073/pnas.0813004106; ISAAC RE, 1984, BIOCHEM J, V221, P459, DOI 10.1042/bj2210459; Johnson EC, 2004, J EXP BIOL, V207, P743, DOI 10.1242/jeb.00818; KATAOKA H, 1989, P NATL ACAD SCI USA, V86, P2976, DOI 10.1073/pnas.86.8.2976; KAY I, 1991, BIOL CHEM H-S, V372, P929, DOI 10.1515/bchm3.1991.372.2.929; KEELEY LL, 1992, EXPERIENTIA, V48, P1145, DOI 10.1007/BF01948010; Kozlova T, 2003, SCIENCE, V301, P1911, DOI 10.1126/science.1087419; LEHMBERG E, 1991, BIOCHEM BIOPH RES CO, V179, P1036, DOI 10.1016/0006-291X(91)91923-Z; Li B, 2008, GENOME RES, V18, P113, DOI 10.1101/gr.6714008; Li XF, 2010, BRAIN RES, V1364, P153, DOI 10.1016/j.brainres.2010.08.036; Lopez-Arias B, 2011, PEPTIDES, V32, P545, DOI 10.1016/j.peptides.2010.07.002; Lu WQ, 2004, ENDOCRINOLOGY, V145, P5786, DOI 10.1210/en.2004-0144; Ma M, 2000, GEN COMP ENDOCR, V118, P1, DOI 10.1006/gcen.1999.7435; Maeno K, 2011, J INSECT PHYSIOL, V57, P514, DOI 10.1016/j.jinsphys.2011.02.004; Marchal E, 2011, INSECT BIOCHEM MOLEC, V41, P219, DOI 10.1016/j.ibmb.2010.12.007; Matsuda K, 2011, ANN NY ACAD SCI, V1220, P117, DOI 10.1111/j.1749-6632.2010.05884.x; Montuenga LM, 1996, CELL TISSUE RES, V285, P331, DOI 10.1007/s004410050650; Opstad R, 2004, J INSECT PHYSIOL, V50, P725, DOI 10.1016/j.jinsphys.2004.05.010; Pascual N, 1995, Z NATURFORSCH C, V50, P862; PATEL M, 1994, PEPTIDES, V15, P591, DOI 10.1016/0196-9781(94)90081-7; PORCHERON P, 1989, INSECT BIOCHEM, V19, P117, DOI 10.1016/0020-1790(89)90081-4; RICHARD O, 1992, CELL TISSUE RES, V270, P587, DOI 10.1007/BF00645062; RICHARD O, 1994, HISTOCHEMISTRY, V102, P233, DOI 10.1007/BF00268900; Roller L, 2008, INSECT BIOCHEM MOLEC, V38, P1147, DOI 10.1016/j.ibmb.2008.04.009; Ronan PJ, 2011, PROG MOL BIOL TRANSL, V98, P235, DOI 10.1016/B978-0-12-385506-0.00006-5; Root CM, 2011, CELL, V145, P133, DOI 10.1016/j.cell.2011.02.008; Shobana K, 2010, J INSECT PHYSIOL, V56, P1065, DOI 10.1016/j.jinsphys.2010.02.018; Stengel A, 2009, ENDOCRINOLOGY, V150, P153, DOI 10.1210/en.2008-0723; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Tamarelle M, 2000, PEPTIDES, V21, P737, DOI 10.1016/S0196-9781(00)00187-X; Tawfik AI, 1997, J INSECT PHYSIOL, V43, P485, DOI 10.1016/S0022-1910(96)00116-3; Tawfik AI, 1999, ARCH INSECT BIOCHEM, V41, P134, DOI 10.1002/(SICI)1520-6327(1999)41:3&lt;134::AID-ARCH4&gt;3.0.CO;2-6; Te Brugge V, 2011, J EXP BIOL, V214, P371, DOI 10.1242/jeb.046292; Turner SL, 2011, NATURE, V474, P87, DOI 10.1038/nature10081; UVAROV BP, 1966, GRASSHOPPERS LOCUSTS, P332; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; van Hoef V, 2011, INSECT BIOCHEM MOLEC, V41, P688, DOI 10.1016/j.ibmb.2011.04.012; van Huis A, 2008, ENTOMOL EXP APPL, V127, P144, DOI 10.1111/j.1570-7458.2008.00682.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wada-Katsumata A, 2011, CHEM SENSES, V36, P589, DOI 10.1093/chemse/bjr023; Wei Z, 2000, J INSECT PHYSIOL, V46, P1259, DOI 10.1016/S0022-1910(00)00046-9; Winther AME, 2006, MOL CELL NEUROSCI, V31, P399, DOI 10.1016/j.mcn.2005.10.010; Yamada R, 2005, ZOOL SCI, V22, P187, DOI 10.2108/zsj.22.187; ZITNAN D, 1993, DEV BIOL, V156, P117, DOI 10.1006/dbio.1993.1063	78	41	41	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31425	10.1371/journal.pone.0031425	http://dx.doi.org/10.1371/journal.pone.0031425			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363645	Green Published, Green Submitted, gold			2022-12-27	WOS:000302871500043
J	Kloos, AD; Kegelmeyer, DA; White, SE; Kostyk, SK				Kloos, Anne D.; Kegelmeyer, Deborah A.; White, Susan E.; Kostyk, Sandra K.			The Impact of Different Types of Assistive Devices on Gait Measures and Safety in Huntington's Disease	PLOS ONE			English	Article							PARKINSONS-DISEASE; OLDER-ADULTS; FALL RISK; MOVEMENT; INDIVIDUALS; VARIABILITY; RELIABILITY; PERFORMANCE; PARAMETERS; DYNAMICS	Background: Gait and balance impairments lead to frequent falls and injuries in individuals with Huntington's disease (HD). Assistive devices (ADs) such as canes and walkers are often prescribed to prevent falls, but their efficacy is unknown. We systematically examined the effects of different types of ADs on quantitative gait measures during walking in a straight path and around obstacles. Methods: Spatial and temporal gait parameters were measured in 21 subjects with HD as they walked across a GAITRite walkway under 7 conditions (i.e., using no AD and 6 commonly prescribed ADs: a cane, a weighted cane, a standard walker, and a 2, 3 or 4 wheeled walker). Subjects also were timed and observed for number of stumbles and falls while walking around two obstacles in a figure-of-eight pattern. Results: Gait measure variability (i.e., coefficient of variation), an indicator of fall risk, was consistently better when using the 4WW compared to other ADs. Subjects also walked the fastest and had the fewest number of stumbles and falls when using the 4WW in the figure-of-eight course. Subjects walked significantly slower using ADs compared to no AD both across the GAITRite and in the figure-of-eight. Measures reflecting gait stability and safety improved with the 4WW but were made worse by some other ADs.	[Kloos, Anne D.; Kegelmeyer, Deborah A.] Ohio State Univ, Ohio State Coll Med, Div Phys Therapy, Columbus, OH 43210 USA; [White, Susan E.] Ohio State Univ, Ohio State Coll Med, Div Hlth Informat Management & Syst, Columbus, OH 43210 USA; [Kostyk, Sandra K.] Ohio State Univ, Dept Neurol, Ohio State Coll Med, Columbus, OH 43210 USA; [Kostyk, Sandra K.] Ohio State Univ, Dept Neurosci, Ohio State Coll Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Kloos, AD (corresponding author), Ohio State Univ, Ohio State Coll Med, Div Phys Therapy, Columbus, OH 43210 USA.	kegelmeyer.1@osu.edu	Kloos, Anne/E-3403-2011; Kegelmeyer, Deb A/E-3359-2011; White, Susan/B-1892-2012	Kegelmeyer, Deb A/0000-0002-7767-8069; White, Susan/0000-0003-1249-8603; Kloos, Anne/0000-0002-9169-6589; Kostyk, Sandra/0000-0002-3371-753X	Columbus Medical Foundation; Lundbeck Inc.; Huntington Study Group; Huntington's Society of Canada; Institute for Optimal Aging; Parkinson Study Group (PSG); National Institutes of Health/National Institute Neurologic Disorders and Stroke; Novartis; Neurologix, Inc.; HDSA Center of Excellence	Columbus Medical Foundation; Lundbeck Inc.(Lundbeck Corporation); Huntington Study Group; Huntington's Society of Canada; Institute for Optimal Aging; Parkinson Study Group (PSG); National Institutes of Health/National Institute Neurologic Disorders and Stroke; Novartis(Novartis); Neurologix, Inc.; HDSA Center of Excellence	This study was supported by the Robert A. Vaughan Fund through the Columbus Medical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Presently ADK, DAK, and SKK are funded for an ongoing study by the Lundbeck Inc. This is separate from the assistive device study. Dr. Kloos has received research support from the Huntington Study Group, the Huntington's Society of Canada, and Lundbeck, Inc. Dr. Kegelmeyer has received research support from the Huntington Study Group, the Huntington's Society of Canada, The Institute for Optimal Aging and Lundbeck, Inc. Dr. White reports no disclosures. Dr. Kostyk receives research support from the Huntington Study Group (HSG), the Parkinson Study Group (PSG), the Huntington's Society of Canada, National Institutes of Health/National Institute Neurologic Disorders and Stroke, Novartis, Neurologix, Inc. and Lundbeck, Inc. and has received travel reimbursement and honoraria from the FDA Office of Orphan Products Development Grant Program. These sources funded other projects and current projects but not the assistive device study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.; We would like to acknowledge the Robert A. Vaughan Family. We would also like to acknowledge the support of the HDSA Center of Excellence staff at OSU along with student helpers Yi Ding, Amanda Owen, Renee Prenger, and Andrea Keller without whom we could not have completed this work.	Alkjaer T, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-2; Bilney B, 2005, MOVEMENT DISORD, V20, P51, DOI 10.1002/mds.20294; Bilney B, 2003, GAIT POSTURE, V17, P68, DOI 10.1016/S0966-6362(02)00053-X; Bleom BR, 2006, J NEUROL SCI, V248, P196, DOI 10.1016/j.jns.2006.05.010; Chamberlin ME, 2005, J GERONTOL A-BIOL, V60, P1163, DOI 10.1093/gerona/60.9.1163; Churchyard AJ, 2001, ADV NEUROL, V87, P375; Cubo E, 2003, PARKINSONISM RELAT D, V10, P9, DOI 10.1016/S1353-8020(03)00060-9; Fay BT, 2002, MED ENG PHYS, V24, P375, DOI 10.1016/S1350-4533(02)00037-1; Grimbergen YAM, 2008, MOVEMENT DISORD, V23, P970, DOI 10.1002/mds.22003; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Hausdorff JM, 1997, J APPL PHYSIOL, V82, P262; Hausdorff JM, 1998, MOVEMENT DISORD, V13, P428, DOI 10.1002/mds.870130310; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Kloos AD, 2010, MOVEMENT DISORD, V25, P2838, DOI 10.1002/mds.23421; MAHONEY J, 1992, J AM GERIATR SOC, V40, P208, DOI 10.1111/j.1532-5415.1992.tb02069.x; Maki BE, 2008, J ELECTROMYOGR KINES, V18, P243, DOI 10.1016/j.jelekin.2007.06.005; Melis EH, 1999, SPINAL CORD, V37, P430, DOI 10.1038/sj.sc.3100850; Quinn L, 2001, MOVEMENT DISORD, V16, P469, DOI 10.1002/mds.1108; Quinn L, 2002, NEUROLOGY REPORT, V26, P145; Rao AK, 2005, MOVEMENT DISORD, V20, P1033, DOI 10.1002/mds.20482; Schaafsma JD, 2003, J NEUROL SCI, V212, P47, DOI 10.1016/S0022-510X(03)00104-7; Schenkman ML, 2001, PHYS THER, V81, P1400, DOI 10.1093/ptj/81.8.1400; Smithson F, 1998, PHYS THER, V78, P577, DOI 10.1093/ptj/78.6.577; TIAN JR, 1991, ACTA OTO-LARYNGOL, P333; TIAN JR, 1992, NEUROLOGY, V42, P1232, DOI 10.1212/WNL.42.6.1232; Verghese J, 2009, J GERONTOL A-BIOL, V64, P896, DOI 10.1093/gerona/glp033; Verza R, 2006, MULT SCLER J, V12, P88, DOI 10.1191/1352458506ms1233oa; Wheelock VL, 2003, NEUROLOGY, V60, P998, DOI 10.1212/01.WNL.0000052992.58107.67; Yaguez L, 2006, J NEUROL, V253, P186, DOI 10.1007/s00415-005-0951-4	29	33	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30903	10.1371/journal.pone.0030903	http://dx.doi.org/10.1371/journal.pone.0030903			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363511	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600084
J	Salvado, B; Vilaprinyo, E; Karathia, H; Sorribas, A; Alves, R				Salvado, Baldiri; Vilaprinyo, Ester; Karathia, Hiren; Sorribas, Albert; Alves, Rui			Two Component Systems: Physiological Effect of a Third Component	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; SIGNAL-TRANSDUCTION; REGULATORY SYSTEMS; RESPONSE REGULATOR; NITROGEN ASSIMILATION; BACTERIA; RESISTANCE; PATHWAY; KINASE; SENSOR	Signal transduction systems mediate the response and adaptation of organisms to environmental changes. In prokaryotes, this signal transduction is often done through Two Component Systems (TCS). These TCS are phosphotransfer protein cascades, and in their prototypical form they are composed by a kinase that senses the environmental signals (SK) and by a response regulator (RR) that regulates the cellular response. This basic motif can be modified by the addition of a third protein that interacts either with the SK or the RR in a way that could change the dynamic response of the TCS module. In this work we aim at understanding the effect of such an additional protein (which we call "third component'') on the functional properties of a prototypical TCS. To do so we build mathematical models of TCS with alternative designs for their interaction with that third component. These mathematical models are analyzed in order to identify the differences in dynamic behavior inherent to each design, with respect to functionally relevant properties such as sensitivity to changes in either the parameter values or the molecular concentrations, temporal responsiveness, possibility of multiple steady states, or stochastic fluctuations in the system. The differences are then correlated to the physiological requirements that impinge on the functioning of the TCS. This analysis sheds light on both, the dynamic behavior of synthetically designed TCS, and the conditions under which natural selection might favor each of the designs. We find that a third component that modulates SK activity increases the parameter space where a bistable response of the TCS module to signals is possible, if SK is monofunctional, but decreases it when the SK is bifunctional. The presence of a third component that modulates RR activity decreases the parameter space where a bistable response of the TCS module to signals is possible.	[Salvado, Baldiri; Karathia, Hiren; Sorribas, Albert; Alves, Rui] Univ Lleida, Dept Ciencies Med Basiques, Lleida, Spain; [Salvado, Baldiri; Karathia, Hiren; Sorribas, Albert; Alves, Rui] IRBLleida, Lleida, Spain; [Vilaprinyo, Ester] Parc de Salut Mar, Evaluat & Clin Epidemiol Dept, Barcelona, Spain; [Vilaprinyo, Ester] CIBER Epidemiol & Publ Hlth CIBERESP, Barcelona, Spain	Universitat de Lleida; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Salvado, B (corresponding author), Univ Lleida, Dept Ciencies Med Basiques, Lleida, Spain.	ralves@cmb.udl.es	Vilaprinyo, Ester/A-6702-2010; Alves, Rui/C-5920-2009; Sorribas, Albert/A-2181-2009; Karathia, Hiren/AAD-2361-2021	Vilaprinyo, Ester/0000-0002-5787-5890; Alves, Rui/0000-0002-8112-5184; Sorribas, Albert/0000-0002-7407-4075; Karathia, Hiren/0000-0003-3607-6552	MICINN (Ministerio de Ciencia e Innovacion, Spain) [BFU2008-0196, BFU2010-17704]; AGAUR (Agencia de Gestio d'Ajuts Universitaris i de Recerca, Catalunya)	MICINN (Ministerio de Ciencia e Innovacion, Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); AGAUR (Agencia de Gestio d'Ajuts Universitaris i de Recerca, Catalunya)	This work was partially supported by grants BFU2008-0196 to AS and BFU2010-17704 to RA, both from MICINN (Ministerio de Ciencia e Innovacion, Spain). HK is funded by a Ph. D. fellowship and EV is funded by a Beatriu de Pinos Post-doctoral fellowship, both from AGAUR (Agencia de Gestio d'Ajuts Universitaris i de Recerca, Catalunya). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khodor S, 2009, INFECT IMMUN, V77, P374, DOI 10.1128/IAI.01081-08; Alves R, 2003, MOL MICROBIOL, V48, P25, DOI 10.1046/j.1365-2958.2003.03344.x; Alves R, 2000, BIOINFORMATICS, V16, P786, DOI 10.1093/bioinformatics/16.9.786; Alves R, 2008, BIOTECHNOL GENET ENG, V25, P1; Atkinson MR, 1998, MOL MICROBIOL, V29, P431, DOI 10.1046/j.1365-2958.1998.00932.x; Batchelor E, 2003, P NATL ACAD SCI USA, V100, P691, DOI 10.1073/pnas.0234782100; Bhattacharya M, 2010, BIOCHIMIE, V92, P263, DOI 10.1016/j.biochi.2009.11.009; Boots M, 2004, SCIENCE, V303, P842, DOI 10.1126/science.1088542; Brencic A, 2009, MOL MICROBIOL, V73, P434, DOI 10.1111/j.1365-2958.2009.06782.x; Buelow DR, 2010, MOL MICROBIOL, V75, P547, DOI 10.1111/j.1365-2958.2009.06982.x; Chen HD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002184; Cheng HY, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-60; Eguchi Y, 2005, TRENDS BIOCHEM SCI, V30, P70, DOI 10.1016/j.tibs.2004.12.003; Fange D, 2009, P NATL ACAD SCI USA, V106, P8215, DOI 10.1073/pnas.0811514106; Vescovi EG, 2010, CURR OPIN MICROBIOL, V13, P210, DOI 10.1016/j.mib.2009.12.012; Gooderham WJ, 2009, FEMS MICROBIOL REV, V33, P279, DOI 10.1111/j.1574-6976.2008.00135.x; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Goodman AL, 2009, GENE DEV, V23, P249, DOI 10.1101/gad.1739009; Hazelbauer GL, 2010, CURR OPIN MICROBIOL, V13, P124, DOI 10.1016/j.mib.2009.12.014; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Igoshin OA, 2008, MOL MICROBIOL, V68, P1196, DOI 10.1111/j.1365-2958.2008.06221.x; Igoshin OA, 2006, MOL MICROBIOL, V61, P165, DOI 10.1111/j.1365-2958.2006.05212.x; KAMBEROV ES, 1994, CELL MOL BIOL RES, V40, P175; Kato A, 2004, GENE DEV, V18, P2302, DOI 10.1101/gad.1230804; Kato A, 2007, P NATL ACAD SCI USA, V104, P12063, DOI 10.1073/pnas.0704462104; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; Lin PL, 2010, J IMMUNOL, V185, P15, DOI 10.4049/jimmunol.0903856; Mattison K, 2002, J BIOL CHEM, V277, P11143, DOI 10.1074/jbc.M111128200; McPhee JB, 2006, J BACTERIOL, V188, P3995, DOI 10.1128/JB.00053-06; Minoia M, 2008, P NATL ACAD SCI USA, V105, P20792, DOI 10.1073/pnas.0806164106; Mitrophanov AY, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000233; MONOD J, 1961, COLD SPRING HARB SYM, V26, P389, DOI 10.1101/SQB.1961.026.01.048; Nalca Y, 2006, ANTIMICROB AGENTS CH, V50, P1680, DOI 10.1128/AAC.50.5.1680-1688.2006; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Perez JC, 2007, MOL MICROBIOL, V63, P283, DOI 10.1111/j.1365-2958.2006.05512.x; Perez JC, 2009, CELL, V138, P233, DOI 10.1016/j.cell.2009.07.002; Raghavan V, 2010, CURR OPIN MICROBIOL, V13, P226, DOI 10.1016/j.mib.2009.12.010; Salvado B, 2011, MATH BIOSCI, V231, P3, DOI 10.1016/j.mbs.2011.02.005; Silversmith RE, 2010, CURR OPIN MICROBIOL, V13, P177, DOI 10.1016/j.mib.2010.01.004; Stewart RC, 2004, J MOL BIOL, V336, P287, DOI 10.1016/j.jmb.2003.11.059; Tiwari A, 2011, MATH BIOSCI, V231, P76, DOI 10.1016/j.mbs.2011.03.004; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002; WOLFE AJ, 1987, J BACTERIOL, V169, P1878, DOI 10.1128/jb.169.5.1878-1885.1987; Wolfram Research I, 2010, MATH; Workentine ML, 2009, FEMS MICROBIOL LETT, V292, P50, DOI 10.1111/j.1574-6968.2008.01445.x; Wuichet K, 2010, CURR OPIN MICROBIOL, V13, P219, DOI 10.1016/j.mib.2009.12.011; Yan Q, 2009, MICROBIOL RES, V164, P18, DOI 10.1016/j.micres.2008.02.001; Yoshida T, 2002, MOL MICROBIOL, V46, P1283, DOI 10.1046/j.1365-2958.2002.03240.x	48	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31095	10.1371/journal.pone.0031095	http://dx.doi.org/10.1371/journal.pone.0031095			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363555	Green Published, gold			2022-12-27	WOS:000302853600110
J	Sircar, K; Huang, H; Hu, LM; Liu, YX; Dhillon, J; Cogdell, D; Aprikian, A; Efstathiou, E; Navone, N; Troncoso, P; Zhang, W				Sircar, Kanishka; Huang, Heng; Hu, Limei; Liu, Yuexin; Dhillon, Jasreman; Cogdell, David; Aprikian, Armen; Efstathiou, Eleni; Navone, Nora; Troncoso, Patricia; Zhang, Wei			Mitosis Phase Enrichment with Identification of Mitotic Centromere-Associated Kinesin As a Therapeutic Target in Castration-Resistant Prostate Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; CENTROSOME HYPERAMPLIFICATION; TUMOR AGGRESSIVENESS; SOLID TUMORS; DOCETAXEL; INHIBITOR; EG5; PHOSPHORYLATION; OVEREXPRESSION; MITOXANTRONE	The recently described transcriptomic switch to a mitosis program in castration-resistant prostate cancer (CRPC) suggests that mitotic proteins may be rationally targeted at this lethal stage of the disease. In this study, we showed upregulation of the mitosis-phase at the protein level in our cohort of 51 clinical CRPC cases and found centrosomal aberrations to also occur preferentially in CRPC compared with untreated, high Gleason-grade hormone-sensitive prostate cancer (P<0.0001). Expression profiling of chemotherapy-resistant CRPC samples (n = 25) was performed, and the results were compared with data from primary chemotherapy-naive CRPC (n = 10) and hormone-sensitive prostate cancer cases (n = 108). Our results showed enrichment of mitosis-phase genes and pathways, with progression to both castration-resistant and chemotherapy-resistant disease. The mitotic centromere-associated kinesin (MCAK) was identified as a novel mitosis-phase target in prostate cancer that was overexpressed in multiple CRPC gene-expression datasets. We found concordant gene expression of MCAK between our parent and murine CRPC xenograft pairs and increased MCAK protein expression with clinical progression of prostate cancer to a castration-resistant disease stage. Knockdown of MCAK arrested the growth of prostate cancer cells suggesting its utility as a potential therapeutic target.	[Sircar, Kanishka; Hu, Limei; Liu, Yuexin; Dhillon, Jasreman; Cogdell, David; Troncoso, Patricia; Zhang, Wei] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Huang, Heng] Univ Texas Arlington, Dept Comp Sci & Engn, Arlington, TX 76019 USA; [Efstathiou, Eleni; Navone, Nora] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Efstathiou, Eleni; Navone, Nora] Univ Texas MD Anderson Canc Ctr, David H Koch Ctr Appl Res Genitourinary Canc, Houston, TX 77030 USA; [Aprikian, Armen] McGill Univ, Div Urol, Montreal, PQ, Canada	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Arlington; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; McGill University	Sircar, K (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA.	ksircar@mdanderson.org; wzhang@mdanderson.org	Sircar, Kanishka/E-4106-2012		MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [P50CA140388] Funding Source: NIH RePORTER	MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This paper is supported by institutional funds from MD Anderson Cancer Center (KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Agarwal N, 2011, NOVEL MOL TARGETS TH; Beer TM, 2008, CLIN GENITOURIN CANC, V6, P103, DOI 10.3816/CGC.2008.n.016; Blagden SP, 2008, BRIT J CANCER, V98, P894, DOI 10.1038/sj.bjc.6604264; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; D'Assoro AB, 2002, BREAST CANCER RES TR, V75, P25, DOI 10.1023/A:1016550619925; Davis DA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-22; De S, 2009, CANCER RES, V69, P8035, DOI 10.1158/0008-5472.CAN-09-1224; Efstathiou E, 2007, CLIN CANCER RES, V13, P1224, DOI 10.1158/1078-0432.CCR-06-1938; Ganguly A, 2011, MOL CANCER THER, V10, P929, DOI 10.1158/1535-7163.MCT-10-1109; Gnjatic S, 2010, INT J CANCER, V127, P381, DOI 10.1002/ijc.25058; Gustafson LM, 2000, LARYNGOSCOPE, V110, P1798; Harrison Michael R, 2009, Clin Adv Hematol Oncol, V7, P54; Hayashi N, 2008, PROSTATE, V68, P1283, DOI 10.1002/pros.20783; Huszar D, 2009, CANCER METAST REV, V28, P197, DOI 10.1007/s10555-009-9185-8; Jabbur JR, 2002, CANCER BIOL THER, V1, P277, DOI 10.4161/cbt.81; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Knowlton AL, 2006, CURR BIOL, V16, P1705, DOI 10.1016/j.cub.2006.07.057; Liu Qingxin, 2011, Chin J Cancer, V30, P612, DOI 10.5732/cjc.011.10225; Marcus AI, 2005, J BIOL CHEM, V280, P11569, DOI 10.1074/jbc.M413471200; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Price ND, 2007, P NATL ACAD SCI USA, V104, P3414, DOI 10.1073/pnas.0611373104; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Sanhaji M, 2010, MOL CELL BIOL, V30, P2594, DOI 10.1128/MCB.00098-10; Shimo A, 2008, CANCER SCI, V99, P62, DOI 10.1111/j.1349-7006.2007.00635.x; Syed ML, 2009, OTOLARYNG HEAD NECK, V140, P498, DOI 10.1016/j.otohns.2008.12.049; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; True L, 2006, P NATL ACAD SCI USA, V103, P10991, DOI 10.1073/pnas.0603678103; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wiltshire C, 2010, MOL CANCER THER, V9, P1730, DOI 10.1158/1535-7163.MCT-09-1103; Yamamoto Y, 2004, CLIN CANCER RES, V10, P6449, DOI 10.1158/1078-0432.CCR-04-0773	31	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31259	10.1371/journal.pone.0031259	http://dx.doi.org/10.1371/journal.pone.0031259			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363599	gold, Green Submitted, Green Published			2022-12-27	WOS:000302853600132
J	Tractenberg, RE; Yumoto, F; Aisen, PS; Kaye, JA; Mislevy, RJ				Tractenberg, Rochelle E.; Yumoto, Futoshi; Aisen, Paul S.; Kaye, Jeffrey A.; Mislevy, Robert J.			Using the Guttman Scale to Define and Estimate Measurement Error in Items over Time: The Case of Cognitive Decline and the Meaning of "Points Lost"	PLOS ONE			English	Article							MINI-MENTAL-STATE; ALZHEIMERS-DISEASE PATIENTS; INTRAINDIVIDUAL VARIABILITY; CLINICAL-PRACTICE; ADAS-COG; MILD; DIAGNOSIS; INDEX; GALANTAMINE; RELIABILITY	We used a Guttman model to represent responses to test items over time as an approximation of what is often referred to as "points lost" in studies of cognitive decline or interventions. To capture this meaning of "point loss", over four successive assessments, we assumed that once an item is incorrect, it cannot be correct at a later visit. If the loss of a point represents actual decline, then failure of an item to fit the Guttman model over time can be considered measurement error. This representation and definition of measurement error also permits testing the hypotheses that measurement error is constant for items in a test, and that error is independent of "true score", which are two key consequences of the definition of "measurement error" -and thereby, reliability-under Classical Test Theory. We tested the hypotheses by fitting our model to, and comparing our results from, four consecutive annual evaluations in three groups of elderly persons: a) cognitively normal (NC, N = 149); b) diagnosed with possible or probable AD (N = 78); and c) cognitively normal initially and a later diagnosis of AD (converters, N = 133). Of 16 items that converged, error-free measurement of "cognitive loss" was observed for 10 items in NC, eight in converters, and two in AD. We found that measurement error, as we defined it, was inconsistent over time and across cognitive functioning levels, violating the theory underlying reliability and other psychometric characteristics, and key regression assumptions.	[Tractenberg, Rochelle E.] Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20007 USA; [Tractenberg, Rochelle E.] Georgetown Univ, Med Ctr, Dept Biostat, Washington, DC 20007 USA; [Tractenberg, Rochelle E.] Georgetown Univ, Med Ctr, Dept Bioinformat & Biomath, Washington, DC 20007 USA; [Tractenberg, Rochelle E.] Georgetown Univ, Med Ctr, Dept Psychiat, Washington, DC 20007 USA; [Yumoto, Futoshi] Univ Maryland, Univ Coll, College Pk, MD 20742 USA; [Aisen, Paul S.] Univ Calif San Diego, Dept Neurol, La Jolla, CA 92093 USA; [Kaye, Jeffrey A.] Oregon Hlth & Sci Univ, Layton Alzheimers Dis Res Ctr, Portland, OR USA; [Mislevy, Robert J.] Educ Testing Serv, Princeton, NJ 08541 USA	Georgetown University; Georgetown University; Georgetown University; Georgetown University; University System of Maryland; University of Maryland College Park; University of Maryland University College; University of California System; University of California San Diego; Oregon Health & Science University; Educational Testing Service (ETS)	Tractenberg, RE (corresponding author), Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20007 USA.	ret7@georgetown.edu		Kaye, Jeffrey/0000-0002-9971-3478	National Institutes of Health [K01 AG027172, M01RR13297-05]; National Institute on Aging [AG08017]; Department of Veteran's Affairs; Pharmaceutical Researchers and Manufacturers Association of America (PhRMA) Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR013297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG027172, P30AG008017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Department of Veteran's Affairs(US Department of Veterans Affairs); Pharmaceutical Researchers and Manufacturers Association of America (PhRMA) Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health K01 AG027172 to RET, and in part by grants M01RR13297-05 from the National Institutes of Health (RET); AG08017 from the National Institute on Aging (JAK); and a Merit Review Grant from the Department of Veteran's Affairs (JAK). This work began as partial fulfillment of a doctoral-level Certificate in Gerontology, which was supported by a Research Starters Grant in Health Outcomes from the Pharmaceutical Researchers and Manufacturers Association of America (PhRMA) Foundation to RET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancoli-Israel S, 2008, J AM GERIATR SOC, V56, P2076, DOI 10.1111/j.1532-5415.2008.01934.x; Aronson S, 2009, DRUG AGING, V26, P231, DOI 10.2165/00002512-200926030-00004; Arsenault-Lapierre G, 2011, J CLIN EXP NEUR 0206, P1; Carcaillon L, 2011, J NUTR HEALTH AGING, V15, P361, DOI 10.1007/s12603-011-0047-z; Carcaillon L, 2007, DEMENT GERIATR COGN, V23, P439, DOI 10.1159/000102017; Charles EP, 2005, PSYCHOL METHODS, V10, P206, DOI 10.1037/1082-989X.10.2.206; Chatterjee S, 2002, REGRESSION ANAL EXAM; Christensen H, 2005, NEUROPSYCHOLOGY, V19, P309, DOI 10.1037/0894-4105.19.3.309; Clogg CC, 1995, SOCIOL METHODOL, V25, P197, DOI 10.2307/271067; Collins LM, 2001, DECADE BEHAV, P273, DOI 10.1037/10409-009; Cortes F, 2007, J NUTR HEALTH AGING, V11, P330; Dayton C. M., 1998, LATENT CLASS SCALING; Dayton CM, 2003, BRIT J MATH STAT PSY, V56, P1, DOI 10.1348/000711003321645304; Eisenstein EL, 2010, J MED SYST; Embretson S, 2000, MULTIVARIATE APPL BO; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Green MS, 2000, NEUROLOGY, V54, P105, DOI 10.1212/WNL.54.1.105; Gustafson P, 2004, INTER DISC; Guttman L, 1944, AM SOCIOL REV, V9, P139, DOI 10.2307/2086306; Haertel E.H., 2006, ED MEASUREMENT, V4th ed., P65; HAYS RD, 1990, BEHAV RES METH INSTR, V22, P162, DOI 10.3758/BF03203139; Hobart JC, 2001, CLINICAL TRIALS IN NEUROLOGY, P17; Hultsch D.F., 2004, NEW FRONTIERS COGNIT, P65, DOI DOI 10.1093/ACPROF:OSO/9780198525691.003.0004; KAYE JA, 1994, ARCH NEUROL-CHICAGO, V51, P1205, DOI 10.1001/archneur.1994.00540240049015; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; McCutcheon AL, 1987, LATENT CLASS ANAL; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mitrushina M., 2005, HDB NORMATIVE DATA N; Nesselroade JR, 2004, J GERONTOL B-PSYCHOL, V59, pP49, DOI 10.1093/geronb/59.2.P49; O'Rourke N, 2009, AGING MENT HEALTH, V13, P280, DOI 10.1080/13607860802154549; Raykov T., 2011, INTRO PSYCHOMETRIC T; Rockwood K, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-26; RUDAS T, 1994, J R STAT SOC B, V56, P623; Rust J., 1999, MODERN PSYCHOMETRICS; Salthouse TA, 2007, NEUROPSYCHOLOGY, V21, P401, DOI 10.1037/0894-4105.21.4.401; Seltzer B, 2010, CLIN INTERV AGING, V5, P1; Shavelson R.J., 1991, GENERALIZABILITY THE; Slick D.J., 2006, COMPENDIUM NEUROPSYC, V3, P3; Soto ME, 2008, DEMENT GERIATR COGN, V26, P109, DOI 10.1159/000144073; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Tractenberg RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016973; van Belle G, 2000, STAT MED, V19, P1411, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1411::AID-SIM433>3.0.CO;2-T; Van Den Wittenboer G, 2000, QUAL QUANT, V34, P177, DOI 10.1023/A:1004775921860; Vellas B, 2007, J NUTR HEALTH AGING, V11, P338; Vermunt J. K., 1997, LEM 1 0 GEN PROGRAM; Walker MP, 2000, NEUROLOGY, V54, P1616, DOI 10.1212/WNL.54.8.1616; Xi L, 1994, MIXTURE INDEX FIT IN; Xi LW, 1996, SOCIOL METHOD RES, V25, P248, DOI 10.1177/0049124196025002005	48	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30019	10.1371/journal.pone.0030019	http://dx.doi.org/10.1371/journal.pone.0030019			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926TC	22363411	Green Submitted, gold, Green Published			2022-12-27	WOS:000302853600009
J	Storchova, H; Muller, K; Lau, S; Olson, MS				Storchova, Helena; Mueller, Karel; Lau, Steffen; Olson, Matthew S.			Mosaic Origins of a Complex Chimeric Mitochondrial Gene in Silene vulgaris	PLOS ONE			English	Article							CYTOPLASMIC MALE-STERILITY; OPEN READING FRAME; COMPLETE NUCLEOTIDE-SEQUENCE; PLANT MITOCHONDRIAL; GYNODIOECIOUS PLANT; ARABIDOPSIS-THALIANA; MAXIMUM-LIKELIHOOD; FLOWERING PLANTS; PATERNAL LEAKAGE; DNA	Chimeric genes are significant sources of evolutionary innovation that are normally created when portions of two or more protein coding regions fuse to form a new open reading frame. In plant mitochondria astonishingly high numbers of different novel chimeric genes have been reported, where they are generated through processes of rearrangement and recombination. Nonetheless, because most studies do not find or report nucleotide variation within the same chimeric gene, evolution after the origination of these chimeric genes remains unstudied. Here we identify two alleles of a complex chimera in Silene vulgaris that are divergent in nucleotide sequence, genomic position relative to other mitochondrial genes, and expression patterns. Structural patterns suggest a history partially influenced by gene conversion between the chimeric gene and functional copies of subunit 1 of the mitochondrial ATP synthase gene (atp1). We identified small repeat structures within the chimeras that are likely recombination sites allowing generation of the chimera. These results establish the potential for chimeric gene divergence in different plant mitochondrial lineages within the same species. This result contrasts with the absence of diversity within mitochondrial chimeras found in crop species.	[Storchova, Helena; Mueller, Karel] Acad Sci Czech Republic, Inst Expt Bot, Prague, Czech Republic; [Storchova, Helena; Lau, Steffen; Olson, Matthew S.] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK USA; [Storchova, Helena; Lau, Steffen; Olson, Matthew S.] Univ Alaska Fairbanks, Dept Biol & Wildlife, Fairbanks, AK USA; [Lau, Steffen] Max Planck Inst Dev Biol, Dept Cell Biol, Tubingen, Germany; [Olson, Matthew S.] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA	Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; University of Alaska System; University of Alaska Fairbanks; University of Alaska System; University of Alaska Fairbanks; Max Planck Society; Texas Tech University System; Texas Tech University	Storchova, H (corresponding author), Acad Sci Czech Republic, Inst Expt Bot, Prague, Czech Republic.	matt.olson@ttu.edu	STORCHOVA, Helena/F-4723-2010; Olson, Matthew S./ABI-7695-2020; Muller, Karel/F-7332-2014	STORCHOVA, Helena/0000-0001-6701-179X; Muller, Karel/0000-0002-0817-8810	United States National Science Foundation [DEB-031637]; Grant Agency of the Czech Republic [521/09/0261]; Ministry of Education, Youth and Sports, Czech Republic (MSMT) [LC06004]; MSMT Kontakt [ME09035]	United States National Science Foundation(National Science Foundation (NSF)); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports, Czech Republic (MSMT); MSMT Kontakt(Ministry of Education, Youth & Sports - Czech Republic)	Funding was graciously provided through a United States National Science Foundation grant DEB-031637 to MSO, and Grant Agency of the Czech Republic grant 521/09/0261, Ministry of Education, Youth and Sports, Czech Republic (MSMT) grant LC06004, and a MSMT Kontakt grant ME09035 to HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JO, 2007, GENETICS, V177, P1173, DOI 10.1534/genetics.107.073312; [Anonymous], 2006, THESIS U TEXAS AUSTI; Archibald JM, 2010, BMC BIOL, V8; Arrieta-Montiel MP, 2009, GENETICS, V183, P1261, DOI 10.1534/genetics.109.108514; Bentley KE, 2010, GENETICS, V185, P961, DOI 10.1534/genetics.110.115360; BONEN L, 1984, EMBO J, V3, P2531, DOI 10.1002/j.1460-2075.1984.tb02168.x; Case AL, 2008, EVOLUTION, V62, P1026, DOI 10.1111/j.1558-5646.2008.00360.x; Cho Y, 2004, P NATL ACAD SCI USA, V101, P17741, DOI 10.1073/pnas.0408302101; CORRENS C, 1906, BER DEUT BOT GES, V24, P459; Darracq A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-233; DEWEY RE, 1987, P NATL ACAD SCI USA, V84, P5374, DOI 10.1073/pnas.84.15.5374; Elansary HO, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-11; Feng X, 2009, THEOR APPL GENET, V118, P1361, DOI 10.1007/s00122-009-0986-5; FRAGOSO LL, 1989, GENOME, V31, P160, DOI 10.1139/g89-028; Fujii S, 2009, P NATL ACAD SCI USA, V106, P9513, DOI 10.1073/pnas.0901860106; GUALBERTO JM, 1991, PLANT CELL, V3, P1109, DOI 10.1105/tpc.3.10.1109; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HANDA H, 1995, CURR GENET, V28, P546, DOI 10.1007/BF00518167; Hanson MR, 1999, J HERED, V90, P362, DOI 10.1093/jhered/90.3.362; Hanson MR, 2004, PLANT CELL, V16, pS154, DOI 10.1105/tpc.015966; Hao WL, 2010, P NATL ACAD SCI USA, V107, P21576, DOI 10.1073/pnas.1016295107; Hao WL, 2009, P NATL ACAD SCI USA, V106, P16728, DOI 10.1073/pnas.0908766106; Hazle T, 2007, MOL BIOL EVOL, V24, P1101, DOI 10.1093/molbev/msm030; Hedgcoth C, 2002, CURR GENET, V41, P357, DOI 10.1007/s00294-002-0315-x; Houliston GJ, 2006, GENETICS, V174, P1983, DOI 10.1534/genetics.106.060202; Katju V, 2006, MOL BIOL EVOL, V23, P1056, DOI 10.1093/molbev/msj114; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; KIMURA M, 1981, P NATL ACAD SCI-BIOL, V78, P454, DOI 10.1073/pnas.78.1.454; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kubo T, 2000, NUCLEIC ACIDS RES, V28, P2571, DOI 10.1093/nar/28.13.2571; Kubo T, 2008, MITOCHONDRION, V8, P5, DOI 10.1016/j.mito.2007.10.006; Libus J, 2006, BIOTECHNIQUES, V41, P156, DOI 10.2144/000112232; Lynch M, 2006, SCIENCE, V311, P1727, DOI 10.1126/science.1118884; Manchekar M, 2009, PLANT SCI, V177, P629, DOI 10.1016/j.plantsci.2009.08.002; McCauley DE, 2008, EVOLUTION, V62, P1013, DOI 10.1111/j.1558-5646.2008.00363.x; McCauley DE, 2003, MOL ECOL, V12, P777, DOI 10.1046/j.1365-294X.2003.01764.x; NEWTON KJ, 1988, ANNU REV PLANT PHYS, V39, P503, DOI 10.1146/annurev.arplant.39.1.503; Olson MS, 2006, J EVOLUTION BIOL, V19, P1190, DOI 10.1111/j.1420-9101.2006.01103.x; Olson MS, 2002, EVOLUTION, V56, P253, DOI 10.1111/j.0014-3820.2002.tb01335.x; PALMER JD, 1988, J MOL EVOL, V28, P87, DOI 10.1007/BF02143500; Pearl SA, 2009, MOL BIOL EVOL, V26, P537, DOI 10.1093/molbev/msn273; Posada D, 2002, ANNU REV GENET, V36, P75, DOI 10.1146/annurev.genet.36.040202.111115; Rogers RL, 2009, GENETICS, V181, P313, DOI 10.1534/genetics.108.091538; Satoh M, 2004, MOL GENET GENOMICS, V272, P247, DOI 10.1007/s00438-004-1058-9; Satoh M, 2006, THEOR APPL GENET, V113, P477, DOI 10.1007/s00122-006-0312-4; Shedge V, 2007, PLANT CELL, V19, P1251, DOI 10.1105/tpc.106.048355; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Sloan DB, 2008, MOL BIOL EVOL, V25, P243, DOI 10.1093/molbev/msm266; Sloan DB, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-260; Sloan DB, 2010, BMC EVOLUTIONARY BIO, V10; Storchova H, 2004, MOL ECOL, V13, P2909, DOI 10.1111/j.1365-294X.2004.02278.x; Storchova H, 2000, TAXON, V49, P79, DOI 10.2307/1223934; Sugiyama Y, 2005, MOL GENET GENOMICS, V272, P603, DOI 10.1007/s00438-004-1075-8; Swofford D.L., 2002, PHYLOGENETIC ANAL US; Tang HV, 1996, PLANT J, V10, P123, DOI 10.1046/j.1365-313X.1996.10010123.x; Terachi T, 2001, CURR GENET, V40, P276, DOI 10.1007/s00294-001-0256-9; Touzet P, 2009, GENETICS, V181, P631, DOI 10.1534/genetics.108.092411; TRIGLIA T, 1988, NUCLEIC ACIDS RES, V16, P8186, DOI 10.1093/nar/16.16.8186; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Wang ZH, 2006, PLANT CELL, V18, P676, DOI 10.1105/tpc.105.038240; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Woloszynska M, 2009, PLANT MOL BIOL, V70, P511, DOI 10.1007/s11103-009-9488-8; YOUNG EG, 1987, CELL, V50, P41, DOI 10.1016/0092-8674(87)90660-X	63	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2012	7	2							e30401	10.1371/journal.pone.0030401	http://dx.doi.org/10.1371/journal.pone.0030401			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OV	22383961	gold, Green Published, Green Submitted			2022-12-27	WOS:000302918500009
J	Jacob, F; Ukegjini, K; Nixdorf, S; Ford, CE; Olivier, J; Caduff, R; Scurry, JP; Guertler, R; Hornung, D; Mueller, R; Fink, DA; Hacker, NF; Heinzelmann-Schwarz, VA				Jacob, Francis; Ukegjini, Kristjan; Nixdorf, Sheri; Ford, Caroline E.; Olivier, Jake; Caduff, Rosmarie; Scurry, James P.; Guertler, Rea; Hornung, Daniela; Mueller, Renato; Fink, Daniel A.; Hacker, Neville F.; Heinzelmann-Schwarz, Viola A.			Loss of Secreted Frizzled-Related Protein 4 Correlates with an Aggressive Phenotype and Predicts Poor Outcome in Ovarian Cancer Patients	PLOS ONE			English	Article							WNT PATHWAY; INHIBITS PROLIFERATION; SIGNALING PATHWAY; EXPRESSION; BREAST; GENE; PROSTATE; RECEPTOR; DISTINCT; MECHANISMS	Background: Activation of the Wnt signaling pathway is implicated in aberrant cellular proliferation in various cancers. In 40% of endometrioid ovarian cancers, constitutive activation of the pathway is due to oncogenic mutations in beta-catenin or other inactivating mutations in key negative regulators. Secreted frizzled-related protein 4 (SFRP4) has been proposed to have inhibitory activity through binding and sequestering Wnt ligands. Methodology/Principal Findings: We performed RT-qPCR and Western-blotting in primary cultures and ovarian cell lines for SFRP4 and its key downstream regulators activated beta-catenin, beta-catenin and GSK3 beta. SFRP4 was then examined by immunohistochemistry in a cohort of 721 patients and due to its proposed secretory function, in plasma, presenting the first ELISA for SFRP4. SFRP4 was most highly expressed in tubal epithelium and decreased with malignant transformation, both on RNA and on protein level, where it was even more profound in the membrane fraction (p<0.0001). SFRP4 was expressed on the protein level in all histotypes of ovarian cancer but was decreased from borderline tumors to cancers and with loss of cellular differentiation. Loss of membrane expression was an independent predictor of poor survival in ovarian cancer patients (p = 0.02 unadjusted; p = 0.089 adjusted), which increased the risk of a patient to die from this disease by the factor 1.8. Conclusions/Significance: Our results support a role for SFRP4 as a tumor suppressor gene in ovarian cancers via inhibition of the Wnt signaling pathway. This has not only predictive implications but could also facilitate a therapeutic role using epigenetic targets.	[Jacob, Francis; Ukegjini, Kristjan; Heinzelmann-Schwarz, Viola A.] Univ Zurich Hosp, Translat Res Grp, CH-8091 Zurich, Switzerland; [Jacob, Francis; Nixdorf, Sheri; Guertler, Rea; Heinzelmann-Schwarz, Viola A.] Univ New S Wales, Fac Med, Prince Wales Clin Sch, Gynaecol Canc Grp,Lowy Canc Res Ctr, Sydney, NSW, Australia; [Ford, Caroline E.] Univ New S Wales, Fac Med, Prince Wales Clin Sch, Wnt Signaling & Metastasis Grp,Lowy Canc Res Ctr, Sydney, NSW, Australia; [Olivier, Jake] Univ New S Wales, Prince Wales Clin Sch, Fac Med, Biostat Grp,Lowy Canc Res Ctr, Sydney, NSW, Australia; [Caduff, Rosmarie] Univ Zurich Hosp, Inst Clin Pathol, CH-8091 Zurich, Switzerland; [Scurry, James P.] Univ Newcastle, John Hunter Hosp, Hunter Area Pathol Serv, Callaghan, NSW 2308, Australia; [Hornung, Daniela] Univ Schleswig Holstein, Dept Obstet & Gynecol, Lubeck, Germany; [Mueller, Renato] Spital Limmattal, Dept Gynecol & Obstet, Zurich, Switzerland; [Fink, Daniel A.] Univ Zurich Hosp, Dept Gynecol, CH-8091 Zurich, Switzerland; [Hacker, Neville F.; Heinzelmann-Schwarz, Viola A.] Royal Hosp Women, Gynaecol Canc Ctr, Sydney, NSW, Australia	University of Zurich; University Zurich Hospital; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of Zurich; University Zurich Hospital; John Hunter Hospital; University of Newcastle; University of Kiel; Schleswig Holstein University Hospital; University of Zurich; University Zurich Hospital	Jacob, F (corresponding author), Univ Zurich Hosp, Translat Res Grp, CH-8091 Zurich, Switzerland.	viola@heinzelmann.ch	Ford, Caroline E/A-7850-2010; Nixdorf, Sheri/F-3269-2013; Olivier, Jake/D-2034-2012; Jacob, Francis/C-7910-2009	Ford, Caroline E/0000-0002-4438-2309; Olivier, Jake/0000-0002-3144-4507; Jacob, Francis/0000-0002-0446-1942; Heinzelmann-Schwarz, Viola/0000-0002-4056-3225; Hacker, Neville/0000-0002-1445-2302	Cancer League Canton Zurich; Oncosuisse [02115-08-2007]; Swiss National Foundation [320000-12543, PBZHP3-133289]; European Science Foundation; Cancer Institute New South Wales [09/CRF/2-02]; Royal Australian and New Zealand College of Obstetricians and Gynaecologists; William Maxwell Trust; Royal Hospital for Women Foundation	Cancer League Canton Zurich; Oncosuisse; Swiss National Foundation(Swiss National Science Foundation (SNSF)); European Science Foundation(European Science Foundation (ESF)European Commission); Cancer Institute New South Wales; Royal Australian and New Zealand College of Obstetricians and Gynaecologists; William Maxwell Trust; Royal Hospital for Women Foundation	This work was supported by Cancer League Canton Zurich (to V.H.S.); Oncosuisse (02115-08-2007 to V.H.S.); Swiss National Foundation (320000-12543 to V.H.S.; PBZHP3-133289 to F.J.); European Science Foundation (to V.H.S.); Cancer Institute New South Wales (09/CRF/2-02 to V.H.S.); Royal Australian and New Zealand College of Obstetricians and Gynaecologists (to V.H.S.); William Maxwell Trust (to V.H.S.) and the Royal Hospital for Women Foundation (to V.H.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2006, EJSO-EUR J SURG ONC, V32, P875, DOI 10.1016/j.ejso.2006.03.041; Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; Bafico A, 1999, J BIOL CHEM, V274, P16180, DOI 10.1074/jbc.274.23.16180; Bali A, 2004, CLIN CANCER RES, V10, P5168, DOI 10.1158/1078-0432.CCR-03-0751; Bast RC, 1998, HYBRIDOMA, V17, P313, DOI 10.1089/hyb.1998.17.313; Carmon KS, 2008, MOL CANCER RES, V6, P1017, DOI 10.1158/1541-7786.MCR-08-0039; Crijns APG, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-232; Dai W, 2011, CLIN CANCER RES, V17, P4052, DOI 10.1158/1078-0432.CCR-10-3021; Dejmek J, 2005, CANCER RES, V65, P9142, DOI 10.1158/0008-5472.CAN-05-1710; Dejmek J, 2005, CLIN CANCER RES, V11, P520; Drake J, 2009, EUR J GYNAECOL ONCOL, V30, P133; Fishman P, 2002, ONCOGENE, V21, P4060, DOI 10.1038/sj.onc.1205531; Ford CE, 2009, P NATL ACAD SCI USA, V106, P3919, DOI 10.1073/pnas.0809516106; He QY, 2005, GYNECOL ONCOL, V98, P68, DOI 10.1016/j.ygyno.2005.04.002; Heinzelmann-Schwarz VA, 2006, BRIT J CANCER, V94, P904, DOI 10.1038/sj.bjc.6603003; Heinzelmann-Schwarz VA, 2004, CLIN CANCER RES, V10, P4427, DOI 10.1158/1078-0432.CCR-04-0073; Horvath LG, 2005, INT J CANCER, V113, P415, DOI 10.1002/ijc.20599; Horvath LG, 2004, CLIN CANCER RES, V10, P615, DOI 10.1158/1078-0432.CCR-0707-03; Horvath LG, 2007, PROSTATE, V67, P1081, DOI 10.1002/pros.20607; Huang Y, 2010, ONCOL REP, V23, P177, DOI 10.3892/or_00000620; Jacob F, 2011, GYNECOL ONCOL, V121, P487, DOI 10.1016/j.ygyno.2011.02.022; Janssens N, 2004, TUMOR BIOL, V25, P161, DOI 10.1159/000081098; Jonsson M, 2002, CANCER RES, V62, P409; Katoh M, 2005, ONCOL REP, V14, P1583; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Li YL, 2009, ANAL BIOCHEM, V394, P110, DOI 10.1016/j.ab.2009.07.022; Lin KM, 1997, P NATL ACAD SCI USA, V94, P11196, DOI 10.1073/pnas.94.21.11196; Liu HY, 2007, FERTIL STERIL, V87, P988, DOI 10.1016/j.fertnstert.2006.08.095; Millar JBA, 2002, GENOME BIOL, V3; Moon Randall T, 2004, Nat Rev Genet, V5, P691, DOI 10.1038/nrg1427; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; Polakis P, 2000, GENE DEV, V14, P1837; Risinger JI, 2005, CANCER RES, V65, P5031, DOI 10.1158/0008-5472.CAN-04-0850; Russell W, 2002, JNCI-J NATL CANCER I, V94, P706; Schwartz DR, 2003, CANCER RES, V63, P2913; Shi Y, 2007, ACTA PHARMACOL SIN, V28, P1499, DOI 10.1111/j.1745-7254.2007.00692.x; Su HY, 2009, INT J CANCER, V124, P387, DOI 10.1002/ijc.23957; Takada T, 2004, CANCER SCI, V95, P741, DOI 10.1111/j.1349-7006.2004.tb03255.x; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Wissmann C, 2003, J PATHOL, V201, P204, DOI 10.1002/path.1449; Wong SCC, 2002, J PATHOL, V196, P145, DOI 10.1002/path.1035; Wu R, 2001, CANCER RES, V61, P8247; Zhai Y, 2002, AM J PATHOL, V160, P1229, DOI 10.1016/S0002-9440(10)62550-3	46	48	51	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31885	10.1371/journal.pone.0031885	http://dx.doi.org/10.1371/journal.pone.0031885			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363760	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000302873700115
J	Liang, XB; Bhattacharya, S; Bajaj, G; Guha, G; Wang, ZX; Jang, HS; Leid, M; Indra, AK; Ganguli-Indra, G				Liang, Xiaobo; Bhattacharya, Shreya; Bajaj, Gaurav; Guha, Gunjan; Wang, Zhixing; Jang, Hyo-Sang; Leid, Mark; Indra, Arup Kumar; Ganguli-Indra, Gitali			Delayed Cutaneous Wound Healing and Aberrant Expression of Hair Follicle Stem Cell Markers in Mice Selectively Lacking Ctip2 in Epidermis	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; KERATIN 15 EXPRESSION; DERMAL PAPILLA CELLS; IN-VITRO; MOUSE SKIN; BASAL LAYER; E-CADHERIN; MIGRATION; PROLIFERATION; DISTINCT	Background: COUP-TF interacting protein 2 [(Ctip2), also known as Bcl11b] is an important regulator of skin homeostasis, and is overexpressed in head and neck cancer. Ctip2(ep-/-) mice, selectively ablated for Ctip2 in epidermal keratinocytes, exhibited impaired terminal differentiation and delayed epidermal permeability barrier (EPB) establishment during development, similar to what was observed in Ctip2 null (Ctip2(-/-)) mice. Considering that as an important role of Ctip2, and the fact that molecular networks which underlie cancer progression partially overlap with those responsible for tissue remodeling, we sought to determine the role of Ctip2 during cutaneous wound healing. Methodology/Principal Findings: Full thickness excisional wound healing experiments were performed on Ctip2(L2/L2) and Ctip2(ep-/-) animals per time point and used for harvesting samples for histology, immunohistochemistry (IHC) and immunoblotting. Results demonstrated inherent defects in proliferation and migration of Ctip2 lacking keratinocytes during re-epithelialization. Mutant mice exhibited reduced epidermal proliferation, delayed keratinocyte activation, altered cell-cell adhesion and impaired ECM development. Post wounding, Ctip2(ep-/-) mice wounds displayed lack of E-Cadherin suppression in the migratory tongue, insufficient expression of alpha smooth muscle actin (alpha SMA) in the dermis, and robust induction of K8. Importantly, dysregulated expression of several hair follicle (HF) stem cell markers such as K15, NFATc1, CD133, CD34 and Lrig1 was observed in mutant skin during wound repair. Conclusions/Significance: Results confirm a cell autonomous role of keratinocytic Ctip2 to modulate cell migration, proliferation and/or differentiation, and to maintain HF stem cells during cutaneous wounding. Furthermore, Ctip2 in a non-cell autonomous manner regulated granulation tissue formation and tissue contraction during wound closure.	[Liang, Xiaobo; Bajaj, Gaurav; Guha, Gunjan; Wang, Zhixing; Jang, Hyo-Sang; Leid, Mark; Indra, Arup Kumar; Ganguli-Indra, Gitali] Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Bhattacharya, Shreya; Leid, Mark; Indra, Arup Kumar; Ganguli-Indra, Gitali] Oregon State Univ, Mol & Cell Biol Program, Corvallis, OR 97331 USA; [Leid, Mark; Indra, Arup Kumar] Oregon State Univ, Environm Hlth Sci Ctr, Corvallis, OR 97331 USA; [Indra, Arup Kumar] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA	Oregon State University; Oregon State University; Oregon State University; Oregon Health & Science University	Liang, XB (corresponding author), Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA.	arup.indra@oregonstate.edu; indrag@onid.orst.edu	Indra, Arup/AAG-2376-2019; Guha, Gunjan/D-8197-2011; Indra, Gitali/G-2963-2016	Indra, Arup/0000-0001-6137-7555; Guha, Gunjan/0000-0002-9224-0241; Bhattacharya, Shreya/0000-0003-4248-2362; Jang, Hyo Sang/0000-0003-0460-9924	National Institute of Arthritis and Musculoskeletal and Skin Diseases [5R01AR056008-02]; Oregon Health & Science University Medical Research Foundation; National Institute of Environmental Health Sciences Center [ES00210]; OSU College of Pharmacy; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Oregon Health & Science University Medical Research Foundation; National Institute of Environmental Health Sciences Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OSU College of Pharmacy; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	These studies were partly supported by grant 5R01AR056008-02 (AI) from National Institute of Arthritis and Musculoskeletal and Skin Diseases, by an Oregon Health & Science University Medical Research Foundation grant to GGI, and by a National Institute of Environmental Health Sciences Center grant (ES00210) to Oregon State University Environmental Health Sciences Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Stephen Hyter, Ling-Juan Zhang and Talicia Savage for help with breeding, genotyping and tape stripping, experiments. We also thank Dr. Daniel Metzger and Jean-Marc Bornert (IGBMC, Illkirch, France) for help in making the Ctip2 mutant mice and Drs. Mark Zabriskie and Gary DeLander of the OSU College of Pharmacy for continuous support and encouragement.	Alt-Holland A, 2008, J INVEST DERMATOL, V128, P2498, DOI 10.1038/jid.2008.102; Ansell DM, 2011, J INVEST DERMATOL, V131, P518, DOI 10.1038/jid.2010.291; Avram D, 2000, J BIOL CHEM, V275, P10315, DOI 10.1074/jbc.275.14.10315; Avram D, 2002, BIOCHEM J, V368, P555, DOI 10.1042/BJ20020496; Baranowsky A, 2010, MATRIX BIOL, V29, P15, DOI 10.1016/j.matbio.2009.09.004; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Bigliardi-Qi M, 2006, DIFFERENTIATION, V74, P174, DOI 10.1111/j.1432-0436.2006.00065.x; Casanova ML, 2004, FASEB J, V18, P1556, DOI 10.1096/fj.04-1683fje; Chu YW, 1996, AM J PATHOL, V148, P63; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Denton CP, 2009, J INVEST DERMATOL, V129, P194, DOI 10.1038/jid.2008.171; Driskell RR, 2011, J CELL SCI, V124, P1179, DOI 10.1242/jcs.082446; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; Fitsialos G, 2007, J BIOL CHEM, V282, P15090, DOI 10.1074/jbc.M606094200; Florin L, 2006, J INVEST DERMATOL, V126, P902, DOI 10.1038/sj.jid.5700123; Foitzik K, 2000, FASEB J, V14, P752, DOI 10.1096/fasebj.14.5.752; Fuchs E, 1995, ANNU REV CELL DEV BI, V11, P123, DOI 10.1146/annurev.cb.11.110195.001011; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Ganguli G, 2000, EMBO J, V19, P5135, DOI 10.1093/emboj/19.19.5135; Ganguli-Indra G, 2009, EXP DERMATOL, V18, P994, DOI 10.1111/j.1600-0625.2009.00876.x; Ganguli-Indra G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005367; Gerritsen MJP, 1997, J DERMATOL SCI, V14, P179, DOI 10.1016/S0923-1811(96)00570-1; Giangreco A, 2009, DEVELOPMENT, V136, P3505, DOI 10.1242/dev.038232; Gilbert S, 2001, J CELL BIOL, V154, P763, DOI 10.1083/jcb.200102130; Golonzhka O, 2007, GENE EXPR PATTERNS, V7, P754, DOI 10.1016/j.modgep.2007.06.002; Golonzhka O, 2009, J INVEST DERMATOL, V129, P1459, DOI 10.1038/jid.2008.392; Grose R, 2002, DEVELOPMENT, V129, P2303; Guo AH, 2009, EXP DERMATOL, V18, P720, DOI 10.1111/j.1600-0625.2009.00900.x; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hardy MM, 2003, J PHARMACOL EXP THER, V304, P959, DOI 10.1124/jpet.102.044545; HIROBE T, 1983, J EXP ZOOL, V227, P423, DOI 10.1002/jez.1402270311; HIROBE T, 1988, GENETICS, V120, P551; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Hosokawa R, 2005, J INVEST DERMATOL, V125, P1302, DOI 10.1111/j.0022-202X.2005.23963.x; Hudson LG, 2009, J DERMATOL SCI, V56, P19, DOI 10.1016/j.jdermsci.2009.06.009; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito Y, 2007, J INVEST DERMATOL, V127, P1052, DOI 10.1038/sj.jid.5700665; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Kanazawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012228; Kazerounian S, 2002, EXP DERMATOL, V11, P428, DOI 10.1034/j.1600-0625.2002.110506.x; Koizumi M, 2005, DEV GROWTH DIFFER, V47, P75; Leid M, 2004, GENE EXPR PATTERNS, V4, P733, DOI 10.1016/j.modgep.2004.03.009; LEIGH IM, 1995, BRIT J DERMATOL, V133, P501, DOI 10.1111/j.1365-2133.1995.tb02696.x; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mauch C, 2010, J INVEST DERMATOL, V130, P2120, DOI 10.1038/jid.2010.60; Mecklenburg L, 2000, J INVEST DERMATOL, V114, P909, DOI 10.1046/j.1523-1747.2000.00954.x; Morasso MI, 2005, BIOL CELL, V97, P173; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Myers SR, 2007, WOUND REPAIR REGEN, V15, P693, DOI 10.1111/j.1524-475X.2007.00297.x; Paladini RD, 1998, J CELL BIOL, V142, P1035, DOI 10.1083/jcb.142.4.1035; Patel GK, 2006, J INVEST DERMATOL, V126, P497, DOI 10.1038/sj.jid.5700101; Pedroso DC, 2007, PLOS ONE, V6; Porter RM, 2000, LAB INVEST, V80, P1701, DOI 10.1038/labinvest.3780180; Repertinger SK, 2004, J INVEST DERMATOL, V123, P982, DOI 10.1111/j.0022-202X.2004.23478.x; Safer JD, 2005, ENDOCRINOLOGY, V146, P4425, DOI 10.1210/en.2005-0192; Santoro MM, 2005, EXP CELL RES, V304, P274, DOI 10.1016/j.yexcr.2004.10.033; SCHREIER T, 1993, RES EXP MED, V193, P195, DOI 10.1007/BF02576227; Segatto O, 2011, J CELL SCI, V124, P1785, DOI 10.1242/jcs.083303; Semenova E, 2008, AM J PATHOL, V173, P1295, DOI 10.2353/ajpath.2008.071177; Sibilia M, 2007, DIFFERENTIATION, V75, P770, DOI 10.1111/j.1432-0436.2007.00238.x; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2005, J INVEST DERMATOL, V124, P13, DOI 10.1111/j.0022-202X.2004.23528.x; SLOMINSKI A, 1993, J INVEST DERMATOL, V101, pS90, DOI 10.1111/1523-1747.ep12362991; Tokumaru S, 2000, J CELL BIOL, V151, P209, DOI 10.1083/jcb.151.2.209; Trempus CS, 2007, CANCER RES, V67, P4173, DOI 10.1158/0008-5472.CAN-06-3128; Usui ML, 2005, WOUND REPAIR REGEN, V13, P468, DOI 10.1111/j.1067-1927.2005.00067.x; Wang ZX, 2011, J INVEST DERMATOL, V131, P177, DOI 10.1038/jid.2010.290; Waseem A, 1999, J INVEST DERMATOL, V112, P362, DOI 10.1046/j.1523-1747.1999.00535.x; Watt FM, 2006, CURR OPIN GENET DEV, V16, P518, DOI 10.1016/j.gde.2006.08.006; Watt FM, 2000, HUM GENE THER, V11, P2261, DOI 10.1089/104303400750035799; Wawersik MJ, 2001, MOL BIOL CELL, V12, P3439, DOI 10.1091/mbc.12.11.3439; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Werner S, 2000, EXP CELL RES, V254, P80, DOI 10.1006/excr.1999.4726; Wojcik SM, 2000, MOL CELL BIOL, V20, P5248, DOI 10.1128/MCB.20.14.5248-5255.2000; Wojcik SM, 2001, J CELL BIOL, V154, P619, DOI 10.1083/jcb.200102079; Yamaguchi R, 2007, WOUND REPAIR REGEN, V15, P87, DOI 10.1111/j.1524-475X.2006.00189.x	83	37	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e29999	10.1371/journal.pone.0029999	http://dx.doi.org/10.1371/journal.pone.0029999			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22383956	gold, Green Published			2022-12-27	WOS:000302873700006
J	Mondoulet, L; Dioszeghy, V; Larcher, T; Ligouis, M; Dhelft, V; Puteaux, E; Cherel, Y; Letourneur, F; Dupont, C; Benhamou, PH				Mondoulet, Lucie; Dioszeghy, Vincent; Larcher, Thibaut; Ligouis, Melanie; Dhelft, Veronique; Puteaux, Emilie; Cherel, Yan; Letourneur, Franck; Dupont, Christophe; Benhamou, Pierre-Henri			Epicutaneous Immunotherapy (EPIT) Blocks the Allergic Esophago-Gastro-Enteropathy Induced by Sustained Oral Exposure to Peanuts in Sensitized Mice	PLOS ONE			English	Article							EXPERIMENTAL EOSINOPHILIC ESOPHAGITIS; FOOD ALLERGY; DELIVERY-SYSTEM; GENE-EXPRESSION; MURINE MODEL; T-CELLS; IN-VIVO; CHILDREN; IL-13; ANAPHYLAXIS	Background: Food allergy may affect the gastrointestinal tract and eosinophilia is often associated with allergic gastrointestinal disorders. Allergy to peanuts is a life-threatening condition and effective and safe treatments still need to be developed. The present study aimed to evaluate the effects of sustained oral exposure to peanuts on the esophageal and jejunal mucosa in sensitized mice. We also evaluated the effects of desensitization with epicutaneous immunotherapy (EPIT) on these processes. Methods: Mice were sensitized by gavages with whole peanut protein extract (PPE) given with cholera toxin. Sensitized mice were subsequently exposed to peanuts via a specific regimen and were then analysed for eosinophilia in the esophagus and gut. We also assessed mRNA expression in the esophagus, antibody levels, and peripheral T-cell response. The effects of EPIT were tested when intercalated with sensitization and sustained oral peanut exposure. Results: Sustained oral exposure to peanuts in sensitized mice led to severe esophageal eosinophilia and intestinal villus sub-atrophia, i.e. significantly increased influx of eosinophils into the esophageal mucosa (136 eosinophils/mm(2)) and reduced villus/crypt ratios (1.6 +/- 0.15). In the sera, specific IgE levels significantly increased as did secretion of Th2 cytokines by peanut-reactivated splenocytes. EPIT of sensitized mice significantly reduced Th2 immunological response (IgE response and splenocyte secretion of Th2 cytokines) as well as esophageal eosinophilia (50 eosinophils/mm(2), p < 0.05), mRNA expression of Th2 cytokines in tissue - eotaxin (p < 0.05), IL-5 (p < 0.05), and IL-13 (p < 0.05) -, GATA-3 (p < 0.05), and intestinal villus sub-atrophia (2.36 +/- 0.15). EPIT also increased specific IgG2a (p < 0.05) and mRNA expression of Foxp3 (p < 0.05) in the esophageal mucosa. Conclusions: Gastro-intestinal lesions induced by sustained oral exposure in sensitized mice are efficaciously treated by allergen specific EPIT.	[Mondoulet, Lucie; Dioszeghy, Vincent; Ligouis, Melanie; Dhelft, Veronique; Puteaux, Emilie; Benhamou, Pierre-Henri] DBV Technol, Pepiniere Sante Paris Cochin, Paris, France; [Larcher, Thibaut; Cherel, Yan] INRA, Natl Vet Sch, UMR703, F-44026 Nantes, France; [Letourneur, Franck] Univ Paris 05, Inst Cochin, INSERM, U567, Paris, France; [Dupont, Christophe] Univ Paris 05, Hop Necker Enfants Malad, Paris, France	Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Mondoulet, L (corresponding author), DBV Technol, Pepiniere Sante Paris Cochin, Paris, France.	lucie.mondoulet@dbv-technologies.com	Larcher, Thibaut/M-9160-2013; Larcher, Thibaut/X-8500-2019	Larcher, Thibaut/0000-0002-0396-3190; Mondoulet, Lucie/0000-0003-0110-0321	DBV Technologies; Viaskin(R) technology	DBV Technologies; Viaskin(R) technology	This study was supported by DBV Technologies, owner of the Viaskin (R) technology. Lucie Mondoulet, Vincent Dioszeghy, Melanie Ligouis, Veronique Dhelft and Emilie Puteaux are DBV Technologies employees. Thibaut Larcher, Yan Cherel, Franck Letourneur, Christophe Dupont and Pierre-Henri Benhamou have received honoraria and/or compensation in regards to the study, as investigators, coordinators or experts, in relation with the time spent on the study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Akei HS, 2005, GASTROENTEROLOGY, V129, P985, DOI 10.1053/j.gastro.2005.06.027; Blanchard C, 2006, J CLIN INVEST, V116, P536, DOI 10.1172/JCI26679; Blanchard Carine, 2008, Gastrointest Endosc Clin N Am, V18, P133, DOI 10.1016/j.giec.2007.09.016; Blanchard C, 2010, J IMMUNOL, V184, P4033, DOI 10.4049/jimmunol.0903069; Cardoso CR, 2008, CLIN EXP ALLERGY, V38, P338; COLLINS PD, 1995, J EXP MED, V182, P1169, DOI 10.1084/jem.182.4.1169; Dioszeghy V, 2011, ALLERGY, V66, P509; Dioszeghy V, 2011, J IMMUNOL IN PRESS; Dubois B, 2009, GASTROENTEROLOGY, V137, P1019, DOI 10.1053/j.gastro.2009.03.055; Dupont C, 2010, J ALLERGY CLIN IMMUN, V125, P1165, DOI 10.1016/j.jaci.2010.02.029; Kalach N, 2005, J ALLERGY CLIN IMMUN, V116, P1321, DOI 10.1016/j.jaci.2005.08.033; Liacouras CA, 2005, CLIN GASTROENTEROL H, V3, P1198, DOI 10.1016/S1542-3565(05)00885-2; Liacouras C, 2011, J ALLERGY CLIN IMMUN, V128, P3, DOI 10.1016/j.jaci.2011.02.040; Mishra A, 2003, GASTROENTEROLOGY, V125, P1419, DOI 10.1016/j.gastro.2003.07.007; Mishra A, 2001, J CLIN INVEST, V107, P83, DOI 10.1172/JCI10224; Mishra A, 2002, J IMMUNOL, V168, P2464, DOI 10.4049/jimmunol.168.5.2464; Mishra A, 2008, GASTROENTEROLOGY, V134, P204, DOI 10.1053/j.gastro.2007.10.002; Mishra A, 2007, J LEUKOCYTE BIOL, V81, P916, DOI 10.1189/jlb.1106653; Mondoulet L, 2010, CLIN EXP ALLERGY, V40, P659, DOI 10.1111/j.1365-2222.2009.03430.x; Mondoulet L, 2011, INT ARCH ALLERGY IMM, V154, P299, DOI 10.1159/000321822; Narisety SD, 2009, J ALLERGY CLIN IMMUN, V124, P610, DOI 10.1016/j.jaci.2009.06.025; Romagnani S, 2000, J ALLERGY CLIN IMMUN, V105, P399, DOI 10.1067/mai.2000.104575; Rothenberg ME, 2004, J ALLERGY CLIN IMMUN, V113, P11, DOI 10.1016/j.jaci.2003.10.047; SAAVEDRADELGADO AM, 1985, ANN ALLERGY, V55, P694; Sampson HA, 1999, J ALLERGY CLIN IMMUN, V103, P717, DOI 10.1016/S0091-6749(99)70411-2; Savilahti E, 2000, J PEDIATR GASTR NUTR, V30, pS61, DOI 10.1097/00005176-200001001-00010; Schaefer ET, 2008, CLIN GASTROENTEROL H, V6, P165, DOI 10.1016/j.cgh.2007.11.008; Senti G, 2009, J ALLERGY CLIN IMMUN; Simon D, 2010, J ALLERGY CLIN IMMUN, V126, P3, DOI 10.1016/j.jaci.2010.01.055; Spergel JM, 2005, ANN ALLERG ASTHMA IM, V95, P336, DOI 10.1016/S1081-1206(10)61151-9; Srivastava KD, 2009, J ALLERGY CLIN IMMUN, V123, P443, DOI 10.1016/j.jaci.2008.12.1107; Strait RT, 2006, J CLIN INVEST, V116, P833, DOI 10.1172/JCI25575; Wasserman RL, 2011, J ALLERGY CLIN IMMUN, V127, pAB28, DOI 10.1016/j.jaci.2010.12.121; Zuo L, 2010, J IMMUNOL, V185, P660, DOI 10.4049/jimmunol.1000471	34	58	63	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31967	10.1371/journal.pone.0031967	http://dx.doi.org/10.1371/journal.pone.0031967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363776	Green Submitted, Green Published, gold			2022-12-27	WOS:000302873700128
J	Cockburn, N; Steven, D; Lecuona, K; Joubert, F; Rogers, G; Cook, C; Polack, S				Cockburn, Nicky; Steven, David; Lecuona, Karin; Joubert, Francois; Rogers, Graeme; Cook, Colin; Polack, Sarah			Prevalence, Causes and Socio-Economic Determinants of Vision Loss in Cape Town, South Africa	PLOS ONE			English	Article							VISUAL IMPAIRMENT; HEALTH-CARE; AVOIDABLE BLINDNESS; RAPID ASSESSMENT; WEST PROVINCE; DISTRICT; ACCESS; POPULATION; GLAUCOMA; CAMEROON	To estimate the prevalence and causes of blindness and visual impairment in Cape Town, South Africa and to explore socio-economic and demographic predictors of vision loss in this setting. Methods: A cross sectional population-based survey was conducted in Cape Town. Eighty-two clusters were selected using probability proportionate to size sampling. Within each cluster 35 or 40 people aged 50 years and above were selected using compact segment sampling. Visual acuity of participants was assessed and eyes with a visual acuity less than 6/18 were examined by an ophthalmologist to determine the cause of vision loss. Demographic data (age, gender and education) were collected and a socio-economic status (SES) index was created using principal components analysis. Results: Out of 3100 eligible people, 2750 (89%) were examined. The sample prevalence of bilateral blindness (presenting visual acuity < 3/60) was 1.4% (95% CI 0.9-1.8). Posterior segment diseases accounted for 65% of blindness and cataract was responsible for 27%. The prevalence of vision loss was highest among people over 80 years (odds ratio (OR) 6.9 95% CI 4.6-10.6), those in the poorest SES group (OR 3.9 95% CI 2.2-6.7) and people with no formal education (OR 5.4 95% CI 1.7-16.6). Cataract surgical coverage was 68% in the poorest SES tertile (68%) compared to 93% in the medium and 100% in the highest tertile. Conclusions: The prevalence of blindness among people >= 50 years in Cape Town was lower than expected and the contribution of posterior segment diseases higher than previously reported in South Africa and Sub Saharan Africa. There were clear socio-economic disparities in prevalence of vision loss and cataract surgical coverage in this setting which need to be addressed in blindness prevention programs.	[Cockburn, Nicky; Lecuona, Karin; Joubert, Francois; Rogers, Graeme; Cook, Colin] Groote Schuur Hosp, Dept Ophthalmol, ZA-7925 Cape Town, South Africa; [Steven, David] Eerste River Hosp, Cape Town, South Africa; [Polack, Sarah] London Sch Hyg & Trop Med, London WC1, England	University of Cape Town; University of London; London School of Hygiene & Tropical Medicine	Cockburn, N (corresponding author), Groote Schuur Hosp, Dept Ophthalmol, ZA-7925 Cape Town, South Africa.	nicole.cockburn@uct.ac.za			Lions District 401a Sight Foundation	Lions District 401a Sight Foundation	This study received funds from the Lions District 401a Sight Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other external funding was received.	Abou-Gareeb I, 2001, Ophthalmic Epidemiol, V8, P39, DOI 10.1076/opep.8.1.39.1540; Braithwaite J., 2008, DISABILITY POVERTY S; BUCHER PJM, 1988, BRIT J OPHTHALMOL, V72, P721, DOI 10.1136/bjo.72.10.721; COOK CD, 1993, S AFR MED J, V83, P590; Dandona L, 2001, INVEST OPHTH VIS SCI, V42, P908; Dandona R, 2001, BRIT J OPHTHALMOL, V85, P1484, DOI 10.1136/bjo.85.12.1484; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Foster A, 2005, EYE, V19, P1133, DOI 10.1038/sj.eye.6701973; Gilbert CE, 2008, BMJ-BRIT MED J, V336, P29, DOI 10.1136/bmj.39395.500046.AE; Groenewald P, 2010, B WORLD HEALTH ORGAN, V88, P444, DOI 10.2471/BLT.09.069435; Habiyakire C, 2010, OPHTHAL EPIDEMIOL, V17, P90, DOI 10.3109/09286580903453514; Harling G, 2008, SOC SCI MED, V66, P492, DOI 10.1016/j.socscimed.2007.08.026; Harris B, 2011, J PUBLIC HEALTH POL, V32, pS102, DOI 10.1057/jphp.2011.35; Joubert J, 2006, CHRONIC DIS LIFESTYL; Kalua K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019226; Kon ZR, 2008, AM J PUBLIC HEALTH, V98, P2272, DOI 10.2105/AJPH.2007.127829; KUPER H, 2005, CURR MED LIT OPHTHAL, V15, P81; Kuper Hannah, 2006, Community Eye Health, V19, P68; Kuper H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015431; Lalloo R, 2004, SAMJ S AFR MED J, V94, P639; Lam D, 2008, CAPE AREA PANEL STUD; Lecuona K, 2011, SAMJ S AFR MED J, V101, P510; LEVITT NS, 1993, DIABETES CARE, V16, P601, DOI 10.2337/diacare.16.4.601; Mathenge W, 2007, PLOS MED, V4, P1187, DOI 10.1371/journal.pmed.0040217; Mathenge W, 2007, OPHTHALMOLOGY, V114, P599, DOI 10.1016/j.ophtha.2006.06.057; Myburgh NG, 2005, INT J QUAL HEALTH C, V17, P473, DOI 10.1093/intqhc/mzi062; Nkonki LL, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-13; Oye JE, 2006, BRIT J OPHTHALMOL, V90, P538, DOI 10.1136/bjo.2005.082271; Oye JE, 2007, BRIT J OPHTHALMOL, V91, P1435, DOI 10.1136/bjo.2007.115840; Polack S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010913; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Resnikoff S, 2008, B WORLD HEALTH ORGAN, V86, P63, DOI 10.2471/BLT.07.041210; Rotchford AP, 2002, ARCH OPHTHALMOL-CHIC, V120, P471, DOI 10.1001/archopht.120.4.471; SALMON JF, 1993, ARCH OPHTHALMOL-CHIC, V111, P1263, DOI 10.1001/archopht.1993.01090090115029; Small K, 2010, SMALL K 2010 POP EST; Statistics South Africa, 2011, GEN HOUS SURV 2010, P28; TIELSCH JM, 1990, ARCH OPHTHALMOL-CHIC, V108, P286, DOI 10.1001/archopht.1990.01070040138048; Turner AG, 1996, INT J EPIDEMIOL, V25, P198, DOI 10.1093/ije/25.1.198; *WHO, 1988, PROGR PREV BLINDN DE, P1	39	42	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30718	10.1371/journal.pone.0030718	http://dx.doi.org/10.1371/journal.pone.0030718			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926YY	22363476	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000302871500014
J	Martinez-Granero, F; Navazo, A; Barahona, E; Redondo-Nieto, M; Rivilla, R; Martin, M				Martinez-Granero, Francisco; Navazo, Ana; Barahona, Emma; Redondo-Nieto, Miguel; Rivilla, Rafael; Martin, Marta			The Gac-Rsm and SadB Signal Transduction Pathways Converge on AlgU to Downregulate Motility in Pseudomonas fluorescens	PLOS ONE			English	Article							COMPETITIVE COLONIZATION ABILITY; MESSENGER-RNA RECOGNITION; RESPONSE REGULATOR; BIOFILM FORMATION; ESCHERICHIA-COLI; CORYNEBACTERIUM-GLUTAMICUM; FLAGELLUM BIOSYNTHESIS; SECONDARY METABOLISM; ALGINATE PRODUCTION; 2-COMPONENT SYSTEM	Flagella mediated motility in Pseudomonas fluorescens F113 is tightly regulated. We have previously shown that motility is repressed by the GacA/GacS system and by SadB through downregulation of the fleQ gene, encoding the master regulator of the synthesis of flagellar components, including the flagellin FliC. Here we show that both regulatory pathways converge in the regulation of transcription and possibly translation of the algU gene, which encodes a sigma factor. AlgU is required for multiple functions, including the expression of the amrZ gene which encodes a transcriptional repressor of fleQ. Gac regulation of algU occurs during exponential growth and is exerted through the RNA binding proteins RsmA and RsmE but not RsmI. RNA immunoprecipitation assays have shown that the RsmA protein binds to a polycistronic mRNA encoding algU, mucA, mucB and mucD, resulting in lower levels of algU. We propose a model for repression of the synthesis of the flagellar apparatus linking extracellular and intracellular signalling with the levels of AlgU and a new physiological role for the Gac system in the downregulation of flagella biosynthesis during exponential growth.	[Martinez-Granero, Francisco; Navazo, Ana; Barahona, Emma; Redondo-Nieto, Miguel; Rivilla, Rafael; Martin, Marta] Univ Autonoma Madrid, Dept Biol, Madrid, Spain	Autonomous University of Madrid	Martinez-Granero, F (corresponding author), Univ Autonoma Madrid, Dept Biol, Madrid, Spain.	m.martin@uam.es	Barahona, Emma/L-6421-2014; Rivilla, Rafael/A-1659-2008; Basanta, Marta Martin/AAI-5459-2020; martin, marta/H-2169-2015; Redondo-Nieto, Miguel/A-6169-2011	Rivilla, Rafael/0000-0003-0701-2939; Basanta, Marta Martin/0000-0003-2498-9768; martin, marta/0000-0003-2498-9768; Redondo-Nieto, Miguel/0000-0002-3361-520X	Spanish Ministry of Science and Education [BIO2009-08596]; Comunidad de Madrid	Spanish Ministry of Science and Education(Spanish Government); Comunidad de Madrid(Comunidad de Madrid)	This work was funded by the Spanish Ministry of Science and Education grant BIO2009-08596, and by the Research Program MICROAMBIENTE-CM from Comunidad de Madrid. AN is the recipient of an FPI fellowship from the Spanish Ministry of Science and Education. EB is the recipient of a predoctoral contract from Comunidad de Madrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarons S, 2000, J BACTERIOL, V182, P3913, DOI 10.1128/JB.182.14.3913-3919.2000; Barahona E, 2011, APPL ENVIRON MICROB, V77, P5412, DOI 10.1128/AEM.00320-11; Beatson SA, 2002, J BACTERIOL, V184, P3605, DOI 10.1128/JB.184.13.3605-3613.2002; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Blumer C, 1999, P NATL ACAD SCI USA, V96, P14073, DOI 10.1073/pnas.96.24.14073; Brencic A, 2009, MOL MICROBIOL, V72, P612, DOI 10.1111/j.1365-2958.2009.06670.x; Burrowes E, 2005, RES MICROBIOL, V156, P7, DOI 10.1016/j.resmic.2004.07.004; Caiazza NC, 2005, J BACTERIOL, V187, P7351, DOI 10.1128/JB.187.21.7351-7361.2005; Caiazza NC, 2004, J BACTERIOL, V186, P4476, DOI 10.1128/JB.186.14.4476-4485.2004; Capdevila S, 2004, MICROBIOL-SGM, V150, P3889, DOI 10.1099/mic.0.27362-0; Chatterjee A, 2003, MOL PLANT MICROBE IN, V16, P1106, DOI 10.1094/MPMI.2003.16.12.1106; Choy WK, 2004, J BACTERIOL, V186, P7221, DOI 10.1128/JB.186.21.7221-7228.2004; Damron FH, 2009, J BACTERIOL, V191, P2285, DOI 10.1128/JB.01490-08; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; Dasgupta N, 2002, J BACTERIOL, V184, P5240, DOI 10.1128/JB.184.19.5240-5250.2002; Dasgupta N, 2001, J BACTERIOL, V183, P6636, DOI 10.1128/JB.183.22.6636-6644.2001; de Souza JT, 2003, ENVIRON MICROBIOL, V5, P1328, DOI 10.1111/j.1462-2920.2003.00438.x; DELORENZO V, 1993, GENE, V123, P17, DOI 10.1016/0378-1119(93)90533-9; DEWEGER LA, 1987, J BACTERIOL, V169, P2769, DOI 10.1128/jb.169.6.2769-2773.1987; Dubern JF, 2006, FEMS MICROBIOL LETT, V263, P169, DOI 10.1111/j.1574-6968.2006.00406.x; Dubern JF, 2005, J BACTERIOL, V187, P5967, DOI 10.1128/JB.187.17.5967-5976.2005; FINAN TM, 1986, J BACTERIOL, V167, P66, DOI 10.1128/jb.167.1.66-72.1986; Goodman AL, 2009, GENE DEV, V23, P249, DOI 10.1101/gad.1739009; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Hassan KA, 2010, ENVIRON MICROBIOL, V12, P899, DOI 10.1111/j.1462-2920.2009.02134.x; Heeb S, 2005, FEMS MICROBIOL LETT, V243, P251, DOI 10.1016/j.femsle.2004.12.008; Heeb S, 2001, MOL PLANT MICROBE IN, V14, P1351, DOI 10.1094/MPMI.2001.14.12.1351; Heurlier K, 2004, J BACTERIOL, V186, P2936, DOI 10.1128/JB.186.10.2936-2945.2004; Kalogeraki VS, 1997, GENE, V188, P69, DOI 10.1016/S0378-1119(96)00778-0; Kang BR, 2006, CURR MICROBIOL, V52, P473, DOI 10.1007/s00284-005-0427-x; Kay E, 2005, P NATL ACAD SCI USA, V102, P17136, DOI 10.1073/pnas.0505673102; Kay E, 2006, J BACTERIOL, V188, P6026, DOI 10.1128/JB.00409-06; Kinscherf TG, 1999, J BACTERIOL, V181, P4133, DOI 10.1128/JB.181.13.4133-4136.1999; Kirchner O, 2003, J BIOTECHNOL, V104, P287, DOI 10.1016/S0168-1656(03)00148-2; Koch B, 2002, APPL ENVIRON MICROB, V68, P4509, DOI 10.1128/AEM.68.9.4509-4516.2002; Kuchma SL, 2007, J BACTERIOL, V189, P8165, DOI 10.1128/JB.00586-07; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; Lapouge K, 2007, MOL MICROBIOL, V66, P341, DOI 10.1111/j.1365-2958.2007.05909.x; LAVILLE J, 1992, P NATL ACAD SCI USA, V89, P1562, DOI 10.1073/pnas.89.5.1562; Liao CH, 1996, CAN J MICROBIOL, V42, P177, DOI 10.1139/m96-026; Lin CR, 2005, MOL CELL BIOL, V25, P7484, DOI 10.1128/MCB.25.17.7484-7493.2005; Ma S, 1997, J BIOL CHEM, V272, P17952, DOI 10.1074/jbc.272.29.17952; Martinez-Granero F, 2005, MICROBIOL-SGM, V151, P975, DOI 10.1099/mic.0.27583-0; Martinez-Granero F, 2006, APPL ENVIRON MICROB, V72, P3429, DOI 10.1128/AEM.72.5.3429-3434.2006; Navazo A, 2009, MICROB BIOTECHNOL, V2, P489, DOI 10.1111/j.1751-7915.2009.00103.x; Pessi G, 2001, J BACTERIOL, V183, P6676, DOI 10.1128/JB.183.22.6676-6683.2001; Petrova OE, 2010, J BACTERIOL, V192, P5275, DOI 10.1128/JB.00387-10; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Redondo-Nieto M, 2012, J BACTERIOL, V194, P1273, DOI 10.1128/JB.06601-11; Reimmann C, 2005, J BACTERIOL, V187, P276, DOI 10.1128/JB.187.1.276-285.2005; Reimmann C, 1997, MOL MICROBIOL, V24, P309, DOI 10.1046/j.1365-2958.1997.3291701.x; RICH JJ, 1994, J BACTERIOL, V176, P7468, DOI 10.1128/JB.176.24.7468-7475.1994; SACHERER P, 1994, FEMS MICROBIOL LETT, V116, P155, DOI 10.1111/j.1574-6968.1994.tb06694.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sanchez-Contreras M, 2002, J BACTERIOL, V184, P1587, DOI 10.1128/JB.184.6.1587-1596.2002; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; SCHER FM, 1982, PHYTOPATHOLOGY, V72, P1567, DOI 10.1094/Phyto-72-1567; Schreiber KJ, 2011, MOL MICROBIOL, V80, P364, DOI 10.1111/j.1365-2958.2011.07571.x; Schubert M, 2007, NAT STRUCT MOL BIOL, V14, P807, DOI 10.1038/nsmb1285; SHANAHAN P, 1992, APPL ENVIRON MICROB, V58, P353, DOI 10.1128/AEM.58.1.353-358.1992; Sonnleitner E, 2011, APPL MICROBIOL BIOT, V91, P63, DOI 10.1007/s00253-011-3332-1; Tart AH, 2005, J BACTERIOL, V187, P7955, DOI 10.1128/JB.187.23.7955-7962.2005; Tart AH, 2006, J BACTERIOL, V188, P6483, DOI 10.1128/JB.00636-06; Valverde C, 2004, J BIOL CHEM, V279, P25066, DOI 10.1074/jbc.M401870200; Valverde C, 2003, MOL MICROBIOL, V50, P1361, DOI 10.1046/j.1365-2958.2003.03774.x; Vodovar N, 2006, NAT BIOTECHNOL, V24, P673, DOI 10.1038/nbt1212; Wei BDL, 2001, MOL MICROBIOL, V40, P245, DOI 10.1046/j.1365-2958.2001.02380.x; Whistler CA, 1998, J BACTERIOL, V180, P6635, DOI 10.1128/JB.180.24.6635-6641.1998; Willis DK, 2001, APPL ENVIRON MICROB, V67, P1400, DOI 10.1128/AEM.67.3.1400-1403.2001; WOZNIAK DJ, 1994, J BACTERIOL, V176, P6007, DOI 10.1128/jb.176.19.6007-6014.1994; Zhang ZG, 2001, APPL ENVIRON MICROB, V67, P4305, DOI 10.1128/AEM.67.9.4305-4315.2001; Zuber S, 2003, MOL PLANT MICROBE IN, V16, P634, DOI 10.1094/MPMI.2003.16.7.634	73	48	49	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31765	10.1371/journal.pone.0031765	http://dx.doi.org/10.1371/journal.pone.0031765			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363726	Green Submitted, gold, Green Published			2022-12-27	WOS:000302871500085
J	Nyqvist, MJ; Gozlan, RE; Cucherousset, J; Britton, JR				Nyqvist, Marina J.; Gozlan, Rodolphe E.; Cucherousset, Julien; Britton, J. Robert			Behavioural Syndrome in a Solitary Predator Is Independent of Body Size and Growth Rate	PLOS ONE			English	Article							PIKE ESOX-LUCIUS; INDIVIDUAL-DIFFERENCES; LIFE-HISTORY; PERSONALITY-TRAITS; PRACTICAL GUIDE; TRADE-OFFS; PREY-SIZE; EVOLUTIONARY; BOLDNESS; STICKLEBACKS	Models explaining behavioural syndromes often focus on state-dependency, linking behavioural variation to individual differences in other phenotypic features. Empirical studies are, however, rare. Here, we tested for a size and growth-dependent stable behavioural syndrome in the juvenile-stages of a solitary apex predator ( pike, Esox lucius), shown as repeatable foraging behaviour across risk. Pike swimming activity, latency to prey attack, number of successful and unsuccessful prey attacks was measured during the presence/absence of visual contact with a competitor or predator. Foraging behaviour across risks was considered an appropriate indicator of boldness in this solitary predator where a trade-off between foraging behaviour and threat avoidance has been reported. Support was found for a behavioural syndrome, where the rank order differences in the foraging behaviour between individuals were maintained across time and risk situation. However, individual behaviour was independent of body size and growth in conditions of high food availability, showing no evidence to support the state-dependent personality hypothesis. The importance of a combination of spatial and temporal environmental variation for generating growth differences is highlighted.	[Nyqvist, Marina J.; Gozlan, Rodolphe E.; Cucherousset, Julien; Britton, J. Robert] Bournemouth Univ, Ctr Conservat Ecol & Environm Sci, Sch Appl Sci, Poole BH12 5BB, Dorset, England; [Cucherousset, Julien] CNRS, UPS, ENFA, EDB Lab Evolut & Diversite Biol UMR5174, Toulouse, France; [Cucherousset, Julien] Univ Toulouse, UPS, EDB UMR5174, Toulouse, France	Bournemouth University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Nyqvist, MJ (corresponding author), Bournemouth Univ, Ctr Conservat Ecol & Environm Sci, Sch Appl Sci, Poole BH12 5BB, Dorset, England.	mnyqvist@bournemouth.ac.uk	Britton, Robert/AAO-6673-2020; Cucherousset, Julien/B-5709-2011; Britton, Robert/B-5040-2009	Britton, Robert/0000-0003-1853-3086; Britton, Robert/0000-0003-1853-3086; Cucherousset, Julien/0000-0003-0533-9479	Bournemouth University	Bournemouth University	Funding was received from a Ph.D. Scholarship awarded to the corresponding author from Bournemouth University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adriaenssens B, 2011, APPL ANIM BEHAV SCI, V132, P90, DOI 10.1016/j.applanim.2011.03.005; Adriaenssens B, 2009, TRENDS ECOL EVOL, V24, P179, DOI 10.1016/j.tree.2008.12.003; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; Baras E, 2010, J FISH BIOL, V77, P985, DOI 10.1111/j.1095-8649.2010.02740.x; Bell AM, 2007, ECOL LETT, V10, P828, DOI 10.1111/j.1461-0248.2007.01081.x; Bell AM, 2007, P ROY SOC B-BIOL SCI, V274, P755, DOI 10.1098/rspb.2006.0199; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Bell AM, 2005, J EVOLUTION BIOL, V18, P464, DOI 10.1111/j.1420-9101.2004.00817.x; Bell AM, 2004, ANIM BEHAV, V68, P1339, DOI 10.1016/j.anbehav.2004.05.007; Biro PA, 2008, TRENDS ECOL EVOL, V23, P361, DOI 10.1016/j.tree.2008.04.003; Biro PA, 2006, J ANIM ECOL, V75, P1165, DOI 10.1111/j.1365-2656.2006.01137.x; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; BRY C, 1995, J FISH BIOL, V46, P99, DOI 10.1111/j.1095-8649.1995.tb05949.x; Budaev S., 2011, FISH COGNITION BEHAV, P135, DOI DOI 10.1002/9781444342536.CH7; Carey MP, 2010, OECOLOGIA, V162, P443, DOI 10.1007/s00442-009-1461-3; Casselman JM, 1996, CAN J FISH AQUAT SCI, V53, P161, DOI 10.1139/cjfas-53-S1-161; Conrad JL, 2011, J FISH BIOL, V78, P395, DOI 10.1111/j.1095-8649.2010.02874.x; Conrad JL, 2009, J FISH BIOL, V75, P1410, DOI 10.1111/j.1095-8649.2009.02372.x; Cucherousset J, 2007, FISH RES, V85, P159, DOI 10.1016/j.fishres.2007.01.011; CUI YB, 1990, COMP BIOCHEM PHYS A, V97, P551, DOI 10.1016/0300-9629(90)90126-D; DAVENPORT J, 1993, HERPETOL J, V3, P19; Dingemanse NJ, 2010, PHILOS T R SOC B, V365, P3947, DOI 10.1098/rstb.2010.0221; Engstrom-Ost J, 2004, J FISH BIOL, V65, P251, DOI 10.1111/j.0022-1112.2004.00448.x; Gabriel PO, 2010, ANIM BEHAV, V80, P689, DOI 10.1016/j.anbehav.2010.07.004; Galarowicz TL, 2005, CAN J FISH AQUAT SCI, V62, P2330, DOI 10.1139/F05-148; Garamszegi LZ, 2006, BEHAV ECOL, V17, P682, DOI 10.1093/beheco/ark005; GILES N, 1986, J FISH BIOL, V29, P107, DOI 10.1111/j.1095-8649.1986.tb04930.x; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; GRIMM MP, 1981, FISH MANAGE, V12, P61; GRIMM MP, 1981, FISH MANAGE, V12, P77; Houston AI, 1999, MODELS ADAPTIVE BEHA; Ivanova M, 1995, J ICHTYOLOGY, V35, P379; KAUSHIK SJ, 1985, J FISH BIOL, V26, P171, DOI 10.1111/j.1095-8649.1985.tb04254.x; Lee JSF, 2008, ENVIRON BIOL FISH, V82, P179, DOI 10.1007/s10641-007-9288-4; Lehtiniemi M, 2005, J FISH BIOL, V66, P1285, DOI 10.1111/j.0022-1112.2005.00681.x; Logue DM, 2009, BEHAV ECOL, V20, P781, DOI 10.1093/beheco/arp061; Luttbeg B, 2010, PHILOS T R SOC B, V365, P3977, DOI 10.1098/rstb.2010.0207; Magnhagen C, 2005, BEHAV ECOL SOCIOBIOL, V57, P295, DOI 10.1007/s00265-004-0834-1; Mangel M, 2005, AM NAT, V166, pE155, DOI 10.1086/444439; Mangel M, 2001, EVOL ECOL RES, V3, P583; MANN R H K, 1990, Aquaculture and Fisheries Management, V21, P471, DOI 10.1111/j.1365-2109.1990.tb00485.x; MANN RHK, 1982, J ANIM ECOL, V51, P81, DOI 10.2307/4312; Martins CIM, 2005, AQUAC RES, V36, P1509, DOI 10.1111/j.1365-2109.2005.01372.x; Mas-Munoz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021393; Monclus R, 2009, OECOLOGIA, V158, P615, DOI 10.1007/s00442-008-1201-0; Moya-Larano J, 2011, PHILOS T R SOC B, V366, P1425, DOI 10.1098/rstb.2010.0241; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Nilsson PA, 1999, BEHAV ECOL, V10, P557, DOI 10.1093/beheco/10.5.557; Pronk R, 2010, J EXP BIOL, V213, P1035, DOI 10.1242/jeb.040675; R Core Team, 2020, R LANG ENV STAT COMP; Raat A, 1988, FAO FISH SYNOPSIS; Ragland GJ, 2004, HEREDITY, V92, P569, DOI 10.1038/sj.hdy.6800462; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Schmitz OJ, 2007, ECOLOGY, V88, P2415, DOI 10.1890/06-0937.1; Schurch R, 2010, BEHAV ECOL, V21, P588, DOI 10.1093/beheco/arq024; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; Stamps JA, 1998, AM NAT, V152, P470, DOI 10.1086/286183; STAMPS JA, 1991, AM ZOOL, V31, P338; Stamps JA, 2007, ECOL LETT, V10, P355, DOI 10.1111/j.1461-0248.2007.01034.x; Stamps JA, 2010, PHILOS T R SOC B, V365, P4029, DOI 10.1098/rstb.2010.0218; Toms CN., 2010, INT J COMPPSYCHOL, V23, P1, DOI DOI 10.1002/CPMO.17; Wang HP, 2003, J WORLD AQUACULT SOC, V34, P379, DOI 10.1111/j.1749-7345.2003.tb00075.x; Ward AJW, 2004, BEHAV ECOL SOCIOBIOL, V55, P561, DOI 10.1007/s00265-003-0751-8; Wilson ADM, 2005, ETHOLOGY, V111, P849, DOI 10.1111/j.1439-0310.2005.01110.x; Wilson ADM, 2007, ANIM BEHAV, V74, P689, DOI 10.1016/j.anbehav.2007.01.009; Wilson DS, 1998, PHILOS T R SOC B, V353, P199, DOI 10.1098/rstb.1998.0202; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1; Wolf M, 2008, P NATL ACAD SCI USA, V105, P15825, DOI 10.1073/pnas.0805473105; Wolf M, 2010, PHILOS T R SOC B, V365, P3959, DOI 10.1098/rstb.2010.0215; Ziliukiene V, 2006, AQUACULTURE, V258, P378, DOI 10.1016/j.aquaculture.2006.04.010	75	20	20	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31619	10.1371/journal.pone.0031619	http://dx.doi.org/10.1371/journal.pone.0031619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363687	Green Published, Green Accepted, gold			2022-12-27	WOS:000302871500063
J	Hafner, C; Houben, R; Baeurle, A; Ritter, C; Schrama, D; Landthaler, M; Becker, JC				Hafner, Christian; Houben, Roland; Baeurle, Anne; Ritter, Cathrin; Schrama, David; Landthaler, Michael; Becker, Juergen C.			Activation of the PI3K/AKT Pathway in Merkel Cell Carcinoma	PLOS ONE			English	Article							T-ANTIGEN; PIK3CA MUTATIONS; SQUAMOUS-CELL; MELANOMA; POLYOMAVIRUS; CANCER; TUMORS; AKT; EXPRESSION; RARE	Merkel cell carcinoma (MCC) is a highly aggressive skin cancer with an increasing incidence. The understanding of the molecular carcinogenesis of MCC is limited. Here, we scrutinized the PI3K/AKT pathway, one of the major pathways activated in human cancer, in MCC. Immunohistochemical analysis of 41 tumor tissues and 9 MCC cell lines revealed high levels of AKT phosphorylation at threonine 308 in 88% of samples. Notably, the AKT phosphorylation was not correlated with the presence or absence of the Merkel cell polyoma virus (MCV). Accordingly, knock-down of the large and small T antigen by shRNA in MCV positive MCC cells did not affect phosphorylation of AKT. We also analyzed 46 MCC samples for activating PIK3CA and AKT1 mutations. Oncogenic PIK3CA mutations were found in 2/46 (4%) MCCs whereas mutations in exon 4 of AKT1 were absent. MCC cell lines demonstrated a high sensitivity towards the PI3K inhibitor LY-294002. This finding together with our observation that the PI3K/AKT pathway is activated in the majority of human MCCs identifies PI3K/AKT as a potential new therapeutic target for MCC patients.	[Hafner, Christian; Landthaler, Michael] Univ Regensburg, Dept Dermatol, Regensburg, Germany; [Houben, Roland; Baeurle, Anne; Ritter, Cathrin] Univ Hosp Wurzburg, Dept Dermatol, Wurzburg, Germany; [Schrama, David; Becker, Juergen C.] Med Univ Graz, Dept Gen Dermatol, Graz, Austria	University of Regensburg; University of Wurzburg; Medical University of Graz	Hafner, C (corresponding author), Univ Regensburg, Dept Dermatol, Regensburg, Germany.	christian.hafner@klinik.uni-regensburg.de		Schrama, David/0000-0002-6931-8194; Houben, Roland/0000-0003-4538-2324	DFG [HA 5531/1-1]; Wilhelm-Sander-Stiftung [2007.057.2]	DFG(German Research Foundation (DFG)); Wilhelm-Sander-Stiftung	This project was supported in part by the DFG grant HA 5531/1-1 (www.dfg.de) and by Wilhelm-Sander-Stiftung (2007.057.2; www.sanst.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz SA, 2009, CLIN CANCER RES, V15, P3029, DOI 10.1158/1078-0432.CCR-08-2768; Becker J, 2009, CELL MOL LIFE SCI, V66, P1, DOI 10.1007/s00018-008-8483-6; Becker JC, 2009, J INVEST DERMATOL, V129, P248, DOI 10.1038/jid.2008.198; Bleeker FE, 2008, ONCOGENE, V27, P5648, DOI 10.1038/onc.2008.170; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Dhawan P, 2002, CANCER RES, V62, P7335; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Fernandez-Figueras MT, 2007, MODERN PATHOL, V20, P90, DOI 10.1038/modpathol.3800717; Gaitonde S, 2009, PIGM CELL MELANOMA R, V22, P187, DOI 10.1111/j.1755-148X.2009.00544.x; Garcia-Rostan G, 2005, CANCER RES, V65, P10199, DOI 10.1158/0008-5472.CAN-04-4259; Gymnopoulos M, 2007, P NATL ACAD SCI USA, V104, P5569, DOI 10.1073/pnas.0701005104; Hafner C, 2007, P NATL ACAD SCI USA, V104, P13450, DOI 10.1073/pnas.0705218104; Houben R, 2006, J INVEST DERMATOL, V126, P1135, DOI 10.1038/sj.jid.5700170; Houben R, 2010, J VIROL, V84, P7064, DOI 10.1128/JVI.02400-09; Hurst Carolyn D, 2009, BMC Res Notes, V2, P66, DOI 10.1186/1756-0500-2-66; Karakas B, 2006, BRIT J CANCER, V94, P455, DOI 10.1038/sj.bjc.6602970; Lassacher A, 2008, J INVEST DERMATOL, V128, P1788, DOI 10.1038/sj.jid.5701256; Lemos B, 2007, J INVEST DERMATOL, V127, P2100, DOI 10.1038/sj.jid.5700925; Leonard JH, 1997, GENE CHROMOSOME CANC, V20, P93, DOI 10.1002/(SICI)1098-2264(199709)20:1<93::AID-GCC14>3.0.CO;2-G; LEONARD JH, 1995, INT J CANCER, V60, P100, DOI 10.1002/ijc.2910600115; Lin NX, 2007, J DERMATOL SCI, V48, P71, DOI 10.1016/j.jdermsci.2007.06.011; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Lopez-Knowles E, 2006, CANCER RES, V66, P7401, DOI 10.1158/0008-5472.CAN-06-1182; Pastrana DV, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000578; Paulson KG, 2009, J INVEST DERMATOL, V129, P1547, DOI 10.1038/jid.2008.365; Pollock PM, 2002, MELANOMA RES, V12, P565, DOI 10.1097/00008390-200212000-00006; Popp S, 2002, INT J CANCER, V99, P352, DOI 10.1002/ijc.10321; Rittie L, 2007, AM J PATHOL, V170, P2089, DOI 10.2353/ajpath.2007.060537; RONAN SG, 1993, J AM ACAD DERMATOL, V29, P715, DOI 10.1016/0190-9622(93)70236-M; ROSEN ST, 1987, LAB INVEST, V56, P302; Shuda M, 2008, P NATL ACAD SCI USA, V105, P16272, DOI 10.1073/pnas.0806526105; Shuda M, 2011, J CLIN INVEST, V121, P3623, DOI 10.1172/JCI46323; Stahl JM, 2004, CANCER RES, V64, P7002, DOI 10.1158/0008-5472.CAN-04-1399; Van Gele M, 2000, BRIT J CANCER, V82, P823; Van Gele M, 2001, INT J CANCER, V92, P409, DOI 10.1002/ijc.1209; Yu YJ, 2008, J VIROL, V82, P4521, DOI 10.1128/JVI.02365-07; Yuan H, 2002, J VIROL, V76, P10685, DOI 10.1128/JVI.76.21.10685-10691.2002	37	59	59	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31255	10.1371/journal.pone.0031255	http://dx.doi.org/10.1371/journal.pone.0031255			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363598	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600131
J	Madison, JL; Wegrzynowicz, M; Aschner, M; Bowman, AB				Madison, Jennifer L.; Wegrzynowicz, Michal; Aschner, Michael; Bowman, Aaron B.			Disease-Toxicant Interactions in Manganese Exposed Huntington Disease Mice: Early Changes in Striatal Neuron Morphology and Dopamine Metabolism	PLOS ONE			English	Article							YAC128 MOUSE MODEL; TRANSGENIC MICE; DENDRITIC SPINE; BASAL GANGLIA; RAT-BRAIN; QUANTITATIVE-ANALYSIS; ENVIRONMENTAL-FACTORS; TRINUCLEOTIDE REPEAT; DEGENERATIVE CHANGES; INDUCED PARKINSONISM	YAC128 Huntington's disease (HD) transgenic mice accumulate less manganese (Mn) in the striatum relative to wild-type (WT) littermates. We hypothesized that Mn and mutant Huntingtin (HTT) would exhibit gene-environment interactions at the level of neurochemistry and neuronal morphology. Twelve-week-old WT and YAC128 mice were exposed to MnCl2-4H(2)O (50 mg/kg) on days 0, 3 and 6. Striatal medium spiny neuron (MSN) morphology, as well as levels of dopamine (DA) and its metabolites (which are known to be sensitive to Mn-exposure), were analyzed at 13 weeks (7 days from initial exposure) and 16 weeks (28 days from initial exposure). No genotype-dependent differences in MSN morphology were apparent at 13 weeks. But at 16 weeks, a genotype effect was observed in YAC128 mice, manifested by an absence of the wild-type age-dependent increase in dendritic length and branching complexity. In addition, genotype-exposure interaction effects were observed for dendritic complexity measures as a function of distance from the soma, where only YAC128 mice were sensitive to Mn exposure. Furthermore, striatal DA levels were unaltered at 13 weeks by genotype or Mn exposure, but at 16 weeks, both Mn exposure and the HD genotype were associated with quantitatively similar reductions in DA and its metabolites. Interestingly, Mn exposure of YAC128 mice did not further decrease DA or its metabolites versus YAC128 vehicle exposed or Mn exposed WT mice. Taken together, these results demonstrate Mn-HD disease-toxicant interactions at the onset of striatal dendritic neuropathology in YAC128 mice. Our results identify the earliest pathological change in striatum of YAC128 mice as being between 13 to 16 weeks. Finally, we show that mutant HTT suppresses some Mn-dependent changes, such as decreased DA levels, while it exacerbates others, such as dendritic pathology.	[Madison, Jennifer L.; Aschner, Michael] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Madison, Jennifer L.; Wegrzynowicz, Michal; Bowman, Aaron B.] Vanderbilt Univ, Med Ctr, Dept Neurol, Nashville, TN USA; [Aschner, Michael; Bowman, Aaron B.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Aschner, Michael; Bowman, Aaron B.] Vanderbilt Univ, Med Ctr, Vanderbilt Univ Kennedy Ctr Res Human Dev, Nashville, TN USA; [Aschner, Michael; Bowman, Aaron B.] Vanderbilt Univ, Med Ctr, Ctr Mol Neurosci, Nashville, TN USA; [Aschner, Michael; Bowman, Aaron B.] Vanderbilt Univ, Med Ctr, Ctr Mol Toxicol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Madison, JL (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA.	aaron.bowman@vanderbilt.edu	Wegrzynowicz, Michal/M-3277-2019	Bowman, Aaron/0000-0001-8728-3346; Wegrzynowicz, Michal/0000-0002-5082-9576	National Institute of Environmental Health Sciences (NIEHS) [RO1 ES10563, RO1 ES016931]; National Institute of Child Health and Human Development [P30HD15052]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016931, R01ES010563] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institute of Environmental Health Sciences (NIEHS) RO1 ES10563 to MA and RO1 ES016931 to ABB; and by National Institute of Child Health and Human Development P30HD15052 to Vanderbilt University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIEHS or National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anca MH, 2004, AM J MED GENET A, V124A, P89, DOI 10.1002/ajmg.a.20328; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Aschner M, 2005, CRIT REV TOXICOL, V35, P1, DOI 10.1080/10408440590905920; Aschner M, 2000, ENVIRON HEALTH PERSP, V108, P429, DOI 10.2307/3454532; AUTISSIER N, 1982, TOXICOLOGY, V24, P175, DOI 10.1016/0300-483X(82)90055-5; Bibb JA, 2000, P NATL ACAD SCI USA, V97, P6809, DOI 10.1073/pnas.120166397; Bloss EB, 2010, J NEUROSCI, V30, P6726, DOI 10.1523/JNEUROSCI.0759-10.2010; Bowman AB, 2011, J TRACE ELEM MED BIO; Brinkman RR, 1997, AM J HUM GENET, V60, P1202; Burton NC, 2009, TOXICOL SCI, V111, P131, DOI 10.1093/toxsci/kfp124; CALNE DB, 1994, NEUROLOGY, V44, P1583, DOI 10.1212/WNL.44.9.1583; Carroll JB, 2011, NEUROBIOL DIS, V43, P257, DOI 10.1016/j.nbd.2011.03.018; Carter AG, 2007, J NEUROSCI, V27, P8967, DOI 10.1523/JNEUROSCI.2798-07.2007; Cha JHJ, 1998, P NATL ACAD SCI USA, V95, P6480, DOI 10.1073/pnas.95.11.6480; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; DELAMONTE SM, 1988, J NEUROPATH EXP NEUR, V47, P516, DOI 10.1097/00005072-198809000-00003; Dodd CA, 2005, INT J TOXICOL, V24, P389, DOI 10.1080/10915810500366500; Duan HL, 2003, CEREB CORTEX, V13, P950, DOI 10.1093/cercor/13.9.950; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Dydak U, 2011, ENVIRON HEALTH PERSP, V119, P219, DOI 10.1289/ehp.1002192; Erikson KM, 2005, ENVIRON TOXICOL PHAR, V20, P390, DOI 10.1016/j.etap.2005.03.009; FERRANTE RJ, 1991, J NEUROSCI, V11, P3877; Gaeta A, 2005, BRIT J PHARMACOL, V146, P1041, DOI 10.1038/sj.bjp.0706416; Garcia BG, 2010, CEREB CORTEX, V20, P2423, DOI 10.1093/cercor/bhp317; Georgiou N, 1999, MOVEMENT DISORD, V14, P320, DOI 10.1002/1531-8257(199903)14:2<320::AID-MDS1018>3.0.CO;2-Z; GIANUTSOS G, 1982, NEUROTOXICOLOGY, V3, P75; Golub MS, 2005, NEUROTOXICOL TERATOL, V27, P615, DOI 10.1016/j.ntt.2005.04.003; GRAVELAND GA, 1985, SCIENCE, V227, P770, DOI 10.1126/science.3155875; Grill JD, 2002, BRAIN RES, V937, P8, DOI 10.1016/S0006-8993(02)02457-5; Guidetti P, 2001, EXP NEUROL, V169, P340, DOI 10.1006/exnr.2000.7626; Guilarte TR, 2006, EXP NEUROL, V202, P381, DOI 10.1016/j.expneurol.2006.06.015; Guilarte TR, 2008, J NEUROCHEM, V107, P1236, DOI 10.1111/j.1471-4159.2008.05695.x; Gwiazda RH, 2002, NEUROTOXICOLOGY, V23, P69, DOI 10.1016/S0161-813X(02)00002-5; Hannan AJ, 2004, ACTA BIOCHIM POL, V51, P415; Harmon KM, 2003, BRAIN RES, V992, P60, DOI 10.1016/j.brainres.2003.08.029; JASLOVE SW, 1992, NEUROSCIENCE, V47, P495, DOI 10.1016/0306-4522(92)90161-T; Johnson MA, 2006, J NEUROCHEM, V97, P737, DOI 10.1111/j.1471-4159.2006.03762.x; KAWAGUCHI S, 1995, MECH AGEING DEV, V83, P11, DOI 10.1016/0047-6374(95)01607-2; Klapstein GJ, 2001, J NEUROPHYSIOL, V86, P2667, DOI 10.1152/jn.2001.86.6.2667; KONTUR PJ, 1988, NEUROTOXICOL TERATOL, V10, P295, DOI 10.1016/0892-0362(88)90031-1; Kusnoor SV, 2010, J COMP NEUROL, V518, P2525, DOI 10.1002/cne.22350; Kwakye GE, 2011, NEUROTOXICOLOGY; Lipe GW, 1999, J ENVIRON SCI HEAL B, V34, P119, DOI 10.1080/03601239909373187; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Markham JA, 2002, NEUROBIOL AGING, V23, P579, DOI 10.1016/S0197-4580(02)00004-0; MCNEILL TH, 1990, NEUROBIOL AGING, V11, P537, DOI 10.1016/0197-4580(90)90115-G; MEL BW, 1993, J NEUROPHYSIOL, V70, P1086, DOI 10.1152/jn.1993.70.3.1086; Menalled L, 2009, NEUROBIOL DIS, V35, P319, DOI 10.1016/j.nbd.2009.05.007; Milatovic D, 2009, TOXICOL APPL PHARM, V240, P219, DOI 10.1016/j.taap.2009.07.004; Milnerwood AJ, 2010, NEURON, V65, P178, DOI 10.1016/j.neuron.2010.01.008; Nithianantharajah J, 2009, AM J GERIAT PSYCHIAT, V17, P196, DOI 10.1097/JGP.0b013e318196a632; Olanow CW, 1996, NEUROLOGY, V46, P492, DOI 10.1212/WNL.46.2.492; Olanow CW, 2004, ANN NY ACAD SCI, V1012, P209, DOI 10.1196/annals.1306.018; Ortiz AN, 2011, NEUROSCI LETT, V492, P11, DOI 10.1016/j.neulet.2011.01.036; Ortiz AN, 2010, J NEUROCHEM, V112, P755, DOI 10.1111/j.1471-4159.2009.06501.x; Pal PK, 1999, NEUROTOXICOLOGY, V20, P227; Qin M, 2011, NEUROSCIENCE, V194, P282, DOI 10.1016/j.neuroscience.2011.06.047; Reaney SH, 2006, TOXICOL SCI, V93, P114, DOI 10.1093/toxsci/kfl028; Roth JA, 2003, BIOCHEM PHARMACOL, V66, P1, DOI 10.1016/S0006-2952(03)00145-X; Schmidt-Hieber C, 2007, J NEUROSCI, V27, P8430, DOI 10.1523/JNEUROSCI.1787-07.2007; SHOLL DA, 1953, J ANAT, V87, P387; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Spires TL, 2004, EUR J NEUROSCI, V19, P2799, DOI 10.1111/j.0953-816X.2004.03374.x; Stanwood GD, 2009, J NEUROCHEM, V110, P378, DOI 10.1111/j.1471-4159.2009.06145.x; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; Struve MF, 2007, AM J IND MED, V50, P772, DOI 10.1002/ajim.20489; Takeda A, 2003, BRAIN RES, V965, P279, DOI 10.1016/S0006-8993(02)04157-4; Takeda A, 2002, NEUROSCIENCE, V114, P669, DOI 10.1016/S0306-4522(02)00353-6; Tang TS, 2007, J NEUROSCI, V27, P7899, DOI 10.1523/JNEUROSCI.1396-07.2007; Tsay D, 2004, TRENDS NEUROSCI, V27, P77, DOI 10.1016/j.tins.2003.11.008; van Dellen A, 2004, NEUROGENETICS, V5, P9, DOI 10.1007/s10048-003-0169-5; Van Raamsdonk JM, 2005, J NEUROSCI, V25, P4169, DOI 10.1523/JNEUROSCI.0590-05.2005; Vetter P, 2001, J NEUROPHYSIOL, V85, P926, DOI 10.1152/jn.2001.85.2.926; Vezer T, 2005, ENVIRON TOXICOL PHAR, V19, P797, DOI 10.1016/j.etap.2004.12.046; Vidal L, 2005, NEUROCHEM RES, V30, P1147, DOI 10.1007/s11064-005-7775-6; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Williams BB, 2010, TOXICOL SCI, V117, P169, DOI 10.1093/toxsci/kfq174; Williams BB, 2010, J NEUROCHEM, V112, P227, DOI 10.1111/j.1471-4159.2009.06445.x; Woolley CS, 1997, J NEUROSCI, V17, P1848; Yokel RA, 2006, J ALZHEIMERS DIS, V10, P223	83	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31024	10.1371/journal.pone.0031024	http://dx.doi.org/10.1371/journal.pone.0031024			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363539	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600100
J	Maherally, Z; Smith, JR; An, Q; Pilkington, GJ				Maherally, Zaynah; Smith, James R.; An, Qian; Pilkington, Geoffrey J.			Receptors for Hyaluronic Acid and Poliovirus: A Combinatorial Role in Glioma Invasion?	PLOS ONE			English	Article							CD44 ADHESION MOLECULE; EXTRACELLULAR-MATRIX; CELL-MIGRATION; RHO FAMILY; EXPRESSION; CLEAVAGE; BINDING; CYTOSKELETON; ASSOCIATION; DISPERSAL	Background: CD44 has long been associated with glioma invasion while, more recently, CD155 has been implicated in playing a similar role. Notably, these two receptors have been shown closely positioned on monocytes. Methods and Findings: In this study, an up-regulation of CD44 and CD155 was demonstrated in established and early-passage cultures of glioblastoma. Total internal reflected fluorescence (TIRF) microscopy revealed close proximity of CD44 and CD155. CD44 antibody blocking and gene silencing (via siRNA) resulted in greater inhibition of invasion than that for CD155. Combined interference resulted in 86% inhibition of invasion, although in these investigations no obvious evidence of synergy between CD44 and CD155 in curbing invasion was shown. Both siRNA-CD44 and siRNA-CD155 treated cells lacked processes and were rounder, while live cell imaging showed reduced motility rate compared to wild type cells. Adhesion assay demonstrated that wild type cells adhered most efficiently to laminin, whereas siRNA-treated cells (p<0.0001 for both CD44 and CD155 expression) showed decreased adhesion on several ECMs investigated. BrdU assay showed a higher proliferation of siRNA-CD44 and siRNA-CD155 cells, inversely correlated with reduced invasion. Confocal microscopy revealed overlapping of CD155 and integrins (beta(1), alpha(v)beta(1) and alpha(v)beta(3)) on glioblastoma cell processes whereas siRNA-transfected cells showed consequent reduction in integrin expression with no specific staining patterns. Reduced expression of Rho GTPases, Cdc42, Rac1/2/3, RhoA and RhoB, was seen in siRNA-CD44 and siRNA-CD155 cells. In contrast to CD44-knockdown and 'double'-knockdown cells, no obvious decrease in RhoC expression was observed in CD155-knockdown cells. Conclusions: This investigation has enhanced our understanding of cell invasion and confirmed CD44 to play a more significant role in this biological process than CD155. Joint CD44/CD155 approaches may, however, merit further study in therapeutic targeting of infiltrating glioma cells.	[Maherally, Zaynah; Smith, James R.; An, Qian; Pilkington, Geoffrey J.] Univ Portsmouth, Sch Pharm & Biomed Sci, Inst Biomed & Biomol Sci, Cellular & Mol Neurooncol Res Grp, Portsmouth, Hants, England	University of Portsmouth	Maherally, Z (corresponding author), Univ Portsmouth, Sch Pharm & Biomed Sci, Inst Biomed & Biomol Sci, Cellular & Mol Neurooncol Res Grp, Portsmouth, Hants, England.	Geoff.pilkington@port.ac.uk	Smith, James R/D-2350-2011; Smith, James R/F-1108-2014	Smith, James R/0000-0001-8805-3788; Smith, James R/0000-0001-8805-3788	Brain Tumour UK; Brain Tumour Research; Brainstrust; Isle of Man Anticancer Association	Brain Tumour UK; Brain Tumour Research; Brainstrust; Isle of Man Anticancer Association	This work was funded by grants to GJP from Brain Tumour UK (http://www.braintumouruk.org.uk), Brain Tumour Research (http://www.braintumourresearch.org), Brainstrust (http://www.brainstrust.org.uk/index.php), and the Isle of Man Anticancer Association. These are UK-based brain tumour charities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 2001, J NEURO-ONCOL, V53, P115, DOI 10.1023/A:1012297132047; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Banyard J, 2000, ONCOGENE, V19, P580, DOI 10.1038/sj.onc.1203338; BERNHARDT G, 1994, VIROLOGY, V199, P105, DOI 10.1006/viro.1994.1102; Birks SM, 2011, NEURO-ONCOLOGY, V13, P950, DOI 10.1093/neuonc/nor108; Bogenrieder T, 2003, ONCOGENE, V22, P6524, DOI 10.1038/sj.onc.1206757; Bolteus A J, 2001, Curr Neurol Neurosci Rep, V1, P225, DOI 10.1007/s11910-001-0022-x; CHIQUETEHRISMANN R, 1995, BIOESSAYS, V17, P873, DOI 10.1002/bies.950171009; Christofori G, 2006, NATURE, V441, P444, DOI 10.1038/nature04872; Claes A, 2007, ACTA NEUROPATHOL, V114, P443, DOI 10.1007/s00401-007-0293-7; D'Abaco GM, 2007, J CLIN NEUROSCI, V14, P1041, DOI 10.1016/j.jocn.2007.06.019; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Enloe BM, 2011, J NEURO-ONCOL, V102, P225, DOI 10.1007/s11060-010-0323-5; Frank S, 1996, BIOCHEM BIOPH RES CO, V222, P794, DOI 10.1006/bbrc.1996.0823; Freistadt MS, 1997, MOL IMMUNOL, V34, P1247, DOI 10.1016/S0161-5890(98)00003-0; Giese A, 1996, INT J CANCER, V67, P275, DOI 10.1002/(SICI)1097-0215(19960717)67:2<275::AID-IJC20>3.0.CO;2-9; GIESE A, 1995, NEUROSURGERY, V37, P294, DOI 10.1227/00006123-199508000-00015; GLADSON CL, 1995, J CELL SCI, V108, P947; Goetz C, 2011, FUTURE VIROL, V6, P1045, DOI 10.2217/FVL.11.76; Goldbrunner RH, 1999, ACTA NEUROCHIR, V141, P295, DOI 10.1007/s007010050301; GUNTHERT U, 1991, CELL, V65, P13, DOI 10.1016/0092-8674(91)90403-L; Hu B, 2006, CANCER RES, V66, P775, DOI 10.1158/0008-5472.CAN-05-1149; KNUDSON W, 1989, CIBA F SYMP, V143, P150; Lange R, 2001, VIROLOGY, V285, P218, DOI 10.1006/viro.2001.0943; LUNA EJ, 1992, SCIENCE, V258, P955, DOI 10.1126/science.1439807; Maidment SL, 1997, ANTICANCER RES, V17, P4145; Merzak A, 1997, CANCER METAST REV, V16, P155, DOI 10.1023/A:1005760726850; MERZAK A, 1994, CANCER RES, V54, P3988; Murai T, 2004, J BIOL CHEM, V279, P4541, DOI 10.1074/jbc.M307356200; Nandi A, 2004, IMMUNITY, V20, P455, DOI 10.1016/S1074-7613(04)00077-9; Naor D, 2002, CRIT REV CL LAB SCI, V39, P527, DOI 10.1080/10408360290795574; Okada H, 1996, INT J CANCER, V66, P255, DOI 10.1002/(SICI)1097-0215(19960410)66:2<255::AID-IJC20>3.0.CO;2-A; Okamoto I, 1999, J BIOL CHEM, V274, P25525, DOI 10.1074/jbc.274.36.25525; Okamoto I, 2002, AM J PATHOL, V160, P441, DOI 10.1016/S0002-9440(10)64863-8; PILKINGTON GJ, 1993, NEUROREPORT, V4, P259, DOI 10.1097/00001756-199303000-00008; Pilkington GJ, 1996, BRAZ J MED BIOL RES, V29, P1159; Pilkington GJ, 2005, CELL PROLIFERAT, V38, P423, DOI 10.1111/j.1365-2184.2005.00358.x; PILKINGTON GJ, 1994, BRAIN PATHOL, V4, P157, DOI 10.1111/j.1750-3639.1994.tb00826.x; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; SHEPLEY MP, 1994, J VIROL, V68, P1301, DOI 10.1128/JVI.68.3.1301-1308.1994; Siegelman MH, 2000, J CLIN INVEST, V105, P683, DOI 10.1172/JCI8692; Sloan KE, 2005, CANCER RES, V65, P10930, DOI 10.1158/0008-5472.CAN-05-1890; Sloan KE, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-73; Sneath RJS, 1998, J CLIN PATHOL-MOL PA, V51, P191, DOI 10.1136/mp.51.4.191; Stern R, 2001, EXP CELL RES, V266, P167, DOI 10.1006/excr.2001.5206; Szeto MD, 2009, CANCER RES, V69, P4502, DOI 10.1158/0008-5472.CAN-08-3884; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Westphal M, 2011, NAT REV NEUROSCI, V12, P495, DOI 10.1038/nrn3060; Wiranowska M, 2006, BRAIN CELL BIOL, V35, P159, DOI 10.1007/s11068-007-9009-0; Wiranowska M, 2010, INT J CANCER, V127, P532, DOI 10.1002/ijc.25085	52	15	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30691	10.1371/journal.pone.0030691	http://dx.doi.org/10.1371/journal.pone.0030691			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363471	Green Submitted, Green Published, gold			2022-12-27	WOS:000302853600055
J	Saifur, RGM; Dieng, H; Abu Hassan, A; Salmah, MRC; Satho, T; Miake, F; Hamdan, A				Saifur, Rahman G. M.; Dieng, Hamady; Abu Hassan, Ahmad; Salmah, Md Rawi Che; Satho, Tomomitsu; Miake, Fumio; Hamdan, Ahmad			Changing Domesticity of Aedes aegypti in Northern Peninsular Malaysia: Reproductive Consequences and Potential Epidemiological Implications	PLOS ONE			English	Article							MARK-RELEASE-RECAPTURE; BLOOD MEAL SIZE; HOST-SEEKING; BODY-SIZE; INTRASPECIFIC COMPETITION; DEPENDENT DEVELOPMENT; PUERTO-RICO; L DIPTERA; CULICIDAE; DENGUE	Background: The domestic dengue vector Aedes aegypti mosquitoes breed in indoor containers. However, in northern peninsular Malaysia, they show equal preference for breeding in both indoor and outdoor habitats. To evaluate the epidemiological implications of this peridomestic adaptation, we examined whether Ae. aegypti exhibits decreased survival, gonotrophic activity, and fecundity due to lack of host availability and the changing breeding behavior. Methodology/Principal Findings: This yearlong field surveillance identified Ae. aegypti breeding in outdoor containers on an enormous scale. Through a sequence of experiments incorporating outdoors and indoors adapting as well as adapted populations, we observed that indoors provided better environment for the survival of Ae. aegypti and the observed death patterns could be explained on the basis of a difference in body size. The duration of gonotrophic period was much shorter in large-bodied females. Fecundity tended to be greater in indoor acclimated females. We also found increased tendency to multiple feeding in outdoors adapted females, which were smaller in size compared to their outdoors breeding counterparts. Conclusion/Significance: The data presented here suggest that acclimatization of Ae. aegypti to the outdoor environment may not decrease its lifespan or gonotrophic activity but rather increase breeding opportunities (increased number of discarded containers outdoors), the rate of larval development, but small body sizes at emergence. Size is likely to be correlated with disease transmission. In general, small size in Aedes females will favor increased blood-feeding frequency resulting in higher population sizes and disease occurrence.	[Saifur, Rahman G. M.; Dieng, Hamady; Abu Hassan, Ahmad; Salmah, Md Rawi Che; Hamdan, Ahmad] Univ Sains Malaysia, Sch Biol Sci, George Town, Malaysia; [Satho, Tomomitsu; Miake, Fumio] Fukuoka Univ, Fac Pharmaceut Sci, Fukuoka 81401, Japan	Universiti Sains Malaysia; Fukuoka University	Saifur, RGM (corresponding author), Univ Sains Malaysia, Sch Biol Sci, George Town, Malaysia.	gmsaifur20@yahoo.com	ahmad, abuhassan/E-5918-2013; ahmad, hamdan/E-3635-2012		Uniiversiti Sains Malaysia (USM); Research University (RU) [1001/PBIOLOGI/842004]	Uniiversiti Sains Malaysia (USM); Research University (RU)	This work was supported by the Uniiversiti Sains Malaysia (USM) Fellowship grant and by the Research University (RU) research grant # 1001/PBIOLOGI/842004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad F., 2006, American Journal of Environmental Sciences, V2, P121, DOI 10.3844/ajessp.2006.121.128; Aida H. Nur, 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P472, DOI 10.1016/S2221-1691(11)60103-2; Bedhomme S, 2005, ECOL ENTOMOL, V30, P1, DOI 10.1111/j.0307-6946.2005.00665.x; BRIEGEL H, 1990, J MED ENTOMOL, V27, P839, DOI 10.1093/jmedent/27.5.839; Briegel H, 2001, J VECTOR ECOL, V26, P21; Carrieri M, 2003, ENVIRON ENTOMOL, V32, P1313, DOI 10.1603/0046-225X-32.6.1313; Casanova C, 2009, J MED ENTOMOL, V46, P42, DOI 10.1603/033.046.0106; Pamplona LDC, 2009, TROP MED INT HEALTH, V14, P1347, DOI 10.1111/j.1365-3156.2009.02377.x; CHADEE DD, 1991, ANN TROP MED PARASIT, V85, P461, DOI 10.1080/00034983.1991.11812593; Chadee DD, 2000, J VECTOR ECOL, V25, P158; CHAN K. L., 1971, Sterility principle for insect control or eradication. Proceedings of a symposium on the sterility principle for insect control or eradication jointly organized by the IAEA and FAO and held in Athens, 14-18 September 1970. Vienna, Austria, International Atomic Energy Agency., P131; Cheong WH, 1986, I MED RES B, V23, P155; Cruz EI, 2008, DENGUE B, V32, P171; De Benedictis J, 2003, AM J TROP MED HYG, V68, P437, DOI 10.4269/ajtmh.2003.68.437; Dieng H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011790; DYE C, 1982, ECOL ENTOMOL, V7, P39, DOI 10.1111/j.1365-2311.1982.tb00642.x; DYE C, 1992, ANNU REV ENTOMOL, V37, P1, DOI 10.1146/annurev.en.37.010192.000245; Galliard H., 1957, Annales de Parasitologie Humaine et Comparee, V32, P563; Gibbons RV, 2002, BMJ-BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563; GILLETT JD, 1961, ANN TROP MED PARASIT, V55, P427, DOI 10.1080/00034983.1961.11686070; Gimnig JE, 2002, J MED ENTOMOL, V39, P162, DOI 10.1603/0022-2585-39.1.162; HADDOW A J, 1957, Ann Trop Med Parasitol, V51, P159; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Harrington LC, 2001, J MED ENTOMOL, V38, P411, DOI 10.1603/0022-2585-38.3.411; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; IJUMBA JN, 1990, MED VET ENTOMOL, V4, P425, DOI 10.1111/j.1365-2915.1990.tb00461.x; Ishak Hasanuddin, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P844; Kawada H, 2005, J MED ENTOMOL, V42, P312, DOI 10.1603/0022-2585(2005)042[0312:CSONBO]2.0.CO;2; KLOWDEN MJ, 1979, J INSECT PHYSIOL, V25, P231, DOI 10.1016/0022-1910(79)90048-9; KLOWDEN MJ, 1978, AM J TROP MED HYG, V27, P827, DOI 10.4269/ajtmh.1978.27.827; Lee DJ, 1989, CULICIDAE AUSTRALASI, V7th; Lee H.L., 1990, Tropical Biomedicine, V7, P185; Li C F, 1985, Southeast Asian J Trop Med Public Health, V16, P560; Machado-Allison C. E., 1972, Annals of the Entomological Society of America, V65, P543, DOI 10.1093/aesa/65.3.542; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; MCCLELLAND GA, 1974, T ROY ENT SOC LONDON, V126, P239, DOI 10.1111/j.1365-2311.1974.tb00853.x; MILLER BR, 1989, TROP MED PARASITOL, V40, P396; Monath TP, 1988, ARBOVIRUSES EPIDEMIO, P139; Naksathit AT, 1998, J AM MOSQUITO CONTR, V14, P148; NASCI RS, 1990, J MED ENTOMOL, V27, P716, DOI 10.1093/jmedent/27.4.716; NASCI RS, 1986, J AM MOSQUITO CONTR, V2, P61; Norhaslina H, 2003, P INT PLANN C CAIR E, V39, P1; OMEARA GF, 1995, J MED ENTOMOL, V32, P554, DOI 10.1093/jmedent/32.4.554; Ong WS, GEOLOGY ENG GEOLOGY; PANT CP, 1973, J MED ENTOMOL, V10, P219, DOI 10.1093/jmedent/10.2.219; PETERSEN JJ, 1977, J NEMATOL, V9, P343; Phillips ML, 2008, ENVIRON HEALTH PERSP, V116, pA382, DOI 10.1289/ehp.116-a382; Platt KB, 1997, AM J TROP MED HYG, V57, P119, DOI 10.4269/ajtmh.1997.57.119; Ponlawat A, 2007, J MED ENTOMOL, V44, P422, DOI 10.1603/0022-2585(2007)44[422:AABSIM]2.0.CO;2; Ponlawat A, 2009, AM J TROP MED HYG, V80, P395, DOI 10.4269/ajtmh.2009.80.395; ROITBERG BD, 1993, NATURE, V364, P108, DOI 10.1038/364108a0; RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892; Russell RC, 2005, MED VET ENTOMOL, V19, P451, DOI 10.1111/j.1365-2915.2005.00589.x; Schneider JR, 2004, J MED ENTOMOL, V41, P634, DOI 10.1603/0022-2585-41.4.634; Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89; SCOTT TW, 1993, J MED ENTOMOL, V30, P94, DOI 10.1093/jmedent/30.1.94; SCOTT TW, 1993, J MED ENTOMOL, V30, P922, DOI 10.1093/jmedent/30.5.922; SHEPPARD PM, 1969, J ANIM ECOL, V38, P661, DOI 10.2307/3042; Shriram AN, 2009, NATL MED J INDIA, V22, P116; SUCHARIT S, 1978, Southeast Asian Journal of Tropical Medicine and Public Health, V9, P93; TANAKA K, 1979, Contributions of the American Entomological Institute, V16, P1; TRPIS M, 1975, B ENTOMOL RES, V65, P199, DOI 10.1017/S0007485300005903; TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263; Tsuzuki A, 2009, AM J TROP MED HYG, V80, P752, DOI 10.4269/ajtmh.2009.80.752; Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x; Udaka M., 1959, Kontyu Tokyo, V27, P202; Van Benthem BHB, 2005, AM J TROP MED HYG, V72, P201, DOI 10.4269/ajtmh.2005.72.201; Vanwambeke Sophie O, 2006, Int J Health Geogr, V5, P5, DOI 10.1186/1476-072X-5-5; Wai N.M., 2005, TEKNOLOGI, V42, P1; Watts DM, 1997, AM J TROP MED HYG, V56, P148, DOI 10.4269/ajtmh.1997.56.148; WHO, 2009, DENG DENG HAEM FEV; Winarno F. G., 1991, Food, Nutrition and Agriculture, V1, P11; Wongkoon S., 2007, Dengue Bulletin, V31, P141; XUE RD, 1995, J MED ENTOMOL, V32, P471, DOI 10.1093/jmedent/32.4.471	75	29	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30919	10.1371/journal.pone.0030919	http://dx.doi.org/10.1371/journal.pone.0030919			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363516	gold, Green Published, Green Submitted			2022-12-27	WOS:000302853600090
J	Thanasopoulou, A; Stravopodis, DJ; Dimas, KS; Schwaller, J; Anastasiadou, E				Thanasopoulou, Angeliki; Stravopodis, Dimitrios J.; Dimas, Konstantinos S.; Schwaller, Juerg; Anastasiadou, Ema			Loss of CCDC6 Affects Cell Cycle through Impaired Intra-S-Phase Checkpoint Control	PLOS ONE			English	Article							FACTOR RECEPTOR-BETA; DNA-DAMAGE; GENOMIC INSTABILITY; RET/PTC REARRANGEMENTS; CDC25 PHOSPHATASES; TOPOISOMERASE-II; CANCER-CELLS; H4 D10S170; IN-VIVO; GENE	In most cancers harboring Ccdc6 gene rearrangements, like papillary thyroid tumors or myeloproliferative disorders, the product of the normal allele is supposed to be functionally impaired or absent. To address the consequence of the loss of CCDC6 expression, we applied lentiviral shRNA in several cell lines. Loss of CCDC6 resulted in increased cell death with clear shortening of the S phase transition of the cell cycle. Upon exposure to etoposide, the cells lacking CCDC6 did not achieve S-phase accumulation. In the absence of CCDC6 and in the presence of genotoxic stress, like etoposide treatment or UV irradiation, increased accumulation of DNA damage was observed, as indicated by a significant increase of pH2Ax Ser139. 14-3-3 sigma, a major cell cycle regulator, was down-regulated in CCDC6 lacking cells, regardless of genotoxic stress. Interestingly, in the absence of CCDC6, the well-known genotoxic stress-induced cytoplasmic sequestration of the S-phase checkpoint CDC25C phosphatase did not occur. These observations suggest that CCDC6 plays a key role in cell cycle control, maintenance of genomic stability and cell survival and provide a rational of how disruption of CCDC6 normal function contributes to malignancy.	[Thanasopoulou, Angeliki; Anastasiadou, Ema] Biomed Res Fdn Acad Athens, Dept Genet & Gene Therapy, Athens, Greece; [Stravopodis, Dimitrios J.] Univ Athens, Fac Biol, Dept Cell Biol & Biophys, Athens, Greece; [Dimas, Konstantinos S.] Univ Thessaly, Fac Med, Pharmacol Lab, Larisa, Greece; [Schwaller, Juerg] Univ Basel, Sch Med, Dept Biomed, Basel, Switzerland	Academy of Athens; National & Kapodistrian University of Athens; University of Thessaly; University of Basel	Thanasopoulou, A (corresponding author), Biomed Res Fdn Acad Athens, Dept Genet & Gene Therapy, Athens, Greece.	anastasiadou@bioacademy.gr	Dimas, Konstantinos/AAU-5461-2020; Schwaller, Juerg/A-3044-2016	Schwaller, Juerg/0000-0001-8616-0096; Stravopodis, Dimitrios/0000-0002-9535-2134	Swiss Government; Gertrude Von Meissner Foundation (Basel, Switzerland)	Swiss Government; Gertrude Von Meissner Foundation (Basel, Switzerland)	This work was partially funded by the Swiss Government Scholarships ESKAS. The work of JS is supported by the Gertrude Von Meissner Foundation (Basel, Switzerland). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartek J, 2001, CURR OPIN CELL BIOL, V13, P738, DOI 10.1016/S0955-0674(00)00280-5; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Bulavin DV, 2003, NAT CELL BIOL, V5, P545, DOI 10.1038/ncb994; Celetti A, 2004, ONCOGENE, V23, P109, DOI 10.1038/sj.onc.1206981; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Dierov J, 2004, CANCER CELL, V5, P275, DOI 10.1016/S1535-6108(04)00056-X; Dierov J, 2009, LEUKEMIA, V23, P279, DOI 10.1038/leu.2008.308; Drechsler M, 2007, ANN HEMATOL, V86, P353, DOI 10.1007/s00277-006-0247-5; Dubois F, 2009, MOL CELL PROTEOMICS, V8, P2487, DOI 10.1074/mcp.M800544-MCP200; Elisei R, 2001, J CLIN ENDOCR METAB, V86, P3211, DOI 10.1210/jc.86.7.3211; Gandhi M, 2010, ONCOGENE, V29, P2272, DOI 10.1038/onc.2009.502; GRIECO M, 1994, ONCOGENE, V9, P2531; Guerra A, 2011, ENDOCR J, V58, P31, DOI 10.1507/endocrj.K10E-260; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Hermeking H, 2006, SEMIN CANCER BIOL, V16, P183, DOI 10.1016/j.semcancer.2006.03.002; Kaufmann WK, 1998, P SOC EXP BIOL MED, V217, P327; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Kulkarni S, 2000, CANCER RES, V60, P3592; Lau E, 2006, CELL CYCLE, V5, P1602, DOI 10.4161/cc.5.15.3124; Leone V, 2010, ONCOGENE, V29, P4341, DOI 10.1038/onc.2010.179; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Merolla F, 2007, ONCOGENE, V26, P6167, DOI 10.1038/sj.onc.1210446; Mizuno T, 2000, ONCOGENE, V19, P438, DOI 10.1038/sj.onc.1203343; Motoyama N, 2004, CURR OPIN GENET DEV, V14, P11, DOI 10.1016/j.gde.2003.12.003; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Nikiforov YE, 2002, ENDOCR PATHOL, V13, P3, DOI 10.1385/EP:13:1:03; Nikiforova MN, 2000, SCIENCE, V290, P138, DOI 10.1126/science.290.5489.138; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Penserga ETP, 2007, ONCOGENE, V26, P11, DOI 10.1038/sj.onc.1209756; Puxeddu E, 2005, MUTAT RES-FUND MOL M, V570, P17, DOI 10.1016/j.mrfmmm.2004.09.010; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Salvatore D, 2000, J CLIN ENDOCR METAB, V85, P3898, DOI 10.1210/jc.85.10.3898; Santoro M, 1996, ONCOGENE, V12, P1821; Savage JRK, 2000, SCIENCE, V290, P62, DOI 10.1126/science.290.5489.62; Schwaller J, 2001, BLOOD, V97, P3910, DOI 10.1182/blood.V97.12.3910; Sharpless NE, 2005, NATURE, V436, P636, DOI 10.1038/436636a; Sheils OM, 2000, J PATHOL, V192, P32; Shen ZY, 2011, J MOL CELL BIOL, V3, P1, DOI 10.1093/jmcb/mjq057; Shimada M, 2006, J MOL HISTOL, V37, P253, DOI 10.1007/s10735-006-9039-4; Takizawa CG, 2000, CURR OPIN CELL BIOL, V12, P658, DOI 10.1016/S0955-0674(00)00149-6; TONG Q, 1995, ONCOGENE, V10, P1781; VIGLIETTO G, 1995, ONCOGENE, V11, P1207	43	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31007	10.1371/journal.pone.0031007	http://dx.doi.org/10.1371/journal.pone.0031007			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363533	gold, Green Submitted, Green Published			2022-12-27	WOS:000302853600096
J	Yao, L; Li, ZR; Su, WR; Li, YP; Lin, ML; Zhang, WX; Liu, Y; Wan, Q; Liang, D				Yao, Lin; Li, Zhan-rong; Su, Wen-ru; Li, Yong-ping; Lin, Miao-li; Zhang, Wen-xin; Liu, Yi; Wan, Qian; Liang, Dan			Role of Mesenchymal Stem Cells on Cornea Wound Healing Induced by Acute Alkali Burn	PLOS ONE			English	Article							SEVERE OCULAR BURNS; STROMAL CELLS; CHEMICAL INJURY; T-CELLS; TRANSPLANTATION; MODEL; RECONSTRUCTION; MACROPHAGES; MANAGEMENT; EPITHELIUM	The aim of this study was to investigate the effects of subconjunctivally administered mesenchymal stem cells (MSCs) on corneal wound healing in the acute stage of an alkali burn. A corneal alkali burn model was generated by placing a piece of 3-mm diameter filter paper soaked in NaOH on the right eye of 48 Sprague-Dawley female rats. 24 rats were administered a subconjunctival injection of a suspension of 2610 6 MSCs in 0.1 ml phosphate-buffered saline (PBS) on day 0 and day 3 after the corneal alkali burn. The other 24 rats were administered a subconjunctival injection of an equal amount of PBS as a control. Deficiencies of the corneal epithelium and the area of corneal neovascularization (CNV) were evaluated on days 3 and 7 after the corneal alkali burn. Infiltrated CD68(+) cells were detected by immunofluorescence staining. The mRNA expression levels of macrophage inflammatory protein-1 alpha (MIP-1 alpha), tumor necrosis factor-alpha (TNF-alpha), monocyte chemotactic protein-1 (MCP-1) and vascular endothelial growth factor (VEGF) were analyzed using real-time polymerase chain reaction (real-time PCR). In addition, VEGF protein levels were analyzed using an enzyme-linked immunosorbent assay (ELISA). MSCs significantly enhanced the recovery of the corneal epithelium and decreased the CNV area compared with the control group. On day 7, the quantity of infiltrated CD68(+) cells was significantly lower in the MSC group and the mRNA levels of MIP-1 alpha, TNF-alpha, and VEGF and the protein levels of VEGF were also down-regulated. However, the expression of MCP-1 was not different between the two groups. Our results suggest that subconjunctival injection of MSCs significantly accelerates corneal wound healing, attenuates inflammation and reduces CNV in alkaline-burned corneas; these effects were found to be related to a reduction of infiltrated CD68(+) cells and the down-regulation of MIP-1 alpha, TNF-alpha and VEGF.	[Yao, Lin; Li, Zhan-rong; Su, Wen-ru; Li, Yong-ping; Lin, Miao-li; Zhang, Wen-xin; Liu, Yi; Wan, Qian; Liang, Dan] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Yao, L (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	liangd2@mail.sysu.edu.cn		Su, Wenru/0000-0002-0506-6362	Doctoral Program Foundation of Institutions of Higher Education of China [20090171110084]	Doctoral Program Foundation of Institutions of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was funded by the Doctoral Program Foundation of Institutions of Higher Education of China (20090171110084; http://www.cutech.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamis A P, 1999, Angiogenesis, V3, P9, DOI 10.1023/A:1009071601454; Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Borderie V, 2003, J FR OPHTALMOL, V26, P710; Brodovsky SC, 2000, OPHTHALMOLOGY, V107, P1829, DOI 10.1016/S0161-6420(00)00289-X; Choi JA, 2011, MOL VIS, V17, P404; DiPietro LA, 1998, J CLIN INVEST, V101, P1693, DOI 10.1172/JCI1020; Fish R, 2010, CURR OPIN OPHTHALMOL, V21, P317, DOI 10.1097/ICU.0b013e32833a8da2; Fogla R, 2005, CORNEA, V24, P421, DOI 10.1097/01.ico.0000151550.51556.2d; Groh ME, 2005, EXP HEMATOL, V33, P928, DOI 10.1016/j.exphem.2005.05.002; He JC, 2006, ARCH OPHTHALMOL-CHIC, V124, P70, DOI 10.1001/archopht.124.1.70; Hoogduijn MJ, 2007, STEM CELLS DEV, V16, P597, DOI 10.1089/scd.2006.0110; Jiang TS, 2010, MOL VIS, V16, P1304; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Kuckelkorn R, 2002, ACTA OPHTHALMOL SCAN, V80, P4, DOI 10.1034/j.1600-0420.2002.800102.x; Kuo Irene C, 2004, Curr Opin Ophthalmol, V15, P311, DOI 10.1097/00055735-200408000-00006; Lee JW, 2011, STEM CELLS, V29, P913, DOI 10.1002/stem.643; Ma YL, 2006, STEM CELLS, V24, P315, DOI 10.1634/stemcells.2005-0046; Maggini J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009252; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Oh JY, 2008, STEM CELLS, V26, P1047, DOI 10.1634/stemcells.2007-0737; Oh W, 2008, CELL IMMUNOL, V251, P116, DOI 10.1016/j.cellimm.2008.04.003; Popp FC, 2007, STEM CELLS, V25, P639, DOI 10.1634/stemcells.2006-0515; Shi WY, 2009, GRAEF ARCH CLIN EXP, V247, P101, DOI 10.1007/s00417-008-0934-0; Su WR, 2011, STEM CELLS, V29, P1849, DOI 10.1002/stem.738; Su WR, 2011, GRAEF ARCH CLIN EXP, V249, P421, DOI 10.1007/s00417-010-1539-y; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Wagoner MD, 1997, SURV OPHTHALMOL, V41, P275, DOI 10.1016/S0039-6257(96)00007-0; Wilson SE, 2001, PROG RETIN EYE RES, V20, P625, DOI 10.1016/S1350-9462(01)00008-8; Ye J, 2006, EYE, V20, P482, DOI 10.1038/sj.eye.6701913; Zannettino ACW, 2008, J CELL PHYSIOL, V214, P413, DOI 10.1002/jcp.21210; Zhang QZ, 2010, STEM CELLS, V28, P1856, DOI 10.1002/stem.503; Zhang QZ, 2009, J IMMUNOL, V183, P7787, DOI 10.4049/jimmunol.0902318; Zhao SM, 2010, STEM CELLS DEV, V19, P607, DOI 10.1089/scd.2009.0345	33	117	123	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30842	10.1371/journal.pone.0030842	http://dx.doi.org/10.1371/journal.pone.0030842			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363499	Green Submitted, Green Published, gold			2022-12-27	WOS:000302853600075
J	Domeier, ML; Speare, P				Domeier, Michael L.; Speare, Peter			Dispersal of Adult Black Marlin (Istiompax indica) from a Great Barrier Reef Spawning Aggregation	PLOS ONE			English	Article							MAKAIRA-NIGRICANS; BLUE MARLIN; TRACKING; GROWTH; ISLAND; SEA	The black marlin (Istiompax indica) is one of the largest bony fishes in the world with females capable of reaching a mass of over 700 kg. This highly migratory predator occurs in the tropical regions of the Pacific and Indian Oceans, and is the target of regional recreational and commercial fisheries. Through the sampling of ichthyoplankton and ovaries we provide evidence that the relatively high seasonal abundance of black marlin off the Great Barrier Reef is, in fact, a spawning aggregation. Furthermore, through the tracking of individual black marlin via satellite popup tags, we document the dispersal of adult black marlin away from the spawning aggregation, thereby identifying the catchment area for this spawning stock. Although tag shedding is an issue when studying billfish, we tentatively identify the catchment area for this stock of black marlin to extend throughout the Coral Sea, including the waters of Papua New Guinea, the Solomon Islands, Micronesia, New Caledonia, Kiribati, Vanuatu, Fiji, Tuvalu and Nauru.	[Domeier, Michael L.] Marine Conservat Sci Inst, Fallbrook, CA USA; [Speare, Peter] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Australian Institute of Marine Science	Domeier, ML (corresponding author), Marine Conservat Sci Inst, Fallbrook, CA USA.	ml.domeier@gmail.com			Offield Family Foundation	Offield Family Foundation	This work was funded by a grant from the Offield Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arocha F, 2002, J FISH BIOL, V60, P13, DOI 10.1006/jfbi.2001.1805; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Choukroun S, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005761; Domeier M.L., 2002, TRANSFORMING CORAL R; Domeier ML, 2006, B MAR SCI, V79, P811; Domeier ML, 1997, B MAR SCI, V60, P698; Domeier ML, 2005, FISH B-NOAA, V103, P292; Falterman B, 1999, THESIS VIRGINIA I MA; Gorbunova N.N, 1969, J ICHTHYOL, V9, P375; Govoni JJ, 2003, FISH B-NOAA, V101, P778; Graves JE, 2003, MAR FRESHWATER RES, V54, P287, DOI 10.1071/MF01290; LEIS JM, 1987, FISH B-NOAA, V85, P757; Nakamura H., 1941, ZOOL MAG, V53, P17; Nakamura H, 1942, SUISAN GAKKAI HO, V9, P45; Nakamura H, 1944, T NAT HIST SOC TAIWA, V34, P293; Nakamura I, 1985, FAO SPECIES CATALOGU, V125; Nakamura I., 1975, SPEC SCI REP FISH 3, P17; Nielsen A, 2007, CAN J FISH AQUAT SCI, V64, P1055, DOI 10.1139/F07-064; Pepperell J.G., 1990, Marine Recreational Fisheries, V13, P51; PRINCE ED, 1991, FISH B-NOAA, V89, P441; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Sadovy Y, 2005, CORAL REEFS, V24, P254, DOI 10.1007/s00338-005-0474-6; Serafy JE, 2003, MAR FRESHWATER RES, V54, P299, DOI 10.1071/MF01273; Shimose T, 2008, ICHTHYOL RES, V55, P90, DOI 10.1007/s10228-007-0004-3; Speare P, 2001, OCEANOGRAPHIC PROCESSES OF CORAL REEFS : PHYSICAL AND BIOLOGICAL LINKS IN THE GREAT BARRIER REEF, P237; Sponaugle S, 2005, J FISH BIOL, V66, P822, DOI 10.1111/j.0022-1112.2005.00657.x; Suzuki Z, 1990, P 2 INT BILLF S KA 1; Ueyanagi S., 1964, Proceedings Symp Scombroid fishes Mar Biol Ass India (Ser 1), VPt. I, P499; Ueyanagi S., 1960, Records of Oceanographic Works in Japan NS, V5, P167; Ueyanagi S, 1960, REP NANKAI REG FISH, V12, P85; Williams D, 1993, TRENDS MARLIN ABUNDA, P81; WOLANSKI E, 1988, ESTUAR COAST SHELF S, V26, P169, DOI 10.1016/0272-7714(88)90049-2; YOUNG IR, 1994, CONT SHELF RES, V14, P117, DOI 10.1016/0278-4343(94)90009-4	33	30	30	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31629	10.1371/journal.pone.0031629	http://dx.doi.org/10.1371/journal.pone.0031629			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363692	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700079
J	Gatta, L; Piscitelli, F; Giordano, C; Boccella, S; Lichtman, A; Maione, S; Di Marzo, V				Gatta, Luisa; Piscitelli, Fabiana; Giordano, Catia; Boccella, Serena; Lichtman, Aron; Maione, Sabatino; Di Marzo, Vincenzo			Discovery of Prostamide F-2 alpha and Its Role in Inflammatory Pain and Dorsal Horn Nociceptive Neuron Hyperexcitability	PLOS ONE			English	Article							ENDOCANNABINOID OXYGENATION; MURINE MODEL; ANANDAMIDE; FAAH; PROSTAGLANDINS; HYPERALGESIA; MAINTENANCE; METABOLISM; INHIBITORS; RECEPTORS	It was suggested that endocannabinoids are metabolized by cyclooxygenase (COX)-2 in the spinal cord of rats with kaolin/lambda-carrageenan-induced knee inflammation, and that this mechanism contributes to the analgesic effects of COX-2 inhibitors in this experimental model. We report the development of a specific method for the identification of endocannabinoid COX-2 metabolites, its application to measure the levels of these compounds in tissues, and the finding of prostamide F-2 alpha (PMF2 alpha) in mice with knee inflammation. Whereas the levels of spinal endocannabinoids were not significantly altered by kaolin/lambda-carrageenan-induced knee inflammation, those of the COX-2 metabolite of AEA, PMF2 alpha, were strongly elevated. The formation of PMF2 alpha was reduced by indomethacin (a non-selective COX inhibitor), NS-398 (a selective COX-2 inhibitor) and SC-560 (a selective COX-1 inhibitor). In healthy mice, spinal application of PMF2 alpha increased the firing of nociceptive (NS) neurons, and correspondingly reduced the threshold of paw withdrawal latency (PWL). These effects were attenuated by the PMF2 alpha receptor antagonist AGN211336, but not by the FP receptor antagonist AL8810. Also prostaglandin F-2 alpha increased NS neuron firing and reduced the threshold of PWL in healthy mice, and these effects were antagonized by AL8810, and not by AGN211336. In mice with kaolin/lambda-carrageenan-induced knee inflammation, AGN211336, but not AL8810, reduced the inflammation-induced NS neuron firing and reduction of PWL. These findings suggest that inflammation-induced, and prostanoid-mediated, enhancement of dorsal horn NS neuron firing stimulates the production of spinal PMF2 alpha, which in turn contributes to further NS neuron firing and pain transmission by activating specific receptors.	[Gatta, Luisa; Giordano, Catia; Boccella, Serena; Maione, Sabatino] Univ Naples 2, Endocannabinoid Res Grp, Dept Expt Med, Div Pharmacol L Donatelli, Naples, Italy; [Piscitelli, Fabiana; Di Marzo, Vincenzo] CNR, Endocannabinoid Res Grp, Inst Biomol Chem, Pozzuoli, Italy; [Lichtman, Aron] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Sch Med, Richmond, VA USA	Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); Virginia Commonwealth University	Gatta, L (corresponding author), Univ Naples 2, Endocannabinoid Res Grp, Dept Expt Med, Div Pharmacol L Donatelli, Naples, Italy.	sabatino.maione@unina2.it; vdimarzo@icmib.na.cnr.it	Piscitelli, Fabiana/A-7100-2014; Di Marzo, Vincenzo/AAD-7742-2019	Di Marzo, Vincenzo/0000-0002-1490-3070; Maione, Sabatino/0000-0003-3850-6704; Piscitelli, Fabiana/0000-0001-9343-4622	NIH [DA009789]; Allergan, Irvine, CA, USA; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA009789] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Allergan, Irvine, CA, USA(AbbVieAllergan); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was partly supported by NIH grants (grant no. DA009789 to AHL and VD) and by Allergan, Irvine, CA, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2011, J PHARMACOL EXP THER, V338, P114, DOI 10.1124/jpet.111.180257; Anand P, 2009, BRAIN RES REV, V60, P255, DOI 10.1016/j.brainresrev.2008.12.003; Bisogno T, 2010, CNS NEUROL DISORD-DR, V9, P564, DOI 10.2174/187152710793361568; Davidova A, 2009, CELL MOL NEUROBIOL, V29, P879, DOI 10.1007/s10571-009-9370-x; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Duggan KC, 2011, NAT CHEM BIOL, V7, P803, DOI 10.1038/nchembio.663; Glaser ST, 2010, J PHARMACOL EXP THER, V335, P380, DOI 10.1124/jpet.110.168831; Griffin BW, 1999, J PHARMACOL EXP THER, V290, P1278; Hains BC, 2006, J NEUROSCI, V26, P4308, DOI 10.1523/JNEUROSCI.0003-06.2006; Hu SSJ, 2008, BRIT J PHARMACOL, V153, P1538, DOI 10.1038/bjp.2008.33; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Johnson DS, 2011, ACS MED CHEM LETT, V2, P91, DOI 10.1021/ml100190t; Khasabov SG, 2007, BRAIN RES, V1180, P7, DOI 10.1016/j.brainres.2007.08.075; Kozak KR, 2004, CURR PHARM DESIGN, V10, P659, DOI 10.2174/1381612043453081; McGaraughty S, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-14; Petrosino S, 2007, NEUROPHARMACOLOGY, V52, P415, DOI 10.1016/j.neuropharm.2006.08.011; Petrosino S, 2010, CURR OPIN INVEST DR, V11, P51; Pitcher MH, 2010, PAIN, V151, P756, DOI 10.1016/j.pain.2010.09.008; Schlosburg JE, 2009, AAPS J, V11, P39, DOI 10.1208/s12248-008-9075-y; Simone Donald A., 2008, Shengli Xuebao, V60, P635; Staniaszek LE, 2010, BRIT J PHARMACOL, V160, P669, DOI 10.1111/j.1476-5381.2010.00703.x; Straiker A, 2011, BR J PHARM; Telleria-Diaz A, 2010, PAIN, V148, P26, DOI 10.1016/j.pain.2009.08.013; Vanegas HN, 2001, PROG NEUROBIOL, V64, P327, DOI 10.1016/S0301-0082(00)00063-0; Vasquez E, 2001, J NEUROSCI, V21, P9001, DOI 10.1523/JNEUROSCI.21-22-09001.2001; Vecchio AJ, 2011, J BIOL CHEM, V286, P20736, DOI 10.1074/jbc.M111.230367; Weber A, 2004, J LIPID RES, V45, P757, DOI 10.1194/jlr.M300475-JLR200; Woodward DF, 2008, PHARMACOL THERAPEUT, V120, P71, DOI 10.1016/j.pharmthera.2008.08.001; Yang W, 2005, J LIPID RES, V46, P2745, DOI 10.1194/jlr.M500374-JLR200; Yoshikawa K, 2011, BRAIN RES, V1367, P22, DOI 10.1016/j.brainres.2010.10.019	30	80	80	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31111	10.1371/journal.pone.0031111	http://dx.doi.org/10.1371/journal.pone.0031111			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363560	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700027
J	Kruger, D; Kapturska, D; Fischer, C; Daniel, R; Wubet, T				Krueger, Dirk; Kapturska, Danuta; Fischer, Christiane; Daniel, Rolf; Wubet, Tesfaye			Diversity Measures in Environmental Sequences Are Highly Dependent on Alignment Quality-Data from ITS and New LSU Primers Targeting Basidiomycetes	PLOS ONE			English	Article							RIBOSOMAL-RNA; FUNGAL COMMUNITIES; MICROBIAL COMMUNITIES; NUCLEOTIDE-SEQUENCE; CONCERTED EVOLUTION; SECONDARY STRUCTURE; VERSION 4; SUBSTITUTIONS; ABUNDANCE; TREE	The ribosomal DNA comprised of the ITS1-5.8S-ITS2 regions is widely used as a fungal marker in molecular ecology and systematics but cannot be aligned with confidence across genetically distant taxa. In order to study the diversity of Agaricomycotina in forest soils, we designed primers targeting the more alignable 28S (LSU) gene, which should be more useful for phylogenetic analyses of the detected taxa. This paper compares the performance of the established ITS1F/4B primer pair, which targets basidiomycetes, to that of two new pairs. Key factors in the comparison were the diversity covered, off-target amplification, rarefaction at different Operational Taxonomic Unit (OTU) cutoff levels, sensitivity of the method used to process the alignment to missing data and insecure positional homology, and the congruence of monophyletic clades with OTU assignments and BLAST-derived OTU names. The ITS primer pair yielded no off-target amplification but also exhibited the least fidelity to the expected phylogenetic groups. The LSU primers give complementary pictures of diversity, but were more sensitive to modifications of the alignment such as the removal of difficult-to align stretches. The LSU primers also yielded greater numbers of singletons but also had a greater tendency to produce OTUs containing sequences from a wider variety of species as judged by BLAST similarity. We introduced some new parameters to describe alignment heterogeneity based on Shannon entropy and the extent and contents of the OTUs in a phylogenetic tree space. Our results suggest that ITS should not be used when calculating phylogenetic trees from genetically distant sequences obtained from environmental DNA extractions and that it is inadvisable to define OTUs on the basis of very heterogeneous alignments.	[Krueger, Dirk; Kapturska, Danuta; Wubet, Tesfaye] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Saale, Germany; [Kapturska, Danuta] Int Grad Sch Zittau, Zittau, Germany; [Fischer, Christiane; Daniel, Rolf] Univ Gottingen, Dept Genom & Appl Microbiol, Gottingen, Germany; [Fischer, Christiane; Daniel, Rolf] Gottingen Genom Lab, Inst Microbiol & Genet, Gottingen, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Technische Universitat Dresden; University of Gottingen	Kruger, D (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Saale, Germany.	dirk.krueger@ufz.de	Wubet, Tesfaye/C-6241-2012; Krüger, Dirk/C-3316-2012; Daniel, Rolf/AAQ-5933-2021	Wubet, Tesfaye/0000-0001-8572-4486; Krüger, Dirk/0000-0002-7305-5104; Daniel, Rolf/0000-0002-8646-7925	DFG [KA 1241/15-1, KR 3587/1-1]; Helmholtz Impulse and Networking Fund via the Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE).	DFG(German Research Foundation (DFG)); Helmholtz Impulse and Networking Fund via the Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE).	This work was funded in part by DFG Priority Program 1374 on "nfrastructure-Biodiversity-Exploratories'' (KA 1241/15-1 and KR 3587/1-1). D. Kapturska also was kindly supported by the Helmholtz Impulse and Networking Fund via the Helmholtz Interdisciplinary Graduate School for Environmental Research (HIGRADE). The funders DFG and HIGRADE had no input into the study design, the data collection and analysis, the decision to publish, or the preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Anderson IC, 2007, J MICROBIOL METH, V68, P248, DOI 10.1016/j.mimet.2006.08.005; Anderson IC, 2004, ENVIRON MICROBIOL, V6, P769, DOI 10.1111/j.1462-2920.2004.00675.x; Anderson IC, 2003, ENVIRON MICROBIOL, V5, P1121, DOI [10.1046/j.1462-2920.2003.00522.x, 10.1046/j.1462-2920.2003.00383.x]; Begerow D, 2010, APPL MICROBIOL BIOT, V87, P99, DOI 10.1007/s00253-010-2585-4; Ben Ali A, 1999, NUCLEIC ACIDS RES, V27, P2825; Blaskowski J, 2008, MYCOTAXON, V106, P247; Cerchio S, 1998, SYST BIOL, V47, P336, DOI 10.1080/106351598260941; CHAO A, 1984, SCAND J STAT, V11, P265; Cherry JM, 1997, NATURE, V387, P67, DOI 10.1038/387s067; Cho KM, 2009, J MICROBIOL BIOTECHN, V19, P743, DOI 10.4014/jmb.0807.455; Dessimoz C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r37; Dwivedi B., 2009, BIOL MED PARIS, V1, P50; Dwivedi Bhakti, 2009, BMC Evolutionary Biology, V9; Edwards IP, 2010, MOL ECOL, V19, P1469, DOI 10.1111/j.1365-294X.2010.04566.x; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; Ganley ARD, 2007, GENOME RES, V17, P184, DOI 10.1101/gr.5457707; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gargas A, 1996, MYCOLOGIA, V88, P745, DOI 10.2307/3760969; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Giegerich R, 1996, Proc Int Conf Intell Syst Mol Biol, V4, P68; Gillespie JJ, 2006, INSECT MOL BIOL, V15, P657, DOI 10.1111/j.1365-2583.2006.00689.x; Goremykin VV, 2010, J MOL EVOL, V71, P319, DOI 10.1007/s00239-010-9398-z; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; GUTELL RR, 1993, NUCLEIC ACIDS RES, V21, P3055, DOI 10.1093/nar/21.13.3055; Halanych KM, 1999, J MOL EVOL, V48, P369, DOI 10.1007/PL00006481; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HANCOCK JM, 1988, MOL BIOL EVOL, V5, P377; Hanson CA, 2008, ECOSYSTEMS, V11, P1157, DOI 10.1007/s10021-008-9186-4; HASSOUNA N, 1984, NUCLEIC ACIDS RES, V12, P3563, DOI 10.1093/nar/12.8.3563; Hibbett DS, 2006, MYCOLOGIA, V98, P917, DOI 10.3852/mycologia.98.6.917; Higgs PG, 2000, Q REV BIOPHYS, V33, P199, DOI 10.1017/S0033583500003620; Hughes KW, 2009, NEW PHYTOL, V182, P795, DOI 10.1111/j.1469-8137.2009.02802.x; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Innis MA, 1990, PCR PROTOCOLS GUIDE; James SA, 2009, GENOME RES, V19, P626, DOI 10.1101/gr.084517.108; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Kalendar R., 2009, GENES GENOMES GENOMI, V3, P1; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Ki JS, 2007, J EUKARYOT MICROBIOL, V54, P210, DOI 10.1111/j.1550-7408.2007.00251.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kruger D, 2006, BIOINFORMATION, V1, P327; Kubartova A, 2009, MICROB ECOL, V58, P98, DOI 10.1007/s00248-008-9458-8; Landeweert R, 2003, APPL ENVIRON MICROB, V69, P327, DOI 10.1128/AEM.69.1.327-333.2003; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lindner DL, 2011, MYCOLOGIA, V103, P731, DOI 10.3852/10-331; Liu K, 2012, SYST BIOL, V61, P90, DOI 10.1093/sysbio/syr095; Lutzoni F, 2000, SYST BIOL, V49, P628, DOI 10.1080/106351500750049743; Lutzoni F, 2004, AM J BOT, V91, P1446, DOI 10.3732/ajb.91.10.1446; Manter DK, 2007, J MICROBIOL METH, V71, P7, DOI 10.1016/j.mimet.2007.06.016; Martin KJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-28; Martin MP, 2004, MYCOTAXON, V90, P133; Matheny PB, 2006, MYCOLOGIA, V98, P982, DOI 10.3852/mycologia.98.6.982; Morrison DA, 2010, MOL BIOL EVOL, V27, P1044, DOI 10.1093/molbev/msp309; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Nakatsu CH, 2007, SOIL SCI SOC AM J, V71, P562, DOI 10.2136/sssaj2006.0080; Nilsson RH, 2010, MOL ECOL RESOUR, V10, P1076, DOI 10.1111/j.1755-0998.2010.02850.x; Nilsson RH, 2008, EVOL BIOINFORM, V4, P193; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Parker J, 2011, SHANNON HETEROGENEIT, V1.0; Pivato B, 2007, NEW PHYTOL, V176, P197, DOI 10.1111/j.1469-8137.2007.02151.x; Porter TM, 2008, MOL ECOL, V17, P3037, DOI 10.1111/j.1365-294X.2008.03813.x; Robinson CH, 2009, SOIL BIOL BIOCHEM, V41, P414, DOI 10.1016/j.soilbio.2008.10.021; Rooney AP, 2005, P NATL ACAD SCI USA, V102, P5084, DOI 10.1073/pnas.0409689102; Rosendahl S, 2004, MOL ECOL, V13, P3179, DOI 10.1111/j.1365-294X.2004.02295.x; Rossman A. Y., 2007, INOCULUM, V58, P1; RUSTCHENKO EP, 1993, J BACTERIOL, V175, P7189, DOI 10.1128/JB.175.22.7189-7199.1993; Ryberg M, 2008, BMC EVOLUTIONARY BIO, V8, P14; Salemi M, 2003, J VIROL, V77, P7202, DOI 10.1128/JVI.77.13.7202-7213.2003; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; Seguritan V, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-9; Seifert KA, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2009.02635.x; Shannon C.E, 1949, MATH THEORY COMMUNIC, V1st; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Smith AD, 2004, MOL BIOL EVOL, V21, P419; Soltis DE, 1996, SYST BOT, V21, P169, DOI 10.2307/2419746; SRIKANTHA T, 1994, CURR GENET, V26, P321, DOI 10.1007/BF00310496; Struck TH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-57; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Torzilli AP, 2006, MYCOLOGIA, V98, P690, DOI 10.3852/mycologia.98.5.690; Unterseher M, 2011, MOL ECOL, V20, P275, DOI 10.1111/j.1365-294X.2010.04948.x; Varon A, 2010, CLADISTICS, V26, P72, DOI 10.1111/j.1096-0031.2009.00282.x; Wakeley J, 1996, TRENDS ECOL EVOL, V11, P158, DOI 10.1016/0169-5347(96)10009-4; White WT, 2007, MOL BIOL EVOL, V24, P2029, DOI 10.1093/molbev/msm139; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; XIA X, 2000, DATA ANAL MOL BIOL E; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Yarwood SA, 2010, MICROB ECOL, V60, P606, DOI 10.1007/s00248-010-9675-9; Yu JY, 2006, MOL BIOL EVOL, V23, P1525, DOI 10.1093/molbev/msl015; Yu YN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-57; Zinger L, 2008, J MICROBIOL METH, V72, P42, DOI 10.1016/j.mimet.2007.10.005	96	12	12	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32139	10.1371/journal.pone.0032139	http://dx.doi.org/10.1371/journal.pone.0032139			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363808	Green Submitted, Green Published, gold			2022-12-27	WOS:000302873700149
J	Liu, T; Lipnicki, DM; Zhu, WL; Tao, DC; Zhang, CQ; Cui, Y; Jin, JS; Sachdev, PS; Wen, W				Liu, Tao; Lipnicki, Darren M.; Zhu, Wanlin; Tao, Dacheng; Zhang, Chengqi; Cui, Yue; Jin, Jesse S.; Sachdev, Perminder S.; Wen, Wei			Cortical Gyrification and Sulcal Spans in Early Stage Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; VOXEL-BASED MORPHOMETRY; HUMAN CEREBRAL-CORTEX; GRAY-MATTER LOSS; FOLDING PATTERNS; BRAIN ATROPHY; AD DEMENTIA; MRI; MORPHOLOGY; VOLUME	Alzheimer's disease (AD) is characterized by an insidious onset of progressive cerebral atrophy and cognitive decline. Previous research suggests that cortical folding and sulcal width are associated with cognitive function in elderly individuals, and the aim of the present study was to investigate these morphological measures in patients with AD. The sample contained 161 participants, comprising 80 normal controls, 57 patients with very mild AD, and 24 patients with mild AD. From 3D T1-weighted brain scans, automated methods were used to calculate an index of global cortex gyrification and the width of five individual sulci: superior frontal, intra-parietal, superior temporal, central, and Sylvian fissure. We found that global cortex gyrification decreased with increasing severity of AD, and that the width of all individual sulci investigated other than the intra-parietal sulcus was greater in patients with mild AD than in controls. We also found that cognitive functioning, as assessed by Mini-Mental State Examination (MMSE) scores, decreased as global cortex gyrification decreased. MMSE scores also decreased in association with a widening of all individual sulci investigated other than the intra-parietal sulcus. The results suggest that abnormalities of global cortex gyrification and regional sulcal span are characteristic of patients with even very mild AD, and could thus facilitate the early diagnosis of this condition.	[Liu, Tao; Tao, Dacheng; Zhang, Chengqi; Jin, Jesse S.] Univ Technol Sydney, Fac Engn & Informat Technol, Ctr Quantum Computat & Intelligent Syst, Sydney, NSW 2007, Australia; [Liu, Tao; Lipnicki, Darren M.; Zhu, Wanlin; Sachdev, Perminder S.; Wen, Wei] Univ New S Wales, Sch Psychiat, Brain & Ageing Res Program, Sydney, NSW, Australia; [Liu, Tao; Lipnicki, Darren M.; Zhu, Wanlin; Sachdev, Perminder S.; Wen, Wei] Prince Wales Hosp, Inst Neuropsychiat, Randwick, NSW 2031, Australia; [Cui, Yue; Jin, Jesse S.] Univ Newcastle, Sch Design Commun & IT, Callaghan, NSW 2308, Australia	University of Technology Sydney; University of New South Wales Sydney; University of Newcastle	Liu, T (corresponding author), Univ Technol Sydney, Fac Engn & Informat Technol, Ctr Quantum Computat & Intelligent Syst, Sydney, NSW 2007, Australia.	jesse.jin@newcastle.edu.au; W.Wen@unsw.edu.au	Sachdev, Perminder/ABC-1137-2020; Tao, Dacheng/A-5449-2012; zhang, chi/GRX-3610-2022	Sachdev, Perminder/0000-0002-9595-3220; Liu, Tao/0000-0002-7783-3073; Wen, Wei/0000-0003-2753-3870; Zhang, Chengqi/0000-0001-5715-7154	National Health and Medical Research Council (NHMRC) [ID 510175]; Australian Research Council (ARC) [DP-0774213, DP-120103730]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council)	This research was supported by a National Health and Medical Research Council (NHMRC http://www.nhmrc.gov.au/) Project Grant (ID 510175), and Australian Research Council (ARC http://www.arc.gov.au/) Discovery Grants (ARC DP-0774213 and ARC DP-120103730). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold SE, 1991, CEREB CORTEX, V1, P103, DOI 10.1093/cercor/1.1.103; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bakkour A, 2009, NEUROLOGY, V72, P1048, DOI 10.1212/01.wnl.0000340981.97664.2f; Braak H, 1996, ACTA NEUROL SCAND, V93, P3; Cachia A, 2008, NEUROIMAGE, V39, P927, DOI 10.1016/j.neuroimage.2007.08.049; Chetelat G, 2005, NEUROIMAGE, V27, P934, DOI 10.1016/j.neuroimage.2005.05.015; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dickerson BC, 2009, CEREB CORTEX, V19, P497, DOI 10.1093/cercor/bhn113; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2008, CEREB CORTEX, V18, P1973, DOI 10.1093/cercor/bhm225; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fotenos AF, 2005, NEUROLOGY, V64, P1032, DOI 10.1212/01.WNL.0000154530.72969.11; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; Hamalainen A, 2007, NEUROIMAGE, V37, P1122, DOI 10.1016/j.neuroimage.2007.06.016; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Holsinger T, 2007, JAMA-J AM MED ASSOC, V297, P2391, DOI 10.1001/jama.297.21.2391; Im K, 2008, NEUROIMAGE, V43, P103, DOI 10.1016/j.neuroimage.2008.07.016; Im K, 2008, NEUROSCI LETT, V436, P227, DOI 10.1016/j.neulet.2008.03.032; Jacobs HIL, 2012, NEUROSCI BIOBEHAV R, V36, P297, DOI 10.1016/j.neubiorev.2011.06.009; Jouvent E, 2011, NEUROLOGY, V76, P1472, DOI 10.1212/WNL.0b013e31821810a4; Jouvent E, 2008, BRAIN, V131, P2201, DOI 10.1093/brain/awn129; Karas GB, 2003, NEUROIMAGE, V18, P895, DOI 10.1016/S1053-8119(03)00041-7; King RD, 2010, NEUROIMAGE, V53, P471, DOI 10.1016/j.neuroimage.2010.06.050; Kochunov P, 2005, HUM BRAIN MAPP, V26, P210, DOI 10.1002/hbm.20198; Kochunov P, 2008, HUM BRAIN MAPP, V29, P36, DOI 10.1002/hbm.20369; Kochunov P, 2012, NEUROINFORMATICS, V10, P81, DOI 10.1007/s12021-011-9127-9; Li S, 2008, ACTA RADIOL, V49, P84, DOI 10.1080/02841850701627181; Li SY, 2011, NEUROIMAGE, V58, P381, DOI 10.1016/j.neuroimage.2011.06.041; Li SY, 2010, CEREB CORTEX, V20, P25, DOI 10.1093/cercor/bhp074; Liu T, 2011, NEUROIMAGE, V56, P865, DOI 10.1016/j.neuroimage.2011.03.015; Liu T, 2010, NEUROIMAGE, V51, P19, DOI 10.1016/j.neuroimage.2010.02.016; Mangin JF, 2010, CURR OPIN NEUROL, V23, P359, DOI 10.1097/WCO.0b013e32833a0afc; MANGIN JF, 1995, COMP IMAG VIS, V3, P153; Mangin JF, 2004, NEUROIMAGE, V23, pS129, DOI 10.1016/j.neuroimage.2004.07.019; Marcus DS, 2007, J COGNITIVE NEUROSCI, V19, P1498, DOI 10.1162/jocn.2007.19.9.1498; Morris JC, 2001, ARCH NEUROL-CHICAGO, V58, P397, DOI 10.1001/archneur.58.3.397; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morrison JH, 2002, PROG BRAIN RES, V136, P467; Penttilae J, 2009, J PSYCHIATR NEUROSCI, V34, P127; Riviere D, 2002, MED IMAGE ANAL, V6, P77, DOI 10.1016/S1361-8415(02)00052-X; Rogan Shannon, 2002, Am J Alzheimers Dis Other Demen, V17, P11, DOI 10.1177/153331750201700106; Salat DH, 2009, NEUROIMAGE, V44, P1247, DOI 10.1016/j.neuroimage.2008.10.030; Shi F, 2009, HIPPOCAMPUS, V19, P1055, DOI 10.1002/hipo.20573; Sluimer JD, 2008, RADIOLOGY, V248, P590, DOI 10.1148/radiol.2482070938; Thompson PM, 2003, J NEUROSCI, V23, P994; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Welker W., 1988, CEREB CORTEX, V8, P132; Wen W, 2006, NEUROIMAGE, V29, P1031, DOI 10.1016/j.neuroimage.2005.08.057; Whitwell JL, 2007, BRAIN, V130, P1777, DOI 10.1093/brain/awm112	49	23	23	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31083	10.1371/journal.pone.0031083	http://dx.doi.org/10.1371/journal.pone.0031083			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363554	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700025
J	Marangi, M; Morelli, V; Pati, S; Camarda, A; Cafiero, MA; Giangaspero, A				Marangi, Marianna; Morelli, Vincenzo; Pati, Sandra; Camarda, Antonio; Cafiero, Maria Assunta; Giangaspero, Annunziata			Acaricide Residues in Laying Hens Naturally Infested by Red Mite Dermanyssus gallinae	PLOS ONE			English	Article							ORGANOCHLORINE PESTICIDE-RESIDUES; NORTHERN FOWL MITE; POULTRY FARM; CHICKEN MITE; PREVALENCE; RESISTANCE; EGGS; EXPOSURE; SYSTEMS; ACARINA	In the poultry industry, control of the red mite D. gallinae primarily relies worldwide on acaricides registered for use in agriculture or for livestock, and those most widely used are carbamates, followed by amidines, pyrethroids and organophosphates. Due to the repeated use of acaricides sometimes in high concentrations to control infestation, red mites may become resistant, and acaricides may accumulate in chicken organs and tissues, and also in eggs. To highlight some situations of misuse/abuse of chemicals and of risk to human health, we investigated laying hens, destined to the slaughterhouse, for the presence of acaricide residues in their organs and tissues. We used 45 hens from which we collected a total of 225 samples from the following tissues and organs: skin, fat, liver, muscle, hearth, and kidney. In these samples we analyzed the residual contents of carbaryl and permethrin by LC-MS/MS. Ninety-one (40.4%) samples were positive to carbaryl and four samples (1.7%) were positive to permethrin. Concentrations of carbaryl exceeding the detection limit (0.005 ppm) were registered in the skin and fat of birds from two farms (p<0.01), although these concentrations remained below the maximum residue limit (MRLs) (0.05 ppm) (p<0.01). All organs/tissues of hens from a third farm were significantly more contaminated, with skin and muscle samples exceeding the MRL (0.05 ppm) (p<0.01) of carbaryl in force before its use was banned. Out of 45 chickens tested, 37 (82.2%) were found to be contaminated by carbaryl, and 4 (8.8%) by permethrin. The present study is the first report on the presence of pesticides banned by the EU (carbaryl) or not licensed for use (permethrin) in the organs and tissues of laying hens, which have been treated against red mites, and then slaughtered for human consumption at the end of their life cycle.	[Marangi, Marianna; Giangaspero, Annunziata] Univ Foggia, Dipartimento Sci Prod Ingegneria & Meccan & Econ, Foggia, Italy; [Morelli, Vincenzo] Consorzio ASI, Lab Bonassisa, Foggia, Italy; [Pati, Sandra] Univ Foggia, Dipartimento Sci Alimenti, Foggia, Italy; [Camarda, Antonio] Univ Bari, Dipartimento Sanita Pubbl & Zootecnia, Bari, Italy; [Cafiero, Maria Assunta] Ist Zooprofilatt Sperimentale Puglia & Basilicata, Foggia, Italy	University of Foggia; University of Foggia; Universita degli Studi di Bari Aldo Moro; IZS Puglia e Basilicata	Giangaspero, A (corresponding author), Univ Foggia, Dipartimento Sci Prod Ingegneria & Meccan & Econ, Foggia, Italy.	a.giangaspero@unifg.it	Giangaspero, Annunziata/ABB-3727-2021; Smith, Keely/AAL-4913-2020	Camarda, Antonio/0000-0002-3961-585X; Giangaspero, Annunziata/0000-0002-3357-8672; PATI, SANDRA/0000-0003-4453-0540	Fondazione Cassa di Risparmio di Puglia, Bari, Italy	Fondazione Cassa di Risparmio di Puglia, Bari, Italy	This work was supported by the following Research Grant: Fondazione Cassa di Risparmio di Puglia, 2010-2011, Bari, Italy. The funder had no rule in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ahmad R, 2010, CHEMOSPHERE, V78, P667, DOI 10.1016/j.chemosphere.2009.12.012; Balali-Mood M, 2008, ARCH IRAN MED, V11, P65; Beugnet F, 1997, VET REC, V140, P577, DOI 10.1136/vr.140.22.577; Biggs ML, 2008, CANCER EPIDEM BIOMAR, V17, P2012, DOI 10.1158/1055-9965.EPI-08-0032; Cencek T, 2003, B VET I PULAWY, V47, P465; Charles LE, 2010, WORK, V37, P205, DOI 10.3233/WOR-2010-1071; Chauve C, 1998, VET PARASITOL, V79, P239, DOI 10.1016/S0304-4017(98)00167-8; Chirico J, 2002, VET PARASITOL, V110, P109, DOI 10.1016/S0304-4017(02)00310-2; Covaci A, 2001, SCI TOTAL ENVIRON, V280, P143, DOI 10.1016/S0048-9697(01)00820-8; de Siqueira MT, 2010, B ENVIRON CONTAM TOX, V84, P647, DOI 10.1007/s00128-010-0027-8; Doucet J, 2009, ENVIRON HEALTH PERSP, V117, P605, DOI 10.1289/ehp.0800205; Farkas R, 2005, MAGY ALLATORVOSOK, V127, P348; Fiddes MD, 2005, VET REC, V157, P233, DOI 10.1136/vr.157.8.233; FLETCHER MG, 1991, EXP APPL ACAROL, V13, P137, DOI 10.1007/BF01193664; Fu S, 2001, B ENVIRON CONTAM TOX, V66, P171, DOI 10.1007/s001280000221; Gamlin J, 2007, CHILD CARE HLTH DEV, V33, P246, DOI 10.1111/j.1365-2214.2006.00702.x; GENCHI C, 1984, ARCH VET ITAL, V35, P125; Glynn AW, 2000, SCI TOTAL ENVIRON, V246, P195, DOI 10.1016/S0048-9697(99)00458-1; Guitart R, 2010, VET J, V183, P260, DOI 10.1016/j.tvjl.2009.03.033; Herrero-Mercado M, 2010, B ENVIRON CONTAM TOX, V85, P367, DOI 10.1007/s00128-010-0108-8; HOGLUND J, 1995, POULTRY SCI, V74, P1793, DOI 10.3382/ps.0741793; IVEY MC, 1984, POULTRY SCI, V63, P61, DOI 10.3382/ps.0630061; KAN CA, 1978, J AGR FOOD CHEM, V26, P1051, DOI 10.1021/jf60219a006; Keita A, 2006, REV MED VET-TOULOUSE, V157, P588; Kelly-Hope L, 2008, LANCET INFECT DIS, V8, P387, DOI 10.1016/S1473-3099(08)70045-8; Khajavi M, 2004, BR POULT SCI S, V45, P15; Kilpinen O, 2005, PHYSIOL ENTOMOL, V30, P232, DOI 10.1111/j.1365-3032.2005.00452.x; Kishimba MA, 2004, TALANTA, V64, P48, DOI 10.1016/j.talanta.2003.11.047; Kumar V, 2010, CHEMOSPHERE, V81, P464, DOI 10.1016/j.chemosphere.2010.07.067; LAKE CA, 1995, ARCH ENVIRON CON TOX, V29, P128, DOI 10.1007/BF00213097; LIEBISH A, 2001, SCHADLINGSBEKAMPFER, V3, P11; Magdas C, 2006, B U AGR MED VET M-VE, V63, P309; Marangi M, 2009, EXP APPL ACAROL, V48, P11, DOI 10.1007/s10493-008-9224-0; Mariscal-Arcas M, 2010, FOOD CHEM TOXICOL, V48, P1311, DOI 10.1016/j.fct.2010.02.029; Nordenfors H, 2001, VET PARASITOL, V102, P121, DOI 10.1016/S0304-4017(01)00528-3; Singh S, 2011, TOXICOL APPL PHARM, V252, P130, DOI 10.1016/j.taap.2011.01.014; Sparagano O, 2009, EXP APPL ACAROL, V48, P3, DOI 10.1007/s10493-008-9233-z; Tao S, 2009, ENVIRON POLLUT, V157, P497, DOI 10.1016/j.envpol.2008.09.005; Turi MS, 2000, ACTA VET HUNG, V48, P139; ZEMAN P, 1985, Experimental and Applied Acarology, V1, P17, DOI 10.1007/BF01262196; ZEMAN P, 1987, FOLIA PARASIT, V34, P369	41	51	56	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31795	10.1371/journal.pone.0031795	http://dx.doi.org/10.1371/journal.pone.0031795			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363736	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700099
J	Persson, HT; Aksaas, AK; Kvissel, AK; Punga, T; Engstrom, A; Skalhegg, BS; Akusjarvi, G				Persson, Heidi Tormanen; Aksaas, Anne Kristin; Kvissel, Anne Katrine; Punga, Tanel; Engstrom, Ake; Skalhegg, Bjorn Steen; Akusjarvi, Goran			Two Cellular Protein Kinases, DNA-PK and PKA, Phosphorylate the Adenoviral L4-33K Protein and Have Opposite Effects on L1 Alternative RNA Splicing	PLOS ONE			English	Article							MAJOR LATE TRANSCRIPTION; STRAND BREAK REPAIR; C-TERMINAL DOMAIN; CATALYTIC SUBUNIT; DEPENDENT MANNER; GENE-EXPRESSION; CYCLIC-AMP; BINDING; NUCLEUS; COMPLEX	Accumulation of the complex set of alternatively processed mRNA from the adenovirus major late transcription unit (MLTU) is subjected to a temporal regulation involving both changes in poly (A) site choice and alternative 3' splice site usage. We have previously shown that the adenovirus L4-33K protein functions as an alternative splicing factor involved in activating the shift from L1-52,55K to L1-IIIa mRNA. Here we show that L4-33K specifically associates with the catalytic subunit of the DNA-dependent protein kinase (DNA-PK) in uninfected and adenovirus-infected nuclear extracts. Further, we show that L4-33K is highly phosphorylated by DNA-PK in vitro in a double stranded DNA-independent manner. Importantly, DNA-PK deficient cells show an enhanced production of the L1-IIIa mRNA suggesting an inhibitory role of DNA-PK on the temporal switch in L1 alternative RNA splicing. Moreover, we show that L4-33K also is phosphorylated by protein kinase A (PKA), and that PKA has an enhancer effect on L4-33K-stimulated L1-IIIa splicing. Hence, we demonstrate that these kinases have opposite effects on L4-33K function; DNA-PK as an inhibitor and PKA as an activator of L1-IIIa mRNA splicing. Taken together, this is the first report identifying protein kinases that phosphorylate L4-33K and to suggest novel regulatory roles for DNA-PK and PKA in adenovirus alternative RNA splicing.	[Persson, Heidi Tormanen; Punga, Tanel; Engstrom, Ake; Akusjarvi, Goran] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Aksaas, Anne Kristin; Kvissel, Anne Katrine; Skalhegg, Bjorn Steen] Univ Oslo, Dept Nutr, Oslo, Norway	Uppsala University; University of Oslo	Persson, HT (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	goran.akusjarvi@imbim.uu.se	Skålhegg, Bjørn Steen/AAZ-2976-2021; Punga, Tanel/K-9844-2019	Skålhegg, Bjørn Steen/0000-0002-3481-8084; Punga, Tanel/0000-0002-0561-367X	Swedish Cancer Society [CF100365]; Norweigan Cancer Society [DNK 419114, DNK 418817]; Uppsala RNA Research Center; European Alternative Splicing Network	Swedish Cancer Society(Swedish Cancer Society); Norweigan Cancer Society; Uppsala RNA Research Center; European Alternative Splicing Network	Funding was provided by the Swedish Cancer Society (CF100365; http://cancerfonden.se), the Norweigan Cancer Society (DNK 419114, DNK 418817; http://www.kreftforeningen.no/english), the Uppsala RNA Research Center (http://www.urrc-linnaeuscentre.uu.se/about.html), and the European Alternative Splicing Network (http://www.eurasnet.info/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksaas AK, 2011, J MOL SIGNA IN PRESS; Akusjarvi G, 2008, FRONT BIOSCI-LANDMRK, V13, P5006, DOI 10.2741/3059; Ali H, 2007, J VIROL, V81, P1327, DOI 10.1128/JVI.01584-06; ALLALUNISTURNER MJ, 1993, RADIAT RES, V134, P349, DOI 10.2307/3578196; Anderson CW, 2001, RADIAT RES, V156, P2, DOI 10.1667/0033-7587(2001)156[0002:FMIPTG]2.0.CO;2; AXELROD N, 1978, VIROLOGY, V87, P366, DOI 10.1016/0042-6822(78)90141-1; Backstrom E, 2010, VIRUS RES, V151, P220, DOI 10.1016/j.virusres.2010.05.013; Bateman RL, 2008, J BIOL CHEM, V283, P35756, DOI 10.1074/jbc.M807125200; Berenjian S, 2006, VIRUS RES, V115, P16, DOI 10.1016/j.virusres.2005.07.001; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bosilevac JM, 1998, J BIOL CHEM, V273, P16874, DOI 10.1074/jbc.273.27.16874; Boyer J, 1999, VIROLOGY, V263, P307, DOI 10.1006/viro.1999.9866; CARTER T, 1990, MOL CELL BIOL, V10, P6460, DOI 10.1128/MCB.10.12.6460; Di Pasquale G, 2003, EMBO J, V22, P1716, DOI 10.1093/emboj/cdg153; Ewing SG, 2007, J VIROL, V81, P12450, DOI 10.1128/JVI.01470-07; Farley DC, 2004, J VIROL, V78, P1782, DOI 10.1128/JVI.78.4.1782-1791.2004; Fax P, 2001, VIROLOGY, V285, P30, DOI 10.1006/viro.2001.0926; Fessler SP, 1999, VIROLOGY, V263, P507, DOI 10.1006/viro.1999.9951; Finnen RL, 2001, VIROLOGY, V289, P388, DOI 10.1006/viro.2001.1130; Gallagher SR., 2007, CURR PROTOC CELL BIO; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Han I, 2002, MOL CELL BIOL, V22, P2136, DOI 10.1128/MCB.22.7.2136-2146.2002; Han I, 2001, J VIROL, V75, P2475, DOI 10.1128/JVI.75.5.2475-2481.2001; HAROOTUNIAN AT, 1993, MOL BIOL CELL, V4, P993, DOI 10.1091/mbc.4.10.993; Hirose Y, 2007, J BIOCHEM, V141, P601, DOI 10.1093/jb/mvm090; JACKSON SP, 1995, TRENDS BIOCHEM SCI, V20, P412, DOI 10.1016/S0968-0004(00)89090-8; Jarnaess E, 2009, J BIOL CHEM, V284, P35154, DOI 10.1074/jbc.M109.056465; Ko L, 2003, J BIOL CHEM, V278, P11471, DOI 10.1074/jbc.M209723200; KOONIN EV, 1994, PROTEIN SCI, V3, P2045, DOI 10.1002/pro.5560031117; Kvissel AK, 2007, EXP CELL RES, V313, P2795, DOI 10.1016/j.yexcr.2007.05.014; Labugger R, 2000, CIRCULATION, V102, P1221, DOI 10.1161/01.CIR.102.11.1221; LeesMiller SP, 1996, BIOCHEM CELL BIOL, V74, P503, DOI 10.1139/o96-054; LEESMILLER SP, 1990, MOL CELL BIOL, V10, P6472, DOI 10.1128/MCB.10.12.6472; LEESMILLER SP, 1995, SCIENCE, V267, P1183, DOI 10.1126/science.7855602; Lempiainen H, 2009, EMBO J, V28, P3067, DOI 10.1038/emboj.2009.281; Maldonado E, 1996, NATURE, V381, P86, DOI 10.1038/381086a0; Mo XM, 2002, MOL CELL BIOL, V22, P8088, DOI 10.1128/MCB.22.22.8088-8099.2002; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Moore DD, 1995, GLOB MOB SURV; Morris SJ, 2009, J VIROL, V83, P3049, DOI 10.1128/JVI.02455-08; Muhlemann Oliver, 2007, Methods Mol Med, V131, P33; Murshid A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013830; Neal JA, 2011, MUTAT RES-FUND MOL M, V711, P73, DOI 10.1016/j.mrfmmm.2011.02.010; NIGG EA, 1985, EMBO J, V4, P2801, DOI 10.1002/j.1460-2075.1985.tb04006.x; Nock A, 2009, J BIOL CHEM, V284, P19915, DOI 10.1074/jbc.M109.016295; NORDQVIST K, 1994, MOL CELL BIOL, V14, P437, DOI 10.1128/MCB.14.1.437; Orstavik S, 2005, FEBS J, V272, P1559, DOI 10.1111/j.1742-4658.2005.04568.x; Ostapchuk P, 2006, J VIROL, V80, P6973, DOI 10.1128/JVI.00123-06; Oyama S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004199; PETERSON SR, 1992, GENE DEV, V6, P426, DOI 10.1101/gad.6.3.426; Pidoux G, 2010, J MOL ENDOCRINOL, V44, P271, DOI 10.1677/JME-10-0010; Punga T, 2003, FEBS LETT, V552, P214, DOI 10.1016/S0014-5793(03)00927-X; RANNELS SR, 1980, J BIOL CHEM, V255, P7085; Sastri M, 2005, P NATL ACAD SCI USA, V102, P349, DOI 10.1073/pnas.0408608102; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Shi JH, 2011, J BIOL CHEM, V286, P14639, DOI 10.1074/jbc.M110.204453; Skalhegg BS, 2000, FRONT BIOSCI-LANDMRK, V5, pD678, DOI 10.2741/Skalhegg; Skalhegg BS, 2005, CURR DRUG TARGETS, V6, P655, DOI 10.2174/1389450054863644; Skroblin P, 2010, INT REV CEL MOL BIO, V283, P235, DOI 10.1016/S1937-6448(10)83005-9; Suomalainen M, 2001, EMBO J, V20, P1310, DOI 10.1093/emboj/20.6.1310; Tormanen H, 2006, J BIOL CHEM, V281, P36510, DOI 10.1074/jbc.M607601200; Trigon S, 1998, J BIOL CHEM, V273, P6769, DOI 10.1074/jbc.273.12.6769; WEIDEN MD, 1994, P NATL ACAD SCI USA, V91, P153, DOI 10.1073/pnas.91.1.153; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Woodard RL, 1999, J BIOL CHEM, V274, P478, DOI 10.1074/jbc.274.1.478; Yaneva M, 1997, EMBO J, V16, P5098, DOI 10.1093/emboj/16.16.5098; Zhang SS, 2004, NUCLEIC ACIDS RES, V32, P1, DOI 10.1093/nar/gkg933; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6	68	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31871	10.1371/journal.pone.0031871	http://dx.doi.org/10.1371/journal.pone.0031871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363758	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700113
J	Rudge, JW; Hanvoravongchai, P; Krumkamp, R; Chavez, I; Adisasmito, W; Chau, PN; Phommasak, B; Putthasri, W; Shih, CS; Stein, M; Timen, A; Touch, S; Reintjes, R; Coker, R				Rudge, James W.; Hanvoravongchai, Piya; Krumkamp, Ralf; Chavez, Irwin; Adisasmito, Wiku; Pham Ngoc Chau; Phommasak, Bounlay; Putthasri, Weerasak; Shih, Chin-Shui; Stein, Mart; Timen, Aura; Touch, Sok; Reintjes, Ralf; Coker, Richard		AsiaFluCap Project Consortium	Health System Resource Gaps and Associated Mortality from Pandemic Influenza across Six Asian Territories	PLOS ONE			English	Article							CRITICAL-CARE RESOURCES; DEVELOPING-COUNTRIES; INFECTIOUS-DISEASES; HOSPITAL SERVICES; SURGE CAPACITY; DEMAND; INTERVENTIONS; PREPAREDNESS; CHALLENGES; TRIAGE	Background: Southeast Asia has been the focus of considerable investment in pandemic influenza preparedness. Given the wide variation in socio-economic conditions, health system capacity across the region is likely to impact to varying degrees on pandemic mitigation operations. We aimed to estimate and compare the resource gaps, and potential mortalities associated with those gaps, for responding to pandemic influenza within and between six territories in Asia. Methods and Findings: We collected health system resource data from Cambodia, Indonesia (Jakarta and Bali), Lao PDR, Taiwan, Thailand and Vietnam. We applied a mathematical transmission model to simulate a "mild-to-moderate'' pandemic influenza scenario to estimate resource needs, gaps, and attributable mortalities at province level within each territory. The results show that wide variations exist in resource capacities between and within the six territories, with substantial mortalities predicted as a result of resource gaps (referred to here as "avoidable'' mortalities), particularly in poorer areas. Severe nationwide shortages of mechanical ventilators were estimated to be a major cause of avoidable mortalities in all territories except Taiwan. Other resources (oseltamivir, hospital beds and human resources) are inequitably distributed within countries. Estimates of resource gaps and avoidable mortalities were highly sensitive to model parameters defining the transmissibility and clinical severity of the pandemic scenario. However, geographic patterns observed within and across territories remained similar for the range of parameter values explored. Conclusions: The findings have important implications for where (both geographically and in terms of which resource types) investment is most needed, and the potential impact of resource mobilization for mitigating the disease burden of an influenza pandemic. Effective mobilization of resources across administrative boundaries could go some way towards minimizing avoidable deaths.	[Rudge, James W.; Hanvoravongchai, Piya; Coker, Richard] London Sch Hyg & Trop Med, Communicable Dis Policy Res Grp, Bangkok, Thailand; [Krumkamp, Ralf; Reintjes, Ralf] Hamburg Univ Appl Sci, Dept Hlth Sci, Hamburg, Germany; [Chavez, Irwin] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Adisasmito, Wiku] Univ Indonesia, Fac Publ Hlth, Depok, Indonesia; [Pham Ngoc Chau] Vietnam Mil Med Univ, Hanoi, Vietnam; [Phommasak, Bounlay] Minist Hlth, Natl Emerging Infect Dis Coordinat Off, Viangchan, Laos; [Putthasri, Weerasak] Int Hlth Policy Programme Thailand, Nonthaburi, Thailand; [Shih, Chin-Shui] Taiwan Ctr Dis Control, Taipei, Taiwan; [Stein, Mart; Timen, Aura] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Touch, Sok] Minist Hlth, Dept Communicable Dis Control, Phnom Penh, Cambodia	Hochschule Angewandte Wissenschaft Hamburg; Mahidol University; University of Indonesia; Netherlands National Institute for Public Health & the Environment	Rudge, JW (corresponding author), London Sch Hyg & Trop Med, Communicable Dis Policy Res Grp, Bangkok, Thailand.	james.rudge@lshtm.ac.uk	Hanvoravongchai, Piya/A-1569-2012; Stein, Mart/U-8914-2019; Timen, Aura/GLV-4130-2022; Shih, Chin-Shui/V-2934-2019	Hanvoravongchai, Piya/0000-0003-4256-1271; Shih, Chin-Shui/0000-0001-7230-2356; Stein, Mart L./0000-0003-0502-7993	Rockefeller Foundation [2008 DSN 2001]; European Commission [Health-F3-2008-201823]	Rockefeller Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was conducted as part of "AsiaFluCap: Heath system analysis to support capacity development in response to the threat of pandemic influenza in Asia'', a project funded within the European Commission Seventh Framework Programme (FP7/2007-2013), grant agreement number: Health-F3-2008-201823; and the Rockefeller Foundation Grant 2008 DSN 2001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TA, 2003, J CRIT CARE, V18, P173, DOI 10.1016/j.jcrc.2003.08.008; Balcan D, 2009, PLOS CURR INFLUENZA; Coker RJ, 2011, LANCET, V377, P599, DOI 10.1016/S0140-6736(10)62004-1; Corley A, 2010, INT J NURS STUD, V47, P577, DOI 10.1016/j.ijnurstu.2009.11.015; Ercole A, 2009, ANAESTHESIA, V64, P937, DOI 10.1111/j.1365-2044.2009.06070.x; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Hanvoravongchai P, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-322; Hick JL, 2006, ACAD EMERG MED, V13, P223, DOI [10.1111/j.1553-2712.2006.tb01677.x, 10.1197/j.aem.2005.07.037]; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kanter RK, 2007, ANN EMERG MED, V50, P314, DOI 10.1016/j.annemergmed.2006.10.019; Krumkamp R, 2011, EPIDEMIOL INFECT, V139, P59, DOI 10.1017/S0950268810002220; Limwattananon C, 2011, SE ASIA J T IN PRESS; Lunelli A, 2009, MATH BIOSCI; Menon DK, 2005, ANAESTHESIA, V60, P952, DOI 10.1111/j.1365-2044.2005.04372.x; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Murray CJL, 2006, LANCET, V368, P2211, DOI 10.1016/S0140-6736(06)69895-4; Nap RE, 2007, EMERG INFECT DIS, V13, P1714, DOI 10.3201/eid1311.070103; Niska Richard W, 2007, Adv Data, P1; Oshitani H, 2008, EMERG INFECT DIS, V14, P875, DOI 10.3201/eid1406.070839; Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068; PETZOLDT T, 2007, J STAT SOFTWARE, V22; Putthasri W, 2009, EMERG INFECT DIS, V15, P423, DOI 10.3201/eid1503.080872; Schull MJ, 2006, ACAD EMERG MED, V13, P1228, DOI [10.1197/j.aem.2006.04.011, 10.1111/j.1553-2712.2006.tb01653.x]; Sobieraj JA, 2007, MIL MED, V172, P486, DOI 10.7205/MILMED.172.5.486; Takeuchi Shouhei, 2010, Nihon Eiseigaku Zasshi, V65, P48; Talmor D, 2007, CRIT CARE MED, V35, P1251, DOI 10.1097/01.CCM.0000262385.95721.CC; Ten Eyck RP, 2008, PREHOSPITAL DISASTER, V23, P103, DOI 10.1017/S1049023X00005707; TUITE AR, 2009, CMAJ; [United Nations System Influenza Coordination World Bank], 2010, INT MIN C A IN PRESS; United Nations System Influenza Coordinator and World Bank, 2008, RESP AV INFL STAT PA; Valdmanis V, 2004, HEALTH SERV RES, V39, P2117, DOI 10.1111/j.1475-6773.2004.00335.x; Vidondo B, 2009, SWISS MED WKLY, V139, P505, DOI smw-12737; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Zhang XZ, 2006, MED DECIS MAKING, V26, P617, DOI 10.1177/0272989X06295359	34	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31800	10.1371/journal.pone.0031800	http://dx.doi.org/10.1371/journal.pone.0031800			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363739	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000302873700101
J	Wang, JL; Shaffer, ML; Eslinger, PJ; Sun, XY; Weitekamp, CW; Patel, MM; Dossick, D; Gill, DJ; Connor, JR; Yang, QX				Wang, Jianli; Shaffer, Michele L.; Eslinger, Paul J.; Sun, Xiaoyu; Weitekamp, Christopher W.; Patel, Megha M.; Dossick, Deborah; Gill, David J.; Connor, James R.; Yang, Qing X.			Maturational and Aging Effects on Human Brain Apparent Transverse Relaxation	PLOS ONE			English	Article							WHITE-MATTER; T-2 RELAXATION; 3.0 T; AGE; TIMES; TISSUE; ADOLESCENCE; RELAXOMETRY; IRON; VISUALIZATION	The goal of this study was to address the need for comprehensive reference data regarding maturational and aging effects on regional transverse relaxation rates (R-2) of the brain in normal humans. Regional R(2)s were measured in twenty-five brain structures from a sample of seventy-seven normal volunteers 9 to 85 years of age. The relationships between regional R-2 and age were determined using generalized additive models, without the constraint of a specified a priori model. Data analysis demonstrated that the brain tissue R-2-age correlations followed various time courses with both linear and non-linear characteristics depending on the particular brain structure. Most anatomical structures studied exhibited non-linear characteristics, including the amygdala, hippocampus, thalamus, globus pallidus, putamen, caudate nucleus, red nucleus, substantia nigra, orbitofrontal white matter and temporal white matter. Linear trends were detected in occipital white matter and in the genu of corpus callosum. These results indicate the complexity of age-related R-2 changes in the brain while providing normative reference data that can be utilized in clinical examinations and studies utilizing quantitative transverse relaxation.	[Wang, Jianli; Eslinger, Paul J.; Sun, Xiaoyu; Weitekamp, Christopher W.; Patel, Megha M.; Dossick, Deborah; Yang, Qing X.] Penn State Univ, Coll Med, Dept Radiol, Hershey, PA USA; [Shaffer, Michele L.; Eslinger, Paul J.] Penn State Univ, Coll Med, Dept Publ Hlth Sci, Hershey, PA USA; [Eslinger, Paul J.; Gill, David J.] Penn State Univ, Coll Med, Dept Neurol, Hershey, PA USA; [Connor, James R.; Yang, Qing X.] Penn State Univ, Coll Med, Dept Neurosurg, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Wang, JL (corresponding author), Penn State Univ, Coll Med, Dept Radiol, Hershey, PA USA.	jxw73@psu.edu	Yang, Heroine/GRY-2630-2022		Charles A. Dana Foundation [DANAFDN-01]; National Institutes of Health [RO1 EB00454]; G.M. Leader Family Foundation; Pennsylvania Department of Health; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000454] Funding Source: NIH RePORTER	Charles A. Dana Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G.M. Leader Family Foundation; Pennsylvania Department of Health; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research was supported by the Charles A. Dana Foundation (DANAFDN-01), National Institutes of Health (RO1 EB00454), the G.M. Leader Family Foundation, and the Pennsylvania Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartha R, 2002, MAGNET RESON MED, V47, P742, DOI 10.1002/mrm.10112; BARTZOKIS G, 1993, MAGN RESON MED, V29, P459, DOI 10.1002/mrm.1910290406; BOTTOMLEY PA, 1984, MED PHYS, V11, P425, DOI 10.1118/1.595535; Carmody DP, 2004, NEURORADIOLOGY, V46, P781, DOI 10.1007/s00234-004-1241-z; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; Ding XQ, 2004, INVEST RADIOL, V39, P740, DOI 10.1097/00004424-200412000-00005; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRISTON KJ, 1994, NEUROSCIENCE, V59, P229, DOI 10.1016/0306-4522(94)90592-4; Gelman N, 1999, RADIOLOGY, V210, P759, DOI 10.1148/radiology.210.3.r99fe41759; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; Hasan KM, 2008, MAGN RESON MED, V59, P7, DOI 10.1002/mrm.21434; Hasan KM, 2010, MAGN RESON MED, V64, P1382, DOI 10.1002/mrm.22515; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hendry J, 2006, NEUROIMAGE, V29, P1049, DOI 10.1016/j.neuroimage.2005.08.039; Kim EY, 2007, INT J DEV NEUROSCI, V25, P409, DOI 10.1016/j.ijdevneu.2007.05.005; Kumar R, 2011, MAGN RESON IMAGING, V29, P185, DOI 10.1016/j.mri.2010.08.006; Ma JF, 1996, J MAGN RESON SER B, V111, P61, DOI 10.1006/jmrb.1996.0060; MACKAY A, 1994, MAGNET RESON MED, V31, P673, DOI 10.1002/mrm.1910310614; MENON RS, 1991, MAGNET RESON MED, V20, P214, DOI 10.1002/mrm.1910200205; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; NGO F Q H, 1985, Magnetic Resonance Imaging, V3, P145, DOI 10.1016/0730-725X(85)90251-6; Oh J, 2006, MAGN RESON IMAGING, V24, P33, DOI 10.1016/j.mri.2005.10.016; Pfefferbaum A, 1999, PSYCHIAT RES-NEUROIM, V91, P93, DOI 10.1016/S0925-4927(99)00023-2; Saito N, 2009, MAGN RESON IMAGING, V27, P895, DOI 10.1016/j.mri.2009.05.006; Sharkey RJ, 2010, EPILEPSY RES, V92, P41, DOI 10.1016/j.eplepsyres.2010.08.005; Siemonsen S, 2008, AM J NEURORADIOL, V29, P950, DOI 10.3174/ajnr.A0951; Steen RG, 1997, AM J NEURORADIOL, V18, P819; Stevenson VL, 2000, J NEUROL SCI, V178, P81, DOI 10.1016/S0022-510X(00)00339-7; Wansapura JP, 1999, JMRI-J MAGN RESON IM, V9, P531, DOI 10.1002/(SICI)1522-2586(199904)9:4<531::AID-JMRI4>3.0.CO;2-L; Williams LA, 2005, RADIOLOGY, V235, P595, DOI 10.1148/radiol.2352031769	30	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31907	10.1371/journal.pone.0031907	http://dx.doi.org/10.1371/journal.pone.0031907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363767	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700121
J	Zwaan, RA; van der Stoep, N; Guadalupe, T; Bouwmeester, S				Zwaan, Rolf A.; van der Stoep, Nathan; Guadalupe, Tulio; Bouwmeester, Samantha			Language Comprehension in the Balance: The Robustness of the Action-Compatibility Effect (ACE)	PLOS ONE			English	Article							MOTOR RESONANCE; SENTENCES; SYSTEM	How does language comprehension interact with motor activity? We investigated the conditions under which comprehending an action sentence affects people's balance. We performed two experiments to assess whether sentences describing forward or backward movement modulate the lateral movements made by subjects who made sensibility judgments about the sentences. In one experiment subjects were standing on a balance board and in the other they were seated on a balance board that was mounted on a chair. This allowed us to investigate whether the action compatibility effect (ACE) is robust and persists in the face of salient incompatibilities between sentence content and subject movement. Growth-curve analysis of the movement trajectories produced by the subjects in response to the sentences suggests that the ACE is indeed robust. Sentence content influenced movement trajectory despite salient inconsistencies between implied and actual movement. These results are interpreted in the context of the current discussion of embodied, or grounded, language comprehension and meaning representation.	[Zwaan, Rolf A.; Bouwmeester, Samantha] Erasmus Univ, Dept Psychol, Rotterdam, Netherlands; [van der Stoep, Nathan] Univ Utrecht, Dept Expt Psychol, Hemholtz Inst, NL-3508 TC Utrecht, Netherlands; [Guadalupe, Tulio] Max Planck Inst Psycholinguist, Nijmegen, Netherlands	Erasmus University Rotterdam; Utrecht University; Max Planck Society	Zwaan, RA (corresponding author), Erasmus Univ, Dept Psychol, Rotterdam, Netherlands.	zwaan@fsw.eur.nl	Van der Stoep, Nathan/M-1417-2017	Van der Stoep, Nathan/0000-0002-0412-2078; Zwaan, Rolf/0000-0001-9967-7879				Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Bedny M, 2011, ANN NY ACAD SCI, V1224, P81, DOI 10.1111/j.1749-6632.2011.06013.x; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Desai RH, 2010, CEREB CORTEX, V20, P468, DOI 10.1093/cercor/bhp115; Fischer MH, 2008, Q J EXP PSYCHOL, V61, P825, DOI 10.1080/17470210701623605; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; Glenberg AM, 1997, BEHAV BRAIN SCI, V20, P1, DOI 10.1017/S0140525X97470012; KINTSCH W, 1978, PSYCHOL REV, V85, P363, DOI 10.1037/0033-295X.85.5.363; Mirman D, 2008, J MEM LANG, V59, P475, DOI 10.1016/j.jml.2007.11.006; Raposo A, 2009, NEUROPSYCHOLOGIA, V47, P388, DOI 10.1016/j.neuropsychologia.2008.09.017; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Taylor LJ, 2008, Q J EXP PSYCHOL, V61, P896, DOI 10.1080/17470210701625519; Taylor LJ, 2009, LANG COGN, V1, P45, DOI 10.1515/LANGCOG.2009.003; Tettamanti M, 2005, J COGNITIVE NEUROSCI, V17, P273, DOI 10.1162/0898929053124965; Vermunt J.K., 2008, LG SYNTAX USERS GUID; Willems RM, 2011, PSYCHOL SCI, V22, P849, DOI 10.1177/0956797611412387; Zwaan RA, 2006, J EXP PSYCHOL GEN, V135, P1, DOI 10.1037/0096-3445.135.1.1; Zwaan RA, 2004, PSYCHOL LEARN MOTIV, V44, P35; Zwaan RA, 2010, BRAIN LANG, V112, P143, DOI 10.1016/j.bandl.2008.11.004	19	19	19	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31204	10.1371/journal.pone.0031204	http://dx.doi.org/10.1371/journal.pone.0031204			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926ZM	22363580	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700032
J	Gallardo-Cruz, JA; Meave, JA; Gonzalez, EJ; Lebrija-Trejos, EE; Romero-Romero, MA; Perez-Garcia, EA; Gallardo-Cruz, R; Hernandez-Stefanoni, JL; Martorell, C				Alberto Gallardo-Cruz, J.; Meave, Jorge A.; Gonzalez, Edgar J.; Lebrija-Trejos, Edwin E.; Romero-Romero, Marco A.; Perez-Garcia, Eduardo A.; Gallardo-Cruz, Rodrigo; Luis Hernandez-Stefanoni, Jose; Martorell, Carlos			Predicting Tropical Dry Forest Successional Attributes from Space: Is the Key Hidden in Image Texture?	PLOS ONE			English	Article							SECONDARY FOREST; THEMATIC MAPPER; RAIN-FOREST; LAND-COVER; COUNTRYSIDE BIOGEOGRAPHY; ABOVEGROUND BIOMASS; CROSS-VALIDATION; CARBON STOCKS; VEGETATION; BIODIVERSITY	Biodiversity conservation and ecosystem-service provision will increasingly depend on the existence of secondary vegetation. Our success in achieving these goals will be determined by our ability to accurately estimate the structure and diversity of such communities at broad geographic scales. We examined whether the texture (the spatial variation of the image elements) of very high-resolution satellite imagery can be used for this purpose. In 14 fallows of different ages and one mature forest stand in a seasonally dry tropical forest landscape, we estimated basal area, canopy cover, stem density, species richness, Shannon index, Simpson index, and canopy height. The first six attributes were also estimated for a subset comprising the tallest plants. We calculated 40 texture variables based on the red and the near infrared bands, and EVI and NDVI, and selected the best-fit linear models describing each vegetation attribute based on them. Basal area (R-2 = 0.93), vegetation height and cover (0.89), species richness (0.87), and stand age (0.85) were the best-described attributes by two-variable models. Cross validation showed that these models had a high predictive power, and most estimated vegetation attributes were highly accurate. The success of this simple method (a single image was used and the models were linear and included very few variables) rests on the principle that image texture reflects the internal heterogeneity of successional vegetation at the proper scale. The vegetation attributes best predicted by texture are relevant in the face of two of the gravest threats to biosphere integrity: climate change and biodiversity loss. By providing reliable basal area and fallow-age estimates, image-texture analysis allows for the assessment of carbon sequestration and diversity loss rates. New and exciting research avenues open by simplifying the analysis of the extent and complexity of successional vegetation through the spatial variation of its spectral information.	[Alberto Gallardo-Cruz, J.; Meave, Jorge A.; Gonzalez, Edgar J.; Romero-Romero, Marco A.; Perez-Garcia, Eduardo A.; Gallardo-Cruz, Rodrigo; Martorell, Carlos] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Ecol & Recursos Nat, Mexico City 04510, DF, Mexico; [Lebrija-Trejos, Edwin E.] Univ Wageningen & Res Ctr, Forest Ecol & Management Grp, Wageningen, Netherlands; [Luis Hernandez-Stefanoni, Jose] Ctr Invest Cient Yucatan AC, Merida, Yucatan, Mexico; [Lebrija-Trejos, Edwin E.] Tel Aviv Univ, Fac Life Sci, Dept Plant Sci, IL-69978 Tel Aviv, Israel	Universidad Nacional Autonoma de Mexico; Wageningen University & Research; Centro de Investigacion Cientifica de Yucatan; Tel Aviv University	Gallardo-Cruz, JA (corresponding author), Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Ecol & Recursos Nat, Mexico City 04510, DF, Mexico.	jagc@ciencias.unam.mx	Meave, Jorge/B-3673-2008; Martorell, Carlos/A-2265-2008; Gallardo-Cruz, José Alberto/AAG-1579-2020; Pérez-García, Eduardo/A-6517-2008; González, Edgar J./AAH-7144-2019	Meave, Jorge/0000-0002-6241-8803; Martorell, Carlos/0000-0002-0758-3953; Gallardo-Cruz, José Alberto/0000-0002-0509-7003; González, Edgar J./0000-0001-9113-1070; Lebrija-Trejos, Edwin/0000-0003-1511-1718; Romero Romero, Marco Antonio/0000-0003-1091-6584; Perez-Garcia, Eduardo A./0000-0002-4136-4500; Hernandez-Stefanoni, Jose Luis/0000-0002-9559-7131	CONACyT [CB-2009-01-128136]; PAPIIT [IN221503, IN220027]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT))	This work received funding from CONACyT (www.conacyt.mx; project number: CB-2009-01-128136) and PAPIIT (http://dgapa.unam.mx; projects IN221503 and IN220027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aide TM, 2000, RESTOR ECOL, V8, P328, DOI 10.1046/j.1526-100x.2000.80048.x; Gallardo-Cruz J, 2009, LANDSCAPE ECOL, V24, P473, DOI 10.1007/s10980-009-9332-1; [Anonymous], 2010, R LANG ENV STAT COMP; Arroyo-Mora JP, 2005, BIOTROPICA, V37, P497, DOI 10.1111/j.1744-7429.2005.00068.x; Barbier N, 2011, REMOTE SENS ENVIRON, V115, P167, DOI 10.1016/j.rse.2010.08.015; Barbier N, 2010, GLOBAL ECOL BIOGEOGR, V19, P72, DOI 10.1111/j.1466-8238.2009.00493.x; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Baumann K, 2003, TRAC-TREND ANAL CHEM, V22, P395, DOI 10.1016/S0165-9936(03)00607-1; Belisle M, 2001, ECOLOGY, V82, P1893, DOI 10.1890/0012-9658(2001)082[1893:IOFCOT]2.0.CO;2; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Boyd DS, 2005, PROG PHYS GEOG, V29, P1, DOI 10.1191/0309133305pp432ra; Boyd DS, 1996, INT J REMOTE SENS, V17, P249, DOI 10.1080/01431169608949003; BRANDT J, 1988, J BIOGEOGR, V15, P41, DOI 10.2307/2845044; Brearley FQ, 2004, FOREST ECOL MANAG, V195, P385, DOI 10.1016/j.foreco.2004.02.048; Brienen RJW, 2009, BIOTROPICA, V41, P186, DOI 10.1111/j.1744-7429.2008.00462.x; Brodie J, 2010, NATURE, V468, P634, DOI 10.1038/468634c; Brondizio E, 1996, PHOTOGRAMM ENG REM S, V62, P921; Brown S, 1997, ESTIMATING BIOMASS B; Browne MW, 2000, J MATH PSYCHOL, V44, P108, DOI 10.1006/jmps.1999.1279; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Canadell JG, 2007, TERRESTRIAL ECOSYSTE, P59, DOI [10.1007/978-3-540-32730-1_6, DOI 10.1007/978-3-540-32730-1]; Carreiras JMB, 2006, REMOTE SENS ENVIRON, V101, P283, DOI 10.1016/j.rse.2005.12.017; Castro KL, 2003, INT J REMOTE SENS, V24, P1853, DOI 10.1080/01431160210154056; Chazdon RL, 2009, CONSERV BIOL, V23, P1406, DOI 10.1111/j.1523-1739.2009.01338.x; Chazdon RL, 2009, BIOTROPICA, V41, P142, DOI 10.1111/j.1744-7429.2008.00471.x; Chinea JD, 2003, FOREST ECOL MANAG, V180, P227, DOI 10.1016/S0378-1127(02)00565-0; Couteron P, 2005, J APPL ECOL, V42, P1121, DOI 10.1111/j.1365-2664.2005.01097.x; Daily GC, 2001, ECOL APPL, V11, P1, DOI 10.1890/1051-0761(2001)011[0001:CBUOHD]2.0.CO;2; Dent DH, 2009, BIOL CONSERV, V142, P2833, DOI 10.1016/j.biocon.2009.05.035; Diaz S, 2006, PLOS BIOL, V4, P1300, DOI 10.1371/journal.pbio.0040277; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Ewel J. J., 1977, Geo-Eco-Trop, V1, P103; Fearnside PM, 2004, ECOL APPL, V14, P982, DOI 10.1890/03-5225; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foley JA, 2007, P NATL ACAD SCI USA, V104, P12585, DOI 10.1073/pnas.0705190104; Foody GM, 2006, ECOL MODEL, V195, P37, DOI 10.1016/j.ecolmodel.2005.11.007; Foody GM, 2001, GLOBAL ECOL BIOGEOGR, V10, P379, DOI 10.1046/j.1466-822X.2001.00248.x; Frazer GW, 2005, FOREST ECOL MANAG, V214, P65, DOI 10.1016/j.foreco.2005.03.056; Fuchs H, 2009, REMOTE SENS ENVIRON, V113, P518, DOI 10.1016/j.rse.2008.07.017; Gao X, 2000, REMOTE SENS ENVIRON, V74, P609, DOI 10.1016/S0034-4257(00)00150-4; Garcia Sevilla P., 2006, IMAGE PROCESSING DEA; Gillespie TW, 2006, GLOBAL ECOL BIOGEOGR, V15, P225, DOI [10.1111/j.1466-8238.2005.00203.x, 10.1111/j.1466-822X.2005.00203.x]; Gould W, 2000, ECOL APPL, V10, P1861, DOI 10.1890/1051-0761(2000)010[1861:RSOVPS]2.0.CO;2; Guariguata MR, 2001, FOREST ECOL MANAG, V148, P185, DOI 10.1016/S0378-1127(00)00535-1; HARALICK RM, 1979, P IEEE, V67, P786, DOI 10.1109/PROC.1979.11328; Harvey CA, 2006, ECOL APPL, V16, P1986, DOI 10.1890/1051-0761(2006)016[1986:POADID]2.0.CO;2; Hay GJ, 1996, REMOTE SENS ENVIRON, V55, P108, DOI 10.1016/0034-4257(95)00189-1; Helmer EH, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000568; Helmer EH, 2000, INT J REMOTE SENS, V21, P2163, DOI 10.1080/01431160050029495; Helmer EH, 2002, CARIBB J SCI, V38, P165; Helmer EH, 2009, J APPL REMOTE SENS, V3, DOI 10.1117/1.3082116; Hernandez-Stefanoni JL, 2011, ECOL INDIC, DOI [10.1016/j.ecolind.2010.1011.1003, DOI 10.1016/J.ECOLIND.2010.1011.1003]; ITT, 2008, ENVI 4 5 IDL VERS 7; Janzen D, 1998, SCIENCE, V279, P1312, DOI 10.1126/science.279.5355.1312; Jepsen MR, 2006, FOREST ECOL MANAG, V225, P287, DOI 10.1016/j.foreco.2006.01.005; Kalacska M, 2007, REMOTE SENS ENVIRON, V108, P82, DOI 10.1016/j.rse.2006.11.007; Kalacska M, 2004, FOREST ECOL MANAG, V200, P227, DOI 10.1016/j.foreco.2004.07.001; Kenzo T, 2010, FOREST ECOL MANAG, V260, P875, DOI 10.1016/j.foreco.2010.06.006; Kerr JT, 2003, TRENDS ECOL EVOL, V18, P299, DOI 10.1016/S0169-5347(03)00071-5; Kimes DS, 1999, INT J REMOTE SENS, V20, P3625, DOI 10.1080/014311699211246; Krause K., 2005, RADIOMETRIC USE QUIC; Kuplich TM, 2005, INT J REMOTE SENS, V26, P4829, DOI 10.1080/01431160500239107; Laliberte AS, 2004, REMOTE SENS ENVIRON, V93, P198, DOI 10.1016/j.rse.2004.07.011; Lebrija-Trejos E, 2008, BIOTROPICA, V40, P422, DOI 10.1111/j.1744-7429.2008.00398.x; Lebrija-Trejos E, 2011, J TROP ECOL, V27, P477, DOI 10.1017/S0266467411000253; Lebrija-Trejos E, 2010, ECOLOGY, V91, P386, DOI 10.1890/08-1449.1; Lepers E, 2005, BIOSCIENCE, V55, P115, DOI 10.1641/0006-3568(2005)055[0115:ASOIOR]2.0.CO;2; Levin N, 2007, DIVERS DISTRIB, V13, P692, DOI 10.1111/j.1472-4642.2007.00372.x; Liu W, 2008, INT J REMOTE SENS, V29, P3855, DOI 10.1080/01431160701840166; Lu D, 2005, INT J REMOTE SENS, V26, P2509, DOI 10.1080/01431160500142145; Lu DS, 2006, INT J REMOTE SENS, V27, P1297, DOI 10.1080/01431160500486732; LUCAS RM, 1993, INT J REMOTE SENS, V14, P3061, DOI 10.1080/01431169308904419; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Malhi Y, 2008, REMOTE SENS ENVIRON, V112, P2074, DOI 10.1016/j.rse.2008.01.009; Marques MJ, 2007, SCI TOTAL ENVIRON, V378, P161, DOI 10.1016/j.scitotenv.2007.01.043; Marquez J, 2008, TEXTURE CHARACTERIZA; Mausel P., 1993, GEOCARTO INT, V8, P61, DOI [10.1080/10106049309354430., DOI 10.1080/10106049309354430]; Mayfield MM, 2005, ECOL APPL, V15, P423, DOI 10.1890/03-5369; Murray H, 2010, INT J APPL EARTH OBS, V12, P138, DOI 10.1016/j.jag.2010.01.006; Nagendra H, 2001, INT J REMOTE SENS, V22, P2377, DOI 10.1080/01431160117096; Nelson GC., 2005, ECOSYSTEMS HUMAN WEL, P73; Nelson RF, 2000, BIOSCIENCE, V50, P419, DOI 10.1641/0006-3568(2000)050[0419:SFAATF]2.0.CO;2; Palmer MW, 2002, ENVIRONMETRICS, V13, P121, DOI 10.1002/env.516; Perez-Garcia EA, 2010, FOLIA GEOBOT, V45, P143, DOI 10.1007/s12224-010-9064-7; Perfecto I, 2008, ANN NY ACAD SCI, V1134, P173, DOI 10.1196/annals.1439.011; Proisy C, 2007, REMOTE SENS ENVIRON, V109, P379, DOI 10.1016/j.rse.2007.01.009; Putz FE, 2001, CONSERV BIOL, V15, P7, DOI 10.1046/j.1523-1739.2001.00018.x; Rhoades CC, 2000, ECOL APPL, V10, P497, DOI 10.1890/1051-0761(2000)010[0497:SCDAFA]2.0.CO;2; Rignot E, 1997, REMOTE SENS ENVIRON, V59, P167, DOI 10.1016/S0034-4257(96)00150-2; Rocchini D, 2004, ACTA OECOL, V26, P117, DOI 10.1016/j.actao.2004.03.008; Rocchini D, 2010, ECOL INFORM, V5, P318, DOI 10.1016/j.ecoinf.2010.06.001; Rocchini D, 2010, INT J REMOTE SENS, V31, P2745, DOI 10.1080/01431160903085651; SADER SA, 1989, REMOTE SENS ENVIRON, V28, P143, DOI 10.1016/0034-4257(89)90112-0; Safriel U., 2005, ECOSYSTEMS HUMAN WEL, P623; Sanchez-Azofeifa GA, 2009, ECOL APPL, V19, P480, DOI 10.1890/08-1149.1; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Sarker LR, 2011, REMOTE SENS ENVIRON, V115, P968, DOI 10.1016/j.rse.2010.11.010; Satterthwaite D, 2008, ENVIRON URBAN, V20, P539, DOI 10.1177/0956247808096127; Schowengerdt R. A., 2007, REMOTE SENSING MODEL; SHAO J, 1993, J AM STAT ASSOC, V88, P486, DOI 10.2307/2290328; Shevliakova E, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2007GB003176; Slik JWF, 2010, GLOBAL ECOL BIOGEOGR, V19, P50, DOI 10.1111/j.1466-8238.2009.00489.x; Sohn YS, 1999, PHOTOGRAMM ENG REM S, V65, P947; Song C, 2007, REMOTE SENS ENVIRON, V106, P228, DOI 10.1016/j.rse.2006.08.008; Steininger MK, 2000, INT J REMOTE SENS, V21, P1139, DOI 10.1080/014311600210119; Steininger MK, 1996, INT J REMOTE SENS, V17, P9, DOI 10.1080/01431169608948984; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomson AM, 2010, P NATL ACAD SCI USA, V107, P19633, DOI 10.1073/pnas.0910467107; Tottrup C, 2007, INT J REMOTE SENS, V28, P1263, DOI 10.1080/01431160600928575; Trzcinski MK, 1999, ECOL APPL, V9, P586, DOI 10.1890/1051-0761(1999)009[0586:IEOFCA]2.0.CO;2; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; van Dijk AIJM, 2002, J HYDROL, V261, P1, DOI 10.1016/S0022-1694(02)00020-3; Vieira ICG, 2003, REMOTE SENS ENVIRON, V87, P470, DOI 10.1016/j.rse.2002.09.002; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wijaya A, 2010, FOREST ECOL MANAG, V259, P2315, DOI 10.1016/j.foreco.2010.03.004; Wunderle AL, 2007, INT J REMOTE SENS, V28, P4351, DOI 10.1080/01431160701244849; Yang X, 2010, BIOGEOSCIENCES, V7, P3041, DOI 10.5194/bg-7-3041-2010	117	60	62	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30506	10.1371/journal.pone.0030506	http://dx.doi.org/10.1371/journal.pone.0030506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363443	Green Submitted, Green Published, gold			2022-12-27	WOS:000302871500010
J	Claidiere, N; Bowler, M; Whiten, A				Claidiere, Nicolas; Bowler, Mark; Whiten, Andrew			Evidence for Weak or Linear Conformity but Not for Hyper-Conformity in an Everyday Social Learning Context	PLOS ONE			English	Article							TRANSMISSION; EVOLUTION; ENVIRONMENT; NORMS	Conformity is thought to be an important force in cultural evolution because it has the potential to stabilize cooperation in large groups, potentiate group selection and thus explain uniquely human behaviors. However, the effects of such conformity on cultural and biological evolution will depend much on the way individuals are influenced by the frequency of alternative behavioral options witnessed. Theoretical modeling has suggested that only what we refer to as 'hyper-conformity', an exaggerated tendency to perform the most frequent behavior witnessed in other individuals, is able to increase within-group homogeneity and between-group diversity, for instance. Empirically however, few experiments have addressed how the frequency of behavior witnessed affects behavior. Accordingly we performed an experiment to test for the presence of conformity in a natural situation with humans. Visitors to a Zoo exhibit were invited to write or draw answers to questions on A5 cards and potentially win a small prize. We manipulated the proportion of existing writings versus drawings visible to visitors and measured the proportion of written cards submitted. We found a strong and significant effect of the proportion of text displayed on the proportion of text in the answers, thus demonstrating social learning. We show that this effect is approximately linear, with potentially a small, weak-conformist component but no hyper-conformist one. The present experiment therefore provides evidence for linear conformity in humans in a very natural context.	[Claidiere, Nicolas; Bowler, Mark; Whiten, Andrew] Univ St Andrews, Ctr Social Learning & Cognit Evolut, St Andrews, Fife, Scotland	University of St Andrews	Claidiere, N (corresponding author), Univ St Andrews, Ctr Social Learning & Cognit Evolut, St Andrews, Fife, Scotland.	nicolas.claidiere@normalesup.org	Claidiere, Nicolas/HGE-8036-2022	Whiten, Andrew/0000-0003-2426-5890; Claidiere, Nicolas/0000-0002-4472-6597; Bowler, Mark/0000-0001-5236-3477	Fyssen fellowship; Wellcome trust	Fyssen fellowship; Wellcome trust(Wellcome TrustEuropean Commission)	This work was funded by a Fyssen fellowship (http://www.fondation-fyssen.org/) to Dr. Claidiere and a Wellcome trust VIP award (http://www.wellcome.ac.uk/) to Dr. Whiten. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ASCH SE, 1955, SCI AM, V193, P31, DOI 10.1038/scientificamerican1155-31; ASCH SE, 1956, PSYCHOL MONOGR, V70, P1, DOI 10.1037/h0093718; Boyd R., 1985, CULTURE EVOLUTIONARY; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; CAMPBELL JD, 1989, J PERS SOC PSYCHOL, V57, P457, DOI 10.1037/0022-3514.57.3.457; Cialdini R.B., 1998, HDB SOCIAL PSYCHOL 4, P151; Cialdini RB, 2004, ANNU REV PSYCHOL, V55, P591, DOI 10.1146/annurev.psych.55.090902.142015; Claidiere N, 2012, PSYCHOL BULL, V138, P126, DOI 10.1037/a0025868; Corriveau KH, 2010, DEV PSYCHOL, V46, P437, DOI 10.1037/a0017553; Corriveau KH, 2009, PSYCHOL SCI, V20, P372, DOI 10.1111/j.1467-9280.2009.02291.x; Coultas JC, 2004, GROUP PROCESS INTERG, V7, P317, DOI 10.1177/1368430204046141; DEUTSCH MORTON, 1955, JOUR ABNORMAL AND SOCIAL PSYCHOL, V51-31, P629, DOI 10.1037/h0046408; Efferson C, 2008, EVOL HUM BEHAV, V29, P56, DOI 10.1016/j.evolhumbehav.2007.08.003; Efferson C, 2007, EVOL HUM BEHAV, V28, P11, DOI 10.1016/j.evolhumbehav.2006.05.005; Eriksson K., 2009, J EVOL PSYCHOL, V7, P5, DOI [10.1556/JEP.7.2009.1.3, DOI 10.1556/JEP.7.2009.1.3]; Eriksson K., 2007, J EVOL PSYCHOL, V5, P67, DOI [10.1556/JEP.2007.1009, DOI 10.1556/JEP.2007.1009]; Galef BG, 2008, ANIM BEHAV, V75, P2035, DOI 10.1016/j.anbehav.2007.11.012; Henrich J, 1998, EVOL HUM BEHAV, V19, P215, DOI 10.1016/S1090-5138(98)00018-X; Henrich J, 2001, J THEOR BIOL, V208, P79, DOI 10.1006/jtbi.2000.2202; Kameda T, 2002, EVOL HUM BEHAV, V23, P373, DOI 10.1016/S1090-5138(02)00101-0; Kendal J, 2009, J THEOR BIOL, V260, P210, DOI 10.1016/j.jtbi.2009.05.029; Kendal Rachel L., 2009, P249; Kendal RL, 2005, ADV STUD BEHAV, V35, P333, DOI 10.1016/S0065-3454(05)35008-X; Macdonald C., 2011, International Zoo Yearbook, V45, P7, DOI 10.1111/j.1748-1090.2010.00120.x; McElreath R, 2005, EVOL HUM BEHAV, V26, P483, DOI 10.1016/j.evolhumbehav.2005.04.003; McElreath R, 2008, PHILOS T R SOC B, V363, P3515, DOI 10.1098/rstb.2008.0131; Mesoudi A, 2011, EVOL HUM BEHAV, V32, P334, DOI 10.1016/j.evolhumbehav.2010.12.001; Nakahashi W, 2007, THEOR POPUL BIOL, V72, P52, DOI 10.1016/j.tpb.2007.03.003; Perry S, 2009, ANIM COGN, V12, P705, DOI 10.1007/s10071-009-0230-3; Pike TW, 2010, BIOL LETTERS, V6, P466, DOI 10.1098/rsbl.2009.1014; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Richerson PJ., 2005, NOT GENES ALONE CULT; Wakano JY, 2007, THEOR POPUL BIOL, V72, P504, DOI 10.1016/j.tpb.2007.04.003; Walker MB, 1996, J SOC PSYCHOL, V136, P367, DOI 10.1080/00224545.1996.9714014; Whiten A, 2005, NATURE, V437, P737, DOI 10.1038/nature04047; Whiten A, 2010, DEV PSYCHOL, V46, P1694, DOI 10.1037/a0020786	37	21	21	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30970	10.1371/journal.pone.0030970	http://dx.doi.org/10.1371/journal.pone.0030970			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926YY	22363524	gold, Green Published			2022-12-27	WOS:000302871500021
J	Harbi, D; Parthiban, M; Gendoo, DMA; Ehsani, S; Kumar, M; Schmitt-Ulms, G; Sowdhamini, R; Harrison, PM				Harbi, Djamel; Parthiban, Marimuthu; Gendoo, Deena M. A.; Ehsani, Sepehr; Kumar, Manish; Schmitt-Ulms, Gerold; Sowdhamini, Ramanathan; Harrison, Paul M.			PrionHome: A Database of Prions and Other Sequences Relevant to Prion Phenomena	PLOS ONE			English	Article							COMPOSITIONAL BIAS; GENETIC-VARIATION; APLYSIA CPEB; PROTEIN; YEAST; PROPAGATION; REGIONS; FORM; DOMAINS; SCRAPIE	Prions are units of propagation of an altered state of a protein or proteins; prions can propagate from organism to organism, through cooption of other protein copies. Prions contain no necessary nucleic acids, and are important both as both pathogenic agents, and as a potential force in epigenetic phenomena. The original prions were derived from a misfolded form of the mammalian Prion Protein PrP. Infection by these prions causes neurodegenerative diseases. Other prions cause non-Mendelian inheritance in budding yeast, and sometimes act as diseases of yeast. We report the bioinformatic construction of the PrionHome, a database of >2000 prion-related sequences. The data was collated from various public and private resources and filtered for redundancy. The data was then processed according to a transparent classification system of prionogenic sequences (i.e., sequences that can make prions), prionoids (i.e., proteins that propagate like prions between individual cells), and other prion-related phenomena. There are eight PrionHome classifications for sequences. The first four classifications are derived from experimental observations: prionogenic sequences, prionoids, other prion-related phenomena, and prion interactors. The second four classifications are derived from sequence analysis: orthologs, paralogs, pseudogenes, and candidate-prionogenic sequences. Database entries list: supporting information for PrionHome classifications, prion-determinant areas (where relevant), and disordered and compositionally-biased regions. Also included are literature references for the PrionHome classifications, transcripts and genomic coordinates, and structural data (including comparative models made for the PrionHome from manually curated alignments). We provide database usage examples for both vertebrate and fungal prion contexts. Using the database data, we have performed a detailed analysis of the compositional biases in known budding-yeast prionogenic sequences, showing that the only abundant bias pattern is for asparagine bias with subsidiary serine bias. We anticipate that this database will be a useful experimental aid and reference resource. It is freely available at: http://libaio.biol.mcgill.ca/prion.	[Harbi, Djamel; Gendoo, Deena M. A.; Harrison, Paul M.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Kumar, Manish] Univ Delhi, Dept Biophys, New Delhi, India; [Sowdhamini, Ramanathan] Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Ehsani, Sepehr; Schmitt-Ulms, Gerold] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [Ehsani, Sepehr; Schmitt-Ulms, Gerold] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Parthiban, Marimuthu] Abo Akad Univ, Dept Biosci, Turku, Finland	McGill University; University of Delhi; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of Toronto; University of Toronto; Abo Akademi University	Harbi, D (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	paul.harrison@mcgill.ca	Ehsani, Sepehr/E-9257-2010; Marimuthu, Parthiban/AAU-6138-2021; Kumar, Manish/AGP-1250-2022	Ehsani, Sepehr/0000-0002-9613-6898; Marimuthu, Parthiban/0000-0003-4960-2160; Kumar, Manish/0000-0002-7936-9892; Gendoo, Deena/0000-0001-8891-4138	PrioNet Canada Network of Centres of Excellence; Medical Research Council [MC_G1000734] Funding Source: researchfish; MRC [MC_G1000734] Funding Source: UKRI	PrioNet Canada Network of Centres of Excellence; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a grant from the PrioNet Canada Network of Centres of Excellence (http://www.prionetcanada.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Alexandrov IM, 2008, J BIOL CHEM, V283, P15185, DOI 10.1074/jbc.M802071200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971; Brown JCS, 2009, GENE DEV, V23, P2320, DOI 10.1101/gad.1839109; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Gehlenborg N, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap011; Gendoo DMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027342; Gitler AD, 2011, PRION, V5, P179, DOI 10.4161/pri.5.3.17230; GOLDFARB LG, 1991, P NATL ACAD SCI USA, V88, P10926, DOI 10.1073/pnas.88.23.10926; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Halfmann R, 2011, MOL CELL, V43, P72, DOI 10.1016/j.molcel.2011.05.013; Harbi D, 2011, DATABASE-OXFORD, DOI 10.1093/database/baq031; Harrison LB, 2007, J MOL BIOL, V368, P273, DOI 10.1016/j.jmb.2007.01.070; Harrison PM, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-441; Harrison PM, 2010, GENOMICS, V95, P268, DOI 10.1016/j.ygeno.2010.02.008; Harrison PM, 2005, NUCLEIC ACIDS RES, V33, P2374, DOI 10.1093/nar/gki531; Harrison PM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-r40; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; LACROUTE F, 1971, J BACTERIOL, V106, P519, DOI 10.1128/JB.106.2.519-522.1971; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Maddelein ML, 1999, MOL CELL BIOL, V19, P4516; McGlinchey RP, 2011, P NATL ACAD SCI USA, V108, P5337, DOI 10.1073/pnas.1102762108; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Moore R, 1997, J MOL BIOL, V292, P797; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Ohhashi Y, 2010, NAT CHEM BIOL, V6, P225, DOI 10.1038/NCHEMBIO.306; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Paramithiotis E, 2003, NAT MED, V9, P893, DOI 10.1038/nm883; Patel BK, 2009, NAT CELL BIOL, V11, P344, DOI 10.1038/ncb1843; Pawlicki S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-273; Pierce MM, 2005, BIOCHEMISTRY-US, V44, P321, DOI 10.1021/bi047964d; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Rivera-Milla E, 2003, TRENDS GENET, V19, P72, DOI 10.1016/S0168-9525(02)00032-X; Roberts BT, 2003, GENE DEV, V17, P2083, DOI 10.1101/gad.1115803; Rogoza T, 2010, P NATL ACAD SCI USA, V107, P10573, DOI 10.1073/pnas.1005949107; Ross ED, 2005, P NATL ACAD SCI USA, V102, P12825, DOI 10.1073/pnas.0506136102; Ross ED, 2004, MOL CELL BIOL, V24, P7206, DOI 10.1128/MCB.24.16.7206-7213.2004; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; SCHATZL HM, 1995, J MOL BIOL, V245, P362, DOI 10.1006/jmbi.1994.0030; Scheibel T, 2001, NAT STRUCT BIOL, V8, P958, DOI 10.1038/nsb1101-958; Schmitt-Ulms G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007208; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Toombs JA, 2010, MOL CELL BIOL, V30, P319, DOI 10.1128/MCB.01140-09; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Watts J, 2007, EMBO J; Westaway D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002391; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 2004, ANNU REV GENET, V38, P681, DOI 10.1146/annurev.genet.38.072902.092200; Wopfner F, 1999, J MOL BIOL, V289, P1163, DOI 10.1006/jmbi.1999.2831; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145	72	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31785	10.1371/journal.pone.0031785	http://dx.doi.org/10.1371/journal.pone.0031785			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363733	gold, Green Published, Green Submitted			2022-12-27	WOS:000302871500088
J	Richard, G; Belta, C; Julius, AA; Amar, S				Richard, Guilhem; Belta, Calin; Julius, A. Agung; Amar, Salomon			Controlling the Outcome of the Toll-Like Receptor Signaling Pathways	PLOS ONE			English	Article							NF-KAPPA-B; TRANSCRIPTIONAL REGULATION; MODELS; FAMILY	The Toll-Like Receptors (TLRs) are proteins involved in the immune system that increase cytokine levels when triggered. While cytokines coordinate the response to infection, they appear to be detrimental to the host when reaching too high levels. Several studies have shown that the deletion of specific TLRs was beneficial for the host, as cytokine levels were decreased consequently. It is not clear, however, how targeting other components of the TLR pathways can improve the responses to infections. We applied the concept of Minimal Cut Sets (MCS) to the ihsTLR v1.0 model of the TLR pathways to determine sets of reactions whose knockouts disrupt these pathways. We decomposed the TLR network into 34 modules and determined signatures for each MCS, i.e. the list of targeted modules. We uncovered 2,669 MCS organized in 68 signatures. Very few MCS targeted directly the TLRs, indicating that they may not be efficient targets for controlling these pathways. We mapped the species of the TLR network to genes in human and mouse, and determined more than 10,000 Essential Gene Sets (EGS). Each EGS provides genes whose deletion suppresses the network's outputs.	[Richard, Guilhem; Belta, Calin; Amar, Salomon] Boston Univ, Program Bioinformat, Boston, MA 02215 USA; [Julius, A. Agung] Rensselaer Polytech Inst, Dept Elect Comp & Syst Engn, Troy, NY USA; [Amar, Salomon] Boston Univ, Ctr Antiinflammatory Therapeut, Goldman Sch Dent Med, Boston, MA 02215 USA	Boston University; Rensselaer Polytechnic Institute; Boston University	Richard, G (corresponding author), Boston Univ, Program Bioinformat, Boston, MA 02215 USA.	samar@bu.edu		Richard, Guilhem/0000-0002-6544-4257; Amar, Salomon/0000-0002-0017-5930	National Insititues of Health/National Institute of Dental and Craniofacial Reasearch [R01DE015989-S1]; National Science Foundation [EF-1137906, EF-1137900]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015989] Funding Source: NIH RePORTER	National Insititues of Health/National Institute of Dental and Craniofacial Reasearch; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The research presented in this paper is supported by the National Insititues of Health/National Institute of Dental and Craniofacial Reasearch under grant number R01DE015989-S1, and the National Science Foundation under grant numbers EF-1137906 and EF-1137900. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Covert MW, 2008, BIOINFORMATICS, V24, P2044, DOI 10.1093/bioinformatics/btn352; Dasika MS, 2006, BIOPHYS J, V91, P382, DOI 10.1529/biophysj.105.069724; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Gilmore TD, 1999, ONCOGENE, V18, P6842, DOI 10.1038/sj.onc.1203237; Gowen BB, 2006, J IMMUNOL, V177, P6301, DOI 10.4049/jimmunol.177.9.6301; Guzik TJ, 2003, J PHYSIOL PHARMACOL, V54, P469; Hasan U, 2005, J IMMUNOL, V174, P2942, DOI 10.4049/jimmunol.174.5.2942; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Imielinski M, 2010, CHAOS, V20, DOI 10.1063/1.3456056; Imielinski M, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-40; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Khan MA, 2006, INFECT IMMUN, V74, P2522, DOI 10.1128/IAI.74.5.2522-2536.2006; Klamt S, 2004, BIOINFORMATICS, V20, P226, DOI 10.1093/bioinformatics/btg395; Lee JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000086; Li F, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000292; Lu RQ, 2001, J BIOL CHEM, V276, P45491, DOI 10.1074/jbc.C100421200; Madan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003204; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Misch EA, 2008, CLIN SCI, V114, P347, DOI 10.1042/CS20070214; Oda K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100057; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Papin JA, 2004, BIOPHYS J, V87, P37, DOI 10.1529/biophysj.103.029884; Paun A, 2007, BIOCHIMIE, V89, P744, DOI 10.1016/j.biochi.2007.01.014; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Ruths D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000005; Saez-Rodriguez J, 2007, PLOS COMPUT BIOL, V3, P1580, DOI 10.1371/journal.pcbi.0030163; Schilling CH, 2000, J THEOR BIOL, V203, P229, DOI 10.1006/jtbi.2000.1073; Shlomi T, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100141; VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	35	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31341	10.1371/journal.pone.0031341	http://dx.doi.org/10.1371/journal.pone.0031341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363624	gold, Green Published, Green Submitted			2022-12-27	WOS:000302871500036
J	Fadista, J; Bendixen, C				Fadista, Joao; Bendixen, Christian			Genomic Position Mapping Discrepancies of Commercial SNP Chips	PLOS ONE			English	Article							HIV-1 CONTROL; DETERMINANTS; SEQUENCE	The field of genetics has come to rely heavily on commercial genotyping arrays and accompanying annotations for insights into genotype-phenotype associations. However, in order to avoid errors and false leads, it is imperative that the annotation of SNP chromosomal positions is accurate and unambiguous. We report on genomic positional discrepancies of various SNP chips for human, cattle and mouse species, and discuss their causes and consequences.	[Fadista, Joao] Lund Univ, CRC, Dept Clin Sci Malmo, Malmo, Sweden; [Bendixen, Christian] Aarhus Univ, Fac Sci & Technol, Dept Mol Biol & Genet, Tjele, Denmark	Lund University; Aarhus University	Fadista, J (corresponding author), Lund Univ, CRC, Dept Clin Sci Malmo, Malmo, Sweden.	christian.bendixen@agrsci.dk	Fadista, Joao/AAM-4870-2020	Fadista, Joao/0000-0003-2539-634X; fadista, joao/0000-0001-7558-7043	European Commission [KBBE-2A-222664]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This research paper has been financed by the European Commission, within the 7th Framework Programme, Grant Agreement KBBE-2A-222664 ("Quantomics''). The text represents the authors' views and does not necessarily represent a position of the Commission who will not be liable for the use made of such information. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson CA, 2008, AM J HUM GENET, V83, P112, DOI 10.1016/j.ajhg.2008.06.008; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Fredman D, 2004, NAT GENET, V36, P861, DOI 10.1038/ng1401; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Ho MR, 2011, NUCLEIC ACIDS RES, V39, pD920, DOI 10.1093/nar/gkq1197; Luethy Roland, 2004, Biosilico, V2, P12; Macgregor S, 2010, HUM MOL GENET, V19, P2716, DOI 10.1093/hmg/ddq144; Pelak K, 2010, J INFECT DIS, V201, P1141, DOI 10.1086/651382; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Schmitt AO, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-80; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	13	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31025	10.1371/journal.pone.0031025	http://dx.doi.org/10.1371/journal.pone.0031025			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363540	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600101
J	Piras, D; Doro, MG; Casu, G; Melis, PM; Vaccargiu, S; Piras, I; Parracciani, D; Stradoni, R; Frongia, B; Lai, G; Sale, S; Cattari, W; Piras, R; Querci, O; Demuro, P; Cui, S; Atzori, F; Mancosu, M; Marchiori, F; Cammelli, R; Spiga, A; Loddo, PP; Pili, G; Boi, R; Argiolas, G; Mereu, P; Leoni, GG; Naitana, S; Pirastu, M; Novelletto, A				Piras, Daniela; Doro, Maria Grazia; Casu, Giuseppina; Melis, Paola Maria; Vaccargiu, Simona; Piras, Ignazio; Parracciani, Debora; Stradoni, Roberta; Frongia, Bruno; Lai, Graziano; Sale, Salvatore; Cattari, Walter; Piras, Roberto; Querci, Ombretta; Demuro, Piergiorgio; Cui, Sandro; Atzori, Franco; Mancosu, Marco; Marchiori, Francesca; Cammelli, Rossana; Spiga, Alessandra; Loddo, Pier Paolo; Pili, Gianfranco; Boi, Roberto; Argiolas, Giuseppe; Mereu, Paolo; Leoni, Giovanni Giuseppe; Naitana, Salvatore; Pirastu, Mario; Novelletto, Andrea			Haplotype Affinities Resolve a Major Component of Goat (Capra hircus) MtDNA D-Loop Diversity and Reveal Specific Features of the Sardinian Stock	PLOS ONE			English	Article							GENETIC DIVERSITY; POPULATION-GENETICS; BREEDS; DNA; EVOLUTION; LINEAGES; SOFTWARE; MUTATION; ANIMALS; ORIGIN	Goat mtDNA haplogroup A is a poorly resolved lineage absorbing most of the overall diversity and is found in locations as distant as Eastern Asia and Southern Africa. Its phylogenetic dissection would cast light on an important portion of the spread of goat breeding. The aims of this work were 1) to provide an operational definition of meaningful mtDNA units within haplogroup A, 2) to investigate the mechanisms underlying the maintenance of diversity by considering the modes of selection operated by breeders and 3) to identify the peculiarities of Sardinian mtDNA types. We sequenced the mtDNA D-loop in a large sample of animals (1,591) which represents a non-trivial quota of the entire goat population of Sardinia. We found that Sardinia mirrors a large quota of mtDNA diversity of Western Eurasia in the number of variable sites, their mutational pattern and allele frequency. By using Bayesian analysis, a distance-based tree and a network analysis, we recognized demographically coherent groups of sequences identified by particular subsets of the variable positions. The results showed that this assignment system could be reproduced in other studies, capturing the greatest part of haplotype diversity. We identified haplotype groups overrepresented in Sardinian goats as a result of founder effects. We found that breeders maintain diversity of matrilines most likely through equalization of the reproductive potential. Moreover, the relevant amount of inter-farm mtDNA diversity found does not increase proportionally with distance. Our results illustrate the effects of breeding practices on the composition of maternal gene pool and identify mtDNA types that may be considered in projects aimed at retrieving the maternal component of the oldest breeds of Sardinia.	[Piras, Daniela; Doro, Maria Grazia; Casu, Giuseppina; Melis, Paola Maria; Vaccargiu, Simona; Pirastu, Mario] CNR, Inst Populat Genet, Sassari, Italy; [Piras, Ignazio] Shardna Life Sci, Cagliari, Italy; [Parracciani, Debora; Stradoni, Roberta; Frongia, Bruno; Lai, Graziano; Pirastu, Mario] Genet Pk Ogliastra, Perdasdefogu, Italy; [Sale, Salvatore; Cattari, Walter; Piras, Roberto; Querci, Ombretta; Demuro, Piergiorgio; Cui, Sandro; Atzori, Franco; Mancosu, Marco; Marchiori, Francesca; Cammelli, Rossana; Spiga, Alessandra; Loddo, Pier Paolo; Pili, Gianfranco; Boi, Roberto; Argiolas, Giuseppe] Reg Assoc Sardinian Farmers, ARAS, Cagliari, Italy; [Mereu, Paolo] Univ Sassari, Dept Physiol Biochem & Cell Sci, I-07100 Sassari, Italy; [Leoni, Giovanni Giuseppe; Naitana, Salvatore] Univ Sassari, Fac Vet Sci, I-07100 Sassari, Italy; [Novelletto, Andrea] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Sassari; University of Sassari; University of Rome Tor Vergata	Piras, D (corresponding author), CNR, Inst Populat Genet, Sassari, Italy.	novelletto@bio.uniroma2.it	doro, maria grazia/AAX-8971-2020; Mereu, Paolo/AAE-7100-2019	Mereu, Paolo/0000-0001-6615-4828; Novelletto, Andrea/0000-0002-1146-7680; Piras, Ignazio/0000-0003-4024-3368	Sardinia Region (P.O.R. Sardegna); MIUR	Sardinia Region (P.O.R. Sardegna); MIUR(Ministry of Education, Universities and Research (MIUR))	Work supported by Sardinia Region (P.O.R. Sardegna 2000/2006, Asse 3 - Risorse Umane "Progetti di ricerca e innovazione al di sotto della soglia DE MINIMIS") http://www.regione.sardegna.it/regione/programmazione_europea/2000-2006/por/ and PRIN-MIUR 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosti F, 1980, RIV SCI PREISTORICHE, V35, P75; Ajmone-Marsan P, 2002, ANIM GENET, V33, P280, DOI 10.1046/j.1365-2052.2002.00865.x; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Berthouly C, 2009, MOL ECOL, V18, P3980, DOI 10.1111/j.1365-294X.2009.04342.x; Brandano P, 1978, ANN FAC AGR SASSARI, V26, P232; Bruford MW, 2003, NAT REV GENET, V4, P900, DOI 10.1038/nrg1203; Carenti G, 2006, INT J ARCHAEOLOGY, V4, P17; Cetti F, 1774, 1 QUADRUPEDI SARDEGN; Clutton-Brock J, 1999, NATURAL HIST DOMESTI; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Dubeuf JP, 2009, LIVEST SCI, V120, P225, DOI 10.1016/j.livsci.2008.07.005; Ellis N, 2002, GENOME RES, V12, P339; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fernandez H, 2006, P NATL ACAD SCI USA, V103, P15375, DOI 10.1073/pnas.0602753103; Forster P, 1996, AM J HUM GENET, V59, P935; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Galtier N, 2006, GENOME RES, V16, P215, DOI 10.1101/gr.4305906; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hassanin A, 2010, MITOCHONDR DNA, V21, P68, DOI 10.3109/19401736.2010.490583; Hedrick P, 2001, EUR J HUM GENET, V9, P969, DOI 10.1038/sj.ejhg.5200735; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Iamartino D, 2005, SMALL RUMINANT RES, V57, P249, DOI 10.1016/j.smallrumres.2004.08.003; ISTAT, 2000, PLAN 5 AGR CENS IT; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Levine M., 1983, GROTTA FILIESTRU BON; Liu Ruo-Yu, 2006, Acta Genetica Sinica, V33, P420, DOI 10.1016/S0379-4172(06)60069-3; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Luikart G, 2001, P NATL ACAD SCI USA, V98, P5927, DOI 10.1073/pnas.091591198; Malone C, 2003, J WORLD PREHIST, V17, P235, DOI 10.1023/B:JOWO.0000012729.36053.42; Miller M.A., 2010, P GAT COMP ENV WORKS; Mirkena T, 2010, LIVEST SCI, V132, P1, DOI 10.1016/j.livsci.2010.05.003; Naderi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001012; Noe L., 2005, RAZZE CAPRINE ITALIA, P381; Ollivier L, 2002, 53 ANN M EUR ASS AN; Pariset Lorraine, 2009, BMC Ecology, V9, P20, DOI 10.1186/1472-6785-9-20; Pereira F, 2005, MOL ECOL, V14, P2313, DOI 10.1111/j.1365-294X.2005.02594.x; Pereira F, 2009, MOL BIOL EVOL, V26, P2765, DOI 10.1093/molbev/msp200; Rischkowsky B, 2007, STAT WORLDS AN GEN R; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rowley-Conwy P, 2011, CURR ANTHROPOL S, VS4, pS000; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Sechi T, 2007, ANIM GENET, V38, P614, DOI 10.1111/j.1365-2052.2007.01655.x; Sechi T, 2005, ITAL J ANIM SCI, V4, P58; Simianer H, 2005, ECOL ECON, V53, P559, DOI 10.1016/j.ecolecon.2004.11.016; Vacca GM, 2010, J ANIM BREED GENET, V127, P352, DOI 10.1111/j.1439-0388.2010.00863.x; Wang J, 2008, SMALL RUMINANT RES, V74, P231, DOI 10.1016/j.smallrumres.2007.03.007; Wilkens B, 2003, INT J ARCHEOLOGY I 2, V1, P181; Wu YP, 2009, ANIM SCI J, V80, P372, DOI 10.1111/j.1740-0929.2009.00659.x; Yang ZH, 1996, TRENDS ECOL EVOL, V11, P367, DOI 10.1016/0169-5347(96)10041-0	53	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30785	10.1371/journal.pone.0030785	http://dx.doi.org/10.1371/journal.pone.0030785			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363488	gold, Green Submitted, Green Published			2022-12-27	WOS:000302853600068
J	Prole, DL; Marrion, NV				Prole, David L.; Marrion, Neil V.			Identification of Putative Potassium Channel Homologues in Pathogenic Protozoa	PLOS ONE			English	Article							K-ATP CHANNELS; PLASMODIUM-FALCIPARUM; ION CHANNELS; GENOME SEQUENCE; PHYLOGENETIC ANALYSES; SIGNATURE SEQUENCE; CRYSTAL-STRUCTURES; ADENYLYL-CYCLASE; VOLTAGE SENSOR; D-TUBOCURARINE	K+ channels play a vital homeostatic role in cells and abnormal activity of these channels can dramatically alter cell function and survival, suggesting that they might be attractive drug targets in pathogenic organisms. Pathogenic protozoa lead to diseases such as malaria, leishmaniasis, trypanosomiasis and dysentery that are responsible for millions of deaths each year worldwide. The genomes of many protozoan parasites have recently been sequenced, allowing rational design of targeted therapies. We analyzed the genomes of pathogenic protozoa and show the existence within them of genes encoding putative homologues of K+ channels. These protozoan K+ channel homologues represent novel targets for anti-parasitic drugs. Differences in the sequences and diversity of human and parasite proteins may allow pathogen-specific targeting of these K+ channel homologues.	[Prole, David L.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England; [Marrion, Neil V.] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England	University of Cambridge; University of Bristol	Prole, DL (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.	dp350@cam.ac.uk		Prole, David/0000-0003-2782-6665	St. John's College, Cambridge	St. John's College, Cambridge	This work was funded by a Meres Senior Research Associateship from St. John's College, Cambridge (to DLP). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Adamczak R, 2005, PROTEINS, V59, P467, DOI 10.1002/prot.20441; Ahmed A, 1999, CELL, V99, P283, DOI 10.1016/S0092-8674(00)81659-1; Aittoniemi J, 2009, PHILOS T R SOC B, V364, P257, DOI 10.1098/rstb.2008.0142; Akrouh A, 2009, IUBMB LIFE, V61, P971, DOI 10.1002/iub.246; Allen RJW, 2004, J BIOL CHEM, V279, P11264, DOI 10.1074/jbc.M311110200; Aurrecoechea C, 2007, NUCLEIC ACIDS RES, V35, pD427, DOI 10.1093/nar/gkl880; Bankier AT, 2003, GENOME RES, V13, P1787, DOI 10.1101/gr.1555203; Bao L, 2011, AM J PHYSIOL-HEART C, V300, pH262, DOI 10.1152/ajpheart.00857.2010; Bernal RM, 1998, PARASITOL RES, V84, P687, DOI 10.1007/s004360050471; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Billker O, 2009, CELL HOST MICROBE, V5, P612, DOI 10.1016/j.chom.2009.05.017; Brayton KA, 2007, PLOS PATHOG, V3, P1401, DOI 10.1371/journal.ppat.0030148; Burg ED, 2006, J MEMBRANE BIOL, V209, P3, DOI 10.1007/s00232-005-0838-4; Campomanes CR, 2002, J BIOL CHEM, V277, P8298, DOI 10.1074/jbc.M110276200; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Castillo E, 2010, CURR MED CHEM, V17, P4027, DOI 10.2174/092986710793205345; Chapman M, 2006, PFLUG ARCH EUR J PHY, V451, P776, DOI 10.1007/s00424-005-1515-2; Chatelain FC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007496; Chen Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019257; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P319, DOI 10.1038/nsmb1070; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cui J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000782; Czuczwar P, 2010, PHARMACOL REP, V62, P211, DOI 10.1016/S1734-1140(10)70260-7; de Boer TP, 2010, BRIT J PHARMACOL, V159, P1532, DOI 10.1111/j.1476-5381.2010.00658.x; Decher N, 2010, EMBO J, V29, P2101, DOI 10.1038/emboj.2010.88; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Devulder J, 2010, CNS DRUGS, V24, P867, DOI 10.2165/11536230-000000000-00000; DUNN MJ, 1969, J CLIN INVEST, V48, P674, DOI 10.1172/JCI106025; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; Ellekvist P, 2004, BIOCHEM BIOPH RES CO, V318, P477, DOI 10.1016/j.bbrc.2004.04.049; Ellekvist P, 2008, P NATL ACAD SCI USA, V105, P6398, DOI 10.1073/pnas.0802384105; EVANS SG, 1993, BIOCHEM PHARMACOL, V45, P1168, DOI 10.1016/0006-2952(93)90264-W; Fairman C, 1999, J MEMBRANE BIOL, V168, P149, DOI 10.1007/s002329900505; Flynn GE, 2007, STRUCTURE, V15, P671, DOI 10.1016/j.str.2007.04.008; Foley M, 1998, PHARMACOL THERAPEUT, V79, P55, DOI 10.1016/S0163-7258(98)00012-6; Franzen O, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000560; Gajdanowicz P, 2011, P NATL ACAD SCI USA, V108, P864, DOI 10.1073/pnas.1009777108; Gardner MJ, 2002, NATURE, V419, P531, DOI 10.1038/nature01094; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Geng XH, 2003, DIABETES, V52, P767, DOI 10.2337/diabetes.52.3.767; GINSBURG H, 1986, Z PARASITENKD, V72, P185, DOI 10.1007/BF00931146; GLASER TA, 1992, MOL BIOCHEM PARASIT, V51, P9, DOI 10.1016/0166-6851(92)90195-P; Gobert A, 2007, P NATL ACAD SCI USA, V104, P10726, DOI 10.1073/pnas.0702595104; Goldstein SAN, 1998, J MOL MED-JMM, V76, P13, DOI 10.1007/s109-1998-8100-0; Haug T, 2004, J GEN PHYSIOL, V124, P173, DOI 10.1085/jgp.200308949; Haynes WJ, 2003, EUKARYOT CELL, V2, P737, DOI 10.1128/EC.2.4.737-745.2003; HEGINBOTHAM L, 1992, NEURON, V8, P483, DOI 10.1016/0896-6273(92)90276-J; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hille B., 1992, IONIC CHANNELS EXCIT; Hirsch RE, 1998, SCIENCE, V280, P918, DOI 10.1126/science.280.5365.918; Isayenkov S, 2011, PLANT CELL, V23, P756, DOI 10.1105/tpc.110.081463; Ishii TM, 1997, J BIOL CHEM, V272, P23195, DOI 10.1074/jbc.272.37.23195; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jarmuszkiewicz W, 2010, FEBS LETT, V584, P2057, DOI 10.1016/j.febslet.2010.01.023; Jerlstrom-Hultqvist J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-543; Jimenez V, 2011, J CELL BIOCHEM, V112, P1093, DOI 10.1002/jcb.23023; Kelly ML, 2005, PANCREATOLOGY, V5, P443, DOI 10.1159/000086556; KETCHUM KA, 1995, NATURE, V376, P690, DOI 10.1038/376690a0; Khawaled R, 1999, PFLUG ARCH EUR J PHY, V438, P314, DOI 10.1007/s004240050915; KIRSCH GE, 1993, NEURON, V11, P503, DOI 10.1016/0896-6273(93)90154-J; KIRSCH GE, 1995, BIOPHYS J, V68, P1804, DOI 10.1016/S0006-3495(95)80357-7; Kuo MMC, 2005, FEMS MICROBIOL REV, V29, P961, DOI 10.1016/j.femsre.2005.03.003; Kuo MMC, 2003, EMBO J, V22, P4049, DOI 10.1093/emboj/cdg409; Lamy C, 2010, J BIOL CHEM, V285, P27067, DOI 10.1074/jbc.M110.110072; Latorre R, 2003, J GEN PHYSIOL, V122, P459, DOI 10.1085/jgp.200308818; Laurentino EC, 2004, MOL BIOCHEM PARASIT, V137, P81, DOI 10.1016/j.molbiopara.2004.05.001; LEE P, 1988, AM J TROP MED HYG, V39, P157, DOI 10.4269/ajtmh.1988.39.157; Lee US, 2010, TRENDS NEUROSCI, V33, P415, DOI 10.1016/j.tins.2010.06.004; Leung YM, 2010, LIFE SCI, V86, P775, DOI 10.1016/j.lfs.2010.04.004; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Lorenzi H, 2008, ANNOTATION TOXOPLASM; Loukin SH, 2005, J GEN PHYSIOL, V125, P521, DOI 10.1085/jgp.200509261; MACKINNON R, 1990, SCIENCE, V250, P276, DOI 10.1126/science.2218530; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; Madeja M, 2010, J BIOL CHEM, V285, P33898, DOI 10.1074/jbc.M110.159897; Makioka A, 2002, PARASITOL RES, V88, P454, DOI 10.1007/s00436-002-0601-z; Mangubat EZ, 2003, J MOL MICROB BIOTECH, V5, P216, DOI 10.1159/000071073; Mannikko R, 2002, NATURE, V419, P837, DOI 10.1038/nature01038; Martin RJ, 2011, EXP PARASIT IN PRESS; MATSUMOTO Y, 1987, EUR J CELL BIOL, V45, P36; MAZUMDER S, 1992, J BIOL CHEM, V267, P18440; MAZZANTI M, 1990, NATURE, V343, P764, DOI 10.1038/343764a0; McArthur AG, 2000, FEMS MICROBIOL LETT, V189, P271, DOI 10.1111/j.1574-6968.2000.tb09242.x; Meera P, 1997, P NATL ACAD SCI USA, V94, P14066, DOI 10.1073/pnas.94.25.14066; MILLER C, 2000, GENOME BIOL, V1, P4; Mitcheson John, 2005, V266, P136; Monzote Lianet, 2011, Open Med Chem J, V5, P1, DOI 10.2174/1874104501105010001; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Muhia DK, 2003, J BIOL CHEM, V278, P22014, DOI 10.1074/jbc.M301639200; Nagamune K, 2006, MOL BIOL EVOL, V23, P1613, DOI 10.1093/molbev/msl026; Nagamune Kisaburo, 2008, V47, P70; Ng KE, 2010, J MEMBRANE BIOL, V234, P137, DOI 10.1007/s00232-010-9241-x; Nolan DP, 2000, EUR J BIOCHEM, V267, P4615, DOI 10.1046/j.1432-1327.2000.01477.x; Ono T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000008; OVERMAN RB, 1948, AM J PHYSIOL, V152, P113, DOI 10.1152/ajplegacy.1947.152.1.113; Pau VPT, 2011, P NATL ACAD SCI USA, V108, P17684, DOI 10.1073/pnas.1107229108; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Petersen I, 2011, FEBS LETT, V585, P1551, DOI 10.1016/j.febslet.2011.04.042; Pezzella N, 1997, EUR J CELL BIOL, V74, P92; Pongs O, 2010, PHYSIOL REV, V90, P755, DOI 10.1152/physrev.00020.2009; Prole DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026218; Quesada I, 2002, P NATL ACAD SCI USA, V99, P9544, DOI 10.1073/pnas.142039299; Remillard CV, 2004, AM J PHYSIOL-LUNG C, V286, pL49, DOI 10.1152/ajplung.00041.2003; Roberts SK, 2003, EUKARYOT CELL, V2, P181, DOI 10.1128/EC.2.1.181-190.2003; Rodrigo GC, 2005, CURR PHARM DESIGN, V11, P1915, DOI 10.2174/1381612054021015; Rodriguez-Menchaca AA, 2008, P NATL ACAD SCI USA, V105, P1364, DOI 10.1073/pnas.0708153105; ROJAS MO, 1995, J BIOCHEM, V118, P1118, DOI 10.1093/oxfordjournals.jbchem.a124996; Rossokhin A, 2006, MOL PHARMACOL, V69, P1356, DOI 10.1124/mol.105.017970; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Sanguinetti Michael C., 2005, V266, P159; SCHACHTMAN DP, 1992, SCIENCE, V258, P1654, DOI 10.1126/science.8966547; SCHULTZ JE, 1992, SCIENCE, V255, P600, DOI 10.1126/science.1371017; Schumacher MA, 2004, STRUCTURE, V12, P849, DOI 10.1016/S0969-2126(04)00112-1; Serrano-Martin X, 2006, ANTIMICROB AGENTS CH, V50, P4214, DOI 10.1128/AAC.00617-06; Serrano-Martin X, 2009, ANTIMICROB AGENTS CH, V53, P1403, DOI 10.1128/AAC.01215-08; Sesti F, 2003, NAT NEUROSCI, V6, P353, DOI 10.1038/nn1028; Shealy RT, 2003, BIOPHYS J, V84, P2929, DOI 10.1016/S0006-3495(03)70020-4; So I, 2001, J PHYSIOL-LONDON, V531, P37, DOI 10.1111/j.1469-7793.2001.0037j.x; Song Hyun-Ouk, 2004, Korean Journal of Parasitology, V42, P185, DOI 10.3347/kjp.2004.42.4.185; Szewczyk A, 2009, IUBMB LIFE, V61, P134, DOI 10.1002/iub.155; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Waller KL, 2008, EXP PARASITOL, V120, P280, DOI 10.1016/j.exppara.2008.07.010; Waller KL, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-19; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; WARD JM, 1994, PLANT CELL, V6, P669; Ward JM, 2009, ANNU REV PHYSIOL, V71, P59, DOI 10.1146/annurev.physiol.010908.163204; Weatherall KL, 2011, P NATL ACAD SCI USA, V108, P18494, DOI 10.1073/pnas.1110724108; Weatherall KL, 2010, PROG NEUROBIOL, V91, P242, DOI 10.1016/j.pneurobio.2010.03.002; Weber JH, 2004, CELL SIGNAL, V16, P115, DOI 10.1016/S0898-6568(03)00129-3; Wiser MF, 2011, PROTOZOA AND HUMAN DISEASE, P1; Wu YK, 2010, NATURE, V466, P393, DOI 10.1038/nature09252; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977; YAKUBU MA, 1994, MOL BIOCHEM PARASIT, V66, P119, DOI 10.1016/0166-6851(94)90042-6; Yamashita M, 2006, FEBS J, V273, P3585, DOI 10.1111/j.1742-4658.2006.05365.x; Yang H, 2007, P NATL ACAD SCI USA, V104, P18270, DOI 10.1073/pnas.0705873104; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Yusifov T, 2008, P NATL ACAD SCI USA, V105, P376, DOI 10.1073/pnas.0705261105; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhou L, 2007, STRUCTURE, V15, P655, DOI 10.1016/j.str.2007.04.012; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zhou Y, 2010, J GEN PHYSIOL, V135, P481, DOI 10.1085/jgp.201010403	149	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32264	10.1371/journal.pone.0032264	http://dx.doi.org/10.1371/journal.pone.0032264			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363819	gold, Green Submitted, Green Published			2022-12-27	WOS:000302873700160
J	Moen, GK; Stoen, OG; Sahlen, V; Swenson, JE				Moen, Gro Kvelprud; Stoen, Ole-Gunnar; Sahlen, Veronica; Swenson, Jon E.			Behaviour of Solitary Adult Scandinavian Brown Bears (Ursus arctos) when Approached by Humans on Foot	PLOS ONE			English	Article							ESTIMATING POPULATION-SIZE; HUMAN DISTURBANCE; NATIONAL-PARK; LARGE CARNIVORES; HUMAN ATTITUDES; RESPONSES; HABITAT; PREDATORS; PATTERNS; RISK	Successful management has brought the Scandinavian brown bear (Ursus arctos L.) back from the brink of extinction, but as the population grows and expands the probability of bear-human encounters increases. More people express concerns about spending time in the forest, because of the possibility of encountering bears, and acceptance for the bear is decreasing. In this context, reliable information about the bear's normal behaviour during bear-human encounters is important. Here we describe the behaviour of brown bears when encountering humans on foot. During 2006-2009, we approached 30 adult (21 females, 9 males) GPS-collared bears 169 times during midday, using 1-minute positioning before, during and after the approach. Observer movements were registered with a handheld GPS. The approaches started 869 +/- 348 m from the bears, with the wind towards the bear when passing it at approximately 50 m. The bears were detected in 15% of the approaches, and none of the bears displayed any aggressive behaviour. Most bears (80%) left the initial site during the approach, going away from the observers, whereas some remained at the initial site after being approached (20%). Young bears left more often than older bears, possibly due to differences in experience, but the difference between ages decreased during the berry season compared to the pre-berry season. The flight initiation distance was longer for active bears (115 +/- 94 m) than passive bears (69 +/- 47 m), and was further affected by horizontal vegetation cover and the bear's age. Our findings show that bears try to avoid confrontations with humans on foot, and support the conclusions of earlier studies that the Scandinavian brown bear is normally not aggressive during encounters with humans.	[Moen, Gro Kvelprud; Stoen, Ole-Gunnar; Sahlen, Veronica; Swenson, Jon E.] Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, As, Norway; [Stoen, Ole-Gunnar] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden; [Swenson, Jon E.] Norwegian Inst Nat Res, N-7004 Trondheim, Norway	Norwegian University of Life Sciences; Swedish University of Agricultural Sciences; Norwegian Institute Nature Research	Moen, GK (corresponding author), Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, As, Norway.	ole.stoen@umb.no	Swenson, Jon/AAE-2890-2019; Swenson, Jon/E-2883-2013; Støen, Ole-Gunnar/AAY-6457-2020	Chiaradia, Andre/0000-0002-6178-4211	Swedish Environmental Protection Agency; Norwegian Directorate for Nature Management; Swedish Association for Hunting and Wildlife Management, WWF Sweden; Research Council of Norway; research program "Adaptive Management of Fish and Wildlife'	Swedish Environmental Protection Agency; Norwegian Directorate for Nature Management; Swedish Association for Hunting and Wildlife Management, WWF Sweden; Research Council of Norway(Research Council of Norway); research program "Adaptive Management of Fish and Wildlife'	The Scandinavian Brown Bear Research Project is funded by the Swedish Environmental Protection Agency, the Norwegian Directorate for Nature Management, the Swedish Association for Hunting and Wildlife Management, WWF Sweden and the Research Council of Norway. This study received additional financial support from the research program "Adaptive Management of Fish and Wildlife'' and the Norwegian Directorate for Nature Management. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALBERT DM, 1991, WILDLIFE SOC B, V19, P339; ALTMANN MARGARET, 1958, JOUR WILDLIFE MANAGEMENT, V22, P207, DOI 10.2307/3797334; Apps CD, 2004, J WILDLIFE MANAGE, V68, P138, DOI 10.2193/0022-541X(2004)068[0138:EGBDAA]2.0.CO;2; Arnemo JM, 2006, WILDLIFE BIOL, V12, P109, DOI 10.2981/0909-6396(2006)12[109:ROCMIL]2.0.CO;2; Beale C. M., 2007, INT J COMP PSYCHOL, V20, P111; Bellemain E, 2005, CONSERV BIOL, V19, P150, DOI 10.1111/j.1523-1739.2005.00549.x; Bischof R, 2008, J WILDLIFE MANAGE, V72, P79, DOI 10.2193/2007-149; BURGER J, 1981, BIOL CONSERV, V21, P231, DOI 10.1016/0006-3207(81)90092-6; Clark JD, 2002, URSUS, V13, P335; Cooper WE, 2008, ANIM BEHAV, V76, P1365, DOI 10.1016/j.anbehav.2008.03.029; Dahle B, 2003, J ZOOL, V260, P329, DOI 10.1017/S0952836903003753; Dahle B, 2006, J MAMMAL, V87, P859, DOI 10.1644/05-MAMM-A-352R1.1; De Giorgio F, 2007, FORENSIC SCI INT, V173, P64, DOI 10.1016/j.forsciint.2006.08.026; ELGMORK K, 1978, BIOL CONSERV, V13, P81, DOI 10.1016/0006-3207(78)90063-0; Ericsson G, 2009, 20091 I VILT  FISK M, P55; ESRI Inc, 1999, ESRI ARCVIEW 9 2; Frid A, 2002, CONSERV ECOL, V6; Gander H, 1997, BIOL CONSERV, V79, P107, DOI 10.1016/S0006-3207(96)00102-4; Gibeau ML, 2002, BIOL CONSERV, V103, P227, DOI 10.1016/S0006-3207(01)00131-8; Giese M, 1996, BIOL CONSERV, V75, P157, DOI 10.1016/0006-3207(95)00060-7; Gill JA, 2001, BIOL CONSERV, V97, P265, DOI 10.1016/S0006-3207(00)00002-1; Gurung B, 2008, BIOL CONSERV, V141, P3069, DOI 10.1016/j.biocon.2008.09.013; Holmern T, 2007, BIOL CONSERV, V135, P518, DOI 10.1016/j.biocon.2006.10.049; Karlsson J, 2007, CAN J ZOOL, V85, P1193, DOI 10.1139/Z07-099; Karlsson J, 2007, BIOL CONSERV, V137, P610, DOI 10.1016/j.biocon.2007.03.023; Kindberg J, 2011, WILDLIFE BIOL, V17, P114, DOI 10.2981/10-100; Kitchen AM, 2000, CAN J ZOOL, V78, P853, DOI 10.1139/cjz-78-5-853; Loehr J, 2005, CAN J ZOOL, V83, P1602, DOI 10.1139/Z05-162; LONNBERG E, 1923, SVERIGES JAKTBARA DJ; MACARTHUR RA, 1982, J WILDLIFE MANAGE, V46, P351, DOI 10.2307/3808646; Matson G., 1993, LAB MANUAL CEMENTUM; MCLELLAN BN, 1989, WILDLIFE SOC B, V17, P269; Moe TF, 2007, CAN J ZOOL, V85, P518, DOI 10.1139/Z07-034; Montgomery DC., 2019, INTRO STAT QUALITY C; Myrberget S, 1978, NATUREN, V5, P219; Nellemann C, 2003, BIOL CONSERV, V113, P307, DOI 10.1016/S0006-3207(03)00048-X; Nellemann C, 2007, BIOL CONSERV, V138, P157, DOI 10.1016/j.biocon.2007.04.011; Olson TL, 1997, BIOL CONSERV, V82, P95, DOI 10.1016/S0006-3207(96)00151-6; Ordiz A, 2011, OECOLOGIA, V166, P59, DOI 10.1007/s00442-011-1920-5; Ordiz A, 2009, URSUS, V20, P109, DOI 10.2192/08SC031.1; Packer C, 2005, NATURE, V436, P927, DOI 10.1038/436927a; Papouchis CM, 2001, J WILDLIFE MANAGE, V65, P573, DOI 10.2307/3803110; PULLIAINEN E, 1972, Annales Zoologici Fennici, V9, P199; R Core Team, 2020, R LANG ENV STAT COMP; Roskaft E, 2003, EVOL HUM BEHAV, V24, P184, DOI 10.1016/S1090-5138(03)00011-4; Roskaft E, 2007, WILDLIFE BIOL, V13, P172, DOI 10.2981/0909-6396(2007)13[172:HATLCI]2.0.CO;2; Schleyer BO, 1984, EFFECTS NONMOTORIZED; Smith TS, 2005, URSUS, V16, P1, DOI 10.2192/1537-6176(2005)016[0001:ABBHAH]2.0.CO;2; Solberg KH, 2006, BIOL CONSERV, V128, P158, DOI 10.1016/j.biocon.2005.09.025; STALMASTER MV, 1978, J WILDLIFE MANAGE, V42, P506, DOI 10.2307/3800811; Stankowich T, 2006, BEHAV ECOL, V17, P246, DOI 10.1093/beheco/arj020; Stankowich T, 2008, BIOL CONSERV, V141, P2159, DOI 10.1016/j.biocon.2008.06.026; Stevens MA, 2003, J ZOOL, V260, P145, DOI 10.1017/S0952836903003583; Sunde P, 1998, WILDLIFE BIOL, V4, P177, DOI 10.2981/wlb.1998.020; SUTHERLAND WJ, 1993, BIOL CONSERV, V63, P61, DOI 10.1016/0006-3207(93)90074-B; Swenson J.E., 1999, BIOSPH CONS, V2, P1; Swenson JE, 1998, URSUS-SERIES, V10, P17; Swenson JE, 1999, CAN J ZOOL, V77, P551, DOI 10.1139/cjz-77-4-551; Swenson JE., 2000, CONV CONS EUR WILDL; Swenson JE, 1995, WILDLIFE BIOL, V1, P11, DOI 10.2981/wlb.1995.005; Swenson Jon E., 1999, Ursus, V11, P157; Tarlow EM, 2007, APPL ANIM BEHAV SCI, V102, P429, DOI 10.1016/j.applanim.2006.05.040; Tobiassen C, 2011, 649 BIOF, V6, P49; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Wauters LA, 1997, BIOL CONSERV, V82, P101, DOI 10.1016/S0006-3207(97)00007-4; Wesslen S, 1996, LAPPLANDSFJALLEN BLA, P172; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8; Zedrosser A, 2006, J MAMMAL, V87, P510, DOI 10.1644/05-MAMM-A-218R1.1	69	34	34	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31699	10.1371/journal.pone.0031699	http://dx.doi.org/10.1371/journal.pone.0031699			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363710	gold, Green Published, Green Submitted			2022-12-27	WOS:000302871500077
J	Atallah, M; Krispin, A; Trahtemberg, U; Ben-Hamron, S; Grau, A; Verbovetski, I; Mevorach, D				Atallah, Mizhir; Krispin, Alon; Trahtemberg, Uriel; Ben-Hamron, Sandrine; Grau, Amir; Verbovetski, Inna; Mevorach, Dror			Constitutive Neutrophil Apoptosis: Regulation by Cell Concentration via S100 A8/9 and the MEK - ERK Pathway	PLOS ONE			English	Article							BONE-MARROW; FAS LIGAND; PHOSPHATIDYLINOSITOL 3-KINASE; DIFFERENTIAL EXPRESSION; RHEUMATOID-ARTHRITIS; GM-CSF; DEATH; SURVIVAL; CYTOKINES; INFLAMMATION	Programmed cell death (PCD) is a fundamental mechanism in tissue and cell homeostasis. It was long suggested that apoptosis regulates the cell number in diverse cell populations; however no clear mechanism was shown. Neutrophils are the short-lived, first-line defense of innate immunity, with an estimated t = 1/2 of 8 hours and a high turnover rate. Here we first show that spontaneous neutrophil constitutive PCD is regulated by cell concentrations. Using a proteomic approach, we identified the S100 A8/9 complex, which constitutes roughly 40% of cytosolic protein in neutrophils, as mediating this effect. We further demonstrate that it regulates cell survival via a signaling mechanism involving MEK-ERK via TLR4 and CD11B/CD18. This mechanism is suggested to have a fine-tuning role in regulating the neutrophil number in bone marrow, peripheral blood, and inflammatory sites.	[Atallah, Mizhir; Krispin, Alon; Trahtemberg, Uriel; Ben-Hamron, Sandrine; Grau, Amir; Verbovetski, Inna; Mevorach, Dror] Hadassah Hebrew Univ, Med Ctr Jerusalem, Rheumatol Res Ctr, Lab Cellular & Mol Immunol,Dept Med, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center	Atallah, M (corresponding author), Hadassah Hebrew Univ, Med Ctr Jerusalem, Rheumatol Res Ctr, Lab Cellular & Mol Immunol,Dept Med, Jerusalem, Israel.	mevorachd@hadassah.org.il	Trahtemberg, Uriel/B-3127-2008	Trahtemberg, Uriel/0000-0001-9103-2494	Hadassah-Hebrew University Medical Center	Hadassah-Hebrew University Medical Center	This research was partially supported by a grant from the Hadassah-Hebrew University Medical Center. No additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altznauer F, 2004, J EXP MED, V199, P1343, DOI 10.1084/jem.20032033; BEGLEY CG, 1986, BLOOD, V68, P162; Brown SB, 1999, J IMMUNOL, V162, P480; Chuang PI, 1998, BIOCHEM BIOPH RES CO, V249, P361, DOI 10.1006/bbrc.1998.9155; COLOTTA F, 1992, BLOOD, V80, P2012; COX G, 1992, AM J RESP CELL MOL, V7, P507, DOI 10.1165/ajrcmb/7.5.507; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; DANCEY JT, 1976, J CLIN INVEST, V58, P705, DOI 10.1172/JCI108517; DRANSFIELD I, 1994, J IMMUNOL, V153, P1254; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; Fecho K, 1998, J LEUKOCYTE BIOL, V64, P373, DOI 10.1002/jlb.64.3.373; Francois S, 2005, J IMMUNOL, V174, P3633, DOI 10.4049/jimmunol.174.6.3633; Frosch M, 2000, ARTHRITIS RHEUM-US, V43, P628, DOI 10.1002/1529-0131(200003)43:3<628::AID-ANR20>3.0.CO;2-X; Furze RC, 2008, FASEB J, V22, P3111, DOI 10.1096/fj.08-109876; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; IWAI K, 1994, BLOOD, V84, P1201; JOYCE RA, 1976, J LAB CLIN MED, V88, P614; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kerkhoff C, 2001, BIOCHEMISTRY-US, V40, P241, DOI 10.1021/bi001791k; Kobayashi SD, 2003, MICROBES INFECT, V5, P1337, DOI 10.1016/j.micinf.2003.09.013; Kotone-Miyahara Y, 2004, J LEUKOCYTE BIOL, V76, P1047, DOI 10.1189/jlb.0104048; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Krispin A, 2006, BLOOD, V108, P3580, DOI 10.1182/blood-2006-03-013334; LEE A, 1993, J LEUKOCYTE BIOL, V54, P283, DOI 10.1002/jlb.54.4.283; Liles WC, 1996, J EXP MED, V184, P429, DOI 10.1084/jem.184.2.429; LOPEZ AF, 1986, J CLIN INVEST, V78, P1220, DOI 10.1172/JCI112705; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Manitz MP, 2003, MOL CELL BIOL, V23, P1034, DOI 10.1128/MCB.23.3.1034-1043.2003; Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2; Mayadas TN, 2005, TRENDS IMMUNOL, V26, P388, DOI 10.1016/j.it.2005.05.002; Metcalf D, 2008, BLOOD, V111, P485, DOI 10.1182/blood-2007-03-079681; Moulding DA, 1998, BLOOD, V92, P2495, DOI 10.1182/blood.V92.7.2495.2495_2495_2502; Moulding DA, 2001, J LEUKOCYTE BIOL, V70, P783; Nacken W, 2003, MICROSC RES TECHNIQ, V60, P569, DOI 10.1002/jemt.10299; Newton RA, 1998, J IMMUNOL, V160, P1427; ODINK K, 1987, NATURE, V330, P80, DOI 10.1038/330080a0; Passey RJ, 1999, J IMMUNOL, V163, P2209; Petrin D, 2006, CELL SIGNAL, V18, P479, DOI 10.1016/j.cellsig.2005.05.021; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Ryckman C, 2004, J LEUKOCYTE BIOL, V76, P433, DOI 10.1189/jlb.0603294; Santos-Beneit AM, 2000, J LEUKOCYTE BIOL, V67, P712, DOI 10.1002/jlb.67.5.712; SASAKI K, 1995, ACTA ANAT, V153, P111; Shi JL, 2001, BLOOD, V98, P1226, DOI 10.1182/blood.V98.4.1226; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Trahtemberg U, 2007, APOPTOSIS, V12, P1769, DOI 10.1007/s10495-007-0097-1; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Watson RWG, 1997, J IMMUNOL, V158, P945; Weinmann P, 1999, BLOOD, V93, P3106; Weinmann P, 2003, BLOOD, V101, P739, DOI 10.1182/blood-2002-01-0239	50	30	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e29333	10.1371/journal.pone.0029333	http://dx.doi.org/10.1371/journal.pone.0029333			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363402	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600006
J	Malek, AA; Wargo, MJ; Hogan, DA				Malek, Adel A.; Wargo, Matthew J.; Hogan, Deborah A.			Absence of Membrane Phosphatidylcholine Does Not Affect Virulence and Stress Tolerance Phenotypes in the Opportunistic Pathogen Pseudomonas aeruginosa	PLOS ONE			English	Article							CYSTIC-FIBROSIS; PHOSPHOLIPASE-C; SYNTHESIZES PHOSPHATIDYLCHOLINE; SIGNAL-TRANSDUCTION; BIOFILM DEVELOPMENT; BRUCELLA-ABORTUS; BIOSYNTHESIS; BACTERIA; HOST; RESISTANCE	During growth in presence of choline, both laboratory and clinical Pseudomonas aeruginosa strains synthesize phosphatidylcholine (PC), and PC makes up similar to 4% of the total membrane phospholipid content. In all the strains tested, PC synthesis occurred only when choline is provided exogenously. Mutants defective in synthesis of PC were generated in the strain backgrounds PAO1 and PA14. Minimum inhibitory concentration studies testing sensitivity of PC-deficient strains towards various antibiotics and cationic antimicrobial peptides revealed no differences as compared to wild-type strains. Mutants incapable of synthesizing PC were also found to be unaffected in motility and biofilm formation on abiotic surfaces, colonization of biotic surfaces and virulence in a mouse infection model. A global phenotypic microarray was further used to identify conditions wherein membrane PC may play a role of in P. aeruginosa. No culture conditions were identified wherein wild-type and PC-deficient mutants showed phenotypic differences. Membrane PC may serve a highly specific role during P. aeruginosa interactions with its eukaryotic hosts based on all the clinical strains tested retaining the ability to synthesize it during availability of choline.	[Malek, Adel A.; Hogan, Deborah A.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Microbiol & Immunol, Hanover, NH 03756 USA; [Wargo, Matthew J.] Univ Vermont, Coll Med, Dept Microbiol & Mol Genet, Burlington, VT USA	Dartmouth College; University of Vermont	Malek, AA (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Microbiol & Immunol, Hanover, NH 03756 USA.	dhogan@dartmouth.edu	Malek, Adel/ABF-9944-2021	Hogan, Deborah A./0000-0002-6366-2971; Wargo, Matthew/0000-0001-5659-749X	National Institutes of Health from the National Center for Research Resources [P20-RR018787]; National Institutes of Health [RO1-AI091702]; NCRR [P20-RR021905]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018787, P20RR021905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103496] Funding Source: NIH RePORTER	National Institutes of Health from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants P20-RR018787 from the IDeA Program of the National Center for Research Resources (to D. A. H.), RO1-AI091702 (to D. A. H.) and NCRR P20-RR021905 (to M.J.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas M, 2010, EUR J CELL BIOL, V89, P888, DOI 10.1016/j.ejcb.2010.06.013; Anderson GG, 2008, INFECT IMMUN, V76, P1423, DOI 10.1128/IAI.01373-07; Baysse C, 2005, MICROBIOL-SGM, V151, P2529, DOI 10.1099/mic.0.28185-0; Bochner BR, 2009, FEMS MICROBIOL REV, V33, P191, DOI 10.1111/j.1574-6976.2008.00149.x; Bogdanov Mikhail, 2008, V49, P197, DOI 10.1007/978-1-4020-8831-5_8; Bragonzi A, 2006, MICROBIOL-SGM, V152, P3261, DOI 10.1099/mic.0.29175-0; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Comerci DJ, 2006, J BACTERIOL, V188, P1929, DOI 10.1128/JB.188.5.1929-1934.2006; Conde-Alvarez R, 2006, CELL MICROBIOL, V8, P1322, DOI 10.1111/j.1462-5822.2006.00712.x; Conover GM, 2008, CELL MICROBIOL, V10, P514, DOI 10.1111/j.1462-5822.2007.01066.x; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; D'Argenio DA, 2007, MOL MICROBIOL, V64, P512, DOI 10.1111/j.1365-2958.2007.05678.x; de Rudder KEE, 1999, J BIOL CHEM, V274, P20011, DOI 10.1074/jbc.274.28.20011; de Rudder KEE, 2000, MOL MICROBIOL, V37, P763, DOI 10.1046/j.1365-2958.2000.02032.x; Exton JH, 1997, PHYSIOL REV, V77, P303, DOI 10.1152/physrev.1997.77.2.303; EXTON JH, 1994, BBA-LIPID LIPID MET, V1212, P26, DOI 10.1016/0005-2760(94)90186-4; FOLCH J, 1957, J BIOL CHEM, V226, P497; Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004; Hamilton A, 2006, INFECT IMMUN, V74, P6179, DOI 10.1128/IAI.00895-06; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Hauser AR, 2002, CRIT CARE MED, V30, P521, DOI 10.1097/00003246-200203000-00005; Henry SA, 1998, PROG NUCLEIC ACID RE, V61, P133, DOI 10.1016/S0079-6603(08)60826-0; Hogan DA, 2002, SCIENCE, V296, P2229, DOI 10.1126/science.1070784; HOLLSING AE, 1987, J CLIN MICROBIOL, V25, P1868, DOI 10.1128/JCM.25.10.1868-1874.1987; Jain M, 2004, J CLIN MICROBIOL, V42, P5229, DOI 10.1128/JCM.42.11.5229-5237.2004; Kang PJ, 1997, MOL MICROBIOL, V24, P1249; Kida Y, 2011, INFECT IMMUN, V79, P211, DOI 10.1128/IAI.01053-10; Klein S, 2009, MOL MICROBIOL, V71, P551, DOI 10.1111/j.1365-2958.2008.06562.x; Klusener S, 2009, J BACTERIOL, V191, P365, DOI 10.1128/JB.01183-08; KURIOKA S, 1976, ANAL BIOCHEM, V75, P281, DOI 10.1016/0003-2697(76)90078-6; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Lysenko ES, 2000, INFECT IMMUN, V68, P1664, DOI 10.1128/IAI.68.3.1664-1671.2000; MAHENTHIRALINGAM E, 1994, INFECT IMMUN, V62, P596, DOI 10.1128/IAI.62.2.596-605.1994; Martinez-Morales F, 2003, MICROBIOL-SGM, V149, P3461, DOI 10.1099/mic.0.26522-0; Minder AC, 2001, MOL MICROBIOL, V39, P1186, DOI 10.1111/j.1365-2958.2001.02325.x; Miyata S, 2003, INFECT IMMUN, V71, P2404, DOI 10.1128/IAI.71.5.2404-2413.2003; Moreau-Marquis S., 2010, J VIS EXP; Murad AMA, 2001, EMBO J, V20, P4742, DOI 10.1093/emboj/20.17.4742; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; O'Toole GA, 2000, J BACTERIOL, V182, P425, DOI 10.1128/JB.182.2.425-431.2000; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; SCHWEIZER HP, 1991, GENE, V97, P109, DOI 10.1016/0378-1119(91)90016-5; SCHWEIZER HP, 1993, BIOTECHNIQUES, V15, P831; SHORTRIDGE VD, 1992, MOL MICROBIOL, V6, P863, DOI 10.1111/j.1365-2958.1992.tb01537.x; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; VANCE DE, 1988, PROG LIPID RES, V27, P61, DOI 10.1016/0163-7827(88)90005-7; Wargo MJ, 2011, AM J RESP CRIT CARE, V184, P345, DOI 10.1164/rccm.201103-0374OC; Wargo MJ, 2009, INFECT IMMUN, V77, P1103, DOI 10.1128/IAI.01008-08; Wessel M, 2006, MOL MICROBIOL, V62, P906, DOI 10.1111/j.1365-2958.2006.05425.x; Wilderman PJ, 2002, J BACTERIOL, V184, P4792, DOI 10.1128/JB.184.17.4792-4799.2002; Willumeit R, 2005, BBA-BIOMEMBRANES, V1669, P125, DOI 10.1016/j.bbamem.2005.01.011; Zhang W, 2005, J BIOL CHEM, V280, P26032, DOI 10.1074/jbc.M504929200	56	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30829	10.1371/journal.pone.0030829	http://dx.doi.org/10.1371/journal.pone.0030829			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363496	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600073
J	Tao, XL; Zheng, DQ; Liu, TZ; Wang, PM; Zhao, WP; Zhu, MY; Jiang, XH; Zhao, YH; Wu, XC				Tao, Xianglin; Zheng, Daoqiong; Liu, Tianzhe; Wang, Pinmei; Zhao, Wenpeng; Zhu, Muyuan; Jiang, Xinhang; Zhao, Yuhua; Wu, Xuechang			A Novel Strategy to Construct Yeast Saccharomyces cerevisiae Strains for Very High Gravity Fermentation	PLOS ONE			English	Article							ETHANOL TOLERANCE; LIPID-COMPOSITION; TREHALOSE METABOLISM; EXPRESSION ANALYSIS; PLASMA-MEMBRANE; ADAPTATION; STRESS; ACID; OPTIMIZATION; ACCUMULATION	Very high gravity (VHG) fermentation is aimed to considerably increase both the fermentation rate and the ethanol concentration, thereby reducing capital costs and the risk of bacterial contamination. This process results in critical issues, such as adverse stress factors (ie., osmotic pressure and ethanol inhibition) and high concentrations of metabolic byproducts which are difficult to overcome by a single breeding method. In the present paper, a novel strategy that combines metabolic engineering and genome shuffling to circumvent these limitations and improve the bioethanol production performance of Saccharomyces cerevisiae strains under VHG conditions was developed. First, in strain Z5, which performed better than other widely used industrial strains, the gene GPD2 encoding glycerol 3-phosphate dehydrogenase was deleted, resulting in a mutant (Z5 Delta GPD2) with a lower glycerol yield and poor ethanol productivity. Second, strain Z5 Delta GPD2 was subjected to three rounds of genome shuffling to improve its VHG fermentation performance, and the best performing strain SZ3-1 was obtained. Results showed that strain SZ3-1 not only produced less glycerol, but also increased the ethanol yield by up to 8% compared with the parent strain Z5. Further analysis suggested that the improved ethanol yield in strain SZ3-1 was mainly contributed by the enhanced ethanol tolerance of the strain. The differences in ethanol tolerance between strains Z5 and SZ3-1 were closely associated with the cell membrane fatty acid compositions and intracellular trehalose concentrations. Finally, genome rearrangements in the optimized strain were confirmed by karyotype analysis. Hence, a combination of genome shuffling and metabolic engineering is an efficient approach for the rapid improvement of yeast strains for desirable industrial phenotypes.	[Tao, Xianglin; Zheng, Daoqiong; Liu, Tianzhe; Wang, Pinmei; Zhao, Wenpeng; Zhu, Muyuan; Jiang, Xinhang; Zhao, Yuhua; Wu, Xuechang] Zhejiang Univ, Inst Microbiol, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Wu, XC (corresponding author), Zhejiang Univ, Inst Microbiol, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	mblab@163.com			State Key Laboratory of Motor Vehicle Biofuel Technology, China	State Key Laboratory of Motor Vehicle Biofuel Technology, China	This work was supported by State Key Laboratory of Motor Vehicle Biofuel Technology, China. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS J, 1992, CURR GENET, V22, P13, DOI 10.1007/BF00351736; AGUDO LD, 1992, APPL MICROBIOL BIOT, V37, P647, DOI 10.1007/BF00240742; Aguilera F, 2006, INT J FOOD MICROBIOL, V110, P34, DOI 10.1016/j.ijfoodmicro.2006.02.002; Argueso JL, 2008, P NATL ACAD SCI USA, V105, P11845, DOI 10.1073/pnas.0804529105; Bai FW, 2008, BIOTECHNOL ADV, V26, P89, DOI 10.1016/j.biotechadv.2007.09.002; Belviso S, 2004, CAN J MICROBIOL, V50, P669, DOI [10.1139/w04-051, 10.1139/W04-051]; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chi Z, 1999, J APPL MICROBIOL, V86, P1047, DOI 10.1046/j.1365-2672.1999.00793.x; Ding JM, 2009, APPL MICROBIOL BIOT, V85, P253, DOI 10.1007/s00253-009-2223-1; Dinh TN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002623; Dong YS, 2007, BIOCHEM ENG J, V37, P226, DOI 10.1016/j.bej.2007.04.004; Fiedurek J, 2011, POL J MICROBIOL, V60, P51, DOI 10.33073/pjm-2011-007; Gibson BR, 2007, FEMS MICROBIOL REV, V31, P535, DOI 10.1111/j.1574-6976.2007.00076.x; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gong JX, 2009, BIOTECHNOL ADV, V27, P996, DOI 10.1016/j.biotechadv.2009.05.016; Graves T, 2007, APPL MICROBIOL BIOT, V73, P1190, DOI 10.1007/s00253-006-0573-5; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hallsworth JE, 1998, J FERMENT BIOENG, V85, P125, DOI 10.1016/S0922-338X(97)86756-6; HOTTIGER T, 1987, J BACTERIOL, V169, P5518, DOI 10.1128/jb.169.12.5518-5522.1987; Hou LH, 2010, APPL BIOCHEM BIOTECH, V160, P1084, DOI 10.1007/s12010-009-8552-9; Hou LH, 2009, BIOTECHNOL LETT, V31, P671, DOI 10.1007/s10529-009-9916-5; Ingledew W.M., 1999, ALCOHOL PRODUCTION S; Jules M, 2004, APPL ENVIRON MICROB, V70, P2771, DOI 10.1128/AEM.70.5.2771-2778.2004; Jules M, 2008, APPL ENVIRON MICROB, V74, P605, DOI 10.1128/AEM.00557-07; Kaino T, 2008, APPL MICROBIOL BIOT, V79, P273, DOI 10.1007/s00253-008-1431-4; Kim HS, 2011, BIOTECHNOL LETT, P1; Lei J, 2007, J BIOTECHNOL, V131, P270, DOI 10.1016/j.jbiotec.2007.07.937; Li LL, 2009, BIOCHEM BIOPH RES CO, V387, P778, DOI 10.1016/j.bbrc.2009.07.113; Liang LK, 2007, APPL MICROBIOL BIOT, V74, P1084, DOI 10.1007/s00253-006-0688-8; Mannazzu I, 2008, INT J FOOD MICROBIOL, V121, P84, DOI 10.1016/j.ijfoodmicro.2007.11.003; Mizoguchi H, 1996, J FERMENT BIOENG, V81, P406, DOI 10.1016/0922-338X(96)85141-5; Mussatto SI, 2010, BIOTECHNOL ADV, V28, P817, DOI 10.1016/j.biotechadv.2010.07.001; Nissen TL, 2000, METAB ENG, V2, P69, DOI 10.1006/mben.1999.0140; Otte B, 2009, APPL ENVIRON MICROB, V75, P7610, DOI 10.1128/AEM.01774-09; Shi DJ, 2009, J IND MICROBIOL BIOT, V36, P139, DOI 10.1007/s10295-008-0481-z; Shobayashi M, 2005, BIOSCI BIOTECH BIOCH, V69, P2381, DOI 10.1271/bbb.69.2381; Tan HD, 2010, INT J MOL SCI, V11, P4962, DOI 10.3390/ijms11124962; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Valadi H, 1998, APPL MICROBIOL BIOT, V50, P434, DOI 10.1007/s002530051317; Vianna CR, 2008, ANTON LEEUW INT J G, V93, P205, DOI 10.1007/s10482-007-9194-y; Wang FQ, 2007, BIOTECHNOL LETT, V29, P233, DOI 10.1007/s10529-006-9220-6; Wu H, 2006, APPL ENVIRON MICROB, V72, P7353, DOI 10.1128/AEM.01097-06; You KM, 2003, APPL ENVIRON MICROB, V69, P1499, DOI 10.1128/AEM.69.3.1499-1503.2003; Zhao XQ, 2009, J BIOTECHNOL, V144, P23, DOI 10.1016/j.jbiotec.2009.05.001; Zheng DQ, 2011, BIORESOURCE TECHNOL, V102, P3020, DOI 10.1016/j.biortech.2010.09.122	45	51	55	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31235	10.1371/journal.pone.0031235	http://dx.doi.org/10.1371/journal.pone.0031235			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363590	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600128
J	Yamaura, Y; Nakajima, M; Takagi, S; Fukami, T; Tsuneyama, K; Yokoi, T				Yamaura, Yu; Nakajima, Miki; Takagi, Shingo; Fukami, Tatsuki; Tsuneyama, Koichi; Yokoi, Tsuyoshi			Plasma MicroRNA Profiles in Rat Models of Hepatocellular Injury, Cholestasis, and Steatosis	PLOS ONE			English	Article							INDUCED LIVER-INJURY; CIRCULATING MICRORNAS; NONALCOHOLIC STEATOHEPATITIS; CANCER-DETECTION; BIOMARKERS; EXPRESSION; DISEASE; SERUM; MECHANISM; ZONATION	MicroRNAs (miRNAs) are small RNA molecules that function to modulate the expression of target genes, playing important roles in a wide range of physiological and pathological processes. The miRNAs in body fluids have received considerable attention as potential biomarkers of various diseases. In this study, we compared the changes of the plasma miRNA expressions by acute liver injury (hepatocellular injury or cholestasis) and chronic liver injury (steatosis, steatohepatitis and fibrosis) using rat models made by the administration of chemicals or special diets. Using miRNA array analysis, we found that the levels of a large number of miRNAs (121-317 miRNAs) were increased over 2-fold and the levels of a small number of miRNAs (6-35 miRNAs) were decreased below 0.5-fold in all models except in a model of cholestasis caused by bile duct ligation. Interestingly, the expression profiles were different between the models, and the hierarchical clustering analysis discriminated between the acute and chronic liver injuries. In addition, miRNAs whose expressions were typically changed in each type of liver injury could be specified. It is notable that, in acute liver injury models, the plasma level of miR-122, the most abundant miRNA in the liver, was more quickly and dramatically increased than the plasma aminotransferase level, reflecting the extent of hepatocellular injury. This study demonstrated that the plasma miRNA profiles could reflect the types of liver injury (e.g. acute/chronic liver injury or hepatocellular injury/cholestasis/steatosis/steatohepatitis/fibrosis) and identified the miRNAs that could be specific and sensitive biomarkers of liver injury.	[Yamaura, Yu; Nakajima, Miki; Takagi, Shingo; Fukami, Tatsuki; Yokoi, Tsuyoshi] Kanazawa Univ, Fac Pharmaceut Sci, Kanazawa, Ishikawa, Japan; [Tsuneyama, Koichi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Sugitani, Toyama, Japan	Kanazawa University; University of Toyama	Yamaura, Y (corresponding author), Kanazawa Univ, Fac Pharmaceut Sci, Kakuma Machi, Kanazawa, Ishikawa, Japan.	tyokoi@kenroku.kanazawa-u.ac.jp	yokoi, tsuyoshi/I-7115-2014; Nakajima, Miki/C-3990-2015; Fukami, Tatsuki/C-8907-2015	Tsuneyama, Koichi/0000-0002-0670-9868; Yokoi, Tsuyoshi/0000-0002-3239-2817; Fukami, Tatsuki/0000-0003-2416-5988	Japan Society for the Promotion of Science [21390174]; Ministry of Health, Labor and Welfare of Japan [H20-BIO-G001]; Grants-in-Aid for Scientific Research [21390174] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-Aid for Scientific Research (B) from Japan Society for the Promotion of Science (21390174) and in part by a Health and Labor Science Research Grant from the Ministry of Health, Labor and Welfare of Japan (H20-BIO-G001). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoine DJ, 2009, XENOBIOTICA, V39, P565, DOI 10.1080/00498250903046993; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENICHOU C, 1990, J HEPATOL, V11, P272; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; DANAN G, 1993, J CLIN EPIDEMIOL, V46, P1323, DOI 10.1016/0895-4356(93)90101-6; DESMET VJ, 1968, AM J PATHOL, V52, P401; Dillhoff M, 2009, J SURG RES, V154, P349, DOI 10.1016/j.jss.2008.02.046; Dolganiuc A, 2009, ALCOHOL CLIN EXP RES, V33, P1704, DOI 10.1111/j.1530-0277.2009.01007.x; GEBHARDT R, 1992, PHARMACOL THERAPEUT, V53, P275, DOI 10.1016/0163-7258(92)90055-5; Hanke M, 2010, UROL ONCOL-SEMIN ORI, V28, P655, DOI 10.1016/j.urolonc.2009.01.027; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Jin X, 2009, DIGEST LIVER DIS, V41, P289, DOI 10.1016/j.dld.2008.08.008; JUNGERMANN K, 1995, HISTOCHEM CELL BIOL, V103, P81, DOI 10.1007/BF01454004; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Li WQ, FEBS J IN PRESS; Michael A, 2010, ORAL DIS, V16, P34, DOI 10.1111/j.1601-0825.2009.01604.x; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Murakami Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016081; Nathwani RA, 2005, HEPATOLOGY, V41, P380, DOI 10.1002/hep.20548; Ozer J, 2008, TOXICOLOGY, V245, P194, DOI 10.1016/j.tox.2007.11.021; Park NJ, 2009, CLIN CANCER RES, V15, P5473, DOI 10.1158/1078-0432.CCR-09-0736; Pogribny IP, 2010, LAB INVEST, V90, P1437, DOI 10.1038/labinvest.2010.113; Reid G., 2010, CRIT REV ON IN PRESS; Shi Q, 2010, EXPERT REV GASTROENT, V4, P225, DOI [10.1586/egh.10.8, 10.1586/EGH.10.8]; Shigehara K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023584; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850	32	71	74	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30250	10.1371/journal.pone.0030250	http://dx.doi.org/10.1371/journal.pone.0030250			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363424	gold, Green Published, Green Submitted			2022-12-27	WOS:000302853600018
J	Glendorf, T; Knudsen, L; Stidsen, CE; Hansen, BF; Hegelund, AC; Sorensen, AR; Nishimura, E; Kjeldsen, T				Glendorf, Tine; Knudsen, Louise; Stidsen, Carsten E.; Hansen, Bo F.; Hegelund, Anne Charlotte; Sorensen, Anders R.; Nishimura, Erica; Kjeldsen, Thomas			Systematic Evaluation of the Metabolic to Mitogenic Potency Ratio for B10-Substituted Insulin Analogues	PLOS ONE			English	Article							GROWTH-FACTOR-I; RECEPTOR-BINDING; MONOCLONAL-ANTIBODIES; SYNTHETIC PEPTIDE; IGF-1 RECEPTOR; LIGAND-BINDING; B-CHAIN; ACTIVATION; AFFINITY; REGIONS	Background: Insulin analogues comprising acidic amino acid substitutions at position B10 have previously been shown to display increased mitogenic potencies compared to human insulin and the underlying molecular mechanisms have been subject to much scrutiny and debate. However, B10 is still an attractive position for amino acid substitutions given its important role in hexamer formation. The aim of this study was to investigate the relationships between the receptor binding properties as well as the metabolic and mitogenic potencies of a series of insulin analogues with different amino acid substitutions at position B10 and to identify a B10-substituted insulin analogue without an increased mitogenic to metabolic potency ratio. Methodology/Principal Findings: A panel of ten singly-substituted B10 insulin analogues with different amino acid side chain characteristics were prepared and insulin receptor (both isoforms) and IGF-I receptor binding affinities using purified receptors, insulin receptor dissociation rates using BHK cells over-expressing the human insulin receptor, metabolic potencies by lipogenesis in isolated rat adipocytes, and mitogenic potencies using two different cell types predominantly expressing either the insulin or the IGF-I receptor were systematically investigated. Only analogues B10D and B10E with significantly increased insulin and IGF-I receptor affinities as well as decreased insulin receptor dissociation rates displayed enhanced mitogenic potencies in both cell types employed. For the remaining analogues with less pronounced changes in receptor affinities and insulin receptor dissociation rates, no apparent correlation between insulin receptor occupancy time and mitogenicity was observed. Conclusions/Significance: Several B10-substituted insulin analogues devoid of disproportionate increases in mitogenic compared to metabolic potencies were identified. In the present study, receptor binding affinity rather than insulin receptor off-rate appears to be the major determinant of both metabolic and mitogenic potency. Our results also suggest that the increased mitogenic potency is attributable to both insulin and IGF-I receptor activation.	[Glendorf, Tine; Stidsen, Carsten E.; Hansen, Bo F.; Hegelund, Anne Charlotte; Sorensen, Anders R.; Nishimura, Erica; Kjeldsen, Thomas] Novo Nordisk AS, Diabet Res Unit, Malov, Denmark; [Knudsen, Louise] Novo Nordisk AS, Diabet Res Unit, DK-2820 Gentofte, Denmark	Novo Nordisk; Novo Nordisk	Glendorf, T (corresponding author), Novo Nordisk AS, Diabet Res Unit, Malov, Denmark.	tgle@novonordisk.com		Kjeldsen, Thomas/0000-0003-0094-9286; Nishimura, Erica/0000-0001-5741-3648	Danish Ministry of Science, Technology and Innovation; Novo Nordisk Training and Research Program; Novo Nordisk A/S	Danish Ministry of Science, Technology and Innovation; Novo Nordisk Training and Research Program; Novo Nordisk A/S(Novo Nordisk)	This work was supported by the Danish Ministry of Science, Technology and Innovation, the Novo Nordisk Training and Research Program, and Novo Nordisk A/S. The commercial funders of the study did have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript as the authors are employed by Novo Nordisk A/S.	Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; ANDERSEN AS, 1990, BIOCHEMISTRY-US, V29, P7363, DOI 10.1021/bi00484a002; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Baudry A, 2001, FEBS LETT, V488, P174, DOI 10.1016/S0014-5793(00)02435-2; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Bennett RG, 2003, J ENDOCRINOL, V177, P399, DOI 10.1677/joe.0.1770399; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; CARROLL RJ, 1988, P NATL ACAD SCI USA, V85, P8943, DOI 10.1073/pnas.85.23.8943; De Meyts P, 2004, BIOESSAYS, V26, P1351, DOI 10.1002/bies.20151; DEMEYTS P, 1994, DIABETOLOGIA, V37, pS135, DOI 10.1007/BF00400837; DEMEYTS P, 1973, BIOCHEM BIOPH RES CO, V55, P154, DOI 10.1016/S0006-291X(73)80072-5; DREJER K, 1991, DIABETES, V40, P1488, DOI 10.2337/diabetes.40.11.1488; DREJER K, 1992, DIABETES METAB REV, V8, P259, DOI 10.1002/dmr.5610080305; Eckardt K, 2007, DIABETOLOGIA, V50, P2534, DOI 10.1007/s00125-007-0815-9; EMDIN SO, 1980, DIABETOLOGIA, V19, P174, DOI 10.1007/BF00275265; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; FUJITAYAMAGUCHI Y, 1983, J BIOL CHEM, V258, P5045; Gauguin L, 2008, J BIOL CHEM, V283, P20821, DOI 10.1074/jbc.M802620200; Glendorf T, 2008, BIOCHEMISTRY-US, V47, P4743, DOI 10.1021/bi800054z; Hamel FG, 1999, METABOLISM, V48, P611, DOI 10.1016/S0026-0495(99)90059-8; Hansen BF, 2008, HORM METAB RES, V40, P431, DOI 10.1055/s-2008-1062740; Hansen BF, 2011, DIABETOLOGIA, V54, P2226, DOI 10.1007/s00125-011-2203-8; Hansen BF, 2010, DIABETOLOGIA, V53, pS22; Hansen BF, 1996, BIOCHEM J, V315, P271; HEINEMANN L, 1990, DIABETOLOGIA, V33, P384, DOI 10.1007/BF00404644; HUMBEL RE, 1990, EUR J BIOCHEM, V190, P445, DOI 10.1111/j.1432-1033.1990.tb15595.x; IshShalom D, 1997, DIABETOLOGIA, V40, pS25, DOI 10.1007/s001250051393; Jensen M, 2008, BIOCHEM J, V412, P435, DOI 10.1042/BJ20080279; Jensen M, 2007, J BIOL CHEM, V282, P35179, DOI 10.1074/jbc.M704599200; Jensen M, 2009, VITAM HORM, V80, P51, DOI 10.1016/S0083-6729(08)00603-1; JORGENSEN LN, 1992, DIABETOLOGIA, V35, pA3; KAARSHOLM NC, 1993, BIOCHEMISTRY-US, V32, P10773, DOI 10.1021/bi00091a031; KJELDSEN T, 1991, P NATL ACAD SCI USA, V88, P4404, DOI 10.1073/pnas.88.10.4404; Kurtzhals P, 2000, DIABETES, V49, P999, DOI 10.2337/diabetes.49.6.999; Lou MZ, 2006, P NATL ACAD SCI USA, V103, P12429, DOI 10.1073/pnas.0605395103; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; Milazzo G, 1997, MOL CARCINOGEN, V18, P19, DOI 10.1002/(SICI)1098-2744(199701)18:1<19::AID-MC3>3.0.CO;2-M; MOODY AJ, 1974, HORM METAB RES, V6, P12, DOI 10.1055/s-0028-1093895; MOXHAM CP, 1989, J BIOL CHEM, V264, P13238; Rakatzi I, 2003, DIABETES, V52, P2227, DOI 10.2337/diabetes.52.9.2227; RODBELL M, 1964, J BIOL CHEM, V239, P375; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; SCHAFFER L, 1994, EUR J BIOCHEM, V221, P1127, DOI 10.1111/j.1432-1033.1994.tb18833.x; SCHWARTZ GP, 1987, P NATL ACAD SCI USA, V84, P6408, DOI 10.1073/pnas.84.18.6408; Sciacca L, 2010, DIABETOLOGIA, V53, P1743, DOI 10.1007/s00125-010-1760-6; Siddle K, 2001, BIOCHEM SOC T, V29, P513, DOI 10.1042/BST0290513; Slaaby R, 2006, J BIOL CHEM, V281, P25869, DOI 10.1074/jbc.M605189200; Slieker LJ, 1997, DIABETOLOGIA, V40, pS54, DOI 10.1007/s001250051402; Sommerfeld MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009540; SOOS MA, 1989, BIOCHEM J, V263, P553, DOI 10.1042/bj2630553; SOOS MA, 1992, J BIOL CHEM, V267, P12955; SOOS MA, 1986, BIOCHEM J, V235, P199, DOI 10.1042/bj2350199; Uhles S, 2007, FASEB J, V21, P1609, DOI 10.1096/fj.06-7589com; VOLUND A, 1978, BIOMETRICS, V34, P357, DOI 10.2307/2530598	54	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e29198	10.1371/journal.pone.0029198	http://dx.doi.org/10.1371/journal.pone.0029198			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22383948	Green Submitted, Green Published, gold			2022-12-27	WOS:000302875500002
J	Bright, JA				Bright, Jen A.			The Importance of Craniofacial Sutures in Biomechanical Finite Element Models of the Domestic Pig	PLOS ONE			English	Article							CRANIAL SUTURES; GEOMETRIC MORPHOMETRICS; FUNCTIONAL IMPLICATIONS; PERIODONTAL-LIGAMENT; ELASTIC PROPERTIES; ZYGOMATIC ARCH; SURFACE STRAIN; CORTICAL BONE; SENSITIVITY; VALIDATION	Craniofacial sutures are a ubiquitous feature of the vertebrate skull. Previous experimental work has shown that bone strain magnitudes and orientations often vary when moving from one bone to another, across a craniofacial suture. This has led to the hypothesis that craniofacial sutures act to modify the strain environment of the skull, possibly as a mode of dissipating high stresses generated during feeding or impact. This study tests the hypothesis that the introduction of craniofacial sutures into finite element (FE) models of a modern domestic pig skull would improve model accuracy compared to a model without sutures. This allowed the mechanical effects of sutures to be assessed in isolation from other confounding variables. These models were also validated against strain gauge data collected from the same specimen ex vivo. The experimental strain data showed notable strain differences between adjacent bones, but this effect was generally not observed in either model. It was found that the inclusion of sutures in finite element models affected strain magnitudes, ratios, orientations and contour patterns, yet contrary to expectations, this did not improve the fit of the model to the experimental data, but resulted in a model that was less accurate. It is demonstrated that the presence or absence of sutures alone is not responsible for the inaccuracies in model strain, and is suggested that variations in local bone material properties, which were not accounted for by the FE models, could instead be responsible for the pattern of results.	Univ Bristol, Dept Earth Sci, Bristol, Avon, England	University of Bristol	Bright, JA (corresponding author), Univ Bristol, Dept Earth Sci, Bristol, Avon, England.	j.bright@bristol.ac.uk	Bright, Jen/AAK-8750-2020	Bright, Jen/0000-0002-9284-9591	Natural Environmental Research Council [NE/F007310/1]	Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was funded by Natural Environmental Research Council Studentship, NE/F007310/1 (http://www.nerc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PSL, 2011, BIOL LETT IN PRESS, DOI [10.1098/rsbl.2011.0674, DOI 10.1098/RSBL.2011.0674.IN]; Bright JA, 2011, J MORPHOL, V272, P1388, DOI 10.1002/jmor.10991; Bright JA, 2011, J ANAT, V219, P456, DOI 10.1111/j.1469-7580.2011.01408.x; Bright JA, 2011, ANAT REC, V294, P610, DOI 10.1002/ar.21358; Byron CD, 2004, ANAT REC PART A, V279A, P676, DOI 10.1002/ar.a.20055; Byron CD, 2009, J HUM EVOL, V57, P649, DOI 10.1016/j.jhevol.2008.11.006; Cox PG, 2011, J ANAT, V219, P696, DOI 10.1111/j.1469-7580.2011.01436.x; Dechow PC, 2010, ANAT REC, V293, P618, DOI 10.1002/ar.21124; Farke AA, 2008, J EXP BIOL, V211, P3085, DOI 10.1242/jeb.019042; Groning F, 2011, J BIOMECH, V44, P1304, DOI 10.1016/j.jbiomech.2011.01.008; Hall Brian, 2005, P1; Herrel A, 2000, J EXP BIOL, V203, P1415; Herring SW, 2000, AM J PHYS ANTHROPOL, V112, P575, DOI 10.1002/1096-8644(200008)112:4&lt;575::AID-AJPA10&gt;3.0.CO;2-0; HERRING SW, 1972, ACTA ANAT, V83, P222; Herring SW, 2001, COMP BIOCHEM PHYS A, V131, P207, DOI 10.1016/S1095-6433(01)00472-X; HERRING SW, 1973, J MORPHOL, V141, P427, DOI 10.1002/jmor.1051410405; HERRING SW, 1991, J MORPHOL, V207, P225, DOI 10.1002/jmor.1052070302; Jasinoski SC, 2010, J BIOMECH, V43, P3104, DOI 10.1016/j.jbiomech.2010.08.007; JASLOW CR, 1990, J BIOMECH, V23, P313, DOI 10.1016/0021-9290(90)90059-C; JASLOW CR, 1995, J ZOOL, V235, P193; Kupczik K, 2007, J ANAT, V210, P41, DOI 10.1111/j.1469-7580.2006.00662.x; Kupczik K, 2009, AM J PHYS ANTHROPOL, V139, P193, DOI 10.1002/ajpa.20972; Marinescu R, 2005, ANAT REC PART A, V283A, P300, DOI 10.1002/ar.a.20166; Moazen M, 2009, P ROY SOC B-BIOL SCI, V276, P39, DOI 10.1098/rspb.2008.0863; Nicolay CW, 2006, J MORPHOL, V267, P841, DOI 10.1002/jmor.10445; Panagiotopoulou O, 2010, J BIOMECH, V43, P1603, DOI 10.1016/j.jbiomech.2009.12.027; Panagiotopoulou O, 2011, J ANAT, V218, P75, DOI 10.1111/j.1469-7580.2010.01257.x; Peterson J, 2003, ANAT REC PART A, V274A, P785, DOI 10.1002/ar.a.10096; Popowics TE, 2007, J BIOMECH, V40, P837, DOI 10.1016/j.jbiomech.2006.03.011; Rafferty KL, 2003, J MORPHOL, V257, P33, DOI 10.1002/jmor.10104; Rafferty KL, 1999, J MORPHOL, V242, P167, DOI 10.1002/(SICI)1097-4687(199911)242:2<167::AID-JMOR8>3.3.CO;2-T; Rayfield EJ, 2007, ANNU REV EARTH PL SC, V35, P541, DOI 10.1146/annurev.earth.35.031306.140104; Rayfield EJ, 2011, J ANAT, V218, P47, DOI 10.1111/j.1469-7580.2010.01296.x; Reed DA, 2011, J ANAT, V218, P59, DOI 10.1111/j.1469-7580.2010.01319.x; Richmond BG, 2005, ANAT REC PART A, V283A, P259, DOI 10.1002/ar.a.20169; Ross CF, 2011, J ANAT, V218, P112, DOI 10.1111/j.1469-7580.2010.01322.x; Ross CF, 2005, ANAT REC PART A, V283A, P288, DOI 10.1002/ar.a.20170; Strait DS, 2005, ANAT REC PART A, V283A, P275, DOI 10.1002/ar.a.20172; Sun ZY, 2004, ANAT REC PART A, V276A, P150, DOI 10.1002/ar.a.20002; Thomason JJ, 2001, ANAT REC, V264, P325, DOI 10.1002/ar.10025; Tickhill J, 2007, VIRTUAL PIG HEAD DIG; Wang Q, 2006, AM J PHYS ANTHROPOL, V131, P402, DOI 10.1002/ajpa.20438; Wang QA, 2010, ANAT REC, V293, P1477, DOI 10.1002/ar.21203; Wang Q, 2010, ANAT REC, V293, P607, DOI 10.1002/ar.21123; Wang Qian, 2008, P149, DOI 10.1007/978-0-387-76585-3_8; Wood SA, 2011, J BIOMECH, V44, P1831, DOI 10.1016/j.jbiomech.2011.03.022; Zienkiewicz OC, 2005, FINITE ELEMENT METHOD FOR FLUID DYNAMICS, 6TH EDITION, P1	47	25	28	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31769	10.1371/journal.pone.0031769	http://dx.doi.org/10.1371/journal.pone.0031769			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926ZM	22363727	Green Published, gold			2022-12-27	WOS:000302873700094
J	Jonas, RA; Yuan, TF; Liang, YX; Jonas, JB; Tay, DKC; Ellis-Behnke, RG				Jonas, Rahul A.; Yuan, Ti-Fei; Liang, Yu-Xiang; Jonas, Jost B.; Tay, David K. C.; Ellis-Behnke, Rutledge G.			The Spider Effect: Morphological and Orienting Classification of Microglia in Response to Stimuli in Vivo	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; BRAIN; CELLS; MACROPHAGES; INFLAMMATION; MIGRATION; ACTIVATION; DISEASE; LESIONS; INJURY	The different morphological stages of microglial activation have not yet been described in detail. We transected the olfactory bulb of rats and examined the activation of the microglial system histologically. Six stages of bidirectional microglial activation (A) and deactivation (R) were observed: from stage 1A to 6A, the cell body size increased, the cell process number decreased, and the cell processes retracted and thickened, orienting toward the direction of the injury site; until stage 6A, when all processes disappeared. In contrast, in deactivation stages 6R to 1R, the microglia returned to the original site exhibiting a stepwise retransformation to the original morphology. Thin highly branched processes re-formed in stage 1R, similar to those in stage 1A. This reverse transformation mirrored the forward transformation except in stages 6R to 1R: cells showed multiple nuclei which were slowly absorbed. Our findings support a morphologically defined stepwise activation and deactivation of microglia cells.	[Jonas, Rahul A.; Jonas, Jost B.; Ellis-Behnke, Rutledge G.] Univ Heidelberg, Med Fac Mannheim, Dept Ophthalmol, D-6800 Mannheim, Germany; [Yuan, Ti-Fei; Liang, Yu-Xiang; Tay, David K. C.; Ellis-Behnke, Rutledge G.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Liang, Yu-Xiang; Ellis-Behnke, Rutledge G.] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China; [Ellis-Behnke, Rutledge G.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Ruprecht Karls University Heidelberg; University of Hong Kong; University of Hong Kong; Massachusetts Institute of Technology (MIT)	Jonas, RA (corresponding author), Univ Heidelberg, Med Fac Mannheim, Dept Ophthalmol, D-6800 Mannheim, Germany.	rutledge@medma.uni-heidelberg.de	Jonas, Rahul A/N-9304-2017	Jonas, Rahul/0000-0002-5389-3047				ALROY J, 1987, HISTOCHEMISTRY, V86, P603, DOI 10.1007/BF00489554; Carbonell WS, 2005, J NEUROSCI, V25, P7040, DOI 10.1523/JNEUROSCI.5171-04.2005; Chew LJ, 2006, MENT RETARD DEV D R, V12, P105, DOI 10.1002/mrdd.20102; COLTON CA, 2009, CNS NEUROL DISORD DR; Dissing-Olesen L, 2007, NEUROSCIENCE, V149, P112, DOI 10.1016/j.neuroscience.2007.06.037; Duan YL, 2003, J NEUROBIOL, V57, P183, DOI 10.1002/neu.10262; Fischer HG, 2001, J IMMUNOL, V166, P2717, DOI 10.4049/jimmunol.166.4.2717; FORD AL, 1995, J IMMUNOL, V154, P4309; GEHRMANN J, 1993, GLIA, V7, P50, DOI 10.1002/glia.440070110; Gehrmann J, 1996, RES VIROLOGY, V147, P79, DOI 10.1016/0923-2516(96)80220-2; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Imai F, 1997, NEUROSCI LETT, V237, P49, DOI 10.1016/S0304-3940(97)00808-2; Kettenmann H, 1999, Adv Neurol, V79, P565; Lam D, 2009, MOL VIS, V15, P2217; Magnus T, 2002, J NEUROPATH EXP NEUR, V61, P760, DOI 10.1093/jnen/61.9.760; MCGLADEMCCULLOH E, 1989, P NATL ACAD SCI USA, V86, P1093, DOI 10.1073/pnas.86.3.1093; Ohsawa K, 2010, GLIA, V58, P790, DOI 10.1002/glia.20963; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Petersen MA, 2004, GLIA, V46, P195, DOI 10.1002/glia.10362; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Soulet D, 2008, CURR BIOL, V18, pR506, DOI 10.1016/j.cub.2008.04.047; Stoll G, 1999, PROG NEUROBIOL, V58, P233, DOI 10.1016/S0301-0082(98)00083-5; Streit WJ, 2005, BRAIN RES REV, V48, P234, DOI 10.1016/j.brainresrev.2004.12.013; WILLIAMS K, 1994, ADV NEUROIMMUNOL, V4, P273, DOI 10.1016/S0960-5428(06)80267-6; Wohl SG, 2010, INVEST OPHTH VIS SCI, V51, P2686, DOI 10.1167/iovs.09-4537	25	86	86	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e30763	10.1371/journal.pone.0030763	http://dx.doi.org/10.1371/journal.pone.0030763			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363486	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700011
J	Palaniyandi, S; Mitra, A; Herren, CD; Lockatell, CV; Johnson, DE; Zhu, XP; Mukhopadhyay, S				Palaniyandi, Senthilkumar; Mitra, Arindam; Herren, Christopher D.; Lockatell, C. Virginia; Johnson, David E.; Zhu, Xiaoping; Mukhopadhyay, Suman			BarA-UvrY Two-Component System Regulates Virulence of Uropathogenic E-coli CFT073	PLOS ONE			English	Article							SEROVAR TYPHIMURIUM INVASION; URINARY-TRACT-INFECTION; GENE-EXPRESSION; PROTEIN CSRA; HEMOLYSIN; MOTILITY; IDENTIFICATION; EPIDEMIOLOGY; DETERMINANT; INDUCTION	Uropathogenic Escherichia coli (UPEC), a member of extraintestinal pathogenic E. coli, cause similar to 80% of community-acquired urinary tract infections (UTI) in humans. UPEC initiates its colonization in epithelial cells lining the urinary tract with a complicated life cycle, replicating and persisting in intracellular and extracellular niches. Consequently, UPEC causes cystitis and more severe form of pyelonephritis. To further understand the virulence characteristics of UPEC, we investigated the roles of BarA-UvrY two-component system (TCS) in regulating UPEC virulence. Our results showed that mutation of BarA-UvrY TCS significantly decreased the virulence of UPEC CFT073, as assessed by mouse urinary tract infection, chicken embryo killing assay, and cytotoxicity assay on human kidney and uroepithelial cell lines. Furthermore, mutation of either barA or uvrY gene reduced the production of hemolysin, lipopolysaccharide (LPS), proinflammatory cytokines (TNF-alpha and IL-6) and chemokine (IL-8). The virulence phenotype was restored similar to that of wild-type by complementation of either barA or uvrY gene in trans. In addition, we discussed a possible link between the BarA-UvrY TCS and CsrA in positively and negatively controlling virulence in UPEC. Overall, this study provides the evidences for BarA-UvrY TCS regulates the virulence of UPEC CFT073 and may point to mechanisms by which virulence regulations are observed in different ways may control the long-term survival of UPEC in the urinary tract.	[Palaniyandi, Senthilkumar; Mitra, Arindam; Herren, Christopher D.; Zhu, Xiaoping; Mukhopadhyay, Suman] Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA; [Palaniyandi, Senthilkumar; Zhu, Xiaoping] Univ Maryland, Maryland Pathogen Res Inst, College Pk, MD 20742 USA; [Mitra, Arindam] Arizona State Univ, Ctr Infect Dis & Vaccinol, Biodesign Inst, Tempe, AZ USA; [Lockatell, C. Virginia; Johnson, David E.] Univ Maryland, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21201 USA; [Johnson, David E.] Dept Vet Affairs, Baltimore, MD USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Arizona State University; Arizona State University-Tempe; University System of Maryland; University of Maryland Baltimore	Palaniyandi, S (corresponding author), Univ Maryland, Virginia Maryland Reg Coll Vet Med, College Pk, MD 20742 USA.	mukhopadhyays@mail.nih.gov	Mitra, Arindam/A-1379-2013; Palaniyandi, Senthilkumar/B-9575-2016	Mitra, Arindam/0000-0002-1591-6164; 	United States Department of Agriculture (USDA)-National Research Initiative-Cooperative State Research, Education, and Extension Service Competitive [2004-35204-14749]; USDA-Animal Health [2002-1106-0195318]; University of Maryland; National Institutes of Health [R01 AI65892]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065892] Funding Source: NIH RePORTER	United States Department of Agriculture (USDA)-National Research Initiative-Cooperative State Research, Education, and Extension Service Competitive; USDA-Animal Health; University of Maryland; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by United States Department of Agriculture (USDA)-National Research Initiative-Cooperative State Research, Education, and Extension Service Competitive Grant 2004-35204-14749, USDA-Animal Health 2002-1106-0195318, Maryland Agriculture Experimental Station grant from the University of Maryland (to SM) and a National Institutes of Health Grant R01 AI65892 (to XZ). No other additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGACE WW, 1993, J CLIN INVEST, V92, P780, DOI 10.1172/JCI116650; Altier C, 2000, MOL MICROBIOL, V35, P635, DOI 10.1046/j.1365-2958.2000.01734.x; Altier C, 2000, INFECT IMMUN, V68, P6790, DOI 10.1128/IAI.68.12.6790-6797.2000; Backhed F, 2001, CELL MICROBIOL, V3, P153, DOI 10.1046/j.1462-5822.2001.00101.x; Biswas S, 2006, J BACTERIOL, V188, P988, DOI 10.1128/JB.188.3.988-998.2006; Brooks T, 1997, LETT APPL MICROBIOL, V24, P203, DOI 10.1046/j.1472-765X.1997.00378.x; BRUMFITT W, 1987, LANCET, V1, P824; Buckles EL, 2009, J INFECT DIS, V199, P1689, DOI 10.1086/598524; Craig JC, 2009, NEW ENGL J MED, V361, P1748, DOI 10.1056/NEJMoa0902295; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; den Heijer CDJ, 2010, J ANTIMICROB CHEMOTH, V65, P2128, DOI 10.1093/jac/dkq286; ELSINGHORST EA, 1994, METHOD ENZYMOL, V236, P405; Emody L, 2003, INT J ANTIMICROB AG, V22, pS29, DOI 10.1016/S0924-8579(03)00236-X; Ewers C, 2007, INT J MED MICROBIOL, V297, P163, DOI 10.1016/j.ijmm.2007.01.003; FELMLEE T, 1985, J BACTERIOL, V163, P94, DOI 10.1128/JB.163.1.94-105.1985; Forsbach-Birk V, 2004, INT J MED MICROBIOL, V294, P15, DOI 10.1016/j.ijmm.2003.12.003; Foxman B, 2003, DM-DIS MON, V49, P53, DOI 10.1067/mda.2003.7; Goodier RI, 2001, J BACTERIOL, V183, P2249, DOI 10.1128/JB.183.7.2249-2258.2001; Gryllos I, 2003, P NATL ACAD SCI USA, V100, P4227, DOI 10.1073/pnas.0636231100; Hagan EC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001187; Hatt JK, 2008, CURR TOP MICROBIOL, V322, P163; HEDGES S, 1994, INFECT IMMUN, V62, P2315, DOI 10.1128/IAI.62.6.2315-2321.1994; HEDGES S, 1991, INFECT IMMUN, V59, P421, DOI 10.1128/IAI.59.1.421-427.1991; Hedlund M, 1999, MOL MICROBIOL, V33, P693, DOI 10.1046/j.1365-2958.1999.01513.x; Heeb S, 2001, MOL PLANT MICROBE IN, V14, P1351, DOI 10.1094/MPMI.2001.14.12.1351; Herren CD, 2006, INFECT IMMUN, V74, P4900, DOI 10.1128/IAI.00412-06; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Hung DL, 2001, EMBO J, V20, P1508, DOI 10.1093/emboj/20.7.1508; HURLEY JC, 1995, CLIN MICROBIOL REV, V8, P268, DOI 10.1128/CMR.8.2.268; ISHIGE K, 1994, EMBO J, V13, P5195, DOI 10.1002/j.1460-2075.1994.tb06850.x; Jackson DW, 2002, J BACTERIOL, V184, P290, DOI 10.1128/JB.184.1.290-301.2002; JOHNSON JR, 1991, CLIN MICROBIOL REV, V4, P80, DOI 10.1128/CMR.4.1.80-128.1991; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; Lawhon SD, 2002, MOL MICROBIOL, V46, P1451, DOI 10.1046/j.1365-2958.2002.03268.x; Le Bouguenec C, 2005, INT J MED MICROBIOL, V295, P471, DOI 10.1016/j.ijmm.2005.07.001; MACKMAN N, 1985, MOL GEN GENET, V201, P282, DOI 10.1007/BF00425672; Mizuno T, 1997, DNA Res, V4, P161, DOI 10.1093/dnares/4.2.161; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; MORRISON DC, 1987, ANNU REV MED, V38, P417, DOI 10.1146/annurev.me.38.020187.002221; Mukhopadhyay S, 1997, J BACTERIOL, V179, P330, DOI 10.1128/jb.179.2.330-338.1997; Mukhopadhyay S, 2000, MOL MICROBIOL, V37, P371, DOI 10.1046/j.1365-2958.2000.01999.x; Nicolle LE, 2001, INFECT MED, V18, P153; Parkins MD, 2001, MOL MICROBIOL, V40, P1215, DOI 10.1046/j.1365-2958.2001.02469.x; Pernestig AK, 2001, J BIOL CHEM, V276, P225, DOI 10.1074/jbc.M001550200; Prouty AM, 2000, INFECT IMMUN, V68, P6763, DOI 10.1128/IAI.68.12.6763-6769.2000; Robinson VL, 2000, NAT STRUCT BIOL, V7, P626, DOI 10.1038/77915; Russo TA, 2000, J INFECT DIS, V181, P1753, DOI 10.1086/315418; Sahu SC, 2008, ESCHERICHIA COLI STR, P205; Suzuki K, 2002, J BACTERIOL, V184, P5130, DOI 10.1128/JB.184.18.5130-5140.2002; Teplitski M, 2003, J BACTERIOL, V185, P7257, DOI 10.1128/JB.185.24.7257-7265.2003; Tomenius H, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-27; Wang X, 2005, MOL MICROBIOL, V56, P1648, DOI 10.1111/j.1365-2958.2005.04648.x; Wei BDL, 2001, MOL MICROBIOL, V40, P245, DOI 10.1046/j.1365-2958.2001.02380.x; WELCH RA, 1981, NATURE, V294, P665, DOI 10.1038/294665a0; WELCH RA, 1984, INFECT IMMUN, V43, P156, DOI 10.1128/IAI.43.1.156-160.1984; Wong SM, 1998, INFECT IMMUN, V66, P5854, DOI 10.1128/IAI.66.12.5854-5861.1998; Zhang LX, 2003, FRONT BIOSCI-LANDMRK, V8, pE235, DOI 10.2741/1007	57	32	33	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31348	10.1371/journal.pone.0031348	http://dx.doi.org/10.1371/journal.pone.0031348			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363626	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700052
J	Peterson, BL; Larson, J; Buffenstein, R; Park, TJ; Fall, CP				Peterson, Bethany L.; Larson, John; Buffenstein, Rochelle; Park, Thomas J.; Fall, Christopher P.			Blunted Neuronal Calcium Response to Hypoxia in Naked Mole-Rat Hippocampus	PLOS ONE			English	Article							METHYL-D-ASPARTATE; GLUTAMATE RELEASE; SOMATOSENSORY ORGANIZATION; INTRACELLULAR CALCIUM; HETEROCEPHALUS-GLABER; VERTEBRATE NEURONS; BRAIN ISCHEMIA; CA1 NEURONS; TOLERANCE; ANOXIA	Naked mole-rats are highly social and strictly subterranean rodents that live in large communal colonies in sealed and chronically oxygen-depleted burrows. Brain slices from naked mole-rats show extreme tolerance to hypoxia compared to slices from other mammals, as indicated by maintenance of synaptic transmission under more hypoxic conditions and three fold longer latency to anoxic depolarization. A key factor in determining whether or not the cellular response to hypoxia is reversible or leads to cell death may be the elevation of intracellular calcium concentration. In the present study, we used fluorescent imaging techniques to measure relative intracellular calcium changes in CA1 pyramidal cells of hippocampal slices during hypoxia. We found that calcium accumulation during hypoxia was significantly and substantially attenuated in slices from naked mole-rats compared to slices from laboratory mice. This was the case for both neonatal (postnatal day 6) and older (postnatal day 20) age groups. Furthermore, while both species demonstrated more calcium accumulation at older ages, the older naked mole-rats showed a smaller calcium accumulation response than even the younger mice. A blunted intracellular calcium response to hypoxia may contribute to the extreme hypoxia tolerance of naked mole-rat neurons. The results are discussed in terms of a general hypothesis that a very prolonged or arrested developmental process may allow adult naked mole-rat brain to retain the hypoxia tolerance normally only seen in neonatal mammals.	[Peterson, Bethany L.; Larson, John; Park, Thomas J.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Larson, John; Park, Thomas J.] Univ Illinois, Lab Integrat Neurosci, Chicago, IL 60680 USA; [Larson, John] Univ Illinois, Inst Psychiat, Dept Psychiat, Chicago, IL 60680 USA; [Fall, Christopher P.] Univ Illinois, Dept Bioengn, Chicago, IL 60680 USA; [Buffenstein, Rochelle] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst, San Antonio, TX 78229 USA; [Buffenstein, Rochelle] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Fall, Christopher P.] Georgetown Univ, Dept Comp Sci, Washington, DC USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Georgetown University	Peterson, BL (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.	tpark@uic.edu			National Science Foundation [0744979]; National Institutes of Health-National Institute of Mental Health Neurotechnology [MH-085973]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH085973] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [0744979] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health-National Institute of Mental Health Neurotechnology; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	National Science Foundation grant 0744979 (TJP, JL), (www.nsf.gov/), National Institutes of Health-National Institute of Mental Health Neurotechnology program through grant MH-085973 (CPF), (www.nimh.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIELI R, 1979, COMP BIOCHEM PHYS A, V63, P569, DOI 10.1016/0300-9629(79)90197-X; Avivi A, 2010, P NATL ACAD SCI USA, V107, P21570, DOI 10.1073/pnas.1015379107; Beierlein M, 2002, J NEUROSCI, V22, P9885; Bennett N.C., 2000, AFRICAN MOLE RATS EC; Bickler PE, 2009, NEUROSCIENCE, V160, P51, DOI 10.1016/j.neuroscience.2009.02.013; Bickler PE, 1996, NEUROPHARMACOLOGY, V35, P679, DOI 10.1016/S0028-3908(96)00030-5; Bickler PE, 1998, J EXP BIOL, V201, P1141; Bickler PE, 2004, J EXP BIOL, V207, P3243, DOI 10.1242/jeb.00977; Bickler PE, 2002, J EXP BIOL, V205, P3579; BICKLER PE, 1993, J CEREBR BLOOD F MET, V13, P811, DOI 10.1038/jcbfm.1993.103; Bickler PE, 2003, NEUROSCIENCE, V118, P25, DOI 10.1016/S0306-4522(02)00763-7; Brand A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015162; Brett R.A., 1991, P137; Buck LT, 1998, J EXP BIOL, V201, P289; Buck LT, 2004, COMP BIOCHEM PHYS B, V139, P401, DOI 10.1016/j.cbpc.2004.04.002; BUFFENSTEIN R, 1991, J THERM BIOL, V16, P227, DOI 10.1016/0306-4565(91)90030-6; Buffenstein R, 2005, J GERONTOL A-BIOL, V60, P1369, DOI 10.1093/gerona/60.11.1369; Buffenstein R, 1996, MAMMALIA, V60, P591, DOI 10.1515/mamm.1996.60.4.591; Crish SD, 2003, BRAIN BEHAV EVOLUT, V62, P141, DOI 10.1159/000072723; DESHPANDE JK, 1987, J CEREBR BLOOD F MET, V7, P89, DOI 10.1038/jcbfm.1987.13; Diarra A, 1999, NEUROSCIENCE, V93, P1003, DOI 10.1016/S0306-4522(99)00230-4; Drew KL, 2004, J EXP BIOL, V207, P3155, DOI 10.1242/jeb.01114; Edrey YH, 2011, EXP GERONTOL, V46, P116, DOI 10.1016/j.exger.2010.09.005; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Folkow LP, 2008, NEUROSCI LETT, V446, P147, DOI 10.1016/j.neulet.2008.09.040; Frerichs KU, 1998, J CEREBR BLOOD F MET, V18, P168, DOI 10.1097/00004647-199802000-00007; FRIEDMAN JE, 1993, J NEUROSCI, V13, P63; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Hedrick MS, 2005, J EXP BIOL, V208, P681, DOI 10.1242/jeb.01436; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; JARVIS JUM, 1981, SCIENCE, V212, P571, DOI 10.1126/science.7209555; JARVIS JUM, 1994, TRENDS ECOL EVOL, V9, P47, DOI 10.1016/0169-5347(94)90267-4; JOHANSEN K, 1976, RESP PHYSIOL, V28, P303, DOI 10.1016/0034-5687(76)90025-6; Kasaikina MV, 2011, J BIOL CHEM, V286, P17005, DOI 10.1074/jbc.M110.216267; Kim EB, 2011, NATURE, V479, P223, DOI 10.1038/nature10533; Larson J, 2009, NEUROREPORT, V20, P1634, DOI 10.1097/WNR.0b013e32833370cf; Laurie DJ, 1997, MOL BRAIN RES, V51, P23, DOI 10.1016/S0169-328X(97)00206-4; LaVinka PC, 2009, J COMP PHYSIOL A, V195, P419, DOI 10.1007/s00359-009-0420-0; Lavocat R., 1978, P69; LEE KS, 1991, P NATL ACAD SCI USA, V88, P7233, DOI 10.1073/pnas.88.16.7233; Liang ST, 2010, AGING CELL, V9, P626, DOI 10.1111/j.1474-9726.2010.00588.x; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Maclean JN, 2005, IMAGING NEUROSCIENCE, P351; MITANI A, 1990, NEUROSCI LETT, V120, P42, DOI 10.1016/0304-3940(90)90163-4; MULLER D, 1989, DEV BRAIN RES, V49, P105, DOI 10.1016/0165-3806(89)90063-1; Neher E, 2005, IMAGING NEUROSCIENCE, P245; Park TJ, 2008, PLOS BIOL, V6, P156, DOI 10.1371/journal.pbio.0060013; Park TJ, 2003, J COMP NEUROL, V465, P104, DOI 10.1002/cne.10824; Peterson BL, 2011, NEUROSCIENC IN PRESS; Ross AP, 2006, J CEREBR BLOOD F MET, V26, P1148, DOI 10.1038/sj.jcbfm.9600271; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Seluanov A, 2009, P NATL ACAD SCI USA, V106, P19352, DOI 10.1073/pnas.0905252106; Shimazaki K, 1998, NEUROREPORT, V9, P1875, DOI 10.1097/00001756-199806010-00038; Smith ESJ, 2011, SCIENCE, V334, P1557, DOI 10.1126/science.1213760; SZATKOWSKI M, 1994, TRENDS NEUROSCI, V17, P359, DOI 10.1016/0166-2236(94)90040-X; Takahashi A, 1999, PHYSIOL REV, V79, P1089, DOI 10.1152/physrev.1999.79.4.1089; Zhao HWW, 2006, J CHEM NEUROANAT, V32, P196, DOI 10.1016/j.jchemneu.2006.09.002	57	42	48	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31568	10.1371/journal.pone.0031568	http://dx.doi.org/10.1371/journal.pone.0031568			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363676	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700074
J	Vaccaro, A; Tauffenberger, A; Aggad, D; Rouleau, G; Drapeau, P; Parker, JA				Vaccaro, Alexandra; Tauffenberger, Arnaud; Aggad, Dina; Rouleau, Guy; Drapeau, Pierre; Parker, J. Alex			Mutant TDP-43 and FUS Cause Age-Dependent Paralysis and Neurodegeneration in C. elegans	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CORTICAL HYPEREXCITABILITY; DROSOPHILA MODEL; MUTATIONS; INSIGHTS; NEURONS; PROTEIN; ONSET; ALS	Mutations in the DNA/RNA binding proteins TDP-43 and FUS are associated with Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration. Intracellular accumulations of wild type TDP-43 and FUS are observed in a growing number of late-onset diseases suggesting that TDP-43 and FUS proteinopathies may contribute to multiple neurodegenerative diseases. To better understand the mechanisms of TDP-43 and FUS toxicity we have created transgenic Caenorhabditis elegans strains that express full-length, untagged human TDP-43 and FUS in the worm's GABAergic motor neurons. Transgenic worms expressing mutant TDP-43 and FUS display adult-onset, age-dependent loss of motility, progressive paralysis and neuronal degeneration that is distinct from wild type alleles. Additionally, mutant TDP-43 and FUS proteins are highly insoluble while wild type proteins remain soluble suggesting that protein misfolding may contribute to toxicity. Populations of mutant TDP-43 and FUS transgenics grown on solid media become paralyzed over 7 to 12 days. We have developed a liquid culture assay where the paralysis phenotype evolves over several hours. We introduce C. elegans transgenics for mutant TDP-43 and FUS motor neuron toxicity that may be used for rapid genetic and pharmacological suppressor screening.	[Vaccaro, Alexandra; Tauffenberger, Arnaud; Aggad, Dina; Rouleau, Guy; Parker, J. Alex] Univ Montreal, Res Ctr, Ctr Hosp, Montreal, PQ, Canada; [Vaccaro, Alexandra; Tauffenberger, Arnaud; Aggad, Dina; Rouleau, Guy; Drapeau, Pierre; Parker, J. Alex] Univ Montreal, Ctr Excellence Neur, Montreal, PQ, Canada; [Vaccaro, Alexandra; Tauffenberger, Arnaud; Aggad, Dina; Drapeau, Pierre; Parker, J. Alex] Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ, Canada; [Rouleau, Guy] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Vaccaro, A (corresponding author), Univ Montreal, Res Ctr, Ctr Hosp, Montreal, PQ, Canada.	ja.parker@umontreal.ca	Parker, Alex/F-4953-2014	Parker, Alex/0000-0002-3333-2445; Vaccaro, Alexandra/0000-0002-3183-7343; Tauffenberger, Arnaud/0000-0003-0207-9659	Montreal University Hospital Foundation; Natural Sciences and Engineering Research Council; Canadian Institutes of Health Research New Investigator; Frick Foundation; ALS Society of Canada	Montreal University Hospital Foundation; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research New Investigator(Canadian Institutes of Health Research (CIHR)); Frick Foundation; ALS Society of Canada	This research was supported by: Montreal University Hospital Foundation (http://fondationduchum.com/fr) to JAP, Natural Sciences and Engineering Research Council Discovery Grant (http://www.nserc-crsng.gc.ca) to JAP, Canadian Institutes of Health Research New Investigator (http://www.cihr-irsc.gc.ca) to JAP, Frick Foundation for ALS Research (http://frick-fondation.ch) to PD and JAP and a Bernice Ramsay Discovery Grant from the ALS Society of Canada (http://www.als.ca/) to JAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ash P.E.A., 2010, HUM MOL GENET; Belzil VV, 2009, NEUROLOGY, V73, P1176, DOI 10.1212/WNL.0b013e3181bbfeef; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Brown RH, 2017, NEW ENGL J MED, V377, P1602, DOI [10.1038/nrdp.2017.85, 10.1056/NEJMra1603471, 10.1056/NEJMc1710379, 10.1016/S0140-6736(17)31287-4, 10.1016/S0140-6736(10)61156-7, 10.1038/nrdp.2017.71]; Caramia MD, 2000, NEUROLOGY, V54, P58, DOI 10.1212/WNL.54.1.58; Catoire H, 2008, HUM MOL GENET; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Collins James J, 2008, WormBook, P1, DOI 10.1895/wormbook.1.137.1; Deng HX, 2011, NATURE; Dion PA, 2009, NAT REV GENET, V10, P769, DOI 10.1038/nrg2680; Duerr Janet S, 2006, WormBook, P1; Earls LR, 2010, P NATL ACAD SCI USA, V107, P14460, DOI 10.1073/pnas.0910630107; Evans T. C., 2006, WORMBOOK, DOI [10.1895/wormbook.1.108.1, DOI 10.1895/WORMBOOK.1.108.1, 10.1895/ wormbook.1.108.1]; Gitcho MA, 2008, ANN NEUROL; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Jorgensen E.M., 2005, WORMBOOK, P1, DOI [10.1895/wormbook.1.14.1, DOI 10.1895/WORMBOOK.1.14.1]; Ju SL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001052; Kabashi E, 2008, NAT GENET; Kabashi E, 2011, PLOS GENET IN PRESS, VPLoS Genet; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Kim SH, 2010, J BIOL CHEM, V285, P34097, DOI 10.1074/jbc.M110.154831; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lanson NA, 2011, HUM MOL GENET, V20, P2510, DOI 10.1093/hmg/ddr150; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Liachko NF, 2010, J NEUROSCI, V30, P16208, DOI 10.1523/JNEUROSCI.2911-10.2010; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Lomen-Hoerth C, 2008, SEMIN NEUROL, V28, P205, DOI 10.1055/s-2008-1062265; Loria PM, 2004, J NEUROSCI, V24, P2191, DOI 10.1523/JNEUROSCI.5462-03.2004; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Mahoney TR, 2006, NAT PROTOC, V1, P1772, DOI 10.1038/nprot.2006.281; McCaffery JM, 2008, P NATL ACAD SCI US; McDonald PW, 2007, J NEUROSCI, V27, P14216, DOI 10.1523/JNEUROSCI.2992-07.2007; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; Murakami T, 2011, HUM MOL GENET; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Saxena S, 2011, NEURON, V71, P35, DOI 10.1016/j.neuron.2011.06.031; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Steinkraus KA, 2008, AGING CELL, V7, P394, DOI 10.1111/j.1474-9726.2008.00385.x; Stiernagle Theresa, 2006, WormBook, P1; Swarup V, 2011, BRAIN; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Vashlishan AB, 2008, NEURON, V58, P346, DOI 10.1016/j.neuron.2008.02.019; Vucic S, 2008, BRAIN, V131, P1540, DOI 10.1093/brain/awn071; Wang J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000350; Wang JW, 2011, J CLIN INVEST; Zhang T, 2011, HUM MOL GENET	48	64	66	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31321	10.1371/journal.pone.0031321	http://dx.doi.org/10.1371/journal.pone.0031321			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363618	gold, Green Published, Green Submitted			2022-12-27	WOS:000302873700047
J	Wu, TJ; Chen, TC; Wang, F; Chan, KM; Soong, RS; Chou, HS; Lee, WC; Yeh, CT				Wu, Ting-Jung; Chen, Tse-Ching; Wang, Frank; Chan, Kun-Ming; Soong, Ruey-Shyang; Chou, Hong-Shiue; Lee, Wei-Chen; Yeh, Chau-Ting			Large Fragment Pre-S Deletion and High Viral Load Independently Predict Hepatitis B Relapse after Liver Transplantation	PLOS ONE			English	Article							VIRUS RECURRENCE; IMMUNE GLOBULIN; HEPATOCELLULAR-CARCINOMA; LAMIVUDINE THERAPY; LOW-RISK; PROPHYLAXIS; REINFECTION; GENOTYPE; IMMUNOGLOBULIN; PREVENTION	Hepatitis B virus (HBV) associated end-stage liver diseases are the leading causes of liver transplantation (LT) in Taiwan. Relapse of hepatitis B occurs after LT, raising the risk of graft failure and reducing patient survival. Although several oral antiviral agents have been approved for anti-HBV treatment, lamivudine (LAM) remained to be the most widely used preventive regimen in Taiwan. While several clinical predictors have been identified for hepatitis B relapse, the predictive roles of the histopathological characteristics in liver explants as well as the genotypic features of the viruses in pre-LT serum samples have not been assessed. Between September 2002 and August 2009, 150 consecutive hepatitis B surface antigen (HBsAg) positive patients undergoing LT were included for outcome analysis following assessment of the clinicopathological and virological factors prior to LT. Kaplan-Meier analyses discovered that pre-operative LAM treatment <= 3 months; membranous distribution and higher expression of tissue HBsAg in liver explants; preoperative viral load >= 10(6) copies/ml; and presence of large fragment (> 100 base pairs) pre-S deletion (LFpreSDel) correlated significantly with hepatitis B relapse. Multivariate Cox regression analysis showed that the presence of LFpreSDel (P = 0.001) and viral load >= 10(6) copies/mL (P = 0.023) were independent predictors for hepatitis B relapse. In conclusion, besides high viral load, LFpreSDel mutation is an important independent predictor for hepatitis B relapse after LT. More aggressive preventive strategies should be applied for patients carrying these risk factors.	[Wu, Ting-Jung; Wang, Frank; Chan, Kun-Ming; Soong, Ruey-Shyang; Chou, Hong-Shiue; Lee, Wei-Chen] Chang Gung Mem Hosp, Dept Gen Surg, Div Liver & Transplantat Surg, Tao Yuan, Taiwan; [Wu, Ting-Jung] Chang Gung Univ, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Chen, Tse-Ching] Chang Gung Mem Hosp, Dept Pathol, Tao Yuan, Taiwan; [Yeh, Chau-Ting] Chang Gung Med Ctr, Dept Hepatogastroenterol, Liver Res Ctr, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Wu, TJ (corresponding author), Chang Gung Mem Hosp, Dept Gen Surg, Div Liver & Transplantat Surg, Tao Yuan, Taiwan.	weichen@adm.cgmh.org.tw; chautingy@gmail.com			Chang Gung Medical Research Program [CMRPG370693]; national science council [NMRP 98-2314-B-182A-048]	Chang Gung Medical Research Program; national science council(Ministry of Science and Technology, Taiwan)	This study is supported by a grant from Chang Gung Medical Research Program (CMRPG370693) and a grant from the national science council (NMRP 98-2314-B-182A-048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus PW, 2008, LIVER TRANSPLANT, V14, pS15, DOI 10.1002/lt.21614; Angus PW, 2000, LIVER TRANSPLANT, V6, P429, DOI 10.1053/jlts.2000.8310; Chen BF, 2006, GASTROENTEROLOGY, V130, P1153, DOI 10.1053/j.gastro.2006.01.011; Chen CH, 2007, GASTROENTEROLOGY, V133, P1466, DOI 10.1053/j.gastro.2007.09.002; CHEN DS, 1993, SCIENCE, V262, P369, DOI 10.1126/science.8211155; Chun J, 2010, AM J TRANSPLANT, V10, P1649, DOI 10.1111/j.1600-6143.2010.03162.x; Degertekin B, 2010, AM J TRANSPLANT, V10, P1823, DOI 10.1111/j.1600-6143.2010.03046.x; Faria LC, 2008, GASTROENTEROLOGY, V134, P1890, DOI 10.1053/j.gastro.2008.02.064; Fung J, 2011, GASTROENTEROLOGY, V141, P1212, DOI 10.1053/j.gastro.2011.06.083; Gaglio P, 2008, LIVER TRANSPLANT, V14, P1420, DOI 10.1002/lt.21563; Grottola A, 2002, LIVER TRANSPLANT, V8, P443, DOI 10.1053/jlts.2002.32719; Han SHB, 2000, LIVER TRANSPLANT, V6, P741, DOI 10.1053/jlts.2000.18702; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Kao JH, 2002, LANCET INFECT DIS, V2, P395, DOI 10.1016/S1473-3099(02)00315-8; Kim WR, 2004, LIVER TRANSPLANT, V10, P968, DOI 10.1002/lt.20217; Lake JR, 2008, LIVER TRANSPLANT, V14, pS23, DOI 10.1002/lt.21637; LAKE JR, 1991, HEPATOLOGY, V13, P796, DOI 10.1002/hep.1840130429; Lenci I, 2011, J HEPATOL, V55, P587, DOI 10.1016/j.jhep.2010.12.036; Lo CM, 2005, AM J TRANSPLANT, V5, P1893, DOI 10.1111/j.1600-6143.2005.00952.x; Locarnini S, 2003, SEMIN LIVER DIS, V23, P5, DOI 10.1055/s-2003-37587; Lok ASF, 2002, LIVER TRANSPLANT, V8, pS67, DOI 10.1053/jlts.2002.35780; Markowitz JS, 1998, HEPATOLOGY, V28, P585, DOI 10.1002/hep.510280241; Marzano A, 2005, LIVER TRANSPLANT, V11, P402, DOI 10.1002/lt.20402; Marzano A, 2001, J HEPATOL, V34, P903, DOI 10.1016/S0168-8278(01)00080-0; Nath DS, 2006, CLIN TRANSPLANT, V20, P206, DOI 10.1111/j.1399-0012.2005.00467.x; Rosenau J, 2001, J HEPATOL, V34, P895, DOI 10.1016/S0168-8278(01)00089-7; Saab S, 2009, LIVER TRANSPLANT, V15, P1525, DOI 10.1002/lt.21882; Shouval D, 2000, HEPATOLOGY, V32, P1189, DOI 10.1053/jhep.2000.19789; STARZL TE, 1963, SURG GYNECOL OBSTET, V117, P659; Steinmuller T, 2002, HEPATOLOGY, V35, P1528, DOI 10.1053/jhep.2002.33681; Tchervenkov J, 1997, ANN SURG, V226, P367; Tchervenkov JI, 1997, ANN SURG, V226, P356, DOI 10.1097/00000658-199709000-00015; TODO S, 1991, HEPATOLOGY, V13, P619, DOI 10.1002/hep.1840130402; Wong SN, 2007, LIVER TRANSPLANT, V13, P374, DOI 10.1002/lt.21041; Woo HY, 2008, J MED VIROL, V80, P1891, DOI 10.1002/jmv.21324; Yeh CT, 2010, HEPATOLOGY, V52, P1922, DOI 10.1002/hep.23898; Yi NJ, 2007, LIVER TRANSPLANT, V13, P451, DOI 10.1002/lt.21043; Yuen MF, 2003, HEPATOLOGY, V37, P562, DOI 10.1053/jhep.2003.50098	38	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32189	10.1371/journal.pone.0032189	http://dx.doi.org/10.1371/journal.pone.0032189			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363813	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700154
J	Gray, SA; Weigel, KM; Ali, IKM; Lakey, AA; Capalungan, J; Domingo, GJ; Cangelosi, GA				Gray, Sean A.; Weigel, Kris M.; Ali, Ibne K. M.; Lakey, Annie A.; Capalungan, Jeremy; Domingo, Gonzalo J.; Cangelosi, Gerard A.			Toward Low-Cost Affinity Reagents: Lyophilized Yeast-scFv Probes Specific for Pathogen Antigens	PLOS ONE			English	Article							SINGLE-CHAIN ANTIBODY; ENTAMOEBA-HISTOLYTICA; SURFACE DISPLAY; FLOW-CYTOMETRY; DIAGNOSIS; BANGLADESH; EXPRESSION; AMEBIASIS; LIBRARY; GENES	The generation of affinity reagents, usually monoclonal antibodies, remains a critical bottleneck in biomedical research and diagnostic test development. Recombinant antibody-like proteins such as scFv have yet to replace traditional monoclonal antibodies in antigen detection applications, in large part because of poor performance of scFv in solution. To address this limitation, we have developed assays that use whole yeast cells expressing scFv on their surfaces (yeast-scFv) in place of soluble purified scFv or traditional monoclonal antibodies. In this study, a nonimmune library of human scFv displayed on the surfaces of yeast cells was screened for clones that bind to recombinant cyst proteins of Entamoeba histolytica, an enteric pathogen of humans. Selected yeast-scFv clones were stabilized by lyophilization and used in detection assay formats in which the yeast-scFv served as solid support-bound monoclonal antibodies. Specific binding of antigen to the yeast-scFv was detected by staining with rabbit polyclonal antibodies. In flow cytometry-based assays, lyophilized yeast-scFv reagents retained full binding activity and specificity for their cognate antigens after 4 weeks of storage at room temperature in the absence of desiccants or stabilizers. Because flow cytometry is not available to all potential assay users, an immunofluorescence assay was also developed that detects antigen with similar sensitivity and specificity. Antigen-specific whole-cell yeast-scFv reagents can be selected from nonimmune libraries in 2-3 weeks, produced in vast quantities, and packaged in lyophilized form for extended shelf life. Lyophilized yeast-scFv show promise as low cost, renewable alternatives to monoclonal antibodies for diagnosis and research.	[Gray, Sean A.; Weigel, Kris M.; Lakey, Annie A.; Cangelosi, Gerard A.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Ali, Ibne K. M.] Univ Virginia Hlth Syst, Div Infect Dis & Int Hlth, Charlottesville, VA USA; [Capalungan, Jeremy; Domingo, Gonzalo J.] PATH, Seattle, WA USA	Center for Infectious Disease Research; University of Virginia	Gray, SA (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	jerry.cangelosi@seattlebiomed.org		Weigel, Kris/0000-0003-3199-2148; Domingo, Gonzalo/0000-0002-1004-4395	NIAID [R21 AI0744571, U01AI082186]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082186] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was funded by NIAID grant R21 AI0744571 to S.A.G. and by a NIAID grant U01AI082186 to G.A.C. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babaei A, 2011, J MICROBIOL BIOTECHN, V21, P529, DOI 10.4014/jmb.1010.10022; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chatterjee A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000498; Cho YK, 2009, J IMMUNOL METHODS, V341, P117, DOI 10.1016/j.jim.2008.11.005; Ehrenkaufer GM, 2007, CELL MICROBIOL, V9, P1426, DOI 10.1111/j.1462-5822.2006.00882.x; Feldhaus Michael, 2004, Methods Mol Biol, V263, P311; Feldhaus MJ, 2003, NAT BIOTECHNOL, V21, P163, DOI 10.1038/nbt785; Ghosh SK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000750; Gray SA, 2011, BIOTECHNOL BIOENG; Gray SA, 2010, BIOTECHNOL BIOENG, V105, P973, DOI 10.1002/bit.22607; Haque R, 2006, ARCH MED RES, V37, P273, DOI 10.1016/j.arcmed.2005.09.001; Haque R, 2003, AM J TROP MED HYG, V69, P398, DOI 10.4269/ajtmh.2003.69.398; HAQUE R, 1995, J CLIN MICROBIOL, V33, P2558, DOI 10.1128/JCM.33.10.2558-2561.1995; Haque R, 2010, J CLIN MICROBIOL, V48, P2798, DOI 10.1128/JCM.00152-10; Hobson-Peters J, 2010, J VIROL METHODS, V168, P177, DOI 10.1016/j.jviromet.2010.05.012; Kemmer G, 2010, NAT PROTOC, V5, P267, DOI 10.1038/nprot.2009.182; Liu DB, 2011, J BIOL CHEM, V286, P24500, DOI 10.1074/jbc.M110.211847; Perez-Toledo K, 2009, NUCLEIC ACIDS RES, V37, P2596, DOI 10.1093/nar/gkp115; Petri WA, 2000, PARASITOL TODAY, V16, P320, DOI 10.1016/S0169-4758(00)01730-0; Scholler N, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-41; Siegel RW, 2004, J IMMUNOL METHODS, V286, P141, DOI 10.1016/j.jim.2004.01.005; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; Ta HT, 2011, CIRC RES, V109, P365, DOI 10.1161/CIRCRESAHA.111.249375; VanAntwerp JJ, 2000, BIOTECHNOL PROGR, V16, P31, DOI 10.1021/bp990133s	24	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e32042	10.1371/journal.pone.0032042	http://dx.doi.org/10.1371/journal.pone.0032042			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363793	Green Published, Green Submitted, gold			2022-12-27	WOS:000302871500107
J	Ye, ZJ; Yuan, ML; Zhou, Q; Du, RH; Yang, WB; Xiong, XZ; Zhang, JC; Wu, C; Qin, SM; Shi, HZ				Ye, Zhi-Jian; Yuan, Ming-Li; Zhou, Qiong; Du, Rong-Hui; Yang, Wei-Bing; Xiong, Xian-Zhi; Zhang, Jian-Chu; Wu, Cong; Qin, Shou-Ming; Shi, Huan-Zhong			Differentiation and Recruitment of Th9 Cells Stimulated by Pleural Mesothelial Cells in Human Mycobacterium tuberculosis Infection	PLOS ONE			English	Article							T-CELLS; TGF-BETA; IL-9; CD4(+)	Newly discovered IL-9-producing CD4(+) helper T cells (Th9 cells) have been reported to contribute to tissue inflammation and immune responses, however, differentiation and immune regulation of Th9 cells in tuberculosis remain unknown. In the present study, our data showed that increased Th9 cells with the phenotype of effector memory cells were found to be in tuberculous pleural effusion as compared with blood. TGF-beta was essential for Th9 cell differentiation from naive CD4(+)T cells stimulated with PMA and ionomycin in vitro for 5 h, and addition of IL-1 beta, IL-4 or IL-6 further augmented Th9 cell differentiation. Tuberculous pleural effusion and supernatants of cultured pleural mesothelial cells were chemotactic for Th9 cells, and this activity was partly blocked by anti-CCL20 antibody. IL-9 promoted the pleural mesothelial cell repairing and inhibited IFN-gamma-induced pleural mesothelial cell apoptosis. Moreover, pleural mesothelial cells promoted Th9 cell differentiation by presenting antigen. Collectively, these data provide new information concerning Th9 cells, in particular the collaborative immune regulation between Th9 cells and pleural mesothelial cells in human M. tuberculosis infection. In particular, pleural mesothelial cells were able to function as antigen-presenting cells to stimulate Th9 cell differentiation.	[Ye, Zhi-Jian; Yuan, Ming-Li; Zhou, Qiong; Yang, Wei-Bing; Xiong, Xian-Zhi; Zhang, Jian-Chu; Shi, Huan-Zhong] Huazhong Univ Sci & Technol, Tongji Med Coll, Key Lab Pulm Dis, Hlth Minist,Dept Resp Dis,Union Hosp, Wuhan 430074, Peoples R China; [Du, Rong-Hui] Wuhan Inst TB Prevent & Control, Dept Internal Med, Wuhan, Peoples R China; [Wu, Cong; Qin, Shou-Ming] Guangxi Med Univ, Affiliated Hosp 1, Inst Resp Dis, Nanning, Peoples R China	Huazhong University of Science & Technology; Guangxi Medical University	Ye, ZJ (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Key Lab Pulm Dis, Hlth Minist,Dept Resp Dis,Union Hosp, Wuhan 430074, Peoples R China.	shihuanzhong@sina.com			National Basic Research Program of China (973 Program) [2012CB518700]; National Science Fund for Distinguished Young Scholars of China [30925032]; National Natural Science Foundation of China [30872343]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by a grant from the National Basic Research Program of China (973 Program 2012CB518700); in part by a grant from the National Science Fund for Distinguished Young Scholars of China (No. 30925032); and in part by a grant from the National Natural Science Foundation of China (No. 30872343). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barberis MCP, 1997, ACTA CYTOL, V41, P1757; BARNES PF, 1990, J IMMUNOL, V145, P149; Beriou G, 2010, J IMMUNOL, V185, P46, DOI 10.4049/jimmunol.1000356; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Eller K, 2011, J IMMUNOL, V186, P83, DOI 10.4049/jimmunol.1001183; Elyaman W, 2009, P NATL ACAD SCI USA, V106, P12885, DOI 10.1073/pnas.0812530106; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Hauber HP, 2004, INT ARCH ALLERGY IMM, V134, P79, DOI 10.1159/000078384; Jantz MA, 2008, RESPIRATION, V75, P121, DOI 10.1159/000113629; Leard LE, 2004, RESPIROLOGY, V9, P292, DOI 10.1111/j.1440-1843.2004.00602.x; Li HM, 2010, J NEUROIMMUNE PHARM, V5, P198, DOI 10.1007/s11481-009-9186-y; McAdam AJ, 1998, IMMUNOL REV, V165, P231; Mitra DK, 2005, EUR J IMMUNOL, V35, P2367, DOI 10.1002/eji.200525977; Mutsaers SE, 2004, RESPIROLOGY, V9, P428, DOI 10.1111/j.1440-1843.2004.00633.x; Mutsaers SE, 2002, RESPIROLOGY, V7, P171, DOI 10.1046/j.1440-1843.2002.00404.x; Nasreen N, 1999, J INFECT DIS, V180, P1616, DOI 10.1086/315057; Putheti P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008706; Qin XJ, 2005, EUR RESPIR J, V25, P605, DOI 10.1183/09031936.05.00090804; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Stephens GL, 2011, EUR J IMMUNOL, V41, P952, DOI 10.1002/eji.201040879; UYTTENHOVE C, 1988, P NATL ACAD SCI USA, V85, P6934, DOI 10.1073/pnas.85.18.6934; VANSNICK J, 1989, J EXP MED, V169, P363, DOI 10.1084/jem.169.1.363; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Wang TT, 2011, TUBERCULOSIS, V91, P231, DOI 10.1016/j.tube.2011.02.002; Wong MT, 2010, IMMUNOL CELL BIOL, V88, P624, DOI 10.1038/icb.2010.53; Wu B, 2008, CLIN IMMUNOL, V126, P202, DOI 10.1016/j.clim.2007.09.009; Wu C, 2010, RESPIROLOGY, V15, P522, DOI 10.1111/j.1440-1843.2010.01719.x; Yang HB, 2008, CHINESE MED J-PEKING, V121, P579, DOI 10.1097/00029330-200804010-00001; Ye ZJ, 2010, J IMMUNOL, V185, P6348, DOI 10.4049/jimmunol.1001728; Zhou Y, 2011, J IMMUNOL, V186, P4415, DOI 10.4049/jimmunol.1003307	33	50	58	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31710	10.1371/journal.pone.0031710	http://dx.doi.org/10.1371/journal.pone.0031710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363712	Green Published, gold, Green Submitted			2022-12-27	WOS:000302871500079
J	Zhang, C; Xiong, Y; Li, JN; Yang, Y; Liu, L; Wang, W; Wang, L; Li, MH; Fang, ZY				Zhang, Chao; Xiong, Yi; Li, Jiana; Yang, Yang; Liu, Li; Wang, Wen; Wang, Luo; Li, Manhui; Fang, Zhengyu			Deletion and Down-Regulation of HRH4 Gene in Gastric Carcinomas: A Potential Correlation with Tumor Progression	PLOS ONE			English	Article							HISTAMINE-RECEPTOR ANTAGONISTS; COLORECTAL-CANCER; COPY NUMBER; HELICOBACTER-PYLORI; AUTOCRINE REGULATOR; CELL-PROLIFERATION; H-4 RECEPTORS; H4 RECEPTORS; GROWTH; EXPRESSION	Background: Histamine is an established growth factor for gastrointestinal malignancies. The effect of histamine is largely determined locally by the histamine receptor expression pattern. Histamine receptor H4 (HRH4), the newest member of the histamine receptor family, is positively expressed on the epithelium of the gastrointestinal tract, and its function remains to be elucidated. Previously, we reported the decreased expression of HRH4 in colorectal cancers and revealed its correlation with tumor proliferation. In the current study, we aimed to investigate the abnormalities of HRH4 gene in gastric carcinomas (GCs). Methodology/Principal Findings: We analyzed H4R expression in collected GC samples by quantitative PCR, Western blot analysis, and immunostaining. Our results showed that the protein and mRNA levels of HRH4 were reduced in some GC samples, especially in advanced GC samples. Copy number decrease of HRH4 gene was observed (17.6%, 23 out of 131), which was closely correlated with the attenuated expression of H4R. In vitro studies, using gastric cancer cell lines, showed that the alteration of HRH4 expression on gastric cancer cells influences tumor growth upon exposure to histamine. Conclusions/Significance: We show for the first time that deletion of HRH4 gene is present in GC cases and is closely correlated with attenuated gene expression. Down-regulation of HRH4 in gastric carcinomas plays a role in histamine-mediated growth control of GC cells.	[Zhang, Chao; Xiong, Yi; Li, Jiana; Yang, Yang; Liu, Li; Wang, Wen; Wang, Luo; Li, Manhui; Fang, Zhengyu] Shenzhen PKU HKUST Med Ctr, Biomed Res Inst, Shenzhen, Guangdong, Peoples R China	Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center	Zhang, C (corresponding author), Shenzhen PKU HKUST Med Ctr, Biomed Res Inst, Shenzhen, Guangdong, Peoples R China.	fangzy796@gmail.com	Fang, Zhengyu/GRY-6636-2022		National Natural Science Foundation of China [81001173/H1622]; Fundamental Research Plan of Shenzhen City [JC201005260215A]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Plan of Shenzhen City	This work was supported by National Natural Science Foundation of China (81001173/H1622) and Fundamental Research Plan of Shenzhen City(JC201005260215A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMLAND P F, 1987, Tidsskrift for den Norske Laegeforening, V107, P1058; Bach S, 2002, INFECT IMMUN, V70, P988, DOI 10.1128/IAI.70.2.988-992.2002; Backert S, 2005, PROTEOMICS, V5, P3902, DOI 10.1002/pmic.200401240; Blaya Bruno, 2010, Inflammation & Allergy Drug Targets, V9, P146; Boer K, 2008, EUR J CELL BIOL, V87, P227, DOI 10.1016/j.ejcb.2007.12.003; BURTIN C, 1988, LANCET, V2, P1369; BURTIN C, 1982, BRIT J CANCER, V45, P54, DOI 10.1038/bjc.1982.7; Campanella GSV, 2008, P NATL ACAD SCI USA, V105, P4814, DOI 10.1073/pnas.0801544105; Ciacci C, 1996, DIGEST DIS SCI, V41, P972, DOI 10.1007/BF02091539; Cianchi F, 2005, CLIN CANCER RES, V11, P6807, DOI 10.1158/1078-0432.CCR-05-0675; Cricco GP, 2008, INFLAMM RES, V57, pS23, DOI 10.1007/s00011-007-0611-5; de Esch IJP, 2005, TRENDS PHARMACOL SCI, V26, P462, DOI 10.1016/j.tips.2005.07.002; Fang ZY, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-195; Fang ZY, 2011, PATHOL ONCOL RES, V17, P657, DOI 10.1007/s12253-010-9359-2; Fukushima Yasushi, 2004, Nihon Rinsho, V62, P551; Knosel T, 2003, HISTOPATHOLOGY, V43, P323, DOI 10.1046/j.1365-2559.2003.01720.x; Lassmann S, 2007, J MOL MED-JMM, V85, P289, DOI 10.1007/s00109-006-0126-5; Malaviya R, 2000, LEUKEMIA LYMPHOMA, V36, P367, DOI 10.3109/10428190009148858; Medina MA, 1999, BIOCHEM PHARMACOL, V57, P1341, DOI 10.1016/S0006-2952(99)00005-2; Medina V, 2008, CANCER BIOL THER, V7, P28, DOI 10.4161/cbt.7.1.5123; Molnar EL, 2001, INFLAMM RES, V50, pS102; NIELSEN HJ, 1991, ACTA CHIR-EUR J SURG, V157, P437; Petit-Bertron AF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006504; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sakakura C, 1999, GENE CHROMOSOME CANC, V24, P299, DOI 10.1002/(SICI)1098-2264(199904)24:4<299::AID-GCC2>3.0.CO;2-U; Sander LE, 2006, GUT, V55, P498, DOI 10.1136/gut.2004.061762; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Speleman F, 2008, CYTOGENET GENOME RES, V123, P176, DOI 10.1159/000184706; SUONIO E, 1994, AGENTS ACTIONS, V41, pC118, DOI 10.1007/BF02007793; Takaishi S, 2005, GASTROENTEROLOGY, V128, P1965, DOI 10.1053/j.gastro.2005.03.027; Thurmond RL, 2008, NAT REV DRUG DISCOV, V7, P41, DOI 10.1038/nrd2465; Yamamoto S, 2010, GENE CHROMOSOME CANC, V49, P487, DOI 10.1002/gcc.20759; Yu B, 2010, BRIT J DERMATOL, V163, P935, DOI 10.1111/j.1365-2133.2010.09928.x	33	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31207	10.1371/journal.pone.0031207	http://dx.doi.org/10.1371/journal.pone.0031207			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363581	gold, Green Published, Green Submitted			2022-12-27	WOS:000302871500029
J	Van Gameren-Oosterom, HBM; Van Dommelen, P; Oudesluys-Murphy, AM; Buitendijk, SE; Van Buuren, S; Van Wouwe, JP				Van Gameren-Oosterom, Helma B. M.; Van Dommelen, Paula; Oudesluys-Murphy, Anne Marie; Buitendijk, Simone E.; Van Buuren, Stef; Van Wouwe, Jacobus P.			Healthy Growth in Children with Down Syndrome	PLOS ONE			English	Article							BODY-MASS INDEX; HEAD CIRCUMFERENCE; DUTCH CHILDREN; HEIGHT; WEIGHT; CURVES; CHARTS; BIRTH; REFERENCES; CARE	Objective: To provide cross-sectional height and head circumference (HC) references for healthy Dutch children with Down syndrome (DS), while considering the influence of concomitant disorders on their growth, and to compare growth between children with DS and children from the general population. Study design: Longitudinal growth and medical data were retrospectively collected from medical records in 25 of the 30 regional hospital-based outpatient clinics for children with DS in the Netherlands. Children with Trisomy 21 karyotype of Dutch descent born after 1982 were included. The LMS method was applied to fit growth references. Results: We enrolled 1,596 children, and collected 10,558 measurements for height and 1,778 for HC. Children with DS without concomitant disorders (otherwise healthy children) and those suffering only from mild congenital heart defects showed similar growth patterns. The established growth charts, based on all measurements of these two groups, demonstrate the three age periods when height differences between children with and without DS increase: during pregnancy, during the first three years of life, and during puberty. This growth pattern results in a mean final height of 163.4 cm in boys and 151.8 cm in girls (-2.9 standard deviation (SD) and -3.0 SD on general Dutch charts, respectively). Mean HC (0 to 15 months) was 2 SD less than in the general Dutch population. The charts are available at www.tno.nl/growth. Conclusions: Height and HC references showed that growth retardation in otherwise healthy children with DS meanly occurs in three critical periods of growth, resulting in shorter final stature and smaller HC than the general Dutch population shows. With these references, health care professionals can optimize their preventive care: monitoring growth of individual children with DS optimal, so that growth retarding comorbidities can be identified early, and focusing on the critical age periods to establish ways to optimize growth.	[Van Gameren-Oosterom, Helma B. M.; Van Wouwe, Jacobus P.] Netherlands Org Appl Sci Res TNO, Dept Child Hlth, Leiden, Netherlands; [Van Gameren-Oosterom, Helma B. M.; Van Dommelen, Paula; Van Buuren, Stef] Netherlands Org Appl Sci Res TNO, Dept Life Style, Leiden, Netherlands; [Oudesluys-Murphy, Anne Marie] Leiden Univ, Dept Pediat, Med Ctr, Leiden, Netherlands; [Van Buuren, Stef] Univ Utrecht, Dept Methodol & Stat, FSS, Utrecht, Netherlands	Netherlands Organization Applied Science Research; Netherlands Organization Applied Science Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University	Van Gameren-Oosterom, HBM (corresponding author), Netherlands Org Appl Sci Res TNO, Dept Child Hlth, Leiden, Netherlands.	helma.vangameren@tno.nl	Van Wouwe, Jacobus P/D-5549-2018	Van Wouwe, Jacobus P/0000-0001-9273-6258; Oudesluys-Murphy, Anne Marie/0000-0003-2282-0571; van Buuren, Stef/0000-0003-1098-2119	Netherlands Organization for Health Research and Development (ZonMw) [150020031]; Tamarinde foundation (Stichting Tamarinde); Netherlands Organisation for Scientific Research (NWO)	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Tamarinde foundation (Stichting Tamarinde); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The study is financially supported by grant 150020031 from the Netherlands Organization for Health Research and Development (ZonMw) and by the Tamarinde foundation (Stichting Tamarinde). An additional funding is received for open access publication from the Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the maunscript.	Al Husain M, 2003, INT J CLIN PRACT, V57, P170; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Cole TJ, 1998, STAT MED, V17, P407, DOI 10.1002/(SICI)1097-0258(19980228)17:4&lt;407::AID-SIM742&gt;3.0.CO;2-L; Cole TJ, 1999, ANN HUM BIOL, V26, P303, DOI 10.1080/030144699282633; Cremers MJG, 1996, J INTELL DISABIL RES, V40, P412; CRONK C, 1988, PEDIATRICS, V81, P102; CRONK CE, 1978, PEDIATRICS, V61, P564; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Fredriks AM, 2000, PEDIATR RES, V47, P316, DOI 10.1203/00006450-200003000-00006; Fredriks AM, 2004, ACTA PAEDIATR, V93, P817, DOI 10.1111/j.1651-2227.2004.tb03024.x; Fredriks AM, 2002, GROWTH CHARTS MANUAL; Grote FK, 2008, ARCH DIS CHILD, V93, P212, DOI 10.1136/adc.2007.120188; Hermanussen M, 2003, HORM RES, V59, P180, DOI 10.1159/000069321; Kamphuis Mascha, 2010, Ned Tijdschr Geneeskd, V154, pA2366; KARLBERG J, 1987, STAT MED, V6, P185, DOI 10.1002/sim.4780060210; Kimura J, 2003, ACTA PAEDIATR, V92, P1039, DOI 10.1080/08035250310004306; LYON AJ, 1985, ARCH DIS CHILD, V60, P932, DOI 10.1136/adc.60.10.932; Meguid N A, 2004, East Mediterr Health J, V10, P106; Myrelid A, 2002, ARCH DIS CHILD, V87, P97, DOI 10.1136/adc.87.2.97; PALMER CGS, 1992, AM J MED GENET, V42, P61, DOI 10.1002/ajmg.1320420114; PIRO E, 1990, AM J MED GENET, P66; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; Styles ME, 2002, ARCH DIS CHILD, V87, P104, DOI 10.1136/adc.87.2.104; Talma H, 2010, GROWTH CHARTS 2010 M; Toledo C, 1999, ANN GENET-PARIS, V42, P81; van Buuren S, 2001, STAT MED, V20, P1259, DOI 10.1002/sim.746; van Buuren S, 2008, ARCH DIS CHILD, V93, P549, DOI 10.1136/adc.2007.136010; van Dommelen P, 2012, ARCH DIS CHILD, V97, DOI 10.1136/archdischild-2011-301095; Van Wouwe JP, 2001, NED TIJDSCHR GENEES, V145, P1617; Weijerman ME, 2010, EUR J PEDIATR, V169, P1195, DOI 10.1007/s00431-010-1200-0	30	32	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31079	10.1371/journal.pone.0031079	http://dx.doi.org/10.1371/journal.pone.0031079			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363551	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600108
J	Lewis, V; Whitehouse, IJ; Baybutt, H; Manson, JC; Collins, SJ; Hooper, NM				Lewis, Victoria; Whitehouse, Isobel J.; Baybutt, Herbert; Manson, Jean C.; Collins, Steven J.; Hooper, Nigel M.			Cellular Prion Protein Expression Is Not Regulated by the Alzheimer's Amyloid Precursor Protein Intracellular Domain	PLOS ONE			English	Article							WILD-TYPE; TRANSCRIPTIONAL CONTROL; DISEASE; APP; COEXISTENCE; IMPAIRMENT; MECHANISMS; NEPRILYSIN; BRAIN; RISK	There is increasing evidence of molecular and cellular links between Alzheimer's disease (AD) and prion diseases. The cellular prion protein, PrPC, modulates the posttranslational processing of the AD amyloid precursor protein (APP), through its inhibition of the beta-secretase BACE1, and oligomers of amyloid-beta bind to PrPC which may mediate amyloid-beta neurotoxicity. In addition, the APP intracellular domain (AICD), which acts as a transcriptional regulator, has been reported to control the expression of PrPC. Through the use of transgenic mice, cell culture models and manipulation of APP expression and processing, this study aimed to clarify the role of AICD in regulating PrPC. Overexpression of the three major isoforms of human APP (APP(695), APP(751) and APP(770)) in cultured neuronal and non-neuronal cells had no effect on the level of endogenous PrPC. Furthermore, analysis of brain tissue from transgenic mice over-expressing either wild type or familial AD associated mutant human APP revealed unaltered PrPC levels. Knockdown of endogenous APP expression in cells by siRNA or inhibition of gamma-secretase activity also had no effect on PrPC levels. Overall, we did not detect any significant difference in the expression of PrPC in any of the cell or animal-based paradigms considered, indicating that the control of cellular PrPC levels by AICD is not as straightforward as previously suggested.	[Lewis, Victoria; Whitehouse, Isobel J.; Hooper, Nigel M.] Univ Leeds, Inst Mol & Cellular Biol, Fac Biol Sci, Leeds, W Yorkshire, England; [Lewis, Victoria; Collins, Steven J.] Univ Edinburgh, Neuropathogenesis Unit, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland; [Baybutt, Herbert; Manson, Jean C.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia	University of Leeds; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Melbourne	Lewis, V (corresponding author), Univ Leeds, Inst Mol & Cellular Biol, Fac Biol Sci, Leeds, W Yorkshire, England.	n.m.hooper@leeds.ac.uk		manson, jean/0000-0002-0175-9890; Lewis, Victoria/0000-0003-2936-6308; Hooper, Nigel/0000-0002-5811-3484	Medical Research Council [G0802189]; Alzheimer's Research UK; NHMRC (National Health and Medical Research Council) [567123, 400183]; BBSRC [BBS/E/D/20251969, BBS/E/D/20251968, BBS/E/D/20251967] Funding Source: UKRI; MRC [G0802189] Funding Source: UKRI; Alzheimers Research UK [ART-PPG2009B-8] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BBS/E/D/20251969, BBS/E/D/20251967, BBS/E/D/20251968] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); NHMRC (National Health and Medical Research Council)(National Health and Medical Research Council (NHMRC) of Australia); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors gratefully acknowledge the financial support of the Medical Research Council (G0802189 to NMH) and Alzheimer's Research UK (NMH and JCM). VL is supported by NHMRC (National Health and Medical Research Council) Training Fellowship (#567123). SJC is supported by NHMRC Practitioner Fellowship (#400183). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Barnham KJ, 2006, TRENDS BIOCHEM SCI, V31, P465, DOI 10.1016/j.tibs.2006.06.006; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Belyaev ND, 2010, J BIOL CHEM, V285, P41443, DOI 10.1074/jbc.M110.141390; Belyaev ND, 2009, EMBO REP, V10, P94, DOI 10.1038/embor.2008.222; BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Checler F, 2002, TRENDS NEUROSCI, V25, P616, DOI 10.1016/S0166-2236(02)02263-4; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Del Bo R, 2006, NEUROBIOL AGING, V27, DOI 10.1016/j.neurobiolaging.2005.05.025; DESLYS JP, 1994, J GEN VIROL, V75, P23, DOI 10.1099/0022-1317-75-1-23; Freir DB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1341; Gacia M, 2006, J NEURAL TRANSM, V113, P1747, DOI 10.1007/s00702-006-0540-4; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Goodger ZV, 2009, J CELL SCI, V122, P3703, DOI 10.1242/jcs.048090; Griffiths HH, 2011, J BIOL CHEM, V286, P33489, DOI 10.1074/jbc.M111.278556; Hainfellner JA, 1998, ACTA NEUROPATHOL, V96, P116, DOI 10.1007/s004010050870; Hoey SE, 2009, J NEUROSCI, V29, P4442, DOI 10.1523/JNEUROSCI.6017-08.2009; Kellett KAB, 2009, PRION, V3, P190, DOI 10.4161/pri.3.4.9980; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Morales R, 2010, J NEUROSCI, V30, P4528, DOI 10.1523/JNEUROSCI.5924-09.2010; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nishida N, 2000, J VIROL, V74, P320, DOI 10.1128/JVI.74.1.320-325.2000; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Riemenschneider M, 2004, NEUROLOGY, V63, P364, DOI 10.1212/01.WNL.0000130198.72589.69; Takahashi RH, 2010, NEUROPATHOLOGY, V3; TANAKA S, 1988, BIOCHEM BIOPH RES CO, V157, P472, DOI 10.1016/S0006-291X(88)80273-0; Taylor DR, 2007, SEMIN CELL DEV BIOL, V18, P638, DOI 10.1016/j.semcdb.2007.07.008; Tsuchiya K, 2004, NEUROPATHOLOGY, V24, P46, DOI 10.1111/j.1440-1789.2003.00513.x; Vardy ERLC, 2005, TRENDS MOL MED, V11, P464, DOI 10.1016/j.molmed.2005.08.004; Vincent B, 2009, J NEUROSCI, V29, P6752, DOI 10.1523/JNEUROSCI.0789-09.2009; Voigtlander T, 2001, ACTA NEUROPATHOL, V101, P417; Windl O, 1996, HUM GENET, V98, P259, DOI 10.1007/s004390050204; Wisniewski T, 2007, FEBS J, V274, P3784, DOI 10.1111/j.1742-4658.2007.05919.x	37	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31754	10.1371/journal.pone.0031754	http://dx.doi.org/10.1371/journal.pone.0031754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363722	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700090
J	Miranda, NAF; Perissinotto, R				Miranda, Nelson A. F.; Perissinotto, Renzo			Stable Isotope Evidence for Dietary Overlap between Alien and Native Gastropods in Coastal Lakes of Northern KwaZulu-Natal, South Africa	PLOS ONE			English	Article							TAREBIA-GRANIFERA LAMARCK; POTAMOPYRGUS-ANTIPODARUM; GUT CONTENT; COMPETITIVE INTERACTIONS; BIOMPHALARIA-GLABRATA; BIOLOGICAL-CONTROL; THIARA-GRANIFERA; MIXING MODELS; SNAILS; HABITATS	Background: Tarebia granifera (Lamarck, 1822) is originally from South-East Asia, but has been introduced and become invasive in many tropical and subtropical parts of the world. In South Africa, T. granifera is rapidly invading an increasing number of coastal lakes and estuaries, often reaching very high population densities and dominating shallow water benthic invertebrate assemblages. An assessment of the feeding dynamics of T. granifera has raised questions about potential ecological impacts, specifically in terms of its dietary overlap with native gastropods. Methodology/Principal Findings: A stable isotope mixing model was used together with gut content analysis to estimate the diet of T. granifera and native gastropod populations in three different coastal lakes. Population density, available biomass of food and salinity were measured along transects placed over T. granifera patches. An index of isotopic (stable isotopes) dietary overlap (IDO, %) aided in interpreting interactions between gastropods. The diet of T. granifera was variable, including contributions from microphytobenthos, filamentous algae (Cladophora sp.), detritus and sedimentary organic matter. IDO was significant (>60%) between T. granifera and each of the following gastropods: Haminoea natalensis (Krauss, 1848), Bulinus natalensis (Kuster, 1841) and Melanoides tuberculata (Muller, 1774). However, food did not appear to be limiting. Salinity influenced gastropod spatial overlap. Tarebia granifera may only displace native gastropods, such as Assiminea cf. ovata (Krauss, 1848), under salinity conditions below 20. Ecosystem-level impacts are also discussed. Conclusion/Significance: The generalist diet of T. granifera may certainly contribute to its successful establishment. However, although competition for resources may take place under certain salinity conditions and if food is limiting, there appear to be other mechanisms at work, through which T. granifera displaces native gastropods. Complementary stable isotope and gut content analysis can provide helpful ecological insights, contributing to monitoring efforts and guiding further invasive species research.	[Miranda, Nelson A. F.; Perissinotto, Renzo] Univ KwaZulu Natal, Sch Biol & Conservat Sci, Durban, South Africa	University of Kwazulu Natal	Miranda, NAF (corresponding author), Univ KwaZulu Natal, Sch Biol & Conservat Sci, Durban, South Africa.	204507499@ukzn.ac.za	Miranda, Nelson/H-9349-2013	Miranda, Nelson/0000-0002-9308-6688	National Research Foundation, South Africa, Marine and Coastal Management (DEAT-MCM); World Wide Fund for Nature (WWF)	National Research Foundation, South Africa, Marine and Coastal Management (DEAT-MCM); World Wide Fund for Nature (WWF)	Funding was provided by the National Research Foundation, South Africa, Marine and Coastal Management (DEAT-MCM) and the World Wide Fund for Nature (WWF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT RT, 1952, P US NATL MUS, V102, P72; Aberle N, 2005, FRESHWATER BIOL, V50, P369, DOI 10.1111/j.1365-2427.2004.01325.x; Alfaro AC, 2008, ESTUAR COAST SHELF S, V79, P718, DOI 10.1016/j.ecss.2008.06.016; ALLANSON BR, 1979, MONOGRAPHIAE BIOL, V36, P42; Antonio ES, 2010, ESTUAR COAST SHELF S, V86, P401, DOI 10.1016/j.ecss.2009.05.010; Appleton C. C., 2003, African Journal of Aquatic Science, V28, P69, DOI 10.2989/16085914.2003.9626602; Appleton C.C., 2002, P42; Appleton C. C., 2009, Zoologische Mededelingen (Leiden), V83, P525; Appleton CC, 2005, INVASIVE FRESHWATER; BARNESE LE, 1990, J N AM BENTHOL SOC, V9, P35, DOI 10.2307/1467932; Bate GC, 2008, ENVIRON GEOL, V55, P1089, DOI 10.1007/s00254-007-1057-3; BEGG GW, 1980, STUDIES ECOLOGY MAPU; Ben-Ami F, 2006, NAUTILUS, V120, P156; Ben-David M, 2001, OECOLOGIA, V127, P180, DOI 10.1007/s004420000570; BOLTT RE, 1975, T ROY SOC S AFR, V41, P295, DOI 10.1080/00359197509519445; Brenneis VEF, 2010, OIKOS, V119, P1755, DOI 10.1111/j.1600-0706.2010.18471.x; BROWN KM, 1982, ECOLOGY, V63, P412, DOI 10.2307/1938959; Bruton M.N., 1980, P382; BRUTON MN, 1975, J FISH BIOL, V7, P423, DOI 10.1111/j.1095-8649.1975.tb04618.x; Bruton MN, 1975, SCIENTIAE, V16, P18; Carlsson Nils O.L., 2006, P61; Caut S, 2008, J APPL ECOL, V45, P428, DOI 10.1111/j.1365-2664.2007.01438.x; Caut S, 2006, ECOL APPL, V16, P1893, DOI 10.1890/1051-0761(2006)016[1893:CSIWBT]2.0.CO;2; CHANIOTIS B N, 1980, Caribbean Journal of Science, V16, P81; Clarke LR, 2005, ECOL FRESHW FISH, V14, P267, DOI 10.1111/j.1600-0633.2005.00103.x; Coat S, 2009, FRESHWATER BIOL, V54, P1028, DOI 10.1111/j.1365-2427.2008.02149.x; Dawson T.E, 2007, STABLE ISOTOPES INDI; de Kock Kenne N., 2006, African Journal of Aquatic Science, V31, P63, DOI 10.2989/16085910609503872; Doi H, 2010, J MOLLUS STUD, V76, P384, DOI 10.1093/mollus/eyq020; Fang L, 2010, FRESHWATER BIOL, V55, P1191, DOI 10.1111/j.1365-2427.2009.02343.x; FRY B, 1984, CONTRIB MAR SCI, V27, P13; Gabler HM, 2010, AQUAT ECOL, V44, P325, DOI 10.1007/s10452-009-9243-x; Gearing JN, 1991, STUDY DIET TROPHIC R; Genner MJ, 2008, BIOL INVASIONS, V10, P41, DOI 10.1007/s10530-007-9105-1; Genner MJ, 2007, MOL ECOL, V16, P517, DOI 10.1111/j.1365-294X.2006.03171.x; Genner MJ, 2004, MOL ECOL, V13, P2135, DOI 10.1111/j.1365-294X.2004.02222.x; GOMEZ JD, 1990, TROP MED PARASITOL, V41, P43; Grosholz E, 2002, TRENDS ECOL EVOL, V17, P22, DOI 10.1016/S0169-5347(01)02358-8; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; HART RC, 1979, LAKE SIBAYA, V36, P108; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Humphries P, 2003, DROUGHT AQUATIC ECOS, P1141; KAWATA M, 1992, OECOLOGIA, V91, P245, DOI 10.1007/BF00317791; Kerans BL, 2005, J N AM BENTHOL SOC, V24, P123, DOI 10.1899/0887-3593(2005)024<0123:PADDAE>2.0.CO;2; KILHAM P, 1982, AM MIDL NAT, V108, P202, DOI 10.2307/2425311; Kiljunen M, 2006, J APPL ECOL, V43, P1213, DOI 10.1111/j.1365-2664.2006.01224.x; Krebs C.J., 2014, ECOLOGICAL METHODOLO; Kurata K, 2001, MAR ECOL PROG SER, V223, P167, DOI 10.3354/meps223167; Larned ST, 2001, BIOTROPICA, V33, P241, DOI 10.1111/j.1744-7429.2001.tb00175.x; Lockwood JL, 2007, INVASION ECOLOGY; Lopez-Lopez Eugenia, 2009, Aquatic Invasions, V4, P435, DOI 10.3391/ai.2009.4.3.2; MacKay F, 2010, ESTUAR COAST SHELF S, V86, P553, DOI 10.1016/j.ecss.2009.11.011; MACNAE WILLIAM, 1962, ANN NATAL MUS, V15, P183; MADSEN H, 1992, HYDROBIOLOGIA, V228, P203, DOI 10.1007/BF00006587; Malaquias MAE, 2004, J MAR BIOL ASSOC UK, V84, P767, DOI 10.1017/S0025315404009890h; Mantel SMK, 2004, J N AM BENTHOL SOC, V23, P728, DOI 10.1899/0887-3593(2004)023<0728:FSIATA>2.0.CO;2; McCarthy TS, 1998, AFR J ECOL, V36, P44, DOI 10.1046/j.1365-2028.1998.89-89089.x; McIntyre PB, 2006, OECOLOGIA, V148, P12, DOI 10.1007/s00442-005-0354-3; Miranda NAF, 2010, S AFR J SCI, V106, P55, DOI 10.4102/sajs.v106i3/4.156; Miranda NAF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024337; Miranda NAF, 2011, ESTUAR COAST SHELF S, V91, P442, DOI 10.1016/j.ecss.2010.11.007; Pape E, 2008, ESTUAR COAST SHELF S, V76, P797, DOI 10.1016/j.ecss.2007.08.007; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; PEREZ JG, 1991, MEM I OSWALDO CRUZ, V86, P341, DOI 10.1590/S0074-02761991000300008; Perissinotto R, 2010, MAR ECOL PROG SER, V405, P147, DOI 10.3354/meps08542; Peterson BJ, 1999, ACTA OECOL, V20, P479, DOI 10.1016/S1146-609X(99)00120-4; Phillips DL, 2005, OECOLOGIA, V144, P520, DOI [10.1007/s00442-004-1816-8, 10.1007/s000442-004-1816-8]; Pillay D, 2009, J EXP MAR BIOL ECOL, V380, P47, DOI 10.1016/j.jembe.2009.08.016; Pointier JP, 2000, ACTA TROP, V77, P53, DOI 10.1016/S0001-706X(00)00123-6; Pointier JP, 1999, MALACOLOGIA, V41, P403; POINTIER JP, 2003, XENOPHORA, V104, P14; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Reise K, 2006, HELGOLAND MAR RES, V60, P77, DOI 10.1007/s10152-006-0024-9; Rudnick D, 2005, FRESHWATER BIOL, V50, P1323, DOI 10.1111/j.1365-2427.2005.01398.x; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Schreiber E. S. G., 2002, Biological Invasions, V4, P317, DOI 10.1023/A:1020925022843; Seuffert ME, 2010, BIOL INVASIONS, V12, P1695, DOI 10.1007/s10530-009-9582-5; Strickland J.D.H., 1972, B FISH RES BOARD CAN, V167, P1; Taylor Ricky, 2006, African Journal of Aquatic Science, V31, P31, DOI 10.2989/16085910609503869; Vander Zanden MJ, 1999, NATURE, V401, P464, DOI 10.1038/46762; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; WIENS JA, 1993, TRENDS ECOL EVOL, V8, P348, DOI 10.1016/0169-5347(93)90216-C; Winsome T, 2006, APPL SOIL ECOL, V32, P38, DOI 10.1016/j.apsoil.2005.01.008; Wojdak JM, 2005, ECOL MONOGR, V75, P489, DOI 10.1890/04-1174; Wong PK, 2009, BIOL INVASIONS, V11, P2223, DOI 10.1007/s10530-008-9378-z; Zambrano L, 2010, BIOL INVASIONS, V12, P3061, DOI 10.1007/s10530-010-9697-8; Zambrano L, 2010, HYDROBIOLOGIA, V646, P327, DOI 10.1007/s10750-010-0182-2	90	32	34	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31897	10.1371/journal.pone.0031897	http://dx.doi.org/10.1371/journal.pone.0031897			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363764	Green Submitted, Green Published, gold			2022-12-27	WOS:000302873700118
J	Reddy, SB; Anders, RF; Beeson, JG; Farnert, A; Kironde, F; Berenzon, SK; Wahlgren, M; Linse, S; Persson, KEM				Reddy, Sreenivasulu B.; Anders, Robin F.; Beeson, James G.; Farnert, Anna; Kironde, Fred; Berenzon, Sharon Kuhlman; Wahlgren, Mats; Linse, Sara; Persson, Kristina E. M.			High Affinity Antibodies to Plasmodium falciparum Merozoite Antigens Are Associated with Protection from Malaria	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; SURFACE PROTEIN-2 MSP2; AMYLOID-LIKE FIBRILS; THIOCYANATE ELUTION; MONOCLONAL-ANTIBODY; IMMUNE-RESPONSE; REDUCED RISK; VACCINE; FORMS; DIVERSITY	Background: Malaria kills almost 1 million people every year, but the mechanisms behind protective immunity against the disease are still largely unknown. Methodology/Principal Findings: In this study, surface plasmon resonance technology was used to evaluate the affinity (measured as k(d)) of naturally acquired antibodies to the Plasmodium falciparum antigens MSP2 and AMA1. Antibodies in serum samples from residents in endemic areas bound with higher affinities to AMA1 than to MSP2, and with higher affinities to the 3D7 allele of MSP2-3D7 than to the FC27 allele. The affinities against AMA1 and MSP2-3D7 increased with age, and were usually within similar range as the affinities for the monoclonal antibodies also examined in this study. The finding of MSP2-3D7 type parasites in the blood was associated with a tendency for higher affinity antibodies to both forms of MSP2 and AMA1, but this was significant only when analyzing antibodies against MSP2-FC27, and individuals infected with both allelic forms of MSP2 at the same time showed the highest affinities. Individuals with the highest antibody affinities for MSP2-3D7 at baseline had a prolonged time to clinical malaria during 40 weeks of follow-up, and among individuals who were parasite positive at baseline higher antibody affinities to all antigens were seen in the individuals that did not experience febrile malaria during follow up. Conclusions/Significance: This study contributes important information for understanding how immunity against malaria arises. The findings suggest that antibody affinity plays an important role in protection against disease, and differs between antigens. In light of this information, antibody affinity measurements would be a key assessment in future evaluation of malaria vaccine formulations.	[Reddy, Sreenivasulu B.; Wahlgren, Mats; Persson, Kristina E. M.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden; [Anders, Robin F.] La Trobe Univ, Dept Biochem, Melbourne, Vic, Australia; [Beeson, James G.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Beeson, James G.] Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic, Australia; [Farnert, Anna] Karolinska Inst, Karolinska Univ Hosp, Dept Med Solna, Infect Dis Unit, Stockholm, Sweden; [Kironde, Fred] Makerere Univ, Dept Biochem, Kampala, Uganda; [Berenzon, Sharon Kuhlman] Swedish Inst Infect Dis Control, Solna, Sweden; [Linse, Sara] Lund Univ, Dept Biochem & Struct Biol, Lund, Sweden	Karolinska Institutet; La Trobe University; Royal Melbourne Hospital; Walter & Eliza Hall Institute; Burnet Institute; Karolinska Institutet; Karolinska University Hospital; Makerere University; Swedish Institute for Infectious Disease Control; Lund University	Reddy, SB (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden.	kristina.persson@ki.se	Kühlmann-Berenzon, Sharon/J-1554-2019	Kühlmann-Berenzon, Sharon/0000-0002-8138-1196; Persson, Kristina E M/0000-0003-2661-3115; Farnert, Anna/0000-0001-7583-282X; Anders, Robin/0000-0002-0693-4547; Linse, Sara/0000-0001-9629-7109	Wenner-Gren Stiftelserna; Vinnova; Jeanssons Stiftelser; Svenska Lakaresallskapet; Stiftelsen Groschinskys Minnesfond; OE och Edla Johanssons Vetenskapliga Stiftelse; Swedish International Development Agency; Ake Wibergs Stiftelse; Magnus Bergvalls Stiftelse	Wenner-Gren Stiftelserna; Vinnova(Vinnova); Jeanssons Stiftelser; Svenska Lakaresallskapet; Stiftelsen Groschinskys Minnesfond; OE och Edla Johanssons Vetenskapliga Stiftelse; Swedish International Development Agency; Ake Wibergs Stiftelse; Magnus Bergvalls Stiftelse	Financial support has been granted from Wenner-Gren Stiftelserna, Vinnova, Jeanssons Stiftelser, Svenska Lakaresallskapet, Stiftelsen Groschinskys Minnesfond, OE och Edla Johanssons Vetenskapliga Stiftelse, Swedish International Development Agency, Ake Wibergs Stiftelse, and Magnus Bergvalls Stiftelse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach P, 2004, J CLIN INVEST, V114, P589, DOI 10.1172/JCI200421307; Adda CG, 2009, MOL BIOCHEM PARASIT, V166, P159, DOI 10.1016/j.molbiopara.2009.03.012; ANDERS RF, 1986, PARASITE IMMUNOL, V8, P529, DOI 10.1111/j.1365-3024.1986.tb00867.x; [Anonymous], 2009, WORLD MAL REP 2009; Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; Bargieri DY, 2007, MEM I OSWALDO CRUZ, V102, P313, DOI 10.1590/S0074-02762007005000039; Bereczky S, 2004, INT J PARASITOL, V34, P935, DOI 10.1016/j.ijpara.2004.04.007; Bereczky S, 2007, MICROBES INFECT, V9, P103, DOI 10.1016/j.micinf.2006.10.014; Breukels MA, 2002, CLIN INFECT DIS, V34, P191, DOI 10.1086/338259; Chesne-Seck ML, 2005, MOL BIOCHEM PARASIT, V144, P55, DOI 10.1016/j.molbiopara.2005.07.007; Coley AM, 2001, PROTEIN ENG, V14, P691, DOI 10.1093/protein/14.9.691; Coley AM, 2007, PLOS PATHOG, V3, P1308, DOI 10.1371/journal.ppat.0030138; Demanga CG, 2010, INFECT IMMUN, V78, P486, DOI 10.1128/IAI.01359-08; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Engelbrecht F, 2000, ACTA TROP, V74, P63, DOI 10.1016/S0001-706X(99)00044-3; FERREIRA MU, 1995, J IMMUNOL METHODS, V187, P297, DOI 10.1016/0022-1759(95)00186-4; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Genton B, 2002, J INFECT DIS, V185, P820, DOI 10.1086/339342; Goldblatt D, 1998, J INFECT DIS, V177, P1112, DOI 10.1086/517407; Guevara-Patino JA, 1997, J EXP MED, V186, P1689, DOI 10.1084/jem.186.10.1689; Hearty S, 2010, EXPERT REV VACCINES, V9, P645, DOI [10.1586/erv.10.52, 10.1586/ERV.10.52]; Henderson KA, 2007, STRUCTURE, V15, P1452, DOI 10.1016/j.str.2007.09.011; Henning L, 2004, T ROY SOC TROP MED H, V98, P687, DOI 10.1016/j.trstmh.2004.03.010; Hodder AN, 2001, INFECT IMMUN, V69, P3286, DOI 10.1128/IAI.69.5.3286-3294.2001; HOMMEL M, 1988, BIOL CELL, V64, P183, DOI 10.1016/0248-4900(88)90078-0; Iber D, 2001, AFFINITY MATURATION; Igonet S, 2007, J MOL BIOL, V366, P1523, DOI 10.1016/j.jmb.2006.12.028; KARUSH F, 1970, ANN NY ACAD SCI, V169, P56, DOI 10.1111/j.1749-6632.1970.tb55970.x; Kusi KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008110; Lv JP, 2006, ALZ DIS ASSOC DIS, V20, P127, DOI 10.1097/00002093-200607000-00001; MACDONALD RA, 1988, J IMMUNOL METHODS, V106, P191, DOI 10.1016/0022-1759(88)90196-2; Manivel V, 2000, IMMUNITY, V13, P611, DOI 10.1016/S1074-7613(00)00061-3; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; Mayxay M, 2001, AM J TROP MED HYG, V65, P918, DOI 10.4269/ajtmh.2001.65.918; Mwingira F, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-79; NARUM DL, 1994, MOL BIOCHEM PARASIT, V67, P59, DOI 10.1016/0166-6851(94)90096-5; Normark J, 2007, P NATL ACAD SCI USA, V104, P15835, DOI 10.1073/pnas.0610485104; Persson KEM, 2008, J CLIN INVEST, V118, P342, DOI 10.1172/JCI32138; Peyerl-Hoffmann G, 2001, TROP MED INT HEALTH, V6, P607, DOI 10.1046/j.1365-3156.2001.00761.x; Plassmeyer ML, 2009, J BIOL CHEM, V284, P26951, DOI 10.1074/jbc.M109.013706; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; Proietti C, 2011, AM J TROP MED HYG, V84, P830, DOI 10.4269/ajtmh.2011.10-0498; PULLEN GR, 1986, J IMMUNOL METHODS, V86, P83, DOI 10.1016/0022-1759(86)90268-1; RAY P, 1994, INFECT IMMUN, V62, P2354, DOI 10.1128/IAI.62.6.2354-2361.1994; Richards JS, 2010, CLIN INFECT DIS, V51, pE50, DOI 10.1086/656413; Richards JS, 2009, IMMUNOL CELL BIOL, V87, P377, DOI 10.1038/icb.2009.27; Saul A, 2005, VACCINE, V23, P3076, DOI 10.1016/j.vaccine.2004.09.040; SAUL A, 1987, PARASITE IMMUNOL, V9, P1, DOI 10.1111/j.1365-3024.1987.tb00483.x; SHIMIZU F, 1978, BRIT J EXP PATHOL, V59, P624; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; SMYTHE JA, 1990, MOL BIOCHEM PARASIT, V39, P227, DOI 10.1016/0166-6851(90)90061-P; Snounou G, 1999, T ROY SOC TROP MED H, V93, P369, DOI 10.1016/S0035-9203(99)90120-7; SOOTHILL JF, 1971, CLIN EXP IMMUNOL, V9, P193; Steward MW, 1983, ANTIBODY AFFINITY TH; Tang Y, 2007, J IMMUNOL, V179, P2815, DOI 10.4049/jimmunol.179.5.2815; Taylor RR, 1998, AM J TROP MED HYG, V58, P406, DOI 10.4269/ajtmh.1998.58.406; THOMAS AW, 1990, MOL BIOCHEM PARASIT, V43, P211, DOI 10.1016/0166-6851(90)90146-D; Uthaipibull C, 2001, J MOL BIOL, V307, P1381, DOI 10.1006/jmbi.2001.4574; Wong SE, 2011, PROTEINS, V79, P821, DOI 10.1002/prot.22920; Yang X, 2007, J PEPT SCI, V13, P839, DOI 10.1002/psc.910; Zhang XC, 2008, J MOL BIOL, V379, P105, DOI 10.1016/j.jmb.2008.03.039	61	43	46	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32242	10.1371/journal.pone.0032242	http://dx.doi.org/10.1371/journal.pone.0032242			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363818	Green Published, gold			2022-12-27	WOS:000302873700159
J	Sun, DL; Chan, CCH; Lee, TMC				Sun, Delin; Chan, Chetwyn C. H.; Lee, Tatia M. C.			Identification and Classification of Facial Familiarity in Directed Lying: An ERP Study	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; HUMAN FACE PERCEPTION; UPSIDE-DOWN FACES; BRAIN POTENTIALS; NEURAL SYSTEMS; RECOGNITION; EXPRESSION; INVERSION; GENDER; WOMEN	Recognizing familiar faces is essential to social functioning, but little is known about how people identify human faces and classify them in terms of familiarity. Face identification involves discriminating familiar faces from unfamiliar faces, whereas face classification involves making an intentional decision to classify faces as "familiar'' or "unfamiliar.'' This study used a directed-lying task to explore the differentiation between identification and classification processes involved in the recognition of familiar faces. To explore this issue, the participants in this study were shown familiar and unfamiliar faces. They responded to these faces (i.e., as familiar or unfamiliar) in accordance with the instructions they were given (i.e., to lie or to tell the truth) while their EEG activity was recorded. Familiar faces (regardless of lying vs. truth) elicited significantly less negative-going N400f in the middle and right parietal and temporal regions than unfamiliar faces. Regardless of their actual familiarity, the faces that the participants classified as "familiar'' elicited more negative-going N400f in the central and right temporal regions than those classified as "unfamiliar.'' The P600 was related primarily with the facial identification process. Familiar faces (regardless of lying vs. truth) elicited more positive-going P600f in the middle parietal and middle occipital regions. The results suggest that N400f and P600f play different roles in the processes involved in facial recognition. The N400f appears to be associated with both the identification (judgment of familiarity) and classification of faces, while it is likely that the P600f is only associated with the identification process (recollection of facial information). Future studies should use different experimental paradigms to validate the generalizability of the results of this study.	[Sun, Delin; Lee, Tatia M. C.] Univ Hong Kong, Neuropsychol Lab, Hong Kong, Hong Kong, Peoples R China; [Sun, Delin; Lee, Tatia M. C.] Univ Hong Kong, Lab Cognit Affect Neurosci, Hong Kong, Hong Kong, Peoples R China; [Chan, Chetwyn C. H.] Hong Kong Polytech Univ, Appl Cognit Neurosci Lab, Dept Rehabil Sci, Hong Kong, Hong Kong, Peoples R China; [Lee, Tatia M. C.] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; Hong Kong Polytechnic University; University of Hong Kong	Sun, DL (corresponding author), Univ Hong Kong, Neuropsychol Lab, Hong Kong, Hong Kong, Peoples R China.	chetwyn.chan@inet.polyu.edu.hk; tmclee@hku.hk	Sun, Delin/H-8070-2019; Sun, Delin/A-4154-2010	Sun, Delin/0000-0003-3283-423X; Sun, Delin/0000-0003-3283-423X; Chan, Chetwyn C. H./0000-0003-0307-6337	University of Hong Kong [201007176233]; Hong Kong Polytechnic University; Research Grant Council [PolyU9/CRF/09]	University of Hong Kong(University of Hong Kong); Hong Kong Polytechnic University(Hong Kong Polytechnic University); Research Grant Council(Hong Kong Research Grants Council)	This project was supported by the May Endowed Professorship of The University of Hong Kong awarded to TMC Lee, a Research and Conference Grant (#201007176233) of The University of Hong Kong awarded to DL Sun, an internal research and development grant from The Hong Kong Polytechnic University awarded to CCH Chan, and the Research Grant Council Collaborative Research Fund (PolyU9/CRF/09) awarded to TMC Lee and CCH Chan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; Bentin S, 2000, COGN NEUROPSYCHOL, V17, P35, DOI 10.1080/026432900380472; Bhatt S, 2009, BRAIN COGNITION, V69, P382, DOI 10.1016/j.bandc.2008.08.033; Boehm SG, 2006, CLIN EEG NEUROSCI, V37, P322, DOI 10.1177/155005940603700410; Boly M, 2011, SCIENCE, V332, P858, DOI 10.1126/science.1202043; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; DIRKS J, 1977, CHILD DEV, V48, P124, DOI 10.2307/1128890; Eimer M, 2000, COGNITIVE BRAIN RES, V10, P145, DOI 10.1016/S0926-6410(00)00038-0; Eimer M, 2000, CLIN NEUROPHYSIOL, V111, P694, DOI 10.1016/S1388-2457(99)00285-0; Einav S, 2008, DEV PSYCHOL, V44, P1655, DOI 10.1037/a0013299; Farrow TFD, 2003, PERCEPT MOTOR SKILL, V97, P451, DOI 10.2466/PMS.97.6.451-460; Fox CJ, 2008, CORTEX, V44, P996, DOI 10.1016/j.cortex.2008.04.003; Gobbini MI, 2007, NEUROPSYCHOLOGIA, V45, P32, DOI 10.1016/j.neuropsychologia.2006.04.015; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Henson RN, 2008, NEUROIMAGE, V40, P884, DOI 10.1016/j.neuroimage.2007.12.003; Hoffmann H, 2010, ACTA PSYCHOL, V135, P278, DOI 10.1016/j.actpsy.2010.07.012; Jemel B, 1999, PSYCHOPHYSIOLOGY, V36, P437; Jemel B, 2003, NEUROREPORT, V14, P525, DOI 10.1097/01.wnr.0000057864.05120.ba; Keller L, 1998, NATURE, V394, P121, DOI 10.1038/28031; Kiebel SJ, 2004, NEUROIMAGE, V22, P492, DOI 10.1016/j.neuroimage.2004.02.012; Kiebel SJ, 2004, NEUROIMAGE, V22, P503, DOI 10.1016/j.neuroimage.2004.02.013; Lee TMY, 2011, NEURAL CORR IN PRESS; Leveroni CL, 2000, J NEUROSCI, V20, P878, DOI 10.1523/JNEUROSCI.20-02-00878.2000; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Proverbio AM, 2006, NEUROPSYCHOLOGIA, V44, P2987, DOI 10.1016/j.neuropsychologia.2006.06.015; Puce A, 1999, CEREB CORTEX, V9, P445, DOI 10.1093/cercor/9.5.445; Rossion B, 2001, J COGNITIVE NEUROSCI, V13, P1019, DOI 10.1162/089892901753165917; SMITH TW, 1992, SOC BIOL, V39, P203; VALENTINE T, 1988, BRIT J PSYCHOL, V79, P471, DOI 10.1111/j.2044-8295.1988.tb02747.x; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474	31	13	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31250	10.1371/journal.pone.0031250	http://dx.doi.org/10.1371/journal.pone.0031250			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926ZM	22363597	Green Published, gold			2022-12-27	WOS:000302873700040
J	Hilton, JF; Barkoff, L; Chang, O; Halperin, L; Ratanawongsa, N; Sarkar, U; Leykin, Y; Munoz, RF; Thom, DH; Kahn, JS				Hilton, Joan F.; Barkoff, Lynsey; Chang, Olivia; Halperin, Lindsay; Ratanawongsa, Neda; Sarkar, Urmimala; Leykin, Yan; Munoz, Ricardo F.; Thom, David H.; Kahn, James S.			A Cross-Sectional Study of Barriers to Personal Health Record Use among Patients Attending a Safety-Net Clinic	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; PRIMARY-CARE; DIGITAL DIVIDE; HIV-INFECTION; DRUG-USE; DISPARITIES; IMPLEMENTATION; SERVICES; PEOPLE; ACCESS	Background: Personal health records (PHR) may improve patients' health by providing access to and context for health information. Among patients receiving care at a safety-net HIV/AIDS clinic, we examined the hypothesis that a mental health (MH) or substance use (SU) condition represents a barrier to engagement with web-based health information, as measured by consent to participate in a trial that provided access to personal (PHR) or general (non-PHR) health information portals and by completion of baseline study surveys posted there. Methods: Participants were individually trained to access and navigate individualized online accounts and to complete study surveys. In response to need, during accrual months 4 to 12 we enhanced participant training to encourage survey completion with the help of staff. Using logistic regression models, we estimated odds ratios for study participation and for survey completion by combined MH/SU status, adjusted for levels of computer competency, on-study training, and demographics. Results: Among 2,871 clinic patients, 70% had MH/SU conditions, with depression (38%) and methamphetamine use (17%) most commonly documented. Middle-aged patients and those with a MH/SU condition were over-represented among study participants (N = 338). Survey completion was statistically independent of MH/SU status (OR, 1.85 [95% CI, 0.93-3.66]) but tended to be higher among those with MH/SU conditions. Completion rates were low among beginner computer users, regardless of training level (<50%), but adequate among advanced users (>70%). Conclusions: Among patients attending a safety-net clinic, MH/SU conditions were not barriers to engagement with web-based health information. Instead, level of computer competency was useful for identifying individuals requiring substantial computer training in order to fully participate in the study. Intensive on-study training was insufficient to enable beginner computer users to complete study surveys.	[Hilton, Joan F.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Barkoff, Lynsey; Chang, Olivia; Halperin, Lindsay; Ratanawongsa, Neda; Sarkar, Urmimala; Kahn, James S.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Barkoff, Lynsey; Chang, Olivia; Halperin, Lindsay; Ratanawongsa, Neda; Sarkar, Urmimala; Kahn, James S.] San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA 94110 USA; [Leykin, Yan; Munoz, Ricardo F.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Thom, David H.] Univ Calif San Francisco, Dept Family & Community Med, San Francisco Gen Hosp, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Hilton, JF (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.	joan@biostat.ucsf.edu	Leykin, Yan/ABE-5502-2021	Leykin, Yan/0000-0002-9851-0142	Commonwealth Fund [20070269]; AHRQ [R18 HS017784-01]; NIH [K24RR024369, MH088341]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R18HS017784] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR024369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH088341] Funding Source: NIH RePORTER; AHRQ [5R18HS017784-02] Funding Source: Federal RePORTER	Commonwealth Fund; AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The study was supported by Commonwealth Fund 20070269; AHRQ R18 HS017784-01; NIH K24RR024369 and MH088341. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball MJ, 2008, STUD HEALTH TECHNOL, V134, P35; Binns P, 2004, HEALTHC PAP, V5, P82; Binns Patrick, 2004, Healthc Pap, V5, P47; Boland P, 2007, J AMBUL CARE MANAG, V30, P126, DOI 10.1097/01.JAC.0000264602.19629.84; Chew-Graham CA, 2002, FAM PRACT, V19, P632, DOI 10.1093/fampra/19.6.632; Cooper H, 2005, ANN EPIDEMIOL, V15, P326, DOI 10.1016/j.annepidem.2004.10.008; Crane HM, 2007, CURR HIV RES, V5, P109, DOI 10.2174/157016207779316369; Craske MG, 2009, DEPRESS ANXIETY, V26, P235, DOI 10.1002/da.20542; Cunningham WE, 2000, J ACQ IMMUN DEF SYND, V25, P115, DOI 10.1097/00126334-200010010-00005; Dearness K L, 2001, Health Info Libr J, V18, P167, DOI 10.1046/j.0265-6647.2001.00344.x; Detmer D, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-45; Estrada AL, 2005, AIDS, V19, pS47, DOI 10.1097/01.aids.0000192070.95819.7c; Farrell SP, 2004, ARCH PSYCHIAT NURS, V18, P121, DOI 10.1016/j.apnu.2004.05.003; Fiscella K, 2005, J AMBUL CARE MANAG, V28, P304, DOI 10.1097/00004479-200510000-00005; Grant RW, 2006, DIABETES TECHNOL THE, V8, P576, DOI 10.1089/dia.2006.8.576; Greasley P, 2000, J Psychiatr Ment Health Nurs, V7, P227, DOI 10.1046/j.1365-2850.2000.00281.x; Herman M, 1997, J ADDICT DIS, V16, P91, DOI 10.1300/J069v16n01_06; Hillestad R, 2005, HEALTH AFFAIR, V24, P1103, DOI 10.1377/hlthaff.24.5.1103; Hirshfield S, 2008, AIDS CARE, V20, P904, DOI 10.1080/09540120701796892; Hsu J, 2005, J AM MED INFORM ASSN, V12, P164, DOI 10.1197/jamia.M1672; Kahn JS, 2010, J AM MED INFORM ASSN, V17, P224, DOI 10.1136/jamia.2009.000315; Kahn JS, 2009, HEALTH AFFAIR, V28, P369, DOI 10.1377/hlthaff.28.2.369; Mooney M, 1998, MEDINFO, V9, P14; Munoz RF, 2009, NICOTINE TOB RES, V11, P1025, DOI 10.1093/ntr/ntp090; Osborn CY, 2007, AM J PREV MED, V33, P374, DOI 10.1016/j.amepre.2007.07.022; Raisinghani Mahesh S, 2008, Int J Electron Healthc, V4, P67, DOI 10.1504/IJEH.2008.018921; Reinke Tom, 2007, Manag Care, V16, P40; Royal SW, 2009, AIDS CARE, V21, P448, DOI 10.1080/09540120802270250; Sarkar U, 2011, J AM MED INFORM ASSN, V18, P318, DOI [10.1136/jamia.2010.006015, 10.1136/amiajnl.2010.006015]; Sarkar U, 2010, J HEALTH COMMUN, V15, P183, DOI 10.1080/10810730.2010.499988; Sohler N, 2007, PUBLIC HEALTH REP, V122, P347, DOI 10.1177/003335490712200308; Sohler NL, 2007, AIDS PATIENT CARE ST, V21, pS68, DOI 10.1089/apc.2007.9985; Tang PC, 2006, J AM MED INFORM ASSN, V13, P121, DOI 10.1197/jamia.M2025; Viswanath K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014550	34	19	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31888	10.1371/journal.pone.0031888	http://dx.doi.org/10.1371/journal.pone.0031888			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926YY	22363761	Green Published, gold			2022-12-27	WOS:000302871500097
J	Mau, YS; Collins, PJ; Daglish, GJ; Nayak, MK; Pavic, H; Ebert, PR				Mau, Yosep S.; Collins, Patrick J.; Daglish, Gregory J.; Nayak, Manoj K.; Pavic, Hervoika; Ebert, Paul R.			The rph1 Gene Is a Common Contributor to the Evolution of Phosphine Resistance in Independent Field Isolates of Rhyzopertha Dominica	PLOS ONE			English	Article							LESSER GRAIN BORER; F COLEOPTERA; INSECTICIDE; INHERITANCE; STRAINS; TOXICITY; DAMAGE	Phosphine is the only economically viable fumigant for routine control of insect pests of stored food products, but its continued use is now threatened by the world-wide emergence of high-level resistance in key pest species. Phosphine has a unique mode of action relative to well-characterised contact pesticides. Similarly, the selective pressures that lead to resistance against field sprays differ dramatically from those encountered during fumigation. The consequences of these differences have not been investigated adequately. We determine the genetic basis of phosphine resistance in Rhyzopertha dominica strains collected from New South Wales and South Australia and compare this with resistance in a previously characterised strain from Queensland. The resistance levels range from 225 and 100 times the baseline response of a sensitive reference strain. Moreover, molecular and phenotypic data indicate that high-level resistance was derived independently in each of the three widely separated geographical regions. Despite the independent origins, resistance was due to two interacting genes in each instance. Furthermore, complementation analysis reveals that all three strains contain an incompletely recessive resistance allele of the autosomal rph1 resistance gene. This is particularly noteworthy as a resistance allele at rph1 was previously proposed to be a necessary first step in the evolution of high-level resistance. Despite the capacity of phosphine to disrupt a wide range of enzymes and biological processes, it is remarkable that the initial step in the selection of resistance is so similar in isolated outbreaks.	[Mau, Yosep S.; Ebert, Paul R.] Univ Queensland, Sch Integrat Biol, St Lucia, Qld, Australia; [Mau, Yosep S.] Univ Nusa Cendana, Fac Agr, Kupang, Nusa Tenggara T, Indonesia; [Collins, Patrick J.; Daglish, Gregory J.; Nayak, Manoj K.; Pavic, Hervoika] Ecosci Precinct, Dept Employment Econ Dev & Innovat, Brisbane, Qld, Australia; [Collins, Patrick J.; Daglish, Gregory J.; Nayak, Manoj K.; Pavic, Hervoika] Cooperat Res Ctr Natl Plant Biosecur, Bruce, ACT, Australia	University of Queensland; Universitas Nusa Cendana	Mau, YS (corresponding author), Univ Queensland, Sch Integrat Biol, St Lucia, Qld, Australia.	p.ebert@uq.edu	Mau, Yosep Seran/GNP-4795-2022; Mau, Yosep Seran/AAC-4003-2021	Mau, Yosep Seran/0000-0001-6654-5407; Daglish, Gregory/0000-0003-1940-2643; Ebert, Paul/0000-0002-4435-0737	Grain Research Development Corporation [UQ00010]; Australian Research Council [C10027038]; AusAID scholarship; Australian Government	Grain Research Development Corporation(Grains R&D Corp); Australian Research Council(Australian Research Council); AusAID scholarship; Australian Government(Australian GovernmentCGIAR)	Paul Ebert acknowledges financial support from the Grain Research Development Corporation (grant UQ00010, http://www.grdc.com.au/) and the Australian Research Council (grant C10027038, (http://www.arc.gov.au/) and an AusAID scholarship (http://www.ausaid.gov.au/) for Yosep Mau. Patrick Collins, Gregory Daglish and Manoj Nayak acknowledge the support from the Australian Government: Cooperative Research Centres Program (http://www.crcplantbiosecurity.com.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Acda MA., 2000, THESIS U QUEENSLAND; [Anonymous], 1975, FAO PLANT PROTECT B, V23, P12; Ansell M. R., 1990, P 5 INT WORK C STOR, P961; Bengston M, 1999, J ECON ENTOMOL, V92, P17, DOI 10.1093/jee/92.1.17; BOLTER CJ, 1990, ARCH BIOCHEM BIOPHYS, V278, P65, DOI 10.1016/0003-9861(90)90232-N; Cha'on U, 2007, TOXICOL SCI, V96, P194, DOI 10.1093/toxsci/kfl187; Champ BR, 1976, REPORT FAO GLOBAL SU; CHAUDHRY MQ, 1992, PESTIC BIOCHEM PHYS, V42, P167, DOI 10.1016/0048-3575(92)90063-6; Chaudhry MQ, 1997, PESTIC SCI, V49, P213, DOI 10.1002/(SICI)1096-9063(199703)49:3&lt;213::AID-PS516&gt;3.0.CO;2-#; CHAUDHRY MQ, 1990, J STORED PROD RES, V26, P101, DOI 10.1016/0022-474X(90)90008-G; CHEFURKA W, 1976, PESTIC BIOCHEM PHYS, V6, P65, DOI 10.1016/0048-3575(76)90010-9; Collins PJ, 2002, J ECON ENTOMOL, V95, P862, DOI 10.1603/0022-0493-95.4.862; Collins PJ, 1998, STORED GRAIN AUSTR, P55; Daglish GJ, 1998, STORED PRODUCT PROTE, P584; Feyereisen R, 1995, TOXICOL LETT, V82-3, P83, DOI 10.1016/0378-4274(95)03470-6; ffrench-Constant RH, 1998, PHILOS T R SOC B, V353, P1685, DOI 10.1098/rstb.1998.0319; FFRENCHCONSTANT RH, 1994, INSECT BIOCHEM MOLEC, V24, P335, DOI 10.1016/0965-1748(94)90026-4; FINNEY D J, 1971, P333; GEORGHIOU GP, 1969, EXP PARASITOL, V26, P224, DOI 10.1016/0014-4894(69)90116-7; Hsu CH, 2000, FREE RADICAL BIO MED, V28, P636, DOI 10.1016/S0891-5849(99)00277-4; KASHI KP, 1976, PESTIC BIOCHEM PHYS, V6, P350, DOI 10.1016/0048-3575(76)90045-6; Li Yan-Sheng, 1994, Acta Entomologica Sinica, V37, P271; NAKAKITA H, 1976, Journal of Pesticide Science, V1, P235; Nath NS, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/494168; Pimentel MAG, 2007, PEST MANAG SCI, V63, P876, DOI 10.1002/ps.1416; Pratt SJ, 2003, J STORED PROD RES, V39, P507, DOI 10.1016/S0022-474X(02)00057-7; PREISLER HK, 1990, J ECON ENTOMOL, V83, P1649, DOI 10.1093/jee/83.5.1649; PRICE NR, 1984, J STORED PROD RES, V20, P163, DOI 10.1016/0022-474X(84)90025-0; PRICE NR, 1981, COMP BIOCHEM PHYS C, V69, P129, DOI 10.1016/0306-4492(81)90113-1; Quistad GB, 2000, PEST MANAG SCI, V56, P779, DOI 10.1002/1526-4998(200009)56:9<779::AID-PS207>3.3.CO;2-L; RAJENDRAN S, 1994, INT J PEST MANAGE, V40, P207, DOI 10.1080/09670879409371883; RAJENDRAN S, 1992, B ENTOMOL RES, V82, P119, DOI 10.1017/S000748530005152X; REN YL, 1994, STORED PRODUCT PROTECTION, VOLS 1 AND 2, P173; Schlipalius D., 2006, Outlooks on Pest Management, V17, P52, DOI 10.1564/16apr02; Schlipalius DI, 2008, HEREDITY, V100, P506, DOI 10.1038/hdy.2008.4; Schlipalius DI, 2002, GENETICS, V161, P773; STONE BF, 1968, B WORLD HEALTH ORGAN, V38, P325; TABASHNIK BE, 1991, J ECON ENTOMOL, V84, P703, DOI 10.1093/jee/84.3.703; TAYLOR R W D, 1989, International Pest Control, V31, P10; Tyler P. S., 1983, International Pest Control, V25, P10; TYLER PS, 1983, INT PEST CONTROL, V25, P21; Valmas N, 2008, TOXICOLOGY, V252, P33, DOI 10.1016/j.tox.2008.07.060; Valmas N, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000130; Wallbank BE, 2002, P STOR GRAIN AUSTR 2, P105; Zuryn S, 2008, TOXICOL SCI, V102, P179, DOI 10.1093/toxsci/kfm278	46	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31541	10.1371/journal.pone.0031541	http://dx.doi.org/10.1371/journal.pone.0031541			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363668	Green Published, Green Submitted, gold			2022-12-27	WOS:000302871500056
J	Santosa, S; Jensen, MD				Santosa, Sylvia; Jensen, Michael D.			Effects of Male Hypogonadism on Regional Adipose Tissue Fatty Acid Storage and Lipogenic Proteins	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; BODY-COMPOSITION; LIPOPROTEIN-LIPASE; IN-VIVO; MEAL; SEX; MEN; TESTOSTERONE; TRANSPORT; HUMANS	Testosterone has long been known to affect body fat distribution, although the underlying mechanisms remain elusive. We investigated the effects of chronic hypogonadism in men on adipose tissue fatty acid (FA) storage and FA storage factors. Twelve men with chronic hypogonadism and 13 control men matched for age and body composition: 1) underwent measures of body composition with dual energy x-ray absorptiometry and an abdominal CT scan; 2) consumed an experimental meal containing [H-3]triolein to determine the fate of meal FA (biopsy-measured adipose storage vs. oxidation); 3) received infusions of [U-C-13]palmitate and [1-C-14]palmitate to measure rates of direct free (F) FA storage (adipose biopsies). Adipose tissue lipoprotein lipase, acyl-CoA synthetase (ACS), and diacylglycerol acetyl-transferase (DGAT) activities, as well as, CD36 content were measured to understand the mechanism by which alterations in fat storage occur in response to testosterone deficiency. Results of the study showed that hypogonadal men stored a greater proportion of both dietary FA and FFA in lower body subcutaneous fat than did eugonadal men (both p < 0.05). Femoral adipose tissue ACS activity was significantly greater in hypogonadal than eugonadal men, whereas CD36 and DGAT were not different between the two groups. The relationships between these proteins and FA storage varied somewhat between the two groups. We conclude that chronic effects of testosterone deficiency has effects on leg adipose tissue ACS activity which may relate to greater lower body FA storage. These results provide further insight into the role of androgens in body fat distribution and adipose tissue metabolism in humans.	[Santosa, Sylvia; Jensen, Michael D.] Mayo Clin, Endocrine Res Unit, Rochester, MN 55905 USA; [Santosa, Sylvia] Concordia Univ, Dept Exercise Sci, Montreal, PQ, Canada	Mayo Clinic; Concordia University - Canada	Santosa, S (corresponding author), Mayo Clin, Endocrine Res Unit, Rochester, MN 55905 USA.	jensen@mayo.edu	Santosa, Sylvia/U-5332-2019; Santosa, Sylvia/M-5207-2018	Santosa, Sylvia/0000-0001-5814-6086; Santosa, Sylvia/0000-0001-5814-6086	National Center for Research Resources [1UL1 RR024150]; National Institutes of Health [DK45343]; American Diabetes Association [7-06-DCS-03]; Natural Sciences and Engineering Council of Canada and Canadian Diabetes Association; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050456, R01DK045343] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Natural Sciences and Engineering Council of Canada and Canadian Diabetes Association; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Center for Research Resources grant 1UL1 RR024150; National Institutes of Health grant DK45343; American Diabetes Association grant 7-06-DCS-03; Natural Sciences and Engineering Council of Canada and Canadian Diabetes Association incentive funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred CC, 2011, J LIPID RES, V52, P408, DOI 10.1194/jlr.M008995; Berenguer B, 1999, ANN PLAS SURG, V43, P306, DOI 10.1097/00000637-199909000-00015; CAUSON RC, 1981, ANAL BIOCHEM, V116, P223, DOI 10.1016/0003-2697(81)90347-X; Elbers JMH, 1999, METABOLISM, V48, P1371, DOI 10.1016/S0026-0495(99)90146-4; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; Hall AM, 2003, J BIOL CHEM, V278, P43008, DOI 10.1074/jbc.M306575200; Hamilton JA, 1999, DIABETES, V48, P2255, DOI 10.2337/diabetes.48.12.2255; HARMON CM, 1993, J MEMBRANE BIOL, V133, P43; Hou XG, 2009, OBESITY, V17, P1129, DOI 10.1038/oby.2008.659; HUMPHREYS SM, 1990, ANN CLIN BIOCHEM, V27, P597, DOI 10.1177/000456329002700613; JENSEN MD, 1993, MAYO CLIN PROC, V68, P867, DOI 10.1016/S0025-6196(12)60695-8; JENSEN MD, 1995, AM J CLIN NUTR, V61, P274, DOI 10.1093/ajcn/61.2.274; Knudsen J, 1999, MOL CELL BIOCHEM, V192, P95, DOI 10.1023/A:1006830606060; Koutsari C, 2011, DIABETES, V60, P2032, DOI 10.2337/db11-0154; MARIN P, 1995, J CLIN ENDOCR METAB, V80, P239, DOI 10.1210/jc.80.1.239; MARIN P, 1990, EUR J CLIN INVEST, V20, P158, DOI 10.1111/j.1365-2362.1990.tb02263.x; Marin P, 1995, OBES RES, V3, pS609, DOI 10.1002/j.1550-8528.1995.tb00233.x; Mashek DG, 2007, FUTURE LIPIDOL, V2, P465, DOI 10.2217/17460875.2.4.465; Mauras N, 1998, J CLIN ENDOCR METAB, V83, P1886, DOI 10.1210/jc.83.6.1886; NILSSONEHLE P, 1976, J LIPID RES, V17, P536; Persson XMT, 2010, J LIPID RES, V51, P2761, DOI 10.1194/jlr.M008011; POMERANTZ H Z, 1959, Can Med Assoc J, V80, P362; Ramirez ME, 1997, METABOLISM, V46, P179, DOI 10.1016/S0026-0495(97)90299-7; Romanski SA, 2000, AM J PHYSIOL-ENDOC M, V279, pE455, DOI 10.1152/ajpendo.2000.279.2.E455; Romanski SA, 2000, AM J PHYSIOL-ENDOC M, V279, pE447, DOI 10.1152/ajpendo.2000.279.2.E447; Santosa S, 2008, AM J CLIN NUTR, V88, P1134, DOI 10.1093/ajcn/88.4.1134; SCHOELLER DA, 1980, AM J CLIN NUTR, V33, P2686, DOI 10.1093/ajcn/33.12.2686; Sfeir Z, 1997, PROSTAG LEUKOTR ESS, V57, P17, DOI 10.1016/S0952-3278(97)90487-7; Shadid S, 2007, DIABETES, V56, P1369, DOI 10.2337/db06-1680; Snyder PJ, 1999, J CLIN ENDOCR METAB, V84, P2647, DOI 10.1210/jc.84.8.2647; TANNER JM, 1949, J APPL PHYSIOL, V2, P1; Tchoukalova YD, 2003, J LIPID RES, V44, P1795, DOI 10.1194/jlr.D300001-JLR200; Votruba SB, 2006, AM J PHYSIOL-ENDOC M, V291, pE1115, DOI 10.1152/ajpendo.00196.2006; Wells JCK, 2007, BEST PRACT RES CL EN, V21, P415, DOI 10.1016/j.beem.2007.04.007; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200	36	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31473	10.1371/journal.pone.0031473	http://dx.doi.org/10.1371/journal.pone.0031473			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363653	Green Submitted, Green Published, gold			2022-12-27	WOS:000302871500046
J	Wang, YL; Zhou, T				Wang, Yali; Zhou, Tong			A Relative Variation-Based Method to Unraveling Gene Regulatory Networks	PLOS ONE			English	Article							RECONSTRUCTION; INFERENCE; SYSTEMS; SIMULATION; ALGORITHM	Gene regulatory network (GRN) reconstruction is essential in understanding the functioning and pathology of a biological system. Extensive models and algorithms have been developed to unravel a GRN. The DREAM project aims to clarify both advantages and disadvantages of these methods from an application viewpoint. An interesting yet surprising observation is that compared with complicated methods like those based on nonlinear differential equations, etc., methods based on a simple statistics, such as the so-called Z-score, usually perform better. A fundamental problem with the Z-score, however, is that direct and indirect regulations can not be easily distinguished. To overcome this drawback, a relative expression level variation (RELV) based GRN inference algorithm is suggested in this paper, which consists of three major steps. Firstly, on the basis of wild type and single gene knockout/knockdown experimental data, the magnitude of RELV of a gene is estimated. Secondly, probability for the existence of a direct regulation from a perturbed gene to a measured gene is estimated, which is further utilized to estimate whether a gene can be regulated by other genes. Finally, the normalized RELVs are modified to make genes with an estimated zero in-degree have smaller RELVs in magnitude than the other genes, which is used afterwards in queuing possibilities of the existence of direct regulations among genes and therefore leads to an estimate on the GRN topology. This method can in principle avoid the so-called cascade errors under certain situations. Computational results with the Size 100 sub-challenges of DREAM3 and DREAM4 show that, compared with the Z-score based method, prediction performances can be substantially improved, especially the AUPR specification. Moreover, it can even outperform the best team of both DREAM3 and DREAM4. Furthermore, the high precision of the obtained most reliable predictions shows that the suggested algorithm may be very helpful in guiding biological experiment designs.	[Wang, Yali; Zhou, Tong] Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China; [Zhou, Tong] Tsinghua Univ, Tsinghua Natl Lab Informat Sci & Technol TNList, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Wang, YL (corresponding author), Tsinghua Univ, Dept Automat, Beijing 100084, Peoples R China.	yl-wang06@mails.tsinghua.edu.cn	Zhou, Tong/AAD-1593-2019		973 Program [2012CB316504, 2009CB320602]; National Natural Science Foundation of China [61174122, 61021063, 60721003, 60625305]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The reported work was financially supported in part by the 973 Program under Grant 2012CB316504 and 2009CB320602 and by the National Natural Science Foundation of China under Grants 61174122, 61021063, 60721003 and 60625305. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu T, 1999, Pac Symp Biocomput, P17; Cantone I, 2009, CELL, V137, P172, DOI 10.1016/j.cell.2009.01.055; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Faith JJ, 2008, NUCLEIC ACIDS RES, V36, pD866, DOI 10.1093/nar/gkm815; Ferrazzi F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S5-S2; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Greenfield A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013397; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; LATTIN J, 2003, ANALYZING MULTIVARIA; Ljung L., 1999, SYSTEM IDENTIFICATIO; Madar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009803; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Martin S, 2007, BIOINFORMATICS, V23, P866, DOI 10.1093/bioinformatics/btm021; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37; Perrin BE, 2003, BIOINFORMATICS, V19, pII138, DOI 10.1093/bioinformatics/btg1071; Pinna A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012912; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Rice JJ, 2005, BIOINFORMATICS, V21, P765, DOI 10.1093/bioinformatics/bti064; Schafer J, 2006, R NEWS, V6, P50; Schaffter T, 2011, BIOINFORMATICS, V27, P2263, DOI 10.1093/bioinformatics/btr373; Wang Y, 2006, BIOINFORMATICS, V22, P2413, DOI 10.1093/bioinformatics/btl396; Yip KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008121; Zhou K., 1996, ROBUST OPTIMAL CONTR; Zhou T, 2010, BIOINFORMATICS, V26, P2020, DOI 10.1093/bioinformatics/btq325	27	10	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31194	10.1371/journal.pone.0031194	http://dx.doi.org/10.1371/journal.pone.0031194			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363578	Green Submitted, Green Published, gold			2022-12-27	WOS:000302871500028
J	Bansal, P; Banga, S; Banga, SS				Bansal, Payal; Banga, Shashi; Banga, S. S.			Heterosis as Investigated in Terms of Polyploidy and Genetic Diversity Using Designed Brassica juncea Amphiploid and Its Progenitor Diploid Species	PLOS ONE			English	Article							MAIZE; EXPRESSION; HYBRID; LINES; MARKER; RICE; MICROSATELLITES; BIOMASS; LOCI; RAPA	Fixed heterosis resulting from favorable interactions between the genes on their homoeologous genomes in an allopolyploid is considered analogous to classical heterosis accruing from interactions between homologous chromosomes in heterozygous plants of a diploid species. It has been hypothesized that fixed heterosis may be one of the causes of low classical heterosis in allopolyploids. We used Indian mustard (Brassica juncea, 2n = 36; AABB) as a model system to analyze this hypothesis due to ease of its resynthesis from its diploid progenitors, B. rapa (2n = 20; AA) and B. nigra (2n = 16; BB). Both forms of heterosis were investigated in terms of ploidy level, gene action and genetic diversity. To facilitate this, eleven B. juncea genotypes were resynthesized by hybridizing ten near inbred lines of B. rapa and nine of B. nigra. Three half diallel combinations involving resynthesized B. juncea (11x11) and the corresponding progenitor genotypes of B. rapa (10x10) and B. nigra (9x9) were evaluated. Genetic diversity was estimated based on DNA polymorphism generated by SSR primers. Heterosis and genetic diversity in parental diploid species appeared not to predict heterosis and genetic diversity at alloploid level. There was also no association between combining ability, genetic diversity and heterosis across ploidy. Though a large proportion (0.47) of combinations showed positive values, the average fixed heterosis was low for seed yield but high for biomass yield. The genetic diversity was a significant contributor to fixed heterosis for biomass yield, due possibly to adaptive advantage it may confer on de novo alloploids during evolution. Good general/specific combiners at diploid level did not necessarily produce good general/specific combiners at amphiploid level. It was also concluded that polyploidy impacts classical heterosis indirectly due to the negative association between fixed heterosis and classical heterosis.	[Bansal, Payal; Banga, Shashi; Banga, S. S.] Punjab Agr Univ, Dept Plant Breeding & Genet, Ludhiana 141004, Punjab, India	Punjab Agricultural University	Bansal, P (corresponding author), Punjab Agr Univ, Dept Plant Breeding & Genet, Ludhiana 141004, Punjab, India.	nppbg@pau.edu	BANSAL, Dr PAYAL/AGO-3537-2022; Banga, Surinder Singh/A-2753-2011	Banga, Surinder Singh/0000-0001-8209-7341	All India Coordinated Research Project on Rapesee-Mustard	All India Coordinated Research Project on Rapesee-Mustard	This work was supported by the All India Coordinated Research Project on Rapesee-Mustard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2007, PLANT BREEDING, V126, P642, DOI 10.1111/j.1439-0523.2007.01405.x; Abel S, 2005, EUPHYTICA, V146, P157, DOI 10.1007/s10681-005-3364-7; BERNARDO R, 1992, THEOR APPL GENET, V83, P628, DOI 10.1007/BF00226908; Birchler JA, 2003, PLANT CELL, V15, P2236, DOI 10.1105/tpc.151030; CHARCOSSET A, 1991, THEOR APPL GENET, V81, P571, DOI 10.1007/BF00226720; Chen ZJ, 2006, BIOESSAYS, V28, P240, DOI 10.1002/bies.20374; DOBZHANSKY T, 1950, GENETICS, V35, P288; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Duvick DN, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P19; East EM, 1936, GENETICS, V21, P375; Falconer D., INTRO QUANTITATIVE G, V4th; Falconer D. S., 1981, INTRO QUANTITATIVE G; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; GRIFFING B., 1956, AUSTRALIAN JOUR BIOL SCI, V9, P463; Guo M, 2006, THEOR APPL GENET, V113, P831, DOI 10.1007/s00122-006-0335-x; HAYMAN BI, 1954, GENETICS, V39, P789; Huang Y, 2006, PLANT MOL BIOL, V62, P579, DOI 10.1007/s11103-006-9040-z; JINKS J. L., 1955, HEREDITY, V9, P223, DOI 10.1038/hdy.1955.21; JINKS JL, 1954, GENETICS, V39, P767; Lamkey KR, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P31; Li ZK, 2001, GENETICS, V158, P1737; Lippman ZB, 2006, TRENDS GENET, V23, P47; Lowe AJ, 2004, THEOR APPL GENET, V108, P1103, DOI 10.1007/s00122-003-1522-7; Lu H, 2003, THEOR APPL GENET, V107, P494, DOI 10.1007/s00122-003-1271-7; MATZINGER D. F., 1962, CROP SCI, V2, P383, DOI 10.2135/cropsci1962.0011183X000200050006x; MELCHINGER AE, 1994, THEOR APPL GENET, V88, P343, DOI 10.1007/BF00223643; Meyer S, 2007, PLANT MOL BIOL, V63, P381, DOI 10.1007/s11103-006-9095-x; Omholt SW, 2000, GENETICS, V155, P969; Pruitt RE, 2003, NAT GENET, V33, P294, DOI 10.1038/ng1108; Rholf F. J., 1998, NTSYS PC NUMERICAL T; Riddle NC, 2008, THEOR APPL GENET, V116, P563, DOI 10.1007/s00122-007-0691-1; Schauer N, 2006, NAT BIOTECHNOL, V24, P447, DOI 10.1038/nbt1192; Shokeen B, 2007, PLANT SCI, V172, P441, DOI 10.1016/j.plantsci.2006.10.010; Shyam Prakash, 2004, Brassica, V6, P1; Springer NM, 2007, GENOME RES, V17, P264, DOI 10.1101/gr.5347007; STUBER CW, 1992, GENETICS, V132, P823; Stupar RM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-33; Suwabe K, 2002, THEOR APPL GENET, V104, P1092, DOI 10.1007/s00122-002-0875-7; Swanson-Wagner RA, 2006, P NATL ACAD SCI USA, V103, P6805, DOI 10.1073/pnas.0510430103; Wang JL, 2006, GENETICS, V172, P507, DOI 10.1534/genetics.105.047894; Wei G, 2009, P NATL ACAD SCI USA, V106, P7695, DOI 10.1073/pnas.0902340106; Wright S., 1978, EVOLUTION GENETIC PO	42	26	26	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e29607	10.1371/journal.pone.0029607	http://dx.doi.org/10.1371/journal.pone.0029607			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363404	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700003
J	Haldar, S; Paul, S; Joshi, N; Dasgupta, A; Chattopadhyay, K				Haldar, Shubhasis; Paul, Simantasarani; Joshi, Nidhi; Dasgupta, Anindya; Chattopadhyay, Krishnananda			The Presence of the Iron-Sulfur Motif Is Important for the Conformational Stability of the Antiviral Protein, Viperin	PLOS ONE			English	Article							AMPHIPATHIC ALPHA-HELIX; PARTIALLY FOLDED STATE; 3-DIMENSIONAL STRUCTURES; TRIFLUOROETHANOL; RECOGNITION; ALIGNMENT; VIRUS; MECHANISMS; DATABASE; INHIBIT	Viperin, an antiviral protein, has been shown to contain a CX3CX2C motif, which is conserved in the radical S-adenosylmethionine (SAM) enzyme family. A triple mutant which replaces these three cysteines with alanines has been shown to have severe deficiency in antiviral activity. Since the crystal structure of Viperin is not available, we have used a combination of computational methods including multi-template homology modeling and molecular dynamics simulation to develop a low-resolution predicted structure. The results show that Viperin is an alpha-beta protein containing iron-sulfur cluster at the center pocket. The calculations suggest that the removal of iron-sulfur cluster would lead to collapse of the protein tertiary structure. To verify these predictions, we have prepared, expressed and purified four mutant proteins. In three mutants individual cysteine residues were replaced by alanine residues while in the fourth all the cysteines were replaced by alanines. Conformational analyses using circular dichroism and steady state fluorescence spectroscopy indicate that the mutant proteins are partially unfolded, conformationally unstable and aggregation prone. The lack of conformational stability of the mutant proteins may have direct relevance to the absence of their antiviral activity.	[Haldar, Shubhasis; Dasgupta, Anindya] CSIR, Indian Inst Chem Biol, Div Infect Dis, Kolkata, W Bengal, India; [Dasgupta, Anindya] CSIR, Indian Inst Chem Biol, Div Immunol, Kolkata, W Bengal, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Haldar, S (corresponding author), CSIR, Indian Inst Chem Biol, Div Infect Dis, Kolkata, W Bengal, India.	krish@iicb.res.in		Haldar, Shubhasis/0000-0002-4304-5570; Chattopadhyay, Krishnananda/0000-0002-1449-8909	CSIR EMPOWER [olp004]	CSIR EMPOWER	The work is supported by CSIR EMPOWER grant (olp004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDRESCU AT, 1994, J MOL BIOL, V235, P587, DOI 10.1006/jmbi.1994.1015; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Banci L, 2003, BIOCHEMISTRY-US, V42, P9543, DOI 10.1021/bi034324m; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bruccoleri RE, 2000, METH MOL B, V143, P247; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; BUCK M, 1993, BIOCHEMISTRY-US, V32, P669, DOI 10.1021/bi00053a036; Chattopadhyay K, 2000, BIOCHEMISTRY-US, V39, P263, DOI 10.1021/bi990729o; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; Chugh J, 2008, BIOCHEMISTRY-US, V47, P12945, DOI 10.1021/bi801698q; Corpet F, 1999, NUCLEIC ACIDS RES, V27, P263, DOI 10.1093/nar/27.1.263; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Duschene KS, 2010, FEBS LETT, V584, P1263, DOI 10.1016/j.febslet.2010.02.041; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Garai K, 2011, BIOCHEMISTRY-US, V50, P2550, DOI 10.1021/bi1020106; HAMADA D, 1993, BIOCHEMISTRY-US, V32, P10351, DOI 10.1021/bi00090a010; Hanzelmann P, 2004, J BIOL CHEM, V279, P34721, DOI 10.1074/jbc.M313398200; Hinson ER, 2009, P NATL ACAD SCI USA, V106, P20452, DOI 10.1073/pnas.0911679106; Hinson ER, 2009, J BIOL CHEM, V284, P4705, DOI 10.1074/jbc.M807261200; Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Larsson P, 2008, PROTEIN SCI, V17, P990, DOI 10.1110/ps.073344908; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Niu WL, 2010, J PHYS CHEM B, V114, P16156, DOI 10.1021/jp106041v; Pons JL, 2009, NUCLEIC ACIDS RES, V37, pW485, DOI 10.1093/nar/gkp368; Reyda MR, 2008, ARCH BIOCHEM BIOPHYS, V471, P32, DOI 10.1016/j.abb.2007.12.001; Sadreyev R, 2003, J MOL BIOL, V326, P317, DOI 10.1016/S0022-2836(02)01371-2; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shaveta G, 2010, BIOCHEM BIOPH RES CO, V391, P1390, DOI 10.1016/j.bbrc.2009.12.070; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; SHIRAKI K, 1995, J MOL BIOL, V245, P180, DOI 10.1006/jmbi.1994.0015; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stehling O, 2008, MOL CELL BIOL, V28, P5517, DOI 10.1128/MCB.00545-08; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Zhou HY, 2005, PROTEINS, V58, P321, DOI 10.1002/prot.20308	42	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31797	10.1371/journal.pone.0031797	http://dx.doi.org/10.1371/journal.pone.0031797			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363738	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700100
J	Lee, ASG; Ong, DCT; Wong, JCL; Siu, GKH; Yam, WC				Lee, Ann S. G.; Ong, Danny C. T.; Wong, Joshua C. L.; Siu, Gilman K. H.; Yam, Wing-Cheong			High-Resolution Melting Analysis for the Rapid Detection of Fluoroquinolone and Streptomycin Resistance in Mycobacterium tuberculosis	PLOS ONE			English	Article							GYRASE MUTATIONS; MOLECULAR CHARACTERIZATION; DRUG SUSCEPTIBILITY; FUNCTIONAL-ANALYSIS; GLOBAL TRENDS; RRS MUTATIONS; GENE; EFFLUX; DIFFERENTIATION; IDENTIFICATION	Background: Molecular methods for the detection of drug-resistant tuberculosis are potentially more rapid than conventional culture-based drug susceptibility testing, facilitating the commencement of appropriate treatment for patients with drug resistant tuberculosis. We aimed to develop and evaluate high-resolution melting (HRM) assays for the detection of mutations within gyrA, rpsL, and rrs, for the determination of fluoroquinolone and streptomycin resistance in Mycobacterium tuberculosis (MTB). Methodology/Principal Findings: A blinded series of DNA samples extracted from a total of 92 clinical isolates of MTB were analyzed by HRM analysis, and the results were verified using DNA sequencing. The sensitivity and specificity of the HRM assays in comparison with drug susceptibility testing were 74.1% and 100.0% for the detection of fluoroquinolone resistance, and 87.5% and 100.0% for streptomycin resistance. Five isolates with low level resistance to ofloxacin had no mutations detected in gyrA, possibly due to the action of efflux pumps, or false negativity due to mixed infections. One fluoroquinolone-resistant isolate had a mutation in a region of gyrA not encompassed by our assay. Six streptomycin-resistant strains had undetectable mutations by HRM and DNA sequencing, which may be explained by the fact that not all streptomycin-resistant isolates have mutations within rpsL and rrs, and suggesting that other targets may be involved. Conclusion: The HRM assays described here are potentially useful adjunct tests for the efficient determination of fluoroquinolone and streptomycin resistance in MTB, and could facilitate the timely administration of appropriate treatment for patients infected with drug-resistant TB.	[Lee, Ann S. G.; Ong, Danny C. T.; Wong, Joshua C. L.] Natl Canc Ctr, Div Med Sci, Singapore, Singapore; [Lee, Ann S. G.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117595, Singapore; [Siu, Gilman K. H.; Yam, Wing-Cheong] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China	National Cancer Centre Singapore (NCCS); National University of Singapore; University of Hong Kong	Lee, ASG (corresponding author), Natl Canc Ctr, Div Med Sci, Singapore, Singapore.	dmslsg@nccs.com.sg	SIU, Kit Hang/L-7796-2017	SIU, Kit Hang/0000-0002-4354-3393	Biomedical Research Council (BMRC) of Singapore [BMRC 07/1/31/19/511]	Biomedical Research Council (BMRC) of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by a grant from the Biomedical Research Council (BMRC) of Singapore (BMRC 07/1/31/19/511). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubry A, 2006, ANTIMICROB AGENTS CH, V50, P104, DOI 10.1128/AAC.50.1.104-112.2006; Brossier F, 2010, J CLIN MICROBIOL, V48, P1683, DOI 10.1128/JCM.01947-09; Campbell PJ, 2011, ANTIMICROB AGENTS CH, V55, P2032, DOI 10.1128/AAC.01550-10; Castellanos E, 2010, J CLIN MICROBIOL, V48, P1474, DOI 10.1128/JCM.02484-09; Clinical and Laboratory Standards Institute, 2003, M24A NCCLS CLIN LAB; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; De Leeneer K, 2008, CLIN CHEM, V54, P982, DOI 10.1373/clinchem.2007.098764; de Oliveira MM, 2003, J MICROBIOL METH, V53, P335, DOI 10.1016/S0167-7012(02)00253-1; Dorman SE, 2007, NAT MED, V13, P295, DOI 10.1038/nm0307-295; DOUGLASS J, 1993, J INFECT DIS, V167, P1505, DOI 10.1093/infdis/167.6.1505; Dye C, 2002, SCIENCE, V295, P2042, DOI 10.1126/science.1063814; Escribano I, 2007, CHEMOTHERAPY, V53, P397, DOI 10.1159/000109769; Espinal MA, 2001, NEW ENGL J MED, V344, P1294, DOI 10.1056/NEJM200104263441706; Fortini D, 2007, CLIN CHEM, V53, P1377, DOI 10.1373/clinchem.2007.085993; Goyal M, 1997, J CLIN MICROBIOL, V35, P647, DOI 10.1128/JCM.35.3.647-651.1997; Guillemin I, 1998, ANTIMICROB AGENTS CH, V42, P2084, DOI 10.1128/AAC.42.8.2084; Hu Y, 2011, TUBERCULOSIS, V91, P238, DOI 10.1016/j.tube.2011.03.001; Huang WL, 2011, J CLIN MICROBIOL, V49, P2502, DOI 10.1128/JCM.00197-11; Ioerger TR, 2010, J BACTERIOL, V192, P3645, DOI 10.1128/JB.00166-10; Katsukawa E, 1997, J APPL MICROBIOL, V83, P634, DOI 10.1046/j.1365-2672.1997.00279.x; Kocagoz T, 1996, ANTIMICROB AGENTS CH, V40, P1768, DOI 10.1128/AAC.40.8.1768; Lau RWT, 2011, ANTIMICROB AGENTS CH, V55, P608, DOI 10.1128/AAC.00920-10; Lee Ann S. G., 2002, International Journal of Infectious Diseases, V6, P48, DOI 10.1016/S1201-9712(02)90136-0; Lee ASG, 2005, J CLIN MICROBIOL, V43, P2026, DOI 10.1128/JCM.43.4.2026-2027.2005; Lee ASG, 2004, ANTIMICROB AGENTS CH, V48, P4447, DOI 10.1128/AAC.48.11.4447-4449.2004; Lin JH, 2008, J CLIN MICROBIOL, V46, P1090, DOI 10.1128/JCM.02015-07; Louw GE, 2011, AM J RESP CRIT CARE, V184, P269, DOI 10.1164/rccm.201011-1924OC; MUSSER JM, 1995, CLIN MICROBIOL REV, V8, P496, DOI 10.1128/CMR.8.4.496; Niemann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007407; Okamoto S, 2007, MOL MICROBIOL, V63, P1096, DOI 10.1111/j.1365-2958.2006.05585.x; Ong DCT, 2010, J CLIN MICROBIOL, V48, P1047, DOI 10.1128/JCM.02036-09; Perlman DC, 1997, AIDS, V11, P1473, DOI 10.1097/00002030-199712000-00011; Ramaswamy SV, 2003, ANTIMICROB AGENTS CH, V47, P1241, DOI 10.1128/AAC.47.4.1241-1250.2003; ROBERTS GD, 1983, J CLIN MICROBIOL, V18, P689, DOI 10.1128/JCM.18.3.689-696.1983; Sekiguchi J, 2007, J CLIN MICROBIOL, V45, P179, DOI 10.1128/JCM.00750-06; Shamputa IC, 2004, J CLIN MICROBIOL, V42, P5528, DOI 10.1128/JCM.42.12.5528-5536.2004; Siddiqi N, 2002, ANTIMICROB AGENTS CH, V46, P443, DOI 10.1128/AAC.46.2.443-450.2002; Singh M, 2011, INDIAN J MED RES, V133, P535; Spies FS, 2008, ANTIMICROB AGENTS CH, V52, P2947, DOI 10.1128/AAC.01570-07; Spies FS, 2011, J CLIN MICROBIOL, V49, P2625, DOI 10.1128/JCM.00168-11; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Sreevatsan S, 1996, ANTIMICROB AGENTS CH, V40, P1024, DOI 10.1128/AAC.40.4.1024; Steer PA, 2009, J CLIN MICROBIOL, V47, P311, DOI 10.1128/JCM.01567-08; Sun YJ, 2010, CLIN MICROBIOL INFEC, V16, P287, DOI 10.1111/j.1469-0691.2009.02800.x; TAKIFF HE, 1994, ANTIMICROB AGENTS CH, V38, P773, DOI 10.1128/AAC.38.4.773; Telles MAS, 2002, BRAZ J MED BIOL RES, V35, P1127, DOI 10.1590/S0100-879X2002001000003; Tracevska T, 2004, RES MICROBIOL, V155, P830, DOI 10.1016/j.resmic.2004.06.007; Von Groll A, 2009, ANTIMICROB AGENTS CH, V53, P4498, DOI 10.1128/AAC.00287-09; Vossen RHAM, 2009, HUM MUTAT, V30, P860, DOI 10.1002/humu.21019; Xu C, 1996, J INFECT DIS, V174, P1127, DOI 10.1093/infdis/174.5.1127; Yam WC, 2006, J MED MICROBIOL, V55, P529, DOI 10.1099/jmm.0.46298-0; Yin XM, 2010, J INFECTION, V61, P150, DOI 10.1016/j.jinf.2010.05.001; Zhang Y, 2009, INT J TUBERC LUNG D, V13, P1320; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	54	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31934	10.1371/journal.pone.0031934	http://dx.doi.org/10.1371/journal.pone.0031934			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363772	gold, Green Published, Green Submitted			2022-12-27	WOS:000302873700126
J	Rioux, G; Babin, C; Majeau, N; Leclerc, D				Rioux, Gervais; Babin, Cindy; Majeau, Nathalie; Leclerc, Denis			Engineering of Papaya Mosaic Virus (PapMV) Nanoparticles through Fusion of the HA11 Peptide to Several Putative Surface-Exposed Sites	PLOS ONE			English	Article							POTEXVIRUS COAT PROTEIN; TRITIUM PLANIGRAPHY; PARTICLES; MOVEMENT; EPITOPES; IMMUNITY; BINDING; CELL; RNA	Papaya mosaic virus has been shown to be an efficient adjuvant and vaccine platform in the design and improvement of innovative flu vaccines. So far, all fusions based on the PapMV platform have been located at the C-terminus of the PapMV coat protein. Considering that some epitopes might interfere with the self-assembly of PapMV CP when fused at the C-terminus, we evaluated other possible sites of fusion using the influenza HA11 peptide antigen. Two out of the six new fusion sites tested led to the production of recombinant proteins capable of self assembly into PapMV nanoparticles; the two functional sites are located after amino acids 12 and 187. Immunoprecipitation of each of the successful fusions demonstrated that the HA11 epitope was located at the surface of the nanoparticles. The stability and immunogenicity of the PapMV-HA11 nanoparticles were evaluated, and we could show that there is a direct correlation between the stability of the nanoparticles at 37 degrees C (mammalian body temperature) and the ability of the nanoparticles to trigger an efficient immune response directed towards the HA11 epitope. This strong correlation between nanoparticle stability and immunogenicity in animals suggests that the stability of any nanoparticle harbouring the fusion of a new peptide should be an important criterion in the design of a new vaccine.	[Rioux, Gervais; Babin, Cindy; Majeau, Nathalie; Leclerc, Denis] Univ Laval, Infect Dis Res Ctr, Quebec City, PQ, Canada	Laval University	Rioux, G (corresponding author), Univ Laval, Infect Dis Res Ctr, Quebec City, PQ, Canada.	Denis.Leclerc@crchul.ulaval.ca	Majeau, Nathalie/AAU-1964-2021; Leclerc, Denis/P-1604-2019; Leclerc, Denis/AAG-6112-2019		National Sciences and Engineering Research Council of Canada (NSERC) [227041-2008]	National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research project was supported by National Sciences and Engineering Research Council of Canada (NSERC) grant #227041-2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Ramirez E, 2008, IMMUNOLOGY, V124, P186, DOI 10.1111/j.1365-2567.2007.02753.x; BARATOVA LA, 1992, VIROLOGY, V188, P175, DOI 10.1016/0042-6822(92)90747-D; BARATOVA LA, 1992, J GEN VIROL, V73, P229, DOI 10.1099/0022-1317-73-2-229; Cruz SS, 1996, P NATL ACAD SCI USA, V93, P6286, DOI 10.1073/pnas.93.13.6286; Denis J, 2008, VACCINE, V26, P3395, DOI 10.1016/j.vaccine.2008.04.052; Denis J, 2007, VIROLOGY, V363, P59, DOI 10.1016/j.virol.2007.01.011; Gagne MEL, 2008, FEBS J, V275, P1474, DOI 10.1111/j.1742-4658.2008.06306.x; Lacasse P, 2008, J VIROL, V82, P785, DOI 10.1128/JVI.01811-07; Leclerc D, 2007, J VIROL, V81, P1319, DOI 10.1128/JVI.01720-06; Lecours K, 2006, PROTEIN EXPRES PURIF, V47, P273, DOI 10.1016/j.pep.2005.10.013; Lico C, 2006, J GEN VIROL, V87, P3103, DOI 10.1099/vir.0.82097-0; Marusic C, 2001, J VIROL, V75, P8434, DOI 10.1128/JVI.75.18.8434-8439.2001; Morin H, 2007, J BIOTECHNOL, V128, P423, DOI 10.1016/j.jbiotec.2006.10.013; Plchova H, 2011, PROTEIN EXPRES PURIF, V77, P146, DOI 10.1016/j.pep.2011.01.008; Savard C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021522; SIT TL, 1989, J GEN VIROL, V70, P2325, DOI 10.1099/0022-1317-70-9-2325; Tremblay MH, 2006, FEBS J, V273, P14, DOI 10.1111/j.1742-4658.2005.05033.x; Uhde K, 2005, ARCH VIROL, V150, P327, DOI 10.1007/s00705-004-0402-z; Yang CD, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-62	19	33	35	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31925	10.1371/journal.pone.0031925	http://dx.doi.org/10.1371/journal.pone.0031925			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363771	Green Published, gold			2022-12-27	WOS:000302873700125
J	Sangwung, P; Greco, TM; Wang, YZ; Ischiropoulos, H; Sessa, WC; Iwakiri, Y				Sangwung, Panjamaporn; Greco, Todd M.; Wang, Yanzhuang; Ischiropoulos, Harry; Sessa, William C.; Iwakiri, Yasuko			Proteomic Identification of S-Nitrosylated Golgi Proteins: New Insights into Endothelial Cell Regulation by eNOS-Derived NO	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MATRIX-METALLOPROTEINASE INDUCER; HYPERDYNAMIC CIRCULATION; TRANSPORT; EXPRESSION; COMPLEX; PATIENT; STRESS; LINKS	Background: Endothelial nitric oxide synthase (eNOS) is primarily localized on the Golgi apparatus and plasma membrane caveolae in endothelial cells. Previously, we demonstrated that protein S-nitrosylation occurs preferentially where eNOS is localized. Thus, in endothelial cells, Golgi proteins are likely to be targets for S-nitrosylation. The aim of this study was to identify S-nitrosylated Golgi proteins and attribute their S-nitrosylation to eNOS-derived nitric oxide in endothelial cells. Methods: Golgi membranes were isolated from rat livers. S-nitrosylated Golgi proteins were determined by a modified biotin-switch assay coupled with mass spectrometry that allows the identification of the S-nitrosylated cysteine residue. The biotin switch assay followed by Western blot or immunoprecipitation using an S-nitrosocysteine antibody was also employed to validate S-nitrosylated proteins in endothelial cell lysates. Results: Seventy-eight potential S-nitrosylated proteins and their target cysteine residues for S-nitrosylation were identified; 9 of them were Golgi-resident or Golgi/endoplasmic reticulum (ER)-associated proteins. Among these 9 proteins, S-nitrosylation of EMMPRIN and Golgi phosphoprotein 3 (GOLPH3) was verified in endothelial cells. Furthermore, S-nitrosylation of these proteins was found at the basal levels and increased in response to eNOS stimulation by the calcium ionophore A23187. Immunofluorescence microscopy and immunoprecipitation showed that EMMPRIN and GOLPH3 are co-localized with eNOS at the Golgi apparatus in endothelial cells. S-nitrosylation of EMMPRIN was notably increased in the aorta of cirrhotic rats. Conclusion: Our data suggest that the selective S-nitrosylation of EMMPRIN and GOLPH3 at the Golgi apparatus in endothelial cells results from the physical proximity to eNOS-derived nitric oxide.	[Sangwung, Panjamaporn; Iwakiri, Yasuko] Yale Univ, Sch Med, Dept Internal Med, Sect Digest Dis, New Haven, CT 06510 USA; [Greco, Todd M.; Ischiropoulos, Harry] Childrens Hosp Philadelphia, Dept Pharmacol, Philadelphia, PA 19104 USA; [Greco, Todd M.; Ischiropoulos, Harry] Childrens Hosp Philadelphia, Res Inst, Philadelphia, PA 19104 USA; [Greco, Todd M.; Ischiropoulos, Harry] Univ Penn, Philadelphia, PA 19104 USA; [Greco, Todd M.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Wang, Yanzhuang] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Sessa, William C.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA	Yale University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Princeton University; University of Michigan System; University of Michigan; Yale University	Sangwung, P (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Digest Dis, New Haven, CT 06510 USA.	yasuko.iwakiri@yale.edu	Sessa, William C/B-6844-2011; Wang, Yanzhuang/AAE-5299-2019; Greco, Todd/E-8279-2010	Sessa, William C/0000-0001-5759-1938; Wang, Yanzhuang/0000-0002-1864-7094; Greco, Todd/0000-0002-5845-713X; Sangwung, Panjamaporn/0000-0002-8145-7947	National Institutes of Health (NIH) [RO1DK082600, KO1DK067933, GM087364, RO1HL054926, HL64793, HL61371, HL081190, HL096670]; American Cancer Society [RGS-09278-01-CSM]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081190, R01HL054926, R37HL061371, R01HL064793, R01HL061371, R01HL096670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK067933, R01DK082600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087364] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants RO1DK082600, KO1DK067933 from the National Institutes of Health (NIH) (to YI), GM087364 from NIH and RGS-09278-01-CSM from the American Cancer Society (to YW), RO1HL054926 from NIH (to HI) and RO1 grants HL64793, HL61371, HL081190, HL096670 from NIH (to WCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera-Romero A, 2008, J CELL BIOL, V180, P713, DOI 10.1083/jcb.200710025; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; BISWAS C, 1995, CANCER RES, V55, P434; Capitani M, 2009, FEBS LETT, V583, P3863, DOI 10.1016/j.febslet.2009.10.053; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Doulias PT, 2010, P NATL ACAD SCI USA, V107, P16958, DOI 10.1073/pnas.1008036107; Fernandez-Varo G, 2003, AM J PATHOL, V162, P1985, DOI 10.1016/S0002-9440(10)64331-3; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; GarciaCardena G, 1997, J BIOL CHEM, V272, P25437, DOI 10.1074/jbc.272.41.25437; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; Guo HM, 1997, J BIOL CHEM, V272, P24; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Iwakiri Y, 2006, HEPATOLOGY, V43, pS121, DOI 10.1002/hep.20993; Iwakiri Y, 2002, AM J PHYSIOL-GASTR L, V283, pG1074, DOI 10.1152/ajpgi.00145.2002; Iwakiri Y, 2006, P NATL ACAD SCI USA, V103, P19777, DOI 10.1073/pnas.0605907103; Iwakiri Y, 2011, NITRIC OXIDE-BIOL CH, V25, P95, DOI 10.1016/j.niox.2011.04.014; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Kutateladze TG, 2010, NAT CHEM BIOL, V6, P507, DOI [10.1038/NCHEMBIO.390, 10.1038/nchembio.390]; Loureiro-Silva MR, 2006, J HEPATOL, V44, P886, DOI 10.1016/j.jhep.2006.01.032; Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0; Renna M, 2006, INT J BIOCHEM CELL B, V38, P2040, DOI 10.1016/j.biocel.2006.05.016; SESSA WC, 1995, J BIOL CHEM, V270, P17641, DOI 10.1074/jbc.270.30.17641; SOHDA M, 1994, BIOCHEM BIOPH RES CO, V205, P1399, DOI 10.1006/bbrc.1994.2821; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; Strating JRPM, 2009, BIOL CELL, V101, P495, DOI 10.1042/BC20080233; Sun JX, 2001, CANCER RES, V61, P2276; Tang W, 2004, MOL BIOL CELL, V15, P4043, DOI 10.1091/mbc.E04-05-0402; Tazi KA, 2002, GASTROENTEROLOGY, V122, P1869, DOI 10.1053/gast.2002.33586; Toki C, 1997, CELL STRUCT FUNCT, V22, P565, DOI 10.1247/csf.22.565; Wang YJ, 2006, 2006 OPTICS VALLEY OF CHINA INTERNATIONAL SYMPOSIUM ON OPTOELECTRONICS, P33; Wilson MC, 2002, J BIOL CHEM, V277, P3666, DOI 10.1074/jbc.M109658200; Wood CS, 2009, J CELL BIOL, V187, P967, DOI 10.1083/jcb.200909063; Wu CC, 2004, MOL BIOL CELL, V15, P2907, DOI 10.1091/mbc.E04-02-0101	35	19	20	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31564	10.1371/journal.pone.0031564	http://dx.doi.org/10.1371/journal.pone.0031564			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363674	Green Submitted, gold, Green Published			2022-12-27	WOS:000302873700072
J	Schat, KA; Bingham, J; Butler, JM; Chen, LM; Lowther, S; Crowley, TM; Moore, RJ; Donis, RO; Lowenthal, JW				Schat, Karel A.; Bingham, John; Butler, Jeff M.; Chen, Li-Mei; Lowther, Sue; Crowley, Tamsyn M.; Moore, Robert J.; Donis, Ruben O.; Lowenthal, John W.			Role of Position 627 of PB2 and the Multibasic Cleavage Site of the Hemagglutinin in the Virulence of H5N1 Avian Influenza Virus in Chickens and Ducks	PLOS ONE			English	Article							FOWL PLAGUE VIRUS; A-VIRUS; ANAS-PLATYRHYNCHOS; HIGH-PATHOGENICITY; AMINO-ACID; CLINICAL-DISEASE; GENES CONTRIBUTE; THROMBOCYTES; PATHOGENESIS; REPLICATION	Highly pathogenic H5N1 avian influenza viruses have caused major disease outbreaks in domestic and free-living birds with transmission to humans resulting in 59% mortality amongst 564 cases. The mutation of the amino acid at position 627 of the viral polymerase basic-2 protein (PB2) from glutamic acid (E) in avian isolates to lysine (K) in human isolates is frequently found, but it is not known if this change affects the fitness and pathogenicity of the virus in birds. We show here that horizontal transmission of A/Vietnam/1203/2004 H5N1 (VN/1203) virus in chickens and ducks was not affected by the change of K to E at PB2-627. All chickens died between 21 to 48 hours post infection (pi), while 70% of the ducks survived infection. Virus replication was detected in chickens within 12 hours pi and reached peak titers in spleen, lung and brain between 18 to 24 hours for both viruses. Viral antigen in chickens was predominantly in the endothelium, while in ducks it was present in multiple cell types, including neurons, myocardium, skeletal muscle and connective tissues. Virus replicated to a high titer in chicken thrombocytes and caused upregulation of TLR3 and several cell adhesion molecules, which may explain the rapid virus dissemination and location of viral antigen in endothelium. Virus replication in ducks reached peak values between 2 and 4 days pi in spleen, lung and brain tissues and in contrast to infection in chickens, thrombocytes were not involved. In addition, infection of chickens with low pathogenic VN/1203 caused neuropathology, with E at position PB2-627 causing significantly higher infection rates than K, indicating that it enhances virulence in chickens.	[Schat, Karel A.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Bingham, John; Butler, Jeff M.; Lowther, Sue; Crowley, Tamsyn M.; Moore, Robert J.; Lowenthal, John W.] Australian Anim Hlth Lab, Commonwealth Sci & Ind Res Org, Geelong, Vic, Australia; [Chen, Li-Mei; Donis, Ruben O.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Crowley, Tamsyn M.] Deakin Univ, Ctr Biotechnol Chem & Syst Biol, Geelong, Vic 3217, Australia	Cornell University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Centers for Disease Control & Prevention - USA; Deakin University	Schat, KA (corresponding author), Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA.	john.lowenthal@csiro.au	Bingham, John/H-8591-2013; Moore, Robert J/D-8352-2011; lowenthal, john w/G-4459-2010	Bingham, John/0000-0003-2360-3827; Moore, Robert J/0000-0002-0776-5861; lowenthal, john w/0000-0002-0548-2497; Crowley, Tamsyn/0000-0002-3698-8917	Commonwealth Scientific and Industrial Research Organisation	Commonwealth Scientific and Industrial Research Organisation(Commonwealth Scientific & Industrial Research Organisation (CSIRO))	Funding was provided by the Commonwealth Scientific and Industrial Research Organisation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiki-Raji CO, 2008, EMERG INFECT DIS, V14, P1753, DOI 10.3201/eid1411.080557; Al-Azemi A, 2008, EMERG INFECT DIS, V14, P958, DOI 10.3201/eid1406.080056; Aldous EW, 2010, AVIAN PATHOL, V39, P265, DOI 10.1080/03079457.2010.492825; Barber MRW, 2010, P NATL ACAD SCI USA, V107, P5913, DOI 10.1073/pnas.1001755107; Bertram EM, 1998, RES VET SCI, V64, P267, DOI 10.1016/S0034-5288(98)90139-4; Bingham J, 2009, AVIAN PATHOL, V38, P267, DOI 10.1080/03079450903055371; Brown IH, 2009, INFLUENZA OTHER RESP, V3, P59, DOI 10.1111/j.1750-2659.2009.00078.x; CARLSON HC, 1968, AVIAN DIS, V12, P700, DOI 10.2307/1588457; Chakrabarti AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007846; Chen HL, 2006, J VIROL, V80, P5976, DOI 10.1128/JVI.00110-06; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; de Wit E, 2008, J CLIN VIROL, V41, P1, DOI 10.1016/j.jcv.2007.10.017; Ferdous F, 2008, POULTRY SCI, V87, P61, DOI 10.3382/ps.2007-00356; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; GLICK B, 1964, J RETICULOENDOTH SOC, V1, P442; Gowthaman V, 2010, AVIAN DIS, V54, P576, DOI 10.1637/8695-031509-ResNote.1; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hatta M, 2007, PLOS PATHOG, V3, P1374, DOI 10.1371/journal.ppat.0030133; Heine HG, 2007, AVIAN DIS, V51, P370, DOI 10.1637/7587-040206R.1; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hulse DJ, 2004, J VIROL, V78, P9954, DOI 10.1128/JVI.78.18.9954-9964.2004; Hulse-Post DJ, 2007, J VIROL, V81, P8515, DOI 10.1128/JVI.00435-07; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Isoda N, 2006, ARCH VIROL, V151, P1267, DOI 10.1007/s00705-005-0723-6; Karpala AJ, 2011, J INTERF CYTOK RES, V31, P393, DOI 10.1089/jir.2010.0069; Kishida N, 2005, ARCH VIROL, V150, P1383, DOI 10.1007/s00705-004-0473-x; Kiss I, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-113; Le Gall-Recule G, 2008, AVIAN PATHOL, V37, P15, DOI 10.1080/03079450701774835; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Le Goffic R, 2010, J IMMUNOL, V185, P4812, DOI 10.4049/jimmunol.0903952; Lee CW, 2005, J VIROL, V79, P3692, DOI 10.1128/JVI.79.6.3692-3702.2005; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Li YB, 2010, J VIROL, V84, P8389, DOI 10.1128/JVI.00413-10; Londt BZ, 2010, INFLUENZA OTHER RESP, V4, P17, DOI 10.1111/j.1750-2659.2009.00116.x; Londt B, 2008, AVIAN PATHOL, V37, P619, DOI 10.1080/03079450802499126; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Marjuki H, 2009, ADV VIROL, V2009, DOI 10.1155/2009/294520; Mehle A, 2008, CELL HOST MICROBE, V4, P111, DOI 10.1016/j.chom.2008.06.007; Muller T, 2009, AVIAN DIS, V53, P578, DOI 10.1637/8851-040909-Reg.1; Mundt E, 2009, ARCH VIROL, V154, P1241, DOI 10.1007/s00705-009-0437-2; Nagy A, 2009, VET MICROBIOL, V133, P257, DOI 10.1016/j.vetmic.2008.07.013; *OIE, 2009, MAN DIAGN TESTS VACC; Pantin-Jackwood MJ, 2007, VIRUS RES, V130, P151, DOI 10.1016/j.virusres.2007.06.006; Pantin-Jackwood MJ, 2007, AVIAN DIS, V51, P250, DOI 10.1637/7710-090606R.1; Perkins LEL, 2003, AVIAN DIS, V47, P956, DOI 10.1637/0005-2086-47.s3.956; Pfeiffer J, 2009, VIRUS RES, V142, P108, DOI 10.1016/j.virusres.2009.01.019; Pillai SPS, 2010, ARCH VIROL, V155, P1439, DOI 10.1007/s00705-010-0727-8; Prele CM, 2008, J IMMUNOL, V181, P8018, DOI 10.4049/jimmunol.181.11.8018; Quynh ML, 2009, J VIROL, V83, P5278, DOI 10.1128/JVI.00063-09; Ray K, 2008, VIRUS GENES, V36, P345, DOI 10.1007/s11262-007-0195-8; Salomon R, 2006, J EXP MED, V203, P689, DOI 10.1084/jem.20051938; Savic V, 2010, VECTOR-BORNE ZOONOT, V10, P915, DOI 10.1089/vbz.2009.0107; Scott T, 2008, MOL IMMUNOL, V45, P1001, DOI 10.1016/j.molimm.2007.07.035; Shinya K, 2004, VIROLOGY, V320, P258, DOI 10.1016/j.virol.2003.11.030; Song JS, 2011, J VIROL, V85, P2180, DOI 10.1128/JVI.01975-10; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; STERZ I, 1974, MED MICROBIOL IMMUN, V159, P151, DOI 10.1007/BF02123728; STERZ I, 1973, ZBL VET MED B, V20, P613; Suarez DL, 1998, J VIROL, V72, P6678, DOI 10.1128/JVI.72.8.6678-6688.1998; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Suguitan AL, 2009, VIROLOGY, V395, P280, DOI 10.1016/j.virol.2009.09.017; Swayne DE, 2007, AVIAN DIS, V51, P242, DOI 10.1637/7763-110706-REGR.1; Tada T, 2011, J VIROL, V85, P1834, DOI 10.1128/JVI.01648-10; Tang YH, 2009, AVIAN PATHOL, V38, P457, DOI 10.1080/03079450903349147; Tran TT, 2008, INT J BIOCHEM CELL B, V40, P2671, DOI 10.1016/j.biocel.2008.05.019; Tregaskes CA, 2005, DEV COMP IMMUNOL, V29, P361, DOI 10.1016/j.dci.2004.09.001; Wasilenko JL, 2011, ARCH VIROL, V156, P37, DOI 10.1007/s00705-010-0813-y; Wasilenko JL, 2008, J VIROL, V82, P4544, DOI 10.1128/JVI.02642-07; Wasilenko JL, 2009, ARCH VIROL, V154, P969, DOI 10.1007/s00705-009-0399-4; WHO, 2007, UN NOM SYST HIGHL PA; WHO, 2012, CUM NUMB CONF HUM CA; Zhou JY, 2006, J GEN VIROL, V87, P1823, DOI 10.1099/vir.0.81800-0	74	47	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e30960	10.1371/journal.pone.0030960	http://dx.doi.org/10.1371/journal.pone.0030960			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363523	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700016
J	Tatters, AO; Fu, FX; Hutchins, DA				Tatters, Avery O.; Fu, Fei-Xue; Hutchins, David A.			High CO2 and Silicate Limitation Synergistically Increase the Toxicity of Pseudo-nitzshia fraudulenta	PLOS ONE			English	Article							DOMOIC ACID PRODUCTION; NITZSCHIA-MULTISERIES; CALIFORNIA COAST; IRON LIMITATION; DIATOM; GROWTH; BLOOMS; NEUROTOXIN; SEAWATER; PLANKTON	Anthropogenic CO2 is progressively acidifying the ocean, but the responses of harmful algal bloom species that produce toxins that can bioaccumulate remain virtually unknown. The neurotoxin domoic acid is produced by the globally-distributed diatom genus Pseudo-nitzschia. This toxin is responsible for amnesic shellfish poisoning, which can result in illness or death in humans and regularly causes mass mortalities of marine mammals and birds. Domoic acid production by Pseudo-nitzschia cells is known to be regulated by nutrient availability, but potential interactions with increasing seawater CO2 concentrations are poorly understood. Here we present experiments measuring domoic acid production by acclimatized cultures of Pseudo-nitzschia fraudulenta that demonstrate a strong synergism between projected future CO2 levels (765 ppm) and silicate-limited growth, which greatly increases cellular toxicity relative to growth under modern atmospheric (360 ppm) or pre-industrial (200 ppm) CO2 conditions. Cellular Si:C ratios decrease with increasing CO2, in a trend opposite to that seen for domoic acid production. The coastal California upwelling system where this species was isolated currently exhibits rapidly increasing levels of anthropogenic acidification, as well as widespread episodic silicate limitation of diatom growth. Our results suggest that the current ecosystem and human health impacts of toxic Pseudo-nitzschia blooms could be greatly exacerbated by future ocean acidification and 'carbon fertilization' of the coastal ocean.	[Tatters, Avery O.; Fu, Fei-Xue; Hutchins, David A.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA	University of Southern California	Tatters, AO (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.	dahutch@usc.edu	Hutchins, David A/D-3301-2013; Tatters, Avery/V-7723-2019	Hutchins, David A/0000-0002-6637-756X; Tatters, Avery/0000-0002-5616-1044	United States National Science Foundation (NSF) [0850730, 0942379, 0962309]; Division Of Ocean Sciences [0850730] Funding Source: National Science Foundation	United States National Science Foundation (NSF)(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This study was fully supported by the United States National Science Foundation (NSF) grants OCE 0850730, 0942379, and 0962309. NSF URL: http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley R, 2007, CLIMATE CHANGE 2007; Anderson CR, 2006, MAR ECOL PROG SER, V327, P119, DOI 10.3354/meps327119; Anderson CR, 2009, HARMFUL ALGAE, V8, P478, DOI 10.1016/j.hal.2008.10.005; Bates SS, 2006, ECOL STU AN, V189, P81, DOI 10.1007/978-3-540-32210-8_7; Bates S.S., 1998, PHYSL ECOLOGY HARMFU, P267; Boyd PW, 2010, LIMNOL OCEANOGR, V55, P1353, DOI 10.4319/lo.2010.55.3.1353; BRZEZINSKI MA, 1995, DEEP-SEA RES PT I, V42, P1215, DOI 10.1016/0967-0637(95)93592-3; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dybas CL, 2006, BIOSCIENCE, V56, P642, DOI 10.1641/0006-3568(2006)56[642:OACCOP]2.0.CO;2; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Firme GF, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001824; Fu FX, 2007, J PHYCOL, V43, P485, DOI 10.1111/j.1529-8817.2007.00355.x; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Guillard R.R.L., 1973, HDB PHYCOLOGICAL MET, P289; Hallegraeff GM, 2010, J PHYCOL, V46, P220, DOI 10.1111/j.1529-8817.2010.00815.x; Hasle Grethe R., 2002, Harmful Algae, V1, P137, DOI 10.1016/S1568-9883(02)00014-8; Howard MDA, 2007, HARMFUL ALGAE, V6, P206, DOI 10.1016/j.hal.2006.06.003; Hutchins DA, 1998, LIMNOL OCEANOGR, V43, P1037, DOI 10.4319/lo.1998.43.6.1037; Hutchins DA, 1998, NATURE, V393, P561, DOI 10.1038/31203; Hutchins DA, 2009, OCEANOGRAPHY, V22, P128, DOI 10.5670/oceanog.2009.103; Lane JQ, 2009, MAR ECOL PROG SER, V383, P37, DOI 10.3354/meps07999; Lewis E, ORNLCDIAC105; Lundholm N, 2004, MAR ECOL PROG SER, V273, P1, DOI 10.3354/meps273001; Macintyre HL, 2011, J PLANKTON RES, V33, P273, DOI 10.1093/plankt/fbq146; Mafra LL, 2009, J CHROMATOGR A, V1216, P6003, DOI 10.1016/j.chroma.2009.06.050; Maldonado MT, 2002, LIMNOL OCEANOGR, V47, P515, DOI 10.4319/lo.2002.47.2.0515; Milligan AJ, 2004, LIMNOL OCEANOGR, V49, P322, DOI 10.4319/lo.2004.49.2.0322; Pan YL, 1996, MAR ECOL PROG SER, V131, P225, DOI 10.3354/meps131225; Pan YL, 1996, MAR ECOL PROG SER, V131, P235, DOI 10.3354/meps131235; Pan Youlian, 1998, Natural Toxins, V6, P127, DOI 10.1002/(SICI)1522-7189(199805/08)6:3/4<127::AID-NT9>3.3.CO;2-U; Peng YG, 1996, FUND APPL TOXICOL, V31, P162, DOI 10.1006/faat.1996.0087; Ramsey Una P., 1998, Natural Toxins, V6, P137, DOI 10.1002/(SICI)1522-7189(199805/08)6:3/4<137::AID-NT28>3.3.CO;2-C; Saito MA, 2008, LIMNOL OCEANOGR, V53, P276, DOI 10.4319/lo.2008.53.1.0276; Schnetzer A, 2007, HARMFUL ALGAE, V6, P372, DOI 10.1016/j.hal.2006.11.004; Scholin CA, 2000, NATURE, V403, P80, DOI 10.1038/47481; Sekula-Wood E, 2011, HARMFUL ALGAE, V10, P567, DOI 10.1016/j.hal.2011.04.009; Sun J, 2011, LIMNOL OCEANOGR, V56, P829, DOI 10.4319/lo.2011.56.3.0829; Trick CG, 2010, P NATL ACAD SCI USA, V107, P5887, DOI 10.1073/pnas.0910579107; Trimborn S, 2008, PHYSIOL PLANTARUM, V133, P92, DOI 10.1111/j.1399-3054.2007.01038.x; Utermohl H., 1931, MITTEILUNGEN INT VER, V5, P567, DOI DOI 10.1080/05384680.1958; Wells ML, 2005, LIMNOL OCEANOGR, V50, P1908, DOI 10.4319/lo.2005.50.6.1908; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985	42	107	111	2	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32116	10.1371/journal.pone.0032116	http://dx.doi.org/10.1371/journal.pone.0032116			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363805	Green Submitted, Green Published, gold			2022-12-27	WOS:000302873700146
J	Wang, WL; Hong, TM; Chang, YL; Wu, CT; Pan, SH; Yang, PC				Wang, Wen-Lung; Hong, Tse-Ming; Chang, Yih-Leong; Wu, Chen-Tu; Pan, Szu-Hua; Yang, Pan-Chyr			Phosphorylation of LCRMP-1 by GSK3 beta Promotes Filopoda Formation, Migration and Invasion Abilities in Lung Cancer Cells	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; RESPONSE MEDIATOR PROTEIN-1; METASTASIS; MECHANISM; GSK-3	LCRMP-1, a novel isoform of CRMP-1, can promote cancer cell migration, invasion and associate with poor clinical outcome in patients with non-small-cell lung cancer (NSCLC). However, the underlying regulatory mechanisms of LCRMP-1 in cancer cell invasiveness still remain obscure. Here, we report that GSK3 beta can phosphorylate LCRMP-1 at Thr-628 in consensus sequences and this phosphorylation is crucial for function of LCRMP-1 to promote filopodia formation, migration and invasion in cancer cells. Impediment of Thr-628 phosphorylation attenuates the stimulatory effects of LCRMP-1 on filopodia forming, migration and invasion abilities in cancer cells; simultaneously, kinase-dead GSK3 beta diminishes regulation of LCRMP-1 on cancer cell invasion. Furthermore, we also found that patients with low-level Ser-9-phosphorylated GSK3 beta expression and high-level LCRMP-1 expression have worse overall survival than those with high-level inactive GSK3 beta expressions and low-level LCRMP-1 expressions (P<0.0001). Collectively, these results demonstrate that GSK3 beta-dependent phosphorylation of LCRMP-1 provides an important mechanism for regulation of LCRMP-1 on cancer cell invasiveness and clinical outcome.	[Wang, Wen-Lung] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Hong, Tse-Ming; Pan, Szu-Hua; Yang, Pan-Chyr] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Hong, Tse-Ming] Natl Cheng Kong Univ, Grad Inst Clin Med, Tainan, Taiwan; [Chang, Yih-Leong; Wu, Chen-Tu] Natl Taiwan Univ, Dept Pathol, Taipei 10764, Taiwan; [Chang, Yih-Leong; Wu, Chen-Tu] Natl Taiwan Univ, Grad Inst Pathol, Taipei 10764, Taiwan; [Pan, Szu-Hua] Natl Taiwan Univ, Grad Inst Clin Genom, Coll Med, Taipei 10764, Taiwan; [Yang, Pan-Chyr] Natl Taiwan Univ, NTU Ctr Genom Med, Taipei 10764, Taiwan; [Yang, Pan-Chyr] Natl Taiwan Univ, Dept Internal Med, Coll Med, Taipei 10764, Taiwan	National Defense Medical Center; Academia Sinica - Taiwan; National Cheng Kung University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Wang, WL (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.	pcyang@ntu.edu.tw		Pan, Szu-Hua/0000-0002-0138-0434; WU, CHEN-TU/0000-0001-8458-4119; CHANG, YIH-LEONG/0000-0001-5309-0554; YANG, PAN-CHYR/0000-0001-6330-6048	National Science Council [NSC 98-2628-B-002-086-MY3, NSC100-3112-B-006-005, NSC100-2321-B-002071]	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council (NSC 98-2628-B-002-086-MY3, NSC100-3112-B-006-005, and NSC100-2321-B-002071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bijur GN, 2003, NEUROREPORT, V14, P2415, DOI 10.1097/00001756-200312190-00025; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Cai XM, 2006, MOL CELL BIOL, V26, P2857, DOI 10.1128/MCB.26.7.2857-2868.2006; Chao YC, 2009, AM J RESP CRIT CARE, V179, P123, DOI 10.1164/rccm.200803-456OC; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Cole AR, 2004, J BIOL CHEM, V279, P50176, DOI 10.1074/jbc.C400412200; Conacci-Sorrell M, 2003, J CELL BIOL, V163, P847, DOI 10.1083/jcb.200308162; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; Pan SH, 2011, J CLIN INVEST, V121, P3189, DOI 10.1172/JCI42975; Pan SH, 2010, LUNG CANCER, V67, P93, DOI 10.1016/j.lungcan.2009.03.006; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Shih JY, 2001, JNCI-J NATL CANCER I, V93, P1392, DOI 10.1093/jnci/93.18.1392; Shih JY, 2003, CLIN EXP METASTAS, V20, P69, DOI 10.1023/A:1022598604565; Sobin, 2009, UICC TNM CLASSIFICAT; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; Wang LH, 1996, J NEUROSCI, V16, P6197; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	25	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31689	10.1371/journal.pone.0031689	http://dx.doi.org/10.1371/journal.pone.0031689			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363707	gold, Green Published, Green Submitted			2022-12-27	WOS:000302873700084
J	Zhang, H; Ran, X; Hu, CL; Qin, LP; Lu, Y; Peng, C				Zhang, Hong; Ran, Xia; Hu, Chang-Ling; Qin, Lu-Ping; Lu, Ying; Peng, Cheng			Therapeutic Effects of Liposome-Enveloped Ligusticum chuanxiong Essential Oil on Hypertrophic Scars in the Rabbit Ear Model	PLOS ONE			English	Article							POLYGONUM-CUSPIDATUM; APOPTOSIS; EXPRESSION; FIBROBLASTS; CASPASE-9; POLYDATIN; RHIZOMES; PATHWAY; KELOIDS; MEMORY	Hypertrophic scarring, a common proliferative disorder of dermal fibroblasts, results from an overproduction of fibroblasts and excessive deposition of collagen. Although treatment with surgical excision or steroid hormones can modify the symptoms, numerous treatment-related complications have been described. In view of this, we investigated the therapeutic effects of essential oil (EO) from rhizomes of Ligusticum chuanxiong Hort. (Umbelliferae) on formed hypertrophic scars in a rabbit ear model. EO was prepared as a liposomal formulation (liposome-enveloped essential oil, LEO) and a rabbit ear model with hypertrophic scars was established. LEO (2.5, 5, and 10%) was applied once daily to the scars for 28 days. On postoperative day 56, the scar tissue was excised for masson's trichrome staining, detection of fibroblast apoptosis, assays of the levels of collagens I and III, and analysis of the mRNA expression of matrix metalloproteinase-1 (MMP-1), caspase-3 and -9, and transforming growth factor beta 1 (TGF-beta(1)). In addition, the scar elevation index (SEI) was also determined. As a result, LEO treatment significantly alleviated formed hypertrophic scars on rabbit ears. The levels of TGF-beta(1), MMP-1, collagen I, and collagen III were evidently decreased, and caspase-3 and -9 levels and apoptosis cells were markedly increased in the scar tissue. SEI was also significantly reduced. Histological findings exhibited significant amelioration of the collagen tissue. These results suggest that LEO possesses the favorable therapeutic effects on formed hypertrophic scars in the rabbit ear model and may be an effective cure for human hypertrophic scars.	[Zhang, Hong; Ran, Xia; Hu, Chang-Ling; Qin, Lu-Ping] Second Mil Med Univ, Dept Pharmacognosy, Sch Pharm, Shanghai, Peoples R China; [Zhang, Hong; Peng, Cheng] Chengdu Univ Tradit Chinese Med, Coll Pharm, Key Lab Standardizat Chinese Herbal Med, Minist Educ, Chengdu, Peoples R China; [Ran, Xia] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Lu, Ying] Second Mil Med Univ, Dept Pharmaceut, Sch Pharm, Shanghai, Peoples R China	Naval Medical University; Chengdu University of Traditional Chinese Medicine; East China Normal University; Naval Medical University	Zhang, H (corresponding author), Second Mil Med Univ, Dept Pharmacognosy, Sch Pharm, Shanghai, Peoples R China.	lpqin@smmu.edu.cn; Pengchengchengdu@126.com	Hu, Changling/P-7012-2019	zhang, hong/0000-0002-6191-0046; Peng, Cheng/0000-0003-3303-906X	National Natural Science Foundation of China [81173462]; State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources [2011012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources	This work was supported by the National Natural Science Foundation of China (No. 81173462) and the Open Research Fund of State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources (No. 2011012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka Y, 2005, WOUND REPAIR REGEN, V13, P373, DOI 10.1111/j.1067-1927.2005.130404.x; Beldon P, 2000, Nurs Times, V96, P44; Bloemen MCT, 2009, BURNS, V35, P463, DOI 10.1016/j.burns.2008.07.016; Bock O, 2006, ARCH DERMATOL RES, V297, P433, DOI 10.1007/s00403-006-0651-7; Cande C, 2004, CELL DEATH DIFFER, V11, P591, DOI 10.1038/sj.cdd.4401400; Chan SSK, 2006, EUR J PHARMACOL, V537, P111, DOI 10.1016/j.ejphar.2006.03.015; *CHIN PHARM COMM, 2005, CHIN PHARM, V1; Chipuk JE, 2005, NAT REV MOL CELL BIO, V6, P268, DOI [10.1038/nrm1573, 10.1038/nrm2239]; Clark JA, 1996, BURNS, V22, P443, DOI 10.1016/0305-4179(96)00038-1; Dasu MRK, 2004, J PATHOL, V202, P476, DOI 10.1002/path.1539; Du J, 2009, PHYTOMEDICINE, V16, P652, DOI 10.1016/j.phymed.2008.10.001; EGBARIA K, 1990, DRUG DELIV, V5, P287; HAYAKAWA T, 1979, CLIN CHIM ACTA, V93, P119, DOI 10.1016/0009-8981(79)90252-3; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hou YZ, 2004, LIFE SCI, V75, P1775, DOI 10.1016/j.lfs.2004.05.005; Jeong JB, 2009, CANCER EPIDEMIOL, V33, P41, DOI 10.1016/j.canep.2009.04.010; Kryger ZB, 2007, J AM COLL SURGEONS, V205, P78, DOI 10.1016/j.jamcollsurg.2007.03.001; Mazharinia N, 2007, J BURN CARE RES, V28, P312, DOI 10.1097/BCR.0B013E318031A151; Morris DE, 1997, PLAST RECONSTR SURG, V100, P674, DOI 10.1097/00006534-199709000-00021; Niessen FB, 1999, PLAST RECONSTR SURG, V104, P1435, DOI 10.1097/00006534-199910000-00031; Niu F, 2004, CHINA MED ENG, V12, P12; O'Leary R, 2002, EUR J SURG, V168, P523; Peng C, 2009, PHYTOMEDICINE, V16, P25, DOI 10.1016/j.phymed.2008.10.010; Pirnia F, 2002, CELL DEATH DIFFER, V9, P905, DOI 10.1038/sj.cdd.4401062; Reish RG, 2008, J AM COLL SURGEONS, V206, P719, DOI 10.1016/j.jamcollsurg.2007.11.022; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Schaffer M, 1999, CHIRURG, V70, P897, DOI 10.1007/s001040050740; Schmid P, 1998, AM J PATHOL, V152, P485; Sim Y, 2008, ARCH PHARM RES, V31, P497, DOI 10.1007/s12272-001-1184-7; Song BQ, 2009, WOUND REPAIR REGEN, V17, P559, DOI 10.1111/j.1524-475X.2009.00514.x; Tuan TL, 1998, MOL MED TODAY, V4, P19, DOI 10.1016/S1357-4310(97)80541-2; Wang XD, 2001, GENE DEV, V15, P2922; Wu JG, 2011, PHARM BIOL, V49, P764, DOI 10.3109/13880209.2010.542761; Wu JG, 2011, PHARM BIOL, V49, P86, DOI 10.3109/13880209.2010.499517; Wu JG, 2009, PHYTOMEDICINE, V16, P1033, DOI 10.1016/j.phymed.2009.04.005; Wu M, 2002, J BIOL CHEM, V277, P25617, DOI 10.1074/jbc.M202285200; Xing WW, 2009, BIOMED PHARMACOTHER, V63, P457, DOI 10.1016/j.biopha.2008.06.035; Yu R, 2010, W CHINA MED J, V25, P1209; Zhang H, 2008, MATURITAS, V61, P334, DOI 10.1016/j.maturitas.2008.09.023; Zhang H, 2008, PHYTOMEDICINE, V15, P587, DOI 10.1016/j.phymed.2007.12.004; Zhang H, 2007, J PHARM PHARMACOL, V59, P301, DOI 10.1211/jpp.59.2.0016	41	22	22	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31157	10.1371/journal.pone.0031157	http://dx.doi.org/10.1371/journal.pone.0031157			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363569	gold, Green Published, Green Submitted			2022-12-27	WOS:000302873700030
J	Tian, D; Zhang, WJ; He, J; Liu, Y; Song, ZG; Zhou, ZT; Zheng, M; Hu, YW				Tian, Di; Zhang, Wanju; He, Jing; Liu, Yi; Song, Zhigang; Zhou, Zhitong; Zheng, Min; Hu, Yunwen			Novel, Real-Time Cell Analysis for Measuring Viral Cytopathogenesis and the Efficacy of Neutralizing Antibodies to the 2009 Influenza A (H1N1) Virus	PLOS ONE			English	Article							ASSAY	A novel electronic cell sensor array technology, the real-time cell analysis ( RTCA) system, was developed to monitor cell events. Unlike the conventional methods labeling the target cells with fluorescence, luminescence, or light absorption, the RTCA system allows for label-free detection of cell processes directly without the incorporation of labels. Here, we used this new format to measure the cytopathic effect (CPE) of the 2009 influenza A (H1N1) virus and the efficacy of neutralizing antibodies in human sera to this virus. The real-time dynamic monitoring of CPE was performed on MDCK cell cultures infected with the H1N1 virus, ranging from 5.50 x 10(2) to 5.50 x 10(7) copies/mL. The resulting CPE kinetic curves were automatically recorded and were both time and viral load dependent. The CPE kinetics were also distinguishable between different H1N1 stains, as the onset of CPE induced by the A/Shanghai/37T/2009 H1N1 virus was earlier than that of the A/Shanghai/143T/2009 H1N1 virus. Furthermore, inhibition of H1N1 virus-induced CPE in the presence of human specific antisera was detected and quantified using the RTCA system. Antibody titers determined using this new neutralization test correlated well with those obtained independently via the standard hemagglutination inhibition test. Taken together, this new CPE assay format provided label-free and high-throughput measurement of viral growth and the effect of neutralizing antibodies, illustrating its potential in influenza vaccine studies.	[Tian, Di; Zhang, Wanju; He, Jing; Liu, Yi; Song, Zhigang; Zhou, Zhitong; Hu, Yunwen] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Pathogen Diag & Biosafety Dept, Shanghai 200433, Peoples R China; [Zheng, Min] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Infect Dis Diagnost & Treatment, Hangzhou 310003, Zhejiang, Peoples R China	Fudan University; Zhejiang University	Tian, D (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Pathogen Diag & Biosafety Dept, Shanghai 200433, Peoples R China.	ywhu@shaphc.org		Zhang, Wanju/0000-0001-9913-8584	China ministry of health [2009ZX10004-211]; Shanghai Medical College of Fudan University, Shanghai, China [09L-34]	China ministry of health; Shanghai Medical College of Fudan University, Shanghai, China	The study was supported by the National Major Science and Technology Project-Prevention and Treatment of AIDS, Viral Hepatitis, and Other Major Infectious Diseases (Grant NO. 2009ZX10004-211), China ministry of health, and by the grant from the Shanghai Medical College of Fudan University (Grant NO. 09L-34), Shanghai, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], X179A WHO; Arora S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-218; Atienza JM, 2006, ASSAY DRUG DEV TECHN, V4, P597, DOI 10.1089/adt.2006.4.597; Boon ACM, 2010, J VIROL, V84, P7662, DOI 10.1128/JVI.02444-09; Fang Y, 2011, J VIROL METHODS, V173, P251, DOI 10.1016/j.jviromet.2011.02.013; HAHON N, 1972, APPL MICROBIOL, V23, P485, DOI 10.1128/AEM.23.3.485-489.1972; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Huang DY, 2009, ENVIRON SCI TECHNOL, V43, P7803, DOI 10.1021/es901189c; Ke YH, 2007, MOL CELL BIOL, V27, P6706, DOI 10.1128/MCB.01225-07; Kendal AP, 1982, CONCEPTS PROCEDURES; Lehtoranta L, 2009, J VIROL METHODS, V159, P271, DOI 10.1016/j.jviromet.2009.04.015; Liang XF, 2010, LANCET, V375, P56, DOI 10.1016/S0140-6736(09)62003-1; Nathanson N, 2007, VIRAL PATHOGENESIS I, V2; Nissen E, 1997, IN VITRO CELL DEV-AN, V33, P28; Qiu C, 2012, CLIN INFECT DIS, V54, P17, DOI 10.1093/cid/cir753; Qiu C, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022603, 10.1371/journal.pone.0025216]; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Smee DF, 2002, J VIROL METHODS, V106, P71, DOI 10.1016/S0166-0934(02)00137-4; Solly K, 2004, ASSAY DRUG DEV TECHN, V2, P363, DOI 10.1089/adt.2004.2.363; Starsichova A, 2009, BIOL PROCED ONLINE, V11, P316, DOI 10.1007/s12575-009-9017-9; Stephenson I, 2007, VACCINE, V25, P4056, DOI 10.1016/j.vaccine.2007.02.039; Tsai CG, 2009, VACCINE, V27, P6777, DOI 10.1016/j.vaccine.2009.08.056; *WHO, PAND H1N1 2009 GUID; Wu JA, 2010, NEW ENGL J MED, V363, P2416, DOI 10.1056/NEJMoa1006736; Xi Biao, 2008, Biotechnology Journal, V3, P484, DOI 10.1002/biot.200800020; Xing JZ, 2005, CHEM RES TOXICOL, V18, P154, DOI 10.1021/tx049721s; Zhu FC, 2009, NEW ENGL J MED, V361, P2414, DOI 10.1056/NEJMoa0908535	27	23	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31965	10.1371/journal.pone.0031965	http://dx.doi.org/10.1371/journal.pone.0031965			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363775	Green Published, gold, Green Submitted			2022-12-27	WOS:000302871500099
J	Vermeiren, A; Cleeremans, A				Vermeiren, Astrid; Cleeremans, Axel			The Validity of d ' Measures	PLOS ONE			English	Article							UNCONSCIOUS PERCEPTION; VISUAL MASKING; FREE-CHOICE; DISCRIMINATION; IDENTIFICATION; CONSCIOUSNESS; TIME	Subliminal perception occurs when prime stimuli that participants claim not to be aware of nevertheless influence subsequent processing of a target. This claim, however, critically depends on correct methods to assess prime awareness. Typically, d' ("d prime'') tasks administered after a priming task are used to establish that people are unable to discriminate between different primes. Here, we show that such d' tasks are influenced by the nature of the target, by attentional factors, and by the delay between stimulus presentation and response. Our results suggest that the standard d' task is not a straightforward measure of prime visibility. We discuss the implications of our findings for subliminal perception research.	[Vermeiren, Astrid; Cleeremans, Axel] Univ Libre Bruxelles, Consciousness Cognit & Computat Grp, Brussels, Belgium	Universite Libre de Bruxelles	Vermeiren, A (corresponding author), Univ Libre Bruxelles, Consciousness Cognit & Computat Grp, Brussels, Belgium.	asvermei@ulb.ac.be			Ministere de la Communaute Francaise - Direction Generale l'Enseignement non obligatoire et de la Recherche scientifique (Belgium) [06/11-342]	Ministere de la Communaute Francaise - Direction Generale l'Enseignement non obligatoire et de la Recherche scientifique (Belgium)	This work was supported by Concerted Research Action 06/11-342 titled "Culturally Modified Organisms: What It Means to Be Human in the Age of Culture,'' financed by the Ministere de la Communaute Francaise - Direction Generale l'Enseignement non obligatoire et de la Recherche scientifique (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNSTEIN IH, 1989, PERCEPT PSYCHOPHYS, V45, P153, DOI 10.3758/BF03208050; BJORKMAN M, 1993, PERCEPT PSYCHOPHYS, V54, P75, DOI 10.3758/BF03206939; Bodner GE, 2010, EXP PSYCHOL, V57, P360, DOI 10.1027/1618-3169/a000043; Cleeremans A, 2008, PROG BRAIN RES, V168, P19, DOI 10.1016/S0079-6123(07)68003-0; Cleeremans A, 2007, HUM MOVEMENT SCI, V26, P180, DOI 10.1016/j.humov.2007.01.009; DAGENBACH D, 1989, J MEM LANG, V28, P412, DOI 10.1016/0749-596X(89)90020-X; DARK VJ, 1988, MEM COGNITION, V16, P299, DOI 10.3758/BF03197040; DARK VJ, 1991, Q J EXP PSYCHOL-A, V43, P53, DOI 10.1080/14640749108400999; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Dehaene S, 1998, NATURE, V395, P597, DOI 10.1038/26967; Dehaene S, 2011, PROG MATH PHYS, V60, P141, DOI 10.1007/978-3-0346-0428-4_7; Dienes Z, 2007, PROGR BRAIN RES, V168, P269; Dienes Z, 2008, PROG BRAIN RES, V168, P49, DOI 10.1016/S0079-6123(07)68005-4; ERIKSEN CW, 1960, PSYCHOL REV, V67, P279, DOI 10.1037/h0041622; Finkbeiner M, 2011, ATTEN PERCEPT PSYCHO, V73, P1255, DOI 10.3758/s13414-011-0088-8; Fisk GD, 2005, AM J PSYCHOL, V118, P183; Green DM, 1966, SIGNAL DETECTION THE; HOLENDER D, 1986, BEHAV BRAIN SCI, V9, P1, DOI 10.1017/S0140525X00021269; Holender D, 2004, PERCEPT PSYCHOPHYS, V66, P872, DOI 10.3758/BF03194980; Kanai R, 2006, CURR BIOL, V16, P2332, DOI 10.1016/j.cub.2006.10.001; Kiesel A, 2006, CONSCIOUS COGN, V15, P397, DOI 10.1016/j.concog.2005.10.002; Lin ZC, 2009, PROG NEUROBIOL, V87, P195, DOI 10.1016/j.pneurobio.2008.09.002; MACMILLAN NA, 1986, BEHAV BRAIN SCI, V9, P38, DOI 10.1017/S0140525X00021427; MARCEL AJ, 1983, COGNITIVE PSYCHOL, V15, P197, DOI 10.1016/0010-0285(83)90009-9; Pasquali A, 2010, COGNITION, V117, P182, DOI 10.1016/j.cognition.2010.08.010; Pratte MS, 2009, ATTEN PERCEPT PSYCHO, V71, P1276, DOI 10.3758/APP.71.6.1276; Ramsoy T.Z., 2004, PHENOMENOL COGNIT SC, V3, P1, DOI [10.1023/b:phen.0000041900.30172.e8, DOI 10.1023/B:PHEN.0000041900.30172.E8, 10.1023/B:PHEN.0000041900.30172.e8]; REINGOLD EM, 1988, PERCEPT PSYCHOPHYS, V44, P563, DOI 10.3758/BF03207490; Reuss H, 2011, CONSCIOUSNESS COGNIT; Sandberg K, 2010, CONSCIOUS COGN, V19, P1069, DOI 10.1016/j.concog.2009.12.013; Schlaghecken F, 2004, PSYCHON B REV, V11, P463, DOI 10.3758/BF03196596; SHANKS DR, 1994, BEHAV BRAIN SCI, V17, P367, DOI 10.1017/S0140525X00035032; Snodgrass M, 2004, PERCEPT PSYCHOPHYS, V66, P846, DOI 10.3758/BF03194978; Van den Bussche E, 2009, PSYCHOL BULL, V135, P452, DOI 10.1037/a0015329; Van Opstal F, 2010, CONSCIOUS COGN, V19, P999, DOI 10.1016/j.concog.2010.05.002; Vorberg D, 2003, P NATL ACAD SCI USA, V100, P6275, DOI 10.1073/pnas.0931489100	36	27	27	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31595	10.1371/journal.pone.0031595	http://dx.doi.org/10.1371/journal.pone.0031595			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926YY	22363682	Green Published, Green Submitted, gold			2022-12-27	WOS:000302871500059
J	Huang, Y; Gou, JQ; Jia, ZC; Yang, L; Sun, YM; Xiao, XY; Song, F; Luo, KM				Huang, Yan; Gou, Jiqing; Jia, Zhichun; Yang, Li; Sun, Yimin; Xiao, Xunyan; Song, Feng; Luo, Keming			Molecular Cloning and Characterization of Two Genes Encoding Dihydroflavonol-4-Reductase from Populus trichocarpa	PLOS ONE			English	Article							FLAVONOID BIOSYNTHESIS; MEDICAGO-TRUNCATULA; CHEMICAL DEFENSE; TREMBLING ASPEN; EXPRESSION; 4-REDUCTASE; REDUCTASE; TANNIN; ARABIDOPSIS; METABOLISM	Dihydroflavonol 4-reductase (DFR, EC 1.1.1.219) is a rate-limited enzyme in the biosynthesis of anthocyanins and condensed tannins (proanthocyanidins) that catalyzes the reduction of dihydroflavonols to leucoanthocyanins. In this study, two full-length transcripts encoding for PtrDFR1 and PtrDFR2 were isolated from Populus trichocarpa. Sequence alignment of the two PtrDFRs with other known DFRs reveals the homology of these genes. The expression profile of PtrDFRs was investigated in various tissues of P. trichocarpa. To determine their functions, two PtrDFRs were overexpressed in tobacco (Nicotiana tabacum) via Agrobacterium-mediated transformation. The associated color change in the flowers was observed in all 35S:PtrDFR1 lines, but not in 35S: PtrDFR2 lines. Compared to the wild-type control, a significantly higher accumulation of anthocyanins was detected in transgenic plants harboring the PtrDFR1. Furthermore, overexpressing PtrDFR1 in Chinese white poplar (P. tomentosa Carr.) resulted in a higher accumulation of both anthocyanins and condensed tannins, whereas constitutively expressing PtrDFR2 only improved condensed tannin accumulation, indicating the potential regulation of condensed tannins by PtrDFR2 in the biosynthetic pathway in poplars.	[Huang, Yan; Jia, Zhichun; Yang, Li; Sun, Yimin; Xiao, Xunyan; Song, Feng; Luo, Keming] Southwest Univ, Sch Life Sci, Key Lab Ecoenvironm Three Gorges Reservoir Reg, Minist Educ,Inst Resources Bot, Chongqing, Peoples R China; [Huang, Yan; Luo, Keming] Southwest Univ, Chongqing Key Lab Transgen Plant & Safety Control, Chongqing, Peoples R China; [Gou, Jiqing] Samuel Roberts Noble Fdn Inc, Forage Improvement Div, Ardmore, OK USA	Southwest University - China; Southwest University - China; Noble Research Institute	Huang, Y (corresponding author), Southwest Univ, Sch Life Sci, Key Lab Ecoenvironm Three Gorges Reservoir Reg, Minist Educ,Inst Resources Bot, Chongqing, Peoples R China.	kemingl@swu.edu.cn		Yan, Huang/0000-0002-9899-9443	National Natural Science Foundation of China [3081576]; National Key Project for Research on Transgenic Plant [2008ZX08010-003]; Natural Science Foundation (CSTC) [2009BA1004, 2009BB0004]; Fundamental Research Funds for the Central Universities [XDJK2009B018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Project for Research on Transgenic Plant; Natural Science Foundation (CSTC)(National Natural Science Foundation of China (NSFC)Natural Science Foundation Project of CQ CSTC); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (3081576), the National Key Project for Research on Transgenic Plant (2008ZX08010-003), the Natural Science Foundation Project of CQ CSTC (CSTC, 2009BA1004, 2009BB0004), and the Fundamental Research Funds for the Central Universities (XDJK2009B018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida R, 2000, PLANT SCI, V160, P49, DOI 10.1016/S0168-9452(00)00364-2; Bavage AD, 1997, PLANT MOL BIOL, V35, P443, DOI 10.1023/A:1005841214470; BELD M, 1989, PLANT MOL BIOL, V13, P491, DOI 10.1007/BF00027309; BEVAN M, 1984, NUCLEIC ACIDS RES, V12, P8711, DOI 10.1093/nar/12.22.8711; CHEN C, 1990, BIOTECHNOL BIOENG, V36, P993, DOI 10.1002/bit.260361004; Devic M, 1999, PLANT J, V19, P387, DOI 10.1046/j.1365-313X.1999.00529.x; Dixon RA, 2005, NEW PHYTOL, V165, P9, DOI 10.1111/j.1469-8137.2004.01217.x; Dixon RA, 1999, TRENDS PLANT SCI, V4, P394, DOI 10.1016/S1360-1385(99)01471-5; Donaldson JR, 2007, ECOLOGY, V88, P729, DOI 10.1890/06-0064; Driebe EM, 2000, OECOLOGIA, V123, P99, DOI 10.1007/s004420050994; Fischer TC, 2003, ARCH BIOCHEM BIOPHYS, V412, P223, DOI 10.1016/S0003-9861(03)00013-4; Gou JQ, 2011, NEW PHYTOL, V192, P626, DOI 10.1111/j.1469-8137.2011.03837.x; Gou JQ, 2010, PLANT CELL, V22, P623, DOI 10.1105/tpc.109.073239; HORSCH RB, 1988, PLANT MOL BIOL MAN A, V5, P1; Inagaki Y, 1999, GENE, V226, P181, DOI 10.1016/S0378-1119(98)00571-X; Jansson S, 2007, ANNU REV PLANT BIOL, V58, P435, DOI 10.1146/annurev.arplant.58.032806.103956; Jia Z, 2011, TREE PHYSIOL, V30, P1599; Johnson ET, 1999, PLANT J, V19, P81, DOI 10.1046/j.1365-313X.1999.00502.x; KRISTIANSEN KN, 1991, MOL GEN GENET, V230, P49, DOI 10.1007/BF00290650; Lacombe E, 1997, PLANT J, V11, P429, DOI 10.1046/j.1365-313X.1997.11030429.x; Li XX, 2010, BIOTECHNOL LETT, V32, P1333, DOI [10.1007/s10529-010-0297-6, 10.1007/s10529-010-0281-1]; Liew CF, 1998, PLANT SCI, V135, P161, DOI 10.1016/S0168-9452(98)00071-5; Lindroth RL, 1996, RECENT ADV PHYTOCHEM, V30, P25; Lloyd G., 1980, Combined Proceedings, International Plant Propagators' Society, V30, P421; Lo Piero AR, 2006, PHYTOCHEMISTRY, V67, P684, DOI 10.1016/j.phytochem.2006.01.025; Luo KM, 2006, PLANT CELL REP, V25, P403, DOI 10.1007/s00299-005-0051-z; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Martens S, 2003, BIOCHEM ENG J, V14, P227, DOI 10.1016/S1369-703X(02)00224-3; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; OLSEN O, 1993, P NATL ACAD SCI USA, V90, P8043, DOI 10.1073/pnas.90.17.8043; Ostergaard L, 2001, PLANT SCI, V160, P463, DOI 10.1016/S0168-9452(00)00407-6; Pang YZ, 2007, PLANT PHYSIOL, V145, P601, DOI 10.1104/pp.107.107326; Peters DJ, 2002, PLANT J, V32, P701, DOI 10.1046/j.1365-313X.2002.01458.x; Polashock JJ, 2002, PLANT SCI, V163, P241, DOI 10.1016/S0168-9452(02)00087-0; PRICE ML, 1978, J AGR FOOD CHEM, V26, P1214, DOI 10.1021/jf60219a031; Robbins MP, 1998, PLANT PHYSIOL, V116, P1133, DOI 10.1104/pp.116.3.1133; SCHULTZ JC, 1982, SCIENCE, V217, P149, DOI 10.1126/science.217.4555.149; Shimada N, 2005, J EXP BOT, V56, P2573, DOI 10.1093/jxb/eri251; SHIRLEY BW, 1995, PLANT J, V8, P659, DOI 10.1046/j.1365-313X.1995.08050659.x; SPARVOLI F, 1994, PLANT MOL BIOL, V24, P743, DOI 10.1007/BF00029856; Sterky F, 2004, P NATL ACAD SCI USA, V101, P13951, DOI 10.1073/pnas.0401641101; SWAIN T., 1959, Journal of the Science of Food and Agriculture, V10, P63, DOI 10.1002/jsfa.2740100110; Taylor G, 2002, ANN BOT-LONDON, V90, P681, DOI 10.1093/aob/mcf255; Tsai CJ, 2006, NEW PHYTOL, V172, P47, DOI 10.1111/j.1469-8137.2006.01798.x; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Waterman P.G., 1994, OXF BLACKWELL SCI PU, V8, P73; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Winkel-Shirley B, 2001, PLANT PHYSIOL, V127, P1399, DOI 10.1104/pp.127.4.1399; Xie DY, 2004, PLANT PHYSIOL, V134, P979, DOI 10.1104/pp.103.030221	50	41	54	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30364	10.1371/journal.pone.0030364	http://dx.doi.org/10.1371/journal.pone.0030364			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363429	gold, Green Published, Green Submitted			2022-12-27	WOS:000302853600023
J	Studerus, E; Gamma, A; Kometer, M; Vollenweider, FX				Studerus, Erich; Gamma, Alex; Kometer, Michael; Vollenweider, Franz X.			Prediction of Psilocybin Response in Healthy Volunteers	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; ALTERED STATES; CONSCIOUSNESS; ABSORPTION; 5-HT2A; TRAIT; MODEL; EXPERIENCES; BINDING; HUMANS	Responses to hallucinogenic drugs, such as psilocybin, are believed to be critically dependent on the user's personality, current mood state, drug pre-experiences, expectancies, and social and environmental variables. However, little is known about the order of importance of these variables and their effect sizes in comparison to drug dose. Hence, this study investigated the effects of 24 predictor variables, including age, sex, education, personality traits, drug pre-experience, mental state before drug intake, experimental setting, and drug dose on the acute response to psilocybin. The analysis was based on the pooled data of 23 controlled experimental studies involving 409 psilocybin administrations to 261 healthy volunteers. Multiple linear mixed effects models were fitted for each of 15 response variables. Although drug dose was clearly the most important predictor for all measured response variables, several non-pharmacological variables significantly contributed to the effects of psilocybin. Specifically, having a high score in the personality trait of Absorption, being in an emotionally excitable and active state immediately before drug intake, and having experienced few psychological problems in past weeks were most strongly associated with pleasant and mystical-type experiences, whereas high Emotional Excitability, low age, and an experimental setting involving positron emission tomography most strongly predicted unpleasant and/or anxious reactions to psilocybin. The results confirm that non-pharmacological variables play an important role in the effects of psilocybin.	[Studerus, Erich; Kometer, Michael; Vollenweider, Franz X.] Univ Hosp Psychiat, Neuropsychopharmacol & Brain Imaging & Heffter Re, Zurich, Switzerland; [Gamma, Alex] Univ Hosp Psychiat, Dept Clin & Social Psychiat, Zurich, Switzerland		Studerus, E (corresponding author), Univ Hosp Psychiat, Neuropsychopharmacol & Brain Imaging & Heffter Re, Zurich, Switzerland.	erich.studerus@upkbs.ch	Studerus, Erich/AAB-1632-2020	Studerus, Erich/0000-0003-4233-0182	Heffter Research Institute, Santa Fe, New Mexico, United States of America; Swiss Neuromatrix Foundation, Switzerland	Heffter Research Institute, Santa Fe, New Mexico, United States of America; Swiss Neuromatrix Foundation, Switzerland	This work was supported by the Heffter Research Institute, Santa Fe, New Mexico, United States of America (http://www.heffter.org), and the Swiss Neuromatrix Foundation, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KH, 2004, NEUROIMAGE, V21, P1105, DOI 10.1016/j.neuroimage.2003.10.046; Anderson MC, 2009, CURR DIR PSYCHOL SCI, V18, P189, DOI 10.1111/j.1467-8721.2009.01634.x; Angleitner A., 2004, PSYCHOBIOLOGY PERSON, P89105, DOI DOI 10.1016/B978-008044209-9/50007-5; [Anonymous], APPL BEHAV SCI REV; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barr H.L., 1972, LSD PERSONALITY EXPE; Blanchard-Fields F, 2007, CURR DIR PSYCHOL SCI, V16, P26, DOI 10.1111/j.1467-8721.2007.00469.x; Bodmer Ines, 1994, WELTEN BEWUSSTSEINS, V3, P45; Bresnick T, 2006, J CONSCIOUSNESS STUD, V13, P5; Costa P., 2008, SAGE HDB PERSONALITY, V2, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9]; Derogatis L. R., 1994, SCL 90 R SYMPTOM CHE; Dittrich A, 1998, PHARMACOPSYCHIATRY, V31, P80, DOI 10.1055/s-2007-979351; DITTRICH A, 1994, 50 YEARS OF LSD, P101; Dittrich A, 2006, FRAGEBOGEN ERFASSUNG, V3rd; Dittrich A, 1994, WELTEN BEWUSSTSEINS, V3, P45; Edwards LJ, 2008, STAT MED, V27, P6137, DOI 10.1002/sim.3429; Eisner B, 1997, J PSYCHOACTIVE DRUGS, V29, P213; Enders C. K., 2010, APPL MISSING DATA AN; Fahrenberg J, 1978, FREIBURGER PERSNLICH; FISCHER R, 1968, NATURE, V218, P296, DOI 10.1038/218296a0; Franke G., 1995, SCL 90 R SYMPTOM CHE; Frokjaer VG, 2008, BIOL PSYCHIAT, V63, P569, DOI 10.1016/j.biopsych.2007.07.009; Gelman A., 2004, BAYESIAN DATA ANAL; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Geyer MA, 2008, TRENDS PHARMACOL SCI, V29, P445, DOI 10.1016/j.tips.2008.06.006; Gonzalez-Maeso J, 2007, NEURON, V53, P439, DOI 10.1016/j.neuron.2007.01.008; Gonzalez-Maeso J, 2009, TRENDS NEUROSCI, V32, P225, DOI 10.1016/j.tins.2008.12.005; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; Griffiths RR, 2006, PSYCHOPHARMACOLOGY, V187, P268, DOI 10.1007/s00213-006-0457-5; Grinspoon L., 1979, PSYCHEDELIC DRUGS RE; Gurka MJ, 2006, J R STAT SOC A STAT, V169, P273, DOI 10.1111/j.1467-985X.2005.00391.x; Hasler F, 2004, PSYCHOPHARMACOLOGY, V172, P145, DOI 10.1007/s00213-003-1640-6; HEMSLEY DR, 1985, PERS INDIV DIFFER, V6, P515, DOI 10.1016/0191-8869(85)90148-5; Heymans MW, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-33; Hyde RW, 1960, DYNAMICS PSYCHIAT DR, P297, DOI DOI 10.1016/J.BMC.2008.04.050; JANKE W, 1986, INT SKALEN PSYCHIAT, P43; Janke W, RESPONSE VARIABILITY; Janke W, 1978, EIGENSCHAFTSWRTERLIS, V1; Johnson MW, 2008, J PSYCHOPHARMACOL, V22, P603, DOI 10.1177/0269881108093587; KORNETSKY C, 1957, ARCH NEURO PSYCHIATR, V77, P325, DOI 10.1001/archneurpsyc.1957.02330330111017; Langlitz N, 2010, HIST HUM SCI, V23, P37, DOI 10.1177/0952695109352413; LEARY T, 1963, J NERV MENT DIS, V137, P561, DOI 10.1097/00005053-196312000-00007; Liechti ME, 2001, PSYCHOPHARMACOLOGY, V154, P161, DOI 10.1007/s002130000648; Lienert GA, 1996, PERS INDIV DIFFER, V21, P845, DOI 10.1016/S0191-8869(96)00143-2; LINTON HB, 1964, J NERV MENT DIS, V138, P409; MARLATT GA, 1980, ADV SUBSTANC ABUSE, V1, P159; Metrik J, 2009, EXP CLIN PSYCHOPHARM, V17, P217, DOI 10.1037/a0016502; Nichols DE, 2004, PHARMACOL THERAPEUT, V101, P131, DOI 10.1016/j.pharmthera.2003.11.002; Ott U, 2005, AM J MED GENET B, V137B, P29, DOI 10.1002/ajmg.b.30197; PEKALA RJ, 1985, J PERS SOC PSYCHOL, V48, P125, DOI 10.1037/0022-3514.48.1.125; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rinkel M., 1961, NEUROPSYCHOPHARMACOL, V2, P56; RITZ T, 1995, DIAGNOSTICA, V41, P53; ROCHE SM, 1990, J PERS SOC PSYCHOL, V59, P91, DOI 10.1037/0022-3514.59.1.91; Royston P., 2008, MULTIVARIABLE MODEL; Rubin DB, 2004, MULTIPLE IMPUTATION; Sauerbrei W, 2008, STAT COMPUT, V18, P195, DOI 10.1007/s11222-007-9048-5; Schmitz N, 2000, QUAL LIFE RES, V9, P185, DOI 10.1023/A:1008931926181; Schmitz P.G., 2004, PSYCHOBIOLOGY PERSON, P65; Stace Walter T., 1961, MYSTICISM PHILOS; Steyerberg EW, 2019, CLIN PREDICTION MODE, V2nd, DOI 10.1007/978-0-387-77244-8; Studerus E, 2011, J PSYCHOPHARMACOL, V25, P1434, DOI 10.1177/0269881110382466; Studerus E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012412; TELLEGEN A, 1974, J ABNORM PSYCHOL, V83, P268, DOI 10.1037/h0036681; Vaitl D, 2005, PSYCHOL BULL, V131, P98, DOI 10.1037/0033-2909.131.1.98; van Buuren S, J STAT SOFT IN PRESS, P1; VOGELSPROTT M, 1999, EXPECTANCIES SHAPE E, P215, DOI DOI 10.1037/10332-009; Vollenweider FX, 2010, NAT REV NEUROSCI, V11, P642, DOI 10.1038/nrn2884; Vollenweider FX, 2001, BRAIN RES BULL, V56, P495, DOI 10.1016/S0361-9230(01)00646-3; Weil G., 1965, PSYCHEDELIC REV, V1, P3; Zhou X, 2010, AM STAT, V64, P159, DOI 10.1198/tast.2010.09109; Zuckerman M, 2002, BIG FIVE ASSESSMENT, P377	72	169	171	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30800	10.1371/journal.pone.0030800	http://dx.doi.org/10.1371/journal.pone.0030800			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363492	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000302853600069
J	Yang, CW; Chen, SM				Yang, Chu-Wen; Chen, Sy-Mien			A Comparative Study of Human TLR 7/8 Stimulatory Trimer Compositions in Influenza A Viral Genomes	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; SINGLE-STRANDED RNA; TOLL-LIKE RECEPTORS; NUCLEIC-ACID; NS1 PROTEIN; VIRUS; RECOGNITION; AUTOPHAGY; VIRULENCE; TOLL-LIKE-RECEPTOR-7	Background: Variation in the genomes of single-stranded RNA viruses affects their infectivity and pathogenicity in two ways. First, viral genome sequence variations lead to changes in viral protein sequences and activities. Second, viral genome sequence variation produces diversity at the level of nucleotide composition and diversity in the interactions between viral RNAs and host toll-like receptors (TLRs). A viral genome-typing method based on this type of diversity has not yet been established. Methodology/Principal Findings: In this study, we propose a novel genomic trait called the "TLR stimulatory trimer composition" (TSTC) and two quantitative indicators, Score S and Score N, named "TLR stimulatory scores" (TSS). Using the complete genome sequences of 10,994 influenza A viruses (IAV) and 251 influenza B viruses, we show that TSTC analysis reveals the diversity of Score S and Score N among the IAVs isolated from various hosts. In addition, we show that low values of Score S are correlated with high pathogenicity and pandemic potential in IAVs. Finally, we use Score S and Score N to construct a logistic regression model to recognize IAV strains that are highly pathogenic or have high pandemic potential. Conclusions/Significance: Results from the TSTC analysis indicate that there are large differences between human and avian IAV genomes (except for segment 3), as illustrated by Score S. Moreover, segments 1, 2, 3 and 4 may be major determinants of the stimulatory activity exerted on human TLRs 7 and 8. We also find that a low Score S value is associated with high pathogenicity and pandemic potential in IAV. The p value from the TSS-derived logistic regression model is useful for recognizing emerging IAVs that have high pathogenicity and pandemic potential.	[Yang, Chu-Wen] Soochow Univ, Dept Microbiol, Taipei 11102, Taiwan; [Chen, Sy-Mien] Fu Jen Catholic Univ, Dept Math, New Taipei City, Taiwan	Soochow University; Fu Jen Catholic University	Yang, CW (corresponding author), Soochow Univ, Dept Microbiol, Taipei 11102, Taiwan.	smchen@mail.fju.edu.tw			National Science Council (NSC) [98-2321-B-031-001]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council (NSC 98-2321-B-031-001) to C. W. Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer S, 2008, IMMUNOBIOLOGY, V213, P315, DOI 10.1016/j.imbio.2007.10.010; Chen GW, 2009, EMERG INFECT DIS, V15, P1897, DOI 10.3201/eid1512.090845; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Diebold SS, 2008, ADV DRUG DELIVER REV, V60, P813, DOI 10.1016/j.addr.2007.11.004; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Fernandez-Sesma A., 2007, Infectious Disorders - Drug Targets, V7, P336, DOI 10.2174/187152607783018754; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Gannage M, 2009, CELL HOST MICROBE, V6, P367, DOI 10.1016/j.chom.2009.09.005; Greninger AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013381; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hornung Veit, 2008, V183, P71; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Kawai T, 2007, J BIOCHEM, V141, P137, DOI 10.1093/jb/mvm032; KAWAOKA Y, 1988, P NATL ACAD SCI USA, V85, P324, DOI 10.1073/pnas.85.2.324; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Miller RL, 2008, DRUG NEWS PERSPECT, V21, P69, DOI 10.1358/dnp.2008.21.2.1188193; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Rossman JS, 2009, CELL HOST MICROBE, V6, P299, DOI 10.1016/j.chom.2009.09.009; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Tscherne DM, 2011, J CLIN INVEST, V121, P6, DOI 10.1172/JCI44947; von Landenberg P, 2007, CURR OPIN IMMUNOL, V19, P606, DOI 10.1016/j.coi.2007.10.004; Wang JP, 2006, J IMMUNOL, V177, P7114, DOI 10.4049/jimmunol.177.10.7114; Zhou Z, 2009, AUTOPHAGY, V5, P321, DOI 10.4161/auto.5.3.7406	29	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30751	10.1371/journal.pone.0030751	http://dx.doi.org/10.1371/journal.pone.0030751			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363482	Green Submitted, Green Published, gold			2022-12-27	WOS:000302853600064
J	Chung, JH; Jeon, HJ; Hong, SY; Lee, DL; Lee, KH; Kim, SH; Han, YS; Manabe, I; Miller, YI; Lee, SH				Chung, Ji Hyung; Jeon, Hyun Ju; Hong, Sung-Yu; Lee, Da Lyung; Lee, Kyung Hye; Kim, Soo Hyuk; Han, Ye Sun; Manabe, Ichiro; Miller, Yury I.; Lee, Sang-Hak			Palmitate Promotes the Paracrine Effects of Macrophages on Vascular Smooth Muscle Cells: The Role of Bone Morphogenetic Proteins	PLOS ONE			English	Article							SATURATED FATTY-ACIDS; HYPOXIC PULMONARY-HYPERTENSION; ENDOTHELIAL-CELLS; KAPPA-B; PROLIFERATION; EXPRESSION; ACTIVATION; BMP4	Saturated fatty acids are known to activate macrophages and induce vascular inflammation. Although cytokines from activated macrophage influence other vascular cells, the influence of saturated fatty acids on the paracrine effect of macrophages is not fully understood yet. Here we examined the impact of palmitate on the effect of macrophages on vascular smooth muscle cells (SMCs) and their mediators. SMCs proliferation increased significantly after treatment with conditioned media from palmitate-stimulated RAW264.7 cells. SMC migration was found to be greater after treatment with palmitate-conditioned media. SM alpha-actin and SM22 alpha were decreased in SMCs treated with palmitate-conditioned media. When stimulated with palmitate, RAW264.7 cells secreted more bone morphogenetic protein (BMP)2 and BMP4 into the cell culture media. SMC proliferation, migration, and phenotypic changes were attenuated after treatment of neutralizing antibodies against BMPs or knockdown of BMPs with siRNA. The influences of these proteins were further confirmed by direct treatment of recombinant BMP2 and BMP4 on SMCs. Particularly, the effects of BMPs on SMC migration on phenotypic change were obvious, whereas their effect on SMC proliferation seemed not significant or modest. In conclusion, palmitate promoted macrophages' paracrine effects on SMC proliferation, migration, and phenotypic change. The effect of stimulated macrophages was mediated, at least in part, by BMP2 and BMP4. These results suggest a novel mechanism linking saturated fatty acids and the progression of vascular diseases that is possibly mediated by BMPs from macrophages.	[Chung, Ji Hyung; Hong, Sung-Yu] Yonsei Univ Hlth Syst, Cardiovasc Res Inst, Cardiovasc Prod Evaluat Ctr, Seoul, South Korea; [Jeon, Hyun Ju; Kim, Soo Hyuk] Yonsei Univ, Grad Sch, Interdisciplinary Course Sci Aging, Seoul 120749, South Korea; [Lee, Da Lyung] Biobud Inc, Natl Res Lab Cardiovasc Therapy, Seoul, South Korea; [Lee, Kyung Hye] Yonsei Univ, Yonsei Res Inst Aging Sci, Seoul 120749, South Korea; [Han, Ye Sun] Konkuk Univ, Dept Adv Technol Fus, Seoul, South Korea; [Manabe, Ichiro] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; [Miller, Yury I.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Lee, Sang-Hak] Yonsei Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; Konkuk University; University of Tokyo; University of California System; University of California San Diego; Yonsei University; Yonsei University Health System	Chung, JH (corresponding author), Yonsei Univ Hlth Syst, Cardiovasc Res Inst, Cardiovasc Prod Evaluat Ctr, Seoul, South Korea.	shl1106@yuhs.ac	Manabe, Ichiro/AAE-5105-2021; Manabe, Ichiro/E-1529-2014		Departmet of Internal Medicine, Yonsei University College of Medicine; Yonsei University College of Medicine [6-2011-0162]	Departmet of Internal Medicine, Yonsei University College of Medicine; Yonsei University College of Medicine(General Electric)	This study was supported by a faculty research grant from the Departmet of Internal Medicine, Yonsei University College of Medicine for 2007 and a faculty research grant from Yonsei University College of Medicine for 2011 (6-2011-0162). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L, 2010, AM J PHYSIOL-REG I, V298, pR833, DOI 10.1152/ajpregu.00534.2009; Basford JE, 2009, ARTERIOSCL THROM VAS, V29, P1772, DOI 10.1161/ATVBAHA.109.194357; Beamish JA, 2010, TISSUE ENG PART B-RE, V16, P467, DOI [10.1089/ten.teb.2009.0630, 10.1089/ten.TEB.2009.0630]; BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; Chen CN, 2006, P NATL ACAD SCI USA, V103, P2665, DOI 10.1073/pnas.0510973103; Corriere MA, 2008, J SURG RES, V145, P142, DOI 10.1016/j.jss.2007.03.077; Frank DB, 2005, CIRC RES, V97, P496, DOI 10.1161/01.RES.0000181152.65534.07; Haversen L, 2009, ATHEROSCLEROSIS, V202, P382, DOI 10.1016/j.atherosclerosis.2008.05.033; Hayashi K, 2006, MOL CELL BIOL, V26, P9456, DOI 10.1128/MCB.00759-06; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; Lagna G, 2007, J BIOL CHEM, V282, P37244, DOI 10.1074/jbc.M708137200; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Lowery JW, 2010, CYTOKINE GROWTH F R, V21, P287, DOI 10.1016/j.cytogfr.2010.06.001; Maloney E, 2009, ARTERIOSCL THROM VAS, V29, P1370, DOI 10.1161/ATVBAHA.109.188813; Nakaoka T, 1997, J CLIN INVEST, V100, P2824, DOI 10.1172/JCI119830; Orr AW, 2010, J VASC RES, V47, P168, DOI 10.1159/000250095; Pilz S, 2006, J CLIN ENDOCR METAB, V91, P2542, DOI 10.1210/jc.2006-0195; Schwartz EA, 2010, ARTERIOSCL THROM VAS, V30, P802, DOI 10.1161/ATVBAHA.109.201681; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Sorescu GP, 2003, J BIOL CHEM, V278, P31128, DOI 10.1074/jbc.M300703200; Weigert C, 2004, J BIOL CHEM, V279, P23942, DOI 10.1074/jbc.M312692200; Yang XD, 2005, CIRC RES, V96, P1053, DOI 10.1161/01.RES.0000166926.54293.68	22	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e29100	10.1371/journal.pone.0029100	http://dx.doi.org/10.1371/journal.pone.0029100			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363399	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700002
J	Grant, J				Grant, Jeff			Tachykinins Stimulate a Subset of Mouse Taste Cells	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; RAT GUSTATORY PAPILLAE; SUBSTANCE-P; CHORDA TYMPANI; VANILLOID RECEPTOR; BUD CELLS; GLOSSOPHARYNGEAL NERVES; PAIN PATHWAY; SWEET TASTE; CAPSAICIN	The tachykinins substance P (SP) and neurokinin A (NKA) are present in nociceptive sensory fibers expressing transient receptor potential cation channel, subfamily V, member 1 (TRPV1). These fibers are found extensively in and around the taste buds of several species. Tachykinins are released from nociceptive fibers by irritants such as capsaicin, the active compound found in chili peppers commonly associated with the sensation of spiciness. Using real-time Ca2+-imaging on isolated taste cells, it was observed that SP induces Ca2+ -responses in a subset of taste cells at concentrations in the low nanomolar range. These responses were reversibly inhibited by blocking the SP receptor NK-1R. NKA also induced Ca2+-responses in a subset of taste cells, but only at concentrations in the high nanomolar range. These responses were only partially inhibited by blocking the NKA receptor NK-2R, and were also inhibited by blocking NK-1R indicating that NKA is only active in taste cells at concentrations that activate both receptors. In addition, it was determined that tachykinin signaling in taste cells requires Ca2+-release from endoplasmic reticulum stores. RT-PCR analysis further confirmed that mouse taste buds express NK-1R and NK-2R. Using Ca2+-imaging and single cell RT-PCR, it was determined that the majority of tachykinin-responsive taste cells were Type I (Glial-like) and umami-responsive Type II (Receptor) cells. Importantly, stimulating NK-1R had an additive effect on Ca2+ responses evoked by umami stimuli in Type II (Receptor) cells. This data indicates that tachykinin release from nociceptive sensory fibers in and around taste buds may enhance umami and other taste modalities, providing a possible mechanism for the increased palatability of spicy foods.	Univ Miami, Sch Med, Dept Physiol & Biophys, Miami, FL 33152 USA	University of Miami	Grant, J (corresponding author), Univ Miami, Sch Med, Dept Physiol & Biophys, Miami, FL 33152 USA.				National Institute on Deafness and Other Communication Disorders/National Institutes of Health [2R01DC007630, 5R01DC000374, R01DC006308]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000374, R01DC006308, R01DC007630] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institute on Deafness and Other Communication Disorders/National Institutes of Health 2R01DC007630 and 5R01DC000374 to SD Roper and R01DC006308 to N Chaudhari. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DL, 2006, J COMP NEUROL, V497, P1, DOI 10.1002/cne.20954; Bost KL, 2004, FRONT BIOSCI-LANDMRK, V9, P3331, DOI 10.2741/1484; Bozic CR, 1996, SCIENCE, V273, P1722, DOI 10.1126/science.273.5282.1722; Caicedo A, 2002, J PHYSIOL-LONDON, V544, P501, DOI 10.1113/jphysiol.2002.027862; Caicedo A, 2000, J NEUROSCI, V20, P7978; Candenas L, 2005, LIFE SCI, V76, P835, DOI 10.1016/j.lfs.2004.10.004; Cao Y, 2009, P NATL ACAD SCI USA, V106, P4006, DOI 10.1073/pnas.0808672106; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chang GQ, 1996, REGUL PEPTIDES, V63, P85; CHASSAING G, 1991, NEUROPEPTIDES, V19, P91, DOI 10.1016/0143-4179(91)90137-8; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chaudhari N, 1996, J NEUROSCI, V16, P3817; Chaudhari N, 2010, J CELL BIOL, V190, P285, DOI 10.1083/jcb.201003144; Chung KM, 2005, CHEM SENSES, V30, P137, DOI 10.1093/chemse/bji009; Costa RM, 2005, CHEM SENSES, V30, pI198, DOI 10.1093/chemse/bjh183; DAM TV, 1990, BRAIN RES, V531, P333, DOI 10.1016/0006-8993(90)90796-E; Danilova V, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-5; Davis BJ, 1997, NEUROREPORT, V8, P1723, DOI 10.1097/00001756-199705060-00031; De Felipe C, 1998, NATURE, V392, P394, DOI 10.1038/32904; DeFazio RA, 2006, J NEUROSCI, V26, P3971, DOI 10.1523/JNEUROSCI.0515-06.2006; Dvoryanchikov G, 2007, J COMP NEUROL, V505, P302, DOI 10.1002/cne.21494; Dvoryanchikov G, 2011, J NEUROSCI, V31, P5782, DOI 10.1523/JNEUROSCI.5559-10.2011; Dvoryanchikov G, 2009, J COMP NEUROL, V517, P1, DOI 10.1002/cne.22152; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Flynn FW, 2006, BEHAV BRAIN RES, V166, P1, DOI 10.1016/j.bbr.2005.07.022; Geppetti P, 2008, BJU INT, V101, P2, DOI 10.1111/j.1464-410X.2008.07493.x; Green BG, 2003, PHYSIOL BEHAV, V79, P811, DOI 10.1016/S0031-9384(03)00213-0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gu XF, 2009, NUTR NEUROSCI, V12, P149, DOI 10.1179/147683009X423319; Hayashi Y, 1996, BIOPHYS J, V71, P1057, DOI 10.1016/S0006-3495(96)79306-2; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Huang YA, 2008, J NEUROSCI, V28, P13088, DOI 10.1523/JNEUROSCI.4187-08.2008; Huang YJ, 2005, J NEUROSCI, V25, P843, DOI 10.1523/JNEUROSCI.4446-04.2005; Ishida Y, 2002, MOL BRAIN RES, V107, P17, DOI 10.1016/S0169-328X(02)00441-2; Kaya N, 2004, AM J PHYSIOL-REG I, V286, pR649, DOI 10.1152/ajpregu.00572.2003; Kido MA, 2003, J DENT RES, V82, P393, DOI 10.1177/154405910308200513; Kim JW, 2006, CHEM SENSES, V31, P213, DOI 10.1093/chemse/bjj021; Kim MR, 2003, BIOCHEM BIOPH RES CO, V312, P500, DOI 10.1016/j.bbrc.2003.10.137; KING MS, 1993, BRAIN RES, V619, P120, DOI 10.1016/0006-8993(93)91603-P; Kinnamon SC, 2009, ANN NY ACAD SCI, V1170, P55, DOI 10.1111/j.1749-6632.2009.04106.x; Kitagawa M, 2001, BIOCHEM BIOPH RES CO, V283, P236, DOI 10.1006/bbrc.2001.4760; Koga T, 2000, J NEUROPHYSIOL, V84, P1404, DOI 10.1152/jn.2000.84.3.1404; LAWLESS H, 1984, PHYSIOL BEHAV, V32, P995, DOI 10.1016/0031-9384(84)90291-9; Lecci A, 2008, EUR REV MED PHARMACO, V12, P69; Lin WH, 1999, J NEUROPHYSIOL, V82, P2061, DOI 10.1152/jn.1999.82.5.2061; Liu LJ, 2001, BRAIN RES, V923, P58, DOI 10.1016/S0006-8993(01)03190-0; Lu SG, 2003, NEUROSCI LETT, V351, P157, DOI 10.1016/j.neulet.2003.07.016; MAGGI CA, 1995, GEN PHARMACOL-VASC S, V26, P911, DOI 10.1016/0306-3623(94)00292-U; MOUSSAOUI SM, 1992, NEUROSCIENCE, V48, P969, DOI 10.1016/0306-4522(92)90285-A; NAGAHAMA S, 1985, J GEN PHYSIOL, V85, P431, DOI 10.1085/jgp.85.3.431; Nagai T, 1998, J COMP NEUROL, V392, P199, DOI 10.1002/(SICI)1096-9861(19980309)392:2<199::AID-CNE4>3.0.CO;2-Y; NAGY JI, 1982, NEUROSCIENCE, V7, P3137, DOI 10.1016/0306-4522(82)90236-6; NAKANISHI S, 1993, REGUL PEPTIDES, V46, P37, DOI 10.1016/0167-0115(93)90009-W; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; Niki M, 2011, CELL MOL NEUROBIOL; Ninomiya Y, 2000, J NUTR, V130, p950S, DOI 10.1093/jn/130.4.950S; Ogura T, 2002, J NEUROPHYSIOL, V87, P2643, DOI 10.1152/jn.2002.87.6.2643; Osada K, 1997, CHEM SENSES, V22, P249, DOI 10.1093/chemse/22.3.249; Park K, 2003, BRAIN RES, V962, P135, DOI 10.1016/S0006-8993(02)03984-7; Pennefather JN, 2004, LIFE SCI, V74, P1445, DOI 10.1016/j.lfs.2003.09.039; REGOLI D, 1991, ANN NY ACAD SCI, V632, P170, DOI 10.1111/j.1749-6632.1991.tb33105.x; Romanov RA, 2007, EMBO J, V26, P657, DOI 10.1038/sj.emboj.7601526; Severini C, 2002, PHARMACOL REV, V54, P285, DOI 10.1124/pr.54.2.285; Simon SA, 2003, AM J PHYSIOL-REG I, V284, pR1494, DOI 10.1152/ajpregu.00544.2002; Simons CT, 2002, CHEM SENSES, V27, P353, DOI 10.1093/chemse/27.4.353; Simons CT, 2003, J NEUROSCI, V23, P978; Smith DV, 1998, ANN NY ACAD SCI, V855, P450, DOI 10.1111/j.1749-6632.1998.tb10605.x; Starostik MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013639; Tomchik SM, 2007, J NEUROSCI, V27, P10840, DOI 10.1523/JNEUROSCI.1863-07.2007; Toyono T, 2003, CELL TISSUE RES, V313, P29, DOI 10.1007/s00441-003-0740-2; Toyono T, 2007, CELL TISSUE RES, V328, P57, DOI 10.1007/s00441-006-0351-9; TSUCHIDA K, 1990, EUR J BIOCHEM, V193, P751, DOI 10.1111/j.1432-1033.1990.tb19396.x; Vandenbeuch A, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-77; Vandenbeuch A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-1; WANG Y, 1995, J NEUROPHYSIOL, V73, P1468, DOI 10.1152/jn.1995.73.4.1468; Wifall TC, 2007, CHEM SENSES, V32, P161, DOI 10.1093/chemse/bjl043; Yang RB, 2000, J COMP NEUROL, V424, P205, DOI 10.1002/1096-9861(20000821)424:2<205::AID-CNE2>3.0.CO;2-F; YOSHIE S, 1989, ARCH HISTOL CYTOL, V52, P389, DOI 10.1679/aohc.52.Suppl_389; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhao FL, 2005, P NATL ACAD SCI USA, V102, P11100, DOI 10.1073/pnas.0501988102	81	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31697	10.1371/journal.pone.0031697	http://dx.doi.org/10.1371/journal.pone.0031697			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363709	Green Submitted, Green Published, gold			2022-12-27	WOS:000302873700085
J	Kan, SF; Wang, YH; Sun, LL; Jia, P; Qi, YX; Su, JQ; Liu, L; Yang, GH; Liu, LM; Wang, ZY; Wang, JH; Liu, GC; Jin, NY; Li, X; Ding, Z				Kan, Shifu; Wang, Yuhang; Sun, Lili; Jia, Peng; Qi, Yanxin; Su, Jiaqiang; Liu, Lei; Yang, Guohua; Liu, Liming; Wang, Zhuoyue; Wang, Jinhui; Liu, Guangchen; Jin, Ningyi; Li, Xiao; Ding, Zhuang			Attenuation of Vaccinia Tian Tan Strain by Removal of Viral TC7L-TK2L and TA35R Genes	PLOS ONE			English	Article							SMALLPOX VACCINE; VIRUS ANKARA; HOST-RANGE; PROTEIN; RECOMBINANT; VIRULENCE; SYSTEM; MICE; IMMUNOGENICITY; NYVAC	Vaccinia Tian Tan (VTT) was attenuated by deletion of the TC7L-TK2L and TA35R genes to generate MVTT3. The mutant was generated by replacing the open reading frames by a gene encoding enhanced green fluorescent protein (EGFP) flanked by loxP sites. Viruses expressing EGFP were then screened for and purified by serial plaque formation. In a second step the marker EGFP gene was removed by transfecting cells with a plasmid encoding cre recombinase and selecting for viruses that had lost the EGFP phenotype. The MVTT3 mutant was shown to be avirulent and immunogenic. These results support the conclusion that TC7L-TK2L and TA35R deletion mutants can be used as safe viral vectors or as platform for vaccines.	[Kan, Shifu; Wang, Yuhang; Qi, Yanxin; Wang, Zhuoyue; Jin, Ningyi; Ding, Zhuang] Jilin Univ, Coll Anim Sci & Vet Med, Jilin, Peoples R China; [Kan, Shifu; Wang, Yuhang; Sun, Lili; Jia, Peng; Qi, Yanxin; Su, Jiaqiang; Liu, Lei; Yang, Guohua; Liu, Liming; Wang, Zhuoyue; Wang, Jinhui; Liu, Guangchen; Jin, Ningyi; Li, Xiao] Acad Mil Med Sci, Genet Engn Lab PLA, Jilin, Peoples R China; [Sun, Lili] Tumor Hosp Jilin Prov, Dept Head & Neck Surg, Jilin, Peoples R China; [Jia, Peng] Shenzhen Entry Exit Inspect & Quarantine Bur, Anim & Plant Inspect & Quarantine Technol Ctr, Guangzhou, Guangdong, Peoples R China; [Su, Jiaqiang; Liu, Lei; Yang, Guohua; Wang, Jinhui; Liu, Guangchen; Li, Xiao] Jilin Univ, Norman Bethune Sch Med Sci, Jilin, Peoples R China	Jilin University; Academy of Military Medical Sciences - China; Jilin University	Kan, SF (corresponding author), Jilin Univ, Coll Anim Sci & Vet Med, Jilin, Peoples R China.	skylee528112@gmail.com; Lixiao06@mails.jlu.edu.cn; grammar849@sohu.com	Qi, Yanxin/E-8087-2019	Qi, Yanxin/0000-0001-8801-3655	Genetically Modified Organisms Breeding Major Projects [2009ZX08006-002B]; Key Technologies R&D Programme of Jilin Province [10ZDGG007]	Genetically Modified Organisms Breeding Major Projects; Key Technologies R&D Programme of Jilin Province	This work was supported by Genetically Modified Organisms Breeding Major Projects (2009ZX08006-002B) and Key Technologies R&D Programme of Jilin Province (10ZDGG007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backes S, 2010, J GEN VIROL, V91, P470, DOI 10.1099/vir.0.015347-0; Belyakov IM, 2003, P NATL ACAD SCI USA, V100, P9458, DOI 10.1073/pnas.1233578100; Betakova T, 2000, J VIROL, V74, P4085, DOI 10.1128/JVI.74.9.4085-4092.2000; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Busch CJL, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-191; Coulson D, 2011, VIRUS GENES, V42, P171, DOI 10.1007/s11262-010-0560-x; Dai KF, 2008, VACCINE, V26, P5062, DOI 10.1016/j.vaccine.2008.06.011; de Miranda MP, 2003, J GEN VIROL, V84, P2459, DOI 10.1099/vir.0.19292-0; Domi A, 2002, P NATL ACAD SCI USA, V99, P12415, DOI 10.1073/pnas.192420599; Drexler I, 2004, CURR OPIN BIOTECH, V15, P506, DOI 10.1016/j.copbio.2004.09.001; Fang Q, 2005, VIROLOGY, V335, P242, DOI 10.1016/j.virol.2005.02.014; Gaveriaux-Ruff C, 2007, PHARMACOL THERAPEUT, V113, P619, DOI 10.1016/j.pharmthera.2006.12.003; Gomez CE, 2011, CURR GENE THER, V11, P189; Guirakhoo F, 1999, VIROLOGY, V257, P363, DOI 10.1006/viro.1999.9695; HOU YT, 1985, J GEN VIROL, V66, P1819, DOI 10.1099/0022-1317-66-8-1819; Huang XX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004180; Imai H, 2010, J CLIN BIOCHEM NUTR, V46, P1, DOI 10.3164/jcbn.09-94R; Jin Q, 1997, SCI CHINA, V27, P562; KAPLAN C., 1957, JOUR HYG, V55, P494; Kretzschmar M, 2006, PLOS MED, V3, P1341, DOI 10.1371/journal.pmed.0030272; LEE MS, 1992, J VIROL, V66, P2617, DOI 10.1128/JVI.66.5.2617-2630.1992; LIU GQ, 1990, SCI CHINA SER B, V33, P188; Najera JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011406; Meisinger-Henschel C, 2007, J GEN VIROL, V88, P3249, DOI 10.1099/vir.0.83156-0; Meng XZ, 2009, J VIROL, V83, P10627, DOI 10.1128/JVI.01260-09; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Neff J, 2008, CLIN INFECT DIS, V46, pS258, DOI 10.1086/524749; PAOLETTI E, 1994, DEV BIOL STAND, V82, P65; Parrino J, 2006, J ALLERGY CLIN IMMUN, V118, P1320, DOI 10.1016/j.jaci.2006.09.037; Perdiguero B, 2009, J INTERF CYTOK RES, V29, P581, DOI 10.1089/jir.2009.0073; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rehm KE, 2011, VACCINE, V29, P3276, DOI 10.1016/j.vaccine.2011.02.023; Rehm KE, 2010, J VIROL, V84, P418, DOI 10.1128/JVI.01802-09; Roper RL, 2006, J VIROL, V80, P306, DOI 10.1128/JVI.80.1.306-313.2006; Steinwaerder DS, 2001, MOL THER, V4, P211, DOI 10.1006/mthe.2001.0447; Tang XA, 2010, VIRUSES-BASEL, V2, P283, DOI 10.3390/v2010283; TARTAGLIA J, 1992, VIROLOGY, V188, P217, DOI 10.1016/0042-6822(92)90752-B; TURNER PC, 1995, J VIROL, V69, P5978, DOI 10.1128/JVI.69.10.5978-5987.1995; Yu WB, 2010, VACCINE, V28, P2088, DOI 10.1016/j.vaccine.2009.12.038; Zhang WH, 2000, J VIROL, V74, P11654, DOI 10.1128/JVI.74.24.11654-11662.2000; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024296; Zhao L, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-302; Zhu WJ, 2007, J VIROL METHODS, V144, P17, DOI 10.1016/j.jviromet.2007.03.012	43	10	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31979	10.1371/journal.pone.0031979	http://dx.doi.org/10.1371/journal.pone.0031979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363781	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700131
J	McAllister, LJ; Ogunniyi, AD; Stroeher, UH; Paton, JC				McAllister, Lauren J.; Ogunniyi, Abiodun D.; Stroeher, Uwe H.; Paton, James C.			Contribution of a Genomic Accessory Region Encoding a Putative Cellobiose Phosphotransferase System to Virulence of Streptococcus pneumoniae	PLOS ONE			English	Article							INVASIVE DISEASE; GENE-EXPRESSION; IN-VIVO; DIVERSITY; SEQUENCE; IDENTIFICATION; METABOLISM; DATABASE; SULFATASES; SIGNAL	Streptococcus pneumoniae (the pneumococcus) is a formidable human pathogen, responsible for massive global morbidity and mortality. The ability to utilize carbohydrates in a variety of host niches appears to be integral to pneumococcal pathogenesis. In this study we investigated a genomic island, which includes a ROK family protein, a putative cellobiose phosphotransferase system (PTS) and a putative sulfatase. This accessory region is widespread in the pneumococcus in strains of various serotypes and levels of virulence. We have performed simple bioinformatic analysis of the region and investigated its role in vivo in 2 strains with markedly different virulence profiles (WCH206 of serotype 3, ST180; Menzies5 of serotype 11A, ST662). Deleting and replacing the entire island with an antibiotic resistance cassette caused the virulent serotype 3 strain to become attenuated in a murine pneumonia/sepsis model. Further mutants were constructed and used to show that various components of the island contribute significantly to the fitness of WCH206 in a variety of niches of this model, including the nasopharynx, ears and blood, but especially in the lungs. In addition, the island conferred a competitive advantage in nasopharyngeal colonization for the serotype 11A strain, which was essentially avirulent in the pneumonia/sepsis model. The contribution of this island to both pathogenesis and colonization may explain why this accessory region is widespread in the pneumococcus.	[McAllister, Lauren J.; Ogunniyi, Abiodun D.; Stroeher, Uwe H.; Paton, James C.] Univ Adelaide, Sch Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA, Australia	University of Adelaide	McAllister, LJ (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA, Australia.	james.paton@adelaide.edu.au	Paton, James C/A-9920-2008	Stroeher, Uwe/0000-0001-5705-7751; Ogunniyi, Abiodun/0000-0001-9308-5629	National Health and Medical Research Council (NHMRC) of Australia [565526, 627142]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Program Grant 565526 and Project Grant 627142 from the National Health and Medical Research Council (NHMRC) of Australia supported this research. JCP is a NHMRC Australia Fellow. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Blomberg C, 2009, J INFECT DIS, V199, P1032, DOI 10.1086/597205; Bruckner R, 2004, INT J MED MICROBIOL, V294, P157, DOI 10.1016/j.ijmm.2004.06.019; Carlson BL, 2008, J BIOL CHEM, V283, P20117, DOI 10.1074/jbc.M800217200; Chen HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002950; Croucher NJ, 2009, J BACTERIOL, V191, P1480, DOI 10.1128/JB.01343-08; Dutta PK, 2004, J SCI IND RES INDIA, V63, P20; Embry A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-80; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Forbes ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001969; Giammarinaro P, 2002, INFECT IMMUN, V70, P5454, DOI 10.1128/IAI.70.10.5454-5461.2002; Hanson SR, 2004, ANGEW CHEM INT EDIT, V43, P5736, DOI 10.1002/anie.200300632; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Higgins MA, 2009, J BIOL CHEM; Honke K, 2002, MED RES REV, V22, P637, DOI 10.1002/med.10020; Hooper LV, 1996, FASEB J, V10, P1137, DOI 10.1096/fasebj.10.10.8751716; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; Iyer R, 2005, J BACTERIOL, V187, P8340, DOI 10.1128/JB.187.24.8340-8349.2005; Iyer R, 2007, MOL MICROBIOL, V66, P1, DOI 10.1111/j.1365-2958.2007.05878.x; King SJ, 2005, J BACTERIOL, V187, P5376, DOI 10.1128/JB.187.15.5376-5386.2005; Landgrebe J, 2003, GENE, V316, P47, DOI 10.1016/S0378-1119(03)00746-7; Lau GW, 2001, MOL MICROBIOL, V40, P555, DOI 10.1046/j.1365-2958.2001.02335.x; Lee J, 2004, BIOTECHNIQUES, V36, P398, DOI 10.2144/04363BM04; LeMessurier KS, 2006, MICROBIOL-SGM, V152, P305, DOI 10.1099/mic.0.28438-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahdi LK, 2008, INFECT IMMUN, V76, P646, DOI 10.1128/IAI.01161-07; MARTIN B, 1995, MOL MICROBIOL, V15, P367, DOI 10.1111/j.1365-2958.1995.tb02250.x; McAllister LJ, 2004, MOL MICROBIOL, V53, P889, DOI 10.1111/j.1365-2958.2004.04164.x; McAllister LJ, 2011, INFECT IMMUN; McKessar SJ, 2007, J BACTERIOL, V189, P1342, DOI 10.1128/JB.01170-06; Morona JK, 2006, P NATL ACAD SCI USA, V103, P8505, DOI 10.1073/pnas.0602148103; Obert C, 2006, INFECT IMMUN, V74, P4766, DOI 10.1128/IAI.00316-06; Oggioni MR, 2001, FEMS MICROBIOL LETT, V200, P137, DOI 10.1111/j.1574-6968.2001.tb10705.x; Polissi A, 1998, INFECT IMMUN, V66, P5620, DOI 10.1128/IAI.66.12.5620-5629.1998; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Sardiello M, 2005, HUM MOL GENET, V14, P3203, DOI 10.1093/hmg/ddi351; Shafeeq S, 2011, MICROBIOL-SGM, V157, P2854, DOI 10.1099/mic.0.051359-0; Shen K, 2006, INFECT IMMUN, V74, P321, DOI 10.1128/IAI.74.1.321-330.2006; Silva NA, 2006, INFECT IMMUN, V74, P3513, DOI 10.1128/IAI.00079-06; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Standish AJ, 2005, P NATL ACAD SCI USA, V102, P7701, DOI 10.1073/pnas.0409377102; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; TITGEMEYER F, 1994, MICROBIOL-UK, V140, P2349, DOI 10.1099/13500872-140-9-2349; Trappetti C, 2009, J INFECT DIS, V199, P1497, DOI 10.1086/598483; Yu H, 2007, ORG BIOMOL CHEM, V5, P865, DOI 10.1039/b700034k	45	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32385	10.1371/journal.pone.0032385	http://dx.doi.org/10.1371/journal.pone.0032385			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363821	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700162
J	Silva, DCN; Jovino, CN; Silva, CAL; Fernandes, HP; Filho, MM; Lucena, SC; Costa, AMDN; Cesar, CL; Barjas-Castro, ML; Santos, BS; Fontes, A				Silva, Diego C. N.; Jovino, Caueh N.; Silva, Carlos A. L.; Fernandes, Heloise P.; Filho, Milton M.; Lucena, Sheyla C.; Costa, Ana Maria D. N.; Cesar, Carlos L.; Barjas-Castro, Maria L.; Santos, Beate S.; Fontes, Adriana			Optical Tweezers as a New Biomedical Tool to Measure Zeta Potential of Stored Red Blood Cells	PLOS ONE			English	Article							SURFACE-CHARGE; SIALIC-ACID; STORAGE; ERYTHROCYTES; TIME	During storage, red blood cells (RBCs) for transfusion purposes suffer progressive deterioration. Sialylated glycoproteins of the RBC membrane are responsible for a negatively charged surface which creates a repulsive electrical zeta potential. These charges help prevent the interaction between RBCs and other cells, and especially among each RBCs. Reports in the literature have stated that RBCs sialylated glycoproteins can be sensitive to enzymes released by leukocyte degranulation. Thus, the aim of this study was, by using an optical tweezers as a biomedical tool, to measure the zeta potential in standard RBCs units and in leukocyte reduced RBC units (collected in CPD-SAGM) during storage. Optical tweezers is a sensitive tool that uses light for measuring cell biophysical properties which are important for clinical and research purposes. This is the first study to analyze RBCs membrane charges during storage. In addition, we herein also measured the elasticity of RBCs also collected in CPD-SAGM. In conclusion, the zeta potential decreased 42% and cells were 134% less deformable at the end of storage. The zeta potential from leukodepleted units had a similar profile when compared to units stored without leukoreduction, indicating that leukocyte lyses were not responsible for the zeta potential decay. Flow cytometry measurements of reactive oxygen species suggested that this decay is due to membrane oxidative damages. These results show that measurements of zeta potentials provide new insights about RBCs storage lesion for transfusion purposes.	[Silva, Diego C. N.; Silva, Carlos A. L.; Filho, Milton M.; Fontes, Adriana] Univ Fed Pernambuco, Dept Biofis & Radiobiol, Recife, PE, Brazil; [Jovino, Caueh N.; Santos, Beate S.] Univ Fed Pernambuco, Dept Ciencias Farmaceut, Recife, PE, Brazil; [Fernandes, Heloise P.; Barjas-Castro, Maria L.] Univ Estadual Campinas, INCTS, Hematol & Transfus Ctr, Campinas, SP, Brazil; [Lucena, Sheyla C.; Costa, Ana Maria D. N.] Fdn Hemope, Recife, PE, Brazil; [Cesar, Carlos L.] Univ Estadual Campinas, Inst Fis Gleb Wataghin, Campinas, SP, Brazil	Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Universidade Estadual de Campinas; Universidade Estadual de Campinas	Silva, DCN (corresponding author), Univ Fed Pernambuco, Dept Biofis & Radiobiol, Recife, PE, Brazil.	adriana.fontes@pesquisador.cnpq.br	Cesar, Carlos/O-1470-2013; Barjas-Castro, Maria Lourdes/F-9671-2013; Lenz Cesar, Carlos/F-2442-2018; Fontes, Adriana/T-5789-2019; FotonicaUFPE, Inct/J-8388-2013; Santos, Beate/T-5800-2019	Lenz Cesar, Carlos/0000-0001-5573-9636; Fontes, Adriana/0000-0003-4675-2163; Santos, Beate/0000-0002-9909-5462	L'OREAL/UNESCO; Brazilian Academy of Sciences	L'OREAL/UNESCO; Brazilian Academy of Sciences	The authors are grateful to CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Supeior), CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), and FACEPE (Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco). AF received an award in 2008 given by L'OREAL/UNESCO for young women in Science in partnership with Brazilian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMINOFF D, 1977, P NATL ACAD SCI USA, V74, P1521, DOI 10.1073/pnas.74.4.1521; ASHKIN A, 1987, SCIENCE, V235, P1517, DOI 10.1126/science.3547653; Barjas-Castro ML, 2002, TRANSFUSION, V42, P1196, DOI 10.1046/j.1537-2995.2002.00201.x; BORN GVR, 1989, J PHYSIOL-LONDON, V419, P169, DOI 10.1113/jphysiol.1989.sp017867; Brandao MM, 2009, CLIN HEMORHEOL MICRO, V43, P217, DOI 10.3233/CH-2009-1211; Brandao MM, 2003, EUR J HAEMATOL, V70, P207, DOI 10.1034/j.1600-0609.2003.00027.x; Chelidze T, 2002, J NON-CRYST SOLIDS, V305, P285, DOI 10.1016/S0022-3093(02)01101-8; DANON D, 1976, ANN NY ACAD SCI, V275, P47, DOI 10.1111/j.1749-6632.1976.tb43337.x; DANON D, 1961, CR HEBD ACAD SCI, V253, P1271; Dinu CZ, 2009, SOFT MATTER, V5, P3818, DOI 10.1039/b904639a; DUROCHER JR, 1975, BLOOD, V45, P11; EYLAR EH, 1962, J BIOL CHEM, V237, P1992; Fontes A, 2011, J OPTICS-UK, V13, DOI 10.1088/2040-8978/13/4/044012; Fontes A, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2870108; Godin C, 1997, EUR BIOPHYS J BIOPHY, V26, P175, DOI 10.1007/s002490050069; Guck J, 2001, BIOPHYS J, V81, P767, DOI 10.1016/S0006-3495(01)75740-2; Henon S, 1999, BIOPHYS J, V76, P1145, DOI 10.1016/S0006-3495(99)77279-6; Hunter R. J., 1981, ZETA POTENTIAL COLLO, DOI 10.1016/B978-0-12-361961-7.50006-7; Jovtchev S, 2000, COLLOID SURFACE A, V164, P95, DOI 10.1016/S0927-7757(99)00345-3; Laliberte M, 2009, P SOC PHOTO-OPT INS, V7386; Mauritz JMA, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3458919; Nascimento JM, 2008, J R SOC INTERFACE, V5, P297, DOI 10.1098/rsif.2007.1118; Parrow RL, 2006, TRANSFUS APHER SCI, V34, P5; Perkins TT, 2009, LASER PHOTONICS REV, V3, P203, DOI 10.1002/lpor.200810014; POLLACK W, 1977, INT ARCH ALLER A IMM, V54, P29, DOI 10.1159/000231805; Pozzo LY, 2009, MICRON, V40, P617, DOI 10.1016/j.micron.2009.02.008; Raat NJ, 2005, CRIT CARE MED, V33, P39, DOI 10.1097/01.CCM.0000150655.75519.02; Rookard LE, 2009, BRIT J BIOMED SCI, V66, P93, DOI 10.1080/09674845.2009.11730251; Sze A, 2003, J COLLOID INTERF SCI, V261, P402, DOI 10.1016/S0021-9797(03)00142-5; Wang Shi-Kang, 2006, Cardiovasc Eng, V6, P111, DOI 10.1007/s10558-006-9012-6; YAARI A, 1969, BLOOD-J HEMATOL, V33, P159, DOI 10.1182/blood.V33.2.159.159; Zhu C, 2000, ANNU REV BIOMED ENG, V2, P189, DOI 10.1146/annurev.bioeng.2.1.189; Zubair AC, 2010, AM J HEMATOL, V85, P117, DOI 10.1002/ajh.21599	33	24	25	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31778	10.1371/journal.pone.0031778	http://dx.doi.org/10.1371/journal.pone.0031778			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363729	gold, Green Published, Green Submitted			2022-12-27	WOS:000302873700095
J	Sivapalaratnam, S; Basart, H; Watkins, NA; Maiwald, S; Rendon, A; Krishnan, U; Sondermeijer, BM; Creemers, EE; Pinto-Sietsma, SJ; Hovingh, K; Ouwehand, WH; Kastelein, JJP; Goodall, AH; Trip, MD				Sivapalaratnam, Suthesh; Basart, Hanneke; Watkins, Nicholas A.; Maiwald, Stepanie; Rendon, Augusto; Krishnan, Unni; Sondermeijer, Brigitte M.; Creemers, Esther E.; Pinto-Sietsma, Sara J.; Hovingh, Kees; Ouwehand, Willem H.; Kastelein, John J. P.; Goodall, Alison H.; Trip, Mieke D.			Monocyte Gene Expression Signature of Patients with Early Onset Coronary Artery Disease	PLOS ONE			English	Article							GENOME-WIDE EXPRESSION; HUMAN MACROPHAGES; ATHEROSCLEROSIS; RECEPTOR; RISK; POLYMORPHISMS; ASSOCIATION; VARIANTS; STATINS; MARKERS	The burden of cardiovascular disease (CVD) cannot be fully addressed by therapy targeting known pathophysiological pathways. Even with stringent control of all risk factors CVD events are only diminished by half. A number of additional pathways probably play a role in the development of CVD and might serve as novel therapeutic targets. Genome wide expression studies represent a powerful tool to identify such novel pathways. We compared the expression profiles in monocytes from twenty two young male patients with premature familial CAD with those from controls matched for age, sex and smoking status, without a family history of CVD. Since all patients were on statins and aspirin treatment, potentially affecting the expression of genes in monocytes, twelve controls were subsequently treated with simvastatin and aspirin for 6 and 2 weeks, respectively. By whole genome expression arrays six genes were identified to have differential expression in the monocytes of patients versus controls; ABCA1, ABCG1 and RGS1 were downregulated in patients, whereas ADRB2, FOLR3 and GSTM1 were upregulated. Differential expression of all genes, apart from GSTM1, was confirmed by qPCR. Aspirin and statins altered gene expression of ABCG1 and ADBR2. All finding were validated in a second group of twenty four patients and controls. Differential expression of ABCA1, RSG1 and ADBR2 was replicated. In conclusion, we identified these 3 genes to be expressed differently in CAD cases which might play a role in the pathogenesis of atherosclerotic vascular disease.	[Sivapalaratnam, Suthesh; Basart, Hanneke; Maiwald, Stepanie; Sondermeijer, Brigitte M.; Pinto-Sietsma, Sara J.; Hovingh, Kees; Kastelein, John J. P.; Trip, Mieke D.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Watkins, Nicholas A.; Rendon, Augusto; Ouwehand, Willem H.] Univ Cambridge, Dept Hematol, Cambridge, England; [Watkins, Nicholas A.; Rendon, Augusto; Ouwehand, Willem H.] Natl Hlth Serv Blood & Transplant, Cambridge, England; [Rendon, Augusto; Ouwehand, Willem H.] Wellcome Trust Sanger Inst, Dept Human Genet, Hinxton, England; [Rendon, Augusto] MRC Biostat Unit, Cambridge, England; [Krishnan, Unni; Goodall, Alison H.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Krishnan, Unni; Goodall, Alison H.] Glenfield Hosp, Leicester NIHR Biomed Res Unit Cardiovasc Dis, Leicester, Leics, England; [Trip, Mieke D.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands; [Creemers, Esther E.] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Cambridge; NHS Blood & Transplant (NHSBT); Wellcome Trust Sanger Institute; MRC Biostatistics Unit; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Sivapalaratnam, S (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	s.sivapalaratnam@amc.uva.nl	SJ, Pinto-Sietsma/AAI-3207-2021; Kastelein, John/AAF-7950-2020	Creemers, Esther/0000-0002-9001-3854; Rendon, Augusto/0000-0001-8994-0039; Goodall, Alison/0000-0002-7883-9645; Ouwehand, Willem/0000-0002-7744-1790	European Union [LSHM-CT-2004-503485]; Dutch Heart Foundation [1010T082]; British Heart Foundation [RG/09/012/28096] Funding Source: researchfish	European Union(European Commission); Dutch Heart Foundation(Netherlands Heart Foundation); British Heart Foundation(British Heart Foundation)	This project was part of the Bloodomics project and was funded by the European Union 6th Framework Programme (LSHM-CT-2004-503485) and Ipse Movet, Dr. Kastelein is a recipient of The Lifetime Achievement Award (1010T082) of The Dutch Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amouyel P, 2009, ARTERIOSCL THROM VAS, V29, P774, DOI 10.1161/ATVBAHA.108.181388; Antohe F, 2005, CELL TISSUE RES, V320, P277, DOI 10.1007/s00441-004-1071-7; Argmann CA, 2005, J BIOL CHEM, V280, P22212, DOI 10.1074/jbc.M502761200; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Bijnens APJJ, 2006, ARTERIOSCL THROM VAS, V26, P1226, DOI 10.1161/01.ATV.0000219289.06529.f1; Chittenden TW, 2006, CIRCULATION, V114, P1811, DOI 10.1161/CIRCULATIONAHA.106.628396; Di Minno MND, 2010, THROMB HAEMOSTASIS, V103, P942, DOI 10.1160/TH09-06-0393; Fitzgerald ML, 2010, ATHEROSCLEROSIS, V211, P361, DOI 10.1016/j.atherosclerosis.2010.01.011; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; GREEN SA, 1994, BIOCHEMISTRY-US, V33, P9414, DOI 10.1021/bi00198a006; Gu JR, 2009, ARTHRITIS RHEUM-US, V60, P3269, DOI 10.1002/art.24968; Heckbert SR, 2003, CIRCULATION, V107, P2021, DOI 10.1161/01.CIR.0000065231.07729.92; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Lavoie AJ, 2010, AM J CARDIOL, V105, P1679, DOI 10.1016/j.amjcard.2010.01.345; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Mosig S, 2009, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-60; Nakayama M, 2008, ATHEROSCLEROSIS, V198, P426, DOI 10.1016/j.atherosclerosis.2007.09.006; O'Byrne MR, 2010, BIRTH DEFECTS RES A, V88, P689, DOI 10.1002/bdra.20706; Patino WD, 2005, P NATL ACAD SCI USA, V102, P3423, DOI 10.1073/pnas.0408032102; Rangel J, 2008, AM J SURG PATHOL, V32, P1207, DOI 10.1097/PAS.0b013e31816fd53c; Schirmer SH, 2009, J MOL CELL CARDIOL, V46, P177, DOI 10.1016/j.yjmcc.2008.10.029; Sivapalaratnam S, 2011, CURR ATHEROSCLER REP; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Strang AC, 2009, AM J CARDIOL, V104, p22E, DOI 10.1016/j.amjcard.2009.09.016; Tone A, 2007, J RENIN-ANGIO-ALDO S, V8, P45, DOI 10.3317/jraas.2007.007; Tuomisto TT, 2008, CARDIOVASC RES, V78, P175, DOI 10.1093/cvr/cvn007; Watkins NA, 2009, BLOOD, V113, pE1, DOI 10.1182/blood-2008-06-162958; Wong J, 2004, ARTERIOSCL THROM VAS, V24, P2365, DOI 10.1161/01.ATV.0000148707.93054.7d; Wong J, 2008, ATHEROSCLEROSIS, V196, P180, DOI 10.1016/j.atherosclerosis.2007.03.030; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	30	24	24	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32166	10.1371/journal.pone.0032166	http://dx.doi.org/10.1371/journal.pone.0032166			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363809	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700150
J	Fan, X; Sha, LN; Zeng, J; Kang, HY; Zhang, HQ; Wang, XL; Zhang, L; Yang, RW; Ding, CB; Zheng, YL; Zhou, YH				Fan, Xing; Sha, Li-Na; Zeng, Jian; Kang, Hou-Yang; Zhang, Hai-Qin; Wang, Xiao-Li; Zhang, Li; Yang, Rui-Wu; Ding, Chun-Bang; Zheng, You-Liang; Zhou, Yong-Hong			Evolutionary Dynamics of the Pgk1 Gene in the Polyploid Genus Kengyilia (Triticeae: Poaceae) and Its Diploid Relatives	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; PHYLOGENETIC ANALYSIS; NUCLEOTIDE DIVERSITY; DUPLICATED GENES; RPB2 GENE; H-GENOME; ELYMUS; WHEAT; LOCI; CONSTITUTION	The level and pattern of nucleotide variation in duplicate gene provide important information on the evolutionary history of polyploids and divergent process between homoeologous loci within lineages. Kengyilia is a group of allohexaploid species with the StYP genomic constitutions in the wheat tribe. To investigate the evolutionary dynamics of the Pgk1 gene in Kengyilia and its diploid relatives, three copies of Pgk1 homoeologues were isolated from all sampled hexaploid Kengyilia species and analyzed with the Pgk1 sequences from 47 diploid taxa representing 18 basic genomes in Triticeae. Sequence diversity patterns and genealogical analysis suggested that (1) Kengyilia species from the Central Asia and the Qinghai-Tibetan plateau have independent origins with geographically differentiated P genome donors and diverged levels of nucleotide diversity at Pgk1 locus; (2) a relatively long-time sweep event has allowed the Pgk1 gene within Agropyron to adapt to cold climate triggered by the recent uplifts of the Qinghai-Tibetan Plateau; (3) sweep event and population expansion might result in the difference in the d(N)/d(S) value of the Pgk1 gene in allopatric Agropyron populations, and this difference may be genetically transmitted to Kengyilia lineages via independent polyploidization events; (4) an 83 bp MITE element insertion has shaped the Pgk1 loci in the P genome lineage with different geographical regions; (5) the St and P genomes in Kengyilia were donated by Pseudoroegneria and Agropyron, respectively, and the Y genome is closely related to the Xp genome of Peridictyon sanctum. The interplay of evolutionary forces involving diverged natural selection, population expansion, and transposable events in geographically differentiated P genome donors could attribute to geographical differentiation of Kengyilia species via independent origins.	[Fan, Xing; Sha, Li-Na; Kang, Hou-Yang; Zhang, Hai-Qin; Zheng, You-Liang; Zhou, Yong-Hong] Sichuan Agr Univ, Triticeae Res Inst, Yaan, Sichuan, Peoples R China; [Fan, Xing; Zheng, You-Liang; Zhou, Yong-Hong] Sichuan Agr Univ, Key Lab Crop Genet Resources & Improvement, Minist Educ, Yaan, Sichuan, Peoples R China; [Zeng, Jian] Sichuan Agr Univ, Coll Resources & Environm, Yaan, Sichuan, Peoples R China; [Wang, Xiao-Li; Zhang, Li; Yang, Rui-Wu; Ding, Chun-Bang] Sichuan Agr Univ, Dept Biol & Sci, Yaan, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University	Fan, X (corresponding author), Sichuan Agr Univ, Triticeae Res Inst, Yaan, Sichuan, Peoples R China.	zhouyh@sicau.edu.cn	Haiqin, Zhang/ABC-4056-2020		National Trangenic Major Program [20112X08009-001]; National Natural Science Foundation of China [30900087, 30870154]; Special Fund for Agro-Scientific Research in the Public Interest of China [201003021]; Science and Technology Bureau [2060503]; Education Bureau of Sichuan Province	National Trangenic Major Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-Scientific Research in the Public Interest of China; Science and Technology Bureau; Education Bureau of Sichuan Province	This research was supported by the National Trangenic Major Program (Nos. 20112X08009-001), the National Natural Science Foundation of China (Nos. 30900087, 30870154), Special Fund for Agro-Scientific Research in the Public Interest of China (Nos. 201003021), and the Science and Technology Bureau (Nos. 2060503) and Education Bureau of Sichuan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard JE, 2006, J MOL EVOL, V63, P493, DOI 10.1007/s00239-005-0306-x; Chapman BA, 2006, P NATL ACAD SCI USA, V103, P2730, DOI 10.1073/pnas.0507782103; DEWEY D R, 1984, P209; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fan CZ, 2007, GENETICA, V130, P19, DOI 10.1007/s10709-006-0016-3; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fraser HB, 2010, P NATL ACAD SCI USA, V107, P2977, DOI 10.1073/pnas.0912245107; FU YX, 1993, GENETICS, V133, P693; Gong PC, 2008, PLANT SYST EVOL, V276, P243, DOI 10.1007/s00606-008-0093-0; Guo WZ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-314; Hashimoto M, 2007, PROTEOMICS, V7, P1293, DOI 10.1002/pmic.200600921; Haudry A, 2007, MOL BIOL EVOL, V24, P1506, DOI 10.1093/molbev/msm077; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hovav R, 2008, P NATL ACAD SCI USA, V105, P6191, DOI 10.1073/pnas.0711569105; Huang S, 2002, P NATL ACAD SCI USA, V99, P8133, DOI 10.1073/pnas.072223799; Huang SX, 2002, PLANT MOL BIOL, V48, P805, DOI 10.1023/A:1014868320552; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jensen KB, 1996, INT J PLANT SCI, V157, P136, DOI 10.1086/297330; Kilian B, 2007, MOL BIOL EVOL, V24, P217, DOI 10.1093/molbev/msl151; Liu QL, 2006, NEW PHYTOL, V170, P411, DOI 10.1111/j.1469-8137.2006.01665.x; Love A., 1984, Feddes Repertorium, V95, P425; LU BR, 1990, HEREDITAS, V113, P109, DOI 10.1111/j.1601-5223.1990.tb00074.x; Mason-Gamer R. J., 2005, Czech Journal of Genetics and Plant Breeding, V41, P21; Moore RC, 2003, P NATL ACAD SCI USA, V100, P15682, DOI 10.1073/pnas.2535513100; Noor MAF, 2006, NAT REV GENET, V7, P851, DOI 10.1038/nrg1968; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Palme AE, 2008, MOL BIOL EVOL, V25, P2567, DOI 10.1093/molbev/msn194; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A., 2007, TRACER V1 4 MCMC TRA; Rokas A, 2001, HEREDITY, V87, P294, DOI 10.1046/j.1365-2540.2001.00872.x; Rozas J., 2005, DNA SEQUENCE POLYMOR; Salmon A, 2010, NEW PHYTOL, V186, P123, DOI 10.1111/j.1469-8137.2009.03093.x; Slotte T, 2008, MOL BIOL EVOL, V25, P1472, DOI 10.1093/molbev/msn092; Small RL, 2002, MOL BIOL EVOL, V19, P597, DOI 10.1093/oxfordjournals.molbev.a004119; Sokal R. H., 1995, BIOMETRY PRINCIPLES; Soltis DE, 2004, NEW PHYTOL, V161, P173, DOI 10.1046/j.1469-8137.2003.00948.x; Sun GL, 2008, MOL PHYLOGENET EVOL, V46, P897, DOI 10.1016/j.ympev.2007.12.024; Sun GL, 2007, PLANT MOL BIOL, V64, P645, DOI 10.1007/s11103-007-9183-6; Sun G, 2010, MOL PHYLOGENET EVOL, V56, P727, DOI 10.1016/j.ympev.2010.03.037; Symonds VV, 2010, EVOLUTION, V64, P1984, DOI [10.1111/j.1558-5646.2010.00978-x, 10.1111/j.1558-5646.2010.00978.x]; TAJIMA F, 1989, GENETICS, V123, P585; Takano-Kai N, 2009, GENETICS, V182, P1323, DOI 10.1534/genetics.109.103002; Takuno S, 2008, GENETICS, V180, P517, DOI 10.1534/genetics.108.091918; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1999, NUCLEIC ACIDS RES, V27, P2682, DOI 10.1093/nar/27.13.2682; TORABINEJAD J, 1993, GENOME, V36, P147, DOI 10.1139/g93-018; Wakeley J, 1997, GENETICS, V145, P847; Wang R.R.-C., 1994, P 2 INT TRIT S LOG U, P20; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; YANG JL, 1992, HEREDITAS, V116, P25, DOI 10.1111/j.1601-5223.1992.tb00200.x; Yen C, 2006, BIOSYSTEMATICS TRITI, V3; Zeng J, 2008, BIOL PLANTARUM, V52, P231, DOI 10.1007/s10535-008-0051-2; Zeng J, 2008, J APPL GENET, V49, P11, DOI 10.1007/BF03195244; Zhang L, 2005, GENET RESOUR CROP EV, V52, P1011, DOI 10.1007/s10722-004-6087-z; Zhang XQ, 2000, GENET RESOUR CROP EV, V47, P451, DOI 10.1023/A:1008788017938; Zheng BX, 2002, QUATERN INT, V97-8, P93, DOI 10.1016/S1040-6182(02)00054-X; Zhou YH, 2000, ACTA PHYTOTAX SINICA, V38, P515; ZHOU YH, 1994, GUIHAIA, V14, P163	62	31	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31122	10.1371/journal.pone.0031122	http://dx.doi.org/10.1371/journal.pone.0031122			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363562	Green Published, Green Submitted, gold			2022-12-27	WOS:000302871500027
J	Mandalia, S; Westrop, SJ; Beck, EJ; Nelson, M; Gazzard, BG; Imami, N				Mandalia, Sundhiya; Westrop, Samantha J.; Beck, Eduard J.; Nelson, Mark; Gazzard, Brian G.; Imami, Nesrina			Are Long-Term Non-Progressors Very Slow Progressors? Insights from the Chelsea and Westminster HIV Cohort, 1988-2010	PLOS ONE			English	Article							REFERENCE RANGES; INDIVIDUALS; REPLICATION; CONTROLLERS; RESPONSES; SURVIVORS	Define and identify long-term non-progressors (LTNP) and HIV controllers (HIC), and estimate time until disease progression. LTNP are HIV-1(+) patients who maintain stable CD4(+) T-cell counts, with no history of opportunistic infection or antiretroviral therapy (ART). HIC are a subset of LTNP who additionally have undetectable viraemia. These individuals may provide insights for prophylactic and therapeutic development. Records of HIV-1(+) individuals attending Chelsea and Westminster Hospital (1988-2010), were analysed. LTNP were defined as: HIV-1(+) for > 7 years; ART-naive; no history of opportunistic infection and normal, stable CD4(+) T-cell counts. MIXED procedure in SAS using random intercept model identified long-term stable CD4(+) T-cell counts. Survival analysis estimated time since diagnosis until disease progression. Subjects exhibiting long-term stable CD4(+) T-cell counts with history below the normal range (< 450 cells/mu l blood) were compared to LTNP whose CD4(+) T-cell count always remained normal. Within these two groups subjects with HIV-1 RNA load below limit of detection (BLD) were identified. Of 14,227 patients, 1,204 were diagnosed HIV-1(+) over 7 years ago and were ART-naive. Estimated time until disease progression for the 20% (239) whose CD4(+) T-cell counts remained within the normal range, was 6.2 years (IQR: 2.0 to 9.6); significantly longer than 4.0 years (IQR: 1.0 to 7.3) for patients with historical CD4(+) T-cell count below normal (Logrank chi-squared = 21.26; p < 0.001). Within a subpopulation of 312 asymptomatic patients, 50 exhibited long-term stable CD4(+) T-cell counts. Of these, 13 were LTNP, one of whom met HIC criteria. Of the remaining 37 patients with long-term stable low CD4(+) T-cell counts, 3 controlled HIV-1 RNA load BLD. Individuals with stable, normal CD4(+) T-cell counts progressed less rapidly than those with low CD4(+) T-cell counts. Few LTNP and HIC identified in this and other studies, endorse the need for universal definitions to facilitate comparison.	[Mandalia, Sundhiya; Westrop, Samantha J.; Nelson, Mark; Gazzard, Brian G.; Imami, Nesrina] Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Dept Med, London, England; [Beck, Eduard J.] London Sch Hyg & Trop Med, London WC1, England	Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Mandalia, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Dept Med, London, England.	n.imami@imperial.ac.uk		Imami, Nesrina/0000-0001-9673-2895; Westrop, Samantha/0000-0002-6836-4471	St Stephen's AIDS Trust; Westminster Medical School Research Trust; EC [LSHP-CT-2004-503487, LSHP-CT-2007-037616]; MRC [G0501957]; Medical Research Council [G0501957] Funding Source: researchfish	St Stephen's AIDS Trust; Westminster Medical School Research Trust; EC(European CommissionEuropean Commission Joint Research Centre); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by St Stephen's AIDS Trust and the Westminster Medical School Research Trust. NI was also funded by EC (grant nos. LSHP-CT-2004-503487 and LSHP-CT-2007-037616), and MRC (grant no. G0501957). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiuti F, 1995, J BIOL REG HOMEOS AG, V9, P82; [Anonymous], 1993, JAMA, V269, P729; Barre-Sinoussi F, 2011, NY TIMES        0603; CAO YZ, 1995, NEW ENGL J MED, V332, P201, DOI 10.1056/NEJM199501263320401; CLERICI M, 1989, J CLIN INVEST, V84, P1892, DOI 10.1172/JCI114376; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Diggle PJ, 2002, ANAL LONGITUDINAL DA; EASTERBROOK PJ, 1994, AIDS, V8, P1179, DOI 10.1097/00002030-199408000-00023; Grabar S, 2009, AIDS, V23, P1163, DOI 10.1097/QAD.0b013e32832b44c8; Han YF, 2008, AIDS, V22, P541, DOI 10.1097/QAD.0b013e3282f470e4; HULSTAERT F, 1994, CLIN IMMUNOL IMMUNOP, V70, P152, DOI 10.1006/clin.1994.1023; Imami N, 2002, J VIROL, V76, P9011, DOI 10.1128/JVI.76.18.9011-9023.2002; Imami N, 2001, IMMUNOL LETT, V79, P63, DOI 10.1016/S0165-2478(01)00267-X; Kincaid C, 2005, SUGI 30 P; KLEIN MR, 1995, TRENDS MICROBIOL, V3, P386, DOI 10.1016/S0966-842X(00)88984-2; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Lefrere JJ, 1997, BLOOD, V90, P1133, DOI 10.1182/blood.V90.3.1133.1133_1133_1140; Maini MK, 1996, GENITOURIN MED, V72, P27; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Migueles SA, 2010, JAMA-J AM MED ASSOC, V304, P194, DOI 10.1001/jama.2010.925; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Pantaleo G, 1996, ANNU REV MICROBIOL, V50, P825, DOI 10.1146/annurev.micro.50.1.825; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; TUGUME SB, 1995, CLIN DIAGN LAB IMMUN, V2, P233, DOI 10.1128/CDLI.2.2.233-235.1995; Walker Bruce D, 2007, Top HIV Med, V15, P134; Westrop SJ, 2011, INT J STD AIDS, V22, P690, DOI 10.1258/ijsa.2009.009045; Westrop SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005474; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	28	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e29844	10.1371/journal.pone.0029844	http://dx.doi.org/10.1371/journal.pone.0029844			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363409	Green Published, Green Submitted, gold			2022-12-27	WOS:000302871500003
J	Price, HP; Hodgkinson, MR; Curwen, RS; MacLean, LM; Brannigan, JA; Carrington, M; Smith, BA; Ashford, DA; Stark, M; Smith, DF				Price, Helen P.; Hodgkinson, Michael R.; Curwen, Rachel S.; MacLean, Lorna M.; Brannigan, James A.; Carrington, Mark; Smith, Barbara A.; Ashford, David A.; Stark, Meg; Smith, Deborah F.			The Orthologue of Sjogren's Syndrome Nuclear Autoantigen 1 (SSNA1) in Trypanosoma brucei Is an Immunogenic Self-Assembling Molecule	PLOS ONE			English	Article							ACETYLATED ALPHA-TUBULIN; AFRICAN TRYPANOSOMES; PROTEIN; NA14; AUTOANTIBODIES; IDENTIFICATION; TROPOMYOSIN; BIOLOGY; FORM; MICROTUBULES	Primary Sjogren's Syndrome (PSS) is a highly prevalent autoimmune disease, typically manifesting as lymphocytic infiltration of the exocrine glands leading to chronically impaired lacrimal and salivary secretion. Sjogren's Syndrome nuclear autoantigen 1 (SSNA1 or NA14) is a major specific target for autoantibodies in PSS but the precise function and clinical relevance of this protein are largely unknown. Orthologues of the gene are absent from many of the commonly used model organisms but are present in Chlamyodomonas reinhardtii (in which it has been termed DIP13) and most protozoa. We report the functional characterisation of the orthologue of SSNA1 in the kinetoplastid parasite, Trypanosoma brucei. Both TbDIP13 and human SSNA1 are small coiled-coil proteins which are predicted to be remote homologues of the actin-binding protein tropomyosin. We use comparative proteomic methods to identify potential interacting partners of TbDIP13. We also show evidence that TbDIP13 is able to self-assemble into fibril-like structures both in vitro and in vivo, a property which may contribute to its immunogenicity. Endogenous TbDIP13 partially co-localises with acetylated alpha-tubulin in the insect procyclic stage of the parasite. However, deletion of the DIP13 gene in cultured bloodstream and procyclic stages of T. brucei has little effect on parasite growth or morphology, indicating either a degree of functional redundancy or a function in an alternative stage of the parasite life cycle.	[Price, Helen P.; Hodgkinson, Michael R.; Curwen, Rachel S.; MacLean, Lorna M.; Smith, Barbara A.; Smith, Deborah F.] Univ York, Dept Biol, Ctr Immunol & Infect, York YO10 5DD, N Yorkshire, England; [Brannigan, James A.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [Carrington, Mark] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Ashford, David A.; Stark, Meg] Univ York, Dept Biol, Technol Facil, York YO10 5DD, N Yorkshire, England	University of York - UK; University of York - UK; University of Cambridge; University of York - UK	Price, HP (corresponding author), Univ York, Dept Biol, Ctr Immunol & Infect, York YO10 5DD, N Yorkshire, England.	helen.price@york.ac.uk	Carrington, Mark/N-3653-2019; Carrington, Mark/N-4892-2018	Carrington, Mark/0000-0002-6435-7266; Carrington, Mark/0000-0002-6435-7266; Price, Helen/0000-0003-1537-4390	Wellcome Trust [077503]	Wellcome Trust(Wellcome TrustEuropean Commission)	This research was funded by the Wellcome Trust (grant no. 077503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFFOLTER M, 1994, J STRUCT BIOL, V112, P241, DOI 10.1006/jsbi.1994.1024; Aki T, 2008, J CELL PHYSIOL, V217, P194, DOI 10.1002/jcp.21492; Alsford S, 2007, MOL MICROBIOL, V63, P724, DOI 10.1111/j.1365-2958.2006.05553.x; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bizzaro N, 2007, AUTOIMMUN REV, V6, P325, DOI 10.1016/j.autrev.2007.01.006; BLOCH MA, 1995, J CELL SCI, V108, P3541; BOOTHROYD JC, 1982, GENE, V20, P281, DOI 10.1016/0378-1119(82)90046-4; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; BRUN R, 1977, Acta Tropica, V34, P21; Burkard G, 2007, MOL BIOCHEM PARASIT, V153, P220, DOI 10.1016/j.molbiopara.2007.02.008; Casanova M, 2009, MOL MICROBIOL, V71, P1353, DOI 10.1111/j.1365-2958.2009.06594.x; CHAPMAN ER, 1994, J BIOL CHEM, V269, P27427; Eichner T, 2011, FEBS J, V278, P3868, DOI 10.1111/j.1742-4658.2011.08186.x; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Errico A, 2004, HUM MOL GENET, V13, P2121, DOI 10.1093/hmg/ddh223; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; GIBSON W, 1994, MOL BIOCHEM PARASIT, V64, P241, DOI 10.1016/0166-6851(94)00017-4; Gibson W, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-4; Guan JK, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-23; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HART DT, 1984, MOL BIOCHEM PARASIT, V12, P25, DOI 10.1016/0166-6851(84)90041-0; Hart SR, 2009, J AM SOC MASS SPECTR, V20, P167, DOI 10.1016/j.jasms.2008.08.014; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Hertz-Fowler C, 2004, NUCLEIC ACIDS RES, V32, pD339, DOI 10.1093/nar/gkh007; Jarvik JW, 1998, ANNU REV GENET, V32, P601, DOI 10.1146/annurev.genet.32.1.601; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kumar S, 2007, EUKARYOT CELL, V6, P2029, DOI 10.1128/EC.00213-07; Lacomble S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007685; Lai CK, 2011, MOL BIOL CELL, V22, P1104, DOI 10.1091/mbc.E10-07-0596; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; LEDIZET M, 1986, J CELL BIOL, V103, P13, DOI 10.1083/jcb.103.1.13; Mack GJ, 1998, ARTHRITIS RHEUM, V41, P551; MacLean L, 2007, J INFECT DIS, V196, P1620, DOI 10.1086/522011; Marsden HR, 2010, ANGEW CHEM INT EDIT, V49, P2988, DOI 10.1002/anie.200904943; McAlinden A, 2003, J BIOL CHEM, V278, P42200, DOI 10.1074/jbc.M302429200; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Mills E, 2007, MOL BIOCHEM PARASIT, V152, P22, DOI 10.1016/j.molbiopara.2006.11.008; Mor F, 2002, EUR J IMMUNOL, V32, P356, DOI 10.1002/1521-4141(200202)32:2<356::AID-IMMU356>3.0.CO;2-9; Moutevelis E, 2009, J MOL BIOL, V385, P726, DOI 10.1016/j.jmb.2008.11.028; MULLER N, 1992, PARASITOLOGY, V104, P111, DOI 10.1017/S0031182000060856; MULLER N, 1993, PARASITOLOGY, V107, P411, DOI 10.1017/S0031182000067767; Navarro M, 1999, EMBO J, V18, P2265, DOI 10.1093/emboj/18.8.2265; Nozawa K, 2004, ARTHRITIS RES THER, V6, pR95, DOI 10.1186/ar1035; Nozawa K, 2009, FRONT BIOSCI-LANDMRK, V14, P3733, DOI [10.2741/4084, 10.2741/3484]; Pfannenschmid F, 2003, J CELL SCI, V116, P1449, DOI 10.1242/jcs.00337; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Price HP, 2007, MOL BIOCHEM PARASIT, V155, P123, DOI 10.1016/j.molbiopara.2007.06.009; Price HP, 2005, J CELL SCI, V118, P831, DOI 10.1242/jcs.01624; Ramos-Morales F, 1998, J BIOL CHEM, V273, P1634, DOI 10.1074/jbc.273.3.1634; Reese G, 1999, INT ARCH ALLERGY IMM, V119, P247, DOI 10.1159/000024201; Rosenberg AS, 2006, AAPS J, V8, pE501, DOI 10.1208/aapsj080359; SASSE R, 1988, J CELL SCI, V90, P577; Schoppmeier J, 2005, CELL MOTIL CYTOSKEL, V61, P189, DOI 10.1002/cm.20074; Scofield RH, 2004, LANCET, V363, P1544, DOI 10.1016/S0140-6736(04)16154-0; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; Shapiro J, 2005, EUKARYOT CELL, V4, P1591, DOI 10.1128/EC.4.9.1591-1594.2005; Sheetz MP, 1999, EUR J BIOCHEM, V262, P19, DOI 10.1046/j.1432-1327.1999.00340.x; VICKERMAN K, 1985, BRIT MED BULL, V41, P105, DOI 10.1093/oxfordjournals.bmb.a072036; Whitby FG, 2000, PROTEINS, V38, P49; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606	63	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31842	10.1371/journal.pone.0031842	http://dx.doi.org/10.1371/journal.pone.0031842			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363749	Green Submitted, Green Published, gold			2022-12-27	WOS:000302871500093
J	Wu, JG; Zhang, Y; Wang, YS; Kong, RR; Hu, LL; Schuele, R; Du, XJ; Ke, Y				Wu, Jianguo; Zhang, Ying; Wang, Yingshuang; Kong, Ruirui; Hu, Lelin; Schuele, Roland; Du, Xiaojuan; Ke, Yang			Transcriptional Repressor NIR Functions in the Ribosome RNA Processing of Both 40S and 60S Subunits	PLOS ONE			English	Article							SMALL NUCLEOLAR RNA; CELL-CYCLE; U8 SNORNA; PROTEIN-SYNTHESIS; BINDING-PROTEIN; POLYMERASE-I; P53; BIOGENESIS; MDM2; BOP1	Background: NIR was identified as an inhibitor of histone acetyltransferase and it represses transcriptional activation of p53. NIR is predominantly localized in the nucleolus and known as Noc2p, which is involved in the maturation of the 60S ribosomal subunit. However, how NIR functions in the nucleolus remains undetermined. In the nucleolus, a 47S ribosomal RNA precursor (pre-rRNA) is transcribed and processed to produce 18S, 5.8S and 28S rRNAs. The 18S rRNA is incorporated into the 40S ribosomal subunit, whereas the 28S and 5.8S rRNAs are incorporated into the 60S subunit. U3 small nucleolar RNA (snoRNA) directs 18S rRNA processing and U8 snoRNA mediates processing of 28S and 5.8 S rRNAs. Functional disruption of nucleolus often causes p53 activation to inhibit cell proliferation. Methodology/Principal Findings: Western blotting showed that NIR is ubiquitously expressed in different human cell lines. Knock-down of NIR by siRNA led to inhibition of the 18S, 28S and 5.8S rRNAs evaluated by pulse-chase experiment. Pre-rRNA particles (pre-rRNPs) were fractionated from the nucleus by sucrose gradient centrifugation and analysis of the pre-RNPs components showed that NIR existed in the pre-RNPs of both the 60S and 40S subunits and co-fractionated with 32S and 12S pre-rRNAs in the 60S pre-rRNP. Protein-RNA binding experiments demonstrated that NIR is associated with the 32S pre-rRNA and U8 snoRNA. In addition, NIR bound U3 snoRNA. It is a novel finding that depletion of NIR did not affect p53 protein level but de-repressed acetylation of p53 and activated p21. Conclusions: We provide the first evidence for a transcriptional repressor to function in the rRNA biogenesis of both the 40S and 60S subunits. Our findings also suggested that a nucleolar protein may alternatively signal to p53 by affecting the p53 modification rather than affecting p53 protein level.	[Wu, Jianguo; Zhang, Ying; Wang, Yingshuang; Kong, Ruirui; Ke, Yang] Peking Univ, Beijing Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Genet Lab,Sch Oncol, Beijing 100871, Peoples R China; [Hu, Lelin; Du, Xiaojuan] Peking Univ, Hlth Sci Ctr, Dept Cell Biol, Sch Basic Med Sci, Beijing 100871, Peoples R China; [Schuele, Roland] Univ Freiburg, Med Res Ctr, D-79106 Freiburg, Germany	Peking University; Peking University; University of Freiburg	Wu, JG (corresponding author), Peking Univ, Beijing Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Minist Educ,Genet Lab,Sch Oncol, Beijing 100871, Peoples R China.	duxiaojuan100@hsc.pku.edu.cn; keyang@hsc.pku.edu.cn	Wu, Jian/AAU-5221-2020; Du, Xiaojuan/AAY-1186-2021; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507	National Natural Science Foundation of China [81071672, 81171877]; Key Construction Program of the National "985'' Project [985-2-016-24]; National High Technology Research and Development Program of China (863 Program) [2008AA02Z131]; National Basic Research Program of China (973program) [2010CB529303]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Construction Program of the National "985'' Project; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Basic Research Program of China (973program)(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 81071672 and 81171877), the Key Construction Program of the National "985'' Project (Grant No. 985-2-016-24), grant from the National High Technology Research and Development Program of China (863 Program) (Grant No. 2008AA02Z131), and from the National Basic Research Program of China (973program) (Grant No. 2010CB529303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakin AG, 1996, CELL, V86, P823, DOI 10.1016/S0092-8674(00)80156-7; BOWMAN LH, 1981, NUCLEIC ACIDS RES, V9, P4951, DOI 10.1093/nar/9.19.4951; Chamousset D, 2010, PROTEOMICS, V10, P3045, DOI 10.1002/pmic.201000162; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Decatur WA, 2003, J BIOL CHEM, V278, P695, DOI 10.1074/jbc.R200023200; Fath S, 2000, J CELL BIOL, V149, P575, DOI 10.1083/jcb.149.3.575; Ghosh T, 2004, MOL CELL, V13, P817, DOI 10.1016/S1097-2765(04)00127-3; Granneman S, 2004, MOL CELL BIOL, V24, P8600, DOI 10.1128/MCB.24.19.8600-8610.2004; HADJIOLOVA KV, 1993, EUR J BIOCHEM, V212, P211, DOI 10.1111/j.1432-1033.1993.tb17652.x; Heyne K, 2010, NUCLEIC ACIDS RES, V38, P3159, DOI 10.1093/nar/gkq016; Holzel M, 2005, J CELL BIOL, V170, P367, DOI 10.1083/jcb.200501141; Holzel M, 2010, J BIOL CHEM, V285, P6364, DOI 10.1074/jbc.M109.054734; Hsieh JK, 1999, MOL CELL, V3, P181, DOI 10.1016/S1097-2765(00)80309-3; Hu L, J BIOL CHEM, V286, P3119; Hublitz P, 2005, GENE DEV, V19, P2912, DOI 10.1101/gad.351205; HUGHES JMX, 1991, EMBO J, V10, P4231, DOI 10.1002/j.1460-2075.1991.tb05001.x; IAPALUCCIESPINOZA S, 1979, FEBS LETT, V107, P281, DOI 10.1016/0014-5793(79)80390-7; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Kinoshita Y, 2001, J BIOL CHEM, V276, P6656, DOI 10.1074/jbc.M008536200; Kong RR, 2011, J BIOL CHEM, V286, P7139, DOI 10.1074/jbc.M110.173393; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lapik YR, 2004, MOL CELL, V15, P17, DOI 10.1016/j.molcel.2004.05.020; Lerch-Gaggl A, 2002, J BIOL CHEM, V277, P45347, DOI 10.1074/jbc.M208338200; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Meraner J, 2006, NUCLEIC ACIDS RES, V34, P1798, DOI 10.1093/nar/gkl101; Michot B, 1999, NUCLEIC ACIDS RES, V27, P2271, DOI 10.1093/nar/27.11.2271; Milkereit P, 2001, CELL, V105, P499, DOI 10.1016/S0092-8674(01)00358-0; Nozell S, 2002, ONCOGENE, V21, P1285, DOI 10.1038/sj.onc.1205191; PECULIS BA, 1993, CELL, V73, P1233, DOI 10.1016/0092-8674(93)90651-6; Peculis BA, 1997, MOL CELL BIOL, V17, P3702, DOI 10.1128/MCB.17.7.3702; Peng QH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014244; Perez-Fernandez J, 2007, MOL CELL BIOL, V27, P5414, DOI 10.1128/MCB.00380-07; PERRY RP, 1970, P NATL ACAD SCI USA, V65, P609, DOI 10.1073/pnas.65.3.609; Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001; Rohrmoser M, 2007, MOL CELL BIOL, V27, P3682, DOI 10.1128/MCB.00172-07; Sharma K, 1999, MOL CELL BIOL, V19, P6012; Srivastava L, 2010, MOL CELL BIOL, V30, P2947, DOI 10.1128/MCB.00226-10; Strezoska Z, 2002, J BIOL CHEM, V277, P29617, DOI 10.1074/jbc.M204381200; Strezoska Z, 2000, MOL CELL BIOL, V20, P5516, DOI 10.1128/MCB.20.15.5516-5528.2000; Tomasevic N, 2002, MOL CELL BIOL, V22, P4101, DOI 10.1128/MCB.22.12.4101-4112.2002; Tomasevic N, 1999, J BIOL CHEM, V274, P35914, DOI 10.1074/jbc.274.50.35914; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang Y, 2007, BBA-MOL CELL RES, V1773, P863, DOI 10.1016/j.bbamcr.2007.04.002; Wu LM, 2011, J BIOL CHEM, V286, P2236, DOI 10.1074/jbc.M110.174755; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	49	6	6	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31692	10.1371/journal.pone.0031692	http://dx.doi.org/10.1371/journal.pone.0031692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363708	Green Submitted, Green Published, gold			2022-12-27	WOS:000302871500076
J	Bhaskara, VK; Mohanam, I; Rao, JS; Mohanam, S				Bhaskara, Vasantha Kumar; Mohanam, Indra; Rao, Jasti S.; Mohanam, Sanjeeva			Intermittent Hypoxia Regulates Stem-like Characteristics and Differentiation of Neuroblastoma Cells	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; TUMOR-CELLS; CANCER-CELLS; INDUCED DEDIFFERENTIATION; CYCLING HYPOXIA; GENE-EXPRESSION; SOLID TUMORS; REOXYGENATION; ANGIOGENESIS; HIF-1-ALPHA	Background: Neuroblastomas are the most common extracranial solid tumors in children. Neuroblastomas are derived from immature cells of the sympathetic nervous system and are characterized by clinical and biological heterogeneity. Hypoxia has been linked to tumor progression and increased malignancy. Intermittent hypoxia or repeated episodes of hypoxia followed by re-oxygenation is a common phenomenon in solid tumors including neuroblastoma and it has a significant influence on the outcome of therapies. The present study focuses on how intermittent hypoxia modulates the stem-like properties and differentiation in neuroblastoma cells. Methods and Findings: Cell survival was assessed by clonogenic assay and cell differentiation was determined by morphological characterization. Hypoxia-inducible genes were analyzed by real-time PCR and Western blotting. Immunofluorescence, real-time PCR and Western blotting were utilized to study stem cell markers. Analysis of neural crest / sympathetic nervous system (SNS) markers and neuronal differentiation markers were done by real-time PCR and Western blotting, respectively. Intermittent hypoxia stimulated the levels of HIF-1 alpha and HIF-2 alpha proteins and enhanced stem-like properties of neuroblastoma cells. In intermittent hypoxia-conditioned cells, downregulation of SNS marker genes and upregulation of genes expressed in the neural crest were observed. Intermittent hypoxia suppressed the retinoic acid-induced differentiation of neuroblastoma cells. Conclusions: Our results suggest that intermittent hypoxia enhances stem-like characteristics and suppresses differentiation propensities in neuroblastoma cells.	[Bhaskara, Vasantha Kumar; Mohanam, Indra; Rao, Jasti S.; Mohanam, Sanjeeva] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA	University of Illinois System; University of Illinois Peoria	Bhaskara, VK (corresponding author), Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA.	smohanam@uic.edu			National Cancer Institute [CA138466]; NATIONAL CANCER INSTITUTE [R01CA138466] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by a grant from the National Cancer Institute CA138466 to SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldinucci C, 2010, NEUROCHEM RES, V35, P1691, DOI 10.1007/s11064-010-0231-2; Axelson H, 2005, SEMIN CELL DEV BIOL, V16, P554, DOI 10.1016/j.semcdb.2005.03.007; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Cabarcas SM, 2011, INT J CANCER, V129, P2315, DOI 10.1002/ijc.26312; Cairns RA, 2001, CANCER RES, V61, P8903; Chang HH, 2010, CLIN CANCER RES, V16, P4411, DOI 10.1158/1078-0432.CCR-09-3360; Chaudary N, 2009, LAB INVEST, V89, P587, DOI 10.1038/labinvest.2009.16; Daneau G, 2010, CLIN CANCER RES, V16, P410, DOI 10.1158/1078-0432.CCR-09-0583; Das B, 2008, STEM CELLS, V26, P1818, DOI 10.1634/stemcells.2007-0724; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Dewhirst MW, 2007, CANCER RES, V67, P854, DOI 10.1158/0008-5472.CAN-06-4744; Dong Z, 2004, J BIOL CHEM, V279, P9215, DOI 10.1074/jbc.M312225200; Durand RE, 2001, ACTA ONCOL, V40, P929; Ezhilarasan R, 2009, INT J CANCER, V124, P306, DOI 10.1002/ijc.23951; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Grimmer MR, 2006, CURR OPIN PEDIATR, V18, P634, DOI 10.1097/MOP.0b013e32801080fe; Grynfeld A, 2000, INT J CANCER, V88, P401, DOI 10.1002/1097-0215(20001101)88:3<401::AID-IJC12>3.3.CO;2-M; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Holmquist L, 2005, INT J CANCER, V116, P218, DOI 10.1002/ijc.21024; Holmquist L, 2006, ADV EXP MED BIOL, V587, P179; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hsieh CH, 2010, ONCOL REP, V24, P1629, DOI 10.3892/or_00001027; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jogi A, 2003, CANCER LETT, V197, P145, DOI 10.1016/S0304-3835(03)00095-8; Jogi A, 2002, P NATL ACAD SCI USA, V99, P7021, DOI 10.1073/pnas.102660199; Joshi S, 2007, BBA-MOL BASIS DIS, V1772, P1093, DOI 10.1016/j.bbadis.2007.05.009; Kim Y, 2009, CANCER RES, V69, P9271, DOI 10.1158/0008-5472.CAN-09-1605; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Liu YL, 2010, J CELL BIOCHEM, V111, P554, DOI 10.1002/jcb.22739; Lofstedt T, 2004, J BIOL CHEM, V279, P39223, DOI 10.1074/jbc.M402904200; Louie E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2773; Lu HM, 2009, FEBS J, V276, P7291, DOI 10.1111/j.1742-4658.2009.07441.x; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Malec V, 2010, FREE RADICAL BIO MED, V48, P1626, DOI 10.1016/j.freeradbiomed.2010.03.008; Maris JM, 2005, CURR OPIN PEDIATR, V17, P7, DOI 10.1097/01.mop.0000150631.60571.89; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Martinive P, 2006, CANCER RES, V66, P11736, DOI 10.1158/0008-5472.CAN-06-2056; Mathieu J, 2011, CANCER RES, V71, P4640, DOI 10.1158/0008-5472.CAN-10-3320; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; McPake CR, 1998, ONCOL RES, V10, P235; Moeller BJ, 2007, CANCER METAST REV, V26, P241, DOI 10.1007/s10555-007-9056-0; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nilsson MB, 2010, ONCOGENE, V29, P2938, DOI 10.1038/onc.2010.60; Padera TP, 2004, NATURE, V427, P695, DOI 10.1038/427695a; Pietras A, 2008, J PATHOL, V214, P482, DOI 10.1002/path.2304; Reynolds CP, 2001, HEMATOL ONCOL CLIN N, V15, P867, DOI 10.1016/S0889-8588(05)70256-2; Rofstad EK, 2010, INT J CANCER, V127, P1535, DOI 10.1002/ijc.25176; Ross RA, 2007, SEMIN CANCER BIOL, V17, P241, DOI 10.1016/j.semcancer.2006.04.006; Semenza GL, 2000, CRIT REV BIOCHEM MOL, V35, P71, DOI 10.1080/10409230091169186; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Toffoli S, 2008, FEBS J, V275, P2991, DOI 10.1111/j.1742-4658.2008.06454.x; Toffoli S, 2007, BBA-MOL CELL RES, V1773, P1558, DOI 10.1016/j.bbamcr.2007.06.002; Tong QS, 2008, WORLD J PEDIATR, V4, P58, DOI 10.1007/s12519-008-0012-z; Weinmann M, 2004, FASEB J, V18, P1906, DOI 10.1096/fj.04-1918fje; Zamboni WC, 1998, J NATL CANCER I, V90, P505, DOI 10.1093/jnci/90.7.505; Zhao F, 2009, FREE RADICAL BIO MED, V47, P867, DOI 10.1016/j.freeradbiomed.2009.06.029	59	53	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30905	10.1371/journal.pone.0030905	http://dx.doi.org/10.1371/journal.pone.0030905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363512	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600085
J	Matthews, JE; Stephenson, R; Sullivan, PS				Matthews, Jonathan E.; Stephenson, Rob; Sullivan, Patrick S.			Factors Associated with Self-Reported HBV Vaccination among HIV-Negative MSM Participating in an Online Sexual Health Survey: A Cross-Sectional Study	PLOS ONE			English	Article							HEPATITIS-B VACCINATION; BEHAVIORAL SURVEILLANCE SYSTEM; YOUNG MEN; UNITED-STATES; TESTING BEHAVIORS; HOMOSEXUAL-MEN; INFECTION; RISK; IMMUNIZATION; POPULATION	Background: A substantial proportion of men who have sex with men (MSM) in the United States remain unvaccinated against hepatitis B. We sought to understand which factors are associated with vaccination among HIV-negative MSM. Methodology/Principal Findings: Data were from a 2010 web-based survey of adult MSM. We calculated the prevalence of self-reported hepatitis B vaccination among 1,052 HIV-negative or HIV-untested men who knew their hepatitis B vaccination status, and used multivariate logistic regression to determine associated factors. 679 (64.5%) MSM reported being vaccinated. Younger men were more likely to report being vaccinated than older men, and there was a significant interaction between age and history of hepatitis B testing. Men with at least some college education were at least 2.1 times as likely to be vaccinated as men with a high school education or less (95% CI = 1.4-3.1). Provider recommendation for vaccination (aOR = 4.2, 95% CI = 2.4-7.4) was also significantly associated with receipt of vaccination. Conclusions/Significance: Providers should assess sexual histories of male patients and offer those patients with male sex partners testing for hepatitis infection and vaccinate susceptible patients. There may be particular opportunities for screening and vaccination among older and more socioeconomically disadvantaged MSM.	[Matthews, Jonathan E.; Sullivan, Patrick S.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Stephenson, Rob] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health; Emory University; Rollins School Public Health	Matthews, JE (corresponding author), Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.	pssulli@emory.edu	Stephenson, Rob/J-9876-2012	Sullivan, Patrick Sean/0000-0002-7728-0587	Emory Center for AIDS Research [P30 AI050409]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409] Funding Source: NIH RePORTER	Emory Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Emory Center for AIDS Research (http://www.sph.emory.edu/cms/departments_centers/centers/cfar/, P30 AI050409) [to RS and PSS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, MMWR Recomm Rep, V40, P1; Centers for Disease Control and Prevention (CDC), 1996, MMWR Morb Mortal Wkly Rep, V45, P215; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P33; Centers for Disease Control and Prevention (CDC), 1982, MMWR-MORBID MORTAL W, V31, P327; Centers for Disease Control (CDC), 1982, MMWR Morb Mortal Wkly Rep, V31, P317; Choi KH, 2005, SEX TRANSM DIS, V32, P44, DOI 10.1097/01.olq.0000148296.93945.53; Davis CE, 1986, MODERN STAT METHODS, P140; Diamond C, 2003, SEX TRANSM DIS, V30, P425, DOI 10.1097/00007435-200305000-00009; Finlayson Teresa J., 2011, Morbidity and Mortality Weekly Report, V60, P1; Gilbert LK, 2010, INT J STD AIDS, V21, P400, DOI 10.1258/ijsa.2009.009010; MacKellar DA, 2001, AM J PUBLIC HEALTH, V91, P965, DOI 10.2105/AJPH.91.6.965; Mast Eric E., 2006, Morbidity and Mortality Weekly Report, V55, P1; MCCUSKER J, 1990, PUBLIC HEALTH REP, V105, P59; Neighbors K, 1999, J AM COLL HEALTH, V47, P173, DOI 10.1080/07448489909595643; Rhodes SD, 2000, SEX TRANSM INFECT, V76, P408, DOI 10.1136/sti.76.5.408-a; Rhodes SD, 2002, AIDS PATIENT CARE ST, V16, P519, DOI 10.1089/108729102761041074; Rhodes SD, 2001, AM J MED, V110, P628, DOI 10.1016/S0002-9343(01)00706-9; Sanchez Travis, 2006, Morbidity and Mortality Weekly Report, V55, P1; SCHREEDER MT, 1982, J INFECT DIS, V146, P7, DOI 10.1093/infdis/146.1.7; Siconolfi DE, 2009, AM J MENS HEALTH, V3, P141, DOI 10.1177/1557988308315151; SILVESTRE AJ, 1993, AM J PUBLIC HEALTH, V83, P578, DOI 10.2105/AJPH.83.4.578; SZMUNESS W, 1975, ANN INTERN MED, V83, P489, DOI 10.7326/0003-4819-83-4-489; Wall Kristin M, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P284, DOI 10.1177/1545109710379051; Weinbaum CM, 2008, AM J PUBLIC HEALTH, V98, P839, DOI 10.2105/AJPH.2006.101915; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1	25	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30609	10.1371/journal.pone.0030609	http://dx.doi.org/10.1371/journal.pone.0030609			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926TC	22363453	Green Submitted, Green Published, gold			2022-12-27	WOS:000302853600040
J	Nyari, AS; Joseph, L				Nyari, Arpad S.; Joseph, Leo			Evolution in Australasian Mangrove Forests: Multilocus Phylogenetic Analysis of the Gerygone Warblers (Aves: Acanthizidae)	PLOS ONE			English	Article							SPECIES TREES; MOLECULAR PHYLOGENETICS; BIRDS; BIOGEOGRAPHY; SYSTEMATICS; DIVERSIFICATION; SPECIATION; INFERENCE; HISTORY; ORIGIN	The mangrove forests of Australasia have many endemic bird species but their evolution and radiation in those habitats has been little studied. One genus with several mangrove specialist species is Gerygone (Passeriformes: Acanthizidae). The phylogeny of the Acanthizidae is reasonably well understood but limited taxon sampling for Gerygone has constrained understanding of its evolution and historical biogeography in mangroves. Here we report on a phylogenetic analysis of Gerygone based on comprehensive taxon sampling and a multilocus dataset of thirteen loci spread across the avian genome (eleven nuclear and two mitochondrial loci). Since Gerygone includes three species restricted to Australia's coastal mangrove forests, we particularly sought to understand the biogeography of their evolution in that ecosystem. Analyses of individual loci, as well as of a concatenated dataset drawn from previous molecular studies indicates that the genus as currently defined is not monophyletic, and that the Grey Gerygone (G. cinerea) from New Guinea should be transferred to the genus Acanthiza. The multilocus approach has permitted the nuanced view of the group's evolution into mangrove ecosystems having occurred on multiple occasions, in three non-overlapping time frames, most likely first by the G. magnirostris lineage, and subsequently followed by those of G. tenebrosa and G. levigaster.	[Nyari, Arpad S.] Univ Kansas, Biodivers Inst, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Joseph, Leo] Commonwealth Sci & Ind Res Org Ecosyst Sci, Australian Natl Wildlife Collect, Canberra, ACT, Australia	University of Kansas; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Nyari, AS (corresponding author), Univ Kansas, Biodivers Inst, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA.	arpinyari@gmail.com	Joseph, Leo/F-9235-2010	Joseph, Leo/0000-0001-7564-1978	CSIRO Ecosystems Science (CES), Atlas of Living Australia; University of Kansas Biodiversity Institute; American Museum of Natural History	CSIRO Ecosystems Science (CES), Atlas of Living Australia; University of Kansas Biodiversity Institute; American Museum of Natural History	CSIRO Ecosystems Science (CES), Atlas of Living Australia provided funding for laboratory work, consumables and travel within Australia. The University of Kansas Biodiversity Institute provided funding for laboratory consumables, sequencing fees and data analysis. The American Museum of Natural History Frank M. Chapman Memorial Fund provided funding for laboratory consumables and sequencing fees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, TRACER V1 6; Backstroem N, 2008, MOL ECOL, V17, P964, DOI 10.1111/j.1365-294X.2007.03551.x; Barker FK, 2002, P ROY SOC B-BIOL SCI, V269, P295, DOI 10.1098/rspb.2001.1883; Byrne M, 2008, MOL ECOL, V17, P4398, DOI 10.1111/j.1365-294X.2008.03899.x; Christidis L, 2010, MOL PHYLOGENET EVOL, V57, P868, DOI 10.1016/j.ympev.2010.08.029; Degnan JH, 2006, PLOS GENET, V2, P762, DOI 10.1371/journal.pgen.0020068; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edwards SV, 2007, P NATL ACAD SCI USA, V104, P5936, DOI 10.1073/pnas.0607004104; Edwards SV, 2005, P ROY SOC B-BIOL SCI, V272, P979, DOI 10.1098/rspb.2004.3035; Filardi CE, 2005, NATURE, V438, P216, DOI 10.1038/nature04057; Fjeldsa J, 2003, P ROY SOC B-BIOL SCI, V270, pS238, DOI 10.1098/rsbl.2003.0075; Florez-Rodriguez A, 2011, MOL PHYLOGENET EVOL, V58, P297, DOI 10.1016/j.ympev.2010.11.012; FORD J, 1986, EMU, V86, P12, DOI 10.1071/MU9860012; FORD J, 1982, EMU, V82, P12, DOI 10.1071/MU9820012; FORD J, 1983, Records of the Western Australian Museum, V10, P381; Fregin S, 2009, MOL PHYLOGENET EVOL, V52, P866, DOI 10.1016/j.ympev.2009.04.006; Gardner JL, 2010, MOL PHYLOGENET EVOL, V55, P1087, DOI 10.1016/j.ympev.2010.02.005; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Jennings WB, 2005, EVOLUTION, V59, P2033; Johnstone R., 1990, MANGROVES MANGROVE B; JOHNSTONE R E, 1975, Emu, V75, P185; Jonsson KA, 2008, J AVIAN BIOL, V39, P473, DOI 10.1111/j.0908-8857.2008.04486.x; Jonsson KA, 2010, J BIOGEOGR, V37, P245, DOI 10.1111/j.1365-2699.2009.02220.x; Lee JY, 2008, EVOLUTION, V62, P3117, DOI 10.1111/j.1558-5646.2008.00543.x; Li CH, 2010, MOL PHYLOGENET EVOL, V56, P1096, DOI 10.1016/j.ympev.2010.05.017; Liu L, 2008, BIOINFORMATICS, V24, P2542, DOI 10.1093/bioinformatics/btn484; Liu L, 2008, EVOLUTION, V62, P2080, DOI 10.1111/j.1558-5646.2008.00414.x; Liu L, 2007, SYST BIOL, V56, P504, DOI 10.1080/10635150701429982; Liu L, 2009, SYST BIOL, V58, P452, DOI 10.1093/sysbio/syp034; Lovette IJ, 2010, MOL PHYLOGENET EVOL, V57, P753, DOI 10.1016/j.ympev.2010.07.018; Loynes K, 2009, MOL PHYLOGENET EVOL, V53, P212, DOI 10.1016/j.ympev.2009.05.012; Maddison W., 2018, MESQUITE MODULAR SYS; Marini MA, 2002, AUK, V119, P1114, DOI 10.1642/0004-8038(2002)119[1114:AMATTC]2.0.CO;2; McGuire JA, 2007, SYST BIOL, V56, P837, DOI 10.1080/10635150701656360; Moyle RG, 2009, P NATL ACAD SCI USA, V106, P1863, DOI 10.1073/pnas.0809861105; Nicholls JA, 2000, J AVIAN BIOL, V31, P165, DOI 10.1034/j.1600-048X.2000.310208.x; Norman JA, 2007, MOL PHYLOGENET EVOL, V42, P80, DOI 10.1016/j.ympev.2006.05.032; Noske RA, 1996, WILDLIFE RES, V23, P443, DOI 10.1071/WR9960443; Nyari AS, 2009, ZOOL SCR, V38, P553, DOI 10.1111/j.1463-6409.2009.00397.x; Parra JL, 2009, MOL PHYLOGENET EVOL, V53, P425, DOI 10.1016/j.ympev.2009.07.006; Pasquet E, 2007, MOL PHYLOGENET EVOL, V45, P158, DOI 10.1016/j.ympev.2007.03.010; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Primmer CR, 2002, MOL ECOL, V11, P603, DOI 10.1046/j.0962-1083.2001.01452.x; Rheindt FE, 2009, MOL PHYLOGENET EVOL, V53, P961, DOI 10.1016/j.ympev.2009.09.001; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schodde R., 1982, P191; Schodde R, 1999, DIRECTORY AUSTR BIRD; Schodde R, 1979, MANGROVE ECOSYSTEMS, P141; Schodde R, 1972, BRIDGE BARRIER NATUR, P257; Schodde Richard, 2006, P413; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Sorenson MD, 1999, MOL PHYLOGENET EVOL, V12, P105, DOI 10.1006/mpev.1998.0602; Sorenson MD, 1998, AUK, V115, P214, DOI 10.2307/4089130; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toon A, 2010, MOL ECOL, V19, P2980, DOI 10.1111/j.1365-294X.2010.04730.x; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; Wright TF, 2008, MOL BIOL EVOL, V25, P2141, DOI 10.1093/molbev/msn160; Zwickl D., 2008, GARLI PROGRAM PERFOR	61	14	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2012	7	2							e31840	10.1371/journal.pone.0031840	http://dx.doi.org/10.1371/journal.pone.0031840			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925CF	22363748	Green Published, gold, Green Submitted			2022-12-27	WOS:000302737400050
J	Manque, PA; Woehlbier, U; Lara, AM; Tenjo, F; Alves, JM; Buck, GA				Manque, Patricio A.; Woehlbier, Ute; Lara, Ana M.; Tenjo, Fernando; Alves, Joao M.; Buck, Gregory A.			Identification and Characterization of a Novel Calcium-Activated Apyrase from Cryptosporidium Parasites and Its Potential Role in Pathogenesis	PLOS ONE			English	Article							ECTO-ATPASE ACTIVITY; TRIPHOSPHATE DIPHOSPHOHYDROLASE ACTIVITIES; INTESTINAL EPITHELIAL-CELLS; TRYPANOSOMA-CRUZI; BIOCHEMICAL-CHARACTERIZATION; LEISHMANIA-AMAZONENSIS; EXTRACELLULAR ATP; PARVUM INFECTION; INSULIN-RECEPTOR; TYROSINE KINASE	Herein, we report the biochemical and functional characterization of a novel Ca2+-activated nucleoside diphosphatase (apyrase), CApy, of the intracellular gut pathogen Cryptosporidium. The purified recombinant CApy protein displayed activity, substrate specificity and calcium dependency strikingly similar to the previously described human apyrase, SCAN-1 (soluble calcium-activated nucleotidase 1). CApy was found to be expressed in both Cryptosporidium parvum oocysts and sporozoites, and displayed a polar localization in the latter, suggesting a possible co-localization with the apical complex of the parasite. In vitro binding experiments revealed that CApy interacts with the host cell in a dose-dependent fashion, implying the presence of an interacting partner on the surface of the host cell. Antibodies directed against CApy block Cryptosporidium parvum sporozoite invasion of HCT-8 cells, suggesting that CApy may play an active role during the early stages of parasite invasion. Sequence analyses revealed that the capy gene shares a high degree of homology with apyrases identified in other organisms, including parasites, insects and humans. Phylogenetic analysis argues that the capy gene is most likely an ancestral feature that has been lost from most apicomplexan genomes except Cryptosporidium, Neospora and Toxoplasma.	[Manque, Patricio A.; Woehlbier, Ute; Lara, Ana M.; Tenjo, Fernando; Alves, Joao M.; Buck, Gregory A.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Manque, Patricio A.; Woehlbier, Ute; Lara, Ana M.; Tenjo, Fernando; Alves, Joao M.; Buck, Gregory A.] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA; [Tenjo, Fernando] Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Manque, PA (corresponding author), Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA.	gabuck@vcu.edu	Alves, Joao M.P./G-8927-2011	Alves, Joao M.P./0000-0001-5914-2087; manque, patricio/0000-0002-6606-0896; Woehlbier, Ute/0000-0003-3114-9708	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [U54 AI057168]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057168] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant U54 AI057168 from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barros FS, 2000, ARCH BIOCHEM BIOPHYS, V375, P304, DOI 10.1006/abbi.1999.1592; Berredo-Pinho M, 2001, ARCH BIOCHEM BIOPHYS, V391, P16, DOI 10.1006/abbi.2001.2384; Bisaggio DFR, 2003, PARASITOL RES, V91, P273, DOI 10.1007/s00436-003-0965-8; Cavalier-Smith T, 2003, INT J SYST EVOL MICR, V53, P1741, DOI 10.1099/ijs.0.02548-0; Charlab R, 1999, P NATL ACAD SCI USA, V96, P15155, DOI 10.1073/pnas.96.26.15155; Clifford EE, 1997, AM J PHYSIOL-CELL PH, V273, pC973, DOI 10.1152/ajpcell.1997.273.3.C973; Dai JY, 2004, CELL, V116, P649, DOI 10.1016/S0092-8674(04)00172-2; Leite MDS, 2007, EXP PARASITOL, V115, P315, DOI 10.1016/j.exppara.2006.09.002; Devader C, 2006, GENE, V367, P135, DOI 10.1016/j.gene.2005.10.014; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; DUBYAK GR, 1993, AM J PHYSIOL, V265, pC577, DOI 10.1152/ajpcell.1993.265.3.C577; Eltzschig HK, 2009, BLOOD, V113, P224, DOI 10.1182/blood-2008-06-165746; Failer BU, 2002, J BIOL CHEM, V277, P36978, DOI 10.1074/jbc.M201656200; Fietto JLR, 2004, BIOCHEM BIOPH RES CO, V316, P454, DOI 10.1016/j.bbrc.2004.02.071; FILIPPINI A, 1990, J BIOL CHEM, V265, P334; Goodgame RW, 1996, ANN INTERN MED, V124, P429, DOI 10.7326/0003-4819-124-4-199602150-00008; Guerrant RL, 1997, EMERG INFECT DIS, V3, P51, DOI 10.3201/eid0301.970106; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hillis David M., 1996; Jesus JB, 2002, VET PARASITOL, V103, P29, DOI 10.1016/S0304-4017(01)00576-3; Joe A, 1998, INFECT IMMUN, V66, P3429, DOI 10.1128/IAI.66.7.3429-3432.1998; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; Kirley TL, 1997, J BIOL CHEM, V272, P1076, DOI 10.1074/jbc.272.2.1076; KNOWLES AF, 1995, BIOCHEM BIOPH RES CO, V207, P529, DOI 10.1006/bbrc.1995.1220; Kohler D, 2007, CIRCULATION, V116, P1784, DOI 10.1161/CIRCULATIONAHA.107.690180; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laurent F, 1997, INFECT IMMUN, V65, P5067, DOI 10.1128/IAI.65.12.5067-5073.1997; Laurent F, 1999, MICROBES INFECT, V1, P141, DOI 10.1016/S1286-4579(99)80005-7; Luttikhuizen DT, 2004, CELL TISSUE RES, V317, P289, DOI 10.1007/s00441-004-0939-x; MALISZEWSKI CR, 1994, J IMMUNOL, V153, P3574; Manque PA, 2011, CLIN VACCINE IMMUNOL; Manque PM, 2000, INFECT IMMUN, V68, P478, DOI 10.1128/IAI.68.2.478-484.2000; MARGOLIS RN, 1990, BIOCHEM BIOPH RES CO, V166, P562, DOI 10.1016/0006-291X(90)90845-E; Meyer-Fernandes JR, 2002, PARASITOL INT, V51, P299, DOI 10.1016/S1383-5769(02)00017-X; Mizumoto N, 2002, NAT MED, V8, P358, DOI 10.1038/nm0402-358; Murphy DM, 2003, BIOCHEMISTRY-US, V42, P2412, DOI 10.1021/bi026763b; NAJJAR SM, 1993, J BIOL CHEM, V268, P1201; Peres-Sampaio CE, 2001, Z NATURFORSCH C, V56, P820; Pinheiro CM, 2006, EXP PARASITOL, V114, P16, DOI 10.1016/j.exppara.2006.02.007; PLESNER L, 1995, INT REV CYTOL, V158, P141; Sansom FM, 2007, CELL MICROBIOL, V9, P1922, DOI 10.1111/j.1462-5822.2007.00924.x; Sansom FM, 2008, MICROBIOL MOL BIOL R, V72, P765, DOI 10.1128/MMBR.00013-08; Santos RF, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000387; Silverman JA, 1998, J BIOL CHEM, V273, P12352, DOI 10.1074/jbc.273.20.12352; Smith HV, 2005, TRENDS PARASITOL, V21, P133, DOI 10.1016/j.pt.2005.01.007; Smith TM, 2002, ARCH BIOCHEM BIOPHYS, V406, P105, DOI 10.1016/S0003-9861(02)00420-4; STEINBERG TH, 1991, CURR OPIN IMMUNOL, V3, P71, DOI 10.1016/0952-7915(91)90080-K; STOUT JG, 1995, J BIOL CHEM, V270, P11845, DOI 10.1074/jbc.270.20.11845; Uccelletti D, 2008, MOL BIOL CELL, V19, P1337, DOI 10.1091/mbc.E07-06-0547; Valenzuela JG, 1998, J BIOL CHEM, V273, P30583, DOI 10.1074/jbc.273.46.30583; Valenzuela JG, 2001, J EXP BIOL, V204, P229; Wang TF, 1998, BRAIN RES, V790, P318, DOI 10.1016/S0006-8993(97)01562-X; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977	56	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31030	10.1371/journal.pone.0031030	http://dx.doi.org/10.1371/journal.pone.0031030			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22363541	Green Published, Green Submitted, gold			2022-12-27	WOS:000302180600024
J	Carmeli, C; Knyazeva, MG; Cuenod, M; Do, KQ				Carmeli, Cristian; Knyazeva, Maria G.; Cuenod, Michel; Do, Kim Q.			Glutathione Precursor N-Acetyl-Cysteine Modulates EEG Synchronization in Schizophrenia Patients: A Double-Blind, Randomized, Placebo-Controlled Trial	PLOS ONE			English	Article							DOPAMINE UPTAKE INHIBITION; MISMATCH NEGATIVITY; GAMMA-OSCILLATIONS; FUNCTIONAL CONNECTIVITY; NETWORK OSCILLATIONS; DIAGNOSTIC INTERVIEW; PARVALBUMIN NEURONS; COGNITIVE DEFICITS; OXIDATIVE STRESS; ALPHA-RHYTHMS	Glutathione (GSH) dysregulation at the gene, protein, and functional levels has been observed in schizophrenia patients. Together with disease-like anomalies in GSH deficit experimental models, it suggests that such redox dysregulation can play a critical role in altering neural connectivity and synchronization, and thus possibly causing schizophrenia symptoms. To determine whether increased GSH levels would modulate EEG synchronization, N-acetyl-cysteine (NAC), a glutathione precursor, was administered to patients in a randomized, double-blind, crossover protocol for 60 days, followed by placebo for another 60 days (or vice versa). We analyzed whole-head topography of the multivariate phase synchronization (MPS) for 128-channel resting-state EEGs that were recorded at the onset, at the point of crossover, and at the end of the protocol. In this proof of concept study, the treatment with NAC significantly increased MPS compared to placebo over the left parieto-temporal, the right temporal, and the bilateral prefrontal regions. These changes were robust both at the group and at the individual level. Although MPS increase was observed in the absence of clinical improvement at a group level, it correlated with individual change estimated by Liddle's disorganization scale. Therefore, significant changes in EEG synchronization induced by NAC administration may precede clinically detectable improvement, highlighting its possible utility as a biomarker of treatment efficacy.	[Carmeli, Cristian; Cuenod, Michel; Do, Kim Q.] Univ Lausanne, CHUV, Dept Psychiat, Ctr Psychiat Neurosci, Lausanne, Switzerland; [Carmeli, Cristian; Knyazeva, Maria G.] Univ Lausanne, CHUV, Dept Clin Neurosci, Lab Rech Neuroimagerie LREN, Lausanne, Switzerland; [Knyazeva, Maria G.] Univ Lausanne, CHUV, Dept Radiol, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Carmeli, C (corresponding author), Univ Lausanne, CHUV, Dept Psychiat, Ctr Psychiat Neurosci, Lausanne, Switzerland.	Kim.Do@chuv.ch	Do, Kim Q./G-6694-2016	Do, Kim Q./0000-0003-1968-1646; Carmeli, Cristian/0000-0002-1463-4587	Loterie Romande	Loterie Romande	This work was supported by the Loterie Romande (http://www.loro.ch/FR/1/homepage). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREASEN NC, 1995, ARCH GEN PSYCHIAT, V52, P341; Bachman P, 2008, SCHIZOPHR RES, V103, P293, DOI 10.1016/j.schres.2008.04.006; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Basar-Eroglu C, 2009, INT J PSYCHOPHYSIOL, V71, P75, DOI 10.1016/j.ijpsycho.2008.07.004; Basso MR, 1998, SCHIZOPHR RES, V31, P99, DOI 10.1016/S0920-9964(98)00023-1; Behrens MM, 2007, SCIENCE, V318, P1645, DOI 10.1126/science.1148045; Behrens MM, 2009, NEUROPHARMACOLOGY, V57, P193, DOI 10.1016/j.neuropharm.2009.06.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berk M, 2008, BIOL PSYCHIAT, V64, P361, DOI 10.1016/j.biopsych.2008.03.004; Bob P, 2010, PSYCHIAT RES, V177, P37, DOI 10.1016/j.psychres.2009.08.015; Boutros NN, 2008, SCHIZOPHR RES, V99, P225, DOI 10.1016/j.schres.2007.11.020; Cabungcal JH, 2007, NEUROBIOL DIS, V26, P634, DOI 10.1016/j.nbd.2007.03.001; Cabungcal JH, 2006, NEUROBIOL DIS, V22, P624, DOI 10.1016/j.nbd.2006.01.003; Carmeli C, 2005, NEUROIMAGE, V25, P339, DOI 10.1016/j.neuroimage.2004.11.049; Carmeli C, 2006, ASSESSING COOPERATIV; Castagne V, 2004, NEUROSCIENCE, V123, P821, DOI 10.1016/j.neuroscience.2003.11.012; Castagne V, 2004, NEUROBIOL DIS, V15, P93, DOI 10.1016/j.nbd.2003.09.005; Colgin LL, 2010, PHYSIOLOGY, V25, P319, DOI 10.1152/physiol.00021.2010; Do KQ, 2009, HANDBOOK OF NEUROCHEMISTRY AND MOLECULAR NEUROBIOLOGY: SCHIZOPHRENIA, THIRD EDITION, P285, DOI 10.1007/978-0-387-30410-6_2.5; Do KQ, 2009, CURR OPIN NEUROBIOL, V19, P220, DOI 10.1016/j.conb.2009.05.001; Do KQ, 2000, EUR J NEUROSCI, V12, P3721, DOI 10.1046/j.1460-9568.2000.00229.x; Fallani FD, 2010, BRAIN TOPOGR, V23, P214, DOI 10.1007/s10548-010-0133-2; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; Flynn G, 2008, SCHIZOPHR RES, V105, P262, DOI 10.1016/j.schres.2008.05.029; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; Gonzalez-Burgos G, 2008, SCHIZOPHRENIA BULL, V34, P944, DOI 10.1093/schbul/sbn070; Gonzalez-Burgos G, 2010, CURR PSYCHIAT REP, V12, P335, DOI 10.1007/s11920-010-0124-8; Grima G, 2003, SCHIZOPHR RES, V62, P213, DOI 10.1016/S0920-9964(02)00405-X; Gysin R, 2007, P NATL ACAD SCI USA, V104, P16621, DOI 10.1073/pnas.0706778104; Haenschel C, 2011, BEHAV BRAIN RES, V216, P481, DOI 10.1016/j.bbr.2010.08.045; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Higgins J.J., 2004, INTRO MODERN NONPARA; Hughes SW, 2005, NEUROSCIENTIST, V11, P357, DOI 10.1177/1073858405277450; Jalili M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001059; JAVITT DC, 1993, BIOL PSYCHIAT, V33, P513, DOI 10.1016/0006-3223(93)90005-X; Kantrowitz JT, 2010, BRAIN RES BULL, V83, P108, DOI 10.1016/j.brainresbull.2010.04.006; Kayser J, 2006, CLIN NEUROPHYSIOL, V117, P348, DOI 10.1016/j.clinph.2005.08.034; Knyazeva MG, 2010, NEUROBIOL AGING, V31, P1132, DOI 10.1016/j.neurobiolaging.2008.07.019; Knyazeva MG, 2010, J COGN NEUR IN PRESS; Koenig T, 2001, SCHIZOPHR RES, V50, P55, DOI 10.1016/S0920-9964(00)00154-7; Lavoie S, 2008, NEUROPSYCHOPHARMACOL, V33, P2187, DOI 10.1038/sj.npp.1301624; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; LIDDLE PF, 1987, PSYCHOL MED, V17, P49, DOI 10.1017/S0033291700012976; Matsuzawa D, 2011, ANTIOXID RE IN PRESS; Naatanen R, 2009, INT J NEUROPSYCHOPH, V12, P125, DOI 10.1017/S1461145708009322; Ngan ETC, 2000, SCHIZOPHR RES, V46, P195, DOI 10.1016/S0920-9964(00)00027-X; Niedermeyer E, 1997, INT J PSYCHOPHYSIOL, V26, P31, DOI 10.1016/S0167-8760(97)00754-X; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; PERALTA V, 1992, BRIT J PSYCHIAT, V161, P335, DOI 10.1192/bjp.161.3.335; Pignatelli M, 2011, J PHYSL PAR IN PRESS; Pikovsky A, 2001, SYNCHRONIZATION UNIV; Preisig M, 1999, EUR ARCH PSY CLIN N, V249, P174, DOI 10.1007/s004060050084; Rougemont M, 2002, J NEUROSCI RES, V70, P774, DOI 10.1002/jnr.10439; Rutter L, 2009, HUM BRAIN MAPP, V30, P3254, DOI 10.1002/hbm.20746; Schuaz A., 2002, CORTICAL AREAS UNITY, P377, DOI DOI 10.1201/9780203299296.CH16; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Selesnick IW, 1996, IEEE T SIGNAL PROCES, V44, P1879, DOI 10.1109/78.533710; SHELLEY AM, 1991, BIOL PSYCHIAT, V30, P1059, DOI 10.1016/0006-3223(91)90126-7; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Sponheim SR, 2000, BIOL PSYCHIAT, V48, P1088, DOI 10.1016/S0006-3223(00)00907-0; Srinivasan R, 2007, J NEUROSCI METH, V166, P41, DOI 10.1016/j.jneumeth.2007.06.026; Steullet P, 2006, NEUROSCIENCE, V137, P807, DOI 10.1016/j.neuroscience.2005.10.014; Steullet P, 40 ANN M SOC NEUR SA, P13; Steullet P, 2008, FREE RADICAL BIO MED, V44, P1042, DOI 10.1016/j.freeradbiomed.2007.12.006; Steullet P, 2010, J NEUROSCI, V30, P2547, DOI 10.1523/JNEUROSCI.3857-09.2010; Strogatz SH, 2000, PHYSICA D, V143, P1, DOI 10.1016/S0167-2789(00)00094-4; Thompson PM, 2001, P NATL ACAD SCI USA, V98, P11650, DOI 10.1073/pnas.201243998; Tosic M, 2006, AM J HUM GENET, V79, P586, DOI 10.1086/507566; Traub RD, 2004, ANNU REV NEUROSCI, V27, P247, DOI 10.1146/annurev.neuro.27.070203.144303; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Uhlhaas PJ, 2006, J NEUROSCI, V26, P8168, DOI 10.1523/JNEUROSCI.2002-06.2006; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Umbricht D, 2000, ARCH GEN PSYCHIAT, V57, P1139, DOI 10.1001/archpsyc.57.12.1139; Whittington MA, 2011, DEV NEUROBIOL, V71, P92, DOI 10.1002/dneu.20814; Yao JK, 2006, DIS MARKERS, V22, P83, DOI 10.1155/2006/248387	77	60	61	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e29341	10.1371/journal.pone.0029341	http://dx.doi.org/10.1371/journal.pone.0029341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22383949	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000302875500003
J	Drogan, D; Sheldrick, AJ; Schutze, M; Knuppel, S; Andersohn, F; Di Giuseppe, R; Herrmann, B; Willich, SN; Garbe, E; Bergmann, MM; Boeing, H; Weikert, C				Drogan, Dagmar; Sheldrick, Abigail J.; Schuetze, Madlen; Knueppel, Sven; Andersohn, Frank; Di Giuseppe, Romina; Herrmann, Bianca; Willich, Stefan N.; Garbe, Edeltraut; Bergmann, Manuela M.; Boeing, Heiner; Weikert, Cornelia			Alcohol Consumption, Genetic Variants in Alcohol Deydrogenases, and Risk of Cardiovascular Diseases: A Prospective Study and Meta-Analysis	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION; DEHYDROGENASE GENOTYPES; RELATIVE VALIDITY; DRINKING HABITS; EPIC PROJECT; GERMAN PART; CASE-COHORT; STROKE; REPRODUCIBILITY	Objective: First, to investigate and compare associations between alcohol consumption and variants in alcohol dehydrogenase (ADH) genes with incidence of cardiovascular diseases (CVD) in a large German cohort. Second, to quantitatively summarize available evidence of prospective studies on polymorphisms in ADH1B and ADH1C and CVD-risk. Methods: We conducted a case-cohort study nested within the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort including a randomly drawn subcohort (n = 2175) and incident cases of myocardial infarction (MI; n = 230) or stroke (n = 208). Mean follow-up time was 8.2 +/- 2.2 years. The association between alcohol consumption, ADH1B or ADH1C genotypes, and CVD-risk was assessed using Cox proportional hazards regression. Additionally, we report results on associations of variants in ADH1B and ADH1C with ischemic heart disease and stroke in the context of a meta-analysis of previously published prospective studies published up to November 2011. Results: Compared to individuals who drank >0 to 6 g alcohol/d, we observed a reduced risk of MI among females consuming >12 g alcohol/d (HR = 0.31; 95% CI: 0.10-0.97) and among males consuming >24 to 60 g/d (HR = 0.57; 95% CI: 0.33-0.98) or >60 g alcohol/d (HR = 0.30; 95% CI: 0.12-0.78). Stroke risk was not significantly related to alcohol consumption >6 g/d, but we observed an increased risk of stroke in men reporting no alcohol consumption. Individuals with the slow-coding ADH1B*1/1 genotype reported higher median alcohol consumption. Yet, polymorphisms in ADH1B or ADH1C were not significantly associated with risk of CVD in our data and after pooling results of eligible prospective studies [ADH1B*1/1: RR = 1.35 (95% CI: 0.98-1.88; p for heterogeneity: 0.364); ADH1C*2/2: RR = 1.07 (95% CI: 0.90-1.27; p for heterogeneity: 0.098)]. Conclusion: The well described association between alcohol consumption and CVD-risk is not reflected by ADH polymorphisms, which modify the rate of ethanol oxidation.	[Drogan, Dagmar; Schuetze, Madlen; Knueppel, Sven; Di Giuseppe, Romina; Herrmann, Bianca; Bergmann, Manuela M.; Boeing, Heiner; Weikert, Cornelia] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Sheldrick, Abigail J.] Charite Univ Med Ctr, Inst Clin Pharmacol & Toxicol, Berlin, Germany; [Andersohn, Frank; Willich, Stefan N.; Weikert, Cornelia] Charite Univ Med Ctr, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany; [Garbe, Edeltraut] Bremen Inst Prevent Res & Social Med, Dept Clin Epidemiol, Bremen, Germany; [Sheldrick, Abigail J.] Rhein Westfal TH Aachen, Sch Med, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [Herrmann, Bianca] Fed Inst Mat Res & Testing, Dept Biol Mat Protect & Environm Issues 4 1, Berlin, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leibniz Institute for Prevention Research & Epidemiology (BIPS); RWTH Aachen University; Federal Institute for Materials Research & Testing	Drogan, D (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany.	drogan@dife.de	Knüppel, Sven/AAI-7195-2020; Sheldrick, Abigail/AAN-1816-2021; Sheldrick, Abigail Jane/I-5909-2017	Knüppel, Sven/0000-0001-9006-9906; di Giuseppe, Romina/0000-0002-5214-8897; Sheldrick, Abigail Jane/0000-0003-4218-4621	Federal Ministry of Science, Germany [01 EA 9401]; European Union [SOC 95201408 05F02]; German Cancer Aid [70-2488-Ha I]; European Community [SOC 98200769 05F02]	Federal Ministry of Science, Germany; European Union(European Commission); German Cancer Aid(Deutsche Krebshilfe); European Community(European Commission)	The recruitment phase of the EPIC-Potsdam Study was supported by the Federal Ministry of Science, Germany (01 EA 9401), and the European Union (SOC 95201408 05F02). The follow-up was supported by the German Cancer Aid (70-2488-Ha I) and the European Community (SOC 98200769 05F02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bergmann MM, 1999, ANN NUTR METAB, V43, P225, DOI 10.1159/000012789; Boeing H, 1999, ANN NUTR METAB, V43, P205, DOI 10.1159/000012787; BohlscheidThomas S, 1997, INT J EPIDEMIOL, V26, pS71, DOI 10.1093/ije/26.suppl_1.S71; BohlscheidThomas S, 1997, INT J EPIDEMIOL, V26, pS59, DOI 10.1093/ije/26.suppl_1.S59; Brien SE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d636; Chen L, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050052; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; Corrao G, 2000, ADDICTION, V95, P1505, DOI 10.1046/j.1360-0443.2000.951015056.x; Davey Smith G, 2008, ANN MED, V40, P524, DOI 10.1080/07853890802010709; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Djousse L, 2005, AM J CARDIOL, V96, P227, DOI 10.1016/j.amjcard.2005.03.050; Djousse L, 2009, CIRCULATION, V120, P237, DOI 10.1161/CIRCULATIONAHA.108.832360; Ebrahim S, 2008, ATHEROSCLEROSIS, V196, P871, DOI 10.1016/j.atherosclerosis.2007.02.002; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; EHRIG T, 1990, ALCOHOL ALCOHOLISM, V25, P105, DOI 10.1093/oxfordjournals.alcalc.a044985; Hashibe M, 2006, CANCER EPIDEM BIOMAR, V15, P696, DOI 10.1158/1055-9965.EPI-05-0710; Heidrich J, 2007, EUR J CARDIOV PREV R, V14, P769, DOI 10.1097/HJR.0b013e328270b924; Hines LM, 2001, NEW ENGL J MED, V344, P549, DOI 10.1056/NEJM200102223440802; HOOG JO, 1986, EUR J BIOCHEM, V159, P215, DOI 10.1111/j.1432-1033.1986.tb09855.x; Jia CQ, 2007, THROMB RES, V120, P679, DOI 10.1016/j.thromres.2006.12.023; Kim MY, 2006, BIOMETRICS, V62, P929, DOI 10.1111/j.1541-0420.2006.00639_1.x; Kroke A, 1999, ANN NUTR METAB, V43, P216, DOI 10.1159/000012788; Lee SL, 2004, PHARMACOGENETICS, V14, P725, DOI 10.1097/00008571-200411000-00003; Lewis SJ, 2005, CANCER EPIDEM BIOMAR, V14, P1967, DOI 10.1158/1055-9965.EPI-05-0196; Macgregor S, 2009, HUM MOL GENET, V18, P580, DOI 10.1093/hmg/ddn372; Patra J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-258; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; Roerecke M, 2011, AM J EPIDEMIOL, V173, P245, DOI 10.1093/aje/kwq364; Ronksley PE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d671; Rothman K., 2008, MOD EPIDEMIOL, V3, P238; Schutze M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1584; Schwarzer G, 2011, METAANALYSIS R; Suzuki Y, 2004, NEUROLOGY, V63, P1711, DOI 10.1212/01.WNL.0000142971.08275.DB; Tolstrup JS, 2010, SCAND J PUBLIC HEALT, V38, P489, DOI 10.1177/1403494810371248; Tolstrup JS, 2009, CIRC-CARDIOVASC GENE, V2, P507, DOI 10.1161/CIRCGENETICS.109.873604; Tolstrup JS, 2008, PHARMACOGENOMICS J, V8, P220, DOI 10.1038/sj.tpj.6500471; Weikert C, 2007, J NEUROL, V254, P315, DOI 10.1007/s00415-006-0358-x; Weikert C, 2008, CIRCULATION, V118, P2555, DOI 10.1161/CIRCULATIONAHA.108.814418; Younis J, 2005, ATHEROSCLEROSIS, V180, P225, DOI 10.1016/j.atherosclerosis.2004.12.010; Zee RYL, 2004, STROKE, V35, pE39, DOI 10.1161/01.STR.0000114202.86942.61; Zhang GH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013679	42	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32176	10.1371/journal.pone.0032176	http://dx.doi.org/10.1371/journal.pone.0032176			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363810	gold, Green Published, Green Submitted			2022-12-27	WOS:000302873700151
J	Linard, C; Gilbert, M; Snow, RW; Noor, AM; Tatem, AJ				Linard, Catherine; Gilbert, Marius; Snow, Robert W.; Noor, Abdisalan M.; Tatem, Andrew J.			Population Distribution, Settlement Patterns and Accessibility across Africa in 2010	PLOS ONE			English	Article							POVERTY; MAPS	The spatial distribution of populations and settlements across a country and their interconnectivity and accessibility from urban areas are important for delivering healthcare, distributing resources and economic development. However, existing spatially explicit population data across Africa are generally based on outdated, low resolution input demographic data, and provide insufficient detail to quantify rural settlement patterns and, thus, accurately measure population concentration and accessibility. Here we outline approaches to developing a new high resolution population distribution dataset for Africa and analyse rural accessibility to population centers. Contemporary population count data were combined with detailed satellite-derived settlement extents to map population distributions across Africa at a finer spatial resolution than ever before. Substantial heterogeneity in settlement patterns, population concentration and spatial accessibility to major population centres is exhibited across the continent. In Africa, 90% of the population is concentrated in less than 21% of the land surface and the average per-person travel time to settlements of more than 50,000 inhabitants is around 3.5 hours, with Central and East Africa displaying the longest average travel times. The analyses highlight large inequities in access, the isolation of many rural populations and the challenges that exist between countries and regions in providing access to services. The datasets presented are freely available as part of the AfriPop project, providing an evidence base for guiding strategic decisions.	[Linard, Catherine] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford OX1 3PS, England; [Linard, Catherine; Gilbert, Marius] Univ Libre Bruxelles, Brussels, Belgium; [Gilbert, Marius] Fonds Natl Rech Sci, B-1050 Brussels, Belgium; [Snow, Robert W.; Noor, Abdisalan M.] Univ Oxford, Malaria Publ Hlth & Epidemiol Grp, Ctr Geog Med, KEMRI,Wellcome Trust Res Programme, Nairobi, Kenya; [Snow, Robert W.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Tatem, Andrew J.] Univ Florida, Dept Geog, Gainesville, FL 32611 USA; [Tatem, Andrew J.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Tatem, Andrew J.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	University of Oxford; Universite Libre de Bruxelles; Fonds de la Recherche Scientifique - FNRS; University of Oxford; State University System of Florida; University of Florida; State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Linard, C (corresponding author), Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, S Parks Rd, Oxford OX1 3PS, England.	Andy.Tatem@gmail.com	Snow, Robert William/AFR-1436-2022; Linard, Catherine/AAF-1670-2021	Snow, Robert William/0000-0003-3725-6088; Tatem, Andrew/0000-0002-7270-941X; Linard, Catherine/0000-0002-0819-7755; Gilbert, Marius/0000-0003-3708-3359	Bill and Melinda Gates Foundation [49446]; Malaria Atlas Project (MAP); Wellcome Trust, U.K; Fondation Philippe Wiener - Maurice Anspach; Wellcome Trust, U.K.	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Malaria Atlas Project (MAP); Wellcome Trust, U.K(Wellcome Trust); Fondation Philippe Wiener - Maurice Anspach; Wellcome Trust, U.K.(Wellcome Trust)	CL is supported by a grant from the Fondation Philippe Wiener - Maurice Anspach (www.ulb.ac.be/iee/fwa/). AJT is supported by a grant from the Bill and Melinda Gates Foundation (#49446). This work forms part of the output of the AfriPop Project (www.afripop.org), principally funded by the Fondation Philippe Wiener - Maurice Anspach, and the Malaria Atlas Project (MAP, www.map.ox.ac.uk), principally funded by the Wellcome Trust, U.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, TRANSFORMING POPULAT; [Anonymous], IMPROVING CONNECTIVI; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Balk D., 2004, Population, Space and Place, V10, P175, DOI 10.1002/psp.328; Balk DL, 2006, ADV PARASIT, V62, P119, DOI 10.1016/S0065-308X(05)62004-0; Baulch B., 2003, POVERTY INEQUALITY V; Bloom DE, 2008, SCIENCE, V319, P772, DOI 10.1126/science.1153057; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; Deichmann U, 1996, REV SPATIAL POPULATI; Dobson JE, 2000, PHOTOGRAMM ENG REM S, V66, P849; Dorosh P, 2010, CROP PRODUCTION ROAD; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Farrow A, 2005, FOOD POLICY, V30, P510, DOI 10.1016/j.foodpol.2005.09.005; Gabrysch S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000394; Guagliardo Mark F, 2004, Int J Health Geogr, V3, P3; Hay SI, 2005, TROP MED INT HEALTH, V10, P1073, DOI 10.1111/j.1365-3156.2005.01487.x; Kinney MV, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000294; Kristjanson P, 2005, FOOD POLICY, V30, P568, DOI 10.1016/j.foodpol.2005.10.002; Kwan MP, 1998, GEOGR ANAL, V30, P191, DOI 10.1111/j.1538-4632.1998.tb00396.x; Linard C, 2011, GEOJOURNAL, V76, P525, DOI 10.1007/s10708-010-9364-8; Linard Catherine, 2010, Int J Health Geogr, V9, P45, DOI 10.1186/1476-072X-9-45; Mba CJ, 2003, J SOCIAL DEV AFRICA, V18, P111; Mba CJ, 2004, I AFRICAN STUDIES RE, V20, P9; Minot N.W., 2005, ARE POOR REMOTE AREA; Nelson A, 2008, CHRISTIAN TRAVEL PLA; Peter Roberts, 2006, TRANSPORT PAPER SERI; Porter G, 2002, WORLD DEV, V30, P285, DOI 10.1016/S0305-750X(01)00106-1; Pozzi F., 2009, ACCESSIBILITY MAPPIN; Schmidt E., 2009, URBANIZATION SPATIAL; Tatem AJ, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-4; Tatem AJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001298; United Nations Population Division, 2008, WORLD POP PROSP 2008; United Nations (UN) Population Division, 2007, WORLD URB PROSP 2007; Wilson DP, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-16; World Bank, 2009, WORLD DEV REP RESH E; Yetman G., 2004, GLOBAL DISTRIBUTION; Yoshida N., 2009, J INFRASTRUCT DEV, V1, P1, DOI [DOI 10.1177/097493060900100102, 10.1177/097493060900100102]	37	357	373	10	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31743	10.1371/journal.pone.0031743	http://dx.doi.org/10.1371/journal.pone.0031743			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926ZM	22363717	gold, Green Published, Green Submitted			2022-12-27	WOS:000302873700087
J	Shi, L; Chang, Y; Yang, YM; Zhang, Y; Yu, FSX; Wu, XY				Shi, Long; Chang, Yuan; Yang, Yongmei; Zhang, Ying; Yu, Fu-Shin X.; Wu, Xinyi			Activation of JNK Signaling Mediates Connective Tissue Growth Factor Expression and Scar Formation in Corneal Wound Healing	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; N-TERMINAL KINASE; EPITHELIAL-CELLS; FACTOR-BETA; MATRIX CONTRACTION; MESANGIAL CELLS; MAP KINASE; PATHWAY; CTGF; FIBROBLASTS	Connective Tissue Growth Factor (CTGF) and Transforming growth factor-beta 1 (TGF-beta 1) are key growth factors in regulating corneal scarring. Although CTGF was induced by TGF-beta 1 and mediated many of fibroproliferative effects of TGF-beta 1, the signaling pathway for CTGF production in corneal scarring remains to be clarified. In the present study, we firstly investigated the effects of c-Jun N-terminal kinase (JNK) on CTGF expression induce by TGF-beta 1 in Telomerase-immortalized human cornea stroma fibroblasts (THSF). Then, we created penetrating corneal wound model and determined the effect of JNK in the pathogenesis of corneal scarring. TGF-beta 1 activated MAPK pathways in THSF cells. JNK inhibitor significantly inhibited CTGF, fibronectin and collagen I expression induced by TGF-beta 1 in THSF. In corneal wound healing, the JNK inhibitor significantly inhibited CTGF expression, markedly improved the architecture of corneal stroma and reduced corneal scar formation, but did not have a measurable impact on corneal wound healing in vivo. Our results indicate that JNK mediates the expression of CTGF and corneal scarring in corneal wound healing, and might be considered as specific targets of drug therapy for corneal scarring.	[Shi, Long; Chang, Yuan; Yang, Yongmei; Zhang, Ying; Wu, Xinyi] Shandong Univ, Qilu Hosp, Dept Ophthalmol, Jinan 250100, Peoples R China; [Yu, Fu-Shin X.] Wayne State Univ, Sch Med, Dept Ophthalmol, Detroit, MI USA; [Yu, Fu-Shin X.] Wayne State Univ, Sch Med, Dept Anat, Detroit, MI USA; [Yu, Fu-Shin X.] Wayne State Univ, Sch Med, Dept Cell Biol, Detroit, MI USA	Shandong University; Wayne State University; Wayne State University; Wayne State University	Shi, L (corresponding author), Shandong Univ, Qilu Hosp, Dept Ophthalmol, Jinan 250100, Peoples R China.	xywu8868@163.com			Education Ministry Fund of China [20070422081]; Natural Science Foundation of Shandong Province, China [2007GG20002031]	Education Ministry Fund of China; Natural Science Foundation of Shandong Province, China(Natural Science Foundation of Shandong Province)	Research was supported by the Education Ministry Fund of China (No. 20070422081) and Natural Science Foundation of Shandong Province, China (No. 2007GG20002031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black SA, 2007, J BIOL CHEM, V282, P15416, DOI 10.1074/jbc.M610432200; Blalock TD, 2003, INVEST OPHTH VIS SCI, V44, P1879, DOI 10.1167/iovs.02-0860; Blalock TD, 2004, EXP EYE RES, V78, P1127, DOI 10.1016/j.exer.2004.01.012; Bogoyevitch MA, 2010, BBA-PROTEINS PROTEOM, V1804, P463, DOI 10.1016/j.bbapap.2009.11.002; Chang Y, 2009, J INT MED RES, V37, P727, DOI 10.1177/147323000903700316; Chang Y, 2010, MOL CELL BIOCHEM, V335, P83, DOI 10.1007/s11010-009-0245-8; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chen YJ, 2002, KIDNEY INT, V62, P1149, DOI 10.1111/j.1523-1755.2002.kid567.x; Chujo S, 2005, J CELL PHYSIOL, V203, P447, DOI 10.1002/jcp.20251; Cursiefen Claus, 2007, Chem Immunol Allergy, V92, P50, DOI 10.1159/000099253; Daniels JT, 2003, AM J PATHOL, V163, P2043, DOI 10.1016/S0002-9440(10)63562-6; Dessein A, 2009, J EXP MED, V206, P2321, DOI 10.1084/jem.20090383; Fukada T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003642; Garrett Q, 2004, INVEST OPHTH VIS SCI, V45, P1109, DOI 10.1167/iovs.03-0660; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Guo F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019756; Guo H, 2008, IMMUNOL CELL BIOL, V86, P271, DOI 10.1038/sj.icb.7100158; Imamichi Y, 2005, BIOL CHEM, V386, P225, DOI 10.1515/BC.2005.028; Zhang J, 2010, MOL MED, V16, P307, DOI 10.2119/molmed.2009.00121; Kuiper EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002675; Leivonen SK, 2005, J INVEST DERMATOL, V124, P1162, DOI 10.1111/j.0022-202X.2005.23750.x; Lien SC, 2006, CELL SIGNAL, V18, P1270, DOI 10.1016/j.cellsig.2005.10.013; Limburg H, 2008, BRIT J OPHTHALMOL, V92, P315, DOI 10.1136/bjo.2007.125906; Matsuda A, 1997, INVEST OPHTH VIS SCI, V38, P1555; Munireddy S, 2010, SURG CLIN N AM, V90, P1227, DOI 10.1016/j.suc.2010.08.002; Pang KP, 2010, BIOMATERIALS, V31, P7257, DOI 10.1016/j.biomaterials.2010.05.066; Peterziel H, 2002, J CELL BIOL, V159, P157, DOI 10.1083/jcb.200203115; Phanish MK, 2010, NEPHRON EXP NEPHROL, V114, pE83, DOI 10.1159/000262316; Qi W, 2006, AM J PHYSIOL-RENAL, V290, pF703, DOI 10.1152/ajprenal.00254.2005; Ren MY, 2010, IMMUNOL CELL BIOL, V88, P529, DOI 10.1038/icb.2010.6; Saika S, 2004, INVEST OPHTH VIS SCI, V45, P100, DOI 10.1167/iovs.03-0700; Saika S, 2005, AM J PATHOL, V166, P1405, DOI 10.1016/S0002-9440(10)62358-9; Secker GA, 2008, EXP CELL RES, V314, P131, DOI 10.1016/j.yexcr.2007.09.001; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; Sohn M, 2005, KIDNEY INT, V67, P1286, DOI 10.1111/j.1523-1755.2005.00206.x; Song JJ, 2007, J CELL PHYSIOL, V210, P398, DOI 10.1002/jcp.20850; Sugioka K, 2010, TOHOKU J EXP MED, V222, P45, DOI 10.1620/tjem.222.45; Suk FM, 2009, TOXICOL LETT, V187, P22, DOI 10.1016/j.toxlet.2009.01.019; Utsugi M, 2003, AM J RESP CELL MOL, V28, P754, DOI 10.1165/rcmb.4892; Wang XM, 2006, J EXP MED, V203, P2895, DOI 10.1084/jem.20061536; Wu XY, 2006, CHINESE MED J-PEKING, V119, P57, DOI 10.1097/00029330-200601010-00010; Xie SP, 2005, AM J PHYSIOL-LUNG C, V288, pL68, DOI 10.1152/ajplung.00156.2004; Yamanaka O, 2007, MOL VIS, V13, P1730; Zi ZK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000936	44	39	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32128	10.1371/journal.pone.0032128	http://dx.doi.org/10.1371/journal.pone.0032128			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363806	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700147
J	Villarreal, MF; Fridman, EA; Leiguarda, RC				Villarreal, Mirta F.; Fridman, Esteban A.; Leiguarda, Ramon C.			The Effect of the Visual Context in the Recognition of Symbolic Gestures	PLOS ONE			English	Article							SOCIAL COGNITION; BRAIN; INTENTIONS; NETWORK; MIRROR; OTHERS; CORTEX; FMRI; TEMPOROPARIETAL; REPRESENTATION	Background: To investigate, by means of fMRI, the influence of the visual environment in the process of symbolic gesture recognition. Emblems are semiotic gestures that use movements or hand postures to symbolically encode and communicate meaning, independently of language. They often require contextual information to be correctly understood. Until now, observation of symbolic gestures was studied against a blank background where the meaning and intentionality of the gesture was not fulfilled. Methodology/Principal Findings: Normal subjects were scanned while observing short videos of an individual performing symbolic gesture with or without the corresponding visual context and the context scenes without gestures. The comparison between gestures regardless of the context demonstrated increased activity in the inferior frontal gyrus, the superior parietal cortex and the temporoparietal junction in the right hemisphere and the precuneus and posterior cingulate bilaterally, while the comparison between context and gestures alone did not recruit any of these regions. Conclusions/Significance: These areas seem to be crucial for the inference of intentions in symbolic gestures observed in their natural context and represent an interrelated network formed by components of the putative human neuron mirror system as well as the mentalizing system.	[Villarreal, Mirta F.; Fridman, Esteban A.; Leiguarda, Ramon C.] Inst Neurol Res FLENI, Dept Cognit Neurol, Buenos Aires, DF, Argentina; [Villarreal, Mirta F.] Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Villarreal, MF (corresponding author), Inst Neurol Res FLENI, Dept Cognit Neurol, Buenos Aires, DF, Argentina.	mvillarreal@fleni.org.ar		Fridman, Esteban A./0000-0001-7879-8874	National Council for Scientific Research (CONICET); Foundation for the Fight against the Neurological Diseases of Childhood (FLENI); Perez Companc Foundation	National Council for Scientific Research (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Foundation for the Fight against the Neurological Diseases of Childhood (FLENI); Perez Companc Foundation	This work was supported by the National Council for Scientific Research (CONICET) (www.conicet.gov.ar), the Foundation for the Fight against the Neurological Diseases of Childhood (FLENI) (www.fleni.org.ar), and the Perez Companc Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Brass M, 2007, CURR BIOL, V17, P2117, DOI 10.1016/j.cub.2007.11.057; Burgess N, 2001, NEUROIMAGE, V14, P439, DOI 10.1006/nimg.2001.0806; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Ciaramidaro A, 2007, NEUROPSYCHOLOGIA, V45, P3105, DOI 10.1016/j.neuropsychologia.2007.05.011; De Lange FP, 2008, CURR BIOL, V18, P454, DOI 10.1016/j.cub.2008.02.057; den Ouden HEM, 2005, NEUROIMAGE, V28, P787, DOI 10.1016/j.neuroimage.2005.05.001; Farrer C, 2002, NEUROIMAGE, V15, P596, DOI 10.1006/nimg.2001.1009; Friston KJ, 2000, NEUROIMAGE, V12, P196, DOI 10.1006/nimg.2000.0609; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gallagher HL, 2004, NEUROPSYCHOLOGIA, V42, P1725, DOI 10.1016/j.neuropsychologia.2004.05.006; Grafton ST, 2007, HUM MOVEMENT SCI, V26, P590, DOI 10.1016/j.humov.2007.05.009; Grafton ST, 2009, ANN NY ACAD SCI, V1156, P97, DOI 10.1111/j.1749-6632.2009.04425.x; Hamilton AFD, 2006, J NEUROSCI, V26, P1133, DOI 10.1523/JNEUROSCI.4551-05.2006; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; Hassin Ran R., 2005, NEW UNCONSCIOUS; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Iacoboni M, 2004, NEUROIMAGE, V21, P1167, DOI 10.1016/j.neuroimage.2003.11.013; Joly JF, 2008, PERS SOC PSYCHOL B, V34, P1047, DOI 10.1177/0146167208318401; Kukolja J, 2006, NEUROPSYCHOLOGIA, V44, P2846, DOI 10.1016/j.neuropsychologia.2006.06.029; Leichnetz GR, 2001, ANAT RECORD, V263, P215, DOI 10.1002/ar.1082; Lotze M, 2006, NEUROPSYCHOLOGIA, V44, P1787, DOI 10.1016/j.neuropsychologia.2006.03.016; McNeill David, 1996, HAND MIND WHAT GESTU; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parvizi J, 2006, P NATL ACAD SCI USA, V103, P1563, DOI 10.1073/pnas.0507729103; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Samson D, 2004, NAT NEUROSCI, V7, P499, DOI 10.1038/nn1223; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Saxe R, 2006, PSYCHOL SCI, V17, P692, DOI 10.1111/j.1467-9280.2006.01768.x; Schilbach L, 2006, NEUROPSYCHOLOGIA, V44, P718, DOI 10.1016/j.neuropsychologia.2005.07.017; Speer NK, 2007, PSYCHOL SCI, V18, P449, DOI 10.1111/j.1467-9280.2007.01920.x; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Spunt RP, 2011, J COGNITIVE NEUROSCI, V23, P63, DOI 10.1162/jocn.2010.21446; Talairach J., 1988, COPLANAR STEREOTAXIC; Thioux M, 2008, CURR BIOL, V18, pR431, DOI 10.1016/j.cub.2008.03.018; Tylen K, 2009, BRAIN LANG, V108, P159, DOI 10.1016/j.bandl.2008.07.002; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Villarrea M, 2008, NEUROPSYCHOLOGIA, V46, P2371, DOI 10.1016/j.neuropsychologia.2008.03.004; Wheatley T, 2007, PSYCHOL SCI, V18, P469, DOI 10.1111/j.1467-9280.2007.01923.x	41	10	10	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e29644	10.1371/journal.pone.0029644	http://dx.doi.org/10.1371/journal.pone.0029644			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926ZM	22363406	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700004
J	Mueckler, M; Makepeace, C				Mueckler, Mike; Makepeace, Carol			Ligand-Induced Movements of Inner Transmembrane Helices of Glut1 Revealed by Chemical Cross-Linking of Di-Cysteine Mutants	PLOS ONE			English	Article							FACILITATIVE GLUCOSE-TRANSPORTER; ERYTHROCYTE SUGAR-TRANSPORT; SUBSTRATE-BINDING SITE; SCANNING MUTAGENESIS; CYTOCHALASIN-B; ESCHERICHIA-COLI; OUTER HELIX; MOLECULAR-MECHANISM; PERMEATION PATHWAY; HEXOSE TRANSPORTER	The relative orientation and proximity of the pseudo-symmetrical inner transmembrane helical pairs 5/8 and 2/11 of Glut1 were analyzed by chemical cross-linking of di-cysteine mutants. Thirteen functional di-cysteine mutants were created from a C-less Glut1 reporter construct containing cysteine substitutions in helices 5 and 8 or helices 2 and 11. The mutants were expressed in Xenopus oocytes and the sensitivity of each mutant to intramolecular cross-linking by two homobifunctional thiol-specific reagents was ascertained by protease cleavage followed by immunoblot analysis. Five of 9 mutants with cysteine residues predicted to lie in close proximity to each other were susceptible to cross-linking by one or both reagents. None of 4 mutants with cysteine substitutions predicted to lie on opposite faces of their respective helices was susceptible to cross-linking. Additionally, the cross-linking of a di-cysteine pair (A70C/M420C, helices 2/11) predicted to lie near the exoplasmic face of the membrane was stimulated by ethylidene glucose, a non-transported glucose analog that preferentially binds to the exofacial substrate-binding site, suggesting that the binding of this ligand stimulates the closure of helices at the exoplasmic face of the membrane. In contrast, the cross-linking of a second di-cysteine pair (T158C/L325, helices 5/8), predicted to lie near the cytoplasmic face of the membrane, was stimulated by cytochalasin B, a glucose transport inhibitor that competitively inhibits substrate efflux, suggesting that this compound recruits the transporter to a conformational state in which closure of inner helices occurs at the cytoplasmic face of the membrane. This observation provides a structural explanation for the competitive inhibition of substrate efflux by cytochalasin B. These data indicate that the binding of competitive inhibitors of glucose efflux or influx induce occluded states in the transporter in which substrate is excluded from the exofacial or endofacial binding site.	[Mueckler, Mike; Makepeace, Carol] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Mueckler, M (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	mmueckler@.wustl.edu	Mueckler, Mike M/F-6115-2012		National Institutes of Health [R01 DK43695]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded in part by National Institutes of Health R01 DK43695. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Alisio A, PROTEIN EXPR PURIF, V70, P81; APPLEMAN JR, 1985, J BIOL CHEM, V260, P4575; APPLEMAN JR, 1989, BIOCHEMISTRY-US, V28, P8221, DOI 10.1021/bi00446a038; BAKER GF, 1978, J PHYSIOL-LONDON, V278, P377, DOI 10.1113/jphysiol.1978.sp012310; BARNETT JEG, 1975, BIOCHEM J, V145, P417, DOI 10.1042/bj1450417a; Bass RB, 2007, METHOD ENZYMOL, V423, P25, DOI 10.1016/S0076-6879(07)23002-2; BIRNBAUM MJ, 1986, P NATL ACAD SCI USA, V83, P5784, DOI 10.1073/pnas.83.16.5784; BLOCH R, 1973, BIOCHEMISTRY-US, V12, P4799, DOI 10.1021/bi00747a036; CARRUTHERS A, 1991, BIOCHEMISTRY-US, V30, P3907, DOI 10.1021/bi00230a015; CARRUTHERS A, 1990, PHYSIOL REV, V70, P1135, DOI 10.1152/physrev.1990.70.4.1135; Carruthers A, 2009, AM J PHYSIOL-ENDOC M, V297, pE836, DOI 10.1152/ajpendo.00496.2009; Cloherty EK, 1996, BIOCHEMISTRY-US, V35, P10411, DOI 10.1021/bi953077m; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; DEVES R, 1978, BIOCHIM BIOPHYS ACTA, V510, P339, DOI 10.1016/0005-2736(78)90034-2; Forrest LR, 2006, BIOPHYS J, V91, P508, DOI 10.1529/biophysj.106.082313; GARCIA JC, 1992, J BIOL CHEM, V267, P7770; GIBBS AF, 1988, BIOCHEM J, V256, P421, DOI 10.1042/bj2560421; GORGA FR, 1981, BIOCHEMISTRY-US, V20, P5108, DOI 10.1021/bi00521a003; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; GRIFFIN JF, 1982, P NATL ACAD SCI-BIOL, V79, P3759, DOI 10.1073/pnas.79.12.3759; HASHIRAMOTO M, 1992, J BIOL CHEM, V267, P17502; Heinze M, 2004, BIOCHEMISTRY-US, V43, P931, DOI 10.1021/bi030175w; HOLMAN GD, 1987, BIOCHIM BIOPHYS ACTA, V897, P395, DOI 10.1016/0005-2736(87)90437-8; HRESKO RC, 1994, J BIOL CHEM, V269, P20482; Hruz PW, 2000, BIOCHEMISTRY-US, V39, P9367, DOI 10.1021/bi000821g; Hruz PW, 2001, MOL MEMBR BIOL, V18, P183; Hruz PW, 1999, J BIOL CHEM, V274, P36176, DOI 10.1074/jbc.274.51.36176; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Inukai K, 1994, BIOCHEM J, V291, P861; JUNG EKY, 1986, J BIOL CHEM, V261, P9155; KARIM AR, 1987, BIOCHIM BIOPHYS ACTA, V902, P402, DOI 10.1016/0005-2736(87)90208-2; Lowe A.G., 1989, RED BLOOD CELL MEMBR, P597; LOWE AG, 1989, BIOCHEM SOC T, V17, P435, DOI 10.1042/bst0170435; Manolescu AR, 2007, PHYSIOLOGY, V22, P234, DOI 10.1152/physiol.00011.2007; Mueckler M, 1999, J BIOL CHEM, V274, P10923, DOI 10.1074/jbc.274.16.10923; Mueckler M, 2004, J BIOL CHEM, V279, P46876, DOI 10.1074/jbc.M408632200; Mueckler M, 2004, J BIOL CHEM, V279, P10494, DOI 10.1074/jbc.M310786200; Mueckler M, 2002, J BIOL CHEM, V277, P3498, DOI 10.1074/jbc.M109157200; MUECKLER M, 1994, J BIOL CHEM, V269, P20533; Mueckler M, 1997, J BIOL CHEM, V272, P30141, DOI 10.1074/jbc.272.48.30141; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Mueckler M, 2005, J BIOL CHEM, V280, P39562, DOI 10.1074/jbc.M509050200; Mueckler M, 2008, J BIOL CHEM, V283, P11550, DOI 10.1074/jbc.M708896200; Mueckler M, 2006, J BIOL CHEM, V281, P36993, DOI 10.1074/jbc.M608158200; Mueckler M, 2009, BIOCHEMISTRY-US, V48, P5934, DOI 10.1021/bi900521n; Olsowski A, 2000, BIOCHEMISTRY-US, V39, P2469, DOI 10.1021/bi992160x; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Robichaud T, 2011, BIOCHEMISTRY-US, V50, P3137, DOI 10.1021/bi1020327; Saier MH, 2000, MOL MICROBIOL, V35, P699, DOI 10.1046/j.1365-2958.2000.01759.x; Salas-Burgos A, 2004, BIOPHYS J, V87, P2990, DOI 10.1529/biophysj.104.047886; Thorens B, 2009, AM J PHYSL ENDOCRINO; VIDAVER GA, 1966, J THEOR BIOL, V10, P301, DOI 10.1016/0022-5193(66)90128-7; WELLNER M, 1995, FEBS LETT, V370, P19, DOI 10.1016/0014-5793(95)00783-6; Wood IS, 2003, BRIT J NUTR, V89, P3, DOI 10.1079/BJN2002763; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629	56	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31412	10.1371/journal.pone.0031412	http://dx.doi.org/10.1371/journal.pone.0031412			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363641	Green Published, Green Submitted, gold			2022-12-27	WOS:000302871500041
J	Botella-Soler, V; Valderrama, M; Crepon, B; Navarro, V; Le Van Quyen, M				Botella-Soler, Vicente; Valderrama, Mario; Crepon, Benoit; Navarro, Vincent; Le Van Quyen, Michel			Large-Scale Cortical Dynamics of Sleep Slow Waves	PLOS ONE			English	Article							LESS-THAN-1 HZ OSCILLATION; NEOCORTICAL NEURONS; LOW-FREQUENCY; SYNCHRONIZATION; HOMEOSTASIS; ELECTROENCEPHALOGRAM; NETWORKS; RHYTHMS; HUMANS; STATES	Slow waves constitute the main signature of sleep in the electroencephalogram (EEG). They reflect alternating periods of neuronal hyperpolarization and depolarization in cortical networks. While recent findings have demonstrated their functional role in shaping and strengthening neuronal networks, a large-scale characterization of these two processes remains elusive in the human brain. In this study, by using simultaneous scalp EEG and intracranial recordings in 10 epileptic subjects, we examined the dynamics of hyperpolarization and depolarization waves over a large extent of the human cortex. We report that both hyperpolarization and depolarization processes can occur with two different characteristic time durations which are consistent across all subjects. For both hyperpolarization and depolarization waves, their average speed over the cortex was estimated to be approximately 1 m/s. Finally, we characterized their propagation pathways by studying the preferential trajectories between most involved intracranial contacts. For both waves, although single events could begin in almost all investigated sites across the entire cortex, we found that the majority of the preferential starting locations were located in frontal regions of the brain while they had a tendency to end in posterior and temporal regions.	[Botella-Soler, Vicente] Univ Valencia, Dept Fis Teor, CSIC, Valencia, Spain; [Botella-Soler, Vicente] Univ Valencia, Inst Fis Corpuscular IFIC, CSIC, Valencia, Spain; [Crepon, Benoit; Navarro, Vincent] Hop La Pitie Salpetriere, AP HP, Epilepsy Unit, Paris, France; [Valderrama, Mario; Crepon, Benoit; Navarro, Vincent; Le Van Quyen, Michel] Univ Paris 06, Hop La Pitie Salpetriere, Ctr Rech Inst Cerveau & Moelle Epiniere CRICM, INSERM,CNRS,UMR 7225,UMRS 975, Paris, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - UAM - Institut de Fisica Teorica (IFT); University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Fisica Corpuscular (IFIC); University of Valencia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Botella-Soler, V (corresponding author), Univ Valencia, Dept Fis Teor, CSIC, Valencia, Spain.	quyen@t-online.de	Botella-Soler, Vicente/C-6702-2012	Navarro, Vincent/0000-0003-0077-8114; Valderrama, Mario/0000-0001-8791-6078; Botella-Soler, Vicente/0000-0002-8790-1914	European Union [211713]; (MCyT/FEDER, Spain) [FIS2007-60133]; MICINN, Spain [AYA2010-22111-C03-02]; Generalitat Valenciana	European Union(European Commission); (MCyT/FEDER, Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); MICINN, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This work was supported by the European Union-FP7 Project EPILEPSIAE (Evolving Platform for Improving Living Expectation of Subjects Suffering from IctAl Events, Grant No 211713) and by contracts FIS2007-60133 (MCyT/FEDER, Spain) and AYA2010-22111-C03-02 (MICINN, Spain). VBS thanks Generalitat Valenciana for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann P, 1997, NEUROSCIENCE, V81, P213, DOI 10.1016/S0306-4522(97)00186-3; Amzica F, 1998, ELECTROEN CLIN NEURO, V107, P69, DOI 10.1016/S0013-4694(98)00051-0; AMZICA F, 1995, J NEUROPHYSIOL, V73, P20, DOI 10.1152/jn.1995.73.1.20; Cash SS, 2009, SCIENCE, V324, P1084, DOI 10.1126/science.1169626; Cirelli C, 2008, PLOS BIOL, V6, P1605, DOI 10.1371/journal.pbio.0060216; Crunelli V, 2010, NAT NEUROSCI, V13, P10, DOI 10.1038/nn.2445; Csercsa R, 2010, BRAIN, V133, P2814, DOI 10.1093/brain/awq169; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Esser SK, 2007, SLEEP, V30, P1617, DOI 10.1093/sleep/30.12.1617; Ferri R, 2005, CLIN NEUROPHYSIOL, V116, P2783, DOI 10.1016/j.clinph.2005.08.013; Hill S, 2005, J NEUROPHYSIOL, V93, P1671, DOI 10.1152/jn.00915.2004; Holcman D, 2006, PLOS COMPUT BIOL, V2, P174, DOI 10.1371/journal.pcbi.0020023; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; Mohajerani MH, 2010, J NEUROSCI, V30, P3745, DOI 10.1523/JNEUROSCI.6437-09.2010; Murphy M, 2009, P NATL ACAD SCI USA, V106, P1608, DOI 10.1073/pnas.0807933106; Nir Y, 2011, NEURON, V70, P153, DOI 10.1016/j.neuron.2011.02.043; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Riedner BA, 2007, SLEEP, V30, P1643, DOI 10.1093/sleep/30.12.1643; Rigas P, 2007, J NEUROSCI, V27, P4261, DOI 10.1523/JNEUROSCI.0003-07.2007; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; STERIADE M, 1993, J NEUROSCI, V13, P3284; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Talairach J., 1988, COPLANAR STEREOTAXIC; Terzano MG, 2001, SLEEP MED, V2, P537, DOI 10.1016/S1389-9457(01)00149-6; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; Timofeev I, 1996, J NEUROPHYSIOL, V76, P4152, DOI 10.1152/jn.1996.76.6.4152; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Volgushev M, 2006, J NEUROSCI, V26, P5665, DOI 10.1523/JNEUROSCI.0279-06.2006	33	22	22	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30757	10.1371/journal.pone.0030757	http://dx.doi.org/10.1371/journal.pone.0030757			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363484	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600065
J	Du, R; Sun, WJ; Xia, L; Zhao, A; Yu, Y; Zhao, LJ; Wang, HM; Huang, C; Sun, SR				Du, Rui; Sun, Wenjuan; Xia, Lin; Zhao, Ali; Yu, Yan; Zhao, Lijuan; Wang, Hanmin; Huang, Chen; Sun, Shiren			Hypoxia-Induced Down-Regulation of microRNA-34a Promotes EMT by Targeting the Notch Signaling Pathway in Tubular Epithelial Cells	PLOS ONE			English	Article							E-CADHERIN; MESENCHYMAL TRANSITION; HEPATOCELLULAR-CARCINOMA; RENAL FIBROGENESIS; EXPRESSION; CANCER; FAMILY; GROWTH; TRANSCRIPTION; REPRESSION	Background: Hypoxia-induced renal tubular cell epithelial-mesenchymal transition (EMT) is an important event leading to renal fibrosis. MicroRNAs (miRNAs) are small non-coding RNA molecules that bind to their mRNA targets, thereby leading to translational repression. The role of miRNA in hypoxia-induced EMT is largely unknown. Methodology/Principal Findings: miRNA profiling was performed for the identification of differentially expressed miRNAs in HK-2 cells under normal and low oxygen, and the results were then verified by quantitative real time RT-PCR (qRT-PCR). The function of miRNAs in hypoxia-induced renal tubular cell EMT was assessed by the transfection of specific miRNA inhibitors and mimics. Luciferase reporter gene assays and western blot analysis were performed to validate the target genes of miR-34a. siRNA against Jagged1 was designed to investigate the role of the miR-34a-Notch pathway in hypoxia induced renal tubular cell EMT. miRNA-34a was identified as being downregulated in hypoxic renal tubular epithelial cells. Inhibition of miR-34a expression in HK-2 cells, which highly express endogenous miR-34a, promoted a mesenchymal phenotype accompanied by reduced expression of the epithelial marker Z0-1, E-cadherin and increased expression of the mesenchymal markers alpha-SMA and vimentin. Conversely, miR-34a mimics effectively prevented hypoxia-induced EMT. Transfection of miRNA-34a in HK-2 cells under hypoxia abolished hypoxia-induced expression of Notch1 and Jagged1 as well as Notch downstream signals, such as snail. Western blot analysis and luciferase reporter gene assays showed direct evidence for miR-34a targeting Notch1 and Jagged1. siRNAs against Jagged1 or Notch1 effectively prevented miR-34a inhibitor-induced tubular epithelial cell EMT. Conclusions/Significance: Our study provides evidence that the hypoxia-induced decrease of miR-34a expression could promote EMT in renal tubular epithelial cells by directly targeting Notch1 and Jagged1, and subsequently, Notch downstream signaling.	[Du, Rui; Sun, Wenjuan; Zhao, Ali; Yu, Yan; Zhao, Lijuan; Wang, Hanmin; Huang, Chen; Sun, Shiren] Fourth Mil Med Univ, Xijing Hosp, Dept Nephrol, Xian 710032, Peoples R China; [Xia, Lin] Fourth Mil Med Univ, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Xia, Lin] Fourth Mil Med Univ, Xijing Digest Hosp, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Du, R (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Nephrol, Xian 710032, Peoples R China.	Chenhuang@fmmu.edu.cn; Sunshiren@fmmu.edu.cn			National Nature Science Foundation of China [81070570, 81000988, 81100525]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Nature Science Foundation of China (No. 81070570, 81000988, and 81100525). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Attiyeh EF, 2005, NEW ENGL J MED, V353, P2243, DOI 10.1056/NEJMoa052399; Bedogni B, 2008, J CLIN INVEST, V118, P3660, DOI 10.1172/JCI36157; Bielesz B, 2010, J CLIN INVEST, V120, P4040, DOI 10.1172/JCI43025; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Castoldi M, 2006, RNA, V12, P913, DOI 10.1261/rna.2332406; Chen YB, 2007, CANCER RES, V67, P7954, DOI 10.1158/0008-5472.CAN-07-1229; Das I, 2004, J BIOL CHEM, V279, P30771, DOI 10.1074/jbc.M309252200; Du B, 2010, FEBS LETT, V584, P811, DOI 10.1016/j.febslet.2009.12.053; Du R, 2010, BIOCHEM BIOPH RES CO, V391, P135, DOI 10.1016/j.bbrc.2009.11.019; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Evans AJ, 2007, MOL CELL BIOL, V27, P157, DOI 10.1128/MCB.00892-06; Fabbri M, 2011, JAMA-J AM MED ASSOC, V305, P59, DOI 10.1001/jama.2010.1919; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Haase VH, 2009, ANN NY ACAD SCI, V1177, P57, DOI 10.1111/j.1749-6632.2009.05030.x; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Higgins DF, 2008, CELL CYCLE, V7, P1128, DOI 10.4161/cc.7.9.5804; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Hiyama A, 2011, ARTHRITIS RHEUM-US, V63, P1355, DOI 10.1002/art.30246; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Imai T, 2003, AM J PATHOL, V163, P1437, DOI 10.1016/S0002-9440(10)63501-8; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Kadesch T, 2004, CURR OPIN GENET DEV, V14, P506, DOI 10.1016/j.gde.2004.07.007; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Krupa A, 2010, J AM SOC NEPHROL, V21, P438, DOI 10.1681/ASN.2009050530; Kulshreshtha R, 2007, CELL CYCLE, V6, P1426; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Morissey J, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017905.77985.4A; Murea M, 2010, KIDNEY INT, V78, P514, DOI 10.1038/ki.2010.172; Muth M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-24; NAGAI H, 1995, CANCER RES, V55, P1752; Nangaku M, 2006, J AM SOC NEPHROL, V17, P17, DOI 10.1681/ASN.2005070757; Niranjan T, 2008, NAT MED, V14, P290, DOI 10.1038/nm1731; Oba S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013614; Paterson EL, 2008, THESCIENTIFICWORLDJO, V8, P901, DOI 10.1100/tsw.2008.115; Sheng W, 2006, MOL BIOL CELL, V17, P2009, DOI 10.1091/mbc.E05-10-0951; Sjolund J, 2008, J CLIN INVEST, V118, P217, DOI 10.1172/JCI32086; Sun SR, 2009, KIDNEY INT, V75, P1278, DOI 10.1038/ki.2009.62; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Wang B, 2011, DIABETES, V60, P280, DOI 10.2337/db10-0892; Wang B, 2010, DIABETES, V59, P1794, DOI 10.2337/db09-1736; Wang G, 2010, AM J HYPERTENS, V23, P78, DOI 10.1038/ajh.2009.208; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Yanada M, 2005, ONCOL REP, V14, P817; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638; Zheng X, 2008, P NATL ACAD SCI USA, V105, P3368, DOI 10.1073/pnas.0711591105	60	140	162	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30771	10.1371/journal.pone.0030771	http://dx.doi.org/10.1371/journal.pone.0030771			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363487	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600067
J	Liu, YK; Chen, XJ; Zhang, L; Wang, L; Perc, M				Liu, Yongkui; Chen, Xiaojie; Zhang, Lin; Wang, Long; Perc, Matjaz			Win-Stay-Lose-Learn Promotes Cooperation in the Spatial Prisoner's Dilemma Game	PLOS ONE			English	Article							SCALE-FREE NETWORKS; TIT-FOR-TAT; EVOLUTIONARY GAMES; SOCIAL DILEMMAS; ASPIRATION; EMERGENCE; SHIFT; STRATEGIES; DYNAMICS; RULES	Holding on to one's strategy is natural and common if the later warrants success and satisfaction. This goes against widespread simulation practices of evolutionary games, where players frequently consider changing their strategy even though their payoffs may be marginally different than those of the other players. Inspired by this observation, we introduce an aspiration-based win-stay-lose-learn strategy updating rule into the spatial prisoner's dilemma game. The rule is simple and intuitive, foreseeing strategy changes only by dissatisfied players, who then attempt to adopt the strategy of one of their nearest neighbors, while the strategies of satisfied players are not subject to change. We find that the proposed win-stay-lose-learn rule promotes the evolution of cooperation, and it does so very robustly and independently of the initial conditions. In fact, we show that even a minute initial fraction of cooperators may be sufficient to eventually secure a highly cooperative final state. In addition to extensive simulation results that support our conclusions, we also present results obtained by means of the pair approximation of the studied game. Our findings continue the success story of related win-stay strategy updating rules, and by doing so reveal new ways of resolving the prisoner's dilemma.	[Liu, Yongkui; Zhang, Lin] Beihang Univ, Sch Automat Sci & Elect Engn, Beijing, Peoples R China; [Liu, Yongkui] Changan Univ, Sch Elect & Control Engn, Xian, Peoples R China; [Liu, Yongkui] Changan Univ, Ctr Rd Traff Intelligent Detect & Equipment Engn, Xian, Peoples R China; [Chen, Xiaojie] Int Inst Appl Syst Anal, Evolut & Ecol Program, A-2361 Laxenburg, Austria; [Wang, Long] Peking Univ, Coll Engn, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China; [Perc, Matjaz] Univ Maribor, Dept Phys, Fac Nat Sci & Math, SLO-2000 Maribor, Slovenia	Beihang University; Chang'an University; Chang'an University; International Institute for Applied Systems Analysis (IIASA); Peking University; University of Maribor	Liu, YK (corresponding author), Beihang Univ, Sch Automat Sci & Elect Engn, Beijing, Peoples R China.	ykliu@chd.edu.cn; chenx@iiasa.ac.at; matjaz.perc@uni-mb.si	Liu, Yongkui/R-9307-2017; Gao, Y./GWZ-3665-2022; Perc, Matjaz/A-5148-2009; Wang, Long/A-7798-2010	Liu, Yongkui/0000-0003-2165-775X; Perc, Matjaz/0000-0002-3087-541X; Wang, Long/0000-0001-5600-8157	Chang'an University [CHD2010JC134]; National Natural Science Foundation of China (NSFC) [60736022, 10972002, 61074144, 51005012, 61103096]; Slovenian Research Agency (ARRS) [J1-4055]	Chang'an University; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia)	YL acknowledges financial support from the Special Fund for the Basic Scientific Research of Central Colleges of Chang'an University (Grant CHD2010JC134). LW acknowledges financial support from the National Natural Science Foundation of China (NSFC) (Grants 60736022 and 10972002). MP acknowledges financial support from the Slovenian Research Agency (ARRS) (Grant J1-4055). This work was additionally supported by the National Natural Science Foundation of China (NSFC) (Grants 61074144, 51005012 and 61103096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Chen XJ, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.017103; Chen X, 2008, PHYS LETT A, V372, P1161, DOI 10.1016/j.physleta.2007.09.044; Chen XJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046109; Chen X, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051120; Cho IK, 2005, J ECON THEORY, V124, P171, DOI 10.1016/j.jet.2004.12.001; Dai QL, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.011103; Dai QL, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/11/113015; Droz M, 2009, EUR PHYS J B, V71, P579, DOI 10.1140/epjb/e2009-00160-1; Fu F, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016104; Fu F, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036101; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108103; Grujic J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013749; Guan JY, 2006, EUROPHYS LETT, V76, P1214, DOI 10.1209/epl/i2006-10381-4; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hauert C, 2005, AM J PHYS, V73, P405, DOI 10.1119/1.1848514; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Helbing D, 2009, P NATL ACAD SCI USA, V106, P3680, DOI 10.1073/pnas.0811503106; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Hu MB, 2007, PHYSICA A, V381, P467, DOI 10.1016/j.physa.2007.03.021; Imhof LA, 2007, J THEOR BIOL, V247, P574, DOI 10.1016/j.jtbi.2007.03.027; Langer P, 2008, J THEOR BIOL, V250, P634, DOI 10.1016/j.jtbi.2007.11.002; Lee S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028702; Liu RR, 2010, EPL-EUROPHYS LETT, V91, DOI 10.1209/0295-5075/91/20002; Liu YK, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/60002; Liu YK, 2010, PHYSICA A, V389, P2390, DOI 10.1016/j.physa.2010.02.008; Lozano S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001892; Macy MW, 2002, P NATL ACAD SCI USA, V99, P7229, DOI 10.1073/pnas.092080099; Matsen FA, 2004, P NATL ACAD SCI USA, V101, P18053, DOI 10.1073/pnas.0406608102; Maynard Smith J., 1982, pi; Meloni S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.067101; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108106; Ohtsuki H, 2007, J THEOR BIOL, V246, P681, DOI 10.1016/j.jtbi.2007.01.024; Pacheco JM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000596; Pena J, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016110; Perc M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/2/022; Perc M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011904; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Platkowski T, 2009, APPL MATH LETT, V22, P1161, DOI 10.1016/j.aml.2008.09.005; Platkowski T, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036103; Poncela J, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/184; Poncela J, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/38003; Poncela J, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.057101; Poncela J, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/8/083031; Poncela J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002449; Posch M, 1999, J THEOR BIOL, V198, P183, DOI 10.1006/jtbi.1999.0909; Roca CP, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.158701; Roca CP, 2011, P NATL ACAD SCI USA, V108, P11370, DOI 10.1073/pnas.1101044108; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Rong ZH, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.026101; Santos FC, 2006, P ROY SOC B-BIOL SCI, V273, P51, DOI 10.1098/rspb.2005.3272; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Sigmund K, 2010, CALCULUS SELSHNESS; Sigmund K., 1993, GAMES LIFE EXPLORATI; Szabo G, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.047107; Szabo G, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/18007; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szabo G, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016106; Szolnoki A, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/30004; Szolnoki A, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/50007; Szolnoki A, 2008, PHYSICA A, V387, P2075, DOI 10.1016/j.physa.2007.11.021; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056112; Szolnoki A, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/043036; Tomassini M, 2007, INT J MOD PHYS C, V18, P1173, DOI 10.1142/S0129183107011212; Vainstein MH, 2007, J THEOR BIOL, V244, P722, DOI 10.1016/j.jtbi.2006.09.012; Van Segbroeck S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.058105; Vukov J, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.036133; Vukov J, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.067103; Wang QY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015851, 10.1371/journal.pone.0021006]; Wang Z, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021115; Wardil L, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/38001; Wu Z.-X., 2009, PHYS REV E, V80; Wu ZX, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.041114; Wu ZX, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021107; Wu ZX, 2007, PHYSICA A, V379, P672, DOI 10.1016/j.physa.2007.02.085; Wu ZX, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026108; Yang HX, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.065101; Zhang HF, 2010, PHYSICA A, V389, P4734, DOI 10.1016/j.physa.2010.06.023	85	51	52	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30689	10.1371/journal.pone.0030689	http://dx.doi.org/10.1371/journal.pone.0030689			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363470	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000302853600054
J	Ovadje, P; Hamm, C; Pandey, S				Ovadje, Pamela; Hamm, Caroline; Pandey, Siyaram			Efficient Induction of Extrinsic Cell Death by Dandelion Root Extract in Human Chronic Myelomonocytic Leukemia (CMML) Cells	PLOS ONE			English	Article							HUMAN T-CELLS; APOPTOSIS PATHWAYS; OXIDATIVE STRESS; IN-VITRO; AUTOPHAGY; CANCER; ACTIVATION; CASPASE-8; DISEASE; VIVO	Background: Chronic Myelomonocytic Leukemia (CMML) is a heterogeneous disease that is not only hard to diagnose and classify, but is also highly resistant to treatment. Available forms of therapy for this disease have not shown significant effects and patients rapidly develop resistance early on in therapy. These factors lead to the very poor prognosis observed with CMML patients, with median survival duration between 12 and 24 months after diagnosis. This study is therefore centered around evaluating the selective efficacy of a natural extract from dandelion roots, in inducing programmed cell death in aggressive and resistant CMML cell lines. Methodology/Principal Findings: To confirm the induction of programmed cell death in three human CMML cell lines, nuclear condensation and externalization of the phosphatidylserine, two main characteristics of apoptosis, were detected using Hoechst staining and annexin-V binding assay. The induction of another mode of cell death, autophagy, was determined using a monodansylcadaverine (MDC) stain, to detect the formation of autophagy vacuoles. The results from this study indicate that Dandelion Root Extract (DRE) is able to efficiently and selectively induce apoptosis and autophagy in these cell lines in a dose and time dependent manner, with no significant toxicity on non-cancerous peripheral blood mononuclear cells. More importantly, we observed early activation of initiator caspase-8, which led to mitochondrial destabilization and the induction of autophagy, suggesting that DRE acts through the extrinsic pathway of apoptosis. The inability of DRE to induce apoptosis in dominant-negative FADD cells, confirms the mechanism of action of DRE in in vitro models of CMML. Conclusion: The results from this study indicate that natural products, in particular Dandelion Root Extract, have great potential, as non-toxic and effective alternatives to conventional modes of chemotherapy available today.	[Ovadje, Pamela; Pandey, Siyaram] Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada; [Hamm, Caroline] Windsor Reg Canc Ctr, Windsor, ON, Canada	University of Windsor	Ovadje, P (corresponding author), Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada.	spandey@uwindsor.ca	Pandey, Siyaram/AAI-5491-2020; Hamm, Christian W./I-3155-2017	Hamm, Christian W./0000-0001-6763-4161	Seeds4Hope [810257]; Knights of columbus [850285]; Kevin Couvillion Memorial grant [810340]; Seeds4hope Windsor; Essex county Cancer Centre Foundation	Seeds4Hope; Knights of columbus; Kevin Couvillion Memorial grant; Seeds4hope Windsor; Essex county Cancer Centre Foundation	This work was supported by Seeds4Hope: Grant #: 810257, Knights of columbus: Grant #: 850285, and a Kevin Couvillion Memorial grant: 810340. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Seeds4hope Windsor and Essex county Cancer Centre Foundation for the seeds4hope grant, the Knights of Columbus, Windsor Council 9671 and the Couvillion family, for their generous donations. We dedicate this work to the memory of Kevin Couvillion.	Adam-Vizi V, 2006, TRENDS PHARMACOL SCI, V27, P639, DOI 10.1016/j.tips.2006.10.005; Attia RR, 2008, J BIOL CHEM, V283, P30788, DOI 10.1074/jbc.M804159200; Chatterjee SJ, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/129045; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Dalby KN, 2010, AUTOPHAGY, V6, P322, DOI 10.4161/auto.6.3.11625; DWYER JM, 1981, CLIN EXP IMMUNOL, V46, P237; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fadeel B, 2005, J INTERN MED, V258, P479, DOI 10.1111/j.1365-2796.2005.01570.x; Foucar K, 2009, AM J CLIN PATHOL, V132, P281, DOI 10.1309/AJCPJ71PTVIKGEVT; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Fuss IJ, 2009, CURR PROTOC IMMUNOL, V85, DOI DOI 10.1002/0471142735.IM0701S85; Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178; Gordaliza M, 2007, CLIN TRANSL ONCOL, V9, P767, DOI 10.1007/s12094-007-0138-9; Gottlieb RA, 2010, AM J PHYSIOL-CELL PH, V299, pC203, DOI 10.1152/ajpcell.00097.2010; Griffin C, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-6; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Liu ZH, 2007, DEV CELL, V12, P484, DOI 10.1016/j.devcel.2007.03.016; Naderi J, 2003, APOPTOSIS, V8, P91, DOI 10.1023/A:1021657220843; Negoescu A, 1996, J HISTOCHEM CYTOCHEM, V44, P959, DOI 10.1177/44.9.8773561; Ngamwongsatit P, 2008, J MICROBIOL METH, V73, P211, DOI 10.1016/j.mimet.2008.03.002; Ovadje P, 2011, J ETHNOPHARMACOL, V133, P86, DOI 10.1016/j.jep.2010.09.005; Qadir MA, 2008, BREAST CANCER RES TR, V112, P389, DOI 10.1007/s10549-007-9873-4; Ramshaw HS, 2002, EXP HEMATOL, V30, P1124, DOI 10.1016/S0301-472X(02)00903-7; Rosenfeldt MT, 2011, CARCINOGENESIS, V32, P955, DOI 10.1093/carcin/bgr031; Schutz K, 2006, J ETHNOPHARMACOL, V107, P313, DOI 10.1016/j.jep.2006.07.021; Shakibaei M, 2010, ANTIOXID REDOX SIGN, V13, P821, DOI 10.1089/ars.2009.3036; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Somayajulu-Nitu M, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-88; Steensma DP, 2006, MAYO CLIN PROC, V81, P104, DOI 10.4065/81.1.104; Thorburn A, 2008, APOPTOSIS, V13, P1, DOI 10.1007/s10495-007-0154-9; Yarnell E., 2009, INTEGR MED, V8, P35; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103; Zhivotovsky B, 2010, EXP CELL RES, V316, P1374, DOI 10.1016/j.yexcr.2010.02.037; Ziegler U, 2004, NEWS PHYSIOL SCI, V19, P124, DOI 10.1152/nips.01519.2004	34	27	30	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30604	10.1371/journal.pone.0030604	http://dx.doi.org/10.1371/journal.pone.0030604			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363452	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600039
J	Semple, JW; Kim, M; Hou, J; McVey, M; Lee, YJ; Tabuchi, A; Kuebler, WM; Chai, ZW; Lazarus, AH				Semple, John W.; Kim, Michael; Hou, Jing; McVey, Mark; Lee, Young Jin; Tabuchi, Arata; Kuebler, Wolfgang M.; Chai, Zhong-Wei; Lazarus, Alan H.			Intravenous Immunoglobulin Prevents Murine Antibody-Mediated Acute Lung Injury at the Level of Neutrophil Reactive Oxygen Species (ROS) Production	PLOS ONE			English	Article							IDIOPATHIC THROMBOCYTOPENIC PURPURA; RESPIRATORY-DISTRESS-SYNDROME; CLASS-II ANTIBODIES; RED-BLOOD-CELLS; GAMMA-GLOBULIN; TRANSFUSION; PLASMA; AUTOANTIBODIES; PATHOGENESIS; ACTIVATION	Transfusion-related acute lung injury (TRALI) is a leading cause of transfusion-associated mortality that can occur with any type of transfusion and is thought to be primarily due to donor antibodies activating pulmonary neutrophils in recipients. Recently, a large prospective case controlled clinical study of cardiac surgery patients demonstrated that despite implementation of male donors, a high incidence of TRALI still occurred and suggested a need for additional interventions in susceptible patient populations. To examine if intravenous immunoglobulin (IVIg) may be effective, a murine model of antibody-mediated acute lung injury that approximates human TRALI was examined. When BALB/c mice were injected with the anti-major histocompatibility complex class I antibody 34-1-2s, mild shock (reduced rectal temperature) and respiratory distress (dyspnea) were observed and pre-treatment of the mice with 2 g/kg IVIg completely prevented these symptoms. To determine IVIg's usefulness to affect severe lung damage, SCID mice, previously shown to be hypersensitive to 34-1-2s were used. SCID mice treated with 34-1-2s underwent severe shock, lung damage (increased wet/dry ratios) and 40% mortality within 2 hours. Treatment with 2 g/kg IVIg 18 hours before 34-1-2s administration completely protected the mice from all adverse events. Treatment with IVIg after symptoms began also reduced lung damage and mortality. While the prophylactic IVIg administration did not affect 34-1-2s-induced pulmonary neutrophil accumulation, bone marrow-derived neutrophils from the IVIg-treated mice displayed no spontaneous ROS production nor could they be stimulated in vitro with fMLP or 34-1-2s. These results suggest that IVIg prevents murine antibody-mediated acute lung injury at the level of neutrophil ROS production and thus, alleviating tissue damage.	[Semple, John W.; Kim, Michael; Hou, Jing; McVey, Mark; Lee, Young Jin; Chai, Zhong-Wei; Lazarus, Alan H.] Univ Toronto, Toronto Platelet Immunobiol Grp, Toronto, ON, Canada; [Semple, John W.; Kim, Michael; Hou, Jing; McVey, Mark; Lee, Young Jin; Tabuchi, Arata; Kuebler, Wolfgang M.; Chai, Zhong-Wei; Lazarus, Alan H.] Univ Toronto, St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Semple, John W.; Lazarus, Alan H.] Univ Toronto, Canadian Blood Serv, Toronto, ON, Canada; [Semple, John W.] Univ Toronto, Dept Pharmacol, Toronto, ON, Canada; [Semple, John W.; Lazarus, Alan H.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Semple, John W.; Lazarus, Alan H.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [McVey, Mark] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada; [Kuebler, Wolfgang M.] Univ Toronto, Dept Surg, Toronto, ON, Canada	University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Canadian Blood Services; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Semple, JW (corresponding author), Univ Toronto, Toronto Platelet Immunobiol Grp, Toronto, ON, Canada.	semplej@smh.ca; lazarusa@smh.ca	Semple, John W./Q-2513-2019	Semple, John W./0000-0002-1510-0077; McVey, Mark/0000-0002-0918-7030; Lazarus, Alan/0000-0002-5051-6916; Kuebler, Wolfgang/0000-0003-4100-2961	Canadian Institutes for Health Research; Canadian Blood Services	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Blood Services	Canadian Institutes for Health Research; Canadian Blood Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asimakopoulos G, 1999, ANN THORAC SURG, V68, P1107, DOI 10.1016/S0003-4975(99)00781-X; Ballow M, 2003, J AM PHARM ASSOC, V42, P449; Berger-Achituv S, 2008, AM J HEMATOL, V83, P676, DOI 10.1002/ajh.21185; BRUTON OC, 1952, PEDIATRICS, V9, P722; BUSSEL J, 1983, BLOOD, V62, P398; Bux J, 2007, BRIT J HAEMATOL, V136, P788, DOI 10.1111/j.1365-2141.2007.06492.x; Chang JS, 2008, BLOOD, V111, P915, DOI 10.1182/blood-2007-04-084061; Chapman CE, 2009, TRANSFUSION, V49, P440, DOI 10.1111/j.1537-2995.2008.01948.x; Cheema G S, 1999, Curr Opin Pulm Med, V5, P305, DOI 10.1097/00063198-199909000-00007; Cho FN, 2007, J REPROD MED, V52, P661; Cooper N, 2004, BRIT J HAEMATOL, V124, P511, DOI 10.1111/j.1365-2141.2004.04804.x; FEHR J, 1982, NEW ENGL J MED, V306, P1254, DOI 10.1056/NEJM198205273062102; Food and Drug Administration, FAT REP FDA FOLL BLO; Fung YL, 2010, BLOOD, V116, P3073, DOI 10.1182/blood-2010-05-284570; Fung YL, 2009, TRANSFUS MED REV, V23, P266, DOI 10.1016/j.tmrv.2009.06.001; Hagiwara S, 2008, INTENS CARE MED, V34, P1812, DOI 10.1007/s00134-008-1161-1; IMBACH P, 1981, LANCET, V1, P1228; JENSEN S, 1990, VOX SANG, V59, P62, DOI 10.1111/j.1423-0410.1990.tb02119.x; Kelher MR, 2009, BLOOD, V113, P2079, DOI 10.1182/blood-2008-09-177857; Koch C, 2009, ANN THORAC SURG, V88, P1410, DOI 10.1016/j.athoracsur.2009.07.020; Kopko PM, 2002, JAMA-J AM MED ASSOC, V287, P1968, DOI 10.1001/jama.287.15.1968; Kopko PM, 2001, TRANSFUSION, V41, P1244, DOI 10.1046/j.1537-2995.2001.41101244.x; Looney MR, 2006, J CLIN INVEST, V116, P1615, DOI 10.1172/JCI27238; Macmillan HF, 2010, AUTOIMMUNITY, V43, P619, DOI 10.3109/08916931003599062; Maddur MS, 2011, AUTOIMMUN REV, V10, P809, DOI 10.1016/j.autrev.2011.02.007; Maddur MS, 2010, J CLIN IMMUNOL, V30, pS4, DOI 10.1007/s10875-010-9394-5; Molica S, 1996, HAEMATOLOGICA, V81, P121; MUELLERECKHARDT C, 1985, SCAND J HAEMATOL, V34, P394; Navarrete AM, 2011, VACCINE, V29, P2649, DOI 10.1016/j.vaccine.2011.01.095; Netzer G, 2010, CRIT CARE MED, V38, P981, DOI 10.1097/CCM.0b013e3181cfb2eb; Nicolle AL, 2004, TRANSFUSION MED, V14, P225, DOI 10.1111/j.0958-7578.2004.00504.x; OZATO K, 1980, J IMMUNOL, V125, P2473; Palmer AL, 2005, SOUTH MED J, V98, P1031, DOI 10.1097/01.smj.0000182176.71475.a9; POPOVSKY MA, 1983, AM REV RESPIR DIS, V128, P185, DOI 10.1164/arrd.1983.128.1.185; POPOVSKY MA, 1985, TRANSFUSION, V25, P573, DOI 10.1046/j.1537-2995.1985.25686071434.x; Rankin JS, 2005, J HEART VALVE DIS, V14, P783; Reil A, 2008, VOX SANG, V95, P313, DOI 10.1111/j.1423-0410.2008.01092.x; Rizk A, 2001, TRANSFUSION, V41, P264, DOI 10.1046/j.1537-2995.2001.41020264.x; ROSSI F, 1989, J IMMUNOL, V143, P4104; Sachs UJH, 2006, BLOOD, V107, P1217, DOI 10.1182/blood-2005-04-1744; Samuelsson A, 2001, SCIENCE, V291, P484, DOI 10.1126/science.291.5503.484; SAULSBURY FT, 1980, J PEDIATR-US, V97, P61, DOI 10.1016/S0022-3476(80)80131-4; SEEGER W, 1990, BLOOD, V76, P1438; Semple JW, 2002, AM J HEMATOL, V69, P225, DOI 10.1002/ajh.10065; Shaz BH, 2011, BLOOD, V117, P1463, DOI 10.1182/blood-2010-04-278135; Silliman CC, 1998, J CLIN INVEST, V101, P1458, DOI 10.1172/JCI1841; Silliman CC, 2003, TRANSFUSION, V43, P633, DOI 10.1046/j.1537-2995.2003.00385.x; Siragam V, 2006, NAT MED, V12, P688, DOI 10.1038/nm1416; Strait RT, 2011, J EXP MED, V208, P2525, DOI 10.1084/jem.20110159; SULTAN Y, 1984, LANCET, V2, P765; Takeshita S, 2005, APMIS, V113, P269, DOI 10.1111/j.1600-0463.2005.apm_05.x; Tokat O, 2001, J INT MED RES, V29, P252, DOI 10.1177/147323000102900313; Vlaar APJ, 2011, BLOOD, V117, P4218, DOI 10.1182/blood-2010-10-313973; Vlaar APJ, 2010, CRIT CARE MED, V38, P771, DOI 10.1097/CCM.0b013e3181cc4d4b; Voulgari PV, 2010, J RHEUMATOL, V37, P190, DOI 10.3899/jrheum.090725; Win N, 2001, TRANSFUSION, V41, P1421, DOI 10.1046/j.1537-2995.2001.41111421.x; Wray C, 2009, AM J PHYSIOL-LUNG C, V297, pL219, DOI 10.1152/ajplung.00043.2009	57	46	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31357	10.1371/journal.pone.0031357	http://dx.doi.org/10.1371/journal.pone.0031357			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363629	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600142
J	van Gennip, RGP; van de Water, SGP; Potgieter, CA; Wright, IM; Veldman, D; van Rijn, PA				van Gennip, Rene G. P.; van de Water, Sandra G. P.; Potgieter, Christiaan A.; Wright, Isabel M.; Veldman, Daniel; van Rijn, Piet A.			Rescue of Recent Virulent and Avirulent Field Strains of Bluetongue Virus by Reverse Genetics	PLOS ONE			English	Article							PROTEIN; TRAFFICKING; SEROTYPE-8; EPIDEMIC; VECTOR	Since 1998, Bluetongue virus (BTV)-serotypes 1, 2, 4, 9, and 16 have invaded European countries around the Mediterranean Basin. In 2006, a huge BT-outbreak started after incursion of BTV-serotype 8 (BTV8) in North-Western Europe. More recently, BTV6 and BTV11 were reported in North-Western Europe in 2008. These latter strains are closely related to live-attenuated vaccine, whereas BTV8 is virulent and can induce severe disease in ruminants, including cattle. In addition, Toggenburg orbivirus (TOV) was detected in 2008 in Swiss goats, which was recognized as a new serotype of BTV (BTV25). The (re) emergency of known and unknown BTV-serotypes needs a rapid response to supply effective vaccines, and research to study this phenomenon. Recently, orbivirus research achieved an important breakthrough by the establishment of reverse genetics for BTV1. Here, reverse genetics for two recent BTV strains representing virulent BTV8 and avirulent BTV6 was developed. For this purpose, extensive sequencing of full-genomes was performed, resulting in the consensus sequences of BTV8/net07 and BTV6/net08. The recovery of 'synthetic BTV', respectively rgBTV8 and rgBTV6, completely from T7-derived RNA transcripts was confirmed by silent mutations by which these 'synthetic BTVs' could be genetically distinguished from wild type BTV, respectively wtBTV6 and wtBTV8. The in vitro and in vivo properties of rgBTV6 or rgBTV8 were comparable to the properties of their parent strains. The asymptomatic or avirulent properties of rgBTV6 and the virulence of rgBTV8 were confirmed by experimental infection of sheep. Reverse genetics of the vaccine-related BTV6 provides a perfect start to develop new generations of BT-vaccines. Reverse genetics of the virulent BTV8 will accelerate research on the special features of BTV8, like transmission by species of Culicoides in a moderate climate, transplacental transmission, and pathogenesis in cattle.	[van Gennip, Rene G. P.; van de Water, Sandra G. P.; Veldman, Daniel; van Rijn, Piet A.] Cent Vet Inst Wageningen UR CVI, Dept Virol, Lelystad, Netherlands; [Potgieter, Christiaan A.; Wright, Isabel M.] Onderstepoort Vet Inst, Onderstepoort, South Africa	Wageningen University & Research; Agricultural Research Council of South Africa; Onderstepoort Veterinary Institute, Agricultural Research Council	van Gennip, RGP (corresponding author), Cent Vet Inst Wageningen UR CVI, Dept Virol, Lelystad, Netherlands.	rene.vangennip@wur.nl	van Rijn, Piet A/C-1163-2017; van Rijn, Piet A./AAG-7398-2019	van Rijn, Piet A/0000-0002-2594-1232; van Rijn, Piet A./0000-0002-2594-1232; van Gennip, Rene/0000-0002-5450-3493	Dutch Ministry of Economics, Agriculture and Innovation	Dutch Ministry of Economics, Agriculture and Innovation	This project was funded by the Dutch Ministry of Economics, Agriculture and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attoui H, 2009, BIOL ANIM INFECT, P23, DOI 10.1016/B978-012369368-6.50007-1; Backx A, 2009, VET MICROBIOL, V138, P235, DOI 10.1016/j.vetmic.2009.04.003; Boyce M, 2008, J VIROL, V82, P8339, DOI 10.1128/JVI.00808-08; Celma CCP, 2011, J VIROL, V85, P4783, DOI 10.1128/JVI.02352-10; Celma CCP, 2009, J VIROL, V83, P6806, DOI 10.1128/JVI.00263-09; De Clercq K, 2009, TRANSBOUND EMERG DIS, V56, P355, DOI 10.1111/j.1865-1682.2009.01092.x; Dijkstra E, 2008, VET REC, V162, P422, DOI 10.1136/vr.162.13.422-a; DURBIN R, 1991, VIROLOGY, V183, P306, DOI 10.1016/0042-6822(91)90143-Y; EFSA, 2011, EFSA J, V9, p[5175, 51]; Elbers ARW, 2008, PREV VET MED, V87, P21, DOI 10.1016/j.prevetmed.2008.06.004; Eschbaumer M, 2010, VET MICROBIOL, V143, P189, DOI 10.1016/j.vetmic.2009.11.040; Hofmann MA, 2008, EMERG INFECT DIS, V14, P1855, DOI 10.3201/eid1412.080818; HUISMANS H, 1987, VIROLOGY, V157, P172, DOI 10.1016/0042-6822(87)90326-6; ISID Promed mail, 2006, BLUET EUR 1 BLUET OV; ISID Promed mail, 2007, BLUET EUR 19 BTV 8 N; ISID Promed mail, 2008, BLUET EUROPE 69 NETH; Kar AK, 2003, J VIROL, V77, P11347, DOI 10.1128/JVI.77.21.11347-11356.2003; Maan S, 2008, VIROLOGY, V377, P308, DOI 10.1016/j.virol.2008.04.028; Maan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010323; Matsuo E, 2009, J VIROL, V83, P8842, DOI 10.1128/JVI.00465-09; Mehlhorn H, 2007, PARASITOL RES, V101, P219, DOI 10.1007/s00436-007-0519-6; Meiswinkel R, 2007, VET REC, V161, P564, DOI 10.1136/vr.161.16.564; Mertens PPC, VIRUS TAXONOMY 8 REP, P466; MERTENS PPC, 2007, CONSERVED RNA TERMIN; Mueller S, 2006, J VIROL, V80, P9687, DOI 10.1128/JVI.00738-06; OIE, 2022, NUMB NEW H5 OUTBR; Potgieter AC, 2009, J GEN VIROL, V90, P1423, DOI 10.1099/vir.0.009381-0; Roy P, 2005, ADV VIRUS RES, V64, P69, DOI 10.1016/S0065-3527(05)64004-3; Roy P, 2008, CELL BIOCHEM BIOPHYS, V50, P143, DOI 10.1007/s12013-008-9009-4; SATO M, 1977, ARCH VIROL, V54, P333, DOI 10.1007/BF01314778; van Gennip RGP, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-261; van Rijn PA, 2009, ANIMAL TRIALS BLUE T; WECHSLER SJ, 1988, J CLIN MICROBIOL, V26, P2324, DOI 10.1128/JCM.26.11.2324-2327.1988	33	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30540	10.1371/journal.pone.0030540	http://dx.doi.org/10.1371/journal.pone.0030540			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363444	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600034
J	van Loggerenberg, F; Dieter, AA; Sobieszczyk, ME; Werner, L; Grobler, A; Mlisana, K				van Loggerenberg, Francois; Dieter, Alexis A.; Sobieszczyk, Magdalena E.; Werner, Lise; Grobler, Anneke; Mlisana, Koleka		CAPRISA 002 Acute Infection Study Team	HIV Prevention in High-Risk Women in South Africa: Condom Use and the Need for Change	PLOS ONE			English	Article							SEXUAL-BEHAVIOR; REPRODUCTIVE HEALTH; YOUNG-ADULTS; INFECTION; HIV/AIDS; PREVALENCE; CONTEXT; NEGOTIATION; PERCEPTION; EPIDEMIC	Introduction: Young women are at disproportionate risk of HIV infection in South Africa. Understanding risk behaviors and factors associated with ability to negotiate safe sex and condom use is likely to be key in curbing the spread of HIV. Traditionally prevention efforts have focused on creating behavioral changes by increasing knowledge about HIV/AIDS. Methods: This was a cross-sectional analysis from a prospective observational cohort study of 245 women at a high-risk of HIV infection in KwaZulu-Natal, South Africa. Results: Participants demonstrated a high level of HIV/AIDS knowledge. Overall, 60.3% of participants reported condom use. Reported condom use at last sexual encounter varied slightly by partner type (57.0% with steady versus 64.4% with casual partners), and self-perceived ability to choose to use a condom was significantly lower with steady partners compared to casual partners (p<0.01). In multivariate analysis, women who had high school education were more likely to use condoms at their last sex encounter compared to those with only primary school education (RR of 1.36 (95% Confidence Interval (CI) 1.06-1.75) and 1.46 (95% CI 1.13-1.88) for grades 8-10 and 11-12, respectively). Those who used condoms as a contraceptive method were twice as likely to use condoms compared to women who did not report using them as a contraceptive method. Greater perceived ability to choose to use condoms was associated with higher self-reported condom use at last encounter, irrespective of partner type (RR = 2.65 (95% CI 2.15-32.5). Discussion: Self-perceived ability to use condoms, level of formal education and condom use as a contraceptive were all significantly associated with self-reported condom use at last sexual encounter. These findings suggest that that gender inequality and access to formal education, as opposed to lack of HIV/AIDS knowledge, prevent safer sexual practices in South Africa.	[van Loggerenberg, Francois; Werner, Lise; Grobler, Anneke; Mlisana, Koleka] Univ KwaZulu Natal, Ctr AIDS Programme Res S African CAPRISA, Durban, South Africa; [Sobieszczyk, Magdalena E.] Columbia Univ Coll Phys & Surg, Columbia Univ Med Ctr, Dept Med, Div Infect Dis, New York, NY 10032 USA	University of Kwazulu Natal; Columbia University	van Loggerenberg, F (corresponding author), Univ KwaZulu Natal, Ctr AIDS Programme Res S African CAPRISA, Durban, South Africa.	loggerenbergf@ukzn.ac.za	Dieter, Alexis/AAE-2127-2019; Mlisana, Koleka/N-6204-2013	Dieter, Alexis/0000-0003-0850-3289; van Loggerenberg, Francois/0000-0001-5317-7983; Mlisana, Koleka/0000-0002-8436-3268; Grobler, Anneke/0000-0002-7809-7688	Comprehensive International Program of Research on AIDS (CIPRA); National Institute of Allergy and Infectious Disease (NIAID); National Institutes of Health (NIH); US Department of Health and Human Services (DHHS) [1 U19 AI51794]; Columbia University-Southern African Fogarty; Fogarty International Center, National Institutes of Health [D43TW00231]; Doris Duke Charitable Foundation; FOGARTY INTERNATIONAL CENTER [D43TW000231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051794] Funding Source: NIH RePORTER	Comprehensive International Program of Research on AIDS (CIPRA); National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Health and Human Services (DHHS); Columbia University-Southern African Fogarty; Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	CAPRISA received support for the CAPRISA 002 Acute Infection Study from the Comprehensive International Program of Research on AIDS (CIPRA) funded by the National Institute of Allergy and Infectious Disease (NIAID), National Institutes of Health (NIH) and the US Department of Health and Human Services (DHHS) (grant #1 U19 AI51794). The funders supported the initial development of the protocol but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Francois van Loggerenberg was supported by a pre-doctoral fellowship from the Columbia University-Southern African Fogarty AIDS International Training and Research Programme (AITRP) funded by the Fogarty International Center, National Institutes of Health (grant #D43TW00231). Alexis A. Dieter received support from the Doris Duke Charitable Foundation Clinical Research Fellowship Program for Medical Students at Columbia University College of Physicians and Surgeons.	Abdool Q, 2001, J Am Med Womens Assoc (1972), V56, P193; Ackermann Leane, 2002, Health Care Women Int, V23, P163, DOI 10.1080/073993302753429031; Booysen FL, 2002, J HEALTH POPUL NUTR, V20, P285; Boulle A, 2008, AIDS CARE, V20, P771, DOI 10.1080/09540120701660387; Cleland J, 2006, LANCET, V368, P1788, DOI 10.1016/S0140-6736(06)69738-9; Crepaz N, 2002, AIDS, V16, P135, DOI 10.1097/00002030-200201250-00002; Gilbert L, 2002, SOC SCI MED, V54, P1093, DOI 10.1016/S0277-9536(01)00083-1; Hargreaves JR, 2008, J EPIDEMIOL COMMUN H, V62, P113, DOI 10.1136/jech.2006.053827; Hargreaves JR, 2007, AIDS, V21, pS39, DOI 10.1097/01.aids.0000300534.97601.d6; Hargreaves JR, 2009, AIDS CARE, V21, P1058, DOI 10.1080/09540120802657480; Harrison A, 2006, J URBAN HEALTH, V83, P709, DOI 10.1007/s11524-006-9077-y; Hartung TK, 2002, INT J STD AIDS, V13, P829, DOI 10.1258/095646202321020107; Hendriksen ES, 2007, AM J PUBLIC HEALTH, V97, P1241, DOI 10.2105/AJPH.2006.086009; Janssen RS, 2001, AM J PUBLIC HEALTH, V91, P1019, DOI 10.2105/AJPH.91.7.1019; KARIM QA, 1995, AM J PUBLIC HEALTH, V85, P1521, DOI 10.2105/AJPH.85.11.1521; Lurie M, 2008, JAIDS-J ACQ IMM DEF, V47, P484, DOI 10.1097/QAI.0b013e3181648de8; MacPhail C, 2009, CULT HEALTH SEX, V11, P485, DOI 10.1080/13691050902803537; Maharaj P, 2008, AIDS CARE, V20, P838, DOI 10.1080/09540120701742284; Maharaj P, 2005, INT FAM PLAN PERSPEC, V31, P24, DOI 10.1363/3102405; Mantell JE, 2009, CULT HEALTH SEX, V11, P139, DOI 10.1080/13691050802521155; Montgomery CM, 2008, AIDS CARE, V20, P733, DOI 10.1080/09540120701693974; Ndinda C, 2007, AIDS CARE, V19, P844, DOI 10.1080/09540120701203923; Pettifor AE, 2005, AIDS, V19, P1525, DOI 10.1097/01.aids.0000183129.16830.06; Ragnarsson A, 2009, AIDS CARE, V21, P1253, DOI 10.1080/09540120902814361; Rehle TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011094; Saleh-Onoya D, 2009, AIDS CARE, V21, P817, DOI 10.1080/09540120802537823; Sawyer KM, 2006, WOMEN HEALTH, V43, P73, DOI 10.1300/J013v43n02_05; Sayles JN, 2006, JAIDS-J ACQ IMM DEF, V43, P226, DOI 10.1097/01.qai.0000230527.17459.5c; Shisana O, 2009, S AFRICAN NATL HIV P; Shisana O, 2005, S AFRICA NATL HIV PR; Simbayi LC, 2004, AIDS CARE, V16, P605, DOI 10.1080/09540120410001716405; van Loggerenberg F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001954; Varga C A, 1997, Afr J Reprod Health, V1, P74, DOI 10.2307/3583277; Varga CA, 2001, AIDS CARE, V13, P351, DOI 10.1080/09540120120044008; Wechsberg WM, 2010, J PREV INTERV COMMUN, V38, P132, DOI 10.1080/10852351003640799	35	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30669	10.1371/journal.pone.0030669	http://dx.doi.org/10.1371/journal.pone.0030669			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926TC	22363467	gold, Green Published			2022-12-27	WOS:000302853600051
J	Yasugi, M; Nakamura, S; Daidoji, T; Kawashita, N; Ramadhany, R; Yang, CS; Yasunaga, T; Iida, T; Horii, T; Ikuta, K; Takahashi, K; Nakaya, T				Yasugi, Mayo; Nakamura, Shota; Daidoji, Tomo; Kawashita, Norihito; Ramadhany, Ririn; Yang, Cheng-Song; Yasunaga, Teruo; Iida, Tetsuya; Horii, Toshihiro; Ikuta, Kazuyoshi; Takahashi, Kazuo; Nakaya, Takaaki			Frequency of D222G and Q223R Hemagglutinin Mutants of Pandemic (H1N1) 2009 Influenza Virus in Japan between 2009 and 2010	PLOS ONE			English	Article							RECEPTOR-BINDING PROPERTIES; BACTERIAL-INFECTIONS; SEVERE DISEASE; SUBSTITUTION; CELLS	Background: In April 2009, a novel swine-derived influenza A virus (H1N1pdm) emerged and rapidly spread around the world, including Japan. It has been suggested that the virus can bind to both 2,3- and 2,6-linked sialic acid receptors in infected mammals, in contrast to contemporary seasonal H1N1 viruses, which have a predilection for 2,6-linked sialic acid. Methods/Results: To elucidate the existence and transmissibility of alpha 2,3 sialic acid-specific viruses in H1N1pdm, amino acid substitutions within viral hemagglutinin molecules were investigated, especially D187E, D222G, and Q223R, which are related to a shift from human to avian receptor specificity. Samples from individuals infected during the first and second waves of the outbreak in Japan were examined using a high-throughput sequencing approach. In May 2009, three specimens from mild cases showed D222G and/or Q223R substitutions in a minor subpopulation of viruses infecting these individuals. However, the substitutions almost disappeared in the samples from five mild cases in December 2010. The D187E substitution was not widespread in specimens, even in May 2009. Conclusions: These results suggest that alpha 2,3 sialic acid-specific viruses, including G222 and R223, existed in humans as a minor population in the early phase of the pandemic, and that D222 and Q223 became more dominant through human-to-human transmission during the first and second waves of the epidemic. These results are consistent with the low substitution rates identified in seasonal H1N1 viruses in 2008.	[Yasugi, Mayo; Daidoji, Tomo; Ramadhany, Ririn; Yang, Cheng-Song; Iida, Tetsuya; Horii, Toshihiro; Nakaya, Takaaki] Osaka Univ, RIMD, Int Res Ctr Infect Dis, Suita, Osaka, Japan; [Yasugi, Mayo; Ramadhany, Ririn; Yang, Cheng-Song; Ikuta, Kazuyoshi] Osaka Univ, Dept Virol, RIMD, Suita, Osaka, Japan; [Nakamura, Shota; Kawashita, Norihito; Yasunaga, Teruo] Osaka Univ, RIMD, Dept Genome Informat, Suita, Osaka, Japan; [Nakamura, Shota; Iida, Tetsuya; Horii, Toshihiro; Nakaya, Takaaki] Osaka Univ, RIMD, Dept Infect Metagen, Suita, Osaka, Japan; [Kawashita, Norihito] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Environm Pharmacometr, Suita, Osaka, Japan; [Horii, Toshihiro] Osaka Univ, RIMD, Dept Mol Protozool, Suita, Osaka, Japan; [Takahashi, Kazuo] Osaka Prefectural Inst Publ Hlth, Higashinari Ku, Osaka 537, Japan; [Daidoji, Tomo; Nakaya, Takaaki] Kyoto Prefectural Univ Med, Dept Infect Dis, Kamigyo Ku, Kyoto, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Osaka University; Osaka University; Osaka Prefectural Institute of Public Health; Kyoto Prefectural University of Medicine	Yasugi, M (corresponding author), Osaka Univ, RIMD, Int Res Ctr Infect Dis, Suita, Osaka, Japan.	tnakaya@biken.osaka-u.ac.jp	Nakamura, Shota/E-3033-2010	Nakamura, Shota/0000-0003-2058-5942; Horii, Toshihiro/0000-0002-3000-2045; Ramadhany, Ririn/0000-0003-1879-2440	Ministry of Education, Science, Sports, Culture, and Technology (MEXT); Japan Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research [23406017] Funding Source: KAKEN	Ministry of Education, Science, Sports, Culture, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, Culture, and Technology (MEXT) to TN; and a Grant-in-Aid for Young Scientists from the Japan Society for the Promotion of Science (JSPS) to TD and MY. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan PKS, 2011, J CLIN VIROL, V50, P320, DOI 10.1016/j.jcv.2011.01.013; Chen HL, 2010, J INFECT DIS, V201, P1517, DOI 10.1086/652661; Chen ZY, 2010, J VIROL, V84, P44, DOI 10.1128/JVI.02106-09; Chutinimitkul S, 2010, J VIROL, V84, P11802, DOI 10.1128/JVI.01136-10; Daidoji T, 2008, J VIROL, V82, P11294, DOI 10.1128/JVI.01192-08; Ikonen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013329; Kuroda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010256; Ledesma J, 2011, J CLIN VIROL, V51, P75, DOI 10.1016/j.jcv.2011.01.020; Liu Y, 2010, J VIROL, V84, P12069, DOI 10.1128/JVI.01639-10; Mak GC, 2010, EUROSURVEILLANCE, V15, P15; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Melidou A, 2010, VIRUS RES, V151, P192, DOI 10.1016/j.virusres.2010.05.005; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; Mochalova L, 2003, VIROLOGY, V313, P473, DOI 10.1016/S0042-6822(03)00377-5; Nakamura S, 2008, EMERG INFECT DIS, V14, P1784, DOI 10.3201/eid1411.080589; Nakamura S, 2011, EXP BIOL MED, V236, P968, DOI 10.1258/ebm.2011.010378; Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nunthaboot N, 2010, J CHEM INF MODEL, V50, P1410, DOI 10.1021/ci100038g; Puzelli S, 2010, EMERG INFECT DIS, V16, P863, DOI [10.3201/eid1605.091858, 10.3201/eid1605.091815]; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Ueda M, 2010, J VIROL, V84, P3068, DOI 10.1128/JVI.01923-09; Valli MB, 2011, EMERG INFECT DIS, V17, P749, DOI [10.3201/eid1706.100784, 10.3201/eid1704.100784]; Viswanathan K, 2010, GLYCOCONJUGATE J, V27, P561, DOI 10.1007/s10719-010-9303-4	25	17	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30946	10.1371/journal.pone.0030946	http://dx.doi.org/10.1371/journal.pone.0030946			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363521	gold, Green Published, Green Submitted			2022-12-27	WOS:000302853600093
J	Zhu, HW; Xia, LM; Zhang, YG; Wang, HH; Xu, WJ; Hu, H; Wang, J; Xin, J; Gang, Y; Sha, SM; Xu, B; Fan, DM; Nie, YZ; Wu, KC				Zhu, Hongwu; Xia, Limin; Zhang, Yongguo; Wang, Honghong; Xu, Wenjing; Hu, Hao; Wang, Jing; Xin, Jing; Gang, Yi; Sha, Sumei; Xu, Bin; Fan, Daiming; Nie, Yongzhan; Wu, Kaichun			Activating Transcription Factor 4 Confers a Multidrug Resistance Phenotype to Gastric Cancer Cells through Transactivation of SIRT1 Expression	PLOS ONE			English	Article							STRESS-RESPONSE; CISPLATIN RESISTANCE; BREAST-CANCER; CYCLIC-AMP; ATF4; INHIBITOR; ELEMENTS; CHEMORESISTANCE; TRANSLATION; INDUCTION	Background: Multidrug resistance (MDR) in gastric cancer remains a major challenge to clinical treatment. Activating transcription factor 4 (ATF4) is a stress response gene involved in homeostasis and cellular protection. However, the expression and function of ATF4 in gastric cancer MDR remains unknown. In this study, we investigate whether ATF4 play a role in gastric cancer MDR and its potential mechanisms. Methodology/Principal Findings: We demonstrated that ATF4 overexpression confered the MDR phenotype to gastric cancer cells, while knockdown of ATF4 in the MDR variants induced re-sensitization. In this study we also showed that the NAD(+)-dependent histone deacetylase SIRT1 was required for ATF4-induced MDR effect in gastric cancer cells. We demonstrated that ATF4 facilitated MDR in gastric cancer cells through direct binding to the SIRT1 promoter, resulting in SIRT1 up-regulation. Significantly, inhibition of SIRT1 by small interfering RNA (siRNA) or a specific inhibitor (EX-527) reintroduced therapeutic sensitivity. Also, an increased Bcl-2/Bax ratio and MDR1 expression level were found in ATF4-overexpressing cells. Conclusions/Significance: We showed that ATF4 had a key role in the regulation of MDR in gastric cancer cells in response to chemotherapy and these findings suggest that targeting ATF4 could relieve therapeutic resistance in gastric cancer.	[Zhu, Hongwu] Fourth Mil Med Univ, Dept Gastroenterol, Xijing Hosp, Xian 710032, Peoples R China; Fourth Mil Med Univ, State Key Lab Canc Biol, Xijing Hosp, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Zhu, HW (corresponding author), Fourth Mil Med Univ, Dept Gastroenterol, Xijing Hosp, Xian 710032, Peoples R China.	Yongzhan.nie@gmail.com; kaicwu@fmmu.edu.cn			National Natural Science Foundation of China [81090270, 81090273, 81000864]; Chinese Postdoctoral Science Foundation [20100471776]; National Key and Basic Research Development Program of China [2010CB529302]; National Municipal Science and Technology Project [2009ZX09103-667, 2009ZX09301-009-RC06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Key and Basic Research Development Program of China(National Basic Research Program of China); National Municipal Science and Technology Project	This study was supported by combined grants from the National Natural Science Foundation of China (NO. 81090270, NO. 81090273, and NO. 81000864), the Chinese Postdoctoral Science Foundation (NO. 20100471776), the National Key and Basic Research Development Program of China (NO. 2010CB529302), and the National Municipal Science and Technology Project (2009ZX09103-667 and 2009ZX09301-009-RC06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2011, CANCER LETT, V300, P197, DOI 10.1016/j.canlet.2010.10.006; Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; BENBROOK DM, 1994, NUCLEIC ACIDS RES, V22, P1463, DOI 10.1093/nar/22.8.1463; Carr JR, 2010, CANCER RES, V70, P5054, DOI 10.1158/0008-5472.CAN-10-0545; Chu F, 2005, CANCER RES, V65, P10183, DOI 10.1158/0008-5472.CAN-05-2002; DEUTSCH PJ, 1988, J BIOL CHEM, V263, P18466; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Fung H, 2007, MOL CELL BIOL, V27, P8834, DOI 10.1128/MCB.00974-07; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hajji N, 2010, ONCOGENE, V29, P2192, DOI 10.1038/onc.2009.505; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Igarashi T, 2007, ONCOGENE, V26, P4749, DOI 10.1038/sj.onc.1210289; Jansen E, 1997, J BIOL CHEM, V272, P2500; Kabra N, 2009, J BIOL CHEM, V284, P18210, DOI 10.1074/jbc.M109.000034; Kojima K, 2008, BIOCHEM BIOPH RES CO, V373, P423, DOI 10.1016/j.bbrc.2008.06.045; Larsen AK, 1998, BBA-GENE STRUCT EXPR, V1400, P257, DOI 10.1016/S0167-4781(98)00140-7; Larsen AK, 2000, PHARMACOL THERAPEUT, V85, P217, DOI 10.1016/S0163-7258(99)00073-X; Lehr HA, 1997, J HISTOCHEM CYTOCHEM, V45, P1559, DOI 10.1177/002215549704501112; Levenson VV, 2000, CANCER RES, V60, P5027; Liang XJ, 2008, MOL CANCER RES, V6, P1499, DOI 10.1158/1541-7786.MCR-07-2130; LIN YS, 1988, P NATL ACAD SCI USA, V85, P3396, DOI 10.1073/pnas.85.10.3396; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Luo SZ, 2003, J BIOL CHEM, V278, P37375, DOI 10.1074/jbc.M303619200; Matsushita N, 2005, GENES CELLS, V10, P321, DOI 10.1111/j.1365-2443.2005.00836.x; Milani M, 2009, CANCER RES, V69, P4415, DOI 10.1158/0008-5472.CAN-08-2839; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Oh WK, 2010, MOL PHARMACOL, V78, P855, DOI 10.1124/mol.110.065961; Olmos Y, 2010, DRUG RESIST UPDAT; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Rutkowski DT, 2003, DEV CELL, V4, P442, DOI 10.1016/S1534-5807(03)00100-X; Rzymski T, 2010, ONCOGENE, V29, P4424, DOI 10.1038/onc.2010.191; Rzymski T, 2009, CELL CYCLE, V8, P3838, DOI 10.4161/cc.8.23.10086; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Su N, 2008, J BIOL CHEM, V283, P35106, DOI 10.1074/jbc.M806874200; Tanabe M, 2003, CANCER RES, V63, P8592; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Virrey JJ, 2008, MOL CANCER RES, V6, P1268, DOI 10.1158/1541-7786.MCR-08-0060; Wilson TR, 2006, ANN ONCOL, V17, pX315, DOI 10.1093/annonc/mdl280; Zhang DX, 2007, EXPERT REV ANTICANC, V7, P1369, DOI 10.1586/14737140.7.10.1369; Zhang DX, 2010, FUTURE ONCOL, V6, P527, DOI [10.2217/fon.10.21, 10.2217/FON.10.21]	42	47	52	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31431	10.1371/journal.pone.0031431	http://dx.doi.org/10.1371/journal.pone.0031431			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363646	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600146
J	Berkowitz, SA; Bell, RA; Kravitz, RL; Feldman, MD				Berkowitz, Seth A.; Bell, Robert A.; Kravitz, Richard L.; Feldman, Mitchell D.			Vicarious Experience Affects Patients' Treatment Preferences for Depression	PLOS ONE			English	Article							PRIMARY-CARE; ANTIDEPRESSANT ADHERENCE; PREDICTORS; PARTICIPATION; ATTITUDES; SEVERITY; IMPACT	Purpose: Depression is common in primary care but often under-treated. Personal experiences with depression can affect adherence to therapy, but the effect of vicarious experience is unstudied. We sought to evaluate the association between a patient's vicarious experiences with depression (those of friends or family) and treatment preferences for depressive symptoms. Methods: We sampled 1054 English and/or Spanish speaking adult subjects from July through December 2008, randomly selected from the 2008 California Behavioral Risk Factor Survey System, regarding depressive symptoms and treatment preferences. We then constructed a unidimensional scale using item analysis that reflects attitudes about antidepressant pharmacotherapy. This became the dependent variable in linear regression analyses to examine the association between vicarious experiences and treatment preferences for depressive symptoms. Results: Our sample was 68% female, 91% white, and 13% Hispanic. Age ranged from 18-94 years. Mean PHQ-(score was 4.3; 14.5% of respondents had a PHQ-(score > 9.0, consistent with active depressive symptoms. Analyses controlling for current depression symptoms and socio-demographic factors found that in patients both with (coefficient 1.08, p = 0.03) and without (coefficient 0.77, p = 0.03) a personal history of depression, having a vicarious experience (family and friend, respectively) with depression is associated with a more favorable attitude towards antidepressant medications. Conclusions: Patients with vicarious experiences of depression express more acceptance of pharmacotherapy. Conversely, patients lacking vicarious experiences of depression have more negative attitudes towards antidepressants. When discussing treatment with patients, clinicians should inquire about vicarious experiences of depression. This information may identify patients at greater risk for non-adherence and lead to more tailored patient-specific education about treatment.	[Berkowitz, Seth A.; Feldman, Mitchell D.] Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA; [Bell, Robert A.] Univ Calif Davis, Dept Commun, Davis, CA 95616 USA; [Bell, Robert A.] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA; [Kravitz, Richard L.] Univ Calif Davis, Div Gen Med, Sacramento, CA 95817 USA	University of California System; University of California San Francisco; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Berkowitz, SA (corresponding author), Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA.	Seth.Berkowitz@ucsf.edu	Kravitz, Richard/AAF-7425-2021	Kravitz, Richard/0000-0001-5575-529X; Berkowitz, Seth/0000-0003-1030-4297	National Institute of Mental Health [R01MH79387, K24MH72756]; University of California San Francisco; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079387, K24MH072756] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); University of California San Francisco(University of California System); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded with support from grants #R01MH79387 and K24MH72756 from the National Institute of Mental Health (RLK, PI). This work was also supported by a University of California San Francisco Training in Clinical Research Grant (SAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bambauer KZ, 2007, J CLIN PSYCHIAT, V68, P867, DOI 10.4088/JCP.v68n0607; Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Burra TA, 2007, BEHAV MED, V32, P127, DOI 10.3200/BMED.32.4.127-134; Chakraborty K, 2009, SOC PSYCH PSYCH EPID, V44, P482, DOI 10.1007/s00127-008-0468-0; Christensen H, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-25; Demyttenaere K, 2003, EUR NEUROPSYCHOPHARM, V13, pS69, DOI 10.1016/S0924-977X(03)00095-6; Dwight-Johnson M, 2001, MED CARE, V39, P934, DOI 10.1097/00005650-200109000-00004; Feldman MD, 2007, ANN FAM MED, V5, P412, DOI 10.1370/afm.719; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Holma IAK, 2010, J AFFECT DISORDERS, V127, P102, DOI 10.1016/j.jad.2010.04.022; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Kilmer Greta, 2008, Morbidity and Mortality Weekly Report, V57, P1; Kravitz RL, 2006, J GEN INTERN MED, V21, P584, DOI 10.1111/j.1525-1497.2006.00411.x; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lin EHB, 2003, GEN HOSP PSYCHIAT, V25, P303, DOI 10.1016/S0163-8343(03)00074-4; Loh A, 2007, PATIENT EDUC COUNS, V65, P69, DOI 10.1016/j.pec.2006.05.007; Shigemura J, 2010, PSYCHIAT CLIN NEUROS, V64, P179, DOI 10.1111/j.1440-1819.2009.02058.x; Sirey JA, 2010, AM J GERIAT PSYCHIAT, V18, P554, DOI 10.1097/JGP.0b013e3181cdeb7d; Trivedi MH, 2007, CNS SPECTRUMS, V12, P9, DOI 10.1017/S1092852900003746; Vergouwen ACM, 2003, J CLIN PSYCHIAT, V64, P1415, DOI 10.4088/JCP.v64n1203; Wang J, 2008, J AFFECT DISORDERS, V110, P191, DOI 10.1016/j.jad.2008.01.005; Yannacci J., 2006, PRINCIPLES ADULT LEA	24	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31269	10.1371/journal.pone.0031269	http://dx.doi.org/10.1371/journal.pone.0031269			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926ZM	22363603	gold, Green Published			2022-12-27	WOS:000302873700042
J	Gaudet, LM; Singh, K; Weeks, L; Skidmore, B; Tsertsvadze, A; Ansari, MT				Gaudet, Laura M.; Singh, Kavita; Weeks, Laura; Skidmore, Becky; Tsertsvadze, Alexander; Ansari, Mohammed T.			Effectiveness of Terbutaline Pump for the Prevention of Preterm Birth. A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							HEALTH-CARE PROGRAM; GLUCOSE-INTOLERANCE; TOCOLYSIS; LABOR; DELIVERY; TRIALS; AHRQ	Background: Subcutaneous terbutaline (SQ terbutaline) infusion by pump is used in pregnant women as a prolonged (beyond 48-72 h) maintenance tocolytic following acute treatment of preterm contractions. The effectiveness and safety of this maintenance tocolysis have not been clearly established. We aimed to systematically evaluate the effectiveness and safety of subcutaneous (SQ) terbutaline infusion by pump for maintenance tocolysis. Methodology/Principal Findings: MEDLINE, EMBASE, CINAHL, the Cochrane Library, the Centre for Reviews and Dissemination databases, post-marketing surveillance data and grey literature were searched up to April 2011 for relevant experimental and observational studies. Two randomized trials, one nonrandomized trial, and 11 observational studies met inclusion criteria. Non-comparative studies were considered only for pump-related harms. We excluded case-reports but sought FDA summaries of post-marketing surveillance data. Non-English records without an English abstract were excluded. Evidence of low strength from observational studies with risk of bias favored SQ terbutaline pump for the outcomes of delivery at <32 and <37 weeks, mean days of pregnancy prolongation, and neonatal death. Observational studies of medium to high risk of bias also demonstrated benefit for other surrogate outcomes, such as birthweight and neonatal intensive care unit (NICU) admission. Several cases of maternal deaths and maternal cardiovascular events have been reported in patients receiving terbutaline tocolysis. Conclusions/Significance: Although evidence suggests that pump therapy may be beneficial as maintenance tocolysis, our confidence in its validity and reproducibility is low, suggesting that its use should be limited to the research setting. Concerns regarding safety of therapy persist.	[Gaudet, Laura M.; Singh, Kavita; Weeks, Laura; Skidmore, Becky; Tsertsvadze, Alexander; Ansari, Mohammed T.] Ottawa Hosp Res Inst, Evidence Based Practice Ctr, Ottawa, ON, Canada; [Gaudet, Laura M.] Moncton Hosp, Horizon Hlth Network, Dept Obstet & Gynecol, Moncton, NB, Canada; [Gaudet, Laura M.] Univ Ottawa, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Gaudet, LM (corresponding author), Ottawa Hosp Res Inst, Evidence Based Practice Ctr, Ottawa, ON, Canada.	moansari@ohri.ca		Skidmore, Becky/0000-0001-8293-9238; Gaudet, Laura/0000-0002-7527-5354	Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services [HHSA-290-2007-10059-I-EPC3]	Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This project was funded under Contract No. HHSA-290-2007-10059-I-EPC3 from the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services. The authors of this report are responsible for its content. Statements in the report should not be construed as endorsement by the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	ADKINS RT, 1993, SOUTHERN MED J, V86, P157, DOI 10.1097/00007611-199302000-00002; ALLBERT J R, 1991, American Journal of Obstetrics and Gynecology, V164, P365; ALLBERT JR, 1994, J REPROD MED, V39, P614; Atkins D, 2011, J CLIN EPIDEMIOL; Behrman RE, 2007, PRETERM BIRTH CAUSES; Chou R, 2010, J CLIN EPIDEMIOL, V63, P502, DOI 10.1016/j.jclinepi.2008.06.007; de la Torre L, 2008, AM J PERINAT, V25, P555, DOI 10.1055/s-0028-1085622; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Fleming Alfred, 2004, J Perinatol, V24, P223, DOI 10.1038/sj.jp.7211058; Flick AA, 2010, AM J PERINAT, V27, P53, DOI 10.1055/s-0029-1241734; Guinn DK, 1998, AM J OBSTET GYNECOL, V179, P874, DOI 10.1016/S0002-9378(98)70181-4; Hayes Inc, 2006, CONT SUBC TERB INF T; Iams J, 2010, CREASY RESNIKS MATER, P545; KING JF, 1988, BRIT J OBSTET GYNAEC, V95, P211, DOI 10.1111/j.1471-0528.1988.tb06860.x; Lam F, 2001, J Perinatol, V21, P444, DOI 10.1038/sj.jp.7210553; LAM F, 1988, OBSTET GYNECOL, V72, P810; Lam Fung, 2003, Manag Care, V12, P39; LINDENBAUM C, 1992, AM J OBSTET GYNECOL, V166, P925, DOI 10.1016/0002-9378(92)91364-G; Morrison JC, 2003, AM J OBSTET GYNECOL, V188, P1460, DOI 10.1067/mob.2003.399; MORRISON JC, 1992, INT J GYNECOL OBSTET, V38, P189, DOI 10.1016/0020-7292(82)90127-8; Nanda K, 2002, COCHRANE DATABASE SY; Norris SL, 2011, J CLIN EPIDEMIOL; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; REGENSTEIN AC, 1993, OBSTET GYNECOL, V81, P739; Relevo R., 2011, J CLIN EPIDEMIOL; Wenstrom KD, 1997, AM J PERINAT, V14, P87, DOI 10.1055/s-2007-994104	26	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31679	10.1371/journal.pone.0031679	http://dx.doi.org/10.1371/journal.pone.0031679			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363704	Green Submitted, Green Published, gold			2022-12-27	WOS:000302873700082
J	Mahavanakul, W; Nickerson, EK; Srisomang, P; Teparrukkul, P; Lorvinitnun, P; Wongyingsinn, M; Chierakul, W; Hongsuwan, M; West, TE; Day, NP; Limmathurotsakul, D; Peacock, SJ				Mahavanakul, Weera; Nickerson, Emma K.; Srisomang, Pramot; Teparrukkul, Prapit; Lorvinitnun, Pichet; Wongyingsinn, Mingkwan; Chierakul, Wirongrong; Hongsuwan, Maliwan; West, T. Eoin; Day, Nicholas P.; Limmathurotsakul, Direk; Peacock, Sharon J.			Feasibility of Modified Surviving Sepsis Campaign Guidelines in a Resource-Restricted Setting Based on a Cohort Study of Severe S. Aureus Sepsis	PLOS ONE			English	Article							SEPTIC SHOCK; CARE; EPIDEMIOLOGY; MANAGEMENT; BACTEREMIA; INFECTION; MORTALITY; CHILDREN; THERAPY; PROGRAM	Background: The Surviving Sepsis Campaign (SSC) guidelines describe best practice for the management of severe sepsis and septic shock in developed countries, but most deaths from sepsis occur where healthcare is not sufficiently resourced to implement them. Our objective was to define the feasibility and basis for modified guidelines in a resource-restricted setting. Methods and Findings: We undertook a detailed assessment of sepsis management in a prospective cohort of patients with severe sepsis caused by a single pathogen in a 1,100-bed hospital in lower-middle income Thailand. We compared their management with the SSC guidelines to identify care bundles based on existing capabilities or additional activities that could be undertaken at zero or low cost. We identified 72 patients with severe sepsis or septic shock associated with S. aureus bacteraemia, 38 (53%) of who died within 28 days. One third of patients were treated in intensive care units (ICUs). Numerous interventions described by the SSC guidelines fell within existing capabilities, but their implementation was highly variable. Care available to patients on general wards covered the fundamental principles of sepsis management, including non-invasive patient monitoring, antimicrobial administration and intravenous fluid resuscitation. We described two additive care bundles, one for general wards and the second for ICUs, that if consistently performed would be predicted to improve outcome from severe sepsis. Conclusion: It is feasible to implement modified sepsis guidelines that are scaled to resource availability, and that could save lives prior to the publication of international guidelines for developing countries.	[Mahavanakul, Weera; Teparrukkul, Prapit; Lorvinitnun, Pichet] Sappasithiprasong Hosp, Dept Med, Ubon Ratchathani, Thailand; [Nickerson, Emma K.; Chierakul, Wirongrong; Hongsuwan, Maliwan; Day, Nicholas P.; Limmathurotsakul, Direk; Peacock, Sharon J.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Nickerson, Emma K.; Peacock, Sharon J.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; [Srisomang, Pramot] Sappasithiprasong Hosp, Dept Pediat, Ubon Ratchathani, Thailand; [Wongyingsinn, Mingkwan] Siriraj Hosp, Fac Med, Dept Anesthesiol, Bangkok, Thailand; [Chierakul, Wirongrong] Mahidol Univ, Fac Trop Med, Dept Trop Med, Bangkok, Thailand; [West, T. Eoin] Univ Washington, Harborview Med Ctr, Dept Med, Seattle, WA 98104 USA; [West, T. Eoin] Univ Washington, Harborview Med Ctr, Int Resp & Severe Illness Ctr, Seattle, WA 98104 USA; [Day, Nicholas P.] Univ Oxford, Nuffield Dept Clin Med, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Limmathurotsakul, Direk] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand; [Peacock, Sharon J.] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Mahidol University; Mahidol University; Harborview Medical Center; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle; University of Oxford; Mahidol University; Mahidol University	Mahavanakul, W (corresponding author), Sappasithiprasong Hosp, Dept Med, Ubon Ratchathani, Thailand.	direk@tropmedres.ac; sjp97@medschl.cam.ac.uk	Peacock, Sharon J/ABE-6331-2020	Limmathurotsakul, Direk/0000-0001-7240-5320; Wongyingsinn, Mingkwan/0000-0003-4508-5661; West, T Eoin/0000-0001-5503-7204; Peacock, Sharon/0000-0002-1718-2782; /0000-0002-1075-4135; Chierakul, Wirongrong/0000-0003-2103-9425	Wellcome Trust; NIHR Cambridge Biomedical Research Centre	Wellcome Trust(Wellcome Trust); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR))	The study was funded by the Wellcome Trust. SP is supported by the NIHR Cambridge Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; [Anonymous], 2009, CHEST; Becker JU, 2009, LANCET INFECT DIS, V9, P577, DOI 10.1016/S1473-3099(09)70135-5; Berkley J, 1999, T ROY SOC TROP MED H, V93, P283, DOI 10.1016/S0035-9203(99)90024-X; BERN C, 1992, B WORLD HEALTH ORGAN, V70, P705; Carcillo Joseph A, 2005, Pediatr Crit Care Med, V6, pS157, DOI 10.1097/01.PCC.0000161574.36857.CA; Cheng AC, 2008, PLOS MED, V5, P1173, DOI 10.1371/journal.pmed.0050175; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Dunser MW, 2006, CRIT CARE MED, V34, P1234, DOI 10.1097/01.CCM.0000208360.70835.87; Ferrer R, 2008, JAMA-J AM MED ASSOC, V299, P2294, DOI 10.1001/jama.299.19.2294; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Greenwood B, 1999, PHILOS T R SOC B, V354, P777, DOI 10.1098/rstb.1999.0430; Gupta S, 2007, INFECT DIS CLIN N AM, V21, P617, DOI 10.1016/j.idc.2007.07.003; Hatherill Mark, 2005, Pediatr Crit Care Med, V6, pS92, DOI 10.1097/01.PCC.0000161579.39050.6B; Jones AE, 2010, JAMA-J AM MED ASSOC, V303, P739, DOI 10.1001/jama.2010.158; Levy MM, 2010, INTENS CARE MED, V36, P222, DOI 10.1007/s00134-009-1738-3; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; McGee DC, 2003, NEW ENGL J MED, V348, P1123, DOI 10.1056/NEJMra011883; Moore CC, 2008, CLIN INFECT DIS, V46, P215, DOI 10.1086/524665; Nickerson EK, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0004308, 10.1371/journal.pone.0006512]; Phu NH, 2002, NEW ENGL J MED, V347, P895, DOI 10.1056/NEJMoa020074; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Rice TW, 2007, CHEST, V132, P410, DOI 10.1378/chest.07-0617; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Siddiqui Shahla, 2007, J Indian Med Assoc, V105, P221; Silva E, 2004, CRIT CARE, V8, pR251, DOI 10.1186/cc2892; SMITH C, 1991, S AFR MED J, V80, P181; Tanriover MD, 2006, EPIDEMIOL INFECT, V134, P315, DOI 10.1017/S0950268805004978; Vincent JL, 2003, INTENS CARE MED, V29, pS74; Wardlaw T, 2006, LANCET, V368, P1048, DOI 10.1016/S0140-6736(06)69334-3; World Health Organization, WORLD HLTH REP 1996; World Health Organization, 2004, GLOB BURD DIS 2004 U; World Health Organization, 2011, CLIN MAN AD PAT COMP; WRIGHT JP, 1995, TROP DOCT, V25, P5, DOI 10.1177/004947559502500102	36	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e29858	10.1371/journal.pone.0029858	http://dx.doi.org/10.1371/journal.pone.0029858			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363410	Green Submitted, gold, Green Published			2022-12-27	WOS:000302873700005
J	Mark, FC; Lucassen, M; Strobel, A; Barrera-Oro, E; Koschnick, N; Zane, L; Patarnello, T; Portner, HO; Papetti, C				Mark, Felix C.; Lucassen, Magnus; Strobel, Anneli; Barrera-Oro, Esteban; Koschnick, Nils; Zane, Lorenzo; Patarnello, Tomaso; Poertner, Hans O.; Papetti, Chiara			Mitochondrial Function in Antarctic Nototheniids with ND6 Translocation	PLOS ONE			English	Article							SOUTH SHETLAND ISLANDS; CYTOCHROME-C-OXIDASE; FISH TREMATOMUS-BERNACCHII; LIMITED THERMAL TOLERANCE; COMPLEX-I; COLD ADAPTATION; PAGOTHENIA-BORCHGREVINKI; TEMPERATURE ADAPTATION; MUSCLE MITOCHONDRIA; OXYGEN-CONSUMPTION	Fish of the suborder Notothenioidei have successfully radiated into the Southern Ocean and today comprise the dominant fish sub-order in Antarctic waters in terms of biomass and species abundance. During evolution in the cold and stable Antarctic climate, the Antarctic lineage of notothenioids developed several unique physiological adaptations, which make them extremely vulnerable to the rapid warming of Antarctic waters currently observed. Only recently, a further phenomenon exclusive to notothenioid fish was reported: the translocation of the mitochondrial gene encoding the NADH Dehydrogenase subunit 6 (ND6), an indispensable part of complex I in the mitochondrial electron transport system. This study investigated the potential physiological consequences of ND6 translocation for the function and thermal sensitivity of the electron transport system in isolated liver mitochondria of the two nototheniid species Notothenia coriiceps and Notothenia rossii, with special attention to the contributions of complex I (NADH DH) and complex II (Succinate DH) to oxidative phosphorylation. Furthermore, enzymatic activities of NADH: Cytochrome c Oxidoreductase and Cytochrome C Oxidase were measured in membrane-enriched tissue extracts. During acute thermal challenge (0-15 degrees C), capacities of mitochondrial respiration and enzymatic function in the liver could only be increased until 9 degrees C. Mitochondrial complex I (NADH Dehydrogenase) was fully functional but displayed a higher thermal sensitivity than the other complexes of the electron transport system, which may specifically result from its unique amino acid composition, revealing a lower degree of stability in notothenioids in general. We interpret the translocation of ND6 as functionally neutral but the change in amino acid sequence as adaptive and supportive of cold stenothermy in Antarctic nototheniids. From these findings, an enhanced sensitivity to ocean warming can be deduced for Antarctic notothenioid fish.	[Mark, Felix C.; Lucassen, Magnus; Strobel, Anneli; Koschnick, Nils; Poertner, Hans O.; Papetti, Chiara] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany; [Zane, Lorenzo; Papetti, Chiara] Univ Padua, Dept Biol, Padua, Italy; [Barrera-Oro, Esteban] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Barrera-Oro, Esteban] Inst Antartico Argentino, Buenos Aires, DF, Argentina; [Patarnello, Tomaso] Univ Padua, Dept Publ Hlth Comparat Pathol & Vet Hyg, Legnaro, Italy	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Padua; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Instituto Antartico Argentino; University of Padua	Mark, FC (corresponding author), Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany.	fmark@awi.de	Strobel, Anneli/S-5853-2016; Lucassen, Magnus/ABA-8396-2021; Mark, Felix Christopher/P-4759-2016; Lucassen, Magnus/E-8433-2011; Zane, Lorenzo/G-6249-2010; Pörtner, Hans-O./K-9429-2016	Lucassen, Magnus/0000-0003-4276-4781; Mark, Felix Christopher/0000-0002-5586-6704; Lucassen, Magnus/0000-0003-4276-4781; Zane, Lorenzo/0000-0002-6963-2132; Pörtner, Hans-O./0000-0001-6535-6575; PATARNELLO, Tomaso/0000-0003-1794-5791; Papetti, Chiara/0000-0002-4567-459X	EMBO [ASTF 363-2008]; DFG [PO273/13-1, LU1463/1-2]; Helmholtz Association; Italian National Programme for Antarctic Research (PNRA)	EMBO(European Molecular Biology Organization (EMBO)); DFG(German Research Foundation (DFG)); Helmholtz Association(Helmholtz Association); Italian National Programme for Antarctic Research (PNRA)	CP was supported by EMBO grant ASTF 363-2008. AS, HOP and FCM appreciate funding from DFG grant PO273/13-1, and ML from DFG grant LU1463/1-2. The study is a contribution to the PACES research program (work package 1.6) of the Alfred Wegener Institute funded by the Helmholtz Association. It was also supported by the Italian National Programme for Antarctic Research (PNRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonova EI, 2010, CONTEMP PROBL ECOL+, V3, P57, DOI 10.1134/S1995425510010108; Arnold S, 2012, MITOCHONDRION, V12, P46, DOI 10.1016/j.mito.2011.05.003; Bai YD, 2004, ANN NY ACAD SCI, V1011, P272, DOI 10.1196/annals.1293.026; Bai YD, 1998, EMBO J, V17, P4848, DOI 10.1093/emboj/17.16.4848; Barrera-Oro E, 2003, POLAR BIOL, V26, P631, DOI 10.1007/s00300-003-0520-1; Barrera-Oro E, 2010, POLAR BIOL, V33, P877, DOI 10.1007/s00300-010-0763-6; BARRERAORO ER, 1992, ANTARCT SCI, V4, P131, DOI 10.1017/S095410209200021X; Beers JM, 2011, PHYSIOL BIOCHEM ZOOL, V84, P353, DOI 10.1086/660191; Bilyk KT, 2011, COMP BIOCHEM PHYS A, V158, P382, DOI 10.1016/j.cbpa.2010.12.010; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brand MD, 1995, MEASUREMENT MITOCHON; Brodte E, 2006, POLAR BIOL, V30, P95, DOI 10.1007/s00300-006-0165-y; BURCHETT MS, 1983, BRIT ANTARCT SURV B, P63; Campbell HA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001743; Casaux RJ, 2002, ANTARCT SCI, V14, P221, DOI 10.1017/S0954102002000056; CASAUX RJ, 1990, POLAR BIOL, V11, P63; Chen ZZ, 2008, P NATL ACAD SCI USA, V105, P12944, DOI 10.1073/pnas.0802432105; Clarke A, 1999, J ANIM ECOL, V68, P893, DOI 10.1046/j.1365-2656.1999.00337.x; CLARKE A, 1991, AM ZOOL, V31, P81; Clarke A, 2007, PHILOS T R SOC B, V362, P149, DOI 10.1098/rstb.2006.1958; COCCA E, 1995, P NATL ACAD SCI USA, V92, P1817, DOI 10.1073/pnas.92.6.1817; D'Amico S, 2002, PHILOS T R SOC B, V357, P917, DOI 10.1098/rstb.2002.1105; DEVRIES AL, 1971, SCIENCE, V172, P1152, DOI 10.1126/science.172.3988.1152; Dewitt H.H., 1990, P279; Duchen MR, 1999, PHYSL SOC, P1; DUNN JF, 1989, POLAR BIOL, V9, P213, DOI 10.1007/BF00263769; DUNN JF, 1986, MAR BIOL, V91, P433, DOI 10.1007/BF00392593; Eastman JT, 2011, MAR ECOL PROG SER, V438, P195, DOI 10.3354/meps09287; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Egginton S, 1997, J COMP PHYSIOL B, V167, P129, DOI 10.1007/s003600050056; Everson I., 1968, Bulletin British Antarctic Survey, VNo. 15, P59; Feller G, 1997, CELL MOL LIFE SCI, V53, P830, DOI 10.1007/s000180050103; Fields PA, 1998, P NATL ACAD SCI USA, V95, P11476, DOI 10.1073/pnas.95.19.11476; Flinn L, 2009, BRAIN, V132, P1613, DOI 10.1093/brain/awp108; Franklin CE, 2007, J EXP BIOL, V210, P3068, DOI 10.1242/jeb.003137; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gille ST, 2002, SCIENCE, V295, P1275, DOI 10.1126/science.1065863; Gnaiger E, 1998, J EXP BIOL, V201, P1129; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; GON O, 1990, FISHES SO OCEAN; GONZALEZCABRERA PJ, 1995, J EXP BIOL, V198, P2279; Guderley H, 1996, J EXP BIOL, V199, P1311; Guderley H, 1998, TEMPERATURE GROWTH R, P58; GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155; Hagen W, 2000, POLAR BIOL, V23, P785, DOI 10.1007/s003000000153; Hand SC, 2008, J EXP BIOL, V211, P1829, DOI 10.1242/jeb.000299; Hardewig I, 1999, J COMP PHYSIOL B, V169, P597, DOI 10.1007/s003600050260; Hardewig I, 1999, AM J PHYSIOL-REG I, V277, pR508, DOI 10.1152/ajpregu.1999.277.2.R508; Heise K, 2008, REPORTS POLAR MARINE, P320; Hilton Z, 2010, J COMP PHYSIOL B, V180, P979, DOI 10.1007/s00360-010-0477-7; Hulbert AJ, 2006, J COMP PHYSIOL B, V176, P93, DOI 10.1007/s00360-005-0025-z; Iftikar FI, 2010, J EXP MAR BIOL ECOL, V395, P232, DOI 10.1016/j.jembe.2010.09.005; JOHNSTON IA, 1994, J EXP BIOL, V195, P293; Johnston IA, 1998, J EXP BIOL, V201, P1; Kamler E, 2001, POLAR BIOL, V24, P735; KARENTZ D, 1991, ANTARCT SCI, V3, P3, DOI 10.1017/S0954102091000032; Lannig G, 2005, POLAR BIOL, V28, P575, DOI 10.1007/s00300-005-0730-9; Lannig G, 2003, MAR BIOL, V142, P589, DOI 10.1007/s00227-002-0967-6; Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015; LONDRAVILLE RL, 1990, RESP PHYSIOL, V81, P291, DOI 10.1016/0034-5687(90)90110-K; Lowe CJ, 2005, J FISH BIOL, V67, P752, DOI 10.1111/j.0022-1112.2005.00775.x; Lowe CJ, 2005, J COMP PHYSIOL B, V175, P97, DOI 10.1007/s00360-004-0466-9; Lucassen M, 2003, AM J PHYSIOL-REG I, V285, pR1410, DOI 10.1152/ajpregu.00111.2003; Mark FC, 2005, POLAR BIOL, V28, P805, DOI 10.1007/s00300-005-0018-0; Mark FC, 2002, AM J PHYSIOL-REG I, V283, pR1254, DOI 10.1152/ajpregu.00167.2002; Mark FC, 2006, COMP BIOCHEM PHYS D, V1, P365, DOI 10.1016/j.cbd.2006.08.004; Mayewski PA, 2009, REV GEOPHYS, V47, DOI 10.1029/2007RG000231; McDonald TG, 2003, BASIC RES CARDIOL, V98, P219, DOI 10.1007/s00395-003-0417-8; MOLLER IM, 1982, PHYSIOL PLANTARUM, V54, P267, DOI 10.1111/j.1399-3054.1982.tb00258.x; Mortelette H, 2010, MITOCHONDRION, V10, P555, DOI 10.1016/j.mito.2010.05.002; Moyes CD, 1997, AM J PHYSIOL-CELL PH, V272, pC1345, DOI 10.1152/ajpcell.1997.272.4.C1345; North AW, 1996, MAR BIOL, V126, P125, DOI 10.1007/BF00571384; O'Brien KM, 2000, J EXP BIOL, V203, P1287; Papetti C, 2007, J MOL EVOL, V65, P519, DOI 10.1007/s00239-007-9030-z; Patarnello T, 2011, BIOESSAYS, V33, P260, DOI 10.1002/bies.201000124; Podrabsky JE, 2006, POLAR BIOL, V30, P39, DOI 10.1007/s00300-006-0157-y; Portner HO, 2010, J EXP BIOL, V213, P881, DOI 10.1242/jeb.037523; Portner HO, 2006, DEEP-SEA RES PT II, V53, P1071, DOI 10.1016/j.dsr2.2006.02.015; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Portner HO, 2004, RESP PHYSIOL NEUROBI, V141, P243, DOI 10.1016/j.resp.2004.03.011; Portner HO, 1999, COMP BIOCHEM PHYS A, V124, P179, DOI 10.1016/S1095-6433(99)00105-1; Portner HO, 2000, ANTARCTIC ECOSYSTEMS, P109; RALPH R, 1968, COMP BIOCHEM PHYSIOL, V27, P299, DOI 10.1016/0010-406X(68)90772-X; Robinson E, 2008, POLAR BIOL, V31, P317, DOI 10.1007/s00300-007-0361-4; Robinson E, 2011, POLAR BIOL, V34, P371, DOI 10.1007/s00300-010-0891-z; Scheffler IE, 1999, MITOCHONDRIA; Seebacher F, 2005, BIOL LETTERS, V1, P151, DOI 10.1098/rsbl.2004.0280; Sidell BD, 2006, J EXP BIOL, V209, P1791, DOI 10.1242/jeb.02091; Sidell BD, 2007, J EXP BIOL, V210, P815; SOMERO GN, 1967, SCIENCE, V156, P257, DOI 10.1126/science.156.3772.257; SOMERO GN, 1968, COMP BIOCHEM PHYSIOL, V26, P223, DOI 10.1016/0010-406X(68)90327-7; Speers-Roesch B, 2005, COMP BIOCHEM PHYS A, V140, P487, DOI 10.1016/j.cbpb.2005.02.014; Stepanov V, 1997, AM J PHYSIOL-CELL PH, V273, pC1397, DOI 10.1152/ajpcell.1997.273.4.C1397; SUAREZ RK, 1981, J COMP PHYSIOL, V143, P269; TRIGARI G, 1992, LIPIDS, V27, P371, DOI 10.1007/BF02536152; Ugalde C, 2003, ANN NEUROL, V54, P665, DOI 10.1002/ana.10734; Urschel MR, 2008, J EXP BIOL, V211, P2638, DOI 10.1242/jeb.018598; Urschel MR, 2009, POLAR BIOL, V32, P1323, DOI 10.1007/s00300-009-0629-y; VANDENTHILLART G, 1978, BIOCHIM BIOPHYS ACTA, V510, P38, DOI 10.1016/0005-2736(78)90128-1; Walker JL, 2006, J BIOL CHEM, V281, P38127, DOI 10.1074/jbc.M609622200; Weinstein RB, 1998, J COMP PHYSIOL B, V168, P190, DOI 10.1007/s003600050136; Windisch HS, 2011, AM J PHYSIOL-REG I, V301, pR1453, DOI 10.1152/ajpregu.00158.2011; WOHLSCHLAG DE, 1963, ECOLOGY, V44, P557, DOI 10.2307/1932535; Yadava N, 2004, J BIOL CHEM, V279, P12406, DOI 10.1074/jbc.M313588200; Zhuang X, 2010, MOL BIOL EVOL, V27, P1391, DOI 10.1093/molbev/msq026	105	25	26	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31860	10.1371/journal.pone.0031860	http://dx.doi.org/10.1371/journal.pone.0031860			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363756	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700111
J	Rivellini, C; Dina, G; Porrello, E; Cerri, F; Scarlato, M; Domi, T; Ungaro, D; Del Carro, U; Bolino, A; Quattrini, A; Comi, G; Previtali, SC				Rivellini, Cristina; Dina, Giorgia; Porrello, Emanuela; Cerri, Federica; Scarlato, Marina; Domi, Teuta; Ungaro, Daniela; Del Carro, Ubaldo; Bolino, Alessandra; Quattrini, Angelo; Comi, Giancarlo; Previtali, Stefano C.			Urokinase Plasminogen Receptor and the Fibrinolytic Complex Play a Role in Nerve Repair after Nerve Crush in Mice, and in Human Neuropathies	PLOS ONE			English	Article							PERIPHERAL-NERVE; ACTIVATOR SYSTEM; EXTRACELLULAR-MATRIX; FUNCTIONAL RECOVERY; REGENERATION; EXPRESSION; INTEGRINS; MYELINATION; MIGRATION; UPAR	Remodeling of extracellular matrix (ECM) is a critical step in peripheral nerve regeneration. In fact, in human neuropathies, endoneurial ECM enriched in fibrin and vitronectin associates with poor regeneration and worse clinical prognosis. Accordingly in animal models, modification of the fibrinolytic complex activity has profound effects on nerve regeneration: high fibrinolytic activity and low levels of fibrin correlate with better nerve regeneration. The urokinase plasminogen receptor (uPAR) is a major component of the fibrinolytic complex, and binding to urokinase plasminogen activator (uPA) promotes fibrinolysis and cell movement. uPAR is expressed in peripheral nerves, however, little is known on its potential function on nerve development and regeneration. Thus, we investigated uPAR null mice and observed that uPAR is dispensable for nerve development, whereas, loss of uPAR affects nerve regeneration. uPAR null mice showed reduced nerve repair after sciatic nerve crush. This was a consequence of reduced fibrinolytic activity and increased deposition of endoneurial fibrin and vitronectin. Exogenous fibrinolysis in uPAR null mice rescued nerve repair after sciatic nerve crush. Finally, we measured the fibrinolytic activity in sural nerve biopsies from patients with peripheral neuropathies. We showed that neuropathies with defective regeneration had reduced fibrinolytic activity. On the contrary, neuropathies with signs of active regeneration displayed higher fibrinolytic activity. Overall, our results suggest that enforced fibrinolysis may facilitate regeneration and outcome of peripheral neuropathies.	[Rivellini, Cristina; Dina, Giorgia; Porrello, Emanuela; Cerri, Federica; Scarlato, Marina; Domi, Teuta; Bolino, Alessandra; Quattrini, Angelo; Comi, Giancarlo; Previtali, Stefano C.] Ist Sci San Raffaele, Inst Expt Neurol INSPE, I-20132 Milan, Italy; [Rivellini, Cristina; Dina, Giorgia; Porrello, Emanuela; Cerri, Federica; Scarlato, Marina; Domi, Teuta; Bolino, Alessandra; Quattrini, Angelo; Comi, Giancarlo; Previtali, Stefano C.] Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy; [Cerri, Federica; Scarlato, Marina; Ungaro, Daniela; Del Carro, Ubaldo; Quattrini, Angelo; Comi, Giancarlo; Previtali, Stefano C.] Ist Sci San Raffaele, Dept Neurol, I-20132 Milan, Italy; [Bolino, Alessandra] Dulbecco Telethon Inst, Rome, Italy; [Comi, Giancarlo] Vita e Salute San Raffaele Univ, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Vita-Salute San Raffaele University	Rivellini, C (corresponding author), Ist Sci San Raffaele, Inst Expt Neurol INSPE, I-20132 Milan, Italy.	previtali.stefano@hsr.it	domi, teuta/K-9646-2016; Cerri, Federica/AAO-1670-2020; Bolino, Alessandra/AAN-5442-2020; Previtali, Stefano/Z-1962-2019; dina, giorgia/AAN-3770-2020; Rivellini, Cristina/AAN-6194-2020; Bolino, Alessandra/O-2933-2013; scarlato, marina/AAB-8949-2019; Del Carro, Ubaldo/AAO-3457-2020; Porrello, Emanuela/J-7362-2016; Quattrini, Angelo/J-8373-2018	domi, teuta/0000-0002-8377-5594; Bolino, Alessandra/0000-0002-8980-4878; Previtali, Stefano/0000-0003-2546-4357; dina, giorgia/0000-0002-9684-2143; Del Carro, Ubaldo/0000-0003-3301-5412; Porrello, Emanuela/0000-0003-0490-1538; Quattrini, Angelo/0000-0002-8226-8320; scarlato, marina/0000-0003-1060-8207	Fondazione Telethon Italy [GGP08037]; Telethon career award;  [GPP10007]	Fondazione Telethon Italy(Fondazione Telethon); Telethon career award(Fondazione Telethon); 	This work was supported by Fondazione Telethon Italy (GGP08037 to SCP; Telethon career award to AB; and GPP10007 to SCP and AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akassoglou K, 2003, NEUROSCI LETT, V338, P185, DOI 10.1016/S0304-3940(02)01387-3; Akassoglou K, 2002, NEURON, V33, P861, DOI 10.1016/S0896-6273(02)00617-7; Berti C, 2006, NEUROMOL MED, V8, P191, DOI 10.1385/NMM:8:1:191; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Bolis A, 2009, J NEUROSCI, V29, P8858, DOI 10.1523/JNEUROSCI.1423-09.2009; Chapman HA, 1997, CURR OPIN CELL BIOL, V9, P714, DOI 10.1016/S0955-0674(97)80126-3; Chernousov MA, 2008, GLIA, V56, P1498, DOI 10.1002/glia.20740; Dewerchin M, 1996, J CLIN INVEST, V97, P870, DOI 10.1172/JCI118489; East E, 2005, AM J PATHOL, V167, P545, DOI 10.1016/S0002-9440(10)62996-3; Garcia-Monco JC, 2002, J NEUROIMMUNOL, V129, P216, DOI 10.1016/S0165-5728(02)00186-8; Hayden SM, 1996, J NEUROSCI, V16, P2307; Lee JY, 2007, NEUROSCI LETT, V423, P82, DOI 10.1016/j.neulet.2007.06.037; LEFCORT F, 1992, DEVELOPMENT, V116, P767; Lino MM, 2007, J NEUROSCI, V27, P3677, DOI 10.1523/JNEUROSCI.0277-07.2007; Navel KA, 2006, CURR OPIN NEUROBIOL, V16, P492, DOI 10.1016/j.conb.2006.08.008; Previtali SC, 2008, NEUROLOGY, V71, P322, DOI 10.1212/01.wnl.0000319736.43628.04; Previtali SC, 1998, ANN NEUROL, V44, P611, DOI 10.1002/ana.410440406; Previtali SC, 2000, J CELL BIOL, V151, P1035, DOI 10.1083/jcb.151.5.1035; Quattrini A, 1996, GLIA, V17, P294, DOI 10.1002/(SICI)1098-1136(199608)17:4<294::AID-GLIA4>3.0.CO;2-#; Quattrini Angelo, 2003, Critical Reviews in Neurobiology, V15, P1, DOI 10.1615/CritRevNeurobiol.v15.i1.10; SCHERER SS, 2001, GLIAL CELL DEV, P299; Siconolfi LB, 2003, J NEUROSCI RES, V74, P430, DOI 10.1002/jnr.10786; Siconolfi LB, 2001, J NEUROSCI, V21, P4348, DOI 10.1523/JNEUROSCI.21-12-04348.2001; Siconolfi LB, 2001, J NEUROSCI, V21, P4336, DOI 10.1523/JNEUROSCI.21-12-04336.2001; Triolo D, 2006, J CELL SCI, V119, P3981, DOI 10.1242/jcs.03168	25	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32059	10.1371/journal.pone.0032059	http://dx.doi.org/10.1371/journal.pone.0032059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363796	gold, Green Published, Green Submitted			2022-12-27	WOS:000302873700139
J	Serber, DW; Rogala, A; Makarem, M; Rosson, GB; Simin, K; Godfrey, V; Van Dyke, T; Eaves, CJ; Bultman, SJ				Serber, Daniel W.; Rogala, Allison; Makarem, Maisam; Rosson, Gary B.; Simin, Karl; Godfrey, Virginia; Van Dyke, Terry; Eaves, Connie J.; Bultman, Scott J.			The BRG1 Chromatin Remodeler Protects Against Ovarian Cysts, Uterine Tumors, and Mammary Tumors in a Lineage-Specific Manner	PLOS ONE			English	Article							SWI/SNF COMPLEX; RETINOBLASTOMA PROTEIN; ESTROGEN-RECEPTOR; SELF-RENEWAL; EXPRESSION; GLAND; MORPHOGENESIS; CARCINOMA; DELETION; KNOCKOUT	The BRG1 catalytic subunit of SWI/SNF-related complexes is required for mammalian development as exemplified by the early embryonic lethality of Brg1 null homozygous mice. BRG1 is also a tumor suppressor and, in mice, 10% of heterozygous (Brg1(null/+)) females develop mammary tumors. We now demonstrate that BRG1 mRNA and protein are expressed in both the luminal and basal cells of the mammary gland, raising the question of which lineage requires BRG1 to promote mammary homeostasis and prevent oncogenic transformation. To investigate this question, we utilized Wap-Cre to mutate both Brg1 floxed alleles in the luminal cells of the mammary epithelium of pregnant mice where WAP is exclusively expressed within the mammary gland. Interestingly, we found that Brg1(Wap-Cre) conditional homozygotes lactated normally and did not develop mammary tumors even when they were maintained on a Brm-deficient background. However, Brg1(Wap-Cre) mutants did develop ovarian cysts and uterine tumors. Analysis of these latter tissues showed that both, like the mammary gland, contain cells that normally express Brg1 and Wap. Thus, tumor formation in Brg1 mutant mice appears to be confined to particular cell types that require BRG1 and also express Wap. Our results now show that such cells exist both in the ovary and the uterus but not in either the luminal or the basal compartments of the mammary gland. Taken together, these findings indicate that SWI/SNF-related complexes are dispensable in the luminal cells of the mammary gland and therefore argue against the notion that SWI/SNF-related complexes are essential for cell survival. These findings also suggest that the tumor-suppressor activity of BRG1 is restricted to the basal cells of the mammary gland and demonstrate that this function extends to other female reproductive organs, consistent with recent observations of recurrent ARID1A/BAF250a mutations in human ovarian and endometrial tumors.	[Serber, Daniel W.; Rosson, Gary B.; Simin, Karl; Van Dyke, Terry; Bultman, Scott J.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA; [Rogala, Allison; Godfrey, Virginia] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Makarem, Maisam; Eaves, Connie J.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Makarem, Maisam; Eaves, Connie J.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Makarem, Maisam; Eaves, Connie J.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Makarem, Maisam; Eaves, Connie J.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of British Columbia	Serber, DW (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA.	Scott_Bultman@med.unc.edu		Eaves, Connie/0000-0002-3452-1926	National Institutes of Health (National Cancer Institute) [CA125237]; American Institute for Cancer Research; Canadian Breast Cancer Research Alliance [019343]; Canadian Institutes of Health Research Banting; NATIONAL CANCER INSTITUTE [R01CA125237, ZIABC011353] Funding Source: NIH RePORTER	National Institutes of Health (National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Institute for Cancer Research; Canadian Breast Cancer Research Alliance; Canadian Institutes of Health Research Banting(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health (National Cancer Institute grant CA125237) and the American Institute for Cancer Research to SJB, and the Canadian Breast Cancer Research Alliance (#019343) to CJE. MM is a recipient of a Canadian Institutes of Health Research Banting and Best Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2011, ONCOGENE, V30, P445, DOI 10.1038/onc.2010.424; Alessio N, 2010, ONCOGENE, V29, P5452, DOI 10.1038/onc.2010.285; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Becker TM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-4; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Bultman SJ, 2008, ONCOGENE, V27, P460, DOI 10.1038/sj.onc.1210664; Bultman SJ, 2006, GENE DEV, V20, P1744, DOI 10.1101/gad.1435106; BURDON T, 1991, J BIOL CHEM, V266, P6909; CHIBA H, 1994, NUCLEIC ACIDS RES, V22, P1815, DOI 10.1093/nar/22.10.1815; Cohen SM, 2010, NUCLEIC ACIDS RES, V38, P6906, DOI 10.1093/nar/gkq559; Cohet N, 2010, J CELL PHYSIOL, V223, P667, DOI 10.1002/jcp.22072; Cui Y, 2002, J BIOL CHEM, V277, P17830, DOI 10.1074/jbc.M200186200; Daikoku T, 2008, CANCER RES, V68, P5619, DOI 10.1158/0008-5472.CAN-08-1274; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Feng Y, 2007, P NATL ACAD SCI USA, V104, P14718, DOI 10.1073/pnas.0706933104; FRANKS S, 1995, NEW ENGL J MED, V333, P853, DOI 10.1056/NEJM199509283331307; Glaros S, 2008, CANCER RES, V68, P3689, DOI 10.1158/0008-5472.CAN-07-6652; Hendricks KB, 2004, MOL CELL BIOL, V24, P362, DOI 10.1128/MCB.24.1.362-376.2004; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Humphreys RC, 2002, ENDOCRINOLOGY, V143, P3641, DOI 10.1210/en.2002-220224; Humphreys RC, 1996, DEVELOPMENT, V122, P4013; Jiang Z, 2010, J CLIN INVEST, V120, P3296, DOI 10.1172/JCI41490; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kang H, 2004, MOL CELL BIOL, V24, P1188, DOI 10.1128/MCB.24.3.1188-1199.2004; Kia SK, 2008, MOL CELL BIOL, V28, P3457, DOI 10.1128/MCB.02019-07; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; Kuo KT, 2006, MODERN PATHOL, V19, P1570, DOI 10.1038/modpathol.3800687; Kuraguchi M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000367; Lam MH, 2004, CANCER CELL, V6, P45, DOI 10.1016/j.ccr.2004.06.015; Li WM, 2003, DEVELOPMENT, V130, P6143, DOI 10.1242/dev.00820; Long JY, 2003, P NATL ACAD SCI USA, V100, P9791, DOI 10.1073/pnas.1733973100; Ludwig T, 2001, ONCOGENE, V20, P3937, DOI 10.1038/sj.onc.1204512; Matsumoto S, 2006, DEV BIOL, V289, P372, DOI 10.1016/j.ydbio.2005.10.044; Muchardt C, 2001, ONCOGENE, V20, P3067, DOI 10.1038/sj.onc.1204331; Oruetxebarria I, 2004, J BIOL CHEM, V279, P3807, DOI 10.1074/jbc.M309333200; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Shanahan F, 1999, MOL CELL BIOL, V19, P1460; Simin K, 2004, PLOS BIOL, V2, P194, DOI 10.1371/journal.pbio.0020022; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stambolic V, 2000, CANCER RES, V60, P3605; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Strobeck MW, 2000, P NATL ACAD SCI USA, V97, P7748, DOI 10.1073/pnas.97.14.7748; Strober BE, 1996, MOL CELL BIOL, V16, P1576; SumiIchinose C, 1997, MOL CELL BIOL, V17, P5976, DOI 10.1128/MCB.17.10.5976; Triplett AA, 2005, GENESIS, V43, P1, DOI 10.1002/gene.20149; Trouche D, 1997, P NATL ACAD SCI USA, V94, P11268, DOI 10.1073/pnas.94.21.11268; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Weissman B, 2009, CANCER RES, V69, P8223, DOI 10.1158/0008-5472.CAN-09-2166; WEN JY, 1995, MOL REPROD DEV, V41, P399, DOI 10.1002/mrd.1080410402; Wiegand KC, N ENGL J MED, V363, P1532; Xu R, 2007, J BIOL CHEM, V282, P14992, DOI 10.1074/jbc.M610316200; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743	56	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31346	10.1371/journal.pone.0031346	http://dx.doi.org/10.1371/journal.pone.0031346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363625	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700051
J	Sheehy, SH; Duncan, CJA; Elias, SC; Biswas, S; Collins, KA; O'Hara, GA; Halstead, FD; Ewer, KJ; Mahungu, T; Spencer, AJ; Miura, K; Poulton, ID; Dicks, MDJ; Edwards, NJ; Berrie, E; Moyle, S; Colloca, S; Cortese, R; Gantlett, K; Long, CA; Lawrie, AM; Gilbert, SC; Doherty, T; Nicosia, A; Hill, AVS; Draper, SJ				Sheehy, Susanne H.; Duncan, Christopher J. A.; Elias, Sean C.; Biswas, Sumi; Collins, Katharine A.; O'Hara, Geraldine A.; Halstead, Fenella D.; Ewer, Katie J.; Mahungu, Tabitha; Spencer, Alexandra J.; Miura, Kazutoyo; Poulton, Ian D.; Dicks, Matthew D. J.; Edwards, Nick J.; Berrie, Eleanor; Moyle, Sarah; Colloca, Stefano; Cortese, Riccardo; Gantlett, Katherine; Long, Carole A.; Lawrie, Alison M.; Gilbert, Sarah C.; Doherty, Tom; Nicosia, Alfredo; Hill, Adrian V. S.; Draper, Simon J.			Phase Ia Clinical Evaluation of the Safety and Immunogenicity of the Plasmodium falciparum Blood-Stage Antigen AMA1 in ChAd63 and MVA Vaccine Vectors	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; MEROZOITE SURFACE PROTEIN-1; NATURAL IMMUNE-RESPONSES; PRIME-BOOST IMMUNIZATION; MALARIA VACCINE; IN-VITRO; ADJUVANT VACCINES; RHESUS-MACAQUES; PARASITE GROWTH; VIRUS ANKARA	Background: Traditionally, vaccine development against the blood-stage of Plasmodium falciparum infection has focused on recombinant protein-adjuvant formulations in order to induce high-titer growth-inhibitory antibody responses. However, to date no such vaccine encoding a blood-stage antigen(s) alone has induced significant protective efficacy against erythrocytic-stage infection in a pre-specified primary endpoint of a Phase IIa/b clinical trial designed to assess vaccine efficacy. Cell-mediated responses, acting in conjunction with functional antibodies, may be necessary for immunity against blood-stage P. falciparum. The development of a vaccine that could induce both cell-mediated and humoral immune responses would enable important proof-of-concept efficacy studies to be undertaken to address this question. Methodology: We conducted a Phase Ia, non-randomized clinical trial in 16 healthy, malaria-naive adults of the chimpanzee adenovirus 63 (ChAd63) and modified vaccinia virus Ankara (MVA) replication-deficient viral vectored vaccines encoding two alleles (3D7 and FVO) of the P. falciparum blood-stage malaria antigen; apical membrane antigen 1 (AMA1). ChAd63-MVA AMA1 administered in a heterologous prime-boost regime was shown to be safe and immunogenic, inducing highlevel T cell responses to both alleles 3D7 (median 2036 SFU/million PBMC) and FVO (median 1539 SFU/million PBMC), with a mixed CD4(+)/CD8(+) phenotype, as well as substantial AMA1-specific serum IgG responses (medians of 49 mu g/mL and 41 mu g/mL for 3D7 and FVO AMA1 respectively) that demonstrated growth inhibitory activity in vitro. Conclusions: ChAd63-MVA is a safe and highly immunogenic delivery platform for both alleles of the AMA1 antigen in humans which warrants further efficacy testing. ChAd63-MVA is a promising heterologous prime-boost vaccine strategy that could be applied to numerous other diseases where strong cellular and humoral immune responses are required for protection.	[Sheehy, Susanne H.; Duncan, Christopher J. A.; O'Hara, Geraldine A.; Poulton, Ian D.; Gantlett, Katherine; Lawrie, Alison M.] Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford OX3 7LJ, England; [Elias, Sean C.; Biswas, Sumi; Collins, Katharine A.; Halstead, Fenella D.; Ewer, Katie J.; Spencer, Alexandra J.; Dicks, Matthew D. J.; Edwards, Nick J.; Gilbert, Sarah C.; Hill, Adrian V. S.; Draper, Simon J.] Univ Oxford, Jenner Inst, Oxford, England; [Mahungu, Tabitha; Doherty, Tom] Univ Coll London Hosp, Univ Coll London, Clin Res Facil, London, England; [Miura, Kazutoyo; Long, Carole A.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Berrie, Eleanor; Moyle, Sarah] Univ Oxford, Clin Biomfg Facil, Churchill Hosp, Oxford, England; [Colloca, Stefano; Cortese, Riccardo; Nicosia, Alfredo] Okairos AG, Rome, Italy; [Cortese, Riccardo; Nicosia, Alfredo] CEINGE, Naples, Italy	University of Oxford; University of Oxford; Jenner Institute; University College London Hospitals NHS Foundation Trust; University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Oxford; CEINGE Biotecnologie Avanzate	Sheehy, SH (corresponding author), Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford OX3 7LJ, England.	susanne.sheehy@ndm.ox.ac.uk	Draper, Simon J/F-1758-2011; Ewer, Katie J/B-4328-2011; Gilbert, Sarah C./H-2857-2019; Spencer, Alexandra/AAE-6494-2019; Miura, Kazutoyo/AAY-9751-2020; Collins, Katharine/N-4369-2015; Duncan, Christopher/A-2018-2012	Draper, Simon J/0000-0002-9415-1357; Ewer, Katie J/0000-0001-9827-9836; Gilbert, Sarah C./0000-0002-6823-9750; Spencer, Alexandra/0000-0001-7958-6961; Miura, Kazutoyo/0000-0003-4455-2432; Collins, Katharine/0000-0002-7080-2215; Dicks, Matthew/0000-0003-1909-7095; Edwards, Nick/0000-0002-7030-7839; Hodgson, Susanne/0000-0002-0895-3442; Duncan, Christopher/0000-0003-4181-2315; Elias, Sean/0000-0002-6053-8238; Halstead, Fenella/0000-0002-2833-2926	European Malaria Vaccine Development Association (EMVDA); European Commission [LSHP-CT-2007-037506]; UK National Institute of Health Research through the Oxford Biomedical Research Centre [A91301]; Wellcome Trust [084113/Z/07/Z, RTEI0, 45488/Z/05]; PATH Malaria Vaccine Initiative; National Institutes of Health, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001020] Funding Source: NIH RePORTER; MRC [G0700735, G1000527] Funding Source: UKRI; Medical Research Council [G0700735, G1000527] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10233] Funding Source: researchfish	European Malaria Vaccine Development Association (EMVDA)(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); UK National Institute of Health Research through the Oxford Biomedical Research Centre; Wellcome Trust(Wellcome TrustEuropean Commission); PATH Malaria Vaccine Initiative; National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the European Malaria Vaccine Development Association (EMVDA), a European Commission FP6-funded consortium (http://www.emvda.org/) [LSHP-CT-2007-037506]; the UK National Institute of Health Research through the Oxford Biomedical Research Centre (http://www.oxfordbrc.org/) [A91301 Adult Vaccine]; and the Wellcome Trust (http://www.wellcome.ac.uk/) [084113/Z/07/Z]. The GIA work was supported by the PATH Malaria Vaccine Initiative (MVI; http://www.malariavaccine.org/) and the Intramural Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov/Pages/default.aspx). CJAD holds a Wellcome Trust Research Training Fellowship [RTEI0]; SCG, AVSH and SJD are Jenner Investigators; AVSH was supported by a Wellcome Trust Principal Research Fellowship [45488/Z/05]; and SJD is a UK Medical Research Council Career Development Fellow [G1000527]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barouch DH, 2010, CURR OPIN HIV AIDS, V5, P386, DOI 10.1097/COH.0b013e32833cfe4c; Belnoue E, 2008, J IMMUNOL, V181, P8552, DOI 10.4049/jimmunol.181.12.8552; Bett AJ, 2010, VACCINE, V28, P7881, DOI 10.1016/j.vaccine.2010.09.079; Biswas S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020977; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; Bruder JT, 2010, VACCINE, V28, P3201, DOI 10.1016/j.vaccine.2010.02.024; Capone S, 2006, J VIROL, V80, P1688, DOI 10.1128/JVI.80.4.1688-1699.2006; Cech PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022273; Das P, 2010, LANCET, V376, P1515, DOI 10.1016/S0140-6736(10)61551-6; de Cassan SC, 2011, J IMMUNOL, V187, P2602, DOI 10.4049/jimmunol.1101004; Douglas AD, 2010, VACCINE, V28, P7167, DOI 10.1016/j.vaccine.2010.08.068; Draper SJ, 2008, NAT MED, V14, P819, DOI 10.1038/nm.1850; Draper SJ, 2010, J IMMUNOL, V185, P7583, DOI 10.4049/jimmunol.1001760; Draper SJ, 2010, NAT REV MICROBIOL, V8, P62, DOI 10.1038/nrmicro2240; Draper SJ, 2009, CELL HOST MICROBE, V5, P95, DOI 10.1016/j.chom.2008.12.004; Dudareva M, 2009, VACCINE, V27, P3501, DOI 10.1016/j.vaccine.2009.03.080; Duncan CJA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022271; Dutta S, 2007, P NATL ACAD SCI USA, V104, P12488, DOI 10.1073/pnas.0701464104; ELLIS RD, 2010, HUM VACCIN, V6; Ellis RD, 2009, VACCINE, V27, P4104, DOI 10.1016/j.vaccine.2009.04.077; Good MF, 2005, ANNU REV IMMUNOL, V23, P69, DOI 10.1146/annurev.immunol.23.021704.115638; Good MF, 2011, NAT MED, V17, P49, DOI 10.1038/nm0111-49; Goodman AL, 2010, ANN TROP MED PARASIT, V104, P189, DOI 10.1179/136485910X12647085215534; Goodman AL, 2010, INFECT IMMUN, V78, P4601, DOI 10.1128/IAI.00315-10; Hill AVS, 2010, HUM VACCINES, V6, P78, DOI 10.4161/hv.6.1.10116; Joos C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009871; Kawabata Y, 2002, INFECT IMMUN, V70, P6075, DOI 10.1128/IAI.70.11.6075-6082.2002; Keefer MC, 2011, VACCINE, V29, P1948, DOI 10.1016/j.vaccine.2010.12.104; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; Kusi KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008110; Lal AA, 1996, INFECT IMMUN, V64, P1054, DOI 10.1128/IAI.64.3.1054-1059.1996; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lyke KE, 2009, VACCINE, V27, P2171, DOI 10.1016/j.vaccine.2009.01.097; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Miura K, 2008, VACCINE, V26, P193, DOI 10.1016/j.vaccine.2007.10.064; Miura K, 2009, CLIN VACCINE IMMUNOL, V16, P963, DOI 10.1128/CVI.00042-09; Mullen GED, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002940; Pierce MA, 2010, VACCINE, V28, P2236, DOI 10.1016/j.vaccine.2009.12.049; Porter DW, 2011, VACCINE; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Sedegah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024586; Sedegah M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-241; Sheehy SH, 2011, MOL THER; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; Sirima SB, 2011, NEW ENGL J MED, V365, P1062, DOI 10.1056/NEJMc1100670; Spring MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005254; Su Z, 2000, INFECT IMMUN, V68, P4399, DOI 10.1128/IAI.68.8.4399-4406.2000; Takala SL, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000257; Tamminga C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025868; Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115; Udhayakumar V, 2001, AM J TROP MED HYG, V65, P100, DOI 10.4269/ajtmh.2001.65.100; Walther M, 2006, INFECT IMMUN, V74, P2706, DOI 10.1128/IAI.74.5.2706-2716.2006; Webster DP, 2005, P NATL ACAD SCI USA, V102, P4836, DOI 10.1073/pnas.0406381102; Yoneto T, 2001, J IMMUNOL, V166, P6236, DOI 10.4049/jimmunol.166.10.6236	55	124	129	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31208	10.1371/journal.pone.0031208	http://dx.doi.org/10.1371/journal.pone.0031208			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363582	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000302873700033
J	Zhong, R; Tian, Y; Liu, L; Qiu, Q; Wang, Y; Rui, R; Yang, BF; Duan, SY; Shi, JX; Miao, XP; Wang, L; Li, H				Zhong, Rong; Tian, Yao; Liu, Li; Qiu, Qian; Wang, Ying; Rui, Rui; Yang, Bei-Fang; Duan, Sheng-Yu; Shi, Jun-Xin; Miao, Xiao-Ping; Wang, Li; Li, Hui			HBV-Related Hepatocellular Carcinoma Susceptibility Gene KIF1B Is Not Associated with Development of Chronic Hepatitis B	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; VIRUS INFECTION; LOCUS; CHINA; VISUALIZATION; MANAGEMENT; ALPHA	Background: A recent genome-wide association study has identified a new susceptibility locus, kinesin family member 1B gene (KIF1B), strongly associated with progression from chronic hepatitis B (CHB) to hepatitis B virus-related hepatocellular carcinoma (HCC) in Chinese population, this study was carried out to explore the role of the genetic variants in KIF1B in the development of chronic hepatitis B. Methodology/Principal Findings: Three KIF1B polymorphisms (rs8019, rs17401924, and rs17401966) were selected and genotyped in 473 CHB patients and 580 controls with no history of CHB. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated by logistic regression model. None of these three SNPs showed association with CHBs after adjusting for age and gender. Equivalence-based method analysis confirmed the absence of association. In the further haplotype analysis, three common haplotypes were observed in this study population, but no significant effect was also found for haplotypes in the progression to CHB. Conclusions/Significance: This study showed the new locus identified for HCC, KIF1B, was not associated with progression to CHB, implying distinct genetic susceptibility factor contributes to the progression from hepatitis B virus infection to HCC. Nevertheless, further comprehensive analyses are warranted to dissect the mechanism.	[Zhong, Rong; Rui, Rui; Yang, Bei-Fang; Duan, Sheng-Yu; Shi, Jun-Xin; Miao, Xiao-Ping] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Epidemiol & Biostat & Minist, Educ Key Lab Environm & Hlth,Sch Publ Hlth, Wuhan 430074, Hubei, Peoples R China; [Tian, Yao; Qiu, Qian; Wang, Li; Li, Hui] Chinese Acad Med Sci, Dept Epidemiol & Biostat, Inst Basic Med Sci, Beijing 100730, Peoples R China; [Tian, Yao; Qiu, Qian; Wang, Li; Li, Hui] Peking Union Med Coll, Sch Basic Med, Beijing 100021, Peoples R China; [Liu, Li] Guangdong Pharmaceut Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Wang, Ying] Wuhan Ctr Dis Prevent & Control, Dept Virol, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Guangdong Pharmaceutical University	Zhong, R (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Epidemiol & Biostat & Minist, Educ Key Lab Environm & Hlth,Sch Publ Hlth, Wuhan 430074, Hubei, Peoples R China.	miaoxp@mail.hust.edu.cn; liwang@ibms.pumc.edu.cn	Zhong, Rong/Q-1813-2019; miao, xiaoping/C-4336-2011	miao, xiaoping/0000-0002-6818-9722; Zhong, Rong/0000-0002-5060-895X	National Key Project of Infectious Disease [2009ZX10004-903, 2008ZX10002-001]; Science Fund for Creative Research Groups [30721063]; Foundation of Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences [2009PY16]; fundamental research funds for the central universities (HUST) [2011TS019]	National Key Project of Infectious Disease; Science Fund for Creative Research Groups(Science Fund for Creative Research Groups); Foundation of Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences; fundamental research funds for the central universities (HUST)(Fundamental Research Funds for the Central Universities)	This work was supported by National Key Project of Infectious Disease (Grant number: 2009ZX10004-903 and 2008ZX10002-001), Science Fund for Creative Research Groups (Grant number: 30721063), Foundation of Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences (Grant number: 2009PY16), the fundamental research funds for the central universities (HUST: NO.2011TS019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott W, 2007, IMMUNOGENETICS, V59, P187, DOI 10.1007/s00251-006-0184-4; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Carroll MB, 2010, CLIN RHEUMATOL, V29, P1021, DOI 10.1007/s10067-010-1523-2; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Gourraud PA, 2011, GENET EPIDEMIOL, V35, P568, DOI 10.1002/gepi.20592; Guo X, 2010, HEPATOLOGY; Hann HWL, 2010, CURR CLIN ONCOL, P235, DOI 10.1007/978-1-60327-376-3_7; Hohler T, 1997, J HEPATOL, V26, P503, DOI 10.1016/S0168-8278(97)80414-X; Hoofnagle JH, 2007, HEPATOLOGY, V45, P1056, DOI 10.1002/hep.21627; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kumar V, 2011, NAT GENET, V43, P455, DOI 10.1038/ng.809; Li SP, 2001, J HEPATOL, V34, P840, DOI 10.1016/S0168-8278(01)00047-2; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; LIN TM, 1989, ANTICANCER RES, V9, P737; Lu FM, 2009, CHINESE MED J-PEKING, V122, P3, DOI 10.3760/cma.j.issn.0366-6999.2009.01.001; Munirajan AK, 2008, J BIOL CHEM, V283, P24426, DOI 10.1074/jbc.M802316200; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sun ZT, 2002, J MED VIROL, V67, P447, DOI 10.1002/jmv.10094; Suneetha PV, 2006, J HEPATOL, V44, P856, DOI 10.1016/j.jhep.2006.01.028; Wang FS, 2003, WORLD J GASTROENTERO, V9, P641, DOI 10.3748/wjg.v9.i4.641; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017608; Yang CH, 2008, OMICS, V12, P217, DOI 10.1089/omi.2008.0026; Zhang HX, 2010, NAT GENET, V42, P755, DOI 10.1038/ng.638	26	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e28839	10.1371/journal.pone.0028839	http://dx.doi.org/10.1371/journal.pone.0028839			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363396	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700001
J	Beattie, BJ; Thorek, DLJ; Schmidtlein, CR; Pentlow, KS; Humm, JL; Hielscher, AH				Beattie, Bradley J.; Thorek, Daniel L. J.; Schmidtlein, Charles R.; Pentlow, Keith S.; Humm, John L.; Hielscher, Andreas H.			Quantitative Modeling of Cerenkov Light Production Efficiency from Medical Radionuclides	PLOS ONE			English	Article							LUMINESCENCE TOMOGRAPHY; VISIBLE RADIATION; REFRACTIVE-INDEX	There has been recent and growing interest in applying Cerenkov radiation (CR) for biological applications. Knowledge of the production efficiency and other characteristics of the CR produced by various radionuclides would help in accessing the feasibility of proposed applications and guide the choice of radionuclides. To generate this information we developed models of CR production efficiency based on the Frank-Tamm equation and models of CR distribution based on Monte-Carlo simulations of photon and beta particle transport. All models were validated against direct measurements using multiple radionuclides and then applied to a number of radionuclides commonly used in biomedical applications. We show that two radionuclides, Ac-225 and In-111, which have been reported to produce CR in water, do not in fact produce CR directly. We also propose a simple means of using this information to calibrate high sensitivity luminescence imaging systems and show evidence suggesting that this calibration may be more accurate than methods in routine current use.	[Beattie, Bradley J.; Thorek, Daniel L. J.; Schmidtlein, Charles R.; Pentlow, Keith S.; Humm, John L.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Hielscher, Andreas H.] Columbia Univ, New York, NY USA	Memorial Sloan Kettering Cancer Center; Columbia University	Beattie, BJ (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.	beattieb@mskcc.org	Beattie, Bradley J/K-8981-2012; Schmidtlein, Charles/AGW-1825-2022	Beattie, Bradley J/0000-0001-9891-8271; Schmidtlein, Charles/0000-0003-0485-3601	MSKCC's Center for In Vivo Molecular Imaging in Cancer; NIH [P50 CA86438, R24 CA83084, P30 CA08748]; Molecular Imaging Fellowship [R25T]; Molecular Imaging Training in Oncology [5R25CA096945-07]; NATIONAL CANCER INSTITUTE [P30CA008748, R24CA083084, P50CA086438, R25CA096945] Funding Source: NIH RePORTER	MSKCC's Center for In Vivo Molecular Imaging in Cancer; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Imaging Fellowship; Molecular Imaging Training in Oncology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by MSKCC's Center for In Vivo Molecular Imaging in Cancer funded by NIH P50 CA86438. DLJT was supported through the R25T Molecular Imaging Fellowship: Molecular Imaging Training in Oncology (5R25CA096945-07). Technical services provided by the Small-Animal Imaging Facility were supported in part by NIH grants R24 CA83084 and P30 CA08748. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	[Anonymous], 2011, ESTAR STOPP POW RANG; [Anonymous], 2011, XCOM PHOT CROSS SECT; [Anonymous], 2009, IVIS200BR01; [Anonymous], 2011, ICRP COMP SOFT TISS; Axelsson J, 2011, MED PHYS, V38, P4127, DOI 10.1118/1.3592646; BETHE HA, 1953, PHYS REV, V89, P1256, DOI 10.1103/PhysRev.89.1256; BOLIN FP, 1989, APPL OPTICS, V28, P2297, DOI 10.1364/AO.28.002297; Cerenkov PA, 1937, PHYS REV, V52, P0378, DOI 10.1103/PhysRev.52.378; Cherenkov P.A., 1934, DOKL AKAD NAUK SSSR, V2, P451; CRC,, 2005, CRC HDB CHEM PHYS; CSG CSG Inc. and CSGNetwork.Com, 2011, WAT DENS CALC; Dehghani H, 2003, PHYS MED BIOL, V48, P2713, DOI 10.1088/0031-9155/48/16/310; Dothager RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013300; FDA, 2001, FDA APPR DRUG PROD; Frank I, 1937, CR ACAD SCI URSS, V14, P109; Hu ZH, 2010, OPT EXPRESS, V18, P24441, DOI 10.1364/OE.18.024441; Koziorowski J, 2000, J NUCL MED, V41, p80P; Levin CS, 1999, PHYS MED BIOL, V44, P781, DOI 10.1088/0031-9155/44/3/019; Levin CS, 2000, PHYS MED BIOL, V45, P559, DOI 10.1088/0031-9155/45/2/501; Liu HG, 2010, SMALL, V6, P1087, DOI 10.1002/smll.200902408; Liu HG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009470; Lucignani G, 2011, EUR J NUCL MED MOL I, V38, P592, DOI 10.1007/s00259-010-1708-6; Mitchell GS, 2011, PHILOS T R SOC A, V369, P4605, DOI 10.1098/rsta.2011.0271; Nuclear Data WWW Service, 2011, NUCL DAT WWW SERV; Polyanskiy M, 2011, REFRACTIVE INDEX DAT; Pope RM, 1997, APPL OPTICS, V36, P8710, DOI 10.1364/AO.36.008710; Ran C, 2011, MOL IMAGING BIOL; Ritson D, TECHNIQUES HIGH ENER; Robertson R, 2009, PHYS MED BIOL, V54, pN355, DOI 10.1088/0031-9155/54/16/N01; ROHRLICH F, 1954, PHYS REV, V93, P38, DOI 10.1103/PhysRev.93.38; ROSS HH, 1969, ANAL CHEM, V41, P1260, DOI 10.1021/ac60279a011; Ruggiero A, 2010, J NUCL MED, V51, P1123, DOI 10.2967/jnumed.110.076521; Spinelli AE, 2011, OPT EXPRESS, V19, P12605, DOI 10.1364/OE.19.012605; Spinelli AE, 2010, PHYS MED BIOL, V55, P483, DOI 10.1088/0031-9155/55/2/010; Zhong J, 2011, ANN BIOMEDICAL ENG, V39	35	61	65	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31402	10.1371/journal.pone.0031402	http://dx.doi.org/10.1371/journal.pone.0031402			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363636	Green Submitted, gold, Green Published			2022-12-27	WOS:000302871500039
J	Geisberger, R; Huemer, M; Gassner, FJ; Zaborsky, N; Egle, A; Greil, R				Geisberger, Roland; Huemer, Michael; Gassner, Franz J.; Zaborsky, Nadja; Egle, Alexander; Greil, Richard			Lysine Residue at Position 22 of the AID Protein Regulates Its Class Switch Activity	PLOS ONE			English	Article							INDUCED CYTIDINE DEAMINASE; ACTIVATION-INDUCED DEAMINASE; ANTIBODY DIVERSIFICATION ENZYME; CENTER B-CELLS; SOMATIC HYPERMUTATION; DNA DEAMINATION; NUCLEAR-EXPORT; PHOSPHORYLATION; RECOMBINATION; EXPRESSION	Background: Activation induced deaminase (AID) mediates class switch recombination and somatic hypermutation of immunoglobulin (Ig) genes in germinal centre B cells. In order to regulate its specific activity and as a means to keep off-target mutations low, several mechanisms have evolved, including binding to specific cofactors, phosphorylation and destabilization of nuclear AID protein. Although ubiquitination at lysine residues of AID is recognized as an essential step in initiating degradation of nuclear AID, any functional relevance of lysine modifications has remained elusive. Methodology/Principal Findings: Here, we report functional implications of lysine modifications of the human AID protein by generating a panel of lysine to arginine mutants of AID and assessment of their catalytic class switch activity. We found that only mutation of Lys22 to Arg resulted in a significant reduction of class switching to IgG1 in transfected primary mouse B cells. This decrease in activity was neither reflected in reduced hypermutation of Ig genes in AID-mutant transfected DT40 B cell lines nor recapitulated in bacterial deamination assays, pointing to involvement of post-translational modification of Lys22 for AID activity in B cells. Conclusions/Significance: Our results imply that lysine modification may represent a novel level of AID regulation and that Lys22 is important for effective AID activity.	[Geisberger, Roland; Huemer, Michael; Gassner, Franz J.; Zaborsky, Nadja; Egle, Alexander; Greil, Richard] Paracelsus Med Univ Salzburg, Lab Immunol & Mol Canc Res, Med Dept Hematol Med Oncol Hemostaseol Rheumatol, Salzburg, Austria	Paracelsus Private Medical University	Geisberger, R (corresponding author), Paracelsus Med Univ Salzburg, Lab Immunol & Mol Canc Res, Med Dept Hematol Med Oncol Hemostaseol Rheumatol, Salzburg, Austria.	r.geisberger@salk.at	Gassner, Franz/AAN-1735-2021; Greil, Richard F/C-7673-2017; Egle, Alexander/AAC-3787-2020	Greil, Richard F/0000-0002-4462-3694; Egle, Alexander/0000-0003-0648-4416; Zaborsky, Nadja/0000-0002-9775-185X; Geisberger, Roland/0000-0002-0131-2191; Gassner, Franz J/0000-0001-9894-0313	FWF [SFB021, L488-B13, T516-B13]; Paracelsus Medical University Salzburg [E-09/09/047-GRE]; Klinische Malignom und Zytokinforschung Salzburg-Innsbruck GmbH; province of Salzburg	FWF(Austrian Science Fund (FWF)); Paracelsus Medical University Salzburg; Klinische Malignom und Zytokinforschung Salzburg-Innsbruck GmbH; province of Salzburg	This work was supported by the Austrian science fund FWF (SFB021 to R.Greil; L488-B13 to A.E.; Hertha Firnberg T516-B13 to N.Z.; www.fwf.ac.at), a grant from the Paracelsus Medical University Salzburg (PMU grant E-09/09/047-GRE to R.Greil and R.Geisberger; www.pmu.ac.at), the Klinische Malignom und Zytokinforschung Salzburg-Innsbruck GmbH, and the province of Salzburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoufouchi S, 2008, J EXP MED, V205, P1357, DOI 10.1084/jem.20070950; Arakawa H, 2004, PLOS BIOL, V2, P967, DOI 10.1371/journal.pbio.0020179; Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; Brar SS, 2004, J BIOL CHEM, V279, P26395, DOI 10.1074/jbc.M403503200; Cannon JP, 2004, IMMUNOL REV, V200, P12, DOI 10.1111/j.0105-2896.2004.00166.x; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Conticello SG, 2008, MOL CELL, V31, P474, DOI 10.1016/j.molcel.2008.07.009; Crouch EE, 2007, J EXP MED, V204, P1145, DOI 10.1084/jem.20061952; Dedeoglu F, 2004, INT IMMUNOL, V16, P395, DOI 10.1093/intimm/dxh042; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Geisberger R, 2009, P NATL ACAD SCI USA, V106, P6736, DOI 10.1073/pnas.0810808106; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; KIM KM, 1993, EUR J IMMUNOL, V23, P911, DOI 10.1002/eji.1830230422; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Maeda K, 2010, J BIOL CHEM, V285, P23945, DOI 10.1074/jbc.M110.131441; McBride KM, 2008, J EXP MED, V205, P2585, DOI 10.1084/jem.20081319; McBride KM, 2006, P NATL ACAD SCI USA, V103, P8798, DOI 10.1073/pnas.0603272103; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muto T, 2006, P NATL ACAD SCI USA, V103, P2752, DOI 10.1073/pnas.0510970103; Neuberger MS, 2008, IMMUNOL CELL BIOL, V86, P124, DOI 10.1038/sj.icb.7100160; Nowak U, 2011, NAT IMMUNOL, V12, P160, DOI 10.1038/ni.1977; Orthwein A, 2010, J EXP MED, V207, P2751, DOI 10.1084/jem.20101321; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Patenaude AM, 2009, NAT STRUCT MOL BIOL, V16, P517, DOI 10.1038/nsmb.1598; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Sena-Esteves M, 1999, J VIROL, V73, P10426, DOI 10.1128/JVI.73.12.10426-10439.1999; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964; Tran TH, 2010, NAT IMMUNOL, V11, P148, DOI 10.1038/ni.1829; Xu ZM, 2010, NAT STRUCT MOL BIOL, V17, P1124, DOI 10.1038/nsmb.1884; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556	42	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30667	10.1371/journal.pone.0030667	http://dx.doi.org/10.1371/journal.pone.0030667			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363466	gold, Green Published, Green Submitted			2022-12-27	WOS:000302871500013
J	Marrone, V; Piscopo, M; Romano, G; Ianora, A; Palumbo, A; Costantini, M				Marrone, Vincenzo; Piscopo, Marina; Romano, Giovanna; Ianora, Adrianna; Palumbo, Anna; Costantini, Maria			Defensome against Toxic Diatom Aldehydes in the Sea Urchin Paracentrotus lividus	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; STRESS-PROTEINS; EXPRESSION; RESPONSES; EMBRYOS; GROWTH; GENE; METALLOTHIONEIN; INDUCTION	Many diatom species produce polyunsaturated aldehydes, such as decadienal, which compromise embryonic and larval development in benthic organisms. Here newly fertilized Paracentrotus lividus sea urchins were exposed to low concentration of decadienal and the expression levels of sixteen genes, implicated in a broad range of functional responses, were followed by Real Time qPCR in order to identify potential decadienal targets. We show that at low decadienal concentrations the sea urchin Paracentrotus lividus places in motion different classes of genes to defend itself against this toxic aldehyde, activating hsp60 and two proteases, hat and BP10, at the blastula stage and hsp56 and several other genes (14-3-3 epsilon, p38 MAPK, MTase, and GS) at the prism stage. At this latter stage all genes involved in skeletogenesis (Nec, uni, SM50 and SM30) were also down-expressed, following developmental abnormalities that mainly affected skeleton morphogenesis. Moreover, sea urchin embryos treated with increasing concentrations of decadienal revealed a dose-dependent response of activated target genes. Finally, we suggest that this orchestrated defense system against decadienal represents part of the chemical defensome of P. lividus affording protection from environmental toxicants.	[Marrone, Vincenzo; Palumbo, Anna; Costantini, Maria] Stn Zool Anton Dohrn, Lab Cellular & Dev Biol, Naples, Italy; [Piscopo, Marina] Univ Naples Federico II, Dept Struct & Funct Biol, Naples, Italy; [Romano, Giovanna; Ianora, Adrianna] Stn Zool Anton Dohrn, Lab Funct & Evolutionary Ecol, Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli; University of Naples Federico II; Stazione Zoologica Anton Dohrn di Napoli	Marrone, V (corresponding author), Stn Zool Anton Dohrn, Lab Cellular & Dev Biol, Naples, Italy.	maria.costantini@szn.it	Costantini, Maria/AGH-4080-2022; Ianora, Adrianna/O-3408-2019; PISCOPO, MARINA/AAU-5505-2020; Romano, Giovanna/F-4561-2015	PISCOPO, MARINA/0000-0003-0560-6952; Romano, Giovanna/0000-0002-4898-7153; Palumbo, Anna/0000-0002-5972-5589	Stazione Zoologica Anton Dohrn	Stazione Zoologica Anton Dohrn	Funding for this work was provided by the Stazione Zoologica Anton Dohrn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluigi MG, 2010, ECOTOXICOLOGY, V19, P520, DOI 10.1007/s10646-009-0433-z; BAUMAN JW, 1993, FUND APPL TOXICOL, V21, P15, DOI 10.1006/faat.1993.1066; Bonaventura R, 2005, BIOCHEM BIOPH RES CO, V328, P150, DOI 10.1016/j.bbrc.2004.12.161; Bonaventura R, 2011, CELL STRESS CHAPERON, V16, P681, DOI 10.1007/s12192-011-0277-3; Cai HM, 2009, PLANT CELL REP, V28, P527, DOI 10.1007/s00299-008-0665-z; Caldwell GS, 2009, MAR DRUGS, V7, P367, DOI 10.3390/md7030367; Campos ACE, 2007, NEOPLASIA, V9, P1111, DOI 10.1593/neo.07712; Costa C, 2010, MOL DIVERS, V14, P653, DOI 10.1007/s11030-009-9203-3; Cruz-Rodriguez LA, 2002, AQUAT TOXICOL, V60, P157, DOI 10.1016/S0166-445X(02)00008-5; da Silva GFZ, 2006, J BIOL CHEM, V281, P10737, DOI 10.1074/jbc.M510707200; Diller KR, 2006, ANNU REV BIOMED ENG, V8, P403, DOI 10.1146/annurev.bioeng.7.060804.100449; Duboc V, 2005, DEV CELL, V9, P147, DOI 10.1016/j.devcel.2005.05.008; Dupont S, 2010, ECOTOXICOLOGY, V19, P449, DOI 10.1007/s10646-010-0463-6; Fernandez-Guerra A, 2006, DEV BIOL, V300, P238, DOI 10.1016/j.ydbio.2006.09.012; Garaventa F, 2010, ECOTOXICOLOGY, V19, P512, DOI 10.1007/s10646-010-0461-8; Geraci F, 2004, BIOCHEM BIOPH RES CO, V322, P873, DOI 10.1016/j.bbrc.2004.08.005; Goldstone JV, 2006, DEV BIOL, V300, P366, DOI 10.1016/j.ydbio.2006.08.066; Gupta SC, 2010, LIFE SCI, V86, P377, DOI 10.1016/j.lfs.2009.12.015; Hallare AV, 2004, CHEMOSPHERE, V56, P659, DOI 10.1016/j.chemosphere.2004.04.007; Horiguchi T, 2010, ECOTOXICOLOGY, V19, P571, DOI 10.1007/s10646-009-0447-6; Ianora A, 2010, ECOTOXICOLOGY, V19, P493, DOI 10.1007/s10646-009-0434-y; Kiyomoto M, 2010, ECOTOXICOLOGY, V19, P563, DOI 10.1007/s10646-009-0452-9; Kobayashi N, 2005, CHEMOSPHERE, V61, P1198, DOI 10.1016/j.chemosphere.2005.02.071; Kodama K, 2010, ECOTOXICOLOGY, V19, P479, DOI 10.1007/s10646-009-0438-7; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; LEPAGE T, 1992, DEV BIOL, V150, P23, DOI 10.1016/0012-1606(92)90004-Z; Lhomond G, 1996, EUR J BIOCHEM, V238, P744, DOI 10.1111/j.1432-1033.1996.0744w.x; Matranga V, 2006, MAR BIOL, V149, P25, DOI 10.1007/s00227-005-0212-1; Matranga V, 2000, CELL STRESS CHAPERON, V5, P113, DOI 10.1379/1466-1268(2000)005<0113:CABRTE>2.0.CO;2; Matranga V, 2010, ECOTOXICOLOGY, V19, P530, DOI 10.1007/s10646-009-0444-9; NEMER M, 1991, DEV BIOL, V145, P255, DOI 10.1016/0012-1606(91)90124-L; Palotai R, 2008, IUBMB LIFE, V60, P10, DOI 10.1002/iub.8; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinsino A, 2008, CELL BIOL TOXICOL, V24, P541, DOI 10.1007/s10565-008-9055-0; Pinsino A, 2011, TOXICOL SCI, V123, P217, DOI 10.1093/toxsci/kfr152; Pinsino A, 2010, ECOTOXICOLOGY, V19, P555, DOI 10.1007/s10646-009-0432-0; Regev A, 1998, MOL BIOL EVOL, V15, P880, DOI 10.1093/oxfordjournals.molbev.a025992; Ribalet F, 2007, AQUAT TOXICOL, V85, P219, DOI 10.1016/j.aquatox.2007.09.006; Roccheri MC, 2004, BIOCHEM BIOPH RES CO, V321, P80, DOI 10.1016/j.bbrc.2004.06.108; Roccheri MC, 2001, BIOCHEM BIOPH RES CO, V287, P1093, DOI 10.1006/bbrc.2001.5503; Romano G, 2011, PLOS ONE, V10; Romano G, 2010, MAR DRUGS, V8, P950, DOI 10.3390/md8040950; Romanucci M, 2008, CELL STRESS CHAPERON, V13, P253, DOI 10.1007/s12192-008-0030-8; Russo R, 2003, CELL STRESS CHAPERON, V8, P232, DOI 10.1379/1466-1268(2003)008<0232:STCMBM>2.0.CO;2; Russo R, 2010, CELL STRESS CHAPERON, V15, P993, DOI 10.1007/s12192-010-0210-1; SANDERS BM, 1993, CRIT REV TOXICOL, V23, P49, DOI 10.3109/10408449309104074; Sugni M, 2010, ECOTOXICOLOGY, V19, P538, DOI 10.1007/s10646-009-0439-6; Teixeira J, 2009, PLANT PHYSIOL BIOCH, V47, P807, DOI 10.1016/j.plaphy.2009.05.002; Tominaga H, 2010, ECOTOXICOLOGY, V19, P577, DOI 10.1007/s10646-010-0462-7; Zito F, 2003, DEV BIOL, V264, P217, DOI 10.1016/j.ydbio.2003.07.015	51	38	39	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31750	10.1371/journal.pone.0031750	http://dx.doi.org/10.1371/journal.pone.0031750			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363721	gold, Green Published, Green Submitted			2022-12-27	WOS:000302871500084
J	Heegaard, NHH; West-Norager, M; Tanassi, JT; Houen, G; Nedergaard, L; Hogdall, C; Hogdall, E				Heegaard, Niels H. H.; West-Norager, Mikkel; Tanassi, Julia T.; Houen, Gunnar; Nedergaard, Lotte; Hogdall, Claus; Hogdall, Estrid			Circulating Antinuclear Antibodies in Patients with Pelvic Masses Are Associated with Malignancy and Decreased Survival	PLOS ONE			English	Article							OVARIAN-CANCER; AUTOANTIBODIES	Background: Circulating autoantibodies occur more frequently in cancer patients than in patients without cancer. Methods and Findings: We examined sera from patients referred for pelvic mass symptoms to a tertiary university clinic. A total of 127 were diagnosed with epithelial ovarian cancer while 386 had a benign condition. A screen for IgG anti-nuclear antibodies (ANA) by indirect immunofluorescence on HEp-2 cells confirmed a highly significant overrepresentation of ANA in the cancer group where 40% had detectable (i.e., a titer >= 160) ANA compared with less than 12% in the benign group. The overrepresentation of ANA in the cancer group persisted (p<0.0001) after matching the age-profile of the benign group with the ovarian cancer group. Only 19 out of 127 patients in the age-matched benign subgroup were positive for ANA corresponding to an 85% specificity at 40% sensitivity of ANA as the only marker for malignancy. No correlation of ANA positivity in either group with specific bands in immunoblots could be demonstrated even though immunoblot positivity was clearly increased in the malignant group (41% vs. 3%). The presence, strength, and type of ANA did not correlate with serum CA-125 values or with staging, and ANA outcome did not contribute with independent diagnostic information. However, survival was significantly shorter in ANA-positive compared with ANA-negative cancer patients and patients with CA-125 below the median CA-125 value in the cancer group had a significantly decreased survival when positive for ANA. ANA status made no difference in the group with CA-125 values above the median. Also, there was a significant correlation between speckled ANA-strength and histological tumor grade. Conclusions: Circulating antibodies are a promising source for new biomarkers in cancer. Characterization of epitope specificities and measurements of consecutive samples will be important for further elucidating the role of ANA in evaluating ovarian cancer patients.	[Heegaard, Niels H. H.; West-Norager, Mikkel; Tanassi, Julia T.; Houen, Gunnar] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark; [Nedergaard, Lotte] Univ Copenhagen, Rigshosp, Dept Pathol, Copenhagen, Denmark; [Hogdall, Claus] Univ Copenhagen, Juliane Marie Ctr, Gynecol Clin, Rigshosp, Copenhagen, Denmark; [Hogdall, Estrid] Univ Copenhagen, Herlev Hosp, Dept Pathol, DK-2730 Herlev, Denmark	Statens Serum Institut; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital	Heegaard, NHH (corresponding author), Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark.	nhe@ssi.dk		Hogdall, Estrid/0000-0003-4689-5658; Houen, Gunnar/0000-0002-5948-4156; Hogdall, Claus/0000-0002-5959-8874				Andersen-Ranberg K, 2004, CLIN EXP IMMUNOL, V138, P158, DOI 10.1111/j.1365-2249.2004.02575.x; COX DR, 1972, J R STAT SOC B, V34, P187; Dahle C, 2004, J AUTOIMMUN, V22, P241, DOI 10.1016/j.jaut.2003.12.004; Desmetz C, 2009, EXPERT REV PROTEOMIC, V6, P377, DOI 10.1586/EPR.09.56; Hatpio R, 2004, CLIN BIOCHEM, V37, P512, DOI 10.1016/j.clinbiochem.2004.05.012; HIJMANS W, 1984, MECH AGEING DEV, V26, P83, DOI 10.1016/0047-6374(84)90167-2; Hudson ME, 2007, P NATL ACAD SCI USA, V104, P17494, DOI 10.1073/pnas.0708572104; IMAI H, 1992, AM J PATHOL, V140, P859; Karam AK, 2010, NAT REV CLIN ONCOL, V7, P335, DOI 10.1038/nrclinonc.2010.44; KENEMANS P, 1993, CLIN CHEM, V39, P2509; MOORE AE, 1955, CANCER RES, V15, P598; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; TAN EM, 1988, CLIN IMMUNOL IMMUNOP, V47, P121, DOI 10.1016/0090-1229(88)90066-9; Tan EM, 2001, J CLIN INVEST, V108, P1411, DOI 10.1172/JCI200114451; Tan EM, 1997, ARTHRITIS RHEUM-US, V40, P1601, DOI 10.1002/art.1780400909; West-Hielsen M, 2005, ANAL CHEM, V77, P5114, DOI 10.1021/ac050253g; West-Norager M, 2009, ANAL CHEM, V81, P1907, DOI 10.1021/ac802293g	17	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30997	10.1371/journal.pone.0030997	http://dx.doi.org/10.1371/journal.pone.0030997			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363532	Green Submitted, gold, Green Published			2022-12-27	WOS:000302853600095
J	Juric, V; Chen, CC; Lau, LF				Juric, Vladislava; Chen, Chih-Chiun; Lau, Lester F.			TNF alpha-Induced Apoptosis Enabled by CCN1/CYR61: Pathways of Reactive Oxygen Species Generation and Cytochrome c Release	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN; TISSUE GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA; MEDIATED APOPTOSIS; JNK ACTIVATION; LRP; KINASE; P53; BAX; PROLIFERATION	Although TNF alpha is a strong inducer of apoptosis, its cytotoxicity in most normal cells in vitro requires blockade of NF kappa B signaling or inhibition of de novo protein synthesis, typically by the addition of cycloheximide. However, several members of CCN (CYR61/CTGF/NOV) family of extracellular matrix proteins enable TNF alpha-dependent apoptosis in vitro without inhibiting NF kappa B or de novo protein synthesis, and CCN1 (CYR61) is essential for optimal TNF alpha cytotoxicity in vivo. Previous studies showed that CCN1 unmasks the cytotoxicity of TNF alpha by binding integrins alpha(v)beta(5), alpha(6)beta(1), and the cell surface heparan sulfate proteoglycan syndecan 4 to induce the accumulation of a high level of reactive oxygen species (ROS), leading to a biphasic activation of JNK necessary for apoptosis. Here we show for the first time that CCN1 interacts with the low density lipoprotein receptor-related protein 1 (LRP1) in a protein complex, and that binding to LRP1 is critical for CCN1-induced ROS generation and apoptotic synergism with TNF alpha. We also found that neutral sphingomyelinase 1 (nSMase1), which contributes to CCN1-induced ROS generation, is required for CCN1/TNF alpha-induced apoptosis. Furthermore, CCN1 promotes the activation of p53 and p38 MAPK, which mediate enhanced cytochrome c release to amplify the cytotoxicity of TNF alpha. By contrast, LRP1, nSMase1, p53, and p38 MAPK are not required when TNF alpha-dependent apoptosis is facilitated by the presence of cycloheximide, indicating that they function in the CCN1 signaling pathway that converges with TNF alpha-induced signaling events. Since CCN1/CYR61 is a physiological regulator of TNF alpha cytotoxicity at least in some contexts, these findings may reveal important mediators of TNF alpha-induced apoptosis in vivo and identify potential therapeutic targets for thwarting TNF alpha-dependent tissue damage.	[Juric, Vladislava; Chen, Chih-Chiun; Lau, Lester F.] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Juric, V (corresponding author), Univ Calif San Francisco, GW Hooper Res Fdn, San Francisco, CA 94143 USA.	lflau@uic.edu		Lau, Lester/0000-0002-4364-2914	National Institutes of Health [GM78492, HL81390]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078492] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants GM78492 and HL81390 from the National Institutes of Health (http://www.nih.gov/) to LFL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Brown SL, 2002, ARTHRITIS RHEUM-US, V46, P3151, DOI 10.1002/art.10679; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chen CC, 2001, J BIOL CHEM, V276, P47329, DOI 10.1074/jbc.M107666200; Chen CC, 2007, EMBO J, V26, P1257, DOI 10.1038/sj.emboj.7601596; Chen CC, 2011, ADV EXP MED BIOL, V691, P595, DOI 10.1007/978-1-4419-6612-4_63; Chen CC, 2010, J CELL COMMUN SIGNAL, V4, P63, DOI 10.1007/s12079-009-0080-4; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Esposito E, 2009, CURR MED CHEM, V16, P3152, DOI 10.2174/092986709788803024; Gao RP, 2004, J BIOL CHEM, V279, P8848, DOI 10.1074/jbc.M313204200; Gao RP, 2003, HEPATOL RES, V27, P214, DOI 10.1016/S1386-6346(03)00241-9; Gaur U, 2003, BIOCHEM PHARMACOL, V66, P1403, DOI 10.1016/S0006-2952(03)00490-8; Ghatan S, 2000, J CELL BIOL, V150, P335, DOI 10.1083/jcb.150.2.335; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hublitz P, 2005, GENE DEV, V19, P2912, DOI 10.1101/gad.351205; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jensen JK, 2009, BIOCHEM J, V421, P273, DOI 10.1042/BJ20090175; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Juric V, 2009, MOL CELL BIOL, V29, P3266, DOI 10.1128/MCB.00064-09; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Li YH, 2003, FEBS LETT, V555, P346, DOI 10.1016/S0014-5793(03)01272-9; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Lillis AP, 2005, J THROMB HAEMOST, V3, P1884, DOI 10.1111/j.1538-7836.2005.01371.x; Lubel JS, 2007, INTERN MED J, V37, P705, DOI 10.1111/j.1445-5994.2007.01479.x; Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Mercurio S, 2004, DEVELOPMENT, V131, P2137, DOI 10.1242/dev.01045; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Piguet PF, 1998, EUR J IMMUNOL, V28, P3499, DOI 10.1002/(SICI)1521-4141(199811)28:11<3499::AID-IMMU3499>3.0.CO;2-Q; Roulston A, 1998, J BIOL CHEM, V273, P10232, DOI 10.1074/jbc.273.17.10232; Rudiger HA, 2002, GASTROENTEROLOGY, V122, P202, DOI 10.1053/gast.2002.30304; Schafer T, 2003, FASEB J, V17, P660, DOI 10.1096/fj.02-0774com; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Segarini PR, 2001, J BIOL CHEM, V276, P40659, DOI 10.1074/jbc.M105180200; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Todorovic V, 2005, J CELL BIOL, V171, P559, DOI 10.1083/jcb.200504015; Tokushige K, 2000, AM J GASTROENTEROL, V95, P2040; UBEZIO P, 1994, FREE RADICAL BIO MED, V16, P509, DOI 10.1016/0891-5849(94)90129-5; Uggeri J, 2004, HISTOCHEM CELL BIOL, V122, P499, DOI 10.1007/s00418-004-0712-y; Valladares A, 2000, ENDOCRINOLOGY, V141, P4383, DOI 10.1210/en.141.12.4383; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang J, 2010, MUCOSAL IMMUNOL, V3, P523, DOI 10.1038/mi.2010.35; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Werner AB, 2002, J BIOL CHEM, V277, P22781, DOI 10.1074/jbc.M201469200; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; Yang M, 2004, FASEB J, V18, P1920, DOI 10.1096/fj.04-2357fje; Yin M, 1999, GASTROENTEROLOGY, V117, P942, DOI 10.1016/S0016-5085(99)70354-9; Zumbansen M, 2002, MOL CELL BIOL, V22, P3633, DOI 10.1128/MCB.22.11.3633-3638.2002	57	37	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31303	10.1371/journal.pone.0031303	http://dx.doi.org/10.1371/journal.pone.0031303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363611	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600137
J	Kathiria, AS; Butcher, LD; Feagins, LA; Souza, RF; Boland, CR; Theiss, AL				Kathiria, Arwa S.; Butcher, Lindsay D.; Feagins, Linda A.; Souza, Rhonda F.; Boland, C. Richard; Theiss, Arianne L.			Prohibitin 1 Modulates Mitochondrial Stress-Related Autophagy in Human Colonic Epithelial Cells	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; ULCERATIVE-COLITIS; OXIDATIVE STRESS; CROHNS-DISEASE; SUSCEPTIBILITY LOCI; RESPIRATORY-CHAIN; IN-VITRO	Introduction: Autophagy is an adaptive response to extracellular and intracellular stress by which cytoplasmic components and organelles, including damaged mitochondria, are degraded to promote cell survival and restore cell homeostasis. Certain genes involved in autophagy confer susceptibility to Crohn's disease. Reactive oxygen species and pro-inflammatory cytokines such as tumor necrosis factor alpha (TNF alpha), both of which are increased during active inflammatory bowel disease, promote cellular injury and autophagy via mitochondrial damage. Prohibitin (PHB), which plays a role in maintaining normal mitochondrial respiratory function, is decreased during active inflammatory bowel disease. Restoration of colonic epithelial PHB expression protects mice from experimental colitis and combats oxidative stress. In this study, we investigated the potential role of PHB in modulating mitochondrial stress-related autophagy in intestinal epithelial cells. Methods: We measured autophagy activation in response to knockdown of PHB expression by RNA interference in Caco2-BBE and HCT116 WT and p53 null cells. The effect of exogenous PHB expression on TNF alpha- and IFN gamma-induced autophagy was assessed. Autophagy was inhibited using Bafilomycin A(1) or siATG16L1 during PHB knockdown and the affect on intracellular oxidative stress, mitochondrial membrane potential, and cell viability were determined. The requirement of intracellular ROS in siPHB-induced autophagy was assessed using the ROS scavenger N-acetyl-L-cysteine. Results: TNFa and IFN gamma-induced autophagy inversely correlated with PHB protein expression. Exogenous PHB expression reduced basal autophagy and TNF alpha-induced autophagy. Gene silencing of PHB in epithelial cells induces mitochondrial autophagy via increased intracellular ROS. Inhibition of autophagy during PHB knockdown exacerbates mitochondrial depolarization and reduces cell viability. Conclusions: Decreased PHB levels coupled with dysfunctional autophagy renders intestinal epithelial cells susceptible to mitochondrial damage and cytotoxicity. Repletion of PHB may represent a therapeutic approach to combat oxidant and cytokine-induced mitochondrial damage in diseases such as inflammatory bowel disease.	[Kathiria, Arwa S.; Butcher, Lindsay D.; Boland, C. Richard; Theiss, Arianne L.] Baylor Univ, Med Ctr, Div Gastroenterol, Dept Internal Med,Baylor Res Inst, Dallas, TX USA; [Butcher, Lindsay D.] Baylor Univ, Inst Biomed Studies, Waco, TX 76798 USA; [Feagins, Linda A.; Souza, Rhonda F.] Univ Texas SW Med Ctr Dallas, Dept Med, Vet Affairs N Texas Hlth Care Syst, Dallas, TX 75390 USA	Baylor Scott & White Health; Baylor University; Baylor University Medical Center; Baylor University; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA North Texas Health Care System	Kathiria, AS (corresponding author), Baylor Univ, Med Ctr, Div Gastroenterol, Dept Internal Med,Baylor Res Inst, Dallas, TX USA.	arianne.theiss@baylorhealth.edu		Theiss, Arianne/0000-0003-2862-0933; Feagins, Linda/0000-0001-7758-3257	National Institutes of Health [K01-DK085222]; Baylor Research Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK085222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor Research Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant K01-DK085222 (A.L.T.) and funds from the Baylor Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alva AS, 2004, CELL DEATH DIFFER, V11, P1046, DOI 10.1038/sj.cdd.4401445; Artal-Sanz M, 2009, TRENDS ENDOCRIN MET, V20, P394, DOI 10.1016/j.tem.2009.04.004; Baregamian N, 2009, OXID MED CELL LONGEV, V2, P297, DOI 10.4161/oxim.2.5.9541; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Beau I, 2011, INT J BIOCHEM CELL B, V43, P460, DOI 10.1016/j.biocel.2011.01.006; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Chang YP, 2011, MICROBES INFECT, V13, P888, DOI 10.1016/j.micinf.2011.05.008; Chen YQ, 2008, AUTOPHAGY, V4, P246, DOI 10.4161/auto.5432; Dalby KN, 2010, AUTOPHAGY, V6, P322, DOI 10.4161/auto.6.3.11625; Damiani CR, 2007, J GASTROEN HEPATOL, V22, P1846, DOI 10.1111/j.1440-1746.2007.04890.x; Djavaheri-Mergny M, 2006, J BIOL CHEM, V281, P30373, DOI 10.1074/jbc.M602097200; Du G, 1998, FREE RADICAL BIO MED, V25, P1066, DOI 10.1016/S0891-5849(98)00148-8; Fujishima Y, 2011, ARCH BIOCHEM BIOPHYS, V506, P223, DOI 10.1016/j.abb.2010.12.009; Galluzzi L, 2011, ANTIOXID REDOX SIGNA; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Gurusamy N, 2009, ANTIOXID REDOX SIGN, V11, P1975, DOI [10.1089/ars.2009.2524, 10.1089/ARS.2009.2524]; Henschke P, 2006, PROTEOMICS, V6, P1957, DOI 10.1002/pmic.200500245; Homer CR, 2010, GASTROENTEROLOGY, V139, P1630, DOI 10.1053/j.gastro.2010.07.006; Hsieh SY, 2006, PROTEOMICS, V6, P5322, DOI 10.1002/pmic.200500541; JUPE ER, 1995, EXP CELL RES, V218, P577, DOI 10.1006/excr.1995.1194; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kuballa P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003391; Lapaquette P, 2010, J CLIN GASTROENTEROL, V44, pS26, DOI 10.1097/MCG.0b013e3181dd4fa5; LihBrody L, 1996, DIGEST DIS SCI, V41, P2078, DOI 10.1007/BF02093613; Lin-Lee YC, 2001, BIOCHEM PHARMACOL, V61, P555, DOI 10.1016/S0006-2952(00)00592-X; Liu XH, 2009, CELL STRESS CHAPERON, V14, P311, DOI 10.1007/s12192-008-0086-5; Maiuri MC, 2010, CURR OPIN CELL BIOL, V22, P181, DOI 10.1016/j.ceb.2009.12.001; McKenzie SJ, 1996, J CLIN INVEST, V98, P136, DOI 10.1172/JCI118757; Mehrpour M, 2010, AM J PHYSIOL-CELL PH, V298, pC776, DOI 10.1152/ajpcell.00507.2009; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; OMORAIN C, 1985, SCAND J GASTROENTERO, V20, P209, DOI 10.3109/00365528509089659; RACHMILEWITZ D, 1995, GUT, V36, P718, DOI 10.1136/gut.36.5.718; Rastogi S, 2006, J BIOL CHEM, V281, P2951, DOI 10.1074/jbc.M508669200; Restivo NL, 2004, J PEDIATR GASTR NUTR, V38, P534, DOI 10.1097/00005176-200405000-00014; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Roda G, 2010, WORLD J GASTROENTERO, V16, P4264, DOI 10.3748/wjg.v16.i34.4264; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sartor R Balfour, 2007, Curr Gastroenterol Rep, V9, P497; Sasnauskiene A, 2009, APOPTOSIS, V14, P276, DOI 10.1007/s10495-008-0292-8; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Schleicher M, 2008, J CELL BIOL, V180, P101, DOI 10.1083/jcb.200706072; SHIRATORA Y, 1989, DIGESTION, V44, P163, DOI 10.1159/000199906; Sifroni KG, 2010, MOL CELL BIOCHEM, V342, P111, DOI 10.1007/s11010-010-0474-x; Tang H, 2009, HEPATOLOGY, V49, P60, DOI 10.1002/hep.22581; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Theiss AL, 2007, FASEB J, V21, P197, DOI 10.1096/fj.06-6801com; Theiss AL, 2011, INFLAMM BOWEL DIS, V17, P1163, DOI 10.1002/ibd.21469; Theiss AL, 2009, MOL BIOL CELL, V20, P4412, DOI 10.1091/mbc.E09-05-0361; Theiss AL, 2009, GASTROENTEROLOGY, V137, P199, DOI 10.1053/j.gastro.2009.03.033; Tirosh O, 2007, NUTRITION, V23, P878, DOI 10.1016/j.nut.2007.08.019; Tsutsumi T, 2009, HEPATOLOGY, V50, P378, DOI 10.1002/hep.22998; Umeno J, 2011, INFLAMM BOWEL DIS; Vanderborght M, 2004, J PEDIATR GASTR NUTR, V38, P355, DOI 10.1097/00005176-200403000-00023; Wang S, 2002, EMBO J, V21, P3019, DOI 10.1093/emboj/cdf302; Wang S, 2002, ONCOGENE, V21, P8388, DOI 10.1038/sj.onc.1205944; Xiao GT, 2007, CYTOKINE GROWTH F R, V18, P233, DOI 10.1016/j.cytogfr.2007.04.006	62	53	55	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31231	10.1371/journal.pone.0031231	http://dx.doi.org/10.1371/journal.pone.0031231			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363587	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600126
J	Maman, D; Pujades-Rodriguez, M; Subtil, F; Pinoges, L; McGuire, M; Ecochard, R; Etard, JF				Maman, David; Pujades-Rodriguez, Mar; Subtil, Fabien; Pinoges, Loretxu; McGuire, Megan; Ecochard, Rene; Etard, Jean-Francois			Gender Differences in Immune Reconstitution: A Multicentric Cohort Analysis in Sub-Saharan Africa	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HIV-INFECTED ADULTS; TERM IMMUNOLOGICAL RESPONSE; CELL COUNT; HIV-1-INFECTED PATIENTS; COLLABORATIVE ANALYSIS; BASE-LINE; VIROLOGICAL SUPPRESSION; VIRAL SUPPRESSION; INCOME COUNTRIES	Background: In sub-Saharan Africa, men living with HIV often start ART at more advanced stages of disease and have higher early mortality than women. We investigated gender difference in long-term immune reconstitution. Methods/Principal Findings: Antiretroviral-naive adults who received ART for at least 9 months in four HIV programs in sub-Saharan Africa were included. Multivariate mixed linear models were used to examine gender differences in immune reconstitution on first line ART. A total of 21,708 patients (68% women) contributed to 61,912 person-years of follow-up. At ART start,. Median CD4 at ART were 149 [IQR 85-206] for women and 125 cells/mu L [IQR 63-187] for men. After the first year on ART, immune recovery was higher in women than in men, and gender-based differences increased by 20 CD4 cells/mu L per year on average (95% CI 16-23; P<0.001). Up to 6 years after ART start, patients with low initial CD4 levels experienced similar gains compared to patients with high initial levels, including those with CD4>250cells/mu L (difference between patients with <50 cells/mu L and those with >250 was 284 cells/mu L; 95% CI 272-296; LR test for interaction with time p = 0.63). Among patients with initial CD4 count of 150-200 cells/mu L, women reached 500 CD4 cells after 2.4 years on ART (95% CI 2.4-2.5) and men after 4.5 years (95% CI 4.1-4.8) of ART use. Conclusion: Women achieved better long-term immune response to ART, reaching CD4 level associated with lower risks of AIDS related morbidity and mortality quicker than men.	[Maman, David; Pujades-Rodriguez, Mar; Pinoges, Loretxu; McGuire, Megan; Etard, Jean-Francois] Med Sans Frontieres, Epictr, Paris, France; [Maman, David; Subtil, Fabien; Ecochard, Rene] Hosp Civils Lyon, Serv Biostat, Lyon, France; [Etard, Jean-Francois] UMI 233, TransVIHMI, Montpellier, France; [Maman, David; Subtil, Fabien; Ecochard, Rene] Univ Lyon, Lyon, France; [Maman, David; Subtil, Fabien; Ecochard, Rene] Univ Lyon 1, F-69622 Villeurbanne, France; [Maman, David; Subtil, Fabien; Ecochard, Rene] CNRS UMR5558, Lab Biometrie & Biol Evolut, Equipe Biostat Sante, Pierre Benite, France	Doctors Without Borders; CHU Lyon; Universite de Montpellier; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE)	Maman, D (corresponding author), Med Sans Frontieres, Epictr, Paris, France.	david.maman@epicentre.msf.org	Pujades-Rodriguez, Mar/G-4388-2014; Etard, Jean François/A-9630-2008; Pujades-Rodriguez, Mar/T-1129-2018; Etard, Jean-Francois/V-4865-2019	Pujades-Rodriguez, Mar/0000-0002-7778-3520; Etard, Jean François/0000-0002-4873-0788; Pujades-Rodriguez, Mar/0000-0002-1375-1028; Etard, Jean-Francois/0000-0002-4873-0788; Maman, David/0000-0002-9839-3011	Sidaction, France [BI20-3-01644]	Sidaction, France	DM is financially supported by Sidaction, France (BI20-3-01644). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker JV, 2008, AIDS, V22, P841, DOI 10.1097/QAD.0b013e3282f7cb76; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Bila B, 2009, SOC SCI MED, V69, P854, DOI 10.1016/j.socscimed.2009.05.035; Boyer S, 2010, AIDS, V24, pS5, DOI 10.1097/01.aids.0000366078.45451.46; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Braitstein P, 2008, J WOMENS HEALTH, V17, P47, DOI 10.1089/jwh.2007.0353; Bucy RP, 1999, J CLIN INVEST, V103, P1391, DOI 10.1172/JCI5863; Casella G., 2002, STAT INFERENCE, V2nd; Cornell M, 2009, TROP MED INT HEALTH, V14, P722, DOI 10.1111/j.1365-3156.2009.02290.x; De Beaudrap P, 2009, AM J TROP MED HYG, V80, P1047, DOI 10.4269/ajtmh.2009.80.1047; Dou ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022707; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Ekouevi DK, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-28; Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713; Falster K, 2009, JAIDS-J ACQ IMM DEF, V50, P307, DOI 10.1097/QAI.0b013e3181945ed4; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Florence E, 2003, HIV Med, V4, P255, DOI 10.1046/j.1468-1293.2003.00156.x; Garcia F, 2004, JAIDS-J ACQ IMM DEF, V36, P702, DOI 10.1097/00126334-200406010-00007; Giordano TP, 2003, CLIN INFECT DIS, V37, P433, DOI 10.1086/376638; Hawkins C, 2011, AIDS, V25, P1189, DOI 10.1097/QAD.0b013e3283471deb; Hunt PW, 2003, AIDS, V17, P1907, DOI 10.1097/00002030-200309050-00009; Joint United Nations Programme on HIV/AIDS, 2010, REP GLOB HIV AIDS EP; Kaufmann GR, 2000, AIDS, V14, P959, DOI 10.1097/00002030-200005260-00007; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Kigozi IM, 2009, JAIDS-J ACQ IMM DEF, V52, P280, DOI 10.1097/QAI.0b013e3181ab6eab; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lawn SD, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-59; Lodwick RK, 2010, LANCET, V376, P340, DOI 10.1016/S0140-6736(10)60932-4; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Muula AS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-63; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; Nicastri E, 2007, J ANTIMICROB CHEMOTH, V60, P724, DOI 10.1093/jac/dkm302; Olsen NJ, 2011, J INVEST MED, V59, P32; Pakker NG, 1998, NAT MED, V4, P208, DOI 10.1038/nm0298-208; Pujades-Rodriguez M, 2008, AIDS, V22, P1305, DOI 10.1097/QAD.0b013e3282fa75b9; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Smith CJ, 2003, AIDS, V17, P963, DOI 10.1097/00002030-200305020-00004; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Teixeira L, 2001, AIDS, V15, P1749, DOI 10.1097/00002030-200109280-00002; World Health Organization, 2010, UN ACC SCAL PRIOR HI; World Health Organization, 2009, RAP ADV ANT THER HIV	45	36	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31078	10.1371/journal.pone.0031078	http://dx.doi.org/10.1371/journal.pone.0031078			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363550	Green Published, gold			2022-12-27	WOS:000302853600107
J	Ventetuolo, CE; Barr, RG; Bluemke, DA; Jain, A; Delaney, JAC; Hundley, WG; Lima, JAC; Kawut, SM				Ventetuolo, Corey E.; Barr, R. Graham; Bluemke, David A.; Jain, Aditya; Delaney, Joseph A. C.; Hundley, W. Gregory; Lima, Joao A. C.; Kawut, Steven M.			Selective Serotonin Reuptake Inhibitor Use Is Associated with Right Ventricular Structure and Function: The MESA-Right Ventricle Study	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; SMOOTH-MUSCLE HYPERPLASIA; HEART-FAILURE; CARDIAC-HYPERTROPHY; PLASMA SEROTONIN; MYOCARDIAL-INFARCTION; MAJOR DEPRESSION; TRANSPORTER; ATHEROSCLEROSIS; GENDER	Purpose: Serotonin and the serotonin transporter have been implicated in the development of pulmonary hypertension (PH). Selective serotonin reuptake inhibitors (SSRIs) may have a role in PH treatment, but the effects of SSRI use on right ventricular (RV) structure and function are unknown. We hypothesized that SSRI use would be associated with RV morphology in a large cohort without cardiovascular disease (N = 4114). Methods: SSRI use was determined by medication inventory during the Multi-Ethnic Study of Atherosclerosis baseline examination. RV measures were assessed via cardiac magnetic resonance imaging. The cross-sectional relationship between SSRI use and each RV measure was assessed using multivariable linear regression; analyses for RV mass and end-diastolic volume (RVEDV) were stratified by sex. Results: After adjustment for multiple covariates including depression and left ventricular measures, SSRI use was associated with larger RV stroke volume (RVSV) (2.75 mL, 95% confidence interval [CI] 0.48-5.02 mL, p = 0.02). Among men only, SSRI use was associated with greater RV mass (1.08 g, 95% CI 0.19-1.97 g, p = 0.02) and larger RVEDV (7.71 mL, 95% 3.02-12.40 mL, p = 0.001). SSRI use may have been associated with larger RVEDV among women and larger RV end-systolic volume in both sexes. Conclusions: SSRI use was associated with higher RVSV in cardiovascular disease-free individuals and, among men, greater RV mass and larger RVEDV. The effects of SSRI use in patients with (or at risk for) RV dysfunction and the role of sex in modifying this relationship warrant further study.	[Ventetuolo, Corey E.] Brown Univ, Dept Med, Alpert Med Sch, Providence, RI 02912 USA; [Barr, R. Graham] Columbia Univ, Dept Med, Coll Phys & Surg, New York, NY USA; [Barr, R. Graham] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Barr, R. Graham] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [Bluemke, David A.] Natl Inst Biomed Imaging & Bioengn, NIH, Ctr Clin, Bethesda, MD USA; [Jain, Aditya; Lima, Joao A. C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Delaney, Joseph A. C.] Univ Florida, Coll Pharm, Dept Pharmaceut Outcomes & Policy, Gainesville, FL USA; [Hundley, W. Gregory] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med Cardiol, Winston Salem, NC USA; [Kawut, Steven M.] Univ Penn, Dept Med, Penn Cardiovasc Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kawut, Steven M.] Univ Penn, Ctr Clin Epidemiol & Biostat, Perelman Sch Med, Philadelphia, PA 19104 USA	Brown University; Columbia University; Columbia University; Columbia University; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); Johns Hopkins University; State University System of Florida; University of Florida; Wake Forest University; Wake Forest Baptist Medical Center; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Ventetuolo, CE (corresponding author), Brown Univ, Dept Med, Alpert Med Sch, Providence, RI 02912 USA.	kawut@upenn.edu	Ventetuolo, Corey/W-4871-2017; Delaney, Joseph A/J-8204-2019; Stefanadis, Christodoulos/ABH-2232-2020; Bluemke, David/GYU-8169-2022	Ventetuolo, Corey/0000-0002-4223-4775; Delaney, Joseph A/0000-0003-1771-1776; Stefanadis, Christodoulos/0000-0001-5974-6454; Bluemke, David/0000-0002-8323-8086	National Institutes of Health [R01-HL086719, R01-HL074406, RO1-HL074338, R01-HL077612, N01-HC95159, N01-HC95160, N01-HC95161, N01-HC95162, N01-HC95163, N01-HC95164, N01-HC95165, N01-HC95166, N01-HC95167, N01-HC95168, N01-HC95169]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095165, N01HC095160, N01HC095169, N01HC095163, N01HC095168, N01HC095161, N01HC095164, N01HC095162, N01HC095167, N01HC095166, N01HC095159] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074406, R01HL086719, R01HL077612, R01HL074338, R44HL095169, R43HL095169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000072] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL090019] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); CLINICAL CENTER	This work was supported by the National Institutes of Health grants R01-HL086719, R01-HL074406, RO1-HL074338, R01-HL077612, N01-HC95159 through HC95169. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron CP, 2009, AM J RESP CRIT CARE, V179; Aaron CP, 2011, AM J RESP CRIT CARE, V183, P396, DOI 10.1164/rccm.201003-0469OC; Abenhaim L, 1996, NEW ENGL J MED, V335, P609, DOI 10.1056/NEJM199608293350901; Angermann CE, 2007, EUR J HEART FAIL, V9, P1212, DOI 10.1016/j.ejheart.2007.10.005; ANVERSA P, 1983, CIRC RES, V52, P57, DOI 10.1161/01.RES.52.1.57; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Chahal H, 2011, CHEST IN PRESS; Chahal H, 2010, AM J CARDIOL, V106, P110, DOI 10.1016/j.amjcard.2010.02.022; Chambers CD, 2006, NEW ENGL J MED, V354, P579, DOI 10.1056/NEJMoa052744; Coimbra R, 2008, HYPERTENSION, V52, P514, DOI 10.1161/HYPERTENSIONAHA.108.114744; Dorn GW, 2007, HYPERTENSION, V49, P962, DOI 10.1161/HYPERTENSIONAHA.106.079426; Eddahibi S, 2006, CIRCULATION, V113, P1857, DOI 10.1161/CIRCULATIONAHA.105.591321; Eddahibi S, 2001, J CLIN INVEST, V108, P1141, DOI 10.1172/JCI12805; FETKOVSKA N, 1988, THROMB HAEMOSTASIS, V60, P486; Franke L, 2010, J GASTROENTEROL, V45, P389, DOI 10.1007/s00535-009-0167-y; Gan CTJ, 2007, CHEST, V132, P11, DOI 10.1378/chest.06-1263; Glassman AH, 2002, JAMA-J AM MED ASSOC, V288, P701, DOI 10.1001/jama.288.6.701; Guignabert C, 2005, CIRCULATION, V111, P2812, DOI 10.1161/CIRCULATIONAHA.104.524926; Guignabert C, 2006, CIRC RES, V98, P1323, DOI 10.1161/01.RES.0000222546.45372.a0; Guilluy C, 2009, AM J RESP CRIT CARE, V179, P1151, DOI 10.1164/rccm.200805-691OC; Handoko ML, 2009, CIRCULATION, V120, P42, DOI 10.1161/CIRCULATIONAHA.108.829713; Heckbert SR, 2006, J AM COLL CARDIOL, V48, P2285, DOI 10.1016/j.jacc.2006.03.072; Henriksen E, 1999, EUR HEART J, V20, P309, DOI 10.1053/euhj.1998.1197; HERVE P, 1995, AM J MED, V99, P249, DOI 10.1016/S0002-9343(99)80156-9; Hoeper MM, 2006, NEW ENGL J MED, V354, P1091; Jaffre F, 2009, CIRC RES, V104, P113, DOI 10.1161/CIRCRESAHA.108.180976; Kawut SA, 2009, CHEST, V135, P752, DOI 10.1378/chest.08-1758; Kawut SM, 2006, PULM PHARMACOL THER, V19, P370, DOI 10.1016/j.pupt.2006.01.001; Kawut SM, 2011, CIRCULATION, V123, P2542, DOI 10.1161/CIRCULATIONAHA.110.985515; Kereveur A, 2000, ARTERIOSCL THROM VAS, V20, P2233, DOI 10.1161/01.ATV.20.10.2233; Lederer DJ, 2008, PULM PHARMACOL THER, V21, P112, DOI 10.1016/j.pupt.2007.01.003; Liu LL, 2008, FREE RADICAL BIO MED, V45, P847, DOI 10.1016/j.freeradbiomed.2008.06.008; Liu YL, 2011, AM J RESP CELL MOL, V44, P548, DOI 10.1165/rcmb.2010-0078OC; Machado RD, 2006, AM J RESP CRIT CARE, V173, P793, DOI 10.1164/rccm.200509-1365OC; Marazziti D, 2010, NEUROPSYCH DIS TREAT, V6, P9; Marcos E, 2003, AM J RESP CRIT CARE, V168, P487, DOI 10.1164/rccm.200210-1212OC; Morecroft I, 2010, CARDIOVASC RES, V85, P593, DOI 10.1093/cvr/cvp306; Natori S, 2006, AM J ROENTGENOL, V186, pS357, DOI 10.2214/AJR.04.1868; Nebigil CG, 2003, CIRCULATION, V108, P902, DOI 10.1161/01.CIR.0000081520.25714.D9; O'Connor CM, 2008, ARCH INTERN MED, V168, P2232, DOI 10.1001/archinte.168.20.2232; O'Connor CM, 2010, J AM COLL CARDIOL, V56, P692, DOI 10.1016/j.jacc.2010.03.068; PSATY BM, 1992, J CLIN EPIDEMIOL, V45, P683, DOI 10.1016/0895-4356(92)90143-B; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Roeleveld RJ, 2004, CHEST, V125, P572, DOI 10.1378/chest.125.2.572; Sauer WH, 2001, CIRCULATION, V104, P1894, DOI 10.1161/hc4101.097519; Sauer WH, 2003, CIRCULATION, V108, P32, DOI 10.1161/01.CIR.0000079172.43229.CD; Scharhag J, 2002, J AM COLL CARDIOL, V40, P1856, DOI 10.1016/S0735-1097(02)02478-6; Serebruany VL, 2003, CIRCULATION, V108, P939, DOI 10.1161/01.CIR.0000085163.21752.0A; Shah SJ, 2009, CHEST, V136, P694, DOI 10.1378/chest.08-2823; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Shyu KG, 2009, CIRC RES, V104, P1, DOI 10.1161/CIRCRESAHA.108.191122; Tousoulis D, 2008, J CARD FAIL, V14, P456, DOI 10.1016/j.cardfail.2008.02.015; Ventetuolo CE, 2011, AM J RESP CRIT CARE, V183, P659, DOI 10.1164/rccm.201007-1027OC; Vogel-Claussen J, 2006, J COMPUT ASSIST TOMO, V30, P426, DOI 10.1097/00004728-200605000-00013; Wilhelm M, 2011, AM J CARDIOL, V108, P1489, DOI 10.1016/j.amjcard.2011.06.073; Wilkins MR, 2010, AM J RESP CRIT CARE, V181, P1106, DOI [10.1164/rccm.200911-1699OC, 10.1164/rccm.2009111-699OC]; Willens HJ, 2004, AM J CARDIOL, V94, P1087, DOI 10.1016/j.amjcard.2004.06.076; Wong CY, 2006, J AM COLL CARDIOL, V47, P611, DOI 10.1016/j.jacc.2005.11.015; Zhai FG, 2009, CLIN EXP PHARMACOL P, V36, P850, DOI 10.1111/j.1440-1681.2009.05168.x	59	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30480	10.1371/journal.pone.0030480	http://dx.doi.org/10.1371/journal.pone.0030480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363441	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600033
J	Wong, M; Ohrmalm, L; Broliden, K; Aust, C; Hibberd, M; Tolfvenstam, T				Wong, Michelle; Ohrmalm, Lars; Broliden, Kristina; Aust, Carl; Hibberd, Martin; Tolfvenstam, Thomas			Mannose-Binding Lectin 2 Polymorphisms Do Not Influence Frequency or Type of Infection in Adults with Chemotherapy Induced Neutropaenia	PLOS ONE			English	Article							REAL-TIME PCR; ACUTE MYELOID-LEUKEMIA; GENE; DEFICIENCY; PROTEIN; MBL; MUTATIONS; PROMOTER; VIRUSES; FEVER	Background: Mannose-binding Lectin protein (MBL) has been suggested to be relevant in the defence against infections in immunosuppressed individuals. In a Swedish adult cohort immunosuppressed from both the underlying disease and from iatrogenic treatments for their underlying disease we investigated the role of MBL in susceptibility to infection. Methods: In this cross sectional, prospective study, blood samples obtained from 96 neutropaenic febrile episodes, representing 82 individuals were analysed for single nucleotide polymorphism (SNP) in the MBL2 gene. Concurrent measurement of plasma MBL protein concentrations was also performed for observation of acute response during febrile episodes. Findings: No association was observed between MBL2 genotype or plasma MBL concentrations, and the type or frequency of infection. Adding to the literature, we found no evidence that viral infections or co-infections with virus and bacteria would be predisposed by MBL deficiency. We further saw no correlation between MBL2 genotype and the risk of fever. However, fever duration in febrile neutropaenic episodes was negatively associated with MBL2 SNP mutations (p<0.05). Patients with MBL2 SNP mutations presented a median febrile duration of 1.8 days compared with 3 days amongst patients with wildtype MBL2 genotype. Interpretation: We found no clear association between infection, or infection type to MBL2 genotypes or plasma MBL concentration, and add to the reports casting doubts on the benefit of recombinant MBL replacement therapy use during iatrogenic neutropaenia.	[Wong, Michelle; Ohrmalm, Lars; Broliden, Kristina; Aust, Carl; Tolfvenstam, Thomas] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Infect Dis Unit, Stockholm, Sweden; [Hibberd, Martin] Genome Inst Singapore, Singapore, Singapore	Karolinska Institutet; Karolinska University Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Wong, M (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Med, Infect Dis Unit, Stockholm, Sweden.	michelle.wong@ki.se	Hibberd, Martin L/D-5050-2009	Tolfvenstam, Thomas/0000-0003-3549-8083; Hibberd, Martin/0000-0001-8587-1849	Swedish society of Medicine; Stockholm county council; Swedish childhood cancer foundation; Groschinsky foundation	Swedish society of Medicine; Stockholm county council(Stockholm County Council); Swedish childhood cancer foundation(European Commission); Groschinsky foundation	This work was supported by grants from the Swedish society of Medicine, Stockholm county council, Swedish childhood cancer foundation and the Groschinsky foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aittoniemi J, 1997, APMIS, V105, P617, DOI 10.1111/j.1699-0463.1997.tb05062.x; ARAI T, 1993, Q J MED, V86, P575; Bergmann OJ, 2003, EUR J HAEMATOL, V70, P91, DOI 10.1034/j.1600-0609.2003.00012.x; Bernig T, 2004, GENES IMMUN, V5, P461, DOI 10.1038/sj.gene.6364116; Boldt ABW, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-38; Bossuyt X, 2007, CLIN CHEM, V53, P124, DOI 10.1373/clinchem.2007.075861; Brittain-Long R, 2008, J CLIN VIROL, V41, P53, DOI 10.1016/j.jcv.2007.10.029; Dahl M, 2004, J EXP MED, V199, P1391, DOI 10.1084/jem.20040111; Gustafsson I, MULTIPLEX REAL TIME; Hart ML, 2002, AIDS RES HUM RETROV, V18, P1311, DOI 10.1089/088922202320886352; HARTSHORN KL, 1993, J CLIN INVEST, V91, P1414, DOI 10.1172/JCI116345; Ip WKE, 2009, IMMUNOL REV, V230, P9, DOI 10.1111/j.1600-065X.2009.00789.x; Kilpatrick DC, 2003, CLIN EXP IMMUNOL, V134, P279, DOI 10.1046/j.1365-2249.2003.02284.x; Klostergaard A, 2010, EUR J HAEMATOL, V85, P58, DOI 10.1111/j.1600-0609.2010.01443.x; Lu XY, 2008, J CLIN MICROBIOL, V46, P533, DOI 10.1128/JCM.01739-07; MADSEN HO, 1995, J IMMUNOL, V155, P3013; Martinez-Lopez J, 2009, LEUKEMIA LYMPHOMA, V50, P1283, DOI 10.1080/10428190903040006; Michelow IC, 2010, J BIOL CHEM, V285, P24729, DOI 10.1074/jbc.M110.106260; Muto S, 1999, BIOL PHARM BULL, V22, P347; Nauta AJ, 2003, EUR J HAEMATOL, V33, P2583; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; Neth O, 2001, LANCET, V358, P614, DOI 10.1016/S0140-6736(01)05776-2; Nijhuis M, 2002, J CLIN MICROBIOL, V40, P3666, DOI 10.1128/JCM.40.10.3666-3670.2002; Ohrmalm L, VIRUS ASS FEVE UNPUB; Petersen KA, 2006, J CLIN IMMUNOL, V26, P465, DOI 10.1007/s10875-006-9037-z; Peterslund NA, 2001, LANCET, V358, P637, DOI 10.1016/S0140-6736(01)05785-3; Pizzo PA, 1999, NEW ENGL J MED, V341, P893, DOI 10.1056/NEJM199909163411207; Schejbel L, 2007, CLIN CHEM, V53, P159, DOI 10.1373/clinchem.2006.081224; Steffensen R, 2000, J IMMUNOL METHODS, V241, P33, DOI 10.1016/S0022-1759(00)00198-8; Terlizzi ME, 2009, J VIROL METHODS, V160, P172, DOI 10.1016/j.jviromet.2009.04.039; Tivejung-Lindell A, 2009, J MED VIROL, V81, P167, DOI 10.1002/jmv.21368; Turner MW, 2003, MOL IMMUNOL, V40, P423, DOI 10.1016/S0161-5890(03)00155-X; Vekemans M, 2007, CLIN INFECT DIS, V44, P1593, DOI 10.1086/518171; World Health Organization, 2009, CDC PROT REALT RTPCR	34	12	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30819	10.1371/journal.pone.0030819	http://dx.doi.org/10.1371/journal.pone.0030819			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363494	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000302853600071
J	Tsujimoto, H; Kotsyfakis, M; Francischetti, IMB; Eum, JH; Strand, MR; Champagne, DE				Tsujimoto, Hitoshi; Kotsyfakis, Michail; Francischetti, Ivo M. B.; Eum, Jai Hoon; Strand, Michael R.; Champagne, Donald E.			Simukunin from the Salivary Glands of the Black Fly Simulium vittatum Inhibits Enzymes That Regulate Clotting and Inflammatory Responses	PLOS ONE			English	Article							NEUTROPHIL SERINE PROTEASES; ALPHA-TRYPSIN INHIBITOR; FACTOR-XA; STRUCTURAL-CHARACTERIZATION; PROTEINASE-INHIBITOR; THROMBIN INHIBITOR; FLIES DIPTERA; TICK; ANTICOAGULANT; IXOLARIS	Background: Black flies (Diptera: Simuliidae) feed on blood, and are important vectors of Onchocerca volvulus, the etiolytic agent of River Blindness. Blood feeding depends on pharmacological properties of saliva, including anticoagulation, but the molecules responsible for this activity have not been well characterized. Methodology/Principal Findings: Two Kunitz family proteins, SV-66 and SV-170, were identified in the sialome of the black fly Simulium vittatum. As Kunitz proteins are inhibitors of serine proteases, we hypothesized that SV-66 and/or 2170 were involved in the anticoagulant activity of black fly saliva. Our results indicated that recombinant (r) SV-66 but not rSV-170 inhibited plasma coagulation. Mutational analysis suggested that SV-66 is a canonical BPTI-like inhibitor. Functional assays indicated that rSV66 reduced the activity of ten serine proteases, including several involved in mammalian coagulation. rSV66 most strongly inhibited the activity of Factor Xa, elastase, and cathepsin G, exhibited lesser inhibitory activity against Factor IXa, Factor XIa, and plasmin, and exhibited no activity against Factor XIIa and thrombin. Surface plasmon resonance studies indicated that rSV-66 bound with highest affinity to elastase (K-D = 0.4 nM) and to the active site of FXa (K-D = 3.07 nM). We propose the name "Simukunin" for this novel protein. Conclusions: We conclude that Simukunin preferentially inhibits Factor Xa. The inhibition of elastase and cathepsin G further suggests this protein may modulate inflammation, which could potentially affect pathogen transmission.	[Tsujimoto, Hitoshi; Eum, Jai Hoon; Strand, Michael R.; Champagne, Donald E.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA; [Tsujimoto, Hitoshi; Strand, Michael R.; Champagne, Donald E.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Kotsyfakis, Michail] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, Lab Genom & Prote Dis Vectors, CR-37005 Ceske Budejovice, Czech Republic; [Francischetti, Ivo M. B.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Tsujimoto, H (corresponding author), Johns Hopkins Univ, Sch Publ Hlth, Malaria Res Inst, Baltimore, MD 21218 USA.	dchampa@uga.edu	Kotsyfakis, Michail/G-9525-2014	Kotsyfakis, Michail/0000-0002-7526-1876	United States Department of Agriculture National Research Initiative [200704549]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000810] Funding Source: NIH RePORTER	United States Department of Agriculture National Research Initiative(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was in part supported by United States Department of Agriculture National Research Initiative grant 200704549 to M.R. Strand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ABEBE M, 1995, J INSECT PHYSIOL, V41, P1001, DOI 10.1016/0022-1910(95)00039-W; Abebe M, 1996, J MED ENTOMOL, V33, P173, DOI 10.1093/jmedent/33.1.173; ABEBE M, 1994, J MED ENTOMOL, V31, P908, DOI 10.1093/jmedent/31.6.908; ALBRECHT GJ, 1983, H-S Z PHYSIOL CHEM, V364, P1697, DOI 10.1515/bchm2.1983.364.2.1697; ALBRECHT GJ, 1983, H-S Z PHYSIOL CHEM, V364, P1703, DOI 10.1515/bchm2.1983.364.2.1703; ANDERSEN JF, 2009, J PROTEOME RES; Corral-Rodriguez MA, 2009, INSECT BIOCHEM MOLEC, V39, P579, DOI 10.1016/j.ibmb.2009.07.003; Ascenzi P, 2003, CURR PROTEIN PEPT SC, V4, P231, DOI 10.2174/1389203033487180; BERNARDO MJ, 1986, J MED ENTOMOL, V23, P666, DOI 10.1093/jmedent/23.6.666; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chmelar J, 2011, BLOOD, V117, P736, DOI 10.1182/blood-2010-06-293241; Crawley JTB, 2008, ARTERIOSCL THROM VAS, V28, P233, DOI 10.1161/ATVBAHA.107.141606; CUPP MS, 1994, AM J TROP MED HYG, V50, P241, DOI 10.4269/ajtmh.1994.50.241; Cupp MS, 1998, J EXP BIOL, V201, P1553; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Francischetti IMB, 2002, BLOOD, V99, P3602, DOI 10.1182/blood-2001-12-0237; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; Francischetti NMB, 2004, THROMB HAEMOSTASIS, V91, P886, DOI 10.1160/TH03-11-0715; Fries E, 2000, INT J BIOCHEM CELL B, V32, P125, DOI 10.1016/S1357-2725(99)00125-9; Gray EW, 1999, MAINTENANCE OF HUMAN, ANIMAL, AND PLANT PATHOGEN VECTORS, P83; Harvey AL, 2001, TOXICON, V39, P15, DOI 10.1016/S0041-0101(00)00162-8; JACOBS JW, 1990, THROMB HAEMOSTASIS, V64, P235; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kotsyfakis M, 2007, J BIOL CHEM, V282, P29256, DOI 10.1074/jbc.M703143200; Lai R, 2004, GENE, V342, P243, DOI 10.1016/j.gene.2004.07.012; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levi M, 2010, CRIT CARE MED, V38, pS26, DOI 10.1097/CCM.0b013e3181c98d21; LIENER IE, 1986, J NUTR, V116, P920, DOI 10.1093/jn/116.5.920; Macedo-Ribeiro S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001624; Maritz-Olivier C, 2007, TRENDS PARASITOL, V23, P397, DOI 10.1016/j.pt.2007.07.005; McDougall JJ, 2009, ARTHRITIS RHEUM-US, V60, P728, DOI 10.1002/art.24300; Monteiro RQ, 2008, PROTEIN SCI, V17, P146, DOI 10.1110/ps.073016308; MORTON TA, 1995, ANAL BIOCHEM, V227, P176, DOI 10.1006/abio.1995.1268; Nienaber J, 1999, EXP PARASITOL, V93, P82, DOI 10.1006/expr.1999.4448; Oliveira F, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000226; Pham CTN, 2008, INT J BIOCHEM CELL B, V40, P1317, DOI 10.1016/j.biocel.2007.11.008; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Ribeiro JMC, 2010, AM J TROP MED HYG, V82, P1060, DOI 10.4269/ajtmh.2010.09-0769; Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024; TITUS RG, 1988, SCIENCE, V239, P1306, DOI 10.1126/science.3344436; Trivedi NN, 2010, AM J RESP CELL MOL, V42, P257, DOI 10.1165/rcmb.2009-0324RT; TSCHESCHE H, 1987, BIOCHIM BIOPHYS ACTA, V913, P97, DOI 10.1016/0167-4838(87)90238-X; Tschesche H, 1983, Adv Exp Med Biol, V156, P329; Valenzuela JG, 1996, EXP PARASITOL, V83, P184, DOI 10.1006/expr.1996.0065; vandeLocht A, 1996, EMBO J, V15, P6011, DOI 10.1002/j.1460-2075.1996.tb00989.x; VINCENT JP, 1973, EUR J BIOCHEM, V38, P365, DOI 10.1111/j.1432-1033.1973.tb03069.x; Zhao W, 2005, J IMMUNOL, V175, P2635, DOI 10.4049/jimmunol.175.4.2635	48	32	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e29964	10.1371/journal.pone.0029964	http://dx.doi.org/10.1371/journal.pone.0029964			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22383955	Green Published, gold, Green Submitted			2022-12-27	WOS:000302916100003
J	Barretti, P; Moraes, TMC; Camargo, CH; Caramori, JCT; Mondelli, AL; Montelli, AC; da Cunha, MDRS				Barretti, Pasqual; Moraes, Taise M. C.; Camargo, Carlos H.; Caramori, Jacqueline C. T.; Mondelli, Alessandro L.; Montelli, Augusto C.; da Cunha, Maria de Lourdes R. S.			Peritoneal Dialysis-Related Peritonitis Due to Staphylococcus aureus: A Single-Center Experience over 15 Years	PLOS ONE			English	Article							BETA-TOXIN; INFECTIONS RECOMMENDATIONS; STRAINS; UPDATE; PREDICTORS; VIRULENCE; OUTCOMES; CELLS	Peritonitis caused by Staphylococcus aureus is a serious complication of peritoneal dialysis (PD), which is associated with poor outcome and high PD failure rates. We reviewed the records of 62 S. aureus peritonitis episodes that occurred between 1996 and 2010 in the dialysis unit of a single university hospital and evaluated the host and bacterial factors influencing peritonitis outcome. Peritonitis incidence was calculated for three subsequent 5-year periods and compared using a Poisson regression model. The production of biofilm, enzymes, and toxins was evaluated. Oxacillin resistance was evaluated based on minimum inhibitory concentration and presence of the mecA gene. Logistic regression was used for the analysis of demographic, clinical, and microbiological factors influencing peritonitis outcome. Resolution and death rates were compared with 117 contemporary coagulase-negative staphylococcus (CoNS) episodes. The incidence of S. aureus peritonitis declined significantly over time from 0.13 in 1996-2000 to 0.04 episodes/patient/year in 2006-2010 (p = 0.03). The oxacillin resistance rate was 11.3%. Toxin and enzyme production was expressive, except for enterotoxin D. Biofilm production was positive in 88.7% of strains. The presence of the mecA gene was associated with a higher frequency of fever and abdominal pain. The logistic regression model showed that diabetes mellitus (p = 0.009) and beta-hemolysin production (p = 0.006) were independent predictors of non-resolution of infection. The probability of resolution was higher among patients aged 41 to 60 years than among those >60 years (p = 0.02). A trend to higher death rate was observed for S. aureus episodes (9.7%) compared to CoNS episodes (2.5%), (p = 0.08), whereas resolution rates were similar. Despite the decline in incidence, S. aureus peritonitis remains a serious complication of PD that is associated with a high death rate. The outcome of this infection is negatively influenced by host factors such as age and diabetes mellitus. In addition, beta-hemolysin production is predictive of non-resolution of infection, suggesting a pathogenic role of this factor in PD-related S. aureus peritonitis.	[Barretti, Pasqual; Moraes, Taise M. C.; Camargo, Carlos H.; Caramori, Jacqueline C. T.; Mondelli, Alessandro L.; Montelli, Augusto C.] Univ Estadual Paulista, Dept Clin Med, Fac Med, UNESP, Botucatu, SP, Brazil; [Moraes, Taise M. C.; Camargo, Carlos H.; Montelli, Augusto C.; da Cunha, Maria de Lourdes R. S.] Univ Estadual Paulista, Dept Microbiol & Imunol, Inst Biociencias, UNESP, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Barretti, P (corresponding author), Univ Estadual Paulista, Dept Clin Med, Fac Med, UNESP, Botucatu, SP, Brazil.	cunhamlr@ibb.unesp.br	Barretti, Pasqual/AAK-7934-2021; de Lourdes Ribeiro de Souza da Cunha, Maria/A-6287-2008; Camargo, Carlos/E-6448-2010; Caramori, Jacqueline do Socorr C. T./G-1783-2013; Barretti, Pasqual/K-4156-2012	Barretti, Pasqual/0000-0003-4979-4836; de Lourdes Ribeiro de Souza da Cunha, Maria/0000-0001-9079-2723; Camargo, Carlos/0000-0001-6834-0085; Caramori, Jacqueline do Socorr C. T./0000-0002-0093-9515; Barretti, Pasqual/0000-0003-4979-4836; Lia Mondelli, Alessandro/0000-0002-4401-5656	Sao Paulo state funding agency Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Sao Paulo state funding agency Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	This work was supported by a grant from the Sao Paulo state funding agency Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). The funding agency played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript	ALEXANDER W, 1987, DIAGN MICR INFEC DIS, V8, P215, DOI 10.1016/0732-8893(87)90052-6; Barretti P, 2007, PERITON DIALYSIS INT, V27, P332; Barretti P, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-212; Bunke CM, 1997, KIDNEY INT, V52, P524, DOI 10.1038/ki.1997.363; CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318, DOI 10.1128/IAI.37.1.318-326.1982; Clinical and Laboratory Standards Institute, 2008, M100S18 CLSI; da Cunha MDRD, 2005, CLIN NEPHROL, V64, P378; Deleo FR, 2009, INFECT DIS CLIN N AM, V23, P17, DOI 10.1016/j.idc.2008.10.003; DONNELLY CB, 1967, APPL MICROBIOL, V15, P1382, DOI 10.1128/AEM.15.6.1382-1387.1967; Fontan MP, 2005, PERITON DIALYSIS INT, V25, P274; Fowler VG, 2007, J INFECT DIS, V196, P738, DOI 10.1086/520088; Gill SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018673; Govindarajulu S, 2010, PERITON DIALYSIS INT, V30, P311, DOI 10.3747/pdi.2008.00258; Han SH, 2007, NEPHROL DIAL TRANSPL, V22, P2653, DOI 10.1093/ndt/gfm242; Haslinger-Loffler B, 2006, KIDNEY INT, V70, P1089, DOI 10.1038/sj.ki.5001710; Hayashida A, 2009, AM J PATHOL, V174, P509, DOI 10.2353/ajpath.2009.080394; Huseby MJ, 2010, P NATL ACAD SCI USA, V107, P14407, DOI 10.1073/pnas.0911032107; JESSEN OVE, 1959, ACTA PATHOL ET MICROBIOL SCAND, V47, P316; Keane WF, 2000, PERITON DIALYSIS INT, V20, P396; Koneman EW, 1992, COLOR ATLAS TXB DIAG; Krishnan M, 2002, PERITON DIALYSIS INT, V22, P573; LACHICA RUF, 1971, APPL MICROBIOL, V21, P585, DOI 10.1128/AEM.21.4.585-587.1971; Li PKT, 2010, PERITON DIALYSIS INT, V30, P393, DOI 10.3747/pdi.2010.00049; Martinez-Pulgarin S, 2009, MICROBIOL-SGM, V155, P1505, DOI 10.1099/mic.0.025544-0; MATOS JES, 1995, LETT APPL MICROBIOL, V21, P334, DOI 10.1111/j.1472-765X.1995.tb01073.x; Moraes TP, 2009, PERITON DIALYSIS INT, V29, P492; MURAKAMI K, 1991, J CLIN MICROBIOL, V29, P2240, DOI 10.1128/JCM.29.10.2240-2244.1991; Ortiz A, 2006, CURR MED CHEM, V13, P2695, DOI 10.2174/092986706778201576; Peacock SJ, 2000, PERITON DIALYSIS INT, V20, P215; Pimenta-Rodrigues MV, 2011, THESIS U ESTADUAL PA; Piraino B, 2005, PERITON DIALYSIS INT, V25, P107; Szeto CC, 2007, CLIN J AM SOC NEPHRO, V2, P245, DOI 10.2215/CJN.03180906; Zhong J H, 2000, Adv Perit Dial, V16, P36	33	28	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31780	10.1371/journal.pone.0031780	http://dx.doi.org/10.1371/journal.pone.0031780			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363730	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700096
J	de Rooij, MMT; Schimmer, B; Versteeg, B; Schneeberger, P; Berends, BR; Heederik, D; van der Hoek, W; Wouters, IM				de Rooij, Myrna M. T.; Schimmer, Barbara; Versteeg, Bart; Schneeberger, Peter; Berends, Boyd R.; Heederik, Dick; van der Hoek, Wim; Wouters, Inge M.			Risk Factors of Coxiella burnetii (Q Fever) Seropositivity in Veterinary Medicine Students	PLOS ONE			English	Article							NATURAL-HISTORY; NOVA-SCOTIA; SEROPREVALENCE; ANTIBODIES; NETHERLANDS; INFECTION; OUTBREAKS; WORKERS; GOATS	Background: Q fever is an occupational risk for veterinarians, however little is known about the risk for veterinary medicine students. This study aimed to assess the seroprevalence of Coxiella burnetii among veterinary medicine students and to identify associated risk factors. Methods: A cross-sectional study with questionnaire and blood sample collection was performed among all veterinary medicine students studying in the Netherlands in 2006. Serum samples (n = 674), representative of all study years and study directions, were analyzed for C. burnetii IgG and IgM phase I and II antibodies with an immunofluorescence assay (IFA). Seropositivity was defined as IgG phase I and/or II titer of 1: 32 and above. Results: Of the veterinary medicine students 126 (18.7%) had IgG antibodies against C. burnetii. Seropositivity associated risk factors identified were the study direction 'farm animals' (Odds Ratio (OR) 3.27 [95% CI 2.14-5.02]), advanced year of study (OR year 6: 2.31 [1.22-4.39] OR year 3-5 1.83 [1.07-3.10]) having had a zoonosis during the study (OR 1.74 [1.07-2.82]) and ever lived on a ruminant farm (OR 2.73 [1.59-4.67]). Stratified analysis revealed study direction 'farm animals' to be a study-related risk factor apart from ever living on a farm. In addition we identified a clear dose-response relation for the number of years lived on a farm with C. burnetii seropositivity. Conclusions: C. burnetii seroprevalence is considerable among veterinary medicine students and study related risk factors were identified. This indicates Q fever as an occupational risk for veterinary medicine students.	[de Rooij, Myrna M. T.; Heederik, Dick; Wouters, Inge M.] Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands; [Schimmer, Barbara; Versteeg, Bart; van der Hoek, Wim] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Versteeg, Bart; Schneeberger, Peter] Jeroen Bosch Hosp, Dept Med Microbiol & Infect Control, Shertogenbosch, Netherlands; [Berends, Boyd R.] Inst Risk Assessment Sci, Div Vet Publ Hlth, Utrecht, Netherlands	Utrecht University; Netherlands National Institute for Public Health & the Environment; Jeroen Bosch Ziekenhuis; Utrecht University	de Rooij, MMT (corresponding author), Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands.	i.wouters@uu.nl		Wouters, Inge M./0000-0001-7834-9390; Heederik, Dick/0000-0002-4550-1437; de Rooij, Myrna Maria Theresia/0000-0002-6560-4839				Abe T, 2001, EUR J EPIDEMIOL, V17, P1029, DOI 10.1023/A:1020018907452; Blaauw GJ, 2012, EPIDEMIOL INFECT, V140, P36, DOI 10.1017/S0950268811000021; Bond R, 2010, CLIN DERMATOL, V28, P226, DOI 10.1016/j.clindermatol.2009.12.012; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; Cascio A, 2011, CLIN MICROBIOL INFEC, V17, P336, DOI 10.1111/j.1469-0691.2010.03451.x; Chang CC, 2010, ZOONOSES PUBLIC HLTH, V57, pE95, DOI 10.1111/j.1863-2378.2009.01290.x; Dorko E, 2008, ANN AGR ENV MED, V15, P119; DUPONT HT, 1994, CLIN DIAGN LAB IMMUN, V1, P189, DOI 10.1128/CDLI.1.2.189-196.1994; Grohskopf L, 2011, AM J TRANSPLANT, V11, P2250, DOI 10.1111/j.1600-6143.2011.03793.x; Hatchette T, 2003, VECTOR-BORNE ZOONOT, V3, P11, DOI 10.1089/153036603765627415; Heinzen RA, 1999, TRENDS MICROBIOL, V7, P149, DOI 10.1016/S0966-842X(99)01475-4; Madariaga MG, 2003, LANCET INFECT DIS, V3, P709, DOI 10.1016/S1473-3099(03)00804-1; MARRIE TJ, 1995, EUR J EPIDEMIOL, V11, P47, DOI 10.1007/BF01719945; Maurin M, 1999, CLIN MICROBIOL REV, V12, P518, DOI 10.1128/CMR.12.4.518; Mcquiston JH, 2002, VECTOR-BORNE ZOONOT, V2, P179, DOI 10.1089/15303660260613747; Parker NR, 2006, LANCET, V367, P679, DOI 10.1016/S0140-6736(06)68266-4; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Raoult D, 2009, CLIN INFECT DIS, V48, P558, DOI 10.1086/596706; RIEMANN HP, 1974, AM J EPIDEMIOL, V100, P197, DOI 10.1093/oxfordjournals.aje.a112028; Samadi S, 2012, OCCUP ENVIRON MED, V69, P48, DOI 10.1136/oem.2010.064089; Sanchez J, 2006, J COMP PATHOL, V135, P108, DOI 10.1016/j.jcpa.2006.06.003; Schimmer B, 2012, EPIDEMIOL INFECT, V140, P27, DOI 10.1017/S0950268811000136; SCHNURRENBERGER PR, 1964, J AM VET MED ASSOC, V144, P381; Sukocheva OA, 2010, QJM-INT J MED, V103, P847, DOI 10.1093/qjmed/hcq113; Tissot-Dupont H, 2004, EMERG INFECT DIS, V10, P1264, DOI 10.3201/eid1007.030724; Tozer SJ, 2011, EUR J CLIN MICROBIOL, V30, P1287, DOI 10.1007/s10096-011-1225-y; Valencia MDS, 2000, EUR J EPIDEMIOL, V16, P469, DOI 10.1023/A:1007605414042; van der Hoek W, 2011, BMC INFECT DIS, V11, DOI 10.1186/1472-6963-11-57; van Duynhoven Y, STORY HUMAN Q FEVER; Wattiau P, 2011, EMERG INFECT DIS DEC; Whelan J, 2011, EMERG INFECT DIS, V17, P1719, DOI 10.3201/eid1709.110051; Whitney EAS, 2009, CLIN INFECT DIS, V48, P550, DOI 10.1086/596705; Woldehiwet Z, 2004, RES VET SCI, V77, P93, DOI 10.1016/j.rvsc.2003.09.001	34	34	35	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32108	10.1371/journal.pone.0032108	http://dx.doi.org/10.1371/journal.pone.0032108			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363803	gold, Green Published, Green Submitted			2022-12-27	WOS:000302873700144
J	Frigola, D; Casanellas, L; Sancho, JM; Ibanes, M				Frigola, David; Casanellas, Laura; Sancho, Jose M.; Ibanes, Marta			Asymmetric Stochastic Switching Driven by Intrinsic Molecular Noise	PLOS ONE			English	Article							GENE-EXPRESSION; CELL FATE; ESCHERICHIA-COLI; TOGGLE SWITCH; FLUCTUATING ENVIRONMENTS; DYNAMICS; MEMORY; DIFFERENTIATION; CONSEQUENCES; DECISION	Low-copy-number molecules are involved in many functions in cells. The intrinsic fluctuations of these numbers can enable stochastic switching between multiple steady states, inducing phenotypic variability. Herein we present a theoretical and computational study based on Master Equations and Fokker-Planck and Langevin descriptions of stochastic switching for a genetic circuit of autoactivation. We show that in this circuit the intrinsic fluctuations arising from low-copy numbers, which are inherently state-dependent, drive asymmetric switching. These theoretical results are consistent with experimental data that have been reported for the bistable system of the gallactose signaling network in yeast. Our study unravels that intrinsic fluctuations, while not required to describe bistability, are fundamental to understand stochastic switching and the dynamical relative stability of multiple states.	[Frigola, David; Casanellas, Laura; Sancho, Jose M.; Ibanes, Marta] Univ Barcelona, Dept Estruct & Constituents Mat, Fac Fs, Barcelona, Spain	University of Barcelona	Frigola, D (corresponding author), Univ Barcelona, Dept Estruct & Constituents Mat, Fac Fs, Barcelona, Spain.	mibanes@ub.edu	Ibanes, Marta/A-7657-2008; Frigola Tubert, David/B-6191-2014	Ibanes, Marta/0000-0002-7913-7936; Sancho, Jose Maria/0000-0003-3754-2391; Frigola, David/0000-0001-6025-6110	Ministerio de Ciencia e Innovacion of Spain [FIS2009-13360-C03-01, FPU-AP2009-3736]; Generalitat de Catalunya, Spain [2009SGR14]	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya, Spain(Generalitat de Catalunya)	The work was supported by Grant FIS2009-13360-C03-01 from Ministerio de Ciencia e Innovacion of Spain; Grant 2009SGR14 from Generalitat de Catalunya, Spain; and Fellowship FPU-AP2009-3736 from Ministerio de Ciencia e Innovacion of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Allen RJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018104; [Anonymous], 2004, HDB STOCHASTIC METHO; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bialek W, 2000, ADV NEURAL INFORM PR, P103; Canela-Xandri O, 2008, BIOPHYS J, V95, P5111, DOI 10.1529/biophysj.108.133306; Carrillo O, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.046110; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chang HH, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-11; Cheng Z, 2008, FEBS LETT, V582, P3776, DOI 10.1016/j.febslet.2008.10.005; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Kittisopikul M, 2010, P NATL ACAD SCI USA, V107, P13300, DOI 10.1073/pnas.1003975107; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Press W., 1992, NUMERICAL RECIPES FO; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Sagues F, 2007, REV MOD PHYS, V79, P829, DOI 10.1103/RevModPhys.79.829; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Turcotte M, 2008, P NATL ACAD SCI USA, V105, P15732, DOI 10.1073/pnas.0806349105; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Warren PB, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.128101; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; Wolfram Research Inc, 2008, MATH 8 SOFTW; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	42	41	41	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31407	10.1371/journal.pone.0031407	http://dx.doi.org/10.1371/journal.pone.0031407			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363638	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700055
J	Marcombe, S; Mathieu, RB; Pocquet, N; Riaz, MA; Poupardin, R; Selior, S; Darriet, F; Reynaud, S; Yebakima, A; Corbel, V; David, JP; Chandre, F				Marcombe, Sebastien; Mathieu, Romain Blanc; Pocquet, Nicolas; Riaz, Muhammad-Asam; Poupardin, Rodolphe; Selior, Serge; Darriet, Frederic; Reynaud, Stephane; Yebakima, Andre; Corbel, Vincent; David, Jean-Philippe; Chandre, Fabrice			Insecticide Resistance in the Dengue Vector Aedes aegypti from Martinique: Distribution, Mechanisms and Relations with Environmental Factors	PLOS ONE			English	Article							ANOPHELES-GAMBIAE; DETOXIFICATION GENES; PYRETHROID RESISTANCE; CYTOCHROME P450S; MOLECULAR-BASIS; MUTATIONS; POPULATIONS; EXPRESSION; TOLERANCE; EVOLUTION	Dengue is an important mosquito borne viral disease in Martinique Island (French West Indies). The viruses responsible for dengue are transmitted by Aedes aegypti, an indoor day-biting mosquito. The most effective proven method for disease prevention has been by vector control by various chemical or biological means. Unfortunately insecticide resistance has already been observed on the Island and recently showed to significantly reduce the efficacy of vector control interventions. In this study, we investigated the distribution of resistance and the underlying mechanisms in nine Ae. aegypti populations. Statistical multifactorial approach was used to investigate the correlations between insecticide resistance levels, associated mechanisms and environmental factors characterizing the mosquito populations. Bioassays revealed high levels of resistance to temephos and deltamethrin and susceptibility to Bti in the 9 populations tested. Biochemical assays showed elevated detoxification enzyme activities of monooxygenases, carboxylesterases and glutathione S-tranferases in most of the populations. Molecular screening for common insecticide target-site mutations, revealed the presence of the "knockdown resistance'' V1016I Kdr mutation at high frequency (> 87%). Real time quantitative RT-PCR showed the potential involvement of several candidate detoxification genes in insecticide resistance. Principal Component Analysis (PCA) performed with variables characterizing Ae. aegypti from Martinique permitted to underline potential links existing between resistance distribution and other variables such as agriculture practices, vector control interventions and urbanization. Insecticide resistance is widespread but not homogeneously distributed across Martinique. The influence of environmental and operational factors on the evolution of the resistance and mechanisms are discussed.	[Marcombe, Sebastien; Pocquet, Nicolas; Darriet, Frederic; Chandre, Fabrice] IRD, IRD 224, CNRS 5290, Unite Mixte Rech MIVEGEC,UM1, Montpellier, France; [Mathieu, Romain Blanc; Riaz, Muhammad-Asam; Poupardin, Rodolphe; Reynaud, Stephane; David, Jean-Philippe] Univ Grenoble, UMR CNRS 5553, Lab Ecol Alpine LECA, Grenoble, France; [Yebakima, Andre] Conseil Gen Martinique, Ctr Demousticat, Martinique, Martinique, France; [Selior, Serge; Corbel, Vincent] IRD, CREC, Cotonou, Benin	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; Entomological Research Center of Cotonou (CREC); Institut de Recherche pour le Developpement (IRD)	Marcombe, S (corresponding author), IRD, IRD 224, CNRS 5290, Unite Mixte Rech MIVEGEC,UM1, Montpellier, France.	sebastien.marcombe@ird.fr; fabrice.chandre@ird.fr	Corbel, VIncent/G-9576-2016; DAVID, jean-philippe/F-3077-2012; Chandre, Fabrice/Q-3429-2019; Reynaud, Stephane/H-5493-2013; Poupardin, Rodolphe/K-3138-2014	DAVID, jean-philippe/0000-0002-3950-5909; Chandre, Fabrice/0000-0002-1994-9705; Reynaud, Stephane/0000-0003-0248-0602; Blanc-Mathieu, Romain/0000-0002-9485-6330; Poupardin, Rodolphe/0000-0001-5195-5155; Pocquet, Nicolas/0000-0003-3928-6803; Darriet, Frederic/0000-0003-2486-5968; corbel, vincent/0000-0003-0995-3257	French agency Agence Nationale de Securite sanitaire, de l'almentation, de l'environnement et du travail	French agency Agence Nationale de Securite sanitaire, de l'almentation, de l'environnement et du travail	The experiment was funded by the French agency Agence Nationale de Securite sanitaire, de l'almentation, de l'environnement et du travail (www.anses.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Akogbeto M C, 2005, Bull Soc Pathol Exot, V98, P400; Alout H, 2009, INSECT BIOCHEM MOLEC, V39, P884, DOI 10.1016/j.ibmb.2009.10.005; Bocquene G, 2005, MAR POLLUT BULL, V51, P612, DOI 10.1016/j.marpolbul.2005.06.026; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x; Brogdon WG, 1997, J AM MOSQUITO CONTR, V13, P233; BROWN AWA, 1986, J AM MOSQUITO CONTR, V2, P123; Chiu TL, 2008, P NATL ACAD SCI USA, V105, P8855, DOI 10.1073/pnas.0709249105; Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005; CORRIVEAU R, 2003, DENGUE DEP FRANCAIS; David JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-216; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; Donnelly MJ, 2009, TRENDS PARASITOL, V25, P213, DOI 10.1016/j.pt.2009.02.007; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; FINNEY D J, 1971, P333; Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623; Hemingway J, 1998, MED VET ENTOMOL, V12, P1, DOI 10.1046/j.1365-2915.1998.00082.x; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; INVS, 2010, SURV DENG MART; San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346; Lumjuan N, 2005, INSECT BIOCHEM MOLEC, V35, P861, DOI 10.1016/j.ibmb.2005.03.008; Lycett GJ, 2006, INSECT MOL BIOL, V15, P321, DOI 10.1111/j.1365-2583.2006.00647.x; Marcombe S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-494; Marcombe S, 2009, AM J TROP MED HYG, V80, P745, DOI 10.4269/ajtmh.2009.80.745; Mclaughlin LA, 2008, INSECT MOL BIOL, V17, P125, DOI 10.1111/j.1365-2583.2007.00788.x; Muller P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-36; Oakeshott JG, 2005, CHEM-BIOL INTERACT, V157, P269, DOI 10.1016/j.cbi.2005.10.041; Ortelli F, 2003, BIOCHEM J, V373, P957, DOI 10.1042/BJ20030169; Paris M, 2010, PEST MANAG SCI; Paul A, 2006, J MED ENTOMOL, V43, P55, DOI 10.1603/0022-2585(2006)043[0055:EONIFC]2.0.CO;2; Poupardin R, 2010, INSECT MOL BIOL, V19, P185, DOI 10.1111/j.1365-2583.2009.00967.x; Poupardin R, 2008, INSECT BIOCHEM MOLEC, V38, P540, DOI 10.1016/j.ibmb.2008.01.004; R Core Team, 2021, R LANGUAGE ENV STAT; Rajatileka S, 2008, ACTA TROP, V108, P54, DOI 10.1016/j.actatropica.2008.08.004; Ranson H, 2010, TROPIKANET J, V1; Raymond M, 1998, PHILOS T R SOC B, V353, P1707, DOI 10.1098/rstb.1998.0322; Raymond M, 1995, PROBIT SOFTWARE; Riaz MA, 2009, AQUAT TOXICOL, V93, P61, DOI 10.1016/j.aquatox.2009.03.005; Rodriguez MM, 2005, J AM MOSQUITO CONTR, V21, P437, DOI 10.2987/8756-971X(2006)21[437:PISOAA]2.0.CO;2; Rogers SO, 1988, PLANT MOL BIOL MAN A, VA6, P1, DOI DOI 10.1007/978-94-017-5294-7_; Rosine J, 1999, THESIS U P M CURIE P; Rousset F, 1997, TRENDS ECOL EVOL, V12, P313, DOI 10.1016/S0169-5347(97)01104-X; Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x; Saavedra-Rodriguez K, 2008, GENETICS, V180, P1137, DOI 10.1534/genetics.108.087924; Soderlund DM, 2003, INSECT BIOCHEM MOLEC, V33, P563, DOI 10.1016/S0965-1748(03)00023-7; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; WHO, 2005, GUID LAB FIELD TEST; WHO, 2006, WHOCDSNTDWHOPESGCDDP; World Health Organization, 1998, WHOCDSCPCMAL98; Yanola J, 2010, PESTIC BIOCHEM PHYS, V96, P127, DOI 10.1016/j.pestbp.2009.10.005; Yebakima A, 1991, THESIS U MONTPELLIER, P210	54	150	156	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e30989	10.1371/journal.pone.0030989	http://dx.doi.org/10.1371/journal.pone.0030989			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363529	Green Published, gold			2022-12-27	WOS:000302873700019
J	McLaughlin, HP; Xiao, QB; Rea, RB; Pi, HL; Casey, PG; Darby, T; Charbit, A; Sleator, RD; Joyce, SA; Cowart, RE; Hill, C; Klebba, PE; Gahan, CGM				McLaughlin, Heather P.; Xiao, Qiaobin; Rea, Rosemarie B.; Pi, Hualiang; Casey, Pat G.; Darby, Trevor; Charbit, Alain; Sleator, Roy D.; Joyce, Susan A.; Cowart, Richard E.; Hill, Colin; Klebba, Phillip E.; Gahan, Cormac G. M.			A Putative P-Type ATPase Required for Virulence and Resistance to Haem Toxicity in Listeria monocytogenes	PLOS ONE			English	Article							IRON ACQUISITION-SYSTEMS; STAPHYLOCOCCUS-AUREUS; BACTERIAL PATHOGENS; LACTOCOCCUS-LACTIS; GENE-EXPRESSION; FUR; TRANSPORT; PROTEIN; PERR; IDENTIFICATION	Regulation of iron homeostasis in many pathogens is principally mediated by the ferric uptake regulator, Fur. Since acquisition of iron from the host is essential for the intracellular pathogen Listeria monocytogenes, we predicted the existence of Fur-regulated systems that support infection. We examined the contribution of nine Fur-regulated loci to the pathogenicity of L. monocytogenes in a murine model of infection. While mutating the majority of the genes failed to affect virulence, three mutants exhibited a significantly compromised virulence potential. Most striking was the role of the membrane protein we designate FrvA (Fur regulated virulence factor A; encoded by frvA [lmo0641]), which is absolutely required for the systemic phase of infection in mice and also for virulence in an alternative infection model, the Wax Moth Galleria mellonella. Further analysis of the Delta frvA mutant revealed poor growth in iron deficient media and inhibition of growth by micromolar concentrations of haem or haemoglobin, a phenotype which may contribute to the attenuated growth of this mutant during infection. Uptake studies indicated that the Delta frvA mutant is unaffected in the uptake of ferric citrate but demonstrates a significant increase in uptake of haem and haemin. The data suggest a potential role for FrvA as a haem exporter that functions, at least in part, to protect the cell against the potential toxicity of free haem.	[McLaughlin, Heather P.; Rea, Rosemarie B.; Casey, Pat G.; Darby, Trevor; Joyce, Susan A.; Hill, Colin; Gahan, Cormac G. M.] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Alimentary Pharmabiot Ctr, Cork, Ireland; [Gahan, Cormac G. M.] Natl Univ Ireland Univ Coll Cork, Sch Pharm, Cork, Ireland; [Xiao, Qiaobin; Pi, Hualiang; Klebba, Phillip E.] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA; [Rea, Rosemarie B.; Sleator, Roy D.] Cork Inst Technol, Dept Biol Sci, Cork, Ireland; [Charbit, Alain] Univ Paris 05, Fac Med Necker Enfants Malad, Paris, France; [Charbit, Alain] INSERM, U1002, Unite Pathogenie Infect Syst, Paris, France; [Cowart, Richard E.] Univ Dubuque, Dept Nat & Appl Sci, Div Biol Sci, Dubuque, IA USA	University College Cork; University College Cork; University of Oklahoma System; University of Oklahoma - Norman; Cork Institute of Technology; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	McLaughlin, HP (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Microbiol, Alimentary Pharmabiot Ctr, Cork, Ireland.	c.hill@ucc.ie	Gahan, Cormac G/AAE-9346-2019; Hill, Colin/A-5611-2012; Joyce, Susan/ABE-2616-2020	Gahan, Cormac G/0000-0003-2385-8192; Hill, Colin/0000-0002-8527-1445; Joyce, Susan/0000-0003-4771-3123; Sleator, Roy/0000-0001-5846-3938; Darby, Trevor/0000-0002-7379-3836; charbit, alain/0000-0001-5243-4861	Science Foundation Ireland through the Centers for Science Engineering and Technology (CSET); Irish Research Council for Science, Engineering & Technology (IRCSET) [ID1773]; National Institutes of Health (NIH) [GM53836]; National Science Foundation (NSF) [MCB0417694]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053836] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1316251] Funding Source: National Science Foundation	Science Foundation Ireland through the Centers for Science Engineering and Technology (CSET)(Science Foundation Ireland); Irish Research Council for Science, Engineering & Technology (IRCSET)(Irish Research Council for Science, Engineering and Technology); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors acknowledge funding received from Science Foundation Ireland (www.sfi.ie) through the Centers for Science Engineering and Technology (CSET) programme for the Alimentary Pharmabiotic Centre. HM was funded by the Irish Research Council for Science, Engineering & Technology (IRCSET) through the Embark postgraduate scholarship programme (IRCSET ID1773). The research was also supported by National Institutes of Health (NIH) grant GM53836 and National Science Foundation (NSF) grant MCB0417694 to PEK and SMN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS TJ, 1990, INFECT IMMUN, V58, P2715, DOI 10.1128/IAI.58.8.2715-2718.1990; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Anzaldi LL, 2010, INFECT IMMUN, V78, P4977, DOI 10.1128/IAI.00613-10; Autret N, 2001, INFECT IMMUN, V69, P2054, DOI 10.1128/IAI.69.4.2054-2065.2001; Baichoo N, 2002, J BACTERIOL, V184, P5826, DOI 10.1128/JB.184.21.5826-5832.2002; Baichoo N, 2002, MOL MICROBIOL, V45, P1613, DOI 10.1046/j.1365-2958.2002.03113.x; Bockmann R, 1996, MOL MICROBIOL, V22, P643, DOI 10.1046/j.1365-2958.1996.d01-1722.x; Braun Volkmar, 2005, V12, P210, DOI 10.1159/000081697; BULLEN JJ, 1974, BRIT J HAEMATOL, V28, P139; Calder KM, 1998, MICROB PATHOGENESIS, V24, P133, DOI 10.1006/mpat.1997.9999; Camejo A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000449; Conte MP, 2000, J MED MICROBIOL, V49, P681, DOI 10.1099/0022-1317-49-8-681; CORNELISSEN CN, 1994, MOL MICROBIOL, V14, P843, DOI 10.1111/j.1365-2958.1994.tb01320.x; Cowart RE, 2002, ARCH BIOCHEM BIOPHYS, V400, P273, DOI 10.1016/S0003-9861(02)00012-7; Daou N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000675; DENEER HG, 1995, MICROBIOL-UK, V141, P1985, DOI 10.1099/13500872-141-8-1985; Dubail I, 2000, INFECT IMMUN, V68, P3242, DOI 10.1128/IAI.68.6.3242-3250.2000; Dussurget O, 2005, FEMS MICROBIOL LETT, V250, P253, DOI 10.1016/j.femsle.2005.07.015; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Francis MS, 1997, MICROB PATHOGENESIS, V22, P67, DOI 10.1006/mpat.1996.0092; Francis MS, 1997, MOL GEN GENET, V253, P484, DOI 10.1007/s004380050347; Gahan CGM, 2000, MOL MICROBIOL, V36, P498, DOI 10.1046/j.1365-2958.2000.01869.x; Gray MJ, 2006, INFECT IMMUN, V74, P2505, DOI 10.1128/IAI.74.5.2505-2512.2006; Horsburgh MJ, 2001, J BACTERIOL, V183, P468, DOI 10.1128/JB.183.2.468-475.2001; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Jin B, 2006, MOL MICROBIOL, V59, P1185, DOI 10.1111/j.1365-2958.2005.05015.x; Joyce SA, 2010, MICROBIOL-SGM, V156, P3456, DOI 10.1099/mic.0.040782-0; Latunde-Dada GO, 2009, BIOESSAYS, V31, P1309, DOI 10.1002/bies.200900101; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; LAW J, 1995, J BACTERIOL, V177, P7011, DOI 10.1128/jb.177.24.7011-7018.1995; Ledala N, 2010, APPL ENVIRON MICROB, V76, P406, DOI 10.1128/AEM.01389-09; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lungu B, 2009, ANAEROBE, V15, P7, DOI 10.1016/j.anaerobe.2008.08.001; McLaughlin HP, 2011, CURR OPIN BIOTECH, V22, P194, DOI 10.1016/j.copbio.2010.10.005; Milohanic E, 2003, MOL MICROBIOL, V47, P1613, DOI 10.1046/j.1365-2958.2003.03413.x; Mukherjee K, 2010, APPL ENVIRON MICROB, V76, P310, DOI 10.1128/AEM.01301-09; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Newton SMC, 2005, MOL MICROBIOL, V55, P927, DOI 10.1111/j.1365-2958.2004.04436.x; Olsen KN, 2005, MICROBIOL-SGM, V151, P925, DOI 10.1099/mic.0.27552-0; Payne SM, 2006, BIOMETALS, V19, P173, DOI 10.1007/s10534-005-4577-x; Raya R, 1998, J BACTERIOL, V180, P3174, DOI 10.1128/JB.180.12.3174-3180.1998; Rea R, 2005, APPL ENVIRON MICROB, V71, P8314, DOI 10.1128/AEM.71.12.8314-8322.2005; Rea RB, 2004, INFECT IMMUN, V72, P717, DOI 10.1128/IAI.72.2.717-727.2004; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SIMON N, 1995, APPL ENVIRON MICROB, V61, P1643, DOI 10.1128/AEM.61.4.1643-1645.1995; Skaar EP, 2004, MICROBES INFECT, V6, P390, DOI 10.1016/j.micinf.2003.12.008; SMITH K, 1992, BIOCHIMIE, V74, P705, DOI 10.1016/0300-9084(92)90143-3; Stauff DL, 2008, J BACTERIOL, V190, P3588, DOI 10.1128/JB.01921-07; Stauff DL, 2009, MOL MICROBIOL, V72, P763, DOI 10.1111/j.1365-2958.2009.06684.x; Weinberg ED, 2009, BBA-GEN SUBJECTS, V1790, P600, DOI 10.1016/j.bbagen.2008.07.002; Xiao QB, 2011, MOL MICROBIOL, V80, P1581, DOI 10.1111/j.1365-2958.2011.07667.x	52	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e30928	10.1371/journal.pone.0030928	http://dx.doi.org/10.1371/journal.pone.0030928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363518	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700015
J	Ahmed, A; Rabbitt, E; Brady, T; Brown, C; Guest, P; Bujalska, IJ; Doig, C; Newsome, PN; Hubscher, S; Elias, E; Adams, DH; Tomlinson, JW; Stewart, PM				Ahmed, Adeeba; Rabbitt, Elizabeth; Brady, Theresa; Brown, Claire; Guest, Peter; Bujalska, Iwona J.; Doig, Craig; Newsome, Philip N.; Hubscher, Stefan; Elias, Elwyn; Adams, David H.; Tomlinson, Jeremy W.; Stewart, Paul M.			A Switch in Hepatic Cortisol Metabolism across the Spectrum of Non Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; 5-ALPHA-REDUCTASE ACTIVITY; GLUCOCORTICOID METABOLISM; SEVERE STEATOHEPATITIS; PREDNISOLONE THERAPY; COMPUTED-TOMOGRAPHY; ADIPOSE-TISSUE; INSULIN; OBESITY; MICE	Context: Non alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome. NAFLD represents a spectrum of liver disease ranging from reversible hepatic steatosis, to non alcoholic steato-hepatitis (NASH) and cirrhosis. The potential role of glucocorticoids (GC) in the pathogenesis of NAFLD is highlighted in patients with GC excess, Cushing's syndrome, who develop central adiposity, insulin resistance and in 20% of cases, NAFLD. Although in most cases of NAFLD, circulating cortisol levels are normal, hepatic cortisol availability is controlled by enzymes that regenerate cortisol (F) from inactive cortisone (E) (11 beta-hydroxysteroid dehydrogenase type 1, 11 beta-HSD1), or inactivate cortisol through A-ring metabolism (5 alpha- and 5 beta-reductase, 5 alpha R and 5 beta R). Objective and Methods: In vitro studies defined 11 beta-HSD1 expression in normal and NASH liver samples. We then characterised hepatic cortisol metabolism in 16 patients with histologically proven NAFLD compared to 32 obese controls using gas chromatographic analysis of 24 hour urine collection and plasma cortisol generation profile following oral cortisone. Results: In patients with steatosis 5 alpha R activity was increased, with a decrease in hepatic 11 beta-HSD1 activity. Total cortisol metabolites were increased in this group consistent with increased GC production rate. In contrast, in patients with NASH, 11 beta-HSD1 activity was increased both in comparison to patients with steatosis, and controls. Endorsing these findings, 11 beta-HSD1 mRNA and immunostaining was markedly increased in NASH patients in peri septal hepatocytes and within CD68 positive macrophages within inflamed cirrhotic septa. Conclusion: Patients with hepatic steatosis have increased clearance and decreased hepatic regeneration of cortisol and we propose that this may represent a protective mechanism to decrease local GC availability to preserve hepatic metabolic phenotype. With progression to NASH, increased 11 beta-HSD1 activity and consequent cortisol regeneration may serve to limit hepatic inflammation.	[Ahmed, Adeeba; Rabbitt, Elizabeth; Bujalska, Iwona J.; Doig, Craig; Tomlinson, Jeremy W.; Stewart, Paul M.] Univ Birmingham, Sch Clin & Expt Med, Ctr Endocrinol Diabet & Metab, Inst Biomed Res, Birmingham, W Midlands, England; [Brady, Theresa; Brown, Claire] Univ Hosp Birmingham NHS Fdn Trust, Wellcome Trust Clin Res Facil, Birmingham, W Midlands, England; [Newsome, Philip N.; Elias, Elwyn; Adams, David H.] Univ Hosp Birmingham NHS Fdn Trust, Liver Res Ctr, Birmingham, W Midlands, England; [Newsome, Philip N.; Elias, Elwyn; Adams, David H.] Univ Hosp Birmingham NHS Fdn Trust, NIHR Biomed Res Unit Liver Dis, Birmingham, W Midlands, England; [Guest, Peter] Univ Hosp Birmingham NHS Fdn, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham	Ahmed, A (corresponding author), Univ Birmingham, Sch Clin & Expt Med, Ctr Endocrinol Diabet & Metab, Inst Biomed Res, Birmingham, W Midlands, England.	p.m.stewart@bham.ac.uk	Adams, David H/C-9092-2009; Doig, Craig/D-6948-2012; Doig, Craig L./HHZ-0266-2022; Doig, Craig/AAU-7601-2021; Newsome, Philip N/D-4495-2018	Adams, David H/0000-0001-6776-0336; Doig, Craig L./0000-0001-9694-4230; Doig, Craig/0000-0001-9694-4230; Newsome, Philip N/0000-0001-6085-3652; Tomlinson, Jeremy/0000-0002-3170-8533	Wellcome Trust [082809/Z/07/Z]; Medical Research Council [G84/6638]; Medical Research Council [G9818340B, G0802765] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10356] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by grants from the Wellcome Trust (Programme Grant reference number is 082809/Z/07/Z) (to P.M.S.) Medical Research Council G84/6638 (to A.A.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2008, CLIN ENDOCRINOL, V68, P898, DOI 10.1111/j.1365-2265.2007.03125.x; ANTAKLY T, 1984, ENDOCRINOLOGY, V115, P1984, DOI 10.1210/endo-115-5-1984; BAXTER JD, 1972, AM J MED, V53, P573, DOI 10.1016/0002-9343(72)90154-4; Berthiaume M, 2009, METABOLISM; BORKAN GA, 1982, AM J CLIN NUTR, V36, P172, DOI 10.1093/ajcn/36.1.172; Bujalska IJ, 2008, J ENDOCRINOL, V197, P297, DOI 10.1677/JOE-08-0050; BURCHELL A, 1988, CLIN CHIM ACTA, V173, P183, DOI 10.1016/0009-8981(88)90256-2; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Chapman KE, 2009, MOL CELL ENDOCRINOL, V301, P123, DOI 10.1016/j.mce.2008.09.031; Cooper MS, 2001, J BONE MINER RES, V16, P1037, DOI 10.1359/jbmr.2001.16.6.1037; de Alwis NMW, 2008, J HEPATOL, V48, pS104, DOI 10.1016/j.jhep.2008.01.009; Dolinsky VW, 2004, BIOCHEM J, V378, P967, DOI 10.1042/BJ20031320; Dourakis SP, 2002, AM J GASTROENTEROL, V97, P1074; Dover AR, 2007, ENDOCRINOLOGY, V148, P166, DOI 10.1210/en.2006-0996; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; Gilmour JS, 2006, J IMMUNOL, V176, P7605, DOI 10.4049/jimmunol.176.12.7605; Hardy R, 2008, ANN RHEUM DIS, V67, P1204, DOI 10.1136/ard.2008.090662; Hellerstein MK, 1999, EUR J CLIN NUTR, V53, pS53, DOI 10.1038/sj.ejcn.1600744; Heydtmann M, 2009, J VIROL, V83, P2796, DOI 10.1128/JVI.00996-08; Ishii T, 2007, FEBS LETT, V581, P349, DOI 10.1016/j.febslet.2006.11.032; Konopelska S, 2009, CLIN ENDOCRINOL, V70, P554, DOI 10.1111/j.1365-2265.2008.03358.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lavery GG, 2006, J BIOL CHEM, V281, P6546, DOI 10.1074/jbc.M512635200; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Morton NM, 2001, J BIOL CHEM, V276, P41293, DOI 10.1074/jbc.M103676200; Nanki T, 1999, AM J GASTROENTEROL, V94, P3379, DOI 10.1111/j.1572-0241.1999.03379.x; NORRHEIM L, 1990, BIOCHIM BIOPHYS ACTA, V1051, P319, DOI 10.1016/0167-4889(90)90141-Y; Palermo M, 1996, CLIN ENDOCRINOL, V45, P605, DOI 10.1046/j.1365-2265.1996.00853.x; Paterson JM, 2004, P NATL ACAD SCI USA, V101, P7088, DOI 10.1073/pnas.0305524101; Rae MT, 2004, J ENDOCRINOL, V183, P19, DOI 10.1677/joe.1.05754; Ricketts ML, 1998, J CLIN ENDOCR METAB, V83, P1325, DOI 10.1210/jc.83.4.1325; Rockall AG, 2003, EUR J ENDOCRINOL, V149, P543, DOI 10.1530/eje.0.1490543; Rosenstock J, 2010, DIABETES CARE, V33, P1516, DOI 10.2337/dc09-2315; SHACKLETON CHL, 1993, J STEROID BIOCHEM, V45, P127, DOI 10.1016/0960-0760(93)90132-G; Stewart PM, 1999, J CLIN ENDOCR METAB, V84, P1022, DOI 10.1210/jc.84.3.1022; STEWART PM, 1990, CLIN SCI, V78, P49, DOI 10.1042/cs0780049; Targher G, 2006, CLIN ENDOCRINOL, V64, P337, DOI 10.1111/j.1365-2265.2006.02466.x; Tomlinson JW, 2008, DIABETES, V57, P1536, DOI 10.2337/db08-0094; Tomlinson JW, 2005, NAT CLIN PRACT ENDOC, V1, P92, DOI 10.1038/ncpendmet0023; Vassiliadi DA, 2009, J CLIN ENDOCR METAB, V94, P3558, DOI 10.1210/jc.2009-0837; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Westerbacka J, 2003, J CLIN ENDOCR METAB, V88, P4924, DOI 10.1210/jc.2003-030596; Williams LJS, 2000, J BIOL CHEM, V275, P30232, DOI 10.1074/jbc.M001286200; Zbankova S, 2007, J GASTROEN HEPATOL, V22, P1019, DOI 10.1111/j.1440-1746.2006.04529.x	44	62	63	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e29531	10.1371/journal.pone.0029531	http://dx.doi.org/10.1371/journal.pone.0029531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363403	Green Published, gold			2022-12-27	WOS:000302871500001
J	Cambier, L; Rassam, P; Chabi, B; Mezghenna, K; Gross, R; Eveno, E; Auffray, C; Wrutniak-Cabello, C; Lajoix, AD; Pomies, P				Cambier, Linda; Rassam, Patrice; Chabi, Beatrice; Mezghenna, Karima; Gross, Rene; Eveno, Eric; Auffray, Charles; Wrutniak-Cabello, Chantal; Lajoix, Anne-Dominique; Pomies, Pascal			M19 Modulates Skeletal Muscle Differentiation and Insulin Secretion in Pancreatic beta-Cells through Modulation of Respiratory Chain Activity	PLOS ONE			English	Article							MITOCHONDRIAL-DNA NUCLEOIDS; MYOBLAST DIFFERENTIATION; EXPRESSION; PROTEINS; RISK	Mitochondrial dysfunction due to nuclear or mitochondrial DNA alterations contributes to multiple diseases such as metabolic myopathies, neurodegenerative disorders, diabetes and cancer. Nevertheless, to date, only half of the estimated 1,500 mitochondrial proteins has been identified, and the function of most of these proteins remains to be determined. Here, we characterize the function of M19, a novel mitochondrial nucleoid protein, in muscle and pancreatic beta-cells. We have identified a 13-long amino acid sequence located at the N-terminus of M19 that targets the protein to mitochondria. Furthermore, using RNA interference and over-expression strategies, we demonstrate that M19 modulates mitochondrial oxygen consumption and ATP production, and could therefore regulate the respiratory chain activity. In an effort to determine whether M19 could play a role in the regulation of various cell activities, we show that this nucleoid protein, probably through its modulation of mitochondrial ATP production, acts on late muscle differentiation in myogenic C2C12 cells, and plays a permissive role on insulin secretion under basal glucose conditions in INS-1 pancreatic beta-cells. Our results are therefore establishing a functional link between a mitochondrial nucleoid protein and the modulation of respiratory chain activities leading to the regulation of major cellular processes such as myogenesis and insulin secretion.	[Cambier, Linda; Rassam, Patrice; Pomies, Pascal] CNRS, CRBM, UMR5237, F-34033 Montpellier, France; [Chabi, Beatrice; Wrutniak-Cabello, Chantal] INRA, UMR866, F-34060 Montpellier, France; [Mezghenna, Karima; Gross, Rene; Lajoix, Anne-Dominique] CNRS, UMR5232, Ctr Pharmacol & Innovat Diabet, Montpellier, France; [Cambier, Linda; Rassam, Patrice; Chabi, Beatrice; Mezghenna, Karima; Gross, Rene; Wrutniak-Cabello, Chantal; Lajoix, Anne-Dominique; Pomies, Pascal] Univ Montpellier I, Montpellier, France; [Cambier, Linda; Rassam, Patrice; Chabi, Beatrice; Wrutniak-Cabello, Chantal; Pomies, Pascal] Univ Montpellier 2, Montpellier, France; [Eveno, Eric; Auffray, Charles] CNRS, Inst Biol Sci, Villejuif, France; [Pomies, Pascal] INSERM, U1046, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; INRAE; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Cambier, L (corresponding author), CNRS, CRBM, UMR5237, BP 5051, F-34033 Montpellier, France.	pascal.pomies@inserm.fr	Pomiès, Pascal/AAC-8037-2020; Chabi, Beatrice/AAI-6545-2020; Linda, Cambier/AAL-9928-2020; Rassam, Patrice/P-6564-2014	Pomiès, Pascal/0000-0002-5301-6087; Chabi, Beatrice/0000-0002-5604-5668; Linda, Cambier/0000-0001-9482-1413; Rassam, Patrice/0000-0002-8630-0957; Gross, Rene/0000-0001-5884-3607; Eveno, Eric/0000-0002-7282-280X	Association Francaise contre les Myopathies (AFM); Institut National de la Sante et de la Recherche Medicale (Inserm)	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm))	We acknowledge the support of the Association Francaise contre les Myopathies (AFM) and the Institut National de la Sante et de la Recherche Medicale (Inserm). LC is supported by the AFM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Fujimoto S, 2007, DIABETES RES CLIN PR, V77, pS2, DOI 10.1016/j.diabres.2007.01.026; Hamai N, 1997, CELL STRUCT FUNCT, V22, P421, DOI 10.1247/csf.22.421; HERZBERG NH, 1993, BIOCHIM BIOPHYS ACTA, V1181, P63, DOI 10.1016/0925-4439(93)90091-E; KANEKO T, 1988, MOL CELL BIOL, V8, P3311, DOI 10.1128/MCB.8.8.3311; Komarova SV, 2000, AM J PHYSIOL-CELL PH, V279, pC1220, DOI 10.1152/ajpcell.2000.279.4.C1220; Lambert AP, 2004, J CLIN ENDOCR METAB, V89, P4037, DOI 10.1210/jc.2003-032084; Maechler P, 2006, INT J BIOCHEM CELL B, V38, P696, DOI 10.1016/j.biocel.2005.12.006; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Maier LM, 2005, CURR OPIN IMMUNOL, V17, P601, DOI 10.1016/j.coi.2005.09.013; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Roach JC, 2006, AM J HUM GENET, V79, P614, DOI 10.1086/507876; Rochard P, 2000, J BIOL CHEM, V275, P2733, DOI 10.1074/jbc.275.4.2733; Rochard P, 1996, J CELL PHYSIOL, V168, P239, DOI 10.1002/(SICI)1097-4652(199608)168:2<239::AID-JCP2>3.0.CO;2-Q; Seyer P, 2006, J CELL PHYSIOL, V207, P75, DOI 10.1002/jcp.20539; Sobreira C, 1999, BIOCHEM BIOPH RES CO, V266, P179, DOI 10.1006/bbrc.1999.1758; Sumitani M, 2009, J BIOCHEM, V146, P725, DOI 10.1093/jb/mvp118; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; VAYSSIERE JL, 1992, IN VITRO CELL DEV-AN, V28A, P763; Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200	24	12	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31815	10.1371/journal.pone.0031815	http://dx.doi.org/10.1371/journal.pone.0031815			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363741	Green Published, Green Submitted, gold			2022-12-27	WOS:000302871500091
J	Migdall-Wilson, J; Bates, C; Schlegel, J; Brandao, L; Linger, RMA; DeRyckere, D; Graham, DK				Migdall-Wilson, Justine; Bates, Christine; Schlegel, Jennifer; Brandao, Luis; Linger, Rachel M. A.; DeRyckere, Deborah; Graham, Douglas K.			Prolonged Exposure to a Mer Ligand in Leukemia: Gas6 Favors Expression of a Partial Mer Glycoform and Reveals a Novel Role for Mer in the Nucleus	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; ACUTE LYMPHOBLASTIC-LEUKEMIA; GROWTH-FACTOR; PLATELET-AGGREGATION; PLASMA-LEVELS; HUMAN CANCER; CELL-GROWTH; C-MER; PATHWAY; AXL	Mer tyrosine kinase is ectopically expressed in acute lymphoblastic leukemia and associated with enhanced chemoresistance and disease progression. While such effects are generally ascribed to increased engagement of oncogenic pathways downstream of Mer stimulation by its ligand, Gas6, Mer has not been characterized beyond the scope of its signaling activity. The present study explores Mer behavior following prolonged exposure to Gas6, a context similar to the Gas6-enriched microenvironment of the bone marrow, where a steady supply of ligand facilitates continuous engagement of Mer and likely sustains the presence of leukemic cells. Long-term Gas6 exposure induced production of a partially N-glycosylated form of Mer from newly synthesized stores of protein. Preferential expression of the partial Mer glycoform was associated with diminished levels of Mer on the cell surface and altered Mer localization within the nuclear-soluble and chromatin-bound fractions. The presence of Mer in the nucleus is a novel finding for this receptor, and the glycoform-specific preferences observed in each nuclear compartment suggest that glycosylation may influence Mer function within particular subcellular locales. Previous studies have established Mer as an attractive cancer biologic target, and understanding the complexity of its activity has important implications for potential strategies of Mer inhibition in leukemia therapy. Our results identify several novel features of Mer that expand the breadth of its functions and impact the development of therapeutic modalities designed to target Mer.	[Migdall-Wilson, Justine; Bates, Christine; Schlegel, Jennifer; Brandao, Luis; Linger, Rachel M. A.; DeRyckere, Deborah; Graham, Douglas K.] Univ Colorado Anschutz Med Campus, Dept Pediat, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Migdall-Wilson, J (corresponding author), Univ Colorado Anschutz Med Campus, Dept Pediat, Aurora, CO USA.	doug.graham@ucdenver.edu		Maller, Justine/0000-0001-6930-7375	NIH [1R01CA137078]; ACS [RSG-08-291-01-LIB]; NIH/NCRR Colorado CTSI [UL1 RR025780]; NATIONAL CANCER INSTITUTE [P30CA046934, R01CA137078] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008497] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ACS(American Cancer Society); NIH/NCRR Colorado CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH Grant 1R01CA137078 and ACS Grant RSG-08-291-01-LIB to DKG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Imaging experiments were performed in the University of Colorado Anschutz Medical Campus Advance Light Microscopy Core, supported in part by NIH/NCRR Colorado CTSI Grant UL1 RR025780. Contents are the authors' sole responsibility and do not necessarily represent official NIH views.	Anwar A, 2009, J LEUKOCYTE BIOL, V86, P73, DOI [10.1189/jlb.0608334, 10.1189/JLB.0608334]; Avanzi GC, 1997, EXP HEMATOL, V25, P1219; Balogh I, 2005, ARTERIOSCL THROM VAS, V25, P1280, DOI 10.1161/01.ATV.0000163845.07146.48; Borgel D, 2006, CRIT CARE MED, V34, P219, DOI 10.1097/01.CCM.0000195014.56254.8A; Brandao Luis, 2011, Critical Reviews in Oncogenesis, V16, P47; Brown JR, 2007, CRIT REV BIOCHEM MOL, V42, P481, DOI 10.1080/10409230701751611; Bryant DM, 2005, TRAFFIC, V6, P947, DOI 10.1111/j.1600-0854.2005.00332.x; Burnier L, 2006, J THROMB HAEMOST, V4, P2283, DOI 10.1111/j.1538-7836.2006.02155.x; Carpenter G, 2009, EXP CELL RES, V315, P1556, DOI 10.1016/j.yexcr.2008.09.027; Chen J, 1997, ONCOGENE, V14, P2033, DOI 10.1038/sj.onc.1201039; Clauser S, 2006, ARTERIOSCL THROM VAS, V26, pE22, DOI 10.1161/01.ATV.0000201968.72967.f9; Dormady SP, 2000, P NATL ACAD SCI USA, V97, P12260, DOI 10.1073/pnas.97.22.12260; Feng W, 2002, J BIOL CHEM, V277, P17016, DOI 10.1074/jbc.M107876200; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Gomes DA, 2008, J BIOL CHEM, V283, P4344, DOI 10.1074/jbc.M706550200; Gould CM, 2010, NUCLEIC ACIDS RES, V38, pD167, DOI 10.1093/nar/gkp1016; Graham DK, 2006, CLIN CANCER RES, V12, P2662, DOI 10.1158/1078-0432.CCR-05-2208; GRAHAM DK, 1994, CELL GROWTH DIFFER, V5, P647; GRAHAM DK, 1995, ONCOGENE, V10, P2349; Guttridge KL, 2002, J BIOL CHEM, V277, P24057, DOI 10.1074/jbc.M112086200; Hung YJ, 2010, DIABETES CARE, V33, P1840, DOI 10.2337/dc09-1073; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Keating AK, 2006, ONCOGENE, V25, P6092, DOI 10.1038/sj.onc.1209633; Keating AK, 2010, MOL CANCER THER, V9, P1298, DOI 10.1158/1535-7163.MCT-09-0707; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Krysov S, 2010, BLOOD, V115, P4198, DOI 10.1182/blood-2009-12-254847; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Linger RMA, 2009, BLOOD, V114, P2678, DOI 10.1182/blood-2009-03-209247; Linger RM, 2010, EXPERT OPIN THER TAR, V14, P1073, DOI 10.1517/14728222.2010.515980; Liu HS, 2010, CARCINOGENESIS, V31, P1456, DOI 10.1093/carcin/bgq100; Lo HW, 2006, BRIT J CANCER, V94, P184, DOI 10.1038/sj.bjc.6602941; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; MANSFIELD MA, 1995, ANAL BIOCHEM, V229, P140, DOI 10.1006/abio.1995.1391; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; Rogers AEJ, 2012, ONCOGENE, V31, P4171, DOI 10.1038/onc.2011.588; Roth J, 2002, CHEM REV, V102, P285, DOI 10.1021/cr000423j; Sather S, 2007, BLOOD, V109, P1026, DOI 10.1182/blood-2006-05-021634; Sehat B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000628; Seol KC, 2003, BIOCHEM BIOPH RES CO, V306, P898, DOI 10.1016/S0006-291X(03)01046-5; Shiozawa Y, 2010, EXP HEMATOL, V38, P132, DOI 10.1016/j.exphem.2009.11.002; Stachowiak MK, 2003, J CELL BIOCHEM, V90, P662, DOI 10.1002/jcb.10606; Stachowiak MK, 1997, MOL NEUROBIOL, V15, P257, DOI 10.1007/BF02740663; Wang SC, 2004, CANCER CELL, V6, P251, DOI 10.1016/j.ccr.2004.07.012; Wang YN, 2010, ONCOGENE, V29, P3997, DOI 10.1038/onc.2010.157; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; XIE YM, 1994, BIOCHEM BIOPH RES CO, V203, P1589, DOI 10.1006/bbrc.1994.2368; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6	49	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31635	10.1371/journal.pone.0031635	http://dx.doi.org/10.1371/journal.pone.0031635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363695	Green Submitted, gold, Green Published			2022-12-27	WOS:000302871500068
J	Nagarajan, S; Tosh, C; Smith, DK; Peiris, JSM; Murugkar, HV; Sridevi, R; Kumar, M; Katare, M; Jain, R; Syed, Z; Behera, P; Cheung, CL; Khandia, R; Tripathi, S; Guan, Y; Dubey, SC				Nagarajan, Shanmuga; Tosh, Chakradhar; Smith, David K.; Peiris, Joseph Sriyal Malik; Murugkar, Harshad Vinayakrao; Sridevi, Rajangam; Kumar, Manoj; Katare, Megha; Jain, Rajlaxmi; Syed, Zohra; Behera, Padmanava; Cheung, Chung L.; Khandia, Rekha; Tripathi, Sushil; Guan, Yi; Dubey, Shiv Chandra			Avian Influenza (H5N1) Virus of Clade 2.3.2 in Domestic Poultry in India	PLOS ONE			English	Article							WILD BIRDS; HEMAGGLUTININ; VIRULENCE; OUTBREAK	South Asia has experienced regular outbreaks of H5N1 avian influenza virus since its first detection in India and Pakistan in February, 2006. Till 2009, the outbreaks in this region were due to clade 2.2 H5N1 virus. In 2010, Nepal reported the first outbreak of clade 2.3.2 virus in South Asia. In February 2011, two outbreaks of H5N1 virus were reported in the State of Tripura in India. The antigenic and genetic analyses of seven H5N1 viruses isolated during these outbreaks were carried out. Antigenic analysis confirmed 64 to 256-fold reduction in cross reactivity compared with clade 2.2 viruses. The intravenous pathogenicity index of the isolates ranged from 2.80-2.95 indicating high pathogenicity to chickens. Sequencing of all the eight gene-segments of seven H5N1 viruses isolated in these outbreaks was carried out. The predicted amino acid sequence analysis revealed high pathogenicity to chickens and susceptibility to the antivirals, amantadine and oseltamivir. Phylogenetic analyses indicated that these viruses belong to clade 2.3.2.1 and were distinct to the clade 2.3.2.1 viruses isolated in Nepal. Identification of new clade 2.3.2 H5N1 viruses in South Asia is reminiscent of the introduction of clade 2.2 viruses in this region in 2006/7. It is now important to monitor whether the clade 2.3.2.1 is replacing clade 2.2 in this region or co-circulating with it. Continued co-circulation of various subclades of the H5N1 virus which are more adapted to land based poultry in a highly populated region such as South Asia increases the risk of evolution of pandemic H5N1 strains.	[Nagarajan, Shanmuga; Tosh, Chakradhar; Murugkar, Harshad Vinayakrao; Sridevi, Rajangam; Kumar, Manoj; Katare, Megha; Jain, Rajlaxmi; Syed, Zohra; Behera, Padmanava; Khandia, Rekha; Tripathi, Sushil; Dubey, Shiv Chandra] Indian Vet Res Inst, High Secur Anim Dis Lab, Bhopal, India; [Peiris, Joseph Sriyal Malik; Cheung, Chung L.; Guan, Yi] Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Smith, David K.] Shantou Univ, Sch Med, Univ Hong Kong,Int Inst Infect & Immun, State Key Lab Emerging Infect Dis,Li Ka Shing Fac, Shantou, Peoples R China	Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; ICAR - National Institute of High Security Animal Diseases; University of Hong Kong; Shantou University; University of Hong Kong	Nagarajan, S (corresponding author), Indian Vet Res Inst, High Secur Anim Dis Lab, Bhopal, India.	nagavetbio@gmail.com	Khandia, Rekha/AAE-6122-2022; Cheung, Yiu Man/T-2708-2019; Peiris, Joseph Sriyal Malik/C-4380-2009	Khandia, Rekha/0000-0002-9961-3127; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; , Nagarajan/0000-0002-4408-8708; Smith, David/0000-0003-3608-0586; Tosh, Chakradhar/0000-0003-2889-4707; Guan, Yi/0000-0001-6057-9243	Department of Animal Husbandry, Dairying and Fisheries, Ministry of Agriculture, Government of India through CDDL; National Institutes of Health, National Institute of Allergy and Infectious Diseases [HHSN266200700005C]	Department of Animal Husbandry, Dairying and Fisheries, Ministry of Agriculture, Government of India through CDDL; National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a financial grant from the Department of Animal Husbandry, Dairying and Fisheries, Ministry of Agriculture, Government of India through CDDL for Avian influenza diagnosis and research. The study was also supported by a research grant to JSMP and YG from National Institutes of Health, National Institute of Allergy and Infectious Diseases contract HHSN266200700005C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boltz DA, 2010, J GEN VIROL, V91, P949, DOI 10.1099/vir.0.017459-0; Chakrabarti AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007846; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; DESHPANDE KL, 1987, P NATL ACAD SCI USA, V84, P36, DOI 10.1073/pnas.84.1.36; Donis R. O., 2008, Emerging Infectious Diseases, V14, pe1; Duan L, 2008, VIROLOGY, V380, P243, DOI 10.1016/j.virol.2008.07.038; Duan L, 2007, J VIROL, V81, P7529, DOI 10.1128/JVI.00327-07; Dubey SC, 2009, INDIAN J ANIM SCI, V79, P113; Food and Agricultural Organization, 2010, H5N1 HPAI GLOB OV JU; Food and Agricultural Organization, 2011, H5N1 HPAI GLOB OV AP; Guan Y, 2004, P NATL ACAD SCI USA, V101, P8156, DOI 10.1073/pnas.0402443101; Hoffmann E, 2005, P NATL ACAD SCI USA, V102, P12915, DOI 10.1073/pnas.0506416102; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Jiao PR, 2008, J VIROL, V82, P1146, DOI 10.1128/JVI.01698-07; Kang HM, 2011, VET MICROBIOL, V147, P170, DOI 10.1016/j.vetmic.2010.05.045; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Li YB, 2011, EMERG INFECT DIS, V17, P265, DOI 10.3201/eid1702.100732; Li ZJ, 2006, J VIROL, V80, P11115, DOI 10.1128/JVI.00993-06; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Nagarajan S, 2012, RES VET SCI, V93, P504, DOI 10.1016/j.rvsc.2011.06.005; Nagarajan S, 2010, VIRUS GENES, V41, P30, DOI 10.1007/s11262-010-0477-4; Nagarajan S, 2009, VET MICROBIOL, V133, P154, DOI 10.1016/j.vetmic.2008.06.013; Neumann G, 2007, ANTIVIR THER, V12, P617; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Reid SM, 2011, TRANSBOUND EMERG DIS, V58, P76, DOI 10.1111/j.1865-1682.2010.01175.x; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Sharshov K, 2010, EMERG INFECT DIS, V16, P349, DOI 10.3201/eid1602.090974; Smith GJD, 2009, EMERG INFECT DIS, V15, P402, DOI 10.3201/eid1503.081190; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tosh C, 2011, VIRUS GENES, V42, P10, DOI 10.1007/s11262-010-0534-z; Tosh C, 2011, VET MICROBIOL, V148, P132, DOI 10.1016/j.vetmic.2010.08.015; WHO, 2005, REC LAB TESTS ID AV; WHO, 2002, WHO MAN AV INFL DIAG; World Organization for Animal Health, 2011, UPD HIGHL PATH AV IN	36	46	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31844	10.1371/journal.pone.0031844	http://dx.doi.org/10.1371/journal.pone.0031844			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363750	Green Published, gold			2022-12-27	WOS:000302871500094
J	Perry, IJ; Corcoran, P; Fitzgerald, AP; Keeley, HS; Reulbach, U; Arensman, E				Perry, Ivan J.; Corcoran, Paul; Fitzgerald, Anthony P.; Keeley, Helen S.; Reulbach, Udo; Arensman, Ella			The Incidence and Repetition of Hospital-Treated Deliberate Self Harm: Findings from the World's First National Registry	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; EMERGENCY-DEPARTMENT; NONFATAL REPETITION; ATTEMPTED-SUICIDE; EPIDEMIOLOGY; MULTICENTER; PARASUICIDE; PREVENTION; EUROPE; TRENDS	Background: Suicide is a significant public health issue with almost one million people dying by suicide each year worldwide. Deliberate self harm (DSH) is the single most important risk factor for suicide yet few countries have reliable data on DSH. We developed a national DSH registry in the Republic of Ireland to establish the incidence of hospital-treated DSH at national level and the spectrum and pattern of presentations with DSH and repetition. Methods and Findings: Between 2003 and 2009, the Irish National Registry of Deliberate Self Harm collected data on DSH presentations to all 40 hospital emergency departments in the country. Data were collected by trained data registration officers using standard methods of case ascertainment and definition. The Registry recorded 75,119 DSH presentations involving 48,206 individuals. The total incidence rate fell from 209 (95% CI: 205-213) per 100,000 in 2003 to 184 (95% CI: 180-189) per 100,000 in 2006 and increased again to 209 (95% CI: 204-213) per 100,000 in 2009. The most notable annual changes were successive 10% increases in the male rate in 2008 and 2009. There was significant variation by age with peak rates in women in the 15-19 year age group (620 (95% CI: 605-636) per 100,000), and in men in the 20-24 age group (427 (95% CI: 416-439) per 100,000). Repetition rates varied significantly by age, method of self harm and number of previous episodes. Conclusions: Population-based data on hospital-treated DSH represent an important index of the burden of mental illness and suicide risk in the community. The increased DSH rate in Irish men in 2008 and 2009 coincided with the advent of the economic recession in Ireland. The findings underline the need for developing effective interventions to reduce DSH repetition rates as a key priority for health systems.	[Perry, Ivan J.; Fitzgerald, Anthony P.] Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland; [Corcoran, Paul; Reulbach, Udo; Arensman, Ella] Natl Suicide Res Fdn, Cork, Ireland; [Keeley, Helen S.] HSE S, Child & Adolescent Mental Hlth Serv, Mallow, County Cork, Ireland	University College Cork	Perry, IJ (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland.	i.perry@ucc.ie	Reulbach, Udo/F-4239-2012; Fitzgerald, Tony/AAB-5331-2020	Reulbach, Udo/0000-0002-9527-157X; Arensman, Ella/0000-0003-0376-1203; Fitzgerald, Tony/0000-0001-6437-5686; Perry, Ivan/0000-0002-4965-9792	Irish Health Service Executive's National Office for Suicidee Prevention	Irish Health Service Executive's National Office for Suicidee Prevention	The work was funded by the Irish Health Service Executive's National Office for Suicidee Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2003, ASS TREATM PAT SUIC; Arensman E., 2008, J EPIDEMIOLOGY COMMU, V62, pA1; Beghi M, 2010, CURR OPIN PSYCHIATR, V23, P349, DOI 10.1097/YCO.0b013e32833ad783; Bennewith O, 2005, J AFFECT DISORDERS, V89, P91, DOI 10.1016/j.jad.2005.08.011; Bergen H, 2010, BRIT J PSYCHIAT, V197, P493, DOI 10.1192/bjp.bp.110.077651; Bogdanovica I, 2010, CHANGES RATES METHOD; Brown GK, 2005, JAMA-J AM MED ASSOC, V294, P563, DOI 10.1001/jama.294.5.563; Carter GL, 2005, BMJ-BRIT MED J, V331, P805, DOI 10.1136/bmj.38579.455266.E0; Carter GL, 2007, BRIT J PSYCHIAT, V191, P548, DOI 10.1192/bjp.bp.107.038406; Cedereke M, 2005, EUR PSYCHIAT, V20, P101, DOI 10.1016/j.eurpsy.2004.09.008; Cleves M., 2008, INTRO SURVIVAL ANAL; Cook RJ, 2002, STAT METHODS MED RES, V11, P141, DOI 10.1191/0962280202sm278ra; Cooper J, 2005, AM J PSYCHIAT, V162, P297, DOI 10.1176/appi.ajp.162.2.297; Corcoran P, 2004, EUR J PUBLIC HEALTH, V14, P19, DOI 10.1093/eurpub/14.1.19; Gunnell D, 2005, INT J EPIDEMIOL, V34, P433, DOI 10.1093/ije/dyh398; Gunnell D, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1891; Hatcher S, 2009, AUST NZ J PSYCHIAT, V43, P659, DOI 10.1080/00048670902970833; Haw C, 2003, SUICIDE LIFE-THREAT, V33, P353, DOI 10.1521/suli.33.4.353.25232; Haw C, 2007, SUICIDE LIFE-THREAT, V37, P379, DOI 10.1521/suli.2007.37.4.379; Hawton K, 2004, SUICIDE LIFE-THREAT, V34, P199, DOI 10.1521/suli.34.3.199.42776; Hawton K, 2007, SOC PSYCH PSYCH EPID, V42, P513, DOI 10.1007/s00127-007-0199-7; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Hawton K, 2008, BRIT J PSYCHIAT, V193, P503, DOI 10.1192/bjp.bp.107.048561; Kalbfleisch J. D., 1981, STAT ANAL FAILURE TI; Kapur N, 2006, CLIN MED, V6, P529, DOI 10.7861/clinmedicine.6-6-529; Lilley R, 2008, BRIT J PSYCHIAT, V192, P440, DOI 10.1192/bjp.bp.107.043380; Madge N, 2008, J CHILD PSYCHOL PSYC, V49, P667, DOI 10.1111/j.1469-7610.2008.01879.x; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; McManus S, 2009, ADULT PSYCHIAT MORBI, P71; Owens D, 2002, BRIT J PSYCHIAT, V181, P193, DOI 10.1192/bjp.181.3.193; Patel Muhammad Junaid, 2008, J Pak Med Assoc, V58, P298; PLATT S, 1988, PSYCHOL MED, V18, P405, DOI 10.1017/S0033291700007959; Schmidtke A, 1996, ACTA PSYCHIAT SCAND, V93, P327, DOI 10.1111/j.1600-0447.1996.tb10656.x; Skegg K, 2005, LANCET, V366, P1471, DOI 10.1016/S0140-6736(05)67600-3; Slee N, 2008, BRIT J PSYCHIAT, V192, P202, DOI 10.1192/bjp.bp.107.037564; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; UK National Institute for Health and Clinical Excellence, 2004, SELF HARM SHORT TERM; Waterhouse J, 1976, CANC INCIDENCE 5 CON; *WHO, 1999, INJ LEAD CAUS GLOB B; World Health Organization, 2002, SELF DIR VIOL WORLD, P185; World Health Organization, SUIC PREV SUPRE; Yip PSF, 2011, CRISIS, V32, P217, DOI 10.1027/0227-5910/a000069	42	121	121	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31663	10.1371/journal.pone.0031663	http://dx.doi.org/10.1371/journal.pone.0031663			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926YY	22363700	Green Submitted, Green Published, gold			2022-12-27	WOS:000302871500071
J	Liang, D; Jia, WS; Li, JY; Li, K; Zhao, QS				Liang, Dong; Jia, Wenshuang; Li, Jingyun; Li, Kui; Zhao, Qingshun			Retinoic Acid Signaling Plays a Restrictive Role in Zebrafish Primitive Myelopoiesis	PLOS ONE			English	Article							HEMATOPOIETIC STEM; CELL DEVELOPMENT; ACTS DOWNSTREAM; HEART FIELD; CLOCHE; SCL; ENDODERM; DIFFERENTIATION; IDENTIFICATION; PROGENITORS	Retinoic acid (RA) is known to regulate definitive myelopoiesis but its role in vertebrate primitive myelopoiesis remains unclear. Here we report that zebrafish primitive myelopoiesis is restricted by RA in a dose dependent manner mainly before 11 hpf (hours post fertilization) when anterior hemangioblasts are initiated to form. RA treatment significantly reduces expressions of anterior hemangioblast markers scl, lmo2, gata2 and etsrp in the rostral end of ALPM (anterior lateral plate mesoderm) of the embryos. The result indicates that RA restricts primitive myelopoiesis by suppressing formation of anterior hemangioblasts. Analyses of ALPM formation suggest that the defective primitive myelopoiesis resulting from RA treatment before late gastrulation may be secondary to global loss of cells for ALPM fate whereas the developmental defect resulting from RA treatment during 10-11 hpf should be due to ALPM patterning shift. Overexpressions of scl and lmo2 partially rescue the block of primitive myelopoiesis in the embryos treated with 250 nM RA during 10-11 hpf, suggesting RA acts upstream of scl to control primitive myelopoiesis. However, the RA treatment blocks the increased primitive myelopoiesis caused by overexpressing gata4/6 whereas the abolished primitive myelopoiesis in gata4/5/6 depleted embryos is well rescued by 4-diethylamino-benzaldehyde, a retinal dehydrogenase inhibitor, or partially rescued by knocking down aldh1a2, the major retinal dehydrogenase gene that is responsible for RA synthesis during early development. Consistently, overexpressing gata4/6 inhibits aldh1a2 expression whereas depleting gata4/5/6 increases aldh1a2 expression. The results reveal that RA signaling acts downstream of gata4/5/6 to control primitive myelopoiesis. But, 4-diethylamino-benzaldehyde fails to rescue the defective primitive myelopoiesis in either cloche embryos or lycat morphants. Taken together, our results demonstrate that RA signaling restricts zebrafish primitive myelopoiesis through acting downstream of gata4/5/6, upstream of, or parallel to, cloche, and upstream of scl.	[Liang, Dong; Jia, Wenshuang; Li, Jingyun; Li, Kui; Zhao, Qingshun] Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing, Jiangsu, Peoples R China; [Zhao, Qingshun] Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou, Peoples R China	Nanjing University; Wenzhou Medical University	Liang, D (corresponding author), Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing, Jiangsu, Peoples R China.	qingshun@nju.edu.cn			Ministry of Science and Technology of China [2011CB943804, 2007CB947101]; National Natural Science Foundation of China [30871439]; Natural Science Foundation of Jiangsu Province [BK2010390]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by the Ministry of Science and Technology of China (2011CB943804 and 2007CB947101), the National Natural Science Foundation of China (30871439) and the Natural Science Foundation of Jiangsu Province (BK2010390). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; Babuska V, 2010, Prague Med Rep, V111, P289; Begemann G, 2001, DEVELOPMENT, V128, P3081; Bennett CM, 2001, BLOOD, V98, P643, DOI 10.1182/blood.V98.3.643; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Capo-chichi CD, 2010, STEM CELLS INT, V2010, DOI 10.4061/2010/602068; Capo-chichi CD, 2005, DEV BIOL, V286, P574, DOI 10.1016/j.ydbio.2005.07.037; Collins SJ, 2002, LEUKEMIA, V16, P1896, DOI 10.1038/sj.leu.2402718; Davidson AJ, 2004, ONCOGENE, V23, P7233, DOI 10.1038/sj.onc.1207943; de Jong JL, 2010, BLOOD, V54, P1139; Drumea K, 2008, CURR OPIN HEMATOL, V15, P37, DOI 10.1097/MOH.0b013e3282f20a9c; Galloway JL, 2003, CURR TOP DEV BIOL, V53, P139, DOI 10.1016/S0070-2153(03)53004-6; Gering M, 2003, DEVELOPMENT, V130, P6187, DOI 10.1242/dev.00875; Grandel H, 2002, DEVELOPMENT, V129, P2851; Hartenstein V, 2006, ANNU REV CELL DEV BI, V22, P677, DOI 10.1146/annurev.cellbio.22.010605.093317; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Hoshijima K, 2002, GENE DEV, V16, P2518, DOI 10.1101/gad.1001302; Hsia N, 2005, EXP HEMATOL, V33, P1007, DOI 10.1016/j.exphem.2005.06.013; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; Jiang YM, 1999, DEV BIOL, V216, P57, DOI 10.1006/dbio.1999.9469; Kastner P, 2001, BLOOD, V97, P1314, DOI 10.1182/blood.V97.5.1314; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kostetskii I, 1999, DEV BIOL, V206, P206, DOI 10.1006/dbio.1998.9139; Kuwata T, 2000, BLOOD, V95, P3349, DOI 10.1182/blood.V95.11.3349; Li L, 2011, BLOOD, V117, P1359, DOI 10.1182/blood-2010-06-290700; Li X, 2009, BLOOD, V114, P5464, DOI 10.1182/blood-2009-06-227777; Liang D, 2008, GENE EXPR PATTERNS, V8, P248, DOI 10.1016/j.gep.2007.12.007; Liao EC, 1998, GENE DEV, V12, P621, DOI 10.1101/gad.12.5.621; Liao W, 1997, DEVELOPMENT, V124, P381; Lieschke GJ, 2002, DEV BIOL, V246, P274, DOI 10.1006/dbio.2002.0657; Ma ACH, 2010, LEUKEMIA, V24, P2090, DOI 10.1038/leu.2010.206; Mauney JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011513; Meijer AH, 2008, DEV COMP IMMUNOL, V32, P36, DOI 10.1016/j.dci.2007.04.003; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Patterson LJ, 2007, BLOOD, V109, P2389, DOI 10.1182/blood-2006-02-003087; Peterkin T, 2009, DEVELOPMENT, V136, P1465, DOI 10.1242/dev.032748; Purton LE, 1999, BLOOD, V94, P483, DOI 10.1182/blood.V94.2.483.414k12_483_495; Reiter JF, 1999, GENE DEV, V13, P2983, DOI 10.1101/gad.13.22.2983; Ren X, 2010, BLOOD, V115, P5338, DOI 10.1182/blood-2009-09-244640; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Rodaway A, 1999, DEVELOPMENT, V126, P3067; Schoenebeck JJ, 2007, DEV CELL, V13, P254, DOI 10.1016/j.devcel.2007.05.012; Serbedzija GN, 1998, DEVELOPMENT, V125, P1095; STAINIER DYR, 1995, DEVELOPMENT, V121, P3141; Sumanas S, 2005, BLOOD, V106, P534, DOI 10.1182/blood-2004-12-4653; Sumanas S, 2008, BLOOD, V111, P4500, DOI 10.1182/blood-2007-09-110569; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; Ward AC, 2003, BLOOD, V102, P3238, DOI 10.1182/blood-2003-03-0966; Waxman JS, 2009, DEV DYNAM, V238, P1207, DOI 10.1002/dvdy.21951; Waxman JS, 2008, DEV CELL, V15, P923, DOI 10.1016/j.devcel.2008.09.009; Xiong JW, 2008, CIRC RES, V102, P1057, DOI 10.1161/CIRCRESAHA.107.163907; Xu F, 2009, MECH DEVELOP, V126, P771, DOI 10.1016/j.mod.2009.09.001; Yeh JRJ, 2008, DEVELOPMENT, V135, P401, DOI 10.1242/dev.008904; Yelon D, 2000, DEVELOPMENT, V127, P2573; Yu C, 2010, BLOOD, V116, P4786, DOI 10.1182/blood-2010-01-263335	55	17	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30865	10.1371/journal.pone.0030865	http://dx.doi.org/10.1371/journal.pone.0030865			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363502	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600078
J	Serang, O; Mollinari, M; Garcia, AAF				Serang, Oliver; Mollinari, Marcelo; Franco Garcia, Antonio Augusto			Efficient Exact Maximum a Posteriori Computation for Bayesian SNP Genotyping in Polyploids	PLOS ONE			English	Article							LINKAGE; MAP	The problem of genotyping polyploids is extremely important for the creation of genetic maps and assembly of complex plant genomes. Despite its significance, polyploid genotyping still remains largely unsolved and suffers from a lack of statistical formality. In this paper a graphical Bayesian model for SNP genotyping data is introduced. This model can infer genotypes even when the ploidy of the population is unknown. We also introduce an algorithm for finding the exact maximum a posteriori genotype configuration with this model. This algorithm is implemented in a freely available web-based software package SuperMASSA. We demonstrate the utility, efficiency, and flexibility of the model and algorithm by applying them to two different platforms, each of which is applied to a polyploid data set: Illumina GoldenGate data from potato and Sequenom MassARRAY data from sugarcane. Our method achieves state-of-the-art performance on both data sets and can be trivially adapted to use models that utilize prior information about any platform or species.	[Serang, Oliver] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Serang, Oliver] Childrens Hosp Boston, Dept Pathol, Boston, MA USA; [Mollinari, Marcelo; Franco Garcia, Antonio Augusto] Univ Sao Paulo ESALQ, Dept Genet, Sao Paulo, Brazil	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Serang, O (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	Oliver.Serang@Childrens.Harvard.edu	Garcia, Antonio A F/A-4538-2010; Mollinari, Marcelo/E-7678-2012	Garcia, Antonio A F/0000-0003-0634-3277; Mollinari, Marcelo/0000-0002-7001-8498	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2008/52197-4, 2008/54402-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (grant 2008/52197-4 and 2008/54402-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; Alwala S, MOL GENETIC LINKAGE; Andersen SK, 1990, HUGIN SHELL BUILDING, P332; Anithakumari AM, 2010, MOL BREEDING, V26, P65, DOI 10.1007/s11032-009-9377-5; [Anonymous], SEQUENOM TYPER 4 0 M; ARNBORG S, 1987, SIAM J ALGEBRA DISCR, V8, P277, DOI 10.1137/0608024; Baker P, 2010, THEOR APPL GENET, V120, P1653, DOI 10.1007/s00122-010-1283-z; Bilmes J, 2002, INT CONF ACOUST SPEE, P3916; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Fujisawa H, 2004, BIOINFORMATICS, V20, P718, DOI 10.1093/bioinformatics/btg475; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; Garcia AAF, 2006, THEOR APPL GENET, V112, P298, DOI 10.1007/s00122-005-0129-6; Grivet L, 1996, GENETICS, V142, P987; Grivet L, 2002, CURR OPIN PLANT BIOL, V5, P122, DOI 10.1016/S1369-5266(02)00234-0; Hieter P, 1999, SCIENCE, V285, P210, DOI 10.1126/science.285.5425.210; Jannoo N, 2004, HEREDITY, V93, P460, DOI 10.1038/sj.hdy.6800524; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LANDER ES, 1989, GENETICS, V121, P185; Lewin HA, 2009, GENOME RES, V19, P1925, DOI 10.1101/gr.094557.109; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Oeth P, SINGLE NUCLEOTIDE PO, P307; Oliveira KM, 2007, MOL BREEDING, V20, P189, DOI 10.1007/s11032-007-9082-1; Pastina MM, 2010, MOL MAPPING COMPLEX; Ripol MI, 1999, GENE, V235, P31, DOI 10.1016/S0378-1119(99)00218-8; ROBERTSON N, 1984, J COMB THEORY B, V36, P49, DOI 10.1016/0095-8956(84)90013-3; Serang O, 2010, J PROTEOME RES, V9, P5346, DOI 10.1021/pr100594k; Singh R.J., 2002, PLANT CYTOGENETICS; Storm N, CP R SINGLE NUCLEOTI, P241; Voorrips R, 2011, FITTETRA FITTETRA IS; Voorrips RE, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-172; Wang J, 2010, MICROCOLLINEARITY AU, DOI [10.1186/1471-2164-11-261, DOI 10.1186/1471-2164-11-261]; WU KK, 1992, THEOR APPL GENET, V83, P294, DOI 10.1007/BF00224274; Zeng ZB, 1999, GENET RES, V74, P279, DOI 10.1017/S0016672399004255	33	74	74	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30906a	10.1371/journal.pone.0030906	http://dx.doi.org/10.1371/journal.pone.0030906			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363513	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600086
J	Terburg, D; Aarts, H; Putman, P; van Honk, J				Terburg, David; Aarts, Henk; Putman, Peter; van Honk, Jack			In the Eye of the Beholder: Reduced Threat-Bias and Increased Gaze-Imitation towards Reward in Relation to Trait Anger	PLOS ONE			English	Article							SOCIAL COGNITION; SELECTIVE ATTENTION; FACIAL EXPRESSION; VISUAL-ATTENTION; DIRECTION; ANXIETY; FACES; FEAR; EMOTION; CUES	The gaze of a fearful face silently signals a potential threat's location, while the happy-gaze communicates the location of impending reward. Imitating such gaze-shifts is an automatic form of social interaction that promotes survival of individual and group. Evidence from gaze-cueing studies suggests that covert allocation of attention to another individual's gaze-direction is facilitated when threat is communicated and further enhanced by trait anxiety. We used novel eye-tracking techniques to assess whether dynamic fearful and happy facial expressions actually facilitate automatic gaze-imitation. We show that this actual gaze-imitation effect is stronger when threat is signaled, but not further enhanced by trait anxiety. Instead, trait anger predicts facilitated gaze-imitation to reward, and to reward compared to threat. These results agree with an increasing body of evidence on trait anger sensitivity to reward.	[Terburg, David; Aarts, Henk; van Honk, Jack] Univ Utrecht, Dept Psychol, Utrecht, Netherlands; [Putman, Peter] Leiden Univ, Dept Psychol, Leiden, Netherlands; [van Honk, Jack] Univ Cape Town, Dept Psychiat & Mental Hlth, ZA-7925 Cape Town, South Africa	Utrecht University; Leiden University; Leiden University - Excl LUMC; University of Cape Town	Terburg, D (corresponding author), Univ Utrecht, Dept Psychol, Utrecht, Netherlands.	d.terburg@uu.nl		Terburg, David/0000-0003-2356-8734	Hope for Depression Foundation; Utrecht University; Netherlands Organization of Scientific Research [VICI-453-06-002, 056-24-010]	Hope for Depression Foundation; Utrecht University; Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO))	This research was supported by grants from the Hope for Depression Foundation (HDRF, http://www.hopefordepression.org/), Utrecht University High-Potential programme (http://www.uu.nl/university/research/EN/researchatutrechtuniversity/nurturingtalent/Pages/highpotentialprogramme.aspx), and the Netherlands Organization of Scientific Research (http://www.nwo.nl/, VICI-453-06-002 and Brain & Cognition 056-24-010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RB, 2005, EMOTION, V5, P3, DOI 10.1037/1528-3542.5.1.3; Adams RB, 2003, PSYCHOL SCI, V14, P644, DOI 10.1046/j.0956-7976.2003.psci_1479.x; Adolphs R, 2008, CURR OPIN NEUROBIOL, V18, P166, DOI 10.1016/j.conb.2008.06.006; Bogels SM, 2004, CLIN PSYCHOL REV, V24, P827, DOI 10.1016/j.cpr.2004.06.005; Carlson JM, 2010, PSYCHIAT RES-NEUROIM, V182, P281, DOI 10.1016/j.pscychresns.2010.02.001; Carver CS, 2004, EMOTION, V4, P3, DOI 10.1037/1528-3542.4.1.3; Ekman P., 1976, PICTURES FACIAL AFFE; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Farroni T, 2004, INFANCY, V5, P39, DOI 10.1207/s15327078in0501_2; Fox E, 2007, EMOTION, V7, P478, DOI 10.1037/1528-3542.7.3.478; Frewen PA, 2008, CLIN PSYCHOL REV, V28, P307, DOI 10.1016/j.cpr.2007.05.006; Frischen A, 2007, PSYCHOL BULL, V133, P694, DOI 10.1037/0033-2909.133.4.694; Frith CD, 2008, PHILOS T R SOC B, V363, P2033, DOI 10.1098/rstb.2008.0005; Garner M, 2006, J ABNORM PSYCHOL, V115, P760, DOI 10.1037/0021-843X.115.4.760; GUITTON D, 1992, TRENDS NEUROSCI, V15, P174, DOI 10.1016/0166-2236(92)90169-9; Harmon-Jones E, 2004, BIOL PSYCHOL, V67, P51, DOI 10.1016/j.biopsycho.2004.03.003; Hietanen JK, 2003, J EXP PSYCHOL HUMAN, V29, P1228, DOI 10.1037/0096-1523.29.6.1228; Holmes A, 2006, BRAIN COGNITION, V60, P282, DOI 10.1016/j.bandc.2005.05.002; Itier RJ, 2009, NEUROSCI BIOBEHAV R, V33, P843, DOI 10.1016/j.neubiorev.2009.02.004; Kobayashi H, 2001, J HUM EVOL, V40, P419, DOI 10.1006/jhev.2001.0468; Koval MJ, 2005, EXP BRAIN RES, V167, P475, DOI 10.1007/s00221-005-0206-8; Langton SRH, 2000, TRENDS COGN SCI, V4, P50, DOI 10.1016/S1364-6613(99)01436-9; Lundqvist D, KAROLINSKA DIRECTED; Marsh AA, 2008, NEUROSCI BIOBEHAV R, V32, P454, DOI 10.1016/j.neubiorev.2007.08.003; Mathews A, 2003, VIS COGN, V10, P823, DOI 10.1080/13506280344000095; Nummenmaa L, 2006, VISION RES, V46, P3674, DOI 10.1016/j.visres.2006.06.004; Putman P, 2007, BIPOLAR DISORD, V9, P779, DOI 10.1111/j.1399-5618.2007.00425.x; Putman P, 2006, EMOTION, V6, P94, DOI 10.1037/1528-3542.6.1.94; Putman P, 2010, PHYSIOL BEHAV, V99, P294, DOI 10.1016/j.physbeh.2009.11.006; Ricciardelli P, 2002, NEUROREPORT, V13, P2259, DOI 10.1097/00001756-200212030-00018; Spielberger C. D., 1970, SELF EVALUATION QUES; Spielberger CD., 1983, ADV PERSONALITY ASSE, P112; Tipples J, 2006, COGNITION EMOTION, V20, P309, DOI 10.1080/02699930500405550; Tobii Technology, 2006, US MAN; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Vuilleumier P, 2002, CURR OPIN PSYCHIATR, V15, P291, DOI 10.1097/00001504-200205000-00011	36	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31373	10.1371/journal.pone.0031373	http://dx.doi.org/10.1371/journal.pone.0031373			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926TC	22363632	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600143
J	Tomppo, L; Ekelund, J; Lichtermann, D; Veijola, J; Jarvelin, MR; Hennah, W				Tomppo, Liisa; Ekelund, Jesper; Lichtermann, Dirk; Veijola, Juha; Jaervelin, Marjo-Riitta; Hennah, William			DISC1 Conditioned GWAS for Psychosis Proneness in a Large Finnish Birth Cohort	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SCHIZOPHRENIA; SCALES; EXPRESSION; PROTEIN; RISK; GENE; ACTIVATION; SCHIZOTYPY; PATHWAY	Background: Genetic evidence implicates the DISC1 gene in the etiology of a number of mental illnesses. Previously, we have reported association between DISC1 and measures of psychosis proneness, the Revised Social Anhedonia Scale (RSAS) and Revised Physical Anhedonia Scale (RPAS), in the Northern Finland Birth Cohort 1966 (NFBC66). As part of the studies of this Finnish birth cohort genome-wide association analysis has recently been performed. Methodology: In the present study, we re-analyzed the genome-wide association data with regard to these two measures of psychosis proneness, conditioning on our previous DISC1 observation. From the original NFBC66 sample (N = 12 058), 4 561 individuals provided phenotype and genotype data. No markers were significant at the genome-wide level. However, several genes with biological relevance to mental illnesses were highlighted through loci displaying suggestive evidence for association (>= 3 SNP with P<10E-4). These included the protein coding genes, CXCL3, KIAA1128, LCT, MED13L, TMCO7, TTN, and the micro RNA MIR620. Conclusions: By conditioning a previous genome-wide association study on DISC1, we have been able to identify eight genes as associating to psychosis proneness. Further, these molecules predominantly link to the DISC1 pathway, strengthening the evidence for the role of this gene network in the etiology of mental illness. The use of quantitative measures of psychosis proneness in a large population cohort will make these findings, once verified; more generalized to a broad selection of disorders related to psychoses and psychosis proneness.	[Tomppo, Liisa; Hennah, William] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Ekelund, Jesper] Univ Helsinki, Dept Psychiat, SF-00180 Helsinki, Finland; [Tomppo, Liisa; Ekelund, Jesper; Hennah, William] Natl Inst Hlth & Welf, Helsinki, Finland; [Ekelund, Jesper] Vaasa Hosp Dist, Vaasa, Finland; [Lichtermann, Dirk] Cafe Ersatz, Bonn, Germany; [Veijola, Juha] Univ Oulu, Dept Psychiat, Oulu, Finland; [Jaervelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London, England; [Hennah, William] Univ Edinburgh, Med Genet Sect, Edinburgh, Midlothian, Scotland	University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; University of Oulu; Imperial College London; University of Edinburgh	Tomppo, L (corresponding author), Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland.	William.Hennah@helsinki.fi	Ekelund, Jesper/D-6655-2013	Tomppo, Liisa/0000-0002-9369-5846; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Hennah, William/0000-0002-4462-4208	Jalmari and Rauha Ahokas Foundation; Academy of Finland [128504]; Medical Research Council [G0801056B] Funding Source: researchfish	Jalmari and Rauha Ahokas Foundation; Academy of Finland(Academy of Finland); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	LT is supported by the Jalmari and Rauha Ahokas Foundation. WH is supported by the Academy of Finland postdoctoral fellowship (Number 128504). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; [Anonymous], 2001, B WORLD HEALTH ORGAN, V79, P373; [Anonymous], 1991, SCHIZOPHRENIA GENESI; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Blanchard JJ, 2000, J ABNORM PSYCHOL, V109, P87, DOI 10.1037/0021-843X.109.1.87; Bradshaw NJ, 2010, DISC1 BINDING PROTEI; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Chapman L. J., 1978, REVISED PHYS A UNPUB; CHAPMAN LJ, 1976, J ABNORM PSYCHOL, V85, P374, DOI 10.1037/0021-843X.85.4.374; CHAPMAN LJ, 1994, J ABNORM PSYCHOL, V103, P171, DOI 10.1037/0021-843X.103.2.171; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Eckblad M.L., 1982, REVISED SOCIAL UNPUB; Fonseca-Pedrero E, 2009, SPAN J PSYCHOL, V12, P815, DOI 10.1017/S1138741600002183; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hennah W, 2009, MOL PSYCHIATR, V14, P865, DOI 10.1038/mp.2008.22; Hennah W, 2007, HUM MOL GENET, V16, P453, DOI 10.1093/hmg/ddl462; Hennah W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004906; Horan WP, 2008, SCHIZOPHR RES, V100, P224, DOI 10.1016/j.schres.2007.12.469; Hunsberger JG, 2009, NEUROMOL MED, V11, P173, DOI 10.1007/s12017-009-8070-5; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200; Kalovidouris SA, 2005, J AM CHEM SOC, V127, P1340, DOI 10.1021/ja044631v; LeWinter MM, 2010, CIRCULATION, V121, P2137, DOI 10.1161/CIRCULATIONAHA.109.860171; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Miettunen J, 2008, SCHIZOPHR B; Miettunen J, 2011, J NERV MENT DIS, V199, P230, DOI 10.1097/NMD.0b013e3182125d2c; Miettunen J, 2010, PSYCHIAT RES, V178, P408, DOI 10.1016/j.psychres.2008.07.022; Millar JK, 2003, BIOCHEM BIOPH RES CO, V311, P1019, DOI 10.1016/j.bbrc.2003.10.101; Morris JA, 2003, HUM MOL GENET, V12, P1591, DOI 10.1093/hmg/ddg162; Muncke N, 2003, CIRCULATION, V108, P2843, DOI 10.1161/01.CIR.0000103684.77636.CD; Murrey HE, 2006, P NATL ACAD SCI USA, V103, P21, DOI 10.1073/pnas.0503381102; Murrey HE, 2009, BIOCHEMISTRY-US, V48, P7261, DOI 10.1021/bi900640x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rantakallio P, 1969, ACTA PAEDIAT SC S193, V193, P11; Shifman S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040028; Tomppo L, 2009, ARCH GEN PSYCHIAT, V66, P134, DOI 10.1001/archgenpsychiatry.2008.524; Tskhovrebova L, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/612482; Walker DG, 2006, J LEUKOCYTE BIOL, V79, P596, DOI 10.1189/jlb.0705377	40	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30643	10.1371/journal.pone.0030643	http://dx.doi.org/10.1371/journal.pone.0030643			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926TC	22363459	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600046
J	Fournier, D; Tindo, M; Kenne, M; Masse, PSM; Van Bossche, V; De Coninck, E; Aron, S				Fournier, Denis; Tindo, Maurice; Kenne, Martin; Masse, Paul Serge Mbenoun; Van Bossche, Vanessa; De Coninck, Eliane; Aron, Serge			Genetic Structure, Nestmate Recognition and Behaviour of Two Cryptic Species of the Invasive Big-Headed Ant Pheidole megacephala	PLOS ONE			English	Article							DIVISION-OF-LABOR; WASMANNIA-AUROPUNCTATA; FIRE ANT; TRAMP ANT; INTRODUCED POPULATIONS; INBREEDING DEPRESSION; CHEMICAL RECOGNITION; COMPETITIVE ABILITY; CLONAL REPRODUCTION; ARGENTINE ANTS	Background: Biological invasions are recognized as a major cause of biodiversity decline and have considerable impact on the economy and human health. The African big-headed ant Pheidole megacephala is considered one of the world's most harmful invasive species. Methodology/Principal Findings: To better understand its ecological and demographic features, we combined behavioural (aggression tests), chemical (quantitative and qualitative analyses of cuticular lipids) and genetic (mitochondrial divergence and polymorphism of DNA microsatellite markers) data obtained for eight populations in Cameroon. Molecular data revealed two cryptic species of P. megacephala, one inhabiting urban areas and the other rainforests. Urban populations belong to the same phylogenetic group than those introduced in Australia and in other parts of the world. Behavioural analyses show that the eight populations sampled make up four mutually aggressive supercolonies. The maximum distance between nests from the same supercolony was 49 km and the closest distance between two nests belonging to two different supercolonies was 46 m. The genetic data and chemical analyses confirmed the behavioural tests as all of the nests were correctly assigned to their supercolony. Genetic diversity appears significantly greater in Africa than in introduced populations in Australia; by contrast, urban and Australian populations are characterized by a higher chemical diversity than rainforest ones. Conclusions/Significance: Overall, our study shows that populations of P. megacephala in Cameroon adopt a unicolonial social structure, like invasive populations in Australia. However, the size of the supercolonies appears several orders of magnitude smaller in Africa. This implies competition between African supercolonies and explains why they persist over evolutionary time scales.	[Fournier, Denis; Van Bossche, Vanessa; Aron, Serge] Univ Libre Bruxelles, Brussels, Belgium; [Tindo, Maurice; Kenne, Martin] Univ Douala, Dept Biol Organismes Anim, Fac Sci, Douala, Cameroon; [Masse, Paul Serge Mbenoun] Univ Yaounde I, Zool Lab, Fac Sci, Yaounde, Cameroon; [De Coninck, Eliane] Royal Museum Cent Africa, Tervuren, Belgium	Universite Libre de Bruxelles; University of Yaounde I; Royal Museum for Central Africa	Fournier, D (corresponding author), Univ Libre Bruxelles, Brussels, Belgium.	Denis.Fournier@ulb.ac.be	Fournier, Denis/EZX-2474-2022	Fournier, Denis/0000-0003-4094-0390	Belgian National Fund for Scientific Research; Universite Libre de Bruxelles (ULB)	Belgian National Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); Universite Libre de Bruxelles (ULB)	Financial support for this study was provided by grants from the Belgian National Fund for Scientific Research and the Universite Libre de Bruxelles (ULB) to DF and SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEE W. C., 1949; Allendorf FW, 2003, CONSERV BIOL, V17, P24, DOI 10.1046/j.1523-1739.2003.02365.x; Ascunce MS, 2011, SCIENCE, V331, P1066, DOI 10.1126/science.1198734; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Bolton Barry, 1995, P1; BOOMSMA JJ, 1990, INSECT SOC, V37, P363, DOI 10.1007/BF02225998; Breed MD, 1998, BIOSCIENCE, V48, P463, DOI 10.2307/1313244; Buczkowski G, 2004, MOL ECOL, V13, P2235, DOI 10.1111/j.1365-294X.2004.02261.x; Buczkowski G, 2010, BIOL INVASIONS, V12, P3343, DOI 10.1007/s10530-010-9727-6; Cadotte MW, CONCEPTUAL ECOLOGY I; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; CLARK DB, 1982, BIOTROPICA, V14, P196, DOI 10.2307/2388026; Crozier R.H., 1979, P223; Crozier R.H., 1985, P201; d'Ettorre P, 2010, ANT ECOLOGY, P194; Davis M. A., 2009, INVASION BIOL; Dejean A, 2008, CR BIOL, V331, P631, DOI 10.1016/j.crvi.2008.05.004; Dejean A, 2007, CR BIOL, V330, P701, DOI 10.1016/j.crvi.2007.06.005; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DETRAIN C, 1992, BEHAV ECOL SOCIOBIOL, V29, P405, DOI 10.1007/BF00170170; Deyrup M, 2000, T AM ENTOMOL SOC, V126, P293; DEYRUP MA, 1988, FLA ENTOMOL, V71, P163, DOI 10.2307/3495364; Drescher J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013581; Earl DA, 2009, STRUCTURE HARVESTER; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Facon B, 2006, TRENDS ECOL EVOL, V21, P130, DOI 10.1016/j.tree.2005.10.012; Facon B, 2011, CURR BIOL, V21, P424, DOI 10.1016/j.cub.2011.01.068; Fisher BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001787; Folgarait PJ, 2004, ANN ENTOMOL SOC AM, V97, P450, DOI 10.1603/0013-8746(2004)097[0450:AGACIA]2.0.CO;2; Foucaud J, 2006, EVOLUTION, V60, P1646, DOI 10.1111/j.0014-3820.2006.tb00509.x; Foucaud J, 2009, MOL ECOL, V18, P5059, DOI 10.1111/j.1365-294X.2009.04440.x; Fournier D, 2005, NATURE, V435, P1230, DOI 10.1038/nature03705; Fournier D, 2009, MOL ECOL, V18, P186, DOI 10.1111/j.1365-294X.2008.04018.x; Fournier D, 2008, MOL ECOL RESOUR, V8, P919, DOI 10.1111/j.1755-0998.2008.02116.x; Fournier D, 2008, ANIM BEHAV, V75, P151, DOI 10.1016/j.anbehav.2007.04.023; Genton BJ, 2005, MOL ECOL, V14, P4275, DOI 10.1111/j.1365-294X.2005.02750.x; Giraud T, 2002, P NATL ACAD SCI USA, V99, P6075, DOI 10.1073/pnas.092694199; Glemin S, 2003, EVOLUTION, V57, P2678; Goodnight KF, 2000, RELATEDNESS 5 0 8; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Greene MJ, 2007, J EXP BIOL, V210, P897, DOI 10.1242/jeb.02706; GREENSLADE PJ, 1972, INSECT SOC, V19, P195, DOI 10.1007/BF02226626; Griffin AS, 2002, TRENDS ECOL EVOL, V17, P15, DOI 10.1016/S0169-5347(01)02355-2; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Helantera H, 2009, TRENDS ECOL EVOL, V24, P341, DOI 10.1016/j.tree.2009.01.013; Hoffmann BD, 2008, BIOL INVASIONS, V10, P1171, DOI 10.1007/s10530-007-9194-x; Holway DA, 2002, ECOLOGY, V83, P1610, DOI 10.1890/0012-9658(2002)083[1610:ROAFIG]2.0.CO;2; Holway DA, 2004, OECOLOGIA, V138, P216, DOI 10.1007/s00442-003-1414-1; Holway DA, 1998, SCIENCE, V282, P949, DOI 10.1126/science.282.5390.949; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Kenne M, 1999, INSECT SOC, V46, P179, DOI 10.1007/s000400050130; Krushelnycky PD, 2010, ANT ECOLOGY, P245; Lach L, 2008, AUST J ENTOMOL, V47, P275, DOI 10.1111/j.1440-6055.2008.00659.x; Lach L, 2010, ANT ECOLOGY, P261; Lambrinos JG, 2004, ECOLOGY, V85, P2061, DOI 10.1890/03-8013; Le Breton J, 2004, J INSECT BEHAV, V17, P263, DOI 10.1023/B:JOIR.0000028575.28700.71; Lenoir A, 1999, INFORMATION PROCESSING IN SOCIAL INSECTS, P219; Lockwood J, 2006, INVASION ECOLOGY; Lowe S, 2001, 100 WORLDS WORST INV; MANTEL N, 1967, CANCER RES, V27, P209; Martin SJ, 2008, P ROY SOC B-BIOL SCI, V275, P1271, DOI 10.1098/rspb.2007.1708; Marzluff John M., 2005, Urban Ecosystems, V8, P157, DOI 10.1007/s11252-005-4378-6; McGlynn TP, 1999, J BIOGEOGR, V26, P535, DOI 10.1046/j.1365-2699.1999.00310.x; Mikheyev AS, 2007, DIVERS DISTRIB, V13, P573, DOI 10.1111/j.1472-4642.2007.00370.x; Moller H, 1996, BIOL CONSERV, V78, P125, DOI 10.1016/0006-3207(96)00022-5; Moreau CS, 2008, MOL PHYLOGENET EVOL, V48, P224, DOI 10.1016/j.ympev.2008.02.020; Newell W, 1913, US BUREAU ENTOMOLOGY; Newman D, 1997, EVOLUTION, V51, P354, DOI [10.2307/2411107, 10.1111/j.1558-5646.1997.tb02422.x]; Nieminen M, 2001, AM NAT, V157, P237, DOI 10.1086/318630; O'Dowd DJ, 1999, STATUS IMPACT RECOMM; Orivel J, 2009, ECOL ENTOMOL, V34, P504, DOI 10.1111/j.1365-2311.2009.01096.x; PAMILO P, 1991, AM NAT, V138, P412, DOI 10.1086/285224; PAMILO P, 1985, HEREDITAS, V103, P195, DOI 10.1111/j.1601-5223.1985.tb00501.x; Parker IM, 2003, CONSERV BIOL, V17, P59, DOI 10.1046/j.1523-1739.2003.02019.x; PASSERA L, 1994, WESTV STUD, P23; PATEL A D, 1990, Psyche (Cambridge), V97, P181, DOI 10.1155/1990/56747; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pedersen JS, 2006, EVOLUTION, V60, P782, DOI 10.1111/j.0014-3820.2006.tb01156.x; Perrings C, 2010, BIOINVASIONS AND GLOBALIZATION: ECOLOGY, ECONOMICS, MANAGEMENT, AND POLICY, P1; PORTER SD, 1988, ANN ENTOMOL SOC AM, V81, P913, DOI 10.1093/aesa/81.6.913; Pritchard JK, 2000, GENETICS, V155, P945; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; QUELLER DC, 1994, EVOL ECOL, V8, P70, DOI 10.1007/BF01237667; Queller DC, 1998, BIOSCIENCE, V48, P165, DOI 10.2307/1313262; Roques A, 2010, ALIEN TERRESTRIAL AR; ROSS KG, 1993, GENETICS, V135, P843; Sambrook J., 2001, MOL CLONING LAB MANU; Sax D. F., 2005, SPECIES INVASIONS IN; Sax DF, 2000, GLOBAL ECOL BIOGEOGR, V9, P363, DOI 10.1046/j.1365-2699.2000.00217.x; Schmid-Hempel P, 2007, HEREDITY, V99, P414, DOI 10.1038/sj.hdy.6801017; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Smith MA, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-31; Sokal R. H., 1995, BIOMETRY PRINCIPLES; Stachowicz JJ, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P41; Steiner FM, 2007, CURR BIOL, V17, P1903, DOI 10.1016/j.cub.2007.09.061; Suarez AV, 2008, AM NAT, V172, pS72, DOI 10.1086/588638; SUAREZ AV, 1999, BIOL INVASIONS, V1, P1; Swindell WR, 2006, J EVOLUTION BIOL, V19, P1257, DOI 10.1111/j.1420-9101.2005.01074.x; Tchouto MGP, 2009, SYST BIODIVERS, V7, P21, DOI 10.1017/S1477200008002892; Torres CW, 2007, INSECT SOC, V54, P363, DOI 10.1007/s00040-007-0954-5; TSCHINKEL WR, 1988, ANN ENTOMOL SOC AM, V81, P76, DOI 10.1093/aesa/81.1.76; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Ugelvig LV, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-11; van Zweden JS, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P222, DOI 10.1017/CBO9780511711909.012; Vander Meer Robert K., 1998, P79; Vogel V, 2009, EVOLUTION, V63, P1627, DOI 10.1111/j.1558-5646.2009.00628.x; Werren John H., 1993, P42; Wetterer JK, 2007, PAC SCI, V61, P437, DOI 10.2984/1534-6188(2007)61[437:BAIOPI]2.0.CO;2; Wetterer JK, 1999, FLA ENTOMOL, V82, P381, DOI 10.2307/3496865; Wetterer JK, 2003, SOCIOBIOLOGY, V42, P1; WHEELER DE, 1991, AM NAT, V138, P1218, DOI 10.1086/285279; Wheeler W. M., 1922, Bulletin of the American Museum of Natural History, V45, P39; WILSON EO, 1984, BEHAV ECOL SOCIOBIOL, V16, P89, DOI 10.1007/BF00293108; Wilson EO, 1990, SUCCESS DOMINANCE EC	117	27	27	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31480	10.1371/journal.pone.0031480	http://dx.doi.org/10.1371/journal.pone.0031480			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22371822	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700063
J	O'Mahony, FC; Faratian, D; Varley, J; Nanda, J; Theodoulou, M; Riddick, ACP; Harrison, DJ; Stewart, GD				O'Mahony, Fiach C.; Faratian, Dana; Varley, James; Nanda, Jyoti; Theodoulou, Marianna; Riddick, Antony C. P.; Harrison, David J.; Stewart, Grant D.			The Use of Automated Quantitative Analysis to Evaluate Epithelial-to-Mesenchymal Transition Associated Proteins in Clear Cell Renal Cell Carcinoma	PLOS ONE			English	Article							GENE-EXPRESSION; BIOMARKER; CANCER; DIFFERENTIATION; CLASSIFICATION; MICROARRAYS; DIAGNOSIS	Background: Epithelial-to-mesenchymal transition (EMT) has recently been implicated in the initiation and progression of renal cell carcinoma (RCC). Some mRNA gene expression studies have suggested a link between the EMT phenotype and poorer clinical outcome from RCC. This study evaluated expression of EMT-associated proteins in RCC using in situ automated quantitative analysis immunofluorescence (AQUA) and compared expression levels with clinical outcome. Methods/Principal Findings: Unsupervised hierarchical cluster analysis of pre-existing RCC gene expression array data (GSE16449) from 36 patients revealed the presence of an EMT transcriptional signature in RCC [E-cadherin high/SLUG low/SNAIL low]. As automated immunofluorescence technology is dependent on accurate definition of the tumour cells in which measurements take place is critical, extensive optimisation was carried out resulting in a novel pan-cadherin based tumour mask that distinguishes renal cancer cells from stromal components. 61 patients with ccRCC and clinical follow-up were subsequently assessed for expression of EMT-associated proteins (WT1, SNAIL, SLUG, E-cadherin and phospho-beta-catenin) on tissue microarrays. Using Kaplan-Meier analysis both SLUG (p = 0.029) and SNAIL (p = 0.024) (log rank Mantel-Cox) were significantly associated with prolonged progression free survival (PFS). Using Cox regression univariate and multivariate analysis none of the biomarkers were significantly correlated with outcome. 14 of the 61 patients expressed the gene expression analysis predicted EMT-protein signature [E-cadherin high/SLUG low/SNAIL low], which was not found to be associated to PFS when measured at the protein level. A combination of high expression of SNAIL and low stage was able to stratify patients with greater significance (p = 0.001) then either variable alone (high SNAIL p = 0.024, low stage p = 0.029). Conclusions: AQUA has been shown to have the potential to identify EMT related protein targets in RCC allowing for stratification of patients into high and low risk groups, as well the ability to assess the association of reputed EMT signatures to progression of the disease.	[O'Mahony, Fiach C.; Faratian, Dana; Varley, James; Nanda, Jyoti; Theodoulou, Marianna; Riddick, Antony C. P.; Harrison, David J.; Stewart, Grant D.] Univ Edinburgh, Edinburgh Urol Canc Grp, Div Pathol, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland	University of Edinburgh	O'Mahony, FC (corresponding author), Univ Edinburgh, Edinburgh Urol Canc Grp, Div Pathol, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland.	grant.stewart@ed.ac.uk		Stewart, Grant D./0000-0003-3188-9140; harrison, david/0000-0001-9041-9988	Chief Scientist Office [ETM37]; Cancer Research UK Experimental Cancer Medicine Centre; Chief Scientist Office [ETM/37] Funding Source: researchfish	Chief Scientist Office; Cancer Research UK Experimental Cancer Medicine Centre; Chief Scientist Office	The work of authors FCO, DF, JN, ACPR, DJH and GDS mentioned above is funded by the Chief Scientist Office, grant number ETM37, and supported by the Cancer Research UK Experimental Cancer Medicine Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1994, J NATL CANCER I, V86, P829, DOI 10.1093/jnci/86.11.829; Banumathy G, 2010, CANC BIOL THER, V10; Brannon A Rose, 2010, Genes Cancer, V1, P152; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Camp RL., 2004, CLIN CANCER RES, V10, P7252, DOI [DOI 10.1158/1078-0432.CCR-04-0713, 10.1158/1078-0432.CCR-04-0713]; CancerResearchUK, 2010, KIDN CANC STAT; Chin Arnold I, 2006, Rev Urol, V8, P1; Dubois-Marshall S, 2011, CLIN EXP ME IN PRESS; Etzioni R, 2003, BIOSTATISTICS, V4, P523, DOI 10.1093/biostatistics/4.4.523; Faratian D, 2011, EUR J CANCER, V47, P1420, DOI 10.1016/j.ejca.2011.01.014; Faratian D, 2010, METHODS MOL BIOL, V662, P245, DOI 10.1007/978-1-60761-800-3_12; Faratian D, 2009, CANCER RES, V69, P6713, DOI 10.1158/0008-5472.CAN-09-0777; Jayson M, 1998, UROLOGY, V51, P203, DOI 10.1016/S0090-4295(97)00506-2; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kattan MW, 2003, J NATL CANCER I, V95, P634, DOI 10.1093/jnci/95.9.634; Kim MK, 2002, APPL IMMUNOHISTO M M, V10, P332, DOI 10.1097/00022744-200212000-00008; Kluger HM, 2008, LAB INVEST, V88, P962, DOI 10.1038/labinvest.2008.65; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Linehan WM, 2010, NAT REV UROL, V7, P277, DOI 10.1038/nrurol.2010.47; Linehan WM, 2010, ANNU REV MED, V61, P329, DOI 10.1146/annurev.med.042808.171650; Mertz KD, 2007, HUM PATHOL, V38, P1454, DOI 10.1016/j.humpath.2007.05.017; Mikami S, 2011, LAB INVEST; Murphy D, 2002, ADV PHYSIOL EDUC, V26, P256, DOI 10.1152/advan.00043.2002; Pepe MS, 2008, J NATL CANCER I, V100, P1432, DOI 10.1093/jnci/djn326; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Renshaw AA, 1999, AM J CLIN PATHOL, V111, P539; Rosner I, 2009, UROL ONCOL-SEMIN ORI, V27, P131, DOI 10.1016/j.urolonc.2008.11.001; Stewart GD, 2011, NAT REV UROL, V8, P255, DOI 10.1038/nrurol.2011.43; Takahashi M, 2001, P NATL ACAD SCI USA, V98, P9754, DOI 10.1073/pnas.171209998; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Truong LD, 2011, ARCH PATHOL LAB MED, V135, P92, DOI 10.1043/2010-0478-RAR.1; Tun HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010696; Yao M, 2005, J PATHOL, V205, P377, DOI 10.1002/path.1693; Zhao HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006039	35	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31557	10.1371/journal.pone.0031557	http://dx.doi.org/10.1371/journal.pone.0031557			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363672	Green Submitted, Green Published, gold			2022-12-27	WOS:000302873700070
J	Silvestrini, F; Tiburcio, M; Bertuccini, L; Alano, P				Silvestrini, Francesco; Tiburcio, Marta; Bertuccini, Lucia; Alano, Pietro			Differential Adhesive Properties of Sequestered Asexual and Sexual Stages of Plasmodium falciparum on Human Endothelial Cells Are Tissue Independent	PLOS ONE			English	Article							HUMAN BONE-MARROW; HEMATOPOIETIC PROGENITOR CELLS; INFECTED ERYTHROCYTES; TRANSENDOTHELIAL MIGRATION; TRANSMISSION STAGES; IN-VITRO; MALARIA; SEQUESTRATION; GAMETOCYTES; EXPRESSION	The protozoan parasite Plasmodium falciparum, responsible for the most severe form of malaria, is able to sequester from peripheral circulation during infection. The asexual stage parasites sequester by binding to endothelial cell receptors in the microvasculature of various organs. P. falciparum gametocytes, the developmental stages responsible for parasite transmission from humans to Anopheles mosquitoes, also spend the almost ten days necessary for their maturation sequestered away from the peripheral circulation before they are released in blood mainstream. In contrast to those of asexual parasites, the mechanisms and cellular interactions responsible for immature gametocyte sequestration are largely unexplored, and controversial evidence has been produced so far on this matter. Here we present a systematic comparison of cell binding properties of asexual stages and immature and mature gametocytes from the reference P. falciparum clone 3D7 and from a patient parasite isolate on a panel of human endothelial cells from different tissues. This analysis includes assays on human bone marrow derived endothelial cell lines (HBMEC), as this tissue has been proposed as a major site of gametocyte maturation. Our results clearly demonstrate that cell adhesion of asexual stage parasites is consistently more efficient than that, virtually undetectable of immature gametocytes, irrespectively of the endothelial cell lines used and of parasite genotypes. Importantly, immature gametocytes of both lines tested here do not show a higher binding efficiency compared to asexual stages on bone marrow derived endothelial cells, unlike previously reported in the only study on this issue. This indicates that gametocyte-host interactions in this tissue are unlikely to be mediated by the same adhesion processes to specific endothelial receptors as seen with asexual forms.	[Silvestrini, Francesco; Tiburcio, Marta; Alano, Pietro] Ist Super Sanita, Dipartimento Malattie Infett Parassitarie & Immun, I-00161 Rome, Italy; [Bertuccini, Lucia] Ist Super Sanita, Dipartimento Tecnol & Salute, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Silvestrini, F (corresponding author), Ist Super Sanita, Dipartimento Malattie Infett Parassitarie & Immun, Viale Regina Elena 299, I-00161 Rome, Italy.	francesco.silvestrini@iss.it	ALANO, PIETRO/C-2946-2016; Bertuccini, Lucia/AAI-6683-2021; Silvestrini, Francesco/AAA-4221-2021; Silvestrini, Francesco/C-2963-2016; BERTUCCINI, LUCIA/F-2102-2015	ALANO, PIETRO/0000-0003-0092-9840; Bertuccini, Lucia/0000-0002-4278-2376; Silvestrini, Francesco/0000-0003-3288-5088; Silvestrini, Francesco/0000-0003-3288-5088; Tiburcio, Marta/0000-0002-9103-3777	EU [242095]; PITN [215281]; MALSIG [223044]	EU(European Commission); PITN; MALSIG	This work was supported by EU FP7 grants EVIMalaR (contract 242095), PITN InterMalTraining (contract 215281) and MALSIG (contract 223044). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulsalam AH, 2010, AM J HEMATOL, V85, P943, DOI 10.1002/ajh.21796; Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; ALANO P, 1995, EXP PARASITOL, V81, P227, DOI 10.1006/expr.1995.1112; Bachmann A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007459; Bastianelli G., 1899, ATTI SOC STUDI MALAR, V1, P1; Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10; COOKE BM, 1994, BRIT J HAEMATOL, V87, P162, DOI 10.1111/j.1365-2141.1994.tb04887.x; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; Craig A, 2001, MOL BIOCHEM PARASIT, V115, P129, DOI 10.1016/S0166-6851(01)00275-4; Day KP, 1998, MOL BIOCHEM PARASIT, V93, P167, DOI 10.1016/S0166-6851(98)00040-1; DETMAR M, 1992, J INVEST DERMATOL, V98, P147, DOI 10.1111/1523-1747.ep12555746; DLUZEWSKI AR, 1984, T ROY SOC TROP MED H, V78, P622, DOI 10.1016/0035-9203(84)90221-9; Gray C, 2003, MOL BIOCHEM PARASIT, V128, P187, DOI 10.1016/S0166-6851(03)00075-6; HAWKING F, 1971, T ROY SOC TROP MED H, V65, P549, DOI 10.1016/0035-9203(71)90036-8; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Meads MB, 2008, CLIN CANCER RES, V14, P2519, DOI 10.1158/1078-0432.CCR-07-2223; Muller WA, 2009, CIRC RES, V105, P223, DOI 10.1161/CIRCRESAHA.109.200717; OCKENHOUSE CF, 1991, J INFECT DIS, V164, P163, DOI 10.1093/infdis/164.1.163; Peters J, 2002, P NATL ACAD SCI USA, V99, P10689, DOI 10.1073/pnas.162349899; Ratajczak MZ, 2006, LEUKEMIA, V20, P1915, DOI 10.1038/sj.leu.2404357; Ribaut C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-45; Rogers NJ, 1996, INFECT IMMUN, V64, P1480, DOI 10.1128/IAI.64.4.1480-1483.1996; Rogers NJ, 2000, INFECT IMMUN, V68, P3455, DOI 10.1128/IAI.68.6.3455-3462.2000; Rood PML, 2000, EUR J CLIN INVEST, V30, P618; Rood PML, 1999, EXP HEMATOL, V27, P1306, DOI 10.1016/S0301-472X(99)00068-5; Saeed M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002280; Safeukui I, 2008, BLOOD, V112, P2520, DOI 10.1182/blood-2008-03-146779; Sasi P, 2009, J INFECT DIS, V199, P1575, DOI 10.1086/598862; Sauerwein RW, 2011, NAT REV IMMUNOL, V11, P57, DOI 10.1038/nri2902; Schweitzer KM, 1997, LAB INVEST, V76, P25; SINDEN RE, 1982, PARASITOLOGY, V84, P1, DOI 10.1017/S003118200005160X; SMALLEY ME, 1981, T ROY SOC TROP MED H, V75, P103, DOI 10.1016/0035-9203(81)90019-5; Voermans C, 2000, STEM CELLS, V18, P435, DOI 10.1634/stemcells.18-6-435; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; Whetton AD, 1999, TRENDS CELL BIOL, V9, P233, DOI 10.1016/S0962-8924(99)01559-7; Wu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024784	36	38	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31567	10.1371/journal.pone.0031567	http://dx.doi.org/10.1371/journal.pone.0031567			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363675	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700073
J	Xiao, X; Wang, P; Chou, KC				Xiao, Xuan; Wang, Pu; Chou, Kuo-Chen			iNR-PhysChem: A Sequence-Based Predictor for Identifying Nuclear Receptors and Their Subfamilies via Physical-Chemical Property Matrix	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; SUPPORT VECTOR MACHINES; MODIFIED MAHALANOBIS DISCRIMINANT; SUBCELLULAR-LOCALIZATION; APPROXIMATE ENTROPY; APOPTOSIS PROTEINS; WEB-SERVER; LOCATION; SUPERFAMILY; ALGORITHM	Nuclear receptors (NRs) form a family of ligand-activated transcription factors that regulate a wide variety of biological processes, such as homeostasis, reproduction, development, and metabolism. Human genome contains 48 genes encoding NRs. These receptors have become one of the most important targets for therapeutic drug development. According to their different action mechanisms or functions, NRs have been classified into seven subfamilies. With the avalanche of protein sequences generated in the postgenomic age, we are facing the following challenging problems. Given an uncharacterized protein sequence, how can we identify whether it is a nuclear receptor? If it is, what subfamily it belongs to? To address these problems, we developed a predictor called iNR-PhysChem in which the protein samples were expressed by a novel mode of pseudo amino acid composition ( PseAAC) whose components were derived from a physical-chemical matrix via a series of auto-covariance and cross-covariance transformations. It was observed that the overall success rate achieved by iNR-PhysChem was over 98% in identifying NRs or non-NRs, and over 92% in identifying NRs among the following seven subfamilies: NR1-thyroid hormone like, NR2-HNF4-like, NR3-estrogen like, NR4-nerve growth factor IB-like, NR5-fushi tarazu-F1 like, NR6-germ cell nuclear factor like, and NR0-knirps like. These rates were derived by the jackknife tests on a stringent benchmark dataset in which none of protein sequences included has >= 60% pairwise sequence identity to any other in a same subset. As a user-friendly web-server, iNR-PhysChem is freely accessible to the public at either http://www.jci-bioinfo.cn/iNR-PhysChem or http://icpr.jci.edu.cn/bioinfo/iNR-PhysChem. Also a step-by-step guide is provided on how to use the web-server to get the desired results without the need to follow the complicated mathematics involved in developing the predictor. It is anticipated that iNR-PhysChem may become a useful high throughput tool for both basic research and drug design.	[Xiao, Xuan; Wang, Pu] Jing De Zhen Ceram Inst, Dept Comp, Jing De Zhen, Peoples R China; [Xiao, Xuan; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Jingdezhen Ceramic Institute	Xiao, X (corresponding author), Jing De Zhen Ceram Inst, Dept Comp, Jing De Zhen, Peoples R China.	xiaoxuan0326@yahoo.com.cn; kcchou@gordonlifescience.org	Chou, Kuo-Chen/A-8340-2009		National Natural Science Foundation of China [60961003]; Chinese Ministry of Education [210116]; Province National Natural Science Foundation of JiangXi [2010GQS0127, 2010GZS0122]; Department of Education of JiangXi Province [GJJ11557]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Province National Natural Science Foundation of JiangXi; Department of Education of JiangXi Province	This work was supported by the grants from the National Natural Science Foundation of China (No. 60961003), the Key Project of Chinese Ministry of Education (No. 210116), the Province National Natural Science Foundation of JiangXi (2010GQS0127 and 2010GZS0122), and the Department of Education of JiangXi Province (No. GJJ11557). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SE, 1997, THEORETICAL AND COMPUTATIONAL METHODS IN GENOME RESEARCH, P1; Altucci L, 2001, TRENDS ENDOCRIN MET, V12, P460, DOI 10.1016/S1043-2760(01)00502-1; Auwerx J, 1999, CELL, V97, P161; Bhasin M, 2004, NUCLEIC ACIDS RES, V32, pW414, DOI 10.1093/nar/gkh350; Bhasin M, 2004, J BIOL CHEM, V279, P23262, DOI 10.1074/jbc.M401932200; Cai YD, 2003, BIOPHYS J, V84, P3257, DOI 10.1016/S0006-3495(03)70050-2; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen C, 2009, PROTEIN PEPTIDE LETT, V16, P27, DOI 10.2174/092986609787049420; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; Chou KC, 2002, J BIOL CHEM, V277, P45765, DOI 10.1074/jbc.M204161200; Chou KC, 1999, PROTEIN ENG, V12, P107, DOI 10.1093/protein/12.2.107; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1994, J BIOL CHEM, V269, P22014; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2012, MOL BIOSYST, V8, P629, DOI 10.1039/c1mb05420a; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Chou KC, 2009, CURR PROTEOMICS, V6, P262, DOI 10.2174/157016409789973707; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dawson Rex M.C., 1986, DATA BIOCH RES; Ding H, 2011, PROTEIN PEPTIDE LETT, V18, P58, DOI 10.2174/092986611794328708; Ding H, 2009, PROTEIN PEPTIDE LETT, V16, P351, DOI 10.2174/092986609787848045; Ding YS, 2008, PATTERN RECOGN LETT, V29, P1887, DOI 10.1016/j.patrec.2008.06.007; Ding YS, 2007, PROTEIN PEPTIDE LETT, V14, P811; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Gao QB, 2009, ANAL BIOCHEM, V387, P54, DOI 10.1016/j.ab.2009.01.018; Georgiou DN, 2009, J THEOR BIOL, V257, P17, DOI 10.1016/j.jtbi.2008.11.003; Gronemeyer H, 1995, PROTEIN PROFILE, V2, P1173; Gu Q, 2010, PROTEIN PEPTIDE LETT, V17, P559, DOI 10.2174/092986610791112693; Guo JX, 2011, J COMPUT CHEM, V32, P1612, DOI 10.1002/jcc.21740; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Horn F, 2001, NUCLEIC ACIDS RES, V29, P346, DOI 10.1093/nar/29.1.346; Hu LL, 2011, PROTEIN PEPTIDE LETT, V18, P552, DOI 10.2174/092986611795222795; Jiang XY, 2008, AMINO ACIDS, V34, P669, DOI 10.1007/s00726-008-0034-9; Jiang XY, 2008, PROTEIN PEPTIDE LETT, V15, P392, DOI 10.2174/092986608784246443; Kandaswamy KK, 2010, PROTEIN PEPTIDE LETT, V17, P1473; Kawashima S, 2000, NUCLEIC ACIDS RES, V28, P374, DOI 10.1093/nar/28.1.374; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Kumar R, 1999, STEROIDS, V64, P310, DOI 10.1016/S0039-128X(99)00014-8; Laudet V, 1997, J MOL ENDOCRINOL, V19, P207, DOI 10.1677/jme.0.0190207; Laudet V, 2002, NUCL RECEPTORS FACTS; Li DD, 2010, PROTEIN PEPTIDE LETT, V17, P1566, DOI 10.2174/0929866511009011566; Li FM, 2008, PROTEIN PEPTIDE LETT, V15, P612, DOI 10.2174/092986608784966930; Li YX, 2011, PROTEIN PEPTIDE LETT, V18, P186, DOI 10.2174/092986611794475084; Lin H, 2008, PROTEIN PEPTIDE LETT, V15, P739, DOI 10.2174/092986608785133681; Lin H, 2008, J THEOR BIOL, V252, P350, DOI 10.1016/j.jtbi.2008.02.004; Lin H, 2009, ACTA BIOTHEOR, V57, P321, DOI 10.1007/s10441-008-9067-4; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mohabatkar H, 2011, J THEOR BIOL, V281, P18, DOI 10.1016/j.jtbi.2011.04.017; Mohabatkar H, 2010, PROTEIN PEPTIDE LETT, V17, P1207, DOI 10.2174/092986610792231564; Mohammad Beigi Majid, 2011, J Struct Funct Genomics, V12, P191, DOI 10.1007/s10969-011-9120-4; NAKASHIMA H, 1986, J BIOCHEM-TOKYO, V99, P153, DOI 10.1093/oxfordjournals.jbchem.a135454; Nanni L, 2011, IEEE ACM T COMPUT BI, DOI [10.1109/TCBB.2011.1117, DOI 10.1109/TCBB.2011.1117]; Nanni L, 2008, AMINO ACIDS, V34, P653, DOI 10.1007/s00726-007-0018-1; Novac Natalia, 2004, Current Drug Targets - Inflammation and Allergy, V3, P335; Olefsky JM, 2001, J BIOL CHEM, V276, P36863, DOI 10.1074/jbc.R100047200; Qiu JD, 2011, J MOL GRAPH MODEL, V30, P129, DOI 10.1016/j.jmgm.2011.06.014; Qiu JD, 2010, PROTEIN PEPTIDE LETT, V17, P715, DOI 10.2174/092986610791190372; Qiu JD, 2009, ANAL BIOCHEM, V390, P68, DOI 10.1016/j.ab.2009.04.009; Robert CW, 1985, CRC HDB CHEM PHYS; Robinson-Rechavi M, 2003, J CELL SCI, V116, P585, DOI 10.1242/jcs.00247; Sahu SS, 2010, COMPUT BIOL CHEM, V34, P320, DOI 10.1016/j.compbiolchem.2010.09.002; Shen HB, 2008, ANAL BIOCHEM, V373, P386, DOI 10.1016/j.ab.2007.10.012; TANFORD C, 1962, J AM CHEM SOC, V84, P4240, DOI 10.1021/ja00881a009; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023505; Wang YC, 2010, PROTEIN PEPTIDE LETT, V17, P1441, DOI 10.2174/0929866511009011441; WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X; Wu ZC, 2011, MOL BIOSYST, V7, P3287, DOI 10.1039/c1mb05232b; Yu LZ, 2010, J THEOR BIOL, V267, P1, DOI 10.1016/j.jtbi.2010.08.001; Zeng YH, 2009, J THEOR BIOL, V259, P366, DOI 10.1016/j.jtbi.2009.03.028; Zhang GY, 2008, PROTEIN PEPTIDE LETT, V15, P1132, DOI 10.2174/092986608786071184; Zhang GY, 2008, J THEOR BIOL, V253, P310, DOI 10.1016/j.jtbi.2008.03.015; Zhou GP, 2003, PROTEINS, V50, P44, DOI 10.1002/prot.10251; Zhou GP, 1998, J PROTEIN CHEM, V17, P729, DOI 10.1023/A:1020713915365; Zhou GP, 2001, PROTEINS, V44, P57, DOI 10.1002/prot.1071; Zhou XB, 2007, J THEOR BIOL, V248, P546, DOI 10.1016/j.jtbi.2007.06.001; Zou DS, 2011, J COMPUT CHEM, V32, P271, DOI 10.1002/jcc.21616	79	79	79	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e30869	10.1371/journal.pone.0030869	http://dx.doi.org/10.1371/journal.pone.0030869			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363503	Green Submitted, gold, Green Published			2022-12-27	WOS:000302873700013
J	Benavides, J; Walsh, PD; Meyers, LA; Raymond, M; Caillaud, D				Benavides, Julio; Walsh, Peter D.; Meyers, Lauren Ancel; Raymond, Michel; Caillaud, Damien			Transmission of Infectious Diseases En Route to Habitat Hotspots	PLOS ONE			English	Article							OUTBREAK; SARS; NETWORKS; DYNAMICS; EPIDEMIOLOGY; DEFECATION; CYTOKINES; GORILLAS; BEHAVIOR; MAMMALS	Background: The spread of infectious diseases in wildlife populations is influenced by patterns of between-host contacts. Habitat "hotspots'' - places attracting a large numbers of individuals or social groups - can significantly alter contact patterns and, hence, disease propagation. Research on the importance of habitat hotspots in wildlife epidemiology has primarily focused on how inter-individual contacts occurring at the hotspot itself increase disease transmission. However, in territorial animals, epidemiologically important contacts may primarily occur as animals cross through territories of conspecifics en route to habitat hotspots. So far, the phenomenon has received little attention. Here, we investigate the importance of these contacts in the case where infectious individuals keep visiting the hotspots and in the case where these individuals are not able to travel to the hotspot any more. Methodology and Principal Findings: We developed a simulation epidemiological model to investigate both cases in a scenario when transmission at the hotspot does not occur. We find that (i) hotspots still exacerbate epidemics, (ii) when infectious individuals do not travel to the hotspot, the most vulnerable individuals are those residing at intermediate distances from the hotspot rather than nearby, and (iii) the epidemiological vulnerability of a population is the highest when the number of hotspots is intermediate. Conclusions and Significance: By altering animal movements in their vicinity, habitat hotspots can thus strongly increase the spread of infectious diseases, even when disease transmission does not occur at the hotspot itself. Interestingly, when animals only visit the nearest hotspot, creating additional artificial hotspots, rather than reducing their number, may be an efficient disease control measure.	[Benavides, Julio; Raymond, Michel] Univ Montpellier 2, CNRS, Inst Sci Evolut Montpellier, Montpellier, France; [Walsh, Peter D.] Univ Cambridge, Dept Archaeol & Anthropol, Cambridge, England; [Meyers, Lauren Ancel; Caillaud, Damien] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Meyers, Lauren Ancel] Univ Texas Austin, Div Stat & Sci Computat, Austin, TX 78712 USA; [Meyers, Lauren Ancel] Santa Fe Inst, Santa Fe, NM 87501 USA	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Cambridge; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; The Santa Fe Institute	Benavides, J (corresponding author), Univ Montpellier 2, CNRS, Inst Sci Evolut Montpellier, Montpellier, France.	benavidesjulio@yahoo.fr	Caillaud, Damien/AAH-5850-2019; Raymond, Michel/C-9049-2015	Caillaud, Damien/0000-0002-8347-6869; Raymond, Michel/0000-0002-1714-6984; Benavides, Julio/0000-0002-3920-9165; Meyers, Lauren/0000-0002-5828-8874	Ministere Francais de l'Enseignement superieur; Chilean Government; NSF [DEB-0749097]; National Center for Ecological Analysis and Synthesis at the University of California, Santa Barbara; Direct For Biological Sciences [0749097] Funding Source: National Science Foundation	Ministere Francais de l'Enseignement superieur; Chilean Government; NSF(National Science Foundation (NSF)); National Center for Ecological Analysis and Synthesis at the University of California, Santa Barbara; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work received financial support from the Ministere Francais de l'Enseignement superieur, a CONICYT scholarship from the Chilean Government to JB and NSF Grant DEB-0749097 to LAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was conducted as part of the "Efficient Wildlife Disease Control: From Social Network Self-Organization to Optimal Vaccination'' Working Group supported by the National Center for Ecological Analysis and Synthesis at the University of California, Santa Barbara. We thank Gaston B., R. Bodenham, A. Courtiol, V. Durand and E. Huchard for their support. This is contribution ISEM 2012-009.	Anderson RM, 2004, PHILOS T R SOC B, V359, P1091, DOI 10.1098/rstb.2004.1490; Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826; Blake John G., 2011, Diversity, V3, P217, DOI 10.3390/d3020217; Bonnell TR, 2010, ECOL MODEL, V221, P2491, DOI 10.1016/j.ecolmodel.2010.07.020; Caillaud D, 2006, CURR BIOL, V16, pR489, DOI 10.1016/j.cub.2006.06.017; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Cauchemez S, 2009, LANCET INFECT DIS, V9, P473, DOI 10.1016/S1473-3099(09)70176-8; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Dantzer R, 1999, ADV EXP MED BIOL, V461, P83; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Donnelly CA, 2011, CLIN INFECT DIS, V52, pS123, DOI 10.1093/cid/ciq028; Dybiec B, 2009, J R SOC INTERFACE, V6, P941, DOI 10.1098/rsif.2008.0468; Ezenwa VO, 2004, ETHOLOGY, V110, P851, DOI 10.1111/j.1439-0310.2004.01013.x; Ezenwa VO, 2003, PARASITOLOGY, V126, P379, DOI 10.1017/S0031182002002913; FREESE C H, 1978, Primates, V19, P275, DOI 10.1007/BF02382797; FRISCH HL, 1963, J SOC IND APPL MATH, V11, P894, DOI 10.1137/0111066; Gilbert KA, 1997, ANIM BEHAV, V54, P451, DOI 10.1006/anbe.1996.0439; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; Henshaw J., 1971, AFR J ECOL, V9, P73, DOI [10.1111/j.1365-2028.1971.tb00221.x, DOI 10.1111/J.1365-2028.1971.TB00221.X]; Hofle U, 2004, EUR J WILDLIFE RES, V50, P73, DOI 10.1007/s10344-004-0043-2; Hugh-Jones M, 2009, MOL ASPECTS MED, V30, P356, DOI 10.1016/j.mam.2009.08.003; Jeger MJ, 2007, NEW PHYTOL, V174, P279, DOI 10.1111/j.1469-8137.2007.02028.x; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Kuperman M, 2001, PHYS REV LETT, V86, P2909, DOI 10.1103/PhysRevLett.86.2909; Larson SJ, 2001, BRAIN BEHAV IMMUN, V15, P371, DOI 10.1006/brbi.2001.0643; Magliocca F, 2002, AM J PRIMATOL, V57, P67, DOI 10.1002/ajp.10034; Matsubayashi H, 2007, ECOL RES, V22, P742, DOI 10.1007/s11284-006-0313-4; Meyers LA, 2005, J THEOR BIOL, V232, P71, DOI 10.1016/j.jtbi.2004.07.026; Noser R, 2007, ANIM BEHAV, V73, P257, DOI 10.1016/j.anbehav.2006.04.012; Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009; Paunio M, 1998, AM J EPIDEMIOL, V148, P1103, DOI 10.1093/oxfordjournals.aje.a009588; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Plowright RK, 2008, FRONT ECOL ENVIRON, V6, P420, DOI 10.1890/070086; Real LA, 2007, J R SOC INTERFACE, V4, P935, DOI 10.1098/rsif.2007.1041; Sleeman JM, 2000, J ZOO WILDLIFE MED, V31, P322, DOI 10.1638/1042-7260(2000)031[0322:GPOMGG]2.0.CO;2; Small M, 2006, PHYSICA D, V215, P146, DOI 10.1016/j.physd.2006.01.021; Vanleeuwe H, 1998, REV ECOL-TERRE VIE, V53, P171; Vicente J, 2007, VET RES, V38, P451, DOI 10.1051/vetres:2007002; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wobeser G, 2002, REV SCI TECH OIE, V21, P159, DOI 10.20506/rst.21.1.1326	40	13	13	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31290	10.1371/journal.pone.0031290	http://dx.doi.org/10.1371/journal.pone.0031290			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363606	Green Published, gold			2022-12-27	WOS:000302871500031
J	Calderon, LE; Liu, S; Su, W; Xie, ZW; Guo, ZH; Eberhard, W; Gong, MC				Calderon, Lindsay E.; Liu, Shu; Su, Wen; Xie, Zhongwen; Guo, Zhenheng; Eberhard, Wanda; Gong, Ming C.			iPLA(2)beta Overexpression in Smooth Muscle Exacerbates Angiotensin II-Induced Hypertension and Vascular Remodeling	PLOS ONE			English	Article							INDEPENDENT PHOSPHOLIPASE A(2)BETA; ARACHIDONIC-ACID RELEASE; ACTIVATION; MECHANISM; KINASE; EXPRESSION; CELLS; MICE; HYPERCONTRACTILITY; PHOSPHORYLATION	Objectives: Calcium independent group VIA phospholipase A(2) (iPLA(2)beta) is up-regulated in vascular smooth muscle cells in some diseases, but whether the up-regulated iPLA(2)beta affects vascular morphology and blood pressure is unknown. The current study addresses this question by evaluating the basal-and angiotensin II infusion-induced vascular remodeling and hypertension in smooth muscle specific iPLA(2)beta transgenic (iPLA(2)beta-Tg) mice. Method and Results: Blood pressure was monitored by radiotelemetry and vascular remodeling was assessed by morphologic analysis. We found that the angiotensin II-induced increase in diastolic pressure was significantly higher in iPLA(2)beta-Tg than iPLA(2)beta-Wt mice, whereas, the basal blood pressure was not significantly different. The media thickness and media: lumen ratio of the mesenteric arteries were significantly increased in angiotensin II-infused iPLA(2)beta-Tg mice. Analysis revealed no difference in vascular smooth muscle cell proliferation. In contrast, adenovirus-mediated iPLA(2)beta overexpression in cultured vascular smooth muscle cells promoted angiotensin II-induced [H-3]-leucine incorporation, indicating enhanced hypertrophy. Moreover, angiotensin II infusion-induced c-Jun phosphorylation in vascular smooth muscle cells overexpressing iPLA(2)beta to higher levels, which was abolished by inhibition of 12/15 lipoxygenase. In addition, we found that angiotensin II up-regulated the endogenous iPLA(2)beta protein in-vitro and in-vivo. Conclusion: The present study reports that iPLA(2)beta up-regulation exacerbates angiotensin II-induced vascular smooth muscle cell hypertrophy, vascular remodeling and hypertension via the 12/15 lipoxygenase and c-Jun pathways.	[Calderon, Lindsay E.] Univ Kentucky, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA; [Xie, Zhongwen; Eberhard, Wanda; Gong, Ming C.] Univ Kentucky, Dept Physiol, Lexington, KY USA; [Liu, Shu; Su, Wen; Guo, Zhenheng] Univ Kentucky, Dept Internal Med, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky	Calderon, LE (corresponding author), Univ Kentucky, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA.	mcgong2@uky.edu		Calderon, Lindsay/0000-0003-0919-0077	National Institute of Health (NIH) [HL-082791, HL-088389, T32-HL072743]; American Heart Association (AHA) [09PRE2300152]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082791, R01HL088389, T32HL072743] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institute of Health (NIH) grants HL-082791 to M.C.G. and HL-088389 to Z.G. L.E.C. was supported by an American Heart Association (AHA) Fellowship-09PRE2300152 and a National Institute of Health (NIH) T32-HL072743. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anning PB, 2005, AM J PATHOL, V166, P653, DOI 10.1016/S0002-9440(10)62287-0; Boittin FX, 2008, AM J PHYSIOL-HEART C, V295, pH2466, DOI 10.1152/ajpheart.00639.2008; Chang WC, 2004, J BIOL CHEM, V279, P29994, DOI 10.1074/jbc.M403969200; Dietrich HH, 2010, AM J PHYSIOL-HEART C, V298, pH2208, DOI 10.1152/ajpheart.00839.2009; FORD DA, 1991, J CLIN INVEST, V88, P331, DOI 10.1172/JCI115296; Freeman EJ, 1998, AM J PHYSIOL-CELL PH, V274, pC282, DOI 10.1152/ajpcell.1998.274.1.C282; Fujino T, 2004, J CLIN INVEST, V114, P805, DOI 10.1172/JCI200421382; GEISTERFER AAT, 1988, CIRC RES, V62, P749, DOI 10.1161/01.RES.62.4.749; Guo ZH, 2003, J BIOL CHEM, V278, P1856, DOI 10.1074/jbc.M211075200; HAZEN SL, 1991, J BIOL CHEM, V266, P14526; Ichinose F, 2002, J CLIN INVEST, V109, P1493, DOI 10.1172/JCI200214294; Jenkins CM, 2006, J BIOL CHEM, V281, P15615, DOI 10.1074/jbc.M511623200; Jenkins CM, 2001, J BIOL CHEM, V276, P7129, DOI 10.1074/jbc.M010439200; Jennings BL, 2010, HYPERTENSION, V56, P667, DOI 10.1161/HYPERTENSIONAHA.110.154518; Khateeb S, 2006, AM J HUM GENET, V79, P942, DOI 10.1086/508572; Lei XY, 2010, J BIOL CHEM, V285, P6693, DOI 10.1074/jbc.M109.084293; Li F, 2005, AM J PHYSIOL-HEART C, V288, pH2306, DOI 10.1152/ajpheart.00571.2004; Li H, 2010, FASEB J, V24, P4103, DOI 10.1096/fj.10-161356; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Mancuso DJ, 2003, J BIOL CHEM, V278, P22231, DOI 10.1074/jbc.C300033200; McEniery CM, 2005, HYPERTENSION, V46, P221, DOI 10.1161/01.HYP.0000165310.84801.e0; McHowat J, 2011, AM J PHYSIOL-CELL PH, V300, pC825, DOI 10.1152/ajpcell.00502.2010; Moon SH, 2008, J BIOL CHEM, V283, P33975, DOI 10.1074/jbc.M805817200; Morgan NV, 2006, NAT GENET, V38, P752, DOI 10.1038/ng1826; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; NATARAJAN R, 1994, HYPERTENSION, V23, pI142, DOI 10.1161/01.HYP.23.1_Suppl.I142; NOZAWA K, 1990, AM J PHYSIOL, V259, pH1774, DOI 10.1152/ajpheart.1990.259.6.H1774; Owens AP, 2010, CIRC RES, V106, P611, DOI 10.1161/CIRCRESAHA.109.212837; Pang H, 2006, AM J PHYSIOL-CELL PH, V290, pC892, DOI 10.1152/ajpcell.00378.2005; Park KM, 2008, AM J PHYSIOL-HEART C, V294, pH1183, DOI 10.1152/ajpheart.01148.2007; Poulsen KA, 2007, AM J PHYSIOL-CELL PH, V293, pC1605, DOI 10.1152/ajpcell.00012.2007; Qi ZH, 2002, J CLIN INVEST, V110, P61, DOI 10.1172/JCI200214752; RAO GN, 1994, BIOCHEM J, V299, P197, DOI 10.1042/bj2990197; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; Strokin M, 2011, AM J PHYSIOL-CELL PH, V300, pC542, DOI 10.1152/ajpcell.00428.2010; Tanaka K, 2011, ARTERIOSCL THROM VAS, V31, P1133, DOI 10.1161/ATVBAHA.110.218370; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P15022, DOI 10.1074/jbc.273.24.15022; Viedt C, 2000, ARTERIOSCL THROM VAS, V20, P940, DOI 10.1161/01.ATV.20.4.940; Wolf MJ, 1997, J BIOL CHEM, V272, P1522, DOI 10.1074/jbc.272.3.1522; Xie Z, 2007, J BIOL CHEM, V282, P25278, DOI 10.1074/jbc.M611206200; Xie ZW, 2010, J BIOL CHEM, V285, P8628, DOI 10.1074/jbc.M109.057711; Yaghini FA, 2007, J BIOL CHEM, V282, P16878, DOI 10.1074/jbc.M610494200; Yellaturu CR, 2003, J BIOL CHEM, V278, P43831, DOI 10.1074/jbc.M301472200; Zafari AM, 1999, ANTIOXID REDOX SIGN, V1, P167, DOI 10.1089/ars.1999.1.2-167; Zhao XX, 2006, J BIOL CHEM, V281, P29357, DOI 10.1074/jbc.M513105200	45	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31850	10.1371/journal.pone.0031850	http://dx.doi.org/10.1371/journal.pone.0031850			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363752	Green Published, gold, Green Submitted			2022-12-27	WOS:000302871500096
J	Cawthorn, TR; Moreno, JC; Dharsee, M; Danh, TT; Ackloo, S; Zhu, PH; Sardana, G; Chen, J; Kupchak, P; Jacks, LM; Miller, NA; Youngson, BJ; Iakovlev, V; Guidos, CJ; Vallis, KA; Evans, KR; McCready, D; Leong, WL; Done, SJ				Cawthorn, Thomas R.; Moreno, Juan C.; Dharsee, Moyez; Danh Tran-Thanh; Ackloo, Suzanne; Zhu, Pei Hong; Sardana, Girish; Chen, Jian; Kupchak, Peter; Jacks, Lindsay M.; Miller, Naomi A.; Youngson, Bruce J.; Iakovlev, Vladimir; Guidos, Cynthia J.; Vallis, Katherine A.; Evans, Kenneth R.; McCready, David; Leong, Wey L.; Done, Susan J.			Proteomic Analyses Reveal High Expression of Decorin and Endoplasmin (HSP90B1) Are Associated with Breast Cancer Metastasis and Decreased Survival	PLOS ONE			English	Article							TUMOR-MARKERS CA-15-3; B-RAF; PROTEIN; MODULATION; RECEPTOR; ACTIVATION; INDUCTION; APOPTOSIS; SEQUENCE; ISOFORMS	Background: Breast cancer is the most common malignancy among women worldwide in terms of incidence and mortality. About 10% of North American women will be diagnosed with breast cancer during their lifetime and 20% of those will die of the disease. Breast cancer is a heterogeneous disease and biomarkers able to correctly classify patients into prognostic groups are needed to better tailor treatment options and improve outcomes. One powerful method used for biomarker discovery is sample screening with mass spectrometry, as it allows direct comparison of protein expression between normal and pathological states. The purpose of this study was to use a systematic and objective method to identify biomarkers with possible prognostic value in breast cancer patients, particularly in identifying cases most likely to have lymph node metastasis and to validate their prognostic ability using breast cancer tissue microarrays. Methods and Findings: Differential proteomic analyses were employed to identify candidate biomarkers in primary breast cancer patients. These analyses identified decorin (DCN) and endoplasmin (HSP90B1) which play important roles regulating the tumour microenvironment and in pathways related to tumorigenesis. This study indicates that high expression of Decorin is associated with lymph node metastasis (p < 0.001), higher number of positive lymph nodes (p < 0.0001) and worse overall survival (p = 0.01). High expression of HSP90B1 is associated with distant metastasis (p < 0.0001) and decreased overall survival (p < 0.0001) these patients also appear to benefit significantly from hormonal treatment. Conclusions: Using quantitative proteomic profiling of primary breast cancers, two new promising prognostic and predictive markers were found to identify patients with worse survival. In addition HSP90B1 appears to identify a group of patients with distant metastasis with otherwise good prognostic features.	[Cawthorn, Thomas R.; Moreno, Juan C.; Danh Tran-Thanh; Done, Susan J.] Univ Hlth Network, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada; [Moreno, Juan C.; Danh Tran-Thanh; Miller, Naomi A.; Youngson, Bruce J.; Done, Susan J.] Univ Hlth Network, Lab Med Program, Toronto, ON, Canada; [Dharsee, Moyez; Ackloo, Suzanne; Zhu, Pei Hong; Sardana, Girish; Chen, Jian; Kupchak, Peter; Evans, Kenneth R.] Ontario Canc Biomarker Network, Toronto, ON, Canada; [Jacks, Lindsay M.] Univ Hlth Network, Dept Biostat, Toronto, ON, Canada; [Cawthorn, Thomas R.; Done, Susan J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Miller, Naomi A.; Youngson, Bruce J.; Iakovlev, Vladimir; Done, Susan J.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Iakovlev, Vladimir] St Michaels Hosp, Dept Lab Med, Toronto, ON M5B 1W8, Canada; [Guidos, Cynthia J.] Univ Toronto, Hosp Sick Children, Res Inst, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Guidos, Cynthia J.] Univ Toronto, Dept Immunol, Toronto, ON M5G 1X8, Canada; [Vallis, Katherine A.] Univ Oxford, MRC CRUK Gray Inst Radiat Oncol & Biol, Oxford, England; [McCready, David; Leong, Wey L.] Univ Hlth Network, Dept Surg Oncol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Oxford; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Cawthorn, TR (corresponding author), Univ Hlth Network, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada.	sdone@uhnres.utoronto.ca	Iakovlev, Vladimir/AAM-1822-2021; Evans, Kenneth/I-5161-2015	Iakovlev, Vladimir/0000-0002-0765-3034; Cawthorn, Thomas/0000-0001-9069-7857; Evans, Kenneth/0000-0002-6856-8423; Dharsee, Moyez/0000-0002-4175-0719; Ackloo, Suzanne/0000-0002-9696-1839; Done, Susan/0000-0002-1770-988X; Vallis, Katherine/0000-0003-4672-5683; Youngson, Bruce/0000-0001-6526-8081	Genome Canada through the Ontario Genomics Institute; Princess Margaret Hospital Foundation; Canadian Institutes of Health Research [STP-53912]; Ontario institute for Cancer Research [TSAO-OICR-RF-007]	Genome Canada through the Ontario Genomics Institute(Genome Canada); Princess Margaret Hospital Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario institute for Cancer Research	Funding for this project was provided by: Genome Canada through the Ontario Genomics Institute, Princess Margaret Hospital Foundation, Canadian Institutes of Health Research - STP-53912 and The Ontario institute for Cancer Research - TSAO-OICR-RF-007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartsch R, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-81; Becker B, 2004, EXP DERMATOL, V13, P27, DOI 10.1111/j.0906-6705.2004.00114.x; CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Cox C, 2006, ANN SURG ONCOL, V13, P708, DOI 10.1245/ASO.2006.05.017; Dias S, 2002, BLOOD, V99, P2532, DOI 10.1182/blood.V99.7.2532; Dias SD, 2005, CANCER RES, V65, P10686, DOI 10.1158/0008-5472.CAN-05-2632; Feugaing DDS, 2007, BIOCHIMIE, V89, P637, DOI 10.1016/j.biochi.2006.12.012; Fiedler LR, 2008, J BIOL CHEM, V283, P17406, DOI 10.1074/jbc.M710025200; Fiedler LR, 2009, CELL ADHES MIGR, V3, P3, DOI 10.4161/cam.3.1.7275; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Goldoni S, 2008, INT J CANCER, V123, P2473, DOI 10.1002/ijc.23930; Goldoni S, 2009, J CELL BIOL, V185, P743, DOI 10.1083/jcb.200901129; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; Griffiths SD, 2007, MOL BIOTECHNOL, V36, P81, DOI 10.1007/s12033-007-0005-5; Hacihanefioglu A, 2010, MED ONCOL; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Hugh J, 2009, J CLIN ONCOL, V27, P1168, DOI 10.1200/JCO.2008.18.1024; Kell MR, 2000, BRIT J SURG, V87, P1629, DOI 10.1046/j.1365-2168.2000.01606.x; Kuijt GP, 2007, EJSO-EUR J SURG ONC, V33, P832, DOI 10.1016/j.ejso.2006.11.017; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Li CF, 2008, CLIN CANCER RES, V14, P7822, DOI 10.1158/1078-0432.CCR-08-1369; Liu XL, 1999, CHINESE MED J-PEKING, V112, P1133; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; O'Hea BJ, 1998, J AM COLL SURGEONS, V186, P423, DOI 10.1016/S1072-7515(98)00060-X; Pick E, 2007, CANCER RES, V67, P2932, DOI 10.1158/0008-5472.CAN-06-4511; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Simmons RM, 2001, J AM COLL SURGEONS, V193, P206, DOI 10.1016/S1072-7515(01)00998-X; Soletormos G, 2004, EUR J CANCER, V40, P481, DOI 10.1016/j.ejca.2003.10.015; Song XM, 2008, J PROTEOME RES, V7, P2952, DOI 10.1021/pr800072x; Sreedhar AS, 2004, PHARMACOL THERAPEUT, V101, P227, DOI 10.1016/j.pharmthera.2003.11.004; Sreedhar AS, 2004, FEBS LETT, V562, P11; Takayama S, 2003, ONCOGENE, V22, P9041, DOI 10.1038/sj.onc.1207114; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; Xu M, 1998, J BIOL CHEM, V273, P13918, DOI 10.1074/jbc.273.22.13918; Zafiropoulos A, 2008, CONNECT TISSUE RES, V49, P244, DOI 10.1080/03008200802147746; Zafiropoulos A, 2008, MOL CANCER RES, V6, P785, DOI 10.1158/1541-7786.MCR-07-0165	40	68	70	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30992	10.1371/journal.pone.0030992	http://dx.doi.org/10.1371/journal.pone.0030992			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363530	Green Published, Green Submitted, gold			2022-12-27	WOS:000302871500024
J	Larsen, J; Imanishi, M; Hinjoy, S; Tharavichitkul, P; Duangsong, K; Davis, MF; Nelson, KE; Larsen, AR; Skov, RL				Larsen, Jesper; Imanishi, Maho; Hinjoy, Soawapak; Tharavichitkul, Prasit; Duangsong, Kwanjit; Davis, Meghan F.; Nelson, Kenrad E.; Larsen, Anders R.; Skov, Robert L.			Methicillin-Resistant Staphylococcus aureus ST9 in Pigs in Thailand	PLOS ONE			English	Article							EMERGENCE; CLONES; MEC	Background: Methicillin-resistant Staphylococcus aureus (MRSA) is an important nosocomial and community-associated pathogen. Recently, livestock-associated MRSA (LA-MRSA) has emerged and disseminated in Europe and North America and now constitutes a considerable zoonotic burden in humans with risk factors of pig exposure, whereas the extent of the livestock reservoir is relatively unknown on other continents. Methodology/Principal Findings: From March through April 2011, MRSA was identified in pigs from 3 out of 30 production holdings in Chang Mai Province, Thailand. Representative isolates were subjected to molecular characterization and antimicrobial susceptibility testing; all isolates had genotypic and phenotypic characteristics of LA-MRSA previously characterized in the region: they belonged to ST9, lacked the lukF-lukS genes encoding Panton-Valentine leukocidin, and were resistant to multiple non-beta-lactam antimicrobials. However, unlike other Asian LA-MRSA-ST9 variants, they were spa type t337 and harbored a different staphylococcal cassette chromosome mec IX. Conclusions/Significance: A novel MRSA-ST9 lineage has been established in the pig population of Thailand, which differs substantially from LA-MRSA lineages found in other areas of the continent. The emergence of novel LA-MRSA lineages in the animal agriculture setting is worrisome and poses a serious threat to global public health.	[Larsen, Jesper; Larsen, Anders R.; Skov, Robert L.] Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen, Denmark; [Imanishi, Maho; Hinjoy, Soawapak; Nelson, Kenrad E.] Johns Hopkins Univ, Dept Epidemiol, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Hinjoy, Soawapak] Minist Publ Hlth, Bur Epidemiol, Dept Dis Control, Nonthaburi, Thailand; [Tharavichitkul, Prasit; Duangsong, Kwanjit] Chiang Mai Univ, Dept Microbiol, Fac Med, Chiang Mai 50000, Thailand; [Davis, Meghan F.] Johns Hopkins Univ, Dept Environm Hlth Sci, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Statens Serum Institut; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Ministry of Public Health - Thailand; Chiang Mai University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Larsen, J (corresponding author), Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen, Denmark.	JRL@ssi.dk	Larsen, Jesper/AAJ-3161-2021; Davis, Meghan F./C-1494-2013; Skov, Robert/ABB-3105-2020	Larsen, Jesper/0000-0003-0582-0457; Davis, Meghan F./0000-0002-3475-4578; Skov, Robert/0000-0002-6079-5381; Larsen, Anders Rhod/0000-0002-1713-8765; Duangsonk, Kwanjit/0000-0002-3325-1688	Center for a Livable Future, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America	Center for a Livable Future, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America	This study was supported by the Center for a Livable Future, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Chheng K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006630; Clinical and Laboratory Standard Institute, 2011, M100S21 CLSI, V31; Cui SH, 2009, J ANTIMICROB CHEMOTH, V64, P680, DOI 10.1093/jac/dkp275; Davies PR, 2011, EMERG INFECT DIS, V17, P1152, DOI [10.3201/eid/1706.101394, 10.3201/eid1706.101394]; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Fitzgibbon MM, 2007, J CLIN MICROBIOL, V45, P3263, DOI 10.1128/JCM.00836-07; Food and Agriculture Organization of the United Nations/World Organisation for Animal Health/World Bank, 2010, 169 UN FAO WORLD ORG; Guardabassi L, 2009, EMERG INFECT DIS, V15, P1998, DOI 10.3201/eid1512.090378; Hasman H, 2010, VET MICROBIOL, V141, P326, DOI 10.1016/j.vetmic.2009.09.025; Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Li SS, 2011, ANTIMICROB AGENTS CH, V55, P3046, DOI 10.1128/AAC.01475-10; Lim SK, 2011, VET MICROBI IN PRESS; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Liu YD, 2009, ANTIMICROB AGENTS CH, V53, P512, DOI 10.1128/AAC.00804-08; Neela V, 2009, J CLIN MICROBIOL, V47, P4138, DOI 10.1128/JCM.01363-09; Nickerson EK, 2011, AM J TROP MED HYG, V84, P313, DOI 10.4269/ajtmh.2011.10-0300; Perazzi B, 2006, J CLIN MICROBIOL, V44, P3634, DOI 10.1128/JCM.00137-06; Smith TC, 2011, VECTOR-BORNE ZOONOT, V11, P327, DOI 10.1089/vbz.2010.0072; Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Wagenaar JA, 2009, VET MICROBIOL, V139, P405, DOI 10.1016/j.vetmic.2009.06.014; Wulf MWH, 2008, CLIN MICROBIOL INFEC, V14, P29, DOI 10.1111/j.1469-0691.2007.01873.x	24	46	47	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31245	10.1371/journal.pone.0031245	http://dx.doi.org/10.1371/journal.pone.0031245			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363594	Green Submitted, Green Published, gold			2022-12-27	WOS:000302853600129
J	Schley, D; Tanaka, RJ; Leungchavaphongse, K; Shahrezaei, V; Ward, J; Grant, C; Charleston, B; Rhodes, CJ				Schley, David; Tanaka, Reiko J.; Leungchavaphongse, Kritsada; Shahrezaei, Vahid; Ward, John; Grant, Clare; Charleston, Bryan; Rhodes, Christopher J.			Modelling the Influence of Foot-and-Mouth Disease Vaccine Antigen Stability and Dose on the Bovine Immune Response	PLOS ONE			English	Article							TRANSMISSION	Foot and mouth disease virus causes a livestock disease of significant global socio-economic importance. Advances in its control and eradication depend critically on improvements in vaccine efficacy, which can be best achieved by better understanding the complex within-host immunodynamic response to inoculation. We present a detailed and empirically parametrised dynamical mathematical model of the hypothesised immune response in cattle, and explore its behaviour with reference to a variety of experimental observations relating to foot and mouth immunology. The model system is able to qualitatively account for the observed responses during in-vivo experiments, and we use it to gain insight into the incompletely understood effect of single and repeat inoculations of differing dosage using vaccine formulations of different structural stability.	[Schley, David; Grant, Clare; Charleston, Bryan] Inst Anim Hlth, Woking, Surrey, England; [Tanaka, Reiko J.; Leungchavaphongse, Kritsada] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Shahrezaei, Vahid] Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England; [Ward, John] Univ Loughborough, Dept Math Sci, Loughborough, Leics, England; [Rhodes, Christopher J.] Univ London Imperial Coll Sci Technol & Med, Inst Math Sci, London, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Imperial College London; Imperial College London; Loughborough University; Imperial College London	Schley, D (corresponding author), Inst Anim Hlth, Woking, Surrey, England.	David.Schley@iah.ac.uk	Ward, John/B-6188-2018	Ward, John/0000-0003-0570-2725; Charleston, Bryan/0000-0002-6952-9338; Shahrezaei, Vahid/0000-0002-4013-5458	Research Councils United Kingdom; Imperial College London; Biotechnology and Biological Sciences Research Council [IAH1444]; Engineering and Physical Sciences Research Council; BBSRC [BBS/E/I/00001715, BBS/E/I/00001447, BBS/E/I/00001615, BBS/E/I/00001444] Funding Source: UKRI; EPSRC [EP/H00162X/1, EP/H000755/1, EP/G007446/1, EP/H000542/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001715, BBS/E/I/00001444, BBS/E/I/00001615, BBS/E/I/00001447] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/G007446/1, EP/H000755/1, EP/H00162X/1, EP/H000542/1] Funding Source: researchfish	Research Councils United Kingdom; Imperial College London(General Electric); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	CJR is funded by Research Councils United Kingdom and Imperial College London. DS is funded by the Biotechnology and Biological Sciences Research Council [IAH1444]. RJT is funded by the Engineering and Physical Sciences Research Council. The 9th United Kingdom Mathematics in Medicine Study Group (Imperial College London; September 2009) was funding by the Engineering and Physical Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersen S, 2003, J COMP PATHOL, V129, P1, DOI 10.1016/S0021-9975(03)00041-0; Antia R, 2005, NAT REV IMMUNOL, V5, P101, DOI 10.1038/nri1550; Bankowski BM, 2006, 2006 SESS RES GROUP; Beverley PCL, 2010, J COMP PATHOL, V141, pS91, DOI 10.1016/j.jcpa.2009.09.008; BLACK L, 1984, J COMP PATHOL, V94, P417, DOI 10.1016/0021-9975(84)90028-8; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Buckee CO, 2004, P NATL ACAD SCI USA, V101, P10839, DOI 10.1073/pnas.0402000101; Charleston B, 2011, SCIENCE, V332, P726, DOI 10.1126/science.1199884; Defrance T, 2011, CURR OPIN IMMUNOL, V23, P330, DOI 10.1016/j.coi.2011.03.004; DOEL TR, 1981, ARCH VIROL, V70, P21, DOI 10.1007/BF01320790; Doel TR, 1999, VACCINE, V17, P1767, DOI 10.1016/S0264-410X(98)00444-7; Follett B, 2002, 1502 ROYAL SOC; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Grant C, 2010, 2010 OP SESS EUFMD S; Guay HM, 2009, J IMMUNOL, V183, P518, DOI 10.4049/jimmunol.0900068; HARKISS GD, 1981, IMMUNOLOGY, V42, P297; Juleff N, 2009, J VIROL, V83, P3626, DOI 10.1128/JVI.02613-08; Keeling MJ, 2005, P ROY SOC B-BIOL SCI, V272, P1195, DOI 10.1098/rspb.2004.3046; Kelly DF, 2006, BLOOD, V108, P2642, DOI 10.1182/blood-2006-01-009282; Kostova K, 2004, USE MODELS ASSESS FO; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Paton DJ, 2009, PHILOS T R SOC B, V364, P2657, DOI 10.1098/rstb.2009.0100; Perry B. D, 2002, INVESTING ANIMAL HLT; Pollard AJ, 2009, NAT REV IMMUNOL, V9, P212, DOI 10.1038/nri2494; Schley D., 2007, 37 GEN SESS EUR COMM; Shampine LF, 2001, APPL NUMER MATH, V37, P441, DOI 10.1016/S0168-9274(00)00055-6; Thompson D, 2002, REV SCI TECH, V21; Wodarz D, 2005, KILLER CELL DYNAMICS	29	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30435	10.1371/journal.pone.0030435	http://dx.doi.org/10.1371/journal.pone.0030435			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363437	Green Submitted, gold, Green Published			2022-12-27	WOS:000302853600030
J	Wu, XS; Chang, XP; Jing, RL				Wu, Xianshan; Chang, Xiaoping; Jing, Ruilian			Genetic Insight into Yield-Associated Traits of Wheat Grown in Multiple Rain-Fed Environments	PLOS ONE			English	Article							BACKCROSS QTL ANALYSIS; GRAIN-YIELD; AGRONOMIC TRAITS; HEXAPLOID WHEAT; DURUM-WHEAT; MOLECULAR-DETECTION; ORYZA-RUFIPOGON; QUALITY TRAITS; CHROMOSOME 3A; MAPPING QTLS	Background: Grain yield is a key economic driver of successful wheat production. Due to its complex nature, little is known regarding its genetic control. The goal of this study was to identify important quantitative trait loci (QTL) directly and indirectly affecting grain yield using doubled haploid lines derived from a cross between Hanxuan 10 and Lumai 14. Methodology/Principal Findings: Ten yield-associated traits, including yield per plant (YP), number of spikes per plant (NSP), number of grains per spike (NGS), one-thousand grain weight (TGW), total number of spikelets per spike (TNSS), number of sterile spikelets per spike (NSSS), proportion of fertile spikelets per spike (PFSS), spike length (SL), density of spikelets per spike (DSS) and plant height (PH), were assessed across 14 (for YP) to 23 (for TGW) year x location x water regime environments in China. Then, the genetic effects were partitioned into additive main effects (a), epistatic main effects (aa) and their environment interaction effects (ae and aae) by using composite interval mapping in a mixed linear model. Conclusions/Significance: Twelve (YP) to 33 (PH) QTLs were identified on all 21 chromosomes except 6D. QTLs were more frequently observed on chromosomes 1B, 2B, 2D, 5A and 6B, and were concentrated in a few regions on individual chromosomes, exemplified by three striking yield-related QTL clusters on chromosomes 2B, 1B and 4B that explained the correlations between YP and other traits. The additive main-effect QTLs contributed more phenotypic variation than the epistasis and environmental interaction. Consistent with agronomic analyses, a group of progeny derived by selecting TGW and NGS, with higher grain yield, had an increased frequency of QTL for high YP, NGS, TGW, TNSS, PFSS, SL, PH and fewer NSSS, when compared to low yielding progeny. This indicated that it is feasible by marker-assisted selection to facilitate wheat production.	[Wu, Xianshan; Chang, Xiaoping; Jing, Ruilian] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Wu, XS (corresponding author), Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100193, Peoples R China.	jingrl@caas.net.cn			National Basic Research Program of China [2010CB951501]; Generation Challenge Program [G7010.02.01]	National Basic Research Program of China(National Basic Research Program of China); Generation Challenge Program	This work was supported by the National Basic Research Program of China (2010CB951501), and the Generation Challenge Program (G7010.02.01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki E, 1999, THEOR APPL GENET, V98, P977, DOI 10.1007/s001220051158; Araus JL, 2003, CROP SCI, V43, P170, DOI 10.2135/cropsci2003.0170; Borner A, 2002, THEOR APPL GENET, V105, P921, DOI 10.1007/s00122-002-0994-1; Bradshaw JE, 2008, THEOR APPL GENET, V116, P193, DOI 10.1007/s00122-007-0659-1; Campbell BT, 2003, CROP SCI, V43, P1493, DOI 10.2135/cropsci2003.1493; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Causse M, 2007, THEOR APPL GENET, V115, P429, DOI 10.1007/s00122-007-0578-1; CECCARELLI S, 1991, EUPHYTICA, V56, P169, DOI 10.1007/BF00042061; Cuthbert JL, 2008, THEOR APPL GENET, V117, P595, DOI 10.1007/s00122-008-0804-5; Doerge RW, 2002, NAT REV GENET, V3, P43, DOI 10.1038/nrg703; Groos C, 2003, THEOR APPL GENET, V106, P1032, DOI 10.1007/s00122-002-1111-1; Habash DZ, 2007, THEOR APPL GENET, V114, P403, DOI 10.1007/s00122-006-0429-5; Hao ZF, 2003, SCI AGR SIN, V2, P943; Huang XQ, 2006, THEOR APPL GENET, V113, P753, DOI 10.1007/s00122-006-0346-7; Huang XQ, 2003, THEOR APPL GENET, V106, P1379, DOI 10.1007/s00122-002-1179-7; Huang XQ, 2004, THEOR APPL GENET, V109, P933, DOI 10.1007/s00122-004-1708-7; Jing RL, 1999, BIOTECHNOLOGY, V9, P4; Kato K, 2000, THEOR APPL GENET, V101, P1114, DOI 10.1007/s001220051587; Kuchel H, 2007, THEOR APPL GENET, V115, P1029, DOI 10.1007/s00122-007-0629-7; Kumar N, 2007, MOL BREEDING, V19, P163, DOI 10.1007/s11032-006-9056-8; Lanceras JC, 2004, PLANT PHYSIOL, V135, P384, DOI 10.1104/pp.103.035527; Li ZK, 1997, GENETICS, V145, P453; Ma XQ, 2007, MOL BREEDING, V20, P41, DOI 10.1007/s11032-006-9071-9; Ma ZQ, 2007, MOL GENET GENOMICS, V277, P31, DOI 10.1007/s00438-006-0166-0; Maccaferri M, 2008, GENETICS, V178, P489, DOI 10.1534/genetics.107.077297; Maccaferri M, 2011, J EXP BOT, V62, P409, DOI 10.1093/jxb/erq287; Marza F, 2006, THEOR APPL GENET, V112, P688, DOI 10.1007/s00122-005-0172-3; McCartney CA, 2005, GENOME, V48, P870, DOI 10.1139/g05-055; McIntyre CL, 2010, THEOR APPL GENET, V120, P527, DOI 10.1007/s00122-009-1173-4; Narasimhamoorthy B, 2006, THEOR APPL GENET, V112, P787, DOI 10.1007/s00122-005-0159-0; Peng JH, 2003, P NATL ACAD SCI USA, V100, P2489, DOI 10.1073/pnas.252763199; Quarrie SA, 2006, J EXP BOT, V57, P2627, DOI 10.1093/jxb/erl026; Quarrie SA, 2005, THEOR APPL GENET, V110, P865, DOI 10.1007/s00122-004-1902-7; Rattey A, 2009, CROP PASTURE SCI, V60, P717, DOI 10.1071/CP08460; Reynolds M, 2009, ANN APPL BIOL, V155, P309, DOI 10.1111/j.1744-7348.2009.00351.x; Shah MM, 1999, CROP SCI, V39, P1728, DOI 10.2135/cropsci1999.3961728x; Shi JQ, 2009, GENETICS, V182, P851, DOI 10.1534/genetics.109.101642; Slafer GA, 2003, ANN APPL BIOL, V142, P117, DOI 10.1111/j.1744-7348.2003.tb00237.x; Sourdille P, 2003, THEOR APPL GENET, V106, P530, DOI 10.1007/s00122-002-1044-8; Tan LB, 2008, GENOME, V51, P692, DOI 10.1139/G08-054; Thomson MJ, 2003, THEOR APPL GENET, V107, P479, DOI 10.1007/s00122-003-1270-8; Wang DL, 1999, THEOR APPL GENET, V99, P1255, DOI 10.1007/s001220051331; Wang RX, 2009, THEOR APPL GENET, V118, P313, DOI 10.1007/s00122-008-0901-5; Xing YZ, 2002, THEOR APPL GENET, V105, P248, DOI 10.1007/s00122-002-0952-y; Xu SZ, 2007, GENETICS, V175, P1955, DOI 10.1534/genetics.106.066571; Yang DL, 2007, GENETICS, V176, P571, DOI 10.1534/genetics.106.068361; Yang J, 2007, BIOINFORMATICS, V23, P1527, DOI 10.1093/bioinformatics/btm143; Zhou XiaoGuo, 2005, Scientia Agricultura Sinica, V38, P1951; Zhuang JY, 2002, THEOR APPL GENET, V105, P1137, DOI 10.1007/s00122-002-0974-5	49	129	137	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31249	10.1371/journal.pone.0031249	http://dx.doi.org/10.1371/journal.pone.0031249			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363596	gold, Green Submitted, Green Published			2022-12-27	WOS:000302853600130
J	Becquet, R; Marston, M; Dabis, F; Moulton, LH; Gray, G; Coovadia, HM; Essex, M; Ekouevi, DK; Jackson, D; Coutsoudis, A; Kilewo, C; Leroy, V; Wiktor, SZ; Nduati, R; Msellati, P; Zaba, B; Ghys, PD; Newell, ML				Becquet, Renaud; Marston, Milly; Dabis, Francois; Moulton, Lawrence H.; Gray, Glenda; Coovadia, Hoosen M.; Essex, Max; Ekouevi, Didier K.; Jackson, Debra; Coutsoudis, Anna; Kilewo, Charles; Leroy, Valeriane; Wiktor, Stefan Z.; Nduati, Ruth; Msellati, Philippe; Zaba, Basia; Ghys, Peter D.; Newell, Marie-Louise		UNAIDS Child Survival Grp	Children Who Acquire HIV Infection Perinatally Are at Higher Risk of Early Death than Those Acquiring Infection through Breastmilk: A Meta-Analysis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; FEEDING POPULATIONS; ORAL ZIDOVUDINE; FREE SURVIVAL; COTE-DIVOIRE; SOUTH-AFRICA; TRANSMISSION; MORTALITY; PREVENTION; EFFICACY	Background: Assumptions about survival of HIV-infected children in Africa without antiretroviral therapy need to be updated to inform ongoing UNAIDS modelling of paediatric HIV epidemics among children. Improved estimates of infant survival by timing of HIV-infection (perinatally or postnatally) are thus needed. Methodology/Principal Findings: A pooled analysis was conducted of individual data of all available intervention cohorts and randomized trials on prevention of HIV mother-to-child transmission in Africa. Studies were right-censored at the time of infant antiretroviral initiation. Overall mortality rate per 1000 child-years of follow-up was calculated by selected maternal and infant characteristics. The Kaplan-Meier method was used to estimate survival curves by child's HIV infection status and timing of HIV infection. Individual data from 12 studies were pooled, with 12,112 children of HIV-infected women. Mortality rates per 1,000 child-years follow-up were 39.3 and 381.6 for HIV-uninfected and infected children respectively. One year after acquisition of HIV infection, an estimated 26% postnatally and 52% perinatally infected children would have died; and 4% uninfected children by age 1 year. Mortality was independently associated with maternal death (adjusted hazard ratio 2.2, 95% CI 1.6-3.0), maternal CD4<350 cells/ml (1.4, 1.1-1.7), postnatal (3.1, 2.1-4.1) or peri-partum HIV-infection (12.4, 10.1-15.3). Conclusions/Results: These results update previous work and inform future UNAIDS modelling by providing survival estimates for HIV-infected untreated African children by timing of infection. We highlight the urgent need for the prevention of peri-partum and postnatal transmission and timely assessment of HIV infection in infants to initiate antiretroviral care and support for HIV-infected children.	[Becquet, Renaud; Dabis, Francois; Leroy, Valeriane] INSERM, U897, Ctr Rech Epidemiol & Biostat, Bordeaux, France; [Becquet, Renaud; Dabis, Francois; Leroy, Valeriane] Univ Bordeaux 2, ISPED, F-33076 Bordeaux, France; [Marston, Milly; Zaba, Basia] London Sch Hyg & Trop Med, London WC1, England; [Moulton, Lawrence H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Gray, Glenda] Univ Witwatersrand, PHRU, Soweto, South Africa; [Coovadia, Hoosen M.] Univ Witwatersrand, HIV Management Maternal Adolescent & Child Unit, Soweto, South Africa; [Essex, Max] Harvard Univ, Sch Publ Hlth, AIDS Initiat, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Ekouevi, Didier K.] ANRS Site Cote Ivoire, PAC CI Program, Abidjan, Cote Ivoire; [Jackson, Debra] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa; [Coutsoudis, Anna] Univ KwaZulu Natal, Dept Paediat & Child Hlth, Somkhele, South Africa; [Kilewo, Charles] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania; [Wiktor, Stefan Z.] Ctr Dis Control & Prevent, Global HIV AIDS Program, RETRO CI Project, Abidjan, Cote Ivoire; [Nduati, Ruth] Univ Nairobi, Dept Pediat, Nairobi, Kenya; [Msellati, Philippe] CHU Souro Sanou, Serv Pediat, Bobo Dioulasso, Burkina Faso; [Ghys, Peter D.] UNAIDS, Epidemiol & Anal Div, Geneva, Switzerland; [Newell, Marie-Louise] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, South Africa; [Newell, Marie-Louise] UCL, Ctr Paediat Epidemiol & Biostat, Inst Child Hlth, London, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Witwatersrand; University of Witwatersrand; Harvard University; Harvard T.H. Chan School of Public Health; University of the Western Cape; University of Kwazulu Natal; Muhimbili University of Health & Allied Sciences; University of Nairobi; UNAIDS; University of Kwazulu Natal; University of London; University College London	Becquet, R (corresponding author), INSERM, U897, Ctr Rech Epidemiol & Biostat, Bordeaux, France.	Renaud.Becquet@isped.u-bordeaux2.fr	EKOUEVI, Didier K/E-7960-2014; Newell, Marie-Louise/AAE-8222-2019; Leroy, Valeriane/GQB-1102-2022; Van de Perre, Philippe/B-9692-2008; DABIS, FRANCOIS/S-9298-2019; Jackson, Debra/D-2843-2009; John-Stewart, Grace/L-3650-2019; Leroy, Valeriane/F-8129-2013; Becquet, Renaud/F-4837-2013; Leroy, Valeriane/AAO-5175-2020; Castetbon, Katia/F-2686-2017	Newell, Marie-Louise/0000-0002-1074-7699; Leroy, Valeriane/0000-0003-3542-8616; Van de Perre, Philippe/0000-0002-3912-0427; DABIS, FRANCOIS/0000-0002-1614-8857; Jackson, Debra/0000-0001-5252-5325; Leroy, Valeriane/0000-0003-3542-8616; Becquet, Renaud/0000-0003-3277-0985; Leroy, Valeriane/0000-0003-3542-8616; Moulton, Lawrence/0000-0001-7041-7387; Lackritz, Eve/0000-0002-5397-7291; Saba, Wadad/0000-0001-5504-6725; Declich, Silvia/0000-0002-5916-3889; Odette, Ky-Zerbo/0000-0002-0018-1580; Jackson, Debra/0000-0003-3307-632X; Roels, Thierry/0000-0002-0886-5645	Epidemiology and Analysis Division of UNAIDS (Geneva, Switzerland)	Epidemiology and Analysis Division of UNAIDS (Geneva, Switzerland)	This pooled analysis was funded by the Epidemiology and Analysis Division of UNAIDS (Geneva, Switzerland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alioum A, 2003, AM J EPIDEMIOL, V158, P596, DOI 10.1093/aje/kwg188; Alioum A, 2001, STAT MED, V20, P3539, DOI 10.1002/sim.1076; Becquet R, 2007, PLOS MED, V4, P139, DOI 10.1371/journal.pmed.0040017; Becquet R, 2009, CLIN INFECT DIS, V49, P1936, DOI 10.1086/648446; Bedri A, 2008, LANCET, V372, P300, DOI 10.1016/S0140-6736(08)61114-9; Chakraborty R, 2005, CURR HIV RES, V3, P31, DOI 10.2174/1570162052773022; COOVADIA H, 2007, LANCET, V369, P1607; Coutsoudis A, 1999, LANCET, V354, P471, DOI 10.1016/S0140-6736(99)01101-0; Dabis F, 1999, LANCET, V353, P786, DOI 10.1016/S0140-6736(98)11046-2; Gaillard P, 2001, AIDS, V15, P389, DOI 10.1097/00002030-200102160-00012; Humphrey JH, 2006, J INFECT DIS, V193, P960; Jackson DJ, 2007, AIDS, V21, P509, DOI 10.1097/QAD.0b013e32801424d2; Kilewo C, 2009, JAIDS-J ACQ IMM DEF, V52, P406, DOI 10.1097/QAI.0b013e3181b323ff; Kuhn L, 2008, NEW ENGL J MED, V359, P130, DOI 10.1056/NEJMoa073788; Marinda E, 2007, PEDIATR INFECT DIS J, V26, P519, DOI 10.1097/01.inf.0000264527.69954.4c; MARSTON M, 2011, INT J EPIDEMIOL; Moodley D, 2003, J INFECT DIS, V187, P725, DOI 10.1086/367898; Msellati P, 1999, SEX TRANSM INFECT, V75, P420, DOI 10.1136/sti.75.6.420; Ndirangu J, 2010, AIDS, V24, P593, DOI 10.1097/QAD.0b013e328335cff5; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Newell ML, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200406002-00004; Rollins NC, 2007, JAIDS-J ACQ IMM DEF, V44, P321, DOI 10.1097/QAI.0b013e31802ea4b0; Saba J, 2002, LANCET, V359, P1178; Stover J, 2010, SEX TRANSM INFECT, V86, pII16, DOI 10.1136/sti.2010.044222; Taha TE, 2003, LANCET, V362, P1171, DOI 10.1016/S0140-6736(03)14538-2; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; Thomas TK, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001015; *UNAIDS, 2009, AIDS EP UPD; WHO, 2010, REC US ANT DRUGS TRE; Wiktor SZ, 1999, LANCET, V353, P781, DOI 10.1016/S0140-6736(98)10412-9	31	75	75	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2012	7	2							e28510	10.1371/journal.pone.0028510	http://dx.doi.org/10.1371/journal.pone.0028510			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927NZ	22383946	gold, Green Published, Green Accepted			2022-12-27	WOS:000302916100002
J	Andernach, IE; Jutavijittum, P; Samountry, B; Yousukh, A; Thammavong, T; Hubschen, JM; Muller, CP				Andernach, Iris E.; Jutavijittum, Prapan; Samountry, Bounthome; Yousukh, Amnat; Thammavong, Te; Huebschen, Judith M.; Muller, Claude P.			A High Variability of Mixed Infections and Recent Recombinations of Hepatitis B Virus in Laos	PLOS ONE			English	Article							GENOTYPE-C; HIGH PREVALENCE; SUBGENOTYPES; MUTATIONS; SUBTYPES; STRAINS; GENESIS	In Lao PDR, where more than 8% of the population are chronic carriers of HBsAg, multiple genotypes and subgenotypes co-circulate and are prone to generate recombinant viruses. Phylogenetic analyses of multiple clones per donor revealed mixed infections of subgenotypes B1, B2, B4, C1, C5, I1 and I2 in almost 6% of HBsAg positive rejected blood donors. Recombination analyses and distance calculations furthermore showed that about 65% (17/26) of the mixed infected donors showed recombinations in the S-gene alone, involving the predominant genotypes B and C. These results suggest that, at least in Laos, hepatitis B virus (HBV) mixed infections lead to frequent recombinations. In many donors with recombinant strains, the recombinant fragment and a non-recombinant strain of the same genotype co-existed (127/185 analysed recombinant fragments). For a large proportion of these (60/127), the most closely related known virus was found, although not always exclusively, in the same donor. Recombinant virus strains are largely distinct. This is reflected in an unexpected diversity in recombination breakpoints and the relatively rare recombinations with identical recombination patterns of the same genotypes in different donors. Recent recombination events would explain the limited spread of each of the recombinants. Using a published mutation rate of 4.2 x 10(-5) mutations per site and year, the observed minimum genetic distances of 0-0.60% between parent strain and recombinant fragment would correspond to 0-71 years of evolution from a most recent common ancestor (MRCA). Thus several lines of evidence are suggestive of recent independent recombination events, a proportion of these even occurring within the same donors. In conclusion, our analyses revealed a high variability of mixed infections as a very probable breeding ground of multiple variable recombination events in Laos that so far have not led to new dominant strains.	[Andernach, Iris E.; Huebschen, Judith M.; Muller, Claude P.] Ctr Rech Publ Sante, Natl Publ Hlth Lab, Inst Immunol, Luxembourg, Luxembourg; [Jutavijittum, Prapan; Yousukh, Amnat] Chiang Mai Univ, Dept Pathol, Chiang Mai 50000, Thailand; [Samountry, Bounthome] Univ Hlth Sci, Dept Pathol, Viangchan, Laos; [Thammavong, Te] Natl Blood Transfus Ctr, Viangchan, Laos	Luxembourg Institute of Health; Chiang Mai University	Andernach, IE (corresponding author), Ctr Rech Publ Sante, Natl Publ Hlth Lab, Inst Immunol, Luxembourg, Luxembourg.	Claude.Muller@CRP-SANTE.LU	Hübschen, Judith/ABA-7931-2021; Hübschen, Judith/AAF-5113-2020	Hübschen, Judith/0000-0002-5001-2128; 	Ministry of Cooperation of the Grand-Duchy of Luxembourg; National Research Fund, Luxembourg	Ministry of Cooperation of the Grand-Duchy of Luxembourg; National Research Fund, Luxembourg(Luxembourg National Research Fund)	This work was supported by the Ministry of Cooperation of the Grand-Duchy of Luxembourg. I.E.A. was supported by a fellowship from the National Research Fund, Luxembourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arankalle VA, 2010, J VIRAL HEPATITIS, V17, P501, DOI 10.1111/j.1365-2893.2009.01206.x; Baig S, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-128; Bollyky PL, 1996, J MOL EVOL, V42, P97, DOI 10.1007/BF02198834; Bowyer SM, 2000, J GEN VIROL, V81, P379, DOI 10.1099/0022-1317-81-2-379; Cao ZG, 2008, ARCH VIROL, V153, P1807, DOI 10.1007/s00705-008-0176-9; Cavinta L, 2009, J MED VIROL, V81, P983, DOI 10.1002/jmv.21475; Chan HLY, 2005, J INFECT DIS, V191, P2022, DOI 10.1086/430324; Cui CY, 2002, J GEN VIROL, V83, P2773, DOI 10.1099/0022-1317-83-11-2773; Fares MA, 2002, J MOL EVOL, V54, P807, DOI 10.1007/s00239-001-0084-z; GHENDON Y, 1987, J VIROL METHODS, V17, P69, DOI 10.1016/0166-0934(87)90070-X; Gilbert C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000495; Hannoun C, 2000, J GEN VIROL, V81, P2267, DOI 10.1099/0022-1317-81-9-2267; Huang ZM, 2005, WORLD J GASTROENTERO, V11, P6525, DOI 10.3748/wjg.v11.i41.6525; Huy TTT, 2008, J VIROL, V82, P5657, DOI 10.1128/JVI.02556-07; Huy TTT, 2004, J GEN VIROL, V85, P283, DOI 10.1099/vir.0.19633-0; Jutavijittum P, 2006, HEPATOL RES, V35, P263, DOI 10.1016/j.hepres.2006.04.010; Jutavijittum Prapan, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P674; Kao JH, 2001, HEPATOLOGY, V34, P817, DOI 10.1053/jhep.2001.28188; Kramvis A, 2005, VACCINE, V23, P2409, DOI 10.1016/j.vaccine.2004.10.045; Kramvis A, 2008, J MED VIROL, V80, P27, DOI 10.1002/jmv.21049; Kurbanov F, 2008, J VIROL, V82, P8241, DOI 10.1128/JVI.00793-08; Li DD, 2010, J INT MED RES, V38, P195, DOI 10.1177/147323001003800122; Lin CL, 2007, J MED VIROL, V79, P1674, DOI 10.1002/jmv.20985; Locarnini SA, 2010, ANTIVIR THER, V15, P451, DOI 10.3851/IMP1499; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Morozov V, 2000, GENE, V260, P55, DOI 10.1016/S0378-1119(00)00424-8; Mulyanto, 2010, ARCH VIROL, V155, P705, DOI 10.1007/s00705-010-0628-x; Mulyanto, 2009, ARCH VIROL, V154, P1047, DOI 10.1007/s00705-009-0406-9; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; Nurainy N, 2008, ARCH VIROL, V153, P1057, DOI 10.1007/s00705-008-0092-z; Olinger CM, 2008, EMERG INFECT DIS, V14, P1777, DOI 10.3201/eid1411.080437; Olinger CM, 2006, J GEN VIROL, V87, P1163, DOI 10.1099/vir.0.81614-0; Sa-Nguanmoo P, 2010, J MED VIROL, V82, P1341, DOI 10.1002/jmv.21828; Sakamoto T, 2006, J GEN VIROL, V87, P1873, DOI 10.1099/vir.0.81714-0; Sheldon J, 2006, J VIRAL HEPATITIS, V13, P427, DOI 10.1111/j.1365-2893.2005.00713.x; Simmonds P, 2005, J VIROL, V79, P15467, DOI 10.1128/JVI.79.24.15467-15476.2005; Sugauchi F, 2002, J VIROL, V76, P5985, DOI 10.1128/JVI.76.12.5985-5992.2002; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; Thedja MD, 2011, ARCH VIROL, V156, P855, DOI 10.1007/s00705-011-0926-y; Wang ZH, 2005, J GEN VIROL, V86, P985, DOI 10.1099/vir.0.80771-0; Yang J, 2006, J GEN VIROL, V87, P2203, DOI 10.1099/vir.0.81752-0; Yeh CT, 2010, ANTIVIR THER, V15, P471, DOI 10.3851/IMP1552; Yu H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009297; Zhou Y, 2007, J MOL EVOL, V65, P197, DOI 10.1007/s00239-007-0054-1	45	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e30245	10.1371/journal.pone.0030245	http://dx.doi.org/10.1371/journal.pone.0030245			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22383959	Green Published, gold, Green Submitted			2022-12-27	WOS:000302875500004
J	Derenko, M; Malyarchuk, B; Denisova, G; Perkova, M; Rogalla, U; Grzybowski, T; Khusnutdinova, E; Dambueva, I; Zakharov, I				Derenko, Miroslava; Malyarchuk, Boris; Denisova, Galina; Perkova, Maria; Rogalla, Urszula; Grzybowski, Tomasz; Khusnutdinova, Elza; Dambueva, Irina; Zakharov, Ilia			Complete Mitochondrial DNA Analysis of Eastern Eurasian Haplogroups Rarely Found in Populations of Northern Asia and Eastern Europe	PLOS ONE			English	Article							VOLGA-URAL REGION; GENETIC-STRUCTURE; GENOME VARIATION; MTDNA SEQUENCES; MODERN HUMANS; SILK ROAD; SOUTH; DIVERSITY; PHYLOGENY; ORIGIN	With the aim of uncovering all of the most basal variation in the northern Asian mitochondrial DNA (mtDNA) haplogroups, we have analyzed mtDNA control region and coding region sequence variation in 98 Altaian Kazakhs from southern Siberia and 149 Barghuts from Inner Mongolia, China. Both populations exhibit the prevalence of eastern Eurasian lineages accounting for 91.9% in Barghuts and 60.2% in Altaian Kazakhs. The strong affinity of Altaian Kazakhs and populations of northern and central Asia has been revealed, reflecting both influences of central Asian inhabitants and essential genetic interaction with the Altai region indigenous populations. Statistical analyses data demonstrate a close positioning of all Mongolic-speaking populations (Mongolians, Buryats, Khamnigans, Kalmyks as well as Barghuts studied here) and Turkic-speaking Sojots, thus suggesting their origin from a common maternal ancestral gene pool. In order to achieve a thorough coverage of DNA lineages revealed in the northern Asian matrilineal gene pool, we have completely sequenced the mtDNA of 55 samples representing haplogroups R11b, B4, B5, F2, M9, M10, M11, M13, N9a and R9c1, which were pinpointed from a massive collection (over 5000 individuals) of northern and eastern Asian, as well as European control region mtDNA sequences. Applying the newly updated mtDNA tree to the previously reported northern Asian and eastern Asian mtDNA data sets has resolved the status of the poorly classified mtDNA types and allowed us to obtain the coalescence age estimates of the nodes of interest using different calibrated rates. Our findings confirm our previous conclusion that northern Asian maternal gene pool consists of predominantly post-LGM components of eastern Asian ancestry, though some genetic lineages may have a pre-LGM/LGM origin.	[Derenko, Miroslava; Malyarchuk, Boris; Denisova, Galina; Perkova, Maria] Russian Acad Sci, Inst Biol Problems N, Magadan, Russia; [Rogalla, Urszula; Grzybowski, Tomasz] Nicolaus Copernicus Univ, Ludwik Rydygier Coll Med, Inst Forens Med, Dept Mol & Forens Genet, Bydgoszcz, Poland; [Khusnutdinova, Elza] Russian Acad Sci, Inst Biochem & Genet, Ufa Res Ctr, Ufa 450001, Russia; [Dambueva, Irina] Russian Acad Sci, Inst Gen & Expt Biol, Ulan Ude, Russia; [Zakharov, Ilia] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia	Institute of Biological Problems of the North; Russian Academy of Sciences; Nicolaus Copernicus University; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Russian Academy of Sciences; Russian Academy of Sciences; Vavilov Institute of General Genetics	Derenko, M (corresponding author), Russian Acad Sci, Inst Biol Problems N, Magadan, Russia.	mderenko@mail.ru	Khusnutdinova, Elza Kamilevna/A-4810-2013; Dambueva, Irina/AAZ-4313-2020; Dambueva, Irina/K-3073-2018; Denisova, Galina/AAZ-4310-2020; Derenko, Miroslava/J-1495-2018; Malyarchuk, Boris/D-5783-2018; Grzybowski, Tomasz/A-1676-2015; Rogalla, Urszula/E-3342-2014	Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Derenko, Miroslava/0000-0002-1849-784X; Malyarchuk, Boris/0000-0002-0304-0652; Grzybowski, Tomasz/0000-0001-6228-6460; Rogalla, Urszula/0000-0002-2778-9844	Russian Foundation for Basic Research [11-04-00620]; Presidium of Russian Academy of Sciences [09-I-P23-10]; Far-Eastern Branch of the Russian Academy of Sciences [09-III-A-06-220]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Presidium of Russian Academy of Sciences(Russian Academy of Sciences); Far-Eastern Branch of the Russian Academy of Sciences(Russian Academy of Sciences)	This study was supported by grants from the Russian Foundation for Basic Research (11-04-00620), the Presidium of Russian Academy of Sciences (09-I-P23-10), and the Far-Eastern Branch of the Russian Academy of Sciences (09-III-A-06-220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2003, ANN HUM GENET, V67, P512, DOI 10.1046/j.1469-1809.2003.00049.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bermisheva MA, 2002, MOL BIOL+, V36, P802, DOI 10.1023/A:1021677708482; Bilal E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002421; Bodner M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-49; Burger J, 2007, P NATL ACAD SCI USA, V104, P3736, DOI 10.1073/pnas.0607187104; Chaix R, 2007, CURR BIOL, V17, P43, DOI 10.1016/j.cub.2006.10.058; Chandrasekar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007447; Comas D, 1998, AM J HUM GENET, V63, P1824, DOI 10.1086/302133; Comas D, 2004, EUR J HUM GENET, V12, P495, DOI 10.1038/sj.ejhg.5201160; Dancause KN, 2009, J HUM GENET, V54, P86, DOI 10.1038/jhg.2008.12; Derbeneva OA, 2002, AM J HUM GENET, V71, P415, DOI 10.1086/341720; Derenko M, 2006, HUM GENET, V118, P591, DOI 10.1007/s00439-005-0076-y; Derenko M, 2007, AM J HUM GENET, V81, P1025, DOI 10.1086/522933; Derenko M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015214; Derenko MV, 2003, ANN HUM GENET, V67, P391, DOI 10.1046/j.1469-1809.2003.00035.x; Derenko MV, 2000, HUM BIOL, V72, P945; Derenko MV, 1997, MOL BIOL+, V31, P665; Dolukhanov P, 2005, J ARCHAEOL SCI, V32, P1441, DOI 10.1016/j.jas.2005.03.021; Fornarino S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-154; Fu YX, 1997, GENETICS, V147, P915; Gilbert MTP, 2008, SCIENCE, V320, P1787, DOI 10.1126/science.1159750; Goebel T, 1999, EVOL ANTHROPOL, V8, P208; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Gokcumen O, 2008, AM J PHYS ANTHROPOL, V136, P278, DOI 10.1002/ajpa.20802; Grzybowski T, 2007, FORENSIC SCI INT-GEN, V1, P141, DOI 10.1016/j.fsigen.2007.01.010; Guba Z, 2011, J HUM GENET, V56, P784, DOI 10.1038/jhg.2011.103; Gunnarsdottir ED, 2011, GENOME RES, V21, P1, DOI 10.1101/gr.107615.110; Hartmann A, 2009, HUM MUTAT, V30, P115, DOI 10.1002/humu.20816; Hill C, 2007, AM J HUM GENET, V80, P29, DOI 10.1086/510412; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Ingman M, 2007, EUR J HUM GENET, V15, P115, DOI 10.1038/sj.ejhg.5201712; Irwin JA, 2010, INT J LEGAL MED, V124, P195, DOI 10.1007/s00414-009-0406-z; Just RS, 2008, FORENSIC SCI INT-GEN, V2, pE45, DOI [10.1016/j.fsigen.2007.12.001, 10.1016/j.fsigen.2007.11.004]; Kazuno AA, 2005, PSYCHIAT CLIN NEUROS, V59, P497, DOI 10.1111/j.1440-1819.2005.01404.x; Kitchen A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001596; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; Kong QP, 2011, MOL BIOL EVOL, V28, P513, DOI 10.1093/molbev/msq219; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718; LAUKHIN SA, 1993, DOKL AKAD NAUK+, V332, P352; Loo JH, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-21; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Malyarchuk B, 2008, MOL BIOL EVOL, V25, P1651, DOI 10.1093/molbev/msn114; Malyarchuk B, 2004, HUM BIOL, V76, P877, DOI 10.1353/hub.2005.0021; Malyarchuk BA, 2002, ANN HUM GENET, V66, P261, DOI 10.1017/S0003480002001161; Malyarchuk BA, 2001, ANN HUM GENET, V65, P63, DOI 10.1046/j.1469-1809.2001.6510063.x; Malyarchuk BA, 2002, THESIS I BIOL PROBLE; Malyarchuk B, 2010, ANN HUM GENET, V74, P539, DOI 10.1111/j.1469-1809.2010.00601.x; Malyarchuk B, 2010, MOL BIOL EVOL, V27, P2220, DOI 10.1093/molbev/msq065; Malyarchuk BA, 2006, HUM BIOL, V78, P681, DOI 10.1353/hub.2007.0014; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Nohira C, 2010, INT J LEGAL MED, V124, P7, DOI 10.1007/s00414-008-0308-5; Okladnikov AP, 1981, PALEOLITHIC CENTRAL; Palanichamy MG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-304; Peng MS, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-2; Peng MS, 2010, MOL BIOL EVOL, V27, P2417, DOI 10.1093/molbev/msq131; Perego UA, 2010, GENOME RES, V20, P1174, DOI 10.1101/gr.109231.110; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Pierson MJ, 2006, MOL BIOL EVOL, V23, P1966, DOI 10.1093/molbev/msl063; Pitulko VV, 2004, SCIENCE, V303, P52, DOI 10.1126/science.1085219; Qin ZD, 2010, AM J PHYS ANTHROPOL, V143, P555, DOI 10.1002/ajpa.21350; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; Razafindrazaka H, 2010, EUR J HUM GENET, V18, P575, DOI 10.1038/ejhg.2009.222; RENFREW C, 1994, SCI AM, V270, P116, DOI 10.1038/scientificamerican0194-116; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; SCHNEIDER S, 2000, ARLEQUIN VER 2 0 SOF; Schroeder KB, 2007, BIOL LETTERS, V3, P218, DOI 10.1098/rsbl.2006.0609; Soares P, 2008, MOL BIOL EVOL, V25, P1209, DOI 10.1093/molbev/msn068; Soares P, 2011, AM J HUM GENET, V88, P239, DOI 10.1016/j.ajhg.2011.01.009; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Starikovskaya EB, 2005, ANN HUM GENET, V69, P67, DOI 10.1046/j.1529-8817.2003.00127.x; Tabbada KA, 2010, MOL BIOL EVOL, V27, P21, DOI 10.1093/molbev/msp215; TAJIMA F, 1989, GENETICS, V123, P585; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Thangaraj K, 2005, SCIENCE, V308, P996, DOI 10.1126/science.1109987; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; Trejaut JA, 2005, PLOS BIOL, V3, P1362, DOI 10.1371/journal.pbio.0030247; Ueno H, 2009, MITOCHONDRION, V9, P385, DOI 10.1016/j.mito.2009.06.003; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; VASILEV SA, 1993, CURR ANTHROPOL, V34, P82, DOI 10.1086/204141; Volodko NV, 2008, AM J HUM GENET, V82, P1084, DOI 10.1016/j.ajhg.2008.03.019; Wang CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021613; Wen B, 2005, MOL BIOL EVOL, V22, P725, DOI 10.1093/molbev/msi055; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Yao YG, 2004, MOL BIOL EVOL, V21, P2265, DOI 10.1093/molbev/msh238; Zhao M, 2009, P NATL ACAD SCI USA, V106, P21230, DOI 10.1073/pnas.0907844106; Zou Y, 2010, BIOCHEM BIOPH RES CO, V399, P179, DOI 10.1016/j.bbrc.2010.07.051	92	46	48	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32179	10.1371/journal.pone.0032179	http://dx.doi.org/10.1371/journal.pone.0032179			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926ZM	22363811	gold, Green Submitted, Green Published			2022-12-27	WOS:000302873700152
J	Forbes, NE; Ping, JH; Dankar, SK; Jia, JJ; Selman, M; Keleta, L; Zhou, Y; Brown, EG				Forbes, Nicole E.; Ping, Jihui; Dankar, Samar K.; Jia, Jian-Jun; Selman, Mohammed; Keleta, Liya; Zhou, Yan; Brown, Earl G.			Multifunctional Adaptive NS1 Mutations Are Selected upon Human Influenza Virus Evolution in the Mouse	PLOS ONE			English	Article							VIRAL MESSENGER-RNA; A VIRUS; H5N1 INFLUENZA; PROTEIN INTERACTS; HOST-RANGE; NUCLEOCYTOPLASMIC TRANSPORT; INCREASED VIRULENCE; GENE-EXPRESSION; RIG-I; REPLICATION	The role of the NS1 protein in modulating influenza A virulence and host range was assessed by adapting A/Hong Kong/1/1968 (H3N2) (HK-wt) to increased virulence in the mouse. Sequencing the NS genome segment of mouse-adapted variants revealed 11 mutations in the NS1 gene and 4 in the overlapping NEP gene. Using the HK-wt virus and reverse genetics to incorporate mutant NS gene segments, we demonstrated that all NS1 mutations were adaptive and enhanced virus replication (up to 100 fold) in mouse cells and/or lungs. All but one NS1 mutant was associated with increased virulence measured by survival and weight loss in the mouse. Ten of twelve NS1 mutants significantly enhanced IFN-beta antagonism to reduce the level of IFN beta production relative to HK-wt in infected mouse lungs at 1 day post infection, where 9 mutants induced viral yields in the lung that were equivalent to or significantly greater than HK-wt (up to 16 fold increase). Eight of 12 NS1 mutants had reduced or lost the ability to bind the 30 kDa cleavage and polyadenylation specificity factor (CPSF30) thus demonstrating a lack of correlation with reduced IFN beta production. Mutant NS1 genes resulted in increased viral mRNA transcription (10 of 12 mutants), and protein production (6 of 12 mutants) in mouse cells. Increased transcription activity was demonstrated in the influenza mini-genome assay for 7 of 11 NS1 mutants. Although we have shown gain-of-function properties for all mutant NS genes, the contribution of the NEP mutations to phenotypic changes remains to be assessed. This study demonstrates that NS1 is a multifunctional virulence factor subject to adaptive evolution.	[Forbes, Nicole E.; Ping, Jihui; Dankar, Samar K.; Jia, Jian-Jun; Selman, Mohammed; Keleta, Liya; Brown, Earl G.] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Forbes, Nicole E.; Ping, Jihui; Dankar, Samar K.; Jia, Jian-Jun; Selman, Mohammed; Keleta, Liya; Brown, Earl G.] Univ Ottawa, Fac Med, Emerging Pathogens Res Ctr, Ottawa, ON, Canada; [Zhou, Yan] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada; [Zhou, Yan; Brown, Earl G.] Univ Ottawa, CIHR, Canadian Influenza Pathogenesis Team, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Saskatchewan; University of Ottawa	Forbes, NE (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	ebrown@uottawa.ca		Selman, Mohammed/0000-0002-3265-2009; Forbes, Nicole/0000-0002-2645-695X	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [N01-AI-30071, HHSN272200900007C]; Canadian Institutes of Health Research (CIHR) Pandemic Preparedness Team [TPA-90188]; CIHR [MOP-74526]; Ontario Graduate Scholarship in Science and Technology	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Canadian Institutes of Health Research (CIHR) Pandemic Preparedness Team(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship in Science and Technology	This project has been funded in part through the Influenza Genome Sequencing Project with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under contract numbers N01-AI-30071 and HHSN272200900007C, http://www.niaid.nih.gov/; the Canadian Institutes of Health Research (CIHR) Pandemic Preparedness Team grant to the CIHR Canadian Influenza Pathogenesis Team (EGB) TPA-90188, and CIHR operating grant MOP-74526 (EGB); http://www.cihr-irsc.gc.ca/. NE Forbes was funded from an Ontario Graduate Scholarship in Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akarsu H, 2003, EMBO J, V22, P4646, DOI 10.1093/emboj/cdg449; Aragon T, 2000, MOL CELL BIOL, V20, P6259, DOI 10.1128/MCB.20.17.6259-6268.2000; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; BOULOY M, 1978, P NATL ACAD SCI USA, V75, P4886, DOI 10.1073/pnas.75.10.4886; BROWN EG, 1990, J VIROL, V64, P4523, DOI 10.1128/JVI.64.9.4523-4533.1990; Brown EG, 1999, VIRUS RES, V61, P63, DOI 10.1016/S0168-1702(99)00027-1; Brown EG, 2001, P NATL ACAD SCI USA, V98, P6883, DOI 10.1073/pnas.111165798; Burgui I, 2003, J GEN VIROL, V84, P3263, DOI 10.1099/vir.0.19487-0; Chen ZY, 1999, EMBO J, V18, P2273, DOI 10.1093/emboj/18.8.2273; Dankar SK, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-13; Falcon AM, 2004, J VIROL, V78, P3880, DOI 10.1128/JVI.78.8.3880-3888.2004; FORTES P, 1994, EMBO J, V13, P704, DOI 10.1002/j.1460-2075.1994.tb06310.x; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Garaigorta U, 2007, NUCLEIC ACIDS RES, V35, P4573, DOI 10.1093/nar/gkm230; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Guan Y, 2002, P NATL ACAD SCI USA, V99, P8950, DOI 10.1073/pnas.132268999; Guan Y, 2004, P NATL ACAD SCI USA, V101, P8156, DOI 10.1073/pnas.0402443101; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hale BG, 2010, J VIROL, V84, P6909, DOI 10.1128/JVI.00081-10; Hossain MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003170; Ilyushina NA, 2010, J VIROL, V84, P8607, DOI 10.1128/JVI.00159-10; Jia DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013927; Jiao PR, 2008, J VIROL, V82, P1146, DOI 10.1128/JVI.01698-07; Keleta L, 2008, J VIROL, V82, P11599, DOI 10.1128/JVI.01393-08; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; Kuo RL, 2009, J VIROL, V83, P1611, DOI 10.1128/JVI.01491-08; LAMB RA, 1981, P NATL ACAD SCI-BIOL, V78, P4170, DOI 10.1073/pnas.78.7.4170; LAMB RA, 1980, P NATL ACAD SCI-BIOL, V77, P1857, DOI 10.1073/pnas.77.4.1857; Lee JH, 2010, VIROLOGY, V397, P89, DOI 10.1016/j.virol.2009.10.041; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Li SD, 2006, VIROLOGY, V349, P13, DOI 10.1016/j.virol.2006.01.005; Li ZJ, 2006, J VIROL, V80, P11115, DOI 10.1128/JVI.00993-06; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Liu Qinfang, 2009, J Mol Genet Med, V3, P225; Long JX, 2008, VIRUS GENES, V36, P471, DOI 10.1007/s11262-007-0187-8; LU Y, 1994, GENE DEV, V8, P1817, DOI 10.1101/gad.8.15.1817; Ma WJ, 2010, J VIROL, V84, P2122, DOI 10.1128/JVI.01668-09; Marion RM, 1997, J GEN VIROL, V78, P2447, DOI 10.1099/0022-1317-78-10-2447; Meunier I, 2011, J GEN VIROL, V92, P1635, DOI 10.1099/vir.0.032193-0; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Miller J, 2004, BEHAV RES METH INS C, V36, P11, DOI 10.3758/BF03195545; Min JY, 2007, VIROLOGY, V363, P236, DOI 10.1016/j.virol.2007.01.038; Narasaraju T, 2009, MICROBES INFECT, V11, P2, DOI 10.1016/j.micinf.2008.09.013; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; Noah DL, 2003, VIROLOGY, V307, P386, DOI 10.1016/S0042-6822(02)00127-7; Opitz B, 2007, CELL MICROBIOL, V9, P930, DOI 10.1111/j.1462-5822.2006.00841.x; Perez JT, 2010, P NATL ACAD SCI USA, V107, P11525, DOI 10.1073/pnas.1001984107; Ping JH, 2008, BIOCHEM BIOPH RES CO, V371, P168, DOI 10.1016/j.bbrc.2008.04.045; Ping JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021740; Ping JH, 2010, J VIROL, V84, P10606, DOI 10.1128/JVI.01187-10; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Robb NC, 2011, J GEN VIROL; Robb NC, 2011, J VIROL, V85, P5228, DOI 10.1128/JVI.02562-10; Robb NC, 2010, J GEN VIROL, V91, P2331, DOI 10.1099/vir.0.022004-0; Robb NC, 2009, J GEN VIROL, V90, P1398, DOI 10.1099/vir.0.009639-0; Satterly N, 2007, P NATL ACAD SCI USA, V104, P1853, DOI 10.1073/pnas.0610977104; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Shimizu T, 2011, FEBS LETT, V585, P41, DOI 10.1016/j.febslet.2010.11.017; Steidle S, 2010, J VIROL, V84, P12761, DOI 10.1128/JVI.00701-10; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; Wang ZF, 2010, J VIROL, V84, P11323, DOI 10.1128/JVI.01034-10; Watanabe T, 2010, CELL HOST MICROBE, V7, P427, DOI 10.1016/j.chom.2010.05.008; Webster RG, 2007, AVIAN DIS, V51, P269, DOI 10.1637/7641-050206R.1; World Health Organization (WHO), 2011, CUM NUMB CONF HUM CA	65	41	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31839	10.1371/journal.pone.0031839	http://dx.doi.org/10.1371/journal.pone.0031839			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363747	Green Submitted, Green Published, gold			2022-12-27	WOS:000302873700107
J	Martinez-Antonio, A; Lomnitz, JG; Sandoval, S; Aldana, M; Savageau, MA				Martinez-Antonio, Agustino; Lomnitz, Jason G.; Sandoval, Santiago; Aldana, Maximino; Savageau, Michael A.			Regulatory Design Governing Progression of Population Growth Phases in Bacteria	PLOS ONE			English	Article							NUCLEOID-ASSOCIATED PROTEINS; SIGMA SUBUNIT SYNTHESIS; ESCHERICHIA-COLI; RNA-POLYMERASE; TRANSCRIPTIONAL REGULATION; INTRACELLULAR LEVELS; STATIONARY-PHASE; GENE-EXPRESSION; ORGANIZATION; NETWORK	It has long been noted that batch cultures inoculated with resting bacteria exhibit a progression of growth phases traditionally labeled lag, exponential, pre-stationary and stationary. However, a detailed molecular description of the mechanisms controlling the transitions between these phases is lacking. A core circuit, formed by a subset of regulatory interactions involving five global transcription factors (FIS, HNS, IHF, RpoS and GadX), has been identified by correlating information from the well- established transcriptional regulatory network of Escherichia coli and genome-wide expression data from cultures in these different growth phases. We propose a functional role for this circuit in controlling progression through these phases. Two alternative hypotheses for controlling the transition between the growth phases are first, a continuous graded adjustment to changing environmental conditions, and second, a discontinuous hysteretic switch at critical thresholds between growth phases. We formulate a simple mathematical model of the core circuit, consisting of differential equations based on the power-law formalism, and show by mathematical and computer-assisted analysis that there are critical conditions among the parameters of the model that can lead to hysteretic switch behavior, which - if validated experimentally - would suggest that the transitions between different growth phases might be analogous to cellular differentiation. Based on these provocative results, we propose experiments to test the alternative hypotheses.	[Martinez-Antonio, Agustino] CINVESTAV, Dept Ingn Genet, Guanajuato, Mexico; [Lomnitz, Jason G.; Savageau, Michael A.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Sandoval, Santiago; Aldana, Maximino] Univ Nacl Autonoma Mexico, Inst Fis, Cuernavaca 62191, Morelos, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; University of California System; University of California Davis; Universidad Nacional Autonoma de Mexico	Martinez-Antonio, A (corresponding author), CINVESTAV, Dept Ingn Genet, Guanajuato, Mexico.	amartinez@ira.cinvestav.mx	Martínez-Antonio, Agustino/A-3881-2008; Aldana, Maximino/D-9372-2017; Martínez-Antonio, Agustino/GQQ-2363-2022; Antonio, Agustino Martínez/AAG-4309-2021	Martínez-Antonio, Agustino/0000-0003-2231-5014; Aldana, Maximino/0000-0002-3419-6641; Martínez-Antonio, Agustino/0000-0003-2231-5014; Antonio, Agustino Martínez/0000-0003-2231-5014; Lomnitz, Jason/0000-0001-6509-2194	CONACYT [102854]; United States Public Health Service [R01-GM30054]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030054] Funding Source: NIH RePORTER	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a Young Researcher Grant (102854) from CONACYT given to AM-A and United States Public Health Service Grant R01-GM30054 to MAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold CN, 2001, J BACTERIOL, V183, P2178, DOI 10.1128/JB.183.7.2178-2186.2001; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Becker G, 1999, P NATL ACAD SCI USA, V96, P6439, DOI 10.1073/pnas.96.11.6439; Bramkamp M, 2009, CURR OPIN MICROBIOL, V12, P683, DOI 10.1016/j.mib.2009.10.002; Chiancone E, 2010, BIOCH BIOPHYS ACTA; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Chung YS, 2009, NUCLEIC ACIDS RES, V37, P3143, DOI 10.1093/nar/gkp151; COOPER S, 1969, J MOL BIOL, V43, P1, DOI 10.1016/0022-2836(69)90074-6; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; Fang FC, 2008, CURR OPIN MICROBIOL, V11, P113, DOI 10.1016/j.mib.2008.02.011; Fasani RA, BIOINFORMATICS; Freire P, 2009, J MOL BIOL, V385, P1345, DOI 10.1016/j.jmb.2008.12.026; Frenkiel-Krispin D, 2001, EMBO J, V20, P1184, DOI 10.1093/emboj/20.5.1184; Gallardo-Madueno R, 1998, J BIOL CHEM, V273, P18382, DOI 10.1074/jbc.273.29.18382; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; Grainger DC, 2006, NUCLEIC ACIDS RES, V34, P4642, DOI 10.1093/nar/gkl542; Haeusser DP, 2008, CURR OPIN MICROBIOL, V11, P94, DOI 10.1016/j.mib.2008.02.008; Janga SC, 2009, NUCLEIC ACIDS RES, V37, P3680, DOI 10.1093/nar/gkp231; Jishage M, 1996, J BACTERIOL, V178, P5447, DOI 10.1128/jb.178.18.5447-5451.1996; JISHAGE M, 1995, J BACTERIOL, V177, P6832, DOI 10.1128/jb.177.23.6832-6835.1995; Katayama T, 2010, NAT REV MICROBIOL, V8, P163, DOI 10.1038/nrmicro2314; Kirkpatrick C, 2001, J BACTERIOL, V183, P6466, DOI 10.1128/JB.183.21.6466-6477.2001; Klauck Eberhard, 2007, Science Progress, V90, P103, DOI 10.3184/003685007X215922; KOLTER R, 1993, ANNU REV MICROBIOL, V47, P855, DOI 10.1146/annurev.micro.47.1.855; Loewen PC, 1998, CAN J MICROBIOL, V44, P707, DOI 10.1139/cjm-44-8-707; Luijsterburg MS, 2006, J STRUCT BIOL, V156, P262, DOI 10.1016/j.jsb.2006.05.006; MaalOe O, 1966, CONTROL MACROMOLECUL; Marr C, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-18; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; Martinez-Antonio A, 2008, J MOL BIOL, V381, P238, DOI 10.1016/j.jmb.2008.05.054; Martinez-Antonio A, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-247; Mates AK, 2007, J BACTERIOL, V189, P2759, DOI 10.1128/JB.01490-06; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Nair S, 2004, J BACTERIOL, V186, P4192, DOI 10.1128/JB.186.13.4192-4198.2004; Nystrom T, 2004, ANNU REV MICROBIOL, V58, P161, DOI 10.1146/annurev.micro.58.030603.123818; Piper SE, 2009, MOL BIOSYST, V5, P1943, DOI [10.1039/b904955j, 10.1039/B904955j]; Savageau M, 1976, BIOCH SYSTEMS ANAL S; Savageau MA, 2002, MATH BIOSCI, V180, P237, DOI 10.1016/S0025-5564(02)00113-X; Savageau MA, 2001, CHAOS, V11, P142, DOI 10.1063/1.1349892; SAVAGEAU MA, 1971, ARCH BIOCHEM BIOPHYS, V145, P612, DOI 10.1016/S0003-9861(71)80021-8; Savageau MA, 2011, ANN BIOMED ENG, V39, P1278, DOI 10.1007/s10439-010-0220-2; Savageau MA, 2009, FEBS LETT, V583, P3914, DOI 10.1016/j.febslet.2009.10.073; Savageau MA, 2009, P NATL ACAD SCI USA, V106, P6435, DOI 10.1073/pnas.0809869106; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tolla DA, 2011, MOL MICROBIOL, V79, P149, DOI 10.1111/j.1365-2958.2010.07437.x; Tramonti A, 2002, J BACTERIOL, V184, P2603, DOI 10.1128/JB.184.10.2603-2613.2002; Travers A, 2001, BIOCHIMIE, V83, P213, DOI 10.1016/S0300-9084(00)01217-7; Travers A, 1997, CURR BIOL, V7, pR252, DOI 10.1016/S0960-9822(06)00114-X; Vora T, 2009, MOL CELL, V35, P247, DOI 10.1016/j.molcel.2009.06.035; Wilson GS, 1922, J BACTERIOL, V7, P405, DOI 10.1128/JB.7.4.405-446.1922; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	52	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e30654	10.1371/journal.pone.0030654	http://dx.doi.org/10.1371/journal.pone.0030654			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363461	Green Submitted, Green Published, gold			2022-12-27	WOS:000302873700009
J	Oldenburger, A; Roscioni, SS; Jansen, E; Menzen, MH; Halayko, AJ; Timens, W; Meurs, H; Maarsingh, H; Schmidt, M				Oldenburger, Anouk; Roscioni, Sara S.; Jansen, Esther; Menzen, Mark H.; Halayko, Andrew J.; Timens, Wim; Meurs, Herman; Maarsingh, Harm; Schmidt, Martina			Anti-Inflammatory Role of the cAMP Effectors Epac and PKA: Implications in Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							AIRWAY SMOOTH-MUSCLE; PROTEIN-KINASE-A; NF-KAPPA-B; CIGARETTE-SMOKE; BETA(2)-ADRENOCEPTOR AGONISTS; INTERLEUKIN-8 RELEASE; HISTONE DEACETYLASE; EPITHELIAL-CELLS; INFLAMMATION; SALMETEROL	Cigarette smoke-induced release of pro-inflammatory cytokines including interleukin-8 (IL-8) from inflammatory as well as structural cells in the airways, including airway smooth muscle (ASM) cells, may contribute to the development of chronic obstructive pulmonary disease (COPD). Despite the wide use of pharmacological treatment aimed at increasing intracellular levels of the endogenous suppressor cyclic AMP (cAMP), little is known about its exact mechanism of action. We report here that next to the beta(2)-agonist fenoterol, direct and specific activation of either exchange protein directly activated by cAMP (Epac) or protein kinase A (PKA) reduced cigarette smoke extract (CSE)-induced IL-8 mRNA expression and protein release by human ASM cells. CSE-induced I kappa B alpha-degradation and p65 nuclear translocation, processes that were primarily reversed by Epac activation. Further, CSE increased extracellular signal-regulated kinase (ERK) phosphorylation, which was selectively reduced by PKA activation. CSE decreased Epac1 expression, but did not affect Epac2 and PKA expression. Importantly, Epac1 expression was also reduced in lung tissue from COPD patients. In conclusion, Epac and PKA decrease CSE-induced IL-8 release by human ASM cells via inhibition of NF-kappa B and ERK, respectively, pointing at these cAMP effectors as potential targets for anti-inflammatory therapy in COPD. However, cigarette smoke exposure may reduce anti-inflammatory effects of cAMP elevating agents via down-regulation of Epac1.	[Oldenburger, Anouk; Roscioni, Sara S.; Jansen, Esther; Menzen, Mark H.; Meurs, Herman; Maarsingh, Harm; Schmidt, Martina] Univ Groningen, Dept Mol Pharmacol, Groningen, Netherlands; [Halayko, Andrew J.] Univ Manitoba, Dept Physiol & Internal Med, Winnipeg, MB, Canada; [Timens, Wim] Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9713 AV Groningen, Netherlands; [Oldenburger, Anouk; Roscioni, Sara S.; Jansen, Esther; Menzen, Mark H.; Timens, Wim; Meurs, Herman; Maarsingh, Harm; Schmidt, Martina] COPD, Groningen, Netherlands; [Oldenburger, Anouk; Roscioni, Sara S.; Jansen, Esther; Menzen, Mark H.; Timens, Wim; Meurs, Herman; Maarsingh, Harm; Schmidt, Martina] Groningen Res Inst Asthma, Groningen, Netherlands	University of Groningen; University of Manitoba; University of Groningen	Oldenburger, A (corresponding author), Univ Groningen, Dept Mol Pharmacol, Groningen, Netherlands.	a.oldenburger@rug.nl	Timens, Wim/K-5570-2013; Schmidt, Martina/C-5339-2018; Maarsingh, Harm/AAD-5642-2019	Timens, Wim/0000-0002-4146-6363; Schmidt, Martina/0000-0003-3075-0630; Halayko, Andrew/0000-0002-7865-4552	School of Behavioral and Cognitive Neurosciences; Nederlands Astma Fonds (NAF) [3.2.09.034]; University of Groningen; Merck-Sharpe and Dohme (Oss, The Netherlands); Canada Research Chairs; Canadian Institutes of Health Research	School of Behavioral and Cognitive Neurosciences; Nederlands Astma Fonds (NAF); University of Groningen; Merck-Sharpe and Dohme (Oss, The Netherlands)(Netherlands Government); Canada Research Chairs(Canada Research ChairsCGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a Ubbo Emmius Fellowship from the School of Behavioral and Cognitive Neurosciences to S. S. Roscioni, a grant by the Nederlands Astma Fonds (NAF 2009: project nr: 3.2.09.034) to A. Oldenburger and a Rosalind Franklin Fellowship from the University of Groningen to M. Schmidt. H. Maarsingh is supported by the Merck-Sharpe and Dohme (Oss, The Netherlands). A.J. Halayko is supported by the Canada Research Chairs Program and Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammit AJ, 2009, PULM PHARMACOL THER, V22, P446, DOI 10.1016/j.pupt.2008.10.006; Barnes NC, 2006, AM J RESP CRIT CARE, V173, P736, DOI 10.1164/rccm.200508-1321OC; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Bleecker ER, 2007, LANCET, V370, P2118, DOI 10.1016/S0140-6736(07)61906-0; Boterman M, 2006, EUR J PHARMACOL, V529, P151, DOI 10.1016/j.ejphar.2005.10.064; Chiu Jou-Chia, 2007, Journal of Microbiology Immunology and Infection, V40, P388; Culpitt S V, 2000, Expert Opin Pharmacother, V1, P1007, DOI 10.1517/14656566.1.5.1007; FINKELSTEIN R, 1995, AM J RESP CRIT CARE, V152, P1666, DOI 10.1164/ajrccm.152.5.7582312; Foronjy R, 2008, PULM PHARMACOL THER, V21, P370, DOI 10.1016/j.pupt.2007.10.004; Freyer AM, 2004, AM J RESP CELL MOL, V31, P440, DOI 10.1165/rcmb.2003-0241OC; Giembycz MA, 2006, EUR RESPIR J, V27, P1286, DOI 10.1183/09031936.06.00112605; Gosens R, 2006, AM J PHYSIOL-LUNG C, V291, pL523, DOI 10.1152/ajplung.00013.2006; Halayko Andrew J, 2008, Proc Am Thorac Soc, V5, P80, DOI 10.1513/pats.200705-057VS; Hallsworth MP, 2001, BRIT J PHARMACOL, V132, P729, DOI 10.1038/sj.bjp.0703866; Hogg JC, 2009, ANNU REV PATHOL-MECH, V4, P435, DOI 10.1146/annurev.pathol.4.110807.092145; Howarth PH, 2000, RESP MED, V94, pS22, DOI 10.1016/S0954-6111(00)90129-X; Hurst JR, 2006, AM J RESP CRIT CARE, V173, P71, DOI 10.1164/rccm.200505-704OC; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Jensen BO, 2004, BLOOD, V104, P2775, DOI 10.1182/blood-2004-03-1058; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kaur M, 2008, AM J PHYSIOL-LUNG C, V295, pL505, DOI 10.1152/ajplung.00046.2008; Keatings VM, 1997, AM J RESP CRIT CARE, V155, P542, DOI 10.1164/ajrccm.155.2.9032192; Keatings VM, 1996, AM J RESP CRIT CARE, V153, P530, DOI 10.1164/ajrccm.153.2.8564092; Lapperre TS, 2009, ANN INTERN MED, V151, P517, DOI 10.7326/0003-4819-151-8-200910200-00004; Min X, 2008, CHINESE MED J-PEKING, V121, P73, DOI 10.1097/00029330-200801010-00014; Mio T, 1997, AM J RESP CRIT CARE, V155, P1770, DOI 10.1164/ajrccm.155.5.9154890; Mortaz E, 2008, J MOL MED, V86, P1045, DOI 10.1007/s00109-008-0360-0; Numanami H, 2003, AM J RESP CELL MOL, V29, P613, DOI 10.1165/rcmb.2003-0113OC; Oenema TA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-130; Oltmanns U, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-74; Oltmanns U, 2008, PULM PHARMACOL THER, V21, P292, DOI 10.1016/j.pupt.2007.07.001; Panettieri RA, 2003, RESP PHYSIOL NEUROBI, V137, P277, DOI 10.1016/S1569-9048(03)00153-8; Pera T, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-48; Quint JK, 2007, J ALLERGY CLIN IMMUN, V119, P1065, DOI 10.1016/j.jaci.2006.12.640; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rabe KF, 2011, LANCET, V378, P1038, DOI 10.1016/S0140-6736(11)61295-6; Roberts JA, 1999, EUR RESPIR J, V14, P275, DOI 10.1034/j.1399-3003.1999.14b07.x; Roscioni SS, 2011, BRIT J PHARMACOL, V162, P193, DOI 10.1111/j.1476-5381.2010.01011.x; Roscioni SS, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-88; Roscioni SS, 2010, J CELL MOL IN PRESS; Shapiro SD, 2003, AM J PATHOL, V163, P2329, DOI 10.1016/S0002-9440(10)63589-4; Shore SA, 2003, RESP PHYSIOL NEUROBI, V137, P179, DOI 10.1016/S1569-9048(03)00146-0; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Stanescu D, 1996, THORAX, V51, P267, DOI 10.1136/thx.51.3.267; Tanino M, 2002, THORAX, V57, P405, DOI 10.1136/thorax.57.5.405; Yamamoto C, 1997, CHEST, V112, P505, DOI 10.1378/chest.112.2.505; Yang SR, 2006, AM J PHYSIOL-LUNG C, V291, pL46, DOI 10.1152/ajplung.00241.2005; Yokoyama U, 2008, P NATL ACAD SCI USA, V105, P6386, DOI 10.1073/pnas.0801490105	48	51	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31574	10.1371/journal.pone.0031574	http://dx.doi.org/10.1371/journal.pone.0031574			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363678	gold, Green Published, Green Submitted			2022-12-27	WOS:000302873700075
J	Pache, RA; Aloy, P				Pache, Roland A.; Aloy, Patrick			A Novel Framework for the Comparative Analysis of Biological Networks	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; DNA-POLYMERASE-ALPHA; SIGNALING PATHWAY; COP9 SIGNALOSOME; GLOBAL ALIGNMENT; RESOURCE; YEAST; IDENTIFICATION; SEQUENCE; SYSTEMS	Genome sequencing projects provide nearly complete lists of the individual components present in an organism, but reveal little about how they work together. Follow-up initiatives have deciphered thousands of dynamic and context-dependent interrelationships between gene products that need to be analyzed with novel bioinformatics approaches able to capture their complex emerging properties. Here, we present a novel framework for the alignment and comparative analysis of biological networks of arbitrary topology. Our strategy includes the prediction of likely conserved interactions, based on evolutionary distances, to counter the high number of missing interactions in the current interactome networks, and a fast assessment of the statistical significance of individual alignment solutions, which vastly increases its performance with respect to existing tools. Finally, we illustrate the biological significance of the results through the identification of novel complex components and potential cases of cross-talk between pathways and alternative signaling routes.	[Pache, Roland A.; Aloy, Patrick] Inst Biomed Res, Joint BSC IRB Program Computat Biol, Barcelona, Spain; [Aloy, Patrick] ICREA, Barcelona, Spain	ICREA	Pache, RA (corresponding author), Inst Biomed Res, Joint BSC IRB Program Computat Biol, Barcelona, Spain.	patrick.aloy@irbbarcelona.org	Aloy, Patrick/AAB-3538-2019	Aloy, Patrick/0000-0002-3557-0236; Pache, Roland/0000-0002-4723-6729	Spanish Ministerio de Ciencia e Innovacion [PSE-010000-2009-1, BIO2010-22073]; European Commission [223101]; Spanish FPU fellowship; ICREA Funding Source: Custom	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish FPU fellowship(Spanish Government); ICREA(ICREA)	This work was partially supported by the Spanish Ministerio de Ciencia e Innovacion (PSE-010000-2009-1; BIO2010-22073) and the European Commission under FP7 Grant Agreement 223101 (AntiPathoGN). RAP is a recipient of the Spanish FPU fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Bandyopadhyay S, 2010, SCIENCE, V330, P1385, DOI 10.1126/science.1195618; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Beltrao P, 2007, PLOS COMPUT BIOL, V3, P258, DOI 10.1371/journal.pcbi.0030025; Califano A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.117; Cesareni G, 2005, FEBS LETT, V579, P1828, DOI 10.1016/j.febslet.2005.01.064; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Chen YW, 2006, TRENDS GENET, V22, P416, DOI 10.1016/j.tig.2006.06.008; Cheng YF, 2009, CURR OPIN STRUC BIOL, V19, P203, DOI 10.1016/j.sbi.2009.02.004; Cootes AP, 2007, J MOL BIOL, V369, P1126, DOI 10.1016/j.jmb.2007.03.013; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Flannick J, 2009, J COMPUT BIOL, V16, P1001, DOI 10.1089/cmb.2009.0099; Flicek P, 2010, NUCLEIC ACIDS RES, V38, pD557, DOI 10.1093/nar/gkp972; Foiani M, 1997, TRENDS BIOCHEM SCI, V22, P424; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; GRISHIN NV, 1995, J MOL EVOL, V41, P675; Guldener U, 2006, NUCLEIC ACIDS RES, V34, pD436, DOI 10.1093/nar/gkj003; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hirsh E, 2007, BIOINFORMATICS, V23, pE170, DOI 10.1093/bioinformatics/btl295; Juan D, 2008, FEBS LETT, V582, P1225, DOI 10.1016/j.febslet.2008.02.017; Kalaev M, 2009, J COMPUT BIOL, V16, P989, DOI 10.1089/cmb.2009.0136; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kelley BP, 2003, P NATL ACAD SCI USA, V100, P11394, DOI 10.1073/pnas.1534710100; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Kiemer Lars, 2007, Trends Biotechnol, V25, P448, DOI 10.1016/j.tibtech.2007.08.002; Koyuturk M, 2006, J COMPUT BIOL, V13, P182, DOI 10.1089/cmb.2006.13.182; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liao CS, 2009, BIOINFORMATICS, V25, pI253, DOI 10.1093/bioinformatics/btp203; Narayanan M, 2007, J COMPUT BIOL, V14, P892, DOI 10.1089/cmb.2007.0025; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Pache RA, 2008, FEBS LETT, V582, P1259, DOI 10.1016/j.febslet.2008.02.014; Pavlov YI, 2006, CURR BIOL, V16, P202, DOI 10.1016/j.cub.2005.12.002; Pawson T, 2005, FEBS LETT, V579, P1808, DOI 10.1016/j.febslet.2005.02.013; Pazos F, 2002, PROTEINS, V47, P219, DOI 10.1002/prot.10074; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; Sharan R, 2006, NAT BIOTECHNOL, V24, P427, DOI 10.1038/nbt1196; Singh R, 2008, P NATL ACAD SCI USA, V105, P12763, DOI 10.1073/pnas.0806627105; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Teichmann SA, 2002, J MOL BIOL, V324, P399, DOI 10.1016/S0022-2836(02)01144-0; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhang S, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-5; Zhenping L, 2007, BIOINFORMATICS, V23, P1631, DOI 10.1093/bioinformatics/btm156	53	28	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31220	10.1371/journal.pone.0031220	http://dx.doi.org/10.1371/journal.pone.0031220			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363585	Green Submitted, gold, Green Published			2022-12-27	WOS:000302873700035
J	Pages, M; Chevret, P; Gros-Balthazard, M; Hughes, S; Alcover, JA; Hutterer, R; Rando, JC; Michaux, J; Hanni, C				Pages, Marie; Chevret, Pascale; Gros-Balthazard, Muriel; Hughes, Sandrine; Antoni Alcover, Josep; Hutterer, Rainer; Carlos Rando, Juan; Michaux, Jacques; Haenni, Catherine			Paleogenetic Analyses Reveal Unsuspected Phylogenetic Affinities between Mice and the Extinct Malpaisomys insularis, an Endemic Rodent of the Canaries	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; CYTOCHROME-B; LAVA MOUSE; MITOCHONDRIAL; GENE; SEQUENCES; EVOLUTION; MURIDAE; SYSTEMATICS; VERTEBRATES	Background: The lava mouse, Malpaisomys insularis, was endemic to the Eastern Canary islands and became extinct at the beginning of the 14th century when the Europeans reached the archipelago. Studies to determine Malpaisomys' phylogenetic affinities, based on morphological characters, remained inconclusive because morphological changes experienced by this insular rodent make phylogenetic investigations a real challenge. Over 20 years since its first description, Malpaisomys' phylogenetic position remains enigmatic. Methodology/Principal Findings: In this study, we resolved this issue using molecular characters. Mitochondrial and nuclear markers were successfully amplified from subfossils of three lava mouse samples. Molecular phylogenetic reconstructions revealed, without any ambiguity, unsuspected relationships between Malpaisomys and extant mice (genus Mus, Murinae). Moreover, through molecular dating we estimated the origin of the Malpaisomys/mouse clade at 6.9 Ma, corresponding to the maximal age at which the archipelago was colonised by the Malpaisomys ancestor via natural rafting. Conclusion/Significance: This study reconsiders the derived morphological characters of Malpaisomys in light of this unexpected molecular finding. To reconcile molecular and morphological data, we propose to consider Malpaisomys insularis as an insular lineage of mouse.	[Pages, Marie; Chevret, Pascale; Gros-Balthazard, Muriel; Hughes, Sandrine; Haenni, Catherine] Univ Lyon 1, CNRS UMR 5242, Ecole Normale Super Lyon, Inst Genom Fonct Lyon, F-69365 Lyon, France; [Antoni Alcover, Josep] Inst Mediterrani Estudis Avancats, Esporles, Mallorca, Spain; [Antoni Alcover, Josep] Amer Museum Nat Hist, Dept Mammal, New York, NY 10024 USA; [Hutterer, Rainer] Zool Forsch Museum Alexander Koenig, Bonn, Germany; [Carlos Rando, Juan] Univ La Laguna La Laguna, Dept Biol Anim UDI Zool, Tenerife, Canary Islands, Spain; [Carlos Rando, Juan] Isl Ecol & Evolut Res Grp IPNA CSIC, Tenerife, Canary Islands, Spain; [Michaux, Jacques] Univ Montpellier, EPHE ISEM, UMR CNRS 5554, Univ Montpellier 2, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); American Museum of Natural History (AMNH); Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Naturales y Agrobiologia (IPNA); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Pages, M (corresponding author), UMR CBGP INRA IRD Cirad Montpellier SupAgro, Campus Int Baillarguet, Montferrier Sur Lez, France.	pascale.chevret@univ-lyon1.fr	Chevret, Pascale/B-7299-2009; gros-balthazard, muriel/L-7907-2019; Alcover, Josep Antoni/Y-3796-2018	gros-balthazard, muriel/0000-0002-2587-3946; Rando, Juan Carlos/0000-0001-7397-869X; Alcover, Josep Antoni/0000-0001-9905-2588	Foundation ARC; F.R.S.-FNRS; Spanish program [N CGL2007-62047/BTE]; Direccion General de Investigacion (MEC); Cabildo Insular de Fuerteventura; French National Center for Scientific Research; University Lyon 1 and ENS de LYON	Foundation ARC; F.R.S.-FNRS(Fonds de la Recherche Scientifique - FNRS); Spanish program; Direccion General de Investigacion (MEC)(Spanish Government); Cabildo Insular de Fuerteventura; French National Center for Scientific Research(Centre National de la Recherche Scientifique (CNRS)); University Lyon 1 and ENS de LYON	MP held financial support from the Foundation ARC and is currently funded by a F.R.S.-FNRS fellowship (Belgian Fund for Scientific Research). The present study is part of the Spanish program N CGL2007-62047/BTE. The work benefited from the financial support of the Direccion General de Investigacion (MEC), Cabildo Insular de Fuerteventura, French National Center for Scientific Research, University Lyon 1 and ENS de LYON. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar Jean-Pierre, 1996, Acta Zoologica Cracoviensia, V39, P35; Alcover JA, 2009, PALAEOGEOGR PALAEOCL, V277, P184, DOI 10.1016/j.palaeo.2009.03.016; Atoche P, 1995, EVIDENCIAS ARQUEOLOG; Battistuzzi FU, 2010, MOL BIOL EVOL, V27, P1289, DOI 10.1093/molbev/msq014; Bocherens H, 2006, CR PALEVOL, V5, P885, DOI 10.1016/j.crpv.2006.04.001; BONHOMME F, 1986, CURR TOP MICROBIOL, V127, P19; Bonhomme Francois, 1992, Techniques in the Behavioral and Neural Sciences, V8, P41; BOYE P, 1992, Z SAUGETIERKD, V57, P29; Calvignac S, 2008, MOL ECOL, V17, P1962, DOI 10.1111/j.1365-294X.2008.03631.x; Calvignac S, 2008, MOL BIOL EVOL, V25, P1093, DOI 10.1093/molbev/msn054; Carracedo JC, 1998, GEOL MAG, V135, P591, DOI 10.1017/S0016756898001447; Chaimanee Y, 1998, THAI STUDIES BIODIVE, P303; Chevret P, 2005, BIOL J LINN SOC, V84, P417, DOI 10.1111/j.1095-8312.2005.00444.x; Chevret P, 2003, ZOOL J LINN SOC-LOND, V137, P385, DOI 10.1046/j.1096-3642.2003.00050.x; Cooper Alan, 1994, P149; DAMUTH J, 1993, NATURE, V365, P748, DOI 10.1038/365748a0; den Tex RJ, 2010, GENETICA, V138, P979, DOI 10.1007/s10709-010-9481-9; Diepenbroek M, PANMAP; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dubey S, 2009, MOL PHYLOGENET EVOL, V50, P633, DOI 10.1016/j.ympev.2008.12.008; Firmat C, 2011, NATURWISSENSCHAFTEN, V98, P33, DOI 10.1007/s00114-010-0738-z; Fulton TL, 2006, MOL PHYLOGENET EVOL, V41, P165, DOI 10.1016/j.ympev.2006.05.025; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Geraads D, 1998, GEOBIOS-LYON, V31, P229, DOI 10.1016/S0016-6995(98)80040-5; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Gilbert MTP, 2003, AM J HUM GENET, V72, P48, DOI 10.1086/345379; Goldman N, 2000, SYST BIOL, V49, P652, DOI 10.1080/106351500750049752; Gonzalez-Ittig R, 2007, GENOME BIOL, V51, P73; HANNI C, 1995, NUCLEIC ACIDS RES, V23, P881, DOI 10.1093/nar/23.5.881; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Hughes S, 2006, MOL PHYLOGENET EVOL, V40, P285, DOI 10.1016/j.ympev.2006.02.004; Hutterer R., 1988, Palaeovertebrata (Montpellier), V18, P241; Jacobs L.L., 1985, Acta Zoologica Fennica, P149; Jacobs LL, 1978, FOSSIL RODENTS RHIZO, P104; Jacobs LL, 2005, INTERPRETING ESSAYS, P63; Jansa SA, 2006, SYST BIOL, V55, P73, DOI 10.1080/10635150500431254; Johns GC, 1998, MOL BIOL EVOL, V15, P1481, DOI 10.1093/oxfordjournals.molbev.a025875; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kuss S. E., 1968, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V132, P55; Lecompte E, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-199; Lopez-Martinez N., 1998, Journal of Mammalian Evolution, V5, P185, DOI 10.1023/A:1020508428859; LOPEZMARTINEZ N, 1987, DONANA ACTA VERTEBRA, V2, P1; MAYHEW DF, 1977, P K NED AKAD B PHYS, V80, P182; Michaux J, 2007, J ZOOL SYST EVOL RES, V45, P263, DOI 10.1111/j.1439-0469.2006.00390.x; Michaux J, 2001, MOL BIOL EVOL, V18, P2017, DOI 10.1093/oxfordjournals.molbev.a003743; MICHAUX J, 1991, CR ACAD SCI II, V312, P801; Michaux Jacques, 1997, Geobios Memoire Special (Villeurbanne), V20, P379; Michaux JR, 2002, MOL PHYLOGENET EVOL, V23, P123, DOI 10.1016/S1055-7903(02)00007-6; Millien V, 2004, EVOLUTION, V58, P1353; Misonne X, 1969, ANN MUS ROYAL AFR CT, P219; Montgelard Claudine, 1992, Historical Biology, V6, P293; Musser GG, 2005, MAMMAL SPECIES WORLD, P1; NAVARRO JF, 1990, INVESTIGACIONES ARQU, V2, P189; NEWTON MA, 1994, J R STAT SOC B, V56, P3; Nowak R.M., 1999, WALKERS MAMMALS WORL, P680; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Orlando L, 2003, MOL PHYLOGENET EVOL, V28, P485, DOI 10.1016/S1055-7903(03)00023-X; Pages M, 2009, CONSERV GENET, V10, P217, DOI 10.1007/s10592-008-9549-6; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A, TRACER V1 4; Ramirez O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0016072; Rando JC, 2008, IBIS, V150, P188; Rando JC, 2008, QUATERNARY RES, V70, P141, DOI 10.1016/j.yqres.2008.04.012; Renaud S, 2004, ZOOL J LINN SOC-LOND, V142, P555, DOI 10.1111/j.1096-3642.2004.00140.x; Robins JH, 2008, MOL PHYLOGENET EVOL; Rohland N, 2007, NAT PROTOC, V2, P1756, DOI 10.1038/nprot.2007.247; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rowe KC, 2008, MOL PHYLOGENET EVOL, V47, P84, DOI 10.1016/j.ympev.2008.01.001; Rutschmann F., 2005, BAYESIAN MOL DATING; Sato JJ, 2004, CAN J ZOOL, V82, P1343, DOI 10.1139/Z04-112; Shimada T, 2007, ZOOTAXA, P45; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steppan SJ, 2004, SYST BIOL, V53, P533, DOI 10.1080/10635150490468701; Suzuki H, 2004, MOL PHYLOGENET EVOL, V33, P626, DOI 10.1016/j.ympev.2004.08.003; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Winkler A.J., 2010, CENOZOIC MAMMALS AFR, P263; Winkler AJ, 2002, J HUM EVOL, V42, P237, DOI 10.1006/jhev.2001.0501; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yoder AD, 2004, MOL ECOL, V13, P757, DOI 10.1046/j.1365-294X.2004.02106.x	84	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31123	10.1371/journal.pone.0031123	http://dx.doi.org/10.1371/journal.pone.0031123			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363563	Green Published, gold			2022-12-27	WOS:000302873700028
J	Sarovich, DS; Price, EP; Von Schulze, AT; Cook, JM; Mayo, M; Watson, LM; Richardson, L; Seymour, ML; Tuanyok, A; Engelthaler, DM; Pearson, T; Peacock, SJ; Currie, BJ; Keim, P; Wagner, DM				Sarovich, Derek S.; Price, Erin P.; Von Schulze, Alex T.; Cook, James M.; Mayo, Mark; Watson, Lindsey M.; Richardson, Leisha; Seymour, Meagan L.; Tuanyok, Apichai; Engelthaler, David M.; Pearson, Talima; Peacock, Sharon J.; Currie, Bart J.; Keim, Paul; Wagner, David M.			Characterization of Ceftazidime Resistance Mechanisms in Clinical Isolates of Burkholderia pseudomallei from Australia	PLOS ONE			English	Article							PSEUDOMONAS-PSEUDOMALLEI; RECURRENT MELIOIDOSIS; BETA-LACTAMASE; SUSCEPTIBILITY; AMPLIFICATION; EXPRESSION; REGIONS; RELAPSE	Burkholderia pseudomallei is a Gram-negative bacterium that causes the serious human disease, melioidosis. There is no vaccine against melioidosis and it can be fatal if not treated with a specific antibiotic regimen, which typically includes the third-generation cephalosporin, ceftazidime (CAZ). There have been several resistance mechanisms described for B. pseudomallei, of which the best described are amino acid changes that alter substrate specificity in the highly conserved class A beta-lactamase, PenA. In the current study, we sequenced penA from isolates sequentially derived from two melioidosis patients with wild-type (1.5 mu g/mL) and, subsequently, resistant (16 or >= 256 mu g/mL) CAZ phenotypes. We identified two single-nucleotide polymorphisms (SNPs) that directly increased CAZ hydrolysis. One SNP caused an amino acid substitution (C69Y) near the active site of PenA, whereas a second novel SNP was found within the penA promoter region. In both instances, the CAZ resistance phenotype corresponded directly with the SNP genotype. Interestingly, these SNPs appeared after infection and under selection from CAZ chemotherapy. Through heterologous cloning and expression, and subsequent allelic exchange in the native bacterium, we confirmed the role of penA in generating both low-level and high-level CAZ resistance in these clinical isolates. Similar to previous studies, the amino acid substitution altered substrate specificity to other beta-lactams, suggesting a potential fitness cost associated with this mutation, a finding that could be exploited to improve therapeutic outcomes in patients harboring CAZ resistant B. pseudomallei. Our study is the first to functionally characterize CAZ resistance in clinical isolates of B. pseudomallei and to provide proven and clinically relevant signatures for monitoring the development of antibiotic resistance in this important pathogen.	[Sarovich, Derek S.; Price, Erin P.; Von Schulze, Alex T.; Cook, James M.; Watson, Lindsey M.; Seymour, Meagan L.; Tuanyok, Apichai; Pearson, Talima; Keim, Paul; Wagner, David M.] No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA; [Mayo, Mark; Richardson, Leisha; Currie, Bart J.] Menzies Sch Hlth Res, Darwin, NT, Australia; [Engelthaler, David M.] Translat Genom Res Inst, Flagstaff, AZ USA; [Peacock, Sharon J.] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand; [Peacock, Sharon J.] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England	Northern Arizona University; Charles Darwin University; Menzies School of Health Research; Translational Genomics Research Institute; Mahidol University; University of Cambridge	Sarovich, DS (corresponding author), No Arizona Univ, Ctr Microbial Genet & Genom, Flagstaff, AZ 86011 USA.	Dave.Wagner@nau.edu	Peacock, Sharon J/ABE-6331-2020; Pearson, Talima/O-7840-2019; Pacific-Southwest, RCE/B-6155-2009; Price, Erin/N-2336-2013; Sarovich, Derek/H-5587-2019	Pearson, Talima/0000-0003-3696-041X; Price, Erin/0000-0002-1079-4882; Sarovich, Derek/0000-0002-6944-3980; Wagner, David/0000-0003-2684-6007; Von Schulze, Alex/0000-0001-5688-590X; Peacock, Sharon/0000-0002-1718-2782	Pacific-Southwest Regional Center of Excellence [AI065359]; NIH-NIAID [AI075568]; Australian National Health and Medical Research Council [383504, 605820]; NIHR Cambridge Biomedical Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065359, U01AI075568] Funding Source: NIH RePORTER	Pacific-Southwest Regional Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NIHR Cambridge Biomedical Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Pacific-Southwest Regional Center of Excellence (AI065359), NIH-NIAID (AI075568) and the Australian National Health and Medical Research Council (383504, 605820). Sharon Peacock received support from the NIHR Cambridge Biomedical Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; Bachmann HS, 2003, PHARMACOGENETICS, V13, P759, DOI 10.1097/00008571-200312000-00006; Burtnick MN, 1999, ANTIMICROB AGENTS CH, V43, P2648, DOI 10.1128/AAC.43.11.2648; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Cheng AC, 2010, CURR OPIN INFECT DIS, V23, P554, DOI 10.1097/QCO.0b013e32833fb88c; Currie BJ, 2000, T ROY SOC TROP MED H, V94, P301, DOI 10.1016/S0035-9203(00)90333-X; DANCE DAB, 1989, J ANTIMICROB CHEMOTH, V24, P295, DOI 10.1093/jac/24.3.295; DELAMBALLERIE X, 1992, RES MICROBIOL, V143, P785, DOI 10.1016/0923-2508(92)90107-Y; DESMARCHELIER PM, 1993, J CLIN MICROBIOL, V31, P1592, DOI 10.1128/JCM.31.6.1592-1596.1993; Gabor EM, 2004, ENVIRON MICROBIOL, V6, P879, DOI 10.1111/j.1462-2920.2004.00640.x; Germer S, 1999, GENOME RES, V9, P72; GODFREY AJ, 1991, ANTIMICROB AGENTS CH, V35, P1635, DOI 10.1128/AAC.35.8.1635; Godoy D, 2003, J CLIN MICROBIOL, V41, P2068, DOI 10.1128/JCM.41.5.2068-2079.2003; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Hamad MA, 2009, GENE, V430, P123, DOI 10.1016/j.gene.2008.10.011; Hezard N, 1997, THROMB RES, V88, P59, DOI 10.1016/S0049-3848(97)00191-6; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Jenney AWJ, 2001, INT J ANTIMICROB AG, V17, P109, DOI 10.1016/S0924-8579(00)00334-4; Limmathurotsakul D, 2009, AM J TROP MED HYG, V81, P335, DOI 10.4269/ajtmh.2009.81.335; LIVERMORE DM, 1987, J ANTIMICROB CHEMOTH, V20, P313, DOI 10.1093/jac/20.3.313; Maharjan B, 2005, J CLIN MICROBIOL, V43, P6032, DOI 10.1128/JCM.43.12.6032-6034.2005; Moore RA, 1999, ANTIMICROB AGENTS CH, V43, P465, DOI 10.1128/AAC.43.3.465; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; OCALLAGHAN CH, 1980, ANTIMICROB AGENTS CH, V17, P876, DOI 10.1128/AAC.17.5.876; Phillpott R, 1991, COMMUNICABLE DIS INT, V15, P270; Price EP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000725; Rholl DA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00139; Sam IC, 2009, J CLIN MICROBIOL, V47, P1556, DOI 10.1128/JCM.01657-08; Schweizer Herbert P, 2003, Genet Mol Res, V2, P48; Toohey M, 1994, LAB INVESTIGATIONS A, P1; Tribuddharat C, 2003, ANTIMICROB AGENTS CH, V47, P2082, DOI 10.1128/AAC.47.7.2082-2087.2003; Tuanyok A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-566; U'Ren JM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-23; Viktorov Dimitry V, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS103, DOI 10.1016/S0035-9203(08)70025-7	34	56	57	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e30789	10.1371/journal.pone.0030789	http://dx.doi.org/10.1371/journal.pone.0030789			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363490	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700012
J	Serva, M				Serva, Maurizio			The Settlement of Madagascar: What Dialects and Languages Can Tell Us	PLOS ONE			English	Article							SUPPORT; TREE	The dialects of Madagascar belong to the Greater Barito East group of the Austronesian family and it is widely accepted that the Island was colonized by Indonesian sailors after a maritime trek that probably took place around 650 CE. The language most closely related to Malagasy dialects is Maanyan, but Malay is also strongly related especially for navigation terms. Since the Maanyan Dayaks live along the Barito river in Kalimantan (Borneo) and they do not possess the necessary skill for long maritime navigation, they were probably brought as subordinates by Malay sailors. In a recent paper we compared 23 different Malagasy dialects in order to determine the time and the landing area of the first colonization. In this research we use new data and new methods to confirm that the landing took place on the south-east coast of the Island. Furthermore, we are able to state here that colonization probably consisted of a single founding event rather than multiple settlements. To reach our goal we find out the internal kinship relations among all the 23 Malagasy dialects and we also find out the relations of the 23 dialects to Malay and Maanyan. The method used is an automated version of the lexicostatistic approach. The data from Madagascar were collected by the author at the beginning of 2010 and consist of Swadesh lists of 200 items for 23 dialects covering all areas of the Island. The lists for Maanyan and Malay were obtained from a published dataset integrated with the author's interviews.	Univ Aquila, Dipartimento Matemat, I-67100 Laquila, Italy	University of L'Aquila	Serva, M (corresponding author), Univ Aquila, Dipartimento Matemat, I-67100 Laquila, Italy.	serva@univaq.it	Serva, Maurizio/AAU-8091-2021	serva, maurizio/0000-0002-8117-1834	University of L'Aquila	University of L'Aquila	This study was supported by University of L'Aquila. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelaar A, 1995, AUSTRONESIANS HIST, P49; Adelaar A, 2009, LOANWORDS IN THE WORLD'S LANGUAGES, P717, DOI 10.1515/9783110218442.717; Blench R. M., 2009, 11 INT C AUSTR LING; D'Urville D, 1832, B SOC GEOGRAPHIE, V17, P1; Dahl O. C, 1951, MALGACHE MAANJAN COM; Gray RD, 2000, NATURE, V405, P1052, DOI 10.1038/35016575; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; Greenhill Simon, AUSTRONESIAN BASIC V; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Petroni F, 2001, COMPUTER SPEECH LANG, V25, P679; Petroni F, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/08/P08012; Serva M, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/68005; Serva M, 2011, MALAGASY RELATED LAN; Serva M, 2012, J R SOC INTERFACE, V9, P54, DOI 10.1098/rsif.2011.0228; Swadesh M., 1952, P AM PHILOS SOC, V96, P452, DOI DOI 10.2307/3143802; Verin P, 1969, OCEAN LINGUIST, V8, P26	16	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e30666	10.1371/journal.pone.0030666	http://dx.doi.org/10.1371/journal.pone.0030666			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	926ZM	22363465	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700010
J	Westholm, JO; Tronnersjo, S; Nordberg, N; Olsson, I; Komorowski, J; Ronne, H				Westholm, Jakub Orzechowski; Tronnersjo, Susanna; Nordberg, Niklas; Olsson, Ida; Komorowski, Jan; Ronne, Hans			Gis1 and Rph1 Regulate Glycerol and Acetate Metabolism in Glucose Depleted Yeast Cells	PLOS ONE			English	Article							CHRONOLOGICAL LIFE-SPAN; DOMAIN-CONTAINING PROTEINS; GENE-EXPRESSION DATA; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTORS; JMJC-DOMAIN; CALORIC RESTRICTION; SIGNALING PATHWAYS; STATIONARY-PHASE; BUDDING YEAST	Aging in organisms as diverse as yeast, nematodes, and mammals is delayed by caloric restriction, an effect mediated by the nutrient sensing TOR, RAS/cAMP, and AKT/Sch9 pathways. The transcription factor Gis1 functions downstream of these pathways in extending the lifespan of nutrient restricted yeast cells, but the mechanisms involved are still poorly understood. We have used gene expression microarrays to study the targets of Gis1 and the related protein Rph1 in different growth phases. Our results show that Gis1 and Rph1 act both as repressors and activators, on overlapping sets of genes as well as on distinct targets. Interestingly, both the activities and the target specificities of Gis1 and Rph1 depend on the growth phase. Thus, both proteins are associated with repression during exponential growth, targeting genes with STRE or PDS motifs in their promoters. After the diauxic shift, both become involved in activation, with Gis1 acting primarily on genes with PDS motifs, and Rph1 on genes with STRE motifs. Significantly, Gis1 and Rph1 control a number of genes involved in acetate and glycerol formation, metabolites that have been implicated in aging. Furthermore, several genes involved in acetyl CoA metabolism are downregulated by Gis1.	[Westholm, Jakub Orzechowski; Tronnersjo, Susanna; Nordberg, Niklas] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Westholm, Jakub Orzechowski; Komorowski, Jan] Uppsala Univ, Linnaeus Ctr Bioinformat, Uppsala, Sweden; [Tronnersjo, Susanna] Swedish Univ Agr Sci, Dept Plant Biol & Forest Genet, Uppsala, Sweden; [Nordberg, Niklas; Olsson, Ida; Ronne, Hans] Swedish Univ Agr Sci, Dept Microbiol, S-75007 Uppsala, Sweden; [Komorowski, Jan] Univ Warsaw, Interdisciplinary Ctr Math & Computat Modelling, Warsaw, Poland; [Komorowski, Jan] Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Uppsala, Sweden	Uppsala University; Uppsala University; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; University of Warsaw; Interdisciplinary Centre for Mathematical & Computational Modelling; Uppsala University	Westholm, JO (corresponding author), Sloan Kettering Inst, Dept Dev Biol, New York, NY USA.	Hans.Ronne@slu.se	Komorowski, Jan/A-9175-2010; Komorowski, Jan/AAP-1685-2020; Komorowski, Jan/M-2667-2013	Komorowski, Jan/0000-0002-0766-8789; Komorowski, Jan/0000-0002-0766-8789; Ronne, Hans/0000-0002-1645-6091; Westholm, Jakub/0000-0002-6849-6220	Swedish Research Council VR [621-2007-5079, 521-2011-3157]; Swedish Cancer Society; Swedish Foundation for Strategic Research; Agrifungen program; Knut and Alice Wallenberg Foundation	Swedish Research Council VR(Swedish Research Council); Swedish Cancer Society(Swedish Cancer Society); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Agrifungen program; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by grants from the Swedish Research Council VR (621-2007-5079, 521-2011-3157), the Swedish Cancer Society, the Swedish Foundation for Strategic Research, and the Agrifungen program to HR and by a grant from the Knut and Alice Wallenberg Foundation to JK and HR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen C, 2006, J CELL BIOL, V174, P89, DOI 10.1083/jcb.200604072; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Balciunas D, 1999, MOL GEN GENET, V262, P589; Balciunas D, 2000, TRENDS BIOCHEM SCI, V25, P274, DOI 10.1016/S0968-0004(00)01593-0; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boer VM, 2003, J BIOL CHEM, V278, P3265, DOI 10.1074/jbc.M209759200; Boorsma A, 2005, NUCLEIC ACIDS RES, V33, pW592, DOI 10.1093/nar/gki484; Burhans WC, 2009, CELL CYCLE, V8, P2300, DOI 10.4161/cc.8.14.8852; Burtner CR, 2009, CELL CYCLE, V8, P1256, DOI 10.4161/cc.8.8.8287; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Cameroni E, 2004, CELL CYCLE, V3, P462; Chang Y, 2010, BIOCHEM J, V433, P295; Cheng C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-219; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; DEQUARDCHABLAT M, 1991, J BIOL CHEM, V266, P15300; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dwight SS, 2002, NUCLEIC ACIDS RES, V30, P69, DOI 10.1093/nar/30.1.69; ESTRUCH F, 1993, MOL CELL BIOL, V13, P3872, DOI 10.1128/MCB.13.7.3872; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Fabrizio P, 2003, GENETICS, V163, P35; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Falcon AA, 2010, MOL CELL BIOCHEM, V333, P99, DOI 10.1007/s11010-009-0209-z; Fang J, 2007, MOL CELL BIOL, V27, P5055, DOI 10.1128/MCB.00127-07; Feser J, 2010, MOL CELL, V39, P724, DOI 10.1016/j.molcel.2010.08.015; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Jang YK, 1999, MOL CELL BIOL, V19, P7630; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein M, 2010, NATURE, V464, P513, DOI 10.1038/nature08981; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kim T, 2007, J BIOL CHEM, V282, P20827, DOI 10.1074/jbc.M703034200; Klose RJ, 2007, MOL CELL BIOL, V27, P3951, DOI 10.1128/MCB.02180-06; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; KOCH C, 1993, SCIENCE, V261, P1551, DOI 10.1126/science.8372350; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Liu X, 2001, Pac Symp Biocomput, P127; LUNDIN M, 1994, MOL CELL BIOL, V14, P1979, DOI 10.1128/MCB.14.3.1979; Ma J, 2005, TRENDS GENET, V21, P54, DOI 10.1016/j.tig.2004.11.004; Mai B, 2000, MOL CELL BIOL, V20, P478, DOI 10.1128/MCB.20.2.478-487.2000; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261; Mesquita A, 2010, P NATL ACAD SCI USA, V107, P15123, DOI 10.1073/pnas.1004432107; Navarro-Avino JP, 1999, YEAST, V15, P829, DOI 10.1002/(SICI)1097-0061(199907)15:10A<829::AID-YEA423>3.0.CO;2-9; Nguyen DH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100054; Norbeck J, 1997, J BIOL CHEM, V272, P5544, DOI 10.1074/jbc.272.9.5544; Orzechowski J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-484; Oshiro J, 2003, J BIOL CHEM, V278, P31495, DOI 10.1074/jbc.M305452200; Parkinson H, 2005, NUCLEIC ACIDS RES, V33, pD553; Pedruzzi I, 2000, EMBO J, V19, P2569, DOI 10.1093/emboj/19.11.2569; Pedruzzi I, 2003, MOL CELL, V12, P1607, DOI 10.1016/S1097-2765(03)00485-4; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Reinders A, 1998, GENE DEV, V12, P2943, DOI 10.1101/gad.12.18.2943; Roosen J, 2005, MOL MICROBIOL, V55, P862, DOI 10.1111/j.1365-2958.2004.04429.x; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schmitt AP, 1996, P NATL ACAD SCI USA, V93, P5777, DOI 10.1073/pnas.93.12.5777; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Steffen KK, 2008, CELL, V133, P292, DOI 10.1016/j.cell.2008.02.037; Swinnen E, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-3; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; Treger JM, 1998, J BIOL CHEM, V273, P26875, DOI 10.1074/jbc.273.41.26875; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tu SJ, 2007, J BIOL CHEM, V282, P14262, DOI 10.1074/jbc.M609900200; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; Wei M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040013; Wei M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000467; Weinberger M, 2010, AGING-US, V2, P709, DOI 10.18632/aging.100215; White WH, 2003, GENETICS, V163, P69; Wu ZJ, 2004, NAT BIOTECHNOL, V22, P656, DOI 10.1038/nbt0604-656b; Yu Y, 2010, FEMS YEAST RES, V10, P793, DOI 10.1111/j.1567-1364.2010.00680.x; Zhang NS, 2010, J BIOL CHEM, V285, P6465, DOI 10.1074/jbc.M109.073288; Zhang NS, 2009, MICROBIOL-SGM, V155, P1690, DOI 10.1099/mic.0.026377-0; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	83	25	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31577	10.1371/journal.pone.0031577	http://dx.doi.org/10.1371/journal.pone.0031577			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363679	gold, Green Published, Green Submitted			2022-12-27	WOS:000302873700076
J	Zheng, SZ; Qian, P; Li, FX; Qian, GS; Wang, CZ; Wu, GM; Li, Q; Chen, Y; Li, J; Li, HN; He, BF; Ji, FY				Zheng, Shizhen; Qian, Pin; Li, Fuxiang; Qian, Guisheng; Wang, Changzheng; Wu, Guoming; Li, Qi; Chen, Yan; Li, Jin; Li, Haining; He, Binfeng; Ji, Fuyun			Association of Mitochondrial DNA Variations with Lung Cancer Risk in a Han Chinese Population from Southwestern China	PLOS ONE			English	Article							MTDNA VARIATION; TOBACCO-SMOKE; REPAIR; DAMAGE; SEQUENCE; POLYMORPHISM; HAPLOGROUPS; DELETIONS; REPLICATION; INVOLVEMENT	Mitochondrial DNA (mtDNA) is particularly susceptible to oxidative damage and mutation due to the high rate of reactive oxygen species (ROS) production and limited DNA-repair capacity in mitochondrial. Previous studies demonstrated that the increased mtDNA copy number for compensation for damage, which was associated with cigarette smoking, has been found to be associated with lung cancer risk among heavy smokers. Given that the common and "non-pathological'' mtDNA variations determine differences in oxidative phosphorylation performance and ROS production, an important determinant of lung cancer risk, we hypothesize that the mtDNA variations may play roles in lung cancer risk. To test this hypothesis, we conducted a case-control study to compare the frequencies of mtDNA haplogroups and an 822 bp mtDNA deletion between 422 lung cancer patients and 504 controls. Multivariate logistic regression analysis revealed that haplogroups D and F were related to individual lung cancer resistance (OR = 0.465, 95%CI = 0.329-0.656, p < 0.001; and OR = 0.622, 95%CI = 0.425-0.909, p = 0.014, respectively), while haplogroups G and M7 might be risk factors for lung cancer (OR = 3.924, 95%CI = 1.757-6.689, p < 0.001; and OR = 2.037, 95%CI = 1.253-3.312, p = 0.004, respectively). Additionally, multivariate logistic regression analysis revealed that cigarette smoking was a risk factor for the 822 bp mtDNA deletion. Furthermore, the increased frequencies of the mtDNA deletion in male cigarette smoking subjects of combined cases and controls with haplogroup D indicated that the haplogroup D might be susceptible to DNA damage from external ROS caused by heavy cigarette smoking.	[Zheng, Shizhen; Li, Fuxiang; Qian, Guisheng; Wang, Changzheng; Wu, Guoming; Li, Qi; Chen, Yan; Li, Jin; Li, Haining; He, Binfeng; Ji, Fuyun] Third Mil Med Univ, Inst Human Resp Dis, Xinqiao Hosp, Chongqing, Peoples R China; [Qian, Pin] Third Mil Med Univ, Ultrasonog Dept, Xinqiao Hosp, Chongqing, Peoples R China	Army Medical University; Army Medical University	Zheng, SZ (corresponding author), Third Mil Med Univ, Inst Human Resp Dis, Xinqiao Hosp, Chongqing, Peoples R China.	jifuyun@263.net	He, Binfeng/AAM-9190-2021	He, Binfeng/0000-0002-7243-1972	National Natural Science Foundation of China [30772456, 81170044]; Natural Science Foundation of Third Military Medical University [2007XG57, 2010XLC29]; Natural Science Foundation of Chongqing [2009BA5055]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Third Military Medical University; Natural Science Foundation of Chongqing(Natural Science Foundation of Chongqing)	This research was funded by grants from the National Natural Science Foundation of China (Nos. 30772456, 81170044), grants from the Natural Science Foundation of Third Military Medical University (Nos. 2007XG57, 2010XLC29), as well as grants from the Natural Science Foundation of Chongqing (No. 2009BA5055) awarded to Fuyun Ji. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Asami S, 1996, CANCER RES, V56, P2546; Ballinger SW, 1996, CANCER RES, V56, P5692; Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132; Cai XY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006423; Cakir Y, 2007, FREE RADICAL BIO MED, V43, P1279, DOI 10.1016/j.freeradbiomed.2007.07.015; Chen ZW, 2011, MUTAGENESIS, V26, P437, DOI 10.1093/mutage/ger002; CHURCH DF, 1985, ENVIRON HEALTH PERSP, V64, P111, DOI 10.2307/3430003; Cote ML, 2009, AM J EPIDEMIOL, V169, P802, DOI 10.1093/aje/kwn417; Croteau DL, 1997, J BIOL CHEM, V272, P25409, DOI 10.1074/jbc.272.41.25409; De Ruyck K, 2007, MUTAT RES-GEN TOX EN, V631, P101, DOI 10.1016/j.mrgentox.2007.03.010; Derbeneva OA, 2002, AM J HUM GENET, V71, P415, DOI 10.1086/341720; Derbeneva OA, 2002, AM J HUM GENET, V70, P1009, DOI 10.1086/339524; Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820; Gackowski D, 2003, CANCER RES, V63, P4899; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Horiguchi M, 2001, CANCER RES, V61, P3913; Hosgood HD, 2010, CARCINOGENESIS, V31, P847, DOI 10.1093/carcin/bgq045; Ji YL, 2008, AM J HUM GENET, V83, P760, DOI 10.1016/j.ajhg.2008.11.002; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kiyohara Chikako, 2004, Rev Environ Health, V19, P15; Krishnan KJ, 2008, NAT GENET, V40, P275, DOI 10.1038/ng.f.94; Lee HC, 2005, ANN NY ACAD SCI, V1042, P109, DOI 10.1196/annals.1338.011; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Li FX, 2011, MITOCHONDRION, V11, P553, DOI 10.1016/j.mito.2011.02.003; Marcuello A, 2009, MITOCHONDRION, V9, P326, DOI 10.1016/j.mito.2009.04.007; Marcuello A, 2009, MITOCHONDRION, V9, P27, DOI 10.1016/j.mito.2008.10.002; Martinez-Redondo D, 2010, MITOCHONDRION, V10, P102, DOI 10.1016/j.mito.2009.11.005; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; MORROW JD, 1995, NEW ENGL J MED, V332, P1198, DOI 10.1056/NEJM199505043321804; PRYOR WA, 1993, ANN NY ACAD SCI, V686, P12, DOI 10.1111/j.1749-6632.1993.tb39148.x; Rafnar T, 2011, CANCER RES, V71, P1356, DOI 10.1158/0008-5472.CAN-10-2852; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003; SARGENTINI NJ, 1992, MUTAT RES, V265, P83, DOI 10.1016/0027-5107(92)90041-Y; Schabath MB, 2002, LUNG CANCER-J IASLC, V37, P35, DOI 10.1016/S0169-5002(02)00034-X; SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952; Starikovskaya EB, 2005, ANN HUM GENET, V69, P67, DOI 10.1046/j.1529-8817.2003.00127.x; Takagi K, 2004, ATHEROSCLEROSIS, V175, P281, DOI 10.1016/j.atherosclerosis.2004.03.008; Tanaka M, 1998, LANCET, V351, P185, DOI 10.1016/S0140-6736(05)78211-8; THACKER J, 1992, NUCLEIC ACIDS RES, V20, P6183, DOI 10.1093/nar/20.23.6183; TORRONI A, 1994, AM J HUM GENET, V55, P760; Vallyathan Val, 1997, Environmental Health Perspectives, V105, P165, DOI 10.2307/3433405; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; WALLACE DC, 1987, CURR GENET, V12, P81, DOI 10.1007/BF00434661; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wallace DC, 2010, MITOCHONDRION, V10, P12, DOI 10.1016/j.mito.2009.09.006; Wang YD, 2010, EUR J CANCER, V46, P758, DOI 10.1016/j.ejca.2009.12.010; Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Yao YG, 2004, MOL BIOL EVOL, V21, P2265, DOI 10.1093/molbev/msh238; Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392; Yu M, 2009, EUR J CANC PREV 0715; Zhi XY, 2009, ONCOLOGY PROGR, V7, P379; Zhi XY, 2009, CHINESE PRESCRIPTION, V83, P56	57	33	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31322	10.1371/journal.pone.0031322	http://dx.doi.org/10.1371/journal.pone.0031322			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363619	gold, Green Published, Green Submitted			2022-12-27	WOS:000302873700048
J	Cabral, A; Suescun, O; Zigman, JM; Perello, M				Cabral, Agustina; Suescun, Olga; Zigman, Jeffrey M.; Perello, Mario			Ghrelin Indirectly Activates Hypophysiotropic CRF Neurons in Rodents	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; GLUCOCORTICOID NEGATIVE FEEDBACK; DIET-INDUCED OBESITY; BLOOD-BRAIN-BARRIER; NPY MESSENGER-RNA; CHRONIC STRESS; PLASMA GHRELIN; NEUROPEPTIDE-Y; ARCUATE NUCLEUS	Ghrelin is a stomach-derived hormone that regulates food intake and neuroendocrine function by acting on its receptor, GHSR ((G) under bar rowth (H) under bar ormone (S) under bar ecretagogue (R) under bar eceptor). Recent evidence indicates that a key function of ghrelin is to signal stress to the brain. It has been suggested that one of the potential stress-related ghrelin targets is the CRF (Corticotropin-Releasing Factor)-producing neurons of the hypothalamic paraventricular nucleus, which secrete the CRF neuropeptide into the median eminence and activate the hypothalamic-pituitary-adrenal axis. However, the neural circuits that mediate the ghrelin-induced activation of this neuroendocrine axis are mostly uncharacterized. In the current study, we characterized in vivo the mechanism by which ghrelin activates the hypophysiotropic CRF neurons in mice. We found that peripheral or intra-cerebro-ventricular administration of ghrelin strongly activates c-fos - a marker of cellular activation - in CRF-producing neurons. Also, ghrelin activates CRF gene expression in the paraventricular nucleus of the hypothalamus and the hypothalamic-pituitary-adrenal axis at peripheral level. Ghrelin administration directly into the paraventricular nucleus of the hypothalamus also induces c-fos within the CRF-producing neurons and the hypothalamic-pituitary-adrenal axis, without any significant effect on the food intake. Interestingly, dual-label immunohistochemical analysis and ghrelin binding studies failed to show GHSR expression in CRF neurons. Thus, we conclude that ghrelin activates hypophysiotropic CRF neurons, albeit indirectly.	[Cabral, Agustina; Perello, Mario] Argentine Res Council CONICET, Neurophysiol Lab, Multidisciplinary Inst Cell Biol, La Plata, Buenos Aires, Argentina; [Cabral, Agustina; Suescun, Olga; Perello, Mario] Prov Buenos Aires CIC PBA, Sci Res Commiss, La Plata, Buenos Aires, Argentina; [Zigman, Jeffrey M.] Univ Texas SW Med Ctr Dallas, Div Hypothalam Res, Dept Med, Dallas, TX 75390 USA; [Zigman, Jeffrey M.] Univ Texas SW Med Ctr Dallas, Div Endocrinol & Metab, Dept Med, Dallas, TX 75390 USA; [Zigman, Jeffrey M.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Suescun, Olga] Argentine Res Council CONICET, Lab Reprod Endocrinol, Multidisciplinary Inst Cell Biol, La Plata, Buenos Aires, Argentina	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Cabral, A (corresponding author), Argentine Res Council CONICET, Neurophysiol Lab, Multidisciplinary Inst Cell Biol, La Plata, Buenos Aires, Argentina.	marioperello@yahoo.com		Zigman, Jeffrey/0000-0003-3477-1295; Perello, Mario/0000-0003-2114-6765	Florencio Fiorini Foundation; National Institutes of Health (NIH) [R01DA024680, K08DK068069, R01MH085298]; International Brain Research Organization;  [PICT2010-1954]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK068069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085298] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024680] Funding Source: NIH RePORTER	Florencio Fiorini Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Brain Research Organization; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by Florencio Fiorini Foundation, International Brain Research Organization and PICT2010-1954 grants to MP and by R01DA024680, K08DK068069 and R01MH085298 National Institutes of Health (NIH) grants to JMZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Ariyasu H, 2001, J CLIN ENDOCR METAB, V86, P4753, DOI 10.1210/jc.86.10.4753; Asakawa A, 2001, NEUROENDOCRINOLOGY, V74, P143, DOI 10.1159/000054680; Banks WA, 2002, J PHARMACOL EXP THER, V302, P822, DOI 10.1124/jpet.102.034827; Banks WA, 2008, PEPTIDES, V29, P2061, DOI 10.1016/j.peptides.2008.07.001; Broglio F, 2001, J CLIN ENDOCR METAB, V86, P5083, DOI 10.1210/jc.86.10.5083; CASTRO MG, 1990, J MOL ENDOCRINOL, V5, P221, DOI 10.1677/jme.0.0050221; Chuang J.C., 2010, INT J PEPT; Chuang JC, 2011, J CLIN INVEST, V121, P2684, DOI 10.1172/JCI57660; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Cummings DE, 2006, PHYSIOL BEHAV, V89, P71, DOI 10.1016/j.physbeh.2006.05.022; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Currie PJ, 2005, AM J PHYSIOL-REG I, V289, pR353, DOI 10.1152/ajpregu.00756.2004; Dallman MF, 2006, PROG BRAIN RES, V153, P75, DOI 10.1016/S0079-6123(06)53004-3; Dallman MF, 2010, TRENDS ENDOCRIN MET, V21, P159, DOI 10.1016/j.tem.2009.10.004; Dimitrov EL, 2007, ENDOCRINOLOGY, V148, P3666, DOI 10.1210/en.2006-1730; Goldstein J, 2007, J MOL NEUROSCI, V31, P69, DOI 10.1007/BF02686119; Hoffman GE, 2002, J NEUROENDOCRINOL, V14, P259, DOI 10.1046/j.1365-2826.2002.00775.x; Johnstone LE, 2005, STRESS, V8, P59, DOI 10.1080/10253890500095283; Kadar A, 2010, J COMP NEUROL, V518, P3948, DOI 10.1002/cne.22432; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kovacs KJ, 1996, J NEUROSCI, V16, P262; Kristenssson E, 2006, REGUL PEPTIDES, V134, P114, DOI 10.1016/j.regpep.2006.02.003; Li C, 2000, BRAIN RES, V854, P122, DOI 10.1016/S0006-8993(99)02324-0; Locatelli V, 2010, ENDOCR DEV, V17, P108, DOI 10.1159/000262533; Lutter M, 2008, NAT NEUROSCI, V11, P752, DOI 10.1038/nn.2139; Melis MR, 2002, NEUROSCI LETT, V329, P339, DOI 10.1016/S0304-3940(02)00673-0; Mizoguchi K, 2001, PSYCHONEUROENDOCRINO, V26, P443, DOI 10.1016/S0306-4530(01)00004-X; Mizoguchi K, 2003, NEUROSCIENCE, V119, P887, DOI 10.1016/S0306-4522(03)00105-2; Mozid AM, 2003, HORM METAB RES, V35, P455; Myers MG, 2009, CELL METAB, V9, P117, DOI 10.1016/j.cmet.2008.12.001; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Ochi M, 2008, LIFE SCI, V82, P862, DOI 10.1016/j.lfs.2008.01.020; Olszewski PK, 2003, PEPTIDES, V24, P919, DOI 10.1016/S0196-9781(03)00159-1; Patterson ZR, 2010, EUR J NEUROSCI, V32, P632, DOI 10.1111/j.1460-9568.2010.07310.x; Paxinos G., 2001, MOUSE BRAIN; Perello M., 2011, J COMP NEUROL; Perello M, 2006, ENDOCRINOLOGY, V147, P3296, DOI 10.1210/en.2005-1533; Perello M, 2010, AM J PHYSIOL-ENDOC M, V299, pE976, DOI 10.1152/ajpendo.00448.2010; Perello M, 2010, BIOL PSYCHIAT, V67, P880, DOI 10.1016/j.biopsych.2009.10.030; Rouach V, 2007, PSYCHONEUROENDOCRINO, V32, P693, DOI 10.1016/j.psyneuen.2007.04.010; Sakata I, 2009, REGUL PEPTIDES, V155, P91, DOI 10.1016/j.regpep.2009.04.001; Sarkar S, 2003, ENDOCRINOLOGY, V144, P281, DOI 10.1210/en.2002-220675; Seoane LM, 2003, ENDOCRINOLOGY, V144, P544, DOI 10.1210/en.2002-220795; Sgoifo A, 1999, NEUROSCI BIOBEHAV R, V23, P915, DOI 10.1016/S0149-7634(99)00025-1; Shrestha YB, 2004, NEUROREPORT, V15, P1365, DOI 10.1097/01.wnr.0000127141.62476.d5; Smith Sean M, 2006, Dialogues Clin Neurosci, V8, P383; Stevanovic D, 2007, LIFE SCI, V80, P867, DOI 10.1016/j.lfs.2006.11.018; Takaya K, 2000, J CLIN ENDOCR METAB, V85, P4908, DOI 10.1210/jc.85.12.4908; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Tschop M, 2001, J ENDOCRINOL INVEST, V24, pRC19, DOI 10.1007/BF03351037; Tung YL, 2004, EUR J ENDOCRINOL, V150, P905, DOI 10.1530/eje.0.1500905; Willesen MG, 1999, NEUROENDOCRINOLOGY, V70, P306, DOI 10.1159/000054491; Wren AM, 2000, ENDOCRINOLOGY, V141, P4325, DOI 10.1210/en.141.11.4325; Wren AM, 2002, NEUROENDOCRINOLOGY, V76, P316, DOI 10.1159/000066629; Wren AM, 2001, DIABETES, V50, P2540, DOI 10.2337/diabetes.50.11.2540; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002	58	76	81	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31462	10.1371/journal.pone.0031462	http://dx.doi.org/10.1371/journal.pone.0031462			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363652	Green Published, gold, Green Submitted			2022-12-27	WOS:000302871500045
J	Checker, R; Sandur, SK; Sharma, D; Patwardhan, RS; Jayakumar, S; Kohli, V; Sethi, G; Aggarwal, BB; Sainis, KB				Checker, Rahul; Sandur, Santosh K.; Sharma, Deepak; Patwardhan, Raghavendra S.; Jayakumar, S.; Kohli, Vineet; Sethi, Gautam; Aggarwal, Bharat B.; Sainis, Krishna B.			Potent Anti-Inflammatory Activity of Ursolic Acid, a Triterpenoid Antioxidant, Is Mediated through Suppression of NF-kappa B, AP-1 and NF-AT	PLOS ONE			English	Article							CELL-RECEPTOR STIMULATION; FACTOR-ALPHA GENE; T-CELLS; INHALED CORTICOSTEROIDS; SIGNAL-TRANSDUCTION; OLEANOLIC ACID; CYCLOSPORINE-A; ACTIVATION; RESPONSES; INFLAMMATION	Background: Ursolic acid (UA), a pentacyclic triterpenoid carboxylic acid, is the major component of many plants including apples, basil, cranberries, peppermint, rosemary, oregano and prunes and has been reported to possess antioxidant and anti-tumor properties. These properties of UA have been attributed to its ability to suppress NF-kappa B (nuclear factor kappa B) activation. Since NF-kappa B, in co-ordination with NF-AT (nuclear factor of activated T cells) and AP-1(activator protein-1), is known to regulate inflammatory genes, we hypothesized that UA might exhibit potent anti-inflammatory effects. Methodology/Principal Findings: The anti-inflammatory effects of UA were assessed in activated T cells, B cells and macrophages. Effects of UA on ERK, JNK, NF-kappa B, AP-1 and NF-AT were studied to elucidate its mechanism of action. In vivo efficacy of UA was studied using mouse model of graft-versus-host disease. UA inhibited activation, proliferation and cytokine secretion in T cells, B cells and macrophages. UA inhibited mitogen-induced up-regulation of activation markers and co-stimulatory molecules in T and B cells. It inhibited mitogen-induced phosphorylation of ERK and JNK and suppressed the activation of immunoregulatory transcription factors NF-kappa B, NF-AT and AP-1 in lymphocytes. Treatment of cells with UA prior to allogenic transplantation significantly delayed induction of acute graft-versus-host disease in mice and also significantly reduced the serum levels of pro-inflammatory cytokines IL-6 and IFN-gamma. UA treatment inhibited T cell activation even when added post-mitogenic stimulation demonstrating its therapeutic utility as an anti-inflammatory agent. Conclusions/Significance: The present study describes the detailed mechanism of anti-inflammatory activity of UA. Further, UA may find application in the treatment of inflammatory disorders.	[Checker, Rahul; Sandur, Santosh K.; Sharma, Deepak; Patwardhan, Raghavendra S.; Jayakumar, S.; Sainis, Krishna B.] Bhabha Atom Res Ctr, Radiat Biol & Hlth Sci Div, Biomed Grp, Bombay 400085, Maharashtra, India; [Kohli, Vineet] Bhabha Atom Res Ctr, Div Med, Biomed Grp, Bombay 400085, Maharashtra, India; [Sethi, Gautam] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore; [Aggarwal, Bharat B.] Univ Texas MD Anderson Canc Ctr, Cytokine Res Lab, Dept Expt Therapeut, Houston, TX 77030 USA	Bhabha Atomic Research Center (BARC); Bhabha Atomic Research Center (BARC); National University of Singapore; University of Texas System; UTMD Anderson Cancer Center	Checker, R (corresponding author), Bhabha Atom Res Ctr, Radiat Biol & Hlth Sci Div, Biomed Grp, Bombay 400085, Maharashtra, India.	kbsainis@barc.gov.in	Aggarwal, Bharat B/G-3388-2013; Sethi, Gautam/F-2372-2011	Sethi, Gautam/0000-0002-8677-8475; Checker, Rahul/0000-0001-7704-3613; patwardhan, Raghvendra/0000-0001-6608-8779; Sharma, Deepak/0000-0002-7529-5574	Department of Atomic Energy, Government of India	Department of Atomic Energy, Government of India(Department of Atomic Energy (DAE))	This work was funded by the Department of Atomic Energy, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison AC, 2000, IMMUNOPHARMACOLOGY, V47, P63, DOI 10.1016/S0162-3109(00)00186-7; Barnes PJ, 1998, AM J RESP CRIT CARE, V157, pS1, DOI 10.1164/ajrccm.157.3.157315; Cha HJ, 1996, CANCER RES, V56, P2281; Checker R, 2008, INT IMMUNOPHARMACOL, V8, P661, DOI 10.1016/j.intimp.2008.01.012; Checker R, 2010, J CELL BIOCHEM, V110, P1082, DOI 10.1002/jcb.22620; Checker R, 2009, INT IMMUNOPHARMACOL, V9, P949, DOI 10.1016/j.intimp.2009.03.022; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.biochem.63.1.1045; Curry AJ, 2004, TRANSPLANTATION, V78, P807, DOI 10.1097/01.TP.0000131670.99000.54; Dalgleish AG, 2002, ADV CANCER RES, V84, P231, DOI 10.1016/S0065-230X(02)84008-8; DUMONT FJ, 1992, J EXP MED, V176, P751, DOI 10.1084/jem.176.3.751; Edmead CE, 1996, J IMMUNOL, V157, P3290; Falvo JV, 2000, MOL CELL BIOL, V20, P2239, DOI 10.1128/MCB.20.6.2239-2247.2000; Gautam R, 2009, MED RES REV, V29, P767, DOI 10.1002/med.20156; Hommes DW, 2003, GUT, V52, P144, DOI 10.1136/gut.52.1.144; Ikeda Y, 2008, MOL NUTR FOOD RES, V52, P26, DOI 10.1002/mnfr.200700389; Ishiguro Y, 1999, J GASTROENTEROL, V34, P66, DOI 10.1007/s005350050218; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Khan NM, 2011, FREE RADICAL BIO MED, V51, P115, DOI 10.1016/j.freeradbiomed.2011.03.037; Kunwar A, 2011, RADIAT ENVIRON BIOPH, V50, P271, DOI 10.1007/s00411-011-0352-2; Larbi A, 2007, EXP GERONTOL, V42, P852, DOI 10.1016/j.exger.2007.05.004; Lee YJ, 2010, ARCH PHARM RES, V33, P1539, DOI 10.1007/s12272-010-1006-7; Lewis DB, 2002, CURR OPIN IMMUNOL, V14, P644, DOI 10.1016/S0952-7915(02)00388-6; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; Liu Y, 2011, CLIN EXP IMMUNOL, V164, P282, DOI 10.1111/j.1365-2249.2011.04333.x; Macian F, 2000, EMBO J, V19, P4783, DOI 10.1093/emboj/19.17.4783; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Moreau RA, 2002, PROG LIPID RES, V41, P457, DOI 10.1016/S0163-7827(02)00006-1; MURAILLE E, 1995, CELL IMMUNOL, V162, P315, DOI 10.1006/cimm.1995.1084; NAJID A, 1992, FEBS LETT, V299, P213, DOI 10.1016/0014-5793(92)80117-Y; O'Shea JJ, 2002, NAT REV IMMUNOL, V2, P37, DOI 10.1038/nri702; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Ricci M, 1997, J INVEST ALLERG CLIN, V7, P144; Ringbom T, 1998, J NAT PROD, V61, P1212, DOI 10.1021/np980088i; Roland NJ, 2004, CHEST, V126, P213, DOI 10.1378/chest.126.1.213; ROONEY JW, 1995, MOL CELL BIOL, V15, P6299; ROONEY JW, 1995, IMMUNITY, V2, P473, DOI 10.1016/1074-7613(95)90028-4; Ryu SY, 2000, PLANTA MED, V66, P358, DOI 10.1055/s-2000-8531; Sandur SK, 2007, CARCINOGENESIS, V28, P1765, DOI 10.1093/carcin/bgm123; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Sharma D, 2007, MOL IMMUNOL, V44, P2831, DOI 10.1016/j.molimm.2007.01.021; Shishodia S, 2003, CANCER RES, V63, P4375; Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412; SIGAL NH, 1991, J EXP MED, V173, P619, DOI 10.1084/jem.173.3.619; SIGAL NH, 1992, ANNU REV IMMUNOL, V10, P519, DOI 10.1146/annurev.iy.10.040192.002511; Suh N, 1998, CANCER RES, V58, P717; Tsai EY, 1996, MOL CELL BIOL, V16, P5232; Tsai SJ, 2008, J FOOD SCI, V73, pH174, DOI 10.1111/j.1750-3841.2008.00864.x; Wan FY, 2010, CELL RES, V20, P24, DOI 10.1038/cr.2009.137; Wilankar C, 2011, FREE RADICAL BIO MED, V51, P129, DOI 10.1016/j.freeradbiomed.2011.03.038; Williams MS, 2004, FREE RADICAL BIO MED, V37, P1144, DOI 10.1016/j.freeradbiomed.2004.05.029; Xu T, 2011, J BIOL CHEM, V286, P22707, DOI 10.1074/jbc.C111.250407; Yuan XL, 2003, J IMMUNOL, V170, P2949, DOI 10.4049/jimmunol.170.6.2949	56	173	181	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31318	10.1371/journal.pone.0031318	http://dx.doi.org/10.1371/journal.pone.0031318			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363615	Green Submitted, Green Published, gold			2022-12-27	WOS:000302871500034
J	Jiang, GS; Zheng, LD; Pu, JR; Mei, H; Zhao, J; Huang, K; Zeng, FQ; Tong, QS				Jiang, Guosong; Zheng, Liduan; Pu, Jiarui; Mei, Hong; Zhao, Jun; Huang, Kai; Zeng, Fuqing; Tong, Qiangsong			Small RNAs Targeting Transcription Start Site Induce Heparanase Silencing through Interference with Transcription Initiation in Human Cancer Cells	PLOS ONE			English	Article							POLYMERASE-II; GENE PROMOTER; MAMMALIAN HEPARANASE; CHROMOSOMAL DNA; TUMOR INVASION; EXPRESSION; METASTASIS; CLONING; ANGIOGENESIS; METHYLATION	Heparanase (HPA), an endo-h-D-glucuronidase that cleaves the heparan sulfate chain of heparan sulfate proteoglycans, is overexpressed in majority of human cancers. Recent evidence suggests that small interfering RNA (siRNA) induces transcriptional gene silencing (TGS) in human cells. In this study, transfection of siRNA against -9/+10 bp (siH3), but not -174/-155 bp (siH1) or -134/-115 bp (siH2) region relative to transcription start site (TSS) locating at 101 bp upstream of the translation start site, resulted in TGS of heparanase in human prostate cancer, bladder cancer, and gastric cancer cells in a sequence-specific manner. Methylation-specific PCR and bisulfite sequencing revealed no DNA methylation of CpG islands within heparanase promoter in siH3-transfected cells. The TGS of heparanase did not involve changes of epigenetic markers histone H3 lysine 9 dimethylation (H3K9me2), histone H3 lysine 27 trimethylation (H3K27me3) or active chromatin marker acetylated histone H3 (AcH3). The regulation of alternative splicing was not involved in siH3-mediated TGS. Instead, siH3 interfered with transcription initiation via decreasing the binding of both RNA polymerase II and transcription factor II B (TFIIB), but not the binding of transcription factors Sp1 or early growth response 1, on the heparanase promoter. Moreover, Argonaute 1 and Argonaute 2 facilitated the decreased binding of RNA polymerase II and TFIIB on heparanase promoter, and were necessary in siH3-induced TGS of heparanase. Stable transfection of the short hairpin RNA construct targeting heparanase TSS (-9/+10 bp) into cancer cells, resulted in decreased proliferation, invasion, metastasis and angiogenesis of cancer cells in vitro and in athymic mice models. These results suggest that small RNAs targeting TSS can induce TGS of heparanase via interference with transcription initiation, and significantly suppress the tumor growth, invasion, metastasis and angiogenesis of cancer cells.	[Jiang, Guosong; Pu, Jiarui; Mei, Hong; Zhao, Jun; Zeng, Fuqing; Tong, Qiangsong] Huazhong Univ Sci & Technol, Dept Surg, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China; [Zheng, Liduan] Huazhong Univ Sci & Technol, Dept Pathol, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China; [Zheng, Liduan; Huang, Kai; Tong, Qiangsong] Huazhong Univ Sci & Technol, Human Dis Related Gene Res Grp, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China; [Huang, Kai] Huazhong Univ Sci & Technol, Dept Cardiol, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Jiang, GS (corresponding author), Huazhong Univ Sci & Technol, Dept Surg, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China.	zengfuqingunion@hotmail.com; qs_tong@hotmail.com	Tong, Qiangsong/B-4500-2014	Tong, Qiangsong/0000-0002-2615-6404; Zheng, Liduan/0000-0001-5566-673X	National Natural Science Foundation of China [30200284, 30600278, 30772359, 30972980, 81071997, 81072073]; Program for New Century Excellent Talents in University [NCET-06-0641]; Scientific Research Foundation for the Returned Overseas Chinese Scholars [2008-889]; Fundamental Research Funds for the Central Universities [2010JC025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Scientific Research Foundation for the Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China (No. 30200284, No. 30600278, No. 30772359, No. 30972980, No. 81071997, No. 81072073), Program for New Century Excellent Talents in University (NCET-06-0641), Scientific Research Foundation for the Returned Overseas Chinese Scholars (2008-889), and Fundamental Research Funds for the Central Universities (2010JC025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allo M, 2009, NAT STRUCT MOL BIOL, V16, P717, DOI 10.1038/nsmb.1620; Cangemi R, 2008, ONCOGENE, V27, P2877, DOI 10.1038/sj.onc.1210953; Castanotto D, 2005, MOL THER, V12, P179, DOI 10.1016/j.ymthe.2005.03.003; Chen BS, 2004, MOL CELL BIOL, V24, P3983, DOI 10.1128/MCB.24.9.3983-3991.2004; Chen HT, 2004, CELL, V119, P169, DOI 10.1016/j.cell.2004.09.028; de Mestre AM, 2003, J BIOL CHEM, V278, P50377, DOI 10.1074/jbc.M310154200; Dong J, 2000, GENE, V253, P171, DOI 10.1016/S0378-1119(00)00251-1; Down TA, 2002, GENOME RES, V12, P458, DOI 10.1101/gr.216102; Elkin M, 2001, FASEB J, V15, P1661, DOI 10.1096/fj.00-0895fje; Han J, 2007, P NATL ACAD SCI USA, V104, P12422, DOI 10.1073/pnas.0701635104; Haraguchi T, 2007, FEBS LETT, V581, P4949, DOI 10.1016/j.febslet.2007.09.028; Hawkins PG, 2009, NUCLEIC ACIDS RES, V37, P2984, DOI 10.1093/nar/gkp127; Huang D, 2009, CARDIOVASC RES, V81, P98, DOI 10.1093/cvr/cvn264; Hulett MD, 1999, NAT MED, V5, P803, DOI 10.1038/10525; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Izquierdo M, 2005, CANCER GENE THER, V12, P217, DOI 10.1038/sj.cgt.7700791; Janowski BA, 2005, NAT CHEM BIOL, V1, P216, DOI 10.1038/nchembio725; Janowski BA, 2006, NAT PROTOC, V1, P436, DOI 10.1038/nprot.2006.64; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Jiang P, 2002, J BIOL CHEM, V277, P8989, DOI 10.1074/jbc.M105682200; Kavi HH, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-15; Kim DH, 2007, NAT REV GENET, V8, P173, DOI 10.1038/nrg2006; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Komatsu N, 2008, J IMMUNOL METHODS, V331, P82, DOI 10.1016/j.jim.2007.11.014; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; MATZKE MA, 1989, EMBO J, V8, P643, DOI 10.1002/j.1460-2075.1989.tb03421.x; Murayama A, 2006, EMBO J, V25, P1081, DOI 10.1038/sj.emboj.7601012; NAKAJIMA M, 1984, J BIOL CHEM, V259, P2283; Napoli S, 2009, EMBO J, V28, P1708, DOI 10.1038/emboj.2009.139; Ogishima T, 2005, CLIN CANCER RES, V11, P1028; Ogishima T, 2005, ONCOGENE, V24, P6765, DOI 10.1038/sj.onc.1208811; Pulukuri SMK, 2007, CANCER RES, V67, P6637, DOI 10.1158/0008-5472.CAN-07-0751; Sako A, 2004, CANCER RES, V64, P3624, DOI 10.1158/0008-5472.CAN-04-0304; Schubert S, 2005, J MOL BIOL, V348, P883, DOI 10.1016/j.jmb.2005.03.011; Suzuki K, 2009, CURR TOP MED CHEM, V9, P1079, DOI 10.2174/156802609789630875; Tang WH, 2002, MODERN PATHOL, V15, P593, DOI 10.1038/modpathol.3880571; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; Toyoshima M, 1999, J BIOL CHEM, V274, P24153, DOI 10.1074/jbc.274.34.24153; Turner AMW, 2009, MOL THER, V17, P360, DOI 10.1038/mt.2008.268; Turunen MP, 2009, CIRC RES, V105, P604, DOI 10.1161/CIRCRESAHA.109.200774; Vlodavsky I, 2001, J CLIN INVEST, V108, P341, DOI 10.1172/JCI200113662; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; WANG Z, 2004, MODERN PATHOL, V18, P205, DOI DOI 10.1038/M0DPATHOL.3800282; Weinberg MS, 2006, RNA, V12, P256, DOI 10.1261/rna.2235106; Yamagishi M, 2009, MICROBES INFECT, V11, P500, DOI 10.1016/j.micinf.2009.02.003; Yoda M, 2010, NAT STRUCT MOL BIOL, V17, P17, DOI 10.1038/nsmb.1733; Zhang MX, 2005, P NATL ACAD SCI USA, V102, P16967, DOI 10.1073/pnas.0503853102; Zhang ZH, 2007, CANCER BIOL THER, V6, P587, DOI 10.4161/cbt.6.4.3888; Zheng LD, 2010, PATHOL INT, V60, P268, DOI 10.1111/j.1440-1827.2010.02512.x; Zheng LD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-33	51	48	49	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31379	10.1371/journal.pone.0031379	http://dx.doi.org/10.1371/journal.pone.0031379			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363633	Green Published, gold, Green Submitted			2022-12-27	WOS:000302871500038
J	Lagor, WR; Fields, DW; Khetarpal, SA; Kumaravel, A; Lin, W; Weintraub, N; Wu, KJ; Hamm-Alvarez, SF; Drazul-Schrader, D; de la Llera-Moya, M; Rothblat, GH; Rader, DJ				Lagor, William R.; Fields, David W.; Khetarpal, Sumeet A.; Kumaravel, Arthi; Lin, Wen; Weintraub, Nathaniel; Wu, Kaijin; Hamm-Alvarez, Sarah F.; Drazul-Schrader, Denise; de la Llera-Moya, Margarita; Rothblat, George H.; Rader, Daniel J.			The Effects of Apolipoprotein F Deficiency on High Density Lipoprotein Cholesterol Metabolism in Mice	PLOS ONE			English	Article							TRANSFER INHIBITOR PROTEIN; LIPID TRANSFER-REACTIONS; MOUSE SERUM; HDL SUBPOPULATIONS; MOLECULAR-CLONING; HUMAN-PLASMA; DOMAINS; CETP; PARTICIPATION; TRIGLYCERIDE	Apolipoprotein F (apoF) is 29 kilodalton secreted sialoglycoprotein that resides on the HDL and LDL fractions of human plasma. Human ApoF is also known as Lipid Transfer Inhibitor protein (LTIP) based on its ability to inhibit cholesteryl ester transfer protein (CETP)-mediated transfer events between lipoproteins. In contrast to other apolipoproteins, ApoF is predicted to lack strong amphipathic alpha helices and its true physiological function remains unknown. We previously showed that overexpression of Apolipoprotein F in mice reduced HDL cholesterol levels by 20-25% by accelerating clearance from the circulation. In order to investigate the effect of physiological levels of ApoF expression on HDL cholesterol metabolism, we generated ApoF deficient mice. Unexpectedly, deletion of ApoF had no substantial impact on plasma lipid concentrations, HDL size, lipid or protein composition. Sex-specific differences were observed in hepatic cholesterol content as well as serum cholesterol efflux capacity. Female ApoF KO mice had increased liver cholesteryl ester content relative to wild type controls on a chow diet (KO: 3.4+/20.9 mg/dl vs. WT: 1.2+/20.3 mg/dl, p, 0.05). No differences were observed in ABCG1-mediated cholesterol efflux capacity in either sex. Interestingly, ApoB-depleted serum from male KO mice was less effective at promoting ABCA1-mediated cholesterol efflux from J774 macrophages relative to WT controls.	[Lagor, William R.; Fields, David W.; Khetarpal, Sumeet A.; Kumaravel, Arthi; Lin, Wen; Weintraub, Nathaniel; Rader, Daniel J.] Univ Penn, Div Translat Med & Human Genet, Inst Translat Med & Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA; [Wu, Kaijin; Hamm-Alvarez, Sarah F.] Univ So Calif, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA USA; [Drazul-Schrader, Denise; de la Llera-Moya, Margarita; Rothblat, George H.] Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Southern California; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Lagor, WR (corresponding author), Univ Penn, Div Translat Med & Human Genet, Inst Translat Med & Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA.	wlagor@mail.med.upenn.edu		Lin, Wen/0000-0003-1257-9841; Lagor, William/0000-0002-1703-5125; Hamm-Alvarez, Sarah/0000-0001-8195-5703	National Heart Blood and Lung Institute of the National Institutes of Health [P01 HL022633-32]; American Heart Association [09POST2060594]; National Center of the American Heart Association [11SDG7210077]; NIH [U01HG004085]; CSD Consortium [U01HG004080]; Children's Hospital Oakland Research Institute (CHORI) [U42RR024244]; Wellcome Trust Sanger Institute (WTSI); University of California at Davis School of Veterinary Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR024244] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL022633] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004080, U01HG004085] Funding Source: NIH RePORTER	National Heart Blood and Lung Institute of the National Institutes of Health; American Heart Association(American Heart Association); National Center of the American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CSD Consortium; Children's Hospital Oakland Research Institute (CHORI); Wellcome Trust Sanger Institute (WTSI); University of California at Davis School of Veterinary Medicine(University of California System); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was made possible by a Program Project Grant from the National Heart Blood and Lung Institute of the National Institutes of Health (P01 HL022633-32). WRL was supported by a Postdoctoral Fellowship from the Great Rivers Affiliate of the American Heart Association (09POST2060594), as well as a Scientist Development Grant from the National Center of the American Heart Association (11SDG7210077). The authors would like to acknowledge the Gene Therapy Resource Program (GTRP) of the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH) for providing the gene vectors used in this study. NIH grants to Velocigene at Regeneron Inc. (U01HG004085) and the CSD Consortium (U01HG004080, comprised of teams at Children's Hospital Oakland Research Institute (CHORI), the Wellcome Trust Sanger Institute (WTSI), and the University of California at Davis School of Veterinary Medicine) funded the generation of gene-targeted ES cells for 8500 genes in the Knockout Mouse Project (KOMP) Program archived and distributed by the KOMP Repository at UC Davis and Children's Hospital Oakland Research Institute (CHORI) (U42RR024244). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorni MP, 2007, J LIPID RES, V48, P2453, DOI 10.1194/jlr.M700274-JLR200; Asztalos BF, 2005, J LIPID RES, V46, P2246, DOI 10.1194/jlr.M500187-JLR200; Bashtovyy D, 2011, J LIPID RES, V52, P435, DOI 10.1194/jlr.R012658; Boone LR, 2011, ATHEROSCLEROSIS; Brown RJ, 2009, J LIPID RES, V50, P1910, DOI 10.1194/jlr.P900020-JLR200; CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X; COHN JS, 1988, J LIPID RES, V29, P925; Contois JH, 1996, CLIN CHEM, V42, P507; Davidson WS, 2009, ARTERIOSCL THROM VAS, V29, P870, DOI 10.1161/ATVBAHA.109.186031; Davidsson P, 2010, ARTERIOSCL THROM VAS, V30, P156, DOI 10.1161/ATVBAHA.108.179317; DAY JR, 1994, BIOCHEM BIOPH RES CO, V203, P1146, DOI 10.1006/bbrc.1994.2302; GERDES LU, 1992, CLIN CHIM ACTA, V205, P1, DOI 10.1016/0009-8981(92)90348-T; Gordon SM, 2011, TRENDS ENDOCRIN MET, V22, P9, DOI 10.1016/j.tem.2010.10.001; Green PS, 2008, CIRCULATION, V118, P1259, DOI 10.1161/CIRCULATIONAHA.108.770669; Guyard-Dangremont V, 1998, COMP BIOCHEM PHYS B, V120, P517, DOI 10.1016/S0305-0491(98)10038-X; He Y, 2008, J LIPID RES, V49, P1529, DOI 10.1194/jlr.M800087-JLR200; Hogarth CA, 2003, COMP BIOCHEM PHYS B, V135, P219, DOI 10.1016/S1096-4959(03)00046-0; Hoofnagle AF, 2009, J LIPID RES; Izem L, 2009, J LIPID RES, V50, P676, DOI 10.1194/jlr.M800429-JLR200; Jiang XC, 1999, J CLIN INVEST, V103, P907, DOI 10.1172/JCI5578; JONES MK, 1992, J LIPID RES, V33, P287; KANE JP, 1979, P NATL ACAD SCI USA, V76, P5957, DOI 10.1073/pnas.76.11.5957; KOREN E, 1982, BIOCHEMISTRY-US, V21, P5347, DOI 10.1021/bi00264a035; Korstanje R, 2004, ARTERIOSCL THROM VAS, V24, P155, DOI 10.1161/01.ATV.0000104241.44819.10; Lagor WR, 2009, ARTERIOSCL THROM VAS, V29, P40, DOI 10.1161/ATVBAHA.108.177105; Lagor WR, 2005, J BIOL CHEM, V280, P36601, DOI 10.1074/jbc.M504346200; LEONG JC, 1977, P NATL ACAD SCI USA, V74, P276, DOI 10.1073/pnas.74.1.276; Leong JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-279; Massey JB, 2009, J LIPID RES, V50, P1229, DOI 10.1194/jlr.D800044-JLR200; Miao B, 2004, J LIPID RES, V45, P1410, DOI 10.1194/jlr.M300450-JLR200; MONTELARO RC, 1979, VIROLOGY, V98, P20, DOI 10.1016/0042-6822(79)90521-X; MORTON RE, 1994, J LIPID RES, V35, P836; MORTON RE, 1993, ARTERIOSCLER THROMB, V13, P1843, DOI 10.1161/01.ATV.13.12.1843; Morton RE, 2003, J LIPID RES, V44, P2287, DOI 10.1194/jlr.M300171-JLR200; Morton RE, 2008, J LIPID RES, V49, P127, DOI 10.1194/jlr.M700258-JLR200; NISHIDE T, 1989, J LIPID RES, V30, P149; OLOFSSON SO, 1978, BIOCHEMISTRY-US, V17, P1032, DOI 10.1021/bi00599a014; Paromov VM, 2003, J BIOL CHEM, V278, P40859, DOI 10.1074/jbc.M306580200; SEGREST JP, 1992, J LIPID RES, V33, P141; Serdyuk AP, 1999, ARTERIOSCL THROM VAS, V19, P718, DOI 10.1161/01.ATV.19.3.718; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tu AY, 2001, BIOCHEM BIOPH RES CO, V287, P921, DOI 10.1006/bbrc.2001.5687; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; Vaughan AM, 2005, J BIOL CHEM, V280, P30150, DOI 10.1074/jbc.M505368200; Wang XX, 1999, J BIOL CHEM, V274, P1814, DOI 10.1074/jbc.274.3.1814; Wu KJ, 2009, EXP EYE RES, V89, P319, DOI 10.1016/j.exer.2009.03.020; Wu TY, 2002, J VIROL, V76, P2279, DOI 10.1128/JVI.76.5.2279-2286.2002	47	22	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31616	10.1371/journal.pone.0031616	http://dx.doi.org/10.1371/journal.pone.0031616			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363685	gold, Green Published, Green Submitted			2022-12-27	WOS:000302871500062
J	Patten, SA; Jacobs-McDaniels, NL; Zaouter, C; Drapeau, P; Albertson, RC; Moldovan, F				Patten, Shunmoogum A.; Jacobs-McDaniels, Nicole L.; Zaouter, Charlotte; Drapeau, Pierre; Albertson, R. Craig; Moldovan, Florina			Role of Chd7 in Zebrafish: A Model for CHARGE Syndrome	PLOS ONE			English	Article							CRANIAL NERVE ABNORMALITIES; NEURAL CREST; PHENOTYPIC SPECTRUM; RETINAL LAMINATION; N-CADHERIN; INNER-EAR; GENE; EXPRESSION; MUTATIONS; ASSOCIATION	CHARGE syndrome is caused by mutations in the CHD7 gene. Several organ systems including the retina, cranial nerves, inner ear and heart are affected in CHARGE syndrome. However, the mechanistic link between mutations in CHD7 and many of the organ systems dysfunction remains elusive. Here, we show that Chd7 is required for the organization of the neural retina in zebrafish. We observe an abnormal expression or a complete absence of molecular markers for the retinal ganglion cells and photoreceptors, indicating that Chd7 regulates the differentiation of retinal cells and plays an essential role in retinal cell development. In addition, zebrafish with reduced Chd7 display an abnormal organization and clustering of cranial motor neurons. We also note a pronounced reduction in the facial branchiomotor neurons and the vagal motor neurons display aberrant positioning. Further, these fish exhibit a severe loss of the facial nerves. Knock-down of Chd7 results in a curvature of the long body axis and these fish develop irregular shaped vertebrae and have a reduction in bone mineralization. Chd7 knockdown also results in a loss of proper segment polarity illustrated by flawed efnb2a and ttna expression, which is associated with later vascular segmentation defects. These critical roles for Chd7 in retinal and vertebral development were previously unrecognized and our results provide new insights into the role of Chd7 during development and in CHARGE syndrome pathogenesis.	[Patten, Shunmoogum A.; Zaouter, Charlotte; Moldovan, Florina] Hop St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Patten, Shunmoogum A.; Moldovan, Florina] Univ Montreal, Fac Dent, Montreal, PQ, Canada; [Jacobs-McDaniels, Nicole L.; Albertson, R. Craig] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA; [Drapeau, Pierre] Univ Montreal, Fac Med, Dept Pathol & Cell Biol, Montreal, PQ H3C 3J7, Canada; [Albertson, R. Craig] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA	Universite de Montreal; Universite de Montreal; Syracuse University; Universite de Montreal; University of Massachusetts System; University of Massachusetts Amherst	Patten, SA (corresponding author), Hop St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada.	florina.moldovan@umontreal.ca			Yves Cotrel Foundation; CHU Sainte-Justine and Foundation of the Stars scholarship	Yves Cotrel Foundation; CHU Sainte-Justine and Foundation of the Stars scholarship	Dr. Moldovan was supported by Yves Cotrel Foundation and Dr. Patten was supported by CHU Sainte-Justine and Foundation of the Stars scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2000, EUR J PEDIATR, V159, P569, DOI 10.1007/s004319900409; Akisu M, 1998, TURKISH J PEDIATR, V40, P283; Albertson RC, 2005, DEV BIOL, V283, P310, DOI 10.1016/j.ydbio.2005.04.025; Allen MD, 2007, J MOL BIOL, V371, P1135, DOI 10.1016/j.jmb.2007.06.007; Alvarez Y, 2003, DEVELOPMENT, V130, P6329, DOI 10.1242/dev.00881; Amiel J, 2001, AM J MED GENET, V99, P124, DOI 10.1002/1096-8628(20010301)99:2<124::AID-AJMG1114>3.0.CO;2-9; Aramaki M, 2006, J PEDIATR-US, V148, P410, DOI 10.1016/j.jpeds.2005.10.044; Aramaki M, 2007, BIRTH DEFECTS RES A, V79, P50, DOI 10.1002/bdra.20330; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Barrios A, 2003, CURR BIOL, V13, P1571, DOI 10.1016/j.cub.2003.08.030; BENBECHER S, 1994, ARCH PEDIATRIE, V1, P1115; Blake KD, 1998, CLIN PEDIATR, V37, P159, DOI 10.1177/000992289803700302; Blake KD, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-34; Bosman EA, 2005, HUM MOL GENET, V14, P3463, DOI 10.1093/hmg/ddi375; BYERLY KA, 1993, AM J MED GENET, V45, P751, DOI 10.1002/ajmg.1320450617; Carey JC, 2005, AM J MED GENET A, V133A, P227, DOI 10.1002/ajmg.a.30540; Chang W, 2004, DEVELOPMENT, V131, P4201, DOI 10.1242/dev.01292; Childs S, 2002, DEVELOPMENT, V129, P973; Christiansen HE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008481; Devriendt K, 1998, CLIN GENET, V53, P408; Du SJ, 2001, DEV BIOL, V238, P239, DOI 10.1006/dbio.2001.0390; Erdmann B, 2003, DEV DYNAM, V226, P570, DOI 10.1002/dvdy.10266; Gao XC, 2007, AM J HUM GENET, V80, P957, DOI 10.1086/513571; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Grenier J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004381; Hammond KL, 2006, DEVELOPMENT, V133, P1347, DOI 10.1242/dev.02306; Huang X, 2004, DEV BIOL, V275, P1, DOI 10.1016/j.ydbio.2004.07.033; Hurd EA, 2010, DEVELOPMENT, V137, P3139, DOI 10.1242/dev.047894; Jacobs NL, 2011, JOVE-J VIS EXP, DOI 10.3791/2533; Jacobs-McDaniels NL, 2011, DEV DYNAM, V240, P2272, DOI 10.1002/dvdy.22722; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; Jongmans MCJ, 2006, J MED GENET, V43, P306, DOI 10.1136/jmg.2005.036061; Jyonouchi S, 2009, PEDIATRICS, V123, pE871, DOI 10.1542/peds.2008-3400; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knight RD, 2006, ADV EXP MED BIOL, V589, P120; Koizumi K, 2001, DEVELOPMENT, V128, P1391; LACOMBE D, 1994, AM J MED GENET, V49, P351, DOI 10.1002/ajmg.1320490324; Lalani SR, 2006, AM J HUM GENET, V78, P303, DOI 10.1086/500273; Lalani SR, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-8; LARISON KD, 1990, DEVELOPMENT, V109, P567; Layman WS, 2009, HUM MOL GENET, V18, P1909, DOI 10.1093/hmg/ddp112; Link BA, 2000, DEVELOPMENT, V127, P2177; Lwigale PY, 2009, DEV BIOL, V336, P257, DOI 10.1016/j.ydbio.2009.10.008; Marfella CGA, 2007, MUTAT RES-FUND MOL M, V618, P30, DOI 10.1016/j.mrfmmm.2006.07.012; Masai I, 2003, DEVELOPMENT, V130, P2479, DOI 10.1242/dev.00465; Melicharek D, 2008, GENETICS, V180, P2095, DOI 10.1534/genetics.108.093302; Melicharek DJ, 2010, HUM MOL GENET, V19, P4253, DOI 10.1093/hmg/ddq348; MORGAN D, 1993, ARCH OTOLARYNGOL, V119, P49; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Oates AC, 2005, DEV BIOL, V280, P133, DOI 10.1016/j.ydbio.2005.01.010; Sanlaville D, 2006, J MED GENET, V43, P211, DOI 10.1136/jmg.2005.036160; Satar B, 2003, OTOL NEUROTOL, V24, P437, DOI 10.1097/00129492-200305000-00014; Schimmang T, 2007, INT J DEV BIOL, V51, P473, DOI 10.1387/ijdb.072334ts; Schmitt EA, 1999, J COMP NEUROL, V404, P515; Schnetz MP, 2009, GENOME RES, V19, P590, DOI 10.1101/gr.086983.108; Shaw KM, 2006, DEV DYNAM, V235, P1753, DOI 10.1002/dvdy.20814; Smith A, 2006, DEV BIOL, V299, P438, DOI 10.1016/j.ydbio.2006.08.016; Souriau J, 2005, AM J MED GENET A, V133A, P278, DOI 10.1002/ajmg.a.30549; Srinivasan S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000217; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Takahashi Y, 2000, NAT GENET, V25, P390, DOI 10.1038/78062; Tellier AL, 1998, AM J MED GENET, V76, P402, DOI 10.1002/(SICI)1096-8628(19980413)76:5<402::AID-AJMG7>3.0.CO;2-O; THOMAS IT, 1987, ANN CLIN LAB SCI, V17, P207; Uemura O, 2005, DEV BIOL, V278, P587, DOI 10.1016/j.ydbio.2004.11.031; VanMeter TD, 1996, CLIN DYSMORPHOL, V5, P187; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Vuorela P, 2007, GENET MED, V9, P690, DOI 10.1097/GIM.0b013e318156e68e; Wessels K, 2010, EUR J MED GENET, V53, P280, DOI 10.1016/j.ejmg.2010.07.002; Wincent J, 2009, EUR J MED GENET, V52, P271, DOI 10.1016/j.ejmg.2009.02.005; Yokoi H, 2009, DEV BIOL, V329, P1, DOI 10.1016/j.ydbio.2009.01.002	70	46	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31650	10.1371/journal.pone.0031650	http://dx.doi.org/10.1371/journal.pone.0031650			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363697	Green Published, gold, Green Submitted			2022-12-27	WOS:000302871500070
J	Schneider, RR; Hauer, G; Dawe, K; Adamowicz, W; Boutin, S				Schneider, Richard R.; Hauer, Grant; Dawe, Kimberly; Adamowicz, Wiktor; Boutin, Stan			Selection of Reserves for Woodland Caribou Using an Optimization Approach	PLOS ONE			English	Article							WHITE-TAILED DEER; RANGIFER-TARANDUS; MAXIMIZING RETURN; CONSERVATION; ALBERTA; CANADA; PRECIPITATION; TEMPERATURE; POPULATIONS; DISTURBANCE	Habitat protection has been identified as an important strategy for the conservation of woodland caribou (Rangifer tarandus). However, because of the economic opportunity costs associated with protection it is unlikely that all caribou ranges can be protected in their entirety. We used an optimization approach to identify reserve designs for caribou in Alberta, Canada, across a range of potential protection targets. Our designs minimized costs as well as three demographic risk factors: current industrial footprint, presence of white-tailed deer (Odocoileus virginianus), and climate change. We found that, using optimization, 60% of current caribou range can be protected (including 17% in existing parks) while maintaining access to over 98% of the value of resources on public lands. The trade-off between minimizing cost and minimizing demographic risk factors was minimal because the spatial distributions of cost and risk were similar. The prospects for protection are much reduced if protection is directed towards the herds that are most at risk of near-term extirpation.	[Schneider, Richard R.; Dawe, Kimberly; Boutin, Stan] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Hauer, Grant; Adamowicz, Wiktor] Univ Alberta, Dept Resource Econ & Environm Sociol, Edmonton, AB, Canada	University of Alberta; University of Alberta	Schneider, RR (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	ministik99@telus.net	Boutin, Stan A/A-2619-2014	Boutin, Stan A/0000-0001-6317-038X; Adamowicz, Wiktor/0000-0002-7634-2985	Natural Sciences and Engineering Research Council of Canada - Alberta Chamber of Resources Chair in Integrated Landscape Management at the University of Alberta; Alberta-Pacific Forest Industries; Social Science and Humanities Research Council of Canada; Forest Resource Improvement Association of Alberta	Natural Sciences and Engineering Research Council of Canada - Alberta Chamber of Resources Chair in Integrated Landscape Management at the University of Alberta; Alberta-Pacific Forest Industries; Social Science and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Forest Resource Improvement Association of Alberta	Funding for this project was provided by the Natural Sciences and Engineering Research Council of Canada - Alberta Chamber of Resources Chair in Integrated Landscape Management at the University of Alberta, Alberta-Pacific Forest Industries, Social Science and Humanities Research Council of Canada, and the Forest Resource Improvement Association of Alberta. The funders had no input regarding study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberta Department of Energy, 2007, PREL FISC EV ALB OIL; Alberta Department of Energy, 2007, OS1 ALB DEP EN; Alberta Department of Energy, 2007, OG2 ALB DEP EN; Alberta Woodland Caribou Recovery Team, 2005, ALB WOODL CAR REC PL; Bottrill MC, 2008, TRENDS ECOL EVOL, V23, P649, DOI 10.1016/j.tree.2008.07.007; Bowen D, 2002, GEOGR REV, V92, P503, DOI 10.2307/4140932; Charest KS, 2005, THESIS U ALBERTA EDM; Courtois R, 2007, ECOSCIENCE, V14, P491, DOI 10.2980/1195-6860(2007)14[491:EOFDOD]2.0.CO;2; Daily GC, 2009, FRONT ECOL ENVIRON, V7, P21, DOI 10.1890/080025; Dawe K, 2011, THESIS U ALBERTA EDM; DelGiudice GD, 2002, J WILDLIFE MANAGE, V66, P698, DOI 10.2307/3803136; Dyer SJ, 2001, J WILDLIFE MANAGE, V65, P531, DOI 10.2307/3803106; Energy Alberta, 2007, EUB SER PUBL; Environment Canada, 2011, REC STRAT WOODL CAR; Festa-Bianchet M, 2011, CAN J ZOOL, V89, P419, DOI [10.1139/z11-025, 10.1139/Z11-025]; Game ET, 2008, MARXAN USER MANUAL M; GLJ Petroleum Consultants, 2009, CRUD OIL NAT GAS LIQ; GLJ Petroleum Consultants, 2009, NAT GAS SULPH PRIC F; Government of Alberta, 2009, TERMS REF DEV LOW AT; Hauer G., 2010, 1001 U ALB; Hauer G, 2010, ECOL MODEL, V221, P2590, DOI 10.1016/j.ecolmodel.2010.07.013; HUNTER ML, 1988, CONSERV BIOL, V2, P375, DOI 10.1111/j.1523-1739.1988.tb00202.x; Hutchinson MF, 2009, J APPL METEOROL CLIM, V48, P725, DOI 10.1175/2008JAMC1979.1; James ARC, 2004, J WILDLIFE MANAGE, V68, P799, DOI 10.2193/0022-541X(2004)068[0799:SSOCFM]2.0.CO;2; Joseph LN, 2009, CONSERV BIOL, V23, P328, DOI 10.1111/j.1523-1739.2008.01124.x; Latham ADM, 2011, J WILDLIFE MANAGE, V75, P204, DOI 10.1002/jwmg.28; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McDevitt AD, 2009, MOL ECOL, V18, P665, DOI 10.1111/j.1365-294X.2008.04050.x; McDonald-Madden E, 2008, CONSERV BIOL, V22, P656, DOI 10.1111/j.1523-1739.2008.00918.x; MOEN AN, 1976, ECOLOGY, V57, P192, DOI 10.2307/1936411; Murdoch W, 2007, BIOL CONSERV, V139, P375, DOI 10.1016/j.biocon.2007.07.011; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Natural Regions Committee, 2006, NAT REG SUBR ALB; Perhans K, 2008, CONSERV BIOL, V22, P1331, DOI 10.1111/j.1523-1739.2008.00976.x; *PETR SERV ASS CAN, 2008, WELL COST STUD; Sanchez-Azofeifa GA, 2004, ALBERTA GROUND COVER; Schaefer JA, 2003, CONSERV BIOL, V17, P1435, DOI 10.1046/j.1523-1739.2003.02288.x; Schneider RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023254; Schneider RR, 2010, BIOL CONSERV, V143, P1603, DOI 10.1016/j.biocon.2010.04.002; Schneider RR, 2009, CAN J FOREST RES, V39, P1001, DOI 10.1139/X09-033; Sigurdson CJ, 2008, VET RES, V39, DOI 10.1051/vetres:2008018; Sorensen T, 2008, J WILDLIFE MANAGE, V72, P900, DOI 10.2193/2007-079; Underwood EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001515; Vors LS, 2007, J WILDLIFE MANAGE, V71, P1249, DOI 10.2193/2006-263; Wilson HB, 2011, ECOL LETT, V14, P886, DOI 10.1111/j.1461-0248.2011.01652.x; Zhang XB, 2000, ATMOS OCEAN, V38, P395, DOI 10.1080/07055900.2000.9649654	46	13	13	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31672	10.1371/journal.pone.0031672	http://dx.doi.org/10.1371/journal.pone.0031672			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363702	Green Published, Green Submitted, gold			2022-12-27	WOS:000302871500073
J	Babigumira, JB; Stergachis, A; Veenstra, DL; Gardner, JS; Ngonzi, J; Mukasa-Kivunike, P; Garrison, LP				Babigumira, Joseph B.; Stergachis, Andy; Veenstra, David L.; Gardner, Jacqueline S.; Ngonzi, Joseph; Mukasa-Kivunike, Peter; Garrison, Louis P.			Potential Cost-Effectiveness of Universal Access to Modern Contraceptives in Uganda	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; INDUCED-ABORTION; CARE	Background: Over two thirds of women who need contraception in Uganda lack access to modern effective methods. This study was conducted to estimate the potential cost-effectiveness of achieving universal access to modern contraceptives in Uganda by implementing a hypothetical new contraceptive program (NCP) from both societal and governmental (Ministry of Health (MoH)) perspectives. Methodology/Principal Findings: A Markov model was developed to compare the NCP to the status quo or current contraceptive program (CCP). The model followed a hypothetical cohort of 15-year old girls over a lifetime horizon. Data were obtained from the Uganda National Demographic and Health Survey and from published and unpublished sources. Costs, life expectancy, disability-adjusted life expectancy, pregnancies, fertility and incremental cost-effectiveness measured as cost per life-year (LY) gained, cost per disability-adjusted life-year (DALY) averted, cost per pregnancy averted and cost per unit of fertility reduction were calculated. Univariate and probabilistic sensitivity analyses were performed to examine the robustness of results. Mean discounted life expectancy and disability-adjusted life expectancy (DALE) were higher under the NCP vs. CCP (28.74 vs. 28.65 years and 27.38 vs. 27.01 respectively). Mean pregnancies and live births per woman were lower under the NCP (9.51 vs. 7.90 and 6.92 vs. 5.79 respectively). Mean lifetime societal costs per woman were lower for the NCP from the societal perspective ($1,949 vs. $1,987) and the MoH perspective ($636 vs. $685). In the incremental analysis, the NCP dominated the CCP, i.e. it was both less costly and more effective. The results were robust to univariate and probabilistic sensitivity analysis. Conclusion/Significance: Universal access to modern contraceptives in Uganda appears to be highly cost-effective. Increasing contraceptive coverage should be considered among Uganda's public health priorities.	[Babigumira, Joseph B.; Stergachis, Andy; Garrison, Louis P.] Univ Washington, Sch Publ Hlth, Dept Global Hlth, Global Med Program, Seattle, WA 98195 USA; [Babigumira, Joseph B.; Stergachis, Andy; Veenstra, David L.; Gardner, Jacqueline S.; Garrison, Louis P.] Univ Washington, Sch Pharm, Pharmaceut Outcomes Res & Policy Program, Seattle, WA 98195 USA; [Stergachis, Andy] Univ Washington, Dept Epidemiol, Sch Publ Hlth & Community Pharm, Seattle, WA 98195 USA; [Stergachis, Andy] Univ Washington, Dept Global Hlth, Sch Publ Hlth & Community Pharm, Seattle, WA 98195 USA; [Ngonzi, Joseph] Mbarara Univ Sci & Technol, Dept Obstet & Gynecol, Mbarara, Uganda; [Mukasa-Kivunike, Peter] Engender Hlth Fistula Care Project, Kampala, Uganda	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Mbarara University of Science & Technology	Babigumira, JB (corresponding author), Univ Washington, Sch Publ Hlth, Dept Global Hlth, Global Med Program, Seattle, WA 98195 USA.	babijo@uw.edu	Babigumira, Joseph/T-4208-2019		William and Flora Hewlett Foundation; Institute of International Education	William and Flora Hewlett Foundation; Institute of International Education	This study was funded by the William and Flora Hewlett Foundation and Institute of International Education Dissertation Fellowship in Population, Reproductive Health, and Economic Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, MACR HLTH INV HLTH E; Babigumira JB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-904; Babigumira JB, 2011, J INFECT DIS, V204, pS116, DOI 10.1093/infdis/jir132; Babigumira JB, 2009, PHARMACOECONOMICS, V27, P963, DOI 10.2165/11318230-000000000-00000; Bishai D, 2008, INJURY PREV, V14, P223, DOI 10.1136/ip.2008.018341; Blanc AK, 2009, INT PERSPECT SEX R H, V35, P63, DOI 10.1363/ipsrh.35.063.09; Briggs AH, 2000, PHARMACOECONOMICS, V17, P479, DOI 10.2165/00019053-200017050-00006; Casterline JB, 2000, POPUL DEV REV, V26, P691, DOI 10.1111/j.1728-4457.2000.00691.x; CASTERLINE JB, 1989, STUD FAMILY PLANN, V20, P81, DOI 10.2307/1966462; Fiedler JL, 2010, FOOD NUTR BULL, V31, P193, DOI 10.1177/156482651003100202; Gold MR, 1996, COST EFFECTIVENESS H; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; KENNEDY KI, 1992, LANCET, V339, P227, DOI 10.1016/0140-6736(92)90018-X; Khan SM., 2008, UNMET NEED DEMAND FA; Levin A, 2003, INT J HEALTH PLAN M, V18, P3, DOI 10.1002/hpm.690; LISKIN LS, 1992, INT J GYNECOL OBSTET, V37, P77, DOI 10.1016/0020-7292(92)90486-3; Marseille E, 2009, APPL HEALTH ECON HEA, V7, P229, DOI 10.2165/11318740-000000000-00000; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; Okonofua F, 2006, J OBSTET GYNAECOL CA, V28, P974, DOI 10.1016/S1701-2163(16)32307-6; Sedgh G, 2007, 37 GUTTM I; Singh S, 2005, INT FAM PLAN PERSPEC, V31, P183, DOI 10.1363/3118305; Siskind D, 2008, J MENT HEALTH POLICY, V11, P127; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; Sundaram A., 2010, ISSUES BRIEF; Trussell J, 2009, BEST PRACT RES CL OB, V23, P199, DOI 10.1016/j.bpobgyn.2008.11.008; UBOS, 2007, UG DEM HLTH SURV 200; Vlassoff M, 2009, BENEFITS M CONTRACEP; Weissman E, 1999, SAFE MOTHERHOOD PROG; WHO, WORLD HLTH STAT 2011; World Health Organisation, DEATH DALY EST 2004; World Health Organization, LIF TABL COUNTR UG; [No title captured]	32	20	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30735	10.1371/journal.pone.0030735	http://dx.doi.org/10.1371/journal.pone.0030735			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926TC	22363480	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600063
J	Kocemba, KA; Groen, RWJ; van Andel, H; Kersten, MJ; Mahtouk, K; Spaargaren, M; Pals, ST				Kocemba, Kinga A.; Groen, Richard W. J.; van Andel, Harmen; Kersten, Marie Jose; Mahtouk, Karene; Spaargaren, Marcel; Pals, Steven T.			Transcriptional Silencing of the Wnt-Antagonist DKK1 by Promoter Methylation Is Associated with Enhanced Wnt Signaling in Advanced Multiple Myeloma	PLOS ONE			English	Article							FREQUENT EPIGENETIC INACTIVATION; BONE-MARROW MICROENVIRONMENT; BETA-CATENIN; COLORECTAL-CANCER; CELL-GROWTH; IN-VIVO; PATHWAY; DISEASE; DICKKOPF-1; EXPRESSION	The Wnt/beta-catenin pathway plays a crucial role in the pathogenesis of various human cancers. In multiple myeloma (MM), aberrant auto-and/or paracrine activation of canonical Wnt signaling promotes proliferation and dissemination, while overexpression of the Wnt inhibitor Dickkopf1 (DKK1) by MM cells contributes to osteolytic bone disease by inhibiting osteoblast differentiation. Since DKK1 itself is a target of TCF/beta-catenin mediated transcription, these findings suggest that DKK1 is part of a negative feedback loop in MM and may act as a tumor suppressor. In line with this hypothesis, we show here that DKK1 expression is low or undetectable in a subset of patients with advanced MM as well as in MM cell lines. This absence of DKK1 is correlated with enhanced Wnt pathway activation, evidenced by nuclear accumulation of beta-catenin, which in turn can be antagonized by restoring DKK1 expression. Analysis of the DKK1 promoter revealed CpG island methylation in several MM cell lines as well as in MM cells from patients with advanced MM. Moreover, demethylation of the DKK1 promoter restores DKK1 expression, which results in inhibition of beta-catenin/TCF-mediated gene transcription in MM lines. Taken together, our data identify aberrant methylation of the DKK1 promoter as a cause of DKK1 silencing in advanced stage MM, which may play an important role in the progression of MM by unleashing Wnt signaling.	[Kocemba, Kinga A.; Groen, Richard W. J.; van Andel, Harmen; Mahtouk, Karene; Spaargaren, Marcel; Pals, Steven T.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Kersten, Marie Jose] Univ Amsterdam, Acad Med Ctr, Dept Hematol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Kocemba, KA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands.	s.t.pals@amc.uva.nl	kocemba, kinga/AAE-2305-2019; Spaargaren, Marcel/AAU-1298-2021; Kocemba, Kinga/AAE-6520-2021	kocemba, kinga/0000-0002-7119-2412; Spaargaren, Marcel/0000-0002-3135-5109; Groen, Richard/0000-0002-5010-4604; Pals, Steven/0000-0002-1419-0939	Dutch Cancer Society	Dutch Cancer Society(KWF Kankerbestrijding)	Grant support was provided by the Dutch Cancer Society to M. Spaargaren and S.T. Pals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2004, BLOOD, V104, P2484, DOI 10.1182/blood-2003-11-3839; Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Ashihara E, 2009, CLIN CANCER RES, V15, P2731, DOI 10.1158/1078-0432.CCR-08-1350; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Chamorro MN, 2005, EMBO J, V24, P73, DOI 10.1038/sj.emboj.7600460; Chim CS, 2007, LEUKEMIA, V21, P2527, DOI 10.1038/sj.leu.2404939; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Derksen PWB, 2004, P NATL ACAD SCI USA, V101, P6122, DOI 10.1073/pnas.0305855101; Derksen PWB, 2002, BLOOD, V99, P1405, DOI 10.1182/blood.V99.4.1405; Dosen G, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-13; Dutta-Simmons J, 2009, BLOOD, V114, P2699, DOI 10.1182/blood-2008-12-194290; Edwards CM, 2008, BONE, V42, P1007, DOI 10.1016/j.bone.2008.01.027; Edwards CM, 2008, BLOOD, V111, P2833, DOI 10.1182/blood-2007-03-077685; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Esteller M, 2002, SCIENCE, V297, P1807; Feltus FA, 2003, P NATL ACAD SCI USA, V100, P12253, DOI 10.1073/pnas.2037852100; Fulciniti M, 2009, BLOOD, V114, P371, DOI 10.1182/blood-2008-11-191577; Giuliani N, 2007, CANCER RES, V67, P7665, DOI 10.1158/0008-5472.CAN-06-4666; Groen RWJ, 2008, CANCER RES, V68, P6969, DOI 10.1158/0008-5472.CAN-08-1322; Haaber J, 2008, BRIT J HAEMATOL, V140, P25, DOI 10.1111/j.1365-2141.2007.06871.x; Hall CL, 2005, CANCER RES, V65, P7554, DOI 10.1158/0008-5472.CAN-05-1317; Heath DJ, 2009, J BONE MINER RES, V24, P425, DOI 10.1359/JBMR.081104; Herman JG, 2005, COLD SH Q B, V70, P329, DOI 10.1101/sqb.2005.70.036; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kiziltepe T, 2007, MOL CANCER THER, V6, P1718, DOI 10.1158/1535-7163.MCT-07-0010; KLEIN B, 1989, BLOOD, V73, P517; Klein G, 2005, NATURE, V434, P150, DOI 10.1038/434150a; Le Gouill S, 2004, BLOOD, V104, P2886, DOI 10.1182/blood-2004-05-1760; Lescher B, 1998, DEV DYNAM, V213, P440, DOI 10.1002/(SICI)1097-0177(199812)213:4<440::AID-AJA9>3.0.CO;2-6; Lewis SL, 2008, DEVELOPMENT, V135, P1791, DOI 10.1242/dev.018853; Mahtouk K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-198; Malhotra S, 2009, CELL STEM CELL, V4, P27, DOI 10.1016/j.stem.2008.12.004; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Oshima T, 2005, BLOOD, V106, P3160, DOI 10.1182/blood-2004-12-4940; Pinzone JJ, 2009, BLOOD, V113, P517, DOI 10.1182/blood-2008-03-145169; Podar K, 2009, LEUKEMIA, V23, P10, DOI 10.1038/leu.2008.259; Polakis P, 2000, GENE DEV, V14, P1837; Qiang YW, 2008, BLOOD, V112, P196, DOI 10.1182/blood-2008-01-132134; Qiang YW, 2008, BONE, V42, P669, DOI 10.1016/j.bone.2007.12.006; Qiang YW, 2005, BLOOD, V106, P1786, DOI 10.1182/blood-2005-01-0049; Qiang YW, 2003, ONCOGENE, V22, P1536, DOI 10.1038/sj.onc.1206239; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Sato H, 2007, CARCINOGENESIS, V28, P2459, DOI 10.1093/carcin/bgm178; Schmidt M, 2009, BRIT J HAEMATOL, V144, P796, DOI 10.1111/j.1365-2141.2008.07503.x; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; Staal FJT, 2005, NAT REV IMMUNOL, V5, P21, DOI 10.1038/nri1529; Staal FJT, 2008, EUR J IMMUNOL, V38, P1788, DOI 10.1002/eji.200738118; Standal T, 2007, BLOOD, V109, P3024, DOI 10.1182/blood-2006-07-034884; Sukhdeo K, 2007, P NATL ACAD SCI USA, V104, P7516, DOI 10.1073/pnas.0610299104; Suzuki H, 2008, BRIT J CANCER, V98, P1147, DOI 10.1038/sj.bjc.6604259; Suzuki R, 2007, BRIT J HAEMATOL, V138, P624, DOI 10.1111/j.1365-2141.2007.06702.x; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Timm A, 2005, CURR TOP MICROBIOL, V290, P225; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Vibhakar R, 2007, NEURO-ONCOLOGY, V9, P135, DOI 10.1215/15228517-2006-038; Yaccoby S, 2007, BLOOD, V109, P2106, DOI 10.1182/blood-2006-09-047712; Yamaguchi Y, 2008, FASEB J, V22, P1009, DOI 10.1096/fj.07-9475com; Zhan FH, 2007, BLOOD, V109, P1692, DOI 10.1182/blood-2006-07-037077	59	43	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30359	10.1371/journal.pone.0030359	http://dx.doi.org/10.1371/journal.pone.0030359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363428	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600022
J	Mata-Gomez, MA; Yasui, MT; Guerrero-Rangel, A; Valdes-Rodriguez, S; Winkler, R				Mata-Gomez, Marco A.; Yasui, Matthew T.; Guerrero-Rangel, Armando; Valdes-Rodriguez, Silvia; Winkler, Robert			Accelerated Identification of Proteins by Mass Spectrometry by Employing Covalent Pre-Gel Staining with Uniblue A	PLOS ONE			English	Article							POLYACRYLAMIDE-GELS; STATISTICAL-MODEL; ELECTROPHORESIS; PROTEOMICS; DIGESTION; SEARCH; SILVER; SENSITIVITY; GENERATION; RESISTANCE	Background: The identification of proteins by mass spectrometry is a standard method in biopharmaceutical quality control and biochemical research. Prior to identification by mass spectrometry, proteins are usually pre-separated by electrophoresis. However, current protein staining and de-staining protocols are tedious and time consuming, and therefore prolong the sample preparation time for mass spectrometry. Methodology and Principal Findings: We developed a 1-minute covalent pre-gel staining protocol for proteins, which does not require de-staining before the mass spectrometry analysis. We investigated the electrophoretic properties of derivatized proteins and peptides and studied their behavior in mass spectrometry. Further, we elucidated the preferred reaction of proteins with Uniblue A and demonstrate the integration of the peptide derivatization into typical informatics tools. Conclusions and Significance: The Uniblue A staining method drastically speeds up the sample preparation for the mass spectrometry based identification of proteins. The application of this chemo-proteomic strategy will be advantageous for routine quality control of proteins and for time-critical tasks in protein analysis.	[Mata-Gomez, Marco A.; Winkler, Robert] Tecnol Monterrey, Dept Biotechnol & Food Engn, Monterrey, Nuevo Leon, Mexico; [Yasui, Matthew T.] Oregon State Univ, Sch Chem Biol & Environm Engn, Corvallis, OR 97331 USA; [Guerrero-Rangel, Armando; Valdes-Rodriguez, Silvia; Winkler, Robert] CINVESTAV Unidad Irapuato, Dept Biochem & Biotechnol, Guanajuato, Mexico	Tecnologico de Monterrey; Oregon State University; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Mata-Gomez, MA (corresponding author), Tecnol Monterrey, Dept Biotechnol & Food Engn, Monterrey, Nuevo Leon, Mexico.	robert.winkler@ira.cinvestav.mx	Winkler, Robert/A-1500-2009	Winkler, Robert/0000-0001-6732-1958; Mata Gomez, Marco A./0000-0002-3457-7030; Valdes, Silvia/0000-0003-3133-9982	research chair CAT 161 of the Instituto Tecnologico y de Estudios Superiores de Monterrey (Monterrey Institute of Technology and Higher Education, ITESM); Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional (Center for Research and Advanced Studies of the National Polytechnic Institute, CINVESTAV), Unidad Irapuato	research chair CAT 161 of the Instituto Tecnologico y de Estudios Superiores de Monterrey (Monterrey Institute of Technology and Higher Education, ITESM); Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional (Center for Research and Advanced Studies of the National Polytechnic Institute, CINVESTAV), Unidad Irapuato	This work was supported by the research chair CAT 161 of the Instituto Tecnologico y de Estudios Superiores de Monterrey (Monterrey Institute of Technology and Higher Education, ITESM) and by institutional funding of the Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional (Center for Research and Advanced Studies of the National Polytechnic Institute, CINVESTAV), Unidad Irapuato. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, LANCET, V377; Barsnes H, 2009, NAT BIOTECHNOL, V27, P598, DOI 10.1038/nbt0709-598; Bauer MD, 2000, RAPID COMMUN MASS SP, V14, P924, DOI 10.1002/(SICI)1097-0231(20000530)14:10<924::AID-RCM967>3.0.CO;2-X; BJELLQVIST B, 1982, J BIOCHEM BIOPH METH, V6, P317, DOI 10.1016/0165-022X(82)90013-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Compton MM, 2002, ELECTROPHORESIS, V23, P3262, DOI 10.1002/1522-2683(200210)23:19<3262::AID-ELPS3262>3.0.CO;2-8; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Havlis J, 2003, ANAL CHEM, V75, P1300, DOI 10.1021/ac026136s; JENO P, 1995, ANAL BIOCHEM, V224, P75, DOI 10.1006/abio.1995.1010; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Keough T, 1999, P NATL ACAD SCI USA, V96, P7131, DOI 10.1073/pnas.96.13.7131; LABOUESSE J, 1967, EUR J BIOCHEM, V2, P215, DOI 10.1111/j.1432-1033.1967.tb00127.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lewis K, 2009, CMAJ CANADIAN MED AS, V181; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; PARKINSON D, 1984, ANAL BIOCHEM, V141, P121, DOI 10.1016/0003-2697(84)90434-2; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Rabilloud T, 2002, PROTEOMICS, V2, P3, DOI 10.1002/1615-9861(200201)2:1<3::AID-PROT3>3.3.CO;2-I; Rathore AS, 2009, TRENDS BIOTECHNOL, V27, P546, DOI 10.1016/j.tibtech.2009.06.006; RICE RH, 1977, BIOCHIM BIOPHYS ACTA, V492, P316, DOI 10.1016/0005-2795(77)90082-4; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Sambrook J., 2001, MOL CLONING LAB MANU; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Smith MR, 2003, ONCOGENE, V22, P7359, DOI 10.1038/sj.onc.1206939; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; Sumpton D, 2009, RAPID COMMUN MASS SP, V23, P1525, DOI 10.1002/rcm.4029; Usaite R, 2008, J PROTEOME RES, V7, P266, DOI 10.1021/pr700580m; Valdes-Rodriguez S, 2010, PLANT PHYSIOL BIOCH, V48, P469, DOI 10.1016/j.plaphy.2010.03.012; Vizcaino JA, 2009, PROTEOMICS, V9, P4276, DOI 10.1002/pmic.200900402; Wadman M, 2008, NATURE, V452, P924, DOI 10.1038/452924a; Westermeier R, 2006, PROTEOMICS, P61, DOI 10.1002/pmic.200690121; Winkler R, 2010, MOL BIOSYST, V6, P1810, DOI 10.1039/c003112g; Winkler R, 2010, RAPID COMMUN MASS SP, V24, P285, DOI 10.1002/rcm.4384; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958	42	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31438	10.1371/journal.pone.0031438	http://dx.doi.org/10.1371/journal.pone.0031438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363648	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600147
J	Riehm, JM; Vergnaud, G; Kiefer, D; Damdindorj, T; Dashdavaa, O; Khurelsukh, T; Zoller, L; Wolfel, R; Le Fleche, P; Scholz, HC				Riehm, Julia M.; Vergnaud, Gilles; Kiefer, Daniel; Damdindorj, Tserennorov; Dashdavaa, Otgonbaatar; Khurelsukh, Tungalag; Zoeller, Lothar; Woelfel, Roman; Le Fleche, Philippe; Scholz, Holger C.			Yersinia pestis Lineages in Mongolia	PLOS ONE			English	Article							NUMBER TANDEM REPEATS; BACILLUS-ANTHRACIS; PHYLOGENETIC ANALYSIS; PLAGUE; GENOME; MICROEVOLUTION; DYNAMICS; INSIGHTS; TOOLS; DNA	Background: Whole genome sequencing allowed the development of a number of high resolution sequence based typing tools for Yersinia (Y.) pestis. The application of these methods on isolates from most known foci worldwide and in particular from China and the Former Soviet Union has dramatically improved our understanding of the population structure of this species. In the current view, Y. pestis including the non or moderate human pathogen Y. pestis subspecies microtus emerged from Yersinia pseudotuberculosis about 2,600 to 28,600 years ago in central Asia. The majority of central Asia natural foci have been investigated. However these investigations included only few strains from Mongolia. Methodology/Principal Findings: Clustered Regularly Interspaced Short Prokaryotic Repeats (CRISPR) analysis and Multiple-locus variable number of tandem repeats (VNTR) analysis (MLVA) with 25 loci was performed on 100 Y. pestis strains, isolated from 37 sampling areas in Mongolia. The resulting data were compared with previously published data from more than 500 plague strains, 130 of which had also been previously genotyped by single nucleotide polymorphism (SNP) analysis. The comparison revealed six main clusters including the three microtus biovars Ulegeica, Altaica, and Xilingolensis. The largest cluster comprises 78 isolates, with unique and new genotypes seen so far in Mongolia only. Typing of selected isolates by key SNPs was used to robustly assign the corresponding clusters to previously defined SNP branches. Conclusions/Significance: We show that Mongolia hosts the most recent microtus clade (Ulegeica). Interestingly no representatives of the ancestral Y. pestis subspecies pestis nodes previously identified in North-western China were identified in this study. This observation suggests that the subsequent evolution steps within Y. pestis pestis did not occur in Mongolia. Rather, Mongolia was most likely re-colonized by more recent clades coming back from China contemporary of the black death pandemic, or more recently in the past 600 years.	[Riehm, Julia M.; Kiefer, Daniel; Zoeller, Lothar; Woelfel, Roman; Scholz, Holger C.] Bundeswehr Inst Microbiol, Munich, Germany; [Vergnaud, Gilles; Le Fleche, Philippe] Univ Paris 11, Inst Genet & Microbiol, F-91405 Orsay, France; [Vergnaud, Gilles; Le Fleche, Philippe] CNRS, F-91405 Orsay, France; [Vergnaud, Gilles] DGA MRIS Mission Rech & Innovat Sci, Bagneux, France; [Dashdavaa, Otgonbaatar; Khurelsukh, Tungalag] Natl Ctr Infect Dis Nat Foci, Ulaanbaatar, Mongolia; [Le Fleche, Philippe] Direct Gen Armement DGA Maitrise NRBC, Div Analyt Microbiol, Vert Le Petit, France	Bundeswehr Institute of Microbiology (IMB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	Riehm, JM (corresponding author), Bundeswehr Inst Microbiol, Munich, Germany.	juliariehm@bundeswehr.org	Vergnaud, Gilles/P-1304-2015; Vergnaud, Gilles/AAC-1162-2020; Wölfel, Roman/AAQ-3977-2021	Vergnaud, Gilles/0000-0003-0913-194X; Vergnaud, Gilles/0000-0003-0913-194X; Wölfel, Roman/0000-0002-8756-7821	European Defense Agency (EDA) [B-0060-GEM3-GC]	European Defense Agency (EDA)	This study was part of the European Biodefence Laboratory Network (EBLN). Coordination work supported by the European Defense Agency (EDA, B-0060-GEM3-GC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Anisimov AP, 2004, CLIN MICROBIOL REV, V17, P434, DOI 10.1128/CMR.17.2.434-464.2004; Bos KI, 2011, NATURE, V478, P506, DOI 10.1038/nature10549; Ciammaruconi A, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-21; Cui YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002652; Devignat R, 1951, B WORLD HEALTH ORGAN, V4, P241; Galdan B, 2010, VECTOR-BORNE ZOONOT, V10, P69, DOI 10.1089/vbz.2009.0047; Girard JM, 2004, P NATL ACAD SCI USA, V101, P8408, DOI 10.1073/pnas.0401561101; Grissa I, 2008, NUCLEIC ACIDS RES, V36, pW145, DOI 10.1093/nar/gkn228; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Grissa I, 2009, METHODS MOL BIOL, V551, P105, DOI 10.1007/978-1-60327-999-4_9; Haensch S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001134; Keim P, 2004, INFECT GENET EVOL, V4, P205, DOI 10.1016/j.meegid.2004.02.005; Kingston JJ, 2009, ANTON LEEUW INT J G, V96, P303, DOI 10.1007/s10482-009-9347-2; Klevytska AM, 2001, J CLIN MICROBIOL, V39, P3179, DOI 10.1128/JCM.39.9.3179-3185.2001; Le Fleche P, 2001, BMC Microbiol, V1, P2; Li YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006000; Li YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002166; Lista F, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-33; Lowell JL, 2007, MICROBIOL-SGM, V153, P169, DOI 10.1099/mic.0.29059-0; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; PERRIN C, 1993, ETHOLOGY, V93, P21; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Pourcel C, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-22; Ravenel MP, 1936, AM J PUBLIC HEALTH N, V26, P1049, DOI 10.2105/AJPH.26.10.1049; Riehm JM, 2011, MOL CELL PROBE, V25, P8, DOI 10.1016/j.mcp.2010.09.002; Schuenemann VJ, 2011, P NATL ACAD SCI USA, V108, pE746, DOI 10.1073/pnas.1105107108; Van Ert MN, 2007, J CLIN MICROBIOL, V45, P47, DOI 10.1128/JCM.01233-06; Vergnaud G, 2007, ADV EXP MED BIOL, V603, P327; Vogler AJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001319; World Health Organization, 2003, WEEKLY EPIDEMIOLOGIC, V78, P129; Zhang XA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-205; Zhou DS, 2004, J BACTERIOL, V186, P5138, DOI [10.1128/JB.186.15.5138-5146.2004, 10.1128/jb.186.15.5138-5146.2004]	34	49	58	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30624	10.1371/journal.pone.0030624	http://dx.doi.org/10.1371/journal.pone.0030624			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363455	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600042
J	Roelfsema, F; Pijl, H; Keenan, DM; Veldhuis, JD				Roelfsema, Ferdinand; Pijl, Hanno; Keenan, Daniel M.; Veldhuis, Johannes D.			Prolactin Secretion in Healthy Adults Is Determined by Gender, Age and Body Mass Index	PLOS ONE			English	Article							GROWTH-HORMONE-SECRETION; LUTEINIZING-HORMONE; BURST MASS; CIRCADIAN RHYTHMICITY; THYROTROPIN SECRETION; REPLACEMENT THERAPY; METABOLIC-CLEARANCE; LACTOTROPIC AXES; BASAL SECRETION; ENHANCED BASAL	Background: Prolactin (PRL) secretion is quantifiable as mean, peak and nadir PRL concentrations, degree of irregularity (ApEn, approximate entropy) and spikiness (brief staccato-like fluctuations). Hypothesis: Distinct PRL dynamics reflect relatively distinct (combinations of) subject variables, such as gender, age, and BMI. Location: Clinical Research Unit. Subjects: Seventy-four healthy adults aged 22-77 yr (41 women and 33 men), with BMI 18.3-39.4 kg/m(2). Measures: Immunofluorometric PRL assay of 10-min samples collected for 24 hours. Results: Mean 24-h PRL concentration correlated jointly with gender (P<0.0001) and BMI (P = 0.01), but not with age (overall R-2 = 0.308, P<0.0001). Nadir PRL concentration correlated with gender only (P = 0.017) and peak PRL with gender (P<0.001) and negatively with age (P<0.003), overall R-2 = 0.325, P<0.0001. Forward-selection multivariate regression of PRL deconvolution results demonstrated that basal (nonpulsatile) PRL secretion tended to be associated with BMI (R-2 = 0.058, P = 0.03), pulsatile secretion with gender (R-2 = 0.152, P = 0.003), and total secretion with gender and BMI (R-2 = 0.204, P<0.0001). Pulse mass was associated with gender (P = 0.001) and with a negative tendency to age (P = 0.038). In male subjects older than 50 yr (but not in women) approximate entropy was increased (0.942 +/- 0.301 vs. 1.258 +/- 0.267, P = 0.007) compared with younger men, as well as spikiness (0.363 +/- 0.122 vs. 0463 +/- 2.12, P = 0.031). Cosinor analysis disclosed higher mesor and amplitude in females than in men, but the acrophase was gender-independent. The acrophase was determined by age and BMI (R-2 = 0.186, P = 0.001). Conclusion: In healthy adults, selective combinations of gender, age, and BMI specify distinct PRL dynamics, thus requiring balanced representation of these variables in comparative PRL studies.	[Roelfsema, Ferdinand; Pijl, Hanno] Leiden Univ, Dept Endocrinol & Metab Dis, Med Ctr, Leiden, Netherlands; [Keenan, Daniel M.] Univ Virginia, Dept Stat, Charlottesville, VA USA; [Veldhuis, Johannes D.] Mayo Clin, Endocrine Res Unit, Mayo Med Sch, Clin Translat Res Ctr, Rochester, MN USA; [Veldhuis, Johannes D.] Mayo Clin, Endocrine Res Unit, Grad Sch, Clin Translat Res Ctr, Rochester, MN USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Virginia; Mayo Clinic; Mayo Clinic	Roelfsema, F (corresponding author), Leiden Univ, Dept Endocrinol & Metab Dis, Med Ctr, Leiden, Netherlands.	f.roelfsema@lumc.nl	Pijl, Hanno/W-8719-2018	Pijl, Hanno/0000-0002-3076-1551				ARNETZ BB, 1986, LIFE SCI, V39, P135, DOI 10.1016/0024-3205(86)90447-9; Aziz NA, 2010, CLIN ENDOCRINOL, V73, P540, DOI 10.1111/j.1365-2265.2010.03836.x; Ben-Jonathan N, 2008, ENDOCR REV, V29, P1, DOI 10.1210/er.2007-0017; BLACKMAN MR, 1986, J GERONTOL, V41, P699, DOI 10.1093/geronj/41.6.699; Camastra S, 2009, INT J OBESITY, V33, P166, DOI 10.1038/ijo.2008.226; CASTELOBRANCO C, 1995, J REPROD MED, V40, P556; Chattopadhyay S, 2008, Q APPL MATH, V66, P401, DOI 10.1090/S0033-569X-08-01024-4; Chehab FF, 1997, NAT MED, V3, P952, DOI 10.1038/nm0997-952; CHRISTENSEN SE, 1985, ACTA ENDOCRINOL-COP, V109, P458, DOI 10.1530/acta.0.1090458; COOPER DS, 1979, J CLIN INVEST, V64, P1669, DOI 10.1172/JCI109629; COPINSCHI G, 1995, HORM RES, V43, P20, DOI 10.1159/000184232; CORENBLUM B, 1981, FERTIL STERIL, V36, P712; Donjacour CEHM, 2011, AM J PHYSIOL-ENDOC M, V300, pE1069, DOI 10.1152/ajpendo.00623.2010; Ernst B, 2009, OBES SURG, V19, P1159, DOI 10.1007/s11695-009-9856-0; FRANCHIMONT P, 1976, CLIN ENDOCRINOL, V5, P643, DOI 10.1111/j.1365-2265.1976.tb03867.x; Friedrich N, 2010, EXP CLIN ENDOCR DIAB, V118, P266, DOI 10.1055/s-0029-1225616; GENAZZANI AD, 1994, J ENDOCRINOL INVEST, V17, P83, DOI 10.1007/BF03347690; GREENSPAN SL, 1990, AM J PHYSIOL, V258, pE799, DOI 10.1152/ajpendo.1990.258.5.E799; HARTMAN ML, 1994, J CLIN INVEST, V94, P1277, DOI 10.1172/JCI117446; HAUS E, 1989, CHRONOBIOLOGIA, V16, P331; HO KY, 1987, J CLIN ENDOCR METAB, V64, P51, DOI 10.1210/jcem-64-1-51; Hudson SB, 2010, J CLIN ENDOCR METAB, V95, P353, DOI 10.1210/jc.2009-1769; Iranmanesh A, 1999, J CLIN ENDOCR METAB, V84, P1083, DOI 10.1210/jc.84.3.1083; Isidori AM, 2000, J CLIN ENDOCR METAB, V85, P1954, DOI 10.1210/jc.85.5.1954; Keenan DM, 2005, J THEOR BIOL, V236, P242, DOI 10.1016/j.jtbi.2005.03.008; Keenan DM, 2003, AM J PHYSIOL-REG I, V285, pR664, DOI 10.1152/ajpregu.00195.2003; Kok P, 2004, J CLIN ENDOCR METAB, V89, P4445, DOI 10.1210/jc.2003-032184; Kok SW, 2002, J CLIN ENDOCR METAB, V87, P805, DOI 10.1210/jc.87.2.805; Latta F, 2005, SLEEP, V28, P1519, DOI 10.1093/sleep/28.12.1519; Liu PY, 2006, J CLIN ENDOCR METAB, V91, P4077, DOI 10.1210/jc.2005-2811; Liu PY, 2009, AM J PHYSIOL-ENDOC M, V297, pE538, DOI 10.1152/ajpendo.00071.2009; McTiernan A, 2006, OBESITY, V14, P1662, DOI 10.1038/oby.2006.191; Mingrone G, 2008, OBESITY, V16, P1831, DOI 10.1038/oby.2008.297; Molitch ME, 1995, PITUITARY; PERRONE G, 1994, INT J FERTIL MENOP S, V39, P202; Pincus SM, 1997, AM J PHYSIOL-ENDOC M, V273, pE989, DOI 10.1152/ajpendo.1997.273.5.E989; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Pincus SM, 1999, AM J PHYSIOL-ENDOC M, V277, pE948, DOI 10.1152/ajpendo.1999.277.5.E948; Pincus SM, 1996, AM J PHYSIOL-ENDOC M, V270, pE107, DOI 10.1152/ajpendo.1996.270.1.E107; Pincus SM, 1996, P NATL ACAD SCI USA, V93, P14100, DOI 10.1073/pnas.93.24.14100; Pincus SM, 2000, METHOD ENZYMOL, V321, P149; Pincus SM, 2008, J PSYCHIATR RES, V42, P337, DOI 10.1016/j.jpsychires.2007.01.001; Pincus SM, 2011, J PSYCHIATR RES, V45, P386, DOI 10.1016/j.jpsychires.2010.07.006; QUIGLEY ME, 1981, J CLIN ENDOCR METAB, V52, P1043, DOI 10.1210/jcem-52-5-1043; Roelfsema F, 2002, CLIN ENDOCRINOL, V56, P79, DOI 10.1046/j.0300-0664.2001.01433.x; Roelfsema F, 2008, J CLIN ENDOCR METAB, V93, P4052, DOI 10.1210/jc.2008-1145; Roelfsema F, 2010, J CLIN ENDOCR METAB, V95, P928, DOI 10.1210/jc.2009-1959; Roelfsema F, 2009, J CLIN ENDOCR METAB, V94, P3964, DOI 10.1210/jc.2009-1155; SAWIN CT, 1978, J CLIN ENDOCR METAB, V47, P1296, DOI 10.1210/jcem-47-6-1296; Schmitt CP, 2003, J AM SOC NEPHROL, V14, P407, DOI 10.1097/01.ASN.0000043905.35268.86; SHERMAN B, 1985, J CLIN ENDOCR METAB, V61, P439, DOI 10.1210/jcem-61-3-439; SIEVERTSEN GD, 1980, J CLIN ENDOCR METAB, V50, P846, DOI 10.1210/jcem-50-5-846; SIRAGY HM, 1995, J CLIN ENDOCR METAB, V80, P28, DOI 10.1210/jc.80.1.28; Soldin SJ, 2009, CLIN CHEM, V55, P1061, DOI 10.1373/clinchem.2007.100008; Stanosz S, 2009, METABOLISM, V58, P1, DOI 10.1016/j.metabol.2008.07.016; van Aken MO, 2005, J CLIN ENDOCR METAB, V90, P1570, DOI 10.1210/jc.2004-1281; van den Berg G, 1998, EUR J ENDOCRINOL, V138, P164, DOI 10.1530/eje.0.1380164; van der Klaauw AA, 2007, CLIN ENDOCRINOL, V66, P489, DOI 10.1111/j.1365-2265.2006.02757.x; VanCauter E, 1996, J CLIN ENDOCR METAB, V81, P2468, DOI 10.1210/jc.81.7.2468; vandenBerg G, 1997, EUR J ENDOCRINOL, V136, P394, DOI 10.1530/eje.0.1360394; Veldhuis JD, 1999, J CLIN ENDOCR METAB, V84, P3498, DOI 10.1210/jc.84.10.3498; Veldhuis JD, 1997, AM J PHYSIOL-REG I, V272, pR464, DOI 10.1152/ajpregu.1997.272.2.R464; VELDHUIS JD, 1994, EUR J ENDOCRINOL, V131, P489, DOI 10.1530/eje.0.1310489; Veldhuis JD, 2006, ENDOCR REV, V27, P101, DOI 10.1210/er.2005-0006; Veldhuis JD, 2001, J CLIN ENDOCR METAB, V86, P3772, DOI 10.1210/jc.86.8.3772; Veldhuis JD, 2011, J CLIN ENDOCR METAB, V96, P115, DOI 10.1210/jc.2010-1669; Veldhuis JD, 2009, J CLIN ENDOCR METAB, V94, P4045, DOI 10.1210/jc.2009-1143; Veldhuis JD, 2008, ENDOCR REV, V29, P823, DOI 10.1210/er.2008-0005; Veldman RG, 2001, J CLIN ENDOCR METAB, V86, P1562, DOI 10.1210/jc.86.4.1562; Vermeulen A, 2002, Aging Male, V5, P98, DOI 10.1080/713604678; Watanobe H, 1999, BIOCHEM BIOPH RES CO, V263, P162, DOI 10.1006/bbrc.1999.1331; Yu WH, 1997, P NATL ACAD SCI USA, V94, P1023, DOI 10.1073/pnas.94.3.1023	72	66	73	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31305	10.1371/journal.pone.0031305	http://dx.doi.org/10.1371/journal.pone.0031305			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363612	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600138
J	Beriault, DR; Haddad, O; McCuaig, JV; Robinson, ZJ; Russell, D; Lane, EB; Fudge, DS				Beriault, Daniel R.; Haddad, Oualid; McCuaig, John V.; Robinson, Zachary J.; Russell, David; Lane, E. Birgitte; Fudge, Douglas S.			The Mechanical Behavior of Mutant K14-R125P Keratin Bundles and Networks in NEB-1 Keratinocytes	PLOS ONE			English	Article							EPIDERMOLYSIS-BULLOSA SIMPLEX; INTERMEDIATE-FILAMENTS; MUSCULAR-DYSTROPHY; DOWLING-MEARA; MUTATIONS; CELLS; MICROTUBULES; ORGANIZATION; LETHALITY; KNOCKOUT	Epidermolysis bullosa simplex (EBS) is an inherited skin-blistering disease that is caused by dominant mutations in the genes for keratin K5 or K14 proteins. While the link between keratin mutations and keratinocyte fragility in EBS patients is clear, the exact biophysical mechanisms underlying cell fragility are not known. In this study, we tested the hypotheses that mutant K14-R125P filaments and/or networks in human keratinocytes are mechanically defective in their response to large-scale deformations. We found that mutant filaments and networks exhibit no obvious defects when subjected to large uniaxial strains and have no negative effects on the ability of human keratinocytes to survive large strains. We also found that the expression of mutant K14-R125P protein has no effect on the morphology of the F-actin or microtubule networks or their responses to large strains. Disassembly of the F-actin network with Latrunculin A unexpectedly led to a marked decrease in stretch-induced necrosis in both WT and mutant cells. Overall, our results contradict the hypotheses that EBS mutant keratin filaments and/or networks are mechanically defective. We suggest that future studies should test the alternative hypothesis that keratinocytes in EBS cells are fragile because they possess a sparser keratin network.	[Beriault, Daniel R.; Haddad, Oualid; McCuaig, John V.; Robinson, Zachary J.; Fudge, Douglas S.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Russell, David; Lane, E. Birgitte] Univ Dundee, Canc Res United Kingdom UK Cell Struct Res Grp, Coll Life Sci, Dundee, Scotland; [Lane, E. Birgitte] Inst Med Biol, Singapore, Singapore	University of Guelph; University of Dundee; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Beriault, DR (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	dfudge@uoguelph.ca	Fudge, Douglas/I-6860-2016	Fudge, Douglas/0000-0001-9569-1374	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a Canadian Institutes of Health Research Catalyst Grant to Douglas Fudge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONLAMPRECHT I, 1982, DERMATOLOGICA, V164, P221, DOI 10.1159/000250096; BONIFAS JM, 1991, SCIENCE, V254, P1202, DOI 10.1126/science.1720261; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; BRODLAND GW, 1990, J BIOMECH ENG-T ASME, V112, P319, DOI 10.1115/1.2891190; COULOMBE M, 1991, TRANSPLANT P, V23, P31; D'Alessandro M, 2002, J CELL SCI, V115, P4341, DOI 10.1242/jcs.00120; Fine JD, 2008, J AM ACAD DERMATOL, V58, P931, DOI 10.1016/j.jaad.2008.02.004; Fudge D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002327; Herrmann H, 1998, CURR OPIN STRUC BIOL, V8, P177, DOI 10.1016/S0959-440X(98)80035-3; Hesse M, 2007, EXP CELL RES, V313, P3127, DOI 10.1016/j.yexcr.2007.05.019; ISHIDAYAMAMOTO A, 1991, J INVEST DERMATOL, V97, P959, DOI 10.1111/1523-1747.ep12491885; JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155; KITAJIMA Y, 1989, ARCH DERMATOL RES, V281, P5, DOI 10.1007/BF00424265; KRAUSE AW, 1984, J HISTOCHEM CYTOCHEM, V32, P1084, DOI 10.1177/32.10.6090533; Kreplak L, 2005, J MOL BIOL, V354, P569, DOI 10.1016/j.jmb.2005.09.092; Kreplak L, 2008, BIOPHYS J, V94, P2790, DOI 10.1529/biophysj.107.119826; LANE EB, 1992, NATURE, V356, P244, DOI 10.1038/356244a0; Lulevich V, 2010, ULTRAMICROSCOPY, V110, P1435, DOI 10.1016/j.ultramic.2010.07.009; Ma LL, 2001, NAT CELL BIOL, V3, P503, DOI 10.1038/35074576; Morley SM, 2003, BRIT J DERMATOL, V149, P46, DOI 10.1046/j.1365-2133.2003.05493.x; Peters B, 2001, MOL BIOL CELL, V12, P1775, DOI 10.1091/mbc.12.6.1775; Porter RM, 2003, TRENDS GENET, V19, P278, DOI 10.1016/S0168-9525(03)00071-4; Pulkkinen L, 1996, HUM MOL GENET, V5, P1539, DOI 10.1093/hmg/5.10.1539; RUGG EL, 1994, GENE DEV, V8, P2563, DOI 10.1101/gad.8.21.2563; Russell D, 2004, J CELL SCI, V117, P5233, DOI 10.1242/jcs.01407; Smith FJD, 1996, NAT GENET, V13, P450, DOI 10.1038/ng0896-450; Sorensen CB, 1999, J INVEST DERMATOL, V112, P184, DOI 10.1046/j.1523-1747.1999.00495.x; Werner NS, 2004, MOL BIOL CELL, V15, P990, DOI 10.1091/mbc.E03-09-0687; Yoon SM, 2011, HEPATOLOGY, V53, P964, DOI 10.1002/hep.24122; Zhou Q, 2003, MOL BIOL CELL, V14, P2959, DOI 10.1091/mbc.E03-02-0059	30	23	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31320	10.1371/journal.pone.0031320	http://dx.doi.org/10.1371/journal.pone.0031320			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363617	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700046
J	Kesselheim, AS; Myers, JA; Solomon, DH; Winkelmayer, WC; Levin, R; Avorn, J				Kesselheim, Aaron S.; Myers, Jessica A.; Solomon, Daniel H.; Winkelmayer, Wolfgang C.; Levin, Raisa; Avorn, Jerry			The Prevalence and Cost of Unapproved Uses of Top-Selling Orphan Drugs	PLOS ONE			English	Article							NEUROPATHIC PAIN; MEDICARE CLAIMS; LEGISLATION; MANAGEMENT; INNOVATION; DIAGNOSIS; FDA; ACT	Introduction: The Orphan Drug Act encourages drug development for rare conditions. However, some orphan drugs become top sellers for unclear reasons. We sought to evaluate the extent and cost of approved and unapproved uses of orphan drugs with the highest unit sales. Methods: We assessed prescription patterns for four top-selling orphan drugs: lidocaine patch (Lidoderm) approved for post-herpetic neuralgia, modafinil (Provigil) approved for narcolepsy, cinacalcet (Sensipar) approved for hypercalcemia of parathyroid carcinoma, and imatinib (Gleevec) approved for chronic myelogenous leukemia and gastrointestinal stromal tumor. We pooled patient-specific diagnosis and prescription data from two large US state pharmaceutical benefit programs for the elderly. We analyzed the number of new and total patients using each drug and patterns of reimbursement for approved and unapproved uses. For lidocaine patch, we subcategorized approved prescriptions into two subtypes of unapproved uses: neuropathic pain, for which some evidence of efficacy exists, and non-neuropathic pain. Results: We found that prescriptions for lidocaine patch, modafinil, and cinacalcet associated with non-orphan diagnoses rose at substantially higher rates (average monthly increases in number of patients of 14.6, 1.45, and 1.58) than prescriptions associated with their orphan diagnoses (3.12, 0.24, and 0.03, respectively (p<0.001 for all)). By contrast, for imatinib, approved uses increased significantly over off-label (0.97 vs. 0.47 patients, p<0.001). Spending on off-label uses was highest for lidocaine patch and modafinil (>75%). Increases in lidocaine patch use for non-neuropathic pain far exceeded neuropathic pain (10.2 vs. 3.6 patients, p<0.001). Discussion: In our sample, three of four top-selling orphan drugs were used more commonly for non-orphan indications. These orphan drugs treated common clinical symptoms (pain and fatigue) or laboratory abnormalities. We should continue to monitor orphan drug use after approval to identify products that come to be widely used for non-FDA approved indications, particularly those without adequate evidence of efficacy.	[Kesselheim, Aaron S.; Myers, Jessica A.; Solomon, Daniel H.; Levin, Raisa; Avorn, Jerry] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Kesselheim, Aaron S.; Myers, Jessica A.; Solomon, Daniel H.; Levin, Raisa; Avorn, Jerry] Harvard Univ, Sch Med, Boston, MA USA; [Solomon, Daniel H.] Brigham & Womens Hosp, Dept Med, Div Rheumatol, Boston, MA 02115 USA; [Winkelmayer, Wolfgang C.] Stanford Univ, Sch Med, Div Nephrol, Palo Alto, CA 94304 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Stanford University	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.	akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666	Harvard Catalyst/The Harvard Clinical and Translational Science Center; National Institutes of Health [UL1 RR 025758, K24-AR055989]; Harvard University; academic health care centers; Agency for Healthcare Research and Quality [K08HS18465-01]; Robert Wood Johnson Foundation; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018465] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR055989] Funding Source: NIH RePORTER	Harvard Catalyst/The Harvard Clinical and Translational Science Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University; academic health care centers; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was conducted with support from Harvard Catalyst/The Harvard Clinical and Translational Science Center (National Institutes of Health Award #UL1 RR 025758 and financial contributions from Harvard University and its affiliated academic health care centers). ASK is supported by a career development award from the Agency for Healthcare Research and Quality (K08HS18465-01), and a Robert Wood Johnson Foundation Investigator Award in Health Policy Research. DHS is supported by a mentoring award from the National Institutes of Health (K24-AR055989). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, the National Center for Research Resources, or the National Institutes of Health.	Anand G, 2005, WALL ST J       1115; [Anonymous], PHARM SAL 2009; ARNO PS, 1995, MILBANK Q, V73, P231, DOI 10.2307/3350258; Bowen J, 2005, FAM PRACT, V22, P389, DOI 10.1093/fampra/cmi019; Centers for Medicare and Medicaid Services, 2010, STAT DRUG UT DAT; Choudhry NK, 2010, HEALTH AFFAIR, V29, P1995, DOI 10.1377/hlthaff.2010.0336; Collins F, 2011, NAT REV DRUG DISCOV, V10, P14, DOI 10.1038/nrd3357; Drugs@FDA, 2012, FDA APPR DRUG PROD; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; Engelberg AB, 2009, NEW ENGL J MED, V361, P1917, DOI 10.1056/NEJMp0908496; Finnerup NB, 2005, PAIN, V118, P289, DOI 10.1016/j.pain.2005.08.013; Griggs RC, 2009, MOL GENET METAB, V96, P20, DOI 10.1016/j.ymgme.2008.10.003; Grody WW, 2010, NEW ENGL J MED, V363, P2267, DOI 10.1056/NEJMc1009918; Haffner ME, 2008, LANCET, V371, P2041, DOI 10.1016/S0140-6736(08)60873-9; Harrell FE, 2001, REGRESSION MODELING; Kesselheim AS, 2011, MILBANK Q, V89, P450, DOI 10.1111/j.1468-0009.2011.00636.x; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Logan AC, 2011, ANN INTERN MED, V154, P516, DOI 10.7326/0003-4819-154-8-201104190-00002; Loughnot D, 2005, AM J LAW MED, V31, P365, DOI 10.1177/009885880503100210; National Institute of Diabetes and Digestive and Kidney Diseases, 2005, RES GUID USRDS DAT 2; Outterson MK, 2009, HEALTH AFFAIR, V28, pw832; PEABODY JW, 1995, PHARMACOECONOMICS, V8, P374, DOI 10.2165/00019053-199508050-00002; Pollack A, 2008, NY TIMES        0316; Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Rohde DD, 2000, FOOD DRUG LAW J, V55, P125; Roos JCP, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6471; Setoguchi S, 2007, CANCER CAUSE CONTROL, V18, P561, DOI 10.1007/s10552-007-0131-1; Steinbrook R, 2007, NEW ENGL J MED, V356, P2448, DOI 10.1056/NEJMp078100; Upshur CC, 2006, J GEN INTERN MED, V21, P652, DOI 10.1111/j.1525-1497.2006.00412.x; Walsh B, 2009, AM ASS RET PERS REP; Walton SM, 2010, ARCH INTERN MED, V170, P657, DOI 10.1001/archinternmed.2010.69; Wellman-Labadie O, 2010, HEALTH POLICY, V95, P216, DOI 10.1016/j.healthpol.2009.12.001	33	36	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31894	10.1371/journal.pone.0031894	http://dx.doi.org/10.1371/journal.pone.0031894			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926ZM	22363762	Green Submitted, gold, Green Published			2022-12-27	WOS:000302873700116
J	Peuchant, O; Le Roy, C; Herrmann, B; Clerc, M; Bebear, C; de Barbeyrac, B				Peuchant, Olivia; Le Roy, Chloe; Herrmann, Bjorn; Clerc, Maithe; Bebear, Cecile; de Barbeyrac, Bertille			MLVA Subtyping of Genovar E Chlamydia trachomatis Individualizes the Swedish Variant and Anorectal Isolates from Men who Have Sex with Men	PLOS ONE			English	Article							GENOME SEQUENCE; TYPING METHODS; STRAINS	This study describes a new multilocus variable number tandem-repeat (VNTR) analysis (MLVA) typing system for the discrimination of Chlamydia trachomatis genovar D to K isolates or specimens. We focused our MLVA scheme on genovar E which predominates in most populations worldwide. This system does not require culture and therefore can be performed directly on DNA extracted from positive clinical specimens. Our method was based on GeneScan analysis of five VNTR loci labelled with fluorescent dyes by multiplex PCR and capillary electrophoresis. This MLVA, called MLVA-5, was applied to a collection of 220 genovar E and 94 non-E genovar C. trachomatis isolates and specimens obtained from 251 patients and resulted in 38 MLVA-5 types. The genetic stability of the MLVA-5 scheme was assessed for results obtained both in vitro by serial passage culturing and in vivo using concomitant and sequential isolates and specimens. All anorectal genovar E isolates from men who have sex with men exhibited the same MLVA-5 type, suggesting clonal spread. In the same way, we confirmed the clonal origin of the Swedish new variant of C. trachomatis. The MLVA-5 assay was compared to three other molecular typing methods, ompA gene sequencing, multilocus sequence typing (MLST) and a previous MLVA method called MLVA-3, on 43 genovar E isolates. The discriminatory index was 0.913 for MLVA-5, 0.860 for MLST and 0.622 for MLVA-3. Among all of these genotyping methods, MLVA-5 displayed the highest discriminatory power and does not require a time-consuming sequencing step. The results indicate that MLVA-5 enables high-resolution molecular epidemiological characterisation of C. trachomatis genovars D to K infections directly from specimens.	[Peuchant, Olivia; Le Roy, Chloe; Clerc, Maithe; Bebear, Cecile; de Barbeyrac, Bertille] Univ Bordeaux, USC Mycoplasmal & Chlamydial Infect Humans, French Natl Reference Ctr Chlamydial Infect, Bordeaux, France; [Peuchant, Olivia; Le Roy, Chloe; Clerc, Maithe; Bebear, Cecile; de Barbeyrac, Bertille] French Natl Reference Ctr Chlamydial Infect, INRA, USC Mycoplasmal & Chlamydial Infect Humans, Bordeaux, France; [Peuchant, Olivia; Bebear, Cecile; de Barbeyrac, Bertille] CHU Bordeaux, Bacteriol Lab, Bordeaux, France; [Herrmann, Bjorn] Uppsala Univ, Sect Clin Bacteriol, Dept Med Sci, Uppsala, Sweden	UDICE-French Research Universities; Universite de Bordeaux; INRAE; CHU Bordeaux; Uppsala University	Peuchant, O (corresponding author), Univ Bordeaux, USC Mycoplasmal & Chlamydial Infect Humans, French Natl Reference Ctr Chlamydial Infect, Bordeaux, France.	bertille.de.barbeyrac@u-bordeaux2.fr	Bébéar, Cécile/A-6596-2016	Bebear, Cecile/0000-0001-6065-2332	French Institute for Public Health (InVS)	French Institute for Public Health (InVS)	This research was supported by a grant from the French Institute for Public Health (InVS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batteiger BE, 2010, J INFECT DIS, V201, P42, DOI 10.1086/648734; BEbEar C, 2009, CLIN MICROBIOL INFEC, V15, P4, DOI 10.1111/j.1469-0691.2008.02647.x; Bom RJM, 2011, J CLIN MICROBIOL, V49, P2844, DOI 10.1128/JCM.00128-11; Bom RJ, 2011, J CLIN MICROBIO 0608; Carlson JH, 2005, INFECT IMMUN, V73, P6407, DOI 10.1128/IAI.73.10.6407-6418.2005; Christerson L, 2010, EMERG INFECT DIS, V16, P1777, DOI 10.3201/eid1611.100379; Clarke LA, 2001, J CLIN PATHOL-MOL PA, V54, P351, DOI 10.1136/mp.54.5.351; Clerc M, 2011, B EPIDEMIOL HEBD, V26-27-28, P310; de Barbeyrac B, 2007, Euro Surveill, V12, pE11; Dean D, 2009, EMERG INFECT DIS, V15, P1385, DOI 10.3201/eid1509.090272; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Ikryannikova LN, 2010, FEMS IMMUNOL MED MIC, V59, P188, DOI 10.1111/j.1574-695X.2010.00678.x; Jeffrey BM, 2010, INFECT IMMUN, V78, P2544, DOI 10.1128/IAI.01324-09; Jurstrand M, 2010, SEX TRANSM INFECT, V86, P56, DOI 10.1136/sti.2009.037572; Klint M, 2007, J CLIN MICROBIOL, V45, P1410, DOI 10.1128/JCM.02301-06; Laroucau K, 2008, INFECT GENET EVOL, V8, P171, DOI 10.1016/j.meegid.2007.12.002; Laroucau K, 2009, VET MICROBIOL, V137, P335, DOI 10.1016/j.vetmic.2009.01.029; Lutter EI, 2010, INFECT IMMUN, V78, P3678, DOI 10.1128/IAI.00515-10; Mossman D, 2008, SEX TRANSM DIS, V35, P614, DOI 10.1097/OLQ.0b013e31816b1b80; Nunes A, 2009, J BACTERIOL, V191, P7182, DOI 10.1128/JB.00895-09; Pannekoek Y, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-42; Pedersen LN, 2008, CLIN MICROBIOL INFEC, V14, P644, DOI 10.1111/j.1469-0691.2008.02011.x; Pedersen LN, 2009, FEMS IMMUNOL MED MIC, V55, P120, DOI 10.1111/j.1574-695X.2008.00526.x; RODRIGUEZ P, 1991, J CLIN MICROBIOL, V29, P1132, DOI 10.1128/JCM.29.6.1132-1136.1991; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Thomson NR, 2008, GENOME RES, V18, P161, DOI 10.1101/gr.7020108; Thomson NR, 2010, FUTURE MICROBIOL, V5, P555, DOI 10.2217/FMB.10.31; Unemo M, 2010, MICROBIOL-SGM, V156, P1394, DOI 10.1099/mic.0.036830-0; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; Wang YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016971	30	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31538	10.1371/journal.pone.0031538	http://dx.doi.org/10.1371/journal.pone.0031538			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363667	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700066
J	Sirmaci, A; Edwards, YJK; Akay, H; Tekin, M				Sirmaci, Asli; Edwards, Yvonne J. K.; Akay, Hatice; Tekin, Mustafa			Challenges in Whole Exome Sequencing: An Example from Hereditary Deafness	PLOS ONE			English	Article							DNA-BINDING; LINKER SEQUENCES; ZINC FINGERS; HEARING-LOSS; PROTEIN; MUTATIONS; RECOGNITION; AFFINITY; PEPTIDE; DISEASE	Whole exome sequencing provides unprecedented opportunities to identify causative DNA variants in rare Mendelian disorders. Finding the responsible mutation via traditional methods in families with hearing loss is difficult due to a high degree of genetic heterogeneity. In this study we combined autozygosity mapping and whole exome sequencing in a family with 3 affected children having nonsyndromic hearing loss born to consanguineous parents. Two novel missense homozygous variants, c.508C > A (p.H170N) in GIPC3 and c.1328C > T (p.T443M) in ZNF57, were identified in the same similar to 6 Mb autozygous region on chromosome 19 in affected members of the family. Both variants co-segregated with the phenotype and were absent in 335 ethnicity-matched controls. Biallelic GIPC3 mutations have recently been reported to cause autosomal recessive nonsyndromic sensorineural hearing loss. Thus we conclude that the hearing loss in the family described in this report is caused by a novel missense mutation in GIPC3. Identified variant in GIPC3 had a low read depth, which was initially filtered out during the analysis leaving ZNF57 as the only potential causative gene. This study highlights some of the challenges in the analyses of whole exome data in the bid to establish the true causative variant in Mendelian disease.	[Sirmaci, Asli; Edwards, Yvonne J. K.; Tekin, Mustafa] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Sirmaci, Asli; Edwards, Yvonne J. K.; Tekin, Mustafa] Univ Miami, Miller Sch Med, Dr John T Macdonald Dept Human Genet, Miami, FL 33136 USA; [Akay, Hatice] Veni Vidi Hosp, Radiodiagnost Unit, Diyarbakir, Turkey; [Tekin, Mustafa] Ankara Univ, Sch Med, Div Pediat Genet, TR-06100 Ankara, Turkey	University of Miami; University of Miami; Veni Vidi Hospital; Ankara University	Sirmaci, A (corresponding author), Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA.	mtekin@med.miami.edu	Akay, Hatice/AAD-8547-2021; Tekin, Mustafa/ABG-7627-2020	Akay, Hatice/0000-0002-0854-0904; Tekin, Mustafa/0000-0002-3525-7960; Edwards, Yvonne/0000-0001-8505-3168	National Institutes of Health - National Institute on Deafness and Other Communication Disorders [R01DC009645]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009645] Funding Source: NIH RePORTER	National Institutes of Health - National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by National Institutes of Health - National Institute on Deafness and Other Communication Disorders grant R01DC009645 to MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ahmed ZM, 2003, AM J HUM GENET, V72, P1315, DOI 10.1086/375122; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Asan, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r95; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Becker J, 2011, AM J HUM GENET, V88, P362, DOI 10.1016/j.ajhg.2011.01.015; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Charizopoulou N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1200; CHOO Y, 1993, NUCLEIC ACIDS RES, V21, P3341, DOI 10.1093/nar/21.15.3341; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Friedman TB, 2003, ANNU REV GENOM HUM G, V4, P341, DOI 10.1146/annurev.genom.4.070802.110347; Jantz D, 2004, P NATL ACAD SCI USA, V101, P7589, DOI 10.1073/pnas.0402191101; Laity JH, 2000, J MOL BIOL, V295, P719, DOI 10.1006/jmbi.1999.3406; LEE JS, 1993, P NATL ACAD SCI USA, V90, P6145, DOI 10.1073/pnas.90.13.6145; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MERIKA M, 1995, MOL CELL BIOL, V15, P2437; Montenegro G, 2011, ANN NEUROL, V69, P464, DOI 10.1002/ana.22235; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ostergaard P, 2011, J MED GENET, V48, P251, DOI 10.1136/jmg.2010.085563; PERKINS ND, 1994, MOL CELL BIOL, V14, P6570, DOI 10.1128/MCB.14.10.6570; Reed BC, 2005, MOL BIOL CELL, V16, P4183, DOI 10.1091/mbc.e04-11-0978; Rehman AU, 2011, HUMAN GENETICS; Sanborn JZ, 2011, NUCLEIC ACIDS RES, V39, pD951, DOI 10.1093/nar/gkq1113; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Segal DJ, 2006, J MOL BIOL, V363, P405, DOI 10.1016/j.jmb.2006.08.016; Singleton AB, 2011, LANCET NEUROL, V10, P942, DOI 10.1016/S1474-4422(11)70196-X; Sirmaci A, 2010, AM J HUM GENET, V87, P679, DOI 10.1016/j.ajhg.2010.09.018; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Stitziel NO, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-227; THUKRAL SK, 1991, P NATL ACAD SCI USA, V88, P9188, DOI 10.1073/pnas.88.20.9188; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010; Wang YQ, 2010, BMB REP, V43, P212, DOI 10.5483/BMBRep.2010.43.3.212; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Zhang W, 2011, BIOCHEM BIOPH RES CO, V413, P58, DOI 10.1016/j.bbrc.2011.08.043; Zuchner S, 2011, AM J HUM GENET, V88, P201, DOI 10.1016/j.ajhg.2011.01.001	41	35	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e32000	10.1371/journal.pone.0032000	http://dx.doi.org/10.1371/journal.pone.0032000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363784	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700132
J	Sogaard, C; Stenbaek, A; Bernard, S; Hadi, M; Driouich, A; Scheller, HV; Sakuragi, Y				Sogaard, Casper; Stenbaek, Anne; Bernard, Sophie; Hadi, Masood; Driouich, Azeddine; Scheller, Henrik Vibe; Sakuragi, Yumiko			GO-PROMTO Illuminates Protein Membrane Topologies of Glycan Biosynthetic Enzymes in the Golgi Apparatus of Living Tissues	PLOS ONE			English	Article							BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE; XYLOGLUCAN BIOSYNTHESIS; TRANSMEMBRANE TOPOLOGY; ENDOPLASMIC-RETICULUM; UDP-ARABINOFURANOSE; MOLECULAR-CLONING; PREDICTION; GENE; PLANTS; TRANSLOCATION	The Golgi apparatus is the main site of glycan biosynthesis in eukaryotes. Better understanding of the membrane topology of the proteins and enzymes involved can impart new mechanistic insights into these processes. Publically available bioinformatic tools provide highly variable predictions of membrane topologies for given proteins. Therefore we devised a non-invasive experimental method by which the membrane topologies of Golgi-resident proteins can be determined in the Golgi apparatus in living tissues. A Golgi marker was used to construct a series of reporters based on the principle of bimolecular fluorescence complementation. The reporters and proteins of interest were recombinantly fused to split halves of yellow fluorescent protein (YFP) and transiently co-expressed with the reporters in the Nicotiana benthamiana leaf tissue. Output signals were binary, showing either the presence or absence of fluorescence with signal morphologies characteristic of the Golgi apparatus and endoplasmic reticulum (ER). The method allows prompt and robust determinations of membrane topologies of Golgi-resident proteins and is termed GO-PROMTO (for GOlgi PROtein Membrane TOpology). We applied GO-PROMTO to examine the topologies of proteins involved in the biosynthesis of plant cell wall polysaccharides including xyloglucan and arabinan. The results suggest the existence of novel biosynthetic mechanisms involving transports of intermediates across Golgi membranes.	[Sogaard, Casper; Stenbaek, Anne; Sakuragi, Yumiko] Univ Copenhagen, Dept Plant Biol & Biotechnol, Fac Life Sci, Frederiksberg, Denmark; [Sogaard, Casper; Stenbaek, Anne; Sakuragi, Yumiko] Villum Kann Rasmussen Ctr ProAct Plants, Frederiksberg, Denmark; [Bernard, Sophie; Driouich, Azeddine] Univ Rouen, Lab Glycobiol & Matrice Extracellulaire EA 4358, Mont St Aignan, France; [Hadi, Masood] Sandia Natl Labs, Div Technol, Joint BioEnergy Inst, Emeryville, CA USA; [Scheller, Henrik Vibe] Lawrence Berkeley Natl Lab, Feedstocks Div, Joint BioEnergy Inst, Emeryville, CA USA	University of Copenhagen; Villum Fonden; Universite de Rouen Normandie; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Sandia National Laboratories; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Lawrence Berkeley National Laboratory	Sogaard, C (corresponding author), Univ Copenhagen, Dept Plant Biol & Biotechnol, Fac Life Sci, Frederiksberg, Denmark.	ysa@life.ku.dk	Scheller, Henrik/AAH-4770-2020; Scheller, Henrik V/A-8106-2008; Sakuragi, Yumiko/E-9707-2012	Scheller, Henrik/0000-0002-6702-3560; Scheller, Henrik V/0000-0002-6702-3560; Sakuragi, Yumiko/0000-0002-9405-5197	U.S. Department of Energy [DE-AC02-05CH11231]	U.S. Department of Energy(United States Department of Energy (DOE))	The Danish Council for Independent Research and Villum Kann Rasmussen foundation for YS. U.S. Department of Energy DE-AC02-05CH11231 for HVS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA Y, 1987, EMBO J, V6, P3465, DOI 10.1002/j.1460-2075.1987.tb02670.x; Barber C, 2006, J BIOL CHEM, V281, P17276, DOI 10.1074/jbc.M512727200; Bernsel A, 2005, PROTEIN SCI, V14, P1723, DOI 10.1110/ps.051395305; Bogdanov M, 2005, METHODS, V36, P148, DOI 10.1016/j.ymeth.2004.11.002; BOYD D, 1987, P NATL ACAD SCI USA, V84, P8525, DOI 10.1073/pnas.84.23.8525; Brach T, 2009, PLANT J, V57, P534, DOI 10.1111/j.1365-313X.2008.03704.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown DM, 2009, PLANT J, V57, P732, DOI 10.1111/j.1365-313X.2008.03729.x; Burget EG, 2003, PLANT CELL, V15, P523, DOI 10.1105/tpc.008425; Cavalier DM, 2008, PLANT CELL, V20, P1519, DOI 10.1105/tpc.108.059873; CHANG XB, 1994, J BIOL CHEM, V269, P18572; Chevalier L, 2010, PLANT J, V64, P977, DOI 10.1111/j.1365-313X.2010.04388.x; Cocuron JC, 2007, P NATL ACAD SCI USA, V104, P8550, DOI 10.1073/pnas.0703133104; COLLEY KJ, 1992, J BIOL CHEM, V267, P7784; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Davis J, 2010, PLANT J, V64, P1028, DOI 10.1111/j.1365-313X.2010.04392.x; DRIOUICH A, 1993, TRENDS BIOCHEM SCI, V18, P210, DOI 10.1016/0968-0004(93)90191-O; Dunkley TPJ, 2006, P NATL ACAD SCI USA, V103, P6518, DOI 10.1073/pnas.0506958103; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Egelund J, 2006, PLANT CELL, V18, P2593, DOI 10.1105/tpc.105.036566; Emr S, 2009, J CELL BIOL, V187, P449, DOI 10.1083/jcb.200909011; Faik A, 2000, J BIOL CHEM, V275, P15082, DOI 10.1074/jbc.M000677200; Gehl C, 2009, MOL PLANT, V2, P1051, DOI 10.1093/mp/ssp040; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Harholt J, 2006, PLANT PHYSIOL, V140, P49, DOI 10.1104/pp.105.072744; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Jensen JK, 2008, PLANT CELL, V20, P1289, DOI 10.1105/tpc.107.050906; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; Kauko A, 2010, J MOL BIOL, V397, P190, DOI 10.1016/j.jmb.2010.01.042; Kim H, 2006, P NATL ACAD SCI USA, V103, P11142, DOI 10.1073/pnas.0604075103; Konishi T, 2007, GLYCOBIOLOGY, V17, P345, DOI 10.1093/glycob/cwl081; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Madson M, 2003, PLANT CELL, V15, P1662, DOI 10.1105/tpc.009837; Magliery TJ, 2005, J AM CHEM SOC, V127, P146, DOI 10.1021/ja046699g; Melen K, 2003, J MOL BIOL, V327, P735, DOI 10.1016/S0022-2836(03)00182-7; Munoz P, 1996, PLANT PHYSIOL, V112, P1585, DOI 10.1104/pp.112.4.1585; MUNRO S, 1991, EMBO J, V10, P3577, DOI 10.1002/j.1460-2075.1991.tb04924.x; Norambuena L, 2002, J BIOL CHEM, V277, P32923, DOI 10.1074/jbc.M204081200; Pattathil S, 2005, PLANTA, V221, P538, DOI 10.1007/s00425-004-1471-7; Rapoport TA, 2004, TRENDS CELL BIOL, V14, P568, DOI 10.1016/j.tcb.2004.09.002; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rautengarten C, 2011, PLANT CELL, V23, P1373, DOI 10.1105/tpc.111.083931; Sakuragi Y, 2011, METHODS MOL BIOL, V715, P153, DOI 10.1007/978-1-61779-008-9_11; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Seshadri K, 1998, PROTEIN SCI, V7, P2026, DOI 10.1002/pro.5560070919; Swarup R, 2004, PLANT CELL, V16, P3069, DOI 10.1105/tpc.104.024737; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Viklund H, 2004, PROTEIN SCI, V13, P1908, DOI 10.1110/ps.04625404; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; Wallin E, 1997, PROTEIN SCI, V6, P808; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Wilkinson BM, 1996, J BIOL CHEM, V271, P25590, DOI 10.1074/jbc.271.41.25590; Wilson C, 2011, BIOCHEM J, V433, P1, DOI 10.1042/BJ20101058; WONG SH, 1992, J CELL BIOL, V117, P245, DOI 10.1083/jcb.117.2.245; Wu AM, 2009, PLANT J, V57, P718, DOI 10.1111/j.1365-313X.2008.03724.x; Wulff C, 2000, PLANT PHYSIOL, V122, P867, DOI 10.1104/pp.122.3.867; Yin L, 2011, MOL PLANT, V4, P1024, DOI 10.1093/mp/ssr026; Zabotina OA, 2008, PLANT J, V56, P101, DOI 10.1111/j.1365-313X.2008.03580.x; Zamyatnin AA, 2006, PLANT J, V46, P145, DOI 10.1111/j.1365-313X.2006.02674.x; Zeng WQ, 2008, PLANTA, V228, P823, DOI 10.1007/s00425-008-0785-2; ZHANG GF, 1992, PLANT PHYSIOL, V99, P1070, DOI 10.1104/pp.99.3.1070	67	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31324	10.1371/journal.pone.0031324	http://dx.doi.org/10.1371/journal.pone.0031324			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363620	gold, Green Submitted, Green Published			2022-12-27	WOS:000302873700049
J	Sui, Y; Horne, MK; Stanic, D				Sui, Yi; Horne, Malcolm K.; Stanic, Davor			Reduced Proliferation in the Adult Mouse Subventricular Zone Increases Survival of Olfactory Bulb Interneurons	PLOS ONE			English	Article							EXTERNAL PLEXIFORM LAYER; MICROTUBULE-ASSOCIATED PROTEIN; PRECURSOR CELL-PROLIFERATION; NEWLY GENERATED NEURONS; CENTRAL-NERVOUS-SYSTEM; NEWBORN NEURONS; MAMMALIAN BRAIN; RAT-BRAIN; TYROSINE-HYDROXYLASE; SENSORY EXPERIENCE	Neurogenesis in the adult brain is largely restricted to the subependymal zone (SVZ) of the lateral ventricle, olfactory bulb (OB) and the dentate subgranular zone, and survival of adult-born cells in the OB is influenced by factors including sensory experience. We examined, in mice, whether survival of adult-born cells is also regulated by the rate of precursor proliferation in the SVZ. Precursor proliferation was decreased by depleting the SVZ of dopamine after lesioning dopamine neurons in the substantia nigra compacta with 6-hydroxydopamine. Subsequently, we examined the effect of reduced SVZ proliferation on the generation, migration and survival of neuroblasts and mature adult-born cells in the SVZ, rostral migratory stream (RMS) and OB. Proliferating cells in the SVZ, measured by 5-bromo-2-deoxyuridine (BrdU) injected 2 hours prior to death or by immunoreactivity against Ki67, were reduced by 47% or 36%, respectively, 7 days after dopamine depletion, and by 29% or 31% 42 days after dopamine depletion, compared to sham-treated animals. Neuroblast generation in the SVZ and their migration along the RMS were not affected, neither 7 nor 42 days after the 6-hydroxydopamine injection, since the number of doublecortin-immunoreactive neuroblasts in the SVZ and RMS, as well as the number of neuronal nuclei-immunoreactive cells in the OB, were stable compared to control. However, survival analysis 15 days after 6-hydroxydopamine and 6 days after BrdU injections showed that the number of BrdU+ cells in the SVZ was 70% higher. Also, 42 days after 6-hydroxydopamine and 30 days after BrdU injections, we found an 82% increase in co-labeled BrdU+/gamma-aminobutyric acid-immunoreactive cell bodies in the granular cell layer, while double-labeled BrdU+/tyrosine hydroxylase-immunoreactive cell bodies in the glomerular layer increased by 148%. We conclude that the number of OB interneurons following reduced SVZ proliferation is maintained through an increased survival of adult-born precursor cells, neuroblasts and interneurons.	[Sui, Yi; Horne, Malcolm K.; Stanic, Davor] Univ Melbourne, Neurodegenerat Div, Florey Neurosci Inst, Parkville, Vic 3052, Australia; [Sui, Yi; Horne, Malcolm K.; Stanic, Davor] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3052, Australia; [Horne, Malcolm K.] St Vincents Hosp, Dept Neurol, Fitzroy, Vic 3065, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; St Vincent's Hospital Melbourne	Sui, Y (corresponding author), Univ Melbourne, Neurodegenerat Div, Florey Neurosci Inst, Parkville, Vic 3052, Australia.	dstanic@unimelb.edu.au	Horne, Malcolm/AAL-5214-2020; Sui, Yi/I-5278-2019	Horne, Malcolm/0000-0001-9427-2100; Sui, Yi/0000-0002-2898-7877; Stanic, Davor/0000-0002-4310-7030	Victorian Government; Operational Infrastructure Support Grant; Department and other Government agencies; National Health and Medical Research Council (NHMRC); NHMRC Australia [ID 300083]	Victorian Government; Operational Infrastructure Support Grant; Department and other Government agencies; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia)	The Florey Neuroscience Institutes acknowledge the strong support from the Victorian Government and in particular the funding from the Operational Infrastructure Support Grant. All funding received through the Department and other Government agencies are expended on the research activities and services to support the science. Y.S. is a recipient of an Australian Postgraduate Award. M.K.H. was supported by a National Health and Medical Research Council (NHMRC) Practitioner Fellowship. D.S. was supported by an NHMRC Australia CJ Martin Fellowship (ID 300083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Alonso M, 2006, J NEUROSCI, V26, P10508, DOI 10.1523/JNEUROSCI.2633-06.2006; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Baker SA, 2004, EUR J NEUROSCI, V20, P575, DOI 10.1111/j.1460-9568.2004.03486.x; Bauer S, 2003, NEUROSCIENCE, V117, P281, DOI 10.1016/S0306-4522(02)00757-1; Betarbet R, 1996, INT J DEV NEUROSCI, V14, P921, DOI 10.1016/S0736-5748(96)00066-4; Biebl M, 2000, NEUROSCI LETT, V291, P17, DOI 10.1016/S0304-3940(00)01368-9; Breton-Provencher V, 2009, J NEUROSCI, V29, P15245, DOI 10.1523/JNEUROSCI.3606-09.2009; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Cooper-Kuhn CM, 2004, J NEUROSCI RES, V77, P155, DOI 10.1002/jnr.20116; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; De Marchis S, 2007, J NEUROSCI, V27, P657, DOI 10.1523/JNEUROSCI.2870-06.2007; Doetsch F, 2005, CURR OPIN NEUROBIOL, V15, P121, DOI 10.1016/j.conb.2005.01.018; Doetsch F, 1997, J NEUROSCI, V17, P5046; Emsley JG, 2005, PROG NEUROBIOL, V75, P321, DOI 10.1016/j.pneurobio.2005.04.002; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Feierstein CE, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00176; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; FREEMAN WJ, 1972, J NEUROPHYSIOL, V35, P780, DOI 10.1152/jn.1972.35.6.780; Freundlieb N, 2006, J NEUROSCI, V26, P2321, DOI 10.1523/JNEUROSCI.4859-05.2006; GERDES J, 1984, J IMMUNOL, V133, P1710; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Giachino C, 2005, J NEUROSCI, V25, P10105, DOI 10.1523/JNEUROSCI.3512-05.2005; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Hannan AJ, 1999, J NEUROSCI RES, V55, P650, DOI 10.1002/(SICI)1097-4547(19990301)55:5<650::AID-JNR12>3.3.CO;2-J; Herold S, 2011, MOL CELL NEUROSCI, V46, P79, DOI 10.1016/j.mcn.2010.08.008; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; Hu HY, 1996, NEURON, V16, P735, DOI 10.1016/S0896-6273(00)80094-X; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; JACKOWSKI A, 1978, BRAIN RES, V159, P17, DOI 10.1016/0006-8993(78)90106-3; Kaneko N, 2006, GENES CELLS, V11, P1145, DOI 10.1111/j.1365-2443.2006.01010.x; KAPLAN MS, 1985, J COMP NEUROL, V239, P117, DOI 10.1002/cne.902390110; Kippin TE, 2005, J NEUROSCI, V25, P5815, DOI 10.1523/JNEUROSCI.1120-05.2005; Kosaka K, 2007, BRAIN RES, V1167, P42, DOI 10.1016/j.brainres.2007.04.087; Kosaka Katsuko, 2005, Anatomical Science International, V80, P80, DOI 10.1111/j.1447-073x.2005.00092.x; Kosaka T, 2011, NEUROSCI RES, V69, P93, DOI 10.1016/j.neures.2010.10.002; Lazarini F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007017; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Lledo PM, 2005, TRENDS NEUROSCI, V28, P248, DOI 10.1016/j.tins.2005.03.005; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Mandairon N, 2006, NEUROSCIENCE, V141, P443, DOI 10.1016/j.neuroscience.2006.03.066; MCLEAN JH, 1988, J NEUROSCI, V8, P3658; Mechawar N, 2004, P NATL ACAD SCI USA, V101, P9822, DOI 10.1073/pnas.0403361101; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mouret A, 2008, J NEUROSCI, V28, P11511, DOI 10.1523/JNEUROSCI.2954-08.2008; Nagayama S, 2004, J NEUROPHYSIOL, V91, P2532, DOI 10.1152/jn.01266.2003; Ninkovic J, 2010, NEURON, V68, P682, DOI 10.1016/j.neuron.2010.09.030; O'Keeffe GC, 2009, P NATL ACAD SCI USA, V106, P8754, DOI 10.1073/pnas.0803955106; Ohtani N, 2003, J NEUROSCI, V23, P2840; ORONA E, 1983, J COMP NEUROL, V217, P227, DOI 10.1002/cne.902170209; Panagiotakos G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000588; Paratcha G, 2006, MOL CELL NEUROSCI, V31, P505, DOI 10.1016/j.mcn.2005.11.007; Paratcha G, 2003, CELL, V113, P867, DOI 10.1016/S0092-8674(03)00435-5; Parish CL, 2005, NEUROBIOL DIS, V19, P301, DOI 10.1016/j.nbd.2005.01.009; Parish CL, 2001, J NEUROSCI, V21, P5147, DOI 10.1523/JNEUROSCI.21-14-05147.2001; Paxinos G., 2001, MOUSE BRAIN STEREOTA; PEASE DC, 1962, ANAT REC, V142, P342; Petreanu L, 2002, J NEUROSCI, V22, P6106; RAKIC P, 1971, J COMP NEUROL, V141, P283, DOI 10.1002/cne.901410303; RALL W, 1966, EXP NEUROL, V14, P44, DOI 10.1016/0014-4886(66)90023-9; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; ROGERS JH, 1992, NEUROSCIENCE, V51, P843, DOI 10.1016/0306-4522(92)90525-7; ROGERS JH, 1992, BRAIN RES, V587, P203, DOI 10.1016/0006-8993(92)90998-O; Rosselli-Austin L, 1979, J Dev Physiol, V1, P295; SHEPHERD GM, 1972, PHYSIOL REV, V52, P864, DOI 10.1152/physrev.1972.52.4.864; Shipley MT, 1996, J NEUROBIOL, V30, P123; SHIPLEY MT, 1996, HAND CHEM N, V12, P469; Stanic D, 2003, EUR J NEUROSCI, V18, P1175, DOI 10.1046/j.1460-9568.2003.02800.x; Stanic D, 2010, J COMP NEUROL, V518, P770, DOI 10.1002/cne.22226; Sultan S, 2010, FASEB J, V24, P2355, DOI 10.1096/fj.09-151456; Sultan S, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00052; Tada E, 1999, EXP NEUROL, V160, P66, DOI 10.1006/exnr.1999.7172; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; Valley MT, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.003.2009; Veyrac A, 2005, EXP NEUROL, V194, P444, DOI 10.1016/j.expneurol.2005.03.004; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Whitman MC, 2009, PROG NEUROBIOL, V89, P162, DOI 10.1016/j.pneurobio.2009.07.003; Winner B, 2006, EXP NEUROL, V197, P113, DOI 10.1016/j.expneurol.2005.08.028; Winner B, 2002, EUR J NEUROSCI, V16, P1681, DOI 10.1046/j.1460-9568.2002.02238.x; Winner B, 2009, EXP NEUROL, V219, P543, DOI 10.1016/j.expneurol.2009.07.013; Yamaguchi M, 2005, P NATL ACAD SCI USA, V102, P9697, DOI 10.1073/pnas.0406082102; Yang P, 2008, J NEUROSCI, V28, P2231, DOI 10.1523/JNEUROSCI.3574-07.2008; Yang Z, 2008, J COMP NEUROL, V506, P347, DOI 10.1002/cne.21557; ZAMBONI L, 1967, J CELL BIOL, V35, pA148	90	31	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31549	10.1371/journal.pone.0031549	http://dx.doi.org/10.1371/journal.pone.0031549			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363671	Green Published, gold			2022-12-27	WOS:000302873700069
J	Santiago-Alarcon, D; Havelka, P; Schaefer, HM; Segelbacher, G				Santiago-Alarcon, Diego; Havelka, Peter; Schaefer, Hinrich Martin; Segelbacher, Gernot			Bloodmeal Analysis Reveals Avian Plasmodium Infections and Broad Host Preferences of Culicoides (Diptera: Ceratopogonidae) Vectors	PLOS ONE			English	Article							AFRICAN RAIN-FOREST; BITING MIDGES; PARASITES; MALARIA; ASSOCIATIONS; MOSQUITOS; PATTERNS	Changing environmental conditions and human encroachment on natural habitats bring human populations closer to novel sources of parasites, which might then develop into new emerging diseases. Diseases transmitted by host generalist vectors are of special interest due to their capacity to move pathogens into novel hosts. We hypothesize that humans using forests for recreation are exposed to a broad range of parasites from wild animals and their vectors. A corollary of this is that new vector-host, parasite-host, and vector-parasite associations could eventually develop. Thus, we expect to observe atypical vector-host associations. Using molecular bloodmeal analysis via amplification of the mtDNA COI gene we identified the vertebrate hosts of Culicoides (Diptera: Ceratopogonidae) species in a sub-urban forest of Southwestern Germany. Bloodmeals were also checked for haemosporidian infections by amplifying a fragment of the mtDNA cyt b gene. We identified a total of 20 Culicoides species, thirteen of which fed on humans. From 105 screened bloodmeals we obtained high quality sequences for 77 samples, 73 (94.8%) originated from humans, two from livestock (Bos taurus and Equus caballus), and two from wild birds (Sylvia atricapilla and Turdus merula). We found that four Culicoides species previously assumed to feed exclusively on either birds (C. kibunensis) or domestic mammals (C. chiopterus, C. deltus, C. scoticus) fed also on humans. A total of six Culicoides abdomens were infected with avian haemosporidian parasites (Plasmodium or Haemoproteus), four of those abdomens contained blood derived from humans. Our results suggest that parasites of wild animals may be transferred to humans through infectious bites of Culicoides vectors. Further, we show that Culicoides vectors believed to be a specialist on specific vertebrate groups can have plastic feeding preferences, and that Culicoides are susceptible to infection by Plasmodium parasites, though vector viability must still be experimentally demonstrated.	[Santiago-Alarcon, Diego] Inst Ecol AC, Xalapa, Veracruz, Mexico; [Havelka, Peter] Staatliches Museum Nat Kunde, Dept Zool, Karlsruhe, Baden Wurttembe, Germany; [Santiago-Alarcon, Diego; Schaefer, Hinrich Martin] Univ Freiburg, Dept Ecol & Evolutionary Biol, D-79106 Freiburg, Baden Wurttembe, Germany; [Segelbacher, Gernot] Univ Freiburg, Dept Wildlife Ecol & Management, D-79106 Freiburg, Baden Wurttembe, Germany	Instituto de Ecologia - Mexico; University of Freiburg; University of Freiburg	Santiago-Alarcon, D (corresponding author), Inst Ecol AC, Xalapa, Veracruz, Mexico.	diego.santiago@inecol.edu.mx	Segelbacher, Gernot/F-3633-2011; Santiago-Alarcon, Diego/G-2485-2018; Santiago-Alarcon, Diego/AAF-3641-2020	Segelbacher, Gernot/0000-0002-8024-7008; Santiago-Alarcon, Diego/0000-0002-4914-5580; Santiago-Alarcon, Diego/0000-0002-4914-5580	Deutsche Forschungsgemeinschaft [1008/6-1]; Wissenschaftliche Gesellschaft Freiburg; Alexander von Humboldt Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wissenschaftliche Gesellschaft Freiburg; Alexander von Humboldt Stiftung(Alexander von Humboldt Foundation)	This research was funded through an Alexander von Humboldt Stiftung (http://www.humboldt-foundation.de/web/start.html) postdoctoral grant to DS-A, Deutsche Forschungsgemeinschaft to HMS (1008/6-1), and by the Wissenschaftliche Gesellschaft Freiburg to HMS and GS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007092; Bartsch S, 2009, PARASITOL RES, V105, P373, DOI 10.1007/s00436-009-1408-y; BENNETT GORDON F., 1960, CANADIAN JOUR ZOOL, V38, P377, DOI 10.1139/z60-042; BRAVERMAN Y, 1977, RHOD J AGR RES, V15, P101; BURYLOVA A M, 1975, Parazitologiya (St. Petersburg), V9, P197; BUTENKO O M, 1967, Byulleten' Moskovskogo Obshchestva Ispytatelei Prirody Otdel Biologicheskii, V72, P132; CALISHER CH, 1994, CLIN MICROBIOL REV, V7, P89, DOI 10.1128/CMR.7.1.89-116.1994; Chasar A, 2009, MOL ECOL, V18, P4121, DOI 10.1111/j.1365-294X.2009.04346.x; Coggeshall L. T., 1940, J PARASITOL, V26, pS44; Delecolle J. C., 1985, THESIS U L PASTEUR S, P1; Enayati A, 2010, ANNU REV ENTOMOL, V55, P569, DOI 10.1146/annurev-ento-112408-085423; Ewald PW, 1994, EVOLUTION INFECT DIS; Fritz H. G., 1982, THESIS TH DARMSTADT, P108; Gethmann J, 2010, TIERAERZTL UMSCHAU, V65, P4; HAVELKA P, 1976, Beitraege zur Entomologie, V26, P211; Hofmeister EK, 2011, INTEGR ZOOL, V6, P279, DOI 10.1111/j.1749-4877.2011.00251.x; HUFF CLAY G., 1929, ANN TROP MED & PARASIT [LIVERPOOL], V23, P427; Ishtiaq F, 2008, MOL ECOL, V17, P4545, DOI 10.1111/j.1365-294X.2008.03935.x; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; KITAOKA S., 1965, Japanese Journal of Sanitary Zoology, V16, P244; Kremer M., 1965, ENCY ENT A, V11, P3; Lefevre T, 2009, AM J TROP MED HYG, V81, P1023, DOI 10.4269/ajtmh.2009.09-0124; Martinez-de la Puente J, 2011, MOL ECOL, V20, P3275, DOI 10.1111/j.1365-294X.2011.05136.x; Martinsen ES, 2008, MOL PHYLOGENET EVOL, V47, P261, DOI 10.1016/j.ympev.2007.11.012; MAYNE BRUCE, 1928, INDIAN JOUR MED RES, V16, P557; MCGHEE RB, 1951, J INFECT DIS, V88, P86, DOI 10.1093/infdis/88.1.86; McLendon SB, 1943, AM J HYG, V37, P19, DOI 10.1093/oxfordjournals.aje.a118839; Mehlhorn H, 2007, PARASITOL RES, V101, P219, DOI 10.1007/s00436-007-0519-6; Mehlhorn H, 2008, PARASITOL RES, V103, pS79, DOI 10.1007/s00436-008-1100-7; MICKS D. W., 1949, JOUR NATION MALARIA SOC, V8, P206; MINAR JAN, 1965, CESK PARAZITOL, V12, P197; NIELSEN B O, 1971, Entomologica Scandinavica, V2, P94; Nielsen B. O., 1964, ENTOMLOGISKE MEDDELE, VXXXII, P261; Njabo KY, 2011, MOL ECOL, V20, P1049, DOI 10.1111/j.1365-294X.2010.04904.x; Orszagh I., 1976, Acta Facultatis Rerum Naturalium Universitatis Comenianae Series Zoologia, V21, P1; PACLT J, 1970, Biologia (Bratislava), V25, P751; Quan M, 2008, J GEN VIROL, V89, P1159, DOI 10.1099/vir.0.83502-0; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Szadziewski R., 1984, POLSKIE PISMO ENTOMO, V53, P559; Trager William, 1942, JOUR PARASITOL, V28, P457, DOI 10.2307/3272906; Valkiunas G, AVIAN MALARIA PARASI; Valkiunas G, 2009, J PARASITOL, V95, P1512, DOI 10.1645/GE-2105.1; Waldenstrom J, 2004, J PARASITOL, V90, P191, DOI 10.1645/GE-3221RN	43	75	78	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31098	10.1371/journal.pone.0031098	http://dx.doi.org/10.1371/journal.pone.0031098			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363557	Green Published, gold, Green Submitted			2022-12-27	WOS:000302871500026
J	Amarnath, S; Kawli, T; Mohanty, S; Srinivasan, N; Nanjundiah, V				Amarnath, Smita; Kawli, Trupti; Mohanty, Smita; Srinivasan, Narayanaswamy; Nanjundiah, Vidyanand			Pleiotropic Roles of a Ribosomal Protein in Dictyostelium discoideum	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; DEVELOPMENTAL REGULATION; POLARITY ESTABLISHMENT; ACTIN CYTOSKELETON; DOSAGE SENSITIVITY; FOLD RECOGNITION; MESSENGER-RNA; GENE; YEAST	The cell cycle phase at starvation influences post-starvation differentiation and morphogenesis in Dictyostelium discoideum. We found that when expressed in Saccharomyces cerevisiae, a D. discoideum cDNA that encodes the ribosomal protein S4 (DdS4) rescues mutations in the cell cycle genes cdc24, cdc42 and bem1. The products of these genes affect morphogenesis in yeast via a coordinated moulding of the cytoskeleton during bud site selection. D. discoideum cells that over-or under-expressed DdS4 did not show detectable changes in protein synthesis but displayed similar developmental aberrations whose intensity was graded with the extent of over-or under-expression. This suggested that DdS4 might influence morphogenesis via a stoichiometric effect - specifically, by taking part in a multimeric complex similar to the one involving Cdc24p, Cdc42p and Bem1p in yeast. In support of the hypothesis, the S. cerevisiae proteins Cdc24p, Cdc42p and Bem1p as well as their D. discoideum cognates could be co-precipitated with antibodies to DdS4. Computational analysis and mutational studies explained these findings: a C-terminal domain of DdS4 is the functional equivalent of an SH3 domain in the yeast scaffold protein Bem1p that is central to constructing the bud site selection complex. Thus in addition to being part of the ribosome, DdS4 has a second function, also as part of a multi-protein complex. We speculate that the existence of the second role can act as a safeguard against perturbations to ribosome function caused by spontaneous variations in DdS4 levels.	[Amarnath, Smita; Kawli, Trupti; Nanjundiah, Vidyanand] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India; [Mohanty, Smita; Srinivasan, Narayanaswamy] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Amarnath, S (corresponding author), Univ Texas Austin, Dept Mol Cellular & Dev Biol, Austin, TX 78712 USA.	smita-nms@mail.utexas.edu	Mohanty, Smita/AAP-2969-2021					Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; ANAND S, 1987, BIOCHEM INT, V14, P963; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; ATKINS JF, 1972, P NATL ACAD SCI USA, V69, P1192, DOI 10.1073/pnas.69.5.1192; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bates PA, 2001, PROTEINS, P39; BEACH D, 1982, NATURE, V300, P706, DOI 10.1038/300706a0; BENDER A, 1989, P NATL ACAD SCI USA, V86, P9976, DOI 10.1073/pnas.86.24.9976; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bonner JT, 1967, CELLULAR SLIME MOLDS, p[x, 205]; Bose I, 2001, J BIOL CHEM, V276, P7176, DOI 10.1074/jbc.M010546200; Boutet Emmanuel, 2007, V406, P89; Butty AC, 2002, EMBO J, V21, P1565, DOI 10.1093/emboj/21.7.1565; Casamayor A, 2002, CURR OPIN MICROBIOL, V5, P179, DOI 10.1016/S1369-5274(02)00300-4; CORNEY AJ, 1990, MOL MICROBIOL, V4, P613, DOI 10.1111/j.1365-2958.1990.tb00630.x; Danilova N, 2008, BLOOD, V112, P5228, DOI 10.1182/blood-2008-01-132290; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eichinger L, 1999, MICROSC RES TECHNIQ, V47, P124, DOI 10.1002/(SICI)1097-0029(19991015)47:2<124::AID-JEMT5>3.0.CO;2-8; Erijman A, 2011, BIOCHEMISTRY-US, V50, P602, DOI 10.1021/bi101563v; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Ferraro E, 2007, NUCLEIC ACIDS RES, V35, pW451, DOI 10.1093/nar/gkm296; Fields SD, 1998, J CELL SCI, V111, P1717; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Goldenberg O, 2009, NUCLEIC ACIDS RES, V37, pD323, DOI 10.1093/nar/gkn822; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; HALL A, 1994, ANNU REV CELL BIOL, V10, P31, DOI 10.1146/annurev.cb.10.110194.000335; HIRASHIMA A, 1972, J MOL BIOL, V65, P43, DOI 10.1016/0022-2836(72)90490-1; Hodgkin J, 1998, INT J DEV BIOL, V42, P501; Huberts DHEW, 2010, BBA-MOL CELL RES, V1803, P520, DOI 10.1016/j.bbamcr.2010.01.022; HUTTER KJ, 1979, J GEN MICROBIOL, V113, P369, DOI 10.1099/00221287-113-2-369; Ibarra N, 2006, CURR BIOL, V16, P717, DOI 10.1016/j.cub.2006.02.068; Inazu Y, 1999, DEV GENET, V25, P339, DOI 10.1002/(SICI)1520-6408(1999)25:4<339::AID-DVG8>3.0.CO;2-3; Irazoqui JE, 2004, J CELL SCI, V117, P2169, DOI 10.1242/jcs.00953; Jones DT, 1999, J MOL BIOL, V287, P797, DOI 10.1006/jmbi.1999.2583; Kajan L, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-304; KLEBE RJ, 1983, GENE, V25, P333, DOI 10.1016/0378-1119(83)90238-X; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; KNECHT DA, 1986, MOL CELL BIOL, V6, P3973, DOI 10.1128/MCB.6.11.3973; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lee E, 2001, EUR J CELL BIOL, V80, P399, DOI 10.1078/0171-9335-00177; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Mazumder B, 2003, CELL, V115, P187, DOI 10.1016/S0092-8674(03)00773-6; MCDONALD SA, 1984, J CELL SCI, V66, P195; MICHAELIS C, 1993, BIOCHIM BIOPHYS ACTA, V1179, P117, DOI 10.1016/0167-4889(93)90132-9; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; Mondal S, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-23; Moskow JJ, 2000, MOL CELL BIOL, V20, P7559, DOI 10.1128/MCB.20.20.7559-7571.2000; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Para A, 2009, MOL BIOL CELL, V20, P699, DOI 10.1091/mbc.E08-09-0899; Park KC, 2004, EMBO J, V23, P4177, DOI 10.1038/sj.emboj.7600368; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Pikzack C, 2005, CELL MOTIL CYTOSKEL, V62, P210, DOI 10.1002/cm.20098; PODKOVYROV S, 1995, FEBS LETT, V368, P429, DOI 10.1016/0014-5793(95)00702-B; Pollitt AY, 2008, CURR BIOL, V18, P203, DOI 10.1016/j.cub.2008.01.026; PROFFITT JA, 1991, NUCLEIC ACIDS RES, V19, P3867, DOI 10.1093/nar/19.14.3867; Raper KB, 1984, DICTYOSTELIDS, p[x, 453]; Rivero F, 2001, NUCLEIC ACIDS RES, V29, P1068, DOI 10.1093/nar/29.5.1068; SARAN S, 1994, DIFFERENTIATION, V57, P163, DOI 10.1046/j.1432-0436.1994.5730163.x; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; SLOAT BF, 1981, J CELL BIOL, V89, P395, DOI 10.1083/jcb.89.3.395; Souza GM, 1998, DEVELOPMENT, V125, P2291; Stansfield I, 1998, J MOL BIOL, V282, P13, DOI 10.1006/jmbi.1998.1976; Tapparo A, 1998, CURR GENET, V34, P410, DOI 10.1007/s002940050415; Uechi T, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000037; Veitia RA, 2003, J THEOR BIOL, V220, P19, DOI 10.1006/jtbi.2003.3105; Wang S, 2010, NEOPLASIA, V12, P284, DOI 10.1593/neo.91610; WATTS DJ, 1970, BIOCHEM J, V119, P171, DOI 10.1042/bj1190171; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wilkins A, 2001, TRENDS GENET, V17, P41, DOI 10.1016/S0168-9525(00)02181-8; Wilson D, 2007, NUCLEIC ACIDS RES, V35, pD308, DOI 10.1093/nar/gkl910; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8; WRIGHT S, 1964, AM NAT, V98, P65, DOI 10.1086/282301; Yamaguchi Y, 2007, J BIOL CHEM, V282, P29, DOI 10.1074/jbc.M609308200	81	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30644	10.1371/journal.pone.0030644	http://dx.doi.org/10.1371/journal.pone.0030644			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363460	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000302853600047
J	Janzen, G; Haun, DBM; Levinson, SC				Janzen, Gabriele; Haun, Daniel B. M.; Levinson, Stephen C.			Tracking Down Abstract Linguistic Meaning: Neural Correlates of Spatial Frame of Reference Ambiguities in Language	PLOS ONE			English	Article							NAVIGATION; REPRESENTATIONS; ORGANIZATION; HIPPOCAMPUS; COGNITION; MEMORY; FMRI	This functional magnetic resonance imaging (fMRI) study investigates a crucial parameter in spatial description, namely variants in the frame of reference chosen. Two frames of reference are available in European languages for the description of small-scale assemblages, namely the intrinsic (or object-oriented) frame and the relative (or egocentric) frame. We showed participants a sentence such as "the ball is in front of the man'', ambiguous between the two frames, and then a picture of a scene with a ball and a man - participants had to respond by indicating whether the picture did or did not match the sentence. There were two blocks, in which we induced each frame of reference by feedback. Thus for the crucial test items, participants saw exactly the same sentence and the same picture but now from one perspective, now the other. Using this method, we were able to precisely pinpoint the pattern of neural activation associated with each linguistic interpretation of the ambiguity, while holding the perceptual stimuli constant. Increased brain activity in bilateral parahippocampal gyrus was associated with the intrinsic frame of reference whereas increased activity in the right superior frontal gyrus and in the parietal lobe was observed for the relative frame of reference. The study is among the few to show a distinctive pattern of neural activation for an abstract yet specific semantic parameter in language. It shows with special clarity the nature of the neural substrate supporting each frame of spatial reference.	[Janzen, Gabriele] Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands; [Janzen, Gabriele; Levinson, Stephen C.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Haun, Daniel B. M.; Levinson, Stephen C.] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Haun, Daniel B. M.] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany	Radboud University Nijmegen; Radboud University Nijmegen; Max Planck Society; Max Planck Society	Janzen, G (corresponding author), Radboud Univ Nijmegen, Inst Behav Sci, NL-6525 ED Nijmegen, Netherlands.	gabriele.janzen@donders.ru.nl	Janzen, Gabriele/G-2058-2012		Netherlands Organization for Scientific Research [452-07-015]; European Commission (ERC) [204643]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Commission (ERC)(European CommissionEuropean Commission Joint Research CentreEuropean Research Council (ERC))	This work was supported by the Netherlands Organization for Scientific Research (Vidi Grant No. 452-07-015), and the European Commission (ERC Starting Independent Researcher Grant No. 204643). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; Amorapanth PX, 2010, J COGNITIVE NEUROSCI, V22, P1739, DOI 10.1162/jocn.2009.21322; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; BURGESS N, 1999, HIPPOCAMPAL PARIETAL; Chatterjee Anjan, 2008, Seminars in Speech and Language, V29, P226, DOI 10.1055/s-0028-1082886; Cohen YE, 2002, NAT REV NEUROSCI, V3, P553, DOI 10.1038/nrn873; Committeri G, 2004, J COGNITIVE NEUROSCI, V16, P1517, DOI 10.1162/0898929042568550; Damasio H, 2001, NEUROIMAGE, V13, P1053, DOI 10.1006/nimg.2001.0775; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Epstein R, 2003, NEURON, V37, P865, DOI 10.1016/S0896-6273(03)00117-X; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Hagoort P, 2000, NEUROPSYCHOLOGIA, V38, P1531, DOI 10.1016/S0028-3932(00)00053-1; Hartley T, 2004, COGNITION, V94, P39, DOI 10.1016/j.cognition.2003.12.001; Haun DBM, 2006, P NATL ACAD SCI USA, V103, P17568, DOI 10.1073/pnas.0607999103; Haun DBM, 2009, CURR BIOL, V19, pR1068, DOI 10.1016/j.cub.2009.10.041; Janzen G, 2004, NAT NEUROSCI, V7, P673, DOI 10.1038/nn1257; Janzen G, 2007, CEREB CORTEX, V17, P975, DOI 10.1093/cercor/bhl008; Janzen G, 2010, NEUROIMAGE, V52, P364, DOI 10.1016/j.neuroimage.2010.03.083; Jordan K, 2004, NEUROREPORT, V15, P135, DOI 10.1097/00001756-200401190-00026; Kemmerer D, 2005, NEUROPSYCHOLOGIA, V43, P797, DOI 10.1016/j.neuropsychologia.2004.06.025; Kemmerer D, 2000, COGN NEUROPSYCHOL, V17, P393, DOI 10.1080/026432900410766; Kosslyn SM, 1998, PSYCHOBIOLOGY, V26, P333; Kranjec A, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00240; Levelt W., 1989, SPEAKING INTENTION A; Levinson S. C., 2003, SPACE LANGUAGE COGNI; Levinson SC, 2002, COGNITION, V84, P155, DOI 10.1016/S0010-0277(02)00045-8; Lumer ED, 1999, P NATL ACAD SCI USA, V96, P1669, DOI 10.1073/pnas.96.4.1669; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; Maguire EA, 1998, J COGNITIVE NEUROSCI, V10, P61, DOI 10.1162/089892998563789; Majid A, 2004, TRENDS COGN SCI, V8, P108, DOI 10.1016/j.tics.2004.01.003; Mason RA, 2007, BRAIN RES, V1146, P115, DOI 10.1016/j.brainres.2007.02.076; MAYEUX R, 1985, PRINCIPLES NEURAL SC, P688; Neggers SFW, 2005, ACTA PSYCHOL, V118, P25, DOI 10.1016/j.actpsy.2004.10.002; Noordzij ML, 2008, NEUROPSYCHOLOGIA, V46, P1576, DOI 10.1016/j.neuropsychologia.2007.12.022; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Pearson JM, 2011, TRENDS COGN SCI, V15, P143, DOI 10.1016/j.tics.2011.02.002; Pitts MA, 2009, PSYCHOPHYSIOLOGY, V46, P694, DOI 10.1111/j.1469-8986.2009.00822.x; Pulvermuller F, 2001, TRENDS COGN SCI, V5, P517, DOI 10.1016/S1364-6613(00)01803-9; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; Rosenbaum RS, 2004, HIPPOCAMPUS, V14, P826, DOI 10.1002/hipo.10218; Schoth F, 2007, NEUROREPORT, V18, P1335, DOI 10.1097/WNR.0b013e3281668007; Talairach J., 1988, COPLANAR STEREOTAXIC; Uchiyama Y, 2008, NEUROSCI RES, V61, P309, DOI 10.1016/j.neures.2008.03.013; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Vallar G, 1999, EXP BRAIN RES, V124, P281, DOI 10.1007/s002210050624; Wallentin M, 2008, NEUROPSYCHOLOGIA, V46, P399, DOI 10.1016/j.neuropsychologia.2007.08.014; WARRINGTON EK, 1984, BRAIN, V107, P829, DOI 10.1093/brain/107.3.829; Wu DH, 2008, NEUROPSYCHOLOGIA, V46, P704, DOI 10.1016/j.neuropsychologia.2007.09.016; Zaehle T, 2007, BRAIN RES, V1137, P92, DOI 10.1016/j.brainres.2006.12.044	53	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30657	10.1371/journal.pone.0030657	http://dx.doi.org/10.1371/journal.pone.0030657			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926TC	22363462	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600048
J	Kleiven, AR; Olsen, EM; Volstad, JH				Kleiven, Alf Ring; Olsen, Esben Moland; Volstad, Jon Helge			Total Catch of a Red-Listed Marine Species Is an Order of Magnitude Higher than Official Data	PLOS ONE			English	Article							LOBSTER HOMARUS-GAMMARUS; RECREATIONAL FISHERY; ESTIMATING ILLEGAL; FISHING EFFORT; ROCK LOBSTER; MANAGEMENT	Accurate information on total catch and effort is essential for successful fisheries management. Officially reported landings, however, may be underestimates of total catch in many fisheries. We investigated the fishery for the nationally red-listed European lobster (Homarus gammarus) in south-eastern Norway. Probability-based strip transect surveys were used to count buoys in the study area in combination with catch per unit effort data obtained independently from volunteer catch diaries, phone interviews, and questionnaires. We estimate that recreational catch accounts for 65% of total catch in the study area. Moreover, our results indicate that only a small proportion (24%) of lobsters landed commercially were sold through the legal market and documented. Total estimated lobster catch was nearly 14 times higher than reported officially. Our study highlights the need for adequate catch monitoring and data collection efforts in coastal areas, presents a clear warning to resource managers that illegal, unreported and unregulated (IUU) fisheries in coastal areas should not be ignored, and shows the potential impact of recreational fisheries.	[Kleiven, Alf Ring; Olsen, Esben Moland] IMR, Arendal, Norway; [Kleiven, Alf Ring] Univ Tromso, Fac Biosci Fisheries & Econ, Tromso, Norway; [Olsen, Esben Moland] Univ Oslo, Dept Biol, CEES, Oslo, Norway; [Volstad, Jon Helge] IMR, Bergen, Norway	Institute of Marine Research - Norway; UiT The Arctic University of Tromso; University of Oslo; Institute of Marine Research - Norway	Kleiven, AR (corresponding author), IMR, Arendal, Norway.	alf.ring.kleiven@imr.no	Vølstad, Jon/B-7451-2014; Olsen, Esben Moland/B-1894-2012; Vølstad, Jon Helge/V-2992-2019; Kleiven, Alf/J-3650-2012; Kleiven, Alf Ring/ABK-6111-2022	Vølstad, Jon/0000-0001-8738-8543; Olsen, Esben Moland/0000-0003-3807-7524; Kleiven, Alf/0000-0002-9330-8340; 	Research Council of Norway [178376/S40]	Research Council of Norway(Research Council of Norway)	This research was funded by the Research Council of Norway, project number: 178376/S40 (http://www.forskningsraadet.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004570; Ainsworth CH, 2005, FISH RES, V75, P40, DOI 10.1016/j.fishres.2005.05.003; Arlinghaus R, 2006, N AM J FISH MANAGE, V26, P592, DOI 10.1577/M04-220.1; Cockcroft AC, 1997, S AFR J MARINE SCI, V18, P75; Coleman FC, 2004, SCIENCE, V305, P1958, DOI 10.1126/science.1100397; Gavin MC, 2010, CONSERV BIOL, V24, P89, DOI 10.1111/j.1523-1739.2009.01387.x; GOODMAN LA, 1960, J AM STAT ASSOC, V55, P708, DOI 10.2307/2281592; HOLLAND S M, 1992, North American Journal of Fisheries Management, V12, P28, DOI 10.1577/1548-8675(1992)012&lt;0028:FTSATO&gt;2.3.CO;2; King DM, 2010, MAR POLICY, V34, P7, DOI 10.1016/j.marpol.2009.04.023; Kleiven AR, 2011, MAR COAST FISH, V3, P383, DOI 10.1080/19425120.2011.638798; Le Gallic B, 2006, MAR POLICY, V30, P689, DOI 10.1016/j.marpol.2005.09.008; Lewin WC, 2006, REV FISH SCI, V14, P305, DOI 10.1080/10641260600886455; Lyle JM, 2005, NEW ZEAL J MAR FRESH, V39, P703, DOI 10.1080/00288330.2005.9517346; McCluskey SM, 2008, FISH FISH, V9, P188, DOI 10.1111/j.1467-2979.2008.00283.x; McPhee D. P., 2002, Pacific Conservation Biology, V8, P40; Moland E, 2011, CAN J FISH AQUAT SCI, V68, P1197, DOI 10.1139/F2011-053; Muller R. G., 2000, 2000 UPDATE STOCK AS; National Research Council, 2006, REV RECR FISH SURV M; Norwegian Ministry of Fisheries and Coastal Affairs, 2010, NORW FISH MAN WEB BA; Olsen, 2009, INTEGRATED COASTAL Z, P178, DOI DOI 10.1002/9781444316285.CH14; Oug E, 2006, NORSK RODLISTE 2006, P197; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Pauly D, 2009, SCI MAR, V73, P215, DOI 10.3989/scimar.2009.73n2215; Pitcher T, 2009, NATURE, V457, P658, DOI 10.1038/457658a; Pitcher TJ, 2002, FISH FISH, V3, P317, DOI 10.1046/j.1467-2979.2002.00093.x; Pitcher TJ, 2009, MAR POLICY, V33, P223, DOI 10.1016/j.marpol.2008.06.002; Pollock K. H., 1994, ANGLER SURVEYS THEIR; Schenker N, 2001, AM STAT, V55, P182, DOI 10.1198/000313001317097960; Schroeder DM, 2002, CAL COOP OCEAN FISH, V43, P182; Stokke OS, 2009, MAR POLICY, V33, P339, DOI 10.1016/j.marpol.2008.08.002; Sumaila UR, 2006, MAR POLICY, V30, P696, DOI 10.1016/j.marpol.2005.11.001; Varkey DA, 2010, MAR POLICY, V34, P228, DOI 10.1016/j.marpol.2009.06.009	32	37	37	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31216	10.1371/journal.pone.0031216	http://dx.doi.org/10.1371/journal.pone.0031216			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363583	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600124
J	Kushki, A; Andrews, AJ; Power, SD; King, G; Chau, T				Kushki, Azadeh; Andrews, Alexander J.; Power, Sarah D.; King, Gillian; Chau, Tom			Classification of Activity Engagement in Individuals with Severe Physical Disabilities Using Signals of the Peripheral Nervous System	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACE; STUDENT ENGAGEMENT; COMMUNICATION; TECHNOLOGIES; AUTISM; STATE	Communication barriers often result in exclusion of children and youth with disabilities from activities and social settings that are essential to their psychosocial development. In particular, difficulties in describing their experiences of activities and social settings hinder our understanding of the factors that promote inclusion and participation of this group of individuals. To address this specific communication challenge, we examined the feasibility of developing a language-free measure of experience in youth with severe physical disabilities. To do this, we used the activity of the peripheral nervous system to detect patterns of psychological arousal associated with activities requiring different patterns of cognitive/affective and interpersonal involvement (activity engagement). We demonstrated that these signals can differentiate among patterns of arousal associated with these activities with high accuracy (two levels: 81%, three levels: 74%). These results demonstrate the potential for development of a real-time, motor-and language-free measure for describing the experiences of children and youth with disabilities.	[Kushki, Azadeh; Andrews, Alexander J.; Power, Sarah D.; King, Gillian; Chau, Tom] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Power, Sarah D.; Chau, Tom] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Holland Bloorview Kids Rehabilitation Hospital; University of Toronto	Kushki, A (corresponding author), Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada.	tchau@hollandbloorview.ca	Chau, Tom TK/C-8426-2009; Power, Sarah/AAU-9422-2020	Chau, Tom TK/0000-0002-7486-0316; Power, Sarah/0000-0001-5132-2753	Canadian Institutes of Health Research [TWC-95045]; Ontario Ministry of Research and Innovations; Canada Research Chairs programs	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Research and Innovations(Ministry of Research and Innovation, Ontario); Canada Research Chairs programs(Canada Research Chairs)	This work was financially supported by the Canadian Institutes of Health Research [TWC-95045] (http://www.cihr-irsc.gc.ca), the Ontario Ministry of Research and Innovations (http://www.mri.gov.on.ca/english/programs/PDF-Program.asp), and the Canada Research Chairs (http://www.chairs-chaires.gc.ca/) programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen J, 2007, PHYSIOL MEAS, V28, pR1, DOI 10.1088/0967-3334/28/3/R01; Beukelman D., 2020, AUGMENTATIVE ALTERNA, V5th; Blackstone S, 2009, PERSPECTIVES AUGMENT, V18, P78; Blain S, 2008, OPEN REHABILITATION, V1, P27, DOI DOI 10.2174/1874943700801010027; Cacioppo J.T., 1993, HDB EMOTION, P119; Carini RM, 2006, RES HIGH EDUC, V47, P1, DOI 10.1007/s11162-005-8150-9; DAWSON ME, 2000, HDB PSYCHOPHYSIOLOGY, P200; Donchin E, 2000, IEEE T REHABIL ENG, V8, P174, DOI 10.1109/86.847808; Duda R.O., 2006, PATTERN CLASSIFICATI; EKMAN P, 1983, SCIENCE, V221, P1208, DOI 10.1126/science.6612338; Gazzaniga M.S., 2002, COGNITIVE NEUROSCIEN, V2nd ed.; Gibson BE, 2007, SOC SCI MED, V65, P505, DOI 10.1016/j.socscimed.2007.03.043; Haag A, 2004, LECT NOTES COMPUT SC, V3068, P36; Ito T, 1998, PERS SOC PSYCHOL B, V24, P855, DOI 10.1177/0146167298248006; King Gillian, 2003, Physical & Occupational Therapy in Pediatrics, V23, P63, DOI 10.1300/J006v23n01_05; Kingsnorth S, 2011, EVID BASED COMPLEMEN; Kistler A, 1998, INT J PSYCHOPHYSIOL, V29, P35, DOI 10.1016/S0167-8760(97)00087-1; Kreibig SD, 2007, PSYCHOPHYSIOLOGY, V44, P787, DOI 10.1111/j.1469-8986.2007.00550.x; Kushki A, 2011, PHYSL MEAS IN PRESS; Lang P. J., 1997, NIMH CTR STUDY EMOTI, P39; Leary MR, 1996, MENT RETARD, V34, P39; Levenson R. W., 1988, SOCIAL PSYCHOPHYSIOL, P17; Light J, 2007, AUGMENT ALTERN COMM, V23, P204, DOI 10.1080/07434610701553635; Lund SK, 2007, AUGMENT ALTERN COMM, V23, P1, DOI 10.1080/07434610600720442; MAuller-Putz G, 2008, INT J BIOELECTROMAGN, V10, P52; Mauri M, 2010, IEEE ENG MED BIO, P3563, DOI 10.1109/IEMBS.2010.5627465; McCarthy A, 2011, AUGMENT ALT IN PRESS; MCWILLIAM RA, 1995, TOP EARLY CHILD SPEC, V15, P123, DOI 10.1177/027112149501500201; Moghimi S, 2011, J ASSIST TECHN UNPUB; Myrden AJB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024170; Picard RW, 2003, INT J HUM-COMPUT ST, V59, P55, DOI 10.1016/S1071-5819(03)00052-1; Picard RW, 2001, IEEE T PATTERN ANAL, V23, P1175, DOI 10.1109/34.954607; Poh MZ, 2010, IEEE T BIO-MED ENG, V57, P1243, DOI 10.1109/TBME.2009.2038487; Power SD, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026002; Reeve J, 2004, MOTIV EMOTION, V28, P147, DOI 10.1023/B:MOEM.0000032312.95499.6f; Ruble LA, 2007, J AUTISM DEV DISORD, V37, P1457, DOI 10.1007/s10803-006-0222-y; Ryan S, 1966, 22 INT SEAT S, P104; Schmidt S, 2000, J PARAPSYCHOL, V64, P250; Tai K, 2008, ASSIST TECHNOL, V20, P204, DOI 10.1080/10400435.2008.10131947; Wolpaw JR, 2000, IEEE T REHABIL ENG, V8, P164, DOI 10.1109/TRE.2000.847807; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101	42	6	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30373	10.1371/journal.pone.0030373	http://dx.doi.org/10.1371/journal.pone.0030373			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363432	Green Submitted, Green Published, gold			2022-12-27	WOS:000302853600026
J	Thriemer, K; Ley, B; Ame, S; Von Seidlein, L; Pak, GD; Chang, NY; Hashim, R; Schmied, WH; Busch, CJL; Nixon, S; Morrissey, A; Puri, MK; Ali, M; Ochiai, RL; Wierzba, T; Jiddawi, MS; Clemens, JD; Ali, SM; Deen, JL				Thriemer, Kamala; Ley, Benedikt; Ame, Shaali; Von Seidlein, Lorenz; Pak, Gi Deok; Chang, Na Yoon; Hashim, Ramadhan; Schmied, Wolfgang Hellmut; Busch, Clara Jana-Lui; Nixon, Shanette; Morrissey, Anne; Puri, Mahesh K.; Ali, Mohammad; Ochiai, R. Leon; Wierzba, Thomas; Jiddawi, Mohammad S.; Clemens, John D.; Ali, Said M.; Deen, Jaqueline L.			The Burden of Invasive Bacterial Infections in Pemba, Zanzibar	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; MALARIA; CHILDREN; BACTEREMIA; CULTURE; AFRICA; KENYA	Background: We conducted a surveillance study to determine the leading causes of bloodstream infection in febrile patients seeking treatment at three district hospitals in Pemba Island, Zanzibar, Tanzania, an area with low malaria transmission. Methods: All patients above two months of age presenting to hospital with fever were screened, and blood was collected for microbiologic culture and malaria testing. Bacterial sepsis and malaria crude incidence rates were calculated for a one-year period and were adjusted for study participation and diagnostic sensitivity of blood culture. Results: Blood culture was performed on 2,209 patients. Among them, 166 (8%) samples yielded bacterial growth; 87 (4%) were considered as likely contaminants; and 79 (4%) as pathogenic bacteria. The most frequent pathogenic bacteria isolated were Salmonella Typhi (n = 46; 58%), followed by Streptococcus pneumoniae (n = 12; 15%). The crude bacteremia rate was 6/100,000 but when adjusted for potentially missed cases the rate may be as high as 163/100,000. Crude and adjusted rates for S. Typhi infections and malaria were 4 and 110/100,000 and 4 and 47/100,000, respectively. Twenty three (51%), 22 (49%) and 22 (49%) of the S. Typhi isolates were found to be resistant toward ampicillin, chloramphenicol and cotrimoxazole, respectively. Multidrug resistance (MDR) against the three antimicrobials was detected in 42% of the isolates. Conclusions: In the presence of very low malaria incidence we found high rates of S. Typhi and S. pneumoniae infections on Pemba Island, Zanzibar. Preventive measures such as vaccination could reduce the febrile disease burden.	[Thriemer, Kamala; Ley, Benedikt; Pak, Gi Deok; Chang, Na Yoon; Hashim, Ramadhan; Schmied, Wolfgang Hellmut; Busch, Clara Jana-Lui; Puri, Mahesh K.; Ali, Mohammad; Ochiai, R. Leon; Wierzba, Thomas; Clemens, John D.; Deen, Jaqueline L.] Int Vaccine Inst, Seoul, South Korea; [Ley, Benedikt] Univ Vienna, Bioctr, Vienna, Austria; [Ame, Shaali; Ali, Said M.] Publ Hlth Lab Pemba Ivo de Carneri, Chake Chake, Tanzania; [Ame, Shaali; Jiddawi, Mohammad S.; Ali, Said M.] Minist Hlth & Social Welf, Zanzibar, Tanzania; [Von Seidlein, Lorenz; Deen, Jaqueline L.] Menzies Sch Hlth Res, Casuarina, NT, Australia; [Busch, Clara Jana-Lui] Inst Mol Biotechnol GmbH, Vienna, Austria; [Nixon, Shanette; Morrissey, Anne] Duke Univ KCMC Collaborat, Moshi, Tanzania	International Vaccine Institute; University of Vienna; Charles Darwin University; Menzies School of Health Research; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Thriemer, K (corresponding author), Int Vaccine Inst, Seoul, South Korea.	k.leythriemer@gmail.com	Schmied, Wolfgang/AAU-9961-2020; Ali, Mohammad/E-2365-2017	Schmied, Wolfgang/0000-0001-7625-0995; Ali, Mohammad/0000-0003-1410-388X; Ochiai, Leon/0000-0002-5079-6786; Thriemer, Kamala/0000-0001-7536-7497; Ley, Benedikt/0000-0002-5734-0845	Swedish International Development Cooperation Agency (SIDA)	Swedish International Development Cooperation Agency (SIDA)	This work has been supported by a grant from the Swedish International Development Cooperation Agency (SIDA) to the International Vaccine Institute (IV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aregawi MW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-46; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Brent AJ, 2006, LANCET, V367, P482, DOI 10.1016/S0140-6736(06)68180-4; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Clinical and Laboratory Standards Institute, 2007, M100S16 CLIN LAB STA, V26, pM100; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Crump JA, 2011, TROP MED INT HEALTH, V16, P830, DOI 10.1111/j.1365-3156.2011.02774.x; Kariuki S, 2010, J CLIN MICROBIOL, V48, P2171, DOI 10.1128/JCM.01983-09; Lee A, 2007, J CLIN MICROBIOL, V45, P3546, DOI 10.1128/JCM.01555-07; Mackenzie G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010568; Mengo DM, 2010, J INFECT DEV COUNTR, V4, P393, DOI 10.3855/jidc.503; Mindy J., 2003, MANUAL LAB IDENTIFIC; National Bureau of Statistics, 2006, MIN PLANN EC EMP UN, VXII; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Saha S, 2011, J TROP PEDIATRICS, V57, P192, DOI 10.1093/tropej/fmq070; Scott JAG, 2011, LANCET, V378, P1316, DOI 10.1016/S0140-6736(11)60888-X; Thriemer K, REPLACING PAPE UNPUB; Wain J, 2001, J CLIN MICROBIOL, V39, P1571, DOI 10.1128/JCM.39.4.1571-1576.2001; Wain J, 2008, J INFECT DEV COUNTR, V2, P469, DOI 10.3855/jidc.164; WHO, 2010, WORLD MALARIA REPORT 2010, P1; ZAC-Zanzibar Aids Commission, 2008, UNGASS COUNTR PROGR; Zhou LQ, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-14	25	39	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30350	10.1371/journal.pone.0030350	http://dx.doi.org/10.1371/journal.pone.0030350			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363426	Green Submitted, gold, Green Published			2022-12-27	WOS:000302853600020
J	Toulza, E; Tagliabue, A; Blain, S; Piganeau, G				Toulza, Eve; Tagliabue, Alessandro; Blain, Stephane; Piganeau, Gwenael			Analysis of the Global Ocean Sampling (GOS) Project for Trends in Iron Uptake by Surface Ocean Microbes	PLOS ONE			English	Article							ESCHERICHIA-COLI; DISSOLVED IRON; TRANSPORT; SIDEROPHORES; PROTEINS; GENES; BIOGEOGRAPHY; ADAPTATION; CHEMISTRY; GENOMICS	Microbial metagenomes are DNA samples of the most abundant, and therefore most successful organisms at the sampling time and location for a given cell size range. The study of microbial communities via their DNA content has revolutionized our understanding of microbial ecology and evolution. Iron availability is a critical resource that limits microbial communities' growth in many oceanic areas. Here, we built a database of 2319 sequences, corresponding to 140 gene families of iron metabolism with a large phylogenetic spread, to explore the microbial strategies of iron acquisition in the ocean's bacterial community. We estimate iron metabolism strategies from metagenome gene content and investigate whether their prevalence varies with dissolved iron concentrations obtained from a biogeochemical model. We show significant quantitative and qualitative variations in iron metabolism pathways, with a higher proportion of iron metabolism genes in low iron environments. We found a striking difference between coastal and open ocean sites regarding Fe2+ versus Fe3+ uptake gene prevalence. We also show that non-specific siderophore uptake increases in low iron open ocean environments, suggesting bacteria may acquire iron from natural siderophore-like organic complexes. Despite the lack of knowledge of iron uptake mechanisms in most marine microorganisms, our approach provides insights into how the iron metabolic pathways of microbial communities may vary with seawater iron concentrations.	[Toulza, Eve; Blain, Stephane; Piganeau, Gwenael] UPMC Univ Paris 06, Observ Oceanol, UMR 7232, Banyuls Sur Mer, France; [Toulza, Eve; Piganeau, Gwenael] CNRS, UMR 7232, Observ Oceanol, Banyuls Sur Mer, France; [Tagliabue, Alessandro] IPSL Lab Sci Climat & Environnement, Gif Sur Yvette, France; [Blain, Stephane] CNRS, UMR 7621, Observ Oceanol, Banyuls Sur Mer, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite	Toulza, E (corresponding author), UPMC Univ Paris 06, Observ Oceanol, UMR 7232, Banyuls Sur Mer, France.	gwenael.piganeau@obs-banyuls.fr	blain, stéphane/F-6917-2010; Toulza, Eve/A-9919-2012; Piganeau, Gwenael V/C-7600-2011	blain, stéphane/0000-0002-5234-2446; Toulza, Eve/0000-0003-2049-2279; Piganeau, Gwenael V/0000-0002-9992-4187; Tagliabue, Alessandro/0000-0002-3572-3634	European network of excellence Marine Genomics Europe [GOGE-CT-505403]; Agence Nationale de la Recherche [ANR-08-BLAN-0309]; European Union [254619]	European network of excellence Marine Genomics Europe; Agence Nationale de la Recherche(French National Research Agency (ANR)); European Union(European Commission)	ET was funded by the European network of excellence Marine Genomics Europe (GOGE-CT-505403) and the Agence Nationale de la Recherche (ANR-08-BLAN-0309). GP is funded by European Union FP7 program under grant agreement 254619. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; [Anonymous], 1932, STAT METHODS RES WOR; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Bailey S, 2008, BBA-BIOENERGETICS, V1777, P269, DOI 10.1016/j.bbabio.2008.01.002; Bibby TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004601; Biers EJ, 2009, APPL ENVIRON MICROB, V75, P2221, DOI 10.1128/AEM.02118-08; Boyd PW, 2010, NAT GEOSCI, V3, P675, DOI [10.1038/NGEO964, 10.1038/ngeo964]; Brochier-Armanet C, 2011, ISME J, V5, P1291, DOI 10.1038/ismej.2011.16; Butler A, 2005, BIOMETALS, V18, P369, DOI 10.1007/s10534-005-3711-0; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Cartron ML, 2006, BIOMETALS, V19, P143, DOI 10.1007/s10534-006-0003-2; Chauhan D, 2011, BIOCHEMISTRY-US, V50, P686, DOI 10.1021/bi1009425; Chiancone E, 2010, BBA-GEN SUBJECTS, V1800, P798, DOI 10.1016/j.bbagen.2010.01.013; Cornelis P, 2011, METALLOMICS; Daubin V, 2003, SCIENCE, V301, P829, DOI 10.1126/science.1086568; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; Eisen JA, 1995, J MOL EVOL, V41, P1105; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Gianoulis TA, 2009, P NATL ACAD SCI USA, V106, P1374, DOI 10.1073/pnas.0808022106; Gulick AM, 2009, NAT CHEM BIOL, V5, P143, DOI 10.1038/nchembio0309-143; HARLE C, 1995, EMBO J, V14, P1430, DOI 10.1002/j.1460-2075.1995.tb07129.x; Hopkinson BM, 2008, APPL ENVIRON MICROB, V74, P6263, DOI 10.1128/AEM.00964-08; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Katoh H, 2001, J BACTERIOL, V183, P2779, DOI 10.1128/JB.183.9.2779-2784.2001; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Kupper H, 2008, NEW PHYTOL, V179, P784, DOI 10.1111/j.1469-8137.2008.02497.x; Lerat E, 2005, PLOS BIOL, V3, P807, DOI 10.1371/journal.pbio.0030130; Longhurst AR, ECOLOGICAL GEOGRAPHY; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Monier A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r106; Moore JK, 2008, BIOGEOSCIENCES, V5, P631, DOI 10.5194/bg-5-631-2008; Morel FMM, 2008, LIMNOL OCEANOGR, V53, P400, DOI 10.4319/lo.2008.53.1.0400; Nwugo CC, 2010, J PROTEOMICS; Palenik B, 2006, P NATL ACAD SCI USA, V103, P13555, DOI 10.1073/pnas.0602963103; Patel PV, 2010, GENOME RES, V20, P960, DOI 10.1101/gr.102814.109; Pierre JL, 2000, BIOMETALS, V13, P91, DOI 10.1023/A:1009225701332; Piganeau G, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r5; Raes J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.6; RAVEN JA, 1988, NEW PHYTOL, V109, P279, DOI 10.1111/j.1469-8137.1988.tb04196.x; Rivers AR, 2009, ENVIRON MICROBIOL, V11, P382, DOI 10.1111/j.1462-2920.2008.01778.x; Rue EL, 1997, LIMNOL OCEANOGR, V42, P901, DOI 10.4319/lo.1997.42.5.0901; Rusch DB, 2010, P NATL ACAD SCI USA, V107, P16184, DOI 10.1073/pnas.1009513107; Saito MA, 2011, P NATL ACAD SCI USA, V108, P2184, DOI 10.1073/pnas.1006943108; Sandy M, 2009, CHEM REV, V109, P4580, DOI 10.1021/cr9002787; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; Tagliabue A, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003363; Tagliabue A, 2010, NAT GEOSCI, V3, P252, DOI 10.1038/NGEO818; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Thioulouse J, 2007, J STAT SOFTW, V22, P1; Tong Y, 2009, ARCH BIOCHEM BIOPHYS, V481, P1, DOI 10.1016/j.abb.2008.10.013; Tortell PD, 1999, FEMS MICROBIOL ECOL, V29, P1; Visca P, 2002, MOL MICROBIOL, V45, P1177, DOI 10.1046/j.1365-2958.2002.03088.x; Volker C, 1999, MAR CHEM, V65, P227, DOI 10.1016/S0304-4203(99)00004-3; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811	57	45	45	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30931	10.1371/journal.pone.0030931	http://dx.doi.org/10.1371/journal.pone.0030931			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363520	gold, Green Published, Green Submitted			2022-12-27	WOS:000302853600092
J	Wang, RH; Jin, Z; Liu, QX; van de Koppel, J; Alonso, D				Wang, Rong-Hua; Jin, Zhen; Liu, Quan-Xing; van de Koppel, Johan; Alonso, David			A Simple Stochastic Model with Environmental Transmission Explains Multi-Year Periodicity in Outbreaks of Avian Flu	PLOS ONE			English	Article							BORNE TRANSMISSION; INFLUENZA-VIRUSES; TIME-SERIES; DYNAMICS; EPIDEMICS; EVOLUTION; COEXISTENCE; PERSISTENCE; PATTERNS; NUMBER	Avian influenza virus reveals persistent and recurrent outbreaks in North American wild waterfowl, and exhibits major outbreaks at 2-8 years intervals in duck populations. The standard susceptible-infected-recovered (SIR) framework, which includes seasonal migration and reproduction, but lacks environmental transmission, is unable to reproduce the multi-periodic patterns of avian influenza epidemics. In this paper, we argue that a fully stochastic theory based on environmental transmission provides a simple, plausible explanation for the phenomenon of multi-year periodic outbreaks of avian flu. Our theory predicts complex fluctuations with a dominant period of 2 to 8 years which essentially depends on the intensity of environmental transmission. A wavelet analysis of the observed data supports this prediction. Furthermore, using master equations and van Kampen system-size expansion techniques, we provide an analytical expression for the spectrum of stochastic fluctuations, revealing how the outbreak period varies with the environmental transmission.	[Wang, Rong-Hua; Jin, Zhen] N Univ China, Dept Math, Taiyuan, Shanxi, Peoples R China; [Wang, Rong-Hua; Liu, Quan-Xing; van de Koppel, Johan] Netherlands Inst Ecol, Spatial Ecol Dept, Yerseke, Netherlands; [Alonso, David] Univ Groningen, Community & Conservat Ecol Grp, Groningen, Netherlands; [Alonso, David] Spanish Council Sci Res, Ctr Adv Studies, Blanes, Catalunya, Spain	North University of China; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); University of Groningen; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB)	Wang, RH (corresponding author), N Univ China, Dept Math, Taiyuan, Shanxi, Peoples R China.	dalonso@ceab.csic.es	Liu, Quan-Xing/E-4892-2010; Alonso, David/A-5406-2008; Van de Koppel, Johan/E-7266-2010; jin, zhen/B-6563-2015; KNAW, NIOO-KNAW/A-4320-2012	Liu, Quan-Xing/0000-0002-8602-0154; Alonso, David/0000-0002-8888-1644; jin, zhen/0000-0002-9763-707X; KNAW, NIOO-KNAW/0000-0002-3835-159X	Netherlands Institution for Scientific Research (NWO); Netherlands Institute of Ecology (NIOO-KNAW); National Natural Science Foundation of China [10901145]	Netherlands Institution for Scientific Research (NWO); Netherlands Institute of Ecology (NIOO-KNAW); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Support was provided by The Netherlands Institution for Scientific Research (NWO), The Netherlands Institute of Ecology (NIOO-KNAW), and National Natural Science Foundation of China (Grant No. 10901145). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso D, 2002, B MATH BIOL, V64, P913, DOI 10.1006/bulm.2002.0307; Alonso D, 2010, P ROYAL SOC B; Alonso D, 2007, J R SOC INTERFACE, V4, P575, DOI 10.1098/rsif.2006.0192; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; [Anonymous], INFECT DIS HUMANS DY; Batt B. D. J., 1992, ECOLOGY MANAGEMENT B; Black AJ, 2010, J THEOR BIOL, V267, P8594; Black AJ, 2010, J R SOC INTERFACE, V7, P1219, DOI 10.1098/rsif.2009.0514; Blanchong JA, 2006, J WILDLIFE DIS, V42, P33, DOI 10.7589/0090-3558-42.1.33; Breban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000346; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; Cazelles B, 2007, J R SOC INTERFACE, V4, P625, DOI 10.1098/rsif.2007.0212; Chowell G, 2007, MATH BIOSCI, V208, P571, DOI 10.1016/j.mbs.2006.11.011; Codeco CT, 2008, J R SOC INTERFACE, V5, P247, DOI 10.1098/rsif.2007.1135; Colijn C, 2010, J R SOC INTERFACE, V7, P905, DOI 10.1098/rsif.2009.0400; D'Souza DH, 2006, INT J FOOD MICROBIOL, V108, P84, DOI 10.1016/j.ijfoodmicro.2005.10.024; Dangerfield CE, 2009, J R SOC INTERFACE, V6, P761, DOI 10.1098/rsif.2008.0410; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Henning J, 2005, EPIDEMIOL INFECT, V133, P719, DOI 10.1017/S0950268805003766; Joh RI, 2009, B MATH BIOL, V71, P845, DOI 10.1007/s11538-008-9384-4; Johansson MA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000168; Kamo M, 2005, ECOL LETT, V8, P378, DOI 10.1111/j.1461-0248.2005.00734.x; Kampen NGV, 2007, STOCHASTIC PROCESSES, V3; Keeling MJ, 2008, J R SOC INTERFACE, V5, P171, DOI 10.1098/rsif.2007.1106; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; King AA, 2008, NATURE, V454, P877, DOI 10.1038/nature07084; Koelle K, 2004, AM NAT, V163, P901, DOI 10.1086/420798; Koelle K, 2010, J R SOC INTERFACE, V7, P1257, DOI 10.1098/rsif.2010.0007; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Marion G, 2000, THEOR POPUL BIOL, V57, P197, DOI 10.1006/tpbi.2000.1450; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; McKane AJ, 2007, J STAT PHYS, V128, P165, DOI 10.1007/s10955-006-9221-9; McKane AJ, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.041902; McKane AJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.218102; Merler S, 2010, P ROY SOC B-BIOL SCI, V277, P557, DOI 10.1098/rspb.2009.1605; Nguyen HTH, 2008, J R SOC INTERFACE, V5, P403, DOI 10.1098/rsif.2007.1168; Nisbet RM, 1982, MODELLING FLUCTUATIN; Pascual M, 2008, P ROY SOC B-BIOL SCI, V275, P123, DOI 10.1098/rspb.2007.1068; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; Patz JA, 2002, NATURE, V420, P627, DOI 10.1038/420627a; Renshaw E., 1991, MODELLING BIOL POPUL, DOI 10.1017/CBO9780511624094; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Roche B, 2009, INFECT GENET EVOL, V9, P800, DOI 10.1016/j.meegid.2009.04.009; Rohani P, 2002, AM NAT, V159, P469, DOI 10.1086/339467; Rohani P, 2009, P NATL ACAD SCI USA, V106, P10365, DOI 10.1073/pnas.0809026106; Rozhnova G, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041906; SHARP GB, 1993, EPIDEMIOL INFECT, V110, P161, DOI 10.1017/S0950268800050780; Simoes M, 2008, J R SOC INTERFACE, V5, P555, DOI 10.1098/rsif.2007.1206; Thomas F., 2005, PARASITISM ECOSYSTEM; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Webb CT, 2006, P NATL ACAD SCI USA, V103, P6236, DOI 10.1073/pnas.0510090103; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wonham MJ, 2006, ECOL LETT, V9, P706, DOI 10.1111/j.1461-0248.2006.00912.x; Yang L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001399; Zhang ZB, 2009, P ROY SOC B-BIOL SCI, V276, P823, DOI 10.1098/rspb.2008.1284	58	31	31	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e28873	10.1371/journal.pone.0028873	http://dx.doi.org/10.1371/journal.pone.0028873			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363397	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600002
J	Tang, LX; He, RH; Yang, G; Tan, JJ; Zhou, L; Meng, XM; Huang, XR; Lan, HY				Tang, Li-xia; He, Rui-hua; Yang, Guang; Tan, Jia-ju; Zhou, Li; Meng, Xiao-ming; Huang, Xiao Ru; Lan, Hui Yao			Asiatic Acid Inhibits Liver Fibrosis by Blocking TGF-beta/Smad Signaling In Vivo and In Vitro	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CENTELLA-ASIATICA; HEPATIC FIBROGENESIS; RENAL FIBROSIS; GENE-TRANSFER; SMAD7; CELLS; MICE; RAT; EXPRESSION	Liver fibrosis is a major cause of liver failure, but treatment remains ineffective. In the present study, we investigated the mechanisms and anti-hepatofibrotic activities of asiatic acid (AA) in a rat model of liver fibrosis induced by carbon tetrachloride (CCl4) and in vitro in TGF-beta1-stimulated rat hepatic stellate cell line (HSC-T6). Treatment with AA significantly attenuated CCl4-induced liver fibrosis and functional impairment in a dosage-dependent manner, including blockade of the activation of HSC as determined by inhibiting de novo alpha smooth muscle actin (a-SMA) and collagen matrix expression, and an increase in ALT and AST (all p<0.01). The hepatoprotective effects of AA on fibrosis were associated with upregulation of hepatic Smad7, an inhibitor of TGF-beta signaling, thereby blocking upregulation of TGF-beta1 and CTGF and the activation of TGF-beta/Smad signaling. The anti-fibrosis activity and mechanisms of AA were further detected in vitro in HSC-T6. Addition of AA significantly induced Smad7 expression by HSC-T6 cells, thereby inhibiting TGF-beta1-induced Smad2/3 activation, myofibroblast transformation, and collagen matrix expression in a dosage-dependent manner. In contrast, knockdown of Smad7 in HSC-T6 cells prevented AA-induced inhibition of HSC-T6 cell activation and fibrosis in response to TGF-beta1, revealing an essential role for Smad7 in AA-induced anti-fibrotic activities during liver fibrosis in vivo and in vitro. In conclusion, AA may be a novel therapeutic agent for liver fibrosis. Induction of Smad7-dependent inhibition of TGF-beta/Smad-mediated fibrogenesis may be a central mechanism by which AA protects liver from injury.	[Tang, Li-xia; He, Rui-hua; Yang, Guang; Tan, Jia-ju] First Peoples Hosp Foshan, Inst Med Res, Foshan, Guangdong, Peoples R China; [Zhou, Li] W China Hosp Sichuan Univ, Dept Med, Chengdu, Peoples R China; [Meng, Xiao-ming; Huang, Xiao Ru; Lan, Hui Yao] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Meng, Xiao-ming; Huang, Xiao Ru; Lan, Hui Yao] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China	Sichuan University; Chinese University of Hong Kong; Chinese University of Hong Kong	Tang, LX (corresponding author), First Peoples Hosp Foshan, Inst Med Res, Foshan, Guangdong, Peoples R China.	hylan@cuhk.edu.hk	Lan, Hui Yao/C-9734-2015	Lan, Hui Yao/0000-0003-4283-9755	Guangdong Medical Research Foundation [A2007627, 2008225]; Research Grant Council of Hong Kong [RGC CUHK5/CRF/09, GRF 768207, 767508]	Guangdong Medical Research Foundation; Research Grant Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by grants from Guangdong Medical Research Foundation (A2007627 to GY and 2008225 to LXT) and Research Grant Council of Hong Kong (RGC CUHK5/CRF/09, GRF 768207 and 767508 to HYL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Chen HY, 2011, DIABETES, V60, P590, DOI 10.2337/db10-0403; Cheng CL, 2004, LIFE SCI, V74, P2237, DOI 10.1016/j.lfs.2003.09.055; Chung ACK, 2009, NEPHROL DIAL TRANSPL, V24, P1443, DOI 10.1093/ndt/gfn699; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Dong MS, 2004, ARCH PHARM RES, V27, P512, DOI 10.1007/BF02980124; Dooley S, 2003, GASTROENTEROLOGY, V125, P178, DOI 10.1016/S0016-5085(03)00666-8; Dooley S, 2008, GASTROENTEROLOGY, V135, P642, DOI 10.1053/j.gastro.2008.04.038; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Gao J, 2006, J PHARM PHARMACOL, V58, P227, DOI 10.1211/jpp.58.2.0010; Hamzavi J, 2008, J CELL MOL MED, V12, P2130, DOI 10.1111/j.1582-4934.2008.00262.x; Hou CC, 2005, AM J PATHOL, V166, P761, DOI 10.1016/S0002-9440(10)62297-3; Hsu YL, 2005, J PHARMACOL EXP THER, V313, P333, DOI 10.1124/jpet.104.078808; Inagaki Y, 2007, GUT, V56, P284, DOI 10.1136/gut.2005.088690; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kimura Y, 2008, EUR J PHARMACOL, V584, P415, DOI 10.1016/j.ejphar.2008.02.036; Krishnamurthy RG, 2009, J NEUROSCI RES, V87, P2541, DOI 10.1002/jnr.22071; Lan HY, 2008, FRONT BIOSCI-LANDMRK, V13, P4984, DOI 10.2741/3057; Lan HY, 2003, J AM SOC NEPHROL, V14, P1535, DOI 10.1097/01.ASN.0000067632.04658.B8; LAN HY, 1995, J HISTOCHEM CYTOCHEM, V43, P97, DOI 10.1177/43.1.7822770; Latella G, 2009, LIVER INT, V29, P997, DOI 10.1111/j.1478-3231.2009.02011.x; Lee MK, 2009, NAT PROD COMMUN, V4, P765; Li JH, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000014252.37680.E4; Ma KF, 2009, EUR J PHARMACOL, V603, P98, DOI 10.1016/j.ejphar.2008.11.054; Meindl-Beinker NM, 2008, J GASTROEN HEPATOL, V23, pS122, DOI 10.1111/j.1440-1746.2007.05297.x; Park BC, 2005, CANCER LETT, V218, P81, DOI 10.1016/j.canlet.2004.06.039; Pittella F, 2009, INT J MOL SCI, V10, P3713, DOI 10.3390/ijms10093713; RUWART MJ, 1989, HEPATOLOGY, V10, P801, DOI 10.1002/hep.1840100509; Schaneberg BT, 2003, PHARMAZIE, V58, P381; Soumyanath A, 2005, J PHARM PHARMACOL, V57, P1221, DOI 10.1211/jpp.57.9.0018; Tang B, 2011, ARCH DERMATOL RES, V303, P563, DOI 10.1007/s00403-010-1114-8; Ueberham E, 2003, HEPATOLOGY, V37, P1067, DOI 10.1053/jhep.2003.50196; Won JH, 2010, PLANTA MED, V76, P251, DOI 10.1055/s-0029-1186142; Yang FY, 2009, HYPERTENSION, V54, P877, DOI 10.1161/HYPERTENSIONAHA.109.136531; Yun KJ, 2008, INT IMMUNOPHARMACOL, V8, P431, DOI 10.1016/j.intimp.2007.11.003	35	93	106	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31350	10.1371/journal.pone.0031350	http://dx.doi.org/10.1371/journal.pone.0031350			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22363627	Green Published, gold, Green Submitted			2022-12-27	WOS:000302180600034
J	Bassaganya-Riera, J; Viladomiu, M; Pedragosa, M; De Simone, C; Carbo, A; Shaykhutdinov, R; Jobin, C; Arthur, JC; Corl, BA; Vogel, H; Storr, M; Hontecillas, R				Bassaganya-Riera, Josep; Viladomiu, Monica; Pedragosa, Mireia; De Simone, Claudio; Carbo, Adria; Shaykhutdinov, Rustem; Jobin, Christian; Arthur, Janelle C.; Corl, Benjamin A.; Vogel, Hans; Storr, Martin; Hontecillas, Raquel			Probiotic Bacteria Produce Conjugated Linoleic Acid Locally in the Gut That Targets Macrophage PPAR gamma to Suppress Colitis	PLOS ONE			English	Article							ACTIVE ULCERATIVE-COLITIS; POLYUNSATURATED FATTY-ACIDS; INFLAMMATORY-BOWEL-DISEASE; PLACEBO-CONTROLLED TRIAL; INTESTINAL MUCUS; PIG MODEL; VSLNUMBER-3; CELLS; MICE; ROSIGLITAZONE	Background: Inflammatory bowel disease (IBD) therapies are modestly successful and associated with significant side effects. Thus, the investigation of novel approaches to prevent colitis is important. Probiotic bacteria can produce immunoregulatory metabolites in vitro such as conjugated linoleic acid (CLA), a polyunsaturated fatty acid with potent anti-inflammatory effects. This study aimed to investigate the cellular and molecular mechanisms underlying the anti-inflammatory efficacy of probiotic bacteria using a mouse model of colitis. Methodology/Principal Findings: The immune modulatory mechanisms of VSL#3 probiotic bacteria and CLA were investigated in a mouse model of DSS colitis. Colonic specimens were collected for histopathology, gene expression and flow cytometry analyses. Immune cell subsets in the mesenteric lymph nodes (MLN), spleen, blood and colonic lamina propria cells were phenotypically and functionally characterized. Fecal samples and colonic contents were collected to determine the effect of VSL#3 and CLA on gut microbial diversity and CLA production. CLA and VSL#3 treatment ameliorated colitis and decreased colonic bacterial diversity, a finding that correlated with decreased gut pathology. Colonic CLA concentrations were increased in response to probiotic bacterial treatment, but without systemic distribution in blood. VSL#3 and CLA decreased macrophage accumulation in the MLN of mice with DSS colitis. The loss of PPAR c in myeloid cells abrogated the protective effect of probiotic bacteria and CLA in mice with DSS colitis. Conclusions/Significance: Probiotic bacteria modulate gut microbial diversity and favor local production of CLA in the colon that targets myeloid cell PPAR c to suppress colitis.	[Bassaganya-Riera, Josep; Viladomiu, Monica; Pedragosa, Mireia; Carbo, Adria; Hontecillas, Raquel] Virginia Tech, Nutr Immunol & Mol Med Lab, Ctr Modeling Immun Enter Pathogens, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [De Simone, Claudio] LAquila Univ, Laquila, Italy; [Jobin, Christian; Arthur, Janelle C.] Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC USA; [Jobin, Christian; Arthur, Janelle C.] Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC USA; [Shaykhutdinov, Rustem; Vogel, Hans; Storr, Martin] Univ Calgary, Dept Biol Sci, Metabol Res Ctr, Calgary, AB T2N 1N4, Canada; [Shaykhutdinov, Rustem; Vogel, Hans; Storr, Martin] Univ Calgary, Dept Med, Div Gastroenterol, Calgary, AB T2N 1N4, Canada; [Storr, Martin] Univ Munich, Dept Med, Div Gastroenterol, Munich, Germany; [Corl, Benjamin A.] Virginia Tech, Dept Dairy Sci, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Calgary; University of Calgary; University of Munich; Virginia Polytechnic Institute & State University	Bassaganya-Riera, J (corresponding author), Virginia Tech, Nutr Immunol & Mol Med Lab, Ctr Modeling Immun Enter Pathogens, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.	jbassaga@vt.edu	Corl, Benjamin/P-3150-2016; Viladomiu, Monica/GNM-6447-2022	Corl, Benjamin/0000-0002-6495-3279; Arthur, Janelle/0000-0002-4796-0207				Bassaganya-Riera J, 2004, GASTROENTEROLOGY, V127, P777, DOI 10.1053/j.gastro.2004.06.049; Bassaganya-Riera J, 2003, J NUTR, V133, P3204, DOI 10.1093/jn/133.10.3204; Bassaganya-Riera J, 2002, CLIN NUTR, V21, P451, DOI 10.1054/clnu.2002.0594; Bassaganya-Riera J, 2001, J NUTR, V131, P2370, DOI 10.1093/jn/131.9.2370; Bassaganya-Riera J, 2001, J ANIM SCI, V79, P714; Bassaganya-Riera J, 2010, CURR OPIN CLIN NUTR; Bassaganya-Riera J, 2007, AM J CLIN NUTR, V85, P824, DOI 10.1093/ajcn/85.3.824; Bassaganya-Riera J, 2006, CLIN NUTR, V25, P454, DOI 10.1016/j.clnu.2005.12.008; Bassaganya-Riera J, 2009, CELL IMMUNOL, V258, P138, DOI 10.1016/j.cellimm.2009.04.003; Bibiloni R, 2005, AM J GASTROENTEROL, V100, P1539, DOI 10.1111/j.1572-0241.2005.41794.x; Calder PC, 2008, MOL NUTR FOOD RES, V52, P885, DOI 10.1002/mnfr.200700289; Clarke JM, 2011, AM J CLIN NUTR; Collado MC, 2007, LETT APPL MICROBIOL, V45, P454, DOI 10.1111/j.1472-765X.2007.02212.x; Collado MC, 2005, J FOOD PROTECT, V68, P1034, DOI 10.4315/0362-028X-68.5.1034; Crawford PA, 2005, P NATL ACAD SCI USA, V102, P13254, DOI 10.1073/pnas.0504830102; Drakes M, 2004, INFECT IMMUN, V72, P3299, DOI 10.1128/IAI.72.6.3299-3309.2004; Ewaschuk JB, 2006, J NUTR, V136, P1483, DOI 10.1093/jn/136.6.1483; Gionchetti P, 2000, GASTROENTEROLOGY, V119, P305, DOI 10.1053/gast.2000.9370; Gorissen L, 2010, APPL MICROBIOL BIOT, V87, P2257, DOI 10.1007/s00253-010-2713-1; Hofmanova J, 2011, J NUTR BIOCH; Huynh HQ, 2009, INFLAMM BOWEL DIS, V15, P760, DOI 10.1002/ibd.20816; Isaacs KL, 2011, PILOT STUDY EFFECT C; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; Jijon H, 2004, GASTROENTEROLOGY, V126, P1358, DOI 10.1053/j.gastro.2004.02.003; Kumar NSN, 2008, J GASTROEN HEPATOL, V23, P1834, DOI 10.1111/j.1440-1746.2008.05723.x; Lawton EM, 2007, MINI-REV MED CHEM, V7, P1236, DOI 10.2174/138955707782795638; Lewis JD, 2008, GASTROENTEROLOGY, V134, P688, DOI 10.1053/j.gastro.2007.12.012; Lewis JD, 2001, AM J GASTROENTEROL, V96, P3323; Madsen K, 2001, GASTROENTEROLOGY, V121, P580, DOI 10.1053/gast.2001.27224; Mencarelli A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022978; O'Shea M, 2004, AM J CLIN NUTR, V79, p1199S, DOI 10.1093/ajcn/79.6.1199S; Pagnini C, 2010, P NATL ACAD SCI USA, V107, P454, DOI 10.1073/pnas.0910307107; Papadakis KA, 2000, ANNU REV MED, V51, P289, DOI 10.1146/annurev.med.51.1.289; Pronio A, 2008, INFLAMM BOWEL DIS, V14, P662, DOI 10.1002/ibd.20369; Saubermann LJ, 2000, GASTROENTEROLOGY, V119, P119, DOI 10.1053/gast.2000.9114; Serini S, 2009, APOPTOSIS, V14, P135, DOI 10.1007/s10495-008-0298-2; Sood A, 2009, CLIN GASTROENTEROL H, V7, P1202, DOI 10.1016/j.cgh.2009.07.016; Sun J, 2007, LETT APPL MICROBIOL, V44, P79, DOI 10.1111/j.1472-765X.2006.02031.x; Uronis JM, 2011, INFLAMM BOWEL DIS, V17, P289, DOI 10.1002/ibd.21366	39	91	95	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31238	10.1371/journal.pone.0031238	http://dx.doi.org/10.1371/journal.pone.0031238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363592	gold, Green Published, Green Submitted			2022-12-27	WOS:000302873700037
J	McAllister, SL; Dmitrieva, N; Berkley, KJ				McAllister, Stacy L.; Dmitrieva, Natalia; Berkley, Karen J.			Sprouted Innervation into Uterine Transplants Contributes to the Development of Hyperalgesia in a Rat Model of Endometriosis	PLOS ONE			English	Article							SYMPATHETIC REINNERVATION; CARDIAC TRANSPLANTATION; ESTROUS VARIATIONS; NEUROPATHIC PAIN; PELVIC PAIN; DYSMENORRHEA; HYPERSENSITIVITY; INFLAMMATION; DISTENSION; MECHANISMS	Endometriosis is an enigmatic painful disorder whose pain symptoms remain difficult to alleviate in large part because the disorder is defined by extrauteral endometrial growths whose contribution to pain is poorly understood. A rat model (ENDO) involves autotransplanting on abdominal arteries uterine segments that grow into vascularized cysts that become innervated with sensory and sympathetic fibers. ENDO rats exhibit vaginal hyperalgesia. We used behavioral, physiological, and immunohistochemical methods to test the hypothesis that cyst innervation contributes to the development of this hyperalgesia after transplant. Rudimentary sensory and sympathetic innervation appeared in the cysts at two weeks, sprouted further and more densely into the cyst wall by four weeks, and matured by six weeks post-transplant. Sensory fibers became abnormally functionally active between two and three weeks post-transplant, remaining active thereafter. Vaginal hyperalgesia became significant between four and five weeks post-transplant, and stabilized after six to eight weeks. Removing cysts before they acquired functional innervation prevented vaginal hyperalgesia from developing, whereas sham cyst removal did not. Thus, abnormally-active innervation of ectopic growths occurs before hyperalgesia develops, supporting the hypothesis. These findings suggest that painful endometriosis can be classified as a mixed inflammatory/neuropathic pain condition, which opens new avenues for pain relief. The findings also have implications beyond endometriosis by suggesting that functionality of any transplanted tissue can be influenced by the innervation it acquires.	[McAllister, Stacy L.; Dmitrieva, Natalia; Berkley, Karen J.] Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	McAllister, SL (corresponding author), Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA.	kberkley@psy.fsu.edu			National Institutes of Health [NS 11892]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institutes of Health grant NS 11892. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anaf V, 2002, HUM REPROD, V17, P1895, DOI 10.1093/humrep/17.7.1895; Anaf V, 2000, HUM REPROD, V15, P1744, DOI 10.1093/humrep/15.8.1744; Becker JB, 2005, ENDOCRINOLOGY, V146, P1650, DOI 10.1210/en.2004-1142; Berkley KJ, 2011, PAIN, V152, P1940, DOI 10.1016/j.pain.2011.04.013; Berkley KJ, 2005, SCIENCE, V308, P1587, DOI 10.1126/science.1111445; Berkley KJ, 2004, P NATL ACAD SCI USA, V101, P11094, DOI 10.1073/pnas.0403663101; Bradshaw HB, 1999, PAIN, V82, P187, DOI 10.1016/S0304-3959(99)00049-4; Butler JE, 2001, J PHYSIOL-LONDON, V534, P583, DOI 10.1111/j.1469-7793.2001.00583.x; Cason AM, 2003, HORM BEHAV, V44, P123, DOI 10.1016/S0018-506X(03)00121-1; Davis A R, 2001, J Pediatr Adolesc Gynecol, V14, P3, DOI 10.1016/S1083-3188(00)00076-0; de Leon-Casasola O, 2011, PAIN MED, V12, pS100, DOI 10.1111/j.1526-4637.2011.01160.x; De Martin E, 2009, TRANSPL INT, V22, P28; Demir IE, 2011, LANGENBECK ARCH SURG, V396, P151, DOI 10.1007/s00423-010-0731-1; DHILLON AP, 1992, J PATHOL, V167, P211, DOI 10.1002/path.1711670209; Dmitrieva N, 2010, PAIN, V151, P703, DOI 10.1016/j.pain.2010.08.037; Durain D, 2004, J MIDWIFERY WOM HEAL, V49, P520, DOI 10.1016/j.jmwh.2004.08.013; Frokjaer JB, 2005, PAIN, V119, P191, DOI 10.1016/j.pain.2005.09.031; Gebhart GF, 1999, CAN J GASTROENTEROL, V13, p7A; Geny B, 2008, J APPL PHYSIOL, V104, P568, DOI [10.1152/japplphysiol.01159.2007, 10.1152/japplphysiol.00694.2007a]; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; GREEN PG, 1993, NEUROSCIENCE, V55, P1037, DOI 10.1016/0306-4522(93)90317-9; Grisk O, 2001, TRANSPLANTATION, V72, P1153, DOI 10.1097/00007890-200109270-00029; Howard FM, 2009, J MINIM INVAS GYN, V16, P540, DOI 10.1016/j.jmig.2009.06.017; Janig W, 1996, PROG BRAIN RES, V113, P61; Kennedy S, 2005, HUM REPROD, V20, P2698, DOI 10.1093/humrep/dei135; KONDO Y, 1972, ANN SURG, V176, P42, DOI 10.1097/00000658-197207000-00009; Latini C, 2008, CELL TISSUE RES, V334, P1, DOI 10.1007/s00441-008-0657-x; May KE, 2011, HUM REPROD UPDATE, V17, P637, DOI 10.1093/humupd/dmr013; McAllister SL, 2009, PAIN, V147, P255, DOI 10.1016/j.pain.2009.09.022; Mechsner S, 2009, FERTIL STERIL, V92, P1856, DOI 10.1016/j.fertnstert.2008.09.006; Nagabukuro H, 2007, PAIN, V132, pS96, DOI 10.1016/j.pain.2007.04.039; O'Connor AB, 2009, AM J MED, V122, pS22, DOI 10.1016/j.amjmed.2009.04.007; Rapkin Andrea J, 2009, Expert Rev Pharmacoecon Outcomes Res, V9, P157, DOI 10.1586/erp.09.14; Sann H, 1998, Z RHEUMATOL, V57, P8; Sauer SK, 2009, DIGEST DIS, V27, P11, DOI 10.1159/000268116; STARK RP, 1991, NEW ENGL J MED, V324, P1791, DOI 10.1056/NEJM199106203242507; Stratton P, 2011, HUM REPROD UPDATE, V17, P327, DOI 10.1093/humupd/dmq050; Tu CH, 2010, PAIN, V150, P462, DOI 10.1016/j.pain.2010.05.026; Tu CH, 2009, NEUROIMAGE, V47, P28, DOI 10.1016/j.neuroimage.2009.03.080; VERNON MW, 1985, FERTIL STERIL, V44, P684; Vincent K, 2011, PAIN, V152, P1966, DOI 10.1016/j.pain.2011.03.029; WILSON RF, 1991, CIRCULATION, V83, P1210, DOI 10.1161/01.CIR.83.4.1210; WOOLF CJ, 1983, NATURE, V306, P686, DOI 10.1038/306686a0; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Zhang GH, 2008, AM J PHYSIOL-REG I, V294, pR162, DOI 10.1152/ajpregu.00649.2007	45	42	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31758	10.1371/journal.pone.0031758	http://dx.doi.org/10.1371/journal.pone.0031758			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363725	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700093
J	Pelosi, A; Smith, D; Brammananth, R; Topolska, A; Billman-Jacobe, H; Nagley, P; Crellin, PK; Coppel, RL				Pelosi, Assunta; Smith, Danielle; Brammananth, Rajini; Topolska, Agnieszka; Billman-Jacobe, Helen; Nagley, Phillip; Crellin, Paul K.; Coppel, Ross L.			Identification of a Novel Gene Product That Promotes Survival of Mycobacterium smegmatis in Macrophages	PLOS ONE			English	Article							GLYOXYLATE AMINOTRANSFERASE; CULTURED MACROPHAGES; TUBERCULOSIS; ENTRY; BIOSYNTHESIS; DISRUPTION; EXPRESSION; PROTEIN; CLONING; GROWTH	Background: Bacteria of the suborder Corynebacterineae include significant human pathogens such as Mycobacterium tuberculosis and M. leprae. Drug resistance in mycobacteria is increasingly common making identification of new antimicrobials a priority. Mycobacteria replicate intracellularly, most commonly within the phagosomes of macrophages, and bacterial proteins essential for intracellular survival and persistence are particularly attractive targets for intervention with new generations of anti-mycobacterial drugs. Methodology/Principal Findings: We have identified a novel gene that, when inactivated, leads to accelerated death of M. smegmatis within a macrophage cell line in the first eight hours following infection. Complementation of the mutant with an intact copy of the gene restored survival to near wild type levels. Gene disruption did not affect growth compared to wild type M. smegmatis in axenic culture or in the presence of low pH or reactive oxygen intermediates, suggesting the growth defect is not related to increased susceptibility to these stresses. The disrupted gene, MSMEG_5817, is conserved in all mycobacteria for which genome sequence information is available, and designated Rv0807 in M. tuberculosis. Although homology searches suggest that MSMEG_5817 is similar to the serine: pyruvate aminotransferase of Brevibacterium linens suggesting a possible role in glyoxylate metabolism, enzymatic assays comparing activity in wild type and mutant strains demonstrated no differences in the capacity to metabolize glyoxylate. Conclusions/Significance: MSMEG_5817 is a previously uncharacterized gene that facilitates intracellular survival of mycobacteria. Interference with the function of MSMEG_5817 may provide a novel therapeutic approach for control of mycobacterial pathogens by assisting the host immune system in clearance of persistent intracellular bacteria.	[Pelosi, Assunta; Brammananth, Rajini; Topolska, Agnieszka; Crellin, Paul K.; Coppel, Ross L.] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia; [Pelosi, Assunta; Smith, Danielle; Nagley, Phillip] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Billman-Jacobe, Helen] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Pelosi, Assunta; Smith, Danielle; Brammananth, Rajini; Nagley, Phillip; Crellin, Paul K.; Coppel, Ross L.] Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic, Australia	Monash University; Monash University; University of Melbourne; Monash University	Pelosi, A (corresponding author), Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia.	paul.crellin@monash.edu	Coppel, Ross L/A-6626-2008	Coppel, Ross L/0000-0002-4476-9124; Billman-Jacobe, Helen/0000-0001-5713-4657; Crellin, Paul K/0000-0002-2017-4935	National Health and Medical Research Council of Australia; Australian Research Council Centre of Excellence in Structural and Functional Genomics	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Centre of Excellence in Structural and Functional Genomics(Australian Research Council)	This work was supported by the National Health and Medical Research Council of Australia (http://www.nmrc.gov.au) and the Australian Research Council Centre of Excellence in Structural and Functional Genomics (http://www.arc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anes E, 2006, CELL MICROBIOL, V8, P939, DOI 10.1111/j.1462-5822.2005.00675.x; ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; ARRUDA S, 1993, SCIENCE, V261, P1454, DOI 10.1126/science.8367727; Billman-Jacobe H, 1999, MOL MICROBIOL, V33, P1244, DOI 10.1046/j.1365-2958.1999.01572.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Chua J, 2004, CURR OPIN MICROBIOL, V7, P71, DOI 10.1016/j.mib.2003.12.011; Cole ST, 2002, MICROBIOL-SGM, V148, P2919, DOI 10.1099/00221287-148-10-2919; DENIS M, 1991, CELL IMMUNOL, V132, P150, DOI 10.1016/0008-8749(91)90014-3; Flesselles B, 1999, FEMS MICROBIOL LETT, V177, P237, DOI 10.1111/j.1574-6968.1999.tb13738.x; Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100; GORDON AH, 1994, INFECT IMMUN, V62, P4650, DOI 10.1128/IAI.62.10.4650-4651.1994; Haile Y, 2002, FEMS IMMUNOL MED MIC, V33, P125, DOI 10.1111/j.1574-695X.2002.tb00581.x; HERBERT RA, 1980, ARCH MICROBIOL, V128, P233, DOI 10.1007/BF00406164; Hume D A, 2001, BMC Immunol, V2, P11, DOI 10.1186/1471-2172-2-11; Jo EK, 2007, CELL MICROBIOL, V9, P1087, DOI 10.1111/j.1462-5822.2007.00914.x; Klumpp DJ, 2001, INFECT IMMUN, V69, P6689, DOI 10.1128/IAI.69.11.6689-6695.2001; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Kovacevic S, 2006, J BIOL CHEM, V281, P9011, DOI 10.1074/jbc.M511709200; Kuehnel MP, 2001, CELL MICROBIOL, V3, P551, DOI 10.1046/j.1462-5822.2001.00139.x; Kumar A, 2005, FEMS IMMUNOL MED MIC, V43, P185, DOI 10.1016/j.femsim.2004.08.013; Lagier B, 1998, MOL MICROBIOL, V29, P465, DOI 10.1046/j.1365-2958.1998.00933.x; Manca C, 1999, INFECT IMMUN, V67, P74, DOI 10.1128/IAI.67.1.74-79.1999; Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Monahan IM, 2001, METHODS MOL MED, V54; Pahlevan AA, 1999, J IMMUNOL, V163, P3928; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Patterson JH, 2000, J BIOL CHEM, V275, P24900, DOI 10.1074/jbc.M000147200; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Robinson N, 2007, INFECT IMMUN, V75, P581, DOI 10.1128/IAI.00997-06; ROWSELL EV, 1972, INT J BIOCHEM, V3, P247, DOI 10.1016/0020-711X(72)90036-5; Sakuraba H, 2004, J BACTERIOL, V186, P5513, DOI 10.1128/JB.186.16.5513-5518.2004; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sherman DR, 1996, SCIENCE, V272, P1641, DOI 10.1126/science.272.5268.1641; Shimono N, 2003, P NATL ACAD SCI USA, V100, P15918, DOI 10.1073/pnas.2433882100; Singh R, 2005, TUBERCULOSIS, V85, P325, DOI 10.1016/j.tube.2005.08.015; Stokes RW, 2004, INFECT IMMUN, V72, P5676, DOI 10.1128/IAI.72.10.5676-5686.2004; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Vergne I, 2004, MOL BIOL CELL, V15, P751, DOI 10.1091/mbc.E03-05-0307; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	45	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31788	10.1371/journal.pone.0031788	http://dx.doi.org/10.1371/journal.pone.0031788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363734	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700098
J	Serna-Bolea, C; de Deus, N; Acacio, S; Munoz, J; Nhalungo, D; Letang, E; Alonso, P; Naniche, D				Serna-Bolea, Celia; de Deus, Nilsa; Acacio, Sozinho; Munoz, Jose; Nhalungo, Delino; Letang, Emilio; Alonso, Pedro; Naniche, Denise			Recent HIV-1 Infection: Identification of Individuals with High Viral Load Setpoint in a Voluntary Counselling and Testing Centre in Rural Mozambique	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CAPTURE ENZYME-IMMUNOASSAY; SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; SUBTYPE-C; SET-POINT; SOUTHERN MOZAMBIQUE; TYPE-1; TRANSMISSION; WOMEN	Background: Identification of recent HIV-infections is important for describing the HIV epidemic and compiling HIV-RNA-setpoint data for future HIV intervention trials. We conducted a study to characterize recent infections, and HIV-RNA-setpoint within the adult population presenting at a voluntary counselling and testing centre (VCT) in southern Mozambique. Methods: All adults attending the Manhic,a District-Hospital VCT between April and October 2009 were recruited if they had at least one positive rapid HIV-serology test. Patients were screened for recent HIV-1 infection by BED-CEIA HIV-incidence test. Clinical examination, assessment of HIV-RNA and CD4 cell counts were performed at enrollment, 4 and 10 months. Results: Of the 492 participants included in this study, the prevalence of recent infections as defined by BED-CEIA test, CD4 counts >200 cells/mu l and HIV-RNA >400 copies/mL, was 11.58% (57/492; 95% CI 8.89-14.74). Due to heterogeneity in HIV-RNA levels in recently infected patients, individuals were categorized as having "high'' HIV-RNA load if their HIV-RNA level was above the median (4.98 log(10) copies/mL) at diagnosis. The "high'' HIV-RNA group sustained a significantly higher HIV-viral load at all visits with a median HIV-RNA-setpoint of 5.22 log(10) copies/mL (IQR 5.18-5.47) as compared to the median of 4.15 log(10) copies/ml (IQR 3.37-4.43) for the other patients (p = 0.0001). Conclusion: The low proportion of recent HIV-infections among HIV-seropositive VCT clients suggests that most of this population attends the VCT at later stages of HIV/AIDS. Characterization of HIV-RNA-setpoint may serve to identify recently infected individuals maintaining HIV viral load>5 log(10) copies/mL as candidates for antiretroviral treatment as prevention interventions.	[Serna-Bolea, Celia; Munoz, Jose; Letang, Emilio; Alonso, Pedro; Naniche, Denise] Hosp Clin Univ Barcelona, CRESIB, Barcelona Ctr Int Hlth Res, Barcelona, Spain; [de Deus, Nilsa; Acacio, Sozinho; Nhalungo, Delino; Alonso, Pedro] Manhica Hlth Res Ctr CISM, Manhica, Mozambique; [de Deus, Nilsa] Natl Inst Hlth, Maputo, Mozambique	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Centro de Investigacao em Saude de Manhica	Serna-Bolea, C (corresponding author), Hosp Clin Univ Barcelona, CRESIB, Barcelona Ctr Int Hlth Res, Barcelona, Spain.	celia.serna@cresib.cat; dsuzanne@clinic.ub.es	Gutierrez, Jose Muñoz/AAH-6954-2020; Gutiérrez, Jose Muñoz/X-5917-2018; Alonso, Pedro L/AAZ-3645-2020; Gutiérrez, José/GSJ-1846-2022; Naniche, Denise S/S-1814-2018; de Deus, Nilsa/P-8430-2015	Gutierrez, Jose Muñoz/0000-0002-0945-1735; Gutiérrez, Jose Muñoz/0000-0002-0945-1735; Alonso, Pedro L/0000-0003-3292-3443; Naniche, Denise S/0000-0002-4495-6325; de Deus, Nilsa/0000-0001-6769-7111; Fernandez, Ivette/0000-0001-5179-0477	Spanish Ministry of Health [PI071312, PI070233]; European and Developing Countries Clinical Trial Partnership (EDCTP) as part of the AfrEVacc consortium; Spanish Agency for International Cooperation; Generalitat de Catalunya	Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); European and Developing Countries Clinical Trial Partnership (EDCTP) as part of the AfrEVacc consortium; Spanish Agency for International Cooperation(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya)	Financial support was received from the Spanish Ministry of Health (grant PI071312) and from the European and Developing Countries Clinical Trial Partnership (EDCTP) as part of the AfrEVacc consortium. The Centro de Investigacao em Saude de Manhica receives core funding from the Spanish Agency for International Cooperation and the VCT clinic and day hospital from the Generalitat de Catalunya. CSB was supported by a grant from Spanish Ministry of Health (PI070233). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43; Barnighausen T, 2010, EPIDEMIOLOGY, V21, P685, DOI 10.1097/EDE.0b013e3181e9e978; Barnighausen T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003640; Bebell LM, 2010, AIDS, V24, P1945, DOI 10.1097/QAD.0b013e32833bb732; Bollinger RC, 1997, JAMA-J AM MED ASSOC, V278, P2085, DOI 10.1001/jama.278.23.2085; Braunstein SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024321; Braunstein SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018402; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Burgers WA, 2009, J IMMUNOL, V182, P4751, DOI 10.4049/jimmunol.0803801; Busch MP, 2010, AIDS, V24, P2763, DOI 10.1097/QAD.0b013e32833f1142; CDC, 2006, INT REC US BED CAPT; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Davenport MP, 2004, J VIROL, V78, P11340, DOI 10.1128/JVI.78.20.11340-11351.2004; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Dyer JR, 1998, J INFECT DIS, V177, P1742, DOI 10.1086/517436; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gupta SB, 2007, J INFECT DIS, V195, P546, DOI 10.1086/510909; Guy R, 2009, LANCET INFECT DIS, V9, P747, DOI 10.1016/S1473-3099(09)70300-7; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; [Joint United Nations Programme on HIV/AIDS World Health Organization], AIDS EP UPD DEC 2009; Karita E, 2007, AIDS, V21, P403, DOI 10.1097/QAD.0b013e32801481b7; Kigozi IM, 2009, JAIDS-J ACQ IMM DEF, V52, P280, DOI 10.1097/QAI.0b013e3181ab6eab; Laeyendecker O, 2011, AIDS RES HU IN PRESS; Lahuerta M, 2008, AIDS RES HUM RETROV, V24, P327, DOI 10.1089/aid.2007.0134; Lavreys L, 2006, CLIN INFECT DIS, V42, P1333, DOI 10.1086/503258; Lefrere JJ, 1998, J INFECT DIS, V177, P1541, DOI 10.1086/515308; Lyles RH, 2000, J INFECT DIS, V181, P872, DOI 10.1086/315339; Marinda ET, 2011, INT J EPIDEMIOL, V40, P945, DOI 10.1093/ije/dyr055; Marinda ET, 2010, JAIDS-J ACQ IMM DEF, V53, P496, DOI 10.1097/QAI.0b013e3181b61938; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Menendez C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001934; Morrison CS, 2010, AIDS, V24, P573, DOI 10.1097/QAD.0b013e32833433df; Naniche D, 2009, AM J TROP MED HYG, V80, P870, DOI 10.4269/ajtmh.2009.80.870; Nhacolo AQ, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-291; Novitsky V, 2009, JAIDS-J ACQ IMM DEF, V50, P65, DOI 10.1097/QAI.0b013e3181900141; Novitsky V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010148; Parekh BS, 2011, AIDS RES HUM RETROV, V27, P265, DOI 10.1089/aid.2010.0159; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Perez-Hoyos S, 2011, HIV MED; Pilcher CD, 2007, AIDS, V21, P1723, DOI 10.1097/QAD.0b013e3281532c82; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rosenberg ES, 1999, NEW ENGL J MED, V340, P969, DOI 10.1056/NEJM199903253401217; Saathoff E, 2010, JAIDS-J ACQ IMM DEF, V54, P324, DOI 10.1097/QAI.0b013e3181cf30ba; Schacker TW, 1998, ANN INTERN MED, V128, P613, DOI 10.7326/0003-4819-128-8-199804150-00001; Schupbach J, 2007, PLOS MED, V4, P1921, DOI 10.1371/journal.pmed.0040343; Serna-Bolea C, 2010, AIDS, V24, P603, DOI 10.1097/QAD.0b013e328335cda3; Truong HHM, 2011, AIDS RES HUM RETROV, V27, P593, DOI [10.1089/aid.2010.0249, 10.1089/AID.2010.0249]; [UNAIDS WHO], 2010, REP GLOB AIDS EP 201; Wanyenze RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021794; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411	52	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31859	10.1371/journal.pone.0031859	http://dx.doi.org/10.1371/journal.pone.0031859			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363755	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700110
J	Suardi, S; Vimercati, C; Casalone, C; Gelmetti, D; Corona, C; Iulini, B; Mazza, M; Lombardi, G; Moda, F; Ruggerone, M; Campagnani, I; Piccoli, E; Catania, M; Groschup, MH; Balkema-Buschmann, A; Caramelli, M; Monaco, S; Zanusso, G; Tagliavini, F				Suardi, Silvia; Vimercati, Chiara; Casalone, Cristina; Gelmetti, Daniela; Corona, Cristiano; Iulini, Barbara; Mazza, Maria; Lombardi, Guerino; Moda, Fabio; Ruggerone, Margherita; Campagnani, Ilaria; Piccoli, Elena; Catania, Marcella; Groschup, Martin H.; Balkema-Buschmann, Anne; Caramelli, Maria; Monaco, Salvatore; Zanusso, Gianluigi; Tagliavini, Fabrizio			Infectivity in Skeletal Muscle of Cattle with Atypical Bovine Spongiform Encephalopathy	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; PATHOLOGICAL PRION PROTEIN; EARLY BEHAVIORAL-CHANGES; CHRONIC WASTING DISEASE; SCRAPIE; MICE; BSE; TRANSMISSION; STRAIN; HAMSTERS	The amyloidotic form of bovine spongiform encephalopathy (BSE) termed BASE is caused by a prion strain whose biological properties differ from those of typical BSE, resulting in a clinically and pathologically distinct phenotype. Whether peripheral tissues of BASE-affected cattle contain infectivity is unknown. This is a critical issue since the BASE prion is readily transmissible to a variety of hosts including primates, suggesting that humans may be susceptible. We carried out bioassays in transgenic mice overexpressing bovine PrP (Tgbov XV) and found infectivity in a variety of skeletal muscles from cattle with natural and experimental BASE. Noteworthy, all BASE muscles used for inoculation transmitted disease, although the attack rate differed between experimental and natural cases (similar to 70% versus similar to 10%, respectively). This difference was likely related to different prion titers, possibly due to different stages of disease in the two conditions, i.e. terminal stage in experimental BASE and pre-symptomatic stage in natural BASE. The neuropathological phenotype and PrP res type were consistent in all affected mice and matched those of Tgbov XV mice infected with brain homogenate from natural BASE. The immunohistochemical analysis of skeletal muscles from cattle with natural and experimental BASE showed the presence of abnormal prion protein deposits within muscle fibers. Conversely, Tgbov XV mice challenged with lymphoid tissue and kidney from natural and experimental BASE did not develop disease. The novel information on the neuromuscular tropism of the BASE strain, efficiently overcoming species barriers, underlines the relevance of maintaining an active surveillance.	[Vimercati, Chiara; Moda, Fabio; Ruggerone, Margherita; Campagnani, Ilaria; Piccoli, Elena; Catania, Marcella; Tagliavini, Fabrizio] Fdn Carlo Besta Neurol Inst, IRCCS, Milan, Italy; [Casalone, Cristina; Corona, Cristiano; Iulini, Barbara; Mazza, Maria; Caramelli, Maria] Ist Zooprofilatt Sperimentale Piemonte Liguria &, Turin, Italy; [Gelmetti, Daniela; Lombardi, Guerino] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Brescia, Italy; [Groschup, Martin H.; Balkema-Buschmann, Anne] Friedrich Loeffler Inst, Greifswald, Insel Riems, Germany; [Monaco, Salvatore; Zanusso, Gianluigi] Univ Verona, Policlin GB Rossi, I-37100 Verona, Italy	IRCCS Istituto Neurologico Besta; IZS Piemonte Liguria e Valle D'aosta; IZS Lombardia e Emilia; Friedrich Loeffler Institute; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona	Suardi, S (corresponding author), Fdn Carlo Besta Neurol Inst, IRCCS, Milan, Italy.	ftagliavini@istituto-besta.it	Monaco, Salvatore/K-4659-2018; Moda, Fabio/J-6445-2018; Zanusso, Gianluigi/K-2823-2018; Casalone, Cristina/J-6763-2018; Catania, Marcella/K-1430-2016; Tagliavini, Fabrizio/AAO-7891-2021	Monaco, Salvatore/0000-0003-3191-8597; Moda, Fabio/0000-0002-2820-9880; Zanusso, Gianluigi/0000-0001-5199-6264; Casalone, Cristina/0000-0001-5271-832X; Catania, Marcella/0000-0003-0370-1905; Tagliavini, Fabrizio/0000-0003-1039-7315; Lombardi, Guerino/0000-0003-0977-5761	Italian Ministry of Health (Ricerca Corrente) [PRC IZSLER 003/2002, RFPS-2007-7-638803]	Italian Ministry of Health (Ricerca Corrente)(Ministry of Health, Italy)	This work was supported by the Italian Ministry of Health (Ricerca Corrente, grant number PRC IZSLER 003/2002 and RFPS-2007-7-638803). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoletti O, 2004, NAT MED, V10, P591, DOI 10.1038/nm1055; Andreoletti O, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001285; Angers RC, 2006, SCIENCE, V311, P1117, DOI 10.1126/science.1122864; Beringue V, 2008, EMERG INFECT DIS, V14, P1898, DOI 10.3201/eid1412.080941; Beringue V, 2007, J NEUROSCI, V27, P6965, DOI 10.1523/JNEUROSCI.0693-07.2007; Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; Bosque PJ, 2002, P NATL ACAD SCI USA, V99, P3812, DOI 10.1073/pnas.052707499; BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; Brown P, 2006, EMERG INFECT DIS, V12, P1816; Buschmann A, 2005, J INFECT DIS, V192, P934, DOI 10.1086/431602; Buschmann A, 2000, ARCH VIROL, P75; Capobianco R, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030031; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; Comoy EE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003017; Dell'Omo G, 2002, EUR J NEUROSCI, V16, P735, DOI 10.1046/j.1460-9568.2002.02128.x; Dudas S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010638; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; Fukuda S, 2009, MICROBIOL IMMUNOL, V53, P704, DOI 10.1111/j.1348-0421.2009.00169.x; Giaccone G, 2000, BRAIN PATHOL, V10, P31, DOI 10.1111/j.1750-3639.2000.tb00240.x; Gregori L, 2008, EMERG INFECT DIS, V14, P1406, DOI 10.3201/eid1409.080259; Guenther K, 2001, EUR J NEUROSCI, V14, P401, DOI 10.1046/j.0953-816x.2001.01645.x; Hamir AN, 2006, VET PATHOL, V43, P367, DOI 10.1354/vp.43-3-367; Herzog C, 2005, J VIROL, V79, P14339, DOI 10.1128/JVI.79.22.14339-14345.2005; Iwamaru Y, 2010, EMERG INFECT DIS, V16, P1151, DOI 10.3201/eid1607.091882; Jacobs JG, 2007, J CLIN MICROBIOL, V45, P1821, DOI 10.1128/JCM.00160-07; Kong QZ, 2008, J VIROL, V82, P3697, DOI 10.1128/JVI.02561-07; Kovacs GG, 2004, ANN NEUROL, V55, P121, DOI 10.1002/ana.10813; Krasemann S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013906; Ligios C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000859; Lombardi G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000075; Okada H, 2010, J VET MED SCI, V72, P1423, DOI 10.1292/jvms.10-0211; Ono F, 2011, JPN J INFECT DIS, V64, P81; Peralta OA, 2009, PRION, V3, P161, DOI 10.4161/pri.3.3.9772; Richt JA, 2007, J VET DIAGN INVEST, V19, P142, DOI 10.1177/104063870701900202; Siso S, 2006, VET REC, V159, P327, DOI 10.1136/vr.159.10.327-b; Styren SC, 2000, J HISTOCHEM CYTOCHEM, V48, P1223, DOI 10.1177/002215540004800906; Tagliavini F, 1997, SCIENCE, V276, P1119, DOI 10.1126/science.276.5315.1119; Thomzig A, 2006, J GEN VIROL, V87, P251, DOI 10.1099/vir.0.81277-0; Thomzig A, 2004, J CLIN INVEST, V113, P1465, DOI 10.1172/JCI200421083; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Yamakawa Y, 2003, JPN J INFECT DIS, V56, P221	41	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31449	10.1371/journal.pone.0031449	http://dx.doi.org/10.1371/journal.pone.0031449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363650	gold, Green Published, Green Submitted			2022-12-27	WOS:000302873700060
J	Zhu, GP; Bu, WJ; Gao, YB; Liu, GQ				Zhu, Gengping; Bu, Wenjun; Gao, Yubao; Liu, Guoqing			Potential Geographic Distribution of Brown Marmorated Stink Bug Invasion (Halyomorpha halys)	PLOS ONE			English	Article							HEMIPTERA-PENTATOMIDAE; SPECIES DISTRIBUTIONS; HETEROPTERA-PENTATOMIDAE; NICHE CONSERVATISM; ECOLOGICAL NICHES; UNCERTAINTY; PROJECTIONS; PREDICTION; NUMBERS; RECORDS	Background: The Brown Marmorated Stink Bug (BMSB), Halyomorpha halys (Stal) (Hemiptera: Pentatomidae), native to Asia, is becoming an invasive species with a rapidly expanding range in North America and Europe. In the US, it is a household pest and also caused unprecedented damage to agriculture crops. Exploring its climatic limits and estimating its potential geographic distribution can provide critical information for management strategies. Methodology/Principals: We used direct climate comparisons to explore the climatic niche occupied by native and invasive populations of BMSB. Ecological niche modelings based on the native range were used to anticipate the potential distribution of BMSB worldwide. Conversely, niche models based on the introduced range were used to locate the original invasive propagates in Asia. Areas with high invasion potential were identified by two niche modeling algorithms (i.e., Maxent and GARP). Conclusions/Significance: Reduced dimensionality of environmental space improves native model transferability in the invade area. Projecting models from invasive population back to native distributional areas offers valuable information on the potential source regions of the invasive populations. Our models anticipated successfully the current disjunct distribution of BMSB in the US. The original propagates are hypothesized to have come from northern Japan or western Korea. High climate suitable areas at risk of invasion include latitudes between 30 degrees-50 degrees including northern Europe, northeastern North America, southern Australia and the North Island of New Zealand. Angola in Africa and Uruguay in South America also showed high climate suitability.	[Zhu, Gengping] Nankai Univ, Coll Environm Sci & Engn, Tianjin 300071, Peoples R China; [Bu, Wenjun; Gao, Yubao; Liu, Guoqing] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Zhu, GP (corresponding author), Nankai Univ, Coll Environm Sci & Engn, Tianjin 300071, Peoples R China.	gengpingzhu@hotmail.com	Zhu, Gengping/E-4730-2013; Zhu, Gengping/CAF-4192-2022	Zhu, Gengping/0000-0001-6823-5840	Nankai University; National Education Project in Basic Science for Special Subjects [J0630963]; National Natural Science Foundation of China [30725005]	Nankai University; National Education Project in Basic Science for Special Subjects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by a postdoctoral fellowship award to GZ in Nankai University and by the National Education Project in Basic Science for Special Subjects (No. J0630963) and National Natural Science Foundation of China (No. 30725005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich JR, 2009, FLA ENTOMOL, V92, P483, DOI 10.1653/024.092.0310; [Anonymous], 1997, GAZETTEER CHINA; APHIS, 2004, PEST TRACK PUBL WEBS; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; Capinha C, 2011, DIVERS DISTRIB, V17, P13, DOI 10.1111/j.1472-4642.2010.00727.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; ESA, 2011, ENT SOC AM E BRANCH; ESRI, 2006, ARCGIS 9 2; Fitzpatrick MC, 2007, GLOBAL ECOL BIOGEOGR, V16, P24, DOI 10.1111/j.1466-8238.2006.00258.x; Flanders J, 2011, J BIOGEOGR, V38, P439, DOI 10.1111/j.1365-2699.2010.02411.x; Grinnell J, 1924, ECOLOGY, V5, P225, DOI 10.2307/1929447; Grinnell J., 1917, Auk Cambridge Mass, V34; Harris Anthony C., 2010, Weta, V40, P42; Hawlitschek O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016662; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoebeke ER, 2003, P ENTOMOL SOC WASH, V105, P225; Hutchinson G.E., 1978, INTRO POPULATION ECO; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Ji S.L., 2006, NO FRUITS, V5, P25; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Jones JR, 2009, FLA ENTOMOL, V92, P177, DOI 10.1653/024.092.0132; JOSIFOV M, 1978, Fragmenta Faunistica (Warsaw), V23, P137; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Khrimian A, 2008, J AGR FOOD CHEM, V56, P197, DOI 10.1021/jf072087e; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Li Q, 1998, PLANT DOCTOR, V11, P17; Li Zhong-xin, 2004, Chinese Journal of Biological Control, V20, P64; Liu XA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018429; Mandle L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015297; Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x; Nielsen AL, 2008, ENVIRON ENTOMOL, V37, P348, DOI 10.1603/0046-225X(2008)37[348:DREALT]2.0.CO;2; Nielsen AL, 2008, J ECON ENTOMOL, V101, P1439, DOI 10.1603/0022-0493(2008)101[1439:TOITHH]2.0.CO;2; Nielsen AL, 2009, ANN ENTOMOL SOC AM, V102, P608, DOI 10.1603/008.102.0405; Nielsen AL, 2009, J ECON ENTOMOL, V102, P1133, DOI 10.1603/029.102.0335; Niva CC, 2003, ZOOL SCI, V20, P963, DOI 10.2108/zsj.20.963; Nunez MA, 2011, DIVERS DISTRIB, V17, P703, DOI 10.1111/j.1472-4642.2011.00772.x; Papes M, 2007, DIVERS DISTRIB, V13, P890, DOI 10.1111/j.1472-4642.2007.00392.x; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; PEARSON RG, 2007, SPECIES DISTRIBUTION; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Peterson AT, 2008, GLOBAL ECOL BIOGEOGR, V17, P135, DOI 10.1111/j.1466-8238.2007.00347.x; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Peterson AT, 2012, ECOLOGICAL NICHES GE, DOI [10.1515/9781400840670, DOI 10.1515/9781400840670]; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Qiu L.-F., 2007, THESIS CHINESE ACAD; Qiu LF., 2010, N HORT, V9, P181; Qiu LF, 2010, CHINESE AGR SCI B, V26, P211; Rabitsch W, 2008, ZOOTAXA, P1; Rangel TFLVB, 2006, GLOBAL ECOL BIOGEOGR, V15, P321, DOI 10.1111/j.1466-822x.2006.00237.x; Rodder D, 2009, GLOBAL ECOL BIOGEOGR, V18, P674, DOI 10.1111/j.1466-8238.2009.00477.x; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Song HW, 1993, ENTOMOLOGICAL KNOWLE, V4, P225; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Toyama M, 2011, APPL ENTOMOL ZOOL, V46, P37, DOI 10.1007/s13355-010-0002-1; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Waltari E, 2009, J BIOGEOGR, V36, P148, DOI 10.1111/j.1365-2699.2008.01959.x; WERMELINGER B, 2008, B SOC ENTOMOL SUISSE, V81, P1; Wyniger Denise, 2010, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V83, P261; Yang S.Y., 2006, SHANXI FRUITS, V3, P10; Yu CL., 2002, CHINA FRUITS, V2, P5; Zhang Cuituan, 1993, Forest Research, V6, P271; Zhang Y.Q., 2006, DECIDUOUS FRUITS, V3, P42	74	149	175	2	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31246	10.1371/journal.pone.0031246	http://dx.doi.org/10.1371/journal.pone.0031246			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363595	gold, Green Published, Green Submitted			2022-12-27	WOS:000302873700039
J	Fox, A; Le, NMH; Horby, P; van Doorn, HR; Trung, NV; Ha, NH; Cap, NT; Phu, VD; Ha, NM; Diep, NTN; Bich, VTN; Huong, TTK; Taylor, WR; Farrar, J; Wertheim, H; Kinh, NV				Fox, Annette; Le Nguyen Minh Hoa; Horby, Peter; van Doorn, H. Rogier; Nguyen Vu Trung; Nguyen Hong Ha; Nguyen Trung Cap; Vu Dinh Phu; Nguyen Minh Ha; Diep Nguyen Thi Ngoc; Bich Vu Thi Ngoc; Huong Tran Thi Kieu; Taylor, Walter R.; Farrar, Jeremy; Wertheim, Heiman; Nguyen Van Kinh			Severe Pandemic H1N1 2009 Infection Is Associated with Transient NK and T Deficiency and Aberrant CD8 Responses	PLOS ONE			English	Article							INFLUENZA-A H5N1; CELLULAR IMMUNE-RESPONSES; VIRUS-INFECTION; PROTECTIVE IMMUNITY; HUMAN-DISEASE; HONG-KONG; CELLS; ACTIVATION; MICE; PNEUMONIA	Backgorund: It is unclear why the severity of influenza varies in healthy adults or why the burden of severe influenza shifts to young adults when pandemic strains emerge. One possibility is that cross-protective T cell responses wane in this age group in the absence of recent infection. We therefore compared the acute cellular immune response in previously healthy adults with severe versus mild pandemic H1N1 infection. Methods and Principal Findings: 49 previously healthy adults admitted to the National Hospital of Tropical Diseases, Viet Nam with RT-PCR-confirmed 2009 H1N1 infection were prospectively enrolled. 39 recovered quickly whereas 10 developed severe symptoms requiring supplemental oxygen and prolonged hospitalization. Peripheral blood lymphocyte subset counts and activation (HLADR, CD38) and differentiation (CD27, CD28) marker expression were determined on days 0, 2, 5, 10, 14 and 28 by flow cytometry. NK, CD4 and CD8 lymphopenia developed in 100%, 90% and 60% of severe cases versus 13% (p<0.001), 28%, (p = 0.001) and 18% (p = 0.014) of mild cases. CD4 and NK counts normalized following recovery. B cell counts were not significantly associated with severity. CD8 activation peaked 6-8 days after mild influenza onset, when 13% (6-22%) were HLADR+CD38+, and was accompanied by a significant loss of resting/CD27+CD28+ cells without accumulation of CD27+CD282- or CD272CD282- cells. In severe influenza CD8 activation peaked more than 9 days post-onset, and/or was excessive (30-90% HLADR+CD38+) in association with accumulation of CD27+CD282- cells and maintenance of CD8 counts. Conclusion: Severe influenza is associated with transient T and NK cell deficiency. CD8 phenotype changes during mild influenza are consistent with a rapidly resolving memory response whereas in severe influenza activation is either delayed or excessive, and partially differentiated cells accumulate within blood indicating that recruitment of effector cells to the lung could be impaired.	[Fox, Annette; Horby, Peter; van Doorn, H. Rogier; Taylor, Walter R.; Farrar, Jeremy; Wertheim, Heiman] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Dong Da, Ha Noi, Vietnam; [Fox, Annette; Le Nguyen Minh Hoa; Horby, Peter; van Doorn, H. Rogier; Diep Nguyen Thi Ngoc; Bich Vu Thi Ngoc; Huong Tran Thi Kieu; Taylor, Walter R.; Farrar, Jeremy; Wertheim, Heiman] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Nguyen Vu Trung; Nguyen Hong Ha; Nguyen Trung Cap; Vu Dinh Phu; Nguyen Minh Ha; Nguyen Van Kinh] Natl Hosp Trop Dis, Dong Da, Ha Noi, Vietnam; [Taylor, Walter R.] SE Asia Infect Dis Clin Res Network, Jakarta, Indonesia	University of Oxford; University of Oxford; National Hospital of Tropical Diseases	Fox, A (corresponding author), Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Dong Da, Ha Noi, Vietnam.	afox@oucru.org	Wertheim, Heiman FL/F-3338-2016; Farrar, Jeremy J./HGA-7610-2022; Horby, Peter/D-1585-2013; van Doorn, H. Rogier/H-3080-2019	Wertheim, Heiman FL/0000-0002-5003-5565; van Doorn, H. Rogier/0000-0002-9807-1821; Farrar, Jeremy/0000-0002-2700-623X; Horby, Peter/0000-0002-9822-1586; Fox, Annette/0000-0002-0565-7146	Wellcome Trust of Great Britain; South East Asian Infectious Diseases Clinical Research Network; European Union [223498]; National Hospital; Ministry of Health of Viet Nam	Wellcome Trust of Great Britain(Wellcome Trust); South East Asian Infectious Diseases Clinical Research Network; European Union(European Commission); National Hospital; Ministry of Health of Viet Nam	This work was funded by the Wellcome Trust of Great Britain and The South East Asian Infectious Diseases Clinical Research Network. AF was supported by the European Union FP7 project "European Management Platform for Emerging and Re-emerging Infectious Disease Entities (EMPERIE)'' (no. 223498). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank the patients for agreeing to participate in the study. We thank the Ministry of Health of Viet Nam and the staff of the National Hospital of Tropical diseases for their continued support for our work and for their dedication to high quality research into infectious diseases in Viet Nam.	Agrati C, 2010, J INFECT DIS, V202, P681, DOI 10.1086/655469; Ahmed R, 2007, NAT IMMUNOL, V8, P1188, DOI 10.1038/ni1530; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Barbour JD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004408; Bodewes R, 2011, CLIN VACCINE IMMUNOL, V18, P469, DOI 10.1128/CVI.00396-10; Challen K, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-33; Chien YS, 2010, J INFECTION, V60, P168, DOI 10.1016/j.jinf.2009.12.012; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; Chowell G, 2010, P ROY SOC B-BIOL SCI, V277, P1857, DOI 10.1098/rspb.2009.1897; COUCH RB, 1983, ANNU REV MICROBIOL, V37, P529, DOI 10.1146/annurev.mi.37.100183.002525; CRISWELL BS, 1979, AM REV RESPIR DIS, V120, P700; Cui W, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-145; Cunha BA, 2009, CLIN INFECT DIS, V49, P1454, DOI 10.1086/644496; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Donaldson LJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5213; Eichelberger MC, 2006, CELL IMMUNOL, V243, P67, DOI 10.1016/j.cellimm.2006.12.005; Epstein SL, 1998, J IMMUNOL, V160, P322; Epstein SL, 2006, J INFECT DIS, V193, P49, DOI 10.1086/498980; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Fox A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-167; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Glezen WP, 1996, EPIDEMIOL REV, V18, P64, DOI 10.1093/oxfordjournals.epirev.a017917; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; He XS, 2006, J VIROL, V80, P11756, DOI 10.1128/JVI.01460-06; Heltzer ML, 2009, J LEUKOCYTE BIOL, V85, P1036, DOI 10.1189/jlb.1108710; Hien Tran Tinh, 2010, PLoS Med, V7, pe1000277, DOI 10.1371/journal.pmed.1000277; HOPESIMPSON RE, 1972, BMJ-BRIT MED J, V4, P490, DOI 10.1136/bmj.4.5838.490-b; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jiang TJ, 2010, CLIN IMMUNOL, V137, P303, DOI 10.1016/j.clim.2010.07.010; Kamphuis E, 2006, BLOOD, V108, P3253, DOI 10.1182/blood-2006-06-027599; Kreijtz JHCM, 2007, VACCINE, V25, P612, DOI 10.1016/j.vaccine.2006.08.036; LEWIS DE, 1986, J IMMUNOL, V137, P3777; Lichtner M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019872; Mao HW, 2009, J VIROL, V83, P9215, DOI 10.1128/JVI.00805-09; Marcelin G, 2010, J INFECT DIS, V202, P1634, DOI 10.1086/657084; Marelli-Berg FM, 2008, J PATHOL, V214, P179, DOI 10.1002/path.2269; Mathews JD, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-128; MCMICHAEL AJ, 1983, NEW ENGL J MED, V309, P13, DOI 10.1056/NEJM198307073090103; MCMICHAEL AJ, 1983, LANCET, V2, P762; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; MONTO AS, 1993, EPIDEMIOL INFECT, V110, P145, DOI 10.1017/S0950268800050779; Nguyen TL, 2009, CLIN INFECT DIS, V48, P1639, DOI 10.1086/599031; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; Rosenberg YJ, 1997, INT IMMUNOL, V9, P703, DOI 10.1093/intimm/9.5.703; Salazar-Mather TP, 2003, VIRAL IMMUNOL, V16, P291, DOI 10.1089/088282403322396109; Sandalova E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001051; Skowronski DM, 2011, J INFECT DIS, V203, P158, DOI 10.1093/infdis/jiq039; STEINSTREILEIN J, 1986, J IMMUNOL, V136, P1435; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; Tomiyama H, 2004, EUR J IMMUNOL, V34, P999, DOI 10.1002/eji.200324478; Tse H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022534; Tumpey TM, 2000, J VIROL, V74, P6105, DOI 10.1128/JVI.74.13.6105-6116.2000; Van Reeth K, 2003, VACCINE, V21, P1375, DOI 10.1016/S0264-410X(02)00688-6; Vogel AB, 2010, J IMMUNOL, V185, P4824, DOI 10.4049/jimmunol.0903631; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; WEBSTER RG, 1980, EUR J IMMUNOL, V10, P396, DOI 10.1002/eji.1830100515; Welliver TP, 2007, J INFECT DIS, V195, P1126, DOI 10.1086/512615; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9	65	62	65	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31535	10.1371/journal.pone.0031535	http://dx.doi.org/10.1371/journal.pone.0031535			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363665	Green Published, gold			2022-12-27	WOS:000302871500054
J	Hall-Glenn, F; De Young, RA; Huang, BL; van Handel, B; Hofmann, JJ; Chen, TT; Choi, A; Ong, JR; Benya, PD; Mikkola, H; Iruela-Arispe, ML; Lyons, KM				Hall-Glenn, Faith; De Young, R. Andrea; Huang, Bau-Lin; van Handel, Ben; Hofmann, Jennifer J.; Chen, Tom T.; Choi, Aaron; Ong, Jessica R.; Benya, Paul D.; Mikkola, Hanna; Iruela-Arispe, M. Luisa; Lyons, Karen M.			CCN2/Connective Tissue Growth Factor Is Essential for Pericyte Adhesion and Endothelial Basement Membrane Formation during Angiogenesis	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX PRODUCTION; FACTOR CTGF/CCN2; FACTOR CTGF; FACTOR CCN2; PDGF-B; INTEGRIN ALPHA(V)BETA(3); GENE-EXPRESSION; CELL-ADHESION; MIGRATION; MOUSE	CCN2/Connective Tissue Growth Factor (CTGF) is a matricellular protein that regulates cell adhesion, migration, and survival. CCN2 is best known for its ability to promote fibrosis by mediating the ability of transforming growth factor beta (TGF beta) to induce excess extracellular matrix production. In addition to its role in pathological processes, CCN2 is required for chondrogenesis. CCN2 is also highly expressed during development in endothelial cells, suggesting a role in angiogenesis. The potential role of CCN2 in angiogenesis is unclear, however, as both pro- and anti-angiogenic effects have been reported. Here, through analysis of Ccn2-deficient mice, we show that CCN2 is required for stable association and retention of pericytes by endothelial cells. PDGF signaling and the establishment of the endothelial basement membrane are required for pericytes recruitment and retention. CCN2 induced PDGF-B expression in endothelial cells, and potentiated PDGF-B mediated Akt signaling in mural (vascular smooth muscle/pericyte) cells. In addition, CCN2 induced the production of endothelial basement membrane components in vitro, and was required for their expression in vivo. Overall, these results highlight CCN2 as an essential mediator of vascular remodeling by regulating endothelial-pericyte interactions. Although most studies of CCN2 function have focused on effects of CCN2 overexpression on the interstitial extracellular matrix, the results presented here show that CCN2 is required for the normal production of vascular basement membranes.	[Hall-Glenn, Faith; van Handel, Ben; Hofmann, Jennifer J.; Chen, Tom T.; Ong, Jessica R.; Mikkola, Hanna; Iruela-Arispe, M. Luisa; Lyons, Karen M.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90024 USA; [De Young, R. Andrea; Choi, Aaron; Benya, Paul D.; Lyons, Karen M.] Univ Calif Los Angeles, Dept Orthopaed Surg, Los Angeles, CA USA; [Huang, Bau-Lin] Univ Calif Los Angeles, Dept Oral Biol, Los Angeles, CA USA; [Hofmann, Jennifer J.; Iruela-Arispe, M. Luisa; Lyons, Karen M.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Iruela-Arispe, M. Luisa; Lyons, Karen M.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Hall-Glenn, F (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90024 USA.	klyons@mednet.ucla.edu	Iruela-Arispe, M. Luisa/AAJ-1297-2020; Huang, Bau-Lin/S-4133-2019; Huang, Bau-Lin/K-8317-2019; Benya, Paul/I-3449-2015	Iruela-Arispe, M. Luisa/0000-0002-3050-4168; Huang, Bau-Lin/0000-0003-3747-6697; Benya, Paul/0000-0002-1060-7127; Ong, Jessica/0000-0001-5925-8047	NIH [AR052686, HL097766]; Scleroderma Foundation; Jonsson Comprehensive Cancer Center; UCLA [HL069766]; Ruth L. Kirschstein National Research Service [T32HL69766]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097766, T32HL069766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F31AR060687, R01AR052686] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scleroderma Foundation; Jonsson Comprehensive Cancer Center; UCLA; Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH AR052686, Scleroderma Foundation, and the Jonsson Comprehensive Cancer Center, UCLA (KML), UCLA Vascular Biology Training Grant HL069766 and Ruth L. Kirschstein National Research Service Award T32HL69766 (FHG), and NIH HL097766 (HM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Arnott JA, 2007, J CELL PHYSIOL, V210, P843, DOI 10.1002/jcp.20917; Astrof S, 2009, ANGIOGENESIS, V12, P165, DOI 10.1007/s10456-009-9136-6; Babic AM, 1999, MOL CELL BIOL, V19, P2958; Basciani S, 2002, J CLIN ENDOCR METAB, V87, P2310, DOI 10.1210/jc.87.5.2310; Bjarnegard M, 2004, DEVELOPMENT, V131, P1847, DOI 10.1242/dev.01080; BORK P, 1993, FEBS LETT, V327, P125, DOI 10.1016/0014-5793(93)80155-N; BRADHAM DM, 1991, J CELL BIOL, V114, P1285, DOI 10.1083/jcb.114.6.1285; Brigstock David R., 2002, Angiogenesis, V5, P153, DOI 10.1023/A:1023823803510; Brigstock DR, 2010, J CELL COMMUN SIGNAL, V4, P1, DOI 10.1007/s12079-009-0071-5; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Brugger SM, 2004, DEVELOPMENT, V131, P5153, DOI 10.1242/dev.01390; Cattaruzza S, 2002, J BIOL CHEM, V277, P47626, DOI 10.1074/jbc.M206521200; Chen CC, 2001, J BIOL CHEM, V276, P10443, DOI 10.1074/jbc.M008087200; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Chen YJ, 2001, EXP CELL RES, V271, P109, DOI 10.1006/excr.2001.5364; Chen YL, 2004, MOL BIOL CELL, V15, P5635, DOI 10.1091/mbc.E04-06-0490; Chien WW, 2011, INT J ONCOL, V38, P1741, DOI 10.3892/ijo.2011.985; Choi J, 2011, DEVELOPMENT, V138, P1173, DOI 10.1242/dev.054049; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Diaz-Flores L, 2009, HISTOL HISTOPATHOL, V24, P909, DOI 10.14670/HH-24.909; Favor J, 2007, GENETICS, V175, P725, DOI 10.1534/genetics.106.064733; Friedrichsen S, 2005, GROWTH FACTORS, V23, P43, DOI 10.1080/08977190512331340566; Friedrichsen S, 2003, CELL TISSUE RES, V312, P175, DOI 10.1007/s00441-003-0712-6; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Gao R, 2006, GUT, V55, P856, DOI 10.1136/gut.2005.079178; Gao RP, 2005, GASTROENTEROLOGY, V129, P1019, DOI 10.1053/j.gastro.2005.06.067; Gao RP, 2004, J BIOL CHEM, V279, P8848, DOI 10.1074/jbc.M313204200; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Guha M, 2007, FASEB J, V21, P3355, DOI 10.1096/fj.06-6713com; Hashimoto G, 2002, J BIOL CHEM, V277, P36288, DOI 10.1074/jbc.M201674200; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Heng ECK, 2006, J CELL BIOCHEM, V98, P409, DOI 10.1002/jcb.20810; Hoshijima M, 2006, FEBS LETT, V580, P1376, DOI 10.1016/j.febslet.2006.01.061; Huang BL, 2010, J BIOL CHEM, V285, P27702, DOI 10.1074/jbc.M110.108498; Inoki I, 2001, FASEB J, V15, P219, DOI 10.1096/fj.01-0332fje; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jones PL, 1997, J CELL BIOL, V139, P279, DOI 10.1083/jcb.139.1.279; Kale S, 2004, FASEB J, V18, P270, DOI 10.1096/fj.04-1604fje; Kireeva ML, 1997, EXP CELL RES, V233, P63, DOI 10.1006/excr.1997.3548; Kuiper EJ, 2008, J HISTOCHEM CYTOCHEM, V56, P785, DOI 10.1369/jhc.2008.950980; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Liu SX, 2011, ARTHRITIS RHEUM-US, V63, P239, DOI 10.1002/art.30074; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; Mo FE, 2002, MOL CELL BIOL, V22, P8709, DOI 10.1128/MCB.22.24.8709-8720.2002; Nguyen TQ, 2008, J AM SOC NEPHROL, V19, P2098, DOI 10.1681/ASN.2007111261; Nishida T, 2007, J CELL COMMUN SIGNAL, V1, P45, DOI 10.1007/s12079-007-0005-z; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; RISAU W, 1988, DEV BIOL, V125, P441, DOI 10.1016/0012-1606(88)90225-4; Schneller M, 1997, EMBO J, V16, P5600, DOI 10.1093/emboj/16.18.5600; Shi-Wen X, 2006, J BIOL CHEM, V281, P10715, DOI 10.1074/jbc.M511343200; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; Shimo T, 1999, J BIOCHEM-TOKYO, V126, P137, DOI 10.1093/oxfordjournals.jbchem.a022414; Shimo T, 2001, ONCOLOGY-BASEL, V61, P315, DOI 10.1159/000055339; Simon-Assmann P, 2011, INT J DEV BIOL, V55, P455, DOI 10.1387/ijdb.103223ps; Sonnylal S, 2010, ARTHRITIS RHEUM-US, V62, P1523, DOI 10.1002/art.27382; Steffen CL, 1998, GROWTH FACTORS, V15, P199, DOI 10.3109/08977199809002117; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Surveyor GA, 1999, GROWTH FACTORS, V17, P115, DOI 10.3109/08977199909103520; Suzuma K, 2000, J BIOL CHEM, V275, P40725, DOI 10.1074/jbc.M006509200; Van Handel B, 2010, BLOOD, V116, P3321, DOI 10.1182/blood-2010-04-279489; Vorwerk P, 2002, ENDOCRINOLOGY, V143, P1677, DOI 10.1210/en.143.5.1677; Wight TN, 2008, FRONT BIOSCI, V13, P4933, DOI 10.2741/3052; Yokoi H, 2002, AM J PHYSIOL-RENAL, V282, pF933, DOI 10.1152/ajprenal.00122.2001; Yoshida K, 2007, BBA-GEN SUBJECTS, V1770, P672, DOI 10.1016/j.bbagen.2006.11.010	70	91	97	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30562	10.1371/journal.pone.0030562	http://dx.doi.org/10.1371/journal.pone.0030562			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363445	Green Submitted, Green Published, gold			2022-12-27	WOS:000302871500011
J	Larson, JL; Yuan, GC				Larson, Jessica L.; Yuan, Guo-Cheng			Chromatin States Accurately Classify Cell Differentiation Stages	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HUMAN GENOME; HISTONE MODIFICATIONS; GENE-EXPRESSION; PLURIPOTENT; EPIGENOMICS; DISTINCT; IDENTIFICATION; SIGNATURE; ENHANCERS	Gene expression is controlled by the concerted interactions between transcription factors and chromatin regulators. While recent studies have identified global chromatin state changes across cell-types, it remains unclear to what extent these changes are co-regulated during cell-differentiation. Here we present a comprehensive computational analysis by assembling a large dataset containing genome-wide occupancy information of 5 histone modifications in 27 human cell lines (including 24 normal and 3 cancer cell lines) obtained from the public domain, followed by independent analysis at three different representations. We classified the differentiation stage of a cell-type based on its genome-wide pattern of chromatin states, and found that our method was able to identify normal cell lines with nearly 100% accuracy. We then applied our model to classify the cancer cell lines and found that each can be unequivocally classified as differentiated cells. The differences can be in part explained by the differential activities of three regulatory modules associated with embryonic stem cells. We also found that the "hotspot'' genes, whose chromatin states change dynamically in accordance to the differentiation stage, are not randomly distributed across the genome but tend to be embedded in multi-gene chromatin domains, and that specialized gene clusters tend to be embedded in stably occupied domains.	[Larson, Jessica L.; Yuan, Guo-Cheng] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Yuan, Guo-Cheng] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute	Larson, JL (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Biostat, 665 Huntington Ave, Boston, MA 02115 USA.	gcyuan@jimmy.harvard.edu			HSPH; United States National Institutes of Health [HG005085]; NIH [GM074897]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM074897] Funding Source: NIH RePORTER	HSPH; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an HSPH Career Incubator Award and the United States National Institutes of Health grant HG005085 to GCY, and by a NIH training grant (GM074897) to JLL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Chang C.-C., LIBSVM LIB SUPPORT V; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Durbin R, BIOL SEQUENCE ANAL; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hebenstreit D, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1226; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Keerthi SS, 2003, NEURAL COMPUT, V15, P1667, DOI 10.1162/089976603321891855; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Larson JL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-557; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; Massague J, 2000, GENE DEV, V14, P627; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Pollard KS, 2005, MULTTEST RESAMPLING; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Thurman RE, 2007, GENOME RES, V17, P917, DOI 10.1101/gr.6081407; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Young MD, 2011, NUCLEIC ACIDS RES, V39, P7415, DOI 10.1093/nar/gkr416	40	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31414	10.1371/journal.pone.0031414	http://dx.doi.org/10.1371/journal.pone.0031414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363642	Green Published, Green Submitted, gold			2022-12-27	WOS:000302871500042
J	Larsson, P; Ulfhammer, E; Magnusson, M; Bergh, N; Lunke, S; El-Osta, A; Medcalf, RL; Svensson, PA; Karlsson, L; Jern, S				Larsson, Pia; Ulfhammer, Erik; Magnusson, Mia; Bergh, Niklas; Lunke, Sebastian; El-Osta, Assam; Medcalf, Robert L.; Svensson, Per-Arne; Karlsson, Lena; Jern, Sverker			Role of Histone Acetylation in the Stimulatory Effect of Valproic Acid on Vascular Endothelial Tissue-Type Plasminogen Activator Expression	PLOS ONE			English	Article							T-PA RELEASE; DEACETYLASE INHIBITOR; IN-VIVO; PROTEIN INTERACTIONS; IMPAIRED CAPACITY; GENE PROMOTER; SP1 SITES; CELLS; TRANSCRIPTION; HYPERTENSION	Aims: Stimulated release of tissue-type plasminogen activator (t-PA) is pivotal for an intravascular fibrinolytic response and protects the circulation from occluding thrombosis. Hence, an impaired t-PA production is associated with increased risk for atherothrombotic events. A pharmacological means to stimulate the production of this enzyme may thus be desirable. We investigated if the anti-epileptic drug valproic acid (VPA) is capable of enhancing t-PA expression in vitro in vascular endothelial cells, and further examined if its histone deacetylase (HDAC)-inhibitory activity is of importance for regulating t-PA expression. Methods and Results: Human endothelial cells were exposed to valproic acid and t-PA mRNA and protein levels were quantified. Potential changes in histone acetylation status globally and at the t-PA promoter were examined by western blot and chromatin immunoprecipitation. Valproic acid dose-dependently stimulated t-PA mRNA and protein expression in endothelial cells reaching a 2-4-fold increase at clinically relevant concentrations and 10-fold increase at maximal concentrations. Transcription profiling analysis revealed that t-PA is selectively targeted by this agent. Augmented histone acetylation was detected at the t-PA transcription start site, and an attenuated VPA-response was observed with siRNA knock of HDAC3, HDAC5 and HDAC7. Conclusions: Valproic acid induces t-PA expression in cultured endothelial cells, and this is associated with increased histone acetylation at the t-PA promoter. Given the apparent potency of valproic acid in stimulating t-PA expression in vitro this substance may be a candidate for pharmacological modulation of endogenous fibrinolysis in man.	[Larsson, Pia; Ulfhammer, Erik; Magnusson, Mia; Bergh, Niklas; Karlsson, Lena; Jern, Sverker] Univ Gothenburg, Wallenberg Lab Cardiovasc Res, Inst Med, Sahlgrenska Acad, Gothenburg, Sweden; [Lunke, Sebastian; El-Osta, Assam] Baker IDI Heart & Diabet Inst, Epigenet Human Hlth & Dis Lab, Melbourne, Vic, Australia; [Medcalf, Robert L.] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia; [Svensson, Per-Arne] Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, Dept Mol & Clin Med, Inst Med,Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg; Baker Heart and Diabetes Institute; Monash University; University of Gothenburg	Larsson, P (corresponding author), Univ Gothenburg, Wallenberg Lab Cardiovasc Res, Inst Med, Sahlgrenska Acad, Gothenburg, Sweden.	sverker.jern@gu.se	Svensson, Per-Arne/R-4626-2019; Medcalf, Robert L/E-9632-2011	Larsson, Pia/0000-0001-9115-4213; Ulfhammer, Erik/0000-0002-6326-5175; El-Osta, Assam/0000-0001-7968-7375; Bergh, Niklas/0000-0002-7440-2366; Svensson, Per-Arne/0000-0002-6731-806X; El-Osta, Assam/0000-0003-2969-9137	Swedish Research Council [15038, 20758]; Swedish Heart-Lung Foundation; Swedish Hypertension Society; Sahlgrenska Academy at Goteborg University; King Gustaf V:s and Queen Victoria Foundation; King Gustaf V:s 80-year Foundation; Petrus and Augusta Hedlund's Foundation; Emelle Foundation; Lars Hierta Memorial Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Hypertension Society; Sahlgrenska Academy at Goteborg University; King Gustaf V:s and Queen Victoria Foundation; King Gustaf V:s 80-year Foundation; Petrus and Augusta Hedlund's Foundation; Emelle Foundation; Lars Hierta Memorial Foundation	This work was supported by research grants from the Swedish Research Council (http://www.vr.se/)(project no. 15038 and 20758), the Swedish Heart-Lung Foundation (http://www.hjart-lungfonden.se/), the Swedish Hypertension Society, the Sahlgrenska Academy at Goteborg University, King Gustaf V:s and Queen Victoria Foundation, King Gustaf V:s 80-year Foundation, Petrus and Augusta Hedlund's Foundation, Emelle Foundation, and Lars Hierta Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arts J, 1997, NUCLEIC ACIDS RES, V25, P311, DOI 10.1093/nar/25.2.311; ARTS J, 1995, BIOCHEM J, V310, P171, DOI 10.1042/bj3100171; Chatpun S, 2011, J TRAUMA, V70, P787, DOI 10.1155/2010/479364; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; Dunoyer-Geindre S, 2011, CARDIOVASC RES, V90, P457, DOI 10.1093/cvr/cvr028; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Gurvich N, 2004, CANCER RES, V64, P1079, DOI 10.1158/0008-5472.CAN-03-0799; Harikrishnan KN, 2008, CELL CYCLE, V7, P468, DOI 10.4161/cc.7.4.5405; HENDERSON BR, 1992, FEBS LETT, V309, P130, DOI 10.1016/0014-5793(92)81080-6; Hrafnkelsdottir T, 2004, J THROMB HAEMOST, V2, P1960, DOI 10.1111/j.1538-7836.2004.00948.x; Hrafnkelsdottir T, 1998, LANCET, V352, P1597, DOI 10.1016/S0140-6736(05)61044-6; Hrafnkelsdottir T, 2004, HYPERTENSION, V44, P300, DOI 10.1161/01.HYP.0000137380.91476.fb; Huang WQ, 2005, J BIOL CHEM, V280, P10047, DOI 10.1074/jbc.M408680200; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kathiresan S, 2006, ARTERIOSCL THROM VAS, V26, P1405, DOI 10.1161/01.ATV.0000222011.13026.25; Kim S, 2006, BIOCHEM BIOPH RES CO, V342, P1168, DOI 10.1016/j.bbrc.2006.02.081; KOOISTRA T, 1987, BIOCHEM J, V247, P605, DOI 10.1042/bj2470605; Ladenvall P, 2002, THROMB HAEMOSTASIS, V87, P105; Mariadason JM, 2000, CANCER RES, V60, P4561; Marinova Z, 2009, J NEUROCHEM, V111, P976, DOI 10.1111/j.1471-4159.2009.06385.x; MEDCALF RL, 1990, J BIOL CHEM, V265, P14618; Michaelis M, 2004, MOL PHARMACOL, V65, P520, DOI 10.1124/mol.65.3.520; Muldowney JAS, 2007, THROMB HAEMOSTASIS, V97, P263, DOI 10.1160/TH05-02-0092; Newby DE, 2001, CIRCULATION, V103, P1936; Olesen JB, 2011, PHARMACOEPIDEM DR S, V20, P146, DOI 10.1002/pds.2073; Osterlund B, 2008, ACTA ANAESTH SCAND, V52, P1375, DOI 10.1111/j.1399-6576.2008.01741.x; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Ridderstrale W, 2006, HYPERTENSION, V47, P686, DOI 10.1161/01.HYP.0000210540.35296.62; Rossig L, 2002, CIRC RES, V91, P837, DOI 10.1161/01.RES.0000037983.07158.B1; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sowa Y, 1997, BIOCHEM BIOPH RES CO, V241, P142, DOI 10.1006/bbrc.1997.7786; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Takakura M, 2001, NUCLEIC ACIDS RES, V29, P3006, DOI 10.1093/nar/29.14.3006; Van Guilder GP, 2005, AM J PHYSIOL-ENDOC M, V289, pE807, DOI 10.1152/ajpendo.00072.2005; VanLint C, 1996, GENE EXPRESSION, V5, P245; Zhang Y, 2002, J BIOL CHEM, V277, P33431, DOI 10.1074/jbc.M204417200	37	38	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31573	10.1371/journal.pone.0031573	http://dx.doi.org/10.1371/journal.pone.0031573			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363677	Green Published, gold, Green Submitted			2022-12-27	WOS:000302871500057
J	Sanli, T; Linher-Melville, K; Tsakiridis, T; Singh, G				Sanli, Toran; Linher-Melville, Katja; Tsakiridis, Theodoros; Singh, Gurmit			Sestrin2 Modulates AMPK Subunit Expression and Its Response to Ionizing Radiation in Breast Cancer Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; P53 TUMOR-SUPPRESSOR; STRESS; GENE; TARGET; IDENTIFICATION; PHOSPHORYLATION; LOCALIZATION; APOPTOSIS; FAMILY	Background: The sestrin family of stress-responsive genes (SESN1-3) are suggested to be involved in regulation of metabolism and aging through modulation of the AMPK-mTOR pathway. AMP-activated protein kinase (AMPK) is an effector of the tumour suppressor LKB1, which regulates energy homeostasis, cell polarity, and the cell cycle. SESN1/2 can interact directly with AMPK in response to stress to maintain genomic integrity and suppress tumorigenesis. Ionizing radiation (IR), a widely used cancer therapy, is known to increase sestrin expression, and acutely activate AMPK. However, the regulation of AMPK expression by sestrins in response to IR has not been studied in depth. Methods and Findings: Through immunoprecipitation we observed that SESN2 directly interacted with the AMPK alpha 1 beta 1 gamma 1 trimer and its upstream regulator LKB1 in MCF7 breast cancer cells. SESN2 overexpression was achieved using a Flag-tagged SESN2 expression vector or a stably-integrated tetracycline-inducible system, which also increased AMPK alpha 1 and AMPK beta 1 subunit phosphorylation, and co-localized with phosphorylated AMPK alpha-Thr127 in the cytoplasm. Furthermore, enhanced SESN2 expression increased protein levels of LKB1 and AMPK alpha 1 beta 1 gamma 1, as well as mRNA levels of LKB1, AMPK alpha 1, and AMPK beta 1. Treatment of MCF7 cells with IR elevated AMPK expression and activity, but this effect was attenuated in the presence of SESN2 siRNA. In addition, elevated SESN2 inhibited IR-induced mTOR signalling and sensitized MCF7 cells to IR through an AMPK-dependent mechanism. Conclusions: Our results suggest that in breast cancer cells SESN2 is associated with AMPK, it is involved in regulation of basal and IR-induced expression and activation of this enzyme, and it mediates sensitization of cancer cells to IR.	[Sanli, Toran; Linher-Melville, Katja; Singh, Gurmit] McMaster Univ, Res Dept, Juravinski Canc Ctr, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Tsakiridis, Theodoros] McMaster Univ, Dept Oncol, Hamilton, ON, Canada	McMaster University; McMaster University	Sanli, T (corresponding author), McMaster Univ, Res Dept, Juravinski Canc Ctr, Dept Pathol & Mol Med, Hamilton, ON, Canada.	gurmit.singh@jcc.hhsc.ca	Singh, Gurmit/C-6744-2014		Canadian Institute for Health Research	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	Funding was provided by the Canadian Institute for Health Research (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benz CC, 2008, NAT REV CANCER, V8, P875, DOI 10.1038/nrc2522; Braunstein S, 2009, MOL CELL BIOL, V29, P5645, DOI 10.1128/MCB.00711-09; Bristow RG, 2008, NAT REV CANCER, V8, P180, DOI 10.1038/nrc2344; Budanou AV, 2010, EMBO MOL MED, V2, P388, DOI 10.1002/emmm.201000097; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Budanov AV, 2002, ONCOGENE, V21, P6017, DOI 10.1038/sj.onc.1205877; Budanov AV, 2010, ANTIOXID REDOX SIGNA; Chen CC, 2010, DEV CELL, V18, P592, DOI 10.1016/j.devcel.2010.03.008; Feng ZH, 2007, CANCER RES, V67, P3043, DOI 10.1158/0008-5472.CAN-06-4149; Fogarty S, 2009, BIOCHIM BIOPHYS ACTA, V1804, P581; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Hay N, 2008, CELL METAB, V8, P184, DOI 10.1016/j.cmet.2008.08.010; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200; Iseli TJ, 2008, J BIOL CHEM, V283, P4799, DOI 10.1074/jbc.M708298200; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kodiha M, 2007, AM J PHYSIOL-CELL PH, V293, pC1427, DOI 10.1152/ajpcell.00176.2007; Lee JH, 2010, SCIENCE, V327, P1223, DOI 10.1126/science.1182228; Linher-Melville K, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-56; Maiuri MC, 2009, CELL CYCLE, V8, P1571, DOI 10.4161/cc.8.10.8498; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Peeters H, 2003, HUM GENET, V112, P573, DOI 10.1007/s00439-003-0917-5; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; Sanli T, 2011, J THORAC ONCOL, V6, P439, DOI 10.1097/JTO.0b013e3182049d8b; Sanli T, 2010, INT J RADIAT ONCOL, V78, P221, DOI 10.1016/j.ijrobp.2010.03.005; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Velasco-Miguel S, 1999, ONCOGENE, V18, P127, DOI 10.1038/sj.onc.1202274; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P19, DOI 10.2741/3229; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zannella VE, 2011, RADIOTHER ONCOL	35	101	105	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e32035	10.1371/journal.pone.0032035	http://dx.doi.org/10.1371/journal.pone.0032035			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363791	Green Submitted, gold, Green Published			2022-12-27	WOS:000302871500106
J	Zhang, AB; Feng, J; Ward, RD; Wan, P; Gao, Q; Wu, J; Zhao, WZ				Zhang, Ai-bing; Feng, Jie; Ward, Robert D.; Wan, Ping; Gao, Qiang; Wu, Jun; Zhao, Wei-zhong			A New Method for Species Identification via Protein-Coding and Non-Coding DNA Barcodes by Combining Machine Learning with Bioinformatic Methods	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; 2-D GRAPHICAL REPRESENTATION; PROPAGATION NEURAL-NETWORKS; CLASSIFICATION; TAXONOMY; LIFE; BACKPROPAGATION; OPTIMIZATION; DELIMITATION; LEPIDOPTERA	Species identification via DNA barcodes is contributing greatly to current bioinventory efforts. The initial, and widely accepted, proposal was to use the protein-coding cytochrome c oxidase subunit I (COI) region as the standard barcode for animals, but recently non- coding internal transcribed spacer (ITS) genes have been proposed as candidate barcodes for both animals and plants. However, achieving a robust alignment for non-coding regions can be problematic. Here we propose two new methods (DV-RBF and FJ-RBF) to address this issue for species assignment by both coding and non-coding sequences that take advantage of the power of machine learning and bioinformatics. We demonstrate the value of the new methods with four empirical datasets, two representing typical protein-coding COI barcode datasets (neotropical bats and marine fish) and two representing non- coding ITS barcodes (rust fungi and brown algae). Using two random sub-sampling approaches, we demonstrate that the new methods significantly outperformed existing Neighbor-joining (NJ) and Maximum likelihood (ML) methods for both coding and non- coding barcodes when there was complete species coverage in the reference dataset. The new methods also out-performed NJ and ML methods for non- coding sequences in circumstances of potentially incomplete species coverage, although then the NJ and ML methods performed slightly better than the new methods for protein-coding barcodes. A 100% success rate of species identification was achieved with the two new methods for 4,122 bat queries and 5,134 fish queries using COI barcodes, with 95% confidence intervals (CI) of 99.75-100%. The new methods also obtained a 96.29% success rate (95% CI: 91.62-98.40%) for 484 rust fungi queries and a 98.50% success rate (95% CI: 96.60-99.37%) for 1094 brown algae queries, both using ITS barcodes.	[Zhang, Ai-bing; Wan, Ping; Gao, Qiang; Wu, Jun] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Feng, Jie; Zhao, Wei-zhong] Capital Normal Univ, Sch Math Sci, Beijing, Peoples R China; [Ward, Robert D.] CSIRO Marine & Atmospher Res, Wealth Oceans Flagship, Hobart, Tas, Australia	Capital Normal University; Capital Normal University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Zhang, AB (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China.	zhangab2008@mail.cnu.edu.cn	Ward, Robert D/A-2319-2012	zhang, ai bing/0000-0002-6580-5462; ZHANG, Ai-bing/0000-0003-3450-5421	Beijing Municipal Natural Science Foundation [KZ201010028028]; Natural Science Foundation of China [31071963]; Funding Project for Academic Human Resources Development in Institutions of Higher Learning Under the Jurisdiction of Beijing Municipality [PHR201107120]; Research Fund for the Doctoral Program of Higher Education [20101108120002]	Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funding Project for Academic Human Resources Development in Institutions of Higher Learning Under the Jurisdiction of Beijing Municipality; Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP))	This study was supported by Beijing Municipal Natural Science Foundation Key Projects (Grant No. KZ201010028028 to AZ), by Natural Science Foundation of China (Grant No. 31071963 to AZ), by Funding Project for Academic Human Resources Development in Institutions of Higher Learning Under the Jurisdiction of Beijing Municipality (Grant No. PHR201107120 to AZ), and by The Research Fund for the Doctoral Program of Higher Education (Grant No. 20101108120002 to AZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2007, SYST BIOL, V56, P44, DOI 10.1080/10635150601167005; Austerlitz F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S10; Babu AS, 2010, INT J COMPUT SCI ENG, V2, P80; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Brower AVZ, 2006, SYST BIODIVERS, V4, P127, DOI 10.1017/S147720000500191X; Chu KH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S8; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Dopazo J, 1997, J MOL EVOL, V44, P226, DOI 10.1007/PL00006139; Ebach MC, 2005, NATURE, V434, P697, DOI 10.1038/434697b; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ekrem T, 2007, MOL PHYLOGENET EVOL, V43, P530, DOI 10.1016/j.ympev.2006.11.021; Elias M, 2007, P ROY SOC B-BIOL SCI, V274, P2881, DOI 10.1098/rspb.2007.1035; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Giribet G, 2001, CLADISTICS, V17, pS60, DOI 10.1111/j.1096-0031.2001.tb00105.x; Gladstein DS, 1997, POY OPTIMIZATION ALI; Gregory TR, 2005, NATURE, V434, P1067, DOI 10.1038/4341067b; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hajibabaei M, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-24; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; JEFFREY HJ, 1990, NUCLEIC ACIDS RES, V18, P2163, DOI 10.1093/nar/18.8.2163; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kuksa P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S9; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Liao B, 2005, CHEM PHYS LETT, V414, P296, DOI 10.1016/j.cplett.2005.08.079; Lou M, 2010, MOL PHYLOGENET EVOL, V56, P187, DOI 10.1016/j.ympev.2010.01.002; Marshall E, 2005, SCIENCE, V307, P1037, DOI 10.1126/science.307.5712.1037; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Munch K, 2008, PHILOS T R SOC B, V363, P3997, DOI 10.1098/rstb.2008.0169; Munch K, 2008, SYST BIOL, V57, P750, DOI 10.1080/10635150802422316; Nielsen R, 2006, SYST BIOL, V55, P162, DOI 10.1080/10635150500431239; O'Meara BC, 2010, SYST BIOL, V59, P59, DOI 10.1093/sysbio/syp077; Park J, 1991, NEURAL COMPUT, V3, P246, DOI 10.1162/neco.1991.3.2.246; Parker DB, 1987, P IEEE INT C NEUR NE, V2, P593; Prendini L, 2005, CAN J ZOOL, V83, P498, DOI 10.1139/Z05-025; Randic M, 2003, CHEM PHYS LETT, V368, P1, DOI 10.1016/S0009-2614(02)01784-0; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Schindel DE, 2005, NATURE, V435, P17, DOI 10.1038/435017b; Seo TK, 2010, J MOL EVOL, V71, P250, DOI 10.1007/s00239-010-9380-9; Silva-Brandao KL, 2009, NEOTROP ENTOMOL, V38, P441, DOI 10.1590/S1519-566X2009000400001; Smith M, 1993, NEURAL NETWORKS STAT; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Spooner DM, 2009, AM J BOT, V96, P1177, DOI 10.3732/ajb.0800246; Steinke D, 2009, MAR BIOL, V156, P2641, DOI 10.1007/s00227-009-1284-0; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tamhane AC, 2000, STAT DATA ANAL ELEME; Wang HC, 1998, PROTEIN SCI, V7, P2613; Wang WP, 2006, INT J QUANTUM CHEM, V106, P1998, DOI 10.1002/qua.21001; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Werbos P.J., 1974, THESIS HARVARD U CAM; Wheeler W, 1996, CLADISTICS, V12, P1, DOI 10.1111/j.1096-0031.1996.tb00189.x; Whitworth TL, 2007, P ROY SOC B-BIOL SCI, V274, P1731, DOI 10.1098/rspb.2007.0062; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Wu C, 1995, MATH COMPUT SIMULAT, V40, P23, DOI 10.1016/0378-4754(95)00016-4; WU C, 1994, NUCLEIC ACIDS RES, V22, P4291, DOI 10.1093/nar/22.20.4291; Wu C, 1997, APPL INTELL, V7, P27, DOI 10.1023/A:1008228603783; Wu CH, 1997, COMPUT CHEM, V21, P237, DOI 10.1016/S0097-8485(96)00038-1; Zhang AB, 2008, SYST BIOL, V57, P202, DOI 10.1080/10635150802032982; Zhang AB, 2012, MOL ECOL, V21, P1848, DOI 10.1111/j.1365-294X.2011.05235.x; Zhang AB, 2010, MOL PHYLOGENET EVOL, V54, P1035, DOI 10.1016/j.ympev.2009.09.014; Zhang AB, 2009, MOL ECOL RESOUR, V9, P104, DOI 10.1111/j.1755-0998.2008.02372.x; Zhang ZJ, 2009, BIOINFORMATICS, V25, P1112, DOI 10.1093/bioinformatics/btp130	82	17	22	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30986	10.1371/journal.pone.0030986	http://dx.doi.org/10.1371/journal.pone.0030986			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363527	gold, Green Published, Green Submitted			2022-12-27	WOS:000302871500023
J	Amos, JN; Bennett, AF; Mac Nally, R; Newell, G; Pavlova, A; Radford, JQ; Thomson, JR; White, M; Sunnucks, P				Amos, J. Nevil; Bennett, Andrew F.; Mac Nally, Ralph; Newell, Graeme; Pavlova, Alexandra; Radford, James Q.; Thomson, James R.; White, Matt; Sunnucks, Paul			Predicting Landscape-Genetic Consequences of Habitat Loss, Fragmentation and Mobility for Multiple Species of Woodland Birds	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; EXTINCTION DEBT; SOUTHERN AUSTRALIA; CIRCUIT-THEORY; FLOW; DISPERSAL; MODELS; DIFFERENTIATION; THRESHOLDS; INFERENCE	Inference concerning the impact of habitat fragmentation on dispersal and gene flow is a key theme in landscape genetics. Recently, the ability of established approaches to identify reliably the differential effects of landscape structure (e. g. land-cover composition, remnant vegetation configuration and extent) on the mobility of organisms has been questioned. More explicit methods of predicting and testing for such effects must move beyond post hoc explanations for single landscapes and species. Here, we document a process for making a priori predictions, using existing spatial and ecological data and expert opinion, of the effects of landscape structure on genetic structure of multiple species across replicated landscape blocks. We compare the results of two common methods for estimating the influence of landscape structure on effective distance: least-cost path analysis and isolation-by-resistance. We present a series of alternative models of genetic connectivity in the study area, represented by different landscape resistance surfaces for calculating effective distance, and identify appropriate null models. The process is applied to ten species of sympatric woodland-dependant birds. For each species, we rank a priori the expectation of fit of genetic response to the models according to the expected response of birds to loss of structural connectivity and landscape-scale tree-cover. These rankings (our hypotheses) are presented for testing with empirical genetic data in a subsequent contribution. We propose that this replicated landscape, multi-species approach offers a robust method for identifying the likely effects of landscape fragmentation on dispersal.	[Amos, J. Nevil; Mac Nally, Ralph; Pavlova, Alexandra; Thomson, James R.; Sunnucks, Paul] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia; [Amos, J. Nevil; Mac Nally, Ralph; Pavlova, Alexandra; Thomson, James R.; Sunnucks, Paul] Monash Univ, Australian Ctr Biodivers, Melbourne, Vic 3004, Australia; [Bennett, Andrew F.; Radford, James Q.] Deakin Univ, Landscape Ecol Res Grp, Sch Life & Environm Sci, Burwood, Vic, Australia; [Newell, Graeme; White, Matt] Arthur Rylah Inst Environm Res, Dept Sustainabil & Environm, Heidelberg, Vic, Australia	Monash University; Monash University; Deakin University; Arthur Rylah Institute for Environmental Research (ARI)	Amos, JN (corresponding author), Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia.	nevil.amos@monash.edu	Pavlova, Alexandra/H-4749-2014; Thomson, Jim/W-2950-2019	Pavlova, Alexandra/0000-0001-9455-4124; Sunnucks, Paul/0000-0002-8139-7059	Australian Research Council [LP0776322]; Victorian Department of Sustainability and Environment; Museum of Victoria; Victorian Department of Primary Industries; Parks Victoria; North Central Catchment Management Authority; Goulburn Broken Catchment Management Authority; Monash University; Birds Australia; Holsworth Wildlife Research Endowment	Australian Research Council(Australian Research Council); Victorian Department of Sustainability and Environment; Museum of Victoria; Victorian Department of Primary Industries; Parks Victoria; North Central Catchment Management Authority; Goulburn Broken Catchment Management Authority; Monash University(Monash University); Birds Australia; Holsworth Wildlife Research Endowment	This project was funded by Australian Research Council Linkage Project LP0776322, the Victorian Department of Sustainability and Environment, Museum of Victoria, Victorian Department of Primary Industries, Parks Victoria, North Central Catchment Management Authority, and Goulburn Broken Catchment Management Authority. JA was funded by Monash University Dean of Science Scholarship and a stipend from Birds Australia, and travel funded by Monash University and the Holsworth Wildlife Research Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen F, 2003, LANDSCAPE URBAN PLAN, V64, P233, DOI 10.1016/S0169-2046(02)00242-6; Baguette M, 2007, LANDSCAPE ECOL, V22, P1117, DOI 10.1007/s10980-007-9108-4; Balkenhol N, 2011, MOL ECOL, V20, P667, DOI 10.1111/j.1365-294X.2010.04967.x; Balkenhol N, 2009, ECOGRAPHY, V32, P818, DOI 10.1111/j.1600-0587.2009.05807.x; Balkenhol N, 2009, LANDSCAPE ECOL, V24, P455, DOI 10.1007/s10980-009-9334-z; Bates D., 2011, IME4 LINEAR MIXED EF; Bennett AF, 2009, CONSERV BIOL SER, P161; Broquet T, 2006, LANDSCAPE ECOL, V21, P877, DOI 10.1007/s10980-005-5956-y; Bull RAS, 2011, MOL ECOL, V20, P1092, DOI 10.1111/j.1365-294X.2010.04944.x; Callens T, 2011, MOL ECOL, V20, P1829, DOI 10.1111/j.1365-294X.2011.05028.x; Coulon A, 2006, MOL ECOL, V15, P1669, DOI 10.1111/j.1365-294X.2006.02861.x; Coulon A, 2004, MOL ECOL, V13, P2841, DOI 10.1111/j.1365-294X.2004.02253.x; Crooks KR, CONNECTIVITY CONSERV; Cushman SA, 2011, LANDSCAPE ECOL, V26, P1137, DOI 10.1007/s10980-011-9645-8; Cushman SA, 2006, AM NAT, V168, P486, DOI 10.1086/506976; Cushman SA, 2010, MOL ECOL, V19, P3592, DOI 10.1111/j.1365-294X.2010.04656.x; Cushman SA, 2009, CONSERV BIOL, V23, P368, DOI 10.1111/j.1523-1739.2008.01111.x; Czembor CA, 2011, J APPL ECOL, V48, P736, DOI 10.1111/j.1365-2664.2011.01971.x; Dept of Sustainability and Environment, 1990, TREE25 TREE COV; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Doerr VAJ, 2011, EMU, V111, P71, DOI 10.1071/MU09118; Driezen K, 2007, ECOL MODEL, V209, P314, DOI 10.1016/j.ecolmodel.2007.07.002; *ENV CONS COUNC, 1997, BOX IR FOR WOODL INV; Environmental Systems Research Institute, 1999, ARCGIS; Epps CW, 2007, J APPL ECOL, V44, P714, DOI 10.1111/j.1365-2664.2007.01325.x; Ford HA, 2001, BIOL CONSERV, V97, P71, DOI 10.1016/S0006-3207(00)00101-4; FORD HA, 1985, OIKOS, V44, P127, DOI 10.2307/3544053; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Frankham R, 1998, NATURE, V392, P441, DOI 10.1038/33022; Garrard GE, 2012, J ANIM ECOL, V81, P14, DOI 10.1111/j.1365-2656.2011.01891.x; Hanski I, 2000, NATURE, V404, P755, DOI 10.1038/35008063; Hanski I, 1996, AM NAT, V147, P527, DOI 10.1086/285864; Hanski I, 2002, CONSERV BIOL, V16, P666, DOI 10.1046/j.1523-1739.2002.00342.x; Hanski I, 1999, OIKOS, V87, P209, DOI 10.2307/3546736; Higgins PJ, HDB AUSTR NZ ANTARCT, V6; Higgins PJ, HDB AUSTR NZ ANTARCT, V5; HILDEN J, 1991, MED DECIS MAKING, V11, P95, DOI 10.1177/0272989X9101100204; Hilty J. A., 2006, CORRIDOR ECOLOGY SCI; Holderegger R, 2008, BIOSCIENCE, V58, P199, DOI 10.1641/B580306; Jaquiery J, 2011, MOL ECOL, V20, P692, DOI 10.1111/j.1365-294X.2010.04966.x; Jeness J, JEN J EXP CIRC TOOL; Koen EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011785; Lada H, 2008, CONSERV GENET, V9, P569, DOI 10.1007/s10592-007-9372-5; Landguth E, ECOGRAPHY IN PRESS; LEGENDRE P, 1988, LIMNOL OCEANOGR, V33, P1055, DOI 10.4319/lo.1988.33.5.1055; Lindenmayer D, 2006, HABITAT FRAGMENTATIO; Lindenmayer DB, 2007, TRENDS ECOL EVOL, V22, P127, DOI 10.1016/j.tree.2006.11.006; Liu C, 2011, SPECIES DISTRIBUTION; Loehle C, 1996, ECOL APPL, V6, P784, DOI 10.2307/2269483; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Mac Nally R, 1997, BIOL CONSERV, V82, P147, DOI 10.1016/S0006-3207(97)00028-1; Mac Nally R, 2009, DIVERS DISTRIB, V15, P720, DOI 10.1111/j.1472-4642.2009.00578.x; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Martin TG, 2005, J APPL ECOL, V42, P400, DOI 10.1111/j.1365-2664.2005.01012.x; McIntire EJB, 2009, ECOLOGY, V90, P46, DOI 10.1890/07-2096.1; McRae B.H., 2009, CIRCUITSCAPE USERS G; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Mcrae BH, 2007, P NATL ACAD SCI USA, V104, P19885, DOI 10.1073/pnas.0706568104; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; MULDER RA, 1995, J AVIAN BIOL, V26, P234, DOI 10.2307/3677324; Pinto N, 2009, LANDSCAPE ECOL, V24, P253, DOI 10.1007/s10980-008-9303-y; Radford JQ, 2007, J APPL ECOL, V44, P737, DOI 10.1111/j.1365-2664.2007.01327.x; Radford JQ, 2005, BIOL CONSERV, V124, P317, DOI 10.1016/j.biocon.2005.01.039; Robertson OJ, 2009, AUSTRAL ECOL, V34, P435, DOI 10.1111/j.1442-9993.2009.01945.x; ROBINSON D, 1996, CONSERVING WOODLAND; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2000, J EVOLUTION BIOL, V13, P58; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Schwartz MK, 2009, ECOLOGY, V90, P3222, DOI 10.1890/08-1287.1; Segelbacher G, 2010, CONSERV GENET, P1; Segelbacher G, 2008, MOL ECOL, V17, P2356, DOI 10.1111/j.1365-294X.2008.03767.x; Shanahan DF, 2011, LANDSCAPE ECOL, V26, P137, DOI 10.1007/s10980-010-9542-6; Shanahan DF, 2009, J APPL ECOL, V46, P1026, DOI 10.1111/j.1365-2664.2009.01694.x; Shirk AJ, 2010, MOL ECOL, V19, P3603, DOI 10.1111/j.1365-294X.2010.04745.x; Stevens VM, 2006, MOL ECOL, V15, P2333, DOI 10.1111/j.1365-294X.2006.02936.x; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Sunnucks P, 2011, EMU, V111, P19, DOI 10.1071/MU10008; Szabo JK, 2011, EMU, V111, P59, DOI 10.1071/MU09114; Taylor P. D., 2006, CONNECTIVITY CONSERV; TAYLOR PD, 1993, OIKOS, V68, P571, DOI 10.2307/3544927; Theobald D.M, 2006, CONNECTIVITY CONSERV; Walker RS, 2007, LANDSCAPE ECOL, V22, P1303, DOI 10.1007/s10980-007-9118-2; Wasserman TN, 2011, LANDSCAPE ECOLOGY; Wasserman TN, 2010, LANDSCAPE ECOL, V25, P1601, DOI 10.1007/s10980-010-9525-7; Wright S, 1943, GENETICS, V28, P114	85	49	50	0	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30888	10.1371/journal.pone.0030888	http://dx.doi.org/10.1371/journal.pone.0030888			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363508	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600083
J	de Regt, MJA; van Schaik, W; van Luit-Asbroek, M; Dekker, HAT; van Duijkeren, E; Koning, CJM; Bonten, MJM; Willems, RJL				de Regt, Marieke J. A.; van Schaik, Willem; van Luit-Asbroek, Miranda; Dekker, Huberta A. T.; van Duijkeren, Engeline; Koning, Catherina J. M.; Bonten, Marc J. M.; Willems, Rob J. L.			Hospital and Community Ampicillin-Resistant Enterococcus faecium Are Evolutionarily Closely Linked but Have Diversified through Niche Adaptation	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; ANTIMICROBIAL RESISTANCE; INTESTINAL MICROBIOTA; SPECIES DISTRIBUTION; COLLAGEN ADHESIN; TYPING SCHEME; VANCOMYCIN; GENE; ESP; IDENTIFICATION	Background: Ampicillin-resistant Enterococcus faecium (ARE) has emerged as a nosocomial pathogen. Here, we quantified ARE carriage in different community sources and determined genetic relatedness with hospital ARE. Methods and Results: ARE was recovered from rectal swabs of 24 of 79 (30%) dogs, 11 of 85 (13%) cats and 0 of 42 horses and from 3 of 40 (8%) faecal samples of non-hospitalized humans receiving amoxicillin. Multi-locus Sequence Typing revealed 21 sequence types (STs), including 5 STs frequently associated with hospital-acquired infections. Genes previously found to be enriched in hospital ARE, such as IS16, orf903, orf905, orf907, were highly prevalent in community ARE (>= 79%), while genes with a proposed role in pathogenesis, such as esp, hyl and ecbA, were found rarely (<= 5%) in community isolates. Comparative genome analysis of 2 representative dog isolates revealed that the dog strain of ST192 was evolutionarily closely linked to two previously sequenced hospital ARE, but had, based on gene content, more genes in common with the other, evolutionarily more distantly related, dog strain (ST266). Conclusion: ARE were detected in dogs, cats and sporadically in healthy humans, with evolutionary linkage to hospital ARE. Yet, their accessory genome has diversified, probably as a result of niche adaptation.	[de Regt, Marieke J. A.; van Schaik, Willem; van Luit-Asbroek, Miranda; Dekker, Huberta A. T.; Bonten, Marc J. M.; Willems, Rob J. L.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [van Duijkeren, Engeline] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Koning, Catherina J. M.] Univ Hosp Maastricht, Dept Internal Med, Maastricht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Maastricht University; Maastricht University Medical Centre (MUMC)	de Regt, MJA (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	mjaderegt@gmail.com	Willems, Rob JL/E-3681-2010	Willems, Rob JL/0000-0002-7370-0812; van Schaik, Willem/0000-0001-5832-0988	Nederlandse Organisatie voor Wetenschappelijk Onderzoek [NWO-VENI] [916.86.044]	Nederlandse Organisatie voor Wetenschappelijk Onderzoek [NWO-VENI]	Willem van Schaik was funded through the Nederlandse Organisatie voor Wetenschappelijk Onderzoek [NWO-VENI grant 916.86.044]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beres SB, 2010, P NATL ACAD SCI USA, V107, P4371, DOI 10.1073/pnas.0911295107; Biavasco F, 2007, APPL ENVIRON MICROB, V73, P3307, DOI 10.1128/AEM.02239-06; Billstrom H, 2009, J APPL MICROBIOL; Boerlin P, 2001, VET MICROBIOL, V82, P347, DOI 10.1016/S0378-1135(01)00396-0; Brilliantova AN, 2010, INT J ANTIMICROB AG, V35, P177, DOI 10.1016/j.ijantimicag.2009.10.006; Chassard C, 2007, FEMS MICROBIOL ECOL, V61, P121, DOI 10.1111/j.1574-6941.2007.00314.x; Council NR, 2006, NUTR REQ DOGS CATS; Damborg P, 2009, APPL ENVIRON MICROB, V75, P2360, DOI 10.1128/AEM.02035-08; de Regt MJA, 2008, J ANTIMICROB CHEMOTH, V62, P1401, DOI 10.1093/jac/dkn390; GRAYSON ML, 1991, ANTIMICROB AGENTS CH, V35, P2180, DOI 10.1128/AAC.35.11.2180; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Heikens E, 2008, APPL ENVIRON MICROB, V74, P7094, DOI 10.1128/AEM.01378-08; Heikens E, 2007, J BACTERIOL, V189, P8233, DOI 10.1128/JB.01205-07; Hendrickx APA, 2009, TRENDS MICROBIOL, V17, P423, DOI 10.1016/j.tim.2009.06.004; Hendrickx APA, 2009, INFECT IMMUN, V77, P5097, DOI 10.1128/IAI.00275-09; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Homan WL, 2002, J CLIN MICROBIOL, V40, P1963, DOI 10.1128/JCM.40.6.1963-1971.2002; Hsieh YC, 2010, EUR J CLIN MICROBIOL, V29, P25, DOI 10.1007/s10096-009-0810-9; Jackson CR, 2009, J APPL MICROBIOL, V107, P1269, DOI 10.1111/j.1365-2672.2009.04310.x; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Khan MA, 2008, J ANTIMICROB CHEMOTH, V62, P279, DOI 10.1093/jac/dkn173; Klare I, 2005, EUR J CLIN MICROBIOL, V24, P815, DOI 10.1007/s10096-005-0056-0; Koning CJM, 2008, AM J GASTROENTEROL, V103, P178, DOI 10.1111/j.1572-0241.2007.01547.x; Leavis H, 2004, J BACTERIOL, V186, P672, DOI 10.1128/JB.186.3.672-682.2004; Leavis HL, 2007, PLOS PATHOG, V3, P75, DOI 10.1371/journal.ppat.0030007; Leavis HL, 2006, J CLIN MICROBIOL, V44, P1059, DOI 10.1128/JCM.44.3.1059-1064.2006; Lee WG, 2006, LETT APPL MICROBIOL, V43, P274, DOI 10.1111/j.1472-765X.2006.01957.x; Leendertse M, 2009, J INFECT DIS, V200, P1162, DOI 10.1086/605609; Libisch B, 2008, SCAND J INFECT DIS, V40, P778, DOI 10.1080/00365540802165740; Moyaert H, 2006, RES VET SCI, V81, P1, DOI 10.1016/j.rvsc.2005.10.004; Murray BE, 2000, NEW ENGL J MED, V342, P710, DOI 10.1056/NEJM200003093421007; Nallapareddy SR, 2008, INFECT IMMUN, V76, P4110, DOI 10.1128/IAI.00375-08; Olioso D, 2007, MICROB DRUG RESIST, V13, P171, DOI 10.1089/mdr.2007.739; Ossiprandi MC, 2008, COMP IMMUNOL MICROB, V31, P1, DOI 10.1016/j.cimid.2007.08.003; Panesso D, J CLIN MICROBIOL; Rice LB, 2004, ANTIMICROB AGENTS CH, V48, P3028, DOI 10.1128/AAC.48.8.3028-3032.2004; Rodrigues J, 2002, J VET MED B, V49, P278, DOI 10.1046/j.1439-0450.2002.00561.x; Sava IG, 2010, J MED MICROBIOL, V59, P1001, DOI 10.1099/jmm.0.020578-0; Sillanpaa J, 2009, J CLIN MICROBIOL, V47, P896, DOI 10.1128/JCM.02283-08; Sillapaa J, 2008, MICROBIOL-SGM, V154, P3199, DOI 10.1099/mic.0.2008/017319-0; Simjee S, 2002, J CLIN MICROBIOL, V40, P4659, DOI 10.1128/JCM.40.12.4659-4665.2002; Top J, 2007, CLIN MICROBIOL INFEC, V13, P316, DOI 10.1111/j.1469-0691.2006.01631.x; Top J, 2004, J CLIN MICROBIOL, V42, P4503, DOI 10.1128/JCM.42.10.4503-4511.2004; Top J, 2011, J BACTERIOL, V193, P1003, DOI 10.1128/JB.00952-10; van Schaik W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-239; Werner G, 2008, Euro Surveill, V13; Werner G, 2008, INT J MED MICROBIOL, V298, P515, DOI 10.1016/j.ijmm.2007.05.008; Werner G, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-80; Willems RJL, 2001, LANCET, V357, P853, DOI 10.1016/S0140-6736(00)04205-7; Willems RJL, 2005, EMERG INFECT DIS, V11, P821, DOI 10.3201/1106.041204; Willems RJL, 2009, FUTURE MICROBIOL, V4, P1125, DOI [10.2217/fmb.09.82, 10.2217/FMB.09.82]; Zhu X, 2009, J HOSP INFECT, V72, P147, DOI 10.1016/j.jhin.2009.02.014	52	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30319	10.1371/journal.pone.0030319	http://dx.doi.org/10.1371/journal.pone.0030319			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363425	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600019
J	Ketmaier, V; Marrone, F; Alfonso, G; Paulus, K; Wiemann, A; Tiedemann, R; Mura, G				Ketmaier, Valerio; Marrone, Federico; Alfonso, Giuseppe; Paulus, Kirsten; Wiemann, Annika; Tiedemann, Ralph; Mura, Graziella			Mitochondrial DNA Regionalism and Historical Demography in the Extant Populations of Chirocephalus kerkyrensis (Branchiopoda: Anostraca)	PLOS ONE			English	Article							CYST MORPHOMETRICS; ADDITIONAL REMARKS; CRUSTACEA; PHYLOGEOGRAPHY; DIVERSITY; COLONIZATION; BIOGEOGRAPHY; HAPLOTYPES; DISPERSAL; PHYLOGENY	Background: Mediterranean temporary water bodies are important reservoirs of biodiversity and host a unique assemblage of diapausing aquatic invertebrates. These environments are currently vanishing because of increasing human pressure. Chirocephalus kerkyrensis is a fairy shrimp typical of temporary water bodies in Mediterranean plain forests and has undergone a substantial decline in number of populations in recent years due to habitat loss. We assessed patterns of genetic connectivity and phylogeographic history in the seven extant populations of the species from Albania, Corfu Is. (Greece), Southern and Central Italy. Methodology/Principal Findings: We analyzed sequence variation at two mitochondrial DNA genes (Cytochrome Oxidase I and 16s rRNA) in all the known populations of C. kerkyrensis. We used multiple phylogenetic, phylogeographic and coalescence-based approaches to assess connectivity and historical demography across the whole distribution range of the species. C. kerkyrensis is genetically subdivided into three main mitochondrial lineages; two of them are geographically localized (Corfu Is. and Central Italy) and one encompasses a wide geographic area (Albania and Southern Italy). Most of the detected genetic variation (approximate to 81%) is apportioned among the aforementioned lineages. Conclusions/Significance: Multiple analyses of mismatch distributions consistently supported both past demographic and spatial expansions with the former predating the latter; demographic expansions were consistently placed during interglacial warm phases of the Pleistocene while spatial expansions were restricted to cold periods. Coalescence methods revealed a scenario of past isolation with low levels of gene flow in line with what is already known for other co-distributed fairy shrimps and suggest drift as the prevailing force in promoting local divergence. We recommend that these evolutionary trajectories should be taken in proper consideration in any effort aimed at protecting Mediterranean temporary water bodies.	[Ketmaier, Valerio; Paulus, Kirsten; Tiedemann, Ralph] Univ Potsdam, Inst Biochem & Biol, Unit Evolutionary Biol Systemat Zool, Potsdam, Germany; [Ketmaier, Valerio; Mura, Graziella] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Rome, Italy; [Marrone, Federico] Univ Palermo, Dept Environm Biol & Biodivers, Palermo, Italy; [Alfonso, Giuseppe] Univ Salento, DiSTeBA, Lab Zoogeog & Fauna, Lecce, Italy; [Wiemann, Annika] State Off Criminal Invest, Inst Forens Sci, Dept Biol, Hannover, Germany	University of Potsdam; Sapienza University Rome; University of Palermo; University of Salento	Ketmaier, V (corresponding author), Univ Potsdam, Inst Biochem & Biol, Unit Evolutionary Biol Systemat Zool, Potsdam, Germany.	ketmaier@uni-potsdam.de	Marrone, Federico/M-3154-2015; Alfonso, Giuseppe/A-6252-2016	Marrone, Federico/0000-0002-4730-0452; Alfonso, Giuseppe/0000-0003-0016-7006; Tiedemann, Ralph/0000-0002-2604-6336	University of Potsdam (Germany)	University of Potsdam (Germany)	The study was funded by basic funding of the University of Potsdam (Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar A, 2011, AQUAT SCI, V73, P15, DOI 10.1007/s00027-010-0155-6; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Beladjal L, 2009, J CRUSTACEAN BIOL, V29, P266, DOI 10.1651/08-3059R.1; BELK D, 1995, HYDROBIOLOGIA, V298, P315, DOI 10.1007/BF00033826; Bohonak AJ, 1998, CAN J ZOOL, V76, P2049, DOI 10.1139/cjz-76-11-2049; Brtek J., 1968, Annotationes Zoologicae et Botanicae Bratislava, VNo. 51, P1; BRTEK J, 1995, HYDROBIOLOGIA, V298, P263, DOI 10.1007/BF00033821; Brtek J., 1966, Annotationes Zoologicae et Botanicae Bratislava, VNo. 33, P1; Brtek J, 2006, CRUSTACEANA, V79, P89, DOI 10.1163/156854006776759707; Brtek Jan, 1995, Zbornik Slovenskeho Narodneho Muzea Prirodne Vedy, V41, P3; Cesari M, 2007, HYDROBIOLOGIA, V586, P249, DOI 10.1007/s10750-007-0645-2; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; COTTARELLI V, 1979, Rivista di Idrobiologia, V18, P75; Cottarelli V., 1965, Rec Ist Lomb Sci Lett, V99B, P133; Cottarelli V, 1983, QUAD CNR, V18, P1; Cottarelli V, 2007, CRUSTACEANA, V80, P455, DOI 10.1163/156854007780440902; Daniels SR, 2004, BIOL J LINN SOC, V82, P313, DOI 10.1111/j.1095-8312.2004.00359.x; De Gelas K, 2005, MOL ECOL, V14, P753, DOI 10.1111/j.1365-294X.2004.02434.x; De Meester L, 2002, ACTA OECOL, V23, P121, DOI 10.1016/S1146-609X(02)01145-1; DUMONT HJ, 1995, HYDROBIOLOGIA, V298, P281, DOI 10.1007/BF00033822; DUMONT HJ, 2002, INTRO CLASS BRANCHIO; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2004, MOL ECOL, V13, P853, DOI 10.1046/j.1365-294X.2003.02004.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Fu YX, 1997, GENETICS, V147, P915; Gomez A, 2007, MOL ECOL, V16, P3228, DOI 10.1111/j.1365-294X.2007.03372.x; Green AJ, 2005, DIVERS DISTRIB, V11, P149, DOI 10.1111/j.1366-9516.2005.00147.x; Hebert PDN, 2002, EVOLUTION, V56, P909; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Ketmaier V, 2006, MOL PHYLOGENET EVOL, V39, P439, DOI 10.1016/j.ympev.2005.12.008; Ketmaier V, 2005, J ZOOL, V266, P401, DOI 10.1017/S0952836905007041; Ketmaier V, 2003, J ZOOL SYST EVOL RES, V41, P276, DOI 10.1046/j.1439-0469.2003.00222.x; Ketmaier V, 2008, AQUAT SCI, V70, P65, DOI 10.1007/s00027-007-7028-7; Ketmaier V, 2010, MALACOLOGIA, V52, P81, DOI 10.4002/040.052.0106; Korn M, 2010, ORG DIVERS EVOL, V10, P409, DOI 10.1007/s13127-010-0026-y; La Greca M, 1998, MEMORIE SOC ENTOMOLO, V77, P123; Marrone F., 2009, P INT C MED TEMP PON, P189; Marrone F, 2010, HYDROBIOLOGIA, V644, P115, DOI 10.1007/s10750-010-0101-6; Munoz J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011932; Mura G, 1997, HYDROBIOLOGIA, V346, P11, DOI 10.1023/A:1002931606886; MURA G, 1987, Rivista di Idrobiologia, V26, P97; MURA G, 1989, Rivista di Idrobiologia, V28, P283; Mura G, 2004, CRUSTACEANA, V77, P1007, DOI 10.1163/1568540042781694; MURA G, 1984, Rivista di Idrobiologia, V23, P165; MURA G, 1986, Rivista di Idrobiologia, V25, P43; Mura G, 2003, HYDROBIOLOGIA, V495, P93, DOI 10.1023/A:1025406005367; Mura G, 2002, J CRUSTACEAN BIOL, V22, P162, DOI 10.1651/0278-0372(2002)022[0162:MVACDC]2.0.CO;2; MURA G, 1992, CRUSTACEANA, V63, P225, DOI 10.1163/156854092X00389; MURA G, 1986, HYDROBIOLOGIA, V134, P273, DOI 10.1007/BF00008496; Mura G, 1999, HYDROBIOLOGIA, V405, P57, DOI 10.1023/A:1003701004970; MURA G, 1991, CRUSTACEANA, V61, P241, DOI 10.1163/156854091X00137; Mura G, 1986, ATT CONV ASP FAUN PR, P109; Mura G, 2011, J BIOL RES-THESSALON, V15, P17; Mura Graziella, 2001, Journal of Limnology, V60, P45; Mura G, 2010, J BIOL RES-THESSALON, V14, P137; Nielsen R, 2001, GENETICS, V158, P885; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pesta D, 1936, ZOOL ANZ, V114, P241; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Remigio EA, 2003, J CRUSTACEAN BIOL, V23, P436, DOI 10.1651/0278-0372(2003)023[0436:PSOTAF]2.0.CO;2; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rogers D.C., 2003, ZOOTAXA, V257, P1, DOI DOI 10.11646/ZOOTAXA.257.1.1; Rogers DC, 2006, ZOOTAXA, P35, DOI 10.11646/zootaxa.1126.1.3; Rogers DC, 2002, HYDROBIOLOGIA, V486, P125, DOI 10.1023/A:1021390416256; Rogers DC, 2002, HYDROBIOLOGIA, V486, P57, DOI 10.1023/A:1021326129460; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sime LC, 2009, NATURE, V462, P342, DOI 10.1038/nature08564; Stella E, 1963, RENDIC ACCAD NAZ, V13, P1; Stephanides T., 1948, Praktika of the Hellenic Hydrobiological Institute, V2, P1; Swofford D, 2002, PAUP BETA VERSION 4; TEMPLETON AR, 1992, GENETICS, V132, P619; Tourenq C, 2001, BIOL CONSERV, V100, P335, DOI 10.1016/S0006-3207(01)00037-4; TZEDAKIS PC, 1993, NATURE, V364, P437, DOI 10.1038/364437a0; Weekers PHH, 2002, MOL PHYLOGENET EVOL, V25, P535, DOI 10.1016/S1055-7903(02)00289-0; Zierold T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-161	78	25	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30082	10.1371/journal.pone.0030082	http://dx.doi.org/10.1371/journal.pone.0030082			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363417	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600012
J	Lopez-Vernaza, M; Yang, SX; Muller, R; Thorpe, F; de Leau, E; Goodrich, J				Lopez-Vernaza, Manuel; Yang, Suxin; Mueller, Ralf; Thorpe, Frazer; de Leau, Erica; Goodrich, Justin			Antagonistic Roles of SEPALLATA3, FT and FLC Genes as Targets of the Polycomb Group Gene CURLY LEAF	PLOS ONE			English	Article							FLOWERING-LOCUS-C; HISTONE METHYLTRANSFERASE ACTIVITY; FLORAL INDUCTION; ANTISENSE TRANSCRIPTS; EPIGENETIC REGULATION; ARABIDOPSIS; VERNALIZATION; PROTEIN; TIME; FCA	In Arabidopsis, mutations in the Pc-G gene CURLY LEAF (CLF) give early flowering plants with curled leaves. This phenotype is caused by mis-expression of the floral homeotic gene AGAMOUS (AG) in leaves, so that ag mutations largely suppress the clf phenotype. Here, we identify three mutations that suppress clf despite maintaining high AG expression. We show that the suppressors correspond to mutations in FPA and FT, two genes promoting flowering, and in SEPALLATA3 (SEP3) which encodes a co-factor for AG protein. The suppression of the clf phenotype is correlated with low SEP3 expression in all case and reveals that SEP3 has a role in promoting flowering in addition to its role in controlling floral organ identity. Genetic analysis of clf ft mutants indicates that CLF promotes flowering by reducing expression of FLC, a repressor of flowering. We conclude that SEP3 is the key target mediating the clf phenotype, and that the antagonistic effects of CLF target genes masks a role for CLF in promoting flowering.	[Lopez-Vernaza, Manuel; Yang, Suxin; Mueller, Ralf; Thorpe, Frazer; de Leau, Erica; Goodrich, Justin] Univ Edinburgh, Inst Mol Plant Sci, Sch Biol, Edinburgh, Midlothian, Scotland	University of Edinburgh	Lopez-Vernaza, M (corresponding author), Univ Edinburgh, Inst Mol Plant Sci, Sch Biol, Edinburgh, Midlothian, Scotland.	Justin.Goodrich@ed.ac.uk		Lopez Vernaza, Manuel Augusto/0000-0002-9542-7028; Muller-Xing, Ralf/0000-0003-0024-4243; Yang, Suxin/0000-0001-8673-9428	BBSRC Biotechnology and Biological Sciences Research Council [BB/F007442/1, BB/H004319/1]; Darwin Trust of Edinburgh; Biotechnology and Biological Sciences Research Council [BB/F007442/1, BBS/B/05494, BB/H004319/1] Funding Source: researchfish; BBSRC [BB/H004319/1, BB/F007442/1] Funding Source: UKRI	BBSRC Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Darwin Trust of Edinburgh; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	JG, RM, FT, EDL and SY were funded by grants BB/F007442/1 and BB/H004319/1 from BBSRC Biotechnology and Biological Sciences Research Council and ERA-PG, MLV by the Darwin Trust of Edinburgh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian J, 2010, PLANT CELL, V22, P1425, DOI 10.1105/tpc.110.074682; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; Baurle I, 2007, SCIENCE, V318, P109, DOI 10.1126/science.1146565; Bensmihen S, 2004, FEBS LETT, V561, P127, DOI 10.1016/S0014-5793(04)00148-6; Bouyer D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002014; Bratzel F, 2010, CURR BIOL, V20, P1853, DOI 10.1016/j.cub.2010.09.046; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chanvivattana Y, 2004, DEVELOPMENT, V131, P5263, DOI 10.1242/dev.01400; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Cui RF, 2010, PLANT J, V61, P767, DOI 10.1111/j.1365-313X.2009.04101.x; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Deng WW, 2011, P NATL ACAD SCI USA, V108, P6680, DOI 10.1073/pnas.1103175108; Ditta G, 2004, CURR BIOL, V14, P1935, DOI 10.1016/j.cub.2004.10.028; Finnegan EJ, 2011, PLANT J, V65, P382, DOI 10.1111/j.1365-313X.2010.04428.x; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Gomez-Mena C, 2005, DEVELOPMENT, V132, P429, DOI 10.1242/dev.01600; Goodrich J, 1997, NATURE, V386, P44, DOI 10.1038/386044a0; HAIG D, 1989, AM NAT, V134, P147, DOI 10.1086/284971; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Honma T, 2001, NATURE, V409, P525, DOI 10.1038/35054083; Hornyik C, 2010, DEV CELL, V18, P203, DOI 10.1016/j.devcel.2009.12.009; Ito T, 1997, PLANT CELL PHYSIOL, V38, P248, DOI 10.1093/oxfordjournals.pcp.a029160; Jiang DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003404; Kaufmann K, 2009, PLOS BIOL, V7, P854, DOI 10.1371/journal.pbio.1000090; Kim DH, 2010, PLANT PHYSIOL, V154, P949, DOI 10.1104/pp.110.161083; Kobayashi Y, 2007, GENE DEV, V21, P2371, DOI 10.1101/gad.1589007; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Kwon CS, 2009, PLANT J, V60, P112, DOI 10.1111/j.1365-313X.2009.03938.x; Liu C, 2009, DEV CELL, V16, P711, DOI 10.1016/j.devcel.2009.03.011; Liu FQ, 2007, MOL CELL, V28, P398, DOI 10.1016/j.molcel.2007.10.018; Liu FQ, 2010, SCIENCE, V327, P94, DOI 10.1126/science.1180278; Makarevich G, 2006, EMBO REP, V7, P947, DOI 10.1038/sj.embor.7400760; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; MIZUKAMI Y, 1992, CELL, V71, P119, DOI 10.1016/0092-8674(92)90271-D; Moon YH, 2003, PLANT CELL, V15, P681, DOI 10.1105/tpc.007831; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Onouchi H, 2000, PLANT CELL, V12, P885, DOI 10.1105/tpc.12.6.885; Pazhouhandeh M, 2011, P NATL ACAD SCI USA, V108, P3430, DOI 10.1073/pnas.1018242108; Pelaz S, 2001, PLANT J, V26, P385, DOI 10.1046/j.1365-313X.2001.2641042.x; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; Quesada V, 2003, EMBO J, V22, P3142, DOI 10.1093/emboj/cdg305; Reeves PH, 2000, CURR OPIN PLANT BIOL, V3, P37, DOI 10.1016/S1369-5266(99)00041-2; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Schonrock N, 2006, GENE DEV, V20, P1667, DOI 10.1101/gad.377206; Schomburg FM, 2001, PLANT CELL, V13, P1427, DOI 10.1105/tpc.13.6.1427; Schubert D, 2006, EMBO J, V25, P4638, DOI 10.1038/sj.emboj.7601311; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Serrano-Cartagena J, 2000, GENETICS, V156, P1363; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; Sonmez C, 2011, P NATL ACAD SCI USA, V108, P8508, DOI 10.1073/pnas.1105334108; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Teper-Bamnolker P, 2005, PLANT CELL, V17, P2661, DOI 10.1105/tpc.105.035766; Turck F, 2007, PLOS GENET, V3, P855, DOI 10.1371/journal.pgen.0030086; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129	62	53	61	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30715	10.1371/journal.pone.0030715	http://dx.doi.org/10.1371/journal.pone.0030715			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363474	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600058
J	Vinther, TN; Norrman, M; Strauss, HM; Huus, K; Schlein, M; Pedersen, TA; Kjeldsen, T; Jensen, KJ; Hubalek, F				Vinther, Tine N.; Norrman, Mathias; Strauss, Holger M.; Huus, Kasper; Schlein, Morten; Pedersen, Thomas A.; Kjeldsen, Thomas; Jensen, Knud J.; Hubalek, Frantisek			Novel Covalently Linked Insulin Dimer Engineered to Investigate the Function of Insulin Dimerization	PLOS ONE			English	Article							INTERSUBUNIT DISULFIDE BRIDGE; FREE BOVINE INSULIN; GUINEA-PIG INSULIN; SELF-ASSOCIATION; INTRACELLULAR-TRANSPORT; STRUCTURAL SWITCH; DNA-BINDING; RECEPTOR; MODEL; BOND	An ingenious system evolved to facilitate insulin binding to the insulin receptor as a monomer and at the same time ensure sufficient stability of insulin during storage. Insulin dimer is the cornerstone of this system. Insulin dimer is relatively weak, which ensures dissociation into monomers in the circulation, and it is stabilized by hexamer formation in the presence of zinc ions during storage in the pancreatic beta-cell. Due to the transient nature of insulin dimer, direct investigation of this important form is inherently difficult. To address the relationship between insulin oligomerization and insulin stability and function, we engineered a covalently linked insulin dimer in which two monomers were linked by a disulfide bond. The structure of this covalent dimer was identical to the self-association dimer of human insulin. Importantly, this covalent dimer was capable of further oligomerization to form the structural equivalent of the classical hexamer. The covalently linked dimer neither bound to the insulin receptor, nor induced a metabolic response in vitro. However, it was extremely thermodynamically stable and did not form amyloid fibrils when subjected to mechanical stress, underlining the importance of oligomerization for insulin stability.	[Vinther, Tine N.; Norrman, Mathias; Strauss, Holger M.; Huus, Kasper; Schlein, Morten; Pedersen, Thomas A.; Kjeldsen, Thomas; Hubalek, Frantisek] Novo Nordisk A S, Diabet Res Unit, Malov, Denmark; [Vinther, Tine N.; Jensen, Knud J.] Univ Copenhagen, Fac Life Sci, IGM, Frederiksberg, Denmark	Novo Nordisk; University of Copenhagen	Vinther, TN (corresponding author), Novo Nordisk A S, Diabet Res Unit, Novo Nordisk Pk, Malov, Denmark.	fhub@novonordisk.com	Jensen, Knud J/D-1145-2016; Strauss, Holger Martin/I-8403-2012	Jensen, Knud J/0000-0003-3525-5452; Kjeldsen, Thomas/0000-0003-0094-9286; Hubalek, Frantisek/0000-0003-3983-7900	Danish Ministry of Science, Technology and Innovation; Novo Nordisk CORA Training and Research Program	Danish Ministry of Science, Technology and Innovation; Novo Nordisk CORA Training and Research Program	This work was supported by the Danish Ministry of Science, Technology and Innovation and the Novo Nordisk CORA Training and Research Program. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Andersen AS, 2010, J PEPT SCI, V16, P473, DOI 10.1002/psc.1264; Attri AK, 2010, BIOPHYS CHEM, V148, P23, DOI 10.1016/j.bpc.2010.02.001; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; BENEZRA R, 1994, CELL, V79, P1057, DOI 10.1016/0092-8674(94)90036-1; Bjork A, 2003, J MOL BIOL, V334, P811, DOI 10.1016/j.jmb.2003.10.006; Blundell T., 1972, ADV PROTEIN CHEM, V26, P279; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Brange J, 1993, Pharm Biotechnol, V5, P315; Bunting KA, 2002, ARCH BIOCHEM BIOPHYS, V397, P69, DOI 10.1006/abbi.2001.2635; CHAN SJ, 1984, P NATL ACAD SCI-BIOL, V81, P5046, DOI 10.1073/pnas.81.16.5046; DEMEYTS P, 1994, DIABETOLOGIA, V37, pS135, DOI 10.1007/BF00400837; Diao JS, 2003, ACTA CRYSTALLOGR D, V59, P670, DOI 10.1107/S0907444903002208; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; EMDIN SO, 1980, DIABETOLOGIA, V19, P174, DOI 10.1007/BF00275265; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frand AR, 2000, TRENDS CELL BIOL, V10, P203, DOI 10.1016/S0962-8924(00)01745-1; GIVEN BD, 1980, NEW ENGL J MED, V302, P129, DOI 10.1056/NEJM198001173020301; Glendorf T, 2008, BIOCHEMISTRY-US, V47, P4743, DOI 10.1021/bi800054z; GURSKY O, 1992, BIOPHYS J, V63, P1210, DOI 10.1016/S0006-3495(92)81697-1; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; HUANG XF, 1995, J BIOL CHEM, V270, P20417, DOI 10.1074/jbc.270.35.20417; Huus K, 2005, BIOCHEMISTRY-US, V44, P11171, DOI 10.1021/bi0507940; HVIDT S, 1991, BIOPHYS CHEM, V39, P205, DOI 10.1016/0301-4622(91)85023-J; KAARSHOLM NC, 1993, BIOCHEMISTRY-US, V32, P10773, DOI 10.1021/bi00091a031; Kjeldsen T, 1999, J BIOTECHNOL, V75, P195, DOI 10.1016/S0168-1656(99)00159-5; Kjeldsen T, 1996, GENE, V170, P107, DOI 10.1016/0378-1119(95)00822-5; Kjeldsen T, 2003, PROTEIN EXPRES PURIF, V27, P331, DOI 10.1016/S1046-5928(02)00640-X; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Ludvigsen S, 1998, J MOL BIOL, V279, P1, DOI 10.1006/jmbi.1998.1801; MaAuley A, 2008, PROTEIN SCI, V17, P95, DOI 10.1110/ps.073134408; Madala PK, 2010, CHEM REV, V110, pPR1, DOI 10.1021/cr900368a; MARK AE, 1990, BIOL CHEM H-S, V371, P1165, DOI 10.1515/bchm3.1990.371.2.1165; MARK AE, 1987, BIOPHYS CHEM, V27, P103, DOI 10.1016/0301-4622(87)80051-0; MARKUSSEN J, 1985, INT J PEPT PROT RES, V26, P70; Markussen J., 1987, HUMAN INSULIN TRYPTI; MOODY AJ, 1974, HORM METAB RES, V6, P12, DOI 10.1055/s-0028-1093895; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olsen HB, 1996, BIOCHEMISTRY-US, V35, P8836, DOI 10.1021/bi960292+; POSNER BI, 1974, ENDOCRINOLOGY, V95, P521, DOI 10.1210/endo-95-2-521; PULLEN RA, 1976, NATURE, V259, P369, DOI 10.1038/259369a0; Ray SS, 2004, BIOCHEMISTRY-US, V43, P4899, DOI 10.1021/bi030246r; Richards JP, 1998, PHARMACEUT RES, V15, P1434, DOI 10.1023/A:1011961923870; Robinson CR, 2000, BIOCHEMISTRY-US, V39, P12494, DOI 10.1021/bi001484e; RODBELL M, 1964, J BIOL CHEM, V239, P375; SAUER RT, 1986, BIOCHEMISTRY-US, V25, P5992, DOI 10.1021/bi00368a024; SCHAFFER L, 1994, EUR J BIOCHEM, V221, P1127, DOI 10.1111/j.1432-1033.1994.tb18833.x; SCHMITZ A, 1995, EMBO J, V14, P1091, DOI 10.1002/j.1460-2075.1995.tb07092.x; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SCRUTTON NS, 1988, FEBS LETT, V241, P46, DOI 10.1016/0014-5793(88)81028-7; Seabright PJ, 1996, BIOCHEM J, V320, P947, DOI 10.1042/bj3200947; SOWDHAMINI R, 1989, PROTEIN ENG, V3, P95, DOI 10.1093/protein/3.2.95; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; STEINER DF, 1977, DIABETES, V26, P322, DOI 10.2337/diab.26.4.322; TAGER H, 1979, NATURE, V281, P122, DOI 10.1038/281122a0; TAKEDA A, 1977, J BIOCHEM-TOKYO, V82, P1025, DOI 10.1093/oxfordjournals.jbchem.a131773; TAMURA A, 1994, BIOCHEMISTRY-US, V33, P14512, DOI 10.1021/bi00252a018; Thorsoe KS, 2010, BIOCHEMISTRY-US, V49, P6234, DOI 10.1021/bi1000118; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vinther TN, 2011, CHEMBIOCHEM, V12, P2448, DOI 10.1002/cbic.201100464; VOLUND A, 1978, BIOMETRICS, V34, P357, DOI 10.2307/2530598; Xu B, 2004, BIOCHEMISTRY-US, V43, P8356, DOI 10.1021/bi0497796; YPHANTIS DA, 1964, BIOCHEMISTRY-US, V3, P297, DOI 10.1021/bi00891a003; ZIMMERMAN AE, 1974, J BIOL CHEM, V249, P4026; ZIMMERMAN AE, 1974, J BIOL CHEM, V249, P4021	67	24	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30882	10.1371/journal.pone.0030882	http://dx.doi.org/10.1371/journal.pone.0030882			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363506	gold, Green Published, Green Submitted			2022-12-27	WOS:000302853600081
J	West, XZ; Meller, N; Malinin, NL; Deshmukh, L; Meller, J; Mahabeleshwar, GH; Weber, ME; Kerr, BA; Vinogradova, O; Byzova, TV				West, Xiaoxia Z.; Meller, Nahum; Malinin, Nikolay L.; Deshmukh, Lalit; Meller, Julia; Mahabeleshwar, Ganapati H.; Weber, Malory E.; Kerr, Bethany A.; Vinogradova, Olga; Byzova, Tatiana V.			Integrin beta(3) Crosstalk with VEGFR Accommodating Tyrosine Phosphorylation as a Regulatory Switch	PLOS ONE			English	Article							DEPENDENT ACTIVATION; CYTOPLASMIC DOMAIN; BINDING; ALPHA(IIB)BETA(3); ANGIOGENESIS; MODULATION; MECHANISM; ADHESION; SUBUNIT; COMPLEX	Integrins mediate cell adhesion, migration, and survival by connecting intracellular machinery with the surrounding extracellular matrix. Previous studies demonstrated the importance of the interaction between beta(3) integrin and VEGF type 2 receptor (VEGFR2) in VEGF-induced angiogenesis. Here we present in vitro evidence of the direct association between the cytoplasmic tails (CTs) of beta(3) and VEGFR2. Specifically, the membrane-proximal motif around (YLSI)-Y-801 in VEGFR2 mediates its binding to non-phosphorylated beta 3CT, accommodating an alpha-helical turn in integrin bound conformation. We also show that Y-747 phosphorylation of beta(3) enhances the above interaction. To demonstrate the importance of beta(3) phosphorylation in endothelial cell functions, we synthesized beta 3CT-mimicking Y-747 phosphorylated and unphosphorylated membrane permeable peptides. We show that a peptide containing phospho-Y-747 but not F-747 significantly inhibits VEGF-induced signaling and angiogenesis. Moreover, phospho-Y-747 peptide exhibits inhibitory effect only in WT but not in beta(3) integrin knock-out or beta(3) integrin knock-in cells expressing beta(3) with two tyrosines substituted for phenylalanines, demonstrating its specificity. Importantly, these peptides have no effect on fibroblast growth factor receptor signaling. Collectively these data provide novel mechanistic insights into phosphorylation dependent cross-talk between integrin and VEGFR2.	[West, Xiaoxia Z.; Meller, Nahum; Malinin, Nikolay L.; Meller, Julia; Mahabeleshwar, Ganapati H.; Weber, Malory E.; Kerr, Bethany A.; Byzova, Tatiana V.] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA; [Deshmukh, Lalit; Vinogradova, Olga] Univ Connecticut, Dept Pharmaceut Sci, Sch Pharm, Storrs, CT USA; [Deshmukh, Lalit] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; [Mahabeleshwar, Ganapati H.] Case Western Reserve Univ, Sch Med, Univ Hosp Harrington McLaughlin Heart & Vasc Inst, Cleveland, OH USA; [Mahabeleshwar, Ganapati H.] Case Western Reserve Univ, Sch Med, Case Cardiovasc Res Inst, Cleveland, OH USA	Cleveland Clinic Foundation; University of Connecticut; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Case Western Reserve University; Case Western Reserve University	West, XZ (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44106 USA.	olga.vinogradova@uconn.edu; byzovat@ccf.org	Vinogradova, Olga/ABE-8367-2020; Deshmukh, Lalit/C-5073-2015; Kerr, Bethany/D-1644-2012; Malinin, Nikolay/J-4271-2012; Malinin, Nikolay/Z-5308-2019	Vinogradova, Olga/0000-0001-5101-7361; Kerr, Bethany/0000-0002-2995-7549; Malinin, Nikolay/0000-0002-2654-1783; Byzova, Tatiana/0000-0002-2615-875X	National Institute of Health (NIH); American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL098777] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in parts by National Institute of Health (NIH) grants to TVB and American Heart Association and NIH grants to OV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Anthis NJ, 2009, J BIOL CHEM, V284, P36700, DOI 10.1074/jbc.M109.061275; Blystone SD, 1997, J BIOL CHEM, V272, P28757, DOI 10.1074/jbc.272.45.28757; Boettiger D, 2001, MOL BIOL CELL, V12, P1227, DOI 10.1091/mbc.12.5.1227; Butler B, 2003, J BIOL CHEM, V278, P5264, DOI 10.1074/jbc.M206997200; Byzova TV, 2000, EXP CELL RES, V254, P299, DOI 10.1006/excr.1999.4765; Byzova TV, 2000, MOL CELL, V6, P851, DOI 10.1016/S1097-2765(05)00076-6; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Chandhoke SK, 2004, J CELL SCI, V117, P1431, DOI 10.1242/jcs.00987; Cowan KJ, 2000, J BIOL CHEM, V275, P36423, DOI 10.1074/jbc.M004068200; Czuchra A, 2006, J CELL BIOL, V174, P889, DOI 10.1083/jcb.200604060; Datta A, 2002, J BIOL CHEM, V277, P3943, DOI 10.1074/jbc.M109536200; Davis GE, 2011, INT REV CEL MOL BIO, V288, P101, DOI 10.1016/B978-0-12-386041-5.00003-0; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deshmukh L, 2011, J BIOL CHEM, V286, P40943, DOI 10.1074/jbc.M111.231951; Deshmukh L, 2010, J BIOL CHEM, V285, P34875, DOI 10.1074/jbc.M110.159087; Harris PA, 2005, J MED CHEM, V48, P1610, DOI 10.1021/jm049538w; Holmqvist K, 2004, J BIOL CHEM, V279, P22267, DOI 10.1074/jbc.M312729200; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Law DA, 1999, NATURE, V401, P808, DOI 10.1038/44599; Leppanen VM, 2010, P NATL ACAD SCI USA, V107, P2425, DOI 10.1073/pnas.0914318107; Ma YQ, 2007, J THROMB HAEMOST, V5, P1345, DOI 10.1111/j.1538-7836.2007.02537.x; Mahabeleshwar GH, 2008, CELL CYCLE, V7, P335, DOI 10.4161/cc.7.3.5234; Mahabeleshwar GH, 2007, CIRC RES, V101, P570, DOI 10.1161/CIRCRESAHA.107.155655; Mahabeleshwar GH, 2006, J EXP MED, V203, P2495, DOI 10.1084/jem.20060807; Napione L, 2007, AUTOIMMUN REV, V7, P18, DOI 10.1016/j.autrev.2007.03.007; PASSANITI A, 1992, LAB INVEST, V67, P804; Phillips DR, 2001, THROMB HAEMOSTASIS, V86, P246; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Schaffner-Reckinger E, 1998, J BIOL CHEM, V273, P12623, DOI 10.1074/jbc.273.20.12623; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Serini G, 2006, EXP CELL RES, V312, P651, DOI 10.1016/j.yexcr.2005.10.020; Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Vallar L, 1999, J BIOL CHEM, V274, P17257, DOI 10.1074/jbc.274.24.17257; Vaynberg J, 2006, TRENDS BIOTECHNOL, V24, P22, DOI 10.1016/j.tibtech.2005.09.006; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Ward C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012543; Wuthrich K, 1986, NMR PROTEINS NUCL AC	40	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31071	10.1371/journal.pone.0031071	http://dx.doi.org/10.1371/journal.pone.0031071			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363548	gold, Green Published, Green Submitted			2022-12-27	WOS:000302853600105
J	Amir, O; Rand, DG; Gal, YK				Amir, Ofra; Rand, David G.; Gal, Ya'akov Kobi			Economic Games on the Internet: The Effect of $1 Stakes	PLOS ONE			English	Article							PUBLIC-GOODS EXPERIMENTS; ULTIMATUM GAME; MECHANICAL TURK; SIZE MATTER; COOPERATION; FAIRNESS; EXPECTATIONS; CONFUSION; BEHAVIOR; HUMANS	Online labor markets such as Amazon Mechanical Turk (MTurk) offer an unprecedented opportunity to run economic game experiments quickly and inexpensively. Using Mturk, we recruited 756 subjects and examined their behavior in four canonical economic games, with two payoff conditions each: a stakes condition, in which subjects' earnings were based on the outcome of the game (maximum earnings of $1); and a no-stakes condition, in which subjects' earnings are unaffected by the outcome of the game. Our results demonstrate that economic game experiments run on MTurk are comparable to those run in laboratory settings, even when using very low stakes.	[Amir, Ofra; Gal, Ya'akov Kobi] Ben Gurion Univ Negev, Dept Informat Syst Engn, IL-84105 Beer Sheva, Israel; [Rand, David G.] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Gal, Ya'akov Kobi] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Ben Gurion University; Harvard University; Harvard University	Amir, O (corresponding author), Ben Gurion Univ Negev, Dept Informat Syst Engn, IL-84105 Beer Sheva, Israel.	ofraam@bgu.ac.il	Rand, David G./B-3716-2009; Gal, Ya'akov/F-1567-2012	Rand, David G./0000-0002-2821-468X; Rand, David/0000-0001-8975-2783; Gal, Kobi/0000-0001-7187-8572	Harvard University's Berkman Center for Internet and Society; John Templeton Foundation; Marie Curie Reintagration [268362]	Harvard University's Berkman Center for Internet and Society; John Templeton Foundation; Marie Curie Reintagration	This work was funded by a research grant from Harvard University's Berkman Center for Internet and Society (http://cyber.law.harvard.edu) and DR is supported by a grant from the John Templeton Foundation (http://www.templeton.org). YG is supported by FP7 Marie Curie Reintagration Grant no. 268362. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen S, 2011, AM ECON REV, V101, P3427, DOI 10.1257/aer.101.7.3427; ANDREONI J, 1995, AM ECON REV, V85, P891; ANDREONI J, 1995, Q J ECON, V110, P1, DOI 10.2307/2118508; ANDREONI J, 1988, J PUBLIC ECON, V37, P291, DOI 10.1016/0047-2727(88)90043-6; Bahry DL, 2006, J ECON BEHAV ORGAN, V60, P37, DOI 10.1016/j.jebo.2004.07.005; Brandts J, 1996, COOPERATIVE GAINS NO; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Cameron LA, 1999, ECON INQ, V37, P47, DOI 10.1111/j.1465-7295.1999.tb01415.x; Carpenter J, 2005, ECON LETT, V86, P393, DOI 10.1016/j.econlet.2004.08.007; Chandler D., 2010, BREAKING MONOT UNPUB; Dreber A, 2010, BEAUTY QUEENS BATTLI; Engel C, 2010, EXPT EC, P1; FORSYTHE R, 1994, GAME ECON BEHAV, V6, P347, DOI 10.1006/game.1994.1021; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Hoffman E, 1996, INT J GAME THEORY, V25, P289, DOI 10.1007/BF02425259; Horton J., 2010, ONLINE LAB CONDUCTIN; Horton J, 2010, EMPLOYER EXPECTATION; Johansson-Stenman O, 2005, ECON LETT, V88, P365, DOI 10.1016/j.econlet.2005.03.007; Johnson N., 2008, SOCIAL SCI RES NETWO; Kahneman D., 1986, J BUS, V59, P285, DOI DOI 10.1086/296367; Keser C, 1997, PARTNERS CONTRIBUTE; Kocher MG, 2008, ECON LETT, V99, P508, DOI 10.1016/j.econlet.2007.09.048; Larrick RP, 1997, J PERS SOC PSYCHOL, V72, P810, DOI 10.1037/0022-3514.72.4.810; Lawson C, 2010, WORLD POLIT, V62, P561, DOI 10.1017/S0043887110000195; Mason W., 2010, BEHAV RES METHODS, P1; Oosterbeek H, 2004, EXP ECON, V7, P171, DOI 10.1023/B:EXEC.0000026978.14316.74; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Rand D.G., 2011, J THEORETICAL BIOL; Rand DG, 2011, P NATL ACAD SCI USA, V108, P19193, DOI 10.1073/pnas.1108243108; Rand DG, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1442; Solnick SJ, 2001, ECON INQ, V39, P189, DOI 10.1093/ei/39.2.189; STRAUB PG, 1995, J ECON BEHAV ORGAN, V27, P345, DOI 10.1016/0167-2681(94)00072-M; Suri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016836; Wallace B, 2007, P NATL ACAD SCI USA, V104, P15631, DOI 10.1073/pnas.0706642104; WEIMANN J, 1994, J PUBLIC ECON, V54, P185, DOI 10.1016/0047-2727(94)90059-0; Zak PJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001128	36	185	185	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31461	10.1371/journal.pone.0031461	http://dx.doi.org/10.1371/journal.pone.0031461			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926ZM	22363651	gold, Green Published			2022-12-27	WOS:000302873700061
J	Cleveland, ZI; Moller, HE; Hedlund, LW; Nouls, JC; Freeman, MS; Qi, Y; Driehuys, B				Cleveland, Zackary I.; Moeller, Harald E.; Hedlund, Laurence W.; Nouls, John C.; Freeman, Matthew S.; Qi, Yi; Driehuys, Bastiaan			In Vivo MR Imaging of Pulmonary Perfusion and Gas Exchange in Rats via Continuous Extracorporeal Infusion of Hyperpolarized Xe-129	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; LASER-POLARIZED XE-129; INERT-GAS; LUNG; XENON; NMR; VENTILATION; RELAXATION; MICROSCOPY; PROTEIN	Background: Hyperpolarized (HP) Xe-129 magnetic resonance imaging (MRI) permits high resolution, regional visualization of pulmonary ventilation. Additionally, its reasonably high solubility (> 10%) and large chemical shift range (> 200 ppm) in tissues allow HP Xe-129 to serve as a regional probe of pulmonary perfusion and gas transport, when introduced directly into the vasculature. In earlier work, vascular delivery was accomplished in rats by first dissolving HP Xe-129 in a biologically compatible carrier solution, injecting the solution into the vasculature, and then detecting HP Xe-129 as it emerged into the alveolar airspaces. Although easily implemented, this approach was constrained by the tolerable injection volume and the duration of the HP Xe-129 signal. Methods and Principal Findings: Here, we overcome the volume and temporal constraints imposed by injection, by using hydrophobic, microporous, gas-exchange membranes to directly and continuously infuse Xe-129 into the arterial blood of live rats with an extracorporeal (EC) circuit. The resulting gas-phase Xe-129 signal is sufficient to generate diffusive gas exchange-and pulmonary perfusion-dependent, 3D MR images with a nominal resolution of 2x2x2 mm(3). We also show that the Xe-129 signal dynamics during EC infusion are well described by an analytical model that incorporates both mass transport into the blood and longitudinal relaxation. Conclusions: Extracorporeal infusion of HP Xe-129 enables rapid, 3D MR imaging of rat lungs and, when combined with ventilation imaging, will permit spatially resolved studies of the ventilation-perfusion ratio in small animals. Moreover, EC infusion should allow Xe-129 to be delivered elsewhere in the body and make possible functional and molecular imaging approaches that are currently not feasible using inhaled HP Xe-129.	[Cleveland, Zackary I.; Moeller, Harald E.; Hedlund, Laurence W.; Nouls, John C.; Freeman, Matthew S.; Qi, Yi; Driehuys, Bastiaan] Duke Univ, Med Ctr, Dept Radiol, Ctr Vivo Microscopy, Durham, NC 27710 USA; [Moeller, Harald E.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Freeman, Matthew S.] Duke Univ, Grad Program Med Phys, Durham, NC USA	Duke University; Max Planck Society; Duke University	Cleveland, ZI (corresponding author), Duke Univ, Med Ctr, Dept Radiol, Ctr Vivo Microscopy, Durham, NC 27710 USA.	bastiaan.driehuys@duke.edu	Moller, Harald E/A-1565-2008; Möller, Harald/AAB-4679-2019	Moller, Harald E/0000-0002-5659-1925; Möller, Harald/0000-0002-5659-1925; Hedlund, Laurence/0000-0001-5275-0397; Driehuys, Bastiaan/0000-0002-1236-4210	National Cancer Institute (NCI) [R01 CA142842]; National Institutes of Health (nih.gov)/National Center for Research Resources (NCRR) National Biomedical Technology Research Center [P41 RR005959]; NATIONAL CANCER INSTITUTE [R01CA142842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005959] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (nih.gov)/National Center for Research Resources (NCRR) National Biomedical Technology Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was conducted at the Duke Center for In Vivo Microscopy (http://www.civm.duhs.duke.edu), a National Institutes of Health (nih.gov)/National Center for Research Resources (NCRR) National Biomedical Technology Research Center (P41 RR005959) with additional support from the National Cancer Institute (NCI) (R01 CA142842). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro V, 2001, CLIN EXP PHARMACOL P, V28, P419, DOI 10.1046/j.1440-1681.2001.3455.x; Amor N, 2009, J MAGN RESON, V201, P93, DOI 10.1016/j.jmr.2009.08.004; Baumer D, 2006, ANGEW CHEM INT EDIT, V45, P7282, DOI 10.1002/anie.200601008; Boutin C, 2011, BIOORGAN MED CHEM, V19, P4135, DOI 10.1016/j.bmc.2011.05.002; Bucholz E, 2008, MAGN RESON MED, V60, P111, DOI 10.1002/mrm.21618; Budilarto SG, 2009, ARTIF ORGANS, V33, P411, DOI 10.1111/j.1525-1594.2009.00751.x; C Lentner, GEIGY SCI TABLES; Chambers JM, 2009, J AM CHEM SOC, V131, P563, DOI 10.1021/ja806092w; Chen BT, 2005, MAGN RESON MED, V53, P69, DOI 10.1002/mrm.20307; CHEN RYZ, 1980, J APPL PHYSIOL, V49, P178, DOI 10.1152/jappl.1980.49.2.178; Cleveland ZI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012192; Cleveland ZI, 2009, J PHYS CHEM B, V113, P12489, DOI 10.1021/jp9049582; Deninger AJ, 2002, MAGN RESON MED, V48, P223, DOI 10.1002/mrm.10206; Dregely I, 2011, J MAGN RESON IMAGING, V33, P1052, DOI 10.1002/jmri.22533; Driehuys B, 1996, APPL PHYS LETT, V69, P1668, DOI 10.1063/1.117022; Driehuys B, 2008, MAGN RESON MED, V60, P14, DOI 10.1002/mrm.21651; Driehuys B, 2006, P NATL ACAD SCI USA, V103, P18278, DOI 10.1073/pnas.0608458103; Driehuys B, 2009, RADIOLOGY, V252, P386, DOI [10.1148/radiol.2513081550, 10.1148/radiol.2522081550]; Dubois L, 2004, J AM CHEM SOC, V126, P15738, DOI 10.1021/ja046195i; Goodson BM, 2002, J MAGN RESON, V155, P157, DOI 10.1006/jmre.2001.2341; Hirleman E, 2008, PERFUSION-UK, V23, P311, DOI 10.1177/0267659109105079; KAROOR S, 1993, IND ENG CHEM RES, V32, P674, DOI 10.1021/ie00016a014; Kaushik SS, 2011, MAGN RESON MED, V65, P1155, DOI 10.1002/mrm.22697; KETY SS, 1951, PHARMACOL REV, V3, P1; Lei Zhao, 1996, Journal of Magnetic Resonance, Series B, V113, P179, DOI 10.1006/jmrb.1996.0173; Lowery TJ, 2005, PROTEIN SCI, V14, P848, DOI [10.1110/ps.041231005, 10.1110/ps.041231005.]; Mata JF, 2007, J APPL PHYSIOL, V102, P1273, DOI 10.1152/japplphysiol.00418.2006; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Moller HE, 2011, J MAGN RESON, V212, P109, DOI 10.1016/j.jmr.2011.06.017; Moller HE, 2002, MAGN RESON MED, V47, P1029, DOI 10.1002/mrm.10173; Moller HE, 1999, MAGNET RESON MED, V41, P1058, DOI 10.1002/(SICI)1522-2594(199905)41:5<1058::AID-MRM26>3.0.CO;2-C; Mugler JP, 2010, P NATL ACAD SCI USA, V107, P21707, DOI 10.1073/pnas.1011912107; Nouls J, 2011, CONCEPT MAGN RESON B, V39B, P78, DOI 10.1002/cmr.b.20192; Patz S, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/1/015009; Petersson J, 2007, J APPL PHYSIOL, V102, P468, DOI 10.1152/japplphysiol.00732.2006; POPOVIC VP, 1964, AM J PHYSIOL, V207, P767, DOI 10.1152/ajplegacy.1964.207.4.767; Probst RJ, 2006, J AM ASSOC LAB ANIM, V45, P49; RHODES CG, 1989, J APPL PHYSIOL, V66, P1905, DOI 10.1152/jappl.1989.66.4.1905; Richter T, 2010, J APPL PHYSIOL, V108, P422, DOI 10.1152/japplphysiol.91257.2008; Schroder L, 2006, SCIENCE, V314, P446, DOI 10.1126/science.1131847; Schumichen C, 2003, RESPIRATION, V70, P329, DOI 10.1159/000072892; Song JY, 2009, IEEE T BIO-MED ENG, V56, P1134, DOI 10.1109/TBME.2009.2012721; Stupic KF, 2006, SOLID STATE NUCL MAG, V29, P79, DOI 10.1016/j.ssnmr.2005.08.008; Swanson SD, 1997, MAGNET RESON MED, V38, P695, DOI 10.1002/mrm.1910380503; TRUOG WE, 1979, J APPL PHYSIOL, V47, P1112, DOI 10.1152/jappl.1979.47.5.1112; Unsworth J., 1971, Diffusion processes, P599; Voorhees ME, 1996, INT ANESTHESIOL CLIN, V34, P29, DOI 10.1097/00004311-199603420-00005; WEIBEL ER, 1973, RESP PHYSIOL, V18, P285, DOI 10.1016/0034-5687(73)90094-7; Wickramasinghe SR, 2005, CHEM ENG RES DES, V83, P256, DOI 10.1205/cherd.04195; Wickramasinghe SR, 2005, AICHE J, V51, P656, DOI 10.1002/aic.10327; Wickramasinghe SR, 2002, BIOTECHNOL PROGR, V18, P867, DOI 10.1021/bp010192h; Wickramasinghe SR, 2002, J MEMBRANE SCI, V208, P247, DOI 10.1016/S0376-7388(02)00281-8; Wietholt C, 2003, PROC SPIE, V5031, P252, DOI 10.1117/12.485802; Wolber J, 2000, MAGNET RESON MED, V43, P491, DOI 10.1002/(SICI)1522-2594(200004)43:4<491::AID-MRM1>3.0.CO;2-6; Wolber J, 1999, P NATL ACAD SCI USA, V96, P3664, DOI 10.1073/pnas.96.7.3664; Zheng WZ, 2011, J MAGN RESON, V208, P284, DOI 10.1016/j.jmr.2010.11.006; Zhou X, 2009, P NATL ACAD SCI USA, V106, P16903, DOI 10.1073/pnas.0909147106	57	19	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31306	10.1371/journal.pone.0031306	http://dx.doi.org/10.1371/journal.pone.0031306			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363613	Green Submitted, gold, Green Published			2022-12-27	WOS:000302873700045
J	Li, CW; Yu, S; Zhong, XL; Wu, JG; Li, XD				Li, Chengwei; Yu, Shuang; Zhong, Xiaoling; Wu, Jianguo; Li, Xiaodong			Transcriptome Comparison between Fetal and Adult Mouse Livers: Implications for Circadian Clock Mechanisms	PLOS ONE			English	Article							GENE-EXPRESSION; RAT-LIVER; DNA METHYLATION; OSCILLATORS; RHYTHMS; TISSUES; PHASE; TIME; METABOLISM; NAD(+)	Microarray transcriptome analyses of fetal mouse liver did not detect circadian expression rhythms of clock genes or clock-controlled genes, although some rhythmic transcripts that were likely not driven by endogenous cellular clocks were identified. This finding reveals a key distinction between the circadian oscillators in fetal and adult mouse livers. Thus, in this study, the transcriptomes of fetal and adult livers were systematically compared to identify differences in the gene expression profiles between these two developmental stages. Approximately 1000 transcripts were differentially enriched between the fetal and adult livers. These transcripts represent genes with cellular functions characteristic of distinct developmental stages. Clock genes were also differentially expressed between the fetal and adult livers. Developmental differences in liver gene expression might have contributed to the differences in oscillation status and functional states of the cellular circadian clock between fetal and adult livers.	[Li, Chengwei; Yu, Shuang; Zhong, Xiaoling; Wu, Jianguo; Li, Xiaodong] Wuhan Univ, Natl Key Lab Virol, Coll Life Sci, Wuhan 430072, Hubei Province, Peoples R China	Wuhan University	Li, CW (corresponding author), Wuhan Univ, Natl Key Lab Virol, Coll Life Sci, Wuhan 430072, Hubei Province, Peoples R China.	xiaodli@whu.edu.cn		Zhong, Xiaoling/0000-0003-2963-4798; Wu, Jianguo/0000-0002-8326-2895	National Mega Project on Major Drug Development [2011ZX09401-302-1, 2009ZX09301-014-1]; National Basic Research Program of China [2009CB918304]; China Ministry of Education [20070486102]	National Mega Project on Major Drug Development; National Basic Research Program of China(National Basic Research Program of China); China Ministry of Education(Ministry of Education, China)	This research was supported by National Mega Project on Major Drug Development (2011ZX09401-302-1 and 2009ZX09301-014-1), the National Basic Research Program of China (2009CB918304), and by the China Ministry of Education grant 20070486102. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aladjem MI, 1998, CURR BIOL, V8, P145, DOI 10.1016/S0960-9822(98)70061-2; Alenghat T, 2008, NATURE, V456, P997, DOI 10.1038/nature07541; Amano T, 2009, BIOL REPROD, V80, P473, DOI 10.1095/biolreprod.108.069542; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; BALLARD FJ, 1971, BIOCHEM J, V124, P265, DOI 10.1042/bj1240265; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; BOHME HJ, 1983, EXPERIENTIA, V39, P473; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Da Rocha ST, 2008, TRENDS GENET, V24, P306, DOI 10.1016/j.tig.2008.03.011; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; DeBruyne JP, 2007, CURR BIOL, V17, pR538, DOI 10.1016/j.cub.2007.05.067; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Dolatshad H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009855; Dolatshad H, 2009, REPROD FERT DEVELOP, V21, P1, DOI 10.1071/RD08223; Eckel-Mahan K, 2009, NAT STRUCT MOL BIOL, V16, P462, DOI 10.1038/nsmb.1595; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; GIRARD J, 1992, PHYSIOL REV, V72, P507, DOI 10.1152/physrev.1992.72.2.507; Gotter AL, 2000, NAT NEUROSCI, V3, P755, DOI 10.1038/77653; Gruppuso PA, 1999, PEDIATR RES, V46, P14, DOI 10.1203/00006450-199907000-00003; Guo HG, 2006, J NEUROSCI, V26, P6406, DOI 10.1523/JNEUROSCI.4676-05.2006; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Koch-Nolte F, 2011, FEBS LETT, V585, P1651, DOI 10.1016/j.febslet.2011.03.045; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Lakin-Thomas PL, 2006, J BIOL RHYTHM, V21, P83, DOI 10.1177/0748730405286102; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Le Minh N, 2001, EMBO J, V20, P7128, DOI 10.1093/emboj/20.24.7128; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2008, J BIOL RHYTHM, V23, P483, DOI 10.1177/0748730408326682; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; PHILIPPIDIS H, 1969, BIOCHEM J, V113, P651, DOI 10.1042/bj1130651; POLLAK JK, 1975, BIOCHEM J, V150, P477, DOI 10.1042/bj1500477; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reinke H, 2008, GENE DEV, V22, P331, DOI 10.1101/gad.453808; REPPERT SM, 1986, ENDOCRINOLOGY, V119, P1763, DOI 10.1210/endo-119-4-1763; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Schibler U, 2009, J BIOL RHYTHM, V24, P3, DOI 10.1177/0748730408329383; Sladek M, 2007, AM J PHYSIOL-REG I, V292, pR1224, DOI 10.1152/ajpregu.00184.2006; Storch KF, 2009, P NATL ACAD SCI USA, V106, P6808, DOI 10.1073/pnas.0902063106; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Terazono H, 2003, P NATL ACAD SCI USA, V100, P6795, DOI 10.1073/pnas.0936797100; Ukai H, 2010, ANNU REV PHYSIOL, V72, P579, DOI 10.1146/annurev-physiol-073109-130051; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005; VALCARCE C, 1988, J BIOL CHEM, V263, P7767; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Vujovic N, 2008, AM J PHYSIOL-REG I, V295, pR355, DOI 10.1152/ajpregu.00498.2007; WEAVER DR, 1989, DEV BRAIN RES, V46, P291, DOI 10.1016/0165-3806(89)90292-7; Yagita K, 2010, P NATL ACAD SCI USA, V107, P3846, DOI 10.1073/pnas.0913256107; Yamazaki S, 2009, J BIOL RHYTHM, V24, P55, DOI 10.1177/0748730408328438; Yeom M, 2010, P NATL ACAD SCI USA, V107, P9665, DOI 10.1073/pnas.0914078107; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Yoshikawa T, 2005, J BIOL RHYTHM, V20, P500, DOI 10.1177/0748730405280775	68	15	17	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31292	10.1371/journal.pone.0031292	http://dx.doi.org/10.1371/journal.pone.0031292			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363607	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700043
J	Li, HY; Dong, YY; Yang, J; Liu, XM; Wang, YF; Yao, N; Guan, LL; Wang, N; Wu, JY; Li, XK				Li, Haiyan; Dong, Yuanyuan; Yang, Jing; Liu, Xiuming; Wang, Yanfang; Yao, Na; Guan, Lili; Wang, Nan; Wu, Jinyu; Li, Xiaokun			De Novo Transcriptome of Safflower and the Identification of Putative Genes for Oleosin and the Biosynthesis of Flavonoids	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; CARTHAMUS-TINCTORIUS L.; EXPRESSION ANALYSIS; HYDROXYSAFFLOR YELLOW; OIL BODIES; TOOL; ASSOCIATION; ARABIDOPSIS; ANNOTATION; VALIDATION	Safflower (Carthamus tinctorius L.) is one of the most extensively used oil crops in the world. However, little is known about how its compounds are synthesized at the genetic level. In this study, Solexa-based deep sequencing on seed, leaf and petal of safflower produced a de novo transcriptome consisting of 153,769 unigenes. We annotated 82,916 of the unigenes with gene annotation and assigned functional terms and specific pathways to a subset of them. Metabolic pathway analysis revealed that 23 unigenes were predicted to be responsible for the biosynthesis of flavonoids and 8 were characterized as seed-specific oleosins. In addition, a large number of differentially expressed unigenes, for example, those annotated as participating in anthocyanin and chalcone synthesis, were predicted to be involved in flavonoid biosynthesis pathways. In conclusion, the de novo transcriptome investigation of the unique transcripts provided candidate gene resources for studying oleosin-coding genes and for investigating genes related to flavonoid biosynthesis and metabolism in safflower.	[Li, Haiyan; Dong, Yuanyuan; Yang, Jing; Liu, Xiuming; Wang, Yanfang; Yao, Na; Guan, Lili; Wang, Nan; Wu, Jinyu; Li, Xiaokun] Jilin Agr Univ, Minist Educ Engn Res Ctr Bioreactor & Pharmaceut, Changchun, Jilin, Peoples R China; [Li, Haiyan; Liu, Xiuming] Jilin Agr Univ, Coll Life Sci, Changchun, Jilin, Peoples R China; [Wu, Jinyu] Wenzhou Med Coll, Inst Genom Med, Wenzhou, Peoples R China	Jilin Agricultural University; Jilin Agricultural University; Wenzhou Medical University	Li, HY (corresponding author), Jilin Agr Univ, Minist Educ Engn Res Ctr Bioreactor & Pharmaceut, Changchun, Jilin, Peoples R China.	iamwujy@yahoo.com.cn; xiaokunli@163.net	yao, na/HDL-8772-2022		National High Technology Research and Development Program of China (863 Program) [2011AA100606]; Scientific Innovation of Colleges and Universities in China [70S018]; National Natural Science Foundation of China [30971804, 31101091, 31101172]; New Century Excellent Talents in University [NCET-08-0693]; Excellent Innovation Team Project of Jilin Province, China [20111815]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Scientific Innovation of Colleges and Universities in China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Excellent Innovation Team Project of Jilin Province, China	This work was funded by grants from the National High Technology Research and Development Program of China (863 Program) (Grant No. 2011AA100606), the Important Projects in the Scientific Innovation of Colleges and Universities in China (Grant No. 70S018), the National Natural Science Foundation of China (Grant No. 30971804, 31101091, 31101172), the New Century Excellent Talents in University (Grant No. NCET-08-0693) and the Excellent Innovation Team Project of Jilin Province, China (Grant No. 20111815). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKADA S, 1995, PLANT MOL BIOL, V29, P189, DOI 10.1007/BF00043645; Cazzato E, 2011, J SCI FOOD AGR; Chung KJ, 2008, PLANT CELL REP, V27, P29, DOI 10.1007/s00299-007-0440-6; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Giannoulia K, 2007, J PLANT PHYSIOL, V164, P104, DOI 10.1016/j.jplph.2006.03.016; Hemleben V, 2004, PLANT MOL BIOL, V55, P455, DOI 10.1007/s11103-004-1125-y; HRAZDINA G, 1982, PLANT PHYSIOL, V70, P506, DOI 10.1104/pp.70.2.506; Jarosova J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-146; Katavic V, 2006, PROTEOMICS, V6, P4586, DOI 10.1002/pmic.200600020; Lacey DJ, 1998, BIOCHEM J, V334, P469, DOI 10.1042/bj3340469; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li XZ, 2011, ANIM SCI J, V82, P441, DOI 10.1111/j.1740-0929.2010.00857.x; Li YJ, 2011, FEBS J, V278, P156, DOI 10.1111/j.1742-4658.2010.07941.x; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Monnier A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-192; Mu YN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-506; Pitakdantham W, 2010, Pak J Biol Sci, V13, P1000, DOI 10.3923/pjbs.2010.1000.1005; Qiu Q, 2011, TREE PHYSIOL, V31, P452, DOI 10.1093/treephys/tpr015; Roh JS, 2004, BIOL PHARM BULL, V27, P1976, DOI 10.1248/bpb.27.1976; Rudolph CJ, 2010, GENETICS, V186, P473, DOI 10.1534/genetics.110.120691; Siloto RMP, 2006, PLANT CELL, V18, P1961, DOI 10.1105/tpc.106.041269; Simkin AJ, 2006, J PLANT PHYSIOL, V163, P691, DOI 10.1016/j.jplph.2005.11.008; Tang Q, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-343; Thao NTP, 2011, ARCH PHARM RES, V34, P455, DOI 10.1007/s12272-011-0314-x; Vandana S, 2006, PLANT PHYSIOL BIOCH, V44, P714, DOI 10.1016/j.plaphy.2006.09.022; vanEldik GJ, 1997, PLANT J, V11, P105, DOI 10.1046/j.1365-313X.1997.11010105.x; Vega-Arreguin JC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-299; Wenping H, 2011, GENOMICS; Wu CS, 2011, J PHARMACEUT BIOMED, V54, P186, DOI 10.1016/j.jpba.2010.07.010; Wu JA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-234; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Ye SY, 2008, ARCH PHARM RES, V31, P1010, DOI 10.1007/s12272-001-1261-y; Zhang YB, 2011, EUR J PHARMACOL, V660, P438, DOI 10.1016/j.ejphar.2011.04.015	34	47	58	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e30987	10.1371/journal.pone.0030987	http://dx.doi.org/10.1371/journal.pone.0030987			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363528	Green Submitted, Green Published, gold			2022-12-27	WOS:000302873700018
J	Pinske, C; Sawers, RG				Pinske, Constanze; Sawers, R. Gary			Delivery of Iron-Sulfur Clusters to the Hydrogen-Oxidizing [NiFe]-Hydrogenases in Escherichia coli Requires the A-Type Carrier Proteins ErpA and IscA	PLOS ONE			English	Article							FE-S CLUSTER; NIFE HYDROGENASE; MUTATIONAL ANALYSIS; OXYGEN-TOLERANT; AZOTOBACTER-VINELANDII; NICKEL INCORPORATION; CRYSTAL-STRUCTURE; GENETIC-ANALYSIS; MATURATION; OPERON	During anaerobic growth Escherichia coli synthesizes two membrane-associated hydrogen-oxidizing [NiFe]-hydrogenases, termed hydrogenase 1 and hydrogenase 2. Each enzyme comprises a catalytic subunit containing the [NiFe] cofactor, an electron-transferring small subunit with a particular complement of [Fe-S] (iron-sulfur) clusters and a membrane-anchor subunit. How the [Fe-S] clusters are delivered to the small subunit of these enzymes is unclear. A-type carrier (ATC) proteins of the Isc ((i) under bar ron-(s) under bar ulfur-(c) under bar luster) and Suf ((su) under barl (f) under bar ur mobilization) [Fe-S] cluster biogenesis pathways are proposed to traffic preformed [Fe-S] clusters to apoprotein targets. Mutants that could not synthesize SufA had active hydrogenase 1 and hydrogenase 2 enzymes, thus demonstrating that the Suf machinery is not required for hydrogenase maturation. In contrast, mutants devoid of the IscA, ErpA or IscU proteins of the Isc machinery had no detectable hydrogenase 1 or 2 activities. Lack of activity of both enzymes correlated with the absence of the respective [Fe-S]-cluster-containing small subunit, which was apparently rapidly degraded. During biosynthesis the hydrogenase large subunits receive their [NiFe] cofactor from the Hyp maturation machinery. Subsequent to cofactor insertion a specific C-terminal processing step occurs before association of the large subunit with the small subunit. This processing step is independent of small subunit maturation. Using western blotting experiments it could be shown that although the amount of each hydrogenase large subunit was strongly reduced in the iscA and erpA mutants, some maturation of the large subunit still occurred. Moreover, in contrast to the situation in Isc-proficient strains, these processed large subunits were not membrane-associated. Taken together, our findings demonstrate that both IscA and ErpA are required for [Fe-S] cluster delivery to the small subunits of the hydrogen-oxidizing hydrogenases; however, delivery of the Fe atom to the active site might have different requirements.	[Pinske, Constanze; Sawers, R. Gary] Univ Halle Wittenberg, Inst Biol Microbiol, Halle, Saale, Germany	Martin Luther University Halle Wittenberg	Pinske, C (corresponding author), Univ Halle Wittenberg, Inst Biol Microbiol, Halle, Saale, Germany.	gary.sawers@mikrobiologie.uni-halle.de	Pinske, Constanze/N-1302-2017	Pinske, Constanze/0000-0001-6248-2437	Deutsche Forschungsgemeinschaft [Sa 494/3-1548]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grant Sa 494/3-1548 from the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala-Castro C, 2008, MICROBIOL MOL BIOL R, V72, P110, DOI 10.1128/MMBR.00034-07; BALLANTINE SP, 1986, EUR J BIOCHEM, V156, P277, DOI 10.1111/j.1432-1033.1986.tb09578.x; BALLANTINE SP, 1985, J BACTERIOL, V163, P454, DOI 10.1128/JB.163.2.454-459.1985; BEGG YA, 1977, FEMS MICROBIOL LETT, V2, P47, DOI 10.1111/j.1574-6968.1977.tb00905.x; Blokesch M, 2004, J MOL BIOL, V344, P155, DOI 10.1016/j.jmb.2004.09.040; Blokesch M, 2006, FEBS LETT, V580, P4065, DOI 10.1016/j.febslet.2006.06.045; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Chahal HK, 2009, BIOCHEMISTRY-US, V48, P10644, DOI 10.1021/bi901518y; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Dubini A, 2002, INT J HYDROGEN ENERG, V27, P1413, DOI 10.1016/S0360-3199(02)00112-X; Eitinger T, 2000, ARCH MICROBIOL, V173, P1, DOI 10.1007/s002030050001; Forzi L, 2007, BIOMETALS, V20, P565, DOI 10.1007/s10534-006-9048-5; Fritsch J, 2011, NATURE, V479, P249, DOI 10.1038/nature10505; HORMANN K, 1989, ARCH MICROBIOL, V153, P50, DOI 10.1007/BF00277541; Jack RL, 2004, EMBO J, V23, P3962, DOI 10.1038/sj.emboj.7600409; JACOBI A, 1992, ARCH MICROBIOL, V158, P444; JACOBSON MR, 1989, MOL GEN GENET, V219, P49, DOI 10.1007/BF00261156; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Loiseau L, 2007, P NATL ACAD SCI USA, V104, P13626, DOI 10.1073/pnas.0705829104; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lukey MJ, 2011, J AM CHEM SOC, V133, P16881, DOI 10.1021/ja205393w; LUTZ S, 1991, MOL MICROBIOL, V5, P123, DOI 10.1111/j.1365-2958.1991.tb01833.x; Magalon A, 2000, FEBS LETT, V473, P254, DOI 10.1016/S0014-5793(00)01542-8; Manyani H, 2005, J BACTERIOL, V187, P7018, DOI 10.1128/JB.187.20.7018-7026.2005; MENON NK, 1991, J BACTERIOL, V173, P4851, DOI 10.1128/jb.173.15.4851-4861.1991; MENON NK, 1994, J BACTERIOL, V176, P4416, DOI 10.1128/jb.176.14.4416-4423.1994; Ollagnier-de-Choudens S, 2004, J BIOL INORG CHEM, V9, P828, DOI 10.1007/s00775-004-0581-9; Paschos A, 2002, J BIOL CHEM, V277, P49945, DOI 10.1074/jbc.M204601200; Pinske C, 2012, J BACTERIOL IN PRESS; Pinske C, 2011, ARCH MICROBIOL, V193, P893, DOI 10.1007/s00203-011-0726-5; Pinske C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022830; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; ROSSMANN R, 1994, EUR J BIOCHEM, V220, P377, DOI 10.1111/j.1432-1033.1994.tb18634.x; Sargent F, 1998, EUR J BIOCHEM, V255, P746, DOI 10.1046/j.1432-1327.1998.2550746.x; Sargent F, 2007, MICROBIOL-SGM, V153, P633, DOI 10.1099/mic.0.2006/004762-0; SAUTER M, 1992, MOL MICROBIOL, V6, P1523, DOI 10.1111/j.1365-2958.1992.tb00873.x; SAWERS RG, 1986, EUR J BIOCHEM, V156, P265, DOI 10.1111/j.1432-1033.1986.tb09577.x; SAWERS RG, 1985, J BACTERIOL, V164, P1324, DOI 10.1128/JB.164.3.1324-1331.1985; Sawers RG, 1994, ANTON LEEUW INT J G, V66, P57; Shomura Y, 2011, NATURE, V479, P253, DOI 10.1038/nature10504; Soboh B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-173; Soboh B, 2010, FEBS LETT, V584, P4109, DOI 10.1016/j.febslet.2010.08.037; Takahashi Y, 2002, J BIOL CHEM, V277, P28380, DOI 10.1074/jbc.C200365200; Tokumoto U, 2004, J BIOCHEM, V136, P199, DOI 10.1093/jb/mvh104; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vinella D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000497; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Watanabe S, 2007, MOL CELL, V27, P29, DOI 10.1016/j.molcel.2007.05.039; Yang JJ, 2006, J BIOL CHEM, V281, P27956, DOI 10.1074/jbc.M601356200; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	53	26	26	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31755	10.1371/journal.pone.0031755	http://dx.doi.org/10.1371/journal.pone.0031755			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363723	gold, Green Submitted, Green Published			2022-12-27	WOS:000302873700091
J	Shaoul, E; Ayalon, A; Tal, Y; Lotan, T				Shaoul, Esther; Ayalon, Ari; Tal, Yossi; Lotan, Tamar			Transdermal Delivery of Scopolamine by Natural Submicron Injectors: In-Vivo Study in Pig	PLOS ONE			English	Article							DRUG-DELIVERY; POSTOPERATIVE NAUSEA; MOTION SICKNESS; PREVENTION; SKIN; PHARMACOKINETICS; MICRONEEDLES; PENETRATION; ATROPINE; SYSTEMS	Transdermal drug delivery has made a notable contribution to medical practice, but has yet to fully achieve its potential as an alternative to oral delivery and hypodermic injections. While transdermal delivery systems would appear to provide an attractive solution for local and systemic drug delivery, only a limited number of drugs can be delivered through the outer layer of the skin. The most difficult to deliver in this way are hydrophilic drugs. The aquatic phylum Cnidaria, which includes sea anemones, corals, jellyfish and hydra, is one of the most ancient multicellular phyla that possess stinging cells containing organelles (cnidocysts), comprising a sophisticated injection system. The apparatus is folded within collagenous microcapsules and upon activation injects a thin tubule that immediately penetrates the prey and delivers its contents. Here we show that this natural microscopic injection system can be adapted for systemic transdermal drug delivery once it is isolated from the cells and uploaded with the drug. Using a topically applied gel containing isolated natural sea anemone injectors and the muscarinic receptor antagonist scopolamine, we found that the formulated injectors could penetrate porcine skin and immediately deliver this hydrophilic drug. An in-vivo study in pigs demonstrated, for the first time, rapid systemic delivery of scopolamine, with T-max of 30 minutes and C-max 5 times higher than in controls treated topically with a scopolamine-containing gel without cnidocysts. The ability of the formulated natural injection system to penetrate a barrier as thick as the skin and systemically deliver an exogenous compound presents an intriguing and attractive alternative for hydrophilic transdermal drug delivery.	[Shaoul, Esther; Ayalon, Ari; Tal, Yossi] NanoCyte Israel Ltd, Caesarea, Israel; [Lotan, Tamar] Univ Haifa, Leon H Charney Sch Marine Sci, Dept Marine Biol, IL-31999 Haifa, Israel	University of Haifa	Shaoul, E (corresponding author), NanoCyte Israel Ltd, Caesarea, Israel.	lotant@univ.haifa.ac.il		Lotan, Tamar/0000-0002-1679-4904				Apfel CC, 2010, CLIN THER, V32, P1987, DOI 10.1016/j.clinthera.2010.11.014; Ayalon A, 2011, INT J PHARMACEUT, V419, P147, DOI 10.1016/j.ijpharm.2011.07.042; Baroli B, 2010, J PHARM SCI-US, V99, P21, DOI 10.1002/jps.21817; Barry BW, 2004, NAT BIOTECHNOL, V22, P165, DOI 10.1038/nbt0204-165; Brown MB, 2006, DRUG DELIV, V13, P175, DOI 10.1080/10717540500455975; Cevc G, 2010, J CONTROL RELEASE, V141, P277, DOI 10.1016/j.jconrel.2009.10.016; Ceyhan T, 2001, J PHARMACEUT BIOMED, V25, P399, DOI 10.1016/S0731-7085(00)00514-8; David CN, 2008, TRENDS GENET, V24, P431, DOI 10.1016/j.tig.2008.07.001; Donnelly RF, 2010, DRUG DELIV, V17, P187, DOI 10.3109/10717541003667798; Elsayed MMA, 2007, INT J PHARMACEUT, V332, P1, DOI 10.1016/j.ijpharm.2006.12.005; Greenwood PG, 2003, COMP BIOCHEM PHYS A, V134, P275, DOI 10.1016/S1095-6433(02)00262-3; Gupta J, 2011, BIOMATERIALS, V32, P6823, DOI 10.1016/j.biomaterials.2011.05.061; Hart EA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r168; HOLSTEIN TW, 1994, SCIENCE, V265, P402, DOI 10.1126/science.265.5170.402; Kranke P, 2002, ANESTH ANALG, V95, P133, DOI 10.1097/00000539-200207000-00024; Lau OW, 1997, J CHROMATOGR A, V766, P270, DOI 10.1016/S0021-9673(96)01019-9; LOTAN A, 1995, NATURE, V375, P456, DOI 10.1038/375456a0; Lotan T, 2005, PERCUTANEOUS ABSORPT, P521; Lotan T, 2008, MODIFIED RELEASE DRU, P395; LUBBOCK R, 1981, NATURE, V290, P500, DOI 10.1038/290500a0; Nachum Z, 2001, J PHARMACOL EXP THER, V296, P121; Nachum Z, 2006, CLIN PHARMACOKINET, V45, P543, DOI 10.2165/00003088-200645060-00001; Nuchter T, 2006, CURR BIOL, V16, pR316, DOI 10.1016/j.cub.2006.03.089; Oertel R, 2001, J CHROMATOGR B, V750, P121, DOI 10.1016/S0378-4347(00)00433-3; Ozbek S, 2009, TOXICON, V54, P1038, DOI 10.1016/j.toxicon.2009.03.006; Ogura M, 2008, ADV DRUG DELIVER REV, V60, P1218, DOI 10.1016/j.addr.2008.03.006; Park JH, 2010, EUR J PHARM BIOPHARM, V76, P282, DOI 10.1016/j.ejpb.2010.07.001; Prausnitz MR, 2008, NAT BIOTECHNOL, V26, P1261, DOI 10.1038/nbt.1504; Prausnitz MR, 2004, ADV DRUG DELIVER REV, V56, P581, DOI 10.1016/j.addr.2003.10.023; Renner UD, 2005, THER DRUG MONIT, V27, P655, DOI 10.1097/01.ftd.0000168293.48226.57; Sherman CR, 2002, J TRAVEL MED, V9, P251; Simon GA, 2000, SKIN PHARMACOL APPL, V13, P229, DOI 10.1159/000029928; Simon GA, 1998, SKIN PHARMACOL APPL, V11, P80, DOI 10.1159/000029812; Singh Thakur R R, 2011, Recent Pat Drug Deliv Formul, V5, P11; Sivamani RK, 2007, EXPERT OPIN DRUG DEL, V4, P19, DOI 10.1517/17425247.4.1.19; Spinks AB, 2007, COCHRANE DB SYST REV, V18; Swindle MM, 2012, VET PATHOL, V49, P344, DOI 10.1177/0300985811402846; Szczepanek S, 2002, J CELL SCI, V115, P745; TARDENT P, 1995, BIOESSAYS, V17, P351, DOI 10.1002/bies.950170411	39	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31922	10.1371/journal.pone.0031922	http://dx.doi.org/10.1371/journal.pone.0031922			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363770	Green Submitted, Green Published, gold			2022-12-27	WOS:000302873700124
J	Vas, V; Wandhoff, C; Dorr, K; Niebel, A; Geiger, H				Vas, Virag; Wandhoff, Corinna; Doerr, Karin; Niebel, Anja; Geiger, Hartmut			Contribution of an Aged Microenvironment to Aging-Associated Myeloproliferative Disease	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; PROGENITOR CELLS; ELDERLY-PATIENTS; AML1-ETO; NICHE; MICE; LEUKEMOGENESIS; MODEL; DEFICIENCY	The molecular and cellular mechanisms of the age-associated increase in the incidence of acute myeloid leukemia (AML) remain poorly understood. Multiple studies support that the bone marrow (BM) microenvironment has an important influence on leukemia progression. Given that the BM niche itself undergoes extensive functional changes during lifetime, we hypothesized that one mechanism for the age-associated increase in leukemia incidence might be that an aged niche promotes leukemia progression. The most frequent genetic alteration in AML is the t(8;21) translocation, resulting in the expression of the AML1-ETO fusion protein. Expression of the fusion protein in hematopoietic cells results in mice in a myeloproliferative disorder. Testing the role of the age of the niche on leukemia progression, we performed both transplantation and in vitro co-culture experiments. Aged animals transplanted with AML1-ETO positive HSCs presented with a significant increase in the frequency of AML-ETO positive early progenitor cells in BM as well as an increased immature myeloid cell load in blood compared to young recipients. These findings suggest that an aged BM microenvironment allows a relative better expansion of pre-leukemic stem and immature myeloid cells and thus imply that the aged microenvironment plays a role in the elevated incidence of age-associated leukemia.	[Vas, Virag; Wandhoff, Corinna; Doerr, Karin; Niebel, Anja; Geiger, Hartmut] Univ Ulm, Dept Dermatol & Allerg Dis, Ulm, Germany; [Geiger, Hartmut] Univ Cincinnati, Div Expt Hematol & Canc Biol, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA	Ulm University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Vas, V (corresponding author), Univ Ulm, Dept Dermatol & Allerg Dis, Ulm, Germany.	hartmut.geiger@uni-ulm.de	Vas, Virag/B-8067-2016; Virag, Vas/AAD-3532-2022	Vas, Virag/0000-0001-7249-6816; Virag, Vas/0000-0001-7249-6816; Vas, Virag/0000-0002-9722-8188	Deutsche Forschungsgemeinschaft [SFB497, TP10, KFO 142, GE2063/1]; National Institute of Health [HL076604, DK077762]; University of Ulm; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK077762] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Ulm; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Deutsche Forschungsgemeinschaft SFB497, TP10 and KFO 142, GE2063/1 and from the National Institute of Health, HL076604 and DK077762 to H.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Tierforschungszentrum of the University of Ulm for supporting our animal work and Deidre Daria for experimental advice.	Ayala F, 2009, LEUKEMIA, V23, P2233, DOI 10.1038/leu.2009.175; Balduino A, 2005, CELL TISSUE RES, V319, P255, DOI 10.1007/s00441-004-1006-3; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Bellantuono I, 2009, BBA-MOL BASIS DIS, V1792, P364, DOI 10.1016/j.bbadis.2009.01.008; Carlesso N, 2010, CURR OPIN HEMATOL, V17, P281, DOI 10.1097/MOH.0b013e32833a25d8; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Colmone A, 2008, SCIENCE, V322, P1861, DOI 10.1126/science.1164390; de Guzman CG, 2002, MOL CELL BIOL, V22, P5506, DOI 10.1128/MCB.22.15.5506-5517.2002; Deguchi K, 2002, LEUKEMIA, V16, P740, DOI 10.1038/sj.leu.2402500; Fenske TS, 2004, P NATL ACAD SCI USA, V101, P15184, DOI 10.1073/pnas.0400751101; Freemont AJ, 2007, J PATHOL, V211, P252, DOI 10.1002/path.2097; Geiger H, 2007, CELL CYCLE, V6, P884, DOI 10.4161/cc.6.8.4131; Geiger H, 2009, TRENDS IMMUNOL, V30, P360, DOI 10.1016/j.it.2009.03.010; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Greaves M, 2009, HEMATOL-AM SOC HEMAT, P3, DOI DOI 10.1182/ASHEDUCATI0N-2009.1.3; Henry CJ, 2011, AGING-US, V3, P643, DOI 10.18632/aging.100351; Henry CJ, 2010, P NATL ACAD SCI USA, V107, P21713, DOI 10.1073/pnas.1005486107; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Krejci O, 2008, BLOOD, V111, P2190, DOI 10.1182/blood-2007-06-093682; Lane SW, 2009, BLOOD, V114, P1150, DOI 10.1182/blood-2009-01-202606; Lee Kyoo-Hyung, 1996, Journal of Korean Medical Science, V11, P222; Legrand O, 2000, BLOOD, V96, P870, DOI 10.1182/blood.V96.3.870.015k16_870_877; Liang Y, 2005, BLOOD, V106, P1479, DOI 10.1182/blood-2004-11-4282; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Nannya Y, 2002, LEUKEMIA LYMPHOMA, V43, P83, DOI 10.1080/10428190210204; Niebuhr B, 2008, BLOOD CELL MOL DIS, V40, P211, DOI 10.1016/j.bcmd.2007.07.018; Nimer SD, 2004, ONCOGENE, V23, P4249, DOI 10.1038/sj.onc.1207673; NOWELL PC, 1977, AM J PATHOL, V89, P459; Plesa C, 2008, CANCER-AM CANCER SOC, V112, P572, DOI 10.1002/cncr.23219; Raaijmakers MHGP, 2011, HAEMATOL-HEMATOL J, V96, P1041, DOI 10.3324/haematol.2010.028035; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Schessl C, 2005, J CLIN INVEST, V115, P2159, DOI 10.1172/JCI24225; Schwieger M, 2002, J EXP MED, V196, P1227, DOI 10.1084/jem.20020824; Signer RAJ, 2007, BLOOD, V110, P1831, DOI 10.1182/blood-2007-01-069401; Singbrant S, 2011, J CELL BIOCHEM, V112, P1486, DOI 10.1002/jcb.23085; Suarez L, 2005, HAEMATOLOGICA, V90, P54; Wagner W, 2008, EXP GERONTOL, V43, P974, DOI 10.1016/j.exger.2008.04.007; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Wang YY, 2011, P NATL ACAD SCI USA, V108, P2450, DOI 10.1073/pnas.1019625108; Warner JK, 2004, ONCOGENE, V23, P7164, DOI 10.1038/sj.onc.1207933; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Williams RT, 2007, GENE DEV, V21, P2283, DOI 10.1101/gad.1588607; Woolthuis CM, 2011, CURR OPIN IMMUNOL	46	44	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31523	10.1371/journal.pone.0031523	http://dx.doi.org/10.1371/journal.pone.0031523			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363661	Green Submitted, Green Published, gold			2022-12-27	WOS:000302873700065
J	Zhao, SM; Zhao, Y; Mao, FF; Zhang, CQ; Bai, B; Zhang, H; Shi, CH; Xu, ZK				Zhao, Shanmin; Zhao, Yong; Mao, Fengfeng; Zhang, Caiqin; Bai, Bing; Zhang, Hai; Shi, Changhong; Xu, Zhikai			Protective and Therapeutic Efficacy of Mycobacterium smegmatis Expressing HBHA-hIL12 Fusion Protein against Mycobacterium tuberculosis in Mice	PLOS ONE			English	Article							HEPARIN-BINDING HEMAGGLUTININ; CALMETTE-GUERIN VACCINATION; REGULATORY T-CELLS; DNA VACCINES; PHAGOSOME MATURATION; LATENT INFECTION; IMMUNE-RESPONSES; BCG VACCINATION; ACTIVE DISEASE; CHEMOTHERAPY	Tuberculosis (TB) remains a major worldwide health problem. The only vaccine against TB, Mycobacterium bovis Bacille Calmette-Guerin (BCG), has demonstrated relatively low efficacy and does not provide satisfactory protection against the disease. More efficient vaccines and improved therapies are urgently needed to decrease the worldwide spread and burden of TB, and use of a viable, metabolizing mycobacteria vaccine may be a promising strategy against the disease. Here, we constructed a recombinant Mycobacterium smegmatis (rMS) strain expressing a fusion protein of heparin-binding hemagglutinin (HBHA) and human interleukin 12 (hIL-12). Immune responses induced by the rMS in mice and protection against Mycobacterium tuberculosis (MTB) were investigated. Administration of this novel rMS enhanced Th1-type cellular responses (IFN-gamma and IL-2) in mice and reduced bacterial burden in lungs as well as that achieved by BCG vaccination. Meanwhile, the bacteria load in M. tuberculosis infected mice treated with the rMS vaccine also was significantly reduced. In conclusion, the rMS strain expressing the HBHA and human IL-12 fusion protein enhanced immunogencity by improving the Th1-type response against TB, and the protective effect was equivalent to that of the conventional BCG vaccine in mice. Furthermore, it could decrease bacterial load and alleviate histopathological damage in lungs of M. tuberculosis infected mice.	[Zhao, Shanmin; Zhao, Yong; Mao, Fengfeng; Zhang, Caiqin; Bai, Bing; Zhang, Hai; Shi, Changhong] Fourth Mil Med Univ, Lab Anim Ctr, Div Infect & Immunol, Xian 710032, Shaanxi, Peoples R China; [Xu, Zhikai] Fourth Mil Med Univ, Dept Microbiol, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Zhao, SM (corresponding author), Fourth Mil Med Univ, Lab Anim Ctr, Div Infect & Immunol, Xian 710032, Shaanxi, Peoples R China.	changhong@fmmu.edu.cn	, 毛峰峰/AAQ-8349-2020		National Natural Science Foundation of China [30972767]; High Technology Research Project of Shaanxi Province [2007AA02Z473]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High Technology Research Project of Shaanxi Province	This work was supported by the National Natural Science Foundation of China (No. 30972767) and the High Technology Research Project of Shaanxi Province (2007AA02Z473). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardarov S, 1997, P NATL ACAD SCI USA, V94, P10961, DOI 10.1073/pnas.94.20.10961; Cayabyab MJ, 2006, J VIROL, V80, P1645, DOI 10.1128/JVI.80.4.1645-1652.2006; Chen XC, 2007, CLIN IMMUNOL, V123, P50, DOI 10.1016/j.clim.2006.11.009; DasGupta SK, 1998, BIOCHEM BIOPH RES CO, V246, P797, DOI 10.1006/bbrc.1998.8724; Delogu G, 2004, FEMS MICROBIOL LETT, V239, P33, DOI 10.1016/j.femsle.2004.08.015; Delogu G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018315; Esposito C, 2011, BIOCHEM BIOPH RES CO, V410, P339, DOI 10.1016/j.bbrc.2011.05.159; Fine P., 1999, ISSUES RELATING USE; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Ha SJ, 2005, GENE THER, V12, P634, DOI 10.1038/sj.gt.3302465; Ha SJ, 2003, GENE THER, V10, P1592, DOI 10.1038/sj.gt.3302057; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Hovav AH, 2007, J VIROL, V81, P74, DOI 10.1128/JVI.01269-06; Huygen K, 1996, NAT MED, V2, P893, DOI 10.1038/nm0896-893; Ildiko F, 2011, ACTA MICROBIOL IMM H, V58, P13, DOI 10.1556/AMicr.58.2011.1.2; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Kamath AT, 1999, INFECT IMMUN, V67, P1702; Lalor MK, 2011, J INFECT DIS, V204, P1075, DOI 10.1093/infdis/jir515; Li ZM, 1999, INFECT IMMUN, V67, P4780, DOI 10.1128/IAI.67.9.4780-4786.1999; Lindsey DR, 2009, TUBERCULOSIS, V89, pS46, DOI 10.1016/S1472-9792(09)70011-3; Lowrie DB, 2006, VACCINE, V24, P1983, DOI 10.1016/j.vaccine.2005.11.010; Lowrie DB, 1999, NATURE, V400, P269, DOI 10.1038/22326; Luo Y, 2000, MOL IMMUNOL, V37, P527, DOI 10.1016/S0161-5890(00)00077-8; Nolan ST, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013773; Okada M, 2011, HUM VACCINES, V7, P60, DOI 10.4161/hv.7.0.14563; ORME IM, 1988, J IMMUNOL, V140, P3589; Pethe K, 2000, J BIOL CHEM, V275, P14273, DOI 10.1074/jbc.275.19.14273; PierreAudigier C, 1997, CLIN INFECT DIS, V24, P982, DOI 10.1093/clinids/24.5.982; Post FA, 2001, INFECT IMMUN, V69, P1433, DOI 10.1128/IAI.69.3.1433-1439.2001; Repique CJ, 2002, INFECT IMMUN, V70, P3318, DOI 10.1128/IAI.70.7.3318-3323.2002; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Shi CH, 2009, TUBERCULOSIS, V89, P54, DOI 10.1016/j.tube.2008.09.005; Silva CL, 2005, GENE THER, V12, P281, DOI 10.1038/sj.gt.3302418; Soares AP, 2008, J IMMUNOL, V180, P3569, DOI 10.4049/jimmunol.180.5.3569; Sweeney KA, 2011, NAT MED, V17, P1261, DOI 10.1038/nm.2420; Takayanagi K, 2011, JPN J INFECT DIS, V64, P133; Temmerman S, 2004, NAT MED, V10, P935, DOI 10.1038/nm1090; Thom M, 2008, TUBERCULOSIS, V88, P324, DOI 10.1016/j.tube.2007.12.002; van Faassen H, 2004, J IMMUNOL, V172, P3491, DOI 10.4049/jimmunol.172.6.3491; Via LE, 1998, J CELL SCI, V111, P897; Via LE, 1997, J BIOL CHEM, V272, P13326, DOI 10.1074/jbc.272.20.13326; Watford WT, 2003, CYTOKINE GROWTH F R, V14, P361, DOI 10.1016/S1359-6101(03)00043-1; Xu ZW, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-34; Yang C, 2009, INT J TUBERC LUNG D, V13, P1360; Yi ZJ, 2007, VACCINE, V25, P638, DOI 10.1016/j.vaccine.2006.08.037; Zhang H, 2010, SCAND J IMMUNOL, V72, P349, DOI 10.1111/j.1365-3083.2010.02448.x	46	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31908	10.1371/journal.pone.0031908	http://dx.doi.org/10.1371/journal.pone.0031908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363768	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700122
J	Jing, XF; Miwa, H; Sawada, T; Nakanishi, I; Kondo, T; Miyajima, M; Sakaguchi, K				Jing, Xuefeng; Miwa, Hideto; Sawada, Takahiro; Nakanishi, Ichiro; Kondo, Tomoyoshi; Miyajima, Masayasu; Sakaguchi, Kazushige			Ephrin-A1-Mediated Dopaminergic Neurogenesis and Angiogenesis in a Rat Model of Parkinson's Disease	PLOS ONE			English	Article							NEURAL STEM-CELLS; NUCLEOTIDE EXCHANGE FACTOR; FIBROBLAST-GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; ADULT MAMMALIAN BRAIN; SUBVENTRICULAR ZONE; EPHA RECEPTOR; DIVERSE REGIONS; PRECURSOR CELLS; PROLIFERATION	Cells of the neural stem cell lineage in the adult subventricular zone (SVZ) respond to brain insult by increasing their numbers and migrating through the rostral migratory stream. However, in most areas of the brain other than the SVZ and the subgranular zone of the dentate gyrus, such a regenerative response is extremely weak. Even these two neurogenic regions do not show extensive regenerative responses to repair tissue damage, suggesting the presence of an intrinsic inhibitory microenvironment (niche) for stem cells. In the present study, we assessed the effects of injection of clustered ephrin-A1-Fc into the lateral ventricle of rats with unilateral nigrostriatal dopamine depletion. Ephrin-A1-Fc clustered by anti-IgG(Fc) antibody was injected stereotaxically into the ipsilateral lateral ventricle of rats with unilateral nigrostriatal lesions induced by 6-hydroxydopamine, and histologic analysis and behavioral tests were performed. Clustered ephrin-A1-Fc transformed the subventricular niche, increasing bromodeoxyuridine-positive cells in the subventricular area, and the cells then migrated to the striatum and differentiated to dopaminergic neurons and astrocytes. In addition, clustered ephrin-A1-Fc enhanced angiogenesis in the striatum on the injected side. Along with histologic improvements, behavioral derangement improved dramatically. These findings indicate that the subventricular niche possesses a mechanism for regulating both stem cell and angiogenic responses via an EphA-mediated signal. We conclude that activation of EphA receptor-mediated signaling by clustered ephrin-A1-Fc from within the lateral ventricle could potentially be utilized in the treatment of neurodegenerative diseases such as Parkinson's disease.	[Jing, Xuefeng; Sawada, Takahiro; Sakaguchi, Kazushige] Wakayama Med Univ, Inst Adv Med, Dept Mol Cell Biol & Mol Med, Wakayama, Japan; [Miyajima, Masayasu] Wakayama Med Univ, Lab Anim Ctr, Wakayama, Japan; [Miwa, Hideto; Nakanishi, Ichiro; Kondo, Tomoyoshi] Wakayama Med Univ, Dept Neurol, Wakayama, Japan	Wakayama Medical University; Wakayama Medical University; Wakayama Medical University	Jing, XF (corresponding author), Wakayama Med Univ, Inst Adv Med, Dept Mol Cell Biol & Mol Med, Wakayama, Japan.	ksaka@wakayama-med.ac.jp			Japan Society for the Promotion of Science [19300132]; Wakayama Medical University; CNS Degenerative Disease, Ministry of Health, Labour and Welfare of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Wakayama Medical University; CNS Degenerative Disease, Ministry of Health, Labour and Welfare of Japan	This work was supported, in part, by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science [project # 19300132 to K. S.]; by a Research Grant on Priority Areas from the Wakayama Medical University [to K. S.]; and by the Research Committee of CNS Degenerative Disease, Ministry of Health, Labour and Welfare of Japan [to T. K.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla A, 2008, COLD SH Q B, V73, P357, DOI 10.1101/sqb.2008.73.019; Aoki M, 2004, J BIOL CHEM, V279, P32643, DOI 10.1074/jbc.M313247200; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Brantley-Sieders DM, 2006, CANCER RES, V66, P10315, DOI 10.1158/0008-5472.CAN-06-1560; BRIGHTMA.MW, 1965, J CELL BIOL, V26, P99, DOI 10.1083/jcb.26.1.99; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Chumley MJ, 2007, J NEUROSCI, V27, P13481, DOI 10.1523/JNEUROSCI.4158-07.2007; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Depaepe V, 2005, NATURE, V435, P1244, DOI 10.1038/nature03651; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Ford-Perriss M, 2001, CLIN EXP PHARMACOL P, V28, P493, DOI 10.1046/j.1440-1681.2001.03477.x; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Grothe C, 2007, BRAIN RES REV, V54, P80, DOI 10.1016/j.brainresrev.2006.12.001; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Holmberg J, 2005, GENE DEV, V19, P462, DOI 10.1101/gad.326905; Huynh-Do U, 1999, EMBO J, V18, P2165, DOI 10.1093/emboj/18.8.2165; Ii M, 2009, CIRC RES, V105, P860, DOI 10.1161/CIRCRESAHA.109.199299; Jiao JW, 2008, P NATL ACAD SCI USA, V105, P8778, DOI 10.1073/pnas.0708861105; Katakowski M, 2005, NEUROSCI LETT, V385, P204, DOI 10.1016/j.neulet.2005.05.060; Khodosevich K, 2011, J CELL SCI, V124, P1268, DOI 10.1242/jcs.076059; Kim EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018472; Kueh HY, 2009, SCIENCE, V325, P960, DOI 10.1126/science.1168823; Larson J, 2008, AM J PHYSIOL-LUNG C, V295, pL431, DOI 10.1152/ajplung.90256.2008; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Liu BF, 2006, BRAIN RES, V1106, P30, DOI 10.1016/j.brainres.2006.05.111; LO LC, 1991, GENE DEV, V5, P1524, DOI 10.1101/gad.5.9.1524; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Ma DK, 2005, CURR OPIN NEUROBIOL, V15, P514, DOI 10.1016/j.conb.2005.08.003; Marinova-Mutafchieva L, 2009, J NEUROCHEM, V110, P966, DOI 10.1111/j.1471-4159.2009.06189.x; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Mudo G, 2009, J NEURAL TRANSM, V116, P995, DOI 10.1007/s00702-009-0207-z; Palmer TD, 1999, J NEUROSCI, V19, P8487; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Qiu RX, 2008, J CELL BIOL, V181, P973, DOI 10.1083/jcb.200708091; Ramirez-Castillejo C, 2006, NAT NEUROSCI, V9, P331, DOI 10.1038/nn1657; Ricard J, 2006, MOL CELL NEUROSCI, V31, P713, DOI 10.1016/j.mcn.2006.01.002; Sawada T, 2010, GENES CELLS, V15, P297, DOI 10.1111/j.1365-2443.2010.01391.x; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Stevens B, 2008, NEUROSIGNALS, V16, P278, DOI 10.1159/000123038; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Theus MH, 2010, STEM CELLS, V28, P1231, DOI 10.1002/stem.449; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P69; Vindis C, 2003, J CELL BIOL, V162, P661, DOI 10.1083/jcb.200302073; Walker AS, 2010, NEURAL PLAST, V2010, DOI 10.1155/2010/894374; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Yokote H, 2005, P NATL ACAD SCI USA, V102, P18866, DOI 10.1073/pnas.0509741102; Zhang Y, 2007, J BIOL CHEM, V282, P31103, DOI 10.1074/jbc.M704430200; Zou JX, 1999, P NATL ACAD SCI USA, V96, P13813, DOI 10.1073/pnas.96.24.13813	57	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e32019	10.1371/journal.pone.0032019	http://dx.doi.org/10.1371/journal.pone.0032019			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363788	Green Submitted, Green Published, gold			2022-12-27	WOS:000302871500105
J	Temu, EA; Coleman, M; Abilio, AP; Kleinschmidt, I				Temu, Emmanuel A.; Coleman, Mike; Abilio, Ana Paula; Kleinschmidt, Immo			High Prevalence of Malaria in Zambezia, Mozambique: The Protective Effect of IRS versus Increased Risks Due to Pig-Keeping and House Construction	PLOS ONE			English	Article							MOSQUITO NET COVERAGE; PLASMODIUM-FALCIPARUM; ANOPHELES-ARABIENSIS; CHILDREN; AFRICA; VECTOR; ZOOPROPHYLAXIS; INTERVENTIONS; MORBIDITY; FUNESTUS	Background: African countries are scaling up malaria interventions, especially insecticide treated nets (ITN) and indoor residual spraying (IRS), for which ambitious coverage targets have been set. In spite of these efforts infection prevalence remains high in many parts of the continent. This study investigated risk factors for malaria infection in children using three malaria indicator surveys from Zambezia province, Mozambique. The impact of IRS and ITNs, the effects of keeping farm animals and of the construction material of roofs of houses and other potential risk factors associated with malaria infection in children were assessed. Methods: Cross-sectional community-based surveys were conducted in October of 2006, 2007 and 2008. A total of 8338 children (ages 1-15 years) from 2748 households were included in the study. All children were screened for malaria by rapid diagnostic tests. Caregiver interviews were used to assess household demographic and wealth characteristics and ITN and IRS coverage. Associations between malaria infection, vector control interventions and potential risk factors were assessed. Results: Overall, the prevalence of malaria infection was 47.8% (95% CI: 38.7%-57.1%) in children 1-15 years of age, less than a quarter of children (23.1%, 95% CI: 19.1%-27.6%) were sleeping under ITN and almost two thirds were living in IRS treated houses (coverage 65.4%, 95% CI: 51.5%-77.0%). Protective factors that were independently associated with malaria infection were: sleeping in an IRS house without sleeping under ITN (Odds Ratio (OR) = 0.6; 95% CI: 0.4-0.9); additional protection due to sleeping under ITN in an IRS treated house (OR = 0.5; 95% CI: 0.3-0.7) versus sleeping in an unsprayed house without a ITN; and parental education (primary/secondary: OR = 0.6; 95% CI: 0.5-0.7) versus parents with no education. Increased risk of infection was associated with: current fever (OR = 1.2; 95% CI: 1.0-1.5) versus no fever; pig keeping (OR = 3.2; 95% CI: 2.1-4.9) versus not keeping pigs; living in houses with a grass roof (OR = 1.7; 95% CI: 1.3-2.4) versus other roofing materials and bigger household size (8-15 people: OR = 1.6; 95% CI: 1.3-2.1) versus small households (1-4 persons). Conclusion: Malaria infection among children under 15 years of age in Zambezia remained high but conventional malaria vector control methods, in particular IRS, provided effective means of protection. Household ownership of farm animals, particularly pigs, and living in houses with a grass roof were independently associated with increased risk of infection, even after allowing for household wealth. To reduce the burden of malaria, national control programs need to ensure high coverage of effective IRS and promote the use of ITNs, particularly in households with elevated risks of infection, such as those keeping farm animals, and those with grass roofs.	[Temu, Emmanuel A.; Kleinschmidt, Immo] London Sch Hyg & Trop Med, Trop Epidemiol Grp, London WC1, England; [Coleman, Mike] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Abilio, Ana Paula] Natl Inst Hlth, Maputo, Mozambique	University of London; London School of Hygiene & Tropical Medicine; Liverpool School of Tropical Medicine; University of Liverpool	Temu, EA (corresponding author), London Sch Hyg & Trop Med, Trop Epidemiol Grp, London WC1, England.	mcoleman@liverpool.ac.uk		Coleman, Michael/0000-0003-4186-3526; Temu, Emmanuel/0000-0003-4234-2175; Abilio, Ana Paula/0000-0003-3652-1329	Innovative Vector Control Consortium; Medical Research Council [G0700837] Funding Source: researchfish; MRC [G0700837] Funding Source: UKRI	Innovative Vector Control Consortium; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Innovative Vector Control Consortium. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abilio AP, 2011, MALAR J; [Anonymous], 2004, COCHRANE DB SYST REV; Atieli H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-108; Baragatti M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-13; Bogh C, 2002, T ROY SOC TROP MED H, V96, P593, DOI 10.1016/S0035-9203(02)90320-2; Bouyou-Akotet MK, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-166; Bradbury K, 2005, COMMUNITY BASED SOLU, V289746; Brooke BD, 2001, B ENTOMOL RES, V91, P265, DOI 10.1079/BER2001108; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; Casimiro SLR, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-142; Costantini C, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P209; Ghebreyesus TA, 2000, T ROY SOC TROP MED H, V94, P17, DOI 10.1016/S0035-9203(00)90424-3; Gillies T., 1987, SUPPLEMENT ANOPHELES; Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003; Instituto-Nacional-de-Estatistica, 2008, TOT POP PROV 2006 AV; Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0; Kleinschmidt I, 2009, AM J TROP MED HYG, V81, P519, DOI 10.4269/ajtmh.2009.81.519; Korenromp EL, 2003, TROP MED INT HEALTH, V8, P693, DOI 10.1046/j.1365-3156.2003.01084.x; Lee PW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-26; Lindsay SW, 2003, TROP MED INT HEALTH, V8, P512, DOI 10.1046/j.1365-3156.2003.01059.x; Mabunda S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-74; Mahande A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-100; Mahande AM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-109; Muller O, 2003, TROP MED INT HEALTH, V8, P853, DOI 10.1046/j.1365-3156.2003.01119.x; Muriu SM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-43; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; Nicastri E, 2009, AM J TROP MED HYG, V80, P712, DOI 10.4269/ajtmh.2009.80.712; Noor AM, 2009, LANCET, V373, P58, DOI 10.1016/S0140-6736(08)61596-2; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; PMI, 2010, PRES MAL IN OP PLAN; Rehman AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019205; Sharp BL, 2007, AM J TROP MED HYG, V76, P42, DOI 10.4269/ajtmh.2007.76.42; Simooya O, 2005, DRUG SAFETY, V28, P277, DOI 10.2165/00002018-200528040-00001; Sintasath DM, 2005, AM J TROP MED HYG, V72, P682, DOI 10.4269/ajtmh.2005.72.682; Smith T, 1998, AM J TROP MED HYG, V59, P252, DOI 10.4269/ajtmh.1998.59.252; UNPP, 2010, WORLD POP PROSP POP; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2005, MAL IND SURV BAS DOC; WHO UNICEF DHS M Evaluation M CDC, 2005, ROLL BACK MAL GUID C; Worrall E, 2005, TROP MED INT HEALTH, V10, P1047, DOI 10.1111/j.1365-3156.2005.01476.x	41	32	32	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31409	10.1371/journal.pone.0031409	http://dx.doi.org/10.1371/journal.pone.0031409			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363640	Green Accepted, Green Published, gold			2022-12-27	WOS:000302871500040
J	Yin, HF; Copley, CO; Goodrich, LV; Deans, MR				Yin, Haifeng; Copley, Catherine O.; Goodrich, Lisa V.; Deans, Michael R.			Comparison of Phenotypes between Different vangl2 Mutants Demonstrates Dominant Effects of the Looptail Mutation during Hair Cell Development	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; PLANAR POLARITY; INNER-EAR; ENDOPLASMIC-RETICULUM; MOUSE; LOCALIZATION; VERTEBRATES; DROSOPHILA; TAIL; STRABISMUS	Experiments utilizing the Looptail mutant mouse, which harbors a missense mutation in the vangl2 gene, have been essential for studies of planar polarity and linking the function of the core planar cell polarity proteins to other developmental signals. Originally described as having dominant phenotypic traits, the molecular interactions underlying the Looptail mutant phenotype are unclear because Vangl2 protein levels are significantly reduced or absent from mutant tissues. Here we introduce a vangl2 knockout mouse and directly compare the severity of the knockout and Looptail mutant phenotypes by intercrossing the two lines and assaying the planar polarity of inner ear hair cells. Overall the vangl2 knockout phenotype is milder than the phenotype of compound mutants carrying both the Looptail and vangl2 knockout alleles. In compound mutants a greater number of hair cells are affected and changes in the orientation of individual hair cells are greater when quantified. We further demonstrate in a heterologous cell system that the protein encoded by the Looptail mutation (Vangl2(S464N)) disrupts delivery of Vangl1 and Vangl2 proteins to the cell surface as a result of oligomer formation between Vangl1 and Vangl2(S464N), or Vangl2 and Vangl2(S464N), coupled to the intracellular retention of Vangl2(S464N). As a result, Vangl1 protein is missing from the apical cell surface of vestibular hair cells in Looptail mutants, but is retained at the apical cell surface of hair cells in vangl2 knockouts. Similarly the distribution of Prickle-like2, a putative Vangl2 interacting protein, is differentially affected in the two mutant lines. In summary, we provide evidence for a direct physical interaction between Vangl1 and Vangl2 through a combination of in vitro and in vivo approaches and propose that this interaction underlies the dominant phenotypic traits associated with the Looptail mutation.	[Yin, Haifeng; Copley, Catherine O.; Deans, Michael R.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Ctr Hearing & Balance, Baltimore, MD 21205 USA; [Yin, Haifeng; Copley, Catherine O.; Deans, Michael R.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Ctr Hearing & Balance, Baltimore, MD 21205 USA; [Yin, Haifeng; Copley, Catherine O.; Deans, Michael R.] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Baltimore, MD 21205 USA; [Goodrich, Lisa V.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Harvard University; Harvard Medical School	Yin, HF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Ctr Hearing & Balance, Baltimore, MD 21205 USA.	mdeans4@jhmi.edu	Yin, Haifeng/E-8787-2012		Deafness Research Foundation; National Organization of Hearing Research; National Institute of Neurological Disorders and Stroke (NINDS) [T32 NS07484]; National Institute on Deafness and other Communication Disorders (NIDCD) [R03 DC009490, P30 DC005211, R01 DC007195]; March of Dimes; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005211, R01DC007195, R03DC009490] Funding Source: NIH RePORTER	Deafness Research Foundation; National Organization of Hearing Research; National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Deafness and other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); March of Dimes(March of Dimes); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	MRD was funded by the Deafness Research Foundation, the National Organization of Hearing Research, National Institute of Neurological Disorders and Stroke (NINDS) T32 NS07484, and National Institute on Deafness and other Communication Disorders (NIDCD) R03 DC009490 and NIDCD P30 DC005211. LVG was funded by a Basil O' Connor Starter Scholar Award from the March of Dimes and NIDCD R01 DC007195. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Bellaiche Y, 2004, DEVELOPMENT, V131, P469, DOI 10.1242/dev.00928; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Dabdoub A, 2003, DEVELOPMENT, V130, P2375, DOI 10.1242/dev.00448; Deans MR, 2007, J NEUROSCI, V27, P3139, DOI 10.1523/JNEUROSCI.5151-06.2007; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Gao B, DEV CELL, V20, P163; Goodrich LV, DEVELOPMENT, V138, P1877; Guyot MC, DEV DYN, V240, P839; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; Jones C, 2008, NAT GENET, V40, P69, DOI 10.1038/ng.2007.54; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Kibar Z, 2001, GENOMICS, V72, P331, DOI 10.1006/geno.2000.6493; Kibar Z, CLIN GENET, V80, P76; Kibar Z, 2009, HUM MUTAT, V30, pE706, DOI 10.1002/humu.21026; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; McNeill H, COLD SPRING HARB PER, V2; Merte J, NAT CELL BIOL S, V12, p[41, 41]; Miranda KC, 2001, J BIOL CHEM, V276, P22565, DOI 10.1074/jbc.M101907200; Mlodzik M, 1999, EMBO J, V18, P6873, DOI 10.1093/emboj/18.24.6873; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Montcouquiol M, 2006, J NEUROSCI, V26, P5265, DOI 10.1523/JNEUROSCI.4680-05.2006; Murdoch JN, 2001, HUM MOL GENET, V10, P2593, DOI 10.1093/hmg/10.22.2593; Murdoch JN, 2001, GENOMICS, V78, P55, DOI 10.1006/geno.2001.6638; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shafer B, DEV CELL, V20, P177; Simmons DD, J COMP NEUROL, V518, P3785; Song H, NATURE, V466, P378; Strong LC, 1949, J HERED, V40, P5; Torban E, 2004, TRENDS GENET, V20, P570, DOI 10.1016/j.tig.2004.09.003; Torban E, 2008, P NATL ACAD SCI USA, V105, P3449, DOI 10.1073/pnas.0712126105; Torban E, 2007, GENE EXPR PATTERNS, V7, P346, DOI 10.1016/j.modgep.2006.07.007; Tree DRP, 2002, CELL, V109, P371, DOI 10.1016/S0092-8674(02)00715-8; Vandenberg AL, 2009, DEVELOPMENT, V136, P1559, DOI 10.1242/dev.034066; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Wansleeben C, DEVELOPMENT, V137, P1067; Warchol ME, 2007, J COMP NEUROL, V500, P646, DOI 10.1002/cne.21153; Yoshida N, 1999, HEARING RES, V131, P29, DOI 10.1016/S0378-5955(99)00008-8	44	75	78	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31988	10.1371/journal.pone.0031988	http://dx.doi.org/10.1371/journal.pone.0031988			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363783	gold, Green Published, Green Submitted			2022-12-27	WOS:000302871500103
J	Zhang, G; Schetter, A; He, PJ; Funamizu, N; Gaedcke, J; Ghadimi, BM; Ried, T; Hassan, R; Yfantis, HG; Lee, DH; Lacy, C; Maitra, A; Hanna, N; Alexander, HR; Hussain, SP				Zhang, Geng; Schetter, Aaron; He, Peijun; Funamizu, Naotake; Gaedcke, Jochen; Ghadimi, B. Michael; Ried, Thomas; Hassan, Raffit; Yfantis, Harris G.; Lee, Dong H.; Lacy, Curtis; Maitra, Anirban; Hanna, Nader; Alexander, H. Richard; Hussain, S. Perwez			DPEP1 Inhibits Tumor Cell Invasiveness, Enhances Chemosensitivity and Predicts Clinical Outcome in Pancreatic Ductal Adenocarcinoma	PLOS ONE			English	Article							COPY-NUMBER; CANCER; EXPRESSION; GEMCITABINE; MARKERS	Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers worldwide. To identify biologically relevant genes with prognostic and therapeutic significance in PDAC, we first performed the microarray gene-expression profiling in 45 matching pairs of tumor and adjacent non-tumor tissues from resected PDAC cases. We identified 36 genes that were associated with patient outcome and also differentially expressed in tumors as compared with adjacent non-tumor tissues in microarray analysis. Further evaluation in an independent validation cohort (N=27) confirmed that DPEP1 (dipeptidase 1) expression was decreased (T: N ratio similar to 0.1, P < 0.01) in tumors as compared with non-tumor tissues. DPEP1 gene expression was negatively correlated with histological grade (Spearman correlation coefficient = -0.35, P=0.004). Lower expression of DPEP1 in tumors was associated with poor survival (Kaplan Meier log rank) in both test cohort (P=0.035) and validation cohort (P=0.016). DPEP1 expression was independently associated with cancer-specific mortality when adjusted for tumor stage and resection margin status in both univariate (hazard ratio=0.43, 95%CI=0.24-0.76, P=0.004) and multivariate analyses (hazard ratio=0.51, 95%CI=0.27-0.94, P=0.032). We further demonstrated that overexpression of DPEP1 suppressed tumor cells invasiveness and increased sensitivity to chemotherapeutic agent Gemcitabine. Our data also showed that growth factor EGF treatment decreased DPEP1 expression and MEK1/2 inhibitor AZD6244 increased DPEP1 expression in vitro, indicating a potential mechanism for DPEP1 gene regulation. Therefore, we provide evidence that DPEP1 plays a role in pancreatic cancer aggressiveness and predicts outcome in patients with resected PDAC. In view of these findings, we propose that DPEP1 may be a candidate target in PDAC for designing improved treatments.	[Zhang, Geng; Schetter, Aaron; He, Peijun; Funamizu, Naotake; Lacy, Curtis; Hussain, S. Perwez] NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Gaedcke, Jochen; Ghadimi, B. Michael] Univ Med, Dept Gen & Visceral Surg, Gottingen, Germany; [Ried, Thomas] NCI, Genet Branch, NIH, Bethesda, MD 20892 USA; [Hassan, Raffit] NCI, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Yfantis, Harris G.; Lee, Dong H.] Baltimore Vet Affairs Med Ctr, Baltimore, MD USA; [Maitra, Anirban] Johns Hopkins Univ, Sch Med, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD USA; [Hanna, Nader; Alexander, H. Richard] Univ Maryland, Dept Surg, Div Surg Oncol, Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Hanna, Nader; Alexander, H. Richard] Univ Maryland, Sch Med, Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Zhang, G (corresponding author), NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	hussainp@mail.nih.gov		Hussain, S. Perwez/0000-0002-2294-522X	National Cancer Institute, Center for Cancer Research, National Institutes of Health (NIH); NATIONAL CANCER INSTITUTE [ZIABC010816, ZIABC010833, ZIABC011162] Funding Source: NIH RePORTER	National Cancer Institute, Center for Cancer Research, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Cancer Institute, Center for Cancer Research, National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen LA, 2000, PATHOLOGY GENETICS T; AUSTRUY E, 1993, CANCER RES, V53, P2888; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Campagna D, 2008, INT J CLIN EXP PATHO, V1, P32; Collisson EA, 2011, NAT MED; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Fukushige S, 1997, GENE CHROMOSOME CANC, V19, P161, DOI 10.1002/(SICI)1098-2264(199707)19:3<161::AID-GCC5>3.0.CO;2-W; Garcea G, 2005, EUR J CANCER, V41, P2213, DOI 10.1016/j.ejca.2005.04.044; Giehl K, 2000, ONCOGENE, V19, P2930, DOI 10.1038/sj.onc.1203612; Goggins M, 2007, SEMIN ONCOL, V34, P303, DOI 10.1053/j.seminoncol.2007.05.003; Green AR, 2009, BREAST CANCER RES TR, V113, P59, DOI 10.1007/s10549-008-9905-8; Grutzmann R, 2005, ONCOGENE, V24, P5079, DOI 10.1038/sj.onc.1208696; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kim HN, 2007, PANCREAS, V34, P325, DOI 10.1097/MPA.0b013e3180317b01; Kim MP, 2008, CLIN CANCER RES, V14, P1284, DOI 10.1158/1078-0432.CCR-07-2247; Klaunig JE, 1998, ENVIRON HEALTH PERSP, V106, P289, DOI 10.2307/3433929; Kolbert CP, 2008, TECHNOL CANCER RES T, V7, P55, DOI 10.1177/153303460800700107; Lopez-Casas PP, 2010, EXPERT REV MOL DIAGN, V10, P591, DOI 10.1586/ERM.10.43; Mahalingam D, 2009, EXPERT OPIN EMERG DR, V14, P311, DOI 10.1517/14728210902972502; McIver CM, 2004, CANCER LETT, V209, P67, DOI 10.1016/j.canlet.2003.11.033; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Okamoto T, 2011, MODERN PATHOL, V24, P267, DOI 10.1038/modpathol.2010.204; Stratford JK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000307; Toiyama Y, 2011, J GASTROENTEROL, V46, P153, DOI 10.1007/s00535-010-0318-1; Warner SL, 2009, CLIN CANCER RES, V15, P6519, DOI 10.1158/1078-0432.CCR-09-0077; Yeh JJ, 2009, FUTURE ONCOL, V5, P313, DOI [10.2217/fon.09.12, 10.2217/FON.09.12]	26	131	136	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31507	10.1371/journal.pone.0031507	http://dx.doi.org/10.1371/journal.pone.0031507			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363658	Green Published, Green Submitted, gold			2022-12-27	WOS:000302871500049
J	Hasler, R; Jacobs, G; Till, A; Grabe, N; Cordes, C; Nikolaus, S; Lao, KQ; Schreiber, S; Rosenstiel, P				Haesler, Robert; Jacobs, Gunnar; Till, Andreas; Grabe, Nils; Cordes, Christian; Nikolaus, Susanna; Lao, Kaiqin; Schreiber, Stefan; Rosenstiel, Philip			Microbial Pattern Recognition Causes Distinct Functional Micro-RNA Signatures in Primary Human Monocytes	PLOS ONE			English	Article							GENE-EXPRESSION; IN-VIVO; METASTASIS; THOUSANDS; MIRBASE; PCR	Micro-RNAs (miRNAs) are short, non-coding RNAs that regulate gene expression post transcriptionally. Several studies have demonstrated the relevance of miRNAs for a wide range of cellular mechanisms, however, the current knowledge on how miRNAs respond to relevant external stimuli, e. g. in disease scenarios is very limited. To generate a descriptive picture of the miRNA network associated to inflammatory responses, we quantified the levels of 330 miRNAs upon stimulation with a panel of pro-inflammatory components such as microbial pattern molecules (flagellin, diacylated lipopeptide lipopolysaccharide, muramyl dipeptide), infection with Listeria monocytogenes and TNF-alpha as pro-inflammatory control in primary human monocytes using real time PCR. As a result, we found distinct miRNA response clusters for each stimulus used. Additionally, we identified potential target genes of three selected miRNAs miR-129-5p, miR-146a and miR-378 which were part of PAMP-specific response clusters by transfecting THP1 monocytes with the corresponding pre- or anti-miRNAs and microfluidic PCR arrays. The miRNAs induced distinct transcriptomal signatures, e. g. overexpression of miRNA129-5p, which was selectively upregulated by the NOD2-elicitor MDP, led to an upregulation of DEFB1, IRAK1, FBXW7 and IKK gamma (Nemo). Our findings on highly co-regulated clusters of miRNAs support the hypothesis that miRNAs act in functional groups. This study indicates that miRNAs play an important role in fine-tuning inflammatory mechanisms. Further investigation in the field of miRNA responses will help to understand their effects on gene expression and may close the regulatory gap between mRNA and protein expression in inflammatory diseases.	[Haesler, Robert; Jacobs, Gunnar; Till, Andreas; Grabe, Nils; Schreiber, Stefan; Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, Kiel, Schleswig Holst, Germany; [Cordes, Christian; Schreiber, Stefan] Univ Hosp Schleswig Holstein, Dept Otorhinolaryngol Head & Neck, Kiel, Schleswig Holst, Germany; [Nikolaus, Susanna] Univ Hosp Schleswig Holstein, Dept Med 1, Kiel, Schleswig Holst, Germany; [Lao, Kaiqin] Appl Biosyst Inc, Foster City, CA USA	University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Thermo Fisher Scientific; Applied Biosystems	Hasler, R (corresponding author), Univ Kiel, Inst Clin Mol Biol, Kiel, Schleswig Holst, Germany.	p.rosenstiel@mucosa.de	Xie, Huangming/B-2260-2012; Häsler, Robert/A-4908-2009; Till, Andreas/E-9661-2013; Till, Andreas/AAO-6375-2021; Rosenstiel, Philip/A-5137-2009	Häsler, Robert/0000-0003-4174-8229; Till, Andreas/0000-0002-0139-9143; Rosenstiel, Philip/0000-0002-9692-8828	Excellence Cluster "Inflammation at Interfaces'' (Bundesministerium fur Forschung und Bildung); Deutsche Forschungsgemeinschaft [SFB 415]	Excellence Cluster "Inflammation at Interfaces'' (Bundesministerium fur Forschung und Bildung)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Excellence Cluster "Inflammation at Interfaces'' (Bundesministerium fur Forschung und Bildung, www.bmbf.de) and by the SFB 415 "Specificity and Pathophysiology of Pathways'' (Deutsche Forschungsgemeinschaft, www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Curtale G, 2010, BLOOD, V115, P265, DOI 10.1182/blood-2009-06-225987; Dyrskjot L, 2009, CANCER RES, V69, P4851, DOI 10.1158/0008-5472.CAN-08-4043; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Huang ZM, 2009, J DIGEST DIS, V10, P188, DOI 10.1111/j.1751-2980.2009.00384.x; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jurkin J, 2010, J IMMUNOL; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Nahid MA, 2009, J BIOL CHEM; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Saunders MA, 2009, RNA BIOL, V6, P324, DOI 10.4161/rna.6.3.8871; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Suarez Y, 2010, J IMMUNOL, V184, P21, DOI 10.4049/jimmunol.0902369; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Till A, 2008, J CELL SCI, V121, P487, DOI 10.1242/jcs.016980; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Waetzig GH, 2002, J IMMUNOL, V168, P5342, DOI 10.4049/jimmunol.168.10.5342; Waldman SA, 2009, FEBS J, V276, P2157, DOI 10.1111/j.1742-4658.2009.06934.x; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Westfall PH, 1993, RESAMPLING BASED MUL, V1; Williams AE, 2008, BIOCHEM SOC T, V36, P1211, DOI 10.1042/BST0361211; Worm J, 2009, NUCLEIC ACIDS RES, V37, P5784, DOI 10.1093/nar/gkp577; Xie HM, 2009, EXPERT OPIN THER TAR, V13, P1227, DOI 10.1517/14728220903190707	42	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31151	10.1371/journal.pone.0031151	http://dx.doi.org/10.1371/journal.pone.0031151			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363568	Green Submitted, Green Published, gold			2022-12-27	WOS:000302853600117
J	Kos, A; Loohuis, NFMO; Wieczorek, ML; Glennon, JC; Martens, GJM; Kolk, SM; Aschrafi, A				Kos, Aron; Loohuis, Nikkie F. M. Olde; Wieczorek, Martha L.; Glennon, Jeffrey C.; Martens, Gerard J. M.; Kolk, Sharon M.; Aschrafi, Armaz			A Potential Regulatory Role for Intronic microRNA-338-3p for Its Host Gene Encoding Apoptosis-Associated Tyrosine Kinase	PLOS ONE			English	Article							EXPRESSION PROFILES; SYMPATHETIC NEURONS; AATYK; IDENTIFICATION; TARGETS; DIFFERENTIATION; TRANSLATION; AXONS	MicroRNAs (miRNAs) are important gene regulators that are abundantly expressed in both the developing and adult mammalian brain. These non-coding gene transcripts are involved in post-transcriptional regulatory processes by binding to specific target mRNAs. Approximately one third of known miRNA genes are located within intronic regions of protein coding and non-coding regions, and previous studies have suggested a role for intronic miRNAs as negative feedback regulators of their host genes. In the present study, we monitored the dynamic gene expression changes of the intronic miR-338-3p and miR-338-5p and their host gene Apoptosis-associated Tyrosine Kinase (AATK) during the maturation of rat hippocampal neurons. This revealed an uncorrelated expression pattern of mature miR-338 strands with their host gene. Sequence analysis of the 3' untranslated region (UTR) of rat AATK mRNA revealed the presence of two putative binding sites for miR-338-3p. Thus, miR-338-3p may have the capacity to modulate AATK mRNA levels in neurons. Transfection of miR338-3p mimics into rat B35 neuroblastoma cells resulted in a significant decrease of AATK mRNA levels, while the transfection of synthetic miR-338-5p mimics did not alter AATK levels. Our results point to a possible molecular mechanism by which miR-338-3p participates in the regulation of its host gene by modulating the levels of AATK mRNA, a kinase which plays a role during differentiation, apoptosis and possibly in neuronal degeneration.	[Kos, Aron; Loohuis, Nikkie F. M. Olde; Wieczorek, Martha L.; Glennon, Jeffrey C.; Aschrafi, Armaz] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, NL-6525 ED Nijmegen, Netherlands; [Martens, Gerard J. M.; Kolk, Sharon M.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Mol Anim Physiol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Kos, A (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, NL-6525 ED Nijmegen, Netherlands.	A.aschrafi@cns.umcn.nl	Kolk, Sharon M/A-9055-2011; Glennon, Jeffrey C/D-2379-2013; Glennon, Jeffrey/AAK-8394-2020; Aschrafi, Armaz/E-2202-2012; Martens, Gerard JM/D-1925-2010	Kolk, Sharon M/0000-0003-2116-5456; Glennon, Jeffrey C/0000-0002-2371-0422; Glennon, Jeffrey/0000-0002-2371-0422; Aschrafi, Armaz/0000-0003-4089-0960	Radboud University Nijmegen Medical Centre; FP7-Marie Curie International Reintegration	Radboud University Nijmegen Medical Centre; FP7-Marie Curie International Reintegration	This work was supported by a Donders Center for Neuroscience fellowship award of the Radboud University Nijmegen Medical Centre and a grant from FP7-Marie Curie International Reintegration to AA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aschrafi A, 2010, MOL CELL NEUROSCI, V43, P422, DOI 10.1016/j.mcn.2010.01.009; Aschrafi A, 2008, J NEUROSCI, V28, P12581, DOI 10.1523/JNEUROSCI.3338-08.2008; Barik S, 2008, NUCLEIC ACIDS RES, V36, P5232, DOI 10.1093/nar/gkn513; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; Fiore R, 2008, BBA-GENE REGUL MECH, V1779, P471, DOI 10.1016/j.bbagrm.2007.12.006; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gaozza E, 1997, ONCOGENE, V15, P3127, DOI 10.1038/sj.onc.1201575; Gennarino VA, 2009, GENOME RES, V19, P481, DOI 10.1101/gr.084129.108; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hughes JP, 2010, NEUROCHEM RES, V35, P588, DOI 10.1007/s11064-009-0103-9; Ivanovska I, 2008, CELL CYCLE, V7, P3137, DOI 10.4161/cc.7.20.6923; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lutter D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-224; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Natera-Naranjo O, 2010, RNA, V16, P1516, DOI 10.1261/rna.1833310; Olde Loohuis NF, 2011, CELL MOL LIFE SCI; Raghunath M, 2000, MOL BRAIN RES, V77, P151, DOI 10.1016/S0169-328X(00)00048-6; Ragusa M, 2010, J MOL MED, V88, P1041, DOI 10.1007/s00109-010-0643-0; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Smart F, 2007, J NEUROCHEM, V101, P1367, DOI 10.1111/j.1471-4159.2007.04521.x; Tomomura M, 2003, MOL BRAIN RES, V112, P103, DOI 10.1016/S0169-328X(03)00054-8; Tomomura M, 2001, ONCOGENE, V20, P1022, DOI 10.1038/sj.onc.1204210; Wang YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-218; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Willemsen MH, 2011, J MED GENET, V48, P810, DOI 10.1136/jmedgenet-2011-100294; Wu HQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007566; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018; Zhu YL, 2009, SCHIZOPHR RES, V109, P86, DOI 10.1016/j.schres.2009.01.022	37	61	68	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31022	10.1371/journal.pone.0031022	http://dx.doi.org/10.1371/journal.pone.0031022			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363537	gold, Green Published, Green Submitted			2022-12-27	WOS:000302853600098
J	Liu, K; Guo, YH; Liu, HP; Bian, CB; Lam, R; Liu, YS; Mackenzie, F; Rojas, LA; Reinberg, D; Bedford, MT; Xu, RM; Min, JR				Liu, Ke; Guo, Yahong; Liu, Haiping; Bian, Chuanbing; Lam, Robert; Liu, Yongsong; Mackenzie, Farrell; Rojas, Luis Alejandro; Reinberg, Danny; Bedford, Mark T.; Xu, Rui-Ming; Min, Jinrong			Crystal Structure of TDRD3 and Methyl-Arginine Binding Characterization of TDRD3, SMN and SPF30	PLOS ONE			English	Article							TUDOR DOMAIN; HISTONE H3; X-RAY; ROYAL FAMILY; PROTEIN; RECOGNITION; COMPLEX; SITE; REFINEMENT; PRODUCT	SMN (Survival motor neuron protein) was characterized as a dimethyl-arginine binding protein over ten years ago. TDRD3 (Tudor domain-containing protein 3) and SPF30 (Splicing factor 30 kDa) were found to bind to various methyl-arginine proteins including Sm proteins as well later on. Recently, TDRD3 was shown to be a transcriptional coactivator, and its transcriptional activity is dependent on its ability to bind arginine-methylated histone marks. In this study, we systematically characterized the binding specificity and affinity of the Tudor domains of these three proteins quantitatively. Our results show that TDRD3 preferentially recognizes asymmetrical dimethylated arginine mark, and SMN is a very promiscuous effector molecule, which recognizes different arginine containing sequence motifs and preferentially binds symmetrical dimethylated arginine. SPF30 is the weakest methyl-arginine binder, which only binds the GAR motif sequences in our library. In addition, we also reported high-resolution crystal structures of the Tudor domain of TDRD3 in complex with two small molecules, which occupy the aromatic cage of TDRD3.	[Liu, Ke; Min, Jinrong] Huazhong Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China; [Liu, Ke; Guo, Yahong; Bian, Chuanbing; Lam, Robert; Liu, Yongsong; Mackenzie, Farrell; Min, Jinrong] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Liu, Haiping; Xu, Rui-Ming] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Rojas, Luis Alejandro; Reinberg, Danny] NYU, Sch Med, Dept Biochem, Howard Hughes Med Inst, New York, NY 10016 USA; [Bedford, Mark T.] Univ Texas MD Anderson Canc Ctr, Div Sci Pk Res, Smithville, TX USA; [Min, Jinrong] Univ Toronto, Dept Physiol, Toronto, ON, Canada	Central China Normal University; University of Toronto; Structural Genomics Consortium; Chinese Academy of Sciences; Institute of Biophysics, CAS; Howard Hughes Medical Institute; New York University; University of Texas System; UTMD Anderson Cancer Center; University of Toronto	Liu, K (corresponding author), Huazhong Normal Univ, Coll Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China.	rmxu@sun5.ibp.ac.cn; jr.min@utoronto.ca	xu, rui/GRX-5734-2022; Min, Jinrong/G-3449-2011	Min, Jinrong/0000-0001-5210-3130; , KE/0000-0002-7082-262X; Rojas, Luis Alejandro/0000-0001-6445-1562; Reinberg, Danny/0000-0003-4288-2016	Structural Genomics Consortium [1097737]; Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institute; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; CCNU; National Institutes of Health [DK62248]; National Institute of Environmental Health Sciences [ES07784]; Natural Science Foundation of China [90919029, 3098801]; National Basic Research Program of China [2009CB825501, 2010CB944903]; Novo Nordisk-Chinese Academy of Sciences Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062248, R01DK062248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER	Structural Genomics Consortium(University of Toronto); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institute(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); CCNU; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Novo Nordisk-Chinese Academy of Sciences Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Structural Genomics Consortium, a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institute, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. KL is supported by a CCNU scholarship. MB is supported by National Institutes of Health grant number DK62248 and, in part, by institutional grant National Institute of Environmental Health Sciences ES07784. R-MX acknowledges the support from the Natural Science Foundation of China (grants 90919029 & 3098801), the National Basic Research Program of China (grants 2009CB825501 & 2010CB944903), and the Novo Nordisk-Chinese Academy of Sciences Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Cioaba MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013559; Adams-Cioaba MA, 2009, BIOCHEM CELL BIOL, V87, P93, DOI 10.1139/O08-129; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Bian CB, 2011, EMBO J, V30, P2829, DOI 10.1038/emboj.2011.193; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Cote J, 2005, J BIOL CHEM, V280, P28476, DOI 10.1074/jbc.M414328200; Dauter Z, 2002, ACTA CRYSTALLOGR D, V58, P494, DOI 10.1107/S090744490200118X; Di Lorenzo A, 2011, FEBS LETT, V585, P2024, DOI 10.1016/j.febslet.2010.11.010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eryilmaz J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007274; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Gonsalvez GB, 2007, J CELL BIOL, V178, P733, DOI 10.1083/jcb.200702147; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Guo Y, 2009, NUCL ACIDS RES; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Iberg AN, 2008, J BIOL CHEM, V283, P3006, DOI 10.1074/jbc.C700192200; Kirmizis A, 2007, NATURE, V449, P928, DOI 10.1038/nature06160; Lebedev AA, 2008, ACTA CRYSTALLOGR D, V64, P33, DOI 10.1107/S0907444907049839; Lee YH, 2009, MOL ENDOCRINOL, V23, P425, DOI 10.1210/me.2008-0380; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Liu H, 2010, GENES DEV; Liu K, 2010, P NATL ACAD SCI USA, V107, P18398, DOI 10.1073/pnas.1013106107; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Min JR, 2007, NAT STRUCT MOL BIOL, V14, P1229, DOI 10.1038/nsmb1340; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; Selenko P, 2001, NAT STRUCT BIOL, V8, P27; Sims RJ, 2011, SCIENCE, V332, P99, DOI 10.1126/science.1202663; Siomi MC, 2010, GENE DEV, V24, P636, DOI 10.1101/gad.1899210; Sprangers R, 2003, J MOL BIOL, V327, P507, DOI 10.1016/S0022-2836(03)00148-7; Tripsianes K, 2011, NAT STRUCT MOL BIOL, V18, P1414, DOI 10.1038/nsmb.2185; Whitehead SE, 2002, J BIOL CHEM, V277, P48087, DOI 10.1074/jbc.M204551200; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018919; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Xu C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1237; Xu C, 2010, P NATL ACAD SCI USA, V107, P19266, DOI 10.1073/pnas.1008937107; Yang YZ, 2010, MOL CELL, V40, P1016, DOI 10.1016/j.molcel.2010.11.024; Yap KL, 2010, CRIT REV BIOCHEM MOL, V45, P488, DOI 10.3109/10409238.2010.512001; Young PJ, 2003, MOL BRAIN RES, V119, P37, DOI 10.1016/j.molbrainres.2003.08.011	48	62	62	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30375	10.1371/journal.pone.0030375	http://dx.doi.org/10.1371/journal.pone.0030375			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363433	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600027
J	Subramaniam, D; Ponnurangam, S; Ramamoorthy, P; Standing, D; Battafarano, RJ; Anant, S; Sharma, P				Subramaniam, Dharmalingam; Ponnurangam, Sivapriya; Ramamoorthy, Prabhu; Standing, David; Battafarano, Richard J.; Anant, Shrikant; Sharma, Prateek			Curcumin Induces Cell Death in Esophageal Cancer Cells through Modulating Notch Signaling	PLOS ONE			English	Article							FACTOR-KAPPA-B; EXPRESSION PROFILES; PROMOTES APOPTOSIS; COLORECTAL-CANCER; MIR-21 EXPRESSION; IN-VITRO; ADENOCARCINOMA; MICRORNAS; ACTIVATION; METASTASIS	Background: Curcumin inhibits the growth of esophageal cancer cell lines; however, the mechanism of action is not well understood. It is becoming increasingly clear that aberrant activation of Notch signaling has been associated with the development of esophageal cancer. Here, we have determined that curcumin inhibits esophageal cancer growth via a mechanism mediated through the Notch signaling pathway. Methodology/Principal Findings: In this study, we show that curcumin treatment resulted in a dose and time dependent inhibition of proliferation and colony formation in esophageal cancer cell lines. Furthermore, curcumin treatment induced apoptosis through caspase 3 activation, confirmed by an increase in the ratio of Bax to Bcl2. Cell cycle analysis demonstrated that curcumin treatment induced cell death and down regulated cyclin D1 levels. Curcumin treatment also resulted in reduced number and size of esophagospheres. Furthermore, curcumin treatment led to reduced Notch-1 activation, expression of Jagged-1 and its downstream target Hes-1. This reduction in Notch-1 activation was determined to be due to the down-regulation of critical components of the gamma-secretase complex proteins such as Presenilin 1 and Nicastrin. The combination of a known gamma-secretase inhibitor DAPT and curcumin further decreased proliferation and induced apoptosis in esophageal cancer cells. Finally, curcumin treatment down-regulate the expressions of Notch-1 specific microRNAs miR-21 and miR-34a, and upregulated tumor suppressor let-7a miRNA. Conclusion/Significance: Curcumin is a potent inhibitor of esophageal cancer growth that targets the Notch-1 activating gamma-secretase complex proteins. These data suggest that Notch signaling inhibition is a novel mechanism of action for curcumin during therapeutic intervention in esophageal cancers.	[Subramaniam, Dharmalingam; Ponnurangam, Sivapriya; Ramamoorthy, Prabhu; Standing, David; Anant, Shrikant] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA; [Sharma, Prateek] Univ Kansas, Med Ctr, Div Gastroenterol & Hepatol, Kansas City, KS 66103 USA; [Subramaniam, Dharmalingam; Anant, Shrikant; Sharma, Prateek] Univ Kansas, Med Ctr, Ctr Canc, Kansas City, KS 66103 USA; [Battafarano, Richard J.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University System of Maryland; University of Maryland Baltimore	Subramaniam, D (corresponding author), Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA.	dsubramaniam@kumc.edu; psharma@kumc.edu	Anant, Shrikant/AAF-8020-2020		NIH; NATIONAL CANCER INSTITUTE [R01CA109269] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by NIH grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Ali S, 2010, CANCER RES, V70, P3606, DOI 10.1158/0008-5472.CAN-09-4598; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Ashworth T, 2009, CELL CYCLE, V8, P596, DOI 10.4161/cc.8.4.7728; Bansal A, 2011, AM J GASTROENTEROL, V106, P1055, DOI 10.1038/ajg.2011.37; Bao B, 2011, CANCER LETT, V307, P26, DOI 10.1016/j.canlet.2011.03.012; Barnas C, 1997, INT J CANCER, V71, P79, DOI 10.1002/(SICI)1097-0215(19970328)71:1<79::AID-IJC14>3.0.CO;2-4; Bosetti C, 2008, INT J CANCER, V122, P1118, DOI 10.1002/ijc.23232; Dawsey SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014080; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Dong QC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010147; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gong P, 2010, J BIOL CHEM, V285, P38042, DOI 10.1074/jbc.M110.132613; Hartojo W, 2010, TRANSL ONCOL, V3, P99, DOI 10.1593/tlo.09235; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hu YX, 2011, INT J CANCER, V128, P132, DOI 10.1002/ijc.25330; Katoh M, 2007, INT J ONCOL, V30, P247; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; Lee ST, 2011, J NEURO-ONCOL, V102, P19, DOI 10.1007/s11060-010-0286-6; Li HL, 2009, STRUCTURE, V17, P326, DOI 10.1016/j.str.2009.01.007; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Liao SK, 2011, J CELL BIOCHEM, V112, P1055, DOI 10.1002/jcb.23019; Masuda S, 2011, CANCER; Mendelson J, 2011, CANCER-AM CANCER SOC, V117, P3691, DOI 10.1002/cncr.25861; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Miele L, 2006, CURR CANCER DRUG TAR, V6, P313, DOI 10.2174/156800906777441771; Miele L, 2006, CLIN CANCER RES, V12, P1074, DOI 10.1158/1078-0432.CCR-05-2570; Miele L, 2006, CURR MOL MED, V6, P905, DOI 10.2174/156652406779010830; Mudduluru G, 2011, BIOSCIENCE REP, V31, P185, DOI 10.1042/BSR20100065; O'Sullivan-Coyne G, 2009, BRIT J CANCER, V101, P1585, DOI 10.1038/sj.bjc.6605308; Peters JH, 2010, J GASTROINTEST SURG, V14, P81, DOI 10.1007/s11605-009-1011-7; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Saini S, 2011, CANC PREV RES PHILA; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Shishodia S, 2005, BIOCHEM PHARMACOL, V70, P700, DOI 10.1016/j.bcp.2005.04.043; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sotillo E, 2011, ONCOGENE, V30, P2587, DOI 10.1038/onc.2010.634; Su CC, 2006, ANTICANCER RES, V26, P4379; Sun M, 2008, MOL CANCER THER, V7, P464, DOI 10.1158/1535-7163.MCT-07-2272; Tian Fang, 2008, Ai Zheng, V27, P566; Tselepis C, 2003, GUT, V52, P174, DOI 10.1136/gut.52.2.174; Ushida J, 2000, JPN J CANCER RES, V91, P893, DOI 10.1111/j.1349-7006.2000.tb01031.x; VandenBoom TG, 2008, CURR GENOMICS, V9, P97, DOI 10.2174/138920208784139555; Wang ZW, 2010, CANCER LETT, V292, P141, DOI 10.1016/j.canlet.2009.11.012; Wang ZW, 2009, CANCER RES, V69, P2757, DOI 10.1158/0008-5472.CAN-08-3060; Wolfe MS, 2009, SEMIN CELL DEV BIOL, V20, P219, DOI 10.1016/j.semcdb.2008.12.011; Woo SM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-97; Yang J, 2010, MED ONCOL, V27, P1114, DOI 10.1007/s12032-009-9344-3; Yao J, 2007, ORAL DIS, V13, P555, DOI 10.1111/j.1601-0825.2006.01334.x; Yu L, 2008, J PHARMACOL EXP THER, V327, P258, DOI 10.1124/jpet.108.141275; Zhang J, 2010, ONCOL REP, V24, P1217, DOI 10.3892/or_00000975	53	166	178	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30590	10.1371/journal.pone.0030590	http://dx.doi.org/10.1371/journal.pone.0030590			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363450	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600038
J	Todd, KJ; Lan-Chow-Wing, N; Salin-Cantegrel, A; Cotter, A; Zagami, CJ; Lo, R; Stifani, S				Todd, Keith J.; Lan-Chow-Wing, Nathalie; Salin-Cantegrel, Adele; Cotter, Anthony; Zagami, Chrissandra J.; Lo, Rita; Stifani, Stefano			Establishment of Motor Neuron-V3 Interneuron Progenitor Domain Boundary in Ventral Spinal Cord Requires Groucho-Mediated Transcriptional Corepression	PLOS ONE			English	Article							NEURAL-TUBE; HOMEODOMAIN PROTEIN; NERVOUS-SYSTEM; DIFFERENTIATION; IDENTITY; SPECIFICATION; EXPRESSION; REPRESSION; FAMILY; INHIBITION	Background: Dorsoventral patterning of the developing spinal cord is important for the correct generation of spinal neuronal types. This process relies in part on cross-repressive interactions between specific transcription factors whose expression is regulated by Sonic hedgehog. Groucho/transducin-like Enhancer of split (TLE) proteins are transcriptional corepressors suggested to be recruited by at least certain Sonic hedgehog-controlled transcription factors to mediate the formation of spatially distinct progenitor domains within the ventral spinal cord. The aim of this study was to characterize the involvement of TLE in mechanisms regulating the establishment of the boundary between the most ventral spinal cord progenitor domains, termed pMN and p3. Because the pMN domain gives rise to somatic motor neurons while the p3 domain generates V3 interneurons, we also examined the involvement of TLE in the acquisition of these neuronal fates. Methodology and Principal Findings: A combination of in vivo loss- and gain-of-function studies in the developing chick spinal cord was performed to characterize the role of TLE in ventral progenitor domain formation. It is shown here that TLE overexpression causes increased numbers of p3 progenitors and promotes the V3 interneuron fate while suppressing the motor neuron fate. Conversely, dominant-inhibition of TLE increases the numbers of pMN progenitors and postmitotic motor neurons. Conclusion: Based on these results, we propose that TLE is important to promote the formation of the p3 domain and subsequent generation of V3 interneurons.	[Todd, Keith J.; Lan-Chow-Wing, Nathalie; Salin-Cantegrel, Adele; Cotter, Anthony; Zagami, Chrissandra J.; Lo, Rita; Stifani, Stefano] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada	McGill University	Todd, KJ (corresponding author), McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.	stefano.stifani@mcgill.ca		Stifani, Stefano/0000-0002-2376-7701	Canadian Institutes of Health Research [MOP-84577, MOP-42479]; Fonds de la Recherche en Sante du Quebec (FRSQ); Chercheur National of the FRSQ	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Chercheur National of the FRSQ	This research was supported by grants from the Canadian Institutes of Health Research-Operating Grants to S. S. (MOP-84577 and MOP-42479). K.J.T. was supported by a Fonds de la Recherche en Sante du Quebec (FRSQ) Postdoctoral Training Award and S. S. was a Chercheur National of the FRSQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Bajoghli B, 2007, DEV BIOL, V303, P347, DOI 10.1016/j.ydbio.2006.11.020; Beagle B, 2010, DEV DYNAM, V239, P2795, DOI 10.1002/dvdy.22439; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Buscarlet M, 2007, TRENDS CELL BIOL, V17, P353, DOI 10.1016/j.tcb.2007.07.002; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Dessaud E, 2008, DEVELOPMENT, V135, P2489, DOI 10.1242/dev.009324; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; Flowers EB, 2010, DEVELOPMENT, V137, P1799, DOI 10.1242/dev.046219; Gratton MO, 2003, MOL CELL BIOL, V23, P6922, DOI 10.1128/MCB.23.19.6922-6935.2003; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hoffman BG, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-81; Husain J, 1996, BIOCHEM J, V317, P523, DOI 10.1042/bj3170523; Jennings BH, 2006, MOL CELL, V22, P645, DOI 10.1016/j.molcel.2006.04.024; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Lupo G, 2006, NAT REV NEUROSCI, V7, P103, DOI 10.1038/nrn1843; Maira M, 2010, J NEURODEV DISORD, V2, P48, DOI [10.1007/s11689-009-9035-6, 10.1007/s11689-009-9040-9]; McLarren KW, 2000, J BIOL CHEM, V275, P530, DOI 10.1074/jbc.275.1.530; McLarrent FW, 2001, J BIOL CHEM, V276, P1578, DOI 10.1074/jbc.M007629200; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Nuthall HN, 2004, MOL CELL BIOL, V24, P8395, DOI 10.1128/MCB.24.19.8395-8407.2004; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Pinto M, 1996, J BIOL CHEM, V271, P33026, DOI 10.1074/jbc.271.51.33026; Song HY, 2004, MOL CELL BIOL, V24, P4341, DOI 10.1128/MCB.24.10.4341-4350.2004; STIFANI S, 1992, NAT GENET, V2, P119, DOI 10.1038/ng1092-119; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Tetsuka T, 2000, J BIOL CHEM, V275, P4383, DOI 10.1074/jbc.275.6.4383; Yao J, 1998, DEV GROWTH DIFFER, V40, P133; Zhuang BQ, 2006, CURR OPIN NEUROBIOL, V16, P20, DOI 10.1016/j.conb.2005.11.001	33	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31176	10.1371/journal.pone.0031176	http://dx.doi.org/10.1371/journal.pone.0031176			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363571	gold, Green Published, Green Submitted			2022-12-27	WOS:000302853600119
J	Zang, JJ; Wu, SQ; Tang, L; Xu, XD; Bai, J; Ding, CC; Chang, Y; Yue, L; Kang, EM; He, J				Zang, Jiajie; Wu, Shunquan; Tang, Lei; Xu, Xudong; Bai, Jie; Ding, Caicui; Chang, Yue; Yue, Long; Kang, Enming; He, Jia			Incidence and Risk of QTc Interval Prolongation among Cancer Patients Treated with Vandetanib: A Systematic Review and Meta-analysis	PLOS ONE			English	Review							PHASE-II; CLINICAL-TRIALS; DOUBLE-BLIND; THYROID-HORMONE; ZD6474; HYPOTHYROIDISM; INHIBITOR; PLACEBO	Background: Vandetanib is a multikinase inhibitor that is under assessment for the treatment of various cancers. QTc interval prolongation is one of the major adverse effects of this drug, but the reported incidence varies substantially among clinical trials. We performed a systematic review and meta-analysis to obtain a better understanding in the risk of QTc interval prolongation among cancer patients administered vandetanib. Methodology and Principal Findings: Eligible studies were phase II and III prospective clinical trials that involved cancer patients who were prescribed vandetanib 300 mg/d and that included data on QTc interval prolongation. The overall incidence and risk of QTc interval prolongation were calculated using random-effects or fixed-effects models, depending on the heterogeneity of the included studies. Nine trials with 2,188 patients were included for the meta-analysis. The overall incidence of all-grade and high-grade QTc interval prolongation was 16.4% (95% CI, 8.1-30.4%) and 3.7% (8.1-30.4%), respectively, among non-thyroid cancer patients, and 18.0% (10.7-28.6%) and 12.0% (4.5-28.0%), respectively, among thyroid cancer patients. Patients with thyroid cancer who had longer treatment duration also had a higher incidence of high-grade events, with a relative risk of 3.24 (1.57-6.71), than patients who had non-thyroid cancer. Vandetanib was associated with a significantly increased risk of all-grade QTc interval prolongation with overall Peto odds ratios of 7.26 (4.36-12.09) and 5.70 (3.09-10.53) among patients with non-thyroid cancer and thyroid cancer, respectively, compared to the controls. Conclusions/Significance: Treatment with vandetanib is associated with a significant increase in the overall incidence and risk of QTc interval prolongation. Different cancer types and treatment durations may affect the risk of developing high-grade QTc interval prolongation.	[Zang, Jiajie; Wu, Shunquan; Tang, Lei; He, Jia] Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China; [Zang, Jiajie; Wu, Shunquan; Tang, Lei; He, Jia] Second Mil Med Univ, Ctr Evidence Based Med, Shanghai, Peoples R China; [Xu, Xudong] Second Mil Med Univ, Changhai Hosp, Dept Cardiol, Shanghai, Peoples R China; [Bai, Jie] Second Mil Med Univ, Changhai Hosp, Dept Geriatr, Shanghai, Peoples R China; [Ding, Caicui] Peking Univ, Lib Hosp 1, Beijing 100871, Peoples R China; [Chang, Yue; Yue, Long; Kang, Enming] Second Mil Med Univ, Changhai Hosp, Dept Endocrinol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Naval Medical University; Peking University; Naval Medical University	Zang, JJ (corresponding author), Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China.	hejia63@yahoo.com		Zang, Jiajie/0000-0003-2476-2176; He, Jia/0000-0002-2338-9501	National Nature Science Foundation of China [30872186, 81072388]; Leading Talents of Science in Shanghai [022]; Program of Shanghai Subject Chief Scientist [09XD1405500]; Chinese Academy of Sciences, Stem Cell and Regenerative Medicine Research [XDA01040104]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Leading Talents of Science in Shanghai; Program of Shanghai Subject Chief Scientist; Chinese Academy of Sciences, Stem Cell and Regenerative Medicine Research	This study was supported by two grants from the National Nature Science Foundation of China (30872186, 81072388), a grant from the Leading Talents of Science in Shanghai 2010 (022), a grant sponsored by the Program of Shanghai Subject Chief Scientist (09XD1405500), and a "Strategic Priority Research Program" of the Chinese Academy of Sciences, Stem Cell and Regenerative Medicine Research (XDA01040104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, FDA APPROVES NEW TRE; Arnold AM, 2007, J CLIN ONCOL, V25, P4278, DOI 10.1200/JCO.2007.12.3083; Bakiner O, 2008, MED PRIN PRACT, V17, P390, DOI 10.1159/000141503; Barbey JT, 2003, J CLIN ONCOL, V21, P3609, DOI 10.1200/JCO.2003.10.009; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Brell JM, 2010, PROG CARDIOVASC DIS, V53, P164, DOI 10.1016/j.pcad.2010.05.005; Carlomagno F, 2002, CANCER RES, V62, P7284; Colzani RM, 2001, CLIN ENDOCRINOL, V55, P27, DOI 10.1046/j.1365-2265.2001.01295.x; CROWLEY WF, 1977, NEW ENGL J MED, V296, P1, DOI 10.1056/NEJM197701062960101; Danzi S, 2004, Minerva Endocrinol, V29, P139; de Boer RH, 2011, J CLIN ONCOL, V29, P1067, DOI 10.1200/JCO.2010.29.5717; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fazio S, 2004, RECENT PROG HORM RES, V59, P31, DOI 10.1210/rp.59.1.31; Floyd JD, 2005, J CLIN ONCOL, V23, P7685, DOI 10.1200/JCO.2005.08.789; Gillen MS, 2001, BRIT J CLIN PHARMACO, V52, P201, DOI 10.1046/j.0306-5251.2001.01345.x; Herbst RS, 2010, LANCET ONCOL, V11, P619, DOI 10.1016/S1470-2045(10)70132-7; Heymach JV, 2008, J CLIN ONCOL, V26, P5407, DOI 10.1200/JCO.2008.17.3138; Higgins J., 2011, ANAL DATA UNDERTAKIN; Horti J, 2009, CANCER BIOTHER RADIO, V24, P175, DOI 10.1089/cbr.2008.0588; Hsu C, ESMO MULT C 2009; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kiura K, 2008, J THORAC ONCOL, V3, P386, DOI 10.1097/JTO.0b013e318168d228; Leboulleux S, ESMO C OCT 2010; Miller KD, 2005, CLIN CANCER RES, V11, P3369, DOI 10.1158/1078-0432.CCR-04-1923; Natale RB, 2011, J CLIN ONCOL, V29, P1059, DOI 10.1200/JCO.2010.28.5981; Natale RB, 2009, J CLIN ONCOL, V27, P2523, DOI 10.1200/JCO.2008.18.6015; National Cancer Institute, CTC V 2 0 COMM TERM; Ojamaa K, 1999, ENDOCRINOLOGY, V140, P3170, DOI 10.1210/en.140.7.3170; Priori SG, 2003, NEW ENGL J MED, V348, P1866, DOI 10.1056/NEJMoa022147; Strevel EL, 2007, J CLIN ONCOL, V25, P3362, DOI 10.1200/JCO.2006.09.6925; van Noord C, 2008, J ENDOCRINOL, V198, P253, DOI 10.1677/JOE-08-0140; Varterasian M, 2003, J CLIN ONCOL, V21, P3378, DOI 10.1200/JCO.2003.99.104; Viskin S, 2003, PROG CARDIOVASC DIS, V45, P415, DOI 10.1053/pcad.2003.00101; Wedge SR, 2002, CANCER RES, V62, P4645; Wells SA, ESMO C OCT 2010; Wells SA, 2010, J CLIN ONCOL, V28, P767, DOI 10.1200/JCO.2009.23.6604; Woodward M, EPIDEMIOLOGY DESIGN; Yang TS, 2009, J CLIN ONCOL, V27	38	67	67	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30353	10.1371/journal.pone.0030353	http://dx.doi.org/10.1371/journal.pone.0030353			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363427	Green Submitted, Green Published, gold			2022-12-27	WOS:000302853600021
J	Bongfen, SE; Rodrigue-Gervais, IG; Berghout, J; Torre, S; Cingolani, P; Wiltshire, SA; Leiva-Torres, GA; Letourneau, L; Sladek, R; Blanchette, M; Lathrop, M; Behr, MA; Gruenheid, S; Vidal, SM; Saleh, M; Gros, P				Bongfen, Silayuv E.; Rodrigue-Gervais, Ian-Gael; Berghout, Joanne; Torre, Sabrina; Cingolani, Pablo; Wiltshire, Sean A.; Leiva-Torres, Gabriel A.; Letourneau, Louis; Sladek, Robert; Blanchette, Mathieu; Lathrop, Mark; Behr, Marcel A.; Gruenheid, Samantha; Vidal, Silvia M.; Saleh, Maya; Gros, Philippe			An N-Ethyl-N-Nitrosourea (ENU)-Induced Dominant Negative Mutation in the JAK3 Kinase Protects against Cerebral Malaria	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; PLASMODIUM-BERGHEI ANKA; T-CELLS; JANUS KINASES; CITROBACTER-RODENTIUM; IFN-GAMMA; SUSCEPTIBILITY LOCUS; CYTOKINE PRODUCTION; INTERFERON-GAMMA; ENU MUTAGENESIS	Cerebral malaria (CM) is a lethal neurological complication of malaria. We implemented a genome-wide screen in mutagenized mice to identify host proteins involved in CM pathogenesis and whose inhibition may be of therapeutic value. One pedigree (P48) segregated a resistance trait whose CM-protective effect was fully penetrant, mapped to chromosome 8, and identified by genome sequencing as homozygosity for a mis-sense mutation (W81R) in the FERM domain of Janus-associated kinase 3 (Jak3). The causative effect of Jak3(W81R) was verified by complementation testing in Jak3(W81R/-) double heterozygotes that were fully protected against CM. Jak3(W81R) homozygotes showed defects in thymic development with depletion of CD8(+) T cell, B cell, and NK cell compartments, and defective T cell-dependent production of IFN-gamma. Adoptive transfer of normal splenocytes abrogates CM resistance in Jak3(W81R) homozygotes, an effect attributed to the CD8(+) T cells. Jak3(W81R) behaves as a dominant negative variant, with significant CM resistance of Jak3(W81R/+) heterozygotes, compared to CM-susceptible Jak3(+/+) and Jak3(+/-) controls. CM resistance in Jak3(W81R/+) heterozygotes occurs in presence of normal T, B and NK cell numbers. These findings highlight the pathological role of CD8(+) T cells and Jak3-dependent IFN-gamma-mediated Th1 responses in CM pathogenesis.	[Bongfen, Silayuv E.; Berghout, Joanne; Gros, Philippe] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Rodrigue-Gervais, Ian-Gael; Saleh, Maya] McGill Univ, Dept Med, Montreal, PQ, Canada; [Torre, Sabrina; Wiltshire, Sean A.; Leiva-Torres, Gabriel A.; Letourneau, Louis; Sladek, Robert; Vidal, Silvia M.; Gros, Philippe] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Bongfen, Silayuv E.; Rodrigue-Gervais, Ian-Gael; Berghout, Joanne; Torre, Sabrina; Wiltshire, Sean A.; Leiva-Torres, Gabriel A.; Gruenheid, Samantha; Vidal, Silvia M.; Saleh, Maya; Gros, Philippe] McGill Univ, Complex Traits Grp, Montreal, PQ, Canada; [Cingolani, Pablo; Blanchette, Mathieu] McGill Univ, Sch Comp Sci, Montreal, PQ, Canada; [Lathrop, Mark] Ctr Natl Genotypage, Inst Genom, Evry, France; [Behr, Marcel A.; Gruenheid, Samantha] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Behr, Marcel A.] McGill Univ, Ctr Hlth, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; McGill University; CEA; UDICE-French Research Universities; Universite Paris Saclay; McGill University; McGill University	Bongfen, SE (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	philippe.gros@mcgill.ca	Berghout, Joanne/M-5493-2017; Sladek, Robert/R-2391-2019	Berghout, Joanne/0000-0002-9250-9159; Sladek, Robert/0000-0002-2730-1204; Leiva-Torres, Gabriel Andre/0000-0002-8144-1443; Saleh, Maya/0000-0003-1538-9146; Gruenheid, Samantha/0000-0002-0908-6715	Canadian Institutes of Health Research (CIHR) [216406]; European Union [HEALTH-F4-2008-201418]; Fonds De Recherche en Sante du Quebec	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); European Union(European Commission); Fonds De Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by research grants to PG, MS, SV, MB from the Canadian Institutes of Health Research (CIHR; 216406), to SG, and MAB from the CIHR, and to ML from the European Union Framework 7 Program READNA (HEALTH-F4-2008-201418). RS is supported by a salary award from the Fonds De Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amante FH, 2010, J IMMUNOL, V185, P3632, DOI 10.4049/jimmunol.1000944; [Anonymous], 2004, AM J TRANSPLANT, V4, P51, DOI 10.1046/j.1600-6143.2003.00281.x; Bagot S, 2002, P NATL ACAD SCI USA, V99, P9919, DOI 10.1073/pnas.152215199; Balachandar S, 2011, EUR J CLIN MICROBIOL, V30, P483, DOI 10.1007/s10096-010-1122-9; Balling R, 2001, ANNU REV GENOM HUM G, V2, P463, DOI 10.1146/annurev.genom.2.1.463; Baptista FG, 2010, INFECT IMMUN, V78, P4033, DOI 10.1128/IAI.00079-10; Berghout J, 2010, GENES IMMUN, V11, P310, DOI 10.1038/gene.2009.79; Bongfen SE, 2009, TRENDS PARASITOL, V25, P417, DOI 10.1016/j.pt.2009.05.012; Cabrales P, 2011, J INFECT DIS; Campanella GSV, 2008, P NATL ACAD SCI USA, V105, P4814, DOI 10.1073/pnas.0801544105; Campino S, 2005, GENES IMMUN, V6, P416, DOI 10.1038/sj.gene.6364219; Chan ER, 2009, EXP HEMATOL, V37, P276, DOI 10.1016/j.exphem.2008.10.005; Cornejo MG, 2009, INT J BIOCHEM CELL B, V41, P2376, DOI 10.1016/j.biocel.2009.09.004; de Souza JB, 2010, PARASITOLOGY, V137, P755, DOI 10.1017/S0031182009991715; DEKOSSODO S, 1993, J IMMUNOL, V151, P4811; Engwerda CR, 2002, J EXP MED, V195, P1371, DOI 10.1084/jem.20020128; Fernandez L, 2009, MAMM GENOME, V20, P296, DOI 10.1007/s00335-009-9184-7; FINLEY R, 1983, J IMMUNOL, V131, P1522; Fortin A, 2001, GENOMICS, V74, P21, DOI 10.1006/geno.2001.6528; Franklin BS, 2011, P NATL ACAD SCI USA, V108, P3689, DOI 10.1073/pnas.1015406108; Frucht DM, 2001, GENES IMMUN, V2, P422, DOI 10.1038/sj.gene.6363802; GRAU GE, 1989, P NATL ACAD SCI USA, V86, P5572, DOI 10.1073/pnas.86.14.5572; GRAU GE, 1987, SCIENCE, V237, P1210, DOI 10.1126/science.3306918; GROS P, 1981, J IMMUNOL, V127, P2417; Hansen DS, 2007, J IMMUNOL, V178, P5779, DOI 10.4049/jimmunol.178.9.5779; Hermsen C, 1997, PARASITOLOGY, V114, P7, DOI 10.1017/S0031182096008293; Higgins LM, 1999, INFECT IMMUN, V67, P3031, DOI 10.1128/IAI.67.6.3031-3039.1999; Hong CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015333; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Kwiatkowski D, 2000, CURR OPIN GENET DEV, V10, P320, DOI 10.1016/S0959-437X(00)00087-3; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lackner P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-36; McCall MBB, 2010, EUR J IMMUNOL, V40, P3472, DOI 10.1002/eji.201040587; McQuillan JA, 2011, INT J PARASITOL, V41, P155, DOI 10.1016/j.ijpara.2010.08.003; Meyer DM, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-41; Miller G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009137; Mitchell AJ, 2005, INFECT IMMUN, V73, P5645, DOI 10.1128/IAI.73.9.5645-5653.2005; Miu J, 2008, J IMMUNOL, V180, P1217, DOI 10.4049/jimmunol.180.2.1217; Morrell CN, 2011, INFECT IMMUN, V79, P1750, DOI 10.1128/IAI.00810-10; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Notorangelo LD, 2001, HUM MUTAT, V18, P255; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Ohno T, 2004, IMMUNOGENETICS, V56, P675, DOI 10.1007/s00251-004-0739-1; Patel SN, 2008, J EXP MED, V205, P1133, DOI 10.1084/jem.20072248; Rane SG, 2000, ONCOGENE, V19, P5662, DOI 10.1038/sj.onc.1203925; Roberts JL, 2004, BLOOD, V103, P2009, DOI 10.1182/blood-2003-06-2104; Royer Y, 2005, J BIOL CHEM, V280, P27251, DOI 10.1074/jbc.M501376200; Rudin W, 1997, AM J PATHOL, V150, P257; Rudin W, 1997, EUR J IMMUNOL, V27, P810, DOI 10.1002/eji.1830270403; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Senaldi G, 1999, J IMMUNOL, V163, P6820; Simmons CP, 2003, INFECT IMMUN, V71, P5077, DOI 10.1128/IAI.71.9.5077-5086.2003; Simmons CP, 2002, J IMMUNOL, V168, P1804, DOI 10.4049/jimmunol.168.4.1804; THOMIS DC, 1995, SCIENCE, V270, P794, DOI 10.1126/science.270.5237.794; Weatherall DJ, 2008, BRIT J HAEMATOL, V141, P276, DOI 10.1111/j.1365-2141.2008.07085.x; WHO, 2010, GUID TREATM MAL, P37; Yamaoka K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-253; Yanez DM, 1996, J IMMUNOL, V157, P1620; Yanez DM, 1999, INFECT IMMUN, V67, P446; Zhou YJ, 2001, MOL CELL, V8, P959, DOI 10.1016/S1097-2765(01)00398-7	60	19	19	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31012	10.1371/journal.pone.0031012	http://dx.doi.org/10.1371/journal.pone.0031012			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363534	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700021
J	Galfre, E; Pitt, SJ; Venturi, E; Sitsapesan, M; Zaccai, NR; Tsaneva-Atanasova, K; O'Neill, S; Sitsapesan, R				Galfre, Elena; Pitt, Samantha J.; Venturi, Elisa; Sitsapesan, Mano; Zaccai, Nathan R.; Tsaneva-Atanasova, Krasimira; O'Neill, Stephen; Sitsapesan, Rebecca			FKBP12 Activates the Cardiac Ryanodine Receptor Ca2+-Release Channel and Is Antagonised by FKBP12.6	PLOS ONE			English	Article							CALCIUM-RELEASE CHANNELS; FK506-BINDING PROTEIN FKBP12.6; SPONTANEOUS CA2+ RELEASE; SKELETAL-MUSCLE; SARCOPLASMIC-RETICULUM; INTRACELLULAR CALCIUM; SELECTIVE BINDING; CONTRACTION; OVEREXPRESSION; INACTIVATION	Changes in FKBP12.6 binding to cardiac ryanodine receptors (RyR2) are implicated in mediating disturbances in Ca2+-homeostasis in heart failure but there is controversy over the functional effects of FKBP12.6 on RyR2 channel gating. We have therefore investigated the effects of FKBP12.6 and another structurally similar molecule, FKBP12, which is far more abundant in heart, on the gating of single sheep RyR2 channels incorporated into planar phospholipid bilayers and on spontaneous waves of Ca2+-induced Ca2+-release in rat isolated permeabilised cardiac cells. We demonstrate that FKBP12 is a high affinity activator of RyR2, sensitising the channel to cytosolic Ca2+, whereas FKBP12.6 has very low efficacy, but can antagonise the effects of FKBP12. Mathematical modelling of the data shows the importance of the relative concentrations of FKBP12 and FKBP12.6 in determining RyR2 activity. Consistent with the single-channel results, physiological concentrations of FKBP12 (3 mu M) increased Ca2+-wave frequency and decreased the SR Ca2+-content in cardiac cells. FKBP12.6, itself, had no effect on wave frequency but antagonised the effects of FKBP12. We provide a biophysical analysis of the mechanisms by which FK-binding proteins can regulate RyR2 single-channel gating. Our data indicate that FKBP12, in addition to FKBP12.6, may be important in regulating RyR2 function in the heart. In heart failure, it is possible that an alteration in the dual regulation of RyR2 by FKBP12 and FKBP12.6 may occur. This could contribute towards a higher RyR2 open probability, 'leaky' RyR2 channels and Ca2+-dependent arrhythmias.	[Galfre, Elena; Pitt, Samantha J.; Venturi, Elisa; Sitsapesan, Mano; Zaccai, Nathan R.; Sitsapesan, Rebecca] Univ Bristol, Sch Physiol & Pharmacol, Ctr Nanosci & Quantum Informat, Bristol, Avon, England; [Galfre, Elena; Pitt, Samantha J.; Venturi, Elisa; Sitsapesan, Mano; Zaccai, Nathan R.; Sitsapesan, Rebecca] Univ Bristol, Bristol Heart Inst, Bristol, Avon, England; [Tsaneva-Atanasova, Krasimira] Univ Bristol, Dept Engn Math, Bristol, Avon, England; [O'Neill, Stephen] Univ Manchester, Core Technol Facil, Cardiovasc Res Grp, Manchester, Lancs, England	University of Bristol; University of Bristol; University of Bristol; University of Manchester	Galfre, E (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Ctr Nanosci & Quantum Informat, Bristol, Avon, England.	r.sitsapesan@bris.ac.uk	Tsaneva-Atanasova, Krasimira T/AAG-6766-2019	Tsaneva-Atanasova, Krasimira T/0000-0002-6294-7051; Pitt, Samantha/0000-0003-2257-1595; Venturi, Elisa/0000-0001-9302-1537; Zaccai, Nathan/0000-0002-1476-2044	British Heart Foundation [FS/08/069/25929, PG/06/127/21677]; Engineering and Physical Sciences Research Council [EP/I018638/1]; EPSRC [EP/I018638/1] Funding Source: UKRI; British Heart Foundation [RG/10/14/28576, PG/10/27/28312] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); British Heart Foundation(British Heart Foundation)	This work was funded by British Heart Foundation grants (FS/08/069/25929 PG/06/127/21677) to RS and SO and by Engineering and Physical Sciences Research Council grant (EP/I018638/1) to KT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHERN GP, 1994, FEBS LETT, V352, P369, DOI 10.1016/0014-5793(94)01001-3; Ahern GP, 1997, BIOPHYS J, V72, P146, DOI 10.1016/S0006-3495(97)78654-5; Ahern GP, 1997, NEUROSCI LETT, V225, P81, DOI 10.1016/S0304-3940(97)00193-6; Barg S, 1997, AM J PHYSIOL-CELL PH, V272, pC1726, DOI 10.1152/ajpcell.1997.272.5.C1726; Carter S, 2011, J MEMBRANE BIOL, V240, P21, DOI 10.1007/s00232-011-9339-9; Chelu MG, 2004, TRENDS CARDIOVAS MED, V14, P227, DOI 10.1016/j.tcm.2004.06.003; Colquhoun D, 1983, SINGLE CHANNEL RECOR, P191; Copello JA, 1997, BIOPHYS J, V73, P141, DOI 10.1016/S0006-3495(97)78055-X; Deivanayagam CCS, 2000, ACTA CRYSTALLOGR D, V56, P266, DOI 10.1107/S0907444999016571; Eisner DA, 2009, J MOL CELL CARDIOL, V46, P474, DOI 10.1016/j.yjmcc.2008.12.005; EISNER DA, 1989, J PHYSIOL-LONDON, V411, P393, DOI 10.1113/jphysiol.1989.sp017580; Fulton KF, 2003, BIOCHEMISTRY-US, V42, P2364, DOI 10.1021/bi020564a; Guo T, 2010, CIRC RES, V106, P1743, DOI 10.1161/CIRCRESAHA.110.219816; Huang FN, 2006, P NATL ACAD SCI USA, V103, P3456, DOI 10.1073/pnas.0511282103; Jeyakumar LH, 2001, BIOCHEM BIOPH RES CO, V281, P979, DOI 10.1006/bbrc.2001.4444; Jiang MT, 2002, CIRC RES, V91, P1015, DOI 10.1161/01.RES.0000043663.08689.05; Kaftan E, 1996, CIRC RES, V78, P990, DOI 10.1161/01.RES.78.6.990; LAM E, 1995, J BIOL CHEM, V270, P26511, DOI 10.1074/jbc.270.44.26511; Laver DR, 1998, BIOPHYS J, V74, P2352, DOI 10.1016/S0006-3495(98)77944-5; Lehnart SE, 2004, BIOCHEM BIOPH RES CO, V322, P1267, DOI 10.1016/j.bbrc.2004.08.032; Loughrey CM, 2004, J PHYSIOL-LONDON, V556, P919, DOI 10.1113/jphysiol.2003.057166; Marks AR, 2000, CIRC RES, V87, P8, DOI 10.1161/01.RES.87.1.8; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Marx SO, 2001, CIRC RES, V88, P1151, DOI 10.1161/hh1101.091268; Ng GA, 1998, CARDIOVASC RES, V37, P489, DOI 10.1016/S0008-6363(97)00255-1; Noble JE, 2009, METHOD ENZYMOL, V463, P73, DOI 10.1016/S0076-6879(09)63008-1; Overend CL, 1997, J PHYSIOL-LONDON, V502, P471, DOI 10.1111/j.1469-7793.1997.471bj.x; Pogwizd SM, 2004, TRENDS CARDIOVAS MED, V14, P61, DOI 10.1016/j.tcm.2003.12.002; Prestle J, 2001, CIRC RES, V88, P188; Saftenku E, 2001, BIOPHYS J, V80, P2727, DOI 10.1016/S0006-3495(01)76241-8; Samso M, 2006, J MOL BIOL, V356, P917, DOI 10.1016/j.jmb.2005.12.023; Seidler T, 2007, CIRC RES, V101, P1020, DOI 10.1161/CIRCRESAHA.107.154609; Seidler T, 2011, J MOL CELL CARDIOL, V50, P33, DOI 10.1016/j.yjmcc.2010.08.016; Sharma MR, 2006, BIOPHYS J, V90, P164, DOI 10.1529/biophysj.105.063503; Shou WN, 1998, NATURE, V391, P489, DOI 10.1038/35146; Sigalas C, 2009, BRIT J PHARMACOL, V156, P794, DOI 10.1111/j.1476-5381.2008.00092.x; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; SITSAPESAN R, 1994, BIOPHYS J, V67, P1484, DOI 10.1016/S0006-3495(94)80622-8; SITSAPESAN R, 1991, J PHYSIOL-LONDON, V434, P469, DOI 10.1113/jphysiol.1991.sp018481; SITSAPESAN R, 1990, J PHYSIOL-LONDON, V423, P425, DOI 10.1113/jphysiol.1990.sp018031; SITSAPESAN R, 1994, J MEMBRANE BIOL, V137, P215; Smith GL, 2001, J PHYSIOL-LONDON, V534, P37, DOI 10.1111/j.1469-7793.2001.00037.x; Sobie EA, 2006, PROG BIOPHYS MOL BIO, V90, P172, DOI 10.1016/j.pbiomolbio.2005.06.010; Stewart R, 2008, J MEMBRANE BIOL, V222, P65, DOI 10.1007/s00232-008-9102-z; TIMERMAN AP, 1995, J BIOL CHEM, V270, P2451, DOI 10.1074/jbc.270.6.2451; Timerman AP, 1996, J BIOL CHEM, V271, P20385, DOI 10.1074/jbc.271.34.20385; Trafford AW, 2000, CELL CALCIUM, V28, P269, DOI 10.1054/ceca.2000.0156; VALDEOLMILLOS M, 1989, PFLUG ARCH EUR J PHY, V413, P676, DOI 10.1007/BF00581820; Valdivia HH, 2001, CIRC RES, V88, P134; Venetucci LA, 2008, CARDIOVASC RES, V77, P285, DOI 10.1093/cvr/cvm009; Wagenknecht T, 1997, J BIOL CHEM, V272, P32463, DOI 10.1074/jbc.272.51.32463; Wehrens XHT, 2005, P NATL ACAD SCI USA, V102, P9607, DOI 10.1073/pnas.0500353102; Wehrens XHT, 2003, CELL, V113, P829, DOI 10.1016/S0092-8674(03)00434-3; Xiao JM, 2007, J BIOL CHEM, V282, P34828, DOI 10.1074/jbc.M707423200; Xiao RP, 1997, J PHYSIOL-LONDON, V500, P343, DOI 10.1113/jphysiol.1997.sp022025; Xin HB, 1999, J BIOL CHEM, V274, P15315, DOI 10.1074/jbc.274.22.15315; Xin HB, 2002, NATURE, V416, P334, DOI 10.1038/416334a; Zahradnikova A, 1999, PFLUG ARCH EUR J PHY, V438, P283, DOI 10.1007/s004240050911	58	46	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31956	10.1371/journal.pone.0031956	http://dx.doi.org/10.1371/journal.pone.0031956			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363773	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700127
J	Knebel, B; Haas, J; Hartwig, S; Jacob, S; Kollmer, C; Nitzgen, U; Muller-Wieland, D; Kotzka, J				Knebel, Birgit; Haas, Jutta; Hartwig, Sonja; Jacob, Sylvia; Koellmer, Cornelia; Nitzgen, Ulrike; Muller-Wieland, Dirk; Kotzka, Jorg			Liver-Specific Expression of Transcriptionally Active SREBP-1c Is Associated with Fatty Liver and Increased Visceral Fat Mass	PLOS ONE			English	Article							DE-NOVO LIPOGENESIS; INSULIN-RESISTANCE; HEPATIC STEATOSIS; ACID SYNTHESIS; ALPHA-FETOPROTEIN; GENE-EXPRESSION; MICE; CARBOHYDRATE; SENSITIVITY; RECEPTOR	The pathogenesis of fatty liver is not understood in detail, but lipid overflow as well as de novo lipogenesis (DNL) seem to be the key points of hepatocyte accumulation of lipids. One key transcription factor in DNL is sterol regulatory element-binding protein (SREBP)-1c. We generated mice with liver-specific over-expression of mature human SREBP-1c under control of the albumin promoter and a liver-specific enhancer (alb-SREBP-1c) to analyze systemic perturbations caused by this distinct alteration. SREBP-1c targets specific genes and causes key enzymes in DNL and lipid metabolism to be upregulated. The alb-SREBP-1c mice developed hepatic lipid accumulation featuring a fatty liver by the age of 24 weeks under normocaloric nutrition. On a molecular level, clinical parameters and lipid-profiles varied according to the fatty liver phenotype. The desaturation index was increased compared to wild type mice. In liver, fatty acids (FA) were increased by 50% (p<0.01) and lipid composition was shifted to mono unsaturated FA, whereas lipid profile in adipose tissue or serum was not altered. Serum analyses revealed a similar to 2-fold (p<0.01) increase in triglycerides and free fatty acids, and a similar to 3-fold (p<0.01) increase in insulin levels, indicating insulin resistance; however, no significant cytokine profile alterations have been determined. Interestingly and unexpectedly, mice also developed adipositas with considerably increased visceral adipose tissue, although calorie intake was not different compared to control mice. In conclusion, the alb-SREBP-1c mouse model allowed the elucidation of the systemic impact of SREBP-1c as a central regulator of lipid metabolism in vivo and also demonstrated that the liver is a more active player in metabolic diseases such as visceral obesity and insulin resistance.	[Knebel, Birgit; Hartwig, Sonja; Jacob, Sylvia; Koellmer, Cornelia; Nitzgen, Ulrike; Kotzka, Jorg] Univ Dusseldorf, German Diabet Ctr, Leibniz Ctr Diabet Res, Inst Clin Biochem & Pathobiochem, D-40225 Dusseldorf, Germany; [Haas, Jutta; Muller-Wieland, Dirk] Semmelweis Univ, Asklepios Clin St Georg, Fac Med, Inst Diabet Res,Dept Gen Internal Med, Hamburg, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Asklepios Klinik St. Georg; Semmelweis University	Knebel, B (corresponding author), Univ Dusseldorf, German Diabet Ctr, Leibniz Ctr Diabet Res, Inst Clin Biochem & Pathobiochem, D-40225 Dusseldorf, Germany.	jkotzka@ddz.uni-duesseldorf.de		Kotzka, Jorg/0000-0003-1173-9372	Center for Molecular Medicine Cologne [TV1]; city of Hamburg (Norgenta GmbH) within the LiDia project; German Diabetes Center	Center for Molecular Medicine Cologne; city of Hamburg (Norgenta GmbH) within the LiDia project; German Diabetes Center	The work was supported by the Center for Molecular Medicine Cologne (TV1), the city of Hamburg (Norgenta GmbH) within the LiDia project and the German Diabetes Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland A, 1997, AM J CLIN NUTR, V65, P1774, DOI 10.1093/ajcn/65.6.1774; Bjorkegren J, 1999, J CLIN INVEST, V103, P1287; Brewer M, 2005, J BIOL RHYTHM, V20, P195, DOI 10.1177/0748730405275952; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Choi SS, 2008, CURR OPIN LIPIDOL, V19, P295, DOI 10.1097/MOL.0b013e3282ff5e55; Chong MFF, 2008, AM J CLIN NUTR, V87, P817, DOI 10.1093/ajcn/87.4.817; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI200523621; Ehrhart-Bornstein M, 2003, P NATL ACAD SCI USA, V100, P14211, DOI 10.1073/pnas.2336140100; Engelking LJ, 2005, J CLIN INVEST, V115, P2489, DOI 10.1172/JCI25614; Faeh D, 2005, DIABETES, V54, P1907, DOI 10.2337/diabetes.54.7.1907; Ferre P, 2007, HORM RES, V68, P72, DOI 10.1159/000100426; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Heikkinen S, 2007, CURR PROTOC MOL BIOL, DOI DOI 10.1002/0471142727.MB29B03S77; Herbach N, 2007, DIABETES, V56, P1268, DOI 10.2337/db06-0658; Hernandez C, 2009, CELL METAB, V9, P215, DOI 10.1016/j.cmet.2009.02.001; Higuchi N, 2008, HEPATOL RES, V38, P1122, DOI 10.1111/j.1872-034X.2008.00382.x; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; HUA XX, 1995, J BIOL CHEM, V270, P29422, DOI 10.1074/jbc.270.49.29422; Hudgins LC, 2000, J LIPID RES, V41, P595; IZBAN MG, 1989, J BIOL CHEM, V264, P9171; Kantartzis K, 2010, DIGEST DIS, V28, P169, DOI 10.1159/000282082; Kohjima M, 2008, INT J MOL MED, V21, P507; Kotronen A, 2009, DIABETES, V58, P203, DOI 10.2337/db08-1074; Kotzka J, 2010, ATHEROSCLEROSIS, V213, P156, DOI 10.1016/j.atherosclerosis.2010.08.046; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Lomvardas S, 2002, MOL CELL, V9, P209, DOI 10.1016/S1097-2765(02)00463-X; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Mather K, 2009, AM J PHYSIOL-ENDOC M, V296, pE398, DOI 10.1152/ajpendo.90889.2008; Meissburger B, 2011, DIABETOLOGIA, V54, P1468, DOI 10.1007/s00125-011-2093-9; Minehira K, 2008, J LIPID RES, V49, P2038, DOI 10.1194/jlr.M800248-JLR200; Moloney F, 2007, DIABETES, V56, P574, DOI 10.2337/db06-0384; Morin P, 2009, INT J DEV BIOL, V53, P433, DOI 10.1387/ijdb.082643pm; Musso G, 2009, PROG LIPID RES, V48, P1, DOI 10.1016/j.plipres.2008.08.001; NAHON JL, 1987, BIOCHIMIE, V69, P445, DOI 10.1016/0300-9084(87)90082-4; Ndumele CE, 2011, ARTERIOSCL THROM VAS, V31, P1927, DOI 10.1161/ATVBAHA.111.228262; Olofsson SO, 2000, TRENDS CARDIOVAS MED, V10, P338, DOI 10.1016/S1050-1738(01)00071-8; Oosterveer MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006066; Ouyang X, 2008, J HEPATOL, V48, P993, DOI 10.1016/j.jhep.2008.02.011; Parks EJ, 1999, J CLIN INVEST, V104, P1087, DOI 10.1172/JCI6572; Parks EJ, 2002, BRIT J NUTR, V87, pS247, DOI 10.1079/BJN/2002544; Parks EJ, 2008, J NUTR, V138, P1039, DOI 10.1093/jn/138.6.1039; PINKERT CA, 1987, GENE DEV, V1, P268, DOI 10.1101/gad.1.3.268; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Potenza MA, 2006, DIABETES, V55, P3594, DOI 10.2337/db06-0667; Raabe M, 2002, J BIOL CHEM, V277, P5476; Raghow R, 2008, TRENDS ENDOCRIN MET, V19, P65, DOI 10.1016/j.tem.2007.10.009; Sampath H, 2007, J BIOL CHEM, V282, P2483, DOI 10.1074/jbc.M610158200; Schreuder TCMA, 2008, WORLD J GASTROENTERO, V14, P2474, DOI 10.3748/wjg.14.2474; Schwarz JM, 2003, AM J CLIN NUTR, V77, P43, DOI 10.1093/ajcn/77.1.43; Shah A, 2008, JPEN-PARENTER ENTER, V32, P638, DOI 10.1177/0148607108325251; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Shimomura I, 1998, J BIOL CHEM, V273, P35299, DOI 10.1074/jbc.273.52.35299; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Stefan N, 2008, DIABETOLOGIA, V51, P648, DOI 10.1007/s00125-008-0938-7; Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500; Tilg H, 2006, GASTROENTEROLOGY, V131, P934, DOI 10.1053/j.gastro.2006.05.054; TROJAN J, 1995, MOL REPROD DEV, V42, P369, DOI 10.1002/mrd.1080420402; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Verreth W, 2004, CIRCULATION, V110, P3259, DOI 10.1161/01.CIR.0000147614.85888.7A; Wendel AA, 2010, DIABETES, V59, P1321, DOI 10.2337/db09-1380; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9	66	110	120	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31812	10.1371/journal.pone.0031812	http://dx.doi.org/10.1371/journal.pone.0031812			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363740	gold, Green Published, Green Submitted			2022-12-27	WOS:000302873700102
J	Pehl, MJ; Jamieson, WD; Kong, K; Forbester, JL; Fredendall, RJ; Gregory, GA; McFarland, JE; Healy, JM; Orwin, PM				Pehl, Michael J.; Jamieson, William David; Kong, Karen; Forbester, Jessica L.; Fredendall, Richard J.; Gregory, Glenn A.; McFarland, Jacob E.; Healy, Jessica M.; Orwin, Paul M.			Genes That Influence Swarming Motility and Biofilm Formation in Variovorax paradoxus EPS	PLOS ONE			English	Article							COLONY MORPHOLOGY; SURFACE; IDENTIFICATION; GENERATION; REGULATOR; VARIANTS	Background: Variovorax paradoxus is an aerobic soil bacterium associated with important biodegradative processes in nature. We use V. paradoxus EPS to study multicellular behaviors on surfaces. Methodology: We recovered flanking sequence from 123 clones in a Tn5 mutant library, with insertions in 29 different genes, selected based on observed surface behavior phenotypes. We identified three genes, Varpa_4665, Varpa_4680, and Varpa_5900, for further examination. These genes were cloned into pBBR1MCS2 and used to complement the insertion mutants. We also analyzed expression of Varpa_4680 and Varpa_5900 under different growth conditions by qPCR. Results: The 29 genes we identified had diverse predicted functions, many in exopolysaccharide synthesis. Varpa_4680, the most commonly recovered insertion site, encodes a putative N-acetyl-L-fucosamine transferase similar to WbuB. Expression of this gene in trans complemented the mutant fully. Several unique insertions were identified in Varpa_5900, which is one of three predicted pilY1 homologs in the EPS genome. No insertions in the two other putative pilY1 homologs present in the genome were identified. Expression of Varpa_5900 altered the structure of the wild type swarm, as did disruption of the chromosomal gene. The swarming phenotype was complemented by expression of Varpa_5900 from a plasmid, but biofilm formation was not restored. Both Varpa_4680 and Varpa_5900 transcripts were downregulated in biofilms and upregulated during swarming when compared to log phase culture. We identified a putative two component system (Varpa_4664-4665) encoding a response regulator (shkR) and a sensor histidine kinase (shkS), respectively. Biofilm formation increased and swarming was strongly delayed in the Varpa_4665 (shkS) mutant. Complementation of shkS restored the biofilm phenotype but swarming was still delayed. Expression of shkR in trans suppressed biofilm formation in either genetic background, and partially restored swarming in the mutant. Conclusions: The data presented here point to complex regulation of these surface behaviors.	[Pehl, Michael J.; Fredendall, Richard J.; Gregory, Glenn A.; McFarland, Jacob E.; Healy, Jessica M.; Orwin, Paul M.] Calif State Univ San Bernardino, Dept Biol, San Bernardino, CA 92407 USA; [Jamieson, William David; Kong, Karen; Forbester, Jessica L.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Gregory, Glenn A.] Loma Linda Univ, Sch Dent, Loma Linda, CA 92350 USA; [McFarland, Jacob E.] Univ Calif San Francisco, UCSF Sch Pharm, San Francisco, CA 94143 USA; [Healy, Jessica M.] UCD Dept Publ Hlth Sci 5215 VM3A, Davis, CA USA	California State University System; California State University San Bernardino; University of Bath; Loma Linda University; University of California System; University of California San Francisco	Pehl, MJ (corresponding author), Calif State Univ San Bernardino, Dept Biol, San Bernardino, CA 92407 USA.	porwin@csusb.edu	Albers, Pieter/I-2563-2017; Jamieson, David/F-9534-2016	Jamieson, David/0000-0001-8260-5211; Forbester, Jessica/0000-0002-3834-615X	National Institutes of Health [S06 GM073842, R15 GM090242-01]; CSUSB; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM090242, S06GM073842] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CSUSB; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants S06 GM073842 and R15 GM090242-01. This work was also supported by CSUSB internal grants awarded to MJP, JEM, JMH, and PMO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar C, 2007, CURR OPIN MICROBIOL, V10, P638, DOI 10.1016/j.mib.2007.09.006; Allen MS, 2004, ENVIRON MICROBIOL, V6, P780, DOI 10.1111/j.1462-2920.2004.00615.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anesti V, 2005, ENVIRON MICROBIOL, V7, P1227, DOI 10.1111/j.1462-2920.2005.00805.x; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; DeShazer D, 1997, J BACTERIOL, V179, P2116, DOI 10.1128/jb.179.7.2116-2125.1997; Devers M, 2007, GENE, V392, P1, DOI 10.1016/j.gene.2006.09.015; Fong JCN, 2006, J BACTERIOL, V188, P1049, DOI 10.1128/JB.188.3.1049-1059.2006; Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004; Gao F, 2006, NUCLEIC ACIDS RES, V34, pW686, DOI 10.1093/nar/gkl040; Govindasamy V, 2008, CURR MICROBIOL, V57, P312, DOI 10.1007/s00284-008-9195-8; Griffith F, 1928, J HYG-CAMBRIDGE, V27, P113, DOI 10.1017/S0022172400031879; Gualdi L, 2008, MICROBIOL-SGM, V154, P2017, DOI 10.1099/mic.0.2008/018093-0; Han JI, 2011, J BACTERIOL, V193, P1183, DOI 10.1128/JB.00925-10; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Johnson DR, 2005, APPL ENVIRON MICROB, V71, P3866, DOI 10.1128/AEM.71.7.3866-3871.2005; Kirisits MJ, 2005, APPL ENVIRON MICROB, V71, P4809, DOI 10.1128/AEM.71.8.4809-4821.2005; Kolter R, 2006, NATURE, V441; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kuchma SL, 2010, J BACTERIOL, V192, P2950, DOI 10.1128/JB.01642-09; Kuchma SL, 2007, J BACTERIOL, V189, P8165, DOI 10.1128/JB.00586-07; Leadbetter JR, 2000, J BACTERIOL, V182, P6921, DOI 10.1128/JB.182.24.6921-6926.2000; Maimaiti J, 2007, ENVIRON MICROBIOL, V9, P435, DOI 10.1111/j.1462-2920.2006.01155.x; MESELSON M, 1968, NATURE, V217, P1110, DOI 10.1038/2171110a0; Nishino SF, 2006, APPL ENVIRON MICROB, V72, P1040, DOI 10.1128/AEM.72.2.1040-1044.2006; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Orans J, 2010, P NATL ACAD SCI USA, V107, P1065, DOI 10.1073/pnas.0911616107; Overhage J, 2007, J BACTERIOL, V189, P2164, DOI 10.1128/JB.01623-06; PARKE D, 1990, GENE, V93, P135, DOI 10.1016/0378-1119(90)90147-J; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Procaccini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019729; Rozen S, 2000, Methods Mol Biol, V132, P365; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Smith A. W, 1989, NUCLEIC ACIDS RES, V17, P25669; Verstraeten N, 2008, TRENDS MICROBIOL, V16, P496, DOI 10.1016/j.tim.2008.07.004; WANNER BL, 1992, J BACTERIOL, V174, P2053, DOI 10.1128/JB.174.7.2053-2058.1992; WILLEMS A, 1991, INT J SYST BACTERIOL, V41, P445, DOI 10.1099/00207713-41-3-445; Yarwood JA, 2007, J BACTERIOL, V189, P7961, DOI 10.1128/JB.00789-07	41	20	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31832	10.1371/journal.pone.0031832	http://dx.doi.org/10.1371/journal.pone.0031832			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363744	Green Submitted, gold, Green Published			2022-12-27	WOS:000302873700105
J	Hoffmann, A; Kovermann, M; Lilie, H; Fiedler, M; Balbach, J; Rudolph, R; Pfeifer, S				Hoffmann, Andreas; Kovermann, Michael; Lilie, Hauke; Fiedler, Markus; Balbach, Jochen; Rudolph, Rainer; Pfeifer, Sven			New Binding Mode to TNF-Alpha Revealed by Ubiquitin-Based Artificial Binding Protein	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; SMALL-MOLECULE INHIBITION; COMBINATORIAL LIBRARIES; CIRCULAR-DICHROISM; RIBOSOME DISPLAY; PHAGE DISPLAY; SELECTION; AFFINITY; ANTIBODIES; STABILITY	A variety of approaches have been employed to generate binding proteins from non-antibody scaffolds. Utilizing a beta-sheet of the human ubiquitin for paratope creation we obtained binding proteins against tumor necrosis factor (TNF)-alpha. The bioactive form of this validated pharmacological target protein is a non-covalently linked homo-trimer. This structural feature leads to the observation of a certain heterogeneity concerning the binding mode of TNF-alpha binding molecules, for instance in terms of monomer/trimer specificity. We analyzed a ubiquitin-based TNF-alpha binder, selected by ribosome display, with a particular focus on its mode of interaction. Using enzyme-linked immunosorbent assays, specific binding to TNF-alpha with nanomolar affinity was observed. In isothermal titration calorimetry we obtained comparable results regarding the affinity and detected an exothermic reaction with one ubiquitin-derived binding molecule binding one TNF-alpha trimer. Using NMR spectroscopy and other analytical methods the 1:3 stoichiometry could be confirmed. Detailed binding analysis showed that the interaction is affected by the detergent Tween-20. Previously, this phenomenon was reported only for one other type of alternative scaffold-derived binding proteins - designed ankyrin repeat proteins - without further investigation. As demonstrated by size exclusion chromatography and NMR spectroscopy, the presence of the detergent increases the association rate significantly. Since the special architecture of TNF-alpha is known to be modulated by detergents, the access to the recognized epitope is indicated to be restricted by conformational transitions within the target protein. Our results suggest that the ubiquitin-derived binding protein targets a new epitope on TNF-alpha, which differs from the epitopes recognized by TNF-alpha neutralizing antibodies.	[Hoffmann, Andreas; Lilie, Hauke; Rudolph, Rainer; Pfeifer, Sven] Univ Halle Wittenberg, Inst Biochem & Biotechnol, Halle, Germany; [Kovermann, Michael; Balbach, Jochen] Univ Halle Wittenberg, Inst Phys, Halle, Germany; [Fiedler, Markus] Scil Prot GmbH, Halle, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Hoffmann, A (corresponding author), Univ Halle Wittenberg, Inst Biochem & Biotechnol, Halle, Germany.	sven.pfeifer@biochemtech.uni-halle.de			BMBF within the UnternehmenRegion Innovation initiative for the Neue Lander [03IP606]; Deutsche Forschungsgemeinschaft [GRK 1026]; Excellence Initiative of the State of Sachsen-Anhalt; European Union	BMBF within the UnternehmenRegion Innovation initiative for the Neue Lander(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the State of Sachsen-Anhalt; European Union(European Commission)	This work was supported by grants from the BMBF (http://www.bmbf.de) InnoProfile program within the UnternehmenRegion Innovation initiative for the Neue Lander (grant number 03IP606), the Deutsche Forschungsgemeinschaft (http://www.dfg.de) (GRK 1026) and the Excellence Initiative of the State of Sachsen-Anhalt. Significant investments into the NMR facility from the European Regional Development Fund (ERDF) by the European Union (http://ec.europa.eu) are also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALZANI R, 1995, BIOCHEMISTRY-US, V34, P6344, DOI 10.1021/bi00019a012; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; Byla P, 2010, J BIOL CHEM, V285, P12096, DOI 10.1074/jbc.M109.063305; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; CORTI A, 1992, MOL IMMUNOL, V29, P471, DOI 10.1016/0161-5890(92)90004-H; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ebersbach H, 2007, J MOL BIOL, V372, P172, DOI 10.1016/j.jmb.2007.06.045; Fiedler M, 2004, International Patent Application, Patent No. [WO/2004/106368, 2004106368]; Fisher RD, 2003, J BIOL CHEM, V278, P28976, DOI 10.1074/jbc.M302596200; FRESKGARD PO, 1994, BIOCHEMISTRY-US, V33, P14281, DOI 10.1021/bi00251a041; Ganesan R, 2010, BIOCHEM J, V430, P179, DOI 10.1042/BJ20100634; GLOCKSHUBER R, 1990, BIOCHEMISTRY-US, V29, P1362, DOI 10.1021/bi00458a002; He MM, 2005, SCIENCE, V310, P1022, DOI 10.1126/science.1116304; Hey T, 2005, TRENDS BIOTECHNOL, V23, P514, DOI 10.1016/j.tibtech.2005.07.007; Hoffmann A, 2010, PROTEIN EXPRES PURIF, V72, P238, DOI 10.1016/j.pep.2010.03.022; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; JESPERS LS, 1994, BIO-TECHNOL, V12, P899, DOI 10.1038/nbt0994-899; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Jonsson A, 2009, BIOTECHNOL APPL BIOC, V54, P93, DOI 10.1042/BA20090085; Kang RS, 2003, CELL, V113, P621, DOI 10.1016/S0092-8674(03)00362-3; Kaymakcalan Z, 2009, CLIN IMMUNOL, V131, P308, DOI 10.1016/j.clim.2009.01.002; KHORASANIZADEH S, 1993, BIOCHEMISTRY-US, V32, P7054, DOI 10.1021/bi00078a034; Kim HJ, 2009, J AM CHEM SOC, V131, P3565, DOI 10.1021/ja806857r; Kohno T, 2007, J INVEST DERM SYMP P, V12, P5, DOI 10.1038/sj.jidsymp.5650034; Lu RC, 2009, BBA-GEN SUBJECTS, V1790, P134, DOI 10.1016/j.bbagen.2008.10.009; Makhatadze GI, 1998, PROTEIN SCI, V7, P689, DOI 10.1002/pro.5560070318; Markland W, 1996, BIOCHEMISTRY-US, V35, P8045, DOI 10.1021/bi9526286; Miura T, 1999, J MOL BIOL, V290, P213, DOI 10.1006/jmbi.1999.2859; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; Nord K, 1997, NAT BIOTECHNOL, V15, P772, DOI 10.1038/nbt0897-772; Ohashi H, 2007, BIOCHEM BIOPH RES CO, V352, P270, DOI 10.1016/j.bbrc.2006.11.017; PETYOVKA N, 1995, J IMMUNOL METHODS, V186, P161, DOI 10.1016/0022-1759(95)00183-B; POIESI C, 1993, CYTOKINE, V5, P539, DOI 10.1016/S1043-4666(05)80002-X; SAIJO S, 1995, J BIOCHEM-TOKYO, V118, P28, DOI 10.1093/oxfordjournals.jbchem.a124887; Scallon B, 2002, J PHARMACOL EXP THER, V301, P418, DOI 10.1124/jpet.301.2.418; Schlehuber S, 2002, BIOPHYS CHEM, V96, P213, DOI 10.1016/S0301-4622(02)00026-1; Schmid F. Z., 1997, PROTEIN STRUCTURE PR, P261; SCHNEIDER DM, 1992, BIOCHEMISTRY-US, V31, P3645, DOI 10.1021/bi00129a013; Silvian LF, 2011, ACS CHEM BIOL, V6, P636, DOI 10.1021/cb2000346; SMITH RA, 1987, J BIOL CHEM, V262, P6951; Steiner D, 2008, J MOL BIOL, V382, P1211, DOI 10.1016/j.jmb.2008.07.085; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sundberg EJ, 2003, ADV PROTEIN CHEM, V61, P119; VANOSTADE X, 1994, PROTEIN ENG, V7, P5, DOI 10.1093/protein/7.1.5; VUILLEUMIER S, 1993, BIOCHEMISTRY-US, V32, P10303, DOI 10.1021/bi00090a005; Zahnd C, 2007, J MOL BIOL, V369, P1015, DOI 10.1016/j.jmb.2007.03.028; Zahnd C, 2007, NAT METHODS, V4, P269, DOI 10.1038/NMETH1003	47	74	82	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31298	10.1371/journal.pone.0031298	http://dx.doi.org/10.1371/journal.pone.0031298			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363609	Green Published, gold, Green Submitted			2022-12-27	WOS:000302871500032
J	Kidd, S; Spaeth, E; Watson, K; Burks, J; Lu, HB; Klopp, A; Andreeff, M; Marini, FC				Kidd, Shannon; Spaeth, Erika; Watson, Keri; Burks, Jared; Lu, Hongbo; Klopp, Ann; Andreeff, Michael; Marini, Frank C.			Origins of the Tumor Microenvironment: Quantitative Assessment of Adipose-Derived and Bone Marrow-Derived Stroma	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ENDOTHELIAL PROGENITOR CELLS; UMBILICAL-CORD BLOOD; BREAST-CANCER; IN-VIVO; MYOFIBROBLASTS CONTRIBUTE; MOUSE MODEL; ANGIOGENESIS; FIBROBLASTS; PERICYTE	To meet the requirements for rapid tumor growth, a complex array of non-neoplastic cells are recruited to the tumor microenvironment. These cells facilitate tumor development by providing matrices, cytokines, growth factors, as well as vascular networks for nutrient and waste exchange, however their precise origins remain unclear. Through multicolored tissue transplant procedures; we have quantitatively determined the contribution of bone marrow-derived and adipose-derived cells to stromal populations within syngeneic ovarian and breast murine tumors. Our results indicate that subpopulations of tumor-associated fibroblasts (TAFs) are recruited from two distinct sources. The majority of fibroblast specific protein (FSP) positive and fibroblast activation protein (FAP) positive TAFs originate from mesenchymal stem/stromal cells (MSC) located in bone marrow sources, whereas most vascular and fibrovascular stroma (pericytes, alpha-SMA(+) myofibroblasts, and endothelial cells) originates from neighboring adipose tissue. These results highlight the capacity for tumors to utilize multiple sources of structural cells in a systematic and discriminative manner.	[Kidd, Shannon; Spaeth, Erika; Watson, Keri; Burks, Jared; Lu, Hongbo; Andreeff, Michael; Marini, Frank C.] Univ Texas Houston, Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Sect Mol Hematol & Therapy, Houston, TX 77030 USA; [Klopp, Ann] Univ Texas Houston, Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Kidd, S (corresponding author), Univ Texas Houston, Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Sect Mol Hematol & Therapy, Houston, TX 77030 USA.	fmarini@wakehealth.edu	Marini, Frank C/L-8018-2016	Spaeth, Erika/0000-0002-5397-3493	National Cancer Institute [RC1CA146381, CA109451, P50CA083639, R01CA109451, R01NS06994, Ca-116199, CA55164, CA16672, CA49639]; Paul and Mary Haas Chair in Genetics; Rosalie B Hite Foundation; Susan G Komen Breast Cancer Foundation; Ovarian Cancer Research Fund; Army Department of Defense [BC083397]; NATIONAL CANCER INSTITUTE [P01CA055164, RC1CA146381, P01CA049639, P50CA116199, P30CA016672, R01CA109451, P50CA083639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069964] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Paul and Mary Haas Chair in Genetics; Rosalie B Hite Foundation; Susan G Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Ovarian Cancer Research Fund; Army Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported in part by grants from the National Cancer Institute (RC1CA146381, CA109451, P50CA083639, R01CA109451, R01NS06994 and Ca-116199 for FCM, CA55164, CA16672, and CA49639 for Dr. Andreeff) and by the Paul and Mary Haas Chair in Genetics (Dr. Andreeff). Dr. Kidd is supported by the Rosalie B Hite Foundation. Dr. Marini is also supported in part by grants from the Susan G Komen Breast Cancer Foundation. Dr. Klopp is supported in part by the Ovarian Cancer Research Fund. Dr. Spaeth is supported in part by Army Department of Defense (BC083397). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Bababeygy SR, 2008, STEM CELLS DEV, V17, P11, DOI 10.1089/scd.2007.0117; Bartsch K, 2009, TRANSPLANTATION, V87, P217, DOI 10.1097/TP.0b013e3181938998; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; De Palma M, 2003, NAT MED, V9, P789, DOI 10.1038/nm871; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Dickhut A, 2005, ANN HEMATOL, V84, P722, DOI 10.1007/s00277-005-1067-8; Direkze NC, 2004, CANCER RES, V64, P8492, DOI 10.1158/0008-5472.CAN-04-1708; Dome B, 2009, CRIT REV ONCOL HEMAT, V69, P108, DOI 10.1016/j.critrevonc.2008.06.009; Duffy GP, 2009, TISSUE ENG PT A, V15, P2459, DOI [10.1089/ten.tea.2008.0341, 10.1089/ten.TEA.2008.0341]; Emura M, 2000, IN VITRO CELL DEV-AN, V36, P77; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Goon PKY, 2006, NEOPLASIA, V8, P79, DOI 10.1593/neo.05592; Gothert JR, 2004, BLOOD, V104, P1769, DOI 10.1182/blood-2003-11-3952; Grenier G, 2007, STEM CELLS, V25, P3101, DOI 10.1634/stemcells.2006-0795; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Helfman DM, 2005, BRIT J CANCER, V92, P1955, DOI 10.1038/sj.bjc.6602613; Hutchinson L, 2011, STEM CELLS DEV, V20, P11, DOI 10.1089/scd.2010.0139; Ishii G, 2005, INT J CANCER, V117, P212, DOI 10.1002/ijc.21199; Ishii G, 2003, BIOCHEM BIOPH RES CO, V309, P232, DOI 10.1016/S0006-291X(03)01544-4; Jaster R, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-26; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kidd S, 2010, CYTOTHERAPY, V12, P615, DOI 10.3109/14653241003631815; Kidd S, 2009, STEM CELLS, V27, P2614, DOI 10.1002/stem.187; Kunz-Schughart LA, 2002, HISTOL HISTOPATHOL, V17, P599, DOI 10.14670/HH-17.599; Lama Vibha N, 2006, Proc Am Thorac Soc, V3, P373, DOI 10.1513/pats.200512-133TK; Lamagna C, 2006, J LEUKOCYTE BIOL, V80, P677, DOI 10.1189/jlb.0506309; Larrivee B, 2005, J IMMUNOL, V175, P2890, DOI 10.4049/jimmunol.175.5.2890; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Manson JE, 2003, JAMA-J AM MED ASSOC, V289, P229, DOI 10.1001/jama.289.2.229; Mishra PJ, 2008, CANCER RES, V68, P4331, DOI 10.1158/0008-5472.CAN-08-0943; Monsky WL, 2002, CLIN CANCER RES, V8, P1008; Muehlberg FL, 2009, CARCINOGENESIS, V30, P589, DOI 10.1093/carcin/bgp036; Nishitani Y, 2005, KIDNEY INT, V68, P1078, DOI 10.1111/j.1523-1755.2005.00500.x; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Rajantie I, 2004, BLOOD, V104, P2084, DOI 10.1182/blood-2004-01-0336; Rebelatto CK, 2008, EXP BIOL MED, V233, P901, DOI 10.3181/0712-RM-356; Reddy K, 2008, MOL CANCER RES, V6, P929, DOI 10.1158/1541-7786.MCR-07-2189; Rehman J, 2003, J AM COLL CARDIOL, V41, P1408, DOI 10.1016/S0735-1097(03)00231-6; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Rose DP, 2007, ENDOCR REV, V28, P763, DOI 10.1210/er.2006-0019; Sangai T, 2005, INT J CANCER, V115, P885, DOI 10.1002/ijc.20969; Schneider M, 2008, J MOL MED, V86, P507, DOI 10.1007/s00109-007-0301-3; Short Brenton J., 2009, V482, P259, DOI 10.1007/978-1-59745-060-7_16; Song S, 2005, NAT CELL BIOL, V7, P870, DOI 10.1038/ncb1288; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Studeny M, 2001, BLOOD, V98, p696A; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; Udagawa T, 2006, FASEB J, V20, P95, DOI 10.1096/fj.04-3669com; Wang XM, 2005, HEPATOLOGY, V42, P935, DOI 10.1002/hep.20853; Wels J, 2008, GENE DEV, V22, P559, DOI 10.1101/gad.1636908; Zhang Y, 2009, CANCER RES, V69, P5259, DOI 10.1158/0008-5472.CAN-08-3444; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	59	249	255	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30563	10.1371/journal.pone.0030563	http://dx.doi.org/10.1371/journal.pone.0030563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363446	gold, Green Published, Green Submitted			2022-12-27	WOS:000302871500012
J	Pietila, M; Lehtonen, S; Tuovinen, E; Lahteenmaki, K; Laitinen, S; Leskela, HV; Natynki, A; Pesala, J; Nordstrom, K; Lehenkari, P				Pietila, Mika; Lehtonen, Siri; Tuovinen, Elina; Lahteenmaki, Kaarina; Laitinen, Saara; Leskela, Hannu-Ville; Natynki, Antti; Pesala, Juha; Nordstrom, Katrina; Lehenkari, Petri			CD200 Positive Human Mesenchymal Stem Cells Suppress TNF-Alpha Secretion from CD200 Receptor Positive Macrophage-Like Cells	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; MONOCYTE-DERIVED MACROPHAGES; DIFFERENTIATED THP-1 CELLS; ADAPTIVE IMMUNE-RESPONSE; INTERFERON-GAMMA; STROMAL CELLS; INNATE IMMUNITY; CROHNS-DISEASE; IN-VITRO; ACTIVATION	Human mesenchymal stem cells (hMSCs) display immunosuppressive properties in vitro and the potential has also been transferred successfully to clinical trials for treatment of autoimmune diseases. OX-2 (CD200), a member of the immunoglobulin superfamily, is widely expressed in several tissues and has recently been found from hMSCs. The CD200 receptor (CD200R) occurs only in myeloid-lineage cells. The CD200-CD200R is involved in down-regulation of several immune cells, especially macrophages. The present study on 20 hMSC lines shows that the CD200 expression pattern varied from high (CD200Hi) to medium (CD200Me) and low (CD200Lo) in bone marrow-derived mesenchymal stem cell (BMMSC) lines, whereas umbilical cord blood derived mesenchymal stem cells (UCBMSCs) were constantly negative for CD200. The role of the CD200-CD200R axis in BMMSCs mediated immunosuppression was studied using THP-1 human macrophages. Interestingly, hMSCs showed greater inhibition of TNF-alpha secretion in co-cultures with IFN-gamma primed THP-1 macrophages when compared to LPS activated cells. The ability of CD200Hi BMMSCs to suppress TNF-alpha secretion from IFN-gamma stimulated THP-1 macrophages was significantly greater when compared to CD200Lo whereas UCBMSCs did not significantly reduce TNF-alpha secretion. The interference of CD200 binding to the CD200R by anti-CD200 antibody weakened the capability of BMMSCs to inhibit TNF-alpha secretion from IFN-gamma activated THP-1 macrophages. This study clearly demonstrated that the efficiency of BMMSCs to suppress TNF-alpha secretion of THP-1 macrophages was dependent on the type of stimulus. Moreover, the CD200-CD200r axis could have a previously unidentified role in the BMMSC mediated immunosuppression.	[Pietila, Mika; Lehtonen, Siri; Leskela, Hannu-Ville; Natynki, Antti; Pesala, Juha; Lehenkari, Petri] Univ Oulu, Inst Biomed, Dept Anat & Cell Biol, Oulu, Finland; [Pietila, Mika; Lehtonen, Siri; Leskela, Hannu-Ville; Natynki, Antti; Pesala, Juha; Lehenkari, Petri] Univ Oulu, Div Surg, Inst Clin Med, Dept Surg & Intens Care, Oulu, Finland; [Pietila, Mika; Lehtonen, Siri; Leskela, Hannu-Ville; Natynki, Antti; Pesala, Juha; Lehenkari, Petri] Oulu Univ Hosp, Clin Res Ctr, Oulu, Finland; [Tuovinen, Elina; Lahteenmaki, Kaarina; Laitinen, Saara] Finnish Red Cross Blood Serv, Helsinki, Finland; [Nordstrom, Katrina] Aalto Sch Chem Technol, Dept Biotechnol & Chem Technol, Espoo, Finland	University of Oulu; University of Oulu; University of Oulu; Aalto University	Pietila, M (corresponding author), Univ Oulu, Inst Biomed, Dept Anat & Cell Biol, Oulu, Finland.	mika.pietila@aalto.fi	Lehenkari, Petri/O-3009-2016; Nordstrom, Katrina/K-6822-2012	Lehenkari, Petri/0000-0002-0055-5183; Nordstrom, Katrina/0000-0003-3508-9810; Natynki, Antti/0000-0003-4636-4291; Lehtonen, Siri/0000-0002-5578-8232	Academy of Finland [122561]; Finnish Medical Association	Academy of Finland(Academy of Finland); Finnish Medical Association	This study was funded by the Academy of Finland (Grant: 122561) and by the Finnish Medical Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; ASSEFFA A, 1993, ONCOL RES, V5, P11; BARCLAY AN, 1986, BIOCHEM SOC SYMP, P149; Broderick C, 2002, AM J PATHOL, V161, P1669, DOI 10.1016/S0002-9440(10)64444-6; Brown JN, 2010, J LEUKOCYTE BIOL, V87, P655, DOI 10.1189/jlb.0809570; Bystrom J, 2008, BLOOD, V112, P4117, DOI 10.1182/blood-2007-12-129767; Campioni D, 2009, CYTOM PART B-CLIN CY, V76B, P225, DOI 10.1002/cyto.b.20461; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Croitoru-Lamoury J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014698; Cui WG, 2007, P NATL ACAD SCI USA, V104, P14436, DOI 10.1073/pnas.0702811104; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Delorme B, 2008, BLOOD, V111, P2631, DOI 10.1182/blood-2007-07-099622; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Duijvestein M, 2010, GUT, V59, P1662, DOI 10.1136/gut.2010.215152; Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132; Fernandes JL, 2004, CYTOKINE, V26, P131, DOI 10.1016/j.cyto.2004.01.007; Gonzalez MA, 2009, GASTROENTEROLOGY, V136, P978, DOI 10.1053/j.gastro.2008.11.041; Gorczynski RM, 2002, CLIN IMMUNOL, V104, P256, DOI 10.1006/clim.2002.5232; Gorczynski RM, 2001, CLIN IMMUNOL, V101, P328, DOI 10.1006/clim.2001.5117; Harvey EJ, 2005, CARDIOVASC RES, V67, P11, DOI 10.1016/j.cardiores.2005.04.019; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Jenmalm MC, 2006, J IMMUNOL, V176, P191, DOI 10.4049/jimmunol.176.1.191; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Kang SS, 2007, INT IMMUNOPHARMACOL, V7, P1488, DOI 10.1016/j.intimp.2007.07.011; Kawasaki BT, 2008, TRENDS IMMUNOL, V29, P464, DOI 10.1016/j.it.2008.07.005; Kawasaki BT, 2007, BIOCHEM BIOPH RES CO, V364, P778, DOI 10.1016/j.bbrc.2007.10.067; Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004; KOSAKA C, 1992, ATHEROSCLEROSIS, V97, P75, DOI 10.1016/0021-9150(92)90053-J; Laitinen A, 2011, METHODS MOL BIOL, V698, P63, DOI 10.1007/978-1-60761-999-4_6; Langlals CL, 2006, J VIROL, V80, P3098, DOI 10.1128/JVI.80.6.3098-3103.2006; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lepelletier Y, 2010, STEM CELLS DEV, V19, P1075, DOI 10.1089/scd.2009.0212; Leskela HV, 2003, BIOCHEM BIOPH RES CO, V311, P1008, DOI 10.1016/j.bbrc.2003.10.095; Longoni B, 2010, DIABETES TECHNOL THE, V12, P435, DOI 10.1089/dia.2009.0154; Lyons A, 2007, J NEUROSCI, V27, P8309, DOI 10.1523/JNEUROSCI.1781-07.2007; Maggini J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009252; Matsue H, 2005, J INVEST DERMATOL, V125, pX, DOI 10.1111/j.0022-202X.2005.23978.x; MCCAUGHAN GW, 1987, IMMUNOGENETICS, V25, P329, DOI 10.1007/BF00404426; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Miettinen JA, 2011, EXP CELL RES, V317, P791, DOI 10.1016/j.yexcr.2010.12.010; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Opitz CA, 2009, STEM CELLS, V27, P909, DOI 10.1002/stem.7; Puissant N, 2005, BRIT J HAEMATOL, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x; Ren GW, 2010, J IMMUNOL, V184, P2321, DOI 10.4049/jimmunol.0902023; Ryan JM, 2007, CLIN EXP IMMUNOL, V149, P353, DOI 10.1111/j.1365-2249.2007.03422.x; Salata C, 2009, J CELL PHYSIOL, V219, P698, DOI 10.1002/jcp.21722; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Shi DN, 2006, CELL RES, V16, P70, DOI 10.1038/sj.cr.7310009; Simelyte E, 2010, CLIN EXP IMMUNOL, V162, P163, DOI 10.1111/j.1365-2249.2010.04227.x; Simelyte E, 2008, ARTHRITIS RHEUM, V58, P1038, DOI 10.1002/art.23378; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; Strober W, 2010, CURR OPIN GASTROEN, V26, P310, DOI 10.1097/MOG.0b013e328339d099; Taylor S, 2011, EXP EYE RES; Wang M, 2009, IMMUNOLOGY, V126, P220, DOI 10.1111/j.1365-2567.2008.02891.x; Wright GJ, 2000, IMMUNITY, V13, P233, DOI 10.1016/S1074-7613(00)00023-6; YOUNG HA, 1995, J LEUKOCYTE BIOL, V58, P373, DOI 10.1002/jlb.58.4.373; Zhang QZ, 2010, STEM CELLS, V28, P1856, DOI 10.1002/stem.503	59	47	50	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31671	10.1371/journal.pone.0031671	http://dx.doi.org/10.1371/journal.pone.0031671			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363701	Green Published, Green Submitted, gold			2022-12-27	WOS:000302871500072
J	Banada, PP; Chakravorty, S; Shah, D; Burday, M; Mazzella, FM; Alland, D				Banada, Padmapriya P.; Chakravorty, Soumitesh; Shah, Darshini; Burday, Michele; Mazzella, Fermina M.; Alland, David			Highly Sensitive Detection of Staphylococcus aureus Directly from Patient Blood	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; STREAM INFECTIONS; SUSPECTED SEPSIS; FUNGAL PATHOGENS; RAPID DETECTION; MULTIPLEX PCR; AMPLIFICATION; BACTERIAL; DIAGNOSIS	Background: Rapid detection of bloodstream infections (BSIs) can be lifesaving. We investigated the sample processing and assay parameters necessary for highly-sensitive detection of bloodstream bacteria, using Staphylococcus aureus as a model pathogen and an automated fluidic sample processing-polymerase chain reaction (PCR) platform as a model diagnostic system. Methodology/Principal Findings: We compared a short 128 bp amplicon hemi-nested PCR and a relatively shorter 79 bp amplicon nested PCR targeting the S. aureus nuc and sodA genes, respectively. The sodA nested assay showed an enhanced limit of detection (LOD) of 5 genomic copies per reaction or 10 colony forming units (CFU) per ml blood over 50 copies per reaction or 50 CFU/ml for the nuc assay. To establish optimal extraction protocols, we investigated the relative abundance of the bacteria in different components of the blood (white blood cells (WBCs), plasma or whole blood), using the above assays. The blood samples were obtained from the patients who were culture positive for S. aureus. Whole blood resulted in maximum PCR positives with sodA assay (90% positive) as opposed to cell-associated bacteria (in WBCs) (71% samples positive) or free bacterial DNA in plasma (62.5% samples positive). Both the assays were further tested for direct detection of S. aureus in patient whole blood samples that were contemporaneous culture positive. S. aureus was detected in 40/45 of culture-positive patients (sensitivity 89%, 95% CI 0.75-0.96) and 0/59 negative controls with the sodA assay (specificity 100%, 95% CI 0.92-1). Conclusions: We have demonstrated a highly sensitive two-hour assay for detection of sepsis causing bacteria like S. aureus directly in 1 ml of whole blood, without the need for blood culture.	[Banada, Padmapriya P.; Chakravorty, Soumitesh; Alland, David] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Div Infect Dis, Newark, NJ 07103 USA; [Shah, Darshini; Burday, Michele; Mazzella, Fermina M.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Pathol & Lab Med, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Banada, PP (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Div Infect Dis, Newark, NJ 07103 USA.	allandda@umdnj.edu	Banada, Padmapriya/H-6213-2019	Banada, Padmapriya/0000-0002-5217-6142	National Institutes of Health [U01 AI75490]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI075490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant U01 AI75490. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Al-Soud W, 2000, J CLIN MICROBIOL, V38, P345; Abu al-Soud W, 2001, J CLIN MICROBIOL, V39, P485, DOI 10.1128/JCM.39.2.485-493.2001; Casalta JP, 2009, EUR J CLIN MICROBIOL, V28, P569, DOI 10.1007/s10096-008-0672-6; Chakravorty S, 2006, FEMS MICROBIOL LETT, V257, P306, DOI 10.1111/j.1574-6968.2006.00187.x; Chakravorty S, 2010, J CLIN MICROBIOL, V48, P258, DOI 10.1128/JCM.01725-09; Corey GR, 2011, INFECT DIS CLIN PRAC, V19, P307; del Rio A, 2009, CLIN INFECT DIS, V48, pS246, DOI 10.1086/598187; Gaibani Paolo, 2009, Int J Antimicrob Agents, V34 Suppl 4, pS13, DOI 10.1016/S0924-8579(09)70559-X; Harbarth S, 2003, J HOSP INFECT, V54, P258, DOI 10.1016/S0195-6701(03)00150-6; Hein I, 2001, APPL ENVIRON MICROB, V67, P3122, DOI 10.1128/AEM.67.7.3122-3126.2001; Huber JA, 2009, ENVIRON MICROBIOL, V11, P1292, DOI 10.1111/j.1462-2920.2008.01857.x; Ivancic-Jelecki J, 2009, J CHROMATOGR A, V1216, P2717, DOI 10.1016/j.chroma.2008.10.087; Jaeger H, 2010, JAIDS-J ACQ IMM DEF, V54, P334, DOI 10.1097/QAI.0b013e3181d04d12; KELLOGG JA, 1984, J CLIN MICROBIOL, V20, P618, DOI 10.1128/JCM.20.4.618-623.1984; Kleter B, 1998, AM J PATHOL, V153, P1731, DOI 10.1016/S0002-9440(10)65688-X; Klouche M, 2008, CLIN CHEM LAB MED, V46, P888, DOI 10.1515/CCLM.2008.157; Kollef MH, 2003, AM J MED, V115, P582, DOI 10.1016/j.amjmed.2003.09.002; Laforgia N, 1997, ACTA PAEDIATR, V86, P1097, DOI 10.1111/j.1651-2227.1997.tb14815.x; Lehmann LE, 2008, MED MICROBIOL IMMUN, V197, P313, DOI 10.1007/s00430-007-0063-0; Lodise TP, 2003, CLIN INFECT DIS, V36, P1418, DOI 10.1086/375057; Maubon D, 2010, J INFECTION, V61, P335, DOI 10.1016/j.jinf.2010.07.004; Morata P, 1998, J CLIN MICROBIOL, V36, P2443, DOI 10.1128/JCM.36.9.2443-2446.1998; Paolucci M, 2009, J MED MICROBIOL, V58, P533, DOI 10.1099/jmm.0.003848-0; Planella M, 2001, CLIN TRANSL ONCOL, V3, P163; Rozen S, 2000, Methods Mol Biol, V132, P365; Shang S, 2001, ACTA PAEDIATR, V90, P179, DOI 10.1080/080352501300049389; Sikora A, 2010, CLIN CHEM, V56, P136, DOI 10.1373/clinchem.2009.132951; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Tsalik EL, 2010, J CLIN MICROBIOL, V48, P26, DOI 10.1128/JCM.01447-09; Varani S, 2009, J INFECTION, V58, P346, DOI 10.1016/j.jinf.2009.03.001; von Lilienfeld-Toal M, 2009, J CLIN MICROBIOL, V47, P2405, DOI 10.1128/JCM.00491-09; Wallet F, 2010, CLIN MICROBIOL INFEC, V16, P774, DOI 10.1111/j.1469-0691.2009.02940.x; Westh H, 2009, CLIN MICROBIOL INFEC, V15, P544, DOI 10.1111/j.1469-0691.2009.02736.x; Zhao YA, 2009, J CLIN MICROBIOL, V47, P2067, DOI 10.1128/JCM.02230-08; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	35	43	45	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31126	10.1371/journal.pone.0031126	http://dx.doi.org/10.1371/journal.pone.0031126			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363564	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600114
J	Blondeau, B; Sahly, I; Massourides, E; Singh-Estivalet, A; Valtat, B; Dorchene, D; Jaisser, F; Breant, B; Tronche, F				Blondeau, Bertrand; Sahly, Iman; Massourides, Emmanuelle; Singh-Estivalet, Amrit; Valtat, Berengere; Dorchene, Delphine; Jaisser, Frederic; Breant, Bernadette; Tronche, Francois			Novel Transgenic Mice for Inducible Gene Overexpression in Pancreatic Cells Define Glucocorticoid Receptor-Mediated Regulations of Beta Cells	PLOS ONE			English	Article							EXPRESSION; BRAIN	Conditional gene deletion in specific cell populations has helped the understanding of pancreas development. Using this approach, we have shown that deleting the glucocorticoid receptor (GR) gene in pancreatic precursor cells leads to a doubled beta-cell mass. Here, we provide genetic tools that permit a temporally and spatially controlled expression of target genes in pancreatic cells using the Tetracycline inducible system. To efficiently target the Tetracycline transactivator (tTA) in specific cell populations, we generated Bacterial Artificial Chromosomes (BAC) transgenic mice expressing the improved Tetracycline transactivator (itTA) either in pancreatic progenitor cells expressing the transcription factor Pdx1 (BAC-Pdx1-itTA), or in beta cells expressing the insulin1 gene (BAC-Ins1-itTA). In the two transgenic models, itTA-mediated activation of reporter genes was efficient and subject to regulation by Doxycycline (Dox). The analysis of a tetracycline-regulated LacZ reporter gene shows that in BAC-Pdx1-itTA mice, itTA is expressed from embryonic (E) day 11.5 in all pancreatic precursor cells. In the adult pancreas, itTA is active in mature beta, delta cells and in few acinar cells. In BAC-Ins1-itTA mice tTA is active from E13.5 and is restricted to beta cells in fetal and adult pancreas. In both lines, tTA activity was suppressed by Dox treatment and re-induced after Dox removal. Using these transgenic lines, we overexpressed the GR in selective pancreatic cell populations and found that overexpression in precursor cells altered adult beta-cell fraction but not glucose tolerance. In contrast, GR overexpression in mature beta cells did not alter beta-cell fraction but impaired glucose tolerance with insufficient insulin secretion. In conclusion, these new itTA mouse models will allow fine-tuning of gene expression to investigate gene function in pancreatic biology and help us understand how glucocorticoid signaling affects on the long-term distinct aspects of beta-cell biology.	[Blondeau, Bertrand; Sahly, Iman; Singh-Estivalet, Amrit; Valtat, Berengere; Dorchene, Delphine; Jaisser, Frederic; Breant, Bernadette] INSERM, Ctr Rech Cordeliers, UMR S 872, Paris, France; [Blondeau, Bertrand; Sahly, Iman; Massourides, Emmanuelle; Singh-Estivalet, Amrit; Valtat, Berengere; Dorchene, Delphine; Jaisser, Frederic; Breant, Bernadette; Tronche, Francois] Univ Paris 06, Paris, France; [Massourides, Emmanuelle; Tronche, Francois] CNRS, Mol Genet Neurophysiol & Behav Team, UMR7224, Paris, France; [Massourides, Emmanuelle; Tronche, Francois] INSERM, U952, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Blondeau, B (corresponding author), INSERM, Ctr Rech Cordeliers, UMR S 872, Paris, France.	Bertrand.blondeau@crc.jussieu.fr	Jaisser, Frederic/P-4287-2017; TRONCHE, François/F-3895-2011	Jaisser, Frederic/0000-0001-9051-1901; Blondeau, Bertrand/0000-0002-1106-1509; Blondeau, Bertrand/0000-0001-8771-6631; Massourides, Emmanuelle/0000-0002-9829-5008	Univerisite Pierre et Marie Curie; Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; European Union [Food-CT-2005-007036]; Agence Nationale de la Recherche [A05245DS]	Univerisite Pierre et Marie Curie; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); European Union(European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR))	The authors thank E Casanova, N Copeland and R Sprengel for providing plasmids and bacterial strains used in this study. Financial support was provided by Univerisite Pierre et Marie Curie, The Institut National de la Sante et de la Recherche Medicale, the Centre National de la Recherche Scientifique, the European Union Frame Program 6 Earnest program Food-CT-2005-007036 to B Breant and F Tronche and the Agence Nationale de la Recherche (Grant Gramsy No A05245DS) to B Breant and F Tronche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Blondeau B, 2001, AM J PHYSIOL-ENDOC M, V281, pE592, DOI 10.1152/ajpendo.2001.281.3.E592; Collombat P, 2006, MECH DEVELOP, V123, P501, DOI 10.1016/j.mod.2006.05.006; Delaunay F, 1997, J CLIN INVEST, V100, P2094, DOI 10.1172/JCI119743; Gannon M, 2000, GENESIS, V26, P139, DOI 10.1002/(SICI)1526-968X(200002)26:2<139::AID-GENE12>3.0.CO;2-7; Gesina E, 2004, DIABETES, V53, P2322, DOI 10.2337/diabetes.53.9.2322; Giraldo P, 2001, TRANSGENIC RES, V10, P83, DOI 10.1023/A:1008918913249; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Krestel HE, 2004, J NEUROSCI, V24, P10568, DOI 10.1523/JNEUROSCI.4579-03.2004; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Morozov A, 2003, BIOL PSYCHIAT, V54, P1125, DOI 10.1016/S0006-3223(03)00467-0; Murtaugh LC, 2003, ANNU REV CELL DEV BI, V19, P71, DOI 10.1146/annurev.cellbio.19.111301.144752; Sahly I, 2007, MOL CELL NEUROSCI, V36, P27, DOI 10.1016/j.mcn.2007.05.005; Sainte-Marie Y, 2007, FASEB J, V21, P3133, DOI 10.1096/fj.07-8357com; SCHLAKE T, 1994, BIOCHEMISTRY-US, V33, P12746, DOI 10.1021/bi00209a003; Silberg DG, 2000, GASTROENTEROLOGY, V119, P961, DOI 10.1053/gast.2000.18142; SLACK JMW, 1995, DEVELOPMENT, V121, P1569; Stoffers DA, 1999, ENDOCRINOLOGY, V140, P5374, DOI 10.1210/en.140.11.5374; Turiault M, 2007, FEBS J, V274, P3568, DOI 10.1111/j.1742-4658.2007.05886.x; Valtat B, 2011, DIABETOLOGIA, V54, P350, DOI 10.1007/s00125-010-1898-2; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624	21	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30210	10.1371/journal.pone.0030210	http://dx.doi.org/10.1371/journal.pone.0030210			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363422	gold, Green Published, Green Submitted			2022-12-27	WOS:000302853600016
J	Cartei, V; Cowles, HW; Reby, D				Cartei, Valentina; Cowles, Heidi Wind; Reby, David			Spontaneous Voice Gender Imitation Abilities in Adult Speakers	PLOS ONE			English	Article							SPEAKING FUNDAMENTAL-FREQUENCY; SEXUAL ORIENTATION; VOCAL-TRACT; SPEECH; FEMALE; SIZE; DOMINANCE; ATTRACTIVENESS; IDENTIFICATION; INTONATION	Background: The frequency components of the human voice play a major role in signalling the gender of the speaker. A voice imitation study was conducted to investigate individuals' ability to make behavioural adjustments to fundamental frequency (F0), and formants (Fi) in order to manipulate their expression of voice gender. Methodology/Principal Findings: Thirty-two native British-English adult speakers were asked to read out loud different types of text (words, sentence, passage) using their normal voice and then while sounding as 'masculine' and 'feminine' as possible. Overall, the results show that both men and women raised their F0 and Fi when feminising their voice, and lowered their F0 and Fi when masculinising their voice. Conclusions/Significance: These observations suggest that adult speakers are capable of spontaneous glottal and vocal tract length adjustments to express masculinity and femininity in their voice. These results point to a "gender code", where speakers make a conventionalized use of the existing sex dimorphism to vary the expression of their gender and gender-related attributes.	[Cartei, Valentina; Reby, David] Univ Sussex, Sch Psychol, Brighton, E Sussex, England; [Cowles, Heidi Wind] Univ Florida, Dept Linguist, Gainesville, FL USA	University of Sussex; State University System of Florida; University of Florida	Cartei, V (corresponding author), Univ Sussex, Sch Psychol, Brighton, E Sussex, England.	d.reby@sussex.ac.uk	Cowles, Wind/AGU-9176-2022; reby, david/A-4227-2013	Cowles, Wind/0000-0001-9489-0750; Reby, David/0000-0001-9261-1711; Cartei, Canessa-Pollard, Valentina/0000-0002-3646-7871	School of Psychology of the University of Sussex	School of Psychology of the University of Sussex	The research did not receive any external funding. It is part of the first author's DPhil research project and funded by the postgraduate research fund from the School of Psychology of the University of Sussex. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachorowski JA, 1999, J ACOUST SOC AM, V106, P1054, DOI 10.1121/1.427115; BENNETT S, 1981, J ACOUST SOC AM, V69, P231, DOI 10.1121/1.385343; Boersma Paul, 2002, GLOT INT, V5, P341; BUSBY PA, 1995, J ACOUST SOC AM, V97, P2603, DOI 10.1121/1.412975; BYRD D, 1992, J ACOUST SOC AM, V92, P593, DOI 10.1121/1.404271; Collins SA, 2003, ANIM BEHAV, V65, P997, DOI 10.1006/anbe.2003.2123; Deterding David, 1997, J INT PHON ASSOC, V27, P47, DOI DOI 10.1017/S0025100300005417; Ericsdotter C, 2001, WORKING PAPERS LUND, P34; Fairbanks G, 1960, VOICE ARTICULATION D, P126; Fant G., 1960, ACOUSTIC THEORY SPEE; Fant G., 1966, SPEECH TRANSMISSION, V7, P22; Feinberg DR, 2005, ANIM BEHAV, V69, P561, DOI 10.1016/j.anbehav.2004.06.012; Fitch WT, 1999, J ACOUST SOC AM, V106, P1511, DOI 10.1121/1.427148; Fitch WT, 2001, P ROY SOC B-BIOL SCI, V268, P1669, DOI 10.1098/rspb.2001.1704; GAUDIO RP, 1994, AM SPEECH, V69, P30, DOI 10.2307/455948; Gaulin SJC, 1985, ETHOL SOCIOBIOL, V6; Goldstein UG, 1980, ARTICULATORY MODEL V; GRADDOL D, 1983, LANG SPEECH, V26, P351, DOI 10.1177/002383098302600403; GUNZBURGER D, 1987, LANG SPEECH, V30, P47; Harrington J, 2008, J ACOUST SOC AM, V123, P2825, DOI 10.1121/1.2897042; Hawkins S., 2005, J INT PHON ASSOC, V35, P183, DOI DOI 10.1017/S0025100305002124; Hecht MA, 1998, PERS SOC PSYCHOL B, V24, P1332, DOI 10.1177/01461672982412007; HENTON C, 1995, LANG COMMUN, V15, P43, DOI 10.1016/0271-5309(94)00011-Z; HENTON CG, 1989, LANG COMMUN, V9, P299, DOI 10.1016/0271-5309(89)90026-8; HERMES DJ, 1991, J ACOUST SOC AM, V90, P97, DOI 10.1121/1.402397; HILLENBRAND J, 1995, J ACOUST SOC AM, V97, P3099, DOI 10.1121/1.411872; Hirano M., 1981, VOCAL FOLD PHYSL, P33; Horgan, 2000, GENDER EMOTION SOCIA, P97, DOI DOI 10.1017/CBO9780511628191.006; KRAMER C, 1978, SIGNS, V3, P638, DOI 10.1086/493507; Kroos C, 2002, J PHONETICS, V30, P569, DOI 10.1006/jpho.2002.0164; LaFrance M, 2003, PSYCHOL BULL, V129, P305, DOI 10.1037/0033-2909.129.2.305; LaFrance M, 1999, OPTION OBLIGATION SM; Lee S, 1999, J ACOUST SOC AM, V105, P1455, DOI 10.1121/1.426686; Linke C E, 1973, Folia Phoniatr (Basel), V25, P173; MAJEWSKI W, 1972, PHONETICA, V25, P119, DOI 10.1159/000259375; MCCONNELLGINET S, 1978, SIGNS, V3, P541, DOI 10.1086/493501; Munson B, 2006, J PHONETICS, V34, P202, DOI 10.1016/j.wocn.2005.05.003; Munson B, 2007, LANG LINGUIST COMPAS, V1, DOI 10.1111/j.1749-818x.2007.00028.x; OHALA JJ, 1984, PHONETICA, V41, P1, DOI 10.1159/000261706; Ohara Yumiko, 2001, MULTILINGUALISM 2 LA, P231; Perry TL, 2001, J ACOUST SOC AM, V109, P2988, DOI 10.1121/1.1370525; PETERSON GE, 1952, J ACOUST SOC AM, V24, P175, DOI 10.1121/1.1906875; Pierrehumbert JB, 2004, J ACOUST SOC AM, V116, P1905, DOI 10.1121/1.1788729; Pisanski K, 2011, J ACOUST SOC AM, V129, P2201, DOI 10.1121/1.3552866; Puts DA, 2005, EVOL HUM BEHAV, V26, P388, DOI 10.1016/j.evolhumbehav.2005.03.001; Puts DA, 2007, EVOL HUM BEHAV, V28, P340, DOI 10.1016/j.evolhumbehav.2007.05.002; Puts DA, 2006, EVOL HUM BEHAV, V27, P283, DOI 10.1016/j.evolhumbehav.2005.11.003; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Rendall D, 2005, J ACOUST SOC AM, V117, P944, DOI 10.1121/1.1848011; Rendall D, 2008, ARCH SEX BEHAV, V37, P188, DOI 10.1007/s10508-007-9269-x; RIETVELD ACM, 1985, J PHONETICS, V13, P299, DOI 10.1016/S0095-4470(19)30761-2; Sachs J., 1973, LANGUAGE ATTITUDES C; Simpson AP, 2009, LANG LINGUIST COMPAS, V3, P621, DOI 10.1111/j.1749-818x.2009.00125.x; Simpson AP, 2003, P 6 INT SEM SPEECH P; Smith DRR, 2005, J ACOUST SOC AM, V118, P3177, DOI 10.1121/1.2047107; Stevens K.N., 2000, ACOUSTIC PHONETICS, V30; STOPPARD JM, 1993, PERS SOC PSYCHOL B, V19, P143, DOI 10.1177/0146167293192002; Thorsen N, 1980, INTONATION CONTOURS; Titze I. R., 2000, PRINCIPLES VOICE PRO; Tusing KJ, 2000, HUM COMMUN RES, V26, P148, DOI 10.1093/hcr/26.1.148; Vannoni E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003113; Vorperian HK, 2007, J SPEECH LANG HEAR R, V50, P1510, DOI 10.1044/1092-4388(2007/104); Vorperian HK, 2009, J ACOUST SOC AM, V125, P1666, DOI 10.1121/1.3075589; Whiteside S., 1996, TEMPORAL BASED ACOUS, V26, P23, DOI 10.1017/S0025100300005302; Whiteside SP, 2000, SPEECH COMMUN, V32, P267, DOI 10.1016/S0167-6393(00)00013-3; WOLFE VI, 1990, J SPEECH HEAR DISORD, V55, P43, DOI 10.1044/jshd.5501.43; Yehia H, 1998, SPEECH COMMUN, V26, P23, DOI 10.1016/S0167-6393(98)00048-X	68	32	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31353	10.1371/journal.pone.0031353	http://dx.doi.org/10.1371/journal.pone.0031353			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	926TC	22363628	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000302853600141
J	Saudek, V				Saudek, Vladimir			Cystinosin, MPDU1, SWEETs and KDELR Belong to a Well-Defined Protein Family with Putative Function of Cargo Receptors Involved in Vesicle Trafficking	PLOS ONE			English	Article							CLEFT-LIP; SEQUENCE; TRANSLOCATION; GENE; PREDICTION; RETENTION; DOLICHOL; COMPLEX; DOMAIN; ERS1	Classification of proteins into families based on remote homology often helps prediction of their biological function. Here we describe prediction of protein cargo receptors involved in vesicle formation and protein trafficking. Hidden Markov model profile-to-profile searches in protein databases using endoplasmic reticulum lumen protein retaining receptors (KDEL, Erd2) as query reveal a large and diverse family of proteins with seven transmembrane helices and common topology and, most likely, similar function. Their coding genes exist in all eukaryota and in several prokaryota. Some are responsible for metabolic diseases (cystinosis, congenital disorder of glycosylation), others are candidate genes for genetic disorders (cleft lip and palate, certain forms of cancer) or solute uptake and efflux (SWEETs) and many have not yet been assigned a function. Comparison with the properties of KDEL receptors suggests that the family members could be involved in protein trafficking and serve as cargo receptors. This prediction sheds new light on a range of biologically, medically and agronomically important proteins and could open the way to discovering the function of many genes not yet annotated. Experimental testing is suggested.	Univ Cambridge Metab Res Labs, Inst Metab Sci, Addenbrookes Hosp, Cambridge, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Saudek, V (corresponding author), Univ Cambridge Metab Res Labs, Inst Metab Sci, Addenbrookes Hosp, Cambridge, England.	vs317@cam.ac.uk			University of Cambridge Metabolic Research Labs, Institute of Metabolic Science	University of Cambridge Metabolic Research Labs, Institute of Metabolic Science	This work has been supported by University of Cambridge Metabolic Research Labs, Institute of Metabolic Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anand M, 2001, MOL BIOL CELL, V12, P487, DOI 10.1091/mbc.12.2.487; Anantharaman V, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-34; Antignac C, 2010, ROLE CYSTINOSIN VESI; Baroni T, 2010, J CELL PHYSIOL, V222, P748, DOI 10.1002/jcp.22006; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Binda M, 2010, CELL CYCLE, V9, P221, DOI 10.4161/cc.9.2.10585; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020; Eddy Sean R, 2009, Genome Inform, V23, P205; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Frank CG, 2008, NATURE, V454, pE3, DOI 10.1038/nature07165; Gahl WA, 2002, NEW ENGL J MED, V347, P111, DOI 10.1056/NEJMra020552; Gao MG, 2006, NAT CELL BIOL, V8, P657, DOI 10.1038/ncb1419; Gao XD, 2005, FEBS J, V272, P2497, DOI 10.1111/j.1742-4658.2005.04670.x; Gasnier B, 2010, MOL ANATOMY PHYSL HU; HARDWICK KG, 1990, EMBO J, V9, P623, DOI 10.1002/j.1460-2075.1990.tb08154.x; HARDWICK KG, 1990, NUCLEIC ACIDS RES, V18, P2177, DOI 10.1093/nar/18.8.2177; Helenius J, 2002, NATURE, V415, P447, DOI 10.1038/415447a; Hsu VW, 2009, FEBS LETT, V583, P3758, DOI 10.1016/j.febslet.2009.10.056; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Kalatzis V, 2001, EMBO J, V20, P5940, DOI 10.1093/emboj/20.21.5940; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; Kemena C, 2009, BIOINFORMATICS, V25, P2455, DOI 10.1093/bioinformatics/btp452; Kim H, 2006, P NATL ACAD SCI USA, V103, P11142, DOI 10.1073/pnas.0604075103; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; Moriyama EN, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r96; Nicholas KB, 2007, GENEDOC ANAL VISUALI; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Podar M, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-2; Pomorski T, 2006, CELL MOL LIFE SCI, V63, P2908, DOI 10.1007/s00018-006-6167-7; Ponting CP, 2001, GENOME RES, V11, P1996, DOI 10.1101/gr.198701; Pucadyil TJ, 2009, SCIENCE, V325, P1217, DOI 10.1126/science.1171004; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Sanyal S, 2010, P NATL ACAD SCI USA, V107, P11289, DOI 10.1073/pnas.1002408107; Schachter H, 2001, J CLIN INVEST, V108, P1579, DOI 10.1172/JCI200114498; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Stokes AJ, 2005, J CELL BIOCHEM, V94, P669, DOI 10.1002/jcb.20331; Taub ML, 2011, BIOCHEM BIOPH RES CO, V407, P355, DOI 10.1016/j.bbrc.2011.03.022; TOWNSLEY FM, 1993, EMBO J, V12, P2821, DOI 10.1002/j.1460-2075.1993.tb05943.x; Wilmer MJ, 2010, AM J PHYSIOL-RENAL, V299, pF905, DOI 10.1152/ajprenal.00318.2010; Yoshiura K, 1998, GENOMICS, V54, P231, DOI 10.1006/geno.1998.5577; Yu XM, 2008, PLOS BIOL, V6, P581, DOI 10.1371/journal.pbio.0060061; Zhai YF, 2001, BBA-BIOMEMBRANES, V1511, P206, DOI 10.1016/S0005-2736(00)00389-8	49	31	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30876	10.1371/journal.pone.0030876	http://dx.doi.org/10.1371/journal.pone.0030876			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363504	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600079
J	Velten, J; Cakir, C; Youn, E; Chen, JP; Cazzonelli, CI				Velten, Jeff; Cakir, Cahid; Youn, Eunseog; Chen, Junping; Cazzonelli, Christopher I.			Transgene Silencing and Transgene-Derived siRNA Production in Tobacco Plants Homozygous for an Introduced AtMYB90 Construct	PLOS ONE			English	Article							REDUCTASE CO-SUPPRESSION; SMALL RNAS; NITRATE REDUCTASE; ARABIDOPSIS-THALIANA; NITRITE REDUCTASE; GENE-EXPRESSION; MESSENGER-RNA; MECHANISM; MICRORNAS; PATHWAYS	Transgenic tobacco (Nicotiana tabacum) lines were engineered to ectopically over-express AtMYB90 (PAP2), an R2-R3 Myb gene associated with regulation of anthocyanin production in Arabidopsis thaliana. Independently transformed transgenic lines, Myb27 and Myb237, accumulated large quantities of anthocyanin, generating a dark purple phenotype in nearly all tissues. After self-fertilization, some progeny of the Myb27 line displayed an unexpected pigmentation pattern, with most leaves displaying large sectors of dramatically reduced anthocyanin production. The green-sectored 27Hmo plants were all found to be homozygous for the transgene and, despite a doubled transgene dosage, to have reduced levels of AtMYB90 mRNA. The observed reduction in anthocyanin pigmentation and AtMYB90 mRNA was phenotypically identical to the patterns seen in leaves systemically silenced for the AtMYB90 transgene, and was associated with the presence of AtMYB90-derived siRNA homologous to both strands of a portion of the AtMYB90 transcribed region. Activation of transgene silencing in the Myb27 line was triggered when the 35S::AtMYB90 transgene dosage was doubled, in both Myb27 homozygotes, and in plants containing one copy of each of the independently segregating Myb27 and Myb237 transgene loci. Mapping of sequenced siRNA molecules to the Myb27 TDNA (including flanking tobacco sequences) indicated that the 3' half of the AtMYB90 transcript is the primary target for siRNA associated silencing in both homozygous Myb27 plants and in systemically silenced tissues. The transgene within the Myb27 line was found to consist of a single, fully intact, copy of the AtMYB90 construct. Silencing appears to initiate in response to elevated levels of transgene mRNA (or an aberrant product thereof) present within a subset of leaf cells, followed by spread of the resulting small RNA to adjacent leaf tissues and subsequent amplification of siRNA production.	[Velten, Jeff; Cakir, Cahid; Chen, Junping] ARS, USDA, Lubbock, TX USA; [Youn, Eunseog] Texas Tech Univ, Dept Comp Sci, Lubbock, TX 79409 USA; [Cazzonelli, Christopher I.] Australian Natl Univ, Res Sch Biol, Ctr Excellence Plant Energy Biol, Australian Res Council, Canberra, ACT, Australia	United States Department of Agriculture (USDA); Texas Tech University System; Texas Tech University; Australian National University	Velten, J (corresponding author), ARS, USDA, Lubbock, TX USA.	Jeff.Velten@ars.usda.gov	Cazzonelli, Christopher I/A-5347-2010	Cazzonelli, Christopher I/0000-0003-3096-3193	United States Department of Agriculture	United States Department of Agriculture(United States Department of Agriculture (USDA))	Funding for this research is provided by the United States Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2003, MICROBIOL MOL BIOL R, V67, P657, DOI 10.1128/MMBR.67.4.657-685.2003; Allan AC, 2008, TRENDS PLANT SCI, V13, P99, DOI 10.1016/j.tplants.2007.11.012; BOERJAN W, 1994, PLANT CELL, V6, P1401, DOI 10.1105/tpc.6.10.1401; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Brosnan CA, 2007, P NATL ACAD SCI USA, V104, P14741, DOI 10.1073/pnas.0706701104; Brosnan CA, 2009, CURR OPIN CELL BIOL, V21, P416, DOI 10.1016/j.ceb.2009.04.001; Cakir C, 2010, PHYSIOL MOL PLANT P, V74, P246, DOI 10.1016/j.pmpp.2010.04.001; Cazzonelli CI, 2004, PLANT MOL BIOL REP, V22, P347, DOI 10.1007/BF02772678; Chellappan Padmanabhan, 2009, V495, P121, DOI 10.1007/978-1-59745-477-3_11; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Chinnusamy V, 2009, SCI CHINA SER C, V52, P331, DOI 10.1007/s11427-009-0052-1; Chitwood DH, 2010, NATURE, V467, P415, DOI 10.1038/nature09351; Choudhuri S, 2009, BIOCHEM BIOPH RES CO, V388, P177, DOI 10.1016/j.bbrc.2009.08.039; DE CARVALHO-NIEBEL F, 1995, PLANT CELL, V7, P347, DOI 10.2307/3869856; De Paoli E, 2009, RNA, V15, P1965, DOI 10.1261/rna.1706109; DEBORNE FD, 1994, MOL GEN GENET, V243, P613, DOI 10.1007/BF00279570; DECARVALHO F, 1992, EMBO J, V11, P2595, DOI 10.1002/j.1460-2075.1992.tb05324.x; DEHIO C, 1994, P NATL ACAD SCI USA, V91, P5538, DOI 10.1073/pnas.91.12.5538; Depicker A, 2005, ANNU PLANT REV, P1; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Dunoyer P, 2006, NAT GENET, V38, P258, DOI 10.1038/ng1722; Dunoyer P, 2010, EMBO J, V29, P1699, DOI 10.1038/emboj.2010.65; Dunoyer P, 2010, SCIENCE, V328, P912, DOI 10.1126/science.1185880; Dunoyer P, 2009, TRENDS PLANT SCI, V14, P643, DOI 10.1016/j.tplants.2009.09.003; Eamens A, 2008, PLANT PHYSIOL, V147, P456, DOI 10.1104/pp.108.117275; Elmayan T, 1996, PLANT J, V9, P787, DOI 10.1046/j.1365-313X.1996.9060787.x; Fagard M, 2000, ANNU REV PLANT PHYS, V51, P167, DOI 10.1146/annurev.arplant.51.1.167; HART CM, 1992, MOL GEN GENET, V235, P179, DOI 10.1007/BF00279359; Kalantidis K, 2008, BIOL CELL, V100, P13, DOI 10.1042/BC20070079; Kasai A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016895; Kooter JM, 1999, TRENDS PLANT SCI, V4, P340, DOI 10.1016/S1360-1385(99)01467-3; Liu QH, 2010, ANNU REV BIOCHEM, V79, P295, DOI 10.1146/annurev.biochem.052208.151733; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Mallory AC, 2003, PLANT J, V35, P82, DOI 10.1046/j.1365-313X.2003.01785.x; Matzke MA, 2000, PLANT MOL BIOL, V43, P401, DOI 10.1023/A:1006484806925; Mitsuhara I, 2002, GENETICS, V160, P343; Molnar A, 2010, SCIENCE, V328, P872, DOI 10.1126/science.1187959; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Palauqui JC, 1996, PLANT PHYSIOL, V112, P1447, DOI 10.1104/pp.112.4.1447; PALAUQUI JC, 1995, PLANT MOL BIOL, V29, P149, DOI 10.1007/BF00019126; PEACH C, 1991, PLANT MOL BIOL, V17, P49, DOI 10.1007/BF00036805; Qin HX, 2003, PLANT MOL BIOL, V52, P217, DOI 10.1023/A:1023941123149; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Schubert D, 2004, PLANT CELL, V16, P2561, DOI 10.1105/tpc.104.024547; Stam M, 1997, ANN BOT-LONDON, V79, P3, DOI 10.1006/anbo.1996.0295; VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291; VAUCHERET H, 1995, MOL GEN GENET, V248, P311, DOI 10.1007/BF02191598; Vaucheret H, 1998, PLANT J, V16, P651, DOI 10.1046/j.1365-313x.1998.00337.x; Vaucheret H, 2001, J CELL SCI, V114, P3083; Velten J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009917; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Wielopolska A, 2005, PLANT BIOTECHNOL J, V3, P583, DOI 10.1111/j.1467-7652.2005.00149.x; Zhang ZH, 2010, NUCLEIC ACIDS RES, V38, pD806, DOI 10.1093/nar/gkp818	58	16	19	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30141	10.1371/journal.pone.0030141	http://dx.doi.org/10.1371/journal.pone.0030141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363419	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600014
J	Jackson, MC; Donohue, I; Jackson, AL; Britton, JR; Harper, DM; Grey, J				Jackson, Michelle C.; Donohue, Ian; Jackson, Andrew L.; Britton, J. Robert; Harper, David M.; Grey, Jonathan			Population-Level Metrics of Trophic Structure Based on Stable Isotopes and Their Application to Invasion Ecology	PLOS ONE			English	Article							COMMUNITY-WIDE MEASURES; CARP CYPRINUS-CARPIO; LAKE NAIVASHA; RATIOS PROVIDE; NICHE OVERLAP; COMPETITION; PREDATOR; FISHERY; IMPACTS; FUTURE	Biological invasions are a significant driver of human-induced global change and many ecosystems sustain sympatric invaders. Interactions occurring among these invaders have important implications for ecosystem structure and functioning, yet they are poorly understood. Here we apply newly developed metrics derived from stable isotope data to provide quantitative measures of trophic diversity within populations or species. We then use these to test the hypothesis that sympatric invaders belonging to the same functional feeding group occupy a smaller isotopic niche than their allopatric counterparts. Two introduced, globally important, benthic omnivores, Louisiana swamp crayfish (Procambarus clarkii) and carp (Cyprinus carpio), are sympatric in Lake Naivasha, Kenya. We applied our metrics to an 8-year data set encompassing the establishment of carp in the lake. We found a strong asymmetric interaction between the two invasive populations, as indicated by inverse correlations between carp abundance and measures of crayfish trophic diversity. Lack of isotopic niche overlap between carp and crayfish in the majority of years indicated a predominantly indirect interaction. We suggest that carp-induced habitat alteration reduced the diversity of crayfish prey, resulting in a reduction in the dietary niche of crayfish. Stable isotopes provide an integrated signal of diet over space and time, offering an appropriate scale for the study of population niches, but few isotope studies have retained the often insightful information revealed by variability among individuals in isotope values. Our population metrics incorporate such variation, are robust to the vagaries of sample size and are a useful additional tool to reveal subtle dietary interactions among species. Although we have demonstrated their applicability specifically using a detailed temporal dataset of species invasion in a lake, they have a wide array of potential ecological applications.	[Jackson, Michelle C.; Grey, Jonathan] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Donohue, Ian; Jackson, Andrew L.] Trinity Coll Dublin, Sch Nat Sci, Dublin, Ireland; [Donohue, Ian; Jackson, Andrew L.] Trinity Coll Dublin, Trinity Ctr Biodivers Res, Dublin, Ireland; [Britton, J. Robert] Bournemouth Univ, Ctr Conservat Ecol & Environm Change, Bournemouth, Dorset, England; [Harper, David M.] Univ Leicester, Dept Biol, Leicester, Leics, England; [Grey, Jonathan] Max Planck Inst Limnol, Dept Physiol Ecol, Poln, Germany	University of London; Queen Mary University London; Trinity College Dublin; Trinity College Dublin; Bournemouth University; University of Leicester; Max Planck Society	Jackson, MC (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	j.grey@qmul.ac.uk	Jackson, Andrew L/D-3441-2009; Donohue, Ian/A-7270-2010; Harper, David M/A-1765-2011; Britton, Robert/B-5040-2009; Grey, Jonathan/B-3346-2012; Britton, Robert/AAO-6673-2020	Jackson, Andrew L/0000-0001-7334-0434; Donohue, Ian/0000-0002-4698-6448; Britton, Robert/0000-0003-1853-3086; Grey, Jonathan/0000-0001-9069-2271; Britton, Robert/0000-0003-1853-3086; Jackson, Michelle/0000-0003-2227-1111	British Ecological Society	British Ecological Society	The British Ecological Society provided a small ecological project grant (http://www.britishecologicalsociety.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Batschelet E, 1981, CIRCULAR STAT BIOL; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Britton JR, 2007, J FISH BIOL, V71, P239, DOI 10.1111/j.1095-8649.2007.01669.x; Britton JR, 2010, BIOL INVASIONS, V12, P3439, DOI 10.1007/s10530-010-9742-7; Gherardi F, 2011, FRESHWATER BIOL, V56, P1567, DOI 10.1111/j.1365-2427.2011.02595.x; Grey J, 2002, ISOT ENVIRON HEALT S, V38, P245, DOI 10.1080/10256010208033269; Grey J, 2006, POL J ECOL, V54, P563; Griffen BD, 2008, J ANIM ECOL, V77, P32, DOI 10.1111/j.1365-2656.2007.01304.x; Hammerschlag-Peyer CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027104; Hickley P, 2002, HYDROBIOLOGIA, V488, P181, DOI 10.1023/A:1023334715893; Hinojosa-Garro D, 2004, HYDROBIOLOGIA, V515, P115, DOI 10.1023/B:HYDR.0000027323.77213.39; Hoeinghaus DJ, 2008, ECOLOGY, V89, P2353, DOI 10.1890/07-1143.1; Holt RD, 2007, ECOLOGY, V88, P2706, DOI 10.1890/06-1525.1; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Ings NL, 2010, OECOLOGIA, V163, P127, DOI 10.1007/s00442-009-1558-8; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Layman CA, 2007, ECOL LETT, V10, P937, DOI 10.1111/j.1461-0248.2007.01087.x; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Lohrer AM, 2002, ECOLOGY, V83, P719, DOI 10.2307/3071876; Maguire CM, 2006, FRESHWATER BIOL, V51, P1310, DOI 10.1111/j.1365-2427.2006.01568.x; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Miller SA, 2006, FRESHWATER BIOL, V51, P85, DOI 10.1111/j.1365-2427.2005.01477.x; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Petr T, 2000, 396 FAO; PIANKA ER, 1974, P NATL ACAD SCI USA, V71, P2141, DOI 10.1073/pnas.71.5.2141; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Ricciardi A, 2001, CAN J FISH AQUAT SCI, V58, P2513, DOI 10.1139/cjfas-58-12-2513; Ricklefs RE, 1998, FUNCT ECOL, V12, P871, DOI 10.1046/j.1365-2435.1998.00263.x; Schmidt SN, 2007, ECOLOGY, V88, P2793, DOI 10.1890/07-0121.1; Simberloff D, 2006, ECOL LETT, V9, P912, DOI 10.1111/j.1461-0248.2006.00939.x; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Svanback R, 2007, P ROY SOC B-BIOL SCI, V274, P839, DOI 10.1098/rspb.2006.0198; Turner TF, 2010, ECOLOGY, V91, P2227, DOI 10.1890/09-1454.1; van Valen L., 1965, AM NAT, V99, P377, DOI DOI 10.1086/282379; Vander Zanden MJ, 1999, NATURE, V401, P464, DOI 10.1038/46762; Young KA, 2004, ECOLOGY, V85, P134, DOI 10.1890/02-0402	39	244	246	5	157	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31757	10.1371/journal.pone.0031757	http://dx.doi.org/10.1371/journal.pone.0031757			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363724	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700092
J	Konietschke, F; Libiger, O; Hothorn, LA				Konietschke, Frank; Libiger, Ondrej; Hothorn, Ludwig A.			Nonparametric Evaluation of Quantitative Traits in Population-Based Association Studies when the Genetic Model is Unknown	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SAMPLE-SIZE; TESTS	Statistical association between a single nucleotide polymorphism (SNP) genotype and a quantitative trait in genome-wide association studies is usually assessed using a linear regression model, or, in the case of non-normally distributed trait values, using the Kruskal-Wallis test. While linear regression models assume an additive mode of inheritance via equi-distant genotype scores, Kruskal-Wallis test merely tests global differences in trait values associated with the three genotype groups. Both approaches thus exhibit suboptimal power when the underlying inheritance mode is dominant or recessive. Furthermore, these tests do not perform well in the common situations when only a few trait values are available in a rare genotype category (disbalance), or when the values associated with the three genotype categories exhibit unequal variance (variance heterogeneity). We propose a maximum test based on Marcus-type multiple contrast test for relative effect sizes. This test allows model-specific testing of either dominant, additive or recessive mode of inheritance, and it is robust against variance heterogeneity. We show how to obtain mode-specific simultaneous confidence intervals for the relative effect sizes to aid in interpreting the biological relevance of the results. Further, we discuss the use of a related all-pairwise comparisons contrast test with range preserving confidence intervals as an alternative to Kruskal-Wallis heterogeneity test. We applied the proposed maximum test to the Bogalusa Heart Study dataset, and gained a remarkable increase in the power to detect association, particularly for rare genotypes. Our simulation study also demonstrated that the proposed non-parametric tests control family-wise error rate in the presence of non-normality and variance heterogeneity contrary to the standard parametric approaches. We provide a publicly available R library nparcomp that can be used to estimate simultaneous confidence intervals or compatible multiplicity-adjusted p-values associated with the proposed maximum test.	[Konietschke, Frank] Univ Gottingen, Dept Med Stat, Gottingen, Germany; [Libiger, Ondrej; Hothorn, Ludwig A.] Scripps Res Inst, La Jolla, CA 92037 USA; [Hothorn, Ludwig A.] Leibniz Univ Hannover, Inst Biostat, Hannover, Germany	University of Gottingen; Scripps Research Institute; Leibniz University Hannover	Konietschke, F (corresponding author), Univ Gottingen, Dept Med Stat, Gottingen, Germany.	hothorn@biostat.uni-hannover.de		Konietschke, Frank/0000-0002-5674-2076	DFG [Br 655/16-1, HO-1687/9]	DFG(German Research Foundation (DFG))	The work was supported by DFG Br 655/16-1 (Frank Konietschke) and DFG HO-1687/9 (Ludwig A. Hothorn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bathke AC, RECENT ADV TRENDS NO, P109; Benjamini Y, 2005, J AM STAT ASSOC, V100, P71, DOI 10.1198/016214504000001907; Bretz F, 2001, BIOMETRICAL J, V43, P645, DOI 10.1002/1521-4036(200109)43:5<645::AID-BIMJ645>3.0.CO;2-F; Brown BM, 2002, AUST NZ J STAT, V44, P427, DOI 10.1111/1467-842X.00244; Browne RH, 2010, AM STAT, V64, P30, DOI 10.1198/tast.2010.08261; Brunner E, 2000, BIOMETRICAL J, V42, P17, DOI 10.1002/(SICI)1521-4036(200001)42:1<17::AID-BIMJ17>3.0.CO;2-U; Brunner E, 2001, STAT PAP, V42, P1, DOI 10.1007/s003620000039; Fanous AH, 2009, AM J MED GENET B, V150B, P411, DOI 10.1002/ajmg.b.30833; Freidlin B, 2002, HUM HERED, V53, P146, DOI 10.1159/000064976; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Hasler M, 2008, BIOMETRICAL J, V50, P793, DOI 10.1002/bimj.200710466; Hothorn T, 2007, COIN CONDITIONAL INF; JONCKHEERE AR, 1954, BIOMETRIKA, V41, P133, DOI 10.1093/biomet/41.1-2.133; Konietschke F, 2009, THESIS GEORG AUGUST; KRUGLYAK L, 1995, GENETICS, V139, P1421; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Little J, 2009, HUM GENET, V125, P131, DOI 10.1007/s00439-008-0592-7; Marcus R, 1982, STATISTICS A, V11, P615; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Padmanabhan S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001177; Pfeiffer S, 2010, THESIS U GOTTINGEN; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ryu E, 2009, STAT MED, V28, P3179, DOI 10.1002/sim.3700; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Smith EN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001094; Steel R.G.D., 1960, TECHNOMETRICS, VVol. 2, P197, DOI [DOI 10.1080/00401706.1960.10489894, 10.1080/00401706.1960.10489894]; Thangavelu K, 2007, J STAT PLAN INFER, V137, P720, DOI 10.1016/j.jspi.2006.06.005; Wheeler HE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000685	31	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31242	10.1371/journal.pone.0031242	http://dx.doi.org/10.1371/journal.pone.0031242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363593	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700038
J	Mast, TG; Fadool, DA				Mast, Thomas Gerald; Fadool, Debra Ann			Mature and Precursor Brain-Derived Neurotrophic Factor Have Individual Roles in the Mouse Olfactory Bulb	PLOS ONE			English	Article							GATED POTASSIUM CHANNELS; NERVE GROWTH-FACTOR; KV1.3 CHANNEL; MITRAL CELLS; ALZHEIMERS-DISEASE; NEURONAL APOPTOSIS; STATUS-EPILEPTICUS; CRITICAL PERIOD; NARIS CLOSURE; SPINAL-CORD	Background: Sensory deprivation induces dramatic morphological and neurochemical changes in the olfactory bulb (OB) that are largely restricted to glomerular and granule layer interneurons. Mitral cells, pyramidal-like neurons, are resistant to sensory-deprivation-induced changes and are associated with the precursor to brain-derived neurotrophic factor (proBDNF); here, we investigate its unknown function in the adult mouse OB. Principal Findings: As determined using brain-slice electrophysiology in a whole-cell configuration, brain-derived neurotrophic factor (BDNF), but not proBDNF, increased mitral cell excitability. BDNF increased mitral cell action potential firing frequency and decreased interspike interval in response to current injection. In a separate set of experiments, intranasal delivery of neurotrophic factors to awake, adult mice was performed to induce sustained interneuron neurochemical changes. ProBDNF, but not BDNF, increased activated-caspase 3 and reduced tyrosine hydroxylase immunoreactivity in OB glomerular interneurons. In a parallel set of experiments, short-term sensory deprivation produced by unilateral naris occlusion generated an identical phenotype. Conclusions: Our results indicate that only mature BDNF increases mitral cell excitability whereas proBDNF remains ineffective. Our demonstration that proBDNF activates an apoptotic marker in vivo is the first for any proneurotrophin and establishes a role for proBDNF in a model of neuronal plasticity.	[Mast, Thomas Gerald; Fadool, Debra Ann] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Mast, Thomas Gerald; Fadool, Debra Ann] Florida State Univ, Program Neurosci, Tallahassee, FL 32306 USA; [Fadool, Debra Ann] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Mast, TG (corresponding author), Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA.	mast@neuro.fsu.edu			U.S. National Institutes of Health (NIH) [R01 DC003387, T32 DC00044]; National Institutes of Deaf and Communications Disorders (NIDCD); Florida State University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003387, T32DC000044] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Deaf and Communications Disorders (NIDCD); Florida State University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the U.S. National Institutes of Health (NIH) [R01 DC003387, and T32 DC00044] from the National Institutes of Deaf and Communications Disorders (NIDCD) and a Dissertation Award from The Florida State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER H, 1988, BRAIN RES, V450, P69, DOI 10.1016/0006-8993(88)91545-4; BAKER H, 1993, BRAIN RES, V614, P109, DOI 10.1016/0006-8993(93)91023-L; Balu R, 2004, J NEUROPHYSIOL, V92, P743, DOI 10.1152/jn.00016.2004; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Biju KC, 2008, NEUROSCI LETT, V447, P42, DOI 10.1016/j.neulet.2008.09.050; Blum R, 2005, PHYSIOLOGY, V20, P70, DOI 10.1152/physiol.00042.2004; BRUNJES PC, 1985, DEV BRAIN RES, V22, P1, DOI 10.1016/0165-3806(85)90063-X; BRUNJES PC, 1994, BRAIN RES REV, V19, P146; Bush AL, 2008, NEUROSCIENCE, V157, P229, DOI 10.1016/j.neuroscience.2008.08.065; Cao LX, 2007, CURR BIOL, V17, P911, DOI 10.1016/j.cub.2007.04.040; Chen WR, 1997, BRAIN RES, V745, P189, DOI 10.1016/S0006-8993(96)01150-X; CHOQUET D, 1992, J GEN PHYSIOL, V99, P217, DOI 10.1085/jgp.99.2.217; Colley B, 2004, RECEPTOR CHANNEL, V10, P25, DOI 10.1080/10606820490270870; Colley BS, 2007, NEUROSCIENCE, V144, P531, DOI 10.1016/j.neuroscience.2006.09.055; Colley BS, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-8; Conner JM, 1997, J NEUROSCI, V17, P2295; Cowan CM, 2004, J COMP NEUROL, V474, P136, DOI 10.1002/cne.20120; D'Amelio M, 2010, CELL DEATH DIFFER, V17, P1104, DOI 10.1038/cdd.2009.180; Deng P, 2005, NEUROSCIENCE, V131, P135, DOI 10.1016/j.neuroscience.2004.11.004; Deng XL, 2007, BIOL PSYCHIAT, V61, P1235, DOI 10.1016/j.biopsych.2006.09.010; Doczi MA, 2008, AM J PHYSIOL-REG I, V295, pR733, DOI 10.1152/ajpregu.00077.2008; Fadool DA, 2004, NEURON, V41, P389, DOI 10.1016/S0896-6273(03)00844-4; Fadool DA, 1998, J NEUROSCI, V18, P6126; Fadool DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024921; Fayard B, 2005, J NEUROSCI RES, V80, P18, DOI 10.1002/jnr.20432; GARCIACALVO M, 1993, J BIOL CHEM, V268, P18866; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Hamilton KA, 2008, CHEM SENSES, V33, P201, DOI 10.1093/chemse/bjm079; Imamura F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006729; Jan DD, 2007, J NEUROSCI, V27, P132, DOI 10.1523/JNEUROSCI.2439-06.2007; Jang SW, 2010, P NATL ACAD SCI USA, V107, P2687, DOI 10.1073/pnas.0913572107; Kalb R, 2005, TRENDS NEUROSCI, V28, P5, DOI 10.1016/j.tins.2004.11.003; Kasarskis EJ, 1999, NEUROLOGY, V52, P1427; Katoh-Semba R, 1998, NEUROSCI RES, V31, P227, DOI 10.1016/S0168-0102(98)00040-6; Kelsch W, 2009, J NEUROSCI, V29, P11852, DOI 10.1523/JNEUROSCI.2406-09.2009; Kim HH, 2006, J NEUROSCI, V26, P9548, DOI 10.1523/JNEUROSCI.1727-06.2006; Koch RO, 1997, J BIOL CHEM, V272, P27577, DOI 10.1074/jbc.272.44.27577; Koshimizu H, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-27; Kupper J, 2002, PFLUG ARCH EUR J PHY, V443, P541, DOI 10.1007/s00424-001-0734-4; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Leon M, 1998, ANN NY ACAD SCI, V855, P104, DOI 10.1111/j.1749-6632.1998.tb10551.x; Longo FM, 2007, CURR ALZHEIMER RES, V4, P503, DOI 10.2174/156720507783018316; Maher BJ, 2009, P NATL ACAD SCI USA, V106, P16865, DOI 10.1073/pnas.0808946106; Mandairon N, 2003, NEUROSCIENCE, V119, P507, DOI 10.1016/S0306-4522(03)00172-6; MARGOLIS FL, 1974, BRAIN RES, V81, P469, DOI 10.1016/0006-8993(74)90844-0; Marks DR, 2007, J NEUROCHEM, V103, P1608, DOI 10.1111/j.1471-4159.2007.04870.x; Marks DR, 2009, J NEUROSCI, V29, P6734, DOI 10.1523/JNEUROSCI.1350-09.2009; MEISAMI E, 1976, BRAIN RES, V107, P437, DOI 10.1016/0006-8993(76)90243-2; Menteyne A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006770; Michalski B, 2003, MOL BRAIN RES, V111, P148, DOI 10.1016/S0169-328X(03)00003-2; Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200; NAJBAUER J, 1995, BRAIN RES, V674, P245, DOI 10.1016/0006-8993(94)01448-Q; Nakamura Y, 2007, J PHYSIOL-LONDON, V581, P1101, DOI 10.1113/jphysiol.2007.128702; Nickell WT, 1996, BRAIN RES BULL, V39, P57, DOI 10.1016/0361-9230(95)02042-X; Nucci C, 2003, EUR J OPHTHALMOL, V13, pS36; Padmanabhan K, 2010, NAT NEUROSCI, V13, P1276, DOI 10.1038/nn.2630; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Parrish-Aungst S, 2011, BRAIN RES, V1382, P70, DOI 10.1016/j.brainres.2011.01.068; Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Schabitz WR, 2007, STROKE, V38, P2165, DOI 10.1161/STROKEAHA.106.477331; Scholz J, 2005, J NEUROSCI, V25, P7317, DOI 10.1523/JNEUROSCI.1526-05.2005; Schulte-Herbruggen O, 2008, J NEUROSCI RES, V86, P2774, DOI 10.1002/jnr.21704; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; Shi QD, 2009, NEUROSCI LETT, V465, P220, DOI 10.1016/j.neulet.2009.08.049; Speake T, 2004, AM J PHYSIOL-CELL PH, V286, pC611, DOI 10.1152/ajpcell.00292.2003; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Thorne RG, 2004, NEUROSCIENCE, V127, P481, DOI 10.1016/j.neuroscience.2004.05.029; Tucker K, 2002, J PHYSIOL-LONDON, V542, P413, DOI 10.1113/jphysiol.2002.017376; Vicente R, 2006, J BIOL CHEM, V281, P37675, DOI 10.1074/jbc.M605617200; Weise J, 2005, NEUROBIOL DIS, V18, P582, DOI 10.1016/j.nbd.2004.10.025; Williams RW, 2001, BEHAV GENET, V31, P61, DOI 10.1023/A:1010209925783; Yamaguchi M, 2005, P NATL ACAD SCI USA, V102, P9697, DOI 10.1073/pnas.0406082102; Yamashita K, 1997, METAB BRAIN DIS, V12, P271, DOI 10.1007/BF02674671; Yan XX, 2001, J COMP NEUROL, V433, P4, DOI 10.1002/cne.1121; YEH JZ, 1976, J GEN PHYSIOL, V68, P519, DOI 10.1085/jgp.68.5.519	77	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31978	10.1371/journal.pone.0031978	http://dx.doi.org/10.1371/journal.pone.0031978			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363780	gold, Green Submitted, Green Published			2022-12-27	WOS:000302873700130
J	Schneider, NA; Low, M; Arlt, D; Part, T				Schneider, Nicole A.; Low, Matthew; Arlt, Debora; Part, Tomas			Contrast in Edge Vegetation Structure Modifies the Predation Risk of Natural Ground Nests in an Agricultural Landscape	PLOS ONE			English	Article							HABITAT FRAGMENTATION; MUSTELA-NIVALIS; FOREST; FARMLAND; BIRDS; RESPONSES; PERMEABILITY; MECHANISMS; INCREASES; SELECTION	Nest predation risk generally increases nearer forest-field edges in agricultural landscapes. However, few studies test whether differences in edge contrast (i.e. hard versus soft edges based on vegetation structure and height) affect edge-related predation patterns and if such patterns are related to changes in nest conspicuousness between incubation and nestling feeding. Using data on 923 nesting attempts we analyse factors influencing nest predation risk at different edge types in an agricultural landscape of a ground-cavity breeding bird species, the Northern Wheatear (Oenanthe oenanthe). As for many other bird species, nest predation is a major determinant of reproductive success in this migratory passerine. Nest predation risk was higher closer to woodland and crop field edges, but only when these were hard edges in terms of ground vegetation structure (clear contrast between tall vs short ground vegetation). No such edge effect was observed at soft edges where adjacent habitats had tall ground vegetation (crop, ungrazed grassland). This edge effect on nest predation risk was evident during the incubation stage but not the nestling feeding stage. Since wheatear nests are depredated by ground-living animals our results demonstrate: (i) that edge effects depend on edge contrast, (ii) that edge-related nest predation patterns vary across the breeding period probably resulting from changes in parental activity at the nest between the incubation and nestling feeding stage. Edge effects should be put in the context of the nest predator community as illustrated by the elevated nest predation risk at hard but not soft habitat edges when an edge is defined in terms of ground vegetation. These results thus can potentially explain previously observed variations in edge-related nest predation risk.	[Schneider, Nicole A.; Low, Matthew; Arlt, Debora; Part, Tomas] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Arlt, Debora] Univ Reading, Ctr Agri Environm Res, Sch Agr Policy & Dev, Reading, Berks, England	Swedish University of Agricultural Sciences; University of Reading	Schneider, NA (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden.	nicole.schneider@slu.se		Low, Matthew/0000-0002-7345-6063; Part, Tomas/0000-0001-7388-6672	Swedish Research Council; Helge Ax:son Johnson's Foundation; Formas; Royal Swedish Academy of Sciences; Alvin's Foundation; Swedish Ornithological Society	Swedish Research Council(Swedish Research CouncilEuropean Commission); Helge Ax:son Johnson's Foundation; Formas(Swedish Research Council Formas); Royal Swedish Academy of Sciences; Alvin's Foundation; Swedish Ornithological Society	This study was supported by the Swedish Research Council (to TP), Formas (to TP and ML), Helge Ax:son Johnson's Foundation, Royal Swedish Academy of Sciences, Alvin's Foundation, and Swedish Ornithological Society (to DA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREN H, 1988, ECOLOGY, V69, P544, DOI 10.2307/1940455; ANGELSTAM P, 1986, OIKOS, V47, P365, DOI 10.2307/3565450; Arlt D, 2007, ECOLOGY, V88, P792, DOI 10.1890/06-0574; Arlt D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003006; Batary P, 2004, CONSERV BIOL, V18, P389, DOI 10.1111/j.1523-1739.2004.00184.x; Brandt MJ, 2007, ACTA THERIOL, V52, P13, DOI 10.1007/BF03194195; Cain JW, 2006, J WILDLIFE MANAGE, V70, P522, DOI 10.2193/0022-541X(2006)70[522:IOMAON]2.0.CO;2; Chalfoun AD, 2002, CONSERV BIOL, V16, P306, DOI 10.1046/j.1523-1739.2002.00308.x; Cooch E., 2008, PROGRAM MARK GENTLE; Cramp S., 1985, HDB BIRDS EUROPE MID; Donald PF, 2006, AGR ECOSYST ENVIRON, V116, P189, DOI 10.1016/j.agee.2006.02.007; Donovan TM, 1997, ECOLOGY, V78, P2064, DOI 10.1890/0012-9658(1997)078[2064:VILSEE]2.0.CO;2; Eggers S, 2005, BEHAV ECOL, V16, P309, DOI 10.1093/beheco/arh163; Fagan WE, 1999, AM NAT, V153, P165, DOI 10.1086/303162; FenskeCrawford TJ, 1997, CONDOR, V99, P14, DOI 10.2307/1370220; Gehring TM, 2003, BIOL CONSERV, V109, P283, DOI 10.1016/S0006-3207(02)00156-8; Lima SL, 1996, TRENDS ECOL EVOL, V11, P131, DOI 10.1016/0169-5347(96)81094-9; Lopez-Barrera F, 2007, LANDSCAPE ECOL, V22, P189, DOI 10.1007/s10980-006-9020-3; Low M, 2010, J ANIM ECOL, V79, P214, DOI 10.1111/j.1365-2656.2009.01595.x; MacDonald DW, 2004, BIOLOGIA, V59, P235; Malt JM, 2009, ECOL APPL, V19, P1274, DOI 10.1890/08-0598.1; Manson RH, 1999, LANDSCAPE ECOL, V14, P355, DOI 10.1023/A:1008093823391; Martin TE, 2000, P ROY SOC B-BIOL SCI, V267, P2287, DOI 10.1098/rspb.2000.1281; MAYFIELD HF, 1975, WILSON BULL, V87, P456; McDonald PG, 2009, BEHAV ECOL, V20, P821, DOI 10.1093/beheco/arp066; MOLLER AP, 1989, OIKOS, V56, P240, DOI 10.2307/3565342; Moore RP, 2004, ECOLOGY, V85, P1562, DOI 10.1890/03-0088; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; NOUR N, 1993, ECOGRAPHY, V16, P111, DOI 10.1111/j.1600-0587.1993.tb00063.x; Oberg M, 2009, THESIS SWEDISH U AGR, P35; Part T, 2002, J AVIAN BIOL, V33, P39, DOI 10.1034/j.1600-048X.2002.330107.x; Part T, 2001, ANIM BEHAV, V62, P379, DOI 10.1006/anbe.2001.1754; Part T, 2001, P ROY SOC B-BIOL SCI, V268, P2267, DOI 10.1098/rspb.2001.1803; Purger JJ, 2008, POL J ECOL, V56, P481; PUSENIUS J, 1993, ANN ZOOL FENN, V30, P143; R Core Team, 2018, R LANG ENV STAT COMP; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Roos S, 2002, OECOLOGIA, V133, P608, DOI 10.1007/s00442-002-1056-8; Salek M, 2009, AGR ECOSYST ENVIRON, V134, P8, DOI 10.1016/j.agee.2009.06.018; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; SKUTCH AF, 1949, IBIS, V91, P430, DOI 10.1111/j.1474-919X.1949.tb02293.x; Soderstrom B, 1998, OECOLOGIA, V117, P108, DOI 10.1007/s004420050638; STAMPS JA, 1987, AM NAT, V129, P533, DOI 10.1086/284656; Storch I, 2005, LANDSCAPE ECOL, V20, P927, DOI 10.1007/s10980-005-7005-2; Vander Haegen WM, 2009, CONDOR, V104, P496; Vergara PM, 2009, ECOL MODEL, V220, P1189, DOI 10.1016/j.ecolmodel.2009.02.015; Weatherhead PJ, 2004, J AVIAN BIOL, V35, P185, DOI 10.1111/j.0908-8857.2004.03336.x; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Winter M, 2000, CONDOR, V102, P256, DOI 10.1650/0010-5422(2000)102[0256:EFEEOM]2.0.CO;2	49	20	20	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31517	10.1371/journal.pone.0031517	http://dx.doi.org/10.1371/journal.pone.0031517			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363659	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700064
J	Tabu, C; Breiman, RF; Ochieng, B; Aura, B; Cosmas, L; Audi, A; Olack, B; Bigogo, G; Ongus, JR; Fields, P; Mintz, E; Burton, D; Oundo, J; Feikin, DR				Tabu, Collins; Breiman, Robert F.; Ochieng, Benjamin; Aura, Barrack; Cosmas, Leonard; Audi, Allan; Olack, Beatrice; Bigogo, Godfrey; Ongus, Juliette R.; Fields, Patricia; Mintz, Eric; Burton, Deron; Oundo, Joe; Feikin, Daniel R.			Differing Burden and Epidemiology of Non-Typhi Salmonella Bacteremia in Rural and Urban Kenya, 2006-2009	PLOS ONE			English	Article							NON-TYPHOIDAL SALMONELLA; COMMUNITY-ACQUIRED BACTEREMIA; WESTERN KENYA; TRIMETHOPRIM-SULFAMETHOXAZOLE; BACTERIAL-INFECTIONS; FALCIPARUM-MALARIA; INVASIVE BACTERIAL; MALAWIAN CHILDREN; ADULTS; MORTALITY	Background: The epidemiology of non-Typhi Salmonella (NTS) bacteremia in Africa will likely evolve as potential co-factors, such as HIV, malaria, and urbanization, also change. Methods: As part of population-based surveillance among 55,000 persons in malaria-endemic, rural and malaria-nonendemic, urban Kenya from 2006-2009, blood cultures were obtained from patients presenting to referral clinics with fever >= 38.0 degrees C or severe acute respiratory infection. Incidence rates were adjusted based on persons with compatible illnesses, but whose blood was not cultured. Results: NTS accounted for 60/155 (39%) of blood culture isolates in the rural and 7/230 (3%) in the urban sites. The adjusted incidence in the rural site was 568/100,000 person-years, and the urban site was 51/100,000 person-years. In both sites, the incidence was highest in children < 5 years old. The NTS-to-typhoid bacteremia ratio in the rural site was 4.6 and in the urban site was 0.05. S. Typhimurium represented > 85% of blood NTS isolates in both sites, but only 21% (urban) and 64% (rural) of stool NTS isolates. Overall, 76% of S. Typhimurium blood isolates were multi-drug resistant, most of which had an identical profile in Pulse Field Gel Electrophoresis. In the rural site, the incidence of NTS bacteremia increased during the study period, concomitant with rising malaria prevalence (monthly correlation of malaria positive blood smears and NTS bacteremia cases, Spearman's correlation, p = 0.018 for children, p = 0.16 adults). In the rural site, 80% of adults with NTS bacteremia were HIV-infected. Six of 7 deaths within 90 days of NTS bacteremia had HIV/AIDS as the primary cause of death assigned on verbal autopsy. Conclusions: NTS caused the majority of bacteremias in rural Kenya, but typhoid predominated in urban Kenya, which most likely reflects differences in malaria endemicity. Control measures for malaria, as well as HIV, will likely decrease the burden of NTS bacteremia in Africa.	[Tabu, Collins; Oundo, Joe] Field Epidemiol & Lab Training Program, Nairobi, Kenya; [Tabu, Collins] Minist Publ Hlth & Sanitat, Nairobi, Kenya; [Breiman, Robert F.; Ochieng, Benjamin; Aura, Barrack; Cosmas, Leonard; Audi, Allan; Olack, Beatrice; Bigogo, Godfrey; Burton, Deron; Oundo, Joe; Feikin, Daniel R.] Ctr Dis Control & Prevent, Kenya Med Res Inst, Nairobi, Kenya; [Breiman, Robert F.; Burton, Deron; Feikin, Daniel R.] Ctr Dis Control & Prevent, Int Emerging Infect Program, Nairobi, Kenya; [Ongus, Juliette R.] Jomo Kenyatta Univ Agr & Technol, Nairobi, Kenya; [Fields, Patricia; Mintz, Eric] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA	Kenya Medical Research Institute; Jomo Kenyatta University of Agriculture & Technology; Centers for Disease Control & Prevention - USA	Tabu, C (corresponding author), Field Epidemiol & Lab Training Program, Nairobi, Kenya.	dfeikin@jhsph.edu	Bigogo, Godfrey/W-3591-2019	Tabu, Collins/0000-0002-0537-1172; Audi, Allan/0000-0003-1683-554X	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adazu K, 2005, AM J TROP MED HYG, V73, P1151, DOI 10.4269/ajtmh.2005.73.1151; Archibald LK, 2000, J INFECT DIS, V181, P1414, DOI 10.1086/315367; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Breiman RF, PLOS ONE IN PRESS; Brent AJ, 2006, PEDIATR INFECT DIS J, V25, P230, DOI 10.1097/01.inf.0000202066.02212.ff; Bronzan RN, 2007, J INFECT DIS, V195, P895, DOI 10.1086/511437; Brooks JT, 2006, CLIN INFECT DIS, V43, P393, DOI 10.1086/505866; Clinical and Laboratory Standard Institute (CBI), 2009, PERF STAND ANT SUS S; Crump JA, 2011, TROP MED INT HEALTH, V16, P830, DOI 10.1111/j.1365-3156.2011.02774.x; Enwere G, 2006, PEDIATR INFECT DIS J, V25, P700, DOI 10.1097/01.inf.0000226839.30925.a5; Feasey NA, 2010, EMERG INFECT DIS, V16, P1448, DOI 10.3201/eid1609.100125; Feikin DR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-186; Feikin DR, 2010, INT J EPIDEMIOL, V39, P450, DOI 10.1093/ije/dyp374; Gilks CF, 1998, BRIT MED BULL, V54, P383, DOI 10.1093/oxfordjournals.bmb.a011695; Gilks CF, 1996, LANCET, V347, P718, DOI 10.1016/S0140-6736(96)90076-8; Gordon MA, 2002, AIDS, V16, P1633, DOI 10.1097/00002030-200208160-00009; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; Graham SM, 2000, T ROY SOC TROP MED H, V94, P310, DOI 10.1016/S0035-9203(00)90337-7; Graham SM, 2000, PEDIATR INFECT DIS J, V19, P1189, DOI 10.1097/00006454-200012000-00016; GREEN SDR, 1993, ANN TROP PAEDIATR, V13, P45, DOI 10.1080/02724936.1993.11747624; Hamel MJ, 2011, AM J TROP MED HYG, V85, P597, DOI 10.4269/ajtmh.2011.10-0678; Jacob ST, 2009, PLOS ONE, V4, pA115, DOI 10.1371/journal.pone.0007782; Kariuki S, 2006, J MED MICROBIOL, V55, P585, DOI 10.1099/jmm.0.46375-0; Kariuki S, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-101; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; MABEY DCW, 1987, J INFECT DIS, V155, P1319, DOI 10.1093/infdis/155.6.1319; Mackenzie G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010568; Morpeth SC, 2009, CLIN INFECT DIS, V49, P606, DOI 10.1086/603553; Mtove G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-320; Mtove G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009244; Mwangi I, 2002, PEDIATR INFECT DIS J, V21, P1042, DOI 10.1097/00006454-200211000-00013; Ochiai RL, 2008, B WORLD HEALTH ORGAN, V86, P260, DOI 10.2471/BLT.06.039818; OEHLERT GW, 1992, AM STAT, V46, P27, DOI 10.2307/2684406; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Scott JAG, 2011, LANCET, V378, P1316, DOI 10.1016/S0140-6736(11)60888-X; Scott JAG, 2000, LANCET, V355, P1225, DOI 10.1016/S0140-6736(00)02089-4; Sigauque B, 2009, PEDIATR INFECT DIS J, V28, P108, DOI 10.1097/INF.0b013e318187a87d; Tennant SM, 2011, INFECT IMMUN, V79, P4175, DOI 10.1128/IAI.05278-11; van Oosterhout JJG, 2005, JAIDS-J ACQ IMM DEF, V39, P626; Walsh AL, 2000, PEDIATR INFECT DIS J, V19, P312, DOI 10.1097/00006454-200004000-00010; Watera C, 2004, AIDS, V18, P1210, DOI 10.1097/00002030-200405210-00018; WHO, 2008, INT MAN CHILDH ILLN; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0	43	72	72	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31237	10.1371/journal.pone.0031237	http://dx.doi.org/10.1371/journal.pone.0031237			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22363591	gold, Green Published, Green Submitted			2022-12-27	WOS:000302873700036
J	Cho, J; Bhatt, R; Elgersma, Y; Silva, AJ				Cho, Jeiwon; Bhatt, Rushi; Elgersma, Ype; Silva, Alcino J.			alpha-Calcium Calmodulin Kinase II Modulates the Temporal Structure of Hippocampal Bursting Patterns	PLOS ONE			English	Article							COMPLEX-SPIKE CELLS; PLACE CELLS; SPATIAL MEMORY; SYNAPTIC PLASTICITY; FIRING PATTERNS; UNIT-ACTIVITY; RAT-BRAIN; NEURONS; CAMKII; MICE	The alpha calcium calmodulin kinase II (alpha-CaMKII) is known to play a key role in CA1/CA3 synaptic plasticity, hippocampal place cell stability and spatial learning. Additionally, there is evidence from hippocampal electrophysiological slice studies that this kinase has a role in regulating ion channels that control neuronal excitability. Here, we report in vivo single unit studies, with alpha-CaMKII mutant mice, in which threonine 305 was replaced with an aspartate (alpha-CaMKIIT305D mutants), that indicate that this kinase modulates spike patterns in hippocampal pyramidal neurons. Previous studies showed that alpha-CaMKIIT305D mutants have abnormalities in both hippocampal LTP and hippocampal-dependent learning. We found that besides decreased place cell stability, which could be caused by their LTP impairments, the hippocampal CA1 spike patterns of alpha-CaMKIIT305D mutants were profoundly abnormal. Although overall firing rate, and overall burst frequency were not significantly altered in these mutants, inter-burst intervals, mean number of intra-burst spikes, ratio of intra-burst spikes to total spikes, and mean intra-burst intervals were significantly altered. In particular, the intra burst intervals of place cells in alpha-CaMKIIT305D mutants showed higher variability than controls. These results provide in vivo evidence that besides its well-known function in synaptic plasticity, alpha-CaMKII, and in particular its inhibitory phosphorylation at threonine 305, also have a role in shaping the temporal structure of hippocampal burst patterns. These results suggest that some of the molecular processes involved in acquiring information may also shape the patterns used to encode this information.	[Cho, Jeiwon; Elgersma, Ype; Silva, Alcino J.] Univ Calif Los Angeles, Brain Res Inst, Dept Neurobiol, Los Angeles, CA 90024 USA; [Cho, Jeiwon; Elgersma, Ype; Silva, Alcino J.] Univ Calif Los Angeles, Brain Res Inst, Dept Psychiat, Los Angeles, CA 90024 USA; [Cho, Jeiwon; Elgersma, Ype; Silva, Alcino J.] Univ Calif Los Angeles, Brain Res Inst, Dept Psychol, Los Angeles, CA 90024 USA; [Cho, Jeiwon] Korea Inst Sci & Technol, Ctr Neural Sci, Seoul, South Korea; [Cho, Jeiwon] Univ Sci & Technol, Dept Neurosci, Seoul, South Korea; [Bhatt, Rushi] Yahoo SDC, Bangalore, Karnataka, India; [Elgersma, Ype] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Korea Institute of Science & Technology (KIST); Erasmus University Rotterdam; Erasmus MC	Cho, J (corresponding author), Univ Calif Los Angeles, Brain Res Inst, Dept Neurobiol, Los Angeles, CA 90024 USA.	silvaa@mednet.ucla.edu	Elgersma, Ype/F-5164-2013; Silva, Alcino/ABD-7684-2021	Elgersma, Ype/0000-0002-3758-1297; Silva, Alcino/0000-0002-1587-4558; Silva, Alcino/0000-0001-5525-0494	National Institutes of Health [R37-AG013622]; NATIONAL INSTITUTE ON AGING [R37AG013622] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a grant from National Institutes of Health (R37-AG013622) to AJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROCKE L, 1995, J NEUROSCI, V15, P6797; BUTLER LS, 1995, P NATL ACAD SCI USA, V92, P6852, DOI 10.1073/pnas.92.15.6852; Cacucci F, 2007, J NEUROSCI, V27, P7854, DOI 10.1523/JNEUROSCI.1704-07.2007; Cho YH, 1998, SCIENCE, V279, P867, DOI 10.1126/science.279.5352.867; Churn SB, 2000, P NATL ACAD SCI USA, V97, P5604, DOI 10.1073/pnas.080071697; Devijver PA, PATTERN RECOGNITION; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; Fan Y, 2005, NAT NEUROSCI, V8, P1542, DOI 10.1038/nn1568; Gardoni F, 2007, J BIOL CHEM, V282, P28691, DOI 10.1074/jbc.M701899200; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Liu JX, 2006, NAT NEUROSCI, V9, P41, DOI 10.1038/nn1602; Mayford M, 1997, CURR BIOL, V7, pR580, DOI 10.1016/S0960-9822(06)00287-9; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; Muller R, 1996, NEURON, V17, P813, DOI 10.1016/S0896-6273(00)80214-7; MULLER RU, 1987, J NEUROSCI, V7, P1951; MULLER RU, 1987, J NEUROSCI, V7, P1935; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; Nassirpour R, 2010, J NEUROSCI, V30, P13419, DOI 10.1523/JNEUROSCI.2966-10.2010; O'Keefe J, 1987, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1979, PROG NEUROBIOL, V13, P419, DOI 10.1016/0301-0082(79)90005-4; OKEEFE J, 1987, EXP BRAIN RES, V68, P1; QUIRK GJ, 1992, J NEUROSCI, V12, P1945; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Rotenberg A, 2000, J NEUROSCI, V20, P8096; Rotenberg A, 1996, CELL, V87, P1351, DOI 10.1016/S0092-8674(00)81829-2; Sametsky EA, 2009, NEUROBIOL LEARN MEM, V92, P120, DOI 10.1016/j.nlm.2009.02.006; Serodio P, 1998, J NEUROPHYSIOL, V79, P1081, DOI 10.1152/jn.1998.79.2.1081; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Shyu, 1992, STAT MODELS; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; THOMPSON LT, 1989, J NEUROSCI, V9, P2382; Tkatch T, 2000, J NEUROSCI, V20, P579, DOI 10.1523/JNEUROSCI.20-02-00579.2000; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Varga AW, 2004, J NEUROSCI, V24, P3643, DOI 10.1523/JNEUROSCI.0154-04.2004; Welsby PJ, 2003, J NEUROSCI, V23, P10116, DOI 10.1523/jneurosci.23-31-10116.2003; Wilson MA, 1997, TRENDS NEUROSCI, V20, P102, DOI 10.1016/S0166-2236(96)01023-5; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Yao WD, 2001, J NEUROPHYSIOL, V85, P1384, DOI 10.1152/jn.2001.85.4.1384	41	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31649	10.1371/journal.pone.0031649	http://dx.doi.org/10.1371/journal.pone.0031649			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363696	Green Published, Green Submitted, gold			2022-12-27	WOS:000302871500069
J	Liang, CB; Luo, HS; Liu, Y; Cao, JW; Xia, H				Liang, Chengbai; Luo, Hesheng; Liu, Ying; Cao, Jiwang; Xia, Hong			Plasma Hormones Facilitated the Hypermotility of the Colon in a Chronic Stress Rat Model	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; CORTICOTROPIN-RELEASING-FACTOR; UP-REGULATION; MOTILITY; DISTENSION; RECEPTORS; HYPERSENSITIVITY; NEUROPEPTIDES; LOCALIZATION; SENSITIVITY	Objective: To study the relationship between brain-gut peptides, gastrointestinal hormones and altered motility in a rat model of repetitive water avoidance stress (WAS), which mimics the irritable bowel syndrome (IBS). Methods: Male Wistar rats were submitted daily to 1-h of water avoidance stress (WAS) or sham WAS (SWAS) for 10 consecutive days. Plasma hormones were determined using Enzyme Immunoassay Kits. Proximal colonic smooth muscle (PCSM) contractions were studied in an organ bath system. PCSM cells were isolated by enzymatic digestion and IKv and IBKca were recorded by the patch-clamp technique. Results: The number of fecal pellets during 1 h of acute restraint stress and the plasma hormones levels of substance P (SP), thyrotropin-releasing hormone (TRH), motilin (MTL), and cholecystokinin (CCK) in WAS rats were significantly increased compared with SWAS rats, whereas vasoactive intestinal peptide (VIP), calcitonin gene-related peptide (CGRP) and corticotropin releasing hormone (CRH) in WAS rats were not significantly changed and peptide YY (PYY) in WAS rats was significantly decreased. Likewise, the amplitudes of spontaneous contractions of PCSM in WAS rats were significantly increased comparing with SWAS rats. The plasma of WAS rats (100 mu l) decreased the amplitude of spontaneous contractions of controls. The IKv and IBKCa of PCSMs were significantly decreased in WAS rats compared with SWAS rats and the plasma of WAS rats (100 mu l) increased the amplitude of IKv and IBKCa in normal rats. Conclusion: These results suggest that WAS leads to changes of plasma hormones levels and to disordered myogenic colonic motility in the short term, but that the colon rapidly establishes a new equilibrium to maintain the normal baseline functioning.	[Liang, Chengbai; Luo, Hesheng; Liu, Ying; Cao, Jiwang; Xia, Hong] Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan 430060, Peoples R China	Wuhan University	Luo, HS (corresponding author), Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan 430060, Peoples R China.	xhnkLHS@126.com			National Natural Science Foundation of China [30871148]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 30871148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Belgnaoui A, 2005, PAIN, V113, P141, DOI 10.1016/j.pain.2004.10.002; Bennett EJ, 1998, GUT, V43, P256, DOI 10.1136/gut.43.2.256; Bradesi S, 2005, AM J PHYSIOL-GASTR L, V289, pG42, DOI 10.1152/ajpgi.00500.2004; Bradesi S, 2007, PAIN, V130, P56, DOI 10.1016/j.pain.2006.10.028; BRADETTE M, 1994, DIGEST DIS SCI, V39, P449, DOI 10.1007/BF02088327; Cassar-Malek I, 1998, PROD ANIM, V11, P365; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; DROSSMAN DA, 1982, GASTROENTEROLOGY, V83, P529; Gourcerol G, 2011, GASTROENTEROLOGY, V140, P1586, DOI 10.1053/j.gastro.2011.01.039; Gross KJ, 2007, INFLAMM BOWEL DIS, V13, P918, DOI 10.1002/ibd.20129; Gue M, 1997, NEUROGASTROENT MOTIL, V9, P271, DOI 10.1046/j.1365-2982.1997.d01-63.x; Heim C, 2000, JAMA-J AM MED ASSOC, V284, P592, DOI 10.1001/jama.284.5.592; Hillhouse EW, 2006, ENDOCR REV, V27, P260, DOI 10.1210/er.2005-0034; Jaworek J, 2010, J PHYSIOL PHARMACOL, V61, P523; Kamerling IMC, 2003, BRIT J CLIN PHARMACO, V55, P538, DOI 10.1046/j.1365-2125.2003.01812.x; Kaptchuk TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015591; KELLOW JE, 1991, GASTROENTEROLOGY, V101, P1621, DOI 10.1016/0016-5085(91)90400-F; Larauche M, 2009, J PHYSIOL PHARMACOL, V60, P33; Lee Oh Young, 2010, J Neurogastroenterol Motil, V16, P120, DOI 10.5056/jnm.2010.16.2.120; Maunder RG, 2008, CURR MOL MED, V8, P247, DOI 10.2174/156652408784533832; Mayer EA, 2001, AM J PHYSIOL-GASTR L, V280, pG519, DOI 10.1152/ajpgi.2001.280.4.G519; Monnikes H, 2001, DIGEST DIS, V19, P201, DOI 10.1159/000050681; Murray CDR, 2004, GASTROENTEROLOGY, V127, P1695, DOI 10.1053/j.gastro.2004.08.057; NIEDERAU C, 1992, GASTROENTEROLOGY, V102, P1889, DOI 10.1016/0016-5085(92)90310-U; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; Posserud I, 2004, GUT, V53, P1102, DOI 10.1136/gut.2003.017962; Ren TH, 2007, AM J PHYSIOL-GASTR L, V292, pG849, DOI 10.1152/ajpgi.00400.2006; Rettenbacher M, 2001, N-S ARCH PHARMACOL, V364, P291, DOI 10.1007/s002100100454; Rojas-Macias V, 2010, Rev Gastroenterol Mex, V75, P421; Sabate JM, 2002, NEUROGASTROENT MOTIL, V14, P689, DOI 10.1046/j.1365-2982.2002.00370.x; Simren M, 2001, GUT, V48, P20, DOI 10.1136/gut.48.1.20; Sjolund K, 1997, NEUROGASTROENT MOTIL, V9, P143, DOI 10.1046/j.1365-2982.1997.d01-46.x; Van der Veek PPJ, 2006, SCAND J GASTROENTERO, V41, P170, DOI 10.1080/00365520500206210; VASSALLO M, 1992, GASTROENTEROLOGY, V102, P102, DOI 10.1016/0016-5085(92)91789-7; Venkova K, 2010, NEUROPHARMACOLOGY, V58, P1161, DOI 10.1016/j.neuropharm.2010.02.012; Vicari E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018647; Vogalis F, 2000, J AUTON PHARMACOL, V20, P207, DOI 10.1046/j.1365-2680.2000.00183.x; Welberg LAM, 2001, J NEUROENDOCRINOL, V13, P113, DOI 10.1046/j.1365-2826.2001.00601.x; WELGAN P, 1985, PSYCHOSOM MED, V47, P139, DOI 10.1097/00006842-198503000-00005; WHITEHEAD WE, 1992, GUT, V33, P825, DOI 10.1136/gut.33.6.825; Whitehead WE, 1998, GASTROENTEROLOGY, V115, P1263, DOI 10.1016/S0016-5085(98)70099-X; Xu L, 2007, CLIN EXP PHARMACOL P, V34, P120, DOI 10.1111/j.1440-1681.2007.04465.x; Yuan PQ, 2010, PEPTIDES, V31, P322, DOI 10.1016/j.peptides.2009.11.012; Zhang M, 2010, NEUROGASTROENT MOTIL, V22, pe162, DOI 10.1111/j.1365-2982.2009.01467.x; ZHANG ZB, 1992, BIOMED RES-TOKYO, V13, P275; Zou N, 2008, TRANSL RES, V152, P283, DOI 10.1016/j.trsl.2008.10.002	46	23	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31774	10.1371/journal.pone.0031774	http://dx.doi.org/10.1371/journal.pone.0031774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363728	gold, Green Published, Green Submitted			2022-12-27	WOS:000302871500086
J	Liao, CC; Su, TC; Sung, FC; Chou, WH; Chen, TL				Liao, Chien-Chang; Su, Ta-Chen; Sung, Fung-Chang; Chou, Wan-Hsin; Chen, Ta-Liang			Does Hepatitis C Virus Infection Increase Risk for Stroke? A Population-Based Cohort Study	PLOS ONE			English	Article							CAROTID ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; ASSOCIATION; SEROPOSITIVITY; COUNTRIES	Background: relationship between hepatitis C virus infection and risk of stroke remains inconsistent. This study evaluates the risk of stroke in association with chronic hepatitis C infection in a longitudinal population-based cohort. Methods: We identified 4,094 adults newly diagnosed with hepatitis C infection in 2002-2004 from the Taiwan National Health Insurance Research Database. Comparison group consisted of 16,376 adults without hepatitis C infection randomly selected from the same dataset, frequency matched by age and sex. Events of stroke from 2002-2008 were ascertained from medical claims (International Classification of Diseases, Ninth Revision, Clinical Modification, ICD-9-CM, codes 430-438). Multivariate adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated for potential associated factors including HCV infection, age, sex, low-income status, urbanization, cessation of cigarette smoking, alcohol-related illness, obesity, history of chronic diseases and medication use. Findings: During 96,752 person-years of follow-up, there were 1981 newly diagnosed stroke cases. The HRs of stroke associated with medical conditions such as hypertension, diabetes and heart disease were 1.48 (95% CI 1.33 to 1.65), 1.23 (95% CI 1.11 to 1.36) and 1.17 (95% CI 1.06 to 1.30), respectively, after adjustment for covariates. The cumulative risk of stroke for people with hepatitis C and without hepatitis C infections was 2.5% and 1.9%, respectively (p<0.0001). Compared with people without hepatitis C infection, the adjusted HR of stroke was 1.27 (95% CI 1.14 to 1.41) for people with hepatitis C infection. Conclusion: Chronic hepatitis C infection increases stroke risk and should be considered an important and independent risk factor.	[Liao, Chien-Chang; Chou, Wan-Hsin; Chen, Ta-Liang] Taipei Med Univ, Ctr Hlth Policy Res, Taipei, Taiwan; [Liao, Chien-Chang; Chou, Wan-Hsin; Chen, Ta-Liang] Taipei Med Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Su, Ta-Chen] Natl Taiwan Univ Hosp, Dept Cardiol, Taipei, Taiwan; [Sung, Fung-Chang] China Med Univ, Dept Publ Hlth, Taichung, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; National Taiwan University; National Taiwan University Hospital; China Medical University Taiwan	Liao, CC (corresponding author), Taipei Med Univ, Ctr Hlth Policy Res, Taipei, Taiwan.	tlc@tmu.edu.tw		SU, TA-CHEN/0000-0001-7523-7166	Foundation for Anesthesia Education and Research at Taipei Medical University, Taiwan; Clinical Trial and Research Center for Excellence, Department of Health, Taiwan [DOH 100-TD-B-111-004]	Foundation for Anesthesia Education and Research at Taipei Medical University, Taiwan; Clinical Trial and Research Center for Excellence, Department of Health, Taiwan	This research was supported by a Foundation for Anesthesia Education and Research fellowship grant at Taipei Medical University, Taiwan, and by the Clinical Trial and Research Center for Excellence, Department of Health, Taiwan (grant DOH 100-TD-B-111-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcari CM, 2006, CLIN INFECT DIS, V43, pE53, DOI 10.1086/507031; Aslam F, 2010, ATHEROSCLEROSIS, V209, P340, DOI 10.1016/j.atherosclerosis.2009.10.006; Bedimo R, 2010, HIV MED, V11, P462, DOI 10.1111/j.1468-1293.2009.00815.x; Biffi A, 2011, STROKE, V42, P1314, DOI 10.1161/STROKEAHA.110.605923; Bilora F, 2008, ANGIOLOGY, V59, P717, DOI 10.1177/0003319707311536; Boddi M, 2010, J CLIN VIROL, V47, P72, DOI 10.1016/j.jcv.2009.10.005; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Feigin VL, 2007, LANCET NEUROL, V6, P94, DOI 10.1016/S1474-4422(07)70007-8; Flamm SL, 2003, JAMA-J AM MED ASSOC, V289, P2413, DOI 10.1001/jama.289.18.2413; Forton DM, 2001, LANCET, V358, P38, DOI 10.1016/S0140-6736(00)05270-3; Freiberg MS, 2007, AIDS, V21, P193, DOI 10.1097/QAD.0b013e3280118a0d; Fukui M, 2003, JAMA-J AM MED ASSOC, V289, P1245, DOI 10.1001/jama.289.10.1245-b; Ishizaka N, 2002, LANCET, V359, P133, DOI 10.1016/S0140-6736(02)07339-7; Ishizaka Y, 2003, CIRC J, V67, P26, DOI 10.1253/circj.67.26; Kiechl S, 2001, CIRCULATION, V103, P1064, DOI 10.1161/01.CIR.103.8.1064; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lee MH, 2010, STROKE, V41, P2894, DOI 10.1161/STROKEAHA.110.598136; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Oyake N, 2008, J NEPHROL, V21, P345; Rouabhia S, 2010, WORLD J GASTROENTERO, V16, P3427, DOI 10.3748/wjg.v16.i27.3427; Sanyal AJ, 2003, AM J GASTROENTEROL, V98, P2064, DOI [10.1016/S0002-9270(03)00551-3, 10.1111/j.1572-0241.2003.07640.x]; Shah NR, 2010, ANN INTERN MED, V152, DOI 10.7326/0003-4819-152-2-201001190-02004; Sheikh MY, 2008, HEPATOLOGY, V47, P2127, DOI 10.1002/hep.22269; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Volzke H, 2004, ATHEROSCLEROSIS, V174, P99, DOI 10.1016/j.atherosclerosis.2004.01.010; White DL, 2008, J HEPATOL, V49, P831, DOI 10.1016/j.jhep.2008.08.006	26	88	89	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31527	10.1371/journal.pone.0031527	http://dx.doi.org/10.1371/journal.pone.0031527			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363662	Green Published, Green Submitted, gold			2022-12-27	WOS:000302871500051
J	Yan, SQ; Sun, JZ; Yan, YQ; Wang, H; Lou, M				Yan, Shen-Qiang; Sun, Jian-Zhong; Yan, Yu-Qing; Wang, He; Lou, Min			Evaluation of Brain Iron Content Based on Magnetic Resonance Imaging (MRI): Comparison among Phase Value, R2*and Magnitude Signal Intensity	PLOS ONE			English	Article							PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; IN-VIVO; SUSCEPTIBILITY; FERRITIN; VALIDATION; METABOLISM; DISORDERS; METALS; INJURY	Background and Purpose: Several magnetic resonance imaging (MRI) techniques are being exploited to measure brain iron levels increasingly as iron deposition has been implicated in some neurodegenerative diseases. However, there remains no unified evaluation of these methods as postmortem measurement isn't commonly available as the reference standard. The purpose of this study was to make a comparison among these methods and try to find a new index of brain iron. Methods: We measured both phase values and R2* in twenty-four adults, and performed correlation analysis among the two methods and the previously published iron concentrations. We also proposed a new method using magnitude signal intensity and compared it with R2* and brain iron. Results: We found phase value correlated with R2* in substantia nigra (r = -0.723, p<0.001) and putamen (r = -0.514, p = 0.010), while no correlations in red nucleus (r = -0.236, p = 0.268) and globus pallidus (r = -0.111, p = 0.605). And the new magnitude method had significant correlations in red nucleus (r = 20.593, p = 0.002), substantia nigra (r = -0.521, p = 0.009), globus pallidus (r = -0.750, p<0.001) and putamen (r = -0.547, p = 0.006) with R2*. A strong inverse correlation was also found between the new magnitude method and previously published iron concentrations in seven brain regions (r = -0.982, P<0.001). Conclusions: Our study indicates that phase value may not be used for assessing the iron content in some brain regions especially globus pallidus. The new magnitude method is highly consistent with R2* especially in globus pallidus, and we assume that this approach may be acceptable as an index of iron content in iron-rich brain regions.	[Yan, Shen-Qiang; Yan, Yu-Qing; Lou, Min] Zhejiang Univ, Sch Med, Dept Neurol, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Jian-Zhong] Zhejiang Univ, Sch Med, Dept Radiol, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, He] GE Healthcare, Global Appl Sci Lab, Shanghai, Peoples R China	Zhejiang University; Zhejiang University; General Electric	Lou, M (corresponding author), Zhejiang Univ, Sch Med, Dept Neurol, Affiliated Hosp 2, Hangzhou 310003, Zhejiang, Peoples R China.	loumingxc@vip.sina.com		Yan, Shenqiang/0000-0001-6425-0672	National Natural Science Foundation of China [81070915, 81171095]; Science and Technology Department of Zhejiang Province [2008C14078]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Zhejiang Province	This work was supported with grants from the National Natural Science Foundation of China (81070915 and 81171095) and the Science and Technology Department of Zhejiang Province (2008C14078). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamura S, 2009, J ALZHEIMERS DIS, V16, P879, DOI 10.3233/JAD-2009-1010; Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; BARTZOKIS G, 1993, MAGN RESON MED, V29, P459, DOI 10.1002/mrm.1910290406; Berg D, 2006, MOVEMENT DISORD, V21, P1299, DOI 10.1002/mds.21020; BIZZI A, 1990, RADIOLOGY, V177, P59, DOI 10.1148/radiology.177.1.2399339; BOTHWELL TH, 1995, NUTR REV, V53, P237, DOI 10.1111/j.1753-4887.1995.tb05480.x; de Rochefort L, 2010, MAGN RESON MED, V63, P194, DOI 10.1002/mrm.22187; DEXTER DT, 1991, BRAIN, V114, P1953, DOI 10.1093/brain/114.4.1953; DRAYER B, 1986, AM J ROENTGENOL, V147, P103, DOI 10.2214/ajr.147.1.103; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Duce JA, 2010, PROG NEUROBIOL, V92, P1, DOI 10.1016/j.pneurobio.2010.04.003; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Haacke EM, 2007, J MAGN RESON IMAGING, V26, P256, DOI 10.1002/jmri.22987; Haacke EM, 2005, MAGN RESON IMAGING, V23, P1, DOI 10.1016/j.mri.2004.10.001; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; Hasan KM, 2011, MAGN RESON MED; Hua Y, 2007, STROKE, V38, P759, DOI 10.1161/01.STR.0000247868.97078.10; Jin LR, 2011, BRAIN, V134, P50, DOI 10.1093/brain/awq319; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; Langkammer C, 2010, RADIOLOGY, V257, P455, DOI 10.1148/radiol.10100495; Liu T, 2009, MAGN RESON MED, V61, P196, DOI 10.1002/mrm.21828; Lou M, 2009, CEREBROVASC DIS, V27, P266, DOI 10.1159/000199464; Nakamura T, 2006, ACTA NEUROCHIR SUPPL, V96, P194; Ogg RJ, 1999, MAGN RESON IMAGING, V17, P1141, DOI 10.1016/S0730-725X(99)00017-X; Orino K, 2001, BIOCHEM J, V357, P241, DOI 10.1042/0264-6021:3570241; Pfefferbaum A, 2009, NEUROIMAGE, V47, P493, DOI 10.1016/j.neuroimage.2009.05.006; Rhodes SL, 2008, NEUROBIOL DIS, V32, P183, DOI 10.1016/j.nbd.2008.07.001; Stankiewicz J, 2007, NEUROTHERAPEUTICS, V4, P371, DOI 10.1016/j.nurt.2007.05.006; Wagner KR, 2003, J CEREBR BLOOD F MET, V23, P629, DOI 10.1097/01.WCB.0000073905.87928.6D; Xu X, 2008, NEUROIMAGE, V40, P35, DOI 10.1016/j.neuroimage.2007.11.017; Yao B, 2009, NEUROIMAGE, V44, P1259, DOI 10.1016/j.neuroimage.2008.10.029	32	27	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e31748	10.1371/journal.pone.0031748	http://dx.doi.org/10.1371/journal.pone.0031748			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22363719	Green Published, gold, Green Submitted			2022-12-27	WOS:000302871500083
J	Dijk, DJ; Duffy, JF; Silva, EJ; Shanahan, TL; Boivin, DB; Czeisler, CA				Dijk, Derk-Jan; Duffy, Jeanne F.; Silva, Edward J.; Shanahan, Theresa L.; Boivin, Diane B.; Czeisler, Charles A.			Amplitude Reduction and Phase Shifts of Melatonin, Cortisol and Other Circadian Rhythms after a Gradual Advance of Sleep and Light Exposure in Humans	PLOS ONE			English	Article							BRIGHT-LIGHT; PACEMAKER; TEMPERATURE; CLOCK; SUPPRESSION; WAKEFULNESS; SENSITIVITY; PROPENSITY; SCHEDULE; SYSTEM	Background: The phase and amplitude of rhythms in physiology and behavior are generated by circadian oscillators and entrained to the 24-h day by exposure to the light-dark cycle and feedback from the sleep-wake cycle. The extent to which the phase and amplitude of multiple rhythms are similarly affected during altered timing of light exposure and the sleep-wake cycle has not been fully characterized. Methodology/Principal Findings: We assessed the phase and amplitude of the rhythms of melatonin, core body temperature, cortisol, alertness, performance and sleep after a perturbation of entrainment by a gradual advance of the sleep-wake schedule (10 h in 5 days) and associated light-dark cycle in 14 healthy men. The light-dark cycle consisted either of moderate intensity 'room' light (similar to 90-150 lux) or moderate light supplemented with bright light (similar to 10,000 lux) for 5 to 8 hours following sleep. After the advance of the sleep-wake schedule in moderate light, no significant advance of the melatonin rhythm was observed whereas, after bright light supplementation the phase advance was 8.1 h (SEM 0.7 h). Individual differences in phase shifts correlated across variables. The amplitude of the melatonin rhythm assessed under constant conditions was reduced after moderate light by 54% (17-94%) and after bright light by 52% (range 12-84%), as compared to the amplitude at baseline in the presence of a sleep-wake cycle. Individual differences in amplitude reduction of the melatonin rhythm correlated with the amplitude of body temperature, cortisol and alertness. Conclusions/Significance: Alterations in the timing of the sleep-wake cycle and associated bright or moderate light exposure can lead to changes in phase and reduction of circadian amplitude which are consistent across multiple variables but differ between individuals. These data have implications for our understanding of circadian organization and the negative health outcomes associated with shift-work, jet-lag and exposure to artificial light.	[Dijk, Derk-Jan; Duffy, Jeanne F.; Shanahan, Theresa L.; Boivin, Diane B.; Czeisler, Charles A.] Harvard Univ, Sch Med, Div Sleep Med, Boston, MA USA; [Dijk, Derk-Jan; Duffy, Jeanne F.; Silva, Edward J.; Shanahan, Theresa L.; Boivin, Diane B.; Czeisler, Charles A.] Brigham & Womens Hosp, Div Sleep Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Dijk, DJ (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Surrey Sleep Res Ctr, Guildford GU2 5XH, Surrey, England.	d.j.dijk@surrey.ac.uk	Duffy, Jeanne F./AAJ-4845-2020	Duffy, Jeanne F./0000-0003-4177-4179	National Aeronautics and Space Administration [NAG9-524, NAG9-1035]; National Space Biomedical Research Institute [HFP01601]; National Institute of Mental Health [R01-MH45130]; National Institutes of Health (NIH) General Clinic Research Center [NCRR-GCRC-M01-RR02635]; Brigham and Women's Hospital; GSK; Eli Lilly; Merck; Ono Pharma; Philips; Airforce Office of Scientific Research; Biotechnology and the Biological Sciences Research Council; Actelion, Ltd.; Avera Pharmaceuticals, Inc.; Bombardier Inc.; Boston Celtics; Cephalon, Inc.; Columbia River Bar Pilots; Delta Airlines; Eli Lilly and Co.; Federal Motor Carrier Safety Administration (FMCSA), U.S. Department of Transportation; Fedex Kinko's; Fusion Medical Education, LLC; Garda Siochana Inspectorate; Global Ground Support; Hypnion, Inc.; Johnson Johnson; Koninklijke Philips Electronics, N.V.; Minnesota Timberwolves; Morgan Stanley; Norfolk Southern; Portland Trail Blazers; Respironics, Inc.; Sanofi-Aventis Groupe; Sepracor, Inc.; Sleep Multimedia, Inc.; Sleep Research Society; Somnus Therapeutics, Inc.; Takeda Pharmaceuticals; Vanda Pharmaceuticals, Inc.; Vital Issues in Medicine; Warburg-Pincus; Zeo Inc.; Massachusetts Medical Society/New England Journal of Medicine; McGraw Hill, the New York Times Penguin Press and Philips Respironics; ResMed; Transport Canada; Litebook Company; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009524] Funding Source: NIH RePORTER	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Space Biomedical Research Institute; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health (NIH) General Clinic Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brigham and Women's Hospital; GSK(GlaxoSmithKline); Eli Lilly(Eli Lilly); Merck(Merck & Company); Ono Pharma; Philips; Airforce Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Biotechnology and the Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Actelion, Ltd.; Avera Pharmaceuticals, Inc.; Bombardier Inc.; Boston Celtics; Cephalon, Inc.(Teva Pharmaceutical Industries); Columbia River Bar Pilots; Delta Airlines; Eli Lilly and Co.(Eli Lilly); Federal Motor Carrier Safety Administration (FMCSA), U.S. Department of Transportation; Fedex Kinko's; Fusion Medical Education, LLC; Garda Siochana Inspectorate; Global Ground Support; Hypnion, Inc.; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Koninklijke Philips Electronics, N.V.; Minnesota Timberwolves; Morgan Stanley; Norfolk Southern; Portland Trail Blazers; Respironics, Inc.; Sanofi-Aventis Groupe; Sepracor, Inc.; Sleep Multimedia, Inc.; Sleep Research Society; Somnus Therapeutics, Inc.; Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd); Vanda Pharmaceuticals, Inc.; Vital Issues in Medicine; Warburg-Pincus; Zeo Inc.; Massachusetts Medical Society/New England Journal of Medicine; McGraw Hill, the New York Times Penguin Press and Philips Respironics; ResMed; Transport Canada; Litebook Company; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported in part by grants NAG9-524 and NAG9-1035 from the National Aeronautics and Space Administration, HFP01601 from the National Space Biomedical Research Institute and grant and R01-MH45130 from the National Institute of Mental Health; the facility where the studies were conducted was supported in part by National Institutes of Health (NIH) General Clinic Research Center grant NCRR-GCRC-M01-RR02635 and by the Brigham and Women's Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Dijk has received research funding from GSK, Eli Lilly, Merck, Ono Pharma, Philips, Airforce Office of Scientific Research, Biotechnology and the Biological Sciences Research Council and provided consulting services to Johnson and Johnson, Sanofi-aventis, Metro Naps, Pepsi Co, Actelion, Cephalon, GSK, Eli Lilly, Philips, Merck, Ono Pharma, UCB, and CHDI. Dr. Czeisler has received consulting fees/served as a paid member of scientific advisory boards for: Actelion, Ltd.; Avera Pharmaceuticals, Inc.; Bombardier Inc.; Boston Celtics; Cephalon, Inc.; Columbia River Bar Pilots; Delta Airlines; Eli Lilly and Co.; Federal Motor Carrier Safety Administration (FMCSA), U.S. Department of Transportation; Fedex Kinko's; Fusion Medical Education, LLC; Garda Siochana Inspectorate; Global Ground Support; Hypnion, Inc. (acquired by Eli Lilly and Co. in April 2007); Johnson & Johnson; Koninklijke Philips Electronics, N.V.; Minnesota Timberwolves; Morgan Stanley; Norfolk Southern; Portland Trail Blazers; Respironics, Inc.; Sanofi-Aventis Groupe; Sepracor, Inc.; Sleep Multimedia, Inc.; Sleep Research Society; Somnus Therapeutics, Inc.; Takeda Pharmaceuticals; Vanda Pharmaceuticals, Inc.; Vital Issues in Medicine; Warburg-Pincus; Zeo Inc. Dr. Czeisler owns an equity interest in Lifetrac, Inc.; Somnus Therapeutics, Inc.; Vanda Pharmaceuticals, Inc., and Zeo Inc. Dr. Czeisler received royalties from the Massachusetts Medical Society/New England Journal of Medicine; McGraw Hill, the New York Times Penguin Press and Philips Respironics. Dr. Czeisler has clinical trial research contracts from Cephalon, Inc., Merck & Co., Inc., and Pfizer, Inc.; an investigator-initiated research grant from Cephalon, Inc.; and his research laboratory at the Brigham and Women's Hospital has received unrestricted research and education funds for research expenses from Cephalon, Inc., Koninklijke Philips Electronics, N.V., ResMed, and the Brigham and Women's Hospital. Dr. Czeisler is the incumbent of an endowed professorship provided to Harvard University by Cephalon, Inc. and holds a number of process patents in the field of sleep/circadian rhythms, details of which are available on request. Since 1985, Dr. Czeisler has also served as an expert witness on various legal cases related to sleep and/or circadian rhythms. Dr. Duffy has received investigator-initiated research grants from Philips-Respironics. Dr. Boivin has received research support from Transport Canada and the Litebook Company; has participated in speaking and advisory engagements for Servier and Cephalon and is Founder/CEO of Alpha Logik Consultants, Inc. Dr. Shanahan, declares that her spouse is Dr. Czeisler. None of the commercial research grants listed in the statement relate to the current study. Our listed conflicts do not alter our adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Akerstedt T, 1998, AM J PHYSL, P274; BEERSMA DGM, 1993, J BIOL RHYTHM, V8, P340, DOI 10.1177/074873049300800407; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; BOIVIN DB, 1994, J BIOL RHYTHM, V9, P315, DOI 10.1177/074873049400900311; Boivin DB, 2002, J BIOL RHYTHM, V17, P266, DOI 10.1177/07430402017003010; Boivin DB, 1996, NATURE, V379, P540, DOI 10.1038/379540a0; BROWN EN, 1992, J BIOL RHYTHM, V7, P177, DOI 10.1177/074873049200700301; Burgess HJ, 2003, J BIOL RHYTHM, V18, P318, DOI 10.1177/0748730403253585; Cajochen C, 2006, EUR J NEUROSCI, V23, P1082, DOI 10.1111/j.1460-9568.2006.04613.x; Cajochen C, 2003, J PINEAL RES, V35, P149, DOI 10.1034/j.1600-079X.2003.00072.x; Cajochen C, 2007, SLEEP MED REV, V11, P453, DOI 10.1016/j.smrv.2007.07.009; Chang AM, 2011, J PHYSIOL-LONDON, V589, P1095, DOI 10.1113/jphysiol.2010.201194; Czeisler CA, 2007, COLD SPRING HARB SYM, V72, P579, DOI 10.1101/sqb.2007.72.064; Czeisler C. A., 2001, HDB BEHAV NEUROBIOLO, P531; CZEISLER CA, 1990, NEW ENGL J MED, V322, P1253, DOI 10.1056/NEJM199005033221801; CZEISLER CA, 1991, EXP GERONTOL, V26, P217, DOI 10.1016/0531-5565(91)90014-D; Czeisler CA, 1999, SCIENCE, V284, P2177, DOI 10.1126/science.284.5423.2177; Dijk DJ, 2005, J BIOL RHYTHM, V20, P279, DOI 10.1177/0748730405278292; DIJK DJ, 1994, NEUROSCI LETT, V166, P63, DOI 10.1016/0304-3940(94)90841-9; DIJK DJ, 1995, J NEUROSCI, V15, P3526; DIJK DJ, 1989, AM J PHYSIOL, V256, pR106, DOI 10.1152/ajpregu.1989.256.1.R106; Dijk DJ, 1999, J PHYSIOL-LONDON, V516, P611, DOI 10.1111/j.1469-7793.1999.0611v.x; DIJK DJ, 1992, J SLEEP RES, V1, P112, DOI 10.1111/j.1365-2869.1992.tb00021.x; Duffy JE, 2002, J BIOL RHYTHM, V17, P4, DOI 10.1177/074873002129002294; Duffy JF, 2009, SLEEP MED CLIN, V4, P165, DOI 10.1016/j.jsmc.2009.01.004; Eastman CI, 2005, SLEEP, V28, P33, DOI 10.1093/sleep/28.1.33; Gooley JJ, 2011, J CLIN ENDOCR METAB, V96, pE463, DOI 10.1210/jc.2010-2098; Grone BP, 2011, J BIOL RHYTHM, V26, P78, DOI 10.1177/0748730410388404; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hebert M, 2002, J PINEAL RES, V33, P198, DOI 10.1034/j.1600-079X.2002.01885.x; HORNE JA, 1977, BIOL PSYCHOL, V5, P179, DOI 10.1016/0301-0511(77)90001-1; JEWETT ME, 1994, J BIOL RHYTHM, V9, P295, DOI 10.1177/074873049400900310; JEWETT ME, 1991, NATURE, V350, P59, DOI 10.1038/350059a0; Jewett ME, 1998, J THEOR BIOL, V192, P455, DOI 10.1006/jtbi.1998.0667; Jung CM, 2010, J BIOL RHYTHM, V25, P208, DOI 10.1177/0748730410368413; Klerman EB, 2002, J BIOL RHYTHM, V17, P181, DOI 10.1177/074873002129002474; Klerman EB, 1998, AM J PHYSIOL-REG I, V274, pR991; Klerman EB, 1996, AM J PHYSIOL-REG I, V270, pR271, DOI 10.1152/ajpregu.1996.270.1.R271; Kronauer R. E., 1993, LIGHT BIOL RHYTHMS M, V63, P217; LAVIE P, 1986, ELECTROEN CLIN NEURO, V63, P414, DOI 10.1016/0013-4694(86)90123-9; LEWY AJ, 1989, CHRONOBIOL INT, V6, P93, DOI 10.3109/07420528909059144; Monk TH, 2006, AVIAT SPACE ENVIR MD, V77, P677; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Santhi N, 2012, J PINEAL RES, V53, P47, DOI 10.1111/j.1600-079X.2011.00970.x; Shanahan TL, 1999, J BIOL RHYTHM, V14, P237, DOI 10.1177/074873099129000560; Shanahan TL, 1997, J BIOL RHYTHM, V12, P556, DOI 10.1177/074873049701200610; SHANAHAN TL, 1991, J CLIN ENDOCR METAB, V73, P227, DOI 10.1210/jcem-73-2-227; Smith KA, 2004, J CLIN ENDOCR METAB, V89, P3610, DOI 10.1210/jc.2003-032100; Stevens RG, 2009, MUTAT RES-GEN TOX EN, V680, P106, DOI 10.1016/j.mrgentox.2009.08.004; STROGATZ SH, 1987, AM J PHYSIOL, V253, pR172, DOI 10.1152/ajpregu.1987.253.1.R172; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Ukai H, 2010, ANNU REV PHYSIOL, V72, P579, DOI 10.1146/annurev-physiol-073109-130051; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Wright KP, 2001, P NATL ACAD SCI USA, V98, P14027, DOI 10.1073/pnas.201530198; Wyatt JK, 1999, AM J PHYSIOL-REG I, V277, pR1152; Zeitzer JM, 2000, J PHYSIOL-LONDON, V526, P695, DOI 10.1111/j.1469-7793.2000.00695.x	56	91	104	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30037	10.1371/journal.pone.0030037	http://dx.doi.org/10.1371/journal.pone.0030037			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363414	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600011
J	Griebel, U; Oller, DK				Griebel, Ulrike; Oller, D. Kimbrough			Vocabulary Learning in a Yorkshire Terrier: Slow Mapping of Spoken Words	PLOS ONE			English	Article							LANGUAGE; DOG	Rapid vocabulary learning in children has been attributed to "fast mapping", with new words often claimed to be learned through a single presentation. As reported in 2004 in Science a border collie (Rico) not only learned to identify more than 200 words, but fast mapped the new words, remembering meanings after just one presentation. Our research tests the fast mapping interpretation of the Science paper based on Rico's results, while extending the demonstration of large vocabulary recognition to a lap dog. We tested a Yorkshire terrier (Bailey) with the same procedures as Rico, illustrating that Bailey accurately retrieved randomly selected toys from a set of 117 on voice command of the owner. Second we tested her retrieval based on two additional voices, one male, one female, with different accents that had never been involved in her training, again showing she was capable of recognition by voice command. Third, we did both exclusion-based training of new items (toys she had never seen before with names she had never heard before) embedded in a set of known items, with subsequent retention tests designed as in the Rico experiment. After Bailey succeeded on exclusion and retention tests, a crucial evaluation of true mapping tested items previously successfully retrieved in exclusion and retention, but now pitted against each other in a two-choice task. Bailey failed on the true mapping task repeatedly, illustrating that the claim of fast mapping in Rico had not been proven, because no true mapping task had ever been conducted with him. It appears that the task called retention in the Rico study only demonstrated success in retrieval by a process of extended exclusion.	[Griebel, Ulrike] Univ Memphis, Inst Intelligent Syst, Memphis, TN 38152 USA; [Oller, D. Kimbrough] Univ Memphis, Sch Commun Sci & Disorders, Memphis, TN 38152 USA; [Griebel, Ulrike; Oller, D. Kimbrough] Konrad Lorenz Inst Evolut & Cognit Res, Altenberg, Austria	University of Memphis; University of Memphis	Griebel, U (corresponding author), Univ Memphis, Inst Intelligent Syst, Memphis, TN 38152 USA.	ulrikegriebel@gmail.com	Oller, D. Kimbrough/G-1804-2010		Plough Foundation	Plough Foundation	This research was supported in part by the Plough Foundation, which supports Oller's Chair of Excellence at The University of Memphis (http://www.manta.com/c/mmcxph2/plough-foundation). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen Colin, 1997, SPECIES MIND PHILOS; Bates E, 1995, HDB CHILD LANGUAGE, P96; Bekoff M, 1998, COGNITIVE ETHOLOGY C; Bloom P, 2004, SCIENCE, V304, P1605, DOI 10.1126/science.1099899; Carey S., 1982, LANG ACQUIS, P347; de Waal FBM, 2010, TRENDS COGN SCI, V14, P201, DOI 10.1016/j.tics.2010.03.003; Griffin Donald R., 2001, ANIMAL MINDS COGNITI; HERMAN LM, 1985, NEUROSCI BIOBEHAV R, V9, P667, DOI 10.1016/0149-7634(85)90013-2; HERMAN LM, 1984, COGNITION, V16, P129, DOI 10.1016/0010-0277(84)90003-9; Kaminski J, 2004, SCIENCE, V304, P1682, DOI 10.1126/science.1097859; Kastak CR, 2002, J EXP ANAL BEHAV, V78, P449, DOI 10.1901/jeab.2002.78-449; Markman EM, 2004, TRENDS COGN SCI, V8, P479, DOI 10.1016/j.tics.2004.09.007; MERVIS CB, 1994, CHILD DEV, V65, P1646, DOI 10.2307/1131285; Pepperberg IM, 2002, BRAIN BEHAV EVOLUT, V59, P54, DOI 10.1159/000063733; Pilley JW, 2011, BEHAV PROCESS, V86, P184, DOI 10.1016/j.beproc.2010.11.007; PREMACK D, 1971, SCIENCE, V172, P808, DOI 10.1126/science.172.3985.808; PREMACK D, 1985, COGNITION, V19, P207, DOI 10.1016/0010-0277(85)90036-8; Wilkinson KM, 2003, J APPL DEV PSYCHOL, V24, P739, DOI 10.1016/j.appdev.2003.09.006	18	40	40	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30182	10.1371/journal.pone.0030182	http://dx.doi.org/10.1371/journal.pone.0030182			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363421	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600015
J	Loo, LWM; Cheng, I; Tiirikainen, M; Lum-Jones, A; Seifried, A; Dunklee, LM; Church, JM; Gryfe, R; Weisenberger, DJ; Haile, RW; Gallinger, S; Duggan, DJ; Thibodeau, SN; Casey, G; Le Marchand, L				Loo, Lenora W. M.; Cheng, Iona; Tiirikainen, Maarit; Lum-Jones, Annette; Seifried, Ann; Dunklee, Lucas M.; Church, James M.; Gryfe, Robert; Weisenberger, Daniel J.; Haile, Robert W.; Gallinger, Steven; Duggan, David J.; Thibodeau, Stephen N.; Casey, Graham; Le Marchand, Loic			cis-Expression QTL Analysis of Established Colorectal Cancer Risk Variants in Colon Tumors and Adjacent Normal Tissue	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HUMAN GENE-EXPRESSION; SUSCEPTIBILITY LOCI; MICROSATELLITE INSTABILITY; AURORA-A; IN-VIVO; HURP; ARC; CELLS; SCAN	Genome-wide association studies (GWAS) have identified 19 risk variants associated with colorectal cancer. As most of these risk variants reside outside the coding regions of genes, we conducted cis-expression quantitative trait loci (cis-eQTL) analyses to investigate possible regulatory functions on the expression of neighboring genes. Forty microsatellite stable and CpG island methylator phenotype-negative colorectal tumors and paired adjacent normal colon tissues were used for genome-wide SNP and gene expression profiling. We found that three risk variants (rs10795668, rs4444235 and rs9929218, using near perfect proxies rs706771, rs11623717 and rs2059252, respectively) were significantly associated (FDR q-value <= 0.05) with expression levels of nearby genes (<2 Mb up-or down-stream). We observed an association between the low colorectal cancer risk allele (A) for rs10795668 at 10p14 and increased expression of ATP5C1 (q = 0.024) and between the colorectal cancer high risk allele (C) for rs4444235 at 14q22.2 and increased expression of DLGAP5 (q = 0.041), both in tumor samples. The colorectal cancer low risk allele (A) for rs9929218 at 16q22.1 was associated with a significant decrease in expression of both NOL3 (q = 0.017) and DDX28 (q = 0.046) in the adjacent normal colon tissue samples. Of the four genes, DLGAP5 and NOL3 have been previously reported to play a role in colon carcinogenesis and ATP5C1 and DDX28 are mitochondrial proteins involved in cellular metabolism and division, respectively. The combination of GWAS findings, prior functional studies, and the cis-eQTL analyses described here suggest putative functional activities for three of the colorectal cancer GWAS identified risk loci as regulating the expression of neighboring genes.	[Loo, Lenora W. M.; Cheng, Iona; Tiirikainen, Maarit; Lum-Jones, Annette; Seifried, Ann; Dunklee, Lucas M.; Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA; [Church, James M.] Cleveland Clin Fdn, Dept Colorectal Surg, Cleveland, OH 44195 USA; [Gryfe, Robert; Gallinger, Steven] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Surg, Toronto, ON, Canada; [Weisenberger, Daniel J.] Univ So Calif, Keck Sch Med, Epigenome Ctr, Los Angeles, CA 90033 USA; [Haile, Robert W.; Casey, Graham] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90033 USA; [Duggan, David J.] Translat Genom Res Inst, Integrated Canc Genom Div, Phoenix, AZ USA; [Thibodeau, Stephen N.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA	Cancer Research Center of Hawaii; University of Hawaii System; Cleveland Clinic Foundation; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Southern California; University of Southern California; Translational Genomics Research Institute; Mayo Clinic	Loo, LWM (corresponding author), Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA.	lloo@cc.hawaii.edu	Weisenberger, Daniel/AAA-8314-2020; Tirikainen, M/B-6954-2012; Gallinger, Steven/E-4575-2013; Gryfe, Robert/AAF-1870-2021	Weisenberger, Daniel/0000-0001-8303-2603; Tirikainen, M/0000-0002-8124-3818; 	National Cancer Institute, National Institutes of Health under RFA [CA-95-011]; University of Hawaii Colorectal Cancer Family Registry [U01 CA074806]; Mayo Clinic Cooperative Family Registry for Colon Cancer Studies [U01 CA074800]; Ontario Registry for Studies of Familial Colorectal Cancer [U01 CA074783]; University of Southern California Familial Colorectal Neoplasia Collaborative Group [U01 CA074799]; Colon Cancer Family Registry; Affymetrix Collaborations in Cancer Research Program;  [5U24 CA074806]; NATIONAL CANCER INSTITUTE [U01CA074799, U01CA074806, U01CA074800, K22CA095011, U01CA074783, P30CA071789, U24CA074806] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health under RFA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Hawaii Colorectal Cancer Family Registry; Mayo Clinic Cooperative Family Registry for Colon Cancer Studies; Ontario Registry for Studies of Familial Colorectal Cancer; University of Southern California Familial Colorectal Neoplasia Collaborative Group; Colon Cancer Family Registry; Affymetrix Collaborations in Cancer Research Program; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute, National Institutes of Health under RFA # CA-95-011; and through cooperative agreements with the University of Hawaii Colorectal Cancer Family Registry (U01 CA074806), Mayo Clinic Cooperative Family Registry for Colon Cancer Studies (U01 CA074800), Ontario Registry for Studies of Familial Colorectal Cancer (U01 CA074783), the University of Southern California Familial Colorectal Neoplasia Collaborative Group (U01 CA074799), and members of the Colon Cancer Family Registry and P.I.s. In addition, this work was partly supported by grant 5U24 CA074806 and Affymetrix Collaborations in Cancer Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassal S, 2001, GENOMICS, V77, P5, DOI 10.1006/geno.2001.6570; Benjamini Y, 1995, J ROY STAT SOC, V57, P289; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Carvajal-Carmona LG, 2011, HUM MOL GENET, V20, P2879, DOI 10.1093/hmg/ddr190; Cheung VG, 2003, COLD SPRING HARB SYM, V68, P403, DOI 10.1101/sqb.2003.68.403; Cuezva JM, 2002, CANCER RES, V62, P6674; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Duan S, 2008, AM J HUM GENET, V82, P1101, DOI 10.1016/j.ajhg.2008.03.006; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; Foo RSY, 2007, P NATL ACAD SCI USA, V104, P20826, DOI 10.1073/pnas.0710017104; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Funakoshi S, 2008, MOL CANCER RES, V6, P1478, DOI 10.1158/1541-7786.MCR-07-2161; Geschickter C.F., 1930, J CHEM EDUC, DOI [10.1021/ed007p179, DOI 10.1021/ED007P179]; Gudmundsson KO, 2007, STEM CELLS, V25, P1498, DOI 10.1634/stemcells.2005-0479; Heikaus S, 2008, APOPTOSIS, V13, P938, DOI 10.1007/s10495-008-0225-6; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Koffa MD, 2006, CURR BIOL, V16, P743, DOI 10.1016/j.cub.2006.03.056; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Lin F, 2008, CANCER BIOL THER, V7, P1669, DOI 10.4161/cbt.7.10.6660; Lindor NM, 2002, J CLIN ONCOL, V20, P1043, DOI 10.1200/JCO.20.4.1043; Mercier I, 2008, CELL CYCLE, V7, P1640, DOI 10.4161/cc.7.11.5979; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nakagawa Y, 1999, BRIT J CANCER, V80, P914, DOI 10.1038/sj.bjc.6690441; Newcomb PA, 2007, CANCER EPIDEM BIOMAR, V16, P2331, DOI 10.1158/1055-9965.EPI-07-0648; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Pomerantz MM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001204; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Prokunina-Olsson L, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-96; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Shin S, 2007, CANCER RES, V67, P7572, DOI 10.1158/0008-5472.CAN-06-4652; Stein U, 2009, NAT MED, V15, P59, DOI 10.1038/nm.1889; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tsou AP, 2003, ONCOGENE, V22, P298, DOI 10.1038/sj.onc.1206129; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Willers IM, 2010, BIOCHEM J, V426, P319, DOI 10.1042/BJ20091570; Wong J, 2008, MOL BIOL CELL, V19, P2083, DOI 10.1091/mbc.E07-10-1088; Wong J, 2006, J CELL BIOL, V173, P879, DOI 10.1083/jcb.200511132; Wu L, 2010, J BIOL CHEM, V285, P19235, DOI 10.1074/jbc.M110.114892; Yu CTR, 2005, MOL CELL BIOL, V25, P5789, DOI 10.1128/MCB.25.14.5789-5800.2005; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	50	52	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30477	10.1371/journal.pone.0030477	http://dx.doi.org/10.1371/journal.pone.0030477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363440	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600032
J	Osycka-Salut, C; Gervasi, MG; Pereyra, E; Cella, M; Ribeiro, ML; Franchi, AM; Perez-Martinez, S				Osycka-Salut, Claudia; Gracia Gervasi, Maria; Pereyra, Elba; Cella, Maximiliano; Laura Ribeiro, Maria; Maria Franchi, Ana; Perez-Martinez, Silvina			Anandamide Induces Sperm Release from Oviductal Epithelia through Nitric Oxide Pathway in Bovines	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHORYLATION; BULL SPERM; ENDOCANNABINOID SYSTEM; PROMOTES CAPACITATION; CANNABINOID RECEPTOR; ACROSOME REACTION; SPERMATOZOA; SYNTHASE; BINDING; MOUSE	Mammalian spermatozoa are not able to fertilize an egg immediately upon ejaculation. They acquire this ability during their transit through the female genital tract in a process known as capacitation. The mammalian oviduct acts as a functional sperm reservoir providing a suitable environment that allows the maintenance of sperm fertilization competence until ovulation occurs. After ovulation, spermatozoa are gradually released from the oviductal reservoir in the caudal isthmus and ascend to the site of fertilization. Capacitating-related changes in sperm plasma membrane seem to be responsible for sperm release from oviductal epithelium. Anandamide is a lipid mediator that participates in the regulation of several female and male reproductive functions. Previously we have demonstrated that anandamide was capable to release spermatozoa from oviductal epithelia by induction of sperm capacitation in bovines. In the present work we studied whether anandamide might exert its effect by activating the nitric oxide (NO) pathway since this molecule has been described as a capacitating agent in spermatozoa from different species. First, we demonstrated that 1 mu M NOC-18, a NO donor, and 10 mM L-Arginine, NO synthase substrate, induced the release of spermatozoa from the oviductal epithelia. Then, we observed that the anandamide effect on sperm oviduct interaction was reversed by the addition of 1 mu M L-NAME, a NO synthase inhibitor, or 30 mu g/ml Hemoglobin, a NO scavenger. We also demonstrated that the induction of bull sperm capacitation by nanomolar concentrations of R(+)-methanandamide or anandamide was inhibited by adding L-NAME or Hemoglobin. To study whether anandamide is able to produce NO, we measured this compound in both sperm and oviductal cells. We observed that anandamide increased the levels of NO in spermatozoa, but not in oviductal cells. These findings suggest that anandamide regulates the sperm release from oviductal epithelia probably by activating the NO pathway during sperm capacitation.	[Osycka-Salut, Claudia; Gracia Gervasi, Maria; Pereyra, Elba; Cella, Maximiliano; Laura Ribeiro, Maria; Maria Franchi, Ana; Perez-Martinez, Silvina] Ctr Estudios Farmacol & Bot CEFYBO CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Osycka-Salut, C (corresponding author), Ctr Estudios Farmacol & Bot CEFYBO CONICET, Buenos Aires, DF, Argentina.	perezms@fmed.uba.ar		Osycka-Salut, Claudia Elena/0000-0002-8033-5155; Gervasi, Maria Gracia/0000-0002-5468-2700	National Research Council (CONICET)-Argentina [PIP 2008 2204]	National Research Council (CONICET)-Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by National Research Council (CONICET)-Argentina (PIP 2008 2204) to AF, MLR, and SPM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoako AA, 2010, J CHROMATOGR B, V878, P3231, DOI 10.1016/j.jchromb.2010.09.024; Aquila S, 2009, J CELL PHYSIOL, V221, P147, DOI 10.1002/jcp.21837; Bartlett SR, 1999, J PHYSIOL-LONDON, V521, P705, DOI 10.1111/j.1469-7793.1999.00705.x; Bosch P, 2001, THERIOGENOLOGY, V56, P247, DOI 10.1016/S0093-691X(01)00560-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; Cella M, 2008, PLACENTA, V29, P699, DOI 10.1016/j.placenta.2008.05.003; CROSS NL, 1986, GAMETE RES, V15, P213, DOI 10.1002/mrd.1120150303; de Lamirande E, 2008, BBA-PROTEINS PROTEOM, V1784, P106, DOI 10.1016/j.bbapap.2007.08.024; Demuth DG, 2006, LIFE SCI, V78, P549, DOI 10.1016/j.lfs.2005.05.055; DEVANE WA, 1988, MOL PHARMACOL, V34, P605; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; El-Talatini MR, 2010, FERTIL STERIL, V93, P1989, DOI 10.1016/j.fertnstert.2008.12.033; Fazeli A, 1999, BIOL REPROD, V60, P879, DOI 10.1095/biolreprod60.4.879; Francavilla F, 2009, ENDOCRINOLOGY, V150, P4692, DOI 10.1210/en.2009-0057; FUKUI Y, 1990, THERIOGENOLOGY, V34, P579, DOI 10.1016/0093-691X(90)90013-J; GalantinoHomer HL, 1997, BIOL REPROD, V56, P707, DOI 10.1095/biolreprod56.3.707; Ghasemi M, 2007, BJU INT, V100, P1385, DOI 10.1111/j.1464-410X.2007.07180.x; Gervasi MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016993; Gervasi MG, 2009, REPRODUCTION, V137, P403, DOI 10.1530/REP-08-0204; Grisham MB, 1996, METHOD ENZYMOL, V268, P237; Gualtieri R, 2005, REPRODUCTION, V129, P51, DOI 10.1530/rep.1.00374; Herradon E, 2007, BRIT J PHARMACOL, V152, P699, DOI 10.1038/sj.bjp.0707404; Herrero MB, 1996, REPROD FERT DEVELOP, V8, P931, DOI 10.1071/RD9960931; Herrero MB, 1997, FEBS LETT, V411, P39, DOI 10.1016/S0014-5793(97)00570-X; Herrero MB, 2003, CURR PHARM DESIGN, V9, P419, DOI 10.2174/1381612033391720; Hou ML, 2008, ANIM REPROD SCI, V104, P56, DOI 10.1016/j.anireprosci.2007.01.006; Howlett AC, 2005, HANDB EXP PHARMACOL, V168, P53; Hunter RHF, 2008, MOL REPROD DEV, V75, P167, DOI 10.1002/mrd.20776; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Lapointe J, 2006, ENDOCRINOLOGY, V147, P5600, DOI 10.1210/en.2005-1548; LEE MA, 1987, FERTIL STERIL, V48, P649; Lefebvre R, 1996, BIOL REPROD, V54, P575, DOI 10.1095/biolreprod54.3.575; Maccarrone M, 2008, BRIT J PHARMACOL, V153, P189, DOI 10.1038/sj.bjp.0707444; Maccarrone M, 2005, J CELL SCI, V118, P4393, DOI 10.1242/jcs.02536; Martinez SP, 2000, J REPROD FERTIL, V118, P111, DOI 10.1530/reprod/118.1.111; Meiser H, 2003, ANAT HISTOL EMBRYOL, V32, P321, DOI 10.1111/j.1439-0264.2003.00459.x; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; O'Flaherty C, 2004, BBA-GEN SUBJECTS, V1674, P215, DOI 10.1016/j.bbagen.2004.06.020; PALMER RMJ, 1989, BIOCHEM BIOPH RES CO, V158, P348, DOI 10.1016/S0006-291X(89)80219-0; PARRISH JJ, 1988, BIOL REPROD, V38, P1171, DOI 10.1095/biolreprod38.5.1171; PARRISH JJ, 1989, GAMETE RES, V24, P403, DOI 10.1002/mrd.1120240407; Poblete LM, 2005, J PHYSIOL-LONDON, V568, P539, DOI 10.1113/jphysiol.2005.094292; Revah I, 2000, BIOL REPROD, V62, P1010, DOI 10.1095/biolreprod62.4.1010; Rodriguez PC, 2009, ANIM REPROD SCI, V110, P96, DOI 10.1016/j.anireprosci.2007.12.017; Rodriguez PC, 2005, ANIM REPROD SCI, V85, P231, DOI 10.1016/j.anireprosci.2004.05.018; Roessner C, 2010, ANDROLOGIA, V42, P132, DOI 10.1111/j.1439-0272.2009.01005.x; Ross RA, 2003, BRIT J PHARMACOL, V140, P790, DOI 10.1038/sj.bjp.0705467; Rosselli M, 1996, MOL HUM REPROD, V2, P607, DOI 10.1093/molehr/2.8.607; Schuel H, 2002, MOL REPROD DEV, V63, P376, DOI 10.1002/mrd.90021; Signorello MG, 2011, J CELL BIOCHEM, V112, P924, DOI 10.1002/jcb.23008; SMITH TT, 1991, J REPROD FERTIL, V91, P567, DOI 10.1530/jrf.0.0910567; Suarez SS, 2008, INT J DEV BIOL, V52, P455, DOI 10.1387/ijdb.072527ss; Sun XF, 2008, MOL CELL ENDOCRINOL, V286, pS3, DOI 10.1016/j.mce.2008.01.002; Talevi R, 2001, BIOL REPROD, V64, P491, DOI 10.1095/biolreprod64.2.491; Tornblom SA, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-33; Vercelli CA, 2009, REPROD BIOMED ONLINE, V18, P824, DOI 10.1016/S1472-6483(10)60033-8; Visconti PE, 2002, J REPROD IMMUNOL, V53, P133, DOI 10.1016/S0165-0378(01)00103-6; Wang HB, 2005, PROSTAG OTH LIPID M, V77, P84, DOI 10.1016/j.prostaglandins.2004.09.013; WARD CR, 1984, DEV BIOL, V104, P287, DOI 10.1016/0012-1606(84)90084-8; Ye XQ, 2010, TRENDS ENDOCRIN MET, V21, P17, DOI 10.1016/j.tem.2009.08.003	61	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30671	10.1371/journal.pone.0030671	http://dx.doi.org/10.1371/journal.pone.0030671			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363468	gold, Green Submitted, Green Published			2022-12-27	WOS:000302853600052
J	Pankhurst, MW; Gell, DA; Butler, CW; Kirkcaldie, MTK; West, AK; Chung, RS				Pankhurst, Michael W.; Gell, David A.; Butler, Chris W.; Kirkcaldie, Matthew T. K.; West, Adrian K.; Chung, Roger S.			Metallothionein (MT) -I and MT-II Expression Are Induced and Cause Zinc Sequestration in the Liver after Brain Injury	PLOS ONE			English	Article							IMPAIRED INFLAMMATORY RESPONSE; OXIDATIVE STRESS; CELL-DEATH; HEPATIC ZINC; INDUCTION; INTERLEUKIN-6; MICE; INTERFERENCE; ANTIOXIDANT; DISRUPTION	Experiments with transgenic over-expressing, and null mutant mice have determined that metallothionein-I and -II (MT-I/II) are protective after brain injury. MT-I/II is primarily a zinc-binding protein and it is not known how it provides neuroprotection to the injured brain or where MT-I/II acts to have its effects. MT-I/II is often expressed in the liver under stressful conditions but to date, measurement of MT-I/II expression after brain injury has focused primarily on the injured brain itself. In the present study we measured MT-I/II expression in the liver of mice after cryolesion brain injury by quantitative reverse-transcriptase PCR (RT-PCR) and enzyme-linked immunosorbent assay (ELISA) with the UC1MT antibody. Displacement curves constructed using MT-I/II knockout (MT-I/II 2/2) mouse tissues were used to validate the ELISA. Hepatic MT-I and MT-II mRNA levels were significantly increased within 24 hours of brain injury but hepatic MT-I/II protein levels were not significantly increased until 3 days post injury (DPI) and were maximal at the end of the experimental period, 7 DPI. Hepatic zinc content was measured by atomic absorption spectroscopy and was found to decrease at 1 and 3 DPI but returned to normal by 7DPI. Zinc in the livers of MT-I/II-/- mice did not show a return to normal at 7 DPI which suggests that after brain injury, MT-I/II is responsible for sequestering elevated levels of zinc to the liver. Conclusion: MT-I/II is up-regulated in the liver after brain injury and modulates the amount of zinc that is sequestered to the liver.	[Pankhurst, Michael W.; Gell, David A.; Butler, Chris W.; West, Adrian K.; Chung, Roger S.] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia; [Kirkcaldie, Matthew T. K.] Univ Tasmania, Sch Med, Hobart, Tas, Australia; [Pankhurst, Michael W.] Univ Otago, Dept Anat, Dunedin, New Zealand	University of Tasmania; University of Tasmania; University of Otago	Pankhurst, MW (corresponding author), Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia.	michael.pankhurst@anatomy.otago.ac.nz	Chung, Roger/ABF-8395-2020; Pankhurst, Michael/F-2585-2017; Kirkcaldie, Matthew TK/J-4418-2012; West, Adrian/AAR-8857-2021	Pankhurst, Michael/0000-0002-0976-5742; Kirkcaldie, Matthew TK/0000-0003-3285-0168; Gell, David/0000-0003-0382-1181; Chung, Roger/0000-0002-9286-947X	National Health and Medical Research Council of Australia [490025, 544913]; Australian Research Council [DP0984673]; Australian Research Council	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Australian Research Council(Australian Research Council)	This work was supported by research grants from the National Health and Medical Research Council of Australia (ID# 490025, 544913) and Australian Research Council (DP0984673). RSC holds an Australian Research Council Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrani N, 2006, NAT REV MOL CELL BIO, V7, P415, DOI 10.1038/nrm1942; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brettingham-Moore KH, 2005, NUCLEIC ACIDS RES, V33, P225, DOI 10.1093/nar/gki161; Campagne MV, 1999, P NATL ACAD SCI USA, V96, P12870; Carrasco J, 2003, NEUROBIOL DIS, V13, P22, DOI 10.1016/S0969-9961(03)00015-9; Carrasco J, 2000, EUR J NEUROSCI, V12, P2311, DOI 10.1046/j.1460-9568.2000.00128.x; Cho K, 2004, PATHOBIOLOGY, V71, P223, DOI 10.1159/000078677; Chung RS, 2004, J NEUROCHEM, V88, P454, DOI 10.1046/j.1471-4159.2003.02193.x; COYLE P, 1993, J NUTR, V123, P1464, DOI 10.1093/jn/123.9.1464; COYLE P, 1995, BIOCHEM J, V309, P25, DOI 10.1042/bj3090025; DE SK, 1990, J BIOL CHEM, V265, P15267; Ding HQ, 2002, BURNS, V28, P215, DOI 10.1016/S0305-4179(02)00018-9; Emeny RT, 2009, CHEM-BIOL INTERACT, V181, P243, DOI 10.1016/j.cbi.2009.06.018; Findlay JWA, 2007, AAPS J, V9, pE260, DOI 10.1208/aapsj0902029; Giles GI, 2002, BIOCHEM J, V364, P579, DOI 10.1042/BJ20011882; Giralt M, 2002, EXP NEUROL, V173, P114, DOI 10.1006/exnr.2001.7772; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Hernandez J, 2000, CYTOKINE, V12, P791, DOI 10.1006/cyto.1999.0629; ISZARD MB, 1995, TOXICOL APPL PHARM, V133, P305, DOI 10.1006/taap.1995.1155; Jacob ST, 1999, GENE EXPRESSION, V7, P301; Khatai L, 2004, EUR J BIOCHEM, V271, P2408, DOI 10.1111/j.1432-1033.2004.04160.x; Kimura T, 2008, J HEALTH SCI, V54, P251, DOI 10.1248/jhs.54.251; Kukacka J, 2006, NEUROENDOCRINOL LETT, V27, P116; Ling CY, 2006, J NEUROSCI, V26, P731, DOI 10.1523/JNEUROSCI.3502-05.2006; LYNES MA, 1993, TOXICOLOGY, V85, P161, DOI 10.1016/0300-483X(93)90040-Y; MASTERS BA, 1994, P NATL ACAD SCI USA, V91, P584, DOI 10.1073/pnas.91.2.584; MCCLAIN C, 1991, J LAB CLIN MED, V118, P225; MCCLAIN CJ, 1986, J NEUROSURG, V64, P224, DOI 10.3171/jns.1986.64.2.0224; Natale JE, 2004, J NEUROSCI RES, V78, P303, DOI 10.1002/jnr.20265; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; Pankhurst NW, 2008, AQUACULTURE, V275, P311, DOI 10.1016/j.aquaculture.2008.01.001; PENKOWA M, 1995, GLIA, V13, P217, DOI 10.1002/glia.440130308; Penkowa M, 2006, J NEUROSCI RES, V83, P974, DOI 10.1002/jnr.20790; Penkowa M, 2005, J NEUROSCI RES, V79, P522, DOI 10.1002/jnr.20387; Penkowa M, 1999, GLIA, V25, P343; Penkowa M, 2001, J NEUROTRAUM, V18, P447, DOI 10.1089/089771501750171056; Penkowa M, 1999, EXP NEUROL, V156, P149, DOI 10.1006/exnr.1998.7009; Penkowa M, 1999, J NEUROSCI, V19, P2535; PHILCOX JC, 1995, BIOCHEM J, V308, P543, DOI 10.1042/bj3080543; Potter EG, 2007, J NEUROTRAUM, V24, P28, DOI 10.1089/neu.2006.0056.R1; Potter EG, 2009, J NEUROSCI RES, V87, P1356, DOI 10.1002/jnr.21963; Selby C, 1999, ANN CLIN BIOCHEM, V36, P704, DOI 10.1177/000456329903600603; Shohami E, 1999, J NEUROTRAUM, V16, P365, DOI 10.1089/neu.1999.16.365; Spahl DU, 2003, P NATL ACAD SCI USA, V100, P13952, DOI 10.1073/pnas.2335190100; Span PN, 2003, CLIN CHEM, V49, P1708, DOI 10.1373/49.10.1708; Suemori S, 2006, INVEST OPHTH VIS SCI, V47, P3975, DOI 10.1167/iovs.06-0275; Yang Y, 2001, P NATL ACAD SCI USA, V98, P5556, DOI 10.1073/pnas.101123298; Yeiser EC, 2002, NUTR NEUROSCI, V5, P345, DOI 10.1080/1028415021000033811; Young B, 1996, J NEUROTRAUM, V13, P25, DOI 10.1089/neu.1996.13.25; Zhou ZB, 2003, ACTA PHARMACOL SIN, V24, P764; Zhou ZX, 2004, AM J PATHOL, V164, P1547, DOI 10.1016/S0002-9440(10)63713-3	51	12	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e31185	10.1371/journal.pone.0031185	http://dx.doi.org/10.1371/journal.pone.0031185			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22363575	gold, Green Published, Green Submitted			2022-12-27	WOS:000302853600122
J	Lin, S; Gu, HP; Xu, M; Cui, XJ; Zhang, YY; Gao, W; Yuan, G				Lin, Sen; Gu, Huiping; Xu, Ming; Cui, Xiaojie; Zhang, Youyi; Gao, Wei; Yuan, Gu			The Formation and Stabilization of a Novel G-Quadruplex in the 5 '-Flanking Region of the Relaxin Gene	PLOS ONE			English	Article							TELOMERIC G-QUADRUPLEX; RELEVANT G-QUADRUPLEX; AUTOMATED DOCKING; BERBERINE DERIVATIVES; CIRCULAR-DICHROISM; DNA; BINDING; RECOGNITION; PROMOTER; TARGET	It has been reported that binding of STAT3 protein to the 5'-flanking region of the relaxin gene may result in downregulation of the relaxin expression. There is a Guanine(G)-rich segment located in about 3.8 Kb upstream of the relaxin gene and very close to the STAT3's binding site. In our study, NMR spectroscopy revealed the formation of G-quadruplex by this G-rich strand, and the result was confirmed by ESI mass spectrometry and CD spectroscopy. The theoretical structure of RLX G-quadruplex was constructed and refined by molecular modeling. When this relaxin G-quadruplex was stabilized by berberine(Delta Tm=10 degrees C), a natural alkaloid from a Chinese herb, the gene expression could be up-regulated in a dose-dependent manner which was proved by luciferase assay. This result is different from the general G-quadruplex function that inhibiting the telomere replication or down-regulating many oncogenes expression. Therefore, our study reported a novel G- quadruplex in the relaxin gene and complemented the regulation mechanism about gene expression by G- quadruplexes.	[Lin, Sen; Cui, Xiaojie; Yuan, Gu] Peking Univ, Beijing Natl Lab Mol Sci, Key Lab Bioorgan Chem & Mol Engn, Minist Educ,Dept Chem Biol,Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Gu, Huiping; Xu, Ming; Zhang, Youyi; Gao, Wei] Peking Univ, Key Lab Mol Cardiovasc Sci, Key Lab Cardiovasc Mol Biol & Regulatory Peptides, Minist Hlth,Hosp 3,Minist Educ,Inst Vasc Med, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Peking University; Peking University	Lin, S (corresponding author), Peking Univ, Beijing Natl Lab Mol Sci, Key Lab Bioorgan Chem & Mol Engn, Minist Educ,Dept Chem Biol,Coll Chem & Mol Engn, Beijing 100871, Peoples R China.	xuminghi@bjmu.edu.cn; guyuan@pku.edu.cn			National Natural Science Foundation of China [90913004, 81070196]; Program for New Century Excellent Talents in University; Beijing Talents Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Beijing Talents Foundation	This work was supported by the National Natural Science Foundation of China (no. 90913004 and 81070196) and Program for New Century Excellent Talents in University and Beijing Talents Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrus A, 2005, BIOCHEMISTRY-US, V44, P2048, DOI 10.1021/bi048242p; Arora A, 2008, FEBS J, V275, P3971, DOI 10.1111/j.1742-4658.2008.06541.x; Beaudoin JD, 2010, NUCLEIC ACIDS RES, V38, P7022, DOI 10.1093/nar/gkq557; Bishop GR, 2007, BIOPHYS CHEM, V126, P165, DOI 10.1016/j.bpc.2006.07.009; BRYANTGREENWOOD GD, 1994, ENDOCR REV, V15, P5, DOI 10.1210/er.15.1.5; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cheatham TE, 2001, BIOPOLYMERS, V56, P232; Cosconati S, 2009, J AM CHEM SOC, V131, P16336, DOI 10.1021/ja9063662; da Silva MW, 2007, METHODS, V43, P264, DOI 10.1016/j.ymeth.2007.05.007; Dai JX, 2007, NUCLEIC ACIDS RES, V35, P2440, DOI 10.1093/nar/gkm009; Dschietzig T, 2001, FASEB J, V15, P2187, DOI 10.1096/fj.01-0070com; Du XJ, 2003, CARDIOVASC RES, V57, P395, DOI 10.1016/S0008-6363(02)00663-6; Franceschin M, 2006, BIOORG MED CHEM LETT, V16, P1707, DOI 10.1016/j.bmcl.2005.12.001; GOODSELL DS, 1990, PROTEINS, V8, P195, DOI 10.1002/prot.340080302; Grand CL, 2002, EUR J CANCER, V38, pS106; Guo K, 2008, NUCLEIC ACIDS RES, V36, P4598, DOI 10.1093/nar/gkn380; Han HY, 2000, TRENDS PHARMACOL SCI, V21, P136, DOI 10.1016/S0165-6147(00)01457-7; Hounsou C, 2007, CHEMMEDCHEM, V2, P655, DOI 10.1002/cmdc.200600286; Keniry MA, 2001, BIOPOLYMERS, V56, P123, DOI 10.1002/1097-0282(2000/2001)56:3<123::AID-BIP10010>3.0.CO;2-3; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Li HH, 2009, CHEM-EUR J, V15, P2445, DOI 10.1002/chem.200801922; Liao WQ, 2005, FEBS J, V272, P1845, DOI 10.1111/j.1742-4658.2005.04614.x; Liu XH, 2010, CARDIOVASC RES, V88, P150, DOI 10.1093/cvr/cvq181; Ma Y, 2009, BIOORG MED CHEM LETT, V19, P3414, DOI 10.1016/j.bmcl.2009.05.030; Mergny JL, 2003, OLIGONUCLEOTIDES, V13, P515, DOI 10.1089/154545703322860825; Mergny JL, 1998, NAT MED, V4, P1366, DOI 10.1038/3949; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Muller S, 2010, NAT CHEM, V2, P1095, DOI 10.1038/NCHEM.842; Negri AL, 2004, J NEPHROL, V17, P496; Neidle S, 2002, NAT REV DRUG DISCOV, V1, P383, DOI 10.1038/nrd793; Paramasivan S, 2007, METHODS, V43, P324, DOI 10.1016/j.ymeth.2007.02.009; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phan AT, 2010, FEBS J, V277, P1107, DOI 10.1111/j.1742-4658.2009.07464.x; Phan AT, 2005, NAT CHEM BIOL, V1, P167, DOI 10.1038/nchembio723; Ranjan N, 2010, BIOCHEMISTRY-US, V49, P9891, DOI 10.1021/bi101517e; Rizzo A, 2009, NUCLEIC ACIDS RES, V37, P5353, DOI 10.1093/nar/gkp582; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Sherwood O. David, 1994, P861; SMITH FW, 1992, NATURE, V356, P164, DOI 10.1038/356164a0; Soloff MS, 2003, GENE, V323, P149, DOI 10.1016/j.gene.2003.09.015; Yang DZ, 2006, NUCLEOS NUCLEOT NUCL, V25, P951, DOI 10.1080/15257770600809913; Zhang WJ, 2007, BIOORGAN MED CHEM, V15, P5493, DOI 10.1016/j.bmc.2007.05.050; Zhou J, 2007, CHEM-EUR J, V13, P945, DOI 10.1002/chem.200600424	45	19	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31201	10.1371/journal.pone.0031201	http://dx.doi.org/10.1371/journal.pone.0031201			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	22876305	Green Published, Green Submitted, gold			2022-12-27	WOS:000302873700031
J	Zhang, JX; Han, BC; Wei, XN; Tan, CY; Chen, YZ; Jiang, YY				Zhang, Jingxian; Han, Bucong; Wei, Xiaona; Tan, Chunyan; Chen, Yuzong; Jiang, Yuyang			A Two-Step Target Binding and Selectivity Support Vector Machines Approach for Virtual Screening of Dopamine Receptor Subtype-Selective Ligands	PLOS ONE			English	Article							LARGE COMPOUND LIBRARIES; D-3 RECEPTOR; PARKINSONS-DISEASE; CURRENT PERSPECTIVES; MEDICINAL CHEMISTRY; RECENT PROGRESS; DRUG-DISCOVERY; FINGERPRINTS; QSAR; CLASSIFICATION	Target selective drugs, such as dopamine receptor (DR) subtype selective ligands, are developed for enhanced therapeutics and reduced side effects. In silico methods have been explored for searching DR selective ligands, but encountered difficulties associated with high subtype similarity and ligand structural diversity. Machine learning methods have shown promising potential in searching target selective compounds. Their target selective capability can be further enhanced. In this work, we introduced a new two-step support vector machines target-binding and selectivity screening method for searching DR subtype-selective ligands, which was tested together with three previously-used machine learning methods for searching D1, D2, D3 and D4 selective ligands. It correctly identified 50.6%-88.0% of the 21-408 subtype selective and 71.7%-81.0% of the 39-147 multi-subtype ligands. Its subtype selective ligand identification rates are significantly better than, and its multi-subtype ligand identification rates are comparable to the best rates of the previously used methods. Our method produced low false-hit rates in screening 13.56 M PubChem, 168,016 MDDR and 657,736 ChEMBLdb compounds. Molecular features important for subtype selectivity were extracted by using the recursive feature elimination feature selection method. These features are consistent with literature-reported features. Our method showed similar performance in searching estrogen receptor subtype selective ligands. Our study demonstrated the usefulness of the two-step target binding and selectivity screening method in searching subtype selective ligands from large compound libraries.	[Zhang, Jingxian; Tan, Chunyan; Chen, Yuzong; Jiang, Yuyang] Tsinghua Univ, Grad Sch Shenzhen, Key Lab Chem Biol, Shenzhen 518057, Guangdong, Peoples R China; [Zhang, Jingxian; Han, Bucong; Wei, Xiaona; Chen, Yuzong] Natl Univ Singapore, Ctr Computat Sci & Engn, Dept Pharm, Bioinformat & Drug Design Grp, Singapore 117548, Singapore; [Han, Bucong; Wei, Xiaona] Natl Univ Singapore, Singapore MIT Alliance, Singapore 117548, Singapore	Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; National University of Singapore; Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Singapore-MIT Alliance for Research & Technology Centre (SMART)	Zhang, JX (corresponding author), Tsinghua Univ, Grad Sch Shenzhen, Key Lab Chem Biol, Shenzhen 518057, Guangdong, Peoples R China.	phacyz@nus.edu.sg; jiangyy@sz.tsinghua.edu.cn	jiang, yu/HGU-0029-2022; Zhang, Jing/GWZ-7332-2022; Tan, Chunyan/F-2785-2012	Tan, Chunyan/0000-0002-4263-2175; Sarkar, Indra Neil/0000-0003-2054-7356; Chen, Yu Zong/0000-0002-5473-8022	Academic Research Funds Singapore [R-148-000-081-112]; Ministry of Science and Technology; 863 Hi-Tech Program China [2007AA02Z160]; Key Special Project [009ZX09501-004]; Ministry of Science and Technology, China	Academic Research Funds Singapore(Ministry of Education, Singapore); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); 863 Hi-Tech Program China(National High Technology Research and Development Program of China); Key Special Project; Ministry of Science and Technology, China(Ministry of Science and Technology, ChinaMinistry of Science, ICT & Future Planning, Republic of Korea)	The authors acknowledge the support from Academic Research Funds Singapore (R-148-000-081-112), Ministry of Science and Technology, 863 Hi-Tech Program China (2007AA02Z160), Key Special Project Grant 009ZX09501-004. Y.Z. Chen is supported by Academic Research Funds Singapore. Y.Y. Jiang is supported by the Ministry of Science and Technology, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albersen M, 2010, EXPERT OPIN EMERG DR, V15, P467, DOI 10.1517/14728214.2010.480973; Aloisi G, 2011, NEUROPHARMACOLOGY, V60, P439, DOI 10.1016/j.neuropharm.2010.10.018; Audouze K, 2004, J MED CHEM, V47, P3089, DOI 10.1021/jm031111m; Bellis LJ, 2011, BIOCHEM SOC T, V39, P1365, DOI 10.1042/BST0391365; Bender A, 2006, J CHEM INF MODEL, V46, P2445, DOI 10.1021/ci600197y; Boeckler F, 2006, PHARMACOL THERAPEUT, V112, P281, DOI 10.1016/j.pharmthera.2006.04.007; Bostrom J, 2006, J MED CHEM, V49, P6716, DOI 10.1021/jm060167o; Burbidge R, 2001, COMPUT CHEM, V26, P5, DOI 10.1016/S0097-8485(01)00094-8; Carro L, 2009, BIOORG MED CHEM LETT, V19, P6059, DOI 10.1016/j.bmcl.2009.09.041; Cha MY, 2003, BIOORGAN MED CHEM, V11, P1293, DOI 10.1016/S0968-0896(02)00617-X; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Cho DI, 2010, ARCH PHARM RES, V33, P1521, DOI 10.1007/s12272-010-1005-8; Clark RD, 2009, J COMPUT AID MOL DES, V23, P765, DOI 10.1007/s10822-008-9227-2; Czerminski R, 2001, QUANT STRUCT-ACT REL, V20, P227, DOI 10.1002/1521-3838(200110)20:3<227::AID-QSAR227>3.0.CO;2-Y; Durrant JD, 2010, CURR OPIN PHARMACOL, V10, P770, DOI 10.1016/j.coph.2010.09.001; Ehrlich K, 2009, J MED CHEM, V52, P4923, DOI 10.1021/jm900690y; Enguehard-Gueiffier C, 2006, CURR MED CHEM, V13, P2981, DOI 10.2174/092986706778521841; Erhan D, 2006, J CHEM INF MODEL, V46, P626, DOI 10.1021/ci050367t; Givehchi A, 2006, J CHEM INF MODEL, V46, P1078, DOI 10.1021/ci0500233; Han LY, 2008, J MOL GRAPH MODEL, V26, P1276, DOI 10.1016/j.jmgm.2007.12.002; Heidbreder CA, 2010, ANN NY ACAD SCI, V1187, P4, DOI 10.1111/j.1749-6632.2009.05149.x; Herm L, 2009, BIOORGAN MED CHEM, V17, P4756, DOI 10.1016/j.bmc.2009.04.047; Horvath D, 2009, J CHEM INF MODEL, V49, P1762, DOI 10.1021/ci9000579; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Huber D, 2009, J MED CHEM, V52, P6860, DOI 10.1021/jm901120h; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jenner P, 2003, CURR OPIN NEUROL, V16, pS3, DOI 10.1097/00019052-200312001-00002; Johnson R, 1982, APPL MULTIVARIATE ST; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Li H, 2007, J PHARM SCI-US, V96, P2838, DOI 10.1002/jps.20985; Li ZR, 2007, BIOTECHNOL BIOENG, V97, P389, DOI 10.1002/bit.21214; Liu XH, 2009, J CHEM INF MODEL, V49, P2101, DOI 10.1021/ci900135u; Lober S, 2011, TRENDS PHARMACOL SCI, V32, P148, DOI 10.1016/j.tips.2010.12.003; Lober S, 2009, CHEMMEDCHEM, V4, P325, DOI 10.1002/cmdc.200800395; Lopez L, 2010, CHEMMEDCHEM, V5, P1300, DOI 10.1002/cmdc.201000101; Ma XH, 2010, MOL PHARMACEUT, V7, P1545, DOI 10.1021/mp100179t; Ma XH, 2009, COMB CHEM HIGH T SCR, V12, P344, DOI 10.2174/138620709788167944; Mahe P, 2009, COMB CHEM HIGH T SCR, V12, P409, DOI 10.2174/138620709788167926; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; McCall RB, 2005, J PHARMACOL EXP THER, V314, P1248, DOI 10.1124/jpet.105.084202; Micheli F, 2011, CHEMMEDCHEM, V6, P1152, DOI 10.1002/cmdc.201000538; Michielan L, 2009, J CHEM INF MODEL, V49, P2588, DOI 10.1021/ci900299a; Mishra Nitish K., 2010, BMC Pharmacology, V10, P8, DOI 10.1186/1471-2210-10-8; Monge A, 2006, MOL DIVERS, V10, P389, DOI 10.1007/s11030-006-9033-5; Overington John, 2009, J Comput Aided Mol Des, V23, P195, DOI 10.1007/s10822-009-9260-9; Pilla M, 1999, NATURE, V400, P371, DOI 10.1038/43944; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Renner S, 2008, J CHEM INF MODEL, V48, P319, DOI 10.1021/ci7003626; Salama I, 2007, J MED CHEM, V50, P489, DOI 10.1021/jm0611152; Sato T, 2010, J CHEM INF MODEL, V50, P170, DOI 10.1021/ci900382e; Schietgat L, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-2; Shi Z, 2012, J MOL GRAPH MODEL, V32, P49, DOI 10.1016/j.jmgm.2011.09.002; SIBLEY DR, 1992, TRENDS PHARMACOL SCI, V13, P61, DOI 10.1016/0165-6147(92)90025-2; Simpson MM, 1999, MOL PHARMACOL, V56, P1116, DOI 10.1124/mol.56.6.1116; Singer C, 2007, MOVEMENT DISORD, V22, P476, DOI 10.1002/mds.21361; Sprous DG, 2010, CURR TOP MED CHEM, V10, P619, DOI 10.2174/156802610791111506; Sun HM, 2008, CURR MED CHEM, V15, P1018, DOI 10.2174/092986708784049630; Talevi A, 2009, CURR COMPUT-AID DRUG, V5, P23, DOI 10.2174/157340909787580854; Trotter MWB, 2001, MEAS CONTROL-UK, V34, P235, DOI 10.1177/002029400103400803; Tsoumakas G., 2007, INT J DATA WAREHOUS, V3, P1; Tsoumakas G, 2010, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, SECOND EDITION, P667, DOI 10.1007/978-0-387-09823-4_34; Vapnik V., 2013, NATURE STAT LAERNING; Verheij HJ, 2006, MOL DIVERS, V10, P377, DOI 10.1007/s11030-006-9040-6; Wang Q, 2010, J CHEM INF MODEL, V50, P1970, DOI 10.1021/ci1002747; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Wester MJ, 2008, J CHEM INF MODEL, V48, P1311, DOI 10.1021/ci700342h; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211; Willett P, 2011, METHODS MOL BIOL, V672, P133, DOI 10.1007/978-1-60761-839-3_5; Xue Y, 2004, J CHEM INF COMP SCI, V44, P1630, DOI 10.1021/ci049869h; Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707; Zeng CY, 2011, HYPERTENSION, V57, P11, DOI 10.1161/HYPERTENSIONAHA.110.157727; Zhang A, 2007, CHEM REV, V107, P274, DOI 10.1021/cr050263h; Zhang J, 2009, MED RES REV, V29, P272, DOI 10.1002/med.20130; Zhang ML, 2007, PATTERN RECOGN, V40, P2038, DOI 10.1016/j.patcog.2006.12.019	74	246	265	8	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2012	7	6							e39076	10.1371/journal.pone.0039076	http://dx.doi.org/10.1371/journal.pone.0039076			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959WX	22720033	Green Published, gold, Green Submitted			2022-12-27	WOS:000305350000037
J	Wu, SG; Wang, GT; Angert, ER; Wang, WW; Li, WX; Zou, H				Wu, Shangong; Wang, Guitang; Angert, Esther R.; Wang, Weiwei; Li, Wenxiang; Zou, Hong			Composition, Diversity, and Origin of the Bacterial Community in Grass Carp Intestine	PLOS ONE			English	Article							GUT MICROBIOTA; AEROMONAS-SALMONICIDA; PROBIOTIC ACTIVITY; RAINBOW-TROUT; MICROFLORA; RUMEN; FISH; IDENTIFICATION; AMPLIFICATION; FURUNCULOSIS	Gut microbiota has become an integral component of the host, and received increasing attention. However, for many domestic animals, information on the microbiota is insufficient and more effort should be exerted to manage the gastrointestinal bacterial community. Understanding the factors that influence the composition of microbial community in the host alimentary canal is essential to manage or improve the microbial community composition. In the present study, 16S rRNA gene sequence-based comparisons of the bacterial communities in the grass carp (Ctenopharyngodon idellus) intestinal contents and fish culture-associated environments are performed. The results show that the fish intestinal microbiota harbors many cellulose-decomposing bacteria, including sequences related to Anoxybacillus, Leuconostoc, Clostridium, Actinomyces, and Citrobacter. The most abundant bacterial operational taxonomic units (OTUs) in the grass carp intestinal content are those related to feed digestion. In addition, the potential pathogens and probiotics are important members of the intestinal microbiota. Further analyses show that grass carp intestine holds a core microbiota composed of Proteobacteria, Firmicutes, and Actinobacteria. The comparison analyses reveal that the bacterial community in the intestinal contents is most similar to those from the culture water and sediment. However, feed also plays significant influence on the composition of gut microbiota.	[Wu, Shangong; Wang, Guitang; Wang, Weiwei; Li, Wenxiang; Zou, Hong] Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China; [Wu, Shangong; Wang, Guitang; Wang, Weiwei; Li, Wenxiang; Zou, Hong] Chinese Acad Sci, State Key Lab Freshwater Ecol & Biotechnol, Inst Hydrobiol, Wuhan, Peoples R China; [Angert, Esther R.] Cornell Univ, Dept Microbiol, Ithaca, NY USA	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Cornell University	Wu, SG (corresponding author), Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China.	gtwang@ihb.ac.cn		Kuo, Ping-Chung/0000-0003-3019-1138; TENG, CHE-MING/0000-0002-9719-7334	National Basic Research Program of China [2009CB118705]; State Key Laboratory of Freshwater Ecology and Biotechnology [2011FB07]; earmarked fund for China Agriculture Research System [CARS-46-08]	National Basic Research Program of China(National Basic Research Program of China); State Key Laboratory of Freshwater Ecology and Biotechnology(Chinese Academy of Sciences); earmarked fund for China Agriculture Research System	The research was financially supported by grants from National Basic Research Program of China (No. 2009CB118705), the Open Fund of State Key Laboratory of Freshwater Ecology and Biotechnology (No. 2011FB07), and the earmarked fund for China Agriculture Research System (No. CARS-46-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; [Anonymous], 2008, FRESHWATER FISHERY; [Anonymous], [No title captured]; Balcazar JL, 2006, VET MICROBIOL, V114, P173, DOI 10.1016/j.vetmic.2006.01.009; Berg R. D., 1992, Probiotics: the scientific basis., P55; Bjorksten B, 2006, CLIN EXP ALLERGY, V36, P1215, DOI 10.1111/j.1365-2222.2006.02579.x; CAHILL MM, 1990, MICROB ECOL, V19, P21, DOI 10.1007/BF02015051; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Costello EK, 2010, ISME J, V4, P1375, DOI 10.1038/ismej.2010.71; Cui Y., 1991, PROGR NATURAL SCI, V1, P449; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Gibson LF, 1998, AQUACULTURE, V169, P111, DOI 10.1016/S0044-8486(98)00369-X; Gibson LF, 1999, J APPL MICROBIOL, V85, p243S, DOI 10.1111/j.1365-2672.1998.tb05304.x; Han SF, 2010, AQUAC RES, V42, P47, DOI 10.1111/j.1365-2109.2010.02543.x; He Li, 2009, Chinese Journal of Applied and Environmental Biology, V15, P414, DOI 10.3724/SP.J.1145.2009.00414; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; HINEY MP, 1994, DIS AQUAT ORGAN, V19, P161, DOI 10.3354/dao019161; Irianto A, 2002, J FISH DIS, V25, P333, DOI 10.1046/j.1365-2761.2002.00375.x; Koike S, 2001, FEMS MICROBIOL LETT, V204, P361, DOI 10.1111/j.1574-6968.2001.tb10911.x; Kong YH, 2010, FEMS MICROBIOL ECOL, V74, P612, DOI 10.1111/j.1574-6941.2010.00977.x; Kovach W., 1999, MVSP A MULTIVARIATE; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Li J.H., 2010, CHINA FISHERY STAT Y; Li SF, 1980, J FISH CHINA, V4, P275; Lodemel JB, 2001, AQUAC RES, V32, P935, DOI 10.1046/j.1365-2109.2001.00621.x; Luo Lin, 2001, Journal of Fisheries of China, V25, P232; MACKIE RI, 1990, J DAIRY SCI, V73, P2971, DOI 10.3168/jds.S0022-0302(90)78986-2; Ni D S, 1999, BIOL DIS GRASS CARP; Packey CD, 2009, CURR OPIN INFECT DIS, V22, P292, DOI 10.1097/QCO.0b013e32832a8a5d; Pankratov T A, 2006, Dokl Biol Sci, V410, P428, DOI 10.1134/S0012496606050243; Penders J, 2005, FEMS MICROBIOL LETT, V243, P141, DOI 10.1016/j.femsle.2004.11.052; Perumbakkam S, 2011, ANTON LEEUW INT J G, V99, P231, DOI 10.1007/s10482-010-9481-x; Pond MJ, 2006, AQUACULTURE, V261, P194, DOI 10.1016/j.aquaculture.2006.06.037; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Qiu Y, 2010, CHINA FOOD, V19, P34; Raoult D, 2009, NAT REV MICROBIOL, V7, P616, DOI 10.1038/nrmicro2209; Rawls JF, 2004, P NATL ACAD SCI USA, V101, P4596, DOI 10.1073/pnas.0400706101; Ringo E, 1998, AQUACULTURE, V160, P177, DOI 10.1016/S0044-8486(97)00299-8; Ringo E, 1999, AQUAC RES, V30, P73, DOI 10.1046/j.1365-2109.1999.00302.x; Ringo E, 2003, AQUACULTURE, V227, P395, DOI 10.1016/j.aquaculture.2003.05.001; Ringo E, 2006, AQUACULTURE, V261, P829, DOI 10.1016/j.aquaculture.2006.06.030; Roeselers G, 2011, ISME J, DOI [10.1038/ismej.2011.1038, DOI 10.1038/ISMEJ.2011.1038]; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; RUSSELL JB, 1981, J ANIM SCI, V53, P242, DOI 10.2527/jas1981.531242x; Saha S, 2006, AQUAC RES, V37, P380, DOI 10.1111/j.1365-2109.2006.01442.x; Salzman NH, 2002, MICROBIOL-SGM, V148, P3651, DOI 10.1099/00221287-148-11-3651; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SIJPESTEIJN AK, 1951, J GEN MICROBIOL, V5, P869, DOI 10.1099/00221287-5-5-869; Song Xiao, 2009, Acta Hydrobiologica Sinica, V33, P709, DOI 10.3724/SP.J.1035.2009.40709; Sonnenburg JL, 2006, PLOS BIOL, V4, P2213, DOI 10.1371/journal.pbio.0040413; Tan H, 2009, LETT APPL MICROBIOL, V49, P248, DOI 10.1111/j.1472-765X.2009.02649.x; Tomsic B, 2007, CARBOHYD POLYM, V69, P478, DOI 10.1016/j.carbpol.2007.01.003; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Verschuere L, 2000, MICROBIOL MOL BIOL R, V64, P655, DOI 10.1128/MMBR.64.4.655-671.2000; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wu SG, 2010, AQUACULTURE, V303, P1, DOI 10.1016/j.aquaculture.2009.12.025; XU BH, 1988, ACTA HYDROBIOL SIN, V12, P308; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Yang WM, 2010, THESIS CAS WUHAN; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zhou W., 1998, J HUAZHONG AGRIC UNI, V17, P252; Zu G, 2000, FRESHW FISH, V30, P35	63	431	489	19	218	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2012	7	2							e30440	10.1371/journal.pone.0030440	http://dx.doi.org/10.1371/journal.pone.0030440			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926YY	22815798	gold, Green Submitted, Green Published			2022-12-27	WOS:000302871500008
J	Zhang, JB; Hanner, R				Zhang, Junbin; Hanner, Robert			Molecular Approach to the Identification of Fish in the South China Sea	PLOS ONE			English	Article							GENETIC-DIVERGENCE; MITOCHONDRIAL PSEUDOGENES; DNA BARCODES; REEF; POPULATIONS; EVOLUTION; DASCYLLUS; SYSTEM	Background: DNA barcoding is one means of establishing a rapid, accurate, and cost-effective system for the identification of species. It involves the use of short, standard gene targets to create sequence profiles of known species against sequences of unknowns that can be matched and subsequently identified. The Fish Barcode of Life (FISH-BOL) campaign has the primary goal of gathering DNA barcode records for all the world's fish species. As a contribution to FISH-BOL, we examined the degree to which DNA barcoding can discriminate marine fishes from the South China Sea. Methodology/Principal Findings: DNA barcodes of cytochrome oxidase subunit I (COI) were characterized using 1336 specimens that belong to 242 species fishes from the South China Sea. All specimen provenance data (including digital specimen images and geospatial coordinates of collection localities) and collateral sequence information were assembled using Barcode of Life Data System (BOLD; www.barcodinglife.org). Small intraspecific and large interspecific differences create distinct genetic boundaries among most species. In addition, the efficiency of two mitochondrial genes, 16S rRNA (16S) and cytochrome b (cytb), and one nuclear ribosomal gene, 18S rRNA (18S), was also evaluated for a few select groups of species. Conclusions/Significance: The present study provides evidence for the effectiveness of DNA barcoding as a tool for monitoring marine biodiversity. Open access data of fishes from the South China Sea can benefit relative applications in ecology and taxonomy.	[Zhang, Junbin] Shanghai Ocean Univ, Dept Aquaculture & Life Sci, Shanghai, Peoples R China; [Zhang, Junbin; Hanner, Robert] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	Shanghai Ocean University; University of Guelph	Zhang, JB (corresponding author), Shanghai Ocean Univ, Dept Aquaculture & Life Sci, Shanghai, Peoples R China.	jb-zhang@shou.edu.cn	jiang, yu/HGU-0029-2022; Zhang, Jing/GWZ-7332-2022; Tan, Chunyan/F-2785-2012	Tan, Chunyan/0000-0002-4263-2175; Sarkar, Indra Neil/0000-0003-2054-7356; Chen, Yu Zong/0000-0002-5473-8022	Genome Canada (through the Ontario Genomics Institute); Chinese National Funding awards [40776089, U0633007]	Genome Canada (through the Ontario Genomics Institute)(Genome Canada); Chinese National Funding awards	This research was supported through funding to the Canadian Barcode of Life Network from Genome Canada (through the Ontario Genomics Institute) and by Chinese National Funding awards 40776089 and U0633007, which supported specimen collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber PH, 2000, NATURE, V406, P692, DOI 10.1038/35021135; Barbuto M, 2010, FOOD RES INT, V43, P376, DOI 10.1016/j.foodres.2009.10.009; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bernardi G, 2002, P ROY SOC B-BIOL SCI, V269, P599, DOI 10.1098/rspb.2001.1922; Bernardi G, 2001, MAR BIOL, V138, P457, DOI 10.1007/s002270000484; Bucklin A, 2011, ANNU REV MAR SCI, V3, P471, DOI 10.1146/annurev-marine-120308-080950; Chakrabarty Prosanta, 2010, Marine Biodiversity, V40, P107, DOI 10.1007/s12526-010-0037-0; Chen JTF, 1986, SYNOPSIS VERTEBRATES; Chenoweth SF, 1997, J FISH BIOL, V50, P721, DOI 10.1006/jfbi.1996.0336; Comi G, 2005, FOOD CONTROL, V16, P37, DOI 10.1016/j.foodcont.2003.11.003; Cui ZX, 2010, ICHTHYOL RES, V57, P32, DOI 10.1007/s10228-009-0119-9; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Doyle JJ, 2000, PLANT MOL BIOL, V42, P1, DOI 10.1023/A:1006349518932; Dudgeon CL, 2000, MAR BIOL, V137, P1059, DOI 10.1007/s002270000403; Ekrem T, 2007, MOL PHYLOGENET EVOL, V43, P530, DOI 10.1016/j.ympev.2006.11.021; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Greenstone MH, 2005, MOL ECOL, V14, P3247, DOI 10.1111/j.1365-294X.2005.02628.x; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; HANNER R, 2005, PROPOSED STANDARDS B; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hellberg ME, 2002, B MAR SCI, V70, P273; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kochzius M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012620; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lambert DM, 2005, J HERED, V96, P279, DOI 10.1093/jhered/esi035; Liu Jing, 2002, Studia Marina Sinica, V44, P240; Lucy K, 2010, UNDERGRADUATE RES J; Nei M, 2000, MOL EVOLUTION PHYLOG; Neigel J, 2007, CORAL REEFS, V26, P487, DOI 10.1007/s00338-007-0248-4; Ornelas-Garcia Claudia Patricia, 2008, BMC Evol Biol, V8, P340, DOI 10.1186/1471-2148-8-340; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Parin NV, 2004, J ICHTHYOLOGY S1, V44, P33; Pegg GG, 2006, SCI MAR, V70, P7, DOI 10.3989/scimar.2006.70s27; Piganeau G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016342; Planes S, 2001, EVOLUTION, V55, P2263; Rasmussen RS, 2009, J AGR FOOD CHEM, V57, P8379, DOI 10.1021/jf901618z; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rock J, 2008, ANTARCT SCI, V20, P253, DOI 10.1017/S0954102008001120; Rubinoff D, 2006, CONSERV BIOL, V20, P1548, DOI 10.1111/j.1523-1739.2006.00542.x; Ruedas LA, 2000, MOL PHYLOGENET EVOL, V17, P129, DOI 10.1006/mpev.2000.0737; Santos S, 2006, MOL ECOL, V15, P4361, DOI 10.1111/j.1365-294X.2006.03108.x; Sarkar IN, 2002, MOL PHYLOGENET EVOL, V24, P388; Scheffer SJ, 2006, ANN ENTOMOL SOC AM, V99, P204, DOI 10.1603/0013-8746(2006)099[0204:DBATIL]2.0.CO;2; Shen SC, COASTAL FISHES TAIWA, P180; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Sparks JS, 2005, CLADISTICS, V21, P305, DOI 10.1111/j.1096-0031.2005.00067.x; Steinke D, 2009, MAR BIOL, V156, P2641, DOI 10.1007/s00227-009-1284-0; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Swartz ER, 2008, S AFR J SCI, V104, P293; Teletchea F, 2009, REV FISH BIOL FISHER, V19, P265, DOI 10.1007/s11160-009-9107-4; Tuckey JW, 1977, EXPLORATORY DATA ANA, P688; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Victor BC, 2009, ZOOTAXA, P24; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Xiao JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015067; Zhang JB, 2004, J EXP MAR BIOL ECOL, V298, P3, DOI 10.1016/S0022-0981(03)00341-1; Zhou XH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016733, 10.1371/journal.pone.0017812]	62	246	265	8	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30621	10.1371/journal.pone.0030621	http://dx.doi.org/10.1371/journal.pone.0030621			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	22720033	Green Published, Green Submitted, gold			2022-12-27	WOS:000302853600041
J	Xu, J; Ji, PF; Zhao, ZX; Zhang, Y; Feng, JX; Wang, J; Li, JT; Zhang, XF; Zhao, L; Liu, GZ; Xu, P; Sun, XW				Xu, Jian; Ji, Peifeng; Zhao, Zixia; Zhang, Yan; Feng, Jianxin; Wang, Jian; Li, Jiongtang; Zhang, Xiaofeng; Zhao, Lan; Liu, Guangzan; Xu, Peng; Sun, Xiaowen			Genome-Wide SNP Discovery from Transcriptome of Four Common Carp Strains	PLOS ONE			English	Article							ASSOCIATION MAPPING POPULATION; CYPRINUS-CARPIO; LINKAGE MAP; MARKERS; MICROSATELLITE; GENERATION; CATFISH; CONSTRUCTION; SEQUENCES; LOCI	Background: Single nucleotide polymorphisms (SNPs) have been used as genetic marker for genome-wide association studies in many species. Gene-associated SNPs could offer sufficient coverage in trait related research and further more could themselves be causative SNPs for traits. Common carp (Cyprinus carpio) is one of the most important aquaculture species in the world accounting for nearly 14% of freshwater aquaculture production. There are various strains of common carp with different economic traits, however, the genetic mechanism underlying the different traits have not been elucidated yet. In this project, we identified a large number of gene-associated SNPs from four strains of common carp using next-generation sequencing. Results: Transcriptome sequencing of four strains of common carp (mirror carp, purse red carp, Xingguo red carp, Yellow River carp) was performed with Solexa HiSeq2000 platform. De novo assembled transcriptome was used as reference for alignments, and SNP calling was done through BWA and SAMtools. A total of 712,042 Intra-strain SNPs were discovered in four strains, of which 483,276 SNPs for mirror carp, 486,629 SNPs for purse red carp, 478,028 SNPs for Xingguo red carp and 488,281 SNPs for Yellow River carp were discovered, respectively. Besides, 53,893 inter-SNPs were identified. Strain-specific SNPs of four strains were 53,938, 53,866, 48,701, 40,131 in mirror carp, purse red carp, Xingguo red carp and Yellow River carp, respectively. GO and KEGG pathway analysis were done to reveal strain-specific genes affected by strain-specific non-synonymous SNPs. Validation of selected SNPs revealed that 48% percent of SNPs (12 of 25) were tested to be true SNPs. Conclusions: Transcriptome analysis of common carp using RNA-Seq is a cost-effective way of generating numerous reads for SNP discovery. After validation of identified SNPs, these data will provide a solid base for SNP array designing and genome-wide association studies.	[Xu, Jian; Ji, Peifeng; Zhao, Zixia; Zhang, Yan; Wang, Jian; Li, Jiongtang; Zhao, Lan; Xu, Peng; Sun, Xiaowen] Chinese Acad Fishery Sci, Ctr Appl Aquat Genom, Beijing, Peoples R China; [Zhang, Xiaofeng; Sun, Xiaowen] Chinese Acad Fishery Sci, Heilongjiang Fisheries Res Inst, Harbin, Peoples R China; [Feng, Jianxin] Henan Acad Fishery Sci, Zhengzhou, Henan, Peoples R China; [Liu, Guangzan] Natl Fish Hatchery Xingguo Red Carp, Xingguo, Jiangxi, Peoples R China	Chinese Academy of Fishery Sciences; Chinese Academy of Fishery Sciences; Heilongjiang River Fisheries Research Institute, CAFS	Xu, P (corresponding author), Chinese Acad Fishery Sci, Ctr Appl Aquat Genom, Beijing, Peoples R China.	xupeng@cafs.ac.cn; sunxw2002@163.com	Wang, Jian/M-4594-2018; Zhao, Zi-Xia/AAM-8065-2021; Xu, Jian/H-5349-2019; Sun, Xiaowen/F-1516-2014; Xu, Peng/J-4018-2012	Zhao, Zi-Xia/0000-0003-1099-3387; Xu, Jian/0000-0003-0274-4268; Xu, Peng/0000-0002-1531-5078	National Department Public Benefit Research Foundation [200903045]; National High-tech R&D Program of China [2009AA10Z105, 2011AA100401]; China Ministry of Agriculture "948" Program [2010-Z11]; National Natural Science Foundation [31101893]	National Department Public Benefit Research Foundation; National High-tech R&D Program of China(National High Technology Research and Development Program of China); China Ministry of Agriculture "948" Program; National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by the grants from National Department Public Benefit Research Foundation (200903045), National High-tech R&D Program of China (2009AA10Z105 and 2011AA100401), China Ministry of Agriculture "948" Program (2010-Z11) and National Natural Science Foundation (31101893). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Cheng L, 2010, ANIM GENET, V41, P191, DOI 10.1111/j.1365-2052.2009.01985.x; Christoffels A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S2; Duijvesteijn N, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-42; Feugang JM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-176; Fu BD, 2012, DNA RES, V19, P131, DOI 10.1093/dnares/dsr046; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Hubert S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-191; Ji PF, 2012, INT J MOL SCI, V13, P9798, DOI 10.3390/ijms13089798; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Kongchum P, 2010, FISH SHELLFISH IMMUN, V29, P356, DOI 10.1016/j.fsi.2010.04.013; Kucuktas H, 2009, GENETICS, V181, P1649, DOI 10.1534/genetics.108.098855; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Li C, 2012, FISH SHELLFISH IMMUN, V32, P816, DOI 10.1016/j.fsi.2012.02.004; Li Y, 2011, MAR BIOTECHNOL, V13, P706, DOI 10.1007/s10126-010-9332-9; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Mao Rui-Xin, 2009, Yichuan, V31, P407, DOI 10.3724/SP.J.1005.2009.00407; Moen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-223; Moens LN, 2007, J BIOCHEM MOL TOXIC, V21, P299, DOI 10.1002/jbt.20190; Muira WM, 2008, P NATL ACAD SCI USA, V105, P17312, DOI 10.1073/pnas.0806569105; Quilang J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-157; Sanchez CC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-559; Snelling WM, 2010, J ANIM SCI, V88, P837, DOI 10.2527/jas.2009-2257; Sun FY, 2012, DEV COMP IMMUNOL, V38, P169, DOI 10.1016/j.dci.2012.05.006; Sun X., 2012, PLANT ANIMAL GENOME; Sun X, 2004, AQUACULTURE, V238, P8; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Vera M, 2011, AQUACULTURE, V313, P31, DOI 10.1016/j.aquaculture.2011.01.038; Wan Y, 2011, MOL BIOL REPORTS; Wang D, 2007, AQUACULTURE, V271, P558, DOI 10.1016/j.aquaculture.2007.06.001; Williams DR, 2008, J FISH BIOL, V72, P2095, DOI 10.1111/j.1095-8649.2008.01875.x; Wood SH, 2009, IMMUNOGENETICS, V61, P765, DOI 10.1007/s00251-009-0402-y; Xu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021057; Xu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-537; Xu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-188; Yan XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030925; Zhang Ya-Qin, 2011, Medical Mycology, V49, P435, DOI 10.3109/13693786.2010.540723; Zhang Y, 2008, J GENET GENOMICS, V35, P97, DOI 10.1016/S1673-8527(08)60015-6; Zhao XX, 2012, MAR BIOTECHNOL, V14, P730, DOI 10.1007/s10126-012-9438-3; Zheng Xian-Hu, 2011, Yichuan, V33, P1366, DOI 10.3724/SP.J.1005.2011.01366; Zhou Jianfeng, 2004, Genetika, V40, P1389	41	104	115	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48140	10.1371/journal.pone.0048140	http://dx.doi.org/10.1371/journal.pone.0048140			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	22383953	Green Published, gold, Green Submitted			2022-12-27	WOS:000310262500040
J	Zhang, XL; Wang, GB; Zhao, LY; Sun, LL; Wang, J; Wu, P; Lu, L; Shi, J				Zhang, Xiao-Li; Wang, Gui-Bin; Zhao, Li-Yan; Sun, Li-Li; Wang, Jun; Wu, Ping; Lu, Lin; Shi, Jie			Clonidine Improved Laboratory-Measured Decision-Making Performance in Abstinent Heroin Addicts	PLOS ONE			English	Article							SPATIAL WORKING-MEMORY; VENTROMEDIAL PREFRONTAL CORTEX; EXECUTIVE FUNCTIONS; AGONIST CLONIDINE; IMPULSIVITY; COCAINE; DEFICIT; PERSONALITY; DYSFUNCTION; ANTAGONIST	Background: Impulsivity refers to a wide spectrum of actions characterized by quick and nonplanned reactions to external and internal stimuli, without taking into account the possible negative consequences for the individual or others, and decision-making is one of the biologically dissociated impulsive behaviors. Changes in impulsivity may be associated with norepinephrine. Various populations of drug addicts all performed impulsive decision making, which is a key risk factor in drug dependence and relapse. The present study investigated the effects of clonidine, which decreased norepinephrine release through presynaptic alpha-2 receptor activation, on the impaired decision-making performance in abstinent heroin addicts. Methodology/Principal Findings: Decision-making performance was assessed using the original version of Iowa Gambling Task (IGT). Both heroin addicts and normal controls were randomly assigned to three groups receiving clonidine, 0, 75 mu g or 150 mu g orally under double blind conditions. Psychiatric symptoms, including anxiety, depression and impulsivity, were rated on standardized scales. Heroin addicts reported higher scores on the Barratt Impulsiveness Scale and exhibited impaired decision-making on the IGT. A single high-dose of clonidine improved the decision-making performance in heroin addicts. Conclusions/Significance: Our results suggest clonidine may have a potential therapeutic role in heroin addicts by improving the impaired impulsive decision-making. The current findings have important implications for behavioral and pharmacological interventions targeting decision-making in heroin addiction.	[Zhang, Xiao-Li; Wang, Gui-Bin; Zhao, Li-Yan; Sun, Li-Li; Wang, Jun; Wu, Ping; Lu, Lin; Shi, Jie] Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China	Peking University	Zhang, XL (corresponding author), Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China.	shijie@bjmu.edu.cn	SHI, JIE/GXG-3394-2022	ZHENG, GUIXI/0000-0003-2856-9592	National Basic Research Program of China [2009CB522000]; Natural Science Foundation of Beijing Municipality [7092058]; Natural Science Foundation of China [81000571, 91132719]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of Beijing Municipality(Beijing Natural Science Foundation); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the National Basic Research Program of China (No. 2009CB522000), Natural Science Foundation of Beijing Municipality (No. 7092058) and Natural Science Foundation of China (No. 81000571 and 91132719). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TJ, 1998, DRUG ALCOHOL DEPEN, V50, P137, DOI 10.1016/S0376-8716(98)00023-4; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; ANAVEKAR SN, 1989, J CLIN PHARMACOL, V29, P321, DOI 10.1002/j.1552-4604.1989.tb03335.x; Arnsten AFT, 1999, BIOL PSYCHIAT, V45, P26, DOI 10.1016/S0006-3223(98)00296-0; Arnsten AFT, 1996, ARCH GEN PSYCHIAT, V53, P448; Arnsten AFT, 2005, BIOL PSYCHIAT, V57, P1377, DOI 10.1016/j.biopsych.2004.08.019; Arnsten AFT, 1997, PHARMACOL BIOCHEM BE, V58, P55, DOI 10.1016/S0091-3057(96)00477-7; Barraclough DJ, 2004, NAT NEUROSCI, V7, P404, DOI 10.1038/nn1209; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Bechara A, 2001, NEUROPSYCHOLOGIA, V39, P376, DOI 10.1016/S0028-3932(00)00136-6; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Bolla KI, 2003, NEUROIMAGE, V19, P1085, DOI 10.1016/S1053-8119(03)00113-7; Bolla KI, 2005, NEUROIMAGE, V26, P480, DOI 10.1016/j.neuroimage.2005.02.012; Brand M, 2008, DRUG ALCOHOL DEPEN, V97, P64, DOI 10.1016/j.drugalcdep.2008.03.017; Brand M, 2007, J CLIN EXP NEUROPSYC, V29, P86, DOI 10.1080/13803390500507196; CARLSON S, 1992, BEHAV NEURAL BIOL, V58, P113, DOI 10.1016/0163-1047(92)90327-Z; Clark L, 2006, BIOL PSYCHIAT, V60, P515, DOI 10.1016/j.biopsych.2005.11.007; Dobrydnjov I, 2004, ANESTH ANALG, V98, P738, DOI 10.1213/01.ANE.0000099719.97261.DA; Economidou D, 2009, BIOL PSYCHIAT, V65, P851, DOI 10.1016/j.biopsych.2008.12.008; Ersche KD, 2005, NEUROPSYCHOPHARMACOL, V30, P2115, DOI 10.1038/sj.npp.1300812; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; Fillmore MT, 2002, DRUG ALCOHOL DEPEN, V66, P265, DOI 10.1016/S0376-8716(01)00206-X; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; [杨会芹 YANG Huiqin], 2007, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V15, P4; KAWASAKI H, 1986, JPN J PHARMACOL, V42, P561, DOI 10.1254/jjp.42.561; Kim S, 2010, BIOL PSYCHIAT, V2010, P20; LI BM, 1994, BEHAV NEURAL BIOL, V62, P134, DOI 10.1016/S0163-1047(05)80034-2; Mazas CA, 2000, ALCOHOL CLIN EXP RES, V24, P1036, DOI 10.1111/j.1530-0277.2000.tb04647.x; Meana JJ, 1997, BRAIN RES, V744, P216, DOI 10.1016/S0006-8993(96)01080-3; Mintzer MZ, 2005, DRUG ALCOHOL DEPEN, V78, P225, DOI 10.1016/j.drugalcdep.2004.10.008; Morgan MJ, 2006, NEUROPSYCHOPHARMACOL, V31, P1562, DOI 10.1038/sj.npp.1300953; Nieuwenhuis S, 2007, PSYCHOPHARMACOLOGY, V193, P261, DOI 10.1007/s00213-007-0770-7; Passetti F, 2008, DRUG ALCOHOL DEPEN, V94, P82, DOI 10.1016/j.drugalcdep.2007.10.008; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Paulus MP, 2003, BIOL PSYCHIAT, V53, P65, DOI 10.1016/S0006-3223(02)01442-7; Paulus MP, 2002, NEUROPSYCHOPHARMACOL, V26, P53, DOI 10.1016/S0893-133X(01)00334-7; Philipsen A, 2004, J CLIN PSYCHIAT, V65, P1414, DOI 10.4088/JCP.v65n1018; Riekkinen M, 1999, J CLIN PSYCHOPHARM, V19, P444, DOI 10.1097/00004714-199910000-00008; Riekkinen M, 1999, NEUROSCIENCE, V92, P983, DOI 10.1016/S0306-4522(99)00037-8; Shi J, 2007, PHARMACOL BIOCHEM BE, V87, P141, DOI 10.1016/j.pbb.2007.04.010; Sun HS, 2010, BIOL PSYCHIAT, V67, P649, DOI 10.1016/j.biopsych.2009.11.030; Swann AC, 2005, BIOL PSYCHIAT, V57, P1209, DOI 10.1016/j.biopsych.2005.02.007; Verdejo-Garcia A, 2009, NEUROPHARMACOLOGY, V56, P48, DOI 10.1016/j.neuropharm.2008.07.035; Verdejo-Garcia AJ, 2007, ADDICT BEHAV, V32, P950, DOI 10.1016/j.addbeh.2006.06.032; Volkow ND, 2004, NEUROPHARMACOLOGY, V47, P3, DOI 10.1016/j.neuropharm.2004.07.019; Wallis JD, 2007, ANN NY ACAD SCI, V1121, P447, DOI 10.1196/annals.1401.009; Watanabe T, 2006, ACTA ANAESTH SCAND, V50, P180, DOI 10.1111/j.1399-6576.2006.00910.x; Zhang XL, 2011, AM J PSYCHIAT, V168, P610, DOI 10.1176/appi.ajp.2010.10040499; Zhu XZ, 2007, CHINESE MENTAL HLTH, V21, P3	52	84	89	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2012	7	1							e29084	10.1371/journal.pone.0029084	http://dx.doi.org/10.1371/journal.pone.0029084			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909NE	22363757	Green Published, Green Submitted, gold			2022-12-27	WOS:000301570600002
J	Fu, SM; Xu, J; Li, XB; Xie, YF; Qiu, YF; Du, XY; Yu, S; Bai, YX; Chen, YF; Wang, TK; Wang, ZJ; Yu, YQ; Peng, GN; Huang, KH; Huang, LY; Wang, YF; Chen, ZL				Fu, Simei; Xu, Jie; Li, Xianbo; Xie, Yongfei; Qiu, Yefeng; Du, Xinying; Yu, Shuang; Bai, Yaoxia; Chen, Yanfen; Wang, Tongkun; Wang, Zhoujia; Yu, Yaqing; Peng, Guangneng; Huang, Kehe; Huang, Liuyu; Wang, Yufei; Chen, Zeliang			Immunization of Mice with Recombinant Protein CobB or AsnC Confers Protection against Brucella abortus Infection	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; IMMUNE-RESPONSES; GAMMA-INTERFERON; MELITENSIS 16M; BALB/C MICE; LIVE; VACCINATION; IDENTIFICATION; MACROPHAGES; PERSISTENCE	Due to drawbacks of live attenuated vaccines, much more attention has been focused on screening of Brucella protective antigens as subunit vaccine candidates. Brucella is a facultative intracellular bacterium and cell mediated immunity plays essential roles for protection against Brucella infection. Identification of Brucella antigens that present T-cell epitopes to the host could enable development of such vaccines. In this study, 45 proven or putative pathogenesis-associated factors of Brucella were selected according to currently available data. After expressed and purified, 35 proteins were qualified for analysis of their abilities to stimulate T-cell responses in vitro. Then, an in vitro gamma interferon (IFN-gamma) assay was used to identify potential T-cell antigens from B. abortus. In total, 7 individual proteins that stimulated strong IFN-gamma responses in splenocytes from mice immunized with B. abortus live vaccine S19 were identified. The protective efficiencies of these 7 recombinant proteins were further evaluated. Mice given BAB1_1316 (CobB) or BAB1_1688 (AsnC) plus adjuvant could provide protection against virulent B. abortus infection, similarly with the known protective antigen Cu-Zn SOD and the license vaccine S19. In addition, CobB and AsnC could induce strong antibodies responses in BALB/c mice. Altogether, the present study showed that CobB or AsnC protein could be useful antigen candidates for the development of subunit vaccines against brucellosis with adequate immunogenicity and protection efficacy.	[Fu, Simei; Xu, Jie; Li, Xianbo; Xie, Yongfei; Du, Xinying; Yu, Shuang; Bai, Yaoxia; Chen, Yanfen; Wang, Tongkun; Wang, Zhoujia; Huang, Liuyu; Wang, Yufei; Chen, Zeliang] Acad Mil Med Sci, Inst Dis Control & Prevent, Dept Infect Dis Control, Beijing, Peoples R China; [Fu, Simei; Xu, Jie; Chen, Yanfen; Yu, Yaqing] Jilin Univ, Inst Zoonosis, Minist Educ, Key Lab Zoonosis,Sch Publ Hlth, Changchun 130023, Peoples R China; [Qiu, Yefeng] Acad Mil Med Sci, Ctr Expt Anim, Beijing, Peoples R China; [Xie, Yongfei; Huang, Kehe] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China; [Li, Xianbo; Peng, Guangneng] Sichuan Agr Univ, Coll Vet Med, Yaan, Peoples R China	Academy of Military Medical Sciences - China; Jilin University; Academy of Military Medical Sciences - China; Nanjing Agricultural University; Sichuan Agricultural University	Fu, SM (corresponding author), Acad Mil Med Sci, Inst Dis Control & Prevent, Dept Infect Dis Control, Beijing, Peoples R China.	yufeiwang21@yahoo.com; zeliangchen@yahoo.com	Wang, Jian/M-4594-2018; Zhao, Zi-Xia/AAM-8065-2021; Xu, Jian/H-5349-2019; Sun, Xiaowen/F-1516-2014; Xu, Peng/J-4018-2012	Zhao, Zi-Xia/0000-0003-1099-3387; Xu, Jian/0000-0003-0274-4268; Xu, Peng/0000-0002-1531-5078	National Key Program for Infectious Diseases of China [2008ZX10004-015]; National Basic Research Program of China [2009CB522602]; National Natural Science Foundation of China [30901071, 31000041, 81071320]	National Key Program for Infectious Diseases of China; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Key Program for Infectious Diseases of China (2008ZX10004-015), National Basic Research Program of China (Grant No. 2009CB522602), and the National Natural Science Foundation of China (30901071, 31000041, 81071320). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mariri A, 2010, VACCINE, V28, P1766, DOI 10.1016/j.vaccine.2009.12.012; Altindis E, 2009, VACCINE, V27, P542, DOI 10.1016/j.vaccine.2008.11.020; Andrews E, 2006, MICROBIOL IMMUNOL, V50, P389, DOI 10.1111/j.1348-0421.2006.tb03805.x; Arenas GN, 2000, INFECT IMMUN, V68, P4255, DOI 10.1128/IAI.68.7.4255-4263.2000; Baron C, 2006, BIOCHEM CELL BIOL, V84, P890, DOI 10.1139/O06-148; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Cassataro J, 2007, VACCINE, V25, P4437, DOI 10.1016/j.vaccine.2007.03.028; Chen ZJ, 2004, PROTEOMICS, V4, P3203, DOI 10.1002/pmic.200300844; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; Covert BA, 2001, PROTEOMICS, V1, P574; de Jong MF, 2008, MOL MICROBIOL, V70, P1378, DOI 10.1111/j.1365-2958.2008.06487.x; Delpino MV, 2007, VACCINE, V25, P6721, DOI 10.1016/j.vaccine.2007.07.002; den Hartigh AB, 2008, J BACTERIOL, V190, P4427, DOI 10.1128/JB.00406-08; Doolan DL, 2008, PROTEOMICS, V8, P4680, DOI 10.1002/pmic.200800194; Edmonds MD, 2002, VET MICROBIOL, V88, P205, DOI 10.1016/S0378-1135(02)00110-4; Eze MO, 2000, INFECT IMMUN, V68, P257, DOI 10.1128/IAI.68.1.257-263.2000; Ficht TA, 2009, VACCINE, V27, pD40, DOI 10.1016/j.vaccine.2009.08.058; Godfroid J, 2005, VET RES, V36, P313, DOI 10.1051/vetres:2005003; Gomes MS, 1998, IMMUNOLOGY, V95, P165; Grillo MJ, 2009, VACCINE, V27, P187, DOI 10.1016/j.vaccine.2008.10.065; Haine V, 2005, INFECT IMMUN, V73, P5578, DOI 10.1128/IAI.73.9.5578-5586.2005; He YQ, 2002, INFECT IMMUN, V70, P2535, DOI 10.1128/IAI.70.5.2535-2543.2002; Hong PC, 2000, INFECT IMMUN, V68, P4102, DOI 10.1128/IAI.68.7.4102-4107.2000; Kaushik P, 2010, VET RES COMMUN, V34, P119, DOI 10.1007/s11259-009-9337-x; Ko JY, 2003, CLIN MICROBIOL REV, V16, P65, DOI 10.1128/CMR.16.1.65-78.2003; Lestrate P, 2003, INFECT IMMUN, V71, P7053, DOI 10.1128/IAI.71.12.7053-7060.2003; Li B, 2005, INFECT IMMUN, V73, P3734, DOI 10.1128/IAI.73.6.3734-3739.2005; Li B, 2009, INFECT IMMUN, V77, P4356, DOI 10.1128/IAI.00242-09; Mallick AI, 2007, VACCINE, V25, P3692, DOI 10.1016/j.vaccine.2007.01.066; Mallick AI, 2007, VACCINE, V25, P7873, DOI 10.1016/j.vaccine.2007.09.008; Marchesini MI, 2004, MICROB PATHOGENESIS, V37, P95, DOI 10.1016/j.micpath.2004.06.001; Masignani V, 2002, EXPERT OPIN BIOL TH, V2, P895, DOI 10.1517/14712598.2.8.895; Mora M, 2003, DRUG DISCOV TODAY, V8, P459, DOI 10.1016/S1359-6446(03)02689-8; Pasquevich KA, 2009, INFECT IMMUN, V77, P436, DOI 10.1128/IAI.01151-08; Radhakrishnan GK, 2009, J BIOL CHEM, V284, P9892, DOI 10.1074/jbc.M805458200; Schurig GG, 2002, VET MICROBIOL, V90, P479, DOI 10.1016/S0378-1135(02)00255-9; Velikovsky CA, 2002, INFECT IMMUN, V70, P2507, DOI 10.1128/IAI.70.5.2507-2511.2002; Wang Y, 2011, VET MICROBIOLOGY; Yang YL, 2011, FEMS IMMUNOL MED MIC, V61, P159, DOI 10.1111/j.1574-695X.2010.00758.x; ZHAN YF, 1993, INFECT IMMUN, V61, P4899, DOI 10.1128/IAI.61.11.4899-4901.1993	40	104	115	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2012	7	2							e29552	10.1371/journal.pone.0029552	http://dx.doi.org/10.1371/journal.pone.0029552			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927OG	22383953	Green Submitted, Green Published, gold			2022-12-27	WOS:000302916800002
J	Zhang, L; Ren, G				Zhang, Lei; Ren, Gang			IPET and FETR: Experimental Approach for Studying Molecular Structure Dynamics by Cryo-Electron Tomography of a Single-Molecule Structure	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; NEGATIVE-STAINING PROTOCOL; APOLIPOPROTEIN-A-I; ELECTRON-MICROSCOPY; RADIATION-DAMAGE; 3-DIMENSIONAL RECONSTRUCTION; SCATTERING FACTORS; DIFFERENT SIZES; RESOLUTION; PROTEIN	The dynamic personalities and structural heterogeneity of proteins are essential for proper functioning. Structural determination of dynamic/heterogeneous proteins is limited by conventional approaches of X-ray and electron microscopy (EM) of single-particle reconstruction that require an average from thousands to millions different molecules. Cryo-electron tomography (cryoET) is an approach to determine three-dimensional (3D) reconstruction of a single and unique biological object such as bacteria and cells, by imaging the object from a series of tilting angles. However, cconventional reconstruction methods use large-size whole-micrographs that are limited by reconstruction resolution (lower than 20 A), especially for small and low-symmetric molecule (<400 kDa). In this study, we demonstrated the adverse effects from image distortion and the measuring tilt-errors (including tilt-axis and tilt-angle errors) both play a major role in limiting the reconstruction resolution. Therefore, we developed a "focused electron tomography reconstruction" (FETR) algorithm to improve the resolution by decreasing the reconstructing image size so that it contains only a single-instance protein. FETR can tolerate certain levels of image-distortion and measuring tilt-errors, and can also precisely determine the translational parameters via an iterative refinement process that contains a series of automatically generated dynamic filters and masks. To describe this method, a set of simulated cryoET images was employed; to validate this approach, the real experimental images from negative-staining and cryoET were used. Since this approach can obtain the structure of a single-instance molecule/particle, we named it individual-particle electron tomography (IPET) as a new robust strategy/approach that does not require a pre-given initial model, class averaging of multiple molecules or an extended ordered lattice, but can tolerate small tilt-errors for high-resolution single "snapshot" molecule structure determination. Thus, FETR/IPET provides a completely new opportunity for a single-molecule structure determination, and could be used to study the dynamic character and equilibrium fluctuation of macromolecules.	[Zhang, Lei; Ren, Gang] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Zhang, L (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Foundry, Berkeley, CA 94720 USA.	gren@lbl.gov	Zhang, Lei/G-6427-2012; Ren, Gang/B-1567-2012	Zhang, Lei/0000-0002-4880-824X; Ren, Gang/0000-0002-8036-2321; Liu, Guangwei/0000-0002-6008-2891	Office of Science, Office of Basic Energy Sciences of the United States Department of Energy [DE-AC02-05CH11231]; William Myron Keck Foundation [011808]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104427] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); William Myron Keck Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Office of Science, Office of Basic Energy Sciences of the United States Department of Energy (contract no. DE-AC02-05CH11231) and partially supported by the William Myron Keck Foundation (#011808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker LA, 2010, J STRUCT BIOL, V169, P431, DOI 10.1016/j.jsb.2009.11.014; Bammes BE, 2010, J STRUCT BIOL, V169, P331, DOI 10.1016/j.jsb.2009.11.001; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; BRACEWELL RN, 1967, ASTROPHYS J, V150, P427, DOI 10.1086/149346; Cantele F, 2007, J STRUCT BIOL, V158, P59, DOI 10.1016/j.jsb.2006.10.015; Cardone G, 2007, VIROLOGY, V361, P426, DOI 10.1016/j.virol.2006.10.047; Cavigiolio G, 2008, BIOCHEMISTRY-US, V47, P4770, DOI 10.1021/bi7023354; Chen B, 2009, PROTEIN SCI, V18, P921, DOI 10.1002/pro.101; Chen H, 1996, J STRUCT BIOL, V116, P56, DOI 10.1006/jsbi.1996.0010; Chen JZ, 2008, J STRUCT BIOL, V161, P92, DOI 10.1016/j.jsb.2007.09.017; CONWAY JF, 1993, J STRUCT BIOL, V111, P222, DOI 10.1006/jsbi.1993.1052; Cowley JM, 2006, INT TABLES CRYSTALLO, P262; CROWTHER RA, 1971, PHILOS T R SOC B, V261, P221, DOI 10.1098/rstb.1971.0054; Fernandez JJ, 2006, ULTRAMICROSCOPY, V106, P587, DOI 10.1016/j.ultramic.2006.02.004; Fernando KV, 2008, J STRUCT BIOL, V164, P49, DOI 10.1016/j.jsb.2008.06.012; Frank J, 2002, J STRUCT BIOL, V138, P85, DOI 10.1016/S1047-8477(02)00019-9; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Frauenfelder H, 2009, P NATL ACAD SCI USA, V106, P5129, DOI 10.1073/pnas.0900336106; Frey TG, 2006, ANNU REV BIOPH BIOM, V35, P199, DOI 10.1146/annurev.biophys.35.040405.102039; Fung JC, 1996, J STRUCT BIOL, V116, P181, DOI 10.1006/jsbi.1996.0029; Gil D, 2006, J STRUCT BIOL, V156, P546, DOI 10.1016/j.jsb.2006.07.012; GILBERT P, 1972, J THEOR BIOL, V36, P105, DOI 10.1016/0022-5193(72)90180-4; GLAESER RM, 1979, J MICROSC-OXFORD, V117, P77, DOI 10.1111/j.1365-2818.1979.tb00232.x; GLAESER RM, 1971, J ULTRA MOL STRUCT R, V36, P466, DOI 10.1016/S0022-5320(71)80118-1; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Grimm R, 1998, BIOPHYS J, V74, P1031, DOI 10.1016/S0006-3495(98)74028-7; HARRIS JR, 1994, MICRON, V25, P5; HENDERSON R, 1986, ULTRAMICROSCOPY, V19, P147, DOI 10.1016/0304-3991(86)90203-2; HERMAN GT, 1973, J THEOR BIOL, V42, P1, DOI 10.1016/0022-5193(73)90145-8; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Hue F, 2005, J ELECTRON MICROSC, V54, P181, DOI 10.1093/jmicro/dfi042; Jiang W, 2003, NAT STRUCT BIOL, V10, P131, DOI 10.1038/nsb891; Jiang W, 2008, NATURE, V451, P1130, DOI 10.1038/nature06665; Jones MK, 2010, J BIOL CHEM, V285, P41161, DOI 10.1074/jbc.M110.187799; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; KLUG A, 1972, NATURE, V238, P435, DOI 10.1038/238435a0; KONING RI, 2009, ANN ANAT; Leschziner AE, 2006, J STRUCT BIOL, V153, P284, DOI 10.1016/j.jsb.2005.10.012; Liu HR, 2010, SCIENCE, V329, P1038, DOI 10.1126/science.1187433; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mastronarde DN, 2008, J MICROSC-OXFORD, V230, P212, DOI 10.1111/j.1365-2818.2008.01977.x; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Milne JLS, 2009, NAT REV MICROBIOL, V7, P666, DOI 10.1038/nrmicro2183; Peng LM, 1996, ACTA CRYSTALLOGR A, V52, P456, DOI 10.1107/S010876739600089X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ren G, 2000, J MOL BIOL, V301, P369, DOI 10.1006/jmbi.2000.3949; Ren G, 1997, MICRON, V28, P459, DOI 10.1016/S0968-4328(97)00034-6; Ren G, 2001, P NATL ACAD SCI USA, V98, P1398, DOI 10.1073/pnas.041489198; Ren G, 1996, ACTA PHYS SINICA, V45, P1344; Ren G, 2010, P NATL ACAD SCI USA, V107, P1059, DOI 10.1073/pnas.0908004107; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Sandberg K, 2003, J STRUCT BIOL, V144, P61, DOI 10.1016/j.jsb.2003.09.013; SAXTON WO, 1982, J MICROSC-OXFORD, V127, P127, DOI 10.1111/j.1365-2818.1982.tb00405.x; Schaffer B, 2006, ULTRAMICROSCOPY, V106, P1129, DOI 10.1016/j.ultramic.2006.04.028; Segrest JP, 1999, J BIOL CHEM, V274, P31755, DOI 10.1074/jbc.274.45.31755; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Silva RAGD, 2008, P NATL ACAD SCI USA, V105, P12176, DOI 10.1073/pnas.0803626105; Stagg SM, 2006, J STRUCT BIOL, V155, P470, DOI 10.1016/j.jsb.2006.04.005; STOKROOS I, 1983, J BIOL BUCCALE, V11, P339; Suloway C, 2009, J STRUCT BIOL, V167, P11, DOI 10.1016/j.jsb.2009.03.019; TAYLOR KA, 1976, J ULTRA MOL STRUCT R, V55, P448, DOI 10.1016/S0022-5320(76)80099-8; UNSER M, 1987, ULTRAMICROSCOPY, V23, P39, DOI 10.1016/0304-3991(87)90225-7; UNWIN PNT, 1975, J MOL BIOL, V94, P425, DOI 10.1016/0022-2836(75)90212-0; vanAntwerpen R, 1997, J LIPID RES, V38, P659; VANHEEL M, 1985, EMBO J, V4, P2389, DOI 10.1002/j.1460-2075.1985.tb03944.x; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Walz J, 1997, J STRUCT BIOL, V120, P387, DOI 10.1006/jsbi.1997.3934; Winkler H, 2007, J STRUCT BIOL, V157, P126, DOI 10.1016/j.jsb.2006.07.014; XIANG SB, 1993, ACTA CRYSTALLOGR D, V49, P193, DOI 10.1107/S0907444992008540; Zhang L, 2010, BIOPHYSICAL J, V98, p440a; Zhang L, 2010, BIOPHYSICAL J, V98, p441a; Zhang L, 2011, J LIPID RES, V52, P175, DOI 10.1194/jlr.D010959; Zhang L, 2010, J LIPID RES, V51, P1228, DOI 10.1194/jlr.D002493	77	104	106	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 24	2012	7	1							e30249	10.1371/journal.pone.0030249	http://dx.doi.org/10.1371/journal.pone.0030249			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	910LV	22291925	Green Published, Green Submitted, gold			2022-12-27	WOS:000301639600008
J	Liu, Y; Niu, WQ; Wu, ZJ; Su, XX; Chen, QJ; Lu, L; Jin, W				Liu, Yan; Niu, Wenquan; Wu, Zhijun; Su, Xiuxiu; Chen, Qiujin; Lu, Lin; Jin, Wei			Variants in Exon 11 of MEF2A Gene and Coronary Artery Disease: Evidence from a Case-Control Study, Systematic Review, and Meta-Analysis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR MEF2A; CAG REPEAT POLYMORPHISM; GENOME-WIDE ASSOCIATION; MYOCARDIAL-INFARCTION; SEQUENCE VARIANTS; HEART-DISEASE; MUTATIONS; SUSCEPTIBILITY; COMMON; RISK	Background: Coronary artery disease (CAD) is the most common heart disease worldwide. Association of CAD with variants in the myocyte enhancer factor 2A (MEF2A) gene, the first identified CAD-causing gene, has attracted special attention but the results are controversial. We aimed to evaluate this genetic association via a case-control study and meta-analysis. Methodology/Principal Findings: We performed a case-control association study to investigate the relationship between variations in exon 11 of MEF2A gene and CAD in 1045 sporadic patients and 1008 controls enrolled angiographically among southern Chinese population, and then the data from this study were compared and discussed in a systematic review and meta-analysis with all available published studies on MEF2A gene and CAD. In total, eight variants were identified (21-bp deletion, CAG repeats, CCG repeats, a CCA deletion and four SNPs). No significant link was observed between the common (CAG)(n) polymorphism and CAD, whereas the rare 21-bp deletion was detected only in five affected individuals. The meta-analysis of (CAG) n polymorphism and CAD risk, including nine studies with 3801 CAD patients and 4020 controls, also provided no convincing evidence for the genetic association, even upon stratification by race (mainly Whites and Chinese). However, the 21-bp deletion was regarded as a potentially logical, albeit undetermined, candidate for CAD in the following systematic review. Conclusions/Significance: Our findings failed to demonstrate a correlation between (CAG) n polymorphism with CAD, however, we concluded that the rare 21-bp deletion might have a more compelling effect on CAD than the common (CAG) n polymorphism, and MEF2A genetic variant might be a rare but specific cause of CAD/MI.	[Liu, Yan; Wu, Zhijun; Su, Xiuxiu; Chen, Qiujin; Lu, Lin; Jin, Wei] Shanghai Jiao Tong Univ, Dept Cardiol, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Niu, Wenquan] Shanghai Jiao Tong Univ, State Key Lab Med Genom, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Jiao Tong University	Liu, Y (corresponding author), Shanghai Jiao Tong Univ, Dept Cardiol, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China.	jinwei_ivy@126.com	wu, zhi/GXH-3041-2022	Jin, Wei/0000-0002-2905-2109	National Natural Science Foundation of China [81070177]; Shanghai Science and Technology Development Funds, China [08411963500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Development Funds, China	This work was supported by the National Natural Science Foundation of China (Grant Number: 81070177) and Shanghai Science and Technology Development Funds, China (08411963500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, J CLIN INVEST, V115, P831, DOI 10.1172/JCI200524715; Bhagavatula MRK, 2004, HUM MOL GENET, V13, P3181, DOI 10.1093/hmg/ddh329; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Cohn LD, 2003, PSYCHOL METHODS, V8, P243, DOI 10.1037/1082-989X.8.3.243; Dai DP, 2010, EUR J CLIN INVEST, V40, P669, DOI 10.1111/j.1365-2362.2010.02307.x; Dai DP, 2006, CHIN J GERIATR HEART, V8, P671; Damani SB, 2011, JACC-CARDIOVASC INTE, V4, P473, DOI 10.1016/j.jcin.2010.12.016; Dan QH, 2008, J DIAGN CONCEPTS PRA, V7, P404; De La Vega FM, 2011, BIOCOMPUT-PAC SYM, P74; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; EINARSON TR, 1985, AM J HOSP PHARM, V42, P1957, DOI 10.1093/ajhp/42.9.1957; Elhawari S, 2010, ATHEROSCLEROSIS, V209, P152, DOI 10.1016/j.atherosclerosis.2009.09.005; Evans D, 2011, EXPERT REV CARDIOVAS, V9, P637, DOI [10.1586/ERC.11.53, 10.1586/erc.11.53]; Gonzalez P, 2006, J MED GENET, V43, P167, DOI 10.1136/jmg.2005.035071; Guella I, 2009, CIRC-CARDIOVASC GENE, V2, P165, DOI 10.1161/CIRCGENETICS.108.819326; Gulec S, 2008, CLIN APPL THROMB-HEM, V14, P465, DOI 10.1177/1076029607306403; Han YL, 2007, CLIN CHEM LAB MED, V45, P987, DOI 10.1515/CCLM.2007.159; Hartiala J, 2011, HUM GENET, V129, P617, DOI 10.1007/s00439-011-0963-3; He MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004851; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Horan PG, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-65; Hsu LA, 2010, CLIN APPL THROMB-HEM, V16, P301, DOI 10.1177/1076029608330476; Iyengar Sudha K, 2007, Methods Mol Biol, V376, P71; Kajimoto K, 2005, CIRC J, V69, P1192, DOI 10.1253/circj.69.1192; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Li Jing, 2006, Zhonghua Yixue Yichuanxue Zazhi, V23, P265; Lida A, 2003, J HUM GENET, V48, P476, DOI 10.1007/s10038-003-0054-y; Lieb W, 2008, CIRCULATION, V117, P185, DOI 10.1161/CIRCULATIONAHA.107.728485; Lusis AJ, 2003, TRENDS CARDIOVAS MED, V13, P309, DOI 10.1016/j.tcm.2003.08.001; Maiolino G, 2012, EUR J CARDI IN PRESS; Ozaki K, 2005, CELL MOL LIFE SCI, V62, P1804, DOI 10.1007/s00018-005-5098-z; Panagiotou OA, 2010, AM J EPIDEMIOL, V172, P869, DOI 10.1093/aje/kwq234; Patel RS, 2011, HEART, V97, P1463, DOI 10.1136/hrt.2010.219675; Polychronakos C, 2008, CURR ATHEROSCLER REP, V10, P194, DOI 10.1007/s11883-008-0031-1; Reilly MP, 2011, LANCET, V377, P383, DOI 10.1016/S0140-6736(10)61996-4; Scheuner MT, 2003, GENET MED, V5, P269, DOI 10.1097/01.GIM.0000079364.98247.26; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Topol EJ, 2006, HUM MOL GENET, V15, pR117, DOI 10.1093/hmg/ddl183; Tsantes AE, 2007, INT J CARDIOL, V118, P189, DOI 10.1016/j.ijcard.2006.06.047; Wang LJ, 2003, SCIENCE, V302, P1578, DOI 10.1126/science.1088477; Wang Q, 2005, J CLIN INVEST, V115, P1399, DOI 10.1172/JCI25475; Weng L, 2005, J CLIN INVEST, V115, P1016, DOI 10.1172/JCI24186; White AJ, 2007, CARDIOVASC RES, V75, P813, DOI 10.1016/j.cardiores.2007.05.003; Wu D, 2008, CHINESE J CARDIAC PA, V22, P144; Yamada Yoshiji, 2008, Genomic Med, V2, P7, DOI 10.1007/s11568-008-9025-x; Yuan Hong, 2006, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V31, P453	48	126	132	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2012	7	2							e31406	10.1371/journal.pone.0031406	http://dx.doi.org/10.1371/journal.pone.0031406			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZM	23118931	Green Published, gold, Green Submitted			2022-12-27	WOS:000302873700054
J	Singh, A; Baranwal, V; Shankar, A; Kanwar, P; Ranjan, R; Yadav, S; Pandey, A; Kapoor, S; Pandey, GK				Singh, Amarjeet; Baranwal, Vinay; Shankar, Alka; Kanwar, Poonam; Ranjan, Rajeev; Yadav, Sandeep; Pandey, Amita; Kapoor, Sanjay; Pandey, Girdhar K.			Rice Phospholipase A Superfamily: Organization, Phylogenetic and Expression Analysis during Abiotic Stresses and Development	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; PATATIN-RELATED PHOSPHOLIPASES; LIPID ACYL HYDROLASE; GENE FAMILY; SHOOT GRAVITROPISM; PHOSPHATIDIC-ACID; DROUGHT STRESS; GUARD-CELL; REPRODUCTIVE DEVELOPMENT; SIGNAL-TRANSDUCTION	Background: Phospholipase A (PLA) is an important group of enzymes responsible for phospholipid hydrolysis in lipid signaling. PLAs have been implicated in abiotic stress signaling and developmental events in various plants species. Genome-wide analysis of PLA superfamily has been carried out in dicot plant Arabidopsis. A comprehensive genome-wide analysis of PLAs has not been presented yet in crop plant rice. Methodology/Principal Findings: A comprehensive bioinformatics analysis identified a total of 31 PLA encoding genes in the rice genome, which are divided into three classes; phospholipase A(1) (PLA(1)), patatin like phospholipases (pPLA) and low molecular weight secretory phospholipase A(2) (sPLA(2)) based on their sequences and phylogeny. A subset of 10 rice PLAs exhibited chromosomal duplication, emphasizing the role of duplication in the expansion of this gene family in rice. Microarray expression profiling revealed a number of PLA members expressing differentially and significantly under abiotic stresses and reproductive development. Comparative expression analysis with Arabidopsis PLAs revealed a high degree of functional conservation between the orthologs in two plant species, which also indicated the vital role of PLAs in stress signaling and plant development across different plant species. Moreover, sub-cellular localization of a few candidates suggests their differential localization and functional role in the lipid signaling. Conclusion/Significance: The comprehensive analysis and expression profiling would provide a critical platform for the functional characterization of the candidate PLA genes in crop plants.	[Singh, Amarjeet; Baranwal, Vinay; Shankar, Alka; Kanwar, Poonam; Ranjan, Rajeev; Yadav, Sandeep; Pandey, Amita; Kapoor, Sanjay; Pandey, Girdhar K.] Dept Plant Mol Biol, New Delhi, India		Singh, A (corresponding author), Dept Plant Mol Biol, Univ Delhi S Campus, New Delhi, India.	gkpandey@south.du.ac.in	Sharma, Prabhat/AAW-6558-2021; Ranjan, Rajeev/AAY-3243-2021	Ranjan, Rajeev/0000-0002-1344-4044; Kapoor, Sanjay/0000-0002-0283-1137; Pandey, Amita/0000-0001-8717-3227; SINGH, ASHUTOSH/0000-0002-0995-6696; Singh, Abhishek/0000-0001-6263-4410; SHARMA, PRABHAT/0000-0002-2638-2321; Kanwar, Poonam/0000-0002-9328-9274; PANDEY, GIRDHAR KUMAR/0000-0001-9180-0924; Pallikadavath, Saseendran/0000-0002-2598-9949; Ogollah, Reuben/0000-0002-5777-4117	Department of Biotechnology, Council of Scientific and Industrial Research, University Grant Commission, Government of India	Department of Biotechnology, Council of Scientific and Industrial Research, University Grant Commission, Government of India	This work was supported by the Department of Biotechnology, Council of Scientific and Industrial Research, University Grant Commission, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMANN EJ, 1994, J BIOL CHEM, V269, P9227; Agarwal P, 2007, PLANT MOL BIOL, V65, P467, DOI 10.1007/s11103-007-9199-y; Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Bahn SC, 2003, FEBS LETT, V553, P113, DOI 10.1016/S0014-5793(03)00982-7; Balsinde J, 2005, CELL SIGNAL, V17, P1052, DOI 10.1016/j.cellsig.2005.03.002; Bargmann BO, 2006, CURR OPIN PLANT BIOL, V9, P515, DOI 10.1016/j.pbi.2006.07.011; Boss WF, 2008, ANNU PLANT REV, V33, P202, DOI 10.1111/b.9781405160025.2008.00008.x; Chakrabarty R, 2007, MOL PLANT MICROBE IN, V20, P740, DOI 10.1094/MPMI-20-7-0740; Chen GQ, 2011, CRIT REV PLANT SCI, V30, P239, DOI 10.1080/07352689.2011.572033; Clewley J P, 1997, Methods Mol Biol, V70, P119; Cusack BP, 2007, TRENDS GENET, V23, P270, DOI 10.1016/j.tig.2007.03.010; Dessen A, 2000, BBA-MOL CELL BIOL L, V1488, P40, DOI 10.1016/S1388-1981(00)00108-6; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Hetherington AM, 2001, CELL, V107, P711, DOI 10.1016/S0092-8674(01)00606-7; Higgs HN, 1998, J BIOL CHEM, V273, P5468, DOI 10.1074/jbc.273.10.5468; Hirschberg HJHB, 2001, EUR J BIOCHEM, V268, P5037, DOI 10.1046/j.0014-2956.2001.02411.x; Holk A, 2002, PLANT PHYSIOL, V130, P90, DOI 10.1104/pp.006288; Hong YY, 2008, PLANT CELL, V20, P803, DOI 10.1105/tpc.107.056390; Hong YY, 2009, PLANT J, V58, P376, DOI 10.1111/j.1365-313X.2009.03788.x; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huang SS, 2001, PLANT PHYSIOL, V125, P573, DOI 10.1104/pp.125.2.573; Hubbard KE, 2010, GENE DEV, V24, P1695, DOI 10.1101/gad.1953910; Ishiguro S, 2001, PLANT CELL, V13, P2191, DOI 10.1105/tpc.13.10.2191; Kato T, 2002, PLANT CELL, V14, P33, DOI 10.1105/tpc.010215; Kim HJ, 2011, PLANT CELL, V23, P94, DOI 10.1105/tpc.110.074799; Laxalt AM, 2002, CURR OPIN PLANT BIOL, V5, P332, DOI 10.1016/S1369-5266(02)00268-6; Lee HY, 2005, PROG LIPID RES, V44, P52, DOI 10.1016/j.plipres.2004.10.002; Lee HY, 2003, PLANT CELL, V15, P1990, DOI 10.1105/tpc.014423; Lee OR, 2010, PLANT CELL, V22, P1812, DOI 10.1105/tpc.110.074211; Li MY, 2011, PLANT CELL, V23, P1107, DOI 10.1105/tpc.110.081240; Li MY, 2009, BBA-MOL CELL BIOL L, V1791, P927, DOI 10.1016/j.bbalip.2009.02.017; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mansfeld J, 2006, BIOCHEMISTRY-US, V45, P5687, DOI 10.1021/bi052563z; Matos AR, 2008, PHYSIOL PLANTARUM, V134, P110, DOI 10.1111/j.1399-3054.2008.01123.x; Matos AR, 2009, PLANT PHYSIOL BIOCH, V47, P491, DOI 10.1016/j.plaphy.2009.02.011; Matos AR, 2001, FEBS LETT, V491, P188, DOI 10.1016/S0014-5793(01)02194-9; Matsui K, 2004, FEBS LETT, V569, P195, DOI 10.1016/j.febslet.2004.05.064; MAY C, 1998, BBA-LIPID LIPID MET, V1393, P267; Morita MT, 2002, PLANT CELL, V14, P47, DOI 10.1105/tpc.010216; Munnik T, 2001, FEBS LETT, V498, P172, DOI 10.1016/S0014-5793(01)02492-9; Munnik T, 2009, J LIPID RES, V50, pS260, DOI 10.1194/jlr.R800098-JLR200; Nakashima K, 2009, PLANT CELL PHYSIOL, V50, P1345, DOI 10.1093/pcp/pcp083; Narusaka Y, 2003, PLANT CELL PHYSIOL, V44, P1246, DOI 10.1093/pcp/pcg138; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; O'Luanaigh N, 2002, MOL BIOL CELL, V13, P3730, DOI 10.1091/mbc.E02-04-0213; Paul RU, 1998, PLANT J, V16, P601, DOI 10.1046/j.1365-313x.1998.00333.x; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Ray S, 2007, MOL GENET GENOMICS, V278, P493, DOI 10.1007/s00438-007-0267-4; Rietz S, 2010, MOL PLANT, V3, P524, DOI 10.1093/mp/ssp109; Rydel TJ, 2003, BIOCHEMISTRY-US, V42, P6696, DOI 10.1021/bi027156r; Ryu SB, 2004, TRENDS PLANT SCI, V9, P229, DOI 10.1016/j.tplants.2004.03.004; Scherer GFE, 2002, PLANT MOL BIOL, V49, P357, DOI 10.1023/A:1015290510483; Scherer GFE, 2010, TRENDS PLANT SCI, V15, P693, DOI 10.1016/j.tplants.2010.09.005; Schroeder JI, 2001, NATURE, V410, P327, DOI 10.1038/35066500; Singh A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-435; Sirichandra C, 2009, J EXP BOT, V60, P1439, DOI 10.1093/jxb/ern340; Stahl U, 1998, PLANT PHYSIOL, V117, P197, DOI 10.1104/pp.117.1.197; Stahl U, 1999, PLANT MOL BIOL, V41, P481, DOI 10.1023/A:1006323405788; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tuteja N, 2008, PLANT SIGNAL BEHAV, V3, P79, DOI 10.4161/psb.3.2.5303; Vij S, 2008, MOL PLANT, V1, P732, DOI 10.1093/mp/ssn047; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wang XM, 2001, ANNU REV PLANT PHYS, V52, P211, DOI 10.1146/annurev.arplant.52.1.211; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	67	174	181	7	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2012	7	2							e30947	10.1371/journal.pone.0030947	http://dx.doi.org/10.1371/journal.pone.0030947			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926TC	23028594	Green Published, gold, Green Submitted			2022-12-27	WOS:000302853600094
J	Singh, A; Dey, AB; Mohan, A; Sharma, PK; Mitra, DK				Singh, Amar; Dey, Aparajita Ballave; Mohan, Anant; Sharma, Prabhat Kumar; Mitra, Dipendra Kumar			Foxp(3+) Regulatory T Cells among Tuberculosis Patients: Impact on Prognosis and Restoration of Antigen Specific IFN-gamma Producing T Cells	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; PD-1 EXPRESSION; ACTIVE TUBERCULOSIS; PULMONARY TUBERCULOSIS; IMMUNE-RESPONSES; TH1 RESPONSES; INFECTION; SUPPRESSION; EXPANSION; LIGANDS	CD(4+)CD(25+)Foxp(3+) Regulatory T cells (Treg) and programmed death-1 (PD-1) molecules have emerged as pivotal players in immune suppression of chronic diseases. However, their impact on the disease severity, therapeutic response and restoration of immune response in human tuberculosis remains unclear. Here, we describe the possible role of Treg cells, their M. tuberculosis driven expansion and contribution of PD-1 pathway to the suppressive function of Treg cells among pulmonary tuberculosis (PTB) patients. Multicolor flow cytometry, cell culture, cells sorting and ELISA were employed to execute the study. Our results showed significant increase in frequency of antigen-reactive Treg cells, which gradually declined during successful therapy and paralleled with decline of M. tuberculosis-specific IL-10 along with elevation of IFN-gamma production, and raising the IFN-gamma/IL-4 ratio. Interestingly, persistence of Treg cells tightly correlated with MDR tuberculosis. Also, we show that blocking PD-1/PD-L1 pathway abrogates Treg-mediated suppression, suggesting that the PD-1/PD-L1 pathway is required for Treg-mediated suppression of the antigen-specific T cells. Treg cells possibly play a role in dampening the effector immune response and abrogating PD-1 pathway on Treg cells significantly rescued protective T cell response, suggesting its importance in immune restoration among tuberculosis patients.	[Singh, Amar; Sharma, Prabhat Kumar; Mitra, Dipendra Kumar] All India Inst Med Sci, Cellular Immunol Div, Dept TII, New Delhi, India; [Dey, Aparajita Ballave; Mohan, Anant] All India Inst Med Sci, Dept Med, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Mitra, DK (corresponding author), All India Inst Med Sci, Cellular Immunol Div, Dept TII, New Delhi, India.	salilmitra1@yahoo.com	Sharma, Prabhat/AAW-6558-2021; Ranjan, Rajeev/AAY-3243-2021	Ranjan, Rajeev/0000-0002-1344-4044; Kapoor, Sanjay/0000-0002-0283-1137; Pandey, Amita/0000-0001-8717-3227; SINGH, ASHUTOSH/0000-0002-0995-6696; Singh, Abhishek/0000-0001-6263-4410; SHARMA, PRABHAT/0000-0002-2638-2321; Kanwar, Poonam/0000-0002-9328-9274; PANDEY, GIRDHAR KUMAR/0000-0001-9180-0924; Pallikadavath, Saseendran/0000-0002-2598-9949; Ogollah, Reuben/0000-0002-5777-4117	Department of Biotechnology; Indian Council of Medical Research, Government of India, New Delhi, India	Department of Biotechnology; Indian Council of Medical Research, Government of India, New Delhi, India(Indian Council of Medical Research (ICMR))	The study was supported by the Department of Biotechnology and the Indian Council of Medical Research, Government of India, New Delhi, India. For this study the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez IB, 2010, J INFECT DIS, V202, P524, DOI 10.1086/654932; Amarnath S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000302; Antas PRZ, 2007, AM J RESP CRIT CARE, V176, P214, DOI 10.1164/ajrccm.176.2.214; Aramaki O, 2004, TRANSPLANTATION, V77, P6, DOI 10.1097/01.TP.0000108637.65091.4B; Barber DL, 2011, J IMMUNOL, V186, P1598, DOI 10.4049/jimmunol.1003304; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Burl S, 2007, CLIN EXP IMMUNOL, V149, P117, DOI 10.1111/j.1365-2249.2007.03399.x; Chen XC, 2007, CLIN IMMUNOL, V123, P50, DOI 10.1016/j.clim.2006.11.009; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Dong HD, 1999, NAT MED, V5, P1365; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Golden-Mason L, 2007, J VIROL, V81, P9249, DOI 10.1128/JVI.00409-07; Gong JH, 1996, INFECT IMMUN, V64, P913, DOI 10.1128/IAI.64.3.913-918.1996; Green AM, 2010, J INFECT DIS, V202, P533, DOI 10.1086/654896; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Handzel ZT, 2007, ISR MED ASSOC J, V9, P479; Hirsch CS, 1996, P NATL ACAD SCI USA, V93, P3193, DOI 10.1073/pnas.93.8.3193; Hougardy JM, 2007, AM J RESP CRIT CARE, V176, P409, DOI 10.1164/rccm.200701-084OC; HUYGEN K, 1988, SCAND J IMMUNOL, V27, P187, DOI 10.1111/j.1365-3083.1988.tb02338.x; Jaron B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002833; Jurado JO, 2008, J IMMUNOL, V181, P116, DOI 10.4049/jimmunol.181.1.116; Katara GK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001171; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Keir ME, 2007, CURR OPIN IMMUNOL, V19, P309, DOI 10.1016/j.coi.2007.04.012; Kitazawa Y, 2007, TRANSPLANTATION, V83, P774, DOI 10.1097/01.tp.0000256293.90270.e8; Kursar M, 2007, J IMMUNOL, V178, P2661, DOI 10.4049/jimmunol.178.5.2661; Lazar-Molnar E, 2010, P NATL ACAD SCI USA, V107, P13402, DOI 10.1073/pnas.1007394107; Maier H, 2007, J IMMUNOL, V178, P2714, DOI 10.4049/jimmunol.178.5.2714; Mitra DK, 2009, MICROBES INFECT, V11, P1122, DOI 10.1016/j.micinf.2009.08.006; Mitra DK, 2005, EUR J IMMUNOL, V35, P2367, DOI 10.1002/eji.200525977; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Periasamy S, 2011, J INFECT DIS, V203, P1256, DOI 10.1093/infdis/jir011; Punkosdy GA, 2011, P NATL ACAD SCI USA, V108, P3677, DOI 10.1073/pnas.1100213108; Raimondi G, 2006, J IMMUNOL, V176, P2808, DOI 10.4049/jimmunol.176.5.2808; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; Sharma S, 2009, AM J RESP CRIT CARE, V179; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Shen T, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-279; TOOSSI Z, 1986, J EXP MED, V163, P1162, DOI 10.1084/jem.163.5.1162; TORRES M, 1994, CLIN EXP IMMUNOL, V96, P75, DOI 10.1111/j.1365-2249.1994.tb06233.x; Totsuka T, 2005, EUR J IMMUNOL, V35, P1773, DOI 10.1002/eji.200425109; Tousif S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019864; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Tseng SY, 2001, J EXP MED, V193, P839, DOI 10.1084/jem.193.7.839; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; ZHANG M, 1994, J CLIN INVEST, V94, P2435, DOI 10.1172/JCI117611	49	174	181	7	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2012	7	9							e44728	10.1371/journal.pone.0044728	http://dx.doi.org/10.1371/journal.pone.0044728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PP	23028594	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388400035
